PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tang, JR; Isa, NAM; Ch'ng, ES				Tang, Jing Rui; Isa, Nor Ashidi Mat; Ch'ng, Ewe Seng			Evaluating Nuclear Membrane Irregularity for the Classification of Cervical Squamous Epithelial Cells	PLOS ONE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; CANCER; SHAPE; EVOLUTIONARY	Pap test involves searching of morphological changes in cervical squamous epithelial cells by pathologists or cytotechnologists to identify potential cancerous cells in the cervix. Nuclear membrane irregularity is one of the morphological changes of malignancy. This paper proposes two novel techniques for the evaluation of nuclear membrane irregularity. The first technique, namely, penalty-driven smoothing analysis, introduces different penalty values for nuclear membrane contour with different degrees of irregularity. The second technique, which can be subdivided into mean-or median-type residual-based analysis, computes the number of points of nuclear membrane contour that deviates from the mean or median of the nuclear membrane contour. Performance of the proposed techniques was compared to three state-of-the-art techniques, namely, radial asymmetric, shape factor, and rim difference. Friedman and post hoc tests using Holm, Shaffer, and Bergmann procedures returned significant differences for all the three classes, i.e., negative for intraepithelial lesion or malignancy (NILM) versus low grade squamous intraepithelial lesion (LSIL), NILM versus high grade squamous intraepithelial lesion (HSIL), and LSIL versus HSIL when the span value equaled 3 was employed with linear penalty function. When span values equaled 5, 7, and 9, NILM versus LSIL and HSIL showed significant differences regardless of the penalty functions. In addition, the results of penalty-driven smoothing analysis were comparable with those of other state-of-the-art techniques. Residual-based analysis returned significant differences for the comparison among the three diagnostic classes. Findings of this study proved the significance of nuclear membrane irregularity as one of the features to differentiate the different diagnostic classes of cervical squamous epithelial cells.	[Tang, Jing Rui; Isa, Nor Ashidi Mat] Univ Sains Malaysia, Sch Elect & Elect Engn, Imaging & Intelligent Syst Res Team, Nibong Tebal, Pulau Pinang, Malaysia; [Ch'ng, Ewe Seng] Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Isa, NAM (corresponding author), Univ Sains Malaysia, Sch Elect & Elect Engn, Imaging & Intelligent Syst Res Team, Nibong Tebal, Pulau Pinang, Malaysia.	ashidi@usm.my	Isa, Nor Ashidi Mat/I-7826-2017; Ch'ng, Ewe Seng/F-2630-2010	Isa, Nor Ashidi Mat/0000-0002-2675-4914; Ch'ng, Ewe Seng/0000-0001-8831-8678	National Cancer Council Malaysia (MAKNA), Malaysia, under project entitled "Development of an Intelligent Screening System for Cervical Cancer"; Ministry of Higher Education (MOHE), Malaysia	National Cancer Council Malaysia (MAKNA), Malaysia, under project entitled "Development of an Intelligent Screening System for Cervical Cancer"; Ministry of Higher Education (MOHE), Malaysia	This study was partially supported by National Cancer Council Malaysia (MAKNA), Malaysia, under project entitled "Development of an Intelligent Screening System for Cervical Cancer" [http://makna.org.my/]. The fund is received by Nor Ashidi Mat lsa. The study was also partially supported by the Ministry of Higher Education (MOHE), Malaysia under MyPhD Scholarship [https://biasisvia mohe.gov.my/MyBrain15/v2/index_myphd.php]. The fund is received by Jing Rui Tang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by National Cancer Council Malaysia (MAKNA), Malaysia, under project entitled "Development of an Intelligent Screening System for Cervical Cancer" and the Ministry of Higher Education (MOHE), Malaysia, under MyPhD Scholarship. Credits are given to Dr. Yasmin Sulaiman, Dr. Soo Peng Yen, Dr. Farisyah Syakirah Mohd Zain, and Dr. Hairulhasliza Harun for providing the ThinPrep slides. Sincere thanks to Mr. Mohd Sobriey Zakaria for his assistance on capturing the sample images.	Al-Mamun MA, 2014, 2014 IEEE-EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS (BHI), P209, DOI 10.1109/BHI.2014.6864341; Alcala-Fdez J, 2009, SOFT COMPUT, V13, P307, DOI 10.1007/s00500-008-0323-y; Alom Talukdar Nur, 2014, INT J ADV RES COMPUT, V4, P467; Chaddad A., 2013, J BIOMEDICAL SCI ENG, V06, P1029, DOI DOI 10.4236/jbise.2013.611128; Chen S., 2012, COMP MATH MATH PHYS, V2012, P10, DOI DOI 10.16028/J.1009-2722.2012.06.008; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Dey P, 1999, ACTA CYTOL, V43, P429, DOI 10.1159/000331093; Dey P, 2010, DIAGN CYTOPATHOL, V38, P382, DOI 10.1002/dc.21234; Garcia S, 2008, J MACH LEARN RES, V9, P2677; Ginzburg S, 2014, J UROLOGY, V191, P296, DOI 10.1016/j.juro.2013.07.059; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Imbalzano KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055628; Jogai S, 2005, ACTA CYTOL, V49, P483, DOI 10.1159/000326192; Li YZ, 2014, IEEE ENG MED BIO, P6818, DOI 10.1109/EMBC.2014.6945194; Nayar R., 2015, BETHESDA SYSTEM REPO, V3rd; Nikonenko AG, 2015, CYTOM PART A, V87A, P309, DOI 10.1002/cyto.a.22612; PANNO JP, 1988, CYTOMETRY, V9, P195, DOI 10.1002/cyto.990090302; Rajesh L, 2003, ACTA CYTOL, V47, P177, DOI 10.1159/000326500; Sero JE, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145644; Sherris J, 2001, WESTERN J MED, V175, P231, DOI 10.1136/ewjm.175.4.231; Solomon D., 2004, BETHESDA SYSTEM REPO; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; TANAKA N, 1987, APPL OPTICS, V26, P3301, DOI 10.1364/AO.26.003301; Tang JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142830; Thiran JP, 1996, IEEE T BIO-MED ENG, V43, P1011, DOI 10.1109/10.536902; THIRAN JP, 1994, IEEE IMAGE PROC, P706, DOI 10.1109/ICIP.1994.413797; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wee A, 2015, DIAGNOSTIC HISTOPATH, V21, P470; Xing FY, 2015, I S BIOMED IMAGING, P1443, DOI 10.1109/ISBI.2015.7164148; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	30	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164389	10.1371/journal.pone.0164389	http://dx.doi.org/10.1371/journal.pone.0164389			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741266	gold, Green Submitted, Green Published			2022-12-27	WOS:000385507000030
J	Cavalli, RC; Cerdeira, AS; Perniconel, E; Korkes, HA; Burke, SD; Rajakumar, A; Thadhani, RI; Roberts, DJ; Bhasinl, M; Karumanchi, SA; Kopcow, HD				Cavalli, Ricardo C.; Cerdeira, Ana Sofia; Perniconel, Elizabeth; Korkes, Henri A.; Burke, Suzanne D.; Rajakumar, Augustine; Thadhani, Ravi I.; Roberts, Drucilla J.; Bhasinl, Manoj; Karumanchi, S. Ananth; Kopcow, Hernan D.			Induced Human Decidual NK-Like Cells Improve Utero-Placental Perfusion in Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; COLONY-STIMULATING FACTOR; UTERINE ARTERY DOPPLER; PLACENTAL BED; TROPHOBLAST INVASION; INTERFERON-GAMMA; BLOOD-PRESSURE; EXPRESSION; PREECLAMPSIA; ASSOCIATION	Decidual NK (dNK) cells, a distinct type of NK cell, are thought to regulate uterine spiral artery remodeling, a process that allows for increased blood delivery to the fetal-placental unit. Impairment of uterine spiral artery remodeling is associated with decreased placental perfusion, increased uterine artery resistance, and obstetric complications such as pre-eclampsia and intrauterine growth restriction. Ex vivo manipulation of human peripheral blood NK (pNK) cells by a combination of hypoxia, TGF beta- 1 and 5-aza-2'-deoxycytidine yields cells with phenotypic and in vitro functional similarities to dNK cells, called idNK cells. Here, gene expression profiling shows that CD56 (Bright) idNK cells derived ex vivo from human pNK cells, and to a lesser extent CD56 (Dim) idNK cells, are enriched in the gene expression signature that distinguishes dNK cells from pNK cells. When injected into immu-nocompromised pregnant mice with elevated uterine artery resistance, idNK cells homed to the uterus and reduced the uterine artery resistance index, suggesting improved placental perfusion.	[Cavalli, Ricardo C.; Cerdeira, Ana Sofia; Perniconel, Elizabeth; Korkes, Henri A.; Burke, Suzanne D.; Rajakumar, Augustine; Bhasinl, Manoj; Karumanchi, S. Ananth; Kopcow, Hernan D.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Cerdeira, Ana Sofia] Gulbenkian Programme Adv Med Educ, Lisbon, Portugal; [Burke, Suzanne D.; Rajakumar, Augustine; Karumanchi, S. Ananth] Howard Hughes Med Inst, Chevy Chase, MD USA; [Thadhani, Ravi I.] Harvard Med Sch, Massachusetts Gen Hosp, Div Nephrol, Boston, MA USA; [Roberts, Drucilla J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA; [Cavalli, Ricardo C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Obstet & Gynaecol, BR-05508 Sao Paulo, Brazil; [Cerdeira, Ana Sofia] Univ Oxford, Nuffield Dept Obstet Gynaecol, Oxford, England; [Korkes, Henri A.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil; [Rajakumar, Augustine] Emory Univ, Sch Med, Dept Obstet & Gynaecol, Atlanta, GA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universidade de Sao Paulo; University of Oxford; Universidade Federal de Sao Paulo (UNIFESP); Emory University	Kopcow, HD (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.	kopcowh@gmail.com	Karumanchi, Subbian Ananth/AAI-1694-2021; Korkes, Henri/AAN-2954-2020; Korkes, Henri/AAG-3124-2020; Cavalli, Ricardo C/G-2405-2012; Roberts, Drucilla/AAB-6379-2022	Cavalli, Ricardo/0000-0001-5010-4914; Cerdeira, A. Sofia/0000-0002-7643-3537; Korkes, Henri/0000-0001-5345-3861; Bhasin, Manoj/0000-0001-5172-420X	American Heart Association [13GRNT17070111]; Preeclampsia Foundation; Howard Hughes Medical Institute; FAPESP Sao Paulo Research Foundation; CAPES Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK094872] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Preeclampsia Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); FAPESP Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by the American Heart Association (http://www.heart.org) Grant in Aid 13GRNT17070111 to HDK, Preeclampsia Foundation (http://www.preeclampsia.org) Vision Grant to ASC, Howard Hughes Medical Institute (http://www.hhmi.org) to SAK, FAPESP Sao Paulo Research Foundation (http://www.fapesp.br/en/) to RCC, CAPES Foundation (http://www.capes.gov.br) to HAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaiges G, 2000, OBSTET GYNECOL, V96, P559, DOI 10.1016/S0029-7844(00)00946-7; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BROSENS I, 1967, J PATHOL BACTERIOL, V93, P569, DOI 10.1002/path.1700930218; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Burke SD, 2010, HYPERTENSION, V55, P729, DOI 10.1161/HYPERTENSIONAHA.109.144253; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; CAMPBELL S, 1983, LANCET, V1, P675; Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; Colucci F, 1999, J IMMUNOL, V162, P2761; Croy BA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102830; Croy BA, 2011, PREGNANCY HYPERTENS, V1, P87, DOI 10.1016/j.preghy.2010.10.002; Delgado SR, 1996, J LEUKOCYTE BIOL, V59, P262, DOI 10.1002/jlb.59.2.262; Derwig I, 2013, PLACENTA, V34, P885, DOI 10.1016/j.placenta.2013.07.006; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Everett TR, 2012, PLACENTA, V33, P893, DOI 10.1016/j.placenta.2012.07.011; Fraser R, 2012, J PATHOL, V228, P322, DOI 10.1002/path.4057; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Greenwood JD, 2000, PLACENTA, V21, P693, DOI 10.1053/plac.2000.0556; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khalil A, 2014, ULTRASOUND OBST GYN, V43, P541, DOI 10.1002/uog.13257; Koehl U, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00118; Koo HS, 2015, AM J REPROD IMMUNOL, V73, P175, DOI 10.1111/aji.12316; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kopcow HD, 2005, P NATL ACAD SCI USA, V102, P15563, DOI 10.1073/pnas.0507835102; Lash GE, 2010, PLACENTA, V31, pS87, DOI 10.1016/j.placenta.2009.12.022; Lash GE, 2010, HUM REPROD, V25, P1137, DOI 10.1093/humrep/deq050; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; OLOFSSON P, 1993, EUR J OBSTET GYN R B, V49, P161, DOI 10.1016/0028-2243(93)90265-E; PALMER SK, 1992, OBSTET GYNECOL, V80, P1000; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; PEEL S, 1989, ADV ANAT EMBRYOL CEL, V115, P1; Robson A, 2012, FASEB J, V26, P4876, DOI 10.1096/fj.12-210310; SAITO S, 1993, INT IMMUNOL, V5, P559, DOI 10.1093/intimm/5.5.559; Santjohanser C, 2013, ARCH IMMUNOL THER EX, V61, P159, DOI 10.1007/s00005-012-0212-z; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vacca P, 2008, INT IMMUNOL, V20, P1395, DOI 10.1093/intimm/dxn105; Velauthar L, 2013, ULTRASOUND OBSTET GY; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wang Chengxiong, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P736; Whitley GSJ, 2010, PLACENTA, V31, P465, DOI 10.1016/j.placenta.2010.03.002; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wurfel W, 2015, J REPROD IMMUNOL, V108, P123, DOI 10.1016/j.jri.2015.01.010; Wurfel W, 2010, HUM REPROD, V25, P2151, DOI 10.1093/humrep/deq106; Zhang J, 2008, BIOL REPROD, V79, P450, DOI 10.1095/biolreprod.108.067975; Zhang JH, 2005, CELL MOL IMMUNOL, V2, P123; Zhang JH, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.008	59	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164353	10.1371/journal.pone.0164353	http://dx.doi.org/10.1371/journal.pone.0164353			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736914	Green Published, gold			2022-12-27	WOS:000385505800056
J	Cho, M; Jung, SW; Lee, S; Son, K; Park, GH; Jung, JW; Shin, YS; Seo, T; Cho, H; Kang, H				Cho, Miyeon; Jung, Seok Won; Lee, Soomin; Son, Kuwon; Park, Gyu Hwan; Jung, Jong-Wha; Shin, Yu Su; Seo, Taegun; Cho, Hyosun; Kang, Hyojeung			Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance	PLOS ONE			English	Article							AIDS-RELATED MALIGNANCIES; SIGNALING PATHWAY; INDUCED APOPTOSIS; CANCER CELLS; TRANSCRIPTION; ACTIVATION; INDUCTION; LATENCY; ELLIS; CYCLE	Kaposi's sarcoma-associated herpesvirus (KSHV) is a Gammaherpesvirus that causes acute infection and establishes life-long latency. KSHV causes several human cancers, including Kaposi's sarcoma, an acquired immune deficiency syndrome (AIDS)-related form of non-Hodgkin lymphoma. Genipin, an aglycone derived from geniposide found in Gardenia jasminoides, is known to be an excellent natural cross-linker, strong apoptosis inducer, and antiviral agent. Although evidence suggests antiviral activity of genipin in several in vitro viral infection systems, no inhibitory effect of genipin on KSHV infection has been reported. Thus, our aim was to determine, using the iSLK-BAC16 KSHV infection system, whether genipin has inhibitory effects on KSHV infection. For this purpose, we evaluated biological effects of genipin on KSHV infection and finally determined the underlying mechanisms responsible for the bioactive effects of genipin. A cytotoxicity assay revealed that genipin caused 50% cytotoxicity at 49.5 mu M in iSLK-puro (KSHV-negative) cells and at 72.5 mu M in iSLK-BAC16 (KSHV-positive) cells. Caspase 3/7 activities were slightly suppressed by genipin treatment in iSLK-BAC16 cells while significantly induced in iSLK-puro cells. Production of the KSHV latency-associated nuclear antigen (LANA), but not that of the R-transactivator (RTA) protein, was significantly induced by genipin treatment at lower concentration. Consistent with the LANA upregulation, KSHV LANA transcripts, but not RTA transcripts, were expressed at a higher level. Furthermore, KSHV intracellular copy numbers were slightly increased at lower concentration of genipin, while KSHV extracellular copy numbers were significantly increased at higher concentration of genipin. Interestingly, genipin treatment at a lower concentration did induce the expression of DNA (cytosine-5)-methyltransferase 1 (DNMT1); however, a co-immunoprecipitation assay showed that the DNMT1 and LANA induced by genipin did not co-precipitate from iSLK-BAC16 cells. Moreover, a chromatin immunoprecipitation assay demonstrated that genipin treatment enhanced the binding of CCCTC-binding factor (CTCF) to the CTCF-binding site in the KSHV latency control region but suppressed the binding of structural maintenance of chromosomes protein 3 (SMC3) to this site. Genipin treatment also led to the recruitment of additional RNA polymerase to the majority of binding sites of some interesting proteins in the KSHV latency control region, which might be related to the extension of S phase in iSLK-BAC16 cells by genipin treatment. Finally, genipin treatment at lower concentration could promote the KSHV latent replication. In contrast, the treatment at higher concentration could induce the KSHV lytic replication. In conclusion, genipin was shown to be an interesting reagent, which we used to manipulate KSHV life cycle in KSHV latently infected cells.	[Cho, Miyeon; Jung, Seok Won; Lee, Soomin; Son, Kuwon; Park, Gyu Hwan; Jung, Jong-Wha; Kang, Hyojeung] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Cho, Miyeon; Jung, Seok Won; Lee, Soomin; Son, Kuwon; Park, Gyu Hwan; Jung, Jong-Wha; Kang, Hyojeung] Kyungpook Natl Univ, Canc Res Inst, Daegu, South Korea; [Cho, Miyeon; Jung, Seok Won; Lee, Soomin; Son, Kuwon; Park, Gyu Hwan; Jung, Jong-Wha; Kang, Hyojeung] Kyungpook Natl Univ, Inst Microorganism, Daegu, South Korea; [Shin, Yu Su] Natl Inst Hort & Herbal Sci, Dept Med Crop Res, Rural Dev Adm, Eumseong, South Korea; [Seo, Taegun] Dongguk Univ, Dept Life Sci, Goyang, South Korea; [Cho, Hyosun] Duksung Womens Univ, Coll Pharm, Seoul, South Korea; [Cho, Hyosun] Duksung Womens Univ, Innovat Drug Ctr, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Dongguk University; Duksung Women's University; Duksung Women's University	Kang, H (corresponding author), Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea.; Kang, H (corresponding author), Kyungpook Natl Univ, Canc Res Inst, Daegu, South Korea.; Kang, H (corresponding author), Kyungpook Natl Univ, Inst Microorganism, Daegu, South Korea.; Cho, H (corresponding author), Duksung Womens Univ, Coll Pharm, Seoul, South Korea.; Cho, H (corresponding author), Duksung Womens Univ, Innovat Drug Ctr, Seoul, South Korea.	hyosun1102@duksung.ac.kr; hkang72@knus.ac.kr			Next Generation BioGreen 21 Program from the Rural Development Administration, Republic of Korea [PJ011869022016]; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [201602260001]	Next Generation BioGreen 21 Program from the Rural Development Administration, Republic of Korea; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	We gratefully acknowledge financial support of both the Next Generation BioGreen 21 Program (Project No. PJ011869022016) from the Rural Development Administration, Republic of Korea and Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Project No. 201602260001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge financial supports of both the Next Generation BioGreen 21 Program (Project No. PJ011869022016) from the Rural Development Administration, Republic of Korea and Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Project No. 201602260001)	Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Chen HS, 2012, J VIROL, V86, P9454, DOI 10.1128/JVI.00787-12; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Hu B, 2014, J AGR FOOD CHEM, V62, P12443, DOI 10.1021/jf5046766; Hu JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004240; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Kang H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002140; Kang H, 2009, J VIROL, V83, P6199, DOI 10.1128/JVI.00052-09; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Kim ES, 2012, ONCOL REP, V27, P567, DOI 10.3892/or.2011.1508; Kim JM, 2016, J BIOCHEM MOL TOXIC, V30, P45, DOI 10.1002/jbt.21741; Ko Eun-Yi, 2015, J Cancer Prev, V20, P223, DOI 10.15430/JCP.2015.20.4.223; Ko H, 2015, BIOORG MED CHEM LETT, V25, P4191, DOI 10.1016/j.bmcl.2015.08.005; Lee JC, 2011, J CELL BIOCHEM, V112, P1552, DOI 10.1002/jcb.23077; Li DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003880; Lin CH, 2011, J BIOMOL STRUCT DYN, V28, P471, DOI 10.1080/07391102.2011.10508589; Liu H, 2013, J ASIAN NAT PROD RES, V15, P94, DOI 10.1080/10286020.2012.723203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Prasad A, 2012, J VIROL, V86, P4404, DOI 10.1128/JVI.06617-11; Shalini S, 2015, ONCOGENE, V34, P4995, DOI 10.1038/onc.2014.413; Son M, 2015, J MICROBIOL, V53, P155, DOI 10.1007/s12275-015-4672-9; Son M, 2013, J MICROBIOL, V51, P545, DOI 10.1007/s12275-013-3450-9; Tamura S, 2010, BIOORGAN MED CHEM, V18, P5975, DOI 10.1016/j.bmc.2010.06.079; Wu J, 2014, MOL NEUROBIOL, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0093478; Yarchoan R, 2005, NAT CLIN PRACT ONCOL, V2, P406, DOI 10.1038/ncponc0253	31	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163693	10.1371/journal.pone.0163693	http://dx.doi.org/10.1371/journal.pone.0163693			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736870	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505800020
J	De Meester, A; Stodden, D; Brian, A; True, L; Cardon, G; Tallir, I; Haerens, L				De Meester, An; Stodden, David; Brian, Ali; True, Larissa; Cardon, Greet; Tallir, Isabel; Haerens, Leen			Associations among Elementary School Children's Actual Motor Competence, Perceived Motor Competence, Physical Activity and BMI: A Cross-Sectional Study	PLOS ONE			English	Article							FUNDAMENTAL MOVEMENT SKILLS; SELF-PERCEPTION; FITNESS; ADOLESCENTS; OVERWEIGHT; CHILDHOOD; ESTEEM; HEALTH; INTERVENTIONS; PROFICIENCY	Background Positive associations between motor competence and physical activity have been identified by means of variable-centered analyses. To expand the understanding of these associations, this study used a person-centered approach to investigate whether different combinations (i.e., profiles) of actual and perceived motor competence exist (aim 1); and to examine differences in physical activity levels (aim 2) and weight status (aim 3) among children with different motor competence-based profiles. Materials and Methods Children's (N = 361; 180 boys = 50%; M-age = 9.50 +/- 1.24yrs) actual motor competence was measured with the Test of Gross Motor Development-2 and their perceived motor competence via the Self Perception Profile for Children. We assessed physical activity via accelerometers; height through stadiometers, and weight through scales. Cluster analyses (aim 1) and MANCOVAs (aim 2 & 3) were used to analyze the data. Results The analysis generated two predictable groups: one group displaying relatively high levels of both actual (MTGMD-2 percentile = 42.54, SD = 2.33) and perceived motor competence (M = 3.42, SD = .37; high-high), and one group with relatively low levels of both (M percentile = 9.71, SD = 3.21; M PMC = 2.52, SD = .35; low-low). One additional group was also identified as having relatively low levels of actual motor competence (M percentile = 4.22, SD = 2.85) but relatively high levels of perceived motor competence (M = 3.52, SD = .30; low-high). The high-high group demonstrated higher daily physical activity (M = 48.39 +/- 2.03) and lower BMI (M = 18.13 +/-.43) than the low-low group (M-MVPA = 37.93 +/- 2.01; M-BMI = 20.22 +/-.42). The low-high group had similar physical activity-levels as the low-low group (M = 36.21 +/- 2.18) and did not significantly differ in BMI (M = 19.49 +/-.46) from the other two groups. Conclusions A combination of high actual and perceived motor competence is related to higher physical activity and lower weight status. It is thus recommended to expand health interventions in children with components that foster the development of both actual and perceived motor competence. Health professionals should furthermore pay sufficient attention to endorsing children's actual and perceived motor competence.	[De Meester, An; Cardon, Greet; Tallir, Isabel; Haerens, Leen] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium; [Stodden, David; Brian, Ali] Univ South Carolina, Dept Phys Educ & Athlet Training, Columbia, SC 29208 USA; [True, Larissa] SUNY Coll Cortland, Dept Kinesiol, Cortland, NY 13045 USA	Ghent University; University of South Carolina System; University of South Carolina Columbia; State University of New York (SUNY) System; SUNY Cortland	Haerens, L (corresponding author), Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium.	a.demeester@ugent.be; stodden@mailbox.sc.edu; leen.haerens@ugent.be	De Meester, An/H-5410-2019; Stodden, David/I-4015-2017	De Meester, An/0000-0003-2270-719X; Cardon, Greet/0000-0003-4983-6557; Haerens, Leen/0000-0001-5715-9520; Stodden, David/0000-0003-1988-1701	National Institutes of Health [1R15HD071514-01A1, R21 HD055621-01A2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institutes of Health [1R15HD071514-01A1 & R21 HD055621-01A2] (Nida Roncesvalles and Jackie Goodway).	Asendorpf JB, 2001, EUR J PERSONALITY, V15, P169, DOI 10.1002/per.408; Barnett LM, 2015, J SCI MED SPORT, V18, P167, DOI 10.1016/j.jsams.2014.03.001; Barnett LM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-40; Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; Boreham C, 2001, J SPORT SCI, V19, P915, DOI 10.1080/026404101317108426; Breckenridge JN, 2000, MULTIVAR BEHAV RES, V35, P261, DOI 10.1207/S15327906MBR3502_5; Burton A.W., 1998, MOVEMENT SKILL ASSES; Cattuzzo MT, 2016, J SCI MED SPORT, V19, P123, DOI 10.1016/j.jsams.2014.12.004; Clark J.E., 2002, MOTOR DEV RES REV, P163, DOI DOI 10.4081/IJAS.2015.3862; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; D'Hondt E, 2013, INT J OBESITY, V37, P61, DOI 10.1038/ijo.2012.55; De Bourdeaudhuij I, 2002, RES Q EXERCISE SPORT, V73, P376; De Meester A, 2016, J SPORT SCI, V34, P2027, DOI 10.1080/02640414.2016.1149608; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Everitt B. S., 2001, CLUSTER ANAL; Fliers EA, 2010, J DEV BEHAV PEDIATR, V31, P35, DOI 10.1097/DBP.0b013e3181c7227e; Franklin J, 2006, PEDIATRICS, V118, P2481, DOI 10.1542/peds.2006-0511; Frost J, 2004, SEX ROLES, V51, P45, DOI 10.1023/B:SERS.0000032308.90104.c6; Gabbard, 2015, LIFELONG MOTOR DEV; Goodway JD, 2010, RES Q EXERCISE SPORT, V81, P17; Goodway JD, 1997, ADAPT PHYS ACT Q, V14, P314, DOI 10.1123/apaq.14.4.314; Gore P., 2000, HDB APPL MULTIVARIAT, V366, P297; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; HARTER S, 1984, CHILD DEV, V55, P1969, DOI 10.2307/1129772; Harter S., 2012, SELF PERCEPTION PROF; Harter S., 1999, CONSTRUCTION SELF; Haywood K. M., 2014, LIFESPAN MOTOR DEV; Inchley J, 2011, PEDIATR EXERC SCI, V23, P237, DOI 10.1123/pes.23.2.237; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kalaja S, 2010, PERCEPT MOTOR SKILL, V111, P115, DOI 10.2466/06.10.25.PMS.111.4.115-128; Kellou N, 2014, DIABETES METAB, V40, P258, DOI 10.1016/j.diabet.2014.01.002; Khodzhaeva ZS, 2015, J SPORTS SCI, V2015, P1, DOI DOI 10.1080/026404142015.1122202; Lai SK, 2014, SPORTS MED, V44, P67, DOI 10.1007/s40279-013-0099-9; Lindell MK, 2001, J APPL PSYCHOL, V86, P114, DOI 10.1037//0021-9010.86.1.114; Logan SW, 2012, CHILD CARE HLTH DEV, V38, P305, DOI 10.1111/j.1365-2214.2011.01307.x; Lopes VP, 2012, J SCI MED SPORT, V15, P38, DOI 10.1016/j.jsams.2011.07.005; Lubans DR, 2011, PHYS EDUC SPORT PEDA, V16, P237, DOI 10.1080/17408989.2010.532784; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Macura D, 2005, 4th International Scientific Conference on Kinesiology, Proceedings Book, P736; Magnusson D, 1988, INDIVIDUAL DEV INTER; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; McPhillips M, 2007, J CHILD PSYCHOL PSYC, V48, P1214, DOI 10.1111/j.1469-7610.2007.01814.x; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Muris P, 2003, PERS INDIV DIFFER, V35, P1791, DOI 10.1016/S0191-8869(03)00004-7; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Okely AD, 2004, RES Q EXERCISE SPORT, V75, P238, DOI 10.1080/02701367.2004.10609157; Okely AD, 2001, MED SCI SPORT EXER, V33, P1899, DOI 10.1097/00005768-200111000-00015; Pate RR, 2004, PEDIATRICS, V114, P1258, DOI 10.1542/peds.2003-1088-L; Potard C, 2016, ENCEPHALE, V42, P138, DOI 10.1016/j.encep.2015.12.015; Raudsepp L, 2002, PERCEPT MOTOR SKILL, V94, P1059, DOI 10.2466/PMS.94.2.1059-1070; Robinson LE, 2015, SPORTS MED, V45, P1273, DOI 10.1007/s40279-015-0351-6; Rodrigues LP, 2016, J SCI MED SPORT, V19, P87, DOI 10.1016/j.jsams.2015.01.002; Salmon J, 2008, INT J OBESITY, V32, P601, DOI 10.1038/sj.ijo.0803805; Southall JE, 2004, PEDIATR EXERC SCI, V16, P15, DOI 10.1123/pes.16.1.15; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Sung RYT, 2005, EUR J CLIN NUTR, V59, P101, DOI 10.1038/sj.ejcn.1602044; Taymoori P, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-18; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Ulrich D. A., 2019, TEST GROSS MOTOR DEV; Vedul-Kjelsas V, 2012, CHILD CARE HLTH DEV, V38, P394, DOI 10.1111/j.1365-2214.2011.01275.x; Weiss MR, 2005, J SPORT EXERCISE PSY, V27, P226, DOI 10.1123/jsep.27.2.226; Welk GJ, 1999, QUEST, V51, P5, DOI 10.1080/00336297.1999.10484297; Williams HG, 2008, OBESITY, V16, P1421, DOI 10.1038/oby.2008.214; World Health Organization, 2014, HLTH BEH SCH AG CHIL	65	59	59	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164600	10.1371/journal.pone.0164600	http://dx.doi.org/10.1371/journal.pone.0164600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736964	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800096
J	Ford, MJ; Murdoch, AR; Hughes, MS; Seamons, TR; LaHood, ES				Ford, Michael J.; Murdoch, Andrew R.; Hughes, Michael S.; Seamons, Todd R.; LaHood, Eric S.			Broodstock History Strongly Influences Natural Spawning Success in Hatchery Steelhead (Oncorhynchus mykiss)	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; SUPPLEMENTATION PROGRAM; RELATIVE FITNESS; WILD POPULATIONS; PACIFIC SALMON; CHINOOK SALMON; RIVER; WASHINGTON; SELECTION; TROUT	We used genetic parentage analysis of 6200 potential parents and 5497 juvenile offspring to evaluate the relative reproductive success of hatchery and natural steelhead (Onchor-hynchus mykiss) when spawning in the wild between 2008 and 2011 in the Wenatchee River, Washington. Hatchery fish originating from two prior generation hatchery parents had <20% of the reproductive success of natural origin spawners. In contrast, hatchery females originating from a cross between two natural origin parents of the prior generation had equivalent or better reproductive success than natural origin females. Males originating from such a cross had reproductive success of 26-93% that of natural males. The reproductive success of hatchery females and males from crosses consisting of one natural origin fish and one hatchery origin fish was 24-54% that of natural fish. The strong influence of hatchery broodstock origin on reproductive success confirms similar results from a previous study of a different population of the same species and suggests a genetic basis for the low reproductive success of hatchery steelhead, although environmental factors cannot be entirely ruled out. In addition to broodstock origin, fish size, return time, age, and spawning location were significant predictors of reproductive success. Our results indicate that incorporating natural fish into hatchery broodstock is clearly beneficial for improving subsequent natural spawning success, even in a population that has a decades-long history of hatchery releases, as is the case in the Wenatchee River.	[Ford, Michael J.; LaHood, Eric S.] NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Murdoch, Andrew R.; Hughes, Michael S.] Washington Dept Fish & Wildlife, Supplementat Res Team, Wenatchee, WA USA; [Seamons, Todd R.] Washington Dept Fish & Wildlife, Mol Genet Lab, Olympia, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; Washington Department of Fish & Wildlife (WDFW); Washington Department of Fish & Wildlife (WDFW)	Ford, MJ (corresponding author), NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	mike.ford@noaa.gov		Ford, Michael/0000-0002-3517-1534	Chelan County; Northwest Fisheries Science Center	Chelan County; Northwest Fisheries Science Center	This work was partially funded through a contract with Public Utility District No. 1 of Chelan County (https://www.chelanpud.org) to the Washington Department of Fish and Wildlife and the Northwest Fisheries Science Center. The initial study design was discussed with and approved by the funder. The funder provided comments on a contract report associated with this project, but had no role in the decision to publish or the preparation of the manuscript.	Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2007, CONSERV BIOL, V21, P181, DOI 10.1111/j.1523-1739.2006.00564.x; Araki H, 2009, BIOL LETTERS, V5, P621, DOI 10.1098/rsbl.2009.0315; Baskett ML, 2013, CONSERV BIOL, V27, P83, DOI 10.1111/j.1523-1739.2012.01949.x; Berntson EA, 2011, T AM FISH SOC, V140, P685, DOI 10.1080/00028487.2011.584489; Bugert RM, 1998, FISHERIES, V23, P11, DOI 10.1577/1548-8446(1998)023<0014:MOSITC>2.0.CO;2; Busby PJ, 1996, NMFSNWFSC27 NOAA; Chapman D., 1994, STATUS SUMMER STEELH; Chilcote MW, 2003, CAN J FISH AQUAT SCI, V60, P1057, DOI 10.1139/F03-092; Christie M, 2011, P NATL ACAD SCI USA, DOI [10.1073/pnas.1111073109pnas.1111073109, DOI 10.1073/PNAS.1111073109PNAS.1111073109]; Christie MR, 2012, HEREDITY, V109, P254, DOI 10.1038/hdy.2012.39; Christie MR, 2014, EVOL APPL, V7, P883, DOI 10.1111/eva.12183; CUENCO ML, 1993, NATO ADV SCI INST SE, V248, P269; FLEMING IA, 1994, EVOLUTION, V48, P637, DOI 10.1111/j.1558-5646.1994.tb01350.x; Ford M, 2011, NOAA TECHNICAL MEMOR, V113, P1; Ford M.J., 2001, UPPER COLUMBIA RIVER; Ford M, 2012, CONSERV LETT, V5, P450, DOI 10.1111/j.1755-263X.2012.00261.x; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Good TP, 2005, NMFSNWFSC66 NOAA US; Hatchery Scientific Review Group (HSRG), 2004, HATCH REF PRINC REC; Hess MA, 2012, MOL ECOL, V21, P5236, DOI 10.1111/mec.12046; Hillman T, 2015, 2014 ANN REPORT PREP, P2015; *ISAB, 2002, FISHERIES, V27, P16; ISAB, 2005, MON EV SUPPL PROJ; Kalinowski ST, 2005, CAN J FISH AQUAT SCI, V62, P693, DOI 10.1139/F04-239; Kostow KE, 2003, T AM FISH SOC, V132, P780, DOI 10.1577/T02-051; LEIDER SA, 1990, AQUACULTURE, V88, P239, DOI 10.1016/0044-8486(90)90151-C; MEAGHER TR, 1986, THEOR POPUL BIOL, V29, P87, DOI 10.1016/0040-5809(86)90006-7; Miller LM, 2002, POPULATION GENETICS, P329; Mobrand LE, 2005, FISHERIES, V30, P11, DOI 10.1577/1548-8446(2005)30[11:HRIWS]2.0.CO;2; Murdoch AR, 2012, 201003400 BONN POW A; Naish KA, 2008, ADV MAR BIOL, V53, P61, DOI 10.1016/S0065-2881(07)53002-6; R Core Team, 2012, R LANG ENV STAT COMP; Riester M, 2009, BIOINFORMATICS, V25, P2134, DOI 10.1093/bioinformatics/btp064; Scheuerell MD, 2015, ECOL EVOL, V5, P2115, DOI 10.1002/ece3.1509; Seamons TR, 2007, EVOL ECOL RES, V9, P409; Seamons TR, 2012, EXAMINING GENETIC ST, P2012; Sharma R, 2006, CAN J FISH AQUAT SCI, V63, P423, DOI 10.1139/F05-228; Theriault V, 2011, MOL ECOL, V20, P1860, DOI 10.1111/j.1365-294X.2011.05058.x; Waples RS, 2004, ECOLOGICAL GENETIC I; Williams T.H., 2011, STATUS REV UPDATE PA; Williamson KS, 2010, CAN J FISH AQUAT SCI, V67, P1840, DOI 10.1139/F10-099	43	37	38	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164801	10.1371/journal.pone.0164801	http://dx.doi.org/10.1371/journal.pone.0164801			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737000	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800132
J	Landgraf, D; Huh, D; Hallacli, E; Lindquist, S				Landgraf, Dirk; Huh, Dann; Hallacli, Erinc; Lindquist, Susan			Scarless Gene Tagging with One-Step Transformation and Two-Step Selection in Saccharomyces cerevisiae and Schizosaccharomyces pombe	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; GLOBAL ANALYSIS; HETEROLOGOUS MODULES; INTEGRATION METHOD; FLANKING HOMOLOGY; MARKER CASSETTES; DUPLEX STABILITY; 3'-END FORMATION; MESSENGER-RNA; BUDDING YEAST	Gene tagging with fluorescent proteins is commonly applied to investigate the localization and dynamics of proteins in their cellular environment. Ideally, a fluorescent tag is genetically inserted at the endogenous locus at the N- or C-terminus of the gene of interest without disrupting regulatory sequences including the 5' and 3' untranslated region (UTR) and without introducing any extraneous unwanted "scar" sequences, which may create unpredictable transcriptional or translational effects. We present a reliable, low-cost, and highly efficient method for the construction of such scarless C-terminal and N-terminal fusions with fluorescent proteins in yeast. The method relies on sequential positive and negative selection and uses an integration cassette with long flanking regions, which is assembled by two-step PCR, to increase the homologous recombination frequency. The method also enables scarless tagging of essential genes with no need for a complementing plasmid. To further ease high-throughput strain construction, we have computationally automated design of the primers, applied the primer design code to all open reading frames (ORFs) of the budding yeast Saccharomyces cerevisiae (S. cerevisiae) and the fission yeast Schizosaccharomyces pombe (S. pombe), and provide here the computed sequences. To illustrate the scarless N- and C-terminal gene tagging methods in S. cerevisiae, we tagged various genes including the E3 ubiquitin ligase RSP5, the proteasome subunit PRE1, and the eleven Rab GTPases with yeast codon-optimized mNeonGreen or mCherry; several of these represent essential genes. We also implemented the scarless C-terminal gene tagging method in the distantly related organism S. pombe using kanMX6 and HSV1tk as positive and negative selection markers, respectively, as well as ura4. The scarless gene tagging methods presented here are widely applicable to visualize and investigate the functional roles of proteins in living cells.	[Landgraf, Dirk; Hallacli, Erinc; Lindquist, Susan] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Huh, Dann] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Lindquist, S (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.	lindquist_admin@wi.mit.edu			National Institute of Health (NIH) R21 [NS087557]; American Parkinson Disease Foundation; European Molecular Biology Organization (EMBO) Fellowship [ALTF 2832014]; Human Frontier Science Program (HFSP) Fellowship [LT000717/2015-L]; Investigator of the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087557] Funding Source: NIH RePORTER	National Institute of Health (NIH) R21; American Parkinson Disease Foundation; European Molecular Biology Organization (EMBO) Fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP) Fellowship(Human Frontier Science Program); Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	(1) National Institute of Health (NIH) R21 grant (NS087557) (SL), URLs: http://grants.nih. gov/grants/guide/pa-files/PA-12-284.html and http//grantome.comig rant/NIH/R21-NS08755701); (2) A training fellowship from the American Parkinson Disease Foundation (DL), URL: https//www.apdaparkinson.org/user/files/FYE14%20Post%20Doc%20%20Awards%20-%20Dr% 20%20Landgraf.pdf; (3) An European Molecular Biology Organization (EMBO) Fellowship ALTF 2832014 (EH); (4) A Human Frontier Science Program (HFSP) Fellowship LT000717/2015-L (EH); and (5) Investigator of the Howard Hughes Medical Institute (SL).; We thank Rishi Jajoo, David Pincus, and William Hesse for plasmids, Dan Tardiff for the anti-Rsp5 antibody, the tak Linux cluster of the Whitehead Institute for Biomedical Research, FredWinston's lab for strains, Sejin Ahn and Evelyn Amoah-Buahin for help with S. pombe techniques, and Yusuf Tamer and Erdal Toprak for the growth curve analysis code. We also thank Linda Clayton, Catherine McLellan, Rishi Jajoo, Oona Johnstone, and Georgios Karras for comments on the manuscript. This study was supported by an NIH R21 grant (NS087557) (SL), a training fellowship from the American Parkinson Disease Foundation (DL), EMBO Fellowship ALTF 283-2014 (EH), and HFSP Fellowship LT000717/2015-L (EH). SL is an Investigator of the Howard Hughes Medical Institute.	Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Booher Keith R., 2008, Biotechnology Journal, V3, P524, DOI 10.1002/biot.200800012; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; BUVELOT FS, 2006, MOL CELL BIOL, V26, P7299, DOI [DOI 10.1128/MCB.02405-05, 10.1128/MCB.02405-05]; Calero M, 2003, MOL BIOL CELL, V14, P1852, DOI 10.1091/mbc.E02-11-0707; Corral-Debrinski M, 2000, MOL CELL BIOL, V20, P7881, DOI 10.1128/MCB.20.21.7881-7892.2000; Dong J, 2013, ANAL BIOCHEM, V439, P30, DOI 10.1016/j.ab.2013.04.005; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; GOLDEN SS, 1985, SCIENCE, V229, P1104, DOI 10.1126/science.3929379; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Haim L, 2007, NAT METHODS, V4, P409, DOI 10.1038/NMETH1040; Hayashi A, 2009, GENES CELLS, V14, P217, DOI 10.1111/j.1365-2443.2008.01264.x; Hodson JA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng134; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ke N, 2016, J BACTERIOL, V198, P1035, DOI 10.1128/JB.00864-15; Khmelinskii A, 2014, NATURE, V516, P410, DOI 10.1038/nature14096; Khmelinskii A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023794; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Lam MHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004259; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064477; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Mackiewicz P, 2002, YEAST, V19, P619, DOI 10.1002/yea.865; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McElver J., 1992, YEAST, V8, pS627; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shalem O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005147; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Swaminathan A, 2016, NUCLEIC ACIDS RES, V44, P377, DOI 10.1093/nar/gkv1022; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Yofe I, 2014, YEAST, V31, P77, DOI 10.1002/yea.2998; Zordan RE, 2015, GENETICS, V200, P47, DOI 10.1534/genetics.114.169482	49	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163950	10.1371/journal.pone.0163950	http://dx.doi.org/10.1371/journal.pone.0163950			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736907	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800030
J	Mohammadi, N; Wang, Q; Taylor, JE				Mohammadi, Neda; Wang, Qi; Taylor, John E.			Diffusion Dynamics of Energy Saving Practices in Large Heterogeneous Online Networks	PLOS ONE			English	Article							WORD-OF-MOUTH; SOCIAL-INFLUENCE; COMPLEX NETWORK; 2-STEP FLOW; PERCEPTIONS; COMMUNICATION; INFORMATION; PSYCHOLOGY; CAMPAIGNS; BEHAVIOR	Online social networks are today's fastest growing communications channel and a popular source of information for many, so understanding their contribution to building awareness and shaping public perceptions of climate change is of utmost importance. Today's online social networks are composed of complex combinations of entities and communication channels and it is not clear which communicators are the most influential, what the patterns of communication flow are, or even whether the widely accepted two-step flow of communication model applies in this new arena. This study examines the diffusion of energy saving practices in a large online social network across organizations, opinion leaders, and the public by tracking 108,771 communications on energy saving practices among 1,084 communicators, then analyzing the flow of information and influence over a 28 day period. Our findings suggest that diffusion networks of messages advocating energy saving practices are predominantly led by the activities of dedicated organizations but their attempts do not result in substantial public awareness, as most of these communications are effectively trapped in organizational loops in which messages are simply shared between organizations. Despite their comparably significant influential values, opinion leaders played a weak role in diffusing energy saving practices to a wider audience. Thus, the two-step flow of communication model does not appear to describe the sharing of energy conservation practices in large online heterogeneous networks. These results shed new light on the underlying mechanisms driving the diffusion of important societal issues such as energy efficiency, particularly in the context of large online social media outlets.	[Mohammadi, Neda] Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA 24061 USA; [Wang, Qi] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Taylor, John E.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA	Virginia Polytechnic Institute & State University; Harvard University; University System of Georgia; Georgia Institute of Technology	Taylor, JE (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.	jet@vt.edu			National Science Foundation [1142379]; Virginia Tech's Open Access Subvention Fund; Directorate For Engineering [1733695] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Virginia Tech's Open Access Subvention Fund; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study was supported by the National Science Foundation under Grant No. 1142379 [http://www.nsf.gov/]. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. Open access publication of this article was supported by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Science Foundation under Grant No. 1142379 [http://www.nsf.gov/]. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Abrahamse W, 2007, J ENVIRON PSYCHOL, V27, P265, DOI 10.1016/j.jenvp.2007.08.002; Acemoglu D, 2010, GAME ECON BEHAV, V70, P194, DOI 10.1016/j.geb.2010.01.005; Allcott H, 2010, SCIENCE, V327, P1204, DOI 10.1126/science.1180775; American Geophysical Union, HUM IND CLIM CHANG R; Anger I., 2011, P 11 INT C KNOWL MAN; Attari SZ, 2014, P NATL ACAD SCI USA, V111, P5129, DOI 10.1073/pnas.1316402111; Attari SZ, 2010, P NATL ACAD SCI USA, V107, P16054, DOI 10.1073/pnas.1001509107; Bakshy E., 2011, P 4 ACM INT C WEB SE, DOI [10.1145/1935826.1935845, DOI 10.1145/1935826.1935845]; Berger A. A., 1995, ESSENTIALS MASS COMM; Berger J, 2014, J CONSUM PSYCHOL, V24, P586, DOI 10.1016/j.jcps.2014.05.002; Bird S., 2009, NATURAL LANGUAGE PRO; Brossard D, 2013, SCIENCE, V339, P40, DOI 10.1126/science.1232329; BROWN JJ, 1987, J CONSUM RES, V14, P350, DOI 10.1086/209118; Cha M., 2010, ICWSM, P10, DOI DOI 10.1093/JSCR/2010.10.10; Chell K, 2009, T AM GEOPHYS UNION, V90, P401; Chevalier JA, 2006, J MARKETING RES, V43, P345, DOI 10.1509/jmkr.43.3.345; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chu KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145387; Chu Z, 2010, P 26 ANN COMP SEC AP; Contractor NS, 2014, P NATL ACAD SCI USA, V111, P13650, DOI 10.1073/pnas.1401211111; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; CZEPIEL JA, 1974, J MARKETING RES, V11, P172, DOI 10.2307/3150555; del Val E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124049; DENNIS ML, 1990, AM PSYCHOL, V45, P1109, DOI 10.1037/0003-066X.45.10.1109; Dietz T, 2007, FRONT ECOL ENVIRON, V5, P13, DOI 10.1890/1540-9295(2007)5[13:DTHEF]2.0.CO;2; Dietz T, 2010, P NATL ACAD SCI USA, V107, P16007, DOI 10.1073/pnas.1010651107; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Fischhoff B, 2013, P NATL ACAD SCI USA, V110, P14033, DOI 10.1073/pnas.1213273110; FISK G, 1969, J MARKETING RES, V6, P112, DOI 10.2307/3150014; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Godes D, 2009, MARKET SCI, V28, P721, DOI 10.1287/mksc.1080.0444; Gruzd A, 2011, AM BEHAV SCI, V55, P1294, DOI 10.1177/0002764211409378; Internet Live Stats, 2015, INT LIV STATS; Krishnamurthy B., 2008, P 1 WORKSH ONL SOC N; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kwak H., 2010, P 19 INT C WORLD WID; Lazarsfeld P, 1968, PEOPLES CHOICE VOTER; Leiserowitz A, 2014, CLIMATE CHANGE AM MI; Lineman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138996; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Nisbet MC, 2007, PUBLIC OPIN QUART, V71, P444, DOI 10.1093/poq/nfm031; Nisbet MC, 2009, SCI COMMUN, V30, P328, DOI 10.1177/1075547008328797; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Pearce W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094785; ROBINSON JP, 1976, PUBLIC OPIN QUART, V40, P304, DOI 10.1086/268307; Sampei Y, 2009, GLOBAL ENVIRON CHANG, V19, P203, DOI 10.1016/j.gloenvcha.2008.10.005; Showstack R., 2014, EOS TRANS, V95, P34, DOI DOI 10.1002/2014E0040002; Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115545; STERN PC, 1992, AM PSYCHOL, V47, P1224, DOI 10.1037/0003-066X.47.10.1224; Stringhini G., 2013, IMC; Takhteyev Y, 2012, SOC NETWORKS, V34, P73, DOI 10.1016/j.socnet.2011.05.006; Tavares G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065774; The Governor's Office of Planning and Research, 2011, SCI ORG HOLD POS CLI; TROLDAHL VC, 1966, PUBLIC OPIN QUART, V30, P609, DOI 10.1086/267459; Tumasjan A, 2011, SOC SCI COMPUT REV, V29, P402, DOI 10.1177/0894439310386557; Twitter Help Center, FOLL RUL BEST PRACT; U.S. Energy Information Administration, 2014, DOEEIA0484; U.S. Energy Information Administration, 2016, EN BRIEF WHAT AR GRE; U.S. Environmental Protection Agency, 2014, 430R14004 EPA; Valente T.W., 2010, SOCIAL NETWORKS HLTH, P172; Van den Bulte C., 2009, NETWORK CHALLENGE ST, P243; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; Wang Q, 2016, J COMPUT CIVIL ENG, V30, DOI 10.1061/(ASCE)CP.1943-5487.0000469; Wang Q, 2014, ENERG BUILDINGS, V76, P622, DOI 10.1016/j.enbuild.2014.02.074; Wilson C, 2007, ANNU REV ENV RESOUR, V32, P169, DOI 10.1146/annurev.energy.32.053006.141137; Wu S., 2011, P 20 INT C WORLD WID; Xuan Q, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.052813; Xuan Q, 2014, ADV COMPLEX SYST, V17, DOI 10.1142/S0219525915500058; Yang Z, 2010, PROCEEDINGS OF THE 17TH INTERNATIONAL CONGRESS ON SOUND AND VIBRATION	74	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164476	10.1371/journal.pone.0164476	http://dx.doi.org/10.1371/journal.pone.0164476			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736912	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800071
J	Siemering, B; Bresnan, E; Painter, SC; Daniels, CJ; Inall, M; Davidson, K				Siemering, Beatrix; Bresnan, Eileen; Painter, Stuart C.; Daniels, Chris J.; Inall, Mark; Davidson, Keith			Phytoplankton Distribution in Relation to Environmental Drivers on the North West European Shelf Sea	PLOS ONE			English	Article							NUTRIENT; COASTAL; PRODUCTIVITY; HYDROGRAPHY; PLANKTON; FORMS	The edge of the North West European Shelf (NWES) is characterised by a steep continental slope and a northward flowing slope current. These topographic/hydrographic features separate oceanic water and shelf water masses hence potentially separate phytoplankton communities. The slope current may facilitate the advective transport of phytoplankton, with mixing at the shelf edge supporting nutrient supply and therefore phytoplankton production. On the west Scottish shelf in particular, little is known about the phytoplankton communities in and around the shelf break and adjacent waters. Hence, to improve our understanding of environmental drivers of phytoplankton communities, biological and environmental data were collected on seven cross-shelf transects across the Malin and Hebridean Shelves during autumn 2014. Density profiles indicated that shelf break and oceanic stations had a 100 m deep mixed surface layer while stations on the shelf were generally well mixed. Analysis of similarity and multidimensional scaling of phytoplankton counts revealed that phytoplankton communities on the shelf were significantly different to those found at the shelf break and at oceanic stations. Shelf stations were dominated by dinoflagellates, with diatoms contributing a maximum of 37% of cells. Shelf break and oceanic stations were also dinoflagellate dominated but displayed a lower species diversity. Significant difference between shelf and shelf break stations suggested that the continental slope limited cross shelf phytoplankton exchange. Northern and southern phytoplankton communities on the shelf were approximately 15% dissimilar while there was no latitudinal gradient for stations along the slope current, suggesting this current provided south to north connectivity. Fitting environmental data to phytoplankton ordination showed a significant relationship between phytoplankton community dissimilarities and nutrient concentrations and light availability on the shelf compared to shelf break and oceanic stations in the study area.	[Siemering, Beatrix; Inall, Mark; Davidson, Keith] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Bresnan, Eileen] MSS Marine Lab, Aberdeen, Scotland; [Painter, Stuart C.; Daniels, Chris J.] Natl Oceanog Ctr, Southampton, Hants, England; [Inall, Mark] Univ Edinburgh, Grant Inst, Dept Geosci, Edinburgh, Midlothian, Scotland	UHI Millennium Institute; NERC National Oceanography Centre; University of Edinburgh	Siemering, B (corresponding author), Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	Beatrix.siemering@sams.ac.uk	Daniels, Chris/H-2627-2014; Davidson, Keith/A-5474-2013; /I-4835-2014; Painter, Stuart/F-1248-2010	Daniels, Chris/0000-0003-2453-267X; Davidson, Keith/0000-0001-9269-3227; /0000-0002-1624-4275; Painter, Stuart/0000-0001-7934-7346	UK NERC Shelf Seas Biogeochemistry programme [NE/K001884/1]; Natural Environment Research Council [NE/K001701/1, NE/K001884/1] Funding Source: researchfish; NERC [NE/K001701/1, NE/K001884/1] Funding Source: UKRI	UK NERC Shelf Seas Biogeochemistry programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	BS was funded by a studentship that formed part of the UK NERC Shelf Seas Biogeochemistry programme (grant number NE/K001884/1, awarded to KD). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Berdalet E, 2016, J MAR BIOL ASSOC UK, V96, P61, DOI 10.1017/S0025315415001733; Burrows M, 1999, ANN GEOPHYS-ATM HYDR, V17, P280, DOI 10.1007/s00585-999-0280-5; Davidson K, 2013, PROG OCEANOGR, V117, P48, DOI 10.1016/j.pocean.2013.04.001; Davidson K, 2012, ESTUAR COAST SHELF S, V115, P399, DOI 10.1016/j.ecss.2012.09.019; Davidson K, 2011, ISS ENVIRON SCI TECH, V33, P95; Davidson K, 2009, HARMFUL ALGAE, V8, P349, DOI 10.1016/j.hal.2008.07.007; Davis A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020668; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; ELLETT DJ, 1986, P ROY SOC EDINB B, V88, P61, DOI 10.1017/S0269727000004474; Everitt B, 2011, USE R, P1, DOI 10.1007/978-1-4419-9650-3; Farrell H, 2012, HARMFUL ALGAE, V15, P36, DOI 10.1016/j.hal.2011.11.003; Fehling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034098; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Gameiro C, 2011, HYDROBIOLOGIA, V669, P249, DOI 10.1007/s10750-011-0695-3; Garcia-Soto C, 1998, J MAR BIOL ASSOC UK, V78, P17, DOI 10.1017/S002531540003993X; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Gillibrand P, HARMFUL ALG IN PRESS; Gohin F, 2015, J MARINE SYST, V148, P70, DOI 10.1016/j.jmarsys.2015.02.001; Gowen R, 2011, DEV UK PELAGIC PLANK; Gowen RJ, 1998, ICES J MAR SCI, V55, P1095, DOI 10.1006/jmsc.1998.0418; HILL AE, 1995, J PHYS OCEANOGR, V25, P1617, DOI 10.1175/1520-0485(1995)025<1617:LOBSCO>2.0.CO;2; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimate1388, 10.1038/NCLIMATE1388]; HOLLIGAN PM, 1981, PHILOS T R SOC A, V302, P547, DOI 10.1098/rsta.1981.0182; Inall M, 2009, J MARINE SYST, V77, P210, DOI 10.1016/j.jmarsys.2007.12.012; Johns D, 2015, MONTHLY AVERAGE DATA; Johnson C, 2013, DEEP-SEA RES PT I, V82, P95, DOI 10.1016/j.dsr.2013.08.007; JONES KJ, 1990, ESTUAR COAST SHELF S, V30, P557, DOI 10.1016/0272-7714(90)90092-6; Kirkwood D, 1996, NUTR PRACTICAL NOTES; Lee Joon-Baek, 2014, Journal of Ecology and Environment, V37, P271, DOI 10.5141/ecoenv.2014.031; MALONE TC, 1993, DEEP-SEA RES PT I, V40, P903; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; MCMAHON TG, 1992, J MAR BIOL ASSOC UK, V72, P709, DOI 10.1017/S0025315400059464; Muller-Karger FE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021346; OFFICER CB, 1980, MAR ECOL PROG SER, V3, P83, DOI 10.3354/meps003083; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oksanen J, 2014, MULTIVARIATE ANAL EC, P4; Proctor R, 2003, SCI TOTAL ENVIRON, V314, P769, DOI 10.1016/S0048-9697(03)00083-4; Raine R., 2004, AFRICAN J MARINE SCI, V28, P216; Redfield A. C., 1934, P176; SAVIDGE G, 1987, CONT SHELF RES, V7, P45, DOI 10.1016/0278-4343(87)90063-X; Sharples J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040683; Simpson JH, 2012, INTRO PHYS BIOL OCEA, P1; Souza AJ, 2001, OCEANOL ACTA, V24, pS63; Tett P, 2008, ICES J MAR SCI, V65, P1475, DOI 10.1093/icesjms/fsn161; Wetz MS, 2008, ESTUAR COAST, V31, P419, DOI 10.1007/s12237-008-9034-y	46	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164482	10.1371/journal.pone.0164482	http://dx.doi.org/10.1371/journal.pone.0164482			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736920	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505800074
J	Taguchi, A; Murayama, H; Murashima, S				Taguchi, Atsuko; Murayama, Hiroshi; Murashima, Sachiyo			Association between Municipal Health Promotion Volunteers' Health Literacy and Their Level of Outreach Activities in Japan	PLOS ONE			English	Article							WORKERS	Objectives To explore the association between health literacy and levels of three types of core activities among health promotion volunteers (developing a healthy lifestyle, outreach to family, and outreach to community members). Study Design A cross-sectional, anonymous, self-administered postal survey of registered health promotion volunteers in the Konan area in Shiga Prefecture in Japan, conducted in January 2010. The study sample was 575 registered health promotion volunteers. Methods The survey collected data on health literacy, gender, age, education, self-rated health, perceptions about the volunteer organization, and perceptions of recognition in the community. The level of engagement in health promotion activities was measured by the extent to which the participants engaged in seven healthy behaviors and promoted them to family members and the community. The authors compared the health literacy level and other characteristics of the participants by core health promotion activities, using a chi-squared test, to examine the associations between demographic and other variables and the three core activities (healthy lifestyle, outreach to family, and outreach to community). Logistic regression analysis was conducted to examine the association between the degree to which the volunteers engaged in core activities ("healthy lifestyle," "outreach to family," "outreach to community") and the levels of health literacy (low, medium, high) among health promotion volunteers, controlling for the effects of age, gender, health condition, education which may also have an impact on volunteers' outreach activities. Results Four hundred and fifty-four questionnaires were returned, a 79.0% response rate. Excluding 16 cases with missing values on health literacy or the degree of health promotion activities, 438 research subjects were included in the analysis (valid response rate: 76.2%). Health literacy and a few demographic and other characteristics of the volunteers were associated with the three core health promotion activities. In bivariate analyses, active participation in the core activities was more prevalent among older volunteers (p<0.001 for all three activities). Self-rated health condition was associated with both outreach to family (p = 0.018) and community (p = 0.046). Years of experience as volunteer and perception of being recognized in the community also had statistically significant association with outreach to the community (p<0.001). In multiple logistic regression, those with higher level of health literacy were more likely than others to actively engage in outreach to family (OR = 1.70, 95% CI 1.03 to 2.80; OR = 1.76, 95% CI 1.04 to 3.00 for medium and high, respectively) and outreach to community (OR = 2.26, 95% CI 1.34 to 3.83; OR = 2.61 95% CI 1.49 to 4.58 for medium and high, respectively). Perception of being recognized in the community also had a statistically significant and positive impact on outreach to the community (OR = 1.52, 95% CI 1.17 to 1.99). Conclusions Volunteers with higher health literacy were more likely to actively engage in outreach to family and outreach to community. Providing educational programs to improve volunteers' health literacy may facilitate their work.	[Taguchi, Atsuko] Tohoku Univ, Grad Sch Med, Dept Publ Hlth Nursing, Div Hlth Sci, Sendai, Miyagi, Japan; [Murayama, Hiroshi] Univ Tokyo, Inst Gerontol, Tokyo, Japan; [Murashima, Sachiyo] Oita Univ Nursing & Hlth Sci, Oita, Japan	Tohoku University; University of Tokyo; Oita University	Taguchi, A (corresponding author), Tohoku Univ, Grad Sch Med, Dept Publ Hlth Nursing, Div Hlth Sci, Sendai, Miyagi, Japan.	ataguchi@med.tohoku.ac.jp			Ministry of Education [23792691]; Grants-in-Aid for Scientific Research [16KT0119] Funding Source: KAKEN	Ministry of Education; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in Aid for Young Scientists (B) from the Ministry of Education (No. 23792691) https://www.jsps.go.jp/j-grantsinaid/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 2012, JAPANESE INFORM PUBL, V42, P28; Ayala GX, 2010, HEALTH EDUC RES, V25, P815, DOI 10.1093/her/cyq035; Belloc N B, 1972, Prev Med, V1, P409, DOI 10.1016/0091-7435(72)90014-X; Brach C., 2012, ATTRIBUTES A HLTH LI, DOI [10.31478/201201f, DOI 10.31478/201201F]; Davis MH, 2003, PERS SOC PSYCHOL B, V29, P248, DOI 10.1177/0146167202239050; Eng E., 2009, EMERGING THEORIES HL, V2nd ed, P303; Fujii S, 2013, JAPANESE J PUBLIC HL, V68, P416; Furuya Y, 2013, HEALTH PROMOT INT, V23, P269; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Huneke T, 2015, PSYCHOL MARKET, V32, P94, DOI 10.1002/mar.20765; Ishikawa H, 2008, HEALTH PROMOT INT, V23, P269, DOI 10.1093/heapro/dan017; Kudo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133641; Levin-Zamir D., 2012, 21 IUHPE WORLD C HLT; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Murayama H, 2007, J JAPAN ACAD COMMUNI, V9, P24; Murayama H, 2008, PUBLIC HEALTH NURS, V25, P253, DOI 10.1111/j.1525-1446.2008.00702.x; Murayama H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-205; Murayama H, 2011, J AMBUL CARE MANAG, V34, P274, DOI 10.1097/JAC.0b013e318223f427; Murayama H, 2010, HEALTH EDUC BEHAV, V37, P275, DOI 10.1177/1090198109341782; National Research Council, 2012, IMPR HLTH HLTH SYST; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 1998, HEALTH PROMOT INT, P349; Suka M, 2013, ENVIRON HEALTH PREV, V18, P407, DOI 10.1007/s12199-013-0340-z; Takahashi K, 2002, MIYAGI U NURSING REV, V5, P95; Viswanathan M, 2010, MED CARE, V48, P792, DOI 10.1097/MLR.0b013e3181e35b51; World Health Organization, 2006, HLTH PROMOTION INT, V21; Yokokawa H, 2016, J CLIN HYPERTENS, V18, P53, DOI 10.1111/jch.12627	27	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164612	10.1371/journal.pone.0164612	http://dx.doi.org/10.1371/journal.pone.0164612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736942	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505800097
J	Thorin-Trescases, N; Hayami, D; Yu, C; Luo, XY; Nguyen, A; Larouche, JF; Lalonge, J; Henri, C; Arsenault, A; Gayda, M; Juneau, M; Lambert, J; Thorin, E; Nigam, A				Thorin-Trescases, Nathalie; Hayami, Doug; Yu, Carol; Luo, Xiaoyan; Albert Nguyen; Larouche, Jean-Francois; Lalonge, Julie; Henri, Christine; Arsenault, Andre; Gayda, Mathieu; Juneau, Martin; Lambert, Jean; Thorin, Eric; Nigam, Anil			Exercise Lowers Plasma Angiopoietin-Like 2 in Men with Post-Acute Coronary Syndrome	PLOS ONE			English	Article							GENERAL JAPANESE POPULATION; REGULAR PHYSICAL-EXERCISE; C-REACTIVE PROTEIN; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; AEROBIC EXERCISE; ARTERY-DISEASE; HEART-FAILURE; RISK; INFLAMMATION	Pro-inflammatory angiopoietin-like 2 (angptl2) promotes endothelial dysfunction in mice and circulating angptl2 is higher in patients with cardiovascular diseases. We previously reported that a single bout of physical exercise was able to reduce angptl2 levels in coronary patients. We hypothesized that chronic exercise would reduce angptl2 in patients with post-acute coronary syndrome (ACS) and endothelial dysfunction. Post-ACS patients (n = 40, 10 women) were enrolled in a 3-month exercise-based prevention program. Plasma angptl2, hs-CRP, and endothelial function assessed by scintigraphic forearm blood flow, were measured before and at the end of the study. Exercise increased VO(2)peak by 10% (p<0.05), but did not significantly affect endothelial function, in both men and women. In contrast, exercise reduced angptl2 levels only in men (-26 +/- 7%, p<0.05), but unexpectedly not in women (+30 +/- 16%), despite similar initial levels in both groups. Exercise reduced hs-CRP levels in men but not in women. In men, levels of angptl2, but not of hs-CRP, reached at the end of the training program were negatively correlated with VO(2)peak (r = -0.462, p = 0.012) and with endothelial function (r = -0.419, p = 0.033) measured at baseline: better initial cardiopulmonary fitness and endothelial function correlated with lower angptl2 levels after exercise. Pre-exercise angptl2 levels were lower if left ventricular ejection time was long (p<0.05) and the drop in angptl2 induced by exercise was greater if the cardiac output was high (p<0.05). In conclusion, in post-ACS men, angptl2 levels are sensitive to chronic exercise training. Low circulating angptl2 reached after training may reflect good endothelial and cardiopulmonary functions.	[Thorin-Trescases, Nathalie; Hayami, Doug; Yu, Carol; Luo, Xiaoyan; Albert Nguyen; Larouche, Jean-Francois; Henri, Christine; Arsenault, Andre; Gayda, Mathieu; Juneau, Martin; Lambert, Jean; Thorin, Eric; Nigam, Anil] Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ, Canada; [Hayami, Doug; Larouche, Jean-Francois; Lalonge, Julie; Gayda, Mathieu; Juneau, Martin; Nigam, Anil] Univ Montreal, Cardiac Rehabil & Prevent Ctr EPIC, Montreal Heart Inst, Montreal, PQ, Canada; [Yu, Carol; Albert Nguyen; Thorin, Eric] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ, Canada; [Yu, Carol; Albert Nguyen; Thorin, Eric] Univ Montreal, Fac Med, Dept Surg, Montreal, PQ, Canada; [Arsenault, Andre] Montreal Behav Med Ctr, Montreal, PQ, Canada; [Lambert, Jean] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Thorin, E (corresponding author), Univ Montreal, Res Ctr, Montreal Heart Inst, Montreal, PQ, Canada.	eric.thorin@umontreal.ca	Gayda, Mathieu/U-8520-2019; Thorin, Eric/K-3978-2013	Gayda, Mathieu/0000-0003-1721-2299; Thorin, Eric/0000-0001-5827-8935	Canadian Institutes of Health Research [14496, 133649]; Foundation of the Montreal Heart Institute; EPIC Center Foundation; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation of the Montreal Heart Institute; EPIC Center Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Institutes of Health Research (grants number 14496 and 133649 to ET), the Foundation of the Montreal Heart Institute (ET, MJ, A Nigam) and EPIC Center Foundation (MJ, A Nigam). Carol Yu was supported by the Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Dangardt FJ, 2013, NAT REV CARDIOL, V10, P495, DOI 10.1038/nrcardio.2013.90; Davis SN, 2000, J CLIN ENDOCR METAB, V85, P224, DOI 10.1210/jc.85.1.224; Doi Y, 2013, DIABETES CARE, V36, P98, DOI 10.2337/dc12-0166; Endo M, 2014, INT J BIOL MARKER, V29, pE239, DOI 10.5301/jbm.5000080; Farhat N, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000201; Ford ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/00001648-200209000-00012; FRIEDMANN B, 1989, EUR J APPL PHYSIOL O, V59, P1, DOI 10.1007/BF02396572; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gayda M, 2012, APPL PHYSIOL NUTR ME, V37, P1171, DOI 10.1139/h2012-109; Guiraud T, 2011, MED SCI SPORT EXER, V43, P211, DOI 10.1249/MSS.0b013e3181ebc5de; Hambrecht R, 1998, CIRCULATION, V98, P2709, DOI 10.1161/01.CIR.98.24.2709; Hamer M, 2012, MED SCI SPORT EXER, V44, P84, DOI 10.1249/MSS.0b013e3182251077; Hata J, 2016, ARTERIOSCL THROM VAS, V36, P1686, DOI 10.1161/ATVBAHA.116.307291; Hellstrom L, 1996, INT J SPORTS MED, V17, P439, DOI 10.1055/s-2007-972875; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Ide S, 2015, ANN SURG ONCOL, V22, P2585, DOI 10.1245/s10434-014-4315-0; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Larouche JF, 2015, CAN J CARDIOL, V31, P1232, DOI 10.1016/j.cjca.2015.01.038; MCMURRAY RG, 1987, MED SCI SPORT EXER, V19, P570; Meng QX, 2013, EXP THER MED, V5, P1631, DOI 10.3892/etm.2013.1045; Migneault A, 2005, AM J RESP CRIT CARE, V171, P506, DOI 10.1164/rccm.200403-340OC; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; Muramoto A, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.16; Nguyen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153920; Nio AQX, 2015, EUR J SPORT SCI, V15, P286, DOI 10.1080/17461391.2014.936323; NORTHRIDGE DB, 1990, BRIT HEART J, V63, P93; Oike Y, 2009, CIRC J, V73, P2192, DOI 10.1253/circj.CJ-09-0710; Palmefors H, 2014, ATHEROSCLEROSIS, V235, P150, DOI 10.1016/j.atherosclerosis.2014.04.026; Rengo G, 2013, AGING CLIN EXP RES, V25, P487, DOI 10.1007/s40520-013-0117-7; Samayoa L, 2014, CAN J CARDIOL, V30, P793, DOI 10.1016/j.cjca.2013.11.007; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Scherhag A, 2005, KIDNEY BLOOD PRESS R, V28, P77, DOI 10.1159/000083695; SCHULER G, 1992, CIRCULATION, V86, P1, DOI 10.1161/01.CIR.86.1.1; Seals DR, 2014, J APPL PHYSIOL, V117, P425, DOI 10.1152/japplphysiol.00362.2014; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Thorin-Trescases N, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.19; Towfighi A, 2009, ARCH INTERN MED, V169, P1762, DOI 10.1001/archinternmed.2009.318; Usui T, 2013, CIRC J, V77, P2311, DOI 10.1253/circj.CJ-12-1548; Wang ZQ, 2015, ARCH MED RES, V46, P257, DOI 10.1016/j.arcmed.2015.05.003; Yu C, 2015, AM J PHYSIOL-HEART C, V308, pH386, DOI 10.1152/ajpheart.00278.2014; Yu C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001024	43	11	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164598	10.1371/journal.pone.0164598	http://dx.doi.org/10.1371/journal.pone.0164598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736966	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800095
J	Tsuji, J; Weng, ZP				Tsuji, Junko; Weng, Zhiping			DNApi: A De Novo Adapter Prediction Algorithm for Small RNA Sequencing Data	PLOS ONE			English	Article							HUMAN GENOME; ALIGNMENT; MOUSE	With the rapid accumulation of publicly available small RNA sequencing datasets, third-party meta-analysis across many datasets is becoming increasingly powerful. Although removing the 3 A adapter is an essential step for small RNA sequencing analysis, the adapter sequence information is not always available in the metadata. The information can be also erroneous even when it is available. In this study, we developed DNApi, a lightweight Python software package that predicts the 3' adapter sequence de novo and provides the user with cleansed small RNA sequences ready for down stream analysis. Tested on 539 publicly available small RNA libraries accompanied with 3' adapter sequences in their metadata, DNApi shows near-perfect accuracy (98.5%) with fast runtime (similar to 2.85 seconds per library) and efficient memory usage (similar to 43 MB on average). In addition to 3' adapter prediction, it is also important to classify whether the input small RNA libraries were already processed, i.e. the 3' adapters were removed. DNApi perfectly judged that given another batch of datasets, 192 publicly available processed libraries were "ready-to-map" small RNA sequence. DNApi is compatible with Python 2 and 3, and is available at https://github.com/jnktsj/DNApi. The 731 small RNA libraries used for DNApi evaluation were from human tissues and were carefully and manually collected. This study also provides readers with the curated datasets that can be integrated into their studies.	[Tsuji, Junko; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA.	zhipingweng@gmail.com		Tsuji, Junko/0000-0003-0139-3750	National Institutes of Health [R01 NS073947, P01 HD078253]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD078253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been partly supported by the National Institutes of Health grants R01 NS073947 (Epigenetic Markers in Huntington Disease Brain) and P01 HD078253 (Small Silencing RNA Function in Genome Maintenance and Gamete Development). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2010, NAT METHODS, V7, P495, DOI 10.1038/nmeth0710-495; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Ladewig E, 2012, GENOME RES, V22, P1634, DOI 10.1101/gr.133553.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; Renaud G, 2015, BIOINFORMATICS, V31, P770, DOI 10.1093/bioinformatics/btu719; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347; Wen JY, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004441; Yi HS, 2015, BIOINFORMATICS, V31, P4000, DOI 10.1093/bioinformatics/btv501	20	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164228	10.1371/journal.pone.0164228	http://dx.doi.org/10.1371/journal.pone.0164228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736901	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800047
J	Xiang, N; He, M; Ishaq, M; Gao, Y; Song, FF; Guo, L; Ma, L; Sun, GH; Liu, D; Guo, DY; Chen, Y				Xiang, Nian; He, Miao; Ishaq, Musarat; Gao, Yu; Song, Feifei; Guo, Liang; Ma, Li; Sun, Guihong; Liu, Dan; Guo, Deyin; Chen, Yu			The DEAD-Box RNA Helicase DDX3 Interacts with NF-kappa B Subunit p65 and Suppresses p65-Mediated Transcription	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; PROTEIN P68; CANCER; ACTIVATION; BINDING; TUMORIGENESIS; REPLICATION; DEGRADATION; COACTIVATOR; APOPTOSIS	RNA helicase family members exhibit diverse cellular functions, including in transcription, pre-mRNA processing, RNA decay, ribosome biogenesis, RNA export and translation. The RNA helicase DEAD-box family member DDX3 has been characterized as a tumour-associated factor and a transcriptional co-activator/regulator. Here, we demonstrate that DDX3 interacts with the nuclear factor (NF)-kappa B subunit p65 and suppresses NF-kappa B (p65/p50)-mediated transcriptional activity. The downregulation of DDX3 by RNA interference induces the upregulation of NF-kappa B (p65/p50)-mediated transcription. The regulation of NF-kappa B (p65/p50)-mediated transcriptional activity was further confirmed by the expression levels of its downstream cytokines, such as IL-6 and IL-8. Moreover, the binding of the ATP-dependent RNA helicase domain of DDX3 to the N-terminal Rel homology domain (RHD) of p65 is involved in the inhibition of NF-kappa B-regulated gene transcription. In summary, the results suggest that DDX3 functions to suppress the transcriptional activity of the NF-kappa B subunit p65.	[Xiang, Nian; He, Miao; Ishaq, Musarat; Gao, Yu; Guo, Liang; Ma, Li; Guo, Deyin; Chen, Yu] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China; [Song, Feifei; Sun, Guihong; Liu, Dan; Guo, Deyin] Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China	Wuhan University; Wuhan University	Chen, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China.	chenyu@whu.edu.cn		Sun, Guihong/0000-0003-4451-7135	China NSFC [81130083, 81271817, 31221061]; Fundamental Research Funds for the Central Universities [2042016kf0140]	China NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the China NSFC grants (81130083, 81271817 and 31221061) (http://www.nsfc.gov.cn/) and the Fundamental Research Funds for the Central Universities (2042016kf0140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratani S, 2001, MOL CELL BIOL, V21, P4460, DOI 10.1128/MCB.21.14.4460-4469.2001; Arepalli SK, 2015, EXPERT OPIN THER PAT, V25, P319, DOI 10.1517/13543776.2014.998199; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Ariumi Y, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00423; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Benezra M, 2003, J BIOL CHEM, V278, P26333, DOI 10.1074/jbc.M303076200; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guturi KKN, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0496-5; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Ichikawa K, 2015, IET SYST BIOL, V9, P41, DOI 10.1049/iet-syb.2013.0020; Ishaq M, 2009, J CELL BIOCHEM, V106, P296, DOI 10.1002/jcb.22004; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kasim V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059445; Kroll M, 1999, J BIOL CHEM, V274, P7941, DOI 10.1074/jbc.274.12.7941; Lasko P, 2013, BBA-GENE REGUL MECH, V1829, P810, DOI 10.1016/j.bbagrm.2013.04.005; Lee CH, 2014, ORAL DIS, V20, P76, DOI 10.1111/odi.12076; Li F, 2015, ARCH TOXICOL, V89, P711, DOI 10.1007/s00204-015-1470-4; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Olivotto E, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000061; Ou QL, 2001, MOL ENDOCRINOL, V15, P69, DOI 10.1210/me.15.1.69; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; Schroder M, 2011, BIOCHEM SOC T, V39, P679, DOI 10.1042/BST0390679; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Shostak K, 2015, TRENDS MOL MED, V21, P385, DOI 10.1016/j.molmed.2015.04.001; Srinivasan M, 2015, EXPERT OPIN THER TAR, V19, P471, DOI 10.1517/14728222.2014.989834; Sun MN, 2013, BBA-MOL CELL RES, V1833, P1489, DOI 10.1016/j.bbamcr.2013.02.026; Tetsuka T, 2004, EUR J BIOCHEM, V271, P3741, DOI 10.1111/j.1432-1033.2004.04314.x; Tian Y, 2007, J BIOL CHEM, V282, P16776, DOI 10.1074/jbc.M701913200; Valiente-Echeverria F, 2015, REV MED VIROL, V25, P286, DOI 10.1002/rmv.1845; van Delft MAM, 2015, EUR J CLIN INVEST, V45, P529, DOI 10.1111/eci.12430; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Wu DW, 2014, ONCOGENE, V33, P1515, DOI 10.1038/onc.2013.107; Wu DW, 2011, CLIN CANCER RES, V17, P1895, DOI 10.1158/1078-0432.CCR-10-2316; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; You LR, 1999, J VIROL, V73, P2841, DOI 10.1128/JVI.73.4.2841-2853.1999; Zhang HS, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0056-4; Zhao J, 2015, CURR OPIN VIROL, V15, P103, DOI 10.1016/j.coviro.2015.08.013	45	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164471	10.1371/journal.pone.0164471	http://dx.doi.org/10.1371/journal.pone.0164471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736973	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800068
J	Li, HJ; Li, L; Shao, Y; Gong, HG; Zhang, W; Zeng, XJ; Ye, CL; Nie, S; Chen, LT; Peng, DC				Li, Haijun; Li, Lan; Shao, Yi; Gong, Honghan; Zhang, Wei; Zeng, Xianjun; Ye, Chenglong; Nie, Si; Chen, Liting; Peng, Dechang			Abnormal Intrinsic Functional Hubs in Severe Male Obstructive Sleep Apnea: Evidence from a Voxel-Wise Degree Centrality Analysis	PLOS ONE			English	Article							BRAIN STRUCTURAL-CHANGES; RESTING-STATE FMRI; QUALITY-OF-LIFE; NEUROCOGNITIVE FUNCTION; INTERMITTENT HYPOXIA; NETWORK CENTRALITY; PREFRONTAL CORTEX; EXECUTIVE CONTROL; CORTICAL HUBS; LOW-FREQUENCY	Purpose Obstructive sleep apnea (OSA) has been associated with changes in brain structure and regional function in certain brain areas. However, the functional features of network organization in the whole brain remain largely uncertain. The purpose of this study was to identify the OSA-related spatial centrality distribution of the whole brain functional network and to investigate the potential altered intrinsic functional hubs. Methods Forty male patients with newly confirmed severe OSA on polysomnography, and well-matched good sleepers, participated in this study. All participants underwent a resting-state functional MRI scan and clinical and cognitive evaluation. Voxel-wise degree centrality (DC) was measured across the whole brain, and group difference in DC was compared. The relationship between the abnormal DC value and clinical variables was assessed using a linear correlation analysis. Results Remarkably similar spatial distributions of the functional hubs (high DC) were found in both groups. However, OSA patients exhibited a pattern of significantly reduced regional DC in the left middle occipital gyrus, posterior cingulate cortex, left superior frontal gyrus, and bilateral inferior parietal lobule, and DC was increased in the right orbital frontal cortex, bilateral cerebellum posterior lobes, and bilateral lentiform nucleus, including the putamen, extending to the hippocampus, and the inferior temporal gyrus, which overlapped with the functional hubs. Furthermore, a linear correlation analysis revealed that the DC value in the posterior cingulate cortex and left superior frontal gyrus were positively correlated with Montreal cognitive assessment scores, The DC value in the left middle occipital gyrus and bilateral inferior parietal lobule were negatively correlated with apnea-hypopnea index and arousal index in OSA patients. Conclusion Our findings suggest that OSA patients exhibited specific abnormal intrinsic functional hubs including relatively reduced and increased DC. This expands our understanding of the functional characteristics of OSA, which may provide new insights into understanding the dysfunction and pathophysiology of OSA patients.	[Li, Haijun; Li, Lan; Gong, Honghan; Zeng, Xianjun; Ye, Chenglong; Nie, Si; Chen, Liting; Peng, Dechang] Nanchang Univ, Dept Radiol, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China; [Li, Lan] Nanchang Univ, Sch Publ Hlth, Nanchang 330006, Jiangxi, Peoples R China; [Shao, Yi] Nanchang Univ, Dept Ophthalmol, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Wei] Nanchang Univ, Dept Pneumol, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University; Nanchang University	Peng, DC (corresponding author), Nanchang Univ, Dept Radiol, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.	pengdcdoctor@163.com		Li, Haijun/0000-0001-6631-123X	Natural Science Foundation of China [81560285]; Science and Technology Support Program of Jiangxi, China [20141BBG70026, 20132BBG70061]; Natural Science Foundation Project of Jiangxi, China [20132BAB205100]; Graduate Innovation Foundation of Jiangxi, China [YC2015-S082]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of Jiangxi, China; Natural Science Foundation Project of Jiangxi, China; Graduate Innovation Foundation of Jiangxi, China	This study was supported by the Natural Science Foundation of China (Grant No. 81560285), the Science and Technology Support Program of Jiangxi, China (Grant No. 20141BBG70026 and No. 20132BBG70061), the Natural Science Foundation Project of Jiangxi, China (Grant No. 20132BAB205100), and Graduate Innovation Foundation of Jiangxi, China (Grant No. YC2015-S082).; This study was supported by the Natural Science Foundation of China (Grant No. 81560285), the Science and Technology Support Program of Jiangxi, China (Grant No. 20141BBG70026 and No. 20132BBG70061), the Natural Science Foundation Project of Jiangxi, China (Grant No. 20132BAB205100), and Graduate Innovation Foundation of Jiangxi, China (Grant No. YC2015-S082).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ayalon L, 2006, NEUROIMAGE, V31, P1817, DOI 10.1016/j.neuroimage.2006.02.042; Ayalon L, 2009, SLEEP, V32, P373, DOI 10.1093/sleep/32.3.373; Beebe DW, 2003, SLEEP, V26, P298, DOI 10.1093/sleep/26.3.298; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Billings ME, 2014, SLEEP, V37, P2017, DOI 10.5665/sleep.4262; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2002, NEUROIMAGE, V16, P317, DOI 10.1006/nimg.2002.1063; Cai FQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141389; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Castronovo V, 2009, SLEEP, V32, P1161, DOI 10.1093/sleep/32.9.1161; Chiang AA, 2006, CHINESE J PHYSIOL, V49, P234; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Dai XJ, 2016, J CLIN SLEEP MED, V12, P363, DOI 10.5664/jcsm.5586; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daurat A, 2008, J CLIN EXP NEUROPSYC, V30, P91, DOI 10.1080/13803390701236116; Di Martino A, 2013, BIOL PSYCHIAT, V74, P623, DOI 10.1016/j.biopsych.2013.02.011; Engleman HM, 2004, THORAX, V59, P618, DOI 10.1136/thx.2003.015867; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Franklin KA, 2015, J THORAC DIS, V7, P1311, DOI 10.3978/j.issn.2072-1439.2015.06.11; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gale SD, 2004, J INT NEUROPSYCH SOC, V10, P60; Gong L, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00722; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hoffmann LC, 2009, P NATL ACAD SCI USA, V106, P21371, DOI 10.1073/pnas.0908403106; HORNE JA, 1988, SLEEP, V11, P528, DOI 10.1093/sleep/11.6.528; Hou JM, 2014, J PSYCHIATR NEUROSCI, V39, P304, DOI 10.1503/jpn.130220; Joo EY, 2013, SLEEP, V36, P1153, DOI 10.5665/sleep.2876; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Jordan AS, 2014, LANCET, V383, P736, DOI 10.1016/S0140-6736(13)60734-5; Kizilirmak JM, 2015, BRAIN RES, V1614, P14, DOI 10.1016/j.brainres.2015.04.012; Kumar R, 2014, NEUROIMAGE-CLIN, V4, P383, DOI 10.1016/j.nicl.2014.01.009; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Li HJ, 2016, NEUROPSYCH DIS TREAT, V12, P203, DOI 10.2147/NDT.S97449; Li HJ, 2015, NEUROPSYCH DIS TREAT, V11, P207, DOI 10.2147/NDT.S73730; Liu W, 2015, BIOL PSYCHOL, V112, P46, DOI 10.1016/j.biopsycho.2015.09.005; Luo YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139055; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010211; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Oathes DJ, 2015, BIOL PSYCHIAT, V77, P385, DOI 10.1016/j.biopsych.2014.08.006; Park B, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.441; Peng DC, 2014, NEUROPSYCH DIS TREAT, V10, P1819, DOI 10.2147/NDT.S67805; Rosenzweig I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083173; Saint Martin M, 2015, SLEEP, V38, P179, DOI 10.5665/sleep.4392; Salorio CF, 2002, J CLIN EXP NEUROPSYC, V24, P93, DOI 10.1076/jcen.24.1.93.973; Sato JR, 2015, NEUROIMAGE, V104, P44, DOI 10.1016/j.neuroimage.2014.09.063; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sforza E, 2011, EUR RESPIR J, V37, P1137, DOI 10.1183/09031936.00043210; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P1560, DOI 10.1016/j.neuropsychologia.2006.01.018; Snell RS., 2010, CLIN NEUROANATOMY; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Tartar JL, 2010, NEUROSCI LETT, V469, P1, DOI 10.1016/j.neulet.2009.11.032; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Ward KL, 2013, J CLIN SLEEP MED, V9, P1013, DOI 10.5664/jcsm.3072; Aviles-Reyes RX, 2010, J NEUROCHEM, V112, P854, DOI 10.1111/j.1471-4159.2009.06535.x; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x; Zhang Q, 2015, SLEEP MED, V16, P1062, DOI 10.1016/j.sleep.2015.04.018; Zhang Q, 2013, SLEEP, V36, P651, DOI 10.5665/sleep.2620; Zhuang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130524; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	71	27	34	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164031	10.1371/journal.pone.0164031	http://dx.doi.org/10.1371/journal.pone.0164031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723821	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100017
J	Takahashi, Y; Takakura, K; Kawata, M				Takahashi, Yuma; Takakura, Koh-ichi; Kawata, Masakado			Spatial Distribution of Flower Color Induced by Interspecific Sexual Interaction	PLOS ONE			English	Article							GENE FLOW; POLLINATION; COMPETITION; POLLEN; PLANT; POLYMORPHISM; IRIDACEAE; SELECTION; SHAPES	Understanding the mechanisms shaping the spatiotemporal distribution of species has long been a central concern of ecology and evolutionary biology. Contemporary patterns of plant assemblies suggest that sexual interactions among species, i.e., reproductive interference, lead to the exclusive distributions of closely related species that share pollinators. However, the fitness consequences and the initial ecological/evolutionary responses to reproductive interference remain unclear in nature, since reproductive isolation or allopatric distribution has already been achieved in the natural community. In Japan, three species of blue-eyed grasses (Sisyrinchium) with incomplete reproductive isolation have recently colonized and occur sympatrically. Two of them are monomorphic with white flowers, whereas the other exhibits heritable color polymorphism (white and purple morphs). Here we investigated the effects of the presence of two monomorphic species on the distribution and reproductive success of color morphs. The frequency and reproductive success of white morphs decreased in area where monomorphic species were abundant, while those of purple morphs did not. The rate of hybridization between species was higher in white morphs than in the purple ones. Resource competition and habitat preference seemed not to contribute to the spatial distribution and reproductive success of two morphs. Our results supported that color-dependent reproductive interference determines the distribution of flower color polymorphism in a habitat, implying ecological sorting promoted by pollinator-mediated reproductive interference. Our study helps us to understand the evolution and spatial structure of flower color in a community.	[Takahashi, Yuma] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Takahashi, Yuma; Kawata, Masakado] Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Takakura, Koh-ichi] Univ Shiga Prefecture, Sch Environm Sci, 2500 Hassaka Cho, Hikone, Shiga 5228533, Japan; [Takahashi, Yuma] Chiba Univ, Fac Sci, Dept Biol, Inage Ku, 1-33 Yayoi, Chiba 2638522, Japan	Tohoku University; Tohoku University; University Shiga Prefecture; Chiba University	Takahashi, Y (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.; Takahashi, Y (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.; Takahashi, Y (corresponding author), Chiba Univ, Fac Sci, Dept Biol, Inage Ku, 1-33 Yayoi, Chiba 2638522, Japan.	takahashi.yum@gmail.com	Kawata, Masakado/E-3962-2012; Takahashi, Yuma/AGE-7935-2022	Takahashi, Yuma/0000-0003-1490-7837	JSPS [26650154]; JSPS KAKENHI [26650154]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS, Grant Number 26650154, https://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by JSPS KAKENHI Grant Number 26650154.	Alves TLS, 2014, MOL ECOL RESOUR, V14, P324, DOI 10.1111/1755-0998.12182; [Anonymous], 2014, R LANG ENV STAT COMP; ARMBRUSTER WS, 1994, ECOLOGY, V75, P315, DOI 10.2307/1939537; Brown BJ, 2001, OECOLOGIA, V129, P43, DOI 10.1007/s004420100700; Chauveau O, 2011, ANN BOT-LONDON, V107, P1287, DOI 10.1093/aob/mcr080; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Eaton DAR, 2012, ECOLOGY, V93, pS182, DOI 10.1890/11-0501.1; Endler J.A., 1977, Monographs in Population Biology, pi; ENDLER JA, 1973, SCIENCE, V179, P243, DOI 10.1126/science.179.4070.243; Fox J., 2019, R COMPANION APPL REG, V.; HEINRICH B, 1976, ECOL MONOGR, V46, P105, DOI 10.2307/1942246; Kay KM, 2009, ANNU REV ECOL EVOL S, V40, P637, DOI 10.1146/annurev.ecolsys.110308.120310; Kishi S, 2015, POPUL ECOL, V57, P283, DOI 10.1007/s10144-014-0455-0; KUNO E, 1992, RES POPUL ECOL, V34, P275, DOI 10.1007/BF02514797; LEVIN DA, 1970, AM NAT, V104, P455, DOI 10.1086/282680; Makino T., 1956, ILLUSTRATED FLORA JA; Makino TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143443; Matsumoto T, 2010, BIOL INVASIONS, V12, P1617, DOI 10.1007/s10530-009-9574-5; Muchhala N, 2014, EVOLUTION, V68, P2275, DOI 10.1111/evo.12441; Nishida S, 2014, FUNCT ECOL, V28, P450, DOI 10.1111/1365-2435.12165; Nishida S, 2012, BIOL INVASIONS, V14, P439, DOI 10.1007/s10530-011-0088-6; Norton NA, 2015, EVOLUTION, V69, P1191, DOI 10.1111/evo.12659; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Schiestl FP, 2009, ANNU REV ENTOMOL, V54, P425, DOI 10.1146/annurev.ento.54.110807.090603; Silva D. P., 2013, Journal of Pollination Ecology, V11, P27; SLATKIN M, 1973, GENETICS, V75, P733; Tacuatia LO, 2012, GENET MOL BIOL, V35, P99, DOI 10.1590/S1415-47572012005000012; Takahashi Y, 2015, J PLANT RES, V128, P933, DOI 10.1007/s10265-015-0750-7; Takahashi Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-256; Takakura K, 2009, BIOL INVASIONS, V11, P973, DOI 10.1007/s10530-008-9309-z; Yamaguchi H., 1987, Weed Research, Japan, V32, P38; YOSHIMURA J, 1994, THEOR POPUL BIOL, V45, P121, DOI 10.1006/tpbi.1994.1007	34	4	4	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164381	10.1371/journal.pone.0164381	http://dx.doi.org/10.1371/journal.pone.0164381			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723785	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100051
J	Davitkov, P; Chandar, AK; Hirsch, A; Compan, A; Silveira, MG; Anthony, DD; Smith, S; Gideon, C; Bonomo, RA; Falck-Ytter, Y				Davitkov, Perica; Chandar, Apoorva Krishna; Hirsch, Amy; Compan, Anita; Silveira, Marina G.; Anthony, Donald D.; Smith, Suzanne; Gideon, Clare; Bonomo, Robert A.; Falck-Ytter, Yngve			Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; VIRUS-INFECTION; CHRONIC HCV; RIBAVIRIN; ABT-450/R-OMBITASVIR; BOCEPREVIR; TELAPREVIR; SOFOSBUVIR; LEDIPASVIR; DASABUVIR	Background Clinicians often face dilemmas with decisions related to formulary choices when two similar drugs are simultaneously available in the market. We studied the comparative safety, effectiveness, and treatment costs of the two first generation direct-acting antiviral agents (DAA), boceprevir and telaprevir as uncertainty existed regarding the drug of choice between these two seemingly equally Hepatitis-C treatment options. Methods We randomly assigned 50 patients in an open-label, pragmatic randomized controlled trial (RCT) at a VA Medical Center to either boceprevir or telaprevir in combination with pegin-terferon and ribavirin, stratified by the presence of cirrhosis and prior treatment experience. Tolerability was assessed at each visit and reasons for discontinuation of treatment and severity of adverse events due to PI treatment were adjudicated using a blinded adjudication committee. The primary outcome was difference in tolerability between boceprevir vs. telaprevir. Secondary outcomes included viral response rates and cost-per cure achieved. Results Higher rates of treatment discontinuations and/or severe DAA associated adverse events were seen in 10/25 (40%) patients randomized to telaprevir compared to 2/25 (8%) patients randomized to boceprevir (RR: 5; 95% CI: 1.2, 20; p< 0.01). Cure rates did not appear to be significantly different between groups (telaprevir vs. boceprevir: RR 1.23; 95% CI: 0.76, 1.99; p = 0.39). On an intention-to-treat basis, total cost per cure was $ 44,329 for boceprevir vs. $ 57,115 for telaprevir. The significant side effect profile of telaprevir combined with the availability of highly efficacious second generation DAAs led to the early discontinuation of the trial. Conclusion Telaprevir is associated with a significantly higher rate of severe adverse events leading to treatment discontinuations, hospitalizations or severe anemia and a substantially higher cost per SVR when compared to boceprevir. Real-time, point of care, pragmatic randomized controlled trials are necessary for guidance beyond just acquisition costs and to make evidence-based formulary selections when multiple effective treatments are available. (Clinicaltrials. gov registration: NCT02113631).	[Davitkov, Perica; Chandar, Apoorva Krishna; Hirsch, Amy; Compan, Anita; Silveira, Marina G.; Anthony, Donald D.; Smith, Suzanne; Gideon, Clare; Bonomo, Robert A.; Falck-Ytter, Yngve] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA; [Davitkov, Perica; Chandar, Apoorva Krishna; Silveira, Marina G.; Anthony, Donald D.; Bonomo, Robert A.; Falck-Ytter, Yngve] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Davitkov, Perica; Chandar, Apoorva Krishna; Silveira, Marina G.; Anthony, Donald D.; Bonomo, Robert A.; Falck-Ytter, Yngve] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Hirsch, Amy; Bonomo, Robert A.; Falck-Ytter, Yngve] Louis Stokes Cleveland VA Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Falck-Ytter, Y (corresponding author), Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA.; Falck-Ytter, Y (corresponding author), Univ Hosp Case Med Ctr, Cleveland, OH USA.; Falck-Ytter, Y (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.; Falck-Ytter, Y (corresponding author), Louis Stokes Cleveland VA Med Ctr, Geriatr Res Educ & Clin Ctr, Cleveland, OH USA.	Yngve.Falck-Ytter@case.edu	Yngve Falck-Ytter, AGAF/AAC-5362-2019; Falck-Ytter, Yngve/GZH-0993-2022	Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; 	Louis Stokes Cleveland VA Medical Research & Education Foundation; Geriatric Research Education and Clinical Center (GREGG); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001104] Funding Source: NIH RePORTER	Louis Stokes Cleveland VA Medical Research & Education Foundation; Geriatric Research Education and Clinical Center (GREGG); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by the Louis Stokes Cleveland VA Medical Research & Education Foundation (PI: Dr. Yngve Falck-Ytter) and the Geriatric Research Education and Clinical Center (GREGG).	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; [Anonymous], TEL PRESCR INF; [Anonymous], BOC PRESCR INF; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2016, ALIMENT PHARM THER, V44, P400, DOI 10.1111/apt.13696; Bonnet D, 2014, WORLD J HEPATOL, V6, P660, DOI 10.4254/wjh.v6.i9.660; Brok J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005445.pub2; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Ioannou GN, 2016, GASTROENTEROLOGY, V151, P457, DOI 10.1053/j.gastro.2016.05.049; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; McCombs J, 2014, JAMA INTERN MED, V174, P204, DOI 10.1001/jamainternmed.2013.12505; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Pradat P, 2007, LIVER INT, V27, P335, DOI 10.1111/j.1478-3231.2006.01430.x; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; [WHO W. H. Organization], 2014, GUID SCREEN CAR TREA; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	32	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163945	10.1371/journal.pone.0163945	http://dx.doi.org/10.1371/journal.pone.0163945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741230	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000011
J	Ozaslan, C; Farooq, S; Onen, H; Bukun, B; Ozcan, S; Gunal, H				Ozaslan, Cumali; Farooq, Shahid; Onen, Huseyin; Bukun, Bekir; Ozcan, Selcuk; Gunal, Hikmet			Invasion Potential of Two Tropical Physalis Species in Arid and Semi-Arid Climates: Effect of Water-Salinity Stress and Soil Types on Growth and Fecundity	PLOS ONE			English	Article							SALT TOLERANCE; MINERAL-NUTRITION; LEAF-AREA; DROUGHT; PLANTS; INVASIVENESS; ACCUMULATION; REPRODUCTION; POPULATIONS; STRATEGIES	Invasive plants are recognized for their impressive abilities to withstand adverse environmental conditions however, all invaders do not express the similar abilities. Therefore, survival, growth, nutrient uptake and fecundity of two co-occurring, invasive Physalis species were tested under water and salinity stresses, and different soil textures in the current study. Five different water stress levels (100, 75, 50, 25, and 12.5% pot water contents), four different soil salinity levels (0, 3, 6, and 12 dSm(-1)) and four different soil textures (67% clay, 50% clay, silt clay loam and sandy loam) were included in three different pot experiments. Both weeds survived under all levels of water stress except 12.5% water contents and on all soil types however, behaved differently under increasing salinity. The weeds responded similarly to salinity up till 3 dSm(-1) whereas, P. philadelphica survived for longer time than P. angulata under remaining salinity regimes. Water and salinity stress hampered the growth and fecundity of both weeds while, soil textures had slight effect. Both weeds preferred clay textured soils for better growth and nutrient uptake however, interactive effect of weeds and soil textures was non-significant. P. angulata accumulated higher K and Na while P. philadelphica accrued more Ca and Mg as well as maintained better K/Na ratio. P. angulata accumulated more Na and P under salinity stress while, P. philadelphica accrued higher K and Mg, and maintained higher K/Na ratio. Collectively, highest nutrient accumulation was observed under stress free conditions and on clay textured soils. P. philadelphica exhibited higher reproductive output under all experimental conditions than P. angulata. It is predicted that P. philadelphica will be more problematic under optimal water supply and high salinity while P. angulata can better adapt water limited environments. The results indicate that both weeds have considerable potential to further expand their ranges in semi-arid regions of Turkey.	[Ozaslan, Cumali; Bukun, Bekir] Dicle Univ, Dept Plant Protect, Diyarbakir, Turkey; [Farooq, Shahid; Onen, Huseyin] Gaziosmanpasa Univ, Dept Plant Protect, Tokat, Turkey; [Ozcan, Selcuk] Pisachio Res Stn, Gaziantep, Turkey; [Gunal, Hikmet] Gaziosmanpasa Univ, Dept Soil Sci & Plant Nutr, Tokat, Turkey	Dicle University; Gaziosmanpasa University; Gaziosmanpasa University	Farooq, S (corresponding author), Gaziosmanpasa Univ, Dept Plant Protect, Tokat, Turkey.	csfa2006@gmail.com	ÖZASLAN, Cumali/ABI-4376-2020; Onen, Huseyin/AGR-8360-2022; Farooq, Shahid/A-4188-2012; Günal, Hikmet/AAA-1200-2021; Günal, Hikmet/AAH-9798-2021	ÖZASLAN, Cumali/0000-0002-8660-5451; Onen, Huseyin/0000-0003-3135-8040; Farooq, Shahid/0000-0002-6349-1404; GUNAL, Hikmet/0000-0002-4648-2645	Scientific and Technological Council of Turkey, TUBITAK [113 O 790]; Scientific and Technological Council of Turkey (TUBITAK), COST Action (TD 1209 European Information System for Alien Species) [113 O 790]; TUBITAK [2215]	Scientific and Technological Council of Turkey, TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Scientific and Technological Council of Turkey (TUBITAK), COST Action (TD 1209 European Information System for Alien Species); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The current study was funded by the Scientific and Technological Council of Turkey, TUBITAK (http://www.tubitak.gov.trien) with a Grant Number 113 O 790. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The current study was funded by the Scientific and Technological Council of Turkey (TUBITAK) with a Grant Number 113 O 790 as a part of the COST Action (TD 1209 European Information System for Alien Species). Shahid Farooq extends thanks to TUBITAK for supporting doctoral studies through providing fellowship under 2215 Graduate Scholarship program for international students. The authors also extend thanks to Sonnur TAD for her technical help.	Ahmad N, 2015, SOIL ENVIRON, V34, P15; Angert AL, 2007, J ECOL, V95, P321, DOI 10.1111/j.1365-2745.2006.01203.x; Arslan M., 2005, Journal of Agronomy, V4, P134; Asch F, 2000, EUPHYTICA, V113, P109, DOI 10.1023/A:1003981313160; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Barton CJ, 1948, IND ENG CHEM ANAL ED, V20, P1068; Bataglia OC, 1983, METODOS ANALISEQUIMI, P48; Blackburn TM, 2015, MOL ECOL, V24, P1942, DOI 10.1111/mec.13075; Blackburn TM, 2013, BIOL INVASIONS, V15, P1459, DOI 10.1007/s10530-013-0451-x; Bukun Bekir, 2002, Turkish Journal of Botany, V26, P405; Chauhan BS, 2013, WEED SCI, V61, P98, DOI 10.1614/WS-D-12-00060.1; Chauhan BS, 2010, WEED SCI, V58, P132, DOI 10.1614/WS-D-09-00016.1; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Dawson K, 2007, BIOL INVASIONS, V9, P327, DOI 10.1007/s10530-006-9036-2; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; FAO, 2005, MAN IRR IND SALT AFF; Farooq M., 2012, PLANT RESPONSES DROU, P1, DOI [10.1007/978-3-642-32653-0_1, DOI 10.1007/978-3-642-32653-0_1]; Farooq M, 2015, AGRON SUSTAIN DEV, V35, P461, DOI 10.1007/s13593-015-0287-0; Field CB, 2012, SPECIAL REPORT WORKI; Funk JL, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot026; Gonen Oya, 2000, Turkish Journal of Botany, V24, P299; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Hu YC, 2007, ENVIRON EXP BOT, V60, P268, DOI 10.1016/j.envexpbot.2006.11.003; Hunt R., 1990, BASIC GROWTH ANAL; Hussain M, 2013, INT J AGRIC BIOL, V15, P113; IBM Corp, 2013, IBM SPSS STAT WINDOW; IPCC, 2007, CONTRIBUTION WORKING; Kimball S, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou006; Lambers H., 2008, PLANT PHYSL ECOLOGY; Ledger ME, 2013, NAT CLIM CHANGE, V3, P223, DOI [10.1038/nclimate1684, 10.1038/NCLIMATE1684]; Liu F, 2004, SCI HORTIC-AMSTERDAM, V102, P15, DOI 10.1016/j.scienta.2003.11.014; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Quintero JM, 2007, J PLANT PHYSIOL, V164, P60, DOI 10.1016/j.jplph.2005.10.010; Mengel K., 2001, PRINCIPLES PLANT NUT, DOI [10.1007/978-94-010-1009-2, DOI 10.1007/978-94-010-1009-2]; Montes Hernandez S, 1994, PLANT PRODUCTION 26, V26, P117; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Parihar P, 2015, ENVIRON SCI POLLUT R, V22, P4056, DOI 10.1007/s11356-014-3739-1; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Rahlao SJ, 2010, WEED SCI, V58, P154, DOI 10.1614/WS-09-091.1; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Sangakkara UR, 2001, J AGRON CROP SCI, V186, P73, DOI 10.1046/j.1439-037X.2001.00433.x; Sarangi D, 2016, WEED SCI, V64, P42, DOI 10.1614/WS-D-15-00052.1; Scott JK, 2014, ADAPTNRM WEEDS CLIMA; Sensoy S., 2014, CLIMATE OF TURKEY; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Silva Elizamar C., 2009, Braz. J. Plant Physiol., V21, P33, DOI [10.1590/S1677-04202009000100005, 10.1590/S1677-04202009000100006]; Singh K.N., 2001, APPL PHYSL WHEAT BRE, P101; Steadman KJ, 2004, AUST J AGR RES, V55, P1047, DOI 10.1071/AR04083; Travlos IS, 2012, CHIL J AGR RES, V72, P358, DOI 10.4067/S0718-58392012000300009; Tuna AL, 2007, ENVIRON EXP BOT, V59, P173, DOI 10.1016/j.envexpbot.2005.12.007; Turner NC, 1997, ADV AGRON, V58, P293; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Vetterlein D, 2007, J PLANT NUTR SOIL SC, V170, P347, DOI 10.1002/jpln.200521952; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Waraich EA, 2011, AUST J CROP SCI, V5, P764; Webster TM, 2008, WEED SCI, V56, P561, DOI 10.1614/WS-07-186.1; Yang Q, 2015, OIKOS, V124, P216, DOI 10.1111/oik.01552; Zefferman E, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv056; Zhang L, 2014, ECOTOX ENVIRON SAFE, V104, P278, DOI 10.1016/j.ecoenv.2014.03.013; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	67	28	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164369	10.1371/journal.pone.0164369	http://dx.doi.org/10.1371/journal.pone.0164369			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741269	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000027
J	Saetan, U; Sangket, U; Deachamag, P; Chotigeat, W				Saetan, Uraipan; Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan			Ovarian Transcriptome Analysis of Vitellogenic and Non-Vitellogenic Female Banana Shrimp (Fenneropenaeus merguiensis)	PLOS ONE			English	Article							FRESH-WATER PRAWN; WHITE SHRIMP; MOLECULAR-CLONING; GENE-EXPRESSION; MITTEN CRAB; DE-MAN; SEROTONIN; MATURATION; CALMODULIN; CALCIUM	The banana shrimp (Fenneropenaeus merguiensis) is one of the most commercially important penaeid species in the world. Its numbers are declining in the wild, leading to a loss of broodstock for farmers of the shrimp and a need for more successful breeding programs. However, the molecular mechanism of the genes involved in this shrimp's ovarian maturation is still unclear. Consequently, we compared transcriptomic profiles of ovarian tissue from females in both the vitellogenic stage and the non-vitellogenic stage. Using RNA-Seq technology to prepare the transcriptome libraries, a total of 12,187,412 and 11,694,326 sequencing reads were acquired from the non-vitellogenic and vitellogenic stages respectively. The analysis of the differentially expressed genes identified 1,025 which were significantly differentially expressed between the two stages, of which 694 were up-regulated and 331 down-regulated. Four genes putatively involved in the ovarian maturation pathway were chosen for validation by quantitative real-time PCR (RT-qPCR). The data from this study provided information about gene expression in ovarian tissue of the banana shrimp which could be useful for a better understanding of the regulation of this species' reproductive cycle.	[Saetan, Uraipan; Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan] Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Songkhla, Thailand; [Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan] Prince Songkla Univ, Fac Sci, Ctr Excellent Genom & Bioinformat Res, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University	Chotigeat, W (corresponding author), Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Songkhla, Thailand.; Chotigeat, W (corresponding author), Prince Songkla Univ, Fac Sci, Ctr Excellent Genom & Bioinformat Res, Hat Yai, Songkhla, Thailand.	wilaiwan58@hotmail.com	Saetan, Uraipan/GQH-3395-2022; Saetan, Uraipan/AAO-7612-2021	Saetan, Uraipan/0000-0003-0554-0543	Science Achievement Scholarship of Thailand (SAST)	Science Achievement Scholarship of Thailand (SAST)	This study was financially supported by the Science Achievement Scholarship of Thailand (SAST).	Acevedo N, 2007, BIOL REPROD, V77, P872, DOI 10.1095/biolreprod.107.060152; Babu K. N., 2013, International Journal of Pharmacy and Life Sciences (IJPLS), V4, P2785; Benninghoff AD, 2005, GEN COMP ENDOCR, V144, P211, DOI 10.1016/j.ygcen.2005.06.005; CARNEGIE JA, 1984, BIOL REPROD, V30, P515, DOI 10.1095/biolreprod30.2.515; CHARNIAUXCOTTON H, 1985, AM ZOOL, V25, P197; CICIRELLI MF, 1987, DEV BIOL, V121, P48, DOI 10.1016/0012-1606(87)90137-0; Forsatkar M. N., 2013, International Research Journal of Applied and Basic Sciences, V4, P1272; FRANCISCO SKS, 1987, J EXP ZOOL, V244, P133, DOI 10.1002/jez.1402440116; Grey DL, 1983, GUIDE AUSTR PENAEID; Ikhwanuddin Mhd, 2012, World Applied Sciences Journal, V18, P436; Kezele PR, 2002, MOL CELL ENDOCRINOL, V192, P37, DOI 10.1016/S0303-7207(02)00114-4; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Klinbunga S, 2015, AQUACULTURE, V435, P18, DOI 10.1016/j.aquaculture.2014.09.013; Kuo CM, 2009, ZOOL STUD, V48, P597; Leelatanawit R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-15; Maestro MA, 1997, BIOL REPROD, V56, P1126, DOI 10.1095/biolreprod56.5.1126; Makkapan W, 2011, AQUACULTURE, V321, P101, DOI 10.1016/j.aquaculture.2011.08.016; Miura T, 2008, CYBIUM, V32, P130; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakatsuji T, 2009, COMP BIOCHEM PHYS A, V152, P139, DOI 10.1016/j.cbpa.2008.10.012; Palasin K, 2014, AQUACULTURE, V432, P38, DOI 10.1016/j.aquaculture.2014.04.025; Ponza P, 2011, MOL REPROD DEV, V78, P347, DOI 10.1002/mrd.21310; Powell D, 2015, MAR GENOM, V22, P71, DOI 10.1016/j.margen.2015.04.006; Preechaphol R, 2007, J BIOCHEM MOL BIOL, V40, P501; Preechaphol R, 2010, GEN COMP ENDOCR, V168, P440, DOI 10.1016/j.ygcen.2010.06.002; QUACKENBUSH LS, 1992, COMP BIOCHEM PHYS A, V103, P711; Shen BL, 2009, MOL BIOL REP, V36, P1149, DOI 10.1007/s11033-008-9291-7; Subramoniam T, 2011, FISHERIES SCI, V77, P1, DOI 10.1007/s12562-010-0301-z; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tinikul Y, 2008, GEN COMP ENDOCR, V158, P250, DOI 10.1016/j.ygcen.2008.07.009; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Vaca AA, 2000, AQUACULTURE, V182, P373, DOI 10.1016/S0044-8486(99)00267-7; Wong QWL, 2008, MAR BIOTECHNOL, V10, P91, DOI 10.1007/s10126-007-9042-0; Wonglapsuwan M, 2010, MAR BIOTECHNOL, V12, P230, DOI 10.1007/s10126-009-9220-3; Wonglapsuwan M, 2009, AQUAC RES, V40, P633, DOI 10.1111/j.1365-2109.2008.02136.x; Wongprasert K, 2006, AQUACULTURE, V261, P1447, DOI 10.1016/j.aquaculture.2006.08.044; Yariez M, 2012, CALCIUM BINDING PROT; Zeng H, 2011, MAR BIOL RES, V7, P617, DOI 10.1080/17451000.2010.528775; Zhang EF, 2010, DEV GENES EVOL, V220, P151, DOI 10.1007/s00427-010-0336-2; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhao WH, 2011, MOL BIOL REP, V38, P1399, DOI 10.1007/s11033-010-0243-7; Zou ZH, 2011, COMP BIOCHEM PHYS D, V6, P150, DOI 10.1016/j.cbd.2010.12.003	43	15	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164724	10.1371/journal.pone.0164724	http://dx.doi.org/10.1371/journal.pone.0164724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741294	gold, Green Submitted, Green Published			2022-12-27	WOS:000385507000060
J	Sitters, H; York, A; Swan, M; Christie, F; Di Stefano, J				Sitters, Holly; York, Alan; Swan, Matthew; Christie, Fiona; Di Stefano, Julian			Opposing Responses of Bird Functional Diversity to Vegetation Structural Diversity in Wet and Dry Forest	PLOS ONE			English	Article							SPECIES RICHNESS; HABITAT STRUCTURE; FIRE; CONSERVATION; DISTURBANCE; LANDSCAPES; PATTERNS; PRODUCTIVITY; COMMUNITIES; DIVERGENCE	Disturbance regimes are changing worldwide, and the consequences for ecosystem function and resilience are largely unknown. Functional diversity (FD) provides a surrogate measure of ecosystem function by capturing the range, abundance and distribution of trait values in a community. Enhanced understanding of the responses of FD to measures of vegetation structure at landscape scales is needed to guide conservation management. To address this knowledge gap, we used a whole-of-landscape sampling approach to examine relationships between bird FD, vegetation diversity and time since fire. We surveyed birds and measured vegetation at 36 landscape sampling units in dry and wet forest in southeast Australia during 2010 and 2011. Four uncorrelated indices of bird FD (richness, evenness, divergence and dispersion) were derived from six bird traits, and we investigated responses of these indices and species richness to both vertical and horizontal vegetation diversity using linear mixed models. We also considered the extent to which the mean and diversity of time since fire were related to vegetation diversity. Results showed opposing responses of FD to vegetation diversity in dry and wet forest. In dry forest, where fire is frequent, species richness and two FD indices (richness and dispersion) were positively related to vertical vegetation diversity, consistent with theory relating to environmental variation and coexistence. However, in wet forest subject to infrequent fire, the same three response variables were negatively associated with vertical diversity. We suggest that competitive dominance by species results in lower FD as vegetation diversity increases in wet forest. The responses of functional evenness were opposite to those of species richness, functional richness and dispersion in both forest types, highlighting the value of examining multiple FD metrics at management-relevant scales. The mean and diversity of time since fire were uncorrelated with vegetation diversity in wet forest, but positively correlated with vegetation diversity in dry forest. We therefore suggest that protection of older vegetation is important, but controlled application of low-severity fire in dry forest may sustain ecosystem function by enhancing different elements of FD.	[Sitters, Holly; York, Alan; Swan, Matthew; Christie, Fiona; Di Stefano, Julian] Univ Melbourne, Sch Ecosyst & Forest Sci, Creswick, Vic, Australia	University of Melbourne	Sitters, H (corresponding author), Univ Melbourne, Sch Ecosyst & Forest Sci, Creswick, Vic, Australia.	holly.sitters@unimelb.edu.au	York, Alan/M-2443-2015; Di Stefano, Julian/M-9672-2019; Sitters, Holly/L-3302-2019	York, Alan/0000-0003-3161-4075; Di Stefano, Julian/0000-0001-7846-6642; Sitters, Holly/0000-0002-6313-6779; Swan, Matthew/0000-0001-6878-476X	Victorian State Government Department of Environment, Land, Water and Planning; Parks Victoria; Holsworth Wildlife Research Endowment	Victorian State Government Department of Environment, Land, Water and Planning; Parks Victoria; Holsworth Wildlife Research Endowment	This work was funded by the Victorian State Government Department of Environment, Land, Water and Planning (www delwp.vic.gov.au), Parks Victoria (www.parkweb.vic.gov.au) and a Holsworth Wildlife Research Endowment to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2013, FOREST ECOL MANAG, V294, P250, DOI 10.1016/j.foreco.2012.11.039; Bar-Massada A, 2014, ECOGRAPHY, V37, P528, DOI 10.1111/j.1600-0587.2013.00590.x; Barbaro L, 2014, DIVERS DISTRIB, V20, P149, DOI 10.1111/ddi.12132; Barton K, 2015, MUMIN MULTIMODEL INT, V1, P4, DOI DOI 10.1111/J.2041-210X.2012.00261.X; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brotons L, 2005, J BIOGEOGR, V32, P789, DOI 10.1111/j.1365-2699.2004.01195.x; Brotons L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062392; Brown AM, 2014, METHODS ECOL EVOL, V5, P344, DOI 10.1111/2041-210X.12163; Bureau of Meteorology, 2015, CLIM DAT ONL; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cheal D., 2010, GROWTH STAGES TOLERA; Costermans L., 2006, NATIVE TREES SHRUBS; Cousin JA, 2008, AUST J ZOOL, V56, P95, DOI 10.1071/ZO07065; Culbert PD, 2013, AUK, V130, P656, DOI 10.1525/auk.2013.13007; Department of Environment and Primary Industries, 2013, 2013 14 2015 16 FIR; Di Stefano J, 2013, BIOL CONSERV, V166, P111, DOI 10.1016/j.biocon.2013.06.022; Dias DFC, 2016, RESTOR ECOL, V24, P259, DOI 10.1111/rec.12293; ESRI, 2011, ARCGIS VERS 10; FAO, 2020, GLOBAL FOREST RESOUR; Fernandes PM, 2013, FRONT ECOL ENVIRON, V11, pE4, DOI 10.1890/120298; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gonzalez-Maya JF, 2016, DIVERS DISTRIB, V22, P43, DOI 10.1111/ddi.12373; Hidasi-Neto J, 2012, ANIM CONSERV, V15, P407, DOI 10.1111/j.1469-1795.2012.00528.x; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hovick TJ, 2015, ECOL APPL, V25, P662, DOI 10.1890/14-1067.1; Huston M. A., 1994, BIOL DIVERSITY; Huston MA, 2004, DIVERS DISTRIB, V10, P167, DOI 10.1111/j.1366-9516.2004.00083.x; Jankowski JE, 2013, J BIOGEOGR, V40, P950, DOI 10.1111/jbi.12041; Laliberte E., 2014, PACKAGE FD MEASURING; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lindenmayer D, 2015, DIVERS DISTRIB, V21, P836, DOI 10.1111/ddi.12328; Luck GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063671; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Maravalhas J, 2014, J APPL ECOL, V51, P1661, DOI 10.1111/1365-2664.12338; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McWethy DB, 2010, LANDSCAPE ECOL, V25, P533, DOI 10.1007/s10980-009-9437-6; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Penman TD, 2007, FOREST ECOL MANAG, V252, P24, DOI 10.1016/j.foreco.2007.06.004; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; R Core Team, 2021, R LANGUAGE ENV STAT; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Seymour CL, 2015, ECOSYSTEMS, V18, P971, DOI 10.1007/s10021-015-9875-8; Sitters H, 2016, ECOL APPL, V26, P115, DOI 10.1890/14-1562; Sitters H, 2015, INT J WILDLAND FIRE, V24, P690, DOI 10.1071/WF14123; Sitters H, 2014, FOREST ECOL MANAG, V331, P227, DOI 10.1016/j.foreco.2014.08.013; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stoklosa J, 2014, BIOMETRICS, V70, P110, DOI 10.1111/biom.12118; Swan M, 2015, ECOL APPL, V25, P2293, DOI 10.1890/14-1533.1; Taylor RS, 2012, DIVERS DISTRIB, V18, P519, DOI 10.1111/j.1472-4642.2011.00842.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thompson PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117595; Tibshirani R., 1996, J R STAT SOC B, V42, P143; Tilman D., 2001, ENCY BIODIVERSITY, P109, DOI DOI 10.1016/B0-12-226865-2/00132-2; Ibarra JT, 2015, BIOL CONSERV, V192, P418, DOI 10.1016/j.biocon.2015.11.008; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Verschuyl JP, 2008, ECOL APPL, V18, P1155, DOI 10.1890/07-0839.1; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x; Wang Y., 2015, MVABUND STAT METHODS; Watson SJ, 2014, FRONT ECOL ENVIRON, V12, P241, DOI 10.1890/130097; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; Zhang J, 2013, J BIOGEOGR, V40, P1131, DOI 10.1111/jbi.12063; Zuur A, 2009, MIXED EFFECTS MODELS	74	13	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164917	10.1371/journal.pone.0164917	http://dx.doi.org/10.1371/journal.pone.0164917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741290	Green Published, gold			2022-12-27	WOS:000385507000082
J	Munoz-Bravo, JL; Flores-Martinez, A; Herrero-Martin, G; Puri, S; Taketo, MM; Rojas, A; Hebrok, M; Cano, DA				Luis Munoz-Bravo, Jose; Flores-Martinez, Alvaro; Herrero-Martin, Griselda; Puri, Sapna; Taketo, Makoto Mark; Rojas, Anabel; Hebrok, Matthias; Cano, David A.			Loss of Pancreas upon Activated Wnt Signaling Is Concomitant with Emergence of Gastrointestinal Identity	PLOS ONE			English	Article							BETA-CATENIN; EXPRESSION PATTERNS; TRANSGENIC MICE; ORGAN FORMATION; HEDGEHOG; GROWTH; ENDODERM; DIFFERENTIATION; ORGANOGENESIS; DISEASE	Organ formation is achieved through the complex interplay between signaling pathways and transcriptional cascades. The canonical Wnt signaling pathway plays multiple roles during embryonic development including patterning, proliferation and differentiation in distinct tissues. Previous studies have established the importance of this pathway at multiple stages of pancreas formation as well as in postnatal organ function and homeostasis. In mice, gain-of-function experiments have demonstrated that activation of the canonical Wnt pathway results in pancreatic hypoplasia, a phenomenon whose underlying mechanisms remains to be elucidated. Here, we show that ectopic activation of epithelial canonical Wnt signaling causes aberrant induction of gastric and intestinal markers both in the pancreatic epithelium and mesenchyme, leading to the development of gut-like features. Furthermore, we provide evidence that beta-catenin-induced impairment of pancreas formation depends on Hedgehog signaling. Together, our data emphasize the developmental plasticity of pancreatic progenitors and further underscore the key role of precise regulation of signaling pathways to maintain appropriate organ boundaries.	[Luis Munoz-Bravo, Jose; Flores-Martinez, Alvaro; Herrero-Martin, Griselda; Cano, David A.] Hosp Univ Virgen Rocio, Unidad Gest Clin Endocrinol & Nutr, Seville, Spain; [Luis Munoz-Bravo, Jose; Flores-Martinez, Alvaro; Herrero-Martin, Griselda; Cano, David A.] Univ Seville, CSIC, Inst Biomed Sevilla IBiS, Hosp Univ Virgen Rocio, Seville, Spain; [Puri, Sapna; Hebrok, Matthias] Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA; [Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Rojas, Anabel] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain; [Rojas, Anabel] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of California System; University of California San Francisco; Kyoto University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Cano, DA (corresponding author), Hosp Univ Virgen Rocio, Unidad Gest Clin Endocrinol & Nutr, Seville, Spain.; Cano, DA (corresponding author), Univ Seville, CSIC, Inst Biomed Sevilla IBiS, Hosp Univ Virgen Rocio, Seville, Spain.	dcano-ibis@us.es	Cano, David A./B-8013-2015; Martínez, Álvaro Flores/N-6406-2017; IBIS, FISIOLOGIA/O-9485-2015; Rojas, Anabel/E-8768-2014	Cano, David A./0000-0001-6264-3288; Martínez, Álvaro Flores/0000-0002-4926-3288; Rojas, Anabel/0000-0003-0733-8277	Nicolas Monardes program of Andalusian Ministry of Health [C-0015-2014]; Andalusian Ministry of Science and Innovation [CTS-7478]; Ministry of Economy and Competitiveness, Spain [SAF2011-26805, BES-2009-012084]; Ministry of Economy and Competitiveness, Spain; Ramon y Cajal Program [RYC-2013-14533]; Institute de Salud Carlos III, Spain; Fondos FEDER [PI14/00804]; National Institute of Health, US [DK105831]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105831] Funding Source: NIH RePORTER	Nicolas Monardes program of Andalusian Ministry of Health; Andalusian Ministry of Science and Innovation; Ministry of Economy and Competitiveness, Spain; Ministry of Economy and Competitiveness, Spain; Ramon y Cajal Program(Spanish Government); Institute de Salud Carlos III, Spain(Instituto de Salud Carlos III); Fondos FEDER(European Commission); National Institute of Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Nicolas Monardes program of Andalusian Ministry of Health (www.juntadeandalucia.es/fundacionprogresoysalud/es), Grant number: C-0015-2014 (DAC); Andalusian Ministry of Science and Innovation (www.juntadeandalucia.es/ innovacioncienciayempresa), Grant number: CTS-7478 (DAC); Ministry of Economy and Competitiveness, Spain ((www.mineco.gob.es), Grant number: SAF2011-26805 (DAC); Ministry of Economy and Competitiveness, Spain (www.mineco.gob.es), predoctoral fellowship number: BES-2009-012084 (JLMB); Ministry of Economy and Competitiveness, Spain (www.mineco.gob.es), Ramon y Cajal Program number: RYC-2013-14533 (AR); Institute de Salud Carlos III, Spain (www.isciii.es) cofunded by Fondos FEDER, Grant Number: PI14/00804 (AR); and National Institute of Health, US (www.nih.gov) Grant Number: DK105831 (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afelik S, 2015, DEV BIOL, V399, P204, DOI 10.1016/j.ydbio.2014.12.031; Ahnfelt-Ronne J, 2007, J HISTOCHEM CYTOCHEM, V55, P925, DOI 10.1369/jhc.7A7226.2007; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Asayesh A, 2006, GENE DEV, V20, P2208, DOI 10.1101/gad.381906; Baumgartner BK, 2014, DEV BIOL, V391, P89, DOI 10.1016/j.ydbio.2014.03.019; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Cano DA, 2007, GASTROENTEROLOGY, V132, P745, DOI 10.1053/j.gastro.2006.12.054; Cano DA, 2014, CELL MOL LIFE SCI, V71, P2383, DOI 10.1007/s00018-013-1510-2; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; D'Journo XB, 2004, J CLIN PATHOL, V57, P1215, DOI 10.1136/jcp.2004.019091; Gagniere J, 2014, WORLD J GASTRO SURG, V6, P42, DOI 10.4240/wjgs.v6.i3.42; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; Jennings RE, 2015, DEVELOPMENT, V142, P3126, DOI 10.1242/dev.120063; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kim BM, 2007, DEVELOPMENT, V134, P3603, DOI 10.1242/dev.009308; Kim BM, 2007, GASTROENTEROLOGY, V133, P529, DOI 10.1053/j.gastro.2007.04.072; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006; Munoz-Bravo JL, 2013, DEVELOPMENT, V140, P3669, DOI 10.1242/dev.091256; Magenheim J, 2011, DEVELOPMENT, V138, P4743, DOI 10.1242/dev.066548; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Murtaugh LC, 2015, ANNU REV PHYSIOL, V77, P229, DOI 10.1146/annurev-physiol-021014-071727; Murtaugh L Charles, 2008, Organogenesis, V4, P81; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Puri S, 2015, CELL STEM CELL, V16, P18, DOI 10.1016/j.stem.2014.11.001; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Serup P, 2012, SEMIN CELL DEV BIOL, V23, P663, DOI 10.1016/j.semcdb.2012.06.004; Seymour PA, 2012, DEVELOPMENT, V139, P3363, DOI 10.1242/dev.078733; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Sherwood RI, 2009, DEV DYNAM, V238, P29, DOI 10.1002/dvdy.21810; Shih HP, 2015, CELL REP, V13, P326, DOI 10.1016/j.celrep.2015.08.082; Shih HP, 2013, ANNU REV CELL DEV BI, V29, P81, DOI 10.1146/annurev-cellbio-101512-122405; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Strom A, 2007, DEVELOPMENT, V134, P2719, DOI 10.1242/dev.02875; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; van Eyll JM, 2004, J CELL SCI, V117, P2077, DOI 10.1242/jcs.01067; Verzi Michael P, 2008, Organogenesis, V4, P87; Xuan SH, 2016, DEVELOPMENT, V143, P780, DOI 10.1242/dev.127217; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	51	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164714	10.1371/journal.pone.0164714	http://dx.doi.org/10.1371/journal.pone.0164714			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736991	Green Published, gold			2022-12-27	WOS:000385505800119
J	Salinas-Vargas, D; Santillan-Galicia, MT; Guzman-Franco, AW; Hernandez-Lopez, A; Ortega-Arenas, LD; Mora-Aguilera, G				Salinas-Vargas, Delfina; Teresa Santillan-Galicia, Ma; Guzman-Franco, Ariel W.; Hernandez-Lopez, Antonio; Ortega-Arenas, Laura D.; Mora-Aguilera, Gustavo			Analysis of Genetic Variation in Brevipalpus yothersi (Acari: Tenuipalpidae) Populations from Four Species of Citrus Host Plants	PLOS ONE			English	Article							TETRANYCHUS-URTICAE ACARI; PHOENICIS ACARI; MARKERS REVEAL; VIRUS; MITES; CALIFORNICUS; MITOCHONDRIAL; ADAPTATION	We studied species diversity and genetic variation among populations of Brevipalpus mites from four species of citrus host plants. We sampled mites on orange, lime, grapefruit and mandarin trees from orchards at six localities distributed in the five most important citrus producing states in Mexico. Genetic variation among citrus host plants and localities were assessed by analysis of nucleotide sequence data from fragments of the mitochondrial cytochrome oxidase subunit I (COI). Both Brevipalpus yothersi and B. californicus were found at these sites, and B. yothersi was the most abundant species found on all citrus species and in all localities sampled. B. californicus was found mainly on orange and mandarin and only in two of the states sampled. AMOVA and haplotype network analyses revealed no correlation between B. yothersi genetic population structure and geographical origin or citrus host plant species. Considering that a previous study reported greater genetic diversity in B. yothersi populations from Brazil than we observed in Mexico, we discuss the possibility that the Mexican populations may have originated in the southern region of America.	[Salinas-Vargas, Delfina; Teresa Santillan-Galicia, Ma; Guzman-Franco, Ariel W.; Ortega-Arenas, Laura D.] Colegio Postgrad, Posgrad Fitosanidad Entomol & Acarol, Texcoco, Edo De Mexico, Mexico; [Hernandez-Lopez, Antonio] UNAM, Unidad Leon, Escuela Nacl Estudios Super, Guanajuato, Mexico; [Mora-Aguilera, Gustavo] Colegio Postgrad, Posgrad Fitosanidad Fitopatol, Texcoco, Edo De Mexico, Mexico	Colegio de Postgraduados - Mexico; Universidad Nacional Autonoma de Mexico; Colegio de Postgraduados - Mexico	Santillan-Galicia, MT (corresponding author), Colegio Postgrad, Posgrad Fitosanidad Entomol & Acarol, Texcoco, Edo De Mexico, Mexico.	tgalicia@colpos.mx			CONACYT-Mexico	CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	DSV received a scholarship from CONACYT-Mexico. We thank the Crop Protection Committees from the states of Sinaloa, Michoacan, Veracruz, Nuevo Leon and Yucatan for their valuable help during mite collection in the field. No conflict of interest declared by the authors.	Abouzid AM, 2002, PLANT DIS, V86, P1109, DOI [10.1094/PDIS.2002.86.10.1109, 10.1094/PDIS.2002.86.12.1402D]; Bastianel Marinês, 2006, Summa phytopathol., V32, P211, DOI 10.1590/S0100-54052006000300001; Bastianel M, 2010, PLANT DIS, V94, P284, DOI 10.1094/PDIS-94-3-0284; Beard JJ, 2015, ZOOTAXA, V3944, P1, DOI 10.11646/zootaxa.3944.1.1; Beard JJ, 2012, FLAT MITES OF THE WO; Carbonnelle S, 2007, EXP APPL ACAROL, V41, P225, DOI 10.1007/s10493-007-9068-z; Chagas CM, 2003, EXP APPL ACAROL, V30, P203, DOI 10.1023/B:APPA.0000006549.87310.41; Childers CC, 2011, ZOOSYMPOSIA, V6, P180, DOI 10.11646/zoosymposia.6.1.28; Childers CC, 2003, EXP APPL ACAROL, V30, P5, DOI 10.1023/B:APPA.0000006543.34042.b4; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cogni R, 2009, BIOL J LINN SOC, V97, P494, DOI 10.1111/j.1095-8312.2009.01234.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Groot TVM, 2005, EXP APPL ACAROL, V36, P165, DOI 10.1007/s10493-005-3360-6; Guzman-Valencia S, 2014, B ENTOMOL RES, V104, P610, DOI 10.1017/S0007485314000388; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jeppson LR., 1975, MITES INJURIOUS EC P, P614, DOI [10.1525/9780520335431, DOI 10.1525/9780520335431]; Kitajima Elliot W., 2001, Journal of General Plant Pathology, V67, P231, DOI 10.1007/PL00013018; Kitajima Elliot W., 1997, Fitopatologia Brasileira, V22, P555; Kitajima EW, 2010, SCI AGR, V67, P348, DOI 10.1590/S0103-90162010000300014; Kitajima EW, 2003, EXP APPL ACAROL, V30, P225, DOI 10.1023/B:APPA.0000006551.74604.84; Kondo H, 2003, EXP APPL ACAROL, V30, P215, DOI 10.1023/B:APPA.0000006550.88615.10; Magalhaes S, 2007, EXP APPL ACAROL, V42, P225, DOI 10.1007/s10493-007-9091-0; Mesa NC, 2009, ZOOTAXA, P1; Mopper S, 2000, ECOLOGY, V81, P1577, DOI 10.1890/0012-9658(2000)081[1577:SVILPS]2.0.CO;2; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pascual-Ruiz S, 2014, EXP APPL ACAROL, V62, P477, DOI 10.1007/s10493-013-9755-x; Rodrigues JCV, 2008, TROP PLANT PATHOL, V33, P12, DOI 10.1590/S1982-56762008000100003; Rodrigues JCV, 2013, EXP APPL ACAROL, V59, P165, DOI 10.1007/s10493-012-9632-z; Salinas-Vargas D, 2013, NEOTROP ENTOMOL, V42, P419, DOI 10.1007/s13744-013-0140-6; Sanchez-Velazquez EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133861; Sword GA, 2005, MOL ECOL, V14, P2197, DOI 10.1111/j.1365-294X.2005.02546.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsagkarakou A, 1997, HEREDITY, V78, P84, DOI 10.1038/hdy.1997.10; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; Welbourn WC, 2003, EXP APPL ACAROL, V30, P107, DOI 10.1023/B:APPA.0000006545.40017.a0	40	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164552	10.1371/journal.pone.0164552	http://dx.doi.org/10.1371/journal.pone.0164552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736923	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800083
J	Xu, L; Zhou, ZF				Xu, Liang; Zhou, Zhen-Feng			Effects of Cu Pollution on the Expansion of an Amphibious Clonal Herb in Aquatic-Terrestrial Ecotones	PLOS ONE			English	Article							BIOTIC LIGAND MODEL; ALTERNANTHERA-PHILOXEROIDES; PHYSIOLOGICAL INTEGRATION; ALLIGATOR WEED; HEAVY-METALS; NUTRIENT AVAILABILITY; PHENOTYPIC PLASTICITY; COMPETITIVE ABILITY; FRAGARIA-VESCA; PLANT	Physiological integration can enhance the performance of clonal plants in aquatic and terrestrial heterogeneous habitats and associated ecotones. Similar to nutrients, pollutants may be transported among connected ramets via physiological integration. Few studies have examined the expansion of amphibious clonal plants from terrestrial to aquatic environments, particularly when the local water supply is polluted with heavy metals. A greenhouse experiment was conducted using the amphibious plant Alternanthera philoxeroides to determine whether Cu can spread among clonal plants and examine the corresponding effects of this pollution on the expansion of clonal plants in aquatic-terrestrial ecotones. Ramets from the same clonal fragments were rooted in unpolluted soil and polluted water at five different levels. The responses of the ramets in terrestrial and aquatic habitats were quantified via traits associated with growth, morphology and Cu accumulation. The results indicated that ramets in soil and water significantly differed in nearly all of these traits. The expansion of populations from terrestrial to polluted aquatic habitats was facilitated by stem elongation rather than new ramet production. The accumulated Cu in polluted ramets can be horizontally transported to other ramets in soil via connected stolons. In terms of clonal growth patterns, variations in Cu pollution intensity were negatively correlated with variations in the morphological and growth traits of ramets in polluted aquatic habitats and unpolluted soil. We concluded that Cu ions are distributed among the clones and accumulated in different ramet tissues in heterogeneous habitats. Therefore, we suggest that Cu pollution of aquatic-terrestrial ecotones, especially at high levels, can affect the growth and expansion of the whole clones because Cu ions are shared between integrated ramets.	[Xu, Liang; Zhou, Zhen-Feng] Qingdao Agr Univ, Coll Resource & Environm, Qingdao, Peoples R China	Qingdao Agricultural University	Xu, L (corresponding author), Qingdao Agr Univ, Coll Resource & Environm, Qingdao, Peoples R China.	xuliang@qau.edu.cn			Natural Science Foundation of Shandong Province [2014BSB01225]; Advanced Talents Foundation of QAU [631328]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China [6622315013]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Advanced Talents Foundation of QAU; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This study was financed by the Natural Science Foundation of Shandong Province (No. 2014BSB01225), Advanced Talents Foundation of QAU (No. 631328), Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China (No. 6622315013).	Antunes PMC, 2006, ENVIRON TOXICOL CHEM, V25, P875, DOI 10.1897/04-586R.1; Bonser SP, 2003, AM J BOT, V90, P404, DOI 10.3732/ajb.90.3.404; Burgin S, 2010, WEED TECHNOL, V24, P121, DOI 10.1614/WT-08-059.1; DEKROON H, 1991, J ECOL, V79, P519, DOI 10.2307/2260730; Dong BC, 2015, OECOLOGIA, V179, P393, DOI 10.1007/s00442-015-3338-y; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Geng YP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00213; Gruntman M, 2011, ANN BOT-LONDON, V108, P965, DOI 10.1093/aob/mcr204; Guo W, 2012, PLANT SPEC BIOL, V27, P46, DOI 10.1111/j.1442-1984.2011.00335.x; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; Huber H, 2012, NEW PHYTOL, V194, P572, DOI 10.1111/j.1469-8137.2012.04075.x; Kleijn D, 1999, J ECOL, V87, P873, DOI 10.1046/j.1365-2745.1999.00406.x; Lavergne S, 2010, ANN BOT-LONDON, V105, P109, DOI 10.1093/aob/mcp271; Li JJ, 2012, PLANT BIOLOGY, V14, P265, DOI 10.1111/j.1438-8677.2011.00500.x; Liu J, 2008, PHOTOSYNTHETICA, V46, P299, DOI 10.1007/s11099-008-0054-4; Liu L, 2016, AQUAT BOT, V128, P33, DOI 10.1016/j.aquabot.2015.09.005; Luo XS, 2008, CHEMOSPHERE, V73, P401, DOI 10.1016/j.chemosphere.2008.05.031; Malar S, 2014, BOT STUD, V55, DOI 10.1186/s40529-014-0054-6; Soriano-Disla JM, 2014, J SOIL SEDIMENT, V14, P687, DOI 10.1007/s11368-013-0773-4; Mattina MI, 2003, ENVIRON POLLUT, V124, P375, DOI 10.1016/S0269-7491(03)00060-5; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Peltzer DA, 2002, AM J BOT, V89, P494, DOI 10.3732/ajb.89.3.494; Pierik R, 2009, ANN BOT-LONDON, V103, P353, DOI 10.1093/aob/mcn143; Prasad MNV, 1995, ENVIRON EXP BOT, V35, P525, DOI 10.1016/0098-8472(95)00024-0; Rich SM, 2011, NEW PHYTOL, V190, P311, DOI 10.1111/j.1469-8137.2010.03524.x; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Roiloa SR, 2006, PHYSIOL PLANTARUM, V128, P662, DOI 10.1111/j.1399-3054.2006.00790.x; Roiloa SR, 2012, ECOL RES, V27, P95, DOI 10.1007/s11284-011-0876-6; ROSS S.M., 1994, SOURCES FORMS POTENT, P3; SHUMWAY SW, 1995, ANN BOT-LONDON, V76, P225, DOI 10.1006/anbo.1995.1091; Sindhujaa Vajravel, 2013, Journal of Pharmacy Research, V7, P633; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Song ZZ, 2013, WEED SCI, V61, P77, DOI 10.1614/WS-D-12-00100.1; Sui YA, 2011, ANN BOT-LONDON, V107, P693, DOI 10.1093/aob/mcr012; Sun ZG, 2010, PLANT SOIL, V337, P457, DOI 10.1007/s11104-010-0542-8; Wang N, 2009, PLANT BIOLOGY, V11, P483, DOI 10.1111/j.1438-8677.2008.00133.x; Wang N, 2008, ANN BOT-LONDON, V101, P671, DOI 10.1093/aob/mcn005; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Xu CY, 2003, BIODIVERS CONSERV, V12, P637, DOI 10.1023/A:1022453129662; Xu L, 2016, POL J ENVIRON STUD, V25, P395, DOI 10.15244/pjoes/60374; Xu L, 2013, NEW PHYTOL, V199, P991, DOI 10.1111/nph.12315; Xu L, 2012, ANN BOT-LONDON, V109, P1001, DOI 10.1093/aob/mcs006; Yan X, 2013, ENVIRON POLLUT, V174, P114, DOI 10.1016/j.envpol.2012.10.013; Ye WH, 2003, WEED RES, V43, P297, DOI 10.1046/j.1365-3180.2003.00346.x; You WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097246	46	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164361	10.1371/journal.pone.0164361	http://dx.doi.org/10.1371/journal.pone.0164361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736932	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800059
J	Arrizubieta, M; Simon, O; Williams, T; Caballero, P				Arrizubieta, Maite; Simon, Oihane; Williams, Trevor; Caballero, Primitivo			Determinant Factors in the Production of a Co-Occluded Binary Mixture of Helicoverpa armigera Alphabaculovirus (HearNPV) Genotypes with Desirable Insecticidal Characteristics	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; INTRASTADIAL DEVELOPMENTAL RESISTANCE; NUCLEOPOLYHEDROSIS VIRUS; INCUBATION-TEMPERATURE; VELVETBEAN CATERPILLAR; SPODOPTERA-FRUGIPERDA; LEPIDOPTERA-NOCTUIDAE; LYMANTRIA-DISPAR; ZEA LEPIDOPTERA; MASS-PRODUCTION	A co-occluded binary mixture of Helicoverpa armigera nucleopolyhedrovirus genotypes HearSP1B and HearLB6 at a 1:1 ratio (HearSP1B+HearLB6) was selected for the development of a virus-based biological insecticide, which requires an efficient large-scale production system. In vivo production systems require optimization studies in each host-virus pathosystem. In the present study, the effects of larval instar, rearing density, timing of inoculation, inoculum concentration and temperature on the production of HearSP1B+HearLB6 in its homologous host were evaluated. The high prevalence of cannibalism in infected larvae (40-87%) indicated that insects require individual rearing to avoid major losses in OB production. The OB production of recently molted fifth instars (7.0 x 10(9) OBs/larva), combined with a high prevalence of mortality (85.7%), resulted in the highest overall OB yield (6.0 x 10(11) OBs/100 inoculated larvae), compared to those of third or fourth instars. However, as inoculum concentration did not influence final OB yield, the lowest concentration, LC80 (5.5 x 10(6) OBs/ml), was selected. Incubation temperature did not significantly influence OB yield, although larvae maintained at 30 degrees C died 13 and 34 hours earlier than those incubated at 26 degrees C and 23 degrees C, respectively. We conclude that the efficient production of HearSP1B+HearLB6 OBs involves inoculation of recently molted fifth instars with a LC80 concentration of OBs followed by individual rearing at 30 degrees C.	[Arrizubieta, Maite; Simon, Oihane; Caballero, Primitivo] CSIC UPNA, Inst Agrobiotecnol, Bioinsecticidas Microbianos, Gobierno Navarra, Mutilva Baja 31192, Navarra, Spain; [Williams, Trevor] Inst Ecol AC, Xalapa 91070, Veracruz, Mexico; [Caballero, Primitivo] Univ Publ Navarra, Dept Prod Agr, Lab Entomol Agr & Patol Insectos, Pamplona 31006, Navarra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Instituto de Ecologia - Mexico; Universidad Publica de Navarra	Caballero, P (corresponding author), CSIC UPNA, Inst Agrobiotecnol, Bioinsecticidas Microbianos, Gobierno Navarra, Mutilva Baja 31192, Navarra, Spain.; Caballero, P (corresponding author), Univ Publ Navarra, Dept Prod Agr, Lab Entomol Agr & Patol Insectos, Pamplona 31006, Navarra, Spain.	pcm92@unavarra.es	Williams, Trevor/F-1447-2011; Williams, Trevor/ABG-3961-2020; Caballero, Primitivo/D-5063-2009	Williams, Trevor/0000-0003-3414-3440; Caballero, Primitivo/0000-0003-0065-9625	Gobierno de Navarra [IIQI 4065: RI1]; CSIC	Gobierno de Navarra; CSIC	This study received financial support from the Gobierno de Navarra (Project IIQI 4065: RI1). M.A. received a predoctoral fellowship from CSIC.	Arrizubieta M, 2015, APPL ENVIRON MICROB, V81, P3984, DOI 10.1128/AEM.00339-15; Arrizubieta M, 2014, PEST MANAG SCI, V70, P967, DOI 10.1002/ps.3637; Bernal A, 2013, APPL ENVIRON MICROB, V79, P7709, DOI 10.1128/AEM.02409-13; Boots M, 1998, ECOL ENTOMOL, V23, P118, DOI 10.1046/j.1365-2311.1998.00115.x; Burges, 1981, MICROBIAL CONTROL PE, P329; Caballero P, 2015, Patent No. [WO 2015/197900 A1, 2015197900]; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; Chapman JW, 1999, ECOL ENTOMOL, V24, P268, DOI 10.1046/j.1365-2311.1999.00224.x; Chilcutt CF, 2006, J ECON ENTOMOL, V99, P728, DOI 10.1603/0022-0493-99.3.728; Crawley M.J., 1993, GLIM ECOLOGISTS; Czepak C, PESQ AGROPEC TROP; DHANDAPANI N, 1993, INSECT SCI APPL, V14, P427, DOI 10.1017/S1742758400014089; Elvira S, 2010, J ECON ENTOMOL, V103, P577, DOI 10.1603/EC09325; European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3694, 10.2903/j.efsa.2015.4038]; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Murua MG, 2014, FLA ENTOMOL, V97, P854, DOI 10.1653/024.097.0279; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Grove MJ, 2007, BIOL CONTROL, V40, P355, DOI 10.1016/j.biocontrol.2006.12.003; Grzywacz D, 1998, J VIROL METHODS, V71, P115, DOI 10.1016/S0166-0934(97)00209-7; Grzywacz D., 2014, MASS PRODUCTION BENE, P519, DOI [10.1016/B978-0-12-391453-8, DOI 10.1016/B978-0-12-391453-8.00015-7]; Gupta R. K., 2007, Journal of Entomology, V4, P279; Hoover K, 2002, BIOL CONTROL, V25, P92, DOI 10.1016/S1049-9644(02)00041-5; HUGHES PR, 1981, J INVERTEBR PATHOL, V37, P154, DOI 10.1016/0022-2011(81)90069-0; Inceoglu AB, 2001, PEST MANAG SCI, V57, P981, DOI 10.1002/ps.393; Jenkins NE, 2000, BIOCONTROL SCI TECHN, V10, P753, DOI 10.1080/09583150020011717; JOHNSON DW, 1982, J INVERTEBR PATHOL, V40, P292, DOI 10.1016/0022-2011(82)90128-8; Jones KA, 1998, INSECT VIRUSES PEST, P244; JOYNER K, 1985, ANN ENTOMOL SOC AM, V78, P24, DOI 10.1093/aesa/78.1.24; Kalia V, 2001, PHYTOPARASITICA, V29, P23, DOI 10.1007/BF02981810; KELLY PM, 1988, J VIROL METHODS, V19, P249, DOI 10.1016/0166-0934(88)90019-5; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; Le Ora Software, 1987, POLO PC A USERS GUID; Mehrvar A, 2007, Pak J Biol Sci, V10, P3992, DOI 10.3923/pjbs.2007.3992.3999; Nguyen Q, 2011, J VIROL METHODS, V175, P197, DOI 10.1016/j.jviromet.2011.05.011; Pedrini MRS, 2006, J VIROL METHODS, V136, P267, DOI 10.1016/j.jviromet.2006.04.007; Pedrini MRS, 2011, BIOTECHNOL PROGR, V27, P614, DOI 10.1002/btpr.602; Pijlman GP, 2004, BIOTECHNOL BIOENG, V87, P743, DOI 10.1002/bit.20178; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Quan Dong, 1992, P13; RIBEIRO HCT, 1994, J APPL ENTOMOL, V118, P316, DOI 10.1111/j.1439-0418.1994.tb00806.x; SHAPIRO M, 1986, J ECON ENTOMOL, V79, P1174, DOI 10.1093/jee/79.5.1174; Shapiro M., 1981, GYPSY MOTH RES INTEG, P633; SHIEH TR, 1989, ADV VIRUS RES, V36, P315, DOI 10.1016/S0065-3527(08)60589-8; Subramanian S, 2006, BIOL CONTROL, V37, P367, DOI 10.1016/j.biocontrol.2006.01.011; Sun XL, 2005, BIOCONTROL SCI TECHN, V15, P353, DOI 10.1080/09583150400016944; Torres-Vila L. M., 2000, Boletin de Sanidad Vegetal, Plagas, V26, P493; Torres-Vila LM, 2002, AGR ECOSYST ENVIRON, V93, P55, DOI 10.1016/S0167-8809(02)00003-8; van Beek N, 2000, J INVERTEBR PATHOL, V76, P185, DOI 10.1006/jipa.2000.4972; Williams T, 2006, ECOL ENTOMOL, V31, P106, DOI 10.1111/j.0307-6946.2006.00771.x; Zhang G, 1994, RESOUR ENV YANGTZE V, V3, P36	50	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164486	10.1371/journal.pone.0164486	http://dx.doi.org/10.1371/journal.pone.0164486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732657	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300060
J	Hintze, S; Smith, S; Patt, A; Bachmann, I; Wurbel, H				Hintze, Sara; Smith, Samantha; Patt, Antonia; Bachmann, Iris; Wurbel, Hanno			Are Eyes a Mirror of the Soul? What Eye Wrinkles Reveal about a Horse's Emotional State	PLOS ONE			English	Article							FACIAL EXPRESSION; FEAR REACTIONS; PAIN	Finding valid indicators of emotional states is one of the biggest challenges in animal welfare science. Here, we investigated in horses whether variation in the expression of eye wrinkles caused by contraction of the inner eyebrow raiser reflects emotional valence. By confronting horses with positive and negative conditions, we aimed to induce positive and negative emotional states, hypothesising that positive emotions would reduce whereas negative emotions would increase eye wrinkle expression. Sixteen horses were individually exposed in a balanced order to two positive (grooming, food anticipation) and two negative conditions (food competition, waving a plastic bag). Each condition lasted for 60 seconds and was preceded by a 60 second control phase. Throughout both phases, pictures of the eyes were taken, and for each horse four pictures per condition and phase were randomly selected. Pictures were scored in random order and by two experimenters blind to condition and phase for six outcome measures: qualitative impression, eyelid shape, markedness of the wrinkles, presence of eye white, number of wrinkles, and the angle between the line through the eyeball and the highest wrinkle. The angle decreased during grooming and increased during food competition compared to control phases, whereas the two phases did not differ during food anticipation and the plastic bag condition. No effects on the other outcome measures were detected. Taken together, we have defined a set of measures to assess eye wrinkle expression reliably, of which one measure was affected by the conditions the horses were exposed to. Variation in eye wrinkle expression might provide valuable information on horse welfare but further validation of specific measures across different conditions is needed.	[Hintze, Sara; Wurbel, Hanno] Univ Bern, Div Anim Welf, Vetsuisse Fac, Bern, Switzerland; [Hintze, Sara; Bachmann, Iris] Swiss Natl Stud Farm, Agroscope, Avenches, Switzerland; [Smith, Samantha] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Patt, Antonia] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University of Bern; Swiss Federal Research Station Agroscope; University of Edinburgh; University System of Maryland; University of Maryland College Park	Hintze, S (corresponding author), Univ Bern, Div Anim Welf, Vetsuisse Fac, Bern, Switzerland.; Hintze, S (corresponding author), Swiss Natl Stud Farm, Agroscope, Avenches, Switzerland.	sara.hintze@vetsuisse.unibe.ch	; Wuerbel, Hanno/D-6281-2012	Hintze, Sara/0000-0002-8410-3239; Wuerbel, Hanno/0000-0002-2934-3010	Agroscope	Agroscope	SH was funded by Agroscope.	[Anonymous], ANIM BEHAV, V46, P1191, DOI [10.1006/anbe.1993.1309, DOI 10.1006/ANBE.1993.1309]; Arellano D, 2014, LECT NOTES COMPUT SC, V8563, P31, DOI 10.1007/978-3-319-08849-5_4; Bachmann I, 2003, APPL ANIM BEHAV SCI, V82, P297, DOI 10.1016/S0168-1591(03)00086-8; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Caeiro CC, 2013, INT J PRIMATOL, V34, P115, DOI 10.1007/s10764-012-9652-x; Christensen JW, 2008, EQUINE VET J, V40, P46, DOI 10.2746/042516408X245171; Christensen R.H.B, 2015, ORDINAL REGRESSION M; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohn Jeffrey F., 2009, 2009 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPR.2009.5204260; Crowe J., 2009, BODY LANGUAGE 101 2; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; Darwin C., 1872, P374; Des Roches ADB, 2008, PHYSIOL BEHAV, V94, P487, DOI 10.1016/j.physbeh.2008.03.002; EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; Farmer K, 2010, ANIM COGN, V13, P229, DOI 10.1007/s10071-009-0260-x; Gleerup KB, VET ANAESTH ANALG, V42, P1; Holden E, 2014, J SMALL ANIM PRACT, V55, P615, DOI 10.1111/jsap.12283; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Kohut SA, 2009, J PAIN, V10, P214, DOI 10.1016/j.jpain.2008.08.010; Lande R G, 2015, WINNOWER, P1, DOI DOI 10.15200/WINN.143518.81744; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; McBride SD, 2004, J EQUINE VET SCI, V24, P76, DOI 10.1016/j.jevs.2004.01.014; McLennan KM, 2016, APPL ANIM BEHAV SCI, V176, P19, DOI 10.1016/j.applanim.2016.01.007; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Moe RO, 2009, APPL ANIM BEHAV SCI, V121, P171, DOI 10.1016/j.applanim.2009.10.002; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Ninomiya Shigeru, 2004, Animal Science Journal, V75, P465, DOI 10.1111/j.1740-0929.2004.00214.x; Pinheiro J, 2020, R PACKAGE VERSION 31; Sandem AI, 2002, APPL ANIM BEHAV SCI, V79, P1, DOI 10.1016/S0168-1591(02)00029-1; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Swiss Federal Council, 2011, AN WELF ORD, P20; van den Bos R, 2003, BEHAV BRAIN RES, V141, P83, DOI 10.1016/S0166-4328(02)00318-2; Vick SJ, 2007, J NONVERBAL BEHAV, V31, P1, DOI 10.1007/s10919-006-0017-z; von Borstel UUK, 2010, APPL ANIM BEHAV SCI, V125, P124, DOI 10.1016/j.applanim.2010.04.015; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; Wathan J, PLOS ONE, V10; Wieland K., 2013, WHAT ARE MY HORSES E	41	28	28	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164017	10.1371/journal.pone.0164017	http://dx.doi.org/10.1371/journal.pone.0164017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732647	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300036
J	Jaikumkao, K; Pongchaidecha, A; Thongnak, LO; Wanchai, K; Arjinajarn, P; Chatsudthipong, V; Chattipakorn, N; Lungkaphin, A				Jaikumkao, Krit; Pongchaidecha, Anchalee; Thongnak, La-ongdao; Wanchai, Keerati; Arjinajarn, Phatchawan; Chatsudthipong, Varanuj; Chattipakorn, Nipon; Lungkaphin, Anusorn			Amelioration of Renal Inflammation, Endoplasmic Reticulum Stress and Apoptosis Underlies the Protective Effect of Low Dosage of Atorvastatin in Gentamicin-Induced Nephrotoxicity	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; HEART-FAILURE; REDUCTASE INHIBITOR; OXIDATIVE STRESS; CELL APOPTOSIS; RAT MODEL; FIBROSIS; STATINS; TETRAMETHYLPYRAZINE; FLUVASTATIN	Gentamicin is a commonly used aminoglycoside antibiotic. However, its therapeutic use is limited by its nephrotoxicity. The mechanisms of gentamicin-induced nephrotoxicity are principally from renal inflammation and oxidative stress. Since atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, exerts lipid-lowering effects, antioxidant, anti-inflammatory as well as anti-apoptotic effects, this study aimed to investigate the protective effects of atorvastatin against gentamicin-induced nephrotoxicity. Male Sprague Dawley rats were used and nephrotoxicity was induced by intraperitoneal injection of gentamicin, 100 mg/kg/day, for 15 days. Atorvastatin, 10 mg/kg/day, was administered by orally gavage 30 min before gentamicin injection on day 1 to 15 (pretreatment) or on day 10 to 15 (delayed treatment). For only atorvastatin treatment group, it was given on day 1 to 15. At the end of the experiment, kidney weight, blood urea nitrogen and serum creatinine as well as renal inflammation (NF-kappa B, TNFaR1, IL-6 and iNOS), renal fibrosis (TGF beta 1), ER stress (calpain, GRP78, CHOP, and caspase 12) and apoptotic markers (cleaved caspase-3, Bax, and Bcl-2) as well as TUNEL assay were determined. Gentamicin-induced nephrotoxicity was confirmed by marked elevations in serum urea and creatinine, kidney hypertrophy, renal inflammation, fibrosis, ER stress and apoptosis and attenuation of creatinine clearance. Atorvastatin pre and delayed treatment significantly improved renal function and decreased renal NF-kappa B, TNFaR1, IL-6, iNOS and TGF beta 1 expressions. They also attenuated calpain, GRP78, CHOP, caspase 12, Bax, and increased Bcl-2 expressions in gentamicin-treated rat. These results indicate that atorvastatin treatment could attenuate gentamicin-induced nephrotoxicity in rats, substantiated by the reduction of inflammation, ER stress and apoptosis. The effect of atorvastatin in protecting from renal damage induced by gentamicin seems to be more effective when it beginning given along with gentamicin or pretreatment.	[Jaikumkao, Krit; Pongchaidecha, Anchalee; Thongnak, La-ongdao; Wanchai, Keerati; Chattipakorn, Nipon; Lungkaphin, Anusorn] Chiang Mai Univ, Fac Med, Dept Physiol, Chiang Mai, Thailand; [Wanchai, Keerati] Mae Fah Luang Univ, Sch Med, Chiang Rai, Thailand; [Arjinajarn, Phatchawan] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai, Thailand; [Chatsudthipong, Varanuj] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok, Thailand; [Chattipakorn, Nipon] Chiang Mai Univ, Cardiac Electrophysiol Res & Training Ctr, Fac Med, Chiang Mai, Thailand	Chiang Mai University; Mae Fah Luang University; Chiang Mai University; Mahidol University; Chiang Mai University	Lungkaphin, A (corresponding author), Chiang Mai Univ, Fac Med, Dept Physiol, Chiang Mai, Thailand.	onanusorn@yahoo.com	Chattipakorn, Nipon/AAJ-4049-2021; ARJINAJARN, PHATCHAWAN/GNM-8700-2022	Chattipakorn, Nipon/0000-0003-3026-718X	Thailand Research Fund [RSA5780029, TRG5780019]; CMU Mid-Career Research Fellowship program; Faculty of Medicine Research Fund; Chiang Mai University; NSTDA Research Chair grant from National Science and Technology Development Agency of Thailand	Thailand Research Fund(Thailand Research Fund (TRF)); CMU Mid-Career Research Fellowship program; Faculty of Medicine Research Fund; Chiang Mai University; NSTDA Research Chair grant from National Science and Technology Development Agency of Thailand	This work was supported by the Thailand Research Fund academic.trf.or.th RSA5780029 (AL) and TRG5780019 (PA), CMU Mid-Career Research Fellowship program http.//www.cmu.ac.th (13/2558; AL), the Faculty of Medicine Research Fund, Chiang Mai University http.//www.med.cmu.ac.th (10/2559; AL) and the NSTDA Research Chair grant from the National Science and Technology Development Agency of Thailand http//www.nstda.or.th (NC).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami M, 2010, BIOL RES, V43, P83, DOI [10.4067/S0716-97602010000100010, /S0716-97602010000100010]; Bae EH, 2014, J RENIN-ANGIO-ALDO S, V15, P348, DOI 10.1177/1470320312474853; Balakumar P, 2010, PHARMACOL RES, V62, P179, DOI 10.1016/j.phrs.2010.04.004; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bledsoe G, 2006, NEPHROL DIAL TRANSPL, V21, P624, DOI 10.1093/ndt/gfi225; Castro PF, 2008, J HEART LUNG TRANSPL, V27, P435, DOI 10.1016/j.healun.2008.01.012; Chuang YH, 2011, LIFE SCI, V89, P795, DOI 10.1016/j.lfs.2011.09.010; Eshraghi-Jazi F, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/5025097; Ferro D, 2000, J AM COLL CARDIOL, V36, P427, DOI 10.1016/S0735-1097(00)00771-3; Fribley A, 2009, METHODS MOL BIOL, V559, P191, DOI 10.1007/978-1-60327-017-5_14; Gao Xue, 2010, Am J Biomed Sci, V2, P1; Garjani A, 2008, PAK J PHARM SCI, V21, P125; Gautier JC, 2014, TOXICOL PATHOL, V42, P1105, DOI 10.1177/0192623314524489; Geleilete TJ, 2002, J NEPHROL, V15, P633; Hayashidani S, 2002, CIRCULATION, V105, P868, DOI 10.1161/hc0702.104164; Jaikumkao K, 2016, EXP PHYSIOL, V101, P743, DOI 10.1113/EP085571; Juan SH, 2007, NEPHROL DIAL TRANSPL, V22, P732, DOI 10.1093/ndt/gfl699; Kalayarasan S, 2009, EUR J PHARMACOL, V606, P162, DOI 10.1016/j.ejphar.2008.12.055; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; LAURENT G, 1990, BIOCHEM PHARMACOL, V40, P2383, DOI 10.1016/0006-2952(90)90078-Y; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee IC, 2012, ARCH TOXICOL, V86, P1527, DOI 10.1007/s00204-012-0849-8; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Martinez-Salgado C, 2007, TOXICOL APPL PHARM, V223, P86, DOI 10.1016/j.taap.2007.05.004; McGown CC, 2015, N-S ARCH PHARMACOL, V388, P557, DOI 10.1007/s00210-015-1100-y; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Niwa S, 1996, INT J IMMUNOPHARMACO, V18, P669, DOI 10.1016/S0192-0561(96)00068-9; ORTIZ A, 1995, NEPHROL DIAL TRANSPL, V10, P309; Ota T, 2003, DIABETOLOGIA, V46, P843, DOI 10.1007/s00125-003-1099-3; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozbek E, 2009, RENAL FAILURE, V31, P382, DOI 10.1080/08860220902835863; PATTYN VM, 1988, J PHARMACOL EXP THER, V244, P694; Promsan S, 2016, CAN J PHYSIOL PHARM, V94, P808, DOI 10.1139/cjpp-2015-0468; Reiss AB, 2009, THESCIENTIFICWORLDJO, V9, P1242, DOI 10.1100/tsw.2009.141; Rodrigues FAP, 2014, ANTIMICROB AGENTS CH, V58, P1872, DOI 10.1128/AAC.02431-13; Romero F, 2009, BASIC CLIN PHARMACOL, V105, P416, DOI 10.1111/j.1742-7843.2009.00466.x; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Solheim S, 2001, ATHEROSCLEROSIS, V157, P411, DOI 10.1016/S0021-9150(00)00725-5; Song XJ, 2011, INT J MED SCI, V8, P564, DOI 10.7150/ijms.8.564; Sue YM, 2009, NEPHROL DIAL TRANSPL, V24, P769, DOI 10.1093/ndt/gfn545; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tan KHV, 2003, AM J RESP CRIT CARE, V167, P819, DOI 10.1164/rccm.200109-012CC; VERPOOTEN GA, 1989, CLIN PHARMACOL THER, V45, P22, DOI 10.1038/clpt.1989.4; Vieira JM, 2005, NEPHROL DIAL TRANSPL, V20, P1582, DOI 10.1093/ndt/gfh859; VOLPINI RA, 2004, NEPHRON PHYSIOL, V98, P97, DOI DOI 10.1159/000081558; Wahane VD, 2010, PHARMACOL RES, V61, P329, DOI 10.1016/j.phrs.2009.11.006; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Zhang F, 2006, J BIOL CHEM, V281, P30036, DOI 10.1074/jbc.M604674200	50	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164528	10.1371/journal.pone.0164528	http://dx.doi.org/10.1371/journal.pone.0164528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727327	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504400036
J	Miething, A; Rostila, M; Edling, C; Rydgren, J				Miething, Alexander; Rostila, Mikael; Edling, Christofer; Rydgren, Jens			The Influence of Social Network Characteristics on Peer Clustering in Smoking: A Two-Wave Panel Study of 19-and 23-Year-Old Swedes	PLOS ONE			English	Article							ADOLESCENT CIGARETTE-SMOKING; FRIENDSHIP NETWORKS; INTERACTION TERMS; REGULAR SMOKING; YOUNG-ADULTS; ALCOHOL-USE; INITIATION; BEHAVIOR; SELECTION; DYNAMICS	Objectives The present study examines how the composition of social networks and perceived relationship content influence peer clustering in smoking, and how the association changes during the transition from late adolescence to early adulthood. Methods The analysis was based on a Swedish two-wave survey sample comprising ego-centric network data. Respondents were 19 years old in the initial wave, and 23 when the follow-up sample was conducted. 17,227 ego-alter dyads were included in the analyses, which corresponds to an average response rate of 48.7 percent. Random effects logistic regression models were performed to calculate gender-specific average marginal effects of social network characteristics on smoking. Results The association of egos' and alters' smoking behavior was confirmed and found to be stronger when correlated in the female sample. For females, the associations decreased between age 19 and 23. Interactions between network characteristics and peer clustering in smoking showed that intense social interactions with smokers increase egos' smoking probability. The influence of network structures on peer clustering in smoking decreased during the transition from late adolescence to early adulthood. Conclusions The study confirmed peer clustering in smoking and revealed that females' smoking behavior in particular is determined by social interactions. Female smokers' propensity to interact with other smokers was found to be associated with the quality of peer relationships, frequent social interactions, and network density. The influence of social networks on peer clustering in smoking decreased during the transition from late adolescence to early adulthood.	[Miething, Alexander; Rydgren, Jens] Stockholm Univ, Dept Sociol, SE-10691 Stockholm, Sweden; [Rostila, Mikael] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies CHESS, SE-10691 Stockholm, Sweden; [Edling, Christofer] Lund Univ, Dept Sociol, SE-22100 Lund, Sweden	Stockholm University; Karolinska Institutet; Stockholm University; Lund University	Miething, A (corresponding author), Stockholm Univ, Dept Sociol, SE-10691 Stockholm, Sweden.	alexander.miething@sociology.su.se	Rydgren, Jens/AGJ-1921-2022; Edling, Christofer R/C-8541-2013	Edling, Christofer R/0000-0002-3909-1080; Miething, Alexander/0000-0003-2004-3780	Swedish Council for Health, Working Life and Social Research [2007-0806, 2014-0387]; European Research Council Starting Grant [263422]	Swedish Council for Health, Working Life and Social Research; European Research Council Starting Grant(European Research Council (ERC))	This work was supported by the Swedish Council for Health, Working Life and Social Research [grant nos. 2007-0806, 2014-0387], (http://www.forte.se/en/) and The European Research Council Starting Grant [grant no. 263422], (https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Alexander C, 2001, J ADOLESCENT HEALTH, V29, P22, DOI 10.1016/S1054-139X(01)00210-5; Ali MM, 2009, J ADOLESCENT HEALTH, V45, P402, DOI 10.1016/j.jadohealth.2009.02.004; Ali SM, 2009, SCAND J PUBLIC HEALT, V37, P146, DOI 10.1177/1403494808100274; Bank BJ, 2000, PERS RELATIONSHIP, V7, P63, DOI 10.1111/j.1475-6811.2000.tb00004.x; Barclay KJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-784; Benenson JF, 2003, CHILD DEV, V74, P1123, DOI 10.1111/1467-8624.00596; Borsari B, 2006, DRUG ALCOHOL REV, V25, P361, DOI 10.1080/09595230600741339; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; BRESLAU N, 1993, DRUG ALCOHOL DEPEN, V33, P129, DOI 10.1016/0376-8716(93)90054-T; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; de Klepper M, 2010, SOC NETWORKS, V32, P82, DOI 10.1016/j.socnet.2009.06.003; DeLay D, 2013, J RES ADOLESCENCE, V23, P464, DOI 10.1111/jora.12017; DuBois David L, 2005, J Prim Prev, V26, P69, DOI 10.1007/s10935-005-1832-4; EISER JR, 1991, BRIT J SOC PSYCHOL, V30, P339, DOI 10.1111/j.2044-8309.1991.tb00950.x; ENNETT ST, 1993, J HEALTH SOC BEHAV, V34, P226, DOI 10.2307/2137204; Everett SA, 1999, PREV MED, V29, P327, DOI 10.1006/pmed.1999.0560; FRIEDMAN LS, 1985, ADDICT BEHAV, V10, P1, DOI 10.1016/0306-4603(85)90048-6; Fujimoto K, 2015, SOC SCI MED, V125, P173, DOI 10.1016/j.socscimed.2014.05.023; FURMAN W, 1992, CHILD DEV, V63, P103, DOI 10.2307/1130905; Giordano PC, 2003, ANNU REV SOCIOL, V29, P257, DOI 10.1146/annurev.soc.29.010202.100047; Gonzalez R., 2012, APA HDB RES METHODS, P439, DOI DOI 10.1037/13621-022; Haas SA, 2014, J HEALTH SOC BEHAV, V55, P126, DOI 10.1177/0022146514532817; Haynie DL, 2001, AM J SOCIOL, V106, P1013, DOI 10.1086/320298; Hoffman BR, 2007, ADDICT BEHAV, V32, P1546, DOI 10.1016/j.addbeh.2006.11.016; Hoffman BR, 2006, SUBST USE MISUSE, V41, P103, DOI 10.1080/10826080500368892; KANDEL DB, 1978, AM J SOCIOL, V84, P427, DOI 10.1086/226792; KANDEL DB, 1984, AM J PUBLIC HEALTH, V74, P660, DOI 10.2105/AJPH.74.7.660; Karaca-Mandic P, 2012, HEALTH SERV RES, V47, P255, DOI 10.1111/j.1475-6773.2011.01314.x; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Kreager DA, 2011, CRIMINOLOGY, V49, P95, DOI 10.1111/j.1745-9125.2010.00219.x; KROHN MD, 1988, SOC PSYCHOL QUART, V51, P346, DOI 10.2307/2786761; Lakon CM, 2015, J YOUTH ADOLESCENCE, V44, P1767, DOI 10.1007/s10964-014-0187-7; Lakon CM, 2012, SOC SCI MED, V74, P1407, DOI 10.1016/j.socscimed.2012.01.011; Lundborg P, 2005, SOC SCI MED, V61, P1151, DOI 10.1016/j.socscimed.2004.12.031; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mercken L, 2010, SOC NETWORKS, V32, P72, DOI 10.1016/j.socnet.2009.02.005; Mercken L, 2012, J STUD ALCOHOL DRUGS, V73, P99, DOI 10.15288/jsad.2012.73.99; Moore S, 2014, AM J PUBLIC HEALTH, V104, pE72, DOI 10.2105/AJPH.2014.302239; Moran S, 2004, PEDIATRICS, V114, P1028, DOI 10.1542/peds.2003-0558-L; Paavola M, 2001, HEALTH EDUC RES, V16, P49, DOI 10.1093/her/16.1.49; Reifman A, 2006, PERS SOC PSYCHOL B, V32, P820, DOI 10.1177/0146167206286219; Rostila M., 2013, SOCIAL CAPITAL HLTH, DOI [10.1057/9781137305664, DOI 10.1057/9781137305664]; Rostila M, 2013, INT J ENV RES PUB HE, V10, P6517, DOI 10.3390/ijerph10126517; Rostila M, 2010, SOCIOL HEALTH ILL, V32, P382, DOI 10.1111/j.1467-9566.2009.01196.x; Scholz U, 2013, FAM SYST HEALTH, V31, P354, DOI 10.1037/a0033063; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Steglich C, 2010, SOCIOL METHODOL, V40, P329, DOI 10.1111/j.1467-9531.2010.01225.x; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Sumter SR, 2009, J ADOLESCENCE, V32, P1009, DOI 10.1016/j.adolescence.2008.08.010; Takakura M, 2011, SOC SCI MED, V72, P299, DOI 10.1016/j.socscimed.2010.11.003; THORLINDSSON T, 1991, ADOLESCENCE, V26, P399; Tucker JS, 2003, J ADOLESCENT HEALTH, V32, P314, DOI 10.1016/S1054-139X(02)00709-7; Urberg KA, 1997, DEV PSYCHOL, V33, P834, DOI 10.1037/0012-1649.33.5.834; Veenstra R, 2013, J RES ADOLESCENCE, V23, P399, DOI 10.1111/jora.12070; von Bothmer Margareta I K, 2005, Nurs Health Sci, V7, P107, DOI 10.1111/j.1442-2018.2005.00227.x; West P, 1999, ADDICTION, V94, P1397, DOI 10.1046/j.1360-0443.1999.949139711.x; White HR, 2002, DRUG ALCOHOL DEPEN, V65, P167, DOI 10.1016/S0376-8716(01)00159-4	59	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164611	10.1371/journal.pone.0164611	http://dx.doi.org/10.1371/journal.pone.0164611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CI	27727314	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504400046
J	Stoverud, KH; Langtangen, HP; Ringstad, GA; Eide, PK; Mardal, KA				Stoverud, Karen-Helene; Langtangen, Hans Petter; Ringstad, Geir Andre; Eide, Per Kristian; Mardal, Kent-Andre			Computational Investigation of Cerebrospinal Fluid Dynamics in the Posterior Cranial Fossa and Cervical Subarachnoid Space in Patients with Chiari I Malformation	PLOS ONE			English	Article							CYCLIC CSF FLOW; MAGNETIC-RESONANCE; FORAMEN MAGNUM; PULSATILE; PRESSURE; PATTERNS; JUNCTION; TYPE-1	Purpose Previous computational fluid dynamics (CFD) studies have demonstrated that the Chiari malformation is associated with abnormal cerebrospinal fluid (CSF) flow in the cervical part of the subarachnoid space (SAS), but the flow in the SAS of the posterior cranial fossa has received little attention. This study extends previous modelling efforts by including the cerebellomedullary cistern, pontine cistern, and 4th ventricle in addition to the cervical subarachnoid space. Methods The study included one healthy control, Con1, and two patients with Chiari I malformation, P1 and P2. Meshes were constructed by segmenting images obtained from T2-weighted turbo spin-echo sequences. CFD simulations were performed with a previously verified and validated code. Patient-specific flow conditions in the aqueduct and the cervical SAS were used. Two patients with the Chiari malformation and one control were modelled. Results The results demonstrated increased maximal flow velocities in the Chiari patients, ranging from factor 5 in P1 to 14.8 in P2, when compared to Con1 at the level of Foramen Magnum (FM). Maximal velocities in the cervical SAS varied by a factor 2.3, while the maximal flow in the aqueduct varied by a factor 3.5. The pressure drop from the pontine cistern to the cervical SAS was similar in Con1 and P1, but a factor two higher in P2. The pressure drop between the aqueduct and the cervical SAS varied by a factor 9.4 where P1 was the one with the lowest pressure jump and P2 and Con1 differed only by a factor 1.6. Conclusion This pilot study demonstrates that including the posterior cranial fossa is feasible and suggests that previously found flow differences between Chiari I patients and healthy individuals in the cervical SAS may be present also in the SAS of the posterior cranial fossa.	[Stoverud, Karen-Helene; Langtangen, Hans Petter; Mardal, Kent-Andre] Univ Oslo, Simula Res Lab, Ctr Biomed Comp, Oslo, Norway; [Stoverud, Karen-Helene; Langtangen, Hans Petter; Mardal, Kent-Andre] Univ Oslo, Dept Informat, Oslo, Norway; [Ringstad, Geir Andre] Univ Oslo, Rikshosp, Dept Radiol & Nucl Med, Oslo Univ Hosp, Oslo, Norway; [Eide, Per Kristian] Univ Oslo, Oslo Univ Hosp, Dept Neurosurg, Fac Med,Rikshosp, Oslo, Norway; [Mardal, Kent-Andre] Univ Oslo, Dept Math, Oslo, Norway; [Stoverud, Karen-Helene] Umea Univ, Dept Radiat Sci, Umea, Sweden	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Umea University	Mardal, KA (corresponding author), Univ Oslo, Simula Res Lab, Ctr Biomed Comp, Oslo, Norway.; Mardal, KA (corresponding author), Univ Oslo, Dept Informat, Oslo, Norway.; Mardal, KA (corresponding author), Univ Oslo, Dept Math, Oslo, Norway.	kent-and@math.uio.no	Mardal, Kent-Andre/G-8296-2018	Mardal, Kent-Andre/0000-0002-4946-1110	Center of Excellence grant from the Norwegian Research Council [209951]	Center of Excellence grant from the Norwegian Research Council	This work was supported by a Center of Excellence grant (209951) awarded to the Center for Biomedical Computing from the Norwegian Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; ARMONDA RA, 1994, NEUROSURGERY, V35, P214, DOI 10.1227/00006123-199408000-00006; Baledent O, 2014, ADULT HYDROCEPHALUS, P121; BHADELIA RA, 1995, RADIOLOGY, V196, P195, DOI 10.1148/radiology.196.1.7784567; Bilston LE, 2010, J NEUROSURG, V112, P808, DOI 10.3171/2009.5.JNS08945; Bunck AC, 2012, EUR RADIOL, V22, P1860, DOI 10.1007/s00330-012-2457-7; Bunck AC, 2011, EUR RADIOL, V21, P1788, DOI 10.1007/s00330-011-2105-7; ENZMANN DR, 1991, RADIOLOGY, V178, P467, DOI 10.1148/radiology.178.2.1987610; Fric R, 2016, ACTA NEUROCHIR, V158, P341, DOI 10.1007/s00701-015-2669-0; Fric R, 2015, ACTA NEUROCHIR, V157, P1411, DOI 10.1007/s00701-015-2465-x; Greitz D, 1999, INT J NEURORADIOL, V5, P61; Greitz D, 2006, NEUROSURG REV, V29, P251, DOI 10.1007/s10143-006-0029-5; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Heiss JD, 1999, J NEUROSURG, V91, P553, DOI 10.3171/jns.1999.91.4.0553; Helgeland A, 2014, J BIOMECH ELSEVIER; Hentschel S, 2010, AM J NEURORADIOL, V31, P997, DOI 10.3174/ajnr.A1995; Iskandar BJ, 2004, J NEUROSURG, V101, P169, DOI 10.3171/ped.2004.101.2.0169; Jain K, INT J NUMER METH BIO, V224, DOI [10.1097/00006123-199408000-00006, DOI 10.1097/00006123-199408000-00006]; Kurtcuoglu V, 2007, J BIOMECH, V40, P1235, DOI 10.1016/j.jbiomech.2006.05.031; Langtangen HP, 2002, ADV WATER RESOUR, V25, P1125, DOI 10.1016/S0309-1708(02)00052-0; Linge SO, 2013, AM J NEURORADIOL, V34, P41, DOI 10.3174/ajnr.A3282; Linge SO, 2011, AM J NEURORADIOL, V32, P1474, DOI 10.3174/ajnr.A2496; Linge SO, 2010, AM J NEURORADIOL, V31, P185, DOI 10.3174/ajnr.A1766; Logg A., 2012, AUTOMATED SOLUTION D, DOI [10.1007/978-3-642-23099-8, DOI 10.1007/978-3-642-23099-8]; Martin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075335; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Pahlavian SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091888; Pinna G., 2000, NEUROSURG FOCUS, V8, pE3, DOI [10.3171/foc.2000.8.3.3, DOI 10.3171/FOC.2000.8.3.3]; Quigley MF, 2004, RADIOLOGY, V232, P229, DOI 10.1148/radiol.2321030666; Rutkowska G, 2012, AM J NEURORADIOL, V33, P1756, DOI 10.3174/ajnr.A3047; Shaffer N, 2011, NEUROL RES, V33, P247, DOI 10.1179/016164111X12962202723805; Shah S, 2011, AM J NEURORADIOL, V32, P1149, DOI 10.3174/ajnr.A2460; StOverud KH, 2013, NRJ DIGITAL, V3, P163; Tangen KM, 2015, J BIOMECH, V48, P2144, DOI 10.1016/j.jbiomech.2015.02.018; WILLIAMS B, 1981, ACTA NEUROCHIR, V59, P123, DOI 10.1007/BF01411198; Yiallourou TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052284	37	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0162938	10.1371/journal.pone.0162938	http://dx.doi.org/10.1371/journal.pone.0162938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727298	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504400003
J	Miranda, EA; Batalha, H; Congrains, C; Carvalho, AF; Ferreira, KM; Del Lama, MA				Miranda, Elder Assis; Batalha-Filho, Henrique; Congrains, Carlos; Carvalho, Antonio Freire; Ferreira, Katia Maria; Del Lama, Marco Antonio			Phylogeography of Partamona rustica (Hymenoptera, Apidae), an Endemic Stingless Bee from the Neotropical Dry Forest Diagonal	PLOS ONE			English	Article							GENETIC-STRUCTURE; SEX DETERMINATION; HISTORICAL BIOGEOGRAPHY; DRONE CONGREGATIONS; MICROSATELLITE LOCI; NATURAL-HISTORY; CLIMATE-CHANGE; CONSERVATION; BIODIVERSITY; PATTERNS	The South America encompasses the highest levels of biodiversity found anywhere in the world and its rich biota is distributed among many different biogeographical regions. However, many regions of South America are still poorly studied, including its xeric environments, such as the threatened Caatinga and Cerrado phytogeographical domains. In particular, the effects of Quaternary climatic events on the demography of endemic species from xeric habitats are poorly understood. The present study uses an integrative approach to reconstruct the evolutionary history of Partamona rustica, an endemic stingless bee from dry forest diagonal in Brazil, in a spatial-temporal framework. In this sense, we sequenced four mitochondrial genes and genotyped eight microsatellite loci. Our results identified two population groups: one to the west and the other to the east of the Sao Francisco River Valley (SFRV). These groups split in the late Pleistocene, and the Approximate Bayesian Computation approach and phylogenetic reconstruction indicated that P. rustica originated in the west of the SFRV, subsequently colonising eastern region. Our tests of migration detected reduced gene flow between these groups. Finally, our results also indicated that the inferences both from the genetic data analyses and from the spatial distribution modelling are compatible with historical demographic stability.	[Miranda, Elder Assis; Congrains, Carlos; Ferreira, Katia Maria; Del Lama, Marco Antonio] Univ Fed Sao Carlos, Dept Genet & Evolucao, Sao Carlos, SP, Brazil; [Miranda, Elder Assis; Carvalho, Antonio Freire] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Batalha-Filho, Henrique] Univ Fed Bahia, Inst Biol, Dept Zool, Salvador, BA, Brazil	Universidade Federal de Sao Carlos; Universidade Estadual de Santa Cruz; Universidade Federal da Bahia	Miranda, EA (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, Sao Carlos, SP, Brazil.; Miranda, EA (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil.	elderamiranda@gmail.com	Congrains, Carlos/E-5709-2017; Filho, Henrique Batalha/H-9355-2012; Carvalho, Airton Torres/S-5448-2019; Martins, Celso F/H-9339-2012	Congrains, Carlos/0000-0001-7506-6133; Filho, Henrique Batalha/0000-0001-7191-2814; Carvalho, Airton Torres/0000-0003-3395-4444; Martins, Celso F/0000-0001-5953-3758; Freire de Carvalho Filho, Antonio/0000-0002-4270-4554	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2012/23342-1, 2011/21501-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (Project Number: 2012/23342-1) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (Project Number: 2011/21501-2).	Alberdi A, 2015, J BIOGEOGR, V42, P1689, DOI 10.1111/jbi.12535; Araújo E. D., 2004, Braz. J. Biol., V64, P563, DOI 10.1590/S1519-69842004000400003; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 2002, GENETICS, V162, P2025; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Brown KS, 1979, PALEOCLIMAS, V5, P1; Camargo João M. F., 2003, Rev. Bras. entomol., V47, P311, DOI 10.1590/S0085-56262003000300001; Cameron EC, 2004, MOL ECOL, V13, P2357, DOI 10.1111/j.1365-294X.2004.02194.x; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1461; Carvalho AF, 2015, J INSECT CONSERV, V19, P581, DOI 10.1007/s10841-015-9780-7; Cheng H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2415; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 1996, GENETICS, V144, P2001; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; da Rocha LC, 2013, GENETICA, V141, P65, DOI 10.1007/s10709-013-9706-9; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darrouzet E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136680; Drummond AJ, 2013, BEAST V1 8 0 2002 20; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ferreira KM, 2011, THESIS; Francisco FO, 2006, NEOTROP ENTOMOL, V35, P638, DOI 10.1590/S1519-566X2006000500011; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gomez-Zurita J, 2003, J EVOLUTION BIOL, V16, P833, DOI 10.1046/j.1420-9101.2003.00599.x; Goudet J, 2001, FSTAT VERS 2 9 3 PRO; Green CL, 2002, INSECT SOC, V49, P196, DOI 10.1007/s00040-002-8301-3; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Jaffe R, 2009, POPUL ECOL, V51, P227, DOI 10.1007/s10144-008-0133-1; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Kraus FB, 2008, INSECT SOC, V55, P22, DOI 10.1007/s00040-007-0966-1; Leblois R, 2006, MOL ECOL, V15, P3601, DOI 10.1111/j.1365-294X.2006.03046.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lim HC, 2015, CURR ZOOL, V61, P922, DOI 10.1093/czoolo/61.5.922; Lopez-Uribe MM, 2014, MOL ECOL, V23, P1874, DOI 10.1111/mec.12689; Machado CA, 2001, P ROY SOC B-BIOL SCI, V268, P685, DOI 10.1098/rspb.2000.1418; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Miranda EA, 2015, INSECT SOC, V62, P255, DOI 10.1007/s00040-015-0400-z; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Cerantola NDM, 2011, APIDOLOGIE, V42, P214, DOI 10.1051/apido/2010055; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nielsen R, 2001, GENETICS, V158, P885; Nylander J., 2004, MRMODELTEST V2, V2; Paxton RJ, 2000, INSECT SOC, V47, P63, DOI 10.1007/s000400050010; Paz-Vinas I, 2013, MOL ECOL, V22, P3279, DOI 10.1111/mec.12321; Pedro Silvia R. M., 2003, Rev. Bras. entomol., V47, P1, DOI 10.1590/S0085-56262003000500001; Peters JM, 1998, MOL ECOL, V7, P784; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Raes N, 2014, P NATL ACAD SCI USA, V111, P16790, DOI 10.1073/pnas.1403053111; Rambaut A., 2009, TRACER VERSION 1 5; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Sheppard W.S., 1991, P89; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tavares MG, 2007, GENET MOL BIOL, V30, P667, DOI 10.1590/S1415-47572007000400027; Tavares MG, 2003, APIDOLOGIE, V34, P449, DOI 10.1051/apido:2003045; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vollet-Neto A, 2015, J HYMENOPT RES, V45, P125, DOI 10.3897/JHR.45.4769; Werneck FP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0368-3; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; Wille A., 1975, Revista de Biologia Tropical, V22, P253	75	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164441	10.1371/journal.pone.0164441	http://dx.doi.org/10.1371/journal.pone.0164441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723778	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100060
J	Pang, Y; Dai, XM; Roller, A; Carter, K; Paul, I; Bhatt, AJ; Lin, RCS; Fan, LW				Pang, Yi; Dai, Xuemei; Roller, Anna; Carter, Kathleen; Paul, Ian; Bhatt, Abhay J.; Lin, Rick C. S.; Fan, Lir-Wan			Early Postnatal Lipopolysaccharide Exposure Leads to Enhanced Neurogenesis and Impaired Communicative Functions in Rats	PLOS ONE			English	Article							WHITE-MATTER INJURY; BRAIN-INJURY; CELL-DEATH; OLIGODENDROCYTE DEVELOPMENT; SYSTEMIC INFLAMMATION; ADULT NEUROGENESIS; PREMATURE NEWBORNS; NEONATAL-RATS; INFANTS BORN; AUTISM	Perinatal infection is a well-identified risk factor for a number of neurodevelopmental disorders, including brain white matter injury (WMI) and Autism Spectrum Disorders (ASD). The underlying mechanisms by which early life inflammatory events cause aberrant neural, cytoarchitectural, and network organization, remain elusive. This study is aimed to investigate how systemic lipopolysaccharide (LPS)-induced neuroinflammation affects microglia phenotypes and early neural developmental events in rats. We show here that LPS exposure at early postnatal day 3 leads to a robust microglia activation which is characterized with mixed microglial proinflammatory (M1) and anti-inflammatory (M2) phenotypes. More specifically, we found that microglial M1 markers iNOS and MHC-II were induced at relatively low levels in a regionally restricted manner, whereas M2 markers CD206 and TGF beta were strongly upregulated in a sub-set of activated microglia in multiple white and gray matter structures. This unique microglial response was associated with a marked decrease in naturally occurring apoptosis, but an increase in cell proliferation in the subventricular zone (SVZ) and the dentate gyrus (DG) of hippocampus. LPS exposure also leads to a significant increase in oligodendrocyte lineage population without causing discernible hypermyelination. Moreover, LPS-exposed rats exhibited significant impairments in communicative and cognitive functions. These findings suggest a possible role of M2-like microglial activation in abnormal neural development that may underlie ASD-like behavioral impairments.	[Pang, Yi; Dai, Xuemei; Carter, Kathleen; Bhatt, Abhay J.; Fan, Lir-Wan] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Roller, Anna; Paul, Ian; Lin, Rick C. S.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Lin, Rick C. S.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Pang, Y; Fan, LW (corresponding author), Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA.	ypang@umc.edu; lwfan@umc.edu		Pang, Yi/0000-0003-0453-6921	University of Mississippi Medical Center; NIH [R01NS080844]; Animal Behavioral Core of the COBRE Center for Psychiatric Neuroscience at the University of Mississippi Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080844] Funding Source: NIH RePORTER	University of Mississippi Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Animal Behavioral Core of the COBRE Center for Psychiatric Neuroscience at the University of Mississippi Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported partially by an intradepartmental grant (Y. P.), an Intramural Research Support Program from the University of Mississippi Medical Center (Y.P.), a NIH grant R01NS080844 (LW. F), and in addition, by the Animal Behavioral Core of the COBRE Center for Psychiatric Neuroscience at the University of Mississippi Medical Center.; This work is supported partially by an intradepartmental grant (YP), an Intramural Research Support Program from the University of Mississippi Medical Center (YP), a NIH grant R01NS080844 (LF), and in addition, by the Animal Behavioral Core of the COBRE Center for Psychiatric Neuroscience at the University of Mississippi Medical Center.	Anderson PJ, 2014, SEMIN FETAL NEONAT M, V19, P90, DOI 10.1016/j.siny.2013.11.012; Aylward GP, 2014, J DEV BEHAV PEDIATR, V35, P394, DOI 10.1097/01.DBP.0000452240.39511.d4; Back SA, 2015, PEDIATR NEUROL, V53, P185, DOI 10.1016/j.pediatrneurol.2015.04.006; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654; Blatt GJ, 2011, ANAT REC, V294, P1646, DOI 10.1002/ar.21252; Borta A, 2006, BEHAV BRAIN RES, V166, P271, DOI 10.1016/j.bbr.2005.08.009; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Casaccia-Bonnefil P, 2000, GLIA, V29, P124, DOI 10.1002/(SICI)1098-1136(20000115)29:2<124::AID-GLIA5>3.0.CO;2-O; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chapman KZ, 2015, NEUROBIOL DIS, V83, P1, DOI 10.1016/j.nbd.2015.08.013; Chau V, 2009, ANN NEUROL, V66, P155, DOI 10.1002/ana.21713; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Dammann O, 2001, TRENDS NEUROSCI, V24, P320, DOI 10.1016/S0166-2236(00)01811-7; Dammann O, 2016, INFLAMMATION, V39, P672, DOI 10.1007/s10753-015-0293-z; Dinel AL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0155-x; Fan LW, 2015, J NEUROCHEM, V133, P532, DOI 10.1111/jnc.12988; Fan LW, 2011, BRAIN BEHAV IMMUN, V25, P286, DOI 10.1016/j.bbi.2010.09.020; GOTTSCHALL PE, 1992, NEUROENDOCRINOLOGY, V56, P935, DOI 10.1159/000126328; Gupta S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6748; Jha MK, 2016, BIOCHEM PHARMACOL, V103, P1, DOI 10.1016/j.bcp.2015.11.003; Kaushik G, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00012; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kinney HC, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/295389; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Leviton A, 2013, J CHILD NEUROL, V28, P1637, DOI 10.1177/0883073812463068; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; McQuillen PS, 2004, PEDIATR NEUROL, V30, P227, DOI 10.1016/j.pediatrneurol.2003.10.001; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Nunez JL, 2001, J COMP NEUROL, V436, P32; Olah M, 2011, CNS NEUROL DISORD-DR, V10, P108, DOI 10.2174/187152711794488575; Pang Y, 2006, NEUROSCIENCE, V141, P745, DOI 10.1016/j.neuroscience.2006.04.007; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Pang Y, 2010, NEUROSCIENCE, V166, P464, DOI 10.1016/j.neuroscience.2009.12.040; Pang Y, 2012, PEDIATR RES, V71, P552, DOI 10.1038/pr.2012.9; Pinto-Martin JA, 2011, PEDIATRICS, V128, P883, DOI 10.1542/peds.2010-2846; Rolando C, 2014, CURR TOP DEV BIOL, V107, P183, DOI 10.1016/B978-0-12-416022-4.00007-X; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Singh AK, 2004, TOXICOLOGY, V201, P197, DOI 10.1016/j.tox.2004.04.015; Smith PLP, 2014, DEV NEUROSCI-BASEL, V36, P119, DOI 10.1159/000359950; Subramanian M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.2015.00313, 10.3339/fnins.2015.00373]; Takano T, 2015, DEV NEUROSCI-BASEL, V37, P195, DOI 10.1159/000398791; Takebayashi H, 2015, GLIA, V63, P1350, DOI 10.1002/glia.22863; Urban N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00396; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Wohr M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00073; Xavier ALR, 2015, J NEUROSCI, V35, P11848, DOI 10.1523/JNEUROSCI.1217-15.2015	52	39	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164403	10.1371/journal.pone.0164403	http://dx.doi.org/10.1371/journal.pone.0164403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723799	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100055
J	Velichko, S; Zhou, X; Zhu, LX; Anderson, JD; Wu, R; Chen, Y				Velichko, Sharlene; Zhou, Xu; Zhu, Lingxiang; Anderson, Johnathon David; Wu, Reen; Chen, Yin			A Novel Nuclear Function for the Interleukin-17 Signaling Adaptor Protein Act1	PLOS ONE			English	Article							MESSENGER-RNA STABILIZATION; COLONY-STIMULATING FACTOR; HUMAN AIRWAY EPITHELIUM; B ACTIVATOR ACT1; GENE-EXPRESSION; BETA-DEFENSIN-2 EXPRESSION; HOST-DEFENSE; IL-17; INFLAMMATION; RECEPTOR	In the context of the human airway, interleukin-17A (IL-17A) signaling is associated with severe inflammation, as well as protection against pathogenic infection, particularly at mucosal surfaces such as the airway. The intracellular molecule Act1 has been demonstrated to be an essential mediator of IL-17A signaling. In the cytoplasm, it serves as an adaptor protein, binding to both the intracellular domain of the IL-17 receptor as well as members of the canonical nuclear factor kappa B (NF-kappa B) pathway. It also has enzymatic activity, and serves as an E3 ubiquitin ligase. In the context of airway epithelial cells, we demonstrate for the first time that Act1 is also present in the nucleus, especially after IL-17A stimulation. Ectopic Act1 expression can also increase the nuclear localization of Act1. Act1 can up-regulate the expression and promoter activity of a subset of IL-17A target genes in the absence of IL-17A signaling in a manner that is dependent on its N- and C-terminal domains, but is NF-kappa B independent. Finally, we show that nuclear Act1 can bind to both distal and proximal promoter regions of DEFB4, one of the IL-17A responsive genes. This transcriptional regulatory activity represents a novel function for Act1. Taken together, this is the first report to describe a non-adaptor function of Act1 by directly binding to the promoter region of IL-17A responsive genes and directly regulate their transcription.	[Velichko, Sharlene; Anderson, Johnathon David; Wu, Reen] Univ Calif Davis, Dept Internal Med, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA; [Zhou, Xu; Zhu, Lingxiang; Chen, Yin] Univ Arizona, Sch Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of California System; University of California Davis; University of Arizona	Chen, Y (corresponding author), Univ Arizona, Sch Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	ychen@pharmacy.arizona.edu	Anderson, Johnathon D./H-5997-2019; Anderson, Johnathon/AAA-1647-2019	Anderson, Johnathon/0000-0001-5404-2298	National Institute of Health [AI061695, AI113526, HL096373, T32 HL07013, ES00628, HL097087]; Clinical Innovator Award from Flight Attendant Medical Research Institute [123055-CIA]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113526] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Innovator Award from Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health grants: AI061695 (YC), AI113526 (YC), HL096373 (RW), T32 HL07013 (RW), ES00628 (RW), HL097087 (RW). Clinical Innovator Award (123055-CIA) from Flight Attendant Medical Research Institute (YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bauer H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/402593; Brodlie M, 2011, EUR RESPIR J, V37, P1378, DOI 10.1183/09031936.00067110; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Chen Y, 2001, AM J RESP CELL MOL, V25, P542, DOI 10.1165/ajrcmb.25.5.4298; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Chen Y, UNPUB; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Fei Huang, 2009, J IMMUNOL S, V182, P134; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Huang F, 2008, J ALLERGY CLIN IMMUN, V121, P1415, DOI 10.1016/j.jaci.2008.04.016; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Kanamori M, 2002, FEBS LETT, V532, P241, DOI 10.1016/S0014-5793(02)03688-8; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Laan M, 2002, EUR RESPIR J, V19, P534, DOI 10.1183/09031936.02.00280902; Laan M, 2003, EUR RESPIR J, V21, P387, DOI 10.1183/09031936.03.00303503; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; Mauro C, 2003, BIOCHEM BIOPH RES CO, V309, P84, DOI 10.1016/S0006-291X(03)01532-8; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Onishi RM, 2010, J BIOL CHEM, V285, P32751, DOI 10.1074/jbc.M110.121418; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Qian YC, 2002, P NATL ACAD SCI USA, V99, P9386, DOI 10.1073/pnas.142294499; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Sumioka A, 2008, EXP CELL RES, V314, P1155, DOI 10.1016/j.yexcr.2007.12.006; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Zhou XH, 2009, INFECT IMMUN, V77, P5059, DOI 10.1128/IAI.00403-09	41	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163323	10.1371/journal.pone.0163323	http://dx.doi.org/10.1371/journal.pone.0163323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723765	gold, Green Published			2022-12-27	WOS:000385504100006
J	Correa, LS; Hokerberg, YHM; de Vasconcellos, R; de Oliveira, C; Berms, DMD; Alexandria, HAF; Daumas, RP; de Andrade, CAF; Passos, SRL; Brasi, P				Correa, Luana Sicuro; Marques Hokerberg, Yara Hahr; de Vasconcellos, Raquel; de Oliveira, Carvalhaes; de Souza Berms, Danielle Martins; Ferreira Alexandria, Helenara Abadia; Daumas, Regina Paiva; Ferreira de Andrade, Carlos Augusto; Lambert Passos, Sonia Regina; Brasi, Patricia			Use of Warning Signs for Dengue by Pediatric Health Care Staff in Brazil	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; RISK-FACTORS; CULTURAL-ADAPTATION; CASE CLASSIFICATION; CLINICAL-FEATURES; SHOCK SYNDROME; PUERTO-RICO; CHILDREN; DISEASE; INFECTION	Objective The aim of this study was to describe the use of dengue warning signs by pediatric health-care staff in the Brazilian public health care system. Methods Cross-sectional study (2012) with physicians, nurses, and nurse technicians assisting children in five health care facilities. Participants reported the use and importance of dengue warning signs in pediatrics clinical practice through a structured questionnaire. Differences in the use of signs (chi-square test) and in the ranking assigned to each of them (Kruskal-Wallis) were assessed according to health care occupation and level of care (p<0.05). Results The final sample comprised 474 participants (97%), mean age of 37 years (standard deviation = 10.3), mainly females (83.8%), physicians (40.1%) and from tertiary care (75.1%). The majority (91%) reported using warning signs for dengue in pediatrics clinical practice. The most widely used and highly valued signs were major hemorrhages (gastrointestinal, urinary), abdominal pain, and increase in hematocrit concurrent or not with rapid decrease in platelet count. Persistent vomiting as well as other signs of plasma leakage such as respiratory distress and lethargy/restlessness were not identified as having the same degree of importance, especially by nurse technicians and in primary or secondary care. Discussion Although most health care staff reported using dengue warning signs, it would be useful to extend the training for identifying easily recognizable signs of plasma leakage that occur regardless of bleeding.	[Correa, Luana Sicuro; de Souza Berms, Danielle Martins] Univ Estado Rio De Janeiro, Dept Pediat, Rio De Janeiro, RJ, Brazil; [Marques Hokerberg, Yara Hahr; de Vasconcellos, Raquel; Ferreira de Andrade, Carlos Augusto; Lambert Passos, Sonia Regina] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Epidemiol, Rio De Janeiro, RJ, Brazil; [Correa, Luana Sicuro; Marques Hokerberg, Yara Hahr] Univ Estacio Sa, Sch Med, Rio De Janeiro, RJ, Brazil; [Ferreira Alexandria, Helenara Abadia] Univ Estado Rio De Janeiro, Dept Obstet & Gynecol, Rio De Janeiro, RJ, Brazil; [Daumas, Regina Paiva] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Germano Sinval Faria Teaching Primary Care Ctr, Rio De Janeiro, RJ, Brazil; [Brasi, Patricia] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Estacio de Sa; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Correa, LS (corresponding author), Univ Estado Rio De Janeiro, Dept Pediat, Rio De Janeiro, RJ, Brazil.; Correa, LS (corresponding author), Univ Estacio Sa, Sch Med, Rio De Janeiro, RJ, Brazil.	luanascorrea@gmail.com	DAUMAS, REGINA P/M-9387-2013; Oliveira, Raquel de V C de/S-7443-2016	DAUMAS, REGINA P/0000-0002-8923-7711; Brasil, Patricia/0000-0001-9555-7976; Oliveira, Raquel de V C de/0000-0001-9387-8645; Passos, Sonia/0000-0001-9947-2291	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [110.188/2014, E-26/110.964/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq [311414/2013-3]; Rede Dengue Fiocruz	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rede Dengue Fiocruz	This work was funded by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (Grant number 110.188/2014 and E-26/110.964/2013). SRLP was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (311414/2013-3), and PB by Rede Dengue Fiocruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardana S, 2012, CEYLON MED J, V57, P177, DOI 10.4038/cmj.v57i4.5091; Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x; Arora Shilpa Khanna, 2012, J Neurosci Rural Pract, V3, P228, DOI 10.4103/0976-3147.98267; Balasubramanian S, 2012, ARCH DIS CHILD, V97, P907, DOI 10.1136/archdischild-2012-301710; Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059; Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Biswas HH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001562; Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2007, DENG DIAGN MAN CLIN; Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, DIR TECN DENG DIAGN; Correa LS, 2015, CAD SAUDE PUBLICA, V31, P247, DOI 10.1590/0102-311X00213913; da Silva GM, 2009, REV BRAS ENFERM, V62, P362, DOI 10.1590/S0034-71672009000300005; Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003; Ferreira JCDA, 2009, ACTA PAUL ENFERM, V22, P31, DOI 10.1590/S0103-21002009000100005; Figueiro AC, 2011, CAD SAUDE PUBLICA, V27, P2373, DOI 10.1590/S0102-311X2011001200009; Giraldo D, 2011, T ROY SOC TROP MED H, V105, P601, DOI 10.1016/j.trstmh.2011.07.007; Gupta V, 2011, J TROP PEDIATRICS, V57, P451, DOI 10.1093/tropej/fmr020; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Halstead SB, 2009, F1000 MED REP, V1, DOI [10.3410/M1-73, DOI 10.3410/M1-73]; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Herdman M, 1998, QUAL LIFE RES, V7, P323, DOI 10.1023/A:1024985930536; Ho TS, 2013, J FORMOS MED ASSOC, V112, P18, DOI 10.1016/j.jfma.2012.11.004; Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676; Kalayanarooj Siripen, 2011, Trop Med Health, V39, P83, DOI 10.2149/tmh.2011-S10; Kanade T, 2011, J VECTOR DIS, V48, P180; Kularatne Sam, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1198; Lee LK, 2011, ANN ACAD MED SINGAP, V40, P533; Martinez E, 2005, DENGUE; Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397; Potts JA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000769; Rigau-Perez JG, 2006, CLIN INFECT DIS, V42, P1241, DOI 10.1086/501355; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Shah I, 2004, J TROP PEDIATRICS, V50, P301, DOI 10.1093/tropej/50.5.301; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268; Tantracheewathorn Taweewong, 2007, Journal of the Medical Association of Thailand, V90, P272; Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614; Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657; The TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001679; WHO, 2009, WHO TECH REP SER, V958, P1; Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x; World Health Organization, 1997, DENG HAEM FEV DIAGN, P1; Ximenes Neto FRG, 2008, NURSING ASSISTANTS T, P51	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163946	10.1371/journal.pone.0163946	http://dx.doi.org/10.1371/journal.pone.0163946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716812	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100013
J	Wang, LM; Zhang, HB; Li, CY; Yi, Y; Liu, J; Zhao, Y; Tian, JZ; Zhang, YS; Wei, XL; Gao, Y; Liang, AH				Wang, Lianmei; Zhang, Hongbing; Li, Chunying; Yi, Yan; Liu, Jing; Zhao, Yong; Tian, Jingzhuo; Zhang, Yushi; Wei, Xiaolu; Gao, Yue; Liang, Aihua			Omeprazole Alleviates Aristolochia manshuriensis Kom-Induced Acute Nephrotoxicity	PLOS ONE			English	Article							HYDROCARBON RECEPTOR ACTIVATION; ACID-I; BETA-NAPHTHOFLAVONE; DNA-ADDUCTS; UROTHELIAL CANCER; CHINESE HERBS; PROTECTS MICE; KIDNEY INJURY; RENAL INJURY; NEPHROPATHY	Aristolochia manshuriensis Kom (AMK) is a member of the Aristolochiaceae family and is a well-known cause of aristolochic acid (AA) nephropathy. In this study, we investigated the potential of omeprazole (OM) to alleviate AMK-induced nephrotoxicity. We found that OM reduced mouse mortality caused by AMK and attenuated AMK-induced acute nephrotoxicity in rats. OM enhanced hepatic Cyp 1a1/2 and renal Cyp 1a1 expression in rats, as well as CYP 1A1 expression in human renal tubular epithelial cells (HKCs). HKCs with ectopic CYP 1A1 expression were more tolerant to AA than the control cells. Therefore, OM may alleviate AMK-mediated acute nephrotoxicity through induction of CYP 1A1. We suggest that the coadministration of OM might be beneficial for reducing of AA-induced nephrotoxicity.	[Wang, Lianmei; Li, Chunying; Yi, Yan; Liu, Jing; Zhao, Yong; Tian, Jingzhuo; Zhang, Yushi; Wei, Xiaolu; Liang, Aihua] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Zhang, Hongbing] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Dept Physiol, Beijing, Peoples R China; [Zhang, Hongbing] Peking Union Med Coll, Beijing, Peoples R China; [Gao, Yue] Beijing Inst Radiat Med, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China	Liang, AH (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	ahliang@icmm.ac.cn	YI, YAN/GUS-2240-2022		National Science and Technology Major Project [2015ZX09501004]; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Project [Z195]	National Science and Technology Major Project; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Project	This work was supported by National Science and Technology Major Project (Grant 2015ZX09501004); the funder conceived and designed the experiments, analyzed the data and wrote the manuscript; and by Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Project (Grant Z195); the funder performed the experiments, analyzed the data and wrote the manuscript.	Chen CH, 2013, INT J CANCER, V133, P14, DOI 10.1002/ijc.28013; Chen CH, 2012, P NATL ACAD SCI USA, V109, P8241, DOI 10.1073/pnas.1119920109; Cosyns JP, 2003, DRUG SAFETY, V26, P33, DOI 10.2165/00002018-200326010-00004; de Leon MB, 2006, BBA-GENE STRUCT EXPR, V1759, P152, DOI 10.1016/j.bbaexp.2006.03.005; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Dracinska H, 2016, TOXICOLOGY, V344, P7, DOI 10.1016/j.tox.2016.01.011; Feng CC, 2013, ENVIRON TOXICOL PHAR, V36, P850, DOI 10.1016/j.etap.2013.07.017; Grollman AP, 2007, P NATL ACAD SCI USA, V104, P12129, DOI 10.1073/pnas.0701248104; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Hampton DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023669; Hayashi H, 2012, J TOXICOL SCI, V37, P517; Hodek P, 2011, NEUROENDOCRINOL LETT, V32, P25; Krell D, 2013, LANCET ONCOL, V14, P25, DOI 10.1016/S1470-2045(12)70596-X; Ma AP, 2014, HUM MOL GENET, V23, P693, DOI 10.1093/hmg/ddt456; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; MENGS U, 1987, ARCH TOXICOL, V59, P328, DOI 10.1007/BF00295084; MORENO JJ, 1993, IMMUNOPHARMACOLOGY, V26, P1, DOI 10.1016/0162-3109(93)90061-T; Myers RP, 2001, AM J GASTROENTEROL, V96, P3428; Patel RD, 2007, HEPATOLOGY, V46, P209, DOI 10.1002/hep.21671; Pozdzik AA, 2008, NEPHROL DIAL TRANSPL, V23, P2480, DOI 10.1093/ndt/gfn140; Pu XY, 2016, EXP TOXICOL PATHOL, V68, P315, DOI 10.1016/j.etp.2016.03.003; Rastogi S, 2007, TOXICOL APPL PHARM, V224, P228, DOI 10.1016/j.taap.2007.05.020; RIDDICK DS, 1994, J BIOL CHEM, V269, P12118; Rooney PH, 2004, CURR CANCER DRUG TAR, V4, P257, DOI 10.2174/1568009043333014; Rosenquist TA, 2010, DRUG METAB DISPOS, V38, P761, DOI 10.1124/dmd.110.032201; Scelo G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6135; Schmeiser HH, 2014, INT J CANCER, V135, P502, DOI 10.1002/ijc.28681; Shi LZ, 2009, MICROB PATHOGENESIS, V47, P258, DOI 10.1016/j.micpath.2009.08.004; Shivanna B, 2011, J PHARMACOL EXP THER, V339, P106, DOI 10.1124/jpet.111.182980; Stiborova M, 2005, INT J CANCER, V113, P189, DOI 10.1002/ijc.20564; Tanaka A, 2001, INTERNAL MED, V40, P296, DOI 10.2169/internalmedicine.40.296; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Xiao Y, 2009, ACTA PHARMACOL SIN, V30, P1559, DOI 10.1038/aps.2009.156; Xiao Y, 2008, KIDNEY INT, V73, P1231, DOI 10.1038/ki.2008.103; Yang HY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/569325; Yang L, 2007, NEPHROL DIAL TRANSPL, V22, P445, DOI 10.1093/ndt/gfl556; Zhang R, 2011, TOXICOL APPL PHARM, V252, P18, DOI 10.1016/j.taap.2011.01.008; Zhao B, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-442	39	7	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164215	10.1371/journal.pone.0164215	http://dx.doi.org/10.1371/journal.pone.0164215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716846	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100034
J	Miliau, JF; Wijchers, P; Gaudreau, L				Miliau, Jean-Francois; Wijchers, Patrick; Gaudreau, Luc			High-Resolution 4C Reveals Rapid p53-Dependent Chromatin Reorganization of the CDKN1A Locus in Response to Stress	PLOS ONE			English	Article							CANCER CELLS; HUMAN GENOME; REGULATORY ELEMENTS; P53 FAMILY; GENE; COHESIN; TRANSCRIPTION; PROMOTERS; CTCF; APOPTOSIS	A regulatory program involving hundreds of genes is coordinated by p53 to prevent carcinogenesis in response to stress. Given the importance of chromatin loops in gene regulation, we investigated whether DNA interactions participate in the p53 stress response. To shed light on this issue, we measured the binding dynamics of cohesin in response to stress. We reveal that cohesin is remodeled at specific loci during the stress response and that its binding within genes negatively correlates with transcription. At p53 target genes, stress-induced eviction of cohesin from gene bodies is concomitant to spatial reorganization of loci through the disruption of functional chromatin loops. These findings demonstrate that chromatin loops can be remodeled upon stress and contribute to the p53-driven stress response. Additionally, we also propose a mechanism whereby transcription-coupled eviction of cohesin from CDKN1A might act as a molecular switch to control spatial interactions between regulatory elements.	[Miliau, Jean-Francois; Gaudreau, Luc] Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Wijchers, Patrick] Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Wijchers, Patrick] Univ Med Ctr Utrecht, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands	University of Sherbrooke; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Gaudreau, L (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	Luc.Gaudreau@USherbrocke.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research.	Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Benson EK, 2014, ONCOGENE, V33, P3959, DOI 10.1038/onc.2013.378; Botcheva K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113492; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duttke SHC, 2015, MOL CELL, V57, P674, DOI 10.1016/j.molcel.2014.12.029; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Ji MY, 2014, EXP THER MED, V8, P919, DOI 10.3892/etm.2014.1831; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lv XG, 2012, MOL MED REP, V5, P1220, DOI 10.3892/mmr.2012.805; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Millau JF, 2009, MUTAT RES-REV MUTAT, V681, P118, DOI 10.1016/j.mrrev.2008.06.002; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nozell S, 2002, ONCOGENE, V21, P1285, DOI 10.1038/sj.onc.1205191; Pan Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1846; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zheng JF, 2010, AMINO ACIDS, V38, P1261, DOI 10.1007/s00726-009-0437-2	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163885	10.1371/journal.pone.0163885	http://dx.doi.org/10.1371/journal.pone.0163885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741251	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000008
J	Dreher, C; Scholz, C; Pommer, M; Brons, S; Prokesch, H; Ecker, S; Debus, J; Jakel, O; Combs, SE; Habermehl, D				Dreher, Constantin; Scholz, Christian; Pommer, Mira; Brons, Stephan; Prokesch, Hannah; Ecker, Swantje; Debus, Jurgen; Jaekel, Oliver; Combs, Stephanie E.; Habermehl, Daniel			Optimization of Carbon Ion Treatment Plans by Integrating Tissue Specific alpha/beta-Values for Patients with Non-Resectable Pancreatic Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMORADIATION; DOSE DISTRIBUTION; RADIOTHERAPY; THERAPY; IMPACT; REPAIR; BEAMS; MODEL; TRIAL	Background The aim of the thesis is to improve treatment plans of carbon ion irradiation by integrating the tissues' specific alpha/beta-values for patients with locally advanced pancreatic cancer (LAPC). Material and Methods Five patients with LAPC were included in this study. By the use of the treatment planning system Syngo RT Planning (Siemens, Erlangen, Germany) treatment plans with carbon ion beams have been created. Dose calculation was based on alpha/beta-values for both organs at risk (OAR) and the tumor. Twenty-five treatment plans and thirty-five forward calculations were created. With reference to the anatomy five field configurations were included. Single Beam Optimization (SBO) and Intensity Modulated Particle Therapy (IMPT) were used for optimization. The plans were analyzed with respect to both dose distributions and individual anatomy. The plans were evaluated using a customized index. Results With regard to the target, a field setup with one single posterior field achieves the highest score in our index. Field setups made up of three fields achieve good results in OAR sparing. Nevertheless, the field setup with one field is superior in complex topographic conditions. But, allocating an alpha/beta-value of 2 Gy to the spinal cord leads to critical high maximum doses in the spinal cord. The evaluation of dose profiles showed significant dose peaks at borders of the alpha/beta-gradient, especially in case of a single posterior field. Conclusion Optimization with specific alpha=beta-values allows a more accurate view on dose distribution than previously. A field setup with one single posterior field achieves good results in case of difficult topographic conditions, but leads to high maximum doses to the spinal cord. So, field setups with multiple fields seem to be more adequate in case of LAPC, being surrounded by highly radiosensitive normal tissues.	[Dreher, Constantin; Debus, Jurgen; Jaekel, Oliver] Univ Heidelberg Hosp, Dept Radiat Oncol, Heidelberg, Germany; [Dreher, Constantin; Combs, Stephanie E.; Habermehl, Daniel] Klinikum Rechts Der Isar, Dept Radiooncol, Munich, Germany; [Scholz, Christian] Siemens AG, Healthcare Sect, Imaging & Therapy Div, Mannheim, Germany; [Pommer, Mira] Hottinger Baldwin Messtech GmbH, Darmstadt, Germany; [Brons, Stephan; Prokesch, Hannah; Ecker, Swantje] Univ Heidelberg Hosp, Heidelberg Ion Beam Therapy Ctr HIT, Heidelberg, Germany; [Combs, Stephanie E.; Habermehl, Daniel] Helmholtz Zentrum Munchen, Inst Innovat Radiotherapy, Munich, Germany	Ruprecht Karls University Heidelberg; Technical University of Munich; Siemens AG; Siemens Germany; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Dreher, C (corresponding author), Univ Heidelberg Hosp, Dept Radiat Oncol, Heidelberg, Germany.; Dreher, C (corresponding author), Klinikum Rechts Der Isar, Dept Radiooncol, Munich, Germany.	ConstantinDreher@gmail.com	Jäkel, Oliver/AAC-4379-2021	Jäkel, Oliver/0000-0002-6056-9747; Dreher, Constantin/0000-0001-5671-9389				Batista V, 2014, RADIOTHER ONCOL, V111, pS152; BENTZEN SM, 1991, RADIOTHER ONCOL, V20, P159, DOI 10.1016/0167-8140(91)90092-U; Cattaneo GM, 2010, RADIOTHER ONCOL, V97, P525, DOI 10.1016/j.radonc.2010.08.007; Combs SE, 2013, STRAHLENTHER ONKOL, V189, P738, DOI 10.1007/s00066-013-0391-5; Combs SE, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-419; Dreher C, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0538-x; El Shafie RA, 2013, J RADIAT RES, V54, P113, DOI 10.1093/jrr/rrt052; Grun R, 2012, PHYS MED BIOL, V57, P7261, DOI 10.1088/0031-9155/57/22/7261; HABERER T, 1993, NUCL INSTRUM METH A, V330, P296, DOI 10.1016/0168-9002(93)91335-K; Habermehl D, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-59; Habermehl D, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-28; Kirkpatrick JP, 2010, INT J RADIAT ONCOL, V76, pS42, DOI 10.1016/j.ijrobp.2009.04.095; Kramer M, 2000, PHYS MED BIOL, V45, P3319, DOI 10.1088/0031-9155/45/11/314; Kramer M, 2000, PHYS MED BIOL, V45, P3299, DOI 10.1088/0031-9155/45/11/313; Kumagai M, 2009, INT J RADIAT ONCOL, V73, P1276, DOI 10.1016/j.ijrobp.2008.10.055; LAWRENCE TS, 1992, INT J RADIAT ONCOL, V23, P781, DOI 10.1016/0360-3016(92)90651-W; Liu F, 2012, INT J RADIAT ONCOL, V83, pE423, DOI 10.1016/j.ijrobp.2011.12.073; Mori S, 2014, RADIOTHER ONCOL, V111, P258, DOI 10.1016/j.radonc.2014.02.014; Oonishi K, 2012, RADIOTHER ONCOL, V105, P258, DOI 10.1016/j.radonc.2012.08.009; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Richter D, 2014, INT J RADIAT ONCOL, V89, P175, DOI 10.1016/j.ijrobp.2014.01.043; Shinoto M, 2013, CANCER-AM CANCER SOC, V119, P45, DOI 10.1002/cncr.27723; Suit H, 2010, RADIOTHER ONCOL, V95, P3, DOI 10.1016/j.radonc.2010.01.015; Taniguchi CM, 2013, INT J RADIAT ONCOL, V85, P1090, DOI 10.1016/j.ijrobp.2012.07.2366; TURESSON I, 1989, RADIOTHER ONCOL, V15, P169, DOI 10.1016/0167-8140(89)90131-X	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164473	10.1371/journal.pone.0164473	http://dx.doi.org/10.1371/journal.pone.0164473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736917	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800069
J	Fergus, CE; Finley, AO; Soranno, PA; Wagner, T				Fergus, C. Emi; Finley, Andrew O.; Soranno, Patricia A.; Wagner, Tyler			Spatial Variation in Nutrient and Water Color Effects on Lake Chlorophyll at Macroscales	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; CROSS-SCALE INTERACTIONS; PHOSPHORUS RELATIONSHIP; LANDSCAPE; PHYTOPLANKTON; PREDICTION; PATTERNS; REGION; DEPTH; NONSTATIONARY	The nutrient-water color paradigm is a framework to characterize lake trophic status by relating lake primary productivity to both nutrients and water color, the colored component of dissolved organic carbon. Total phosphorus (TP), a limiting nutrient, and water color, a strong light attenuator, influence lake chlorophyll a concentrations (CHL). But, these relationships have been shown in previous studies to be highly variable, which may be related to differences in lake and catchment geomorphology, the forms of nutrients and carbon entering the system, and lake community composition. Because many of these factors vary across space it is likely that lake nutrient and water color relationships with CHL exhibit spatial autocorrelation, such that lakes near one another have similar relationships compared to lakes further away. Including this spatial dependency in models may improve CHL predictions and clarify how well the nutrient-water color paradigm applies to lakes distributed across diverse landscape settings. However, few studies have explicitly examined spatial heterogeneity in the effects of TP and water color together on lake CHL. In this study, we examined spatial variation in TP and water color relationships with CHL in over 800 north temperate lakes using spatially-varying coefficient models (SVC), a robust statistical method that applies a Bayesian framework to explore space-varying and scale-dependent relationships. We found that TP and water color relationships were spatially autocorrelated and that allowing for these relationships to vary by individual lakes over space improved the model fit and predictive performance as compared to models that did not vary over space. The magnitudes of TP effects on CHL differed across lakes such that a 1 mu/L increase in TP resulted in increased CHL ranging from 2-24 mu g/L across lake locations. Water color was not related to CHL for the majority of lakes, but there were some locations where water color had a positive effect such that a unit increase in water color resulted in a 2 mu g/L increase in CHL and other locations where it had a negative effect such that a unit increase in water color resulted in a 2 mu g/L decrease in CHL. In addition, the spatial scales that captured variation in TP and water color effects were different for our study lakes. Variation in TP-CHL relationships was observed at intermediate distances (similar to 20 km) compared to variation in water color-CHL relationships that was observed at regional distances (similar to 200 km). These results demonstrate that there are lake-to-lake differences in the effects of TP and water color on lake CHL and that this variation is spatially structured. Quantifying spatial structure in these relationships furthers our understanding of the variability in these relationships at macroscales and would improve model prediction of chlorophyll a to better meet lake management goals.	[Fergus, C. Emi; Soranno, Patricia A.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Finley, Andrew O.] Michigan State Univ, Dept Forestry & Geog, E Lansing, MI 48824 USA; [Wagner, Tyler] Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA	Michigan State University; Michigan State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey	Fergus, CE (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	fergusca@msu.edu			National Science Foundation Macro Systems Biology Program in the Emerging Frontiers Division of the Biological Sciences Directorate [EF-1065786]; National Science Foundation (NSF) [DMS-1513481, EF-1137309, EF-1241874, EF-1253225]; NASA Carbon Monitoring System grants; Direct For Biological Sciences [1137309] Funding Source: National Science Foundation; Division Of Environmental Biology [1253225] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1513481] Funding Source: National Science Foundation; Emerging Frontiers [1065786] Funding Source: National Science Foundation	National Science Foundation Macro Systems Biology Program in the Emerging Frontiers Division of the Biological Sciences Directorate; National Science Foundation (NSF)(National Science Foundation (NSF)); NASA Carbon Monitoring System grants; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this project was provided by the National Science Foundation Macro Systems Biology Program in the Emerging Frontiers Division of the Biological Science Directorate (EF-1065786). Andrew Finley was supported by National Science Foundation (NSF) DMS-1513481, EF-1137309, EF-1241874, and EF-1253225, as well as NASA Carbon Monitoring System grants. The funders had no role in study design, data collection and analysics, decision to publish, or prepartion of the manuscript.	Arbuckle KE, 2001, LIMNOL OCEANOGR, V46, P970, DOI 10.4319/lo.2001.46.4.0970; Banerjee S., 2014, HIERARCHICAL MODELIN; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Brothers S, 2014, LIMNOL OCEANOGR, V59, P1388, DOI 10.4319/lo.2014.59.4.1388; CANFIELD DE, 1984, CAN J FISH AQUAT SCI, V41, P497, DOI 10.1139/f84-059; Canham CD, 2004, ECOL APPL, V14, P839, DOI 10.1890/02-5271; Carpenter SR, 1998, LIMNOL OCEANOGR, V43, P73, DOI 10.4319/lo.1998.43.1.0073; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; DOWNING JA, 1992, LIMNOL OCEANOGR, V37, P936, DOI 10.4319/lo.1992.37.5.0936; Driscoll CT, 2003, ENVIRON SCI TECHNOL, V37, P2036, DOI 10.1021/es020924h; Fee EJ, 1996, LIMNOL OCEANOGR, V41, P912, DOI 10.4319/lo.1996.41.5.0912; Fergus CE, 2011, LIMNOL OCEANOGR, V56, P2127, DOI 10.4319/lo.2011.56.6.2127; Fergus CE, 2016, LAGOS CHLOROPHYLL TP; Filstrup CT, 2014, LIMNOL OCEANOGR, V59, P1691, DOI 10.4319/lo.2014.59.5.1691; Finley AO, 2011, METHODS ECOL EVOL, V2, P143, DOI 10.1111/j.2041-210X.2010.00060.x; Finley AO, 2015, SPBAYES UNIVARIATE M; Gelfand AE, 2003, J AM STAT ASSOC, V98, P387, DOI 10.1198/016214503000170; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Hakanson L, 2005, HYDROBIOLOGIA, V537, P111, DOI 10.1007/s10750-004-2605-4; Heathwaite AL, 1996, HYDROL PROCESS, V10, P263, DOI 10.1002/(SICI)1099-1085(199602)10:2&lt;263::AID-HYP441&gt;3.0.CO;2-K; Higgins JV, 2005, CONSERV BIOL, V19, P432, DOI 10.1111/j.1523-1739.2005.00504.x; Hoeting JA, 2009, ECOL APPL, V19, P574, DOI 10.1890/08-0836.1; JONES RI, 1992, HYDROBIOLOGIA, V229, P73, DOI 10.1007/BF00006992; Kalff J, 2002, LIMNOLOGY INLAND WAT; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Kissman CEH, 2013, LIMNOL OCEANOGR, V58, P867, DOI 10.4319/lo.2013.58.3.0867; Kling GW, 2000, FRESHWATER BIOL, V43, P477, DOI 10.1046/j.1365-2427.2000.00515.x; Klug JL, 2002, CAN J FISH AQUAT SCI, V59, P85, DOI 10.1139/F01-194; KORTELAINEN P, 1993, CAN J FISH AQUAT SCI, V50, P1477, DOI 10.1139/f93-168; Lapierre JF, 2015, GLOBAL CHANGE BIOL, V21, P4425, DOI 10.1111/gcb.13031; Laudon H, 2011, ECOSYSTEMS, V14, P880, DOI 10.1007/s10021-011-9452-8; MAZUMDER A, 1994, CAN J FISH AQUAT SCI, V51, P390, DOI 10.1139/f94-040; Nurnberg GK, 1998, HYDROBIOLOGIA, V382, P97, DOI 10.1023/A:1003445406964; Oliver SK, 2016, INLAND WATERS, V6, P314, DOI 10.5268/IW-6.3.957; Pan D., 1999, LANDSCAPE ECOLOGY, V14, P35, DOI DOI 10.1023/A:1008022028804; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Phillips G, 2008, AQUAT ECOL, V42, P213, DOI 10.1007/s10452-008-9180-0; PRAIRIE YT, 1989, CAN J FISH AQUAT SCI, V46, P1176, DOI 10.1139/f89-153; PUCKETT LJ, 1995, ENVIRON SCI TECHNOL, V29, pA408, DOI 10.1021/es00009a001; RASMUSSEN JB, 1989, LIMNOL OCEANOGR, V34, P1336, DOI 10.4319/lo.1989.34.7.1336; Seekell DA, 2015, CAN J FISH AQUAT SCI, V72, P1663, DOI 10.1139/cjfas-2015-0187; Seekell DA, 2015, LIMNOL OCEANOGR, V60, P1276, DOI 10.1002/lno.10096; Seekell DA, 2014, LIMNOL OCEANOGR, V59, P1612, DOI 10.4319/lo.2014.59.5.1612; Sobek S, 2011, INLAND WATERS, V1, P177, DOI 10.5268/IW-1.3.426; Soranno PA, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0067-4; Soranno PA, 2014, FRONT ECOL ENVIRON, V12, P65, DOI 10.1890/120366; Soranno PA, 2010, BIOSCIENCE, V60, P440, DOI 10.1525/bio.2010.60.6.8; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taranu ZE, 2008, ECOSYSTEMS, V11, P715, DOI 10.1007/s10021-008-9153-0; Thrane JE, 2014, ECOSYSTEMS, V17, P1040, DOI 10.1007/s10021-014-9776-2; Wagner T, 2011, FRESHWATER BIOL, V56, P1811, DOI 10.1111/j.1365-2427.2011.02621.x; Webster KE, 2008, LIMNOL OCEANOGR, V53, P1137, DOI 10.4319/lo.2008.53.3.1137; Wickham JD, 2013, REMOTE SENS ENVIRON, V130, P294, DOI 10.1016/j.rse.2012.12.001; Williamson CE, 1999, LIMNOL OCEANOGR, V44, P795, DOI 10.4319/lo.1999.44.3_part_2.0795; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Xenopoulos MA, 2003, LIMNOL OCEANOGR, V48, P2321, DOI 10.4319/lo.2003.48.6.2321; Yuan LL, 2014, FRESHW SCI, V33, P1184, DOI 10.1086/678465	59	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164592	10.1371/journal.pone.0164592	http://dx.doi.org/10.1371/journal.pone.0164592			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736962	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800093
J	Gonzales, C; Yoshihara, HAI; Dilek, N; Leignadier, J; Irving, M; Mieville, P; Helm, L; Michielin, O; Schwitter, J				Gonzales, Christine; Yoshihara, Hikari A. I.; Dilek, Nahzli; Leignadier, Julie; Irving, Melita; Mieville, Pascal; Helm, Lothar; Michielin, Olivier; Schwitter, Juerg			In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by F-19-Fluorine MRS/MRI	PLOS ONE			English	Article							F-19 MRI; INFLAMMATION; VISUALIZATION; MIGRATION	Background F-19-MRI and F-19-MRS can identify specific cell types after in-vitro or in-vivo F-19-labeling. Knowledge on the potential to track in-vitro F-19-labeled immune cells in tumor models by F-19-MRI/MRS is scarce. Aim To study F-19-based MR techniques for in-vivo tracking of adoptively transferred immune cells after in-vitro F-19-labeling, i.e. to detect and monitor their migration non-invasively in melanoma-bearing mice. Methods Splenocytes (SP) were labeled in-vitro with a perfluorocarbon (PFC) and IV-injected into non-tumor bearing mice. In-vitro PFC-labeled ovalbumin (OVA)-specific T cells from the T cell receptor-transgenic line OT-1, activated with anti-CD3 and anti-CD28 antibodies (T-act) or OVA-peptide pulsed antigen presenting cells (TOVA-act), were injected into B16 OVA melanoma- bearing mice. The distribution of the F-19-labelled donor cells was determined invivo by F-19-MRI/MRS. In-vivo F-19-MRI/MRS results were confirmed by ex-vivo F-19-NMR and flow cytometry. Results SP, T-act, and TOVA-act were successfully PFC-labeled in-vitro yielding 3x10(11)-1.4x10(12) F-19-atoms/cell in the 3 groups. Adoptively transferred F-19-labeled SP, TOVA-act, and T-act were detected by coil-localized F-19-MRS in the chest, abdomen, and left flank in most animals (corresponding to lungs, livers, and spleens, respectively, with highest signal-to-noise for SP vs TOVA-act and T-act, p<0.009 for both). SP and T-act were successfully imaged by F-19-MRI (n = 3; liver). These in-vivo data were confirmed by ex-vivo high-resolution F-19-NMR-spectroscopy. By flow cytometric analysis, however, TOVA-act tended to be more abundant versus SP and T-act (liver: p = 0.1313; lungs: p = 0.1073; spleen: p = 0.109). Unlike F-19-MRI/MRS, flow cytometry also identified transferred immune cells (SP, T-act, and TOVA-act) in the tumors. Conclusion SP, T-act, and TOVA-act were successfully PFC-labeled in-vitro and detected in-vivo by noninvasive F-19-MRS/MRI in liver, lung, and spleen. The portion of F-19-labeled T cells in the adoptively transferred cell populations was insufficient for F-19-MRS/MRI detection in the tumor. While OVA-peptide-activated T cells (TOVA-act) showed highest infiltration into all organs, SP were detected more reliably by F-19-MRS/MRI, most likely explained by cell division of TOVA-act after injection, which dilutes the F-19 content in the T cell-infiltrated organs. Non-dividing F-19-labeled cell species appear most promising to be tracked by F-19-MRS/MRI.	[Gonzales, Christine; Yoshihara, Hikari A. I.; Schwitter, Juerg] Lausanne Univ Hosp CHUV, Div Cardiol, Lausanne, Switzerland; [Yoshihara, Hikari A. I.] Ecole Polytech Fed Lausanne, Inst Phys Biol Syst, Lausanne, Switzerland; [Dilek, Nahzli; Michielin, Olivier] Swiss Inst Bioinformat, Mol Modeling Grp, Lausanne, Switzerland; [Dilek, Nahzli; Leignadier, Julie; Irving, Melita; Michielin, Olivier] Univ Lausanne, Ludwig Branch Canc Res, Epalinges, Switzerland; [Mieville, Pascal; Helm, Lothar] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland; [Michielin, Olivier] Lausanne Univ Hosp CHUV, Dept Oncol, Lausanne, Switzerland; [Schwitter, Juerg] Lausanne Univ Hosp CHUV, Cardiac Magnet Resonance Ctr, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Schwitter, J (corresponding author), Lausanne Univ Hosp CHUV, Div Cardiol, Lausanne, Switzerland.	jurg.schwitter@chuv.ch	leignadier, julie/G-2701-2017; Michielin, Olivier/ABE-7924-2020	leignadier, julie/0000-0002-6546-1874; Yoshihara, Hikari/0000-0002-3274-7147	Swiss National Science Foundation [310030_144077, 200020_152953]; Swiss Heart Foundation; Oncosuisse (OM) [KFS-3180-02-2013]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; Oncosuisse (OM)	This work is supported in part by grants from the Swiss National Science Foundation (JS: grant no: 310030_144077; LH: grant no: 200020_152953), the Swiss Heart Foundation (JS: grant 2013) and the Oncosuisse (OM: grant no: KFS-3180-02-2013).	Ahrens ET, 2014, MAGN RESON MED, V72, P1696, DOI 10.1002/mrm.25454; Ahrens ET, 2013, NMR BIOMED, V26, P860, DOI 10.1002/nbm.2948; Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Balducci A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23034; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Eger EI, 2005, ANESTH ANALG, V100, P1020, DOI 10.1213/01.ANE.0000146961.70058.A1; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Flogel U, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003717; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Gaudet JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118544; Helfer BM, 2010, CYTOTHERAPY, V12, P238, DOI 10.3109/14653240903446902; Janjic JM, 2008, J AM CHEM SOC, V130, P2832, DOI 10.1021/ja077388j; Kadayakkara DK, 2010, PANCREAS, V39, P510, DOI 10.1097/MPA.0b013e3181bd6501; Manzo T, 2015, HUM MOL GENET, V24, pR67, DOI 10.1093/hmg/ddv270; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Schwitter J, 2008, CIRCULATION, V118, P109, DOI 10.1161/CIRCULATIONAHA.108.790139; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Srinivas M, 2009, MAGN RESON MED, V62, P747, DOI 10.1002/mrm.22063; van Heeswijk RB, 2015, RADIOLOGY, V275, P421, DOI 10.1148/radiol.14141371; van Heeswijk RB, 2013, CIRC-CARDIOVASC IMAG, V6, P277, DOI 10.1161/CIRCIMAGING.112.000125; van Heeswijk RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042236; Ye YX, 2013, CIRCULATION, V128, P1878, DOI 10.1161/CIRCULATIONAHA.113.000731; Zhong J, 2013, MAGN RESON MED, V69, P1683, DOI 10.1002/mrm.24414	26	32	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164557	10.1371/journal.pone.0164557	http://dx.doi.org/10.1371/journal.pone.0164557			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736925	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800084
J	Medina-Gomez, I; Madden, CJ; Herrera-Silveira, J; Kjertve, B				Medina-Gomez, Israel; Madden, Christopher J.; Herrera-Silveira, Jorge; Kjertve, Bjorn			Response of Thalassia Testudinum Morphometry and Distribution to Environmental Drivers in a Pristine Tropical Lagoon	PLOS ONE			English	Article							TURTLE-GRASS; SEAGRASS DISTRIBUTION; PRODUCTION DYNAMICS; PUERTO-MORELOS; COASTAL LAGOON; WATER; BIOMASS; FLORIDA; IMPACT; BAY	This study was undertaken to determine the relationships between the biomass, morphometry, and density of short shoots (SS) of the tropical seagrass Thalassia testudinum and the physical-environmental forcing in the region. Seasonal sampling surveys were undertaken four times in Bahia de la Ascension, a shallow estuary in the western Mexican Caribbean, to measure plant morphology and environmental variables. The estuary has a fresh water-influenced inner bay, a large central basin and a marine zone featuring a barrier reef at the seaward margin. Leaf size was positively correlated with increasing salinity, but total biomass was not, being similar across most of the sites. Aboveground biomass exhibited seasonal differences in dry and rainy seasons along the bay, most markedly in the brackish inner bay where an abrupt decline in biomass coincided with the rainy season. The relationship between nutrients and biomass indicates that the aboveground/belowground biomass ratio increases as nutrient availability increases. Areal cover was inversely correlated with SS density during both dry and rainy seasons. Maximum SS recruitment coincided with the rainy season. Peaks in SS density were recorded in the freshwater-influenced inner bay during an ENSO cold phase in 2007 ("La Nina") which is associated with a wetter dry season and following a strong storm (Hurricane Dean). The onset of the rainy season influences both shoot density and T. testudinum biomass by controlling the freshwater input to the bay and thus, the system's salinity gradient and external nutrients supply from the coastal wetland.	[Medina-Gomez, Israel; Herrera-Silveira, Jorge] CINVESTAV IPN, Dept Recursos Mar, Lab Prod & Primaria, Merida, Yucatan, Mexico; [Madden, Christopher J.] South Florida Water Management Dist, W Palm Beach, FL USA; [Kjertve, Bjorn] Amer Univ Sharjah, University City, Sharjah, U Arab Emirates; [Medina-Gomez, Israel] Km 6,Ant Carr Progreso, Merida 97310, Yucatan, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; South Florida Water Management District; American University of Sharjah	Medina-Gomez, I (corresponding author), CINVESTAV IPN, Dept Recursos Mar, Lab Prod & Primaria, Merida, Yucatan, Mexico.; Medina-Gomez, I (corresponding author), Km 6,Ant Carr Progreso, Merida 97310, Yucatan, Mexico.	imedgomez@gmail.com	Kjerfve, Björn/X-9027-2019	Kjerfve, Björn/0000-0002-3867-3281	Nature Conservancy (TNC)	Nature Conservancy (TNC)	Funding for this study was provided by The Nature Conservancy (TNC), to Dr. Israel Medina-Gomez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado PM, 1998, COAST REG SM ISL PA, P221; Arellano-Mendez LU, 2011, REV BIOL TROP, V59, P385; Beddows P. A., 2004, THESIS; Blake ES, 2007, NWSTPC4 NOAA; Bloomfield AL, 2005, ESTUARIES, V28, P63, DOI 10.1007/BF02732754; Caribbean Coastal Marine Productivity (CARICOMP), 2001, METH MAN LEV 1 2 MAN; Carlson PR, 2003, ENVIRON MONIT ASSESS, V81, P393; Carruthers TJB, 2005, ESTUAR COAST SHELF S, V64, P191, DOI 10.1016/j.ecss.2005.01.015; Chavez-Guillen R, 1986, SINOPSIS GEOHIDROLOG; Corlett H, 2007, SEDIMENT GEOL, V194, P245, DOI 10.1016/j.sedgeo.2006.06.010; Creed J. C., 2003, WORLD ATLAS SEAGRASS, P234; Doering PH, 2000, MAR SCI SER, P81; Enriquez S, 2005, OECOLOGIA, V145, P235, DOI 10.1007/s00442-005-0111-7; FOURQUREAN JW, 1995, OIKOS, V72, P349, DOI 10.2307/3546120; Fourqurean JW, 2003, ECOLOGICAL MONITORIN, P257; Franklin JL, 2008, NOAA TECHNICAL REPOR; GALLEGOS ME, 1993, MAR ECOL PROG SER, V95, P185, DOI 10.3354/meps095185; Gayle PMH, 1998, COAST REG SM ISL PA, P17; Gondwe BRN, 2010, WETLANDS, V30, P1, DOI 10.1007/s13157-009-0016-z; Gonzalez-Ortiz V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104949; Hall MO, 1999, ESTUARIES, V22, P445, DOI 10.2307/1353210; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; INEGI, 2011, PERSP EST QUINT ROO; Irlandi E, 2002, AQUAT BOT, V72, P67, DOI 10.1016/S0304-3770(01)00217-0; Kahn AE, 2006, J EXP MAR BIOL ECOL, V335, P1, DOI 10.1016/j.jembe.2006.02.011; Kaldy JE, 2000, MAR ECOL PROG SER, V193, P271, DOI 10.3354/meps193271; KILAR JA, 1988, CORAL REEFS, V7, P93, DOI 10.1007/BF00301647; KJERFVE B, 1981, J GEOPHYS RES-OCEANS, V86, P4243, DOI 10.1029/JC086iC05p04243; Kjerfve B, 1998, COASTAL REGION SMALL, V3; Knutson TR, 2004, J CLIMATE, V17, P3477, DOI [10.1175/1520-0442(2004)017<3477:IOCWOS>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3477:IOCWOS&gt;2.0.CO;2]; Koch EW, 1999, MAR ECOL PROG SER, V184, P63, DOI 10.3354/meps184063; Koltes KH, 1998, COAST REG SM ISL PA, P79; L'Heureux M, 2008, SCI TECHNOLOGY INFUS, P20; Lipcius RN, 1998, MAR FRESHWATER RES, V49, P807, DOI 10.1071/MF97094; Lirman D, 2003, ESTUARIES, V26, P131, DOI 10.1007/BF02691700; MADDEN CJ, 1992, ESTUARIES, V15, P421, DOI 10.2307/1352789; MARBA N, 1994, AQUAT BOT, V47, P1, DOI 10.1016/0304-3770(94)90043-4; McGroddy M, 2013, FOREST ECOL MANAG, V310, P812, DOI 10.1016/j.foreco.2013.09.027; Medina-Gomez I, 2003, ESTUAR COAST SHELF S, V58, P455, DOI 10.1016/S0272-7714(03)00112-4; Medina-Gomez I, 2016, GULF CAR RES, V27, P52; Medina-Gomez I, 2006, CONT SHELF RES, V26, P971, DOI 10.1016/j.csr.2006.03.003; Medina-Gomez I, 2014, ESTUAR COAST, V37, P1329, DOI 10.1007/s12237-014-9774-9; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Metcalfe CD, 2011, ENVIRON POLLUT, V159, P991, DOI 10.1016/j.envpol.2010.11.031; Mutchler T, 2007, ESTUAR COAST SHELF S, V74, P449, DOI 10.1016/j.ecss.2007.04.005; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; ROBBLEE MB, 1984, B MAR SCI, V34, P335; Ruiz-Renteria F, 1998, COAST REG SM ISL PA, P57; Rutkowski CM, 1999, ESTUARIES, V22, P1033, DOI 10.2307/1353081; Spalding M., 2003, WORLD ATLAS SEAGRASS, P5; Ter Braak C. J. F., 1995, P91; Thorhaug A, 2006, AM J BOT, V93, P110, DOI 10.3732/ajb.93.1.110; TOMASKO DA, 1991, MAR ECOL PROG SER, V75, P9, DOI 10.3354/meps075009; Tomasko DA, 1996, ESTUARIES, V19, P448, DOI 10.2307/1352462; VANTUSSENBROEK BI, 1994, BOT MAR, V37, P421, DOI 10.1515/botm.1994.37.5.421; Wear DJ, 1999, MAR ECOL PROG SER, V179, P201, DOI 10.3354/meps179201; Whelan T, 2011, MAR POLLUT BULL, V62, P2797, DOI 10.1016/j.marpolbul.2011.09.007; ZAR JH, 1996, BIOSTATISTICAL ANAL; Zieman JC, 1975, AQUAT BOT, V1, P107	60	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164014	10.1371/journal.pone.0164014	http://dx.doi.org/10.1371/journal.pone.0164014			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736904	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800035
J	Papeta, N; Patel, A; D'Agati, VD; Gharavi, AG				Papeta, Natalia; Patel, Ami; D'Agati, Vivette D.; Gharavi, Ali G.			Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains	PLOS ONE			English	Article							SEGMENTAL GLOMERULOSCLEROSIS; PODOCYTE INJURY; GENE-EXPRESSION; FRASER-SYNDROME; KIDNEY-DISEASE; METHYLTRANSFERASE; NEPHROPATHY; HIV-1; FOXO1; SET7/9	HIV-1 transgenic mice on the FVB/NJ background (TgFVB) represent a validated model of HIV-associated nephropathy (HIVAN). A major susceptibility locus, HIVAN1, was previously mapped to chromosome 3A1-A3 in a cross between TgFVB and CAST/EiJ (CAST) strains, and introgression of a 51.9 Mb segment encompassing HIVAN1 from CAST into TgFVB resulted in accelerated development of nephropathy. We generated three sub-congenic strains carrying CAST alleles in the proximal or distal regions of the HIVAN1 locus (Sub-II, 3.02-38.93 Mb; Sub-III, 38.45-55.1 Mb and Sub-IV, 47.7-55.1 Mb, build 38). At 5-10 weeks of age, histologic injury and proteinuria did not differ between HIV-1 transgenic Sub-II and TgFVB mice. In contrast, HIV-1 transgenic Sub-III and Sub-IV mice displayed up to 4.4 fold more histopathologic injury and 6-fold more albuminuria compared to TgFVB mice, similar in severity to the full-length congenic mice. The Sub-IV segment defines a maximal 7.4 Mb interval for HIVAN1, and encodes 31 protein coding genes: 15 genes have missense variants differentiating CAST from FVB, and 14 genes show differential renal expression. Of these, Frem1, Foxo1, and Setd7 have been implicated in the pathogenesis of nephropathy. HIVAN1 congenic kidneys are histologically normal without the HIV-1 transgene, yet their global transcriptome is enriched for molecular signatures of apoptosis, adenoviral infection, as well as genes repressed by histone H3 lysine 27 trimethylation, a histone modification associated with HIV-1 life cycle. These data refine HIVAN1to 7.4 Mb and identify latent molecular derangements that may predispose to nephropathy upon exposure to HIV-1.	[Papeta, Natalia; Patel, Ami; Gharavi, Ali G.] Columbia Univ, Dept Med, New York, NY 10027 USA; [D'Agati, Vivette D.] Columbia Univ, Dept Pathol, New York, NY USA	Columbia University; Columbia University	Gharavi, AG (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.	ag2239@cumc.columbia.edu			NIH-NIDDK [R01 DK087626-01]	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 DK087626-01 (NIH-NIDDK) to AGG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chan KT, 2009, KIDNEY INT, V75, P366, DOI 10.1038/ki.2008.625; Chen WC, 2015, AM J PATHOL, V185, P2468, DOI 10.1016/j.ajpath.2015.05.019; D'Agati VD, 2008, KIDNEY INT, V73, P399, DOI 10.1038/sj.ki.5002655; DAgati V, 1997, J AM SOC NEPHROL, V8, P138; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Freedman BI, 1999, AM J KIDNEY DIS, V34, P254, DOI 10.1016/S0272-6386(99)70352-5; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gharavi AG, 2004, P NATL ACAD SCI USA, V101, P2488, DOI 10.1073/pnas.0308649100; Guo F, 2015, BIOCHEM BIOPH RES CO, V466, P260, DOI 10.1016/j.bbrc.2015.09.024; Hayashi K, 2015, KIDNEY INT, V88, P745, DOI 10.1038/ki.2015.178; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Jadeja S, 2005, NAT GENET, V37, P520, DOI 10.1038/ng1549; Kann M, 2015, DEVELOPMENT, V142, P1254, DOI 10.1242/dev.119735; Kerecuk L, 2012, PEDIATR NEPHROL, V27, P991, DOI 10.1007/s00467-012-2100-5; Kim HG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-179; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Lezina L, 2014, CELL DEATH DIFFER, V21, P1889, DOI 10.1038/cdd.2014.108; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Liu F, 2014, NEPHROL DIAL TRANSPL, V29, P1879, DOI 10.1093/ndt/gfu202; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Luo WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145130; Maganti AV, 2015, J BIOL CHEM, V290, P9812, DOI 10.1074/jbc.M114.616219; Mallipattu SK, 2015, J CLIN INVEST, V125, P1347, DOI 10.1172/JCI77084; Marban C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026894; Markowitz GS, 2010, CLIN J AM SOC NEPHRO, V5, P607, DOI 10.2215/CJN.07311009; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Papeta N, 2009, J CLIN INVEST, V119, P1178, DOI 10.1172/JCI37131; Ponugoti B, 2013, J CELL BIOL, V203, P327, DOI 10.1083/jcb.201305074; Prakash S, 2011, J AM SOC NEPHROL, V22, P1497, DOI 10.1681/ASN.2011020209; RAO TKS, 1984, NEW ENGL J MED, V310, P669, DOI 10.1056/NEJM198403153101101; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Sasaki K, 2016, J AM SOC NEPHROL, V27, P203, DOI 10.1681/ASN.2014090850; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Shen CC, 2015, FASEB J, V29, P4313, DOI 10.1096/fj.15-273540; Welsh CE, 2012, MAMM GENOME, V23, P706, DOI 10.1007/s00335-012-9410-6; Winston JA, 2001, NEW ENGL J MED, V344, P1979, DOI 10.1056/NEJM200106283442604; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085	48	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163860	10.1371/journal.pone.0163860	http://dx.doi.org/10.1371/journal.pone.0163860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736906	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800029
J	Park, G; Van Bavel, JJ; Hill, LK; Williams, DP; Thayer, JF				Park, Gewnhi; Van Bavel, Jay J.; Hill, LaBarron K.; Williams, DeWayne P.; Thayer, Julian F.			Social Groups Prioritize Selective Attention to Faces: How Social Identity Shapes Distractor Interference (vol 11, e0161426, 2016)	PLOS ONE			English	Correction													Park, Gewnhi/GNH-1984-2022; Thayer, Julian/AAA-1161-2020	Park, Gewnhi/0000-0001-7832-9664; Thayer, Julian/0000-0001-9385-3421	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000029] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL121708] Funding Source: Medline; NIA NIH HHS [T32 AG000029] Funding Source: Medline; NIMHD NIH HHS [L60 MD009947] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Park G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161426	1	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164909	10.1371/journal.pone.0164909	http://dx.doi.org/10.1371/journal.pone.0164909			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732678	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300080
J	Vaara, ST; Hollmen, M; Korhonen, AM; Maksimow, M; Ala-Kokko, T; Salmi, M; Jalkanen, S; Pettila, V				Vaara, Suvi T.; Hollmen, Maija; Korhonen, Anna-Maija; Maksimow, Mikael; Ala-Kokko, Tero; Salmi, Marko; Jalkanen, Sirpa; Pettila, Ville		FINNAKI Study Grp	Soluble CD73 in Critically Ill Septic Patients Data from the Prospective FINNAKI Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; SEVERE SEPSIS; ECTO-5'-NUCLEOTIDASE CD73; ORGAN FAILURE; MORTALITY	Background CD73 dephosphorylates adenosine monophosphate to adenosine that is an anti-inflammatory molecule inhibiting immune activation and vascular leakage. Therefore, CD73 could be an interesting mediator both in sepsis and acute kidney injury (AKI). We aimed to explore the soluble CD73 (sCD73) levels and their evolution in critically ill patients with severe sepsis and, second, to scrutinize the potential association of sCD73 levels with AKI and 90-day mortality. Methods This was a post-hoc laboratory analysis of the prospective, observational FINNAKI study conducted in 17 Finnish ICU during 5 months in 2011-2012. Plasma samples of 588 patients admitted with severe sepsis/shock or with developing severe sepsis were analyzed at 0h (ICU admission) and 24h, and additionally, on day 3 or day 5 from a subset of the patients. Results The median [IQR] sCD73 levels at 0h were 5.11 [3.29-8.28] ng/mL and they decreased significantly from 0h to 4.14 [2.88-7.11] ng/mL at 24h, P<0.001. From 24h to Day 3 (n = 132) the sCD73 levels rose to 5.18 [2.98-8.83] ng/mL (P = 0.373) and from 24h to Day 5 (n = 224) to 5.52 [3.57-8.90] ng/mL (P<0.001). Patients with AKI had higher sCD73 values at 0h and at 24h compared to those without AKI. Non-survivors with severe sepsis, but not with septic shock, had higher CD73 levels at each time-point compared to survivors. After multivariable adjustments, sCD73 levels at 0h associated independently neither with the development of AKI nor 90-day mortality. Conclusions Compared to normal population, the sCD73 levels were generally low at 0h, showed a decrease to 24h, and later an increase by day 5. The sCD73 levels do not seem useful in predicting the development of AKI or 90-day mortality among patients with severe sepsis or shock.	[Vaara, Suvi T.; Korhonen, Anna-Maija; Pettila, Ville] Univ Helsinki, Dept Anaesthesiol Intens Care & Pain Med, Div Intens Care Med, Helsinki, Finland; [Vaara, Suvi T.; Korhonen, Anna-Maija; Pettila, Ville] Helsinki Univ Hosp, Helsinki, Finland; [Hollmen, Maija; Maksimow, Mikael; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, Med Res Lab, Turku, Finland; [Hollmen, Maija; Maksimow, Mikael; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Ala-Kokko, Tero] Univ Oulu, Dept Anaesthesiol, Oulu, Finland; [Ala-Kokko, Tero] Oulu Univ Hosp, Med Res Ctr Oulu, Div Intens Care Med, Oulu, Finland; [Pettila, Ville] Univ Bern, Univ Hosp Bern, Inselspital, Dept Intens Care Med, Bern, Switzerland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Oulu; University of Oulu; University of Bern; University Hospital of Bern	Vaara, ST (corresponding author), Univ Helsinki, Dept Anaesthesiol Intens Care & Pain Med, Div Intens Care Med, Helsinki, Finland.; Vaara, ST (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	suvi.avaara@helsinki.fi	Hollmén, Maija/B-5831-2017	Hollmén, Maija/0000-0002-3250-7653; Reinikainen, Matti/0000-0001-6878-3740; Gaddnas, Fiia/0000-0002-9825-5014	Helsinki University Hospital [TYH2013343, TYH2016243]; Academy of Finland; Sigrid Juselius Foundation; European Commission (FP7) [305853]	Helsinki University Hospital; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Commission (FP7)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from Helsinki University Hospital (TYH2013343 and TYH2016243) (VP), Academy of Finland (SJ), the Sigrid Juselius Foundation (VP), and European Commission (FP7-Health-2012-Innovation-1; Traumakine 305853) (SJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bauerle JD, 2011, J AM SOC NEPHROL, V22, P14, DOI 10.1681/ASN.2009121217; Bellingan G, 2014, LANCET RESP MED, V2, P98, DOI 10.1016/S2213-2600(13)70259-5; Blume C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037100, DOI 10.1371/JOURNAI.PONE.0037100]; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cohen ES, 2002, AM J RESP CRIT CARE, V166, P16, DOI 10.1164/rccm.200109-014OC; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Jalkanen J, 2015, CIRC RES, V116, P1206, DOI 10.1161/CIRCRESAHA.116.305715; Janz DR, 2013, CRIT CARE, V17, DOI 10.1186/cc13108; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099950; Kim M, 2013, KIDNEY INT, V84, P90, DOI 10.1038/ki.2013.43; Linder A, 2012, CRIT CARE, V16, DOI 10.1186/cc11353; Maksimow M, 2014, CRIT CARE MED, V42, P2556, DOI 10.1097/CCM.0000000000000550; Martin C, 2000, CRIT CARE MED, V28, P3198, DOI 10.1097/00003246-200009000-00014; Nisula S, 2013, INTENS CARE MED, V39, P420, DOI 10.1007/s00134-012-2796-5; Poukkanen M, 2013, ACTA ANAESTH SCAND, V57, P863, DOI 10.1111/aas.12133; Yegutkin GG, 2003, FASEB J, V17, P1328, DOI 10.1096/fj.02-1136fje	22	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164420	10.1371/journal.pone.0164420	http://dx.doi.org/10.1371/journal.pone.0164420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732656	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300055
J	Gagnon, M; Vimont, A; Darveau, A; Fliss, I; Jean, J				Gagnon, Melanie; Vimont, Allison; Darveau, Andre; Fliss, Ismail; Jean, Julie			Study of the Ability of Bifidobacteria of Human Origin to Prevent and Treat Rotavirus Infection Using Colonic Cell and Mouse Models	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; ACUTE GASTROENTERITIS; LACTOBACILLUS GG; GUT MICROBIOTA; PROBIOTICS; DIARRHEA; ADHESION; STRAINS; PROTECTION; CHILDREN	Rotavirus is the leading cause of severe acute gastroenteritis among children worldwide. Despite effective vaccines, inexpensive alternatives such as probiotics are needed. The aim of this study was to assess the ability of probiotic candidate Bifidobacterium thermophilum RBL67 to inhibit rotavirus infection. Bacterial adhesion to intestinal cells and interference with viral attachment were evaluated in vitro. B. thermophilum RBL67 displayed adhesion indexes of 625 +/- 84 and 1958 +/- 318 on Caco-2 and HT-29 cells respectively and was comparable or superior to four other bifidobacteria, including B. longum ATCC 15707 and B. pseudolongum ATCC 25526 strains. Incubation of B. thermophilum RBL67 for 30 min before (exclusion) and simultaneously (competition) with human rotavirus strain Wa decreased virus attachment by 2.0 +/- 0.1 and 1.5 +/- 0.1 log(10) (by 99.0% and 96.8% respectively). Displacement of virus already present was negligible. In CD-1 suckling mice fed B. thermophilum RBL67 challenged with simian rotavirus SA-11, pre-infection feeding with RBL 67 was more effective than post-infection feeding, reducing the duration of diarrhea, limiting epithelial lesions, reducing viral replication in the intestine, accelerating recovery, and stimulating the humoral specific IgG and IgM response, without inducing any adverse effect. B. thermophilum RBL67 had little effect on intestinal IgA titer. These results suggest that humoral immunoglobulin might provide protection against the virus and that B. thermophilum RBL67 has potential as a probiotic able to inhibit rotavirus infection and ultimately reduce its spread.	[Gagnon, Melanie; Vimont, Allison; Fliss, Ismail; Jean, Julie] Univ Laval, Dept Food Sci, Inst Nutr & Funct Foods, Quebec City, PQ, Canada; [Darveau, Andre] Univ Laval, Dept Biochem Microbiol & Bioinformat, Quebec City, PQ, Canada	Laval University; Laval University	Jean, J (corresponding author), Univ Laval, Dept Food Sci, Inst Nutr & Funct Foods, Quebec City, PQ, Canada.	julie.jean@fsaa.ulaval.ca	Jean, Julie/L-6670-2014	Jean, Julie/0000-0003-2553-4204; Vimont, Allison/0000-0002-6963-9158	Fonds de Recherche du Quebec - Nature et Technologies [FR068242]; Fonds de Recherche du Quebec - Nature et Technologies, Scholarship B2	Fonds de Recherche du Quebec - Nature et Technologies; Fonds de Recherche du Quebec - Nature et Technologies, Scholarship B2	This work was supported by Fonds de Recherche du Quebec - Nature et Technologies, FR068242, to Dr. Ismail Fliss, and Fonds de Recherche du Quebec - Nature et Technologies, Scholarship B2, to Dr. Melanie Gagnon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003048.pub3; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49; [Anonymous], 2002, JOINT FAO WHO WORK G; ANSARI SA, 1988, J CLIN MICROBIOL, V26, P1513, DOI 10.1128/JCM.26.8.1513-1518.1988; Arias CF, 2015, J VIROL, V89, P890, DOI 10.1128/JVI.01787-14; Ashraf R, 2014, CRIT REV FOOD SCI, V54, P938, DOI 10.1080/10408398.2011.619671; Atchison CJ, 2016, J INFECT DIS, V213, P243, DOI 10.1093/infdis/jiv398; Attoui H., 2011, VIRUS TAXONOMY, P541; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; BEERENS H, 1990, LETT APPL MICROBIOL, V11, P155, DOI 10.1111/j.1472-765X.1990.tb00148.x; Bilcke J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006060; Boshuizen JA, 2003, J VIROL, V77, P13005, DOI 10.1128/JVI.77.24.13005-13016.2003; Bottacini F, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S4; BURNS JW, 1995, VIROLOGY, V207, P143, DOI 10.1006/viro.1995.1060; Canadian Council on Animal Care, 1993, GUIDE CARE USE EXPT; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Clarke E, 2015, MUCOSAL IMMUNOL, V8, P1, DOI 10.1038/mi.2014.114; Colbere-Garapin F, 2007, MICROBES INFECT, V9, P1623, DOI 10.1016/j.micinf.2007.09.016; CROCIANI J, 1995, LETT APPL MICROBIOL, V21, P146, DOI 10.1111/j.1472-765X.1995.tb01027.x; Di Gioia D, 2014, APPL MICROBIOL BIOT, V98, P563, DOI 10.1007/s00253-013-5405-9; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Franco MA, 2006, VACCINE, V24, P2718, DOI 10.1016/j.vaccine.2005.12.048; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Fukushima Y, 1998, INT J FOOD MICROBIOL, V42, P39, DOI 10.1016/S0168-1605(98)00056-7; Gagnon M, 2004, INT J FOOD MICROBIOL, V92, P69, DOI 10.1016/j.ijfoodmicro.2003.07.010; Gagnon M, 2006, INT J FOOD MICROBIOL, V111, P26, DOI 10.1016/j.ijfoodmicro.2006.04.041; Gagnon M, 2013, J MICROBIOL METH, V94, P274, DOI 10.1016/j.mimet.2013.06.027; Gagnon M, 2011, PROBIOTIC BACTERIA AND ENTERIC INFECTIONS: CYTOPROTECTION BY PROBIOTIC BACTERIA, P65, DOI 10.1007/978-94-007-0386-5_3; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gavi, 2015, ROT VACC SUPP 2015; Gonzalez-Rodriguez I, 2012, APPL ENVIRON MICROB, V78, P3992, DOI 10.1128/AEM.08024-11; Gopal PK, 2001, INT J FOOD MICROBIOL, V67, P207, DOI 10.1016/S0168-1605(01)00440-8; GRAHAM DY, 1987, ARCH VIROL, V92, P261, DOI 10.1007/BF01317483; Grandy G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-253; Guandalini S, 2000, J PEDIATR GASTR NUTR, V30, P54, DOI 10.1097/00005176-200001000-00018; Haschke F, 1998, MONATSSCHR KINDERH, V146, pS26, DOI 10.1007/PL00014763; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Istrate C, 2008, J MED VIROL, V80, P531, DOI 10.1002/jmv.21101; Jans C, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00191-13; Jean J, 2002, FEMS MICROBIOL LETT, V210, P143, DOI 10.1111/j.1574-6968.2002.tb11173.x; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kandasamy S, 2016, J IMMUNOL, DOI [10.40498immunol.1501705, DOI 10.4049/IIMMUNOL.1501705]; Kheadr E, 2004, INT DAIRY J, V14, P1041, DOI 10.1016/j.idairyj.2004.04.010; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lee DK, 2015, CLIN RES HEPATOL GAS, V39, P237, DOI 10.1016/j.clinre.2014.09.006; Liu FN, 2013, J PEDIATR GASTR NUTR, V57, P750, DOI 10.1097/MPG.0b013e3182a356e1; Mohan R, 2008, PEDIATR RES, V64, P418, DOI 10.1203/PDR.0b013e318181b7fa; Munoz JAM, 2011, APPL ENVIRON MICROB, V77, P8775, DOI 10.1128/AEM.05548-11; Mrukowicz J, 2008, J PEDIATR GASTR NUTR, V46, pS32, DOI 10.1097/MPG.0b013e31816f79b0; O'Neal CM, 2000, J VIROL, V74, P4102, DOI 10.1128/JVI.74.9.4102-4109.2000; O'Toole Paul W, 2008, Interdiscip Perspect Infect Dis, V2008, P175285, DOI 10.1155/2008/175285; OFFIT PA, 1984, J VIROL, V51, P233, DOI 10.1128/JVI.51.1.233-236.1984; Pfeiffer JK, 2016, SCIENCE, V351, DOI 10.1126/science.aad5872; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Qiao HP, 2002, PEDIATR RES, V51, P750, DOI 10.1203/01.PDR.0000017481.64723.1F; RAMIA S, 1979, J CLIN MICROBIOL, V10, P609, DOI 10.1128/JCM.10.5.609-614.1979; Robinson CM, 2014, ANNU REV VIROL, V1, P55, DOI 10.1146/annurev-virology-031413-085550; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; SAAVEDRA JM, 1994, LANCET, V344, P1046, DOI 10.1016/S0140-6736(94)91708-6; Sarker SA, 2005, PEDIATRICS, V116, pE221, DOI 10.1542/peds.2004-2334; SATTAR SA, 1986, J HYG-CAMBRIDGE, V96, P277, DOI 10.1017/S0022172400066055; Serafini F, 2013, ANAEROBE, V21, P9, DOI 10.1016/j.anaerobe.2013.03.003; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Shu Q, 2001, MED MICROBIOL IMMUN, V189, P147, DOI 10.1007/s430-001-8021-9; Szajewska H, 2013, ALIMENT PHARM THER, V38, P467, DOI 10.1111/apt.12403; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Toure R, 2003, J APPL MICROBIOL, V95, P1058, DOI 10.1046/j.1365-2672.2003.02085.x; Uchiyama R, 2014, J INFECT DIS, V210, P171, DOI 10.1093/infdis/jiu037; Vlasova AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076962; Von Ah U, 2006, THESIS; von Ah U, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-79; Wold A., 2002, SHORT LONG TERM EFFE, P77, DOI DOI 10.1007/0-306-46830-1_7; YASUI H, 1995, J INFECT DIS, V172, P403, DOI 10.1093/infdis/172.2.403; Zhang W, 2008, VET IMMUNOL IMMUNOP, V122, P175, DOI 10.1016/j.vetimm.2007.10.003; Zihler A, 2014, J FOOD NUTR DISORD I, DOI [10.4172/2324-9323.S1-003, DOI 10.4172/2324-9323.S1-003]; Zihler A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-264	78	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164512	10.1371/journal.pone.0164512	http://dx.doi.org/10.1371/journal.pone.0164512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727323	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400035
J	Azizova, TV; Bragin, EV; Hamada, N; Bannikova, MV				Azizova, Tamara V.; Bragin, Evgeny V.; Hamada, Nobuyuki; Bannikova, Maria V.			Risk of Cataract Incidence in a Cohort of Mayak PA Workers following Chronic Occupational Radiation Exposure	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; LONG-TERM INCIDENCE; IONIZING-RADIATION; SMOKING	This is the first study of cataract incidence in a cohort of Mayak Production Association workers first employed at one of the main facilities in 1948-1982 and followed up till the end of 2008 (22,377 workers). Principal advantages of the study are the large size of the cohort, long-term follow-up and sufficient statistical power, available results of annual eye examinations over the entire follow-up period and detailed information on non-radiation confounders. Individual measured doses from external gamma-rays and neutrons used in the analyses were provided by the Mayak Worker Dosimetry System 2008 (MWDS-2008). Relative risk (RR) and excess relative risk (ERR) per unit dose (Gy) were calculated based on maximum likelihood using the AMFIT module of the EPICURE software. The RR of cataract incidence was found to be the highest in workers exposed at doses above 2.0 Gy. A significant linear association of cataract incidence with cumulative dose from external gamma-rays was found with ERR/Gy equal to 0.28 (95% confidence intervals: 0.20, 0.37). The results obtained varied slightly with inclusion of additional adjustments for non-radiation factors (smoking index, hypertension, glaucoma and body mass index). Adjusting for the dose from neutrons gave a considerable increase in ERR/Gy for cataract incidence.	[Azizova, Tamara V.; Bragin, Evgeny V.; Bannikova, Maria V.] Southern Urals Biophys Inst, Ozyorskoe Shosse 19, Ozyorsk, Chelyabinsk Reg, Russia; [Hamada, Nobuyuki] CRIEPI, Nucl Technol Res Lab, Radiat Safety Res Ctr, 2-11-1 Iwado Kita, Komae, Tokyo, Japan	Southern Urals Biophysics Institute; Central Research Institute of Electric Power Industry - Japan	Azizova, TV (corresponding author), Southern Urals Biophys Inst, Ozyorskoe Shosse 19, Ozyorsk, Chelyabinsk Reg, Russia.	clinic@subi.su	Bannikova, Maria V./Z-1343-2019; Azizova, Tamara V./R-5295-2019; Bragin, Evgeny V./Z-1359-2019	Bannikova, Maria V./0000-0002-2755-6282; Azizova, Tamara V./0000-0001-6954-2674; Bragin, Evgeny V./0000-0003-0410-5048; Hamada, Nobuyuki/0000-0003-2518-6131				Ainsbury EA, 2016, MUTAT RES IN PRESS, V770, DOI [10.1016/j.mrrev.2016.07.010, DOI 10.1016/J.MRREV.2016.07.010).]; [Anonymous], 2010, STATISTICS; Azizova TV, 2008, HEALTH PHYS, V94, P449, DOI 10.1097/01.HP.0000300757.00912.a2; Bragin EV, 2016, OPHTHALMOLOGY, V13, P115; Chodick G, 2008, AM J EPIDEMIOL, V168, P620, DOI 10.1093/aje/kwn171; Guskova A.K, 1971, HUMAN RAD SICKNESS; Hamada N, 2016, MUTAT RES-REV MUTAT, V770, P262, DOI 10.1016/j.mrrev.2016.08.005; Hamada N, 2015, CANCER LETT, V368, P262, DOI 10.1016/j.canlet.2015.02.017; Hamada N, 2014, J RADIAT RES, V55, P831, DOI 10.1093/jrr/rru036; Hamada N, 2014, J RADIAT RES, V55, P629, DOI 10.1093/jrr/rru019; ICRP, 1966, ANN ICRP, V9; Kanthan GL, 2010, ACTA OPHTHALMOL, V88, P773, DOI 10.1111/j.1755-3768.2009.01565.x; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; Lindblad BE, 2007, OPHTHALMOLOGY, V114, P680, DOI 10.1016/j.ophtha.2006.07.046; Morris MS, 2004, OPHTHAL EPIDEMIOL, V11, P53, DOI 10.1076/opep.11.1.53.26439; Nakashima E, 2006, HEALTH PHYS, V90, P154, DOI 10.1097/01.HP.0000175442.03596.63; NCRP (National Council on Radiation Protection and Measurements), 2016, GUID RAD DOS LIM LEN; Neriishi K, 2007, RADIAT RES, V168, P404, DOI 10.1667/RR0928.1; Neriishi K, 2012, RADIOLOGY, V265, P167, DOI 10.1148/radiol.12111947; OTAKE M, 1991, J RADIAT RES, V32, P283, DOI 10.1269/jrr.32.SUPPLEMENT_283; PRESTON D. L., 1993, EPICURE USERS GUIDE; Prokofyeva E, 2013, ACTA OPHTHALMOL, V91, P395, DOI 10.1111/j.1755-3768.2012.02444.x; Rahman A, 2011, PAK J MED SCI, V27, P145; Stewart F. A., 2012, Annals of the ICRP, V41, P37, DOI 10.1016/j.icrp.2012.02.001; Tan JSL, 2008, OPHTHAL EPIDEMIOL, V15, P155, DOI 10.1080/09286580701840362; Theodoropoulou S, 2011, ACTA OPHTHALMOL, V89, pE167, DOI 10.1111/j.1755-3768.2009.01831.x; WHO (World Health Organization), 1980, ICD 9 GUID COD DIS I; Woraul BV, 2007, RADIAT RES, V167, P233, DOI 10.1667/RR0298.1; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147	29	22	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164357	10.1371/journal.pone.0164357	http://dx.doi.org/10.1371/journal.pone.0164357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723789	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100045
J	Dutra, EH; O'Brien, MH; Lima, A; Kalajzic, Z; Tadinada, A; Nanda, R; Yadav, S				Dutra, Eliane H.; O'Brien, Mara H.; Lima, Alexandro; Kalajzic, Zana; Tadinada, Aditya; Nanda, Ravindra; Yadav, Sumit			Cellular and Matrix Response of the Mandibular Condylar Cartilage to Botulinum Toxin	PLOS ONE			English	Article							RESISTANT ACID-PHOSPHATASE; INDUCED MUSCLE PARALYSIS; TEMPOROMANDIBULAR-JOINT; MASTICATORY MUSCLES; BONE; PAIN; INJECTIONS; RABBITS; TISSUES; CELLS	Objectives To evaluate the cellular and matrix effects of botulinum toxin type A (Botox) on mandibular condylar cartilage (MCC) and subchondral bone. Materials and Methods Botox (0.3 unit) was injected into the right masseter of 5-week-old transgenic mice (Col10a1-RFPcherry) at day 1. Left side masseter was used as intra-animal control. The following bone labels were intraperitoneally injected: calcein at day 7, alizarin red at day 14 and calcein at day 21. In addition, EdU was injected 48 and 24 hours before sacrifice. Mice were sacrificed 30 days after Botox injection. Experimental and control side mandibles were dissected and examined by x-ray imaging and micro-CT. Subsequently, MCC along with the subchondral bone was sectioned and stained with tartrate resistant acid phosphatase (TRAP), EdU, TUNEL, alkaline phosphatase, toluidine blue and safranin O. In addition, we performed immunohistochemistry for pSMAD and VEGF. Results Bone volume fraction, tissue density and trabecular thickness were significantly decreased on the right side of the subchondral bone and mineralized cartilage (Botox was injected) when compared to the left side. There was no significant difference in the mandibular length and condylar head length; however, the condylar width was significantly decreased after Botox injection. Our histology showed decreased numbers of Col10a1 expressing cells, decreased cell proliferation and increased cell apoptosis in the subchondral bone and mandibular condylar cartilage, decreased TRAP activity and mineralization of Botox injected side cartilage and subchondral bone. Furthermore, we observed reduced proteoglycan and glycosaminoglycan distribution and decreased expression of pSMAD 1/5/8 and VEGF in the MCC of the Botox injected side in comparison to control side. Conclusion Injection of Botox in masseter muscle leads to decreased mineralization and matrix deposition, reduced chondrocyte proliferation and differentiation and increased cell apoptosis in the MCC and subchondral bone.	[Dutra, Eliane H.; O'Brien, Mara H.; Lima, Alexandro; Nanda, Ravindra; Yadav, Sumit] Univ Connecticut, Ctr Hlth, Dept Orthodont, Farmington, CT 06030 USA; [Kalajzic, Zana] Univ Connecticut, Ctr Hlth, Dept Oral & Maxillofacial Diagnost Sci, Farmington, CT USA; [Tadinada, Aditya] Univ Connecticut, Ctr Hlth, Dept Oral & Maxillofacial Radiol, Farmington, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Yadav, S (corresponding author), Univ Connecticut, Ctr Hlth, Dept Orthodont, Farmington, CT 06030 USA.	yadav_sumit17@yahoo.com		O'Brien, Mara/0000-0002-5646-2541	American Association of Orthodontic Foundation	American Association of Orthodontic Foundation	The study was funded partially by American Association of Orthodontic Foundation and partially by startup funds of Sumit Yadav.	Benjamin M, 2004, INT REV CYTOL, V233, P1, DOI 10.1016/S0074-7696(04)33001-9; Chavan SJ, 2014, PROG ORTHOD, V15, DOI 10.1186/s40510-014-0057-6; Chen J, 2009, OSTEOARTHR CARTILAGE, V17, P354, DOI 10.1016/j.joca.2008.05.021; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; FORWOOD MR, 1995, BONE, V17, pS197, DOI 10.1016/8756-3282(95)00292-L; Grimston SK, 2007, ANN NY ACAD SCI, V1116, P444, DOI 10.1196/annals.1402.009; Guarda-Nardini L, 2008, CRANIO, V26, P126, DOI 10.1179/crn.2008.017; Hayman AR, 2000, J HISTOCHEM CYTOCHEM, V48, P219, DOI 10.1177/002215540004800207; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JY, 2008, ORAL DIS, V14, P626, DOI 10.1111/j.1601-0825.2007.01435.x; Kim NH, 2005, PLAST RECONSTR SURG, V115, P919, DOI 10.1097/01.PRS.0000153236.79775.A0; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; Matthys T, 2015, AM J ORTHOD DENTOFAC, V148, P999, DOI 10.1016/j.ajodo.2015.05.034; Pirttiniemi P, 2004, EUR J ORTHODONT, V26, P1, DOI 10.1093/ejo/26.1.1; Rafferty KL, 2012, BONE, V50, P651, DOI 10.1016/j.bone.2011.11.015; Raphael KG, 2014, J ORAL REHABIL, V41, P555, DOI 10.1111/joor.12180; Rauch F., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P264; Reibmann DR, 2007, J DENT, V35, P643, DOI 10.1016/j.jdent.2007.04.010; Reissmann DR, 2012, J OROFAC PAIN, V26, P181; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Romero-Reyes M, 2014, J PAIN RES, V7, P99, DOI 10.2147/JPR.S37593; Schwartz M, 2002, CLIN J PAIN, V18, pS198, DOI 10.1097/00002508-200211001-00013; Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x; Shen G, 2005, J DENT RES, V84, P691, DOI 10.1177/154405910508400802; Shibukawa Y, 2007, DEV DYNAM, V236, P426, DOI 10.1002/dvdy.21036; Tsai CY, 2010, INT J ORAL MAX SURG, V39, P593, DOI 10.1016/j.ijom.2010.02.011; Tsai CY, 2011, EUR J ORTHODONT, V33, P132, DOI 10.1093/ejo/cjq029; Tsai CY, 2010, J ORAL MAXIL SURG, V68, P1081, DOI 10.1016/j.joms.2009.12.009; Utreja A, 2016, OSTEOARTHR CARTILAGE, V24, P335, DOI 10.1016/j.joca.2015.08.010; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Yu CC, 2007, AESTHET PLAST SURG, V31, P445, DOI 10.1007/s00266-007-0081-8	33	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164599	10.1371/journal.pone.0164599	http://dx.doi.org/10.1371/journal.pone.0164599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723812	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100076
J	Ortiz, JL; Ortiz, A; Milara, J; Armengot, M; Sanz, C; Compan, D; Morcillo, E; Cortijo, J				Luis Ortiz, Jose; Ortiz, Amparo; Milara, Javier; Armengot, Miguel; Sanz, Celia; Compan, Desamparados; Morcillo, Esteban; Cortijo, Julio			Evaluation of Mucociliary Clearance by Three Dimension Micro-CT-SPECT in Guinea Pig: Role of Bitter Taste Agonists	PLOS ONE			English	Article							SOLITARY CHEMOSENSORY CELLS; CILIA MOTILITY; HUMAN BRONCHI; TC-99M DTPA; RECEPTORS; NASAL; AIRWAYS; SCINTIGRAPHY; RELAXATION; EXPRESSION	Different image techniques have been used to analyze mucociliary clearance (MCC) in humans, but current small animal MCC analysis using in vivo imaging has not been well defined. Bitter taste receptor (T2R) agonists increase ciliary beat frequency (CBF) and cause bronchodilation but their effects in vivo are not well understood. This work analyzes in vivo nasal and bronchial MCC in guinea pig animals using three dimension (3D) micro-CT-SPECT images and evaluates the effect of T2R agonists. Intranasal macroaggreggates of albumin-Technetium 99 metastable (MAA-Tc99(m)) and lung nebulized Tc99(m) albumin nanocolloids were used to analyze the effect of T2R agonists on nasal and bronchial MCC respectively, using 3D micro-CT-SPECT in guinea pig. MAA-Tc99(m) showed a nasal mucociliary transport rate of 0.36 mm/min that was increased in presence of T2R agonist to 0.66 mm/min. Tc99(m) albumin nanocolloids were homogeneously distributed in the lung of guinea pig and cleared with time-dependence through the bronchi and trachea of guinea pig. T2R agonist increased bronchial MCC of Tc99(m) albumin nanocolloids. T2R agonists increased CBF in human nasal ciliated cells in vitro and induced bronchodilation in human bronchi ex vivo. In summary, T2R agonists increase MCC in vivo as assessed by 3D micro-CT-SPECT analysis.	[Luis Ortiz, Jose; Ortiz, Amparo; Sanz, Celia; Morcillo, Esteban; Cortijo, Julio] Univ Valencia, Fac Med, Dept Pharmacol, Valencia, Spain; [Milara, Javier; Sanz, Celia] Jaume I Univ, Fac Med, Castellon de La Plana, Spain; [Milara, Javier] Univ Gen Hosp Consortium, Dept Pharm, Valencia, Spain; [Milara, Javier; Morcillo, Esteban; Cortijo, Julio] Hlth Inst Carlos III, CIBERES, Valencia, Spain; [Armengot, Miguel] Univ Gen Hosp Consortium, Rhinol Unit, Valencia, Spain; [Armengot, Miguel] Univ Valencia, Dept Surg, Fac Med, Valencia, Spain; [Compan, Desamparados] Hosp Clin Univ Valencia, Dept Pathol Anat, Valencia, Spain; [Cortijo, Julio] Univ Gen Hosp Consortium, Teaching & Res Unit, Valencia, Spain	University of Valencia; Universitat Jaume I; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Valencia	Milara, J (corresponding author), Jaume I Univ, Fac Med, Castellon de La Plana, Spain.; Milara, J (corresponding author), Univ Gen Hosp Consortium, Dept Pharm, Valencia, Spain.; Milara, J (corresponding author), Hlth Inst Carlos III, CIBERES, Valencia, Spain.	xmilara@hotmail.com	Morcillo, Esteban/I-1552-2015; Armengot, Miguel/E-4664-2016	Morcillo, Esteban/0000-0003-4373-9457; Armengot, Miguel/0000-0001-8258-6292; Ortiz-Seller, Amparo/0000-0003-0200-1667; MILARA, JAVIER/0000-0001-6033-4211	spanish goverment [SAF2014-55322-P, SAF2015-65368-R, FISCP11/00293, FISPI14/01733]; centro de investigaciones biomedicas en red de enfermedades respiratorias (CIBERES) [CB06/06/0027]; TRACE [TRA2009-0311]; fondos de la Generalitat Valenciana Prometeo [II/2013/014]	spanish goverment(Spanish Government); centro de investigaciones biomedicas en red de enfermedades respiratorias (CIBERES); TRACE; fondos de la Generalitat Valenciana Prometeo	The study was supported by the spanish goverment grants SAF2014-55322-P (JC; https://sede.micinn.gob.es/stfls/eSede/Ficheros/2015/Anexo_Preseleccionados_PRP_Proyectos_Excelencia_2014.pdf), SAF2015-65368-R (EM; https://sede.micinn.gob.es/stfls/eSede/Ficheros/2016/Anexo_Preseleccionados_Propuesta_Resolucion_Provisional_Proyectos_Retos_2015.pdf), FISCP11/00293, FISPI14/01733 (JM; http://gesdoc.isciii.es/?action=download&id=08/10/2014-fe2a818ac5) and centro de investigaciones biomedicas en red de enfermedades respiratorias (CIBERES; CB06/06/0027; http://www.ciberes.org/), TRACE (TRA2009-0311; (https://www.boe.es/boe/dias/2010/08/05/pdfs/BOE-A-2010-12605.pdf) as well as by fondos de la Generalitat Valenciana Prometeo II/2013/014 (EM, JC, JM; http://www.cece.gva.es/poci/docs/2013/NUEVAS/RESOLUCIONES/PROMETEOII13_Resolucion_Concesion_c.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Almudever P, 2013, THORAX, V68, P938, DOI 10.1136/thoraxjnl-2013-203408; ARMENGOT M, 1995, INT J PEDIATR OTORHI, V32, P143, DOI 10.1016/0165-5876(95)01133-V; Armengot M, 2010, AM J RHINOL ALLERGY, V24, P175, DOI 10.2500/ajra.2010.24.3448; Ballester C, 2007, BRIT J SURG, V94, P894, DOI 10.1002/bjs.5724; Belvisi MG, 2011, NAT MED, V17, P776, DOI [10.1038/nm0711-776a, 10.1038/nm0711-776b]; Bhashyam AR, 2010, AUTON NEUROSCI-BASIC, V154, P74, DOI 10.1016/j.autneu.2009.12.002; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Ble FX, 2010, BRIT J PHARMACOL, V160, P1008, DOI 10.1111/j.1476-5381.2010.00747.x; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Braun T, 2011, RHINOLOGY, V49, P507, DOI 10.4193/Rhino.11.121; Brewer NR, 1997, CONTEMP TOP LAB ANIM, V36, P100; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Escudier E, 2009, PAEDIATR RESPIR REV, V10, P51, DOI 10.1016/j.prrv.2009.02.001; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Fleming J, 2011, J AEROSOL MED PULM D, V24, P49, DOI 10.1089/jamp.2010.0843; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; GARDNER SF, 1992, AM J HOSP PHARM, V49, P1499, DOI 10.1093/ajhp/49.6.1499; Grassin-Delyle S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-134; GREIFF L, 1990, THORAX, V45, P841, DOI 10.1136/thx.45.11.841; Hofmann W, 2003, TOXICOL SCI, V73, P448, DOI 10.1093/toxsci/kfg075; HUNG JC, 1995, J NUCL MED, V36, P1895; Karacavus S, 2015, CLIN RESPIR J, V9, P189, DOI 10.1111/crj.12123; King Paul T, 2009, Int J Chron Obstruct Pulmon Dis, V4, P411; Krasteva G, 2012, LIFE SCI, V91, P992, DOI 10.1016/j.lfs.2012.06.014; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Milara J, 2012, BRIT J PHARMACOL, V166, P2243, DOI 10.1111/j.1476-5381.2012.01929.x; Morice AH, 2011, NAT MED, V17, P775, DOI 10.1038/nm0711-775; Munkholm M, 2014, CLIN PHYSIOL FUNCT I, V34, P171, DOI 10.1111/cpf.12085; Opanowski A, 2015, CLIN NUCL MED, V40, P553, DOI 10.1097/RLU.0000000000000763; Pulkkinen V, 2012, AM J PHYSIOL-LUNG C, V303, pL956, DOI 10.1152/ajplung.00205.2012; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Volsko TA, 2013, RESP CARE, V58, P1669, DOI 10.4187/respcare.02590; Wang LF, 2012, OTOLARYNG HEAD NECK, V146, P659, DOI 10.1177/0194599811431414; Wu YJ, 2011, MOL IMAGING BIOL, V13, P923, DOI 10.1007/s11307-010-0423-9; Yi DD, 2012, EXP LUNG RES, V38, P325, DOI 10.3109/01902148.2012.700760; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang CH, 2012, NAT MED, V18, P648, DOI 10.1038/nm.2733	45	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164399	10.1371/journal.pone.0164399	http://dx.doi.org/10.1371/journal.pone.0164399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723827	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100054
J	Ta, MHT; Schwensen, KG; Foster, S; Korgaonkar, M; Ozimek-Kulik, JE; Phillips, JK; Peduto, A; Rangan, GK				Ta, Michelle H. T.; Schwensen, Kristina G.; Foster, Sheryl; Korgaonkar, Mayuresh; Ozimek-Kulik, Justyna E.; Phillips, Jacqueline K.; Peduto, Anthony; Rangan, Gopala K.			Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease	PLOS ONE			English	Article							NF-KAPPA-B; RAT MODEL; CYST GROWTH; MOUSE MODEL; GLOMERULAR HYPERTROPHY; URETERAL OBSTRUCTION; CARDIAC-HYPERTROPHY; SIGNALING PATHWAYS; MAMMALIAN TARGET; EPITHELIAL-CELLS	The disease-modifying effects of target of rapamycin complex 1 (TORC1) inhibitors during different stages of polycystic kidney disease (PKD) are not well defined. In this study, male Lewis Polycystic Kidney Disease (LPK) rats (a genetic ortholog of human NPHP9, pheno-typically characterised by diffuse distal nephron cystic growth) and Lewis controls received either vehicle (V) or sirolimus (S, 0.2 mg/kg by intraperitoneal injection 5 days per week) during the early (postnatal weeks 3 to 10) or late stages of disease (weeks 10 to 20). In early-stage disease, sirolimus reduced kidney enlargement (by 63%), slowed the rate of increase in total kidney volume (TKV) in serial MRI by 78.2% (LPK+V: 132.3 +/- 59.7 vs. LPK+S: 28.8 +/- 12.0% per week) but only partly reduced the percentage renal cyst area (by 19%) and did not affect the decline in endogenous creatinine clearance (CrCl) in LPK rats. In late-stage disease, sirolimus reduced kidney enlargement (by 22%) and the rate of increase in TKV by 71.8% (LPK+V: 13.1 +/- 6.6 vs. LPK+S: 3.7 +/- 3.7% per week) but the percentage renal cyst area was unaltered, and the CrCl only marginally better. Sirolimus reduced renal TORC1 activation but not TORC2, NF-kappa B DNA binding activity, CCL2 or TNF alpha expression, and abnormalities in cilia ultrastructure, hypertension and cardiac disease were also not improved. Thus, the relative treatment efficacy of TORC1 inhibition on kidney enlargement was consistent at all disease stages, but the absolute effect was determined by the timing of drug initiation. Furthermore, cystic microarchitecture, renal function and cardiac disease remain abnormal with TORC1 inhibition, indicating that additional approaches to normalise cellular dedifferentiation, inflammation and hypertension are required to completely arrest the progression of PKDs.	[Ta, Michelle H. T.; Schwensen, Kristina G.; Rangan, Gopala K.] Univ Sydney, Westmead Inst Med Res, Ctr Transplant & Renal Res, Michael Stern Translat Lab Polycyst Kidney Dis, Sydney, NSW, Australia; [Foster, Sheryl; Peduto, Anthony] Univ Sydney, Westmead Hosp, Dept Radiol, Sydney, NSW, Australia; [Foster, Sheryl] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Korgaonkar, Mayuresh] Univ Sydney, Westmead Inst Med Res, Brain Dynam Ctr, Sydney, NSW, Australia; [Ozimek-Kulik, Justyna E.; Phillips, Jacqueline K.] Macquarie Univ, Dept Biomed Sci, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Rangan, Gopala K.] Westmead Hosp, Dept Renal Med, Western Sydney Local Heath Dist, Westmead, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Macquarie University; University of Sydney	Rangan, GK (corresponding author), Univ Sydney, Westmead Inst Med Res, Ctr Transplant & Renal Res, Michael Stern Translat Lab Polycyst Kidney Dis, Sydney, NSW, Australia.; Rangan, GK (corresponding author), Westmead Hosp, Dept Renal Med, Western Sydney Local Heath Dist, Westmead, NSW, Australia.	g.rangan@sydney.edu.au	Foster, Sheryl L/AAQ-5677-2020; Korgaonkar, Mayuresh/K-7447-2014; Phillips, Jacqueline/G-7901-2011	Foster, Sheryl L/0000-0003-3725-0823; Korgaonkar, Mayuresh/0000-0002-1339-2221; Phillips, Jacqueline/0000-0002-4917-7734; Ozimek-Kulik, Justyna/0000-0003-3996-3528	Michael Stern Polycystic Kidney Disease Fellowship; Australian Postgraduate Award (University of Sydney); Project Grants from National Health and Medical Research Council of Australia [457575, 632647]	Michael Stern Polycystic Kidney Disease Fellowship; Australian Postgraduate Award (University of Sydney); Project Grants from National Health and Medical Research Council of Australia	Michelle Ta was supported by the Michael Stern Polycystic Kidney Disease Fellowship (a donation from the Gardos and Stern families) and an Australian Postgraduate Award (University of Sydney). The study was funded by Project Grants from the National Health and Medical Research Council of Australia (457575, 632647). The authors thank Professor David C. Harris for advice and support, and Dr. Ben Wyse, Ms. Virginia James and Dr. David Liuwantara for their technical advice and assistance with blood pressure measurement, histology and qPCR respectively.	Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bonegio RGB, 2005, J AM SOC NEPHROL, V16, P2063, DOI 10.1681/ASN.2004030180; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Brown NE, 2003, KIDNEY INT, V63, P1220, DOI 10.1046/j.1523-1755.2003.00863.x; Bumbea V, 2005, NEPHROL DIAL TRANSPL, V20, P2517, DOI 10.1093/ndt/gfh957; Canaud G, 2010, AM J TRANSPLANT, V10, P1701, DOI 10.1111/j.1600-6143.2010.03152.x; Chapman AB, 2010, CLIN J AM SOC NEPHRO, V5, P102, DOI 10.2215/CJN.04310709; Chapman JR, 2010, AM J KIDNEY DIS, V55, P213, DOI 10.1053/j.ajkd.2009.12.003; Council NHaMR, 2013, AUSTR COD CAR US AN, V8th; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; de Borst MH, 2007, AM J PHYSIOL-RENAL, V292, pF313, DOI 10.1152/ajprenal.00180.2006; de Stephanis L, 2017, CLIN EXP NEPHROL, V21, P203, DOI 10.1007/s10157-016-1289-1; DIJOSEPH JF, 1993, TRANSPLANT P, V25, P714; Edelstein CL, 2008, CLIN J AM SOC NEPHRO, V3, P1219, DOI 10.2215/CJN.05611207; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; FICK GM, 1995, J AM SOC NEPHROL, V5, P2048; Gao XM, 2006, J HYPERTENS, V24, P1663, DOI 10.1097/01.hjh.0000239304.01496.83; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Gattone VH, 2009, KIDNEY INT, V76, P178, DOI 10.1038/ki.2009.147; Grantham JJ, 2011, NAT REV NEPHROL, V7, P556, DOI 10.1038/nrneph.2011.109; Halvorson C, 2010, INT J NEPHROL RENOVA, V3; Hammond L, 2004, J UROLOGY, V171, P331, DOI 10.1097/01.ju.0000100700.13657.36; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Ibraghimov-Beskrovnaya O, 2011, TRENDS MOL MED, V17, P625, DOI 10.1016/j.molmed.2011.06.003; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jiang YP, 2001, J BIOL CHEM, V276, P10943, DOI 10.1074/jbc.M007758200; Kuypers DRJ, 2005, DRUG SAFETY, V28, P153, DOI 10.2165/00002018-200528020-00006; Leonhard WN, 2011, AM J PHYSIOL-RENAL, V300, pF1193, DOI 10.1152/ajprenal.00419.2010; Liu CY, 2018, AM J PHYSIOL-RENAL, V314, pF844, DOI 10.1152/ajprenal.00194.2015; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Muchatuta MN, 2009, EXP BIOL MED, V234, P17, DOI 10.3181/0807-RM-215; Muraoka K, 1996, J CLIN INVEST, V97, P2433, DOI 10.1172/JCI118690; Norman J, 2011, BBA-MOL BASIS DIS, V1812, P1327, DOI 10.1016/j.bbadis.2011.06.012; Novalic Z, 2012, J AM SOC NEPHROL, V23, P842, DOI 10.1681/ASN.2011040340; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Ozes ON, 1999, NATURE, V401, P82; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Park S, 2009, CANCER RES, V69, P4107, DOI 10.1158/0008-5472.CAN-09-0474; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Perico N, 2010, J AM SOC NEPHROL, V21, P1031, DOI 10.1681/ASN.2009121302; Phillips JK, 2007, KIDNEY BLOOD PRESS R, V30, P129, DOI 10.1159/000101828; Rangan GK, 2007, NEPHROL DIAL TRANSPL, V22, P2175, DOI 10.1093/ndt/gfm191; Rangan GK, 2013, AM J PHYSIOL-RENAL, V305, pF574, DOI 10.1152/ajprenal.00411.2012; Ravichandran K, 2015, NEPHROL DIAL TRANSPL, V30, P45, DOI 10.1093/ndt/gfu296; Ravichandran K, 2014, HUM MOL GENET, V23, P4919, DOI 10.1093/hmg/ddu208; Reis F, 2009, TRANSPL P, V41, P868, DOI 10.1016/j.transproceed.2009.02.005; Remuzzi G, 2000, INT J CLIN PRACT, P9; Renken C, 2011, NEPHROL DIAL TRANSPL, V26, P92, DOI 10.1093/ndt/gfq384; Rovira J, 2009, TRANSPLANTATION, V88, P646, DOI 10.1097/TP.0b013e3181b24463; Schwensen KG, 2011, NEPHRON EXP NEPHROL, V117, pE93, DOI 10.1159/000320149; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Serra AL, 2009, NEPHROL DIAL TRANSPL, V24, P3334, DOI 10.1093/ndt/gfp280; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2012, J AM SOC NEPHROL, V23, P1674, DOI 10.1681/ASN.2012040367; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Ta Michelle H T, 2016, World J Nephrol, V5, P339, DOI 10.5527/wjn.v5.i4.339; Ta MHT, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12196; Ta MHT, 2013, NEPHROLOGY, V18, P317, DOI 10.1111/nep.12045; Tammachote R, 2009, HUM MOL GENET, V18, P3311, DOI 10.1093/hmg/ddp272; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2013, NEW ENGL J MED, V368, P1259, DOI 10.1056/NEJMc1300762; Torres VE, 2010, ADV CHRONIC KIDNEY D, V17, P190, DOI 10.1053/j.ackd.2010.01.006; Trapp ML, 2008, PEDIATR NEPHROL, V23, P377, DOI 10.1007/s00467-007-0692-y; Verghese E, 2008, NEPHROL DIAL TRANSPL, V23, P834, DOI 10.1093/ndt/gfm743; Verghese E, 2009, J AM SOC NEPHROL, V20, P2147, DOI 10.1681/ASN.2008101105; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wang GY, 2010, TRANSPL P, V42, P1881, DOI 10.1016/j.transproceed.2010.04.013; Wang L, 2008, J ANAT, V213, P79, DOI 10.1111/j.1469-7580.2008.00918.x; Watnick T, 2010, NEW ENGL J MED, V363, P879, DOI 10.1056/NEJMe1006925; Wu MJ, 2006, KIDNEY INT, V69, P2029, DOI 10.1038/sj.ki.5000161; Wu M, 2007, KIDNEY BLOOD PRESS R, V30, P253, DOI 10.1159/000104818; Wu M, 2009, AM J PHYSIOL-RENAL, V297, pF1597, DOI 10.1152/ajprenal.00430.2009; Yin LL, 2012, INT J NEUROSCI, V122, P748, DOI 10.3109/00207454.2012.721827; Yu SY, 2013, THORAC CARDIOV SURG, V61, P223, DOI 10.1055/s-0032-1311548; Zafar I, 2010, KIDNEY INT, V78, P754, DOI 10.1038/ki.2010.250; Zafar I, 2009, NEPHROL DIAL TRANSPL, V24, P2349, DOI 10.1093/ndt/gfp129; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101	82	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164193	10.1371/journal.pone.0164193	http://dx.doi.org/10.1371/journal.pone.0164193			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723777	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100028
J	Parravano, A; Andina-Diaz, A; Melendez-Jimenez, MA				Parravano, Antonio; Andina-Diaz, Ascension; Melendez-Jimenez, Miguel A.			Bounded Confidence under Preferential Flip: A Coupled Dynamics of Structural Balance and Opinions	PLOS ONE			English	Article							SOCIAL-INFLUENCE; BIASED ASSIMILATION; NETWORKS; MODEL; COEVOLUTION; FRIENDSHIP; SEGREGATION; DIVERSITY; EVOLUTION; BELIEFS	In this work we study the coupled dynamics of social balance and opinion formation. We propose a model where agents form opinions under bounded confidence, but only considering the opinions of their friends. The signs of social ties -friendships and enmities- evolve seeking for social balance, taking into account how similar agents' opinions are. We consider both the case where opinions have one and two dimensions. We find that our dynamics produces the segregation of agents into two cliques, with the opinions of agents in one clique differing from those in the other. Depending on the level of bounded confidence, the dynamics can produce either consensus of opinions within each clique or the coexistence of several opinion clusters in a clique. For the uni-dimensional case, the opinions in one clique are all below the opinions in the other clique, hence defining a "left clique'' and a ''right clique'' In the two-dimensional case, our numerical results suggest that the two cliques are separated by a hyperplane in the opinion space. We also show that the phenomenon of uni-dimensional opinions identified by DeMarzo, Vayanos and Zwiebel (Q J Econ 2003) extends partially to our dynamics. Finally, in the context of politics, we comment about the possible relation of our results to the fragmentation of an ideology and the emergence of new political parties.	[Parravano, Antonio; Andina-Diaz, Ascension; Melendez-Jimenez, Miguel A.] Univ Malaga, Dept Teoria & Hist Econ, Malaga, Spain; [Parravano, Antonio] Univ Los Andes, Ctr Fis Fundamental, Merida, Venezuela	Universidad de Malaga; University of Los Andes Venezuela	Parravano, A (corresponding author), Univ Malaga, Dept Teoria & Hist Econ, Malaga, Spain.; Parravano, A (corresponding author), Univ Los Andes, Ctr Fis Fundamental, Merida, Venezuela.	parravan3@gmail.com	Díaz, Ascensión Andina/R-6592-2018	Díaz, Ascensión Andina/0000-0002-8629-8770; Melendez Jimenez, Miguel Angel/0000-0001-5350-3726	Ministerio de Educacion y Ciencia [ECO2011-26996]; Junta de Andalucia [SEJ2011-8065]	Ministerio de Educacion y Ciencia(Spanish Government); Junta de Andalucia(Junta de Andalucia)	We gratefully acknowledge financial support from the Ministerio de Educacion y Ciencia through project ECO2011-26996, and the Junta de Andalucia through project SEJ2011-8065.; We thank an anonymous referee for helpful comments. We gratefully acknowledge financial support from the Ministerio de Educacion y Ciencia through project ECO2011-26996, and the Junta de Andalucia through project SEJ2011-8065.	Abell P, 2009, J MATH SOCIOL, V33, P129, DOI 10.1080/00222500902718239; Aguiar F, 2015, J CONFLICT RESOLUT, V59, P29, DOI 10.1177/0022002713498708; Albi G, 2016, ARXIV160705853; Allahverdyan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099557; Altafini C, 2013, IEEE T AUTOMAT CONTR, V58, P935, DOI 10.1109/TAC.2012.2224251; Altafini C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038135; Andina-Diaz A, 2007, PUBLIC CHOICE, V131, P65, DOI 10.1007/s11127-006-9105-1; Antal T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036121; Antal T, 2006, PHYSICA D, V224, P130, DOI 10.1016/j.physd.2006.09.028; Arifovic J, 2015, J ECON BEHAV ORGAN, V120, P46, DOI 10.1016/j.jebo.2015.08.011; Benczik IJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046104; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; Blomberg SB, 2000, AM ECON REV, V90, P605, DOI 10.1257/aer.90.3.605; Byrne D., 1971, ATTRACTION PARADIGM, V1st ed.; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Currarini S, 2010, P NATL ACAD SCI USA, V107, P4857, DOI 10.1073/pnas.0911793107; Currarini S, 2009, ECONOMETRICA, V77, P1003, DOI 10.3982/ECTA7528; Dandekar P, 2013, P NATL ACAD SCI USA, V110, P5791, DOI 10.1073/pnas.1217220110; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; Del Vicario M, 2016, ARXIV160700022; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; DeMarzo PM, 2003, Q J ECON, V118, P909, DOI 10.1162/00335530360698469; Do Yi S, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012806; Durrett R, 2012, P NATL ACAD SCI USA, V109, P3682, DOI 10.1073/pnas.1200709109; Ehrhardt G, 2008, ANN CONOMIE STAT, DOI [10.2307/20079189, DOI 10.2307/20079189]; Ehrhardt G, 2006, INT J GAME THEORY, V34, P383, DOI 10.1007/s00182-006-0025-6; Facchetti G, 2011, P NATL ACAD SCI USA, V108, P20953, DOI 10.1073/pnas.1109521108; Fan PY, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/08/P08003; Feri F, 2013, J EVOL ECON, V23, P955, DOI 10.1007/s00191-013-0313-9; Flache A, 2011, J CONFLICT RESOLUT, V55, P970, DOI 10.1177/0022002711414371; Flache A, 2011, J MATH SOCIOL, V35, P146, DOI 10.1080/0022250X.2010.532261; Fortunato S, 2005, INT J MOD PHYS C, V16, P1535, DOI 10.1142/S0129183105008126; FRENCH JRP, 1956, PSYCHOL REV, V63, P181, DOI 10.1037/h0046123; Friedkin NE, 1999, ADV GROUP, V16, P1; FRIEDKIN NE, 1990, J MATH SOCIOL, V15, P193, DOI 10.1080/0022250X.1990.9990069; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Fu GY, 2015, PHYSICA A, V419, P558, DOI 10.1016/j.physa.2014.10.045; Funke M, 2016, EUR ECON REV, V88, P227, DOI 10.1016/j.euroecorev.2016.03.006; Gil S, 2006, PHYS LETT A, V356, P89, DOI 10.1016/j.physleta.2006.03.037; Goyal S, 2005, GAME ECON BEHAV, V50, P178, DOI 10.1016/j.geb.2004.01.005; Groeber P, 2014, J MATH SOCIOL, V38, P147, DOI 10.1080/0022250X.2012.724486; Harary F, 2010, AM ECON J-MICROECON, V2, P112, DOI [10.1257/mic.2.1.112, DOI 10.1257/MIC.2.1.112]; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hellmann T, 2014, EUR J OPER RES, V234, P583, DOI 10.1016/j.ejor.2013.08.022; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Hu JP, 2014, PHYS LETT A, V378, P1787, DOI 10.1016/j.physleta.2014.04.070; Iniguez G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066119; Jackson MO, 2002, GAME ECON BEHAV, V41, P265, DOI 10.1016/S0899-8256(02)00504-3; KANDEL DB, 1978, AM J SOCIOL, V84, P427, DOI 10.1086/226792; Kou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043507; Kozma B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016102; Kulakowski K, 2005, INT J MOD PHYS C, V16, P707, DOI 10.1142/S012918310500742X; Lazarsfeld PF, 1948, THE PEOPLES CHOICE; Lazarsfeld PF, 1954, HDB SOCIAL PSYCHOL, VII; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; Lorenz J, 2007, INT J MOD PHYS C, V18, P1819, DOI 10.1142/S0129183107011789; Mas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074516; Mark NP, 2003, AM SOCIOL REV, V68, P319, DOI 10.2307/1519727; Marvel SA, 2011, P NATL ACAD SCI USA, V108, P1771, DOI 10.1073/pnas.1013213108; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meng Z, 2016, ARXIV14022766; Nardini C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158701; Parravano A, 2007, PHYSICA A, V379, P241, DOI 10.1016/j.physa.2006.12.032; Parravano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125085; Pluchino A, 2006, EUR PHYS J B, V50, P169, DOI 10.1140/epjb/e2006-00131-0; Proskurnikov AV, 2016, IEEE T AUTOMAT CONTR, V61, P1524, DOI 10.1109/TAC.2015.2471655; Shi GD, 2016, OPER RES, V64, P585, DOI 10.1287/opre.2015.1448; Sobkowicz P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155098; Srinivasan A, 2011, P NATL ACAD SCI USA, V108, P1751, DOI 10.1073/pnas.1018901108; Traag VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060063; Vazquez F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108702; Xia WG, 2016, IEEE T CONTROL NETW, V3, P46, DOI 10.1109/TCNS.2015.2437528; Zanette DH, 2006, PHYSICA D, V224, P156, DOI 10.1016/j.physd.2006.09.010; Zheng XL, 2015, INFORM SYST FRONT, V17, P1077, DOI 10.1007/s10796-014-9483-8	77	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164323	10.1371/journal.pone.0164323	http://dx.doi.org/10.1371/journal.pone.0164323			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UW	27716815	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100044
J	Caspar, EA; Desantis, A; Dienes, Z; Cleeremans, A; Haggard, P				Caspar, Emilie A.; Desantis, Andrea; Dienes, Zoltan; Cleeremans, Axel; Haggard, Patrick			The Sense of Agency as Tracking Control	PLOS ONE			English	Article							BAYES FACTORS; EXPERIENCE; MODEL; SELF; ATTENUATION; PSYCHOLOGY; MECHANISMS	Does sense of agency (SoA) arise merely from action-outcome associations, or does an additional real-time process track each step along the chain? Tracking control predicts that deviant intermediate steps between action and outcome should reduce SoA. In two experiments, participants learned mappings between two finger actions and two tones. In later test blocks, actions triggered a robot hand moving either the same or a different finger, and also triggered tones, which were congruent or incongruent with the mapping. The perceived delay between actions and tones gave a proxy measure for SoA. Action-tone binding was stronger for congruent than incongruent tones, but only when the robot movement was also congruent. Congruent tones also had reduced N1 amplitudes, but again only when the robot movement was congruent. We suggest that SoA partly depends on a real-time tracking control mechanism, since deviant intermediate action of the robot reduced SoA over the tone.	[Caspar, Emilie A.; Cleeremans, Axel] Univ Libre Bruxelles, ULB Neurosci Inst UNI, Ctr Res Cognit & Neurosci CRCN, Cognit & Computat Grp CO3,Consciousness, Brussels, Belgium; [Caspar, Emilie A.; Desantis, Andrea; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Dienes, Zoltan] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	Universite Libre de Bruxelles; University of London; University College London; University of Sussex	Caspar, EA (corresponding author), Univ Libre Bruxelles, ULB Neurosci Inst UNI, Ctr Res Cognit & Neurosci CRCN, Cognit & Computat Grp CO3,Consciousness, Brussels, Belgium.; Caspar, EA (corresponding author), UCL, Inst Cognit Neurosci, London, England.	ecaspar@ulb.ac.be	Caspar, Emilie/AAC-6322-2022	Caspar, Emilie/0000-0003-1415-2032; Haggard, Patrick/0000-0001-7798-793X; Dienes, Zoltan/0000-0001-7454-3161	FRS-F.N.R.S; EU FP7 grant VERE WP1; ERC Advanced Grant HUMVOL; ESRC Professorial Research Fellowship; BELSPO IAP [P7/33]; ERC Advanced Grant RADICAL; FRS-F.N.R.S (Belgium); F.R.S.-FNRS (Belgium); ESRC [ES/J023140/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023140/1] Funding Source: researchfish	FRS-F.N.R.S(Fonds de la Recherche Scientifique - FNRS); EU FP7 grant VERE WP1; ERC Advanced Grant HUMVOL; ESRC Professorial Research Fellowship(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); BELSPO IAP(Belgian Federal Science Policy Office); ERC Advanced Grant RADICAL; FRS-F.N.R.S (Belgium)(Fonds de la Recherche Scientifique - FNRS); F.R.S.-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	E.A.C is supported by the FRS-F.N.R.S (http://www.frs-fnrs.be/). PH and AD were supported by EU FP7 grant VERE WP1, and by ERC Advanced Grant HUMVOL (https://erc.europa.eu/). PH was additionally supported by an ESRC Professorial Research Fellowship. AC is a Research Director with the F.R.S.-FNRS. This work was partly supported by BELSPO IAP (http.//www.beispo.beiiap/) grant P7/33 to AC, PH, & ZD and by ERC Advanced Grant RADICAL to AC (https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; E.A.C is supported by the FRS-F.N.R.S (Belgium). PH and was supported by EU FP7 grant VERE WP1, and by ERC Advanced Grant HUMVOL. PH was additionally supported by an ESRC Professorial Research Fellowship. AC is a Research Director with the F.R.S.-FNRS (Belgium). This work was partly supported by BELSPO IAP grant P7/33 to AC, PH, & ZD and by ERC Advanced Grant RADICAL to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A, 2006, PERSPECT PSYCHOL SCI, V1, P164, DOI 10.1111/j.1745-6916.2006.00011.x; Bem DJ, 2011, J PERS SOC PSYCHOL, V101, P716, DOI 10.1037/a0024777; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Bratman M., 1987, INTENTION PLANS; Caspar EA, 2015, BEHAV RES METHODS, V47, P744, DOI 10.3758/s13428-014-0498-3; Caspar EA, 2015, CONSCIOUS COGN, V33, P226, DOI 10.1016/j.concog.2015.01.007; Chambon V, 2013, PREMOTOR IDEOMOTOR D; Daprati E, 2000, NEUROCASE, V6, P477, DOI 10.1080/13554790008402718; De Beir A, 2014, 23 IEEE INT S ROB HU; Dennett Daniel, 1993, CONSCIOUSNESS EXPLAI; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Ebert JP, 2010, CONSCIOUS COGN, V19, P481, DOI 10.1016/j.concog.2009.10.002; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gentsch A, 2012, BIOL PSYCHIAT, V71, P652, DOI 10.1016/j.biopsych.2011.12.022; Gentsch A, 2011, J COGNITIVE NEUROSCI, V23, P3817, DOI 10.1162/jocn_a_00012; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hommel B, 2007, J CONSCIOUSNESS STUD, V14, P155; Hughes G, 2013, EUR J NEUROSCI, V37, P1152, DOI 10.1111/ejn.12120; Hughes G, 2013, PSYCHOL BULL, V139, P133, DOI 10.1037/a0028566; Kehrer S, 2009, PSYCHOL RES-PSYCH FO, V73, P751, DOI 10.1007/s00426-008-0194-y; Kuhn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028657; Kumar N, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00145; Liu CC, 2008, J MATH PSYCHOL, V52, P362, DOI 10.1016/j.jmp.2008.03.002; Luck S.J., 2005, INTRO EVENT RELATED; Moore JW, 2012, CONSCIOUS COGN, V21, P1748, DOI 10.1016/j.concog.2012.10.005; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pacherie E, 2014, PHENOMENOL COGN SCI, V13, P25, DOI 10.1007/s11097-013-9329-8; Prinz W, 1987, PERSPECTIVES PERCEPT, P47, DOI DOI 10.2307/1423061; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Wagenmakers EJ, 2010, COGNITIVE PSYCHOL, V60, P158, DOI 10.1016/j.cogpsych.2009.12.001; Wegner DM, 2002, BRADFORD BOOKS, P1; Wegner DM, 1999, AM PSYCHOL, V54, P480, DOI 10.1037/0003-066X.54.7.480; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923	44	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163892	10.1371/journal.pone.0163892	http://dx.doi.org/10.1371/journal.pone.0163892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741253	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000385507000009
J	Badr, MA; Pinto, JR; Davidson, MW; Chase, PB				Badr, Myriam A.; Pinto, Jose R.; Davidson, Michael W.; Chase, P. Bryant			Fluorescent Protein-Based Ca2+ Sensor Reveals Global, Divalent Cation-Dependent Conformational Changes in Cardiac Troponin C	PLOS ONE			English	Article							GENETICALLY ENCODED INDICATORS; MAGNESIUM BINDING-SITES; SKELETAL-MUSCLE FIBERS; CALCIUM-BINDING; HYPERTROPHIC CARDIOMYOPATHY; REGULATORY DOMAIN; MUTATION; ACTIVATION; AFFINITY; DYNAMICS	Cardiac troponin C (cTnC) is a key effector in cardiac muscle excitation-contraction coupling as the Ca2+ sensing subunit responsible for controlling contraction. In this study, we generated several FRET sensors for divalent cations based on cTnC flanked by a donor fluorescent protein (CFP) and an acceptor fluorescent protein (YFP). The sensors report Ca2+ and Mg2+ binding, and relay global structural information about the structural relationship between cTnC's N- and C-domains. The sensors were first characterized using end point titrations to decipher the response to Ca2+ binding in the presence or absence of Mg2+. The sensor that exhibited the largest responses in end point titrations, CTV-TnC, (Cerulean, TnC, and Venus) was characterized more extensively. Most of the divalent cation-dependent FRET signal originates from the high affinity C-terminal EF hands. CTV-TnC reconstitutes into skinned fiber preparations indicating proper assembly of troponin complex, with only similar to 0.2 pCa unit rightward shift of Ca2+-sensitive force development compared to WT-cTnC. Affinity of CTV-TnC for divalent cations is in agreement with known values for WT-cTnC. Analytical ultracentrifugation indicates that CTV-TnC undergoes compaction as divalent cations bind. C-terminal sites induce ion-specific (Ca2+ versus Mg2+) conformational changes in cTnC. Our data also provide support for the presence of additional, non-EF-hand sites on cTnC for Mg2+ binding. In conclusion, we successfully generated a novel FRET-Ca2+ sensor based on full length cTnC with a variety of cellular applications. Our sensor reveals global structural information about cTnC upon divalent cation binding.	[Badr, Myriam A.; Davidson, Michael W.; Chase, P. Bryant] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Badr, Myriam A.; Chase, P. Bryant] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Pinto, Jose R.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Badr, MA (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	myriam.badr@nanotemper-technologies.com	Pinto, Jose Renato/H-2631-2017; Chase, P. Bryant/M-6322-2019	Pinto, Jose Renato/0000-0001-9092-4976; Chase, P. Bryant/0000-0001-9701-561X	National Heart, Lung, and Blood Institute (NIH) [HL103840, HL128683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128683, R00HL103840] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	JRP was supported by National Heart, Lung, and Blood Institute (NIH) Grants HL103840, HL128683; http://www.nhibi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MB, 2000, J BIOL CHEM, V275, P20610, DOI 10.1074/jbc.M909252199; ANDERSSON T, 1981, FEBS LETT, V125, P39, DOI 10.1016/0014-5793(81)80991-X; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Braga CACA, 2006, INT J BIOCHEM CELL B, V38, P110, DOI 10.1016/j.biocel.2005.08.009; Chung WK, 2011, CARDIOL YOUNG, V21, P345, DOI 10.1017/S1047951110001927; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Dong WJ, 1997, J BIOL CHEM, V272, P19229, DOI 10.1074/jbc.272.31.19229; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; EBASHI S, 1972, J BIOCHEM-TOKYO, V72, P787, DOI 10.1093/oxfordjournals.jbchem.a129961; Finley NL, 2004, J BIOL CHEM, V279, P54833, DOI 10.1074/jbc.M408304200; Fuchs F, 2011, BIOCHEM BIOPH RES CO, V408, P697, DOI 10.1016/j.bbrc.2011.04.092; Garaschuk O, 2007, CELL CALCIUM, V42, P351, DOI 10.1016/j.ceca.2007.02.011; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; GRABAREK Z, 1986, J BIOL CHEM, V261, P608; Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017; HANNON JD, 1993, BIOPHYS J, V64, P1632, DOI 10.1016/S0006-3495(93)81517-0; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Jayasundar JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087135; Jin JP, 2007, ARCH BIOCHEM BIOPHYS, V466, P1, DOI 10.1016/j.abb.2007.07.021; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; Kohler J, 2003, PHYSIOL GENOMICS, V14, P117, DOI 10.1152/physiolgenomics.00101.2002; Laine R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049200; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Li MX, 2015, GENE, V571, P153, DOI 10.1016/j.gene.2015.07.074; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Loong CKP, 2013, CELL MOL BIOENG, V6, P183, DOI 10.1007/s12195-013-0269-8; Loong CKP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00080; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Martyn DA, 1999, BIOPHYS J, V76, P1480, DOI 10.1016/S0006-3495(99)77308-X; Matsumoto F, 2004, J MOL BIOL, V342, P1209, DOI 10.1016/j.jmb.2004.07.086; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moreno-Gonzalez A, 2007, J PHYSIOL-LONDON, V579, P313, DOI 10.1113/jphysiol.2006.124164; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; NEGELE JC, 1992, J BIOL CHEM, V267, P825; Parvatiyar MS, 2012, J BIOL CHEM, V287, P31845, DOI 10.1074/jbc.M112.377713; Parvatiyar MS, 2010, J BIOL CHEM, V285, P27785, DOI 10.1074/jbc.M110.112326; POTTER JD, 1975, J BIOL CHEM, V250, P4628; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Regnier M, 2002, J PHYSIOL-LONDON, V540, P485, DOI 10.1113/jphysiol.2001.013179; Regnier M, 1999, BIOPHYS J, V76, P2664, DOI 10.1016/S0006-3495(99)77418-7; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schoffstall B, 2006, J PHYSL; Schoffstall B, 2006, BIOPHYS J, V91, P2216, DOI [10.1529/biophysj.105.079061, 10.1529/biophysj.107.079061]; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Sevrieva I, 2014, J MOL CELL CARDIOL, V75, P181, DOI 10.1016/j.yjmcc.2014.07.015; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Slupsky CM, 1995, BIOCHEMISTRY-US, V34, P15953, DOI 10.1021/bi00049a010; SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; VANEERD JP, 1976, BIOCHEMISTRY-US, V15, P1171, DOI 10.1021/bi00650a033; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/435271; Wang X, 2005, PROTEIN SCI, V14, P2447, DOI 10.1110/ps.051595805; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; ZOT HG, 1982, J BIOL CHEM, V257, P7678	68	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164222	10.1371/journal.pone.0164222	http://dx.doi.org/10.1371/journal.pone.0164222			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736894	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505800046
J	Goemans, N; vanden Hauwe, M; Signorovitch, J; Swallow, E; Song, JL				Goemans, Nathalie; vanden Hauwe, Marleen; Signorovitch, James; Swallow, Elyse; Song, Jinlin		cTAP	Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							CLINICAL-TRIALS; NATURAL-HISTORY; CORTICOSTEROID TREATMENT; DISEASE PROGRESSION; AMBULATION; BOYS; MANAGEMENT	Background Deficits in ambulatory function progress at heterogeneous rates among individuals with Duchenne muscular dystrophy (DMD). The resulting inherent variability in ambulatory outcomes has complicated the design of drug efficacy trials and clouded the interpretation of trial results. We developed a prediction model for 1-year change in the six minute walk distance (6MWD) among DMD patients, and compared its predictive value to that of commonly used prognostic factors (age, baseline 6MWD, and steroid use). Methods Natural history data were collected from DMD patients at routine follow up visits approximately every 6 months over the course of 2-5 years. Assessments included ambulatory function and steroid use. The annualized change in 6MWD (Delta 6MWD) was studied between all pairs of visits separated by 8-16 months. Prediction models were developed using multi-variable regression for repeated measures, and evaluated using cross-validation. Results Among n = 191 follow-up intervals (n = 39 boys), mean starting age was 9.4 years, mean starting 6MWD was 351.8 meters, and 75% had received steroids for at least one year. Over the subsequent 8-16 months, mean Delta 6MWD was -37.0 meters with a standard deviation (SD) of 93.7 meters. Predictions based on a composite of age, baseline 6MWD, and steroid use explained 28% of variation in Delta 6MWD (R-2 = 0.28, residual SD = 79.4 meters). A broadened prognostic model, adding timed 10-meter walk/run, 4-stair climb, and rise from supine, as well as height and weight, significantly improved prediction, explaining 59% of variation in Delta 6MWD after cross-validation (R-2 = 0.59, residual SD = 59.7 meters). Conclusions A prognostic model incorporating timed function tests significantly improved prediction of 1-year changes in 6MWD. Explained variation was more than doubled compared to predictions based only on age, baseline 6MWD, and steroid use. There is significant potential for composite prognostic models to inform DMD clinical trials and clinical practice.	[Goemans, Nathalie; vanden Hauwe, Marleen] Univ Hosp Leuven, Child Neurol, Leuven, Belgium; [Signorovitch, James; Swallow, Elyse; Song, Jinlin] Anal Grp Inc, 111 Huntington Ave,14th Floor, Boston, MA USA; [Signorovitch, James] Trajectory Anal Project TAP Collaborat, One Broadway,14th Floor, Cambridge, MA USA	KU Leuven; University Hospital Leuven; Analysis Group Inc.	Goemans, N (corresponding author), Univ Hosp Leuven, Child Neurol, Leuven, Belgium.	nathalie.goemans@uzleuven.be	Song, Jin/HHS-8731-2022		Biomarin; Pfizer; PTC Therapeutics; Sarepta Therapeutics; Shire as part of the Collaborative Trajectory Anlaysis Project (cTAP); Fonds Spierzieke Kinderen	Biomarin; Pfizer(Pfizer); PTC Therapeutics; Sarepta Therapeutics; Shire as part of the Collaborative Trajectory Anlaysis Project (cTAP); Fonds Spierzieke Kinderen	This study was co-funded by Biomarin, Pfizer, PTC Therapeutics, Sarepta Therapeutics, and Shire as part of the Collaborative Trajectory Anlaysis Project (cTAP). MvdH received funding for physical function testing from Fonds Spierzieke Kinderen. The study sponsors were involved in the research design and review of the manuscript.	ABRAMSON NS, 1992, ANN EMERG MED, V21, P1480, DOI 10.1016/S0196-0644(05)80066-6; Bakker JPJ, 2002, AM J PHYS MED REHAB, V81, P906, DOI 10.1097/00002060-200212000-00004; Bello L, 2015, ANN NEUROL, V77, P684, DOI 10.1002/ana.24370; Biggar WD, 2006, NEUROMUSCULAR DISORD, V16, P249, DOI 10.1016/j.nmd.2006.01.010; Bushby Kate, 2011, Clin Investig (Lond), V1, P1217; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Chung J., 2015, MUSCLE NERVE; Czaplinski A, 2006, NEUROLOGY, V67, P1827, DOI 10.1212/01.wnl.0000244415.48221.81; Dec GW, 2013, J AM COLL CARDIOL, V61, P955, DOI 10.1016/j.jacc.2012.12.011; Emery AE, 2015, OXFORD MONOGRAPHS G, V67; Finanger EL, 2012, PHYS MED REH CLIN N, V23, P1, DOI 10.1016/j.pmr.2011.11.004; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P618, DOI 10.1016/j.nmd.2013.05.006; Henricson Erik, 2012, PLoS Curr, V3, pRRN1297, DOI 10.1371/currents.RRN1297; Hoffman EP, 2013, DISCOV MED, V16, P233; Humbertclaude V, 2012, EUR J PAEDIATR NEURO, V16, P149, DOI 10.1016/j.ejpn.2011.07.001; Ishikawa Y, 2011, NEUROMUSCULAR DISORD, V21, P47, DOI 10.1016/j.nmd.2010.09.006; Kahan BC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-139; Kernan WN, 1999, J CLIN EPIDEMIOL, V52, P19, DOI 10.1016/S0895-4356(98)00138-3; LoMauro A, 2015, THER CLIN RISK MANAG, V11, P1475, DOI 10.2147/TCRM.S55889; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mazzone E, 2010, NEUROMUSCULAR DISORD, V20, P712, DOI 10.1016/j.nmd.2010.06.014; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; Merlini L, 2012, MUSCLE NERVE, V45, P796, DOI 10.1002/mus.23272; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Moxley RT, 2010, J CHILD NEUROL, V25, P1116, DOI 10.1177/0883073810371004; Ohmann C, 1998, INFECTION, V26, P342, DOI 10.1007/BF02962268; Pane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108205; Ricotti V, 2016, J NEUROL NEUROSUR PS, V87, P149, DOI 10.1136/jnnp-2014-309405; Shklyar I, 2015, PEDIATR NEUROL, V52, P202, DOI 10.1016/j.pediatrneurol.2014.09.014; Simon R, 2015, CLIN PHARMACOL THER, V97, P502, DOI 10.1002/cpt.86; SMITH RA, 1991, MUSCLE NERVE, V14, P462, DOI 10.1002/mus.880140513; van den Bergen JC, 2015, J NEUROL NEUROSUR PS, V86, P1060, DOI 10.1136/jnnp-2014-308409; Venur VA, 2015, CHIN CLIN ONCOL, V4, DOI 10.3978/j.issn.2304-3865.2015.06.01; Vickers Andrew J, 2006, J Soc Integr Oncol, V4, P194, DOI 10.2310/7200.2006.023; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; WADE DT, 1992, CURR OPIN NEUROL NEU, V5, P682; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	40	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164684	10.1371/journal.pone.0164684	http://dx.doi.org/10.1371/journal.pone.0164684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737016	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800112
J	Mellery, J; Geay, F; Tocher, DR; Kestemont, P; Debier, C; Rollin, X; Larondelle, Y				Mellery, Julie; Geay, Florian; Tocher, Douglas R.; Kestemont, Patrick; Debier, Cathy; Rollin, Xavier; Larondelle, Yvan			Temperature Increase Negatively Affects the Fatty Acid Bioconversion Capacity of Rainbow Trout (Oncorhynchus mykiss) Fed a Linseed Oil-Based Diet	PLOS ONE			English	Article							SALMO-SALAR L.; ATLANTIC SALMON; FISH-OIL; VEGETABLE-OIL; WATER TEMPERATURE; INTESTINAL ENTEROCYTES; GROWTH-PERFORMANCE; LINOLENIC ACID; CLIMATE-CHANGE; DESATURATION	Aquaculture is meant to provide fish rich in omega-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA). This objective must be reached despite (1) the necessity to replace the finite and limited fish oil in feed production and (2) the increased temperature of the supply water induced by the global warming. The objective of the present paper was to determine to what extent increased water temperature influences the fatty acid bioconversion capacity of rainbow trout (Oncorhynchus mykiss) fed a plant-derived diet. Fish were fed two diets formulated with fish oil (FO) or linseed oil (LO) as only added lipid source at the optimal water temperature of 15 degrees C or at the increased water temperature of 19 degrees C for 60 days. We observed that a temperature increase close to the upper limit of the species temperature tolerance range negatively affected the feed efficiency of rainbow trout fed LO despite a higher feed intake. The negative impact of increased water temperature on fatty acid bioconversion capacity appeared also to be quite clear considering the reduced expression of fatty acid desaturase 2 in liver and intestine and the reduced Delta 6 desaturase enzymatic activity in intestinal microsomes. The present results also highlighted a negative impact of increased temperature on the apparent in vivo enzymatic activity of Delta 5 and Delta 6 desaturases of fish fed LO. Interestingly, this last parameter appeared less affected than those mentioned above. This study highlights that the increased temperature that rainbow trout may face due to global warming could reduce their fatty acid bioconversion capacity. The unavoidable replacement of finite fish oil by more sustainable, readily available and economically viable alternative lipid sources in aquaculture feeds should take this undeniable environmental issue on aquaculture productivity into account.	[Mellery, Julie; Debier, Cathy; Larondelle, Yvan] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium; [Geay, Florian; Kestemont, Patrick] Univ Namur, Unite Rech Biol Environm & Evolut, Namur, Belgium; [Tocher, Douglas R.] Univ Stirling, Sch Nat Sci, Inst Aquaculture, Stirling, Scotland; [Rollin, Xavier] Catholic Univ Louvain, Earth & Life Inst, Louvain La Neuve, Belgium	Universite Catholique Louvain; University of Namur; University of Stirling; Universite Catholique Louvain	Mellery, J; Larondelle, Y (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium.	julie.mellery@uclouvain.be; yvan.larondelle@uclouvain.be	Tocher, Douglas R/C-5652-2011	Tocher, Douglas R/0000-0002-8603-9410	Belgian National Fund for Scientific Research [FNRS-FRFC 6807370]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	This work was supported by funding from the Belgian National Fund for Scientific Research (http://www.frs-fnrs.be/en/index.php, FNRS-FRFC 6807370), including a postdoctoral fellowship to FG and a PhD fellowship to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almroth BC, 2015, J EXP MAR BIOL ECOL, V468, P130, DOI 10.1016/j.jembe.2015.02.018; [Anonymous], 2011, FAO FISHERIES AQUACU; [Anonymous], 1995, OFFICIAL METHODS ANA; Bell JG, 2004, LIPIDS, V39, P223, DOI 10.1007/s11745-004-1223-5; Bowyer JN, 2014, AQUAC RES, V45, P2010, DOI 10.1111/are.12146; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett J., 1979, FISH PHYSIOL, V8, P279, DOI DOI 10.1016/S1546-5098(08)60029-1; Buzzi M, 1996, BBA-LIPID LIPID MET, V1299, P235, DOI 10.1016/0005-2760(95)00211-1; Choubert G, 1983, B FR PECHE PISCIC, V288, P68; Christie W.W., 2003, LIPID ANAL; Cochrane K., 2009, FAO FISH AQUAC TECH, V530, P212; Codabaccus MB, 2013, FOOD CHEM, V141, P236, DOI 10.1016/j.foodchem.2013.02.032; De Silva S.S., 2009, CLIMATE CHANGE IMPLI, V530, P151; DETORRENGO MP, 1976, BIOCHIM BIOPHYS ACTA, V424, P36, DOI 10.1016/0005-2760(76)90047-3; Donelson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097223; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ 2; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis DS, 2014, FISH PHYSIOL BIOCHEM, V40, P577, DOI 10.1007/s10695-013-9868-5; Furukawa A., 1966, B JPN SOC SCI FISH, V32, P502, DOI [10.2331/suisan.32.502, DOI 10.2331/SUISAN.32.502]; Geay F, 2015, LIPIDS, V50, P1219, DOI 10.1007/s11745-015-4079-8; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; Guerreiro I, 2012, AQUACULT NUTR, V18, P98, DOI 10.1111/j.1365-2095.2011.00884.x; HAGAR AF, 1985, J COMP PHYSIOL B, V156, P35, DOI 10.1007/BF00692924; HAZEL JR, 1984, AM J PHYSIOL, V246, pR460, DOI 10.1152/ajpregu.1984.246.4.R460; HAZEL JR, 1979, AM J PHYSIOL, V236, pR91, DOI 10.1152/ajpregu.1979.236.1.R91; Hevroy EM, 2012, GEN COMP ENDOCR, V175, P118, DOI 10.1016/j.ygcen.2011.10.007; Huguet CT, 2015, AQUACULTURE, V436, P160, DOI 10.1016/j.aquaculture.2014.11.011; Jalabert B, 2010, TRUITE ARC EN CIEL B; Jobling M, 2003, AQUAC RES, V34, P1423, DOI 10.1111/j.1365-2109.2003.00970.x; Jorgensen Sven Martin, 2014, BMC Physiology, V14, P2, DOI 10.1186/1472-6793-14-2; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Medale F, 2013, INRA PROD ANIM, V26, P303; Myrick CA, 2000, FISH PHYSIOL BIOCHEM, V22, P245, DOI 10.1023/A:1007805322097; Norambuena F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143622; Norambuena F, 2016, AQUACULTURE, V450, P48, DOI 10.1016/j.aquaculture.2015.06.044; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Rollin X, 2003, COMP BIOCHEM PHYS B, V134, P349, DOI 10.1016/S1096-4959(02)00264-6; Rollin X, 2003, BRIT J NUTR, V90, P865, DOI 10.1079/BJN2003973; Ruiz-Lopez N, 2013, METAB ENG, V17, P30, DOI 10.1016/j.ymben.2013.03.001; Ruxton CHS, 2005, NUTR RES REV, V18, P113, DOI 10.1079/NRR200497; Seiliez I, 2001, COMP BIOCH PHYSL B, P130; Senadheera SD, 2012, AQUACULTURE, V342, P80, DOI 10.1016/j.aquaculture.2012.02.020; Skalli A, 2006, AQUACULTURE, V255, P223, DOI 10.1016/j.aquaculture.2005.12.006; Stitt BC, 2014, PHYSIOL BIOCHEM ZOOL, V87, P15, DOI 10.1086/675259; Thanuthong T, 2011, LIPIDS, V46, P1111, DOI 10.1007/s11745-011-3607-4; Tocher DR, 2003, FISH PHYSIOL BIOCHEM, V29, P193, DOI 10.1023/B:FISH.0000045722.44186.ee; Tocher DR, 2004, COMP BIOCHEM PHYS B, V137, P49, DOI 10.1016/j.cbpc.2003.10.002; Tocher DR, 2002, FISH PHYSIOL BIOCHEM, V26, P157, DOI 10.1023/A:1025416731014; Tocher DR, 2001, COMP BIOCHEM PHYS B, V130, P257, DOI 10.1016/S1096-4959(01)00429-8; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Trattner S, 2008, LIPIDS, V43, P989, DOI 10.1007/s11745-008-3228-8; Turchini GM, 2008, LIPIDS, V43, P977, DOI 10.1007/s11745-008-3213-2; Turchini GM, 2007, LIPIDS, V42, P1065, DOI 10.1007/s11745-007-3105-x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Vagner M, 2007, AQUACULTURE, V266, P179, DOI 10.1016/j.aquaculture.2007.02.040; Vagner M, 2011, AQUACULTURE, V315, P131, DOI 10.1016/j.aquaculture.2010.11.031; Vagner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126489; van Vliet MTH, 2013, GLOBAL ENVIRON CHANG, V23, P450, DOI 10.1016/j.gloenvcha.2012.11.002; Wijekoon MPA, 2014, AQUACULTURE, V433, P74, DOI 10.1016/j.aquaculture.2014.05.028; Yildiz M, 2015, AQUAC RES, V46, P2885, DOI 10.1111/are.12441; Zheng XZ, 2005, BBA-MOL CELL BIOL L, V1734, P13, DOI 10.1016/j.bbalip.2005.01.006; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7; Zheng XZ, 2004, AQUACULTURE, V236, P467, DOI 10.1016/j.aquaculture.2004.02.003	67	23	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164478	10.1371/journal.pone.0164478	http://dx.doi.org/10.1371/journal.pone.0164478			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736913	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800073
J	Sureda, EA; Westrom, B; Pierzynowski, SG; Prykhodko, O				Sureda, Ester Arevalo; Westrom, Bjorn; Pierzynowski, Stefan G.; Prykhodko, Olena			Maturation of the Intestinal Epithelial Barrier in Neonatal Rats Coincides with Decreased FcRn Expression, Replacement of Vacuolated Enterocytes and Changed Blimp-1 Expression	PLOS ONE			English	Article							IMMUNE-SYSTEM; POSTNATAL-DEVELOPMENT; PHASEOLUS-VULGARIS; TRANSPORT; IGG; TRANSMISSION; NUTRITION; MECHANISM; EXPOSURE; ANTIGENS	Background The intestinal barrier is immature in newborn mammals allowing for transfer of bioactive macromolecules, e.g. protecting antibodies, from mother's milk to the blood circulation and in neonatal rodents lasts until weaning. This passage involves the neonatal-Fc-receptor (FcRn) binding IgG in the proximal and highly endocytic vacuolated enterocytes in the distal immature small intestine (SI). Recent studies have suggested an involvement of the transcription factor B-lymphocyte-induced maturation-protein-1 (Blimp-1) in the regulation of SI maturation in mice. Hence, the objective of the present study was to monitor the development of the intestinal barrier function, in relation to Blimp-1 expression during both natural and precociously induced intestinal maturation in rats. Results During the suckling period IgG plasma levels increased, while after gut closure it temporarily decreased. This corresponded to a high expression of FcRn in the proximal SI epithelium and the presence of vacuolated enterocytes in the distal SI. The immature foetal-type epithelium was replaced after weaning or induced precocious maturation, by an adult-type epithelium with FcRn neg cells in the proximal and by non-vacuolated enterocytes in the distal SI. In parallel to this epithelial shift, Blimp-1 expression decreased in the distal SI. Conclusion The switch from foetal-to adult-type epithelium, with decreased proximal expression of FcRn and distal replacement of vacuolated enterocytes, was concurrent in the two SI regions and could be used for monitoring SI maturation in the rat. The changes in expression of Blimp-1 in the distal SI epithelium followed the maturation pattern.	[Sureda, Ester Arevalo; Westrom, Bjorn; Pierzynowski, Stefan G.; Prykhodko, Olena] Lund Univ, Dept Biol, Lund, Sweden; [Pierzynowski, Stefan G.] Innovat Ctr STB, Tczew, Poland	Lund University	Sureda, EA (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	ester.arevalo_sureda@biol.lu.se	Weström, Björn R/N-2232-2016; Arevalo Sureda, Ester/GPF-8594-2022; Pierzynowski, Stefan Grzegorz/AAU-6107-2021; Sureda, Ester Arévalo/AAN-2171-2020; Prykhodko, Olena/D-4224-2014	Weström, Björn R/0000-0001-9296-2845; Pierzynowski, Stefan Grzegorz/0000-0002-0308-3214; Sureda, Ester Arévalo/0000-0002-3299-1510; Prykhodko, Olena/0000-0002-5788-9176	Royal Physiographic Society in Lund; Director Albert Pahlsson Foundation in Malmo	Royal Physiographic Society in Lund; Director Albert Pahlsson Foundation in Malmo	This work was supported by grants from the Royal Physiographic Society in Lund (www.fysiografen.se), 2012 and 2013 (EAS), and Director Albert Pahlsson Foundation in Malmo (www.pahlssonsstiftelse.se) (OP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Ryoko, 2002, Anatomical Science International, V77, P117, DOI 10.1046/j.0022-7722.2002.00017.x; Baintner K, 2007, VET IMMUNOL IMMUNOP, V117, P153, DOI 10.1016/j.vetimm.2007.03.001; Cummins AG, 2002, GUT, V51, P748, DOI 10.1136/gut.51.5.748; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Hanson LA, 2001, PEDIAT ALLERG IMM-UK, V12, P15, DOI 10.1034/j.1399-3038.2001.121404.x; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; Heyman M, 2001, P NUTR SOC, V60, P419, DOI 10.1079/PNS2001117; Holladay SD, 2000, ENVIRON HEALTH PERSP, V108, P463, DOI 10.2307/3454538; Holsapple MP, 2003, BIRTH DEFECTS RES B, V68, P321, DOI 10.1002/bdrb.10035; Jenkins SL, 2003, AM J PHYSIOL-GASTR L, V285, pG714, DOI 10.1152/ajpgi.00130.2003; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kelly D, 2000, P NUTR SOC, V59, P177, DOI 10.1017/S0029665100000197; Kliwinski C, 2013, AM J PHYSIOL-GASTR L, V304, pG262, DOI 10.1152/ajpgi.00340.2012; Kumagai N, 2011, MED MOL MORPHOL, V44, P71, DOI 10.1007/s00795-010-0506-3; Linderoth A, 2005, J PEDIATR GASTR NUTR, V41, P195, DOI 10.1097/01.mpg.0000172262.05297.98; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; Martin MG, 1997, DIGEST DIS SCI, V42, P1062, DOI 10.1023/A:1018853506830; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Masjedi M, 1999, J PEDIATR GASTR NUTR, V29, P556, DOI 10.1097/00005176-199911000-00016; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Parker GA, 2015, TOXICOL PATHOL, V43, P794, DOI 10.1177/0192623315578720; Perez-Cano FJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/537310; Peulen O, 2004, J PEDIATR GASTR NUTR, V38, P524, DOI 10.1097/00005176-200405000-00012; Prykhod'ko O, 2010, J PEDIATR GASTR NUTR, V50, P473, DOI 10.1097/MPG.0b013e3181b47787; Prykhodko O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116947; Puiman P, 2008, CURR OPIN CLIN NUTR, V11, P601, DOI 10.1097/MCO.0b013e32830b5b15; PUSZTAI A, 1974, BIOCHIM BIOPHYS ACTA, V365, P57, DOI 10.1016/0005-2795(74)90250-5; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; SHELDRAKE RF, 1985, RES VET SCI, V39, P10, DOI 10.1016/S0034-5288(18)31762-4; TELEMO E, 1987, BIOL NEONATE, V52, P141, DOI 10.1159/000242703; Walthall K, 2005, BIRTH DEFECTS RES B, V74, P132, DOI 10.1002/bdrb.20040; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007	34	24	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164775	10.1371/journal.pone.0164775	http://dx.doi.org/10.1371/journal.pone.0164775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736989	Green Published, gold			2022-12-27	WOS:000385505800128
J	Iwasa, K; Tanaka, T; Yamada, Y				Iwasa, Kazunori; Tanaka, Tsunehiko; Yamada, Yuki			Factor Structure, Reliability, and Validity of the Japanese Version of the Disgust Propensity and Sensitivity Scale-Revised	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; ANXIETY SENSITIVITY; TRAIT ANXIETY; PSYCHOMETRIC PROPERTIES; SYMPTOMS; STATE; ADOLESCENTS; AVOIDANCE; EXPOSURE	The Disgust Propensity and Sensitivity Scale-Revised is one of the most widely used measures of individual differences for the emotion of disgust. It consists of 2 subscales: disgust propensity and disgust sensitivity. This study examined the factor structure, reliability, and validity of the Japanese version of the revised Disgust Propensity and Sensitivity Scale. Japanese participants (N = 1067) completed the scale as well as the Padua Inventory, Anxiety Sensitivity Index, State-Trait Anxiety Inventory, and Positive and Negative Affective Schedule. The participants were divided into 3 samples: Sample 1 (n = 481, mean age = 23.05, 186 males and 295 females); Sample 2 (n = 492, mean age = 20.27, 243 males and 249 females); and Sample 3 (n = 94, mean age = 22.68, 35 males and 58 females). We combined Samples 1 and 2 (n = 973, mean age = 21.66, 429 males and 544 females), and then created 2 subsamples to ensure the mutual independence of the samples used for two different factor analyses: subsample 1 (n = 486, mean age = 21.86, 199 male and 287 female) for exploratory factor analysis and subsample 2 (n = 487, mean age = 21.40, 230 male and 257 female) for confirmatory factor analysis. We examined test-retest reliability using Sample 3, and construct validity using Samples 1, 2, and the combined sample. Exploratory and confirmatory factor analyses revealed that the item-factor structure of the Japanese Disgust Propensity and Sensitivity Scale-Revised was identical to the English version. Moreover, the scale showed good internal consistency, test-retest reliability, and construct validity for empirical support as provided by correlational analyses. Results revealed adequate psychometric properties of the scale. This study provided the first examples of empirical support for the DPSS-R-J.	[Iwasa, Kazunori] Shujitsu Univ, Dept Educ Psychol, Okayama, Japan; [Iwasa, Kazunori; Tanaka, Tsunehiko] Shiga Univ Med Sci, Dept Community Psychiat Med, Otsu, Shiga, Japan; [Tanaka, Tsunehiko] Niigata Univ, Fac Educ, Niigata, Japan; [Yamada, Yuki] Kyushu Univ, Fac Arts & Sci, Fukuoka, Japan	Shiga University of Medical Science; Niigata University; Kyushu University	Iwasa, K (corresponding author), Shujitsu Univ, Dept Educ Psychol, Okayama, Japan.; Iwasa, K (corresponding author), Shiga Univ Med Sci, Dept Community Psychiat Med, Otsu, Shiga, Japan.	kaiwasa00@gmail.com	Yamada, Yuki/B-2671-2008	Yamada, Yuki/0000-0003-1431-568X; Iwasa, Kazunori/0000-0001-8908-5335	Japan Society for the Promotion of Science [24730611, 15K21543, 26540067, 15H05709]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by funding from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html) as follows; a Grant-in-Aid for Young Scientists (B) (24730611, 15K21543) awarded to KI; Grant-in-Aid for Challenging Exploratory Research (26540067) awarded to YY; Grant-in-Aid for Scientific Research (S) (15H05709) awarded to YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badour CL, 2013, COGNITIVE THER RES, V37, P697, DOI 10.1007/s10608-013-9529-0; Ball TM, 2012, NEUROIMAGE, V59, P1879, DOI 10.1016/j.neuroimage.2011.08.074; Bilgic A, 2013, EUR CHILD ADOLES PSY, V22, P523, DOI 10.1007/s00787-013-0392-z; Bosman RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148626; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Cavanagh K., 2000, BRIT PSYCH SOC WINCH; Charash M, 2002, J ANXIETY DISORD, V16, P529, DOI 10.1016/S0887-6185(02)00171-8; Chu C, 2015, EUR EAT DISORD REV, V23, P545, DOI 10.1002/erv.2373; Cisler JM, 2009, CLIN PSYCHOL REV, V29, P34, DOI 10.1016/j.cpr.2008.09.007; DAVEY GCL, 1993, BEHAV RES THER, V31, P41, DOI 10.1016/0005-7967(93)90041-R; Duncko R, 2016, J BEHAV THER EXP PSY, V51, P92, DOI 10.1016/j.jbtep.2016.01.001; Elwood Lisa S, 2009, DISGUST ITS DISORDER, P99, DOI [10.1037/11856-005, DOI 10.1037/11856-005]; Fergus TA, 2009, J ANXIETY DISORD, V23, P703, DOI 10.1016/j.janxdis.2009.02.009; Fischer FM, 2010, APPL CONTRALLABILITY, DOI [10.1007/978-3-8349-6030-6, DOI 10.1007/978-3-8349-6030-6]; Gelman A, 2015, COMPREHENSIVE R ARCH; Greisberg S, 2003, CLIN PSYCHOL REV, V23, P95, DOI 10.1016/S0272-7358(02)00232-5; Gros DF, 2007, PSYCHOL ASSESSMENT, V19, P369, DOI 10.1037/1040-3590.19.4.369; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Imae K., 1981, JAPANESE J ED PSYCHO, V29, P62; Kline R.B., 2011, PRINCIPLES PRACTICE; Ludvik D, 2015, CLIN PSYCHOL REV, V42, P116, DOI 10.1016/j.cpr.2015.07.001; MATCHETT G, 1991, BEHAV RES THER, V29, P91, DOI 10.1016/S0005-7967(09)80011-9; McNally RJ, 2002, BIOL PSYCHIAT, V52, P938, DOI 10.1016/S0006-3223(02)01475-0; Muranaka Y, 2002, NIHON KOUDOU RYOUHOU, V28, P120; Muranaka Y., 2001, P 27 C JAP ASS BEH S, V27, P227; Muris P, 1999, BEHAV RES THER, V37, P953, DOI 10.1016/S0005-7967(99)00045-5; Muris P, 2001, BEHAV RES THER, V39, P89, DOI 10.1016/S0005-7967(99)00179-5; Olatunji BO, 2005, PERS INDIV DIFFER, V38, P713, DOI 10.1016/j.paid.2004.05.025; Olatunji BO, 2007, J ANXIETY DISORD, V21, P918, DOI 10.1016/j.janxdis.2006.12.005; Olatunji BO, 2010, PSYCHIAT RES, V175, P1, DOI 10.1016/j.psychres.2009.04.007; Randler C, 2012, LEARN INDIVID DIFFER, V22, P419, DOI 10.1016/j.lindif.2012.01.005; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Reiss S, 1997, J ANXIETY DISORD, V11, P201, DOI 10.1016/S0887-6185(97)00006-6; Reynolds LM, 2015, J BEHAV MED, V38, P98, DOI 10.1007/s10865-014-9582-5; Reynolds LM, 2014, HEALTH PSYCHOL, V33, P1495, DOI 10.1037/hea0000023; SANAVIO E, 1988, BEHAV RES THER, V26, P169, DOI 10.1016/0005-7967(88)90116-7; Sato A., 2001, JAPANESE J PERSONALI, V19, P138, DOI [DOI 10.2132/jjpjspp.9.2_138, DOI 10.2132/JJPJSPP.9.2_138]; Sawchuk CN, 1999, BEHAV RES THER, V37, P249, DOI 10.1016/S0005-7967(98)00127-2; Sawchuk CN, 2000, BEHAV RES THER, V38, P753, DOI 10.1016/S0005-7967(99)00093-5; Schienle A, 2013, J NERV MENT DIS, V201, P105, DOI 10.1097/NMD.0b013e31827f64da; Spielberger C., 1983, STAI MANUAL; Sugiura Y., 2000, ARCH PSYCHIATR DIAGN, V11, P175; TAYLOR S, 1991, J ANXIETY DISORD, V5, P293, DOI 10.1016/0887-6185(91)90030-W; van Overveld WJM, 2006, PERS INDIV DIFFER, V41, P1241, DOI 10.1016/j.paid.2006.04.021; VANOPPEN P, 1995, BEHAV RES THER, V33, P15, DOI 10.1016/0005-7967(94)E0010-G; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Widen SC, 2013, PSYCHOL BULL, V139, P271, DOI 10.1037/a0031640	48	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164630	10.1371/journal.pone.0164630	http://dx.doi.org/10.1371/journal.pone.0164630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732659	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505300071
J	Tolentino-Zondervan, F; Berentsen, P; Bush, SR; Digal, L; Lansink, AO				Tolentino-Zondervan, Frazen; Berentsen, Paul; Bush, Simon R.; Digal, Larry; Lansink, Alfons Oude			Fisher-Level Decision Making to Participate in Fisheries Improvement Projects (FIPs) for Yellowfin Tuna in the Philippines	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; FISHING COMMUNITIES; SAMPLE SELECTION; MANAGEMENT; RISK; CAPABILITIES; ADOPTION; SUSTAINABILITY; CERTIFICATION; INSTITUTIONS	This study identifies the capabilities needed by small-scale fishers to participate in Fishery Improvement Projects (FIPs) for yellowfin tuna in the Philippines. The current literature provides little empirical evidence on how different models, or types of FIPs, influence the participation of fishers in their programs and the degree which FIPs are able to foster improvements in fishing practices. To address this literature gap, two different FIPs are empirically analysed, each with different approaches for fostering improvement. The first is the non-governmental organisation-led Partnership Programme Towards Sustainable Tuna, which adopts a bottom-up or development oriented FIP model. The second is the private-led Artesmar FIP, which adopts a top-down or market-oriented FIP approach. The data were obtained from 350 fishers surveyed and were analysed using two separate models run in succession, taking into consideration full, partial, and non-participation in the two FIPs. The results demonstrate that different types of capabilities are required in order to participate in different FIP models. Individual firm capabilities are more important for fishers participation in market-oriented FIPs, which use direct economic incentives to encourage improvements in fisher practices. Collective capabilities are more important for fishers to participate in development-oriented FIPs, which drive improvement by supporting fishers, fisher associations, and governments to move towards market requirements.	[Tolentino-Zondervan, Frazen; Berentsen, Paul; Lansink, Alfons Oude] Wageningen Univ, Business Econ Grp, Wageningen, Netherlands; [Bush, Simon R.] Wageningen Univ, Environm Policy Grp, Wageningen, Netherlands; [Digal, Larry] Univ Philippines Mindanao, Sch Management, Davao Del Sur, Philippines; [Digal, Larry] Commiss Higher Educ, Tuna Value Chain Project, Davao, Philippines	Wageningen University & Research; Wageningen University & Research; University of the Philippines System; University of the Philippines Mindanao	Tolentino-Zondervan, F (corresponding author), Wageningen Univ, Business Econ Grp, Wageningen, Netherlands.	frazen.tolentino@wur.nl	Oude Lansink, Alfons GJM/H-8840-2012	Oude Lansink, Alfons GJM/0000-0002-9273-6044; Tolentino-Zondervan, Frazen/0000-0002-3818-4031; Bush, Simon/0000-0002-6689-2246	Benefiting from Innovations in Sustainable and Equitable Tuna Management in the Coral Triangle and Western Pacific (BESTTuna) under the Interdisciplinary Research and Education Fund (INREF) programme of Wageningen University, The Netherlands; Wageningen University Interdisciplinary Research and Education Fund (INREF)	Benefiting from Innovations in Sustainable and Equitable Tuna Management in the Coral Triangle and Western Pacific (BESTTuna) under the Interdisciplinary Research and Education Fund (INREF) programme of Wageningen University, The Netherlands; Wageningen University Interdisciplinary Research and Education Fund (INREF)	This research is funded by the Benefiting from Innovations in Sustainable and Equitable Tuna Management in the Coral Triangle and Western Pacific (BESTTuna) under the Interdisciplinary Research and Education Fund (INREF) programme of Wageningen University, The Netherlands. The BESTTuna website is found at http://www.wageningenur.nl/en/Research-Results/Projects-and-programmes/BESTTuna.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The main author would like to thank the WWF-PPTST site coordinators in Occidental Mindoro and the Artesmar for their openness to provide information and kind assistance in conducting field surveys. The authors would also like to thank the reviewers for their critical comments and suggestions in improving this manuscript. This research was conducted through the BESTTuna programme at Wageningen University with funds from the Wageningen University Interdisciplinary Research and Education Fund (INREF).	Anderson J. R., 1977, AGR DECISION ANAL; [Anonymous], [No title captured]; [Anonymous], 2014, FISH TRANS; [Anonymous], 2012, FIP OV; Bailey M, FISHERIES R IN PRESS; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Bush SR, 2015, SUSTAINABILITY-BASEL, V7, P1861, DOI 10.3390/su7021861; Bush SR, 2013, MAR POLICY, V37, P288, DOI 10.1016/j.marpol.2012.05.011; California Environmental Associates, 2015, SUMM FIND GLOB LANDS; CASS, 2021, CONS ALL SEAF SOL CO; Cohen DA, 2010, J ACCOUNT ECON, V50, P2, DOI 10.1016/j.jacceco.2010.01.002; Constance D. H., 2000, Agriculture and Human Values, V17, P125, DOI 10.1023/A:1007625606243; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006253; Cummins A., 2006, CORP SOC RESP ENV MA, V11, P85, DOI DOI 10.1002/CSR.56; Davies N, 2014, STOCK ASSESSMENT YEL; De Luca G, 2011, STATA J, V11, P213, DOI 10.1177/1536867X1101100204; Deighan LK, 2015, MAR POLICY, V51, P476, DOI 10.1016/j.marpol.2014.10.009; Dercon S, 2002, WORLD BANK RES OBSER, V17, P141, DOI 10.1093/wbro/17.2.141; DEWEES CM, 1988, HUM ORGAN, V47, P224, DOI 10.17730/humo.47.3.rx251q1987785824; Ferrol-Schulte D, 2014, OCEAN COAST MANAGE, V100, P63, DOI 10.1016/j.ocecoaman.2014.07.016; Ferse SCA, 2012, COAST MANAGE, V40, P525, DOI 10.1080/08920753.2012.694801; Field A., 2013, DISCOVERING STAT USI; Ghadim AKA, 1999, AGR ECON-BLACKWELL, V21, P145, DOI 10.1016/S0169-5150(99)00023-7; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gomez-Mejia LR, 2001, ACAD MANAGE J, V44, P81, DOI 10.2307/3069338; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Greene W.H., 2012, ECONOMETRIC ANAL; Greene W.H., 2010, MODELING ORDERED CHO, DOI [10.1017/CBO9780511845062, DOI 10.1017/CBO9780511845062]; Gulati A., 2007, GROWTH HIGH VALUE AG; HANEMANN WM, 1984, ECONOMETRICA, V52, P541, DOI 10.2307/1913464; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; HENSON S, 2013, PART SMALLH FARM, P12; Herrero I, 2004, ICES J MAR SCI, V61, P211, DOI 10.1016/j.icesjms.2003.12.007; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jager W, 2007, J SOC ISSUES, V63, P97, DOI 10.1111/j.1540-4560.2007.00498.x; Ruddle K, 2011, HUM ORGAN, V70, P224, DOI 10.17730/humo.70.3.v4810k37717h9g01; Kusumawati R, 2013, SOC NATUR RESOUR, V26, P898, DOI 10.1080/08941920.2012.723305; Langley AD, 2008, W CENTRAL PACIFIC TU; Langley A, 2009, MAR POLICY, V33, P271, DOI 10.1016/j.marpol.2008.07.009; Lindner R.K, 1987, ACIAR P SERIES; MacNeil MA, 2013, GLOBAL ENVIRON CHANG, V23, P1393, DOI 10.1016/j.gloenvcha.2013.04.003; Marra M, 2003, AGR SYST, V75, P215, DOI 10.1016/S0308-521X(02)00066-5; McFadden D., 1973, CONDITIONAL LOGIT AN; MSC, 2015, GLOB IMP SUMM REP 20; Murphy C, 2008, SCI ENG ETHICS, V14, P77, DOI 10.1007/s11948-007-9031-8; Ngaruko DD, 2013, INT J EC MANAGEMENT, V2, P919; Nussbaum MC, 2003, FEM ECON, V9, P33, DOI 10.1080/1354570022000077926; Oosterveer P, 2008, OCEAN COAST MANAGE, V51, P797, DOI 10.1016/j.ocecoaman.2008.08.002; OSTROM E, 1994, J THEOR POLIT, V6, P527, DOI 10.1177/0951692894006004006; Pannell DJ, 2006, AUST J EXP AGR, V46, P1407, DOI 10.1071/EA05037; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perez-Ramirez M, 2012, MAR POLICY, V36, P297, DOI 10.1016/j.marpol.2011.06.013; Perez-Sanchez E, 2003, OCEAN COAST MANAGE, V46, P681, DOI 10.1016/S0964-5691(03)00041-3; PLATTEAU JP, 1987, J DEV STUD, V23, P461, DOI 10.1080/00220388708422044; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P531, DOI 10.1016/S0964-5691(01)00064-3; Pomeroy RS, 1995, OCEAN COAST MANAGE, V27, P143, DOI 10.1016/0964-5691(95)00042-9; Prahalad CK, 1990, CORE COMPETENCE CORP; Rohrmann B, 2008, SOC INT GER EM TIEMS; Rothaermel FT, 2007, ORGAN SCI, V18, P898, DOI 10.1287/orsc.1070.0291; Sampson GS, 2015, SCIENCE, V348, P504, DOI 10.1126/science.aaa4639; SCHOEMAKER PJH, 1982, J ECON LIT, V20, P529; Sen Amartya., 1990, HUMAN DEV INT DEV ST; Squires D, 2003, ENVIRON DEV ECON, V8, P481, DOI 10.1017/S1355770X0300263; StataCorp LP, 2015, STAT BAS REF MAN 200; Suzuki A, 2011, WORLD DEV, V39, P1611, DOI 10.1016/j.worlddev.2011.02.007; Teece D., 1994, IND CORP CHANGE, V3, P537, DOI DOI 10.1093/ICC/3.3.537-A; Tolentino-Zondervan F, 2016, WORLD DEV, V83, P264, DOI 10.1016/j.worlddev.2016.01.011; Tsur Y, 1990, OXFORD ECON PAP, P336; Tucker JW, 2010, J ACCOUNTING LIT WIN; Van Putten I, 2010, IIFET 2010 MONTP P; von Essen LM, 2013, OCEAN COAST MANAGE, V73, P101, DOI 10.1016/j.ocecoaman.2012.12.012; Weber J, 2003, J ACCOUNT RES, V41, P681, DOI 10.1111/1475-679X.00120; Wu JS, 2009, J ACCOUNT ECON, V47, P59, DOI 10.1016/j.jacceco.2008.11.002; Zahra SA, 2005, FAM BUS REV, V18, P23, DOI 10.1111/j.1741-6248.2005.00028.x	76	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163537	10.1371/journal.pone.0163537	http://dx.doi.org/10.1371/journal.pone.0163537			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732607	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300018
J	Mohebbi, S; Erfurth, F; Hennersdorf, P; Brakhage, AA; Saluz, HP				Mohebbi, Sara; Erfurth, Florian; Hennersdorf, Philipp; Brakhage, Axel A.; Saluz, Hans Peter			Hyperspectral Imaging Using Intracellular Spies: Quantitative Real-Time Measurement of Intracellular Parameters In Vivo during Interaction of the Pathogenic Fungus Aspergillus fumigatus with Human Monocytes	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; HOST-CELLS; APOPTOSIS; INHIBITION; CHLOROQUINE; FUSION; INFECTION; CONIDIA; SYSTEM; DEATH	Hyperspectral imaging (HSI) is a technique based on the combination of classical spectroscopy and conventional digital image processing. It is also well suited for the biological assays and quantitative real-time analysis since it provides spectral and spatial data of samples. The method grants detailed information about a sample by recording the entire spectrum in each pixel of the whole image. We applied HSI to quantify the constituent pH variation in a single infected apoptotic monocyte as a model system. Previously, we showed that the human-pathogenic fungus Aspergillus fumigatus conidia interfere with the acidification of phagolysosomes. Here, we extended this finding to monocytes and gained a more detailed analysis of this process. Our data indicate that melanised A. fumigatus conidia have the ability to interfere with apoptosis in human monocytes as they enable the apoptotic cell to recover from mitochondrial acidification and to continue with the cell cycle. We also showed that this ability of A. fumigatus is dependent on the presence of melanin, since a non-pigmented mutant did not stop the progression of apoptosis and consequently, the cell did not recover from the acidic pH. By conducting the current research based on the HSI, we could measure the intracellular pH in an apoptotic infected human monocyte and show the pattern of pH variation during 35 h of measurements. As a conclusion, we showed the importance of melanin for determining the fate of intracellular pH in a single apoptotic cell.	[Mohebbi, Sara; Hennersdorf, Philipp; Saluz, Hans Peter] Hans Knoell Inst, Dept Cell & Mol Biol, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Erfurth, Florian] Dept Photon & Sensor Jena, Felsbachstr, Jena, Germany; [Brakhage, Axel A.] Hans Knoell Inst, Dept Mol & Appl Microbiol, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Mohebbi, Sara; Brakhage, Axel A.; Saluz, Hans Peter] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Saluz, HP (corresponding author), Hans Knoell Inst, Dept Cell & Mol Biol, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.; Brakhage, AA (corresponding author), Hans Knoell Inst, Dept Mol & Appl Microbiol, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.; Brakhage, AA; Saluz, HP (corresponding author), Univ Jena, Jena, Germany.	axel.brakhage@hki-jena.de; hanspeter.saluz@hki-jena.de			International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS Jena); Hans Knoll Institute (HKI)	International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS Jena); Hans Knoll Institute (HKI)	This work was supported by the following sources of funding: 1-International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS Jena), https://www.daad.de/deutschland/studienangebote/international-programs/en/?p=d& 2-Hans Knoll Institute (HKI), http://www.hki-jena.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin S, 2014, INT J MED MICROBIOL, V304, P626, DOI 10.1016/j.ijmm.2014.04.009; Bagnasco L, 2015, TALANTA, V144, P1225, DOI 10.1016/j.talanta.2015.07.071; Bertani FR, 2013, J EUR OPT SOC-RAPID, V8, DOI 10.2971/jeos.2013.13078; Bhat M, 2000, AAPS PHARMSCI, V2; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; Brauchle E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04698; Chin MS, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026010; COOK AM, 1962, J GEN MICROBIOL, V29, P97, DOI 10.1099/00221287-29-1-97; Dalponte M, 2009, REMOTE SENS ENVIRON, V113, P2345, DOI 10.1016/j.rse.2009.06.013; Daly JT, 2000, P SOC PHOTO-OPT INS, V3948, P104, DOI 10.1117/12.382145; Dierckx P., 1993, CURVE SURFACE FITTIN; Duann JR, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126005; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Fidel PL, 2006, FUNGAL IMMUNOLOGY OR, DOI [10.1007/b107411, DOI 10.1007/B107411]; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; Furlong IJ, 1997, J CELL SCI, V110, P653; Garcia JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125817; Goldman AS., 1996, MED MICROBIOLOGY, V4th ed; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; Hornik TC, 2016, J CELL SCI, V129, P65, DOI 10.1242/jcs.174631; Hsieh YF, 2011, APPL OPTICS, V50, P6198, DOI 10.1364/AO.50.006198; Jahn B, 1997, INFECT IMMUN, V65, P5110, DOI 10.1128/IAI.65.12.5110-5117.1997; James ER, 2002, CELL DEATH DIFFER, V9, P355, DOI 10.1038/sj.cdd.4400986; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kamruzzaman M, 2015, ANAL CHIM ACTA, V853, P19, DOI 10.1016/j.aca.2014.08.043; Kishishita T, 2016, NUCL INSTRUM METH A, V824, P417, DOI 10.1016/j.nima.2015.09.048; Kneas KA, 2001, COMP CONVENTIONAL CO, P89, DOI [10.1117/12.424540, DOI 10.1117/12.424540]; Knetsch R, 2009, VDI TAG 24 DTSCH FLA, P251; KOVACS AL, 1982, ACTA BIOL MED GER, V41, P125; Krachler AM, 2011, J CELL BIOL, V195, P1083, DOI 10.1083/jcb.201107132; Kriesel J, 2012, PROC SPIE, V8390, DOI 10.1117/12.918643; Krysko DV, 2008, METHOD ENZYMOL, V442, P307, DOI [10.1016/S0070-6879(08)01416-X, 10.1016/S0076-6879(08)01416-X]; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lee H, 2017, J SCI FOOD AGR, V97, P1084, DOI 10.1002/jsfa.7832; Leroux DF, 2015, HYPERSPECTRAL IMAGIN, DOI [10.1117/12.2184140, DOI 10.1117/12.2184140]; Li QL, 2008, CHINESE SCI BULL, V53, P1431, DOI 10.1007/s11434-008-0199-3; Litzka O, 1996, EUR J BIOCHEM, V238, P675, DOI 10.1111/j.1432-1033.1996.0675w.x; Lu GL, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.010901; Madejova J, 2003, VIB SPECTROSC, V31, P1, DOI 10.1016/S0924-2031(02)00065-6; Matsuyama S, 2000, CELL DEATH DIFFER, V7, P1155, DOI 10.1038/sj.cdd.4400779; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; Mendes-Giannini MJS, 2005, FEMS IMMUNOL MED MIC, V45, P383, DOI 10.1016/j.femsim.2005.05.014; Mendes-Giannini MJS, 2000, MED MYCOL, V38, P113, DOI 10.1080/mmy.38.s1.113.123; Millman KJ, 2011, COMPUT SCI ENG, V13, P9, DOI 10.1109/MCSE.2011.36; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Nilsson Cathrine, 2003, Methods Cell Sci, V25, P185; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Park JS, 2004, GLIA, V47, P9, DOI 10.1002/glia.20017; Perskvist N, 2002, J CELL SCI, V115, P1321; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Rajendran S., 2009, HYPERSPECTRAL REMOTE; Reiter M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr505; Serbina NV, 2009, J IMMUNOL, V183, P2678, DOI 10.4049/jimmunol.0803398; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; STURTEVANT J, 1992, J INFECT DIS, V166, P580, DOI 10.1093/infdis/166.3.580; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; TINGBEALL HP, 1995, ANN BIOMED ENG, V23, P666, DOI 10.1007/BF02584463; Tsien RY, 2005, FEBS LETT, V579, P927, DOI 10.1016/j.febslet.2004.11.025; Turra G, 2015, IEEE ENG MED BIO, P759, DOI 10.1109/EMBC.2015.7318473; Uhr JW, 2012, TRANSL RES, V159, P366, DOI 10.1016/j.trsl.2011.08.003; Vo-Dinh T, 2004, IEEE ENG MED BIOL, V23, P40; Volling K, 2007, FEMS MICROBIOL LETT, V275, P250, DOI 10.1111/j.1574-6968.2007.00883.x; Volling K, 2011, CELL MICROBIOL, V13, P1130, DOI 10.1111/j.1462-5822.2011.01605.x; Wagadarikar AA, 2009, OPT EXPRESS, V17, P6368, DOI 10.1364/OE.17.006368; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; WIESMANN UN, 1975, BIOCHEM BIOPH RES CO, V66, P1338, DOI 10.1016/0006-291X(75)90506-9; Yoon SC, 2015, J ELECTRON IMAGING, V24, DOI 10.1117/1.JEI.24.4.043008; Zhao YR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27790; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Ziph-Schatzberg L, 2015, COMPACT HIGH PERFORM, DOI [10.1117/12.2177564, DOI 10.1117/12.2177564]; Zyazin AS, 2015, PROC SPIE, V9412, DOI 10.1117/12.2081836	75	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163505	10.1371/journal.pone.0163505	http://dx.doi.org/10.1371/journal.pone.0163505			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727286	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504400008
J	Lassen, B; Janson, M; Viltrop, A; Neare, K; Hutt, P; Golovljova, I; Tummeleht, L; Jokelainen, P				Lassen, Brian; Janson, Marilin; Viltrop, Arvo; Neare, Kadi; Hutt, Pirje; Golovljova, Irina; Tummeleht, Lea; Jokelainen, Pikka			Serological Evidence of Exposure to Globally Relevant Zoonotic Parasites in the Estonian Population	PLOS ONE			English	Article							TOXOCARA INFECTION; TOXOPLASMA-GONDII; ECHINOCOCCUS-GRANULOSUS; RISK-FACTORS; SEROPREVALENCE; PREVALENCE; AUSTRIA; EASTERN; HEALTH; CANIS	We investigated Estonian population and its selected subgroups for serological evidence of exposure to Ascaris lumbricoides, Echinococcus spp., Taenia solium, Toxocara canis, Toxoplasma gondii, and Trichinella spiralis. Serum samples from 999 adults representing general population, 248 children aged 14-18, 158 veterinarians, 375 animal caretakers, and 144 hunters were tested for specific immunoglobulin G antibodies against the selected parasites using commercial enzyme immunoassays (ELISA). Sera yielding positive or twice grey zone Echinococcus spp, T. solium, T. canis, and T. spiralis results were subjected to western blot (WB) analysis. In the general population, based on the ELISA results, the A. lumbricoides seroprevalence was 12.7%, Echinococcus spp. seroprevalence was 3.3%, T. solium seroprevalence was 0.7%, T. canis seroprevalence was 12.1%, T. gondii seroprevalence was 55.8%, and T. spiralis seroprevalence was 3.1%. Ascaris lumbricoides seroprevalences were higher in children and in animal caretakers than in the general population, and T. canis seroprevalence was higher in animal caretakers than in the general population. Compared with the general population, Echinococcus spp. seroprevalence was higher in children. By contrast, T. gondii seroprevalence was higher in animal caretakers, and lower in children, than in the general population. In the general population, the WB-confirmed Echinococcus spp. seroprevalence was 0.5%, T. solium cysticercosis seroprevalence was 0.0%, Toxocara spp. seroprevalence was 14.5%, and Trichinella spp. seroprevalence was 2.7%. WB-confirmed Toxocara spp. seroprevalence was higher in animal caretakers than in the general population. We found serological evidence of exposure to zoonotic parasites in all tested groups. This calls for higher awareness of zoonotic parasitic infections in Estonia.	[Lassen, Brian; Janson, Marilin; Viltrop, Arvo; Neare, Kadi; Tummeleht, Lea; Jokelainen, Pikka] Estonian Univ Life Sci, Dept Basic Vet Sci & Populat Med, Inst Vet Med & Anim Sci, Tartu, Estonia; [Lassen, Brian] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Hutt, Pirje] Univ Tartu, Fac Med, Chair Med Microbiol & Virol, Inst Biomed & Translat Med, Tartu, Estonia; [Golovljova, Irina] Natl Inst Hlth Dev, Dept Virol, Tallinn, Estonia; [Jokelainen, Pikka] Univ Helsinki, Fac Vet Med, Helsinki, Finland	Estonian University of Life Sciences; University of Copenhagen; University of Tartu; National Institute for Health Development - Estonia; University of Helsinki	Lassen, B (corresponding author), Estonian Univ Life Sci, Dept Basic Vet Sci & Populat Med, Inst Vet Med & Anim Sci, Tartu, Estonia.; Lassen, B (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg C, Denmark.	brian.lassen@gmail.com	Lassen, Brian/G-8165-2012; Jokelainen, Pikka/U-7238-2019; Lassen, Brian/AAT-4451-2020	Jokelainen, Pikka/0000-0002-3035-5094; Lassen, Brian/0000-0002-1745-1516	Health Board of Estonia; European Regional Development Fund [TerVe 3.2.1002.11]; EKZE-SS; Estonian University of Life Sciences [M14143VLVP, 8P160014VLVP]; Estonian Science Foundation [ETF9433]	Health Board of Estonia; European Regional Development Fund(European Commission); EKZE-SS; Estonian University of Life Sciences; Estonian Science Foundation	The study was supported by the Health Board of Estonia, the European Regional Development Fund programme TerVe 3.2.1002.11. project EKZE-SS, project funding M14143VLVP from the Strategic Development Fund of the Estonian University of Life Sciences, the Estonian Science Foundation grant ETF9433, and Base Financing of Estonian University of Life Sciences, project funding 8P160014VLVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birgisdottir A, 2006, SCAND J INFECT DIS, V38, P625, DOI 10.1080/00365540600606556; Boelaert F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3991; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; Dean AG, 2015, OPENEPI OPEN SOURCE; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; Deutz A, 2003, BERL MUNCH TIERARZTL, V116, P306; Devleesschauwer B, 2017, ACTA TROP, V165, P96, DOI 10.1016/j.actatropica.2015.08.006; Esch KJ, 2013, CLIN MICROBIOL REV, V26, P58, DOI 10.1128/CMR.00067-12; Estonian Veterinary Board, 2016, REG LIC VET; European Food Safety Authority (EFSA), BIOL HAZ REP; FAO/WHO, 2014, MICR RISK ASS SER, P1; Fotiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037112; Gutierrez MP, 2003, ENFERM INFEC MICR CL, V21, P563, DOI 10.1157/13054549; HAVASIOVA K, 1993, J HELMINTHOL, V67, P291, DOI 10.1017/S0022149X00013298; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Health Board, 2015, NAKK EEST 2011 2015; Health Board, 2015, NAKK EEST 1999 2005; Health Board, 2015, NAKK EEST 2006 2010; Jogiste A, 2000, COMMUNICABLE DIS STA, V96; Jokelainen P, 2016, ANN M SOC VET EP PRE; Jokelainen P, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0133-z; Karssin A, 2016, VECTOR-BORNE ZOONOT, V16, P604, DOI 10.1089/vbz.2016.1943; Kilic Selcuk, 2007, Turkiye Parazitoloji Dergisi, V31, P109; Kinross P, 2015, EPIDEMIOL INFECT, V143, P2748, DOI 10.1017/S0950268814003318; Kroten A, 2016, PARASITOL RES, V115, P205, DOI 10.1007/s00436-015-4736-0; Lassen B, 2014, SVEPM 2014; Lassen B, 2016, VECTOR-BORNE ZOONOT, V16, P212, DOI 10.1089/vbz.2015.1895; Lassen B, 2009, VET PARASITOL, V166, P212, DOI 10.1016/j.vetpar.2009.08.022; Laurimaa L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0796-3; LJUNGSTROM I, 1989, SCAND J INFECT DIS, V21, P87, DOI 10.3109/00365548909035685; Malafiej E, 2001, Wiad Parazytol, V47, P585; Marcinkute A, 2015, VET PARASITOL, V213, P121, DOI 10.1016/j.vetpar.2015.07.032; Moks E, 2006, J WILDLIFE DIS, V42, P359, DOI 10.7589/0090-3558-42.2.359; Moller LN, 2010, EPIDEMIOL INFECT, V138, P1252, DOI 10.1017/S0950268810000282; Must K, 2015, VECTOR-BORNE ZOONOT, V15, P597, DOI 10.1089/vbz.2015.1809; Nicoletti A, 2008, EPILEPSIA, V49, P594, DOI 10.1111/j.1528-1167.2007.01432.x; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Pehk R., 1994, EESTI ARST, V1, P20; Pinelli E, 2011, EUR J CLIN MICROBIOL, V30, P873, DOI 10.1007/s10096-011-1170-9; Poeppl W, 2013, VECTOR-BORNE ZOONOT, V13, P798, DOI 10.1089/vbz.2012.1283; Ross RD, 2001, RETINA-J RET VIT DIS, V21, P226, DOI 10.1097/00006982-200106000-00005; Sergeant E., EPITOOLS EPIDEMIOLOG; Statistics Estonia, 2015, PH193 INC SEL REG IN; Statistics Estonia, 2015, PO021 POP SEX AG GRO; Stensvold CR, 2009, CLIN VACCINE IMMUNOL, V16, P1372, DOI 10.1128/CVI.00234-09; Talvik H, 2006, ACTA VET HUNG, V54, P399, DOI 10.1556/AVet.54.2006.3.10; Tappe D, 2008, CLIN VACCINE IMMUNOL, V15, P1633, DOI 10.1128/CVI.00272-08; Torgerson PR, 2013, VET PARASITOL, V195, P223, DOI 10.1016/j.vetpar.2013.04.004; Valdmann H, 2004, J WILDLIFE DIS, V40, P356, DOI 10.7589/0090-3558-40.2.356; Villena I, 2010, EUROSURVEILLANCE, V15, P14; Weese JS, 2002, CAN VET J, V43, P799; World Health Organization, 2015, WHO EST GLOB BURD FO, P255; Zammarchi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069537; Zukiewicz-Sobczak W, 2014, ANN AGR ENV MED, V21, P767, DOI 10.5604/12321966.1129930	55	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164142	10.1371/journal.pone.0164142	http://dx.doi.org/10.1371/journal.pone.0164142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723790	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504100024
J	Tahden, M; Manitz, J; Baumgardt, K; Fell, G; Kneib, T; Hegasy, G				Tahden, Maike; Manitz, Juliane; Baumgardt, Klaus; Fell, Gerhard; Kneib, Thomas; Hegasy, Guido			Epidemiological and Ecological Characterization of the EHEC O104: H4 Outbreak in Hamburg, Germany, 2011	PLOS ONE			English	Article							RISK-FACTORS	In 2011, a large outbreak of entero-hemorrhagic E. coli (EHEC) and hemolytic uremic syndrome (HUS) occurred in Germany. The City of Hamburg was the first focus of the epidemic and had the highest incidences among all 16 Federal States of Germany. In this article, we present epidemiological characteristics of the Hamburg notification data. Evaluating the epicurves retrospectively, we found that the first epidemiological signal of the outbreak, which was in form of a HUS case cluster, was received by local health authorities when already 99 EHEC and 48 HUS patients had experienced their first symptoms. However, only two EHEC and seven HUS patients had been notified. Middle-aged women had the highest risk for contracting the infection in Hamburg. Furthermore, we studied timeliness of case notification in the course of the outbreak. To analyze the spatial distribution of EHEC/HUS incidences in 100 districts of Hamburg, we mapped cases' residential addresses using geographic information software. We then conducted an ecological study in order to find a statistical model identifying associations between local socio-economic factors and EHEC/HUS incidences in the epidemic. We employed a Bayesian Poisson model with covariates characterizing the Hamburg districts as well as incorporating structured and unstructured spatial effects. The Deviance Information Criterion was used for stepwise variable selection. We applied different modeling approaches by using primary data, transformed data, and preselected subsets of transformed data in order to identify socioeconomic factors characterizing districts where EHEC/HUS outbreak cases had their residence.	[Tahden, Maike] Leibniz Inst Prevent Res & Epidemiol BIPS, Biometry & Data Management, Bremen, Germany; [Tahden, Maike] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany; [Tahden, Maike] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, Oldenburg, Germany; [Manitz, Juliane] Univ Gottingen, Dept Stat & Econometr, Gottingen, Germany; [Baumgardt, Klaus] Inst Hyg & Umwelt, Div Environm Monitoring, Hamburg, Germany; [Fell, Gerhard; Hegasy, Guido] Inst Hyg & Umwelt, Ctr Infect Dis Epidemiol, Hamburg, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS); Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; University of Gottingen	Hegasy, G (corresponding author), Inst Hyg & Umwelt, Ctr Infect Dis Epidemiol, Hamburg, Germany.	hegasy@gmx.de		Kneib, Thomas/0000-0003-3390-0972	German Research Association (DFG), Research Training Group "Scaling Problems in Statistics" [RTG1644]; Cluster of Excellence "Hearing4all"	German Research Association (DFG), Research Training Group "Scaling Problems in Statistics"; Cluster of Excellence "Hearing4all"	This research was partly funded by the German Research Association (DFG), Research Training Group "Scaling Problems in Statistics" (RTG1644), http://www.unigoettingen.de/de/156602.html#interdis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist. There was no additional external funding received for this study.; We would like to thank the seven Local Health Departments of Hamburg for their cooperation in this project. Furthermore, we thank Havard Rue for comments and suggestions on the use of INLA. We thank Nicole Bollinger for proofreading of the manuscript. Finally, MT would like to thank the Cluster of Excellence "Hearing4all" for their support.	Altmann M, 2011, EMERG INFECT DIS, V17, P1906, DOI 10.3201/eid1710.111027; Askar M, 2011, EURO SURVEILL   0602, P16; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Corner RJ, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-13; Faensen D, 2006, Euro Surveill, V11, P7, DOI 10.2807/esm.11.04.00614-en; Federal Ministry of Justice, 2000, GES VERH BEK INF BEI; Federal Ministry of Justice, 2013, GES DURCHF INT GES 2; Frank C, 2011, EURO SURVEILL, V16; Frank C, 2014, EURO SURVEILL, P19; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Hauri A, 2011, EURO SURVEILL, P16; Lindgren F, 2015, J STAT SOFTWARE, V63; Manitz Juliane, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.f3fdeb08c5b9de7c09ed9cbcef5f01f2; Myers WP, 2006, AM J PUBLIC HEALTH, V96, P685, DOI 10.2105/AJPH.2004.048132; Pardhan-Ali A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-63; Robert Koch-Institut, 2011, BER ABSCH DARST BEW; Robert Koch-Institut, 2014, SURVSTAT RKI 2 0; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schrodle B, 2011, COMPUTATION STAT, V26, P241, DOI 10.1007/s00180-010-0208-2; SCHWARTZ S, 1994, AM J PUBLIC HEALTH, V84, P819, DOI 10.2105/AJPH.84.5.819; Sorbye SH, 2014, SPAT STAT-NETH, V8, P39, DOI 10.1016/j.spasta.2013.06.004; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Statistisches Amt fur Hamburg und Schleswig-Holstein, 2011, HAMB STADTT PROF 201; Tan NX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019648; Weisent J, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-45; Wilking H, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-37; YATES F., 1933, EMPIRE JOUR EXP AGRIC, V1, P129	28	7	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164508	10.1371/journal.pone.0164508	http://dx.doi.org/10.1371/journal.pone.0164508			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723830	Green Published, Green Accepted, gold			2022-12-27	WOS:000385504100069
J	Qumar, M; Khiaosa-ard, R; Pourazad, F; Wetzels, SU; Klevenhusen, F; Kandler, W; Aschenbach, JR; Zebeli, Q				Qumar, Muhammad; Khiaosa-ard, Ratchaneewan; Pourazad, Fouled; Wetzels, Stefanie U.; Klevenhusen, Fenja; Kandler, Wolfgang; Aschenbach, Joerg R.; Zebeli, Qendrim			Evidence of In Vivo Absorption of Lactate and Modulation of Short Chain Fatty Acid Absorption from the Reticulorumen of Non-Lactating Cattle Fed High Concentrate Diets	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; EPITHELIAL BLOOD-FLOW; BEEF-CATTLE; DAIRY-COWS; GASTROINTESTINAL-TRACT; MAGNESIUM ABSORPTION; WASHED RETICULORUMEN; RUMEN FERMENTATION; FEED RESTRICTION; INTRARUMINAL PH	Short-chain fatty acids (SCFAs) and lactate are endproducts of rumen fermentation and important energy sources for the host ruminant. Because their rapid accumulation results in ruminal acidosis, enhancement of the absorption of SCFA and lactate across reticuloruminal wall is instrumental in increasing energy supply and preventing ruminal acidosis in cattle. This study investigated whether the reticuloruminal absorption of SCFAs and lactate was altered by different strategies of high concentrate feeding. Eight rumen-cannulated, non-lactating Holstein cows were fed a forage-only diet (baseline) and then gradually adapted over 6 d to a 60% concentrate level. Thereafter, this concentrate-rich diet was fed for 4 wk either continuously (Con; n = 8) or interruptedly (Int; n = 8). Absorption of SCFAs and lactate was determined in vivo from the experimental buffer introduced into the washed reticulorumen. The buffer contained acetate, propionate, butyrate and lactate at a concentration of 60, 30, 10 and 5 mmol/L, respectively and Cr-EDTA as a marker for correcting ruminal water fluxes. The reticuloruminal absorption after 35 and 65 min of buffer incubation was measured at the baseline, after 1 wk of 60% concentrate feeding in the interrupted model (Int-1) and after 4 wk of concentrate feeding in both feeding models (Int-4 and Con4). Data showed that the absorption rates of individual and total SCFAs during the first 35 min of incubation of Con-4 were highest (similar to 1.7 times compared to baseline), while Int-1 and Int-4 were similar to respective baseline. Lactate was not absorbed during forage-only baseline and 1-wk concentrate feeding, but after 4-wk feeding of concentrates in both models. In conclusion, SCFAs absorption across the reticulorumen of non-lactating cattle was enhanced by the 4-wk continuous concentrate feeding, which seems to be more advantageous in terms of rumen acidosis prevention compared to the interrupted feeding model.The study provides evidence of lactate absorption across the reticulorumen of non-lactating cattle after both continuous and interrupted 4-wk concentrate feeding.	[Qumar, Muhammad; Khiaosa-ard, Ratchaneewan; Pourazad, Fouled; Wetzels, Stefanie U.; Klevenhusen, Fenja; Zebeli, Qendrim] Univ Vet Med Vienna, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Wetzels, Stefanie U.] Univ Vet Med Vienna, Inst Milk Hyg Milk Technol & Food Sci, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Kandler, Wolfgang] Univ Nat Resources & Life Sci Vienna, Dept Agrobiotechnol, IFA Tulin, Ctr Analyt Chem, Tulin, Austria; [Aschenbach, Joerg R.] Free Univ Berlin, Inst Vet Physiol, Berlin, Germany	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; Free University of Berlin	Zebeli, Q (corresponding author), Univ Vet Med Vienna, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	Qendrim.Zebeli@vetmeduni.ac.at	Aschenbach, Joerg R/R-7572-2016; Khiaosa-ard, Ratchaneewan/Y-1733-2019	Aschenbach, Joerg R/0000-0001-5080-1007; Khiaosa-ard, Ratchaneewan/0000-0003-3359-5787; Klevenhusen, Fenja/0000-0001-6015-5459	Vienna Science and Technology Fund (WWTF) through project "D-I.INFLACOW" [LS12-010]; Higher Education Commission of Pakistan	Vienna Science and Technology Fund (WWTF) through project "D-I.INFLACOW"; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	Funding for this research was provided by Vienna Science and Technology Fund (WWTF) through project "D-I.INFLACOW, LS12-010". MQ was supported by a doctoral fellowship of the Higher Education Commission of Pakistan, which is highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albornoz RI, 2013, J ANIM SCI, V91, P4730, DOI 10.2527/jas.2012-6223; Aschenbach JR, 2011, J ANIM SCI, V89, P1092, DOI 10.2527/jas.2010-3301; Aschenbach JR, 2009, AM J PHYSIOL-GASTR L, V296, pG1098, DOI 10.1152/ajpgi.90442.2008; Bannink A, 2008, ANIM FEED SCI TECH, V143, P3, DOI 10.1016/j.anifeedsci.2007.05.002; Bannink A, 2012, ANIM FEED SCI TECH, V172, P80, DOI 10.1016/j.anifeedsci.2011.12.010; Benesch F, 2014, AM J PHYSIOL-REG I, V307, pR1428, DOI 10.1152/ajpregu.00408.2013; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; CARE AD, 1984, Q J EXP PHYSIOL CMS, V69, P577, DOI 10.1113/expphysiol.1984.sp002844; Dengler F, 2015, J ANIM PHYSIOL AN N, V99, P379, DOI 10.1111/jpn.12201; Ding Z, 1998, AUST J AGR RES, V49, P293, DOI 10.1071/A97077; Dirksen GU, 1985, BOVINE PRACT, P116, DOI 10.21423/bovine-vol1985no20p116-120; Dohme F, 2008, J DAIRY SCI, V91, P3554, DOI 10.3168/jds.2008-1264; Etschmann B, 2009, ARCH ANIM NUTR, V63, P26, DOI 10.1080/17450390802506885; Ewaschuk JB, 2005, J NUTR, V135, P1619, DOI 10.1093/jn/135.7.1619; Foote AP, 2013, J ANIM SCI, V91, P5366, DOI 10.2527/jas.2013-6517; GAEBEL G, 1987, Q J EXP PHYSIOL CMS, V72, P501, DOI 10.1113/expphysiol.1987.sp003092; HARMON DL, 1985, J ANIM SCI, V60, P560, DOI 10.2527/jas1985.602560x; HUNTINGTON GB, 1980, J NUTR, V110, P1904, DOI 10.1093/jn/110.9.1904; Khiaosa-ard R, 2014, LIVEST SCI, V162, P66, DOI 10.1016/j.livsci.2014.01.005; Kirat D, 2007, GENE, V391, P140, DOI 10.1016/j.gene.2006.12.020; Kleen JL, 2012, ANIM FEED SCI TECH, V172, P4, DOI 10.1016/j.anifeedsci.2011.12.003; Krause KM, 2006, ANIM FEED SCI TECH, V126, P215, DOI 10.1016/j.anifeedsci.2005.08.004; Malhi M, 2013, J DAIRY SCI, V96, P7603, DOI 10.3168/jds.2013-6700; Metzler-Zebeli BU, 2013, J ANIM SCI, V91, P4256, DOI 10.2527/jas.2012-5570; Muller F, 2002, AM J PHYSIOL-GASTR L, V283, pG1139, DOI 10.1152/ajpgi.00268.2001; Penner GB, 2009, J DAIRY SCI, V92, P2767, DOI 10.3168/jds.2008-1716; Penner GB, 2009, J NUTR, V139, P1714, DOI 10.3945/jn.109.108506; Pourazad P, 2016, J ANIM SCI, V94, P726, DOI 10.2527/jas.2015-9605; Qiu X, 2004, J DAIRY SCI, V87, P3473, DOI 10.3168/jds.S0022-0302(04)73482-7; Schurmann BL, 2014, AM J PHYSIOL-REG I, V307, pR802, DOI 10.1152/ajpregu.00035.2014; Schwaiger T, 2013, J ANIM SCI, V91, P5743, DOI 10.2527/jas.2013-6472; Steele MA, 2016, J DAIRY SCI, V99, P4955, DOI 10.3168/jds.2015-10351; Steele MA, 2011, AM J PHYSIOL-REG I, V300, pR1515, DOI 10.1152/ajpregu.00120.2010; Storm AC, 2011, J DAIRY SCI, V94, P3980, DOI 10.3168/jds.2010-4091; WILLIAMS VJ, 1965, AUST J BIOL SCI, V18, P917, DOI 10.1071/BI9650917; Zebeli Q, 2012, RES VET SCI, V93, P1099, DOI 10.1016/j.rvsc.2012.02.004; Zhang S, 2013, J ANIM SCI, V91, P1696, DOI 10.2527/jas.2012-5774	37	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164192	10.1371/journal.pone.0164192	http://dx.doi.org/10.1371/journal.pone.0164192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716806	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100031
J	Verger, E; Drion, P; Meffre, G; Bernard, C; Duwez, L; Lepareur, N; Couturier, O; Hindre, F; Hustinx, R; Lacoeuille, F				Verger, Elise; Drion, Pierre; Meffre, Genevieve; Bernard, Claire; Duwez, Luc; Lepareur, Nicolas; Couturier, Olivier; Hindre, Francois; Hustinx, Roland; Lacoeuille, Franck			Ga-68 and Re-188 Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RADIATION-THERAPY; LIVER-CANCER; Y-90 RADIOEMBOLIZATION; MICROSPHERES; MANAGEMENT; TECHNETIUM; CHEMISTRY; DELIVERY; HYPOXIA	Purpose This work aims to develop, validate and optimize the radiolabeling of Starch-Based Microparticles (SBMP) by Re-188 and Ga-68 in the form of ready-to-use radiolabeling kits, the ultimate goal being to obtain a unique theranostic vector for the treatment of Hepatocellular Carcinoma. Methods Optimal labeling conditions and composition of freeze-dried kits were defined by monitoring the radiochemical purity while varying several parameters. In vitro stability studies were carried out, as well as an in vivo biodistribution as a preliminary approach with the intra-arterial injection of Ga-68 radiolabeled SBMP into the hepatic artery of DENA-induced rats followed by PET/CT imaging. Results Kits were optimized for Re-188 and Ga-68 with high and stable radiochemical purity (>95% and >98% respectively). The in vivo preliminary study was successful with more than 95% of activity found in the liver and mostly in the tumorous part. Conclusion SBMP are a promising theranostic agent for the Selective Internal Radiation Therapy of Hepatocellular carcinoma.	[Verger, Elise; Hindre, Francois; Lacoeuille, Franck] Univ Angers, INSERM, UMR S MINT Micro & Nanomed Biomimet 1066, Angers, France; [Verger, Elise; Meffre, Genevieve; Bernard, Claire; Hustinx, Roland] Univ Liege, CHU Liege, Dept Nucl Med, Liege, Belgium; [Drion, Pierre; Duwez, Luc] Univ Liege, GIGA R & Credec, Anim Facil, Expt Surg, Liege, Belgium; [Lepareur, Nicolas] INSERM, Ctr Lutte Canc CLCC Eugene Marquis, Dept Nucl Med, U991, Rennes, France; [Couturier, Olivier; Lacoeuille, Franck] Univ Angers, CHU Angers, Dept Nucl Med, Angers, France; [Hindre, Francois; Lacoeuille, Franck] Univ Angers, PRIMEX Plateforme Radiobiol & IMagerie EXperiment, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Liege; University of Liege; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers	Verger, E (corresponding author), Univ Angers, INSERM, UMR S MINT Micro & Nanomed Biomimet 1066, Angers, France.; Verger, E (corresponding author), Univ Liege, CHU Liege, Dept Nucl Med, Liege, Belgium.	elise.verger@univ-angers.fr	Lepareur, Nicolas/N-8914-2019; Lepareur, Nicolas/K-7174-2018; LACOEUILLE, Franck/K-4430-2015	Lepareur, Nicolas/0000-0001-9860-5451; Lepareur, Nicolas/0000-0001-9860-5451; LACOEUILLE, Franck/0000-0002-7070-7664; couturier, olivier-francois/0000-0002-4900-7807; Hindre, Francois/0000-0002-2727-7996	Ministere de l'Enseignement Superieur et de la Recherche; French National Agency for Research called "Investissements d'Avenir" Labex IRON [ANR-11-LABX-0018-01]	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); French National Agency for Research called "Investissements d'Avenir" Labex IRON(French National Research Agency (ANR))	This work has been supported by a grant from the Ministere de l'Enseignement Superieur et de la Recherche in the frame of the Erasmus Mundus Joint Doctorate NanoFar program (EV); and has been supported in part by a grant from the French National Agency for Research called "Investissements d'Avenir" Labex IRON noANR-11-LABX-0018-01 (FH, FL, OC). This work was authorized by Laboratoires Cyclopharma, through patent WO2009013358. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram U, 2006, J BRAZIL CHEM SOC, V17, P1486, DOI 10.1590/S0103-50532006000800004; ACKERMAN NB, 1972, CANCER, V29, P435, DOI 10.1002/1097-0142(197202)29:2<435::AID-CNCR2820290227>3.0.CO;2-K; Ahmadzadehfar H, 2012, EUR J NUCL MED MOL I, V39, P309, DOI 10.1007/s00259-011-1940-8; Ahmadzadehfar H, 2010, SEMIN NUCL MED, V40, P105, DOI 10.1053/j.semnuclmed.2009.11.001; [Anonymous], 2002, CHEM TECHNOL, V2, P235, DOI [10.2298/FUPCT020435V, DOI 10.2298/FUPCT0204235V]; Bal C S, 2008, Trop Gastroenterol, V29, P62; Blake P, 2003, J NEURO-OPHTHALMOL, V23, P34, DOI 10.1097/00041327-200303000-00009; Boschi A, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/529406; BREEDIS C, 1954, AM J PATHOL, V30, P969; Bult W, 2009, Q J NUCL MED MOL IM, V53, P325; Chegai F, 2015, HEPAT ONCOL, V2, P397, DOI 10.2217/hep.15.32; Chen G, 2012, EXP THER MED, V3, P285, DOI 10.3892/etm.2011.406; Dadachova E, 1997, NUCL MED BIOL, V24, P605, DOI 10.1016/S0969-8051(97)00079-6; Denizot B, 2007, Patent No. [WO2009013358, 2009013358]; DEUTSCH E, 1986, NUCL MED BIOL, V13, P465, DOI 10.1016/0883-2897(86)90027-9; DiFilippo FP, 2012, MOL IMAGING, V11, P210, DOI 10.2310/7290.2011.00041; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Elschot M, 2014, EUR J NUCL MED MOL I, V41, P1965, DOI 10.1007/s00259-014-2784-9; European Pharmacopeia, 2010, EUR DIR QUAL MED; Fani M, 2008, CONTRAST MEDIA MOL I, V3, P53, DOI 10.1002/cmmi.232; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fournier LS, 2004, EUR RADIOL, V14, P2125, DOI 10.1007/s00330-004-2339-8; Giammarile F, 2011, EUR J NUCL MED MOL I, V38, P1393, DOI 10.1007/s00259-011-1812-2; Gupta T, 2008, RADIOLOGY, V249, P845, DOI 10.1148/radiol.2491072027; Hamoudeh M, 2008, ADV DRUG DELIVER REV, V60, P1329, DOI 10.1016/j.addr.2008.04.013; Harrison L, 2004, ONCOLOGIST, V9, P31, DOI 10.1634/theoncologist.9-90005-31; Harrison LB, 2002, ONCOLOGIST, V7, P492, DOI 10.1634/theoncologist.7-6-492; Ilhan H, 2015, J NUCL MED, V56, P1654, DOI 10.2967/jnumed.115.162685; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Knapp FR, 2014, THERAPEUTIC NUCL MED, P51, DOI [10.1007/174_2012_669.8892/etm.2011.406, DOI 10.1007/174_2012_6693892/ETM.2011.406]; Lacoeuille F, 2011, BIOMATERIALS, V32, P7999, DOI 10.1016/j.biomaterials.2011.07.007; Lacoeuille F, 2010, EUR J NUCL MED MOL I, V37, P146, DOI 10.1007/s00259-009-1226-6; Lee Y-S, 2014, THERAPEUTIC NUCL MED, P151, DOI 10.1007/174_2012_704; Lepareur N, 2004, J LABELLED COMPD RAD, V47, P857, DOI 10.1002/jlcr.863; Lewandowski Robert J, 2006, Semin Intervent Radiol, V23, P64, DOI 10.1055/s-2006-939842; Lewandowski RJ, 2009, J VASC INTERV RADIOL, V20, P1557, DOI 10.1016/j.jvir.2009.08.021; Lhommel R, 2009, EUR J NUCL MED MOL I, V36, P1696, DOI 10.1007/s00259-009-1210-1; Liu YF, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-107; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Maida M, 2014, WORLD J GASTROENTERO, V20, P4141, DOI 10.3748/wjg.v20.i15.4141; Mazzoccoli G, 2016, CLIN EXP MED, V16, P243, DOI 10.1007/s10238-015-0368-z; Murthy R, 2006, Biomed Imaging Interv J, V2, pe43, DOI 10.2349/biij.2.3.e43; Murthy R, 2005, RADIOGRAPHICS, V25, pS41, DOI 10.1148/rg.25si055515; Padia SA, 2013, J VASC INTERV RADIOL, V24, P1147, DOI 10.1016/j.jvir.2013.04.018; Parvinian A, 2014, DIAGN INTERV RADIOL, V20, P335, DOI 10.5152/dir.2014.13415; Prompers L, 2011, METHODS, V55, P253, DOI 10.1016/j.ymeth.2011.09.014; Quirk M, 2015, WORLD J GASTROENTERO, V21, P3462, DOI 10.3748/wjg.v21.i12.3462; Raoul JL, 2010, NAT REV GASTRO HEPAT, V7, P41, DOI 10.1038/nrgastro.2009.202; Ro E sch F, 2013, J POSTGRAD MED ED RE, V47, P18, DOI [10.5005/jp-journals-10028-1052, DOI 10.5005/JP-JOURNALS-10028-1052]; Roesch F, 2010, CURR TOP MED CHEM, V10, P1633, DOI 10.2174/156802610793176738; Salem R, 2006, J VASC INTERV RADIOL, V17, P1251, DOI 10.1097/01.RVI.0000233785.75257.9A; Sangro B, 2012, J HEPATOL, V56, P464, DOI 10.1016/j.jhep.2011.07.012; Saraswat VA, 2014, J CLIN EXP HEPATOL, V4, pS80, DOI 10.1016/j.jceh.2014.05.004; Sato K, 2006, CARDIOVASC INTER RAD, V29, P522, DOI 10.1007/s00270-005-0171-4; Song YS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000945; Tabrizian P, 2014, WORLD J GASTROENTERO, V20, P10223, DOI 10.3748/wjg.v20.i30.10223; Vanpouille-Box C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016926; Velikyan I, 2015, MOLECULES, V20, P12913, DOI 10.3390/molecules200712913; Velikyan I, 2014, THERANOSTICS, V4, P47, DOI 10.7150/thno.7447; Vesselle G, 2015, DIAGN INTERV IMAG, V96, P547, DOI 10.1016/j.diii.2014.03.014; Vilarinho Silvia, 2015, Curr Treat Options Gastroenterol, V13, P219, DOI 10.1007/s11938-015-0049-8; Vouche M, 2011, J NUCL MED RAD THER, V2, P1, DOI [10.4172/2155-9619.1000113, DOI 10.4172/2155-9619.1000113]; Wondergem M, 2013, J NUCL MED, V54, P1294, DOI 10.2967/jnumed.112.117614	64	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164626	10.1371/journal.pone.0164626	http://dx.doi.org/10.1371/journal.pone.0164626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741267	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000047
J	Crampton, WGR; de Santana, CD; Waddell, JC; Lovejoy, NR				Crampton, William G. R.; de Santana, Carlos David; Waddell, Joseph C.; Lovejoy, Nathan R.			Phylogenetic Systematics, Biogeography, and Ecology of the Electric Fish Genus Brachyhypopomus (Ostariophysi: Gymnotiformes)	PLOS ONE			English	Article							FRESH-WATER FISHES; HISTORICAL BIOGEOGRAPHY; SIGNAL DIVERSITY; ORGAN DISCHARGES; AMAZON BASIN; HYPOPOMIDAE; TELEOSTEI; EVOLUTION; STERNOPYGIDAE; RIVER	A species-level phylogenetic reconstruction of the Neotropical bluntnose knifefish genus Brachyhypopomus (Gymnotiformes, Hypopomidae) is presented, based on 60 morphological characters, approximately 1100 base pairs of the mitochondrial cytb gene, and approximately 1000 base pairs of the nuclear rag2 gene. The phylogeny includes 28 species of Brachyhypopomus and nine outgroup species from nine other gymnotiform genera, including seven in the superfamily Rhamphichthyoidea (Hypopomidae and Rhamphichthyidae). Parsimony and Bayesian total evidence phylogenetic analyses confirm the monophyly of the genus, and identify nine robust species groups. Homoplastic osteological characters associated with diminutive body size and occurrence in small stream habitats, including loss of squamation and simplifications of the skeleton, appear to mislead a phylogenetic analysis based on morphological characters alone-resulting in the incorrect placing of Microsternarchus + Racenisia in a position deeply nested within Brachyhypopomus. Consideration of geographical distribution in light of the total evidence phylogeny indicates an origin for Brachyhypopomus in Greater Amazonia (the superbasin comprising the Amazon, Orinoco and major Guiana drainages), with subsequent dispersal and vicariance in peripheral basins, including the La Plata, the Sao Francisco, and trans-Andean basins of northwest South America and Central America. The ancestral habitat of Brachyhypopomus likely resembled the normoxic, low-conductivity terra firme stream system occupied by many extant species, and the genus has subsequently occupied a wide range of terra firme and floodplain habitats including low-and high-conductivity systems, and normoxic and hypoxic systems. Adaptations for impedance matching to high conductivity, and/or for air breathing in hypoxic systems have attended these habitat transitions. Several species of Brachyhypopomus are eurytopic with respect to habitat occupancy and these generally exhibit wider geographical ranges than stenotopic species.	[Crampton, William G. R.; de Santana, Carlos David; Waddell, Joseph C.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Lovejoy, Nathan R.] Univ Toronto Scarborough, Dept Biol Sci, 1265 Mil Trail, Toronto, ON, Canada; [de Santana, Carlos David] Smithsonian Inst, Natl Museum Nat Hist, Div Fishes, Washington, DC 20560 USA	State University System of Florida; University of Central Florida; University of Toronto; University Toronto Scarborough; Smithsonian Institution; Smithsonian National Museum of Natural History	Crampton, WGR (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	crampton@uct.edu	Crampton, William/AAP-3608-2020	Waddell, Joseph/0000-0003-4397-0704	United States National Science Foundation [DEB-0215388, DEB-0614334, DEB-1146374]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil [CNPq 38062/96-2, 381597/97-0]; Ministerio de Ciencia e Tecnologia - Brazil; Instituto de Desenvolvimento Sustentavel Mamiraua - Brazil; Fisheries Society of the British Isles - UK; Crampton Lab (via startup funds from UCF); National Geographic Young Explorers grant [9048-11]; Canadian National Science and Engineering Reseach Council (NSERC) Discovery grants; NSF [DEB-0614334, DEB-1146374]; Direct For Biological Sciences [1146374] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio de Ciencia e Tecnologia - Brazil; Instituto de Desenvolvimento Sustentavel Mamiraua - Brazil; Fisheries Society of the British Isles - UK; Crampton Lab (via startup funds from UCF); National Geographic Young Explorers grant(National Geographic Society); Canadian National Science and Engineering Reseach Council (NSERC) Discovery grants; NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	WGRC was funded by United States National Science Foundation grants DEB-0215388, DEB-0614334, and DEB-1146374 (and supplements), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil (recem doutorado fellowship and grants CNPq 38062/96-2 & 381597/97-0), Ministerio de Ciencia e Tecnologia - Brazil, Instituto de Desenvolvimento Sustentavel Mamiraua - Brazil, and Fisheries Society of the British Isles - UK. CDS was funded by a post-doctoral fellowship from the Crampton Lab (via startup funds to WGRC from UCF). JCW was funded by Research Assistantships from NSF DEB-1146374 and a National Geographic Young Explorers grant (9048-11). NRL was funded by Canadian National Science and Engineering Reseach Council (NSERC) Discovery grants and by sub awards from NSF grants DEB-0614334 and DEB-1146374.	Aguilera PA, 2001, J EXP BIOL, V204, P185; Albert JS, 2006, J S AM EARTH SCI, V21, P14, DOI 10.1016/j.jsames.2005.07.010; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert James S., 1998, P419; Albert JS, 1996, COPEIA, P85; Albert JS, 2001, MISC PUBL MUS ZOOL U; Albert JS., 2005, SYSTEM BIODIVERS, V4, P375, DOI DOI 10.1017/S1477200004001574; ALVESGOMES JA, 1995, MOL BIOL EVOL, V12, P298; [Anonymous], 1993, COMUNICACOES MUSEU Z, V6, P85; [Anonymous], 2014, TRACER V 1 6; Arnegard ME, 2010, P NATL ACAD SCI USA, V107, P22172, DOI 10.1073/pnas.1011803107; Arnegard ME, 2010, AM NAT, V176, P335, DOI 10.1086/655221; ARRATIA G, 1991, J MORPHOL, V208, P1, DOI 10.1002/jmor.1052080102; Arratia Gloria, 1995, Bonner Zoologische Monographien, V36, P1; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Buckup PA, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P203; Bullock TH, 2005, ELECTRORECEPTION; CARTER G. S., 1931, JOUR LINN SOC LONDON ZOOL, V37, P327; Carvalho T. P., 2013, THESIS; Carvalho TP, 2011, NEOTROP ICHTHYOL, V9, P457, DOI 10.1590/S1679-62252011000300001; Carvalho TP, 2011, HIST BIOGEOGRAPHY NE, P193; Chardon M., 1974, Ichthyologia, V6, P15; Chen WJ, 2013, EVOLUTION, V67, P2218, DOI 10.1111/evo.12104; Costa W. J. E. M., 1992, REV FRANCAISE AQUARI, V18, P117; Crampton WGR, 2013, J EXP BIOL, V216, P2523, DOI 10.1242/jeb.083261; Crampton W.G.R., 2006, COMMUNICATION FISHES, P647; Crampton W.G.R., 2007, FISH LIFE SPECIAL EN, P283; Crampton WGR, 2004, COPEIA, P245; Crampton WGR, 2004, COPEIA, P78, DOI 10.1643/CI-03-072RI; Crampton WGR, 1996, J FISH BIOL, V48, P298, DOI 10.1006/jfbi.1996.0029; Crampton WGR, 1998, J FISH BIOL, V53, P307, DOI 10.1111/j.1095-8649.1998.tb01034.x; Crampton WGR, 2006, COMMUNICATION FISHES, P697; Crampton WGR, 2008, ENVIRON BIOL FISH, V83, P223, DOI 10.1007/s10641-007-9325-3; Crampton William G.R., 2004, Ichthyological Exploration of Freshwaters, V15, P121; Crampton William G. R., 1998, Anais da Academia Brasileira de Ciencias, V70, P805; Crampton WGR, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P165; Crampton WGR, 2011, EVOLUTION, V65, P1650, DOI 10.1111/j.1558-5646.2011.01245.x; Crampton WGR, 2008, J PHYSIOL-PARIS, V102, P304, DOI 10.1016/j.jphysparis.2008.10.001; de la Hoz E., 1984, Bulletin de la Societe Royale des Sciences de Liege, V53, P9; de la Hoz E., 1975, Annales Sci nat (Zool Biol anim), V17, P121; De Santana CD, 2011, ZOOL J LINN SOC-LOND, V163, P1096, DOI 10.1111/j.1096-3642.2011.00736.x; Santana CD, 2013, ZOOL J LINN SOC-LOND, V168, P564, DOI 10.1111/zoj.12022; De Santana CD, 2010, ZOOL J LINN SOC-LOND, V159, P223, DOI 10.1111/j.1096-3642.2009.00588.x; DEPINNA MCC, 1991, CLADISTICS, V7, P367; Drummond AJ, GENEIOUS VER 5 5 6; Dutra GM, 2014, COPEIA, P345, DOI 10.1643/CI-13-066; Farris JS, 1995, CLADISTICS, V11, P377, DOI 10.1111/j.1096-0031.1995.tb00096.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandes CC, 2015, P ACAD NAT SCI PHILA, V164, P213, DOI 10.1635/053.164.0113; Fernandes CC, 2014, P ACAD NAT SCI PHILA, V163, P95, DOI 10.1635/053.163.0107; Fernandez-Yepez A, 1968, EVENCIAS, V20; Fernandez-Yepez A., 1972, ANALISIS ICTIOLOGICO; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Forsberg B, 2003, AMAZON HEADWATERS RI; Gavassa S, 2013, J EXP BIOL, V216, P2403, DOI 10.1242/jeb.082255; Giora J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106515; Hilton EL, 2007, P ACAD NAT SCI PHILA, V156, P1, DOI 10.1635/0097-3157(2007)156[1:ROOTBG]2.0.CO;2; HOPKINS CD, 1978, BEHAV ECOL SOCIOBIOL, V3, P113, DOI 10.1007/BF00294985; Hopkins CD, 1999, J EXP BIOL, V202, P1217; HOPKINS CD, 1974, AM SCI, V62, P426; HOPKINS CD, 1991, COPEIA, P151; Hubbell Stephen P., 2001, V32, pi; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulen KG, 2005, SYST BIODIVERS, V3, P407, DOI 10.1017/S1477200005001726; Jegu M, 1999, CR ACAD SCI III-VIE, V322, P1133, DOI 10.1016/S0764-4469(99)00113-4; Kaup J. J., 1856, CATALOGUE APODAL FIS, P124; Kramer B., 1981, SENSORY PHYSL AQUATI, P195, DOI DOI 10.1016/B978-0-08-027352-5.50018-5; Kullander SO, 1986, CICHLID FISHES AMAZO; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lavoue S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036287; Lima FCT, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P145; Loureiro M, 2006, COPEIA, P665; Lovejoy NR, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P405; Lovejoy NR, 2010, MOL PHYLOGENET EVOL, V54, P278, DOI 10.1016/j.ympev.2009.09.017; Lovejoy NR, 2000, MOL ECOL, V9, P259, DOI 10.1046/j.1365-294x.2000.00845.x; Lowe McConnell R. H., 1964, Journal of the Linnean Society London, V45, P103; Lujan NK, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P211; LUNDBERG JG, 1986, P ACAD NAT SCI PHILA, V138, P53; Lundberg John G., 1998, P13; Maddison WP., 2021, MESQUITE MODULAR SYS; Mago Leccia F., 1978, Acta Cientifica Venezolana Suplemento, V29, P1; Mago-Leccia F., 1985, CONTRIB SCI NAT HIST, V358, P1; Mago-Leccia F., 1994, ELECT FISHES CONTINE; Maldonado-Ocampo JA, 2014, ZOOL SCR, V43, P24, DOI 10.1111/zsc.12035; Markham MR, 2013, J EXP BIOL, V216, P2451, DOI 10.1242/jeb.082628; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pazin VFV, 2006, FRESHWATER BIOL, V51, P1025, DOI 10.1111/j.1365-2427.2006.01552.x; Pearson N. E., 1937, Proceedings of the California Academy of Sciences, V23, P99; Picq S, 2014, J BIOGEOGR, V41, P1520, DOI 10.1111/jbi.12309; Rambaut A., 2012, FIGTREE VERSION 1 4; Randall D., 1990, ELECTROCOMMUNICATION; Rangel-Pereira FS, 2014, VERTEBR ZOOL, V64, P169; Reis R., 2003, CHECK LIST FRESHWATE, P494; Ribeiro AC, 2006, NEOTROP ICHTHYOL, V4, P225, DOI 10.1590/S1679-62252006000200009; Rodriguez-Olarte D, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P243; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salazar VL, 2013, J EXP BIOL, V216, P2459, DOI 10.1242/jeb.082735; Schwassmann H.O., 1978, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V18, P521; Schwassmann H.O., 1978, P235; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Silva AC, 2013, J EXP BIOL, V216, P2412, DOI 10.1242/jeb.082180; Sorenson MD, 2007, TREEROT VER 3; Springer VG, 2000, COPEIA, P300, DOI 10.1643/0045-8511(2000)2000[0300:UAAOES]2.0.CO;2; Stoddard PK, 1999, J COMP PHYSIOL A, V184, P609, DOI 10.1007/s003590050359; Sullivan J. P., 1997, THESIS; Sullivan JP, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.327.5427; Tagliacollo VA, 2016, MOL PHYLOGENET EVOL, V95, P20, DOI 10.1016/j.ympev.2015.11.007; TAYLOR W R, 1985, Cybium, V9, P107; Triques Mauro L., 2003, Lundiana, V4, P61; Vari RP, 1988, NEOTROPICAL DISTRIBU, P313; Waddell JC, J PHYSL PAR IN PRESS; Peixoto LAW, 2015, ZOOL J LINN SOC-LOND, V175, P384, DOI 10.1111/zoj.12274; WEITZMAN S H, 1974, Bulletin of the American Museum of Natural History, V153, P327; WESTBY GWM, 1988, BEHAV ECOL SOCIOBIOL, V22, P341; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Winemiller KO, 2008, J BIOGEOGR, V35, P1551, DOI 10.1111/j.1365-2699.2008.01917.x; Winemiller KO, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P225; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801	123	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0161680	10.1371/journal.pone.0161680	http://dx.doi.org/10.1371/journal.pone.0161680			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736882	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800002
J	Kulikova, S; Hertz-Pannier, L; Dehaene-Lambertz, G; Poupon, C; Dubois, J				Kulikova, Sofya; Hertz-Pannier, Lucie; Dehaene-Lambertz, Ghislaine; Poupon, Cyril; Dubois, Jessica			A New Strategy for Fast MRI-Based Quantification of the Myelin Water Fraction: Application to Brain Imaging in Infants	PLOS ONE			English	Article							WHITE-MATTER; IN-VIVO; MAGNETIC-RESONANCE; RELAXATION-TIME; MULTIPLE-SCLEROSIS; T-2-ASTERISK DECAY; NERVOUS-SYSTEM; DIFFUSION; T-2; TISSUE	The volume fraction of water related to myelin (f(my)) is a promising MRI index for in vivo assessment of brain myelination, that can be derived from multi-component analysis of T1 and T2 relaxometry signals. However, existing quantification methods require rather long acquisition and/or post-processing times, making implementation difficult both in research studies on healthy unsedated children and in clinical examinations. The goal of this work was to propose a novel strategy for f(my) quantification within acceptable acquisition and post-processing times. Our approach is based on a 3-compartment model (myelin-related water, intra/extra-cellular water and unrestricted water), and uses calibrated values of inherent relaxation times (T1(c) and T2(c)) for each compartment c. Calibration was first performed on adult relaxometry datasets (N = 3) acquired with large numbers of inversion times (TI) and echo times (TE), using an original combination of a region contraction approach and a non-negative least-square (NNLS) algorithm. This strategy was compared with voxel-wise fitting, and showed robust estimation of T1(c) and T2(c). The accuracy of f(my) calculations depending on multiple factors was investigated using simulated data. In the testing stage, our strategy enabled fast f(my) mapping, based on relaxometry datasets acquired with reduced TI and TE numbers (acquisition <6 min), and analyzed with NNLS algorithm (post-processing <5min). In adults (N = 13, mean age 22.4 +/- 1.6 years), fmy maps showed variability across white matter regions, in agreement with previous studies. In healthy infants (N = 18, aged 3 to 34 weeks), asynchronous changes in fmy values were demonstrated across bundles, confirming the well-known progression of myelination.	[Kulikova, Sofya; Hertz-Pannier, Lucie] CEA, UNIACT, DRF, INSERM,U1129,Neurospin,I2BM, Gif Sur Yvette, France; [Kulikova, Sofya; Hertz-Pannier, Lucie] Univ Paris 05, Univ Paris Saclay, Sorbonne Paris Cite, Paris, France; [Dehaene-Lambertz, Ghislaine; Dubois, Jessica] CEA, DRF, UNICOS, INSERM,U992,Neurospin,I2BM, Gif Sur Yvette, France; [Dehaene-Lambertz, Ghislaine; Poupon, Cyril; Dubois, Jessica] Univ Paris 11, Univ Paris Saclay, Gif Sur Yvette, France; [Poupon, Cyril] CEA, UNIRS, DRF, Neurospin,I2BM, Gif Sur Yvette, France; [Kulikova, Sofya] Natl Res Univ, Higher Sch Econ, Lab Interdisciplinary Empir Studies, Perm, Russia	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; HSE University (National Research University Higher School of Economics)	Dubois, J (corresponding author), CEA, DRF, UNICOS, INSERM,U992,Neurospin,I2BM, Gif Sur Yvette, France.; Dubois, J (corresponding author), Univ Paris 11, Univ Paris Saclay, Gif Sur Yvette, France.	jessica.dubois@centraliens.net	Kulikova, Sofya/N-9556-2015; Dehaene, Ghislaine/O-3633-2017; Dubois, Jessica/P-2461-2014	Kulikova, Sofya/0000-0002-7079-1018; Dehaene, Ghislaine/0000-0003-2221-9081; Dubois, Jessica/0000-0003-4865-8111; Hertz-Pannier, Lucie/0000-0003-4952-7009	Fyssen Foundation; Fondation de France; Ecole des Neurosciences de Paris; ELA Foundation; French National Agency for Research; European Union Seventh Framework Program [604102]	Fyssen Foundation; Fondation de France(Fondation de France); Ecole des Neurosciences de Paris; ELA Foundation; French National Agency for Research(French National Research Agency (ANR)); European Union Seventh Framework Program(European Commission)	* Fyssen Foundation (JD): funding of the data collection * Fondation de France (JD): funding of the data collection * Ecole des Neurosciences de Paris (JD): 1-year salary for JD * ELA Foundation (LHP): salary for SK * French National Agency for Research (GDL): The funder had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. * European Union Seventh Framework Program (GDL, FP7/2007-2013, grant agreement no 604102): The funder had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the UNIACT clinical team for precious help in scanning the infants, and especially Gaelle Mediouni. This work was supported by the ELA Foundation, the Fyssen Foundation, the "Ecole des Neurosciences de Paris" and the "Fondation de France".	Akhondi-Asl A, 2014, LECT NOTES COMPUT SC, V8675, P145, DOI 10.1007/978-3-319-10443-0_19; Alonso-Ortiz E, 2015, MAGN RESON MED, V73, P70, DOI 10.1002/mrm.25198; Andrews T, 2005, MAGN RESON MED, V54, P449, DOI 10.1002/mrm.20599; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BERGER MF, 1991, IEEE T SIGNAL PROCES, V39, P2377, DOI 10.1109/78.97993; Bernstein MA, 2004, HDB MRI PULSE SEQUEN, P1042; BERTERO M, 1982, P ROY SOC LOND A MAT, V383, P15, DOI 10.1098/rspa.1982.0117; BIRD CR, 1989, AM J NEURORADIOL, V10, P731; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; De Santis S, 2014, NEUROIMAGE, V89, P35, DOI 10.1016/j.neuroimage.2013.12.003; Dean DC, 2014, NEUROIMAGE, V84, P742, DOI 10.1016/j.neuroimage.2013.09.058; Deoni SCL, 2015, PSYCHOL MED, V45, P795, DOI 10.1017/S0033291714001858; Deoni SCL, 2013, MAGN RESON MED, V70, P147, DOI 10.1002/mrm.24429; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; Deoni SCL, 2011, MAGN RESON MED, V65, P1021, DOI 10.1002/mrm.22685; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Does MD, 2002, MAGNET RESON MED, V47, P274, DOI 10.1002/mrm.10060; Du YP, 2007, MAGN RESON MED, V58, P865, DOI 10.1002/mrm.21409; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Dubois J, 2014, MAGN RESON IMAGING, V32, P981, DOI 10.1016/j.mri.2014.05.007; Flechsig P., 1920, ANATOMIE MENSCHLICHE; Gagunashvili ND, 2006, ARXIVPHYSICS0605123; Guo JY, 2013, MAGN RESON MED, V70, P813, DOI 10.1002/mrm.24527; Hwang D, 2010, NEUROIMAGE, V52, P198, DOI 10.1016/j.neuroimage.2010.04.023; Hwang D, 2009, J MAGN RESON IMAGING, V30, P203, DOI 10.1002/jmri.21783; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kolind SH, 2009, MAGN RESON MED, V62, P106, DOI 10.1002/mrm.21966; Kulikova S, 2015, BRAIN STRUCT FUNCT, V220, P3657, DOI 10.1007/s00429-014-0881-y; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; Kwon OI, 2013, NEUROIMAGE, V74, P12, DOI 10.1016/j.neuroimage.2013.01.064; Labadie C, 2014, MAGN RESON MED, V71, P375, DOI 10.1002/mrm.24670; Lancaster JL, 2005, AM J NEURORADIOL, V26, P447; Lancaster JL, 2003, J MAGN RESON IMAGING, V17, P1, DOI 10.1002/jmri.10230; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Laule C, 2008, NEUROIMAGE, V40, P1575, DOI 10.1016/j.neuroimage.2007.12.008; Lawson C. L, 1995, SOLVING LEAST SQUARE, DOI [10.1137/1.9781611971217, DOI 10.1137/1.9781611971217]; Levesque IR, 2010, J MAGN RESON IMAGING, V32, P60, DOI 10.1002/jmri.22170; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Melbourne A, 2016, HUM BRAIN MAPP, V37, P2479, DOI 10.1002/hbm.23188; MENON RS, 1991, MAGNET RESON MED, V20, P214, DOI 10.1002/mrm.1910200205; Oh J, 2006, MAGN RESON IMAGING, V24, P33, DOI 10.1016/j.mri.2005.10.016; Perrin M, 2005, LECT NOTES COMPUT SC, V3565, P52; PODUSLO SE, 1984, NEUROCHEM RES, V9, P1615, DOI 10.1007/BF00964595; Poupon C, 2010, P 18 ANN ISMRM M; Raj A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098391; Schmitt Duclap, 2012, CONNECTOMIST 2 0 NOV; Smith SW, 1997, SCI ENG GUIDE DIGITA; STAUDT M, 1994, PEDIATR RADIOL, V24, P122, DOI 10.1007/BF02020169; Stikov N, 2011, NEUROIMAGE, V54, P1112, DOI 10.1016/j.neuroimage.2010.08.068; Vavasour IM, 1998, THESIS; Wachowicz K, 2002, P 10 ANN ISMRM M; Warntjes J, 2011, P INT SOC MAG RESON, P536; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; YAKOVLEV P I, 1962, Res Publ Assoc Res Nerv Ment Dis, V39, P3; Zhang J., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0110734	60	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163143	10.1371/journal.pone.0163143	http://dx.doi.org/10.1371/journal.pone.0163143			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736872	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800011
J	Moriyama, M; Moriyama, H; Uda, J; Kubo, H; Nakajima, Y; Goto, A; Akaki, J; Yoshida, I; Matsuoka, N; Hayakawa, T				Moriyama, Mariko; Moriyama, Hiroyuki; Uda, Junki; Kubo, Hirokazu; Nakajima, Yuka; Goto, Arisa; Akaki, Junji; Yoshida, Ikuyo; Matsuoka, Nobuya; Hayakawa, Takao			Beneficial Effects of the Genus Aloe on Wound Healing, Cell Proliferation, and Differentiation of Epidermal Keratinocytes	PLOS ONE			English	Article							E-CADHERIN; VERA; GEL; EXTRACT; GROWTH; CREAM	Aloe has been used as a folk medicine because it has several important therapeutic properties. These include wound and burn healing, and Aloe is now used in a variety of commercially available topical medications for wound healing and skin care. However, its effects on epidermal keratinocytes remain largely unclear. Our data indicated that both Aloe vera gel (AVG) and Cape aloe extract (CAE) significantly improved wound healing in human primary epidermal keratinocytes (HPEKs) and a human skin equivalent model. In addition, flow cytometry analysis revealed that cell surface expressions of beta 1-, alpha 6-, beta 4-integrin, and E-cadherin increased in HPEKs treated with AVG and CAE. These increases may contribute to cell migration and wound healing. Treatment with Aloe also resulted in significant changes in cell-cycle progression and in increases in cell number. Aloe increased gene expression of differentiation markers in HPEKs, suggesting roles for AVG and CAE in the improvement of keratinocyte function. Furthermore, human skin epidermal equivalents developed from HPEKs with medium containing Aloe were thicker than control equivalents, indicating the effectiveness of Aloe on enhancing epidermal development. Based on these results, both AVG and CAE have benefits in wound healing and in treatment of rough skin.	[Moriyama, Mariko; Moriyama, Hiroyuki; Uda, Junki; Kubo, Hirokazu; Nakajima, Yuka; Goto, Arisa; Hayakawa, Takao] Kindai Univ, Pharmaceut Res & Technol Inst, Osaka, Japan; [Akaki, Junji; Yoshida, Ikuyo; Matsuoka, Nobuya] KOBAYASHI Pharmaceut Co Ltd, Cent R&D Lab, Osaka, Japan	Kindai University (Kinki University); Kobayashi Pharmaceutical Co Ltd	Moriyama, M (corresponding author), Kindai Univ, Pharmaceut Res & Technol Inst, Osaka, Japan.	mariko@phar.kindai.ac.jp			Ministry of Education, culture, sports, science, and technology (MEXT) KAKENHI grant [26461672]; Japan Agency for Medical Research and Development (AMED); KOBAYASHI Pharmaceutical Co., Ltd; MEXT KAKENHI [26461672]; Grants-in-Aid for Scientific Research [26501007] Funding Source: KAKEN	Ministry of Education, culture, sports, science, and technology (MEXT) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); KOBAYASHI Pharmaceutical Co., Ltd; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, culture, sports, science, and technology (MEXT) KAKENHI grant (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.html) 26461672 to MM. In addition, the study was supported in part by grants from Japan Agency for Medical Research and Development (AMED) (http://www.amed.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KOBAYASHI Pharmaceutical Co., Ltd provided support in the form of salaries for authors JA, IY, and NM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Ryo Morita and Takashi Morita for technical support. This study was financially supported by Kobayashi Pharmaceutical Co., Ltd. It was also supported by MEXT KAKENHI grant 26461672 to MM. In addition, the study was supported in part by grants from Japan Agency for Medical Research and Development (AMED).	BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Chen WY, 2012, PHYTOCHEM LETT, V5, P1, DOI 10.1016/j.phytol.2011.09.001; Choi S, 2003, SEMINARS INTEGRATIVE; Choi SW, 2001, BRIT J DERMATOL, V145, P535, DOI 10.1046/j.1365-2133.2001.04410.x; Dagne E, 2000, CURR ORG CHEM, V4, P1055, DOI 10.2174/1385272003375932; DAVIS RH, 1994, J AM PODIAT MED ASSN, V84, P77, DOI 10.7547/87507315-84-2-77; GRINDLAY D, 1986, J ETHNOPHARMACOL, V16, P117, DOI 10.1016/0378-8741(86)90085-1; Habeeb F, 2007, METHODS, V42, P388, DOI 10.1016/j.ymeth.2007.03.005; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hwang S, 2012, J BIOL CHEM, V287, P22227, DOI 10.1074/jbc.M112.367979; Jia YM, 2008, J ETHNOPHARMACOL, V120, P181, DOI 10.1016/j.jep.2008.08.008; KAWAI K, 1993, PHYTOTHER RES, V7, pS5, DOI 10.1002/ptr.2650070705; MABUSELA WT, 1990, PHYTOCHEMISTRY, V29, P3555, DOI 10.1016/0031-9422(90)85275-K; Manvitha K, 2014, J PHARMACOGNOSY PHYT, P2; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Moriyama N, 2001, J LAB CLIN MED, V138, P236, DOI 10.1067/mlc.2001.118177; O'Brien C, 2011, S AFR J BOT, V77, P988, DOI 10.1016/j.sajb.2011.08.004; Radha Maharjan H, 2015, J Tradit Complement Med, V5, P21, DOI 10.1016/j.jtcme.2014.10.006; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Stuart RW, 1997, INT J IMMUNOPHARMACO, V19, P75, DOI 10.1016/S0192-0561(97)00010-6; Syed TA, 1996, TROP MED INT HEALTH, V1, P505, DOI 10.1046/j.1365-3156.1996.d01-91.x; Takahashi M, 2009, J OLEO SCI, V58, P643, DOI 10.5650/jos.58.643; Tarameshloo M, 2012, ANAT CELL BIOL, V45, P170, DOI 10.5115/acb.2012.45.3.170; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Vogler BK, 1999, BRIT J GEN PRACT, V49, P823; Xing W, 2015, J DERMATOL SCI, V79, P101, DOI 10.1016/j.jdermsci.2015.03.016; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zawahry M E, 1973, Int J Dermatol, V12, P68, DOI 10.1111/j.1365-4362.1973.tb00215.x	29	35	37	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164799	10.1371/journal.pone.0164799	http://dx.doi.org/10.1371/journal.pone.0164799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736988	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800131
J	Park, M; Han, S; Kim, GS; Gwak, MS				Park, MiHye; Han, Sangbin; Kim, Gaab Soo; Gwak, Mi Sook			Evaluation of New Calibrated Pulse-Wave Analysis (VolumeView (TM)/EV1000 (TM)) for Cardiac Output Monitoring Undergoing Living Donor Liver Transplantation	PLOS ONE			English	Article							PULMONARY-ARTERY THERMODILUTION; STROKE VOLUME VARIATION; FORM ANALYSIS; TRANSPULMONARY THERMODILUTION; CIRRHOTIC-PATIENTS; CONTOUR ANALYSIS; SEPTIC SHOCK; SURGERY; VALIDATION; AGREEMENT	Background Intrapulmonary thermodilution technique using a pulmonary artery catheter is widely used for measuring cardiac output (CO) in patients undergoing liver transplantation. However, its invasiveness and associated complications have led to an interest in less invasive modalities. Thus, we aimed to evaluate whether the new calibrated pulse-wave analysis method monitoring (VolumeView (TM) /EV1000 (TM)) is interchangeable with intrapulmonary thermodilution technique. Methods Twenty-eight patients undergoing living donor liver transplantation were enrolled in this prospective observational study. COs were recorded automatically by the two devices and compared simultaneously at 10-minute intervals. The agreement of absolute CO values and the tracking ability of CO changes trends were compared. A Bland-Altman analysis with percentage errors and concordance rate for trend analysis using both a 4-quadrant plot and a polar plot were performed on the data. Results A total of 375 paired datasets from 25 patients were included in analysis. COs measured by intrapulmonary thermodilution ranged from 3.8-13.7 L/min. The mean CO difference between the two techniques was 0.57 L/min, and the 95% limits of agreement were -0.98 L/min to 2.12 L/min with a percentage error of 42.3%. The percentage errors in the dissection, anhepatic, and reperfusion phase were 30.5%, 31.7%, and 27.4%, respectively. The concordance rate between the two techniques was 78.4%. Conclusion The calibrated pulse-wave analysis and intrapulmonary thermodilution failed to show acceptable interchangeability in terms of both estimating CO and tracking CO changes during living donor liver transplantation.	[Park, MiHye] Kyungpook Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Daegu, South Korea; [Han, Sangbin; Kim, Gaab Soo; Gwak, Mi Sook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea	Kyungpook National University; Sungkyunkwan University (SKKU); Samsung Medical Center	Gwak, MS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	gwakms@skku.edu						Belda FJ, 2011, BRIT J ANAESTH, V106, P482, DOI 10.1093/bja/aeq377; Bendjelid K, 2013, BRIT J ANAESTH, V111, P573, DOI 10.1093/bja/aet116; Biancofiore G, 2009, BRIT J ANAESTH, V102, P47, DOI 10.1093/bja/aen343; Biancofiore G, 2011, ANESTH ANALG, V113, P515, DOI 10.1213/ANE.0b013e31822401b2; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Bottiger BW, 1997, ANAESTHESIA, V52, P207, DOI 10.1111/j.1365-2044.1997.079-az0077.x; Costa MG, 2011, TRANSPL P, V43, P1098, DOI 10.1016/j.transproceed.2011.03.022; Critchley LA, 2011, J CARDIOTHOR VASC AN, V25, P536, DOI 10.1053/j.jvca.2011.01.003; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; Critchley LAH, 2011, ANESTH ANALG, V113, P1292, DOI 10.1213/ANE.0b013e31822d6785; Della Rocca G, 2002, BRIT J ANAESTH, V88, P350, DOI 10.1093/bja/88.3.350; Della Rocco G, 2008, LIVER TRANSPLANT, V14, P327, DOI 10.1002/lt.21288; Ellenberger C, 2006, J CLIN ANESTH, V18, P367, DOI 10.1016/j.jclinane.2005.10.007; Feltracco P, 2012, MINERVA ANESTESIOL, V78, P1372; Greim CA, 1997, ANESTH ANALG, V85, P483, DOI 10.1097/00000539-199709000-00003; Gwak MS, 2007, LIVER TRANSPLANT, V13, P1451, DOI 10.1002/lt.21300; Kiefer N, 2012, CRIT CARE, V16, DOI 10.1186/cc11366; Kim SK, 2016, BLOOD PRESS MONIT, V21, P9, DOI 10.1097/MBP.0000000000000155; Krejci V, 2010, LIVER TRANSPLANT, V16, P773, DOI 10.1002/lt.22056; Laight NS, 2015, J CARDIOTHOR VASC AN, V29, P1051, DOI 10.1053/j.jvca.2015.03.013; Lee M, 2015, CRIT CARE RESUSC, V17, P101; Lee RF, 2007, BEST PRACT RES CL GA, V21, P125, DOI 10.1016/j.bpg.2006.06.003; Marik PE, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-38; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Ostergaard M, 2006, ACTA ANAESTH SCAND, V50, P1044, DOI 10.1111/j.1399-6576.2006.01080.x; Peyton PJ, 2010, ANESTHESIOLOGY, V113, P1220, DOI 10.1097/ALN.0b013e3181ee3130; Reuter DA, 2010, ANESTH ANALG, V110, P799, DOI 10.1213/ANE.0b013e3181cc885a; Rudnick MR, 2015, WORLD J HEPATOL, V7, P1302, DOI 10.4254/wjh.v7.i10.1302; Shin YH, 2011, LIVER TRANSPLANT, V17, P53, DOI 10.1002/lt.22186; Slagt C, 2014, BRIT J ANAESTH, V112, P626, DOI 10.1093/bja/aet429; Slagt C, 2015, EUR J ANAESTH, V32, P5, DOI 10.1097/EJA.0000000000000173; Sun QH, 2002, INTENS CARE MED, V28, P1276, DOI 10.1007/s00134-002-1415-2; Trzebicki J, 2011, ANN TRANSPL, V16, P70; Tzenkov IG, 2003, TRANSPLANT P, V35, P1920, DOI 10.1016/S0041-1345(03)00602-x; Monge ALV, 2014, MINERVA ANESTESIOL, V80, P1178	35	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164521	10.1371/journal.pone.0164521	http://dx.doi.org/10.1371/journal.pone.0164521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736921	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800077
J	Robinson, RJ; Hensel, EC; Roundtree, KA; Difrancesco, AG; Nonnemaker, JM; Lee, YO				Robinson, R. J.; Hensel, E. C.; Roundtree, K. A.; Difrancesco, A. G.; Nonnemaker, J. M.; Lee, Y. O.			Week Long Topography Study of Young Adults Using Electronic Cigarettes in Their Natural Environment	PLOS ONE			English	Article							SMOKING TOPOGRAPHY; NICOTINE LEVELS; SMOKERS	Results of an observational, descriptive study quantifying topography characteristics of twenty first generation electronic nicotine delivery system users in their natural environment for a one week observation period are presented. The study quantifies inter-participant variation in puffing topography between users and the intra-participant variation for each user observed during one week of use in their natural environment. Puff topography characteristics presented for each user include mean puff duration, flow rate and volume for each participant, along with descriptive statistics of each quantity. Exposure characteristics including the number of vaping sessions, total number of puffs and cumulative volume of aerosol generated from ENDS use (e-liquid aerosol) are reported for each participant for a one week exposure period and an effective daily average exposure. Significant inter-participant and intra-participant variation in puff topography was observed. The observed range of natural use environment characteristics is used to propose a set of topography protocols for use as command inputs to drive machine-puffed electronic nicotine delivery systems in a controlled laboratory environment.	[Robinson, R. J.; Hensel, E. C.; Roundtree, K. A.; Difrancesco, A. G.] Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA; [Nonnemaker, J. M.; Lee, Y. O.] Res Triangle Int, Res Triangle Pk, NC USA	Rochester Institute of Technology	Robinson, RJ (corresponding author), Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA.	rjreme@rit.edu	Hensel, Edward/Q-6753-2019; Lee, Youn/ABF-9022-2021	Hensel, Edward/0000-0002-2682-0766; Lee, Youn/0000-0001-9042-5392; Robinson, Risa/0000-0001-8488-5448; nonnemaker, james/0000-0003-1044-7482	RTI International [63259-36972]; National Institutes Of Health; National Institute on Drug Abuse; US Food and Drug Administration Center for Tobacco Products [P50DA036128]; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA036128] Funding Source: NIH RePORTER	RTI International; National Institutes Of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); US Food and Drug Administration Center for Tobacco Products; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research reported here was partially supported by National Institutes Of Health, National Institute on Drug Abuse and US Food and Drug Administration Center for Tobacco Products grant number P50DA036128, YOL. Preliminary data collection and analysis activities were supported by institutional funds provided by RTI International. RTI International Grant Number 63259-36972, RJR. Rochester Institute of Technology 63259-15000, RJR. RTI International and Rochester Institute of Technology are both funders and authors of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahijevych K, 1997, RES NURS HEALTH, V20, P505, DOI 10.1002/(SICI)1098-240X(199712)20:6<505::AID-NUR5>3.0.CO;2-Q; Arndt J, 2013, HEALTH PSYCHOL, V32, P525, DOI 10.1037/a0029201; Aung AT, 2004, ADDICT BEHAV, V29, P699, DOI 10.1016/j.addbeh.2004.02.012; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Bialous SA, 2001, AM J PUBLIC HEALTH, V91, P62; Blank MD, 2009, NICOTINE TOB RES, V11, P896, DOI 10.1093/ntr/ntp083; Brauer LH, 1996, ADDICT BEHAV, V21, P233, DOI 10.1016/0306-4603(95)00054-2; BRIDGES RB, 1990, PHARMACOL BIOCHEM BE, V37, P29, DOI 10.1016/0091-3057(90)90037-I; Burling TA, 1996, J SUBST ABUSE, V8, P445, DOI 10.1016/S0899-3289(96)90005-X; Evans SE, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-051489; Farsalinos KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11269; Food and Drug Administration UDoHaHS, DEEM TOB PROD BE SUB; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Hammond D, 2005, CANCER EPIDEM BIOMAR, V14, P1370, DOI 10.1158/1055-9965.EPI-04-0498; HATSUKAMI D, 1987, INT J ADDICT, V22, P719, DOI 10.3109/10826088709027453; HATSUKAMI DK, 1988, ADDICT BEHAV, V13, P91, DOI 10.1016/0306-4603(88)90031-7; HERNING RI, 1983, CLIN PHARMACOL THER, V33, P84, DOI 10.1038/clpt.1983.12; HERNING RI, 1981, BRIT MED J, V283, P187, DOI 10.1136/bmj.283.6285.187; Lee YS, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/520578; Lopez AA, 2016, NICOTINE TOB RES, V18, P720, DOI 10.1093/ntr/ntv182; Lopez AA, 2015, PREV MED, V80, P101, DOI 10.1016/j.ypmed.2015.07.006; Norton KJ, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-17; Pagano DT, 2015, NICOTINE TOBACCO RES; Robinson DR, 2015, PLOS ONE; Sazonov E, 2013, J STUD ALCOHOL DRUGS, V74, P956, DOI 10.15288/jsad.2013.74.956; Singh T, 2016, MMWR-MORBID MORTAL W, V65, P361, DOI 10.15585/mmwr.mm6514a1; Spindle TR, 2015, NICOTINE TOB RES, V17, P142, DOI 10.1093/ntr/ntu186; Tan L., 2013, FUNDAMENTALS APPL, V2nd ed.	28	44	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164038	10.1371/journal.pone.0164038	http://dx.doi.org/10.1371/journal.pone.0164038			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736944	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800036
J	Stock, E; Vanderperren, K; Bosmans, T; Dobbeleir, A; Duchateau, L; Hesta, M; Lybaert, L; Peremans, K; Vandermeulenl, E; Saunders, J				Stock, Emmelie; Vanderperren, Katrien; Bosmans, Tim; Dobbeleir, Andre; Duchateau, Luc; Hesta, Myriam; Lybaert, Lien; Peremans, Kathelijne; Vandermeulenl, Eva; Saunders, Jimmy			Evaluation of Feline Renal Perfusion with Contrast-Enhanced Ultrasonography and Scintigraphy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ANGIOTENSIN-II; BLOOD-FLOW; ULTRASOUND; CATS; DOGS; CIRCULATION; STATES; RAT	Contrast-enhanced ultrasound (CEUS) is an emerging technique to evaluate tissue perfusion. Promising results have been obtained in the evaluation of renal perfusion in health and disease, both in human and veterinary medicine. Renal scintigraphy using Tc-99m-Mercaptoacetyltriglycine (MAG(3)) is another non-invasive technique that can be used to evaluate renal perfusion. However, no data are available on the ability of CEUS or Tc-99m-MAG(3) scintigraphy to detect small changes in renal perfusion in cats. Therefore, both techniques were applied in a normal feline population to evaluate detection possibilities of perfusion changes by angiotensin II (AT II). Contrast-enhanced ultrasound using a bolus injection of commercially available contrast agent and renal scintigraphy using Tc-99m-MAG(3) were performed in 11 healthy cats after infusion of 0,9% NaCl (control) and AT II. Angiotensin II induced changes were noticed on several CEUS parameters. Mean peak enhancement, wash-in perfusion index and wash-out rate for the entire kidney decreased significantly after AT II infusion. Moreover, a tendency towards a lower wash-in area-under-the curve was present. Renal scintigraphy could not detect perfusion changes induced by AT II. This study shows that CEUS is able to detect changes in feline renal perfusion induced by AT II infusion.	[Stock, Emmelie; Vanderperren, Katrien; Peremans, Kathelijne; Vandermeulenl, Eva; Saunders, Jimmy] Univ Ghent, Fac Vet Med, Dept Med Imaging Domest Anim, Salisburylaan 133, Merelbeke, Belgium; [Bosmans, Tim] Univ Ghent, Fac Vet Med, Dept Med & Clin Biol Small Anim, Salisburylaan 133, Merelbeke, Belgium; [Dobbeleir, Andre] Ghent Univ Hosp, Dept Radiol & Nucl Med, Pintelaan 185, B-9000 Ghent, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometry, Salisburylaan 133, Merelbeke, Belgium; [Hesta, Myriam] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Salisburylaan 133, Merelbeke, Belgium; [Lybaert, Lien] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Technol, Ottergemsesteenweg 460, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University	Stock, E (corresponding author), Univ Ghent, Fac Vet Med, Dept Med Imaging Domest Anim, Salisburylaan 133, Merelbeke, Belgium.	emmelie.stock@ugent.be		Hesta, Myriam/0000-0001-9423-9765	Special Research Fund of Ghent University, Belgium (BOF) [2015003301]	Special Research Fund of Ghent University, Belgium (BOF)	This research was supported by the Special Research Fund of Ghent University, Belgium (BOF grant 2015003301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badzynska B, 2002, J PHYSIOL-LONDON, V538, P159, DOI 10.1113/jphysiol.2001.012921; Bartges JW, 2012, VET CLIN N AM-SMALL, V42, P669, DOI 10.1016/j.cvsm.2012.04.008; CHAPMAN BJ, 1980, BRIT J ANAESTH, V52, P389; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Daniel GB, 1999, VET RADIOL ULTRASOUN, V40, P572, DOI 10.1111/j.1740-8261.1999.tb00883.x; Dietrich CF, 2011, Z GASTROENTEROL, V49, P350, DOI 10.1055/s-0029-1245851; Dong Y, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140350; Dong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070337; Drost WT, 2003, AM J VET RES, V64, P1076, DOI 10.2460/ajvr.2003.64.1076; Evans RG, 2010, CLIN EXP PHARMACOL P, V37, pE58, DOI 10.1111/j.1440-1681.2009.05233.x; Fischer T, 2004, ROFO-FORTSCHR RONTG, V176, P472, DOI 10.1055/s-2004-812992; Haers H, 2013, AM J VET RES, V74, P70, DOI 10.2460/ajvr.74.1.70; Hosotani Y, 2002, HYPERTENS RES, V25, P77, DOI 10.1291/hypres.25.77; ITKIN RJ, 1994, AM J VET RES, V55, P1660; ITKIN RJ, 1994, COMP CONT EDUC PRACT, V16, P753; Kay DH, 2009, CLIN RADIOL, V64, P1081, DOI 10.1016/j.crad.2009.06.010; Klein B. G., 2012, CUNNINGHAMS TXB VET; LEE WB, 1980, CIRC RES, V47, P286, DOI 10.1161/01.RES.47.2.286; LULICH JP, 1992, COMP CONT EDUC PRACT, V14, P127; Ma F, 2012, NEPHROL DIAL TRANSPL, V27, P2891, DOI 10.1093/ndt/gfr789; Marino CL, 2014, J FELINE MED SURG, V16, P465, DOI 10.1177/1098612X13511446; NOBES MS, 1991, AM J PHYSIOL, V261, pF998, DOI 10.1152/ajprenal.1991.261.6.F998; REGAN MC, 1995, UROL RES, V23, P1, DOI 10.1007/BF00298844; Schneider AG, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/s40635-014-0033-y; Schneider AG, 2012, NEPHROL DIAL TRANSPL, V27, P674, DOI 10.1093/ndt/gfr345; Seiler GS, 2013, JAVMA-J AM VET MED A, V242, P1255, DOI 10.2460/javma.242.9.1255; Tang MX, 2011, INTERFACE FOCUS, V1, P520, DOI 10.1098/rsfs.2011.0026; TAYLOR A, 1989, RADIOLOGY, V170, P721, DOI 10.1148/radiology.170.3.2521734; Tranquart F, 2012, ULTRASCHALL MED, V33, pS31, DOI 10.1055/s-0032-1312894; Tsuruoka K, 2010, INT HEART J, V51, P176, DOI 10.1536/ihj.51.176; Walker LL, 1999, J PHYSIOL-LONDON, V519, P273, DOI 10.1111/j.1469-7793.1999.0273o.x	31	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164488	10.1371/journal.pone.0164488	http://dx.doi.org/10.1371/journal.pone.0164488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736928	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800075
J	Zeng, R; Wang, GP; Liu, ZH; Liang, XH; Zhao, PF; Wang, ZC; Gong, SS				Zeng, Rong; Wang, Guo-Peng; Liu, Zhao-Hui; Liang, Xi-Hong; Zhao, Peng-Fei; Wang, Zhen Chang; Gong, Shu-Sheng			Sigmoid Sinus Wall Reconstruction for Pulsatile Tinnitus Caused by Sigmoid Sinus Wall Dehiscence: A Single-Center Experience	PLOS ONE			English	Article							IDIOPATHIC INTRACRANIAL HYPERTENSION; SURGICAL-TREATMENT; DIVERTICULUM; ASSOCIATION	Objective To evaluate clinical characteristics and present surgical outcomes of PT caused by sigmoid sinus wall dehiscence (SSWD) Methods This study retrospectively reviewed 34 patients with PT who were diagnosed with SSWD in our institution between December 2008 and July 2013. Among them, 27 patients underwent sigmoid sinus wall reconstruction (surgery group) and 7 patients refused surgery (non-surgery group). Preoperative data were obtained from the patients' medical records. All patients were followed up regularly for at least 25 months. Preoperative and postoperative computed tomography angiography (CTA) images were compared. Student's t-tests were used to compare age, body mass index (BMI) and preoperative Tinnitus Handicap Inventory (THI) scores between the surgery and the non-surgery groups and to compare pre-and follow-up THI scores. Results There was no significant difference in age, body mass index, or preoperative THI scores between groups. Following surgery, 14 patients had complete resolution, 5 had partial resolution, 7 experienced no change and PT was aggravated in 1 patient. The difference between preoperative and postoperative THI scores was significant. No severe complications were found postoperatively. Comparison of the preoperative and postoperative CTA images revealed that remnant unrepaired dehiscences were the cause of unsatisfactory outcomes following surgery. In the non-surgery group, PT remained largely unchanged. Conclusions Sigmoid sinus wall reconstruction is an effective and safe treatment for PT caused by SSWD. It is imperative that all regions of the dehiscence are sufficiently exposed and resurfaced during surgery.	[Zeng, Rong; Wang, Guo-Peng; Gong, Shu-Sheng] Capital Med Univ, Beijing Friendship Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Wang, Guo-Peng; Gong, Shu-Sheng] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Liu, Zhao-Hui; Liang, Xi-Hong] Capital Med Univ, Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China; [Zhao, Peng-Fei; Wang, Zhen Chang] Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Gong, SS (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China.	cjr.wzhch@vip.163.com; gongss1962@163.com	liu, zhao/GXV-6141-2022; 赵, 鹏飞/GWZ-5453-2022	赵, 鹏飞/0000-0002-9210-6544	National Science AMP; Technology Pillar Program [2012BA112B05]; National Natural Science Foundation of China [81171311, 81371545]; Beijing Municipal Commission of Education [KZ20110025029, TJSHG201510025004]; Beijing Municipal Science and Technology Commission [D101100050010031]; Capital Medical University of China [13JL03]	National Science AMP; Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Capital Medical University of China	This work was supported by the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period of China (grant No. 2012BA112B05) to Dr. Shu-Sheng Gong, the National Natural Science Foundation of China (grant Nos. 81171311 and 81371545), the Beijing Municipal Commission of Education (grant Nos. KZ20110025029 and TJSHG201510025004) to M. D. Zhen-Chang Wang, the Beijing Municipal Science and Technology Commission (grant No. D101100050010031) to M.D. Zhen-Chang Wang, and the Capital Medical University of China (grant No. 13JL03) to M.D. Zhao-Hui Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho IK, 2012, ACTA OTO-LARYNGOL, V132, P285, DOI 10.3109/00016489.2011.631190; Eisenman DJ, 2016, NEUROIMAG CLIN N AM, V26, P279, DOI 10.1016/j.nic.2015.12.010; Eisenman DJ, 2011, OTOL NEUROTOL, V32, P1116, DOI 10.1097/MAO.0b013e31822a1c7d; Grewal AK, 2014, OTOL NEUROTOL, V35, P16, DOI 10.1097/MAO.0b013e31829ab6d7; Guo P, 2015, CLIN EXP OTORHINOLAR, V8, P111, DOI 10.3342/ceo.2015.8.2.111; Harvey RS, 2014, OTOL NEUROTOL, V35, P7, DOI 10.1097/MAO.0b013e3182a4756c; Houdart E, 2000, ANN NEUROL, V48, P669, DOI 10.1002/1531-8249(200010)48:4<669::AID-ANA16>3.0.CO;2-6; Kim CS, 2016, J NEUROSURG, V125, P441, DOI 10.3171/2015.6.JNS15961; Liu ZH, 2015, NEURORADIOLOGY, V57, P747, DOI 10.1007/s00234-015-1517-5; Liu ZH, 2015, EUR J RADIOL, V84, P862, DOI 10.1016/j.ejrad.2014.12.024; Liu ZH, 2013, ACTA RADIOL, V54, P812, DOI 10.1177/0284185113481698; Madani G, 2009, CLIN RADIOL, V64, P319, DOI 10.1016/j.crad.2008.08.014; Maria PLS, 2013, J LARYNGOL OTOL, V127, pS57, DOI 10.1017/S0022215113000649; Mattox DE, 2008, ACTA OTO-LARYNGOL, V128, P427, DOI 10.1080/00016480701840106; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; MEHALL CJ, 1995, AM J NEURORADIOL, V16, P905; Meng ZL, 2012, CLIN EXP OTORHINOLAR, V5, P10, DOI 10.3342/ceo.2012.5.1.10; Newman C W, 1998, J Am Acad Audiol, V9, P153; Otto KJ, 2007, OTOL NEUROTOL, V28, P48, DOI 10.1097/01.mao.0000247814.85829.f6; Park YH, 2011, INTERV NEURORADIOL, V17, P376, DOI 10.1177/159101991101700316; Raghavan P, 2016, AM J NEURORADIOL, V37, P136, DOI 10.3174/ajnr.A4511; Reardon MA, 2016, NEUROIMAG CLIN N AM, V26, P237, DOI 10.1016/j.nic.2015.12.006; Sanchez Tanit Ganz, 2002, Int Tinnitus J, V8, P54; Schoeff S, 2014, OTOLARYNG HEAD NECK, V150, P841, DOI 10.1177/0194599813520291; Sismanis A, 2003, OTOLARYNG CLIN N AM, V36, P389, DOI 10.1016/S0030-6665(02)00169-X; Song JJ, 2015, NEUROSURGERY, V77, P709, DOI 10.1227/NEU.0000000000000902; STOUFFER JL, 1990, J SPEECH HEAR DISORD, V55, P439, DOI 10.1044/jshd.5503.439; Wang GP, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000882; Wang GP, 2014, ACTA OTO-LARYNGOL, V134, P7, DOI 10.3109/00016489.2013.831479; Wee JH, 2012, OTOL NEUROTOL, V33, pE41, DOI 10.1097/MAO.0b013e318245cb22; Xue J, 2012, J LARYNGOL OTOL, V128, P409, DOI 10.1017/S0022215111003458; Zhao PF, 2016, EUR RADIOL, V26, P9, DOI 10.1007/s00330-015-3827-8	32	26	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164728	10.1371/journal.pone.0164728	http://dx.doi.org/10.1371/journal.pone.0164728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736970	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800122
J	Utepbergenov, D; Hennig, PM; Derewenda, U; Artamonov, MV; Somlyo, AV; Derewenda, ZS				Utepbergenov, Darkhan; Hennig, Paulina M.; Derewenda, Urszula; Artamonov, Mykhaylo V.; Somlyo, Avril V.; Derewenda, Zygmunt S.			Bacterial Expression, Purification and In Vitro Phosphorylation of Full-Length Ribosomal S6 Kinase 2 (RSK2)	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CANCER-CELL-PROLIFERATION; PROTEIN-KINASE; P90 RSK; HEMATOPOIETIC TRANSFORMATION; TYROSINE PHOSPHORYLATION; MOTIF PHOSPHORYLATION; AGC KINASES; ACTIVATION; INHIBITOR	Ribosomal S6 kinases (RSK) play important roles in cell signaling through the mitogen-activated protein kinase (MAPK) pathway. Each of the four RSK isoforms (RSK1-4) is a single polypeptide chain containing two kinase domains connected by a linker sequence with regulatory phosphorylation sites. Here, we demonstrate that full-length RSK2-which is implicated in several types of cancer, and which is linked to the genetic Coffin-Lowry syndrome-can be overexpressed with high yields in Escherichia coli as a fusion with maltose binding protein (MBP), and can be purified to homogeneity after proteolytic removal of MBP by affinity and size-exclusion chromatography. The purified protein can be fully activated in vitro by phosphorylation with protein kinases ERK2 and PDK1. Compared to full-length RSK2 purified from insect host cells, the bacterially expressed and phosphorylated murine RSK2 shows the same levels of catalytic activity after phosphorylation, and sensitivity to inhibition by RSK-specific inhibitor SL0101. Interestingly, we detect low levels of phosphorylation in the nascent RSK2 on Ser386, owing to autocatalysis by the C-terminal domain, independent of ERK. This observation has implications for in vivo signaling, as it suggests that full activation of RSK2 by PDK1 alone is possible, circumventing at least in some cases the requirement for ERK.	[Utepbergenov, Darkhan; Hennig, Paulina M.; Derewenda, Urszula; Artamonov, Mykhaylo V.; Somlyo, Avril V.; Derewenda, Zygmunt S.] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Hennig, Paulina M.] Univ Lodz, Dept Mol Genet, Lodz, Poland; [Utepbergenov, Darkhan] Nazarbayev Univ, Dept Chem, Astana, Kazakhstan	University of Virginia; University of Lodz; Nazarbayev University	Derewenda, ZS (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	zsd4n@virginia.edu	Utepbergenov, Darkhan/AAA-1249-2021; Artamonov, Mykhaylo/AAD-3488-2021; Hennig, Paulina/Q-2480-2016	Utepbergenov, Darkhan/0000-0002-9005-4103; Artamonov, Mykhaylo/0000-0002-0848-2054; Hennig, Paulina/0000-0003-2633-452X	National Institutes of Health [GM086457]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by National Institutes of Health (GM086457). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; This work was funded by part by National Institutes of Health (GM086457.). We thank Ms Natalya Olekhnovich for excellent technical assistance.	Aronchik I, 2014, MOL CANCER RES, V12, P803, DOI 10.1158/1541-7786.MCR-13-0595; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Avkiran M, 2008, CURR OPIN PHARMACOL, V8, P133, DOI 10.1016/j.coph.2007.12.007; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Boyer SJ, 2012, BIOORG MED CHEM LETT, V22, P733, DOI 10.1016/j.bmcl.2011.10.030; Cameron AC, 2016, CAN J CARDIOL, V32, P852, DOI 10.1016/j.cjca.2015.12.023; Cho YY, 2012, CARCINOGENESIS, V33, P2529, DOI 10.1093/carcin/bgs271; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; Clark DE, 2005, CANCER RES, V65, P3108; Costales A, 2014, BIOORG MED CHEM LETT, V24, P1592, DOI 10.1016/j.bmcl.2014.01.058; Cuadrado A, 2007, CANCER CELL, V12, P187, DOI 10.1016/j.ccr.2007.08.017; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; Downey JM, 2009, CIRC J, V73, P1171, DOI 10.1253/circj.CJ-09-0338; Elf S, 2011, BLOOD, V117, P6885, DOI 10.1182/blood-2010-10-315721; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kang SM, 2009, MOL CELL BIOL, V29, P2105, DOI 10.1128/MCB.00998-08; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Kirrane TM, 2012, BIOORG MED CHEM LETT, V22, P738, DOI 10.1016/j.bmcl.2011.10.029; Lara R, 2013, CANCER RES, V73, P5301, DOI 10.1158/0008-5472.CAN-12-4448; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Maekawa N, 2006, CIRCULATION, V113, P2516, DOI 10.1161/CIRCULATIONAHA.105.563486; Maloney DJ, 2005, ORG LETT, V7, P1097, DOI 10.1021/ol0500463; Manhas N, 2010, J NEUROCHEM, V114, P1476, DOI 10.1111/j.1471-4159.2010.06868.x; Mills RD, 2015, J MUSCLE RES CELL M, V36, P479, DOI 10.1007/s10974-015-9416-2; Mirmohammadsadegh A, 2007, J INVEST DERMATOL, V127, P2207, DOI 10.1038/sj.jid.5700870; Mrozowski RM, 2013, ACS MED CHEM LETT, V4, P175, DOI 10.1021/ml300298v; Nallamsetty S, 2006, PROTEIN EXPRES PURIF, V45, P175, DOI 10.1016/j.pep.2005.06.012; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; No YR, 2015, AM J PHYSIOL-CELL PH, V309, pC14, DOI 10.1152/ajpcell.00067.2015; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pereira PM, 2010, EUR J HUM GENET, V18, P627, DOI 10.1038/ejhg.2009.189; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Poteet-Smith CE, 1999, J BIOL CHEM, V274, P22135, DOI 10.1074/jbc.274.32.22135; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Romeo Y, 2011, EXPERT OPIN THER TAR, V15, P5, DOI 10.1517/14728222.2010.531014; Routzahn Karen M., 2002, Journal of Structural and Functional Genomics, V2, P83, DOI 10.1023/A:1020424023207; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shi X, 2011, J MOL CELL CARDIOL, V51, P272, DOI 10.1016/j.yjmcc.2011.05.005; Smith JA, 2005, CANCER RES, V65, P1027; Sulzmaier FJ, 2013, CANCER RES, V73, P6099, DOI 10.1158/0008-5472.CAN-13-1087; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Utepbergenov D, 2012, BIOCHEMISTRY-US, V51, P6499, DOI 10.1021/bi300620c	51	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164343	10.1371/journal.pone.0164343	http://dx.doi.org/10.1371/journal.pone.0164343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732676	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300048
J	Tseng, TS; Wang, SH; Chang, TW; Wei, HM; Wang, YJ; Tsai, KC; Liao, YD; Chen, CP				Tseng, Tien-Sheng; Wang, Shih-Han; Chang, Ting-Wei; Wei, Hung-Mu; Wang, Yu-June; Tsai, Keng-Chang; Liao, You-Di; Chen, Chinpan			Sarkosyl-Induced Helical Structure of an Antimicrobial Peptide GW-Q6 Plays an Essential Role in the Binding of Surface Receptor OprI in Pseudomonas aeruginosa	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; LIPID INTERACTIONS; TRYPTOPHAN-RICH; NMR SYSTEM; MECHANISMS; DATABASE; RESIDUES; BACTERIA; DESIGN; CRYSTALLOGRAPHY	The emergence of antibiotic-resistant microbial strains has become a public health issue and there is an urgent need to develop new anti-infective molecules. Although natural antimicrobial peptides (AMPs) can exert bactericidal activities, they have not shown clinical efficacy. The limitations of native peptides may be overcome with rational design and synthesis. Here, we provide evidence that the bactericidal activity of a synthetic peptide, GW-Q6, against Pseudomonas aeruginosa is mediated through outer membrane protein OprI. Hyperpolarization/depolarization of membrane potential and increase of membrane permeability were observed after GW-Q6 treatment. Helical structure as well as hydrophobicity was induced by an amphipathic surfactant, sarkosyl, for binding to OprI and possible to membrane. NMR studies demonstrated GW-Q6 is an amphipathic a-helical structure in DPC micelles. The paramagnetic relaxation enhancement (PRE) approach revealed that GW-Q6 orients its a-helix segment (K7-K17) into DPC micelles. Additionally, this a-helix segment is critical for membrane permeabilization and antimicrobial activity. Moreover, residues K3, K7, and K14 could be critical for helical formation and membrane binding while residues Y19 and W20 for directing the C-terminus of the peptide to the surface of micelle. Taken together, our study provides mechanistic insights into the mode of action of the GW-Q6 peptide and suggests its applicability in modifying and developing potent AMPs as therapeutic agents.	[Tseng, Tien-Sheng; Wang, Shih-Han; Chang, Ting-Wei; Wei, Hung-Mu; Wang, Yu-June; Liao, You-Di; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Tsai, Keng-Chang] Natl Res Inst Chinese Med, Minist Hlth & Welf, Taipei, Taiwan; [Tsai, Keng-Chang] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Med Biotechnol, Taipei, Taiwan	Academia Sinica - Taiwan; National Research Institute of Chinese Medicine; Taipei Medical University	Liao, YD; Chen, CP (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	ydliao@ibms.sinica.edu.tw; bmchinp@ibms.sinica.edu.tw	Chen, Chinpan/O-4202-2018; Tseng, Tien-Sheng Emerson/ABB-1352-2021; Liao, You-Di/S-7018-2018; Tseng, Tien-Sheng Emerson/ABB-1365-2021; Wang, Shih-Han/HGA-7092-2022	Tseng, Tien-Sheng Emerson/0000-0002-2344-0485; Liao, You-Di/0000-0001-5527-4736; Tseng, Tien-Sheng Emerson/0000-0003-0515-1855; Tsai, Keng-Chang/0000-0001-8277-9174	Academia Sinica and Ministry of Science and Technology [104-0210-01-09-02]; Ministry of Science and Technology, Taiwan, ROC [MOST103-2311-B0 01-026-MY3]	Academia Sinica and Ministry of Science and Technology; Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	We acknowledge the acquisition of NMR spectra at the High-field Biomacromolecular NMR Core Facility, Academia Sinica. This work was supported by funds from Academia Sinica and Ministry of Science and Technology [104-0210-01-09-02], and the Ministry of Science and Technology, Taiwan, ROC [MOST103-2311-B0 01-026-MY3].	Akter N, 2011, SCI REP-UK, V1, DOI 10.1038/srep00071; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Bahar AA, 2013, PHARMACEUTICALS-BASE, V6, P1543, DOI 10.3390/ph6121543; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Bourbigot S, 2009, BIOPOLYMERS, V91, P1, DOI 10.1002/bip.21071; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Chang TW, 2015, ANTIMICROB AGENTS CH, V59, P6210, DOI 10.1128/AAC.01406-15; Chang TW, 2012, J BIOL CHEM, V287, P418, DOI 10.1074/jbc.M111.290361; Chopra L, 2014, APPL ENVIRON MICROB, V80, P2981, DOI 10.1128/AEM.04259-13; Chou HT, 2008, INT J ANTIMICROB AG, V32, P130, DOI 10.1016/j.ijantimicag.2008.04.003; Chou HT, 2010, PEPTIDES, V31, P1811, DOI 10.1016/j.peptides.2010.06.021; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]; Ghosh S, 2015, J PHYS CHEM B, V119, P7804, DOI 10.1021/acs.jpcb.5b00965; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kar RK, 2016, J PHYS CHEM B, V120, P902, DOI 10.1021/acs.jpcb.5b11164; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee J, 2015, J MICROBIOL BIOTECHN, V25, P759, DOI 10.4014/jmb.1411.11058; Lin YM, 2010, J BIOL CHEM, V285, P8985, DOI 10.1074/jbc.M109.078725; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Mangoni ML, 2009, BBA-BIOMEMBRANES, V1788, P1610, DOI 10.1016/j.bbamem.2009.04.021; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; MIZUNO T, 1979, J BIOCHEM-TOKYO, V85, P115, DOI 10.1093/oxfordjournals.jbchem.a132300; Moncla Bernard J, 2011, Adv Biosci Biotechnol, V2, P404; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; PRESTEGARD YKAJH, 1988, J MAGN RESON, V84, P9; Pushpanathan Muthuirulan, 2013, Int J Pept, V2013, P675391, DOI 10.1155/2013/675391; Putsep K, 1999, NATURE, V398, P671, DOI 10.1038/19439; Raja Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070782; Sanchez E, 2010, APPL ENVIRON MICROB, V76, P6888, DOI 10.1128/AEM.03052-09; Sani MA, 2016, ACCOUNTS CHEM RES, V49, P1130, DOI 10.1021/acs.accounts.6b00074; Sani MA, 2012, BBA-BIOMEMBRANES, V1818, P205, DOI 10.1016/j.bbamem.2011.07.015; Schrank E, 2013, MOLECULES, V18, P7407, DOI 10.3390/molecules18077407; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Staubitz P, 2001, J PEPT SCI, V7, P552, DOI 10.1002/psc.351; Tachi T, 2002, BIOCHEMISTRY-US, V41, P10723, DOI 10.1021/bi0256983; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Tossi A, 2000, BIOPOLYMERS, V55, P4; Vanhauteghem D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060328; Ventola C Lee, 2015, P T, V40, P344; Ventola C Lee, 2015, P T, V40, P277; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang SA, 2015, CURR PROTEIN PEPT SC, V16, P582, DOI 10.2174/1389203716666150630135847; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wei HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156321; Wei SY, 2006, J BACTERIOL, V188, P328, DOI 10.1128/JB.188.1.328-334.2006; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	64	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164597	10.1371/journal.pone.0164597	http://dx.doi.org/10.1371/journal.pone.0164597			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727309	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504400042
J	Lu, MH; Yu, S; Deng, JQ; Yan, Q; Yang, C; Xia, GD; Zhou, X				Lu, Muhan; Yu, Shan; Deng, Jiaqi; Yan, Qiong; Yang, Chun; Xia, Guodong; Zhou, Xian			Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							QUADRUPLE THERAPY; TRIPLE THERAPY; LACTOBACILLUS-ACIDOPHILUS; SACCHAROMYCES-BOULARDII; ANTIBIOTIC-RESISTANCE; CONTAINING YOGURT; PLUS LACTOFERRIN; DOUBLE-BLIND; INFECTION; MANAGEMENT	Background Traditional Helicobacter pylori (H. pylori) eradication therapies have shown efficacies below 80% in several studies, and their use has been accompanied by antibiotic-related side effects. Some recent studies have reported that supplementing standard therapies with probiotics can improve the efficacy and tolerability of Helicobacter pylori eradication therapy. Objective To assess the effects of probiotic supplementation on the eradication rates and therapy-related adverse event rates of anti-Helicobacter pylori regimens. Methods We searched PubMed, Medline, the Cochrane Central Registry of Controlled Trials and the Chinese Biomedical Database for eligible randomized controlled trials published through July, 2015. Review Manager 5.3 was used for all statistical analyses. Results Thirteen randomized controlled trials involving a total of 2306 patients were included in our analysis. Intent-to-treat (ITT) analysis performed using a fixed-effects model (test for heterogeneity I-2 = 45%) showed that the pooled relative risk (RR) of eradication was significantly higher in the probiotic supplementation group than in the control group [RR 1.15, 95% confidence interval (CI): 1.10-1.20, P<0.00001]. The incidence of total antibiotic-related side effects was lower in the probiotic supplementation group than in the control group, and the pooled RR (studies n = 9) was 0.71 (95% CI: 0.54-0.94, P = 0.02), as determined using a random-effects model (heterogeneity test I-2 = 59%). Certain adverse events, such as nausea and vomiting (RR = 0.58, 95% CI 0.35-0.95, P = 0.03), diarrhea (RR = 0.51, 95% CI: 0.31-0.84, P = 0.008) and constipation (RR = 0.47, 95% CI: 0.28-0.80, P = 0.005), were reported at lower rates in the probiotic supplementation group than in the control group. Subgroup analysis showed that eradication rates were significantly improved in both adults (RR = 1.14, 95% CI: 1.09-1.19, P<0.00001) and children (RR = 1.24, 95% CI: 1.05-1.47, P = 0.01) in the probiotic supplementation group and that no regional differences between Europe (RR = 1.17, 95% CI: 1.09-1.24, P<0.00001) and Asia were present (RR = 1.14, 95% CI: 1.06-1.22, P = 0.0002). However, the total adverse event rate was not decreased in the adult group (RR = 0.80, 95% CI: 0.61-1.04, P = 0.1) or the Asian group (RR = 0.68, 95% CI: 0.39-1.18, P = 0.17). Subgroup analyses examining therapy regimens and treatment durations showed that probiotic supplementation increased eradication rates in the triple-therapy (RR = 1.18, 95% CI: 1.12-1.25, P<0.00001), seven-day treatment (RR = 1.21, 95% CI: 1.12-1.31, P<0.00001) and fourteen-day treatment (RR = 1.13, 95% CI: 1.06-1.20, P = 0.0002) groups. The incidence of antibiotic-related side effects was significantly reduced in all groups, with the exception of the quadruple-therapy subgroup (RR = 1.13, 95% CI: 0.60-2.13, P = 0.07) and the fourteen-day therapy subgroup (RR = 0.96, 95% CI 0.61-1.51, P = 0.86). Supplementation with Lactobacillus alone (RR = 1.24, 95% CI: 1.12-1.38, P<0.0001) or multi-strain probiotics (RR = 1.12, 95% CI 1.07-1.18, P<0.00001) was effective at improving H. pylori eradication rates. However, supplementation with Lactobacillus alone did not significantly decrease the overall incidence of side effects (RR = 0.61, 95% CI: 0.11-3.51, P = 0.58). Our study also showed that probiotic supplementation before, during or after H. pylori eradication therapy improved eradication rates, regardless of supplementation duration. Furthermore, probiotic supplementation during H. pylori treatment reduced the incidence of side effects. Conclusion Probiotic supplementation during anti-Helicobacter pylori treatment may be effective for improving H. pylori eradication rates, minimizing the incidence of therapy-related adverse events and alleviating most disease-related clinical symptoms. However, our results should be interpreted with caution because of the presence of heterogeneity across the trials included in this analysis.	[Lu, Muhan; Yu, Shan; Yan, Qiong; Yang, Chun; Xia, Guodong; Zhou, Xian] Southwest Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Luzhou, Sichuan, Peoples R China; [Deng, Jiaqi] Southwest Med Univ, Sch Foreign Languages, Luzhou, Sichuan, Peoples R China; [Yu, Shan] Panzhihua Cent Hosp, Dept Gastroenterol, Panzhihua, Sichuan, Peoples R China	Southwest Medical University; Southwest Medical University	Zhou, X (corresponding author), Southwest Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Luzhou, Sichuan, Peoples R China.	xianzhou2015@163.com			Fund of luzhou technology bureau [2015-s-45]	Fund of luzhou technology bureau	This work was supported by the Fund of luzhou technology bureau, number: 2015-s-45. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors received salary from the funders. This fund is offered by Luzhou technology bureau which was used for polishing and page charges in this manuscript.	Aiba Y, 1998, AM J GASTROENTEROL, V93, P2097, DOI 10.1111/j.1572-0241.1998.00600.x; [Anonymous], 2011, J CLIN GASTROENTEROL, V45, P383, DOI 10.1097/MCG.0b013e31820fb8f6; BELL GD, 1992, ALIMENT PHARM THERAP, V6, P427; Byrd JC, 2000, GASTROENTEROLOGY, V118, P1072, DOI 10.1016/S0016-5085(00)70360-X; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Collado MC, 2005, INT J ANTIMICROB AG, V25, P385, DOI 10.1016/j.ijantimicag.2005.01.017; De Francesco V, 2010, J GASTROINTEST LIVER, V19, P409; Deguchi R, 2012, J GASTROEN HEPATOL, V27, P888, DOI 10.1111/j.1440-1746.2011.06985.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Mario F, 2006, DIGEST DIS, V24, P113, DOI 10.1159/000090315; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Francavilla R, 2014, J CLIN GASTROENTEROL, V48, P407, DOI 10.1097/MCG.0000000000000007; Ghotaslou Reza, 2015, World J Methodol, V5, P164, DOI 10.5662/wjm.v5.i3.164; Go MF, 2002, ALIMENT PHARM THER, V16, P3, DOI 10.1046/j.1365-2036.2002.0160s1003.x; Gotteland M, 2006, ALIMENT PHARM THER, V23, P1077, DOI 10.1111/j.1365-2036.2006.02868.x; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, P619, DOI 10.1097/MPG.0b013e31816e219e; Hauser G, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000685; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hsu PI, 2011, HELICOBACTER, V16, P146, DOI 10.1111/j.1523-5378.2011.00829.x; Hu FL, 2007, J CHINESE MED, V42, P19; Hwang SW, 2012, PROSTAG LEUKOTR ESS, V86, P225, DOI 10.1016/j.plefa.2012.04.002; Jarosz M, 2009, WORLD J GASTROENTERO, V15, P1119, DOI 10.3748/wjg.15.1119; Joint FAO/ WHO Working Group, REP DRAFT GUID EV PR; Khodadad A, 2013, IRAN J PEDIATR, V23, P79; Kostamo P, 2011, INT J ANTIMICROB AG, V37, P22, DOI 10.1016/j.ijantimicag.2010.09.013; Lee JS, 2010, J GASTROEN HEPATOL, V25, P194, DOI 10.1111/j.1440-1746.2009.06127.x; Ling Y., 2014, WORLD J GASTROENTERO, V22, P5203; Lionetti E, 2006, ALIMENT PHARM THER, V24, P1461, DOI 10.1111/j.1365-2036.2006.03145.x; Lv ZF, 2015, EXP THER MED, V9, P707, DOI 10.3892/etm.2015.2174; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Malfertheiner P, 2011, LANCET, V377, P905, DOI 10.1016/S0140-6736(11)60020-2; Manfredi M, 2012, HELICOBACTER, V17, P254, DOI 10.1111/j.1523-5378.2012.00944.x; Matsushima M, 2012, J GASTROEN HEPATOL, V27, P851, DOI 10.1111/j.1440-1746.2012.07094.x; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Megraud F, 1998, GASTROENTEROLOGY, V115, P1278, DOI 10.1016/S0016-5085(98)70101-5; Michetti P, 1999, DIGESTION, V60, P203, DOI 10.1159/000007660; Nam H, 2002, APPL ENVIRON MICROB, V68, P4642, DOI 10.1128/AEM.68.9.4642-4645.2002; Navarro-Rodriguez T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-56; Oh B, 2016, HELICOBACTER, V21, P165, DOI 10.1111/hel.12270; Ojetti V, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/740381; Rafeey Mandana, 2007, Journal of Infection and Chemotherapy, V13, P291, DOI 10.1007/s10156-007-0543-6; Ruggiero Paolo, 2014, World J Gastrointest Pathophysiol, V5, P384, DOI 10.4291/wjgp.v5.i4.384; Sachdeva A, 2009, EUR J GASTROEN HEPAT, V21, P45, DOI 10.1097/MEG.0b013e32830d0eff; Shavakhi A, 2013, HELICOBACTER, V18, P280, DOI 10.1111/hel.12047; Sheu BS, 2006, AM J CLIN NUTR, V83, P864, DOI 10.1093/ajcn/83.4.864; Sonnenberg A, 2010, GASTROENTEROLOGY, V139, P1894, DOI 10.1053/j.gastro.2010.08.018; Szajewska H, 2010, ALIMENT PHARM THER, V32, P1069, DOI 10.1111/j.1365-2036.2010.04457.x; The Cochrane Collaboration, COCH HDB SYST REV; Toh ZQ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00171; Tolone S, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-63; Tong JL, 2007, ALIMENT PHARM THER, V25, P155, DOI 10.1111/j.1365-2036.2006.03179.x; Vitor JMB, 2011, FEMS IMMUNOL MED MIC, V63, P153, DOI 10.1111/j.1574-695X.2011.00865.x; Wang YH, 2014, WORLD J MICROB BIOT, V30, P847, DOI 10.1007/s11274-013-1490-2; Wang ZH, 2013, J CLIN GASTROENTEROL, V47, P25, DOI 10.1097/MCG.0b013e318266f6cf; Wilhelm SM, 2011, ANN PHARMACOTHER, V45, P960, DOI 10.1345/aph.1Q104; Wu DC, 2010, CLIN GASTROENTEROL H, V8, P36, DOI 10.1016/j.cgh.2009.09.030; Yoon H, 2011, J GASTROEN HEPATOL, V26, P44, DOI 10.1111/j.1440-1746.2010.06477.x; Yu LingQi, 2010, Chinese Journal of Prevention and Control of Chronic Diseases, V18, P218; Zou J, 2009, HELICOBACTER, V14, P97, DOI 10.1111/j.1523-5378.2009.00716.x; 郑跃杰, 2013, [中华医学杂志, National Medical Journal of China], V93, P3877	66	86	101	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163743	10.1371/journal.pone.0163743	http://dx.doi.org/10.1371/journal.pone.0163743			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723762	Green Submitted, gold, Green Published			2022-12-27	WOS:000385504100009
J	Vaszko, T; Papp, J; Krausz, C; Casamonti, E; Geczi, L; Olah, E				Vaszko, Tibor; Papp, Janos; Krausz, Csilla; Casamonti, Elena; Geczi, Lajos; Olah, Edith			Discrimination of Deletion and Duplication Subtypes of the Deleted in Azoospermia Gene Family in the Context of Frequent Interloci Gene Conversion	PLOS ONE			English	Article							HUMAN Y-CHROMOSOME; PARTIAL AZFC DELETIONS; SPERMATOGENIC IMPAIRMENT; MALE-INFERTILITY; GR/GR DELETIONS; INCREASED RISK; DAZ GENES; REGION; MEN; POLYMORPHISM	Due to its palindromic setup, AZFc (Azoospermia Factor c) region of chromosome Y is one of the most unstable regions of the human genome. It contains eight gene families expressed mainly in the testes. Several types of rearrangement resulting in changes in the cumulative copy number of the gene families were reported to be associated with diseases such as male infertility and testicular germ cell tumors. The best studied AZFc rearrangement is gr/gr deletion. Its carriers show widespread phenotypic variation from azoospermia to normospermia. This phenomenon was initially attributed to different gr/gr subtypes that would eliminate distinct members of the affected gene families. However, studies conducted to confirm this hypothesis have brought controversial results, perhaps, in part, due to the shortcomings of the utilized subtyping methodology. This proof-of-concept paper is meant to introduce here a novel method aimed at subtyping AZFc rearrangements. It is able to differentiate the partial deletion and partial duplication subtypes of the Deleted in Azoospermia (DAZ) gene family. The keystone of the method is the determination of the copy number of the gene family member-specific variant(s) in a series of sequence family variant (SFV) positions. Most importantly, we present a novel approach for the correct interpretation of the variant copy number data to determine the copy number of the individual DAZ family members in the context of frequent interloci gene conversion. Besides DAZ1/DAZ2 and DAZ3/DAZ4 deletions, not yet described rearrangements such as DAZ2/DAZ4 deletion and three duplication subtypes were also found by the utilization of the novel approach. A striking feature is the extremely high concordance among the individual data pointing to a certain type of rearrangement. In addition to being able to identify DAZ deletion subtypes more reliably than the methods used previously, this approach is the first that can discriminate DAZ duplication subtypes as well.	[Vaszko, Tibor; Papp, Janos; Olah, Edith] Natl Inst Oncol, Dept Mol Genet, Budapest, Hungary; [Geczi, Lajos] Natl Inst Oncol, Dept Chemotherapy, Budapest, Hungary; [Krausz, Csilla; Casamonti, Elena] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Krausz, Csilla] Univ Autonoma Barcelona, Androl Serv, Fundacio Puigvert, Inst Invest Biomed St Pau, Barcelona, Spain	National Institute of Oncology Hungary; National Institute of Oncology Hungary; University of Florence; Autonomous University of Barcelona; Fundacio Puigvert	Vaszko, T (corresponding author), Natl Inst Oncol, Dept Mol Genet, Budapest, Hungary.	vaszko.tibor@oncol.hu		Krausz, Csilla Gabriella/0000-0001-6748-8918	Norwegian Financial Mechanism's Norway Grant [HU-0115/NA/2008-3/OP-9]; Istituto Toscano Tumori;  [KTIA-OTKACK-80745];  [OTKAK-112228]	Norwegian Financial Mechanism's Norway Grant; Istituto Toscano Tumori; ; 	This work was funded by: 1) Research Grants KTIA-OTKACK-80745 (http://www.nih.gov.hu/palyazatok-eredmenyek/otka-programok/cikkcime) received by EO; 2) Research Grants OTKAK-112228 (http://nyilvanos.otka-palyazat.hu/index.php?menuid=930&num=112228&lang=HU) received by EO; 3) Norwegian Financial Mechanism's Norway Grant HU-0115/NA/2008-3/OP-9 (http://eeagrants.org/,http://www.oncol.hu/ site/en/norway_grants.html); 4) the Istituto Toscano Tumori grant proposal to CK.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; D'Amico GL, 2006, INT J MOL MED, V17, P785; Ferlin A, 2005, J MED GENET, V42, P209, DOI 10.1136/jmg.2004.025833; Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Giachini C, 2005, J MED GENET, V42, P497, DOI 10.1136/jmg.2004.028191; Giachini C, 2008, HUM GENET, V124, P399, DOI 10.1007/s00439-008-0561-1; Hall GS, 2007, J VIROL METHODS, V146, P22, DOI 10.1016/j.jviromet.2007.05.029; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Krausz C, 2014, ANDROLOGY-US, V2, P5, DOI 10.1111/j.2047-2927.2013.00173.x; Krausz C, 2009, J MED GENET, V46, P21, DOI 10.1136/jmg.2008.059915; Lardone MC, 2007, FERTIL STERIL, V88, P1318, DOI 10.1016/j.fertnstert.2007.01.038; Lepretre AC, 2005, J ASSIST REPROD GEN, V22, P141, DOI 10.1007/s10815-005-4910-x; Lin YW, 2006, MOL HUM REPROD, V12, P347, DOI 10.1093/molehr/gal038; Lin YW, 2007, HUM MUTAT, V28, P486, DOI 10.1002/humu.20473; Lo Giacco D, 2014, EUR J HUM GENET, V22, P754, DOI 10.1038/ejhg.2013.253; Lynch M, 2005, MOL HUM REPROD, V11, P507, DOI 10.1093/molehr/gah191; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Navarro-Costa P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-342; Navarro-Costa P, 2010, HUM REPROD UPDATE, V16, P525, DOI 10.1093/humupd/dmq005; Noordam MJ, 2011, HUM MOL GENET, V20, P2457, DOI 10.1093/hmg/ddr119; Paracchini S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e27; Premi S, 2007, HUM GENET, V121, P337, DOI 10.1007/s00439-006-0318-7; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Repping S, 2004, AM J HUM GENET, V75, P514, DOI 10.1086/423394; Repping S, 2003, MOL HUM REPROD, V9, P183, DOI 10.1093/molehr/gag032; Roze V, 2007, J ASSIST REPROD GEN, V24, P241, DOI 10.1007/s10815-006-9055-z; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Rozen SG, 2012, AM J HUM GENET, V91, P890, DOI 10.1016/j.ajhg.2012.09.003; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Sin HS, 2010, HUM REPROD, V25, P2396, DOI 10.1093/humrep/deq191; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stouffs K, 2008, HUM REPROD, V23, P1193, DOI 10.1093/humrep/den069; Stouffs K, 2011, HUM REPROD UPDATE, V17, P197, DOI 10.1093/humupd/dmq046; Wilkening S, 2005, BIOTECHNIQUES, V39, P853, DOI 10.2144/000112027; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yang Y, 2010, INT J ANDROL, V33, P745, DOI 10.1111/j.1365-2605.2009.01015.x; Zhang F, 2006, ANN HUM GENET, V70, P304, DOI 10.1111/j.1469-1809.2005.00231.x; Zhang F, 2007, J MED GENET, V44, P437, DOI 10.1136/jmg.2007.049056	41	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163936	10.1371/journal.pone.0163936	http://dx.doi.org/10.1371/journal.pone.0163936			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723784	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100014
J	Vierra-Green, C; Roe, D; Jayaraman, J; Trowsdale, J; Traherne, J; Kuang, R; Spellman, S; Maiers, M				Vierra-Green, Cynthia; Roe, David; Jayaraman, Jyothi; Trowsdale, John; Traherne, James; Kuang, Rui; Spellman, Stephen; Maiers, Martin			Estimating KIR Haplotype Frequencies on a Cohort of 10,000 Individuals: A Comprehensive Study on Population Variations, Typing Resolutions, and Reference Haplotypes	PLOS ONE			English	Article							DIVERSITY; HLA; RECEPTORS; ORGANIZATION; COEVOLUTION; ALGORITHM; EVOLUTION	The killer cell immunoglobulin-like receptors (KIR) mediate human natural killer (NK) cell cytotoxicity via activating or inhibiting signals. Although informative and functional haplotype patterns have been reported, most genotyping has been performed at resolutions that are structurally ambiguous. In order to leverage structural information given low-resolution genotypes, we performed experiments to quantify the effects of population variations, reference haplotypes, and genotyping resolutions on population-level haplotype frequency estimations as well as predictions of individual haplotypes. We genotyped 10,157 unrelated individuals in 5 populations (518 African American[AFA], 258 Asian or Pacific Islander [API], 8,245 European[EUR], 1,073 Hispanic[HIS], and 63 Native American[NAM]) for KIR gene presence/absence (PA), and additionally half of the AFA samples for KIR gene copy number variation (CNV). A custom EM algorithm was used to estimate haplotype frequencies for each population by interpretation in the context of three sets of reference haplotypes. The algorithm also assigns each individual the haplotype pairs of maximum likelihood. Generally, our haplotype frequency estimates agree with similar previous publications to within <5% difference for all haplotypes. The exception is that estimates for NAM from the U.S. showed higher frequency association of cB02 with tA01 (+14%) instead of tB01 (-8.5%) compared to a previous study of NAM from south of the U.S. The higher-resolution CNV genotyping on the AFA samples allowed unambiguous haplotype-pair assignments for the majority of individuals, resulting in a 22% higher median typing resolution score (TRS), which measures likelihood of self-match in the context of population-specific haplo- and geno-types. The use of TRS to quantify reduced ambiguity with CNV data clearly revealed the few individuals with ambiguous genotypes as outliers. It is observed that typing resolution and reference haplotype set influence haplotype frequency estimates. For example, PA resolution may be used with reference haplotype sets up to the point where certain haplotypes are gene-content subsets of others. At that point, CNV must be used for all genes.	[Vierra-Green, Cynthia; Spellman, Stephen] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA; [Roe, David; Maiers, Martin] Natl Marrow Donor Program, Bioinformat Res, Minneapolis, MN USA; [Jayaraman, Jyothi; Trowsdale, John; Traherne, James] Univ Cambridge, Dept Pathol, Cambridge, England; [Roe, David; Kuang, Rui] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA	Center for International Blood & Marrow Transplant Research; National Marrow Donor Program; University of Cambridge; University of Minnesota System; University of Minnesota Twin Cities	Vierra-Green, C (corresponding author), Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA.	cvierra@nmdp.org		Maiers, Martin/0000-0002-0198-2064	Office of Naval Research [ONR N00014-12-1-0142, ONR N00014-13-1-0039, ONR N00014-14-1-0028, ONR N00014-15-1-0848]	Office of Naval Research(Office of Naval Research)	This study was supported by funding from Office of Naval Research grants ONR N00014-12-1-0142, ONR N00014-13-1-0039, ONR N00014-14-1-0028 and ONR N00014-15-1-0848. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGT, 2009, TISSUE ANTIGENS, V73, P188, DOI 10.1111/j.1399-0039.2008.01184.x; Augusto DG, 2015, HUM GENET, V134, P929, DOI 10.1007/s00439-015-1579-9; Augusto DG, 2015, HUM IMMUNOL, V76, P272, DOI 10.1016/j.humimm.2015.01.025; Augusto DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056755; Cooley S, 2014, J IMMUNOL, V192, P4592, DOI 10.4049/jimmunol.1302517; Do CB, 2008, NAT BIOTECHNOL, V26, P897, DOI 10.1038/nbt1406; Erdem E, 2008, EFFICIENT HAPLOTYPE, P436; Erdem E, 2009, LECT NOTES COMPUT SC, V5753, P573, DOI 10.1007/978-3-642-04238-6_60; Gourraud PA, 2007, TISSUE ANTIGENS, V69, P96, DOI 10.1111/j.1399-0039.2006.762_4.x; Gragert L, 2016, HUM IMMUNOL, DOI [10.10.16/j.humimm, DOI 10.1016/J.HUMIMM]; Hilton HG, 2015, J IMMUNOL, V195, P3160, DOI 10.4049/jimmunol.1501358; Hollenbach JA, 2012, IMMUNOGENETICS, V64, P719, DOI 10.1007/s00251-012-0629-x; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; Martin AM, 2004, GENE, V335, P121, DOI 10.1016/j.gene.2004.03.018; Moffett A, 2015, IMMUNOL REV, V267, P283, DOI 10.1111/imr.12323; Nong T, 2007, TISSUE ANTIGENS, V69, P92, DOI 10.1111/j.1399-0039.2006.762_3.x; Nowak RM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-330; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Roe D, DREO NMDP EM1; Single RM, 2008, IMMUNOGENETICS, V60, P711, DOI 10.1007/s00251-008-0331-1; Vendelbosch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067619; Vierra-Green C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047491; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Wu JH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00267; Yoo YJ, 2007, BIOINFORMATICS, V23, P2399, DOI 10.1093/bioinformatics/btm371	26	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163973	10.1371/journal.pone.0163973	http://dx.doi.org/10.1371/journal.pone.0163973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723813	Green Published, gold			2022-12-27	WOS:000385504100016
J	Grella, SL; Guigueno, MF; White, DJ; Sherry, DF; Marrone, DF				Grella, Stephanie L.; Guigueno, Melanie F.; White, David J.; Sherry, David F.; Marrone, Diano F.			Context-Dependent Egr1 Expression in the Avian Hippocampus	PLOS ONE			English	Article							MOVING HOMING PIGEONS; EPISODIC-LIKE MEMORY; ENVIRONMENTAL CONTEXT; ARC EXPRESSION; GRANULE CELLS; CA3; REPRESENTATION; SUBDIVISIONS; ENSEMBLES; RESPONSES	In mammals, episodic memory and spatial cognition involve context-specific recruitment of unique ensembles in the hippocampal formation (HF). Despite their capacity for sophisticated spatial (e. g., for migration) and episodic-like ( e. g., for food-caching) memory, the mechanisms underlying contextual representation in birds is not well understood. Here we demonstrate environment-specific Egr1 expression as male brown-headed cowbirds (Molothrus ater) navigate environments for food reward, showing that the avian HF, like its mammalian counterpart, recruits distinct neuronal ensembles to represent different contexts.	[Grella, Stephanie L.; White, David J.; Marrone, Diano F.] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada; [Guigueno, Melanie F.] Univ Western Ontario, Dept Biol, London, ON N6A 3K7, Canada; [Sherry, David F.] Univ Western Ontario, Dept Psychol, London, ON N6A 3K7, Canada; [Marrone, Diano F.] Univ Arizona, McKnight Brain Inst, Tucson, AZ 85719 USA	Wilfrid Laurier University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Arizona	Marrone, DF (corresponding author), Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada.; Marrone, DF (corresponding author), Univ Arizona, McKnight Brain Inst, Tucson, AZ 85719 USA.	dmarrone@wlu.ca	Sherry, David F/B-2551-2014; Grella, Stephanie/GRJ-1808-2022	Sherry, David F/0000-0001-6623-2232; Grella, Stephanie/0000-0002-7828-4029	Natural Science and Engineering Research council of Canada	Natural Science and Engineering Research council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The Natural Science and Engineering Research council of Canada (www.nserc-crsng.gc.ca) supported this work through a scholarship to SLG, and operating funds to DJW, DFS, and DFM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alme CB, 2010, HIPPOCAMPUS, V20, P1109, DOI 10.1002/hipo.20810; Atoji Y, 2004, J COMP NEUROL, V475, P426, DOI 10.1002/cne.20186; Bingman VP, 2002, CURR OPIN NEUROBIOL, V12, P745, DOI 10.1016/S0959-4388(02)00375-6; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Casini G, 1997, ARCH ITAL BIOL, V135, P73; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Colombo M, 2000, NEUROSCI BIOBEHAV R, V24, P465, DOI 10.1016/S0149-7634(00)00016-6; Eichenbaum H, 2012, NEUROSCI BIOBEHAV R, V36, P1597, DOI 10.1016/j.neubiorev.2011.07.006; ERICHSEN JT, 1991, J COMP NEUROL, V314, P478, DOI 10.1002/cne.903140306; Feeney MC, 2009, ANIM COGN, V12, P767, DOI 10.1007/s10071-009-0236-x; Gheidi A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-100; Gheidi A, 2012, J NEUROSCI RES, V90, P1820, DOI 10.1002/jnr.23057; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hough GE, 2004, J COMP PHYSIOL A, V190, P1047, DOI 10.1007/s00359-004-0562-z; Howard MW, 2014, J NEUROSCI, V34, P4692, DOI 10.1523/JNEUROSCI.5808-12.2014; Jeffery KJ, 2013, BEHAV BRAIN SCI, V36, P523, DOI 10.1017/S0140525X12002476; KRENIK KD, 1989, J IMMUNOL METHODS, V117, P91, DOI 10.1016/0022-1759(89)90122-1; Marrone DF, 2014, HIPPOCAMPUS, V24, P1417, DOI 10.1002/hipo.22367; Marrone DF, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.021; Meconi A, 2015, NEUROSCI LETT, V603, P66, DOI 10.1016/j.neulet.2015.07.029; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Robitsek RJ, 2013, BEHAV BRAIN RES, V254, P65, DOI 10.1016/j.bbr.2012.12.034; Salwiczek LH, 2010, BEHAV BRAIN RES, V215, P221, DOI 10.1016/j.bbr.2010.06.011; Salz DM, 2016, J NEUROSCI, V36, P7476, DOI 10.1523/JNEUROSCI.0087-16.2016; Satvat E, 2011, J NEUROSCI, V31, P7163, DOI 10.1523/JNEUROSCI.0094-11.2011; SHERRY DF, 1989, BEHAV NEUROSCI, V103, P308, DOI 10.1037/0735-7044.103.2.308; Siegel JJ, 2005, HIPPOCAMPUS, V15, P26, DOI 10.1002/hipo.20025; Siegel JJ, 2006, HIPPOCAMPUS, V16, P125, DOI 10.1002/hipo.20139; Skinner DM, 2014, HIPPOCAMPUS, V24, P396, DOI 10.1002/hipo.22233; Striedter GF, 2016, J COMP NEUROL, V524, P496, DOI 10.1002/cne.23803; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338; Zinkivskay A, 2009, ANIM COGN, V12, P119, DOI 10.1007/s10071-008-0176-x	35	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164333	10.1371/journal.pone.0164333	http://dx.doi.org/10.1371/journal.pone.0164333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716817	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100045
J	Schwendeman, AR; Shaham, S				Schwendeman, Andrew R.; Shaham, Shai			A High-Throughput Small Molecule Screen for C-elegans Linker Cell Death Inhibitors	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CED-3 CASPASE; PROTEIN; NEMATODE; ACTIVATION; DRUG; IDENTIFICATION; INCLUSIONS; LINEAGES; POLARITY	Programmed cell death is a ubiquitous process in metazoan development. Apoptosis, one cell death form, has been studied extensively. However, mutations inactivating key mammalian apoptosis regulators do not block most developmental cell culling, suggesting that other cell death pathways are likely important. Recent work in the nematode Caenorhabditis elegans identified a non-apoptotic cell death form mediating the demise of the male-specific linker cell. This cell death process (LCD, linker cell-type death) is morphologically conserved, and its molecular effectors also mediate axon degeneration in mammals and Drosophila. To develop reagents to manipulate LCD, we established a simple high-throughput screening protocol for interrogating the effects of small molecules on C. elegans linker cell death in vivo. From 23,797 compounds assayed, 11 reproducibly block linker cell death onset. Of these, five induce animal lethality, and six promote a reversible developmental delay. These results provide proof-of principle validation of our screening protocol, demonstrate that developmental progression is required for linker cell death, and suggest that larger scale screens may identify LCD-specific small-molecule regulators that target the LCD execution machinery.	[Schwendeman, Andrew R.; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, Lab Dev Genet, 1230 York Ave, New York, NY 10021 USA.	shaham@rockefeller.edu			NIH [HD078703, NS081490]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (www.nih.gov) grants HD078703 and NS081490. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2007, DEV CELL, V12, P73, DOI 10.1016/j.devcel.2006.11.012; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Borsello T, 2002, J COMP NEUROL, V453, P361, DOI 10.1002/cne.10411; BOTS GTAM, 1981, ACTA NEUROPATHOL, V55, P21, DOI 10.1007/BF00691525; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; CAI Y, 2014, MBIO, V5, DOI DOI 10.1128/MBI0.01235-14; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Carre-Pierrat M, 2006, J MUSCLE RES CELL M, V27, P253, DOI 10.1007/s10974-006-9070-9; Chu-Wang I, 1978, JOURNAL OF COMPARATI, V177, DOI [10.1002/cne.901770105, DOI 10.1002/CNE.901770105]; Conery Annie L, 2014, Curr Protoc Chem Biol, V6, P25, DOI 10.1002/9780470559277.ch130160; Davies S W, 1997, Trends Cell Biol, V7, P422, DOI 10.1016/S0962-8924(97)88136-6; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; HODGKIN J, 1979, GENETICS, V91, P67; Hodgkin J, 2002, GENETICS, V162, P767; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kinet MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.12821; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Laraia L, 2015, CHEM BIOL, V22, P689, DOI 10.1016/j.chembiol.2015.04.019; Leung CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062166; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Malin JA, 2016, CELL DEATH DIFFER, V23, P1985, DOI 10.1038/cdd.2016.77; Maurer CW, 2007, DEVELOPMENT, V134, P1357, DOI 10.1242/dev.02818; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Nehme R, 2010, CELL DEATH DIFFER, V17, P1266, DOI 10.1038/cdd.2010.3; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Page AP, 2007, C ELEGANS RES COMMUN, DOI DOI 10.1895/WORMBOOK.1.138.1; Peden E, 2007, GENE DEV, V21, P3195, DOI 10.1101/gad.1607807; PILAR G, 1976, J CELL BIOL, V68, P339, DOI 10.1083/jcb.68.2.339; Rauthan Manish, 2015, Worm, V4, pe1096490, DOI 10.1080/21624054.2015.1096490; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; ROUGVIE AE, 1995, DEVELOPMENT, V121, P2491; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Segalat L, 2007, ACS CHEM BIOL, V2, P231, DOI 10.1021/cb700009m; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Takahashi H, 2001, BRAIN RES, V919, P12, DOI 10.1016/S0006-8993(01)02986-9; Tamai KK, 2007, DEV BIOL, V308, P562, DOI 10.1016/j.ydbio.2007.05.024; Teschner S, 2010, IMMUNOTHERAPY-UK, V2, P637, DOI [10.2217/imt.10.52, 10.2217/IMT.10.52]; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Venepe J, 2015, NAT COMMUN, V6, P7319, DOI [10.1038/ncomms8319, DOI 10.1038/NCOMMS8319]; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Zander C, 2001, HUM MOL GENET, V10, P2569, DOI 10.1093/hmg/10.22.2569; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	62	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164595	10.1371/journal.pone.0164595	http://dx.doi.org/10.1371/journal.pone.0164595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716809	gold, Green Submitted, Green Published			2022-12-27	WOS:000385698100063
J	Domoto, H; Iwaya, K; Ikomi, F; Matsuo, H; Tadano, Y; Fujii, S; Tachi, K; Itoh, Y; Sato, M; Inoue, K; Shinomiya, N				Domoto, Hideharu; Iwaya, Keiichi; Ikomi, Fumitaka; Matsuo, Hirotaka; Tadano, Yutaka; Fujii, Shigenori; Tachi, Kazuyoshi; Itoh, Yoshiyuki; Sato, Michiya; Inoue, Kimitoshi; Shinomiya, Nariyoshi			Up-Regulation of Antioxidant Proteins in the Plasma Proteome during Saturation Diving: Unique Coincidence under Hypobaric Hypoxia	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ALPHA-1-ACID GLYCOPROTEIN; HYPERBARIC STRESS; PLATELET COUNT; TRANSTHYRETIN; HAPTOGLOBIN; BIOMARKERS; DISEASE	Saturation diving (SD) is one of the safest techniques for tolerating hyperbaric conditions for long durations. However, the changes in the human plasma protein profile that occur during SD are unknown. To identify differential protein expression during or after SD, 65 blood samples from 15 healthy Japanese men trained in SD were analyzed by two-dimensional fluorescence difference gel electrophoresis. The expression of two proteins, one 32.4 kDa with an isoelectric point (pI) of 5.8 and the other 44.8 kDa with pI 4.0, were elevated during SD to 60, 100, and 200 meters sea water (msw). The expression of these proteins returned to pre-diving level when the SD training was completed. The two proteins were identified using in-gel digestion and mass spectrometric analysis; the 32.4 kDa protein was transthyretin and the 44.8 kDa protein was alpha-1-acid glycoprotein 1. Oxidation was detected at methionine 13 of transthyretin and at methionine 129 of alpha-1-acid glycoprotein 1 by tandem mass spectrometry. Moreover, haptoglobin was up-regulated during the decompression phase of 200 msw. These plasma proteins up-regulated during SD have a common function as anti-oxidants. This suggests that by coordinating their biological effects, these proteins activate a defense mechanism to counteract the effects of hyperbaric- hyperoxic conditions during SD.	[Domoto, Hideharu; Tadano, Yutaka; Fujii, Shigenori; Tachi, Kazuyoshi; Sato, Michiya; Inoue, Kimitoshi] Maritime Self Def Force Undersea Med Ctr, Div Res, Yokosuka, Kanagawa, Japan; [Iwaya, Keiichi] Kyoundo Hosp, SASAKI Inst, Dept Pathol, Chiyoda Ku, Tokyo, Japan; [Ikomi, Fumitaka] Natl Def Med Coll Res Inst, Tokorozawa, Saitama, Japan; [Matsuo, Hirotaka; Shinomiya, Nariyoshi] Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, Tokorozawa, Saitama, Japan; [Itoh, Yoshiyuki] JEOL Ltd, Akishima, Tokyo, Japan; [Domoto, Hideharu] Keiyu Hosp, Dept Pathol, Yokohama, Kanagawa, Japan; [Sato, Michiya] Minist Def, Maritime Staff Off, Shinjuku Ku, Tokyo, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan; Jeol Ltd; JEOL Japan	Iwaya, K (corresponding author), Kyoundo Hosp, SASAKI Inst, Dept Pathol, Chiyoda Ku, Tokyo, Japan.	iwaya@po.kyoundo.jp	Shinomiya, Nariyoshi/I-9666-2014	Matsuo, Hirotaka/0000-0003-4302-8719	JEOL	JEOL	JEOL provided support in the form of salaries for the author [YI], but did not have any additional role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author [YI] is articulated in the "author contributions" section.	Ahlen C, 1998, OCCUP ENVIRON MED, V55, P141, DOI 10.1136/oem.55.2.141; Ahmad Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098027; Ahmad Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067548; Alcaraz-Garcia MJ, 2008, J PHYSIOL BIOCHEM, V64, P135, DOI 10.1007/BF03168241; ANDO Y, 1993, INTERNAL MED, V32, P920, DOI 10.2169/internalmedicine.32.920; [Anonymous], 2011, US NAV DIV MAN; Anraku M, 2013, BBA-GEN SUBJECTS, V1830, P5465, DOI 10.1016/j.bbagen.2013.04.036; Bachtiar Indra, 2010, BMC Res Notes, V3, P319, DOI 10.1186/1756-0500-3-319; Bag AK, 2014, PROTEOME SCI, V12, DOI 10.1186/s12953-014-0048-z; Bast-Pettersen R, 2015, INT ARCH OCC ENV HEA, V88, P669, DOI 10.1007/s00420-014-0991-0; Bennett PB, 2004, BENNET ELLIOTS PHYSL, P323; Beyerstein G., P ADV SCI DIV WORKS; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; BRADLEY M E, 1974, Undersea Biomedical Research, V1, P151; Brubakk AO, 2014, COMPR PHYSIOL, V4, P1229, DOI 10.1002/cphy.c130048; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Chiellini C, 2002, J CELL PHYSIOL, V190, P251, DOI 10.1002/JCP.10061; Clapperton M, 2007, VET IMMUNOL IMMUNOP, V119, P303, DOI 10.1016/j.vetimm.2007.05.008; Costacou T, 2014, DIABETES VASC DIS RE, V11, P335, DOI 10.1177/1479164114539713; COSTELLO MJ, 1984, CLIN EXP IMMUNOL, V55, P465; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Domoto H, 2001, AVIAT SPACE ENVIR MD, V72, P380; Eftedal I, 2016, PROTEOM CLIN APPL, V10, P699, DOI 10.1002/prca.201600058; Faxen-Irving G, 2013, J ALZHEIMERS DIS, V36, P1, DOI 10.3233/JAD-121828; Fismen L, 2013, EUR J APPL PHYSIOL, V113, P1695, DOI 10.1007/s00421-013-2595-x; Fismen L, 2012, EUR J APPL PHYSIOL, V112, P2717, DOI 10.1007/s00421-011-2241-4; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Gasier HG, 2013, UNDERSEA HYPERBAR M, V40, P125; Gloeckner SF, 2008, J ALZHEIMERS DIS, V14, P17; Gornik O, 2008, DIS MARKERS, V25, P267, DOI 10.1155/2008/493289; Guan J, 2012, AM J PHYSIOL-HEART C, V302, pH544, DOI 10.1152/ajpheart.00815.2011; Hamilton RW, 2004, BENNET ELLIOTS PHYSL, P460; Henschke P, 2006, PROTEOMICS, V6, P1957, DOI 10.1002/pmic.200500245; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; JACKSON RM, 1985, CHEST, V88, P900, DOI 10.1378/chest.88.6.900; Jain K, 2013, HIGH ALT MED BIOL, V14, P65, DOI 10.1089/ham.2012.1064; Jensen FB, 2009, BBA-BIOENERGETICS, V1787, P841, DOI 10.1016/j.bbabio.2009.02.010; Krog J, 2010, AVIAT SPACE ENVIR MD, V81, P467, DOI 10.3357/ASEM.2528.2010; KUSHNER I, 1981, J LAB CLIN MED, V97, P739; Lautridou J, 2016, PROTEOM CLIN APPL, V10, P614, DOI 10.1002/prca.201600017; Lee CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076817; Levett DZH, 2008, POSTGRAD MED J, V84, P571, DOI 10.1136/pgmj.2008.068320; Marchesini GR, 2008, TOXICOL APPL PHARM, V232, P150, DOI 10.1016/j.taap.2008.06.014; Matsuo H, 2000, UNDERSEA HYPERBAR M, V27, P37; MOON RE, 1992, UNDERSEA BIOMED RES, V19, P279; Moore LE, 2012, CANCER-AM CANCER SOC, V118, P91, DOI 10.1002/cncr.26241; Mulkey DK, 2004, AM J PHYSIOL-CELL PH, V286, pC940, DOI 10.1152/ajpcell.00323.2003; Mulkey DK, 2003, J APPL PHYSIOL, V95, P922, DOI 10.1152/japplphysiol.00865.2002; Padhy G, 2013, HIGH ALT MED BIOL, V14, P289, DOI 10.1089/ham.2012.1095; Park Yang Saeng, 1998, Applied Human Science, V17, P1; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Sarrats A, 2010, PROTEOM CLIN APPL, V4, P432, DOI 10.1002/prca.200900150; SHINOMIYA N, 1994, UNDERSEA HYPERBAR M, V21, P277; Sousa JC, 2004, J NEUROCHEM, V88, P1052, DOI 10.1046/j.1471-4159.2003.02309.x; SUZUKI S, 1994, UNDERSEA HYPERBAR M, V21, P235; Takaoka Y, 2004, AM J PATHOL, V164, P337, DOI 10.1016/S0002-9440(10)63123-9; THOM SR, 1992, ARCH BIOCHEM BIOPHYS, V295, P391, DOI 10.1016/0003-9861(92)90532-2; Thornton MA, 2000, SURVEY ENG DESIGN AT, P41; TODNEM K, 1991, BRIT J IND MED, V48, P258; Tseng CF, 2004, PROTEOMICS, V4, P2221, DOI 10.1002/pmic.200300787; VAERNES RJ, 1989, UNDERSEA BIOMED RES, V16, P233; Vann RD, 1984, P 3 ANN CAN OC TECHN, P175; Vann RD, 2007, UNDERSEA HYPERBAR M, V34, P311; Watson L, 2012, LUPUS, V21, P496, DOI 10.1177/0961203311431249; Xu XF, 2009, OXID MED CELL LONGEV, V2, P7, DOI 10.4161/oxim.2.1.7697; Yamazaki F, 2003, AVIAT SPACE ENVIR MD, V74, P643; Yang YF, 2006, ANAL CHEM, V78, P3571, DOI 10.1021/ac051916x; Zhu L, 2014, EXP THER MED, V7, P1332, DOI 10.3892/etm.2014.1558	69	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163804	10.1371/journal.pone.0163804	http://dx.doi.org/10.1371/journal.pone.0163804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741252	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000006
J	Enterria-Morales, D; Lopez-Lopez, I; Lopez-Barneo, J; de Tassigny, XD				Enterria-Morales, Daniel; Lopez-Lopez, Ivette; Lopez-Barneo, Jose; d'Anglemont de Tassigny, Xavier			Striatal GDNF Production Is Independent to Circulating Estradiol Level Despite Pan-Neuronal Activation in the Female Mouse	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; PARKINSONS-DISEASE; SEX-DIFFERENCES; ADULT; NEUROPROTECTION; SURVIVAL; SYSTEM; MODEL; BETA; 17-BETA-ESTRADIOL	Gender difference in Parkinson's disease (PD) suggests that female sex steroids may promote dopaminergic neuron survival and protect them from degeneration. The glial cell line-derived neurotrophic factor (GDNF) is believed to be dopaminotrophic; thus it is considered as a potential therapeutic target in PD. Additionally, GDNF is endogenously synthetized in the caudate/putamen of humans and striatum in rodents. A neuroprotective role of estrogens on the nigrostriatal pathway via the stimulation of GDNF has been proposed. Since the GDNF-producing parvalbumin (Parv) interneurons express the estrogen receptor alpha in the mouse striatum, we sought to determine whether ectopic estrogenic compound modulates the GDNF synthesis in mice. Using an ovariectomized-estradiol (E-2) replacement regimen, which reliably generates a rise of plasma estradiol, we assessed the effects of different levels of E-2 on the activation of striatal neuronal populations, and GDNF production. A strong correlation was found between plasma E-2 and the expression of the immediate early gene cFos in the striatum, as well as in other cortical regions. However, moderate and high E-2 treatments failed to induce any striatal GDNF mRNA and protein synthesis. High E-2 only stimulates cFos induction in a low percentage of striatal Parv neurons whereas the majority of cFos-positive cells are medium spiny neurons. Activation of these projecting neurons by E-2 suggests a role of circulating sex steroids in the modulation of striatal neural pathways.	[Enterria-Morales, Daniel; Lopez-Lopez, Ivette; Lopez-Barneo, Jose; d'Anglemont de Tassigny, Xavier] Univ Seville, Inst Biomed Sevilla IBIS, Dept Fisiol Med & Biofis, Hosp Univ Virgen del Rocio,CSIC, Seville, Spain; [Lopez-Barneo, Jose; d'Anglemont de Tassigny, Xavier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBERNED	de Tassigny, XD (corresponding author), Univ Seville, Inst Biomed Sevilla IBIS, Dept Fisiol Med & Biofis, Hosp Univ Virgen del Rocio,CSIC, Seville, Spain.; de Tassigny, XD (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	xavier-ibis@us.es	IBIS, NEUROBIOLOGIA/O-9922-2015; Enterria-Morales, Daniel/AAO-5729-2021	Enterria Morales, Daniel/0000-0001-8637-0528	Institute de Salud Carlos iii; Miguel Servet fellowship [CP12-03217]; iPFIS studentship	Institute de Salud Carlos iii(Instituto de Salud Carlos III); Miguel Servet fellowship; iPFIS studentship	This work was supported by: Institute de Salud Carlos iii, Miguel Servet fellowship CP12-03217 (XDADT), and iPFIS studentship (DEM). http://www.eng.isciii.es/ISCIII/es/general/index.shtml. Fundacion BBVA (XDADT). http://www.fbbva.es/TLFU/tifu/ing/home/index.jsp. Fundacion Botin (JLB). http://www.fundacionbotin.org/. Centro de Investigacion Biomedica en Red, Enfermedades Neurodegenerativas (JLB). http://ciberned.es/en.html. Ministerio de Economia y Competitividad: Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2013-2016 (JLB). http://www.idi.mineco.gob.es/portal/site/MICINN/menuitern.7eeac5cd345b4f34f09dfd100 1432ea0/?vgnextoid=83b192b9036c2210VgnV CM1000001d04140aRCRD&lang choosen=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sweidi S, 2015, J STEROID BIOCHEM, V2016, P1; Al-Sweidi S, 2011, NEUROPHARMACOLOGY, V61, P583, DOI 10.1016/j.neuropharm.2011.04.031; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; BECKER JB, 1990, NEUROSCI LETT, V118, P169, DOI 10.1016/0304-3940(90)90618-J; BECKER JB, 1990, SYNAPSE, V5, P157, DOI 10.1002/syn.890050211; Bessa A, 2015, BBA-MOL BASIS DIS, V1852, P2035, DOI 10.1016/j.bbadis.2015.07.004; Bode FJ, 2008, HUM MOL GENET, V17, P2595, DOI 10.1093/hmg/ddn159; Bourque M, 2015, NEUROPHARMACOLOGY, V95, P343, DOI 10.1016/j.neuropharm.2015.04.006; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; BRONSON FH, 1981, ENDOCRINOLOGY, V108, P506, DOI 10.1210/endo-108-2-506; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Campos FL, 2012, J NEUROENDOCRINOL, V24, P1386, DOI 10.1111/j.1365-2826.2012.02348.x; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Cordellini MF, 2011, NEUROCHEM RES, V36, P955, DOI 10.1007/s11064-011-0428-z; de Tassigny XD, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00010; D'Astous M, 2006, MOL PHARMACOL, V69, P1492, DOI 10.1124/mol.105.018671; D'Astous M, 2004, NEUROPHARMACOLOGY, V47, P1180, DOI 10.1016/j.neuropharm.2004.08.020; Dluzen D, 1997, BRAIN RES, V767, P340, DOI 10.1016/S0006-8993(97)00630-6; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Gillies GE, 2004, PHARMACOL BIOCHEM BE, V78, P513, DOI 10.1016/j.pbb.2004.04.022; Grove-Strawser D, 2010, NEUROSCIENCE, V170, P1045, DOI 10.1016/j.neuroscience.2010.08.012; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hidalgo-Figueroa M, 2012, J NEUROSCI, V32, P864, DOI 10.1523/JNEUROSCI.2693-11.2012; Jennings PJ, 1998, BEHAV NEUROSCI, V112, P154, DOI 10.1037/0735-7044.112.1.154; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kopra J, 2015, NAT NEUROSCI, V18, P319, DOI 10.1038/nn.3941; Kuppers E, 2008, PSYCHONEUROENDOCRINO, V33, P832, DOI 10.1016/j.psyneuen.2008.03.007; Kumar A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005710; Kuppers E, 1999, NEUROSCI LETT, V276, P95, DOI 10.1016/S0304-3940(99)00815-0; Lammers CH, 1999, SYNAPSE, V34, P222, DOI 10.1002/(SICI)1098-2396(19991201)34:3<222::AID-SYN6>3.0.CO;2-J; Litim N, 2016, NEUROSCI BIOBEHAV R, V67, P79, DOI 10.1016/j.neubiorev.2015.09.024; Liu B, 2007, CLIN EXP PHARMACOL P, V34, P555, DOI 10.1111/j.1440-1681.2007.04616.x; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Morissette M, 2008, J STEROID BIOCHEM, V108, P327, DOI 10.1016/j.jsbmb.2007.09.011; Morissette M, 2007, NEUROPHARMACOLOGY, V52, P1509, DOI 10.1016/j.neuropharm.2007.02.004; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Pascual A, 2015, NAT NEUROSCI, V18, P322, DOI 10.1038/nn.3942; Peterson BM, 2015, BRAIN STRUCT FUNCT, V220, P2415, DOI 10.1007/s00429-014-0794-9; PFAUS JG, 1993, BRAIN RES, V624, P253, DOI 10.1016/0006-8993(93)90085-2; Pleil KE, 2011, ENDOCRINOLOGY, V152, P946, DOI 10.1210/en.2010-0715; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Smith KM, 2014, EXP NEUROL, V259, P44, DOI 10.1016/j.expneurol.2014.03.010; Titolo D, 2008, J NEUROSCI, V28, P6473, DOI 10.1523/JNEUROSCI.0514-08.2008; TOMAC A, 1995, P NATL ACAD SCI USA, V92, P8274, DOI 10.1073/pnas.92.18.8274; Tozzi A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00192, 10.3389/fncel.2015.0010]; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982	49	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164391	10.1371/journal.pone.0164391	http://dx.doi.org/10.1371/journal.pone.0164391			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741271	Green Published, gold			2022-12-27	WOS:000385507000031
J	Laszlo, L; Sarkadi, B; Hegedus, T				Laszlo, Laura; Sarkadi, Balazs; Hegedus, Tamas			Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter	PLOS ONE			English	Article							RESISTANCE PROTEIN BCRP/ABCG2; MOLECULAR-DYNAMICS SIMULATIONS; NUCLEOTIDE-BINDING DOMAIN; ABC TRANSPORTER; P-GLYCOPROTEIN; ATP-BINDING; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; DRUG-RESISTANCE; FORCE-FIELD	ABCG2/BCRP is a membrane protein, involved in xenobiotic and endobiotic transport in key pharmacological barriers and drug metabolizing organs, in the protection of stem cells, and in multidrug resistance of cancer. Pharmacogenetic studies implicated the role of ABCG2 in response to widely used medicines and anticancer agents, as well as in gout. Its Q141K variant exhibits decreased functional expression thus increased drug accumulation and decreased urate secretion. Still, there has been no reliable molecular model available for this protein, as the published structures of other ABC transporters could not be properly fitted to the ABCG2 topology and experimental data. The recently published high resolution structure of a close homologue, the ABCG5-ABCG8 heterodimer, revealed a new ABC transporter fold, unique for ABCG proteins. Here we present a structural model of the ABCG2 homodimer based on this fold and detail the experimental results supporting this model. In order to describe the effect of mutations on structure and dynamics, and characterize substrate recognition and cholesterol regulation we performed molecular dynamics simulations using full length ABCG2 protein embedded in a membrane bilayer and in silico docking simulations. Our results show that in the Q141K variant the introduced positive charge diminishes the interaction between the nucleotide binding and transmembrane domains and the R482G variation alters the orientation of transmembrane helices. Moreover, the R482 position, which plays a role the substrate specificity of the transporter, is located in one of the substrate binding pockets identified by the in silico docking calculations. In summary, the ABCG2 model and in silico simulations presented here may have significant impact on understanding drug distribution and toxicity, as well as drug development against cancer chemotherapy resistance or gout.	[Laszlo, Laura; Sarkadi, Balazs; Hegedus, Tamas] Semmelweis Univ, Mol Biophys Res Grp, Budapest, Hungary; [Laszlo, Laura; Sarkadi, Balazs; Hegedus, Tamas] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary; [Sarkadi, Balazs] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary	Semmelweis University; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Hegedus, T (corresponding author), Semmelweis Univ, Mol Biophys Res Grp, Budapest, Hungary.; Hegedus, T (corresponding author), Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary.	tamas.hegedus@hegelab.org			National Research, Development and Innovation Office [K111678, K115375]; Hungarian Academy of Sciences; Bolyai Fellowship	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Bolyai Fellowship(Hungarian Academy of Sciences)	This work was supported by National Research, Development and Innovation Office, http://nkfih.gov.hu, K111678 (T.H.) and K115375 (B.S.); and Hungarian Academy of Sciences, http://mta.hu, Bolyai Fellowship (T.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; Csanady L, 2005, J GEN PHYSIOL, V125, P43, DOI 10.1085/jgp.200409174; Cusatis G, 2006, J NATL CANCER I, V98, P1739, DOI 10.1093/jnci/djj469; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Diop NK, 2005, BIOCHEMISTRY-US, V44, P5420, DOI 10.1021/bi0479858; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Gal Z, 2015, BBA-BIOMEMBRANES, V1848, P477, DOI 10.1016/j.bbamem.2014.11.006; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Hegedus C, 2015, ADV CANCER RES, V125, P97, DOI 10.1016/bs.acr.2014.10.004; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Honjo Y, 2001, CANCER RES, V61, P6635; Hou YX, 2009, BIOCHEMISTRY-US, V48, P9122, DOI 10.1021/bi900675v; Ieiri I, 2012, DRUG METAB PHARMACOK, V27, P85, DOI 10.2133/dmpk.DMPK-11-RV-098; Ivetac A, 2008, EUR BIOPHYS J BIOPHY, V37, P403, DOI 10.1007/s00249-007-0225-4; Kelly Libusha, 2009, Journal of Structural and Functional Genomics, V10, P269, DOI 10.1007/s10969-009-9069-8; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Kondo C, 2004, PHARM RES-DORDR, V21, P1895, DOI 10.1023/B:PHAM.0000045245.21637.d4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Li YF, 2007, J MOL GRAPH MODEL, V25, P837, DOI 10.1016/j.jmgm.2006.08.005; Litman T, 2000, J CELL SCI, V113, P2011; Liu Y, 2008, J PHARMACOL EXP THER, V326, P33, DOI 10.1124/jpet.108.138115; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Mizuarai S, 2004, INT J CANCER, V109, P238, DOI 10.1002/ijc.11669; Morisaki K, 2005, CANCER CHEMOTH PHARM, V56, P161, DOI 10.1007/s00280-004-0931-x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Ni ZL, 2011, BIOCHEMISTRY-US, V50, P8057, DOI 10.1021/bi200573t; Ni ZL, 2010, AM J PHYSIOL-CELL PH, V299, pC1100, DOI 10.1152/ajpcell.00160.2010; Noguchi K, 2014, PHARMACOGN PERS MED, V7, P53, DOI 10.2147/PGPM.S38295; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Ozvegy-Lacka C, 2005, BBA-BIOMEMBRANES, V1668, P53, DOI 10.1016/j.bbamem.2004.11.005; Ozvegy-Laczka C, 2008, J BIOL CHEM, V283, P26059, DOI 10.1074/jbc.M803230200; Pajeva IK, 2009, FEBS J, V276, P7016, DOI 10.1111/j.1742-4658.2009.07415.x; Polgar O, 2009, BBA-BIOMEMBRANES, V1788, P1434, DOI 10.1016/j.bbamem.2009.04.016; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenberg MF, 2010, STRUCTURE, V18, P482, DOI 10.1016/j.str.2010.01.017; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; Saranko H, 2013, BIOCHEM BIOPH RES CO, V437, P140, DOI 10.1016/j.bbrc.2013.06.054; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Telbisz A, 2013, BIOCHEM J, V450, P387, DOI 10.1042/BJ20121485; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Velamakanni S, 2008, MOL PHARMACOL, V73, P12, DOI 10.1124/mol.108.038299; Wang HG, 2008, BIOCHEMISTRY-US, V47, P13778, DOI 10.1021/bi801644v; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	72	40	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164426	10.1371/journal.pone.0164426	http://dx.doi.org/10.1371/journal.pone.0164426			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741279	gold, Green Published, Green Accepted			2022-12-27	WOS:000385507000032
J	Lee, WSC; Atance, CM				Lee, Wendy S. C.; Atance, Cristina M.			The Effect of Psychological Distance on Children's Reasoning about Future Preferences	PLOS ONE			English	Article							EXECUTIVE FUNCTION; DECISION-MAKING; SELF-REFLECTION; OTHERS; ALTRUISM; THINKING; CHOICES; DELAY	Young preschool-aged children often have difficulty thinking about the future, but tend to reason better about another person's future than their own. This benefit may reflect psychological distance from one's own emotions, beliefs, and states that may bias thinking. In adults, reasoning for others who are more socially distant (i.e., dissimilar, unfamiliar other) is associated with wiser and more adaptive reasoning. The current studies examined whether this effect of social distance could be demonstrated in young children's future thinking. In a future preferences task, 3-and 4-year-olds were shown 5 pairs of child and adult items and selected which ones they would prefer when grown-up. Children answered for themselves, a socially close peer, or a socially distant peer. Social distance was manipulated by varying similarity in Study 1 and familiarity in Study 2. In Study 1, reasoning for similar and dissimilar peers was significantly more accurate than reasoning for the self, but reasoning for similar and dissimilar peers did not differ. In Study 2, scores showed a stepwise increase from self, familiar peer, to unfamiliar peer, but only reasoning for an unfamiliar peer was significantly better more accurate than reasoning for the self. Reasoning for a familiar peer did not differ from reasoning for the self or for an unfamiliar peer. These results suggest that, like adults, children benefit from psychological distance when reasoning for others, but are less sensitive to degrees of social distance, showing no graded effects on performance in Study 1 and weak effects in Study 2. Stronger adult-like effects may only emerge with increasing age and development of other socio-cognitive skills.	[Lee, Wendy S. C.; Atance, Cristina M.] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada	University of Ottawa	Atance, CM (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON, Canada.	atance@uottawa.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN/2015-06446]; Government of Ontario	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Government of Ontario	This research was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN/2015-06446; http://www.nserc-crsng.gc.ca/) and by the Government of Ontario (https.//www.ontario.ca/page/research funding) to CMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atance C. M., 2005, FIRST LANG, V25, P5; Atance CM, 2005, LEARN MOTIV, V36, P126, DOI 10.1016/j.lmot.2005.02.003; Atance CM, 2005, COGNITIVE DEV, V20, P341, DOI 10.1016/j.cogdev.2005.05.001; Atance CM, 2006, PSYCHOL SCI, V17, P583, DOI 10.1111/j.1467-9280.2006.01748.x; Atance CM, 2015, CHILD DEV PERSPECT, V9, P178, DOI 10.1111/cdep.12128; Atance CM, 2010, DEV PSYCHOL, V46, P1505, DOI 10.1037/a0020374; Belanger MJ, 2014, CHILD DEV, V85, P2419, DOI 10.1111/cdev.12282; Busby J, 2005, COGNITIVE DEV, V20, P362, DOI 10.1016/j.cogdev.2005.05.002; Carlson SM, 2008, ENCY INFANT EARLY CH, V3, P288, DOI DOI 10.1016/B978-012370877-9.00158-4; DeJesus JM, 2014, COGNITIVE SCI, V38, P178, DOI 10.1111/cogs.12093; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Garon N, 2011, COGNITIVE DEV, V26, P383, DOI 10.1016/j.cogdev.2011.09.007; Grossmann I, 2014, PSYCHOL SCI, V25, P1571, DOI 10.1177/0956797614535400; Gunia BC, 2009, J EXP SOC PSYCHOL, V45, P1238, DOI 10.1016/j.jesp.2009.07.004; HUDSON JA, 1995, CHILD DEV, V66, P984, DOI 10.1111/j.1467-8624.1995.tb00917.x; KANFER FH, 1981, CHILD DEV, V52, P674, DOI 10.1111/j.1467-8624.1981.tb03095.x; Kim H, 2013, PERS SOC PSYCHOL B, V39, P1005, DOI 10.1177/0146167213488214; Kross E, 2005, PSYCHOL SCI, V16, P709, DOI 10.1111/j.1467-9280.2005.01600.x; Kross E, 2012, J EXP PSYCHOL GEN, V141, P43, DOI 10.1037/a0024158; Kross E, 2011, EMOTION, V11, P1032, DOI 10.1037/a0021787; Lee WSC, 2015, CHILD DEV, V86, P1434, DOI 10.1111/cdev.12401; Liberman N, 2014, TRENDS COGN SCI, V18, P364, DOI 10.1016/j.tics.2014.03.001; Liviatan I, 2008, J EXP SOC PSYCHOL, V44, P1256, DOI 10.1016/j.jesp.2008.04.007; Mahy CEV, 2014, BRIT J DEV PSYCHOL, V32, P65, DOI 10.1111/bjdp.12023; Metcalf JL, 2011, COGNITIVE DEV, V26, P371, DOI 10.1016/j.cogdev.2011.09.003; Miller DT, 1998, EUR J SOC PSYCHOL, V28, P475, DOI 10.1002/(SICI)1099-0992(199805/06)28:3<475::AID-EJSP881>3.0.CO;2-M; Mischel W., 1974, ADV EXP SOC PSYCHOL, V7, P249, DOI [10.1016/S0065-2601(08)60039-8, DOI 10.1016/S0065-2601(08)60039-8]; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Moore C, 1998, SOC DEV, V7, P198, DOI 10.1111/1467-9507.00062; Moore C, 2009, PSYCHOL SCI, V20, P944, DOI 10.1111/j.1467-9280.2009.02378.x; NISAN M, 1977, CHILD DEV, V48, P488, DOI 10.1111/j.1467-8624.1977.tb01188.x; Paulus M, 2015, INT J BEHAV DEV, V39, P53, DOI 10.1177/0165025414537923; Polman E, 2011, PERS SOC PSYCHOL B, V37, P492, DOI 10.1177/0146167211398362; Prencipe A, 2005, PSYCHOL SCI, V16, P501, DOI 10.1111/j.0956-7976.2005.01564.x; Quon E, 2010, J COGN DEV, V11, P37, DOI 10.1080/15248370903453576; Renoult L, 2016, Q J EXP PSYCHOL, V69, P299, DOI 10.1080/17470218.2015.1046463; Russell J, 2010, COGNITION, V114, P56, DOI 10.1016/j.cognition.2009.08.013; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Sigel IE, 1968, MIAMI S PREDICTION B, P99; Stephan E, 2011, J EXP SOC PSYCHOL, V47, P397, DOI 10.1016/j.jesp.2010.11.001; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Suddendorf T, 2011, DEVELOPMENTAL SCI, V14, P26, DOI 10.1111/j.1467-7687.2010.00950.x; Thompson C, 1997, COGNITIVE DEV, V12, P199, DOI 10.1016/S0885-2014(97)90013-7; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Vanderwal T, 2008, NEUROIMAGE, V41, P1437, DOI 10.1016/j.neuroimage.2008.03.058; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; White RE, 2016, DEVELOPMENTAL SCI, V19, P419, DOI 10.1111/desc.12314; White RE, 2015, CHILD DEV, V86, P1272, DOI 10.1111/cdev.12370	49	20	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164382	10.1371/journal.pone.0164382	http://dx.doi.org/10.1371/journal.pone.0164382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741264	Green Submitted, gold, Green Published			2022-12-27	WOS:000385507000029
J	Newsom, C; Schut, HK; Stroebe, MS; Wilson, S; Birrell, J				Newsom, Catherine; Schut, Hen K.; Stroebe, Margaret S.; Wilson, Stewart; Birrell, John			Initial Validation of a Comprehensive Assessment Instrument for Bereavement-Related Grief Symptoms and Risk of Complications: The Indicator of Bereavement Adaptation-Cruse Scotland (IBACS)	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; TRAUMATIC GRIEF; DEPRESSION; ANXIETY; PRINCIPLES; AVOIDANCE; INVENTORY; HEALTH; SCALE; CARE	Objective This study assessed the validity of the Indicator of Bereavement Adaptation Cruse Scotland (IBACS). Designed for use in clinical and non-clinical settings, the IBACS measures severity of grief symptoms and risk of developing complications. Method N = 196 (44 male, 152 female) help-seeking, bereaved Scottish adults participated at two timepoints: T1 (baseline) and T2 (after 18 months). Four validated assessment instruments were administered: CORE-R, ICG-R, IES-R, SCL-90-R. Discriminative ability was assessed using ROC curve analysis. Concurrent validity was tested through correlation analysis at T1. Predictive validity was assessed using correlation analyses and ROC curve analysis. Optimal IBACS cutoff values were obtained by calculating a maximal Youden index J in ROC curve analysis. Clinical implications were compared across instruments. Results ROC curve analysis results (AUC=.84, p < .01, 95% CI between .77 and .90) indicated the IBACS is a good diagnostic instrument for assessing complicated grief. Positive correlations (p < .01, 2-tailed) with all four instruments at T1 demonstrated the IBACS' concurrent validity, strongest with complicated grief measures (r = .82). Predictive validity was shown to be fair in T2 ROC curve analysis results (n = 67, AUC = .78, 95% CI between .65 and .92; p < .01). Predictive validity was also supported by stable positive correlations between IBACS and other instruments at T2. Clinical indications were found not to differ across instruments. Conclusions The IBACS offers effective grief symptom and risk assessment for use by non-clinicians. Indications are sufficient to support intake assessment for a stepped model of bereavement intervention.	[Newsom, Catherine; Schut, Hen K.; Stroebe, Margaret S.] Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands; [Stroebe, Margaret S.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Wilson, Stewart; Birrell, John] Cruse Bereavement Care Scotland, Perth, Scotland	Utrecht University; University of Groningen	Newsom, C (corresponding author), Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands.	c.newsom1@uu.nl		Newsom, Catherine/0000-0002-7453-3817	Utrecht University's Linschoten Institute for Psychological Research	Utrecht University's Linschoten Institute for Psychological Research	Funding was provided by a grant from Utrecht University's Linschoten Institute for Psychological Research.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Aoun SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121101; Barkham M, 2006, COUNS PSYCHOTHER RES, V6, P3, DOI 10.1080/14733140600581218; Bech P, 2014, J AFFECT DISORDERS, V160, P98, DOI 10.1016/j.jad.2013.12.005; Boelen P., 2013, COMPLICATED GRIEF SC, P85; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; Boelen PA, 2007, EUR ARCH PSY CLIN N, V257, P444, DOI 10.1007/s00406-007-0744-0; Boyle PJ, 2011, EPIDEMIOLOGY, V22, P1, DOI 10.1097/EDE.0b013e3181fdcc0b; Breen LJ, 2014, DEATH STUD, V38, P54, DOI 10.1080/07481187.2012.725451; Buckley T, 2012, AM J CARDIOL, V110, P1378, DOI 10.1016/j.amjcard.2012.06.045; Burke L.A., 2013, COMPLICATED GRIEF SC, P145; Cohen J.E., 1988, STAT POWER ANAL BEHA; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Currier JM, 2008, PSYCHOL BULL, V134, P648, DOI 10.1037/0033-2909.134.5.648; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Derogatis LR, 1977, SCL 90 R MANUAL; Derogatis LR., 2010, CORSINI ENCY PSYCHOL, DOI [10.1002/9780470479216.corpsy0970, DOI 10.1002/9780470479216.CORPSY0970]; Eisma MC, 2013, J ABNORM PSYCHOL, V122, P961, DOI 10.1037/a0034051; Ettema J, 1986, SCL 90 HANDLEIDING B; Evans C, 2002, BRIT J PSYCHIAT, V180, P51, DOI 10.1192/bjp.180.1.51; Faschingbauer T.R., 1981, TEXAS REVISED INVENT; Feltham C, 2000, HDB COUNSELLING PSYC, P2; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Guldin MB, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-9; Hogan NS, 2001, DEATH STUD, V25, P1, DOI 10.1080/074811801750058609; Ito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031209; Kersting A, 2011, J AFFECT DISORDERS, V131, P339, DOI 10.1016/j.jad.2010.11.032; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Michalski MJ, 2006, OMEGA-J DEATH DYING, V54, P91; Neimeyer R.A., 2008, HDB BEREAVEMENT RES, P133, DOI [10.1037/14498-007, DOI 10.1037/14498-007, DOI 10.1037/14498-000]; Newsom C, 2016, DEATH STUD, V40, P71, DOI 10.1080/07481187.2015.1068244; Prigerson H.G., 2001, HDB BEREAVEMENT RES, P613, DOI DOI 10.1037/10436-026; Prigerson HG, 1996, ANXIETY, V2, P1; Prigerson HG, 1999, BRIT J PSYCHIAT, V174, P67, DOI 10.1192/bjp.174.1.67; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Prinz U, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-104; Schut Henk, 2005, J Palliat Med, V8 Suppl 1, pS140; Sealey M, 2015, PALLIATIVE MED, V29, P577, DOI 10.1177/0269216315576262; Shear M. K., 2015, EVIDENCE BASED TREAT, P299, DOI [10.1007/978-3-319-07109-1_15, DOI 10.1007/978-3-319-07109-1_15(1950)3:1%3C32::AID-CNCR2820030106%3E3.0.CO;2-3]; Shear M Katherine, 2012, Dialogues Clin Neurosci, V14, P119; Shear MK, 2012, CURR PSYCHIAT REP, V14, P169, DOI 10.1007/s11920-012-0270-2; Sim J, 2014, QUAL LIFE RES, V23, P1211, DOI 10.1007/s11136-013-0551-1; Stephen AI, 2008, NURS TIMES, V104, P32; Stephen AI, 2015, DEATH STUD, V39, P151, DOI 10.1080/07481187.2014.920435; Stephen AI, 2009, DEATH STUD, V33, P239, DOI 10.1080/07481180802671944; Stroebe M, 2007, EUR ARCH PSY CLIN N, V257, P462, DOI 10.1007/s00406-007-0746-y; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; STROEBE MS, 1989, OMEGA-J DEATH DYING, V20, P1, DOI 10.2190/C3JE-C9L1-5R91-DWDU; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; The Scottish Government, 2010, SHAP BER CAR; Weiss Daniel S., 1997, P399; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zisook S, 1998, Ann Clin Psychiatry, V10, P157, DOI 10.3109/10401239809147032; Zisook S, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0482-8; Zisook S, 2010, J CLIN PSYCHIAT, V71, P1097, DOI 10.4088/JCP.10ac06391blu	55	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164005	10.1371/journal.pone.0164005	http://dx.doi.org/10.1371/journal.pone.0164005			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741246	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000014
J	Barri, FR				Rafael Barri, Fernando			Reintroducing Guanaco in the Upper Belt of Central Argentina: Using Population Viability Analysis to Evaluate Extinction Risk and Management Priorities	PLOS ONE			English	Article							CONDORITO NATIONAL-PARK; LAMA-GUANICOE POPULATION; MONTE DESERT; HABITAT USE; CONSERVATION; DEFAUNATION; MOUNTAINS; DIVERSITY; PATAGONIA; SURVIVAL	Wildlife reintroduction is an increasingly used strategy to reverse anthropocene defaunation. For the purpose of ecosystem restoration, in 2007 the guanaco (Lama guanicoe) was reintroduced to the Quebrada del Condorito National Park, situated in the mountains of central Argentina. With the aim of developing management recommendations, the project included permanently monitoring the population to evaluate its dynamics and the ecological response of the individuals released into the area. Nine years later and after two releases of guanacos (113 individuals in 2007 without and 25 in 2011 with a pre-adaptation period), only 24 individuals, which conform three reproductive groups, and one group of solitary males were settled in the Park. Here I modeled a population viability analysis to evaluate extinction risk, using VORTEX software. Initial population structure, specified age distribution, mortality and reproductive rates, and mate monopolization recorded during field work were used in the model, whereas the remaining used demographic parameters, such as age of first offspring, maximum number of broods per year, mean foaling rate, and length of fecundity period, were taken from the literature. Each of the three different scenarios (without supplementation of individuals, and with a realistic and optimistic supplementation) and two possible catastrophic events (fires and food shortage) covering 100 years was repeated 1000 times. Even though the guanaco reintroduction project can be considered to have been partially successful since its start, the model predicts that the current reintroduced population could be extinct in the next few decades if no reinforcements occur, and that only a continuous supplementation can reach the probability that the population survives over the next 100 years. I conclude that, so far, the current population is at a high risk of extinction if further supplementation of individuals is discontinued.	[Rafael Barri, Fernando] Univ Nacl Cordoba, CONICET UNC, IDEA, Av Velez Sarsfield 299, RA-5000 Cordoba, Argentina; [Rafael Barri, Fernando] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Av Velez Sarsfield 299, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Barri, FR (corresponding author), Univ Nacl Cordoba, CONICET UNC, IDEA, Av Velez Sarsfield 299, RA-5000 Cordoba, Argentina.; Barri, FR (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Av Velez Sarsfield 299, RA-5000 Cordoba, Argentina.	fernando.barri@unc.edu.ar			Secretaria de Ciencia y Tecnica (SECyT) of Universidad Nacional de Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Secretaria de Ciencia y Tecnica (SECyT) of Universidad Nacional de Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was funded by Secretaria de Ciencia y Tecnica (SECyT) of Universidad Nacional de Cordoba, and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) of Argentina.; We are grateful to the Delegacion Regional Centro of the Administracion de Parques Nacionales of Argentina for granting the permission to conduct the research in the Quebrada del Condorito National Park. German Jaacks contributed with field data monitoring, Daniel Renison and anonymous reviewer constructively criticized the manuscript and Jorgelina Brasca helped with the English. Financial support was provided by Secretaria de Ciencia y Tecnica (SECyT) of Universidad Nacional de Cordoba, and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET).	Acebes P, 2010, MAMMALIA, V74, P57, DOI 10.1515/MAMM.2009.071; Arganaraz JP, 2015, SCI TOTAL ENVIRON, V520, P1, DOI 10.1016/j.scitotenv.2015.02.081; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Armstrong DP, 2007, J APPL ECOL, V44, P953, DOI 10.1111/j.1365-2664.2007.01320.x; Armstrong Doug P., 2012, P165; Bach LA, 2010, J NAT CONSERV, V18, P237, DOI 10.1016/j.jnc.2009.09.001; Bank MS, 2003, BIOL CONSERV, V112, P427, DOI 10.1016/S0006-3207(02)00342-7; Barri Fernando R, 2014, Ecol. austral, V24, P203; Barri Fernando R, 2014, Mastozool. neotrop., V21, P09; Barri FR, 2011, ACTA ETHOL, V14, P103, DOI 10.1007/s10211-011-0098-5; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Berberian E., 2001, HIST ARGENTINA PREHI, V2, P635; Cabido D., 2003, SERIE C PUBLICACIONE; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Cingolani AM, 2008, J BIOGEOGR, V35, P538, DOI 10.1111/j.1365-2699.2007.01807.x; Cingolani AM, 2015, J HYDROL, V525, P178, DOI 10.1016/j.jhydrol.2015.03.041; Cingolani AM, 2013, RANGELAND J, V35, P285, DOI 10.1071/RJ12095; Cingolani AM, 2014, PERSPECT PLANT ECOL, V16, P143, DOI 10.1016/j.ppees.2014.04.002; Colladon, 2014, ANUARIO PLUVIOMETRIC; Converse SJ, 2013, J WILDLIFE MANAGE, V77, P1145, DOI 10.1002/jwmg.472; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Ellner SP, 2002, CONSERV BIOL, V16, P258, DOI 10.1046/j.1523-1739.2002.00553.x; Flores CE, 2012, RANGELAND J, V34, P439, DOI 10.1071/RJ12040; Forys EA, 1999, J WILDLIFE MANAGE, V63, P251, DOI 10.2307/3802507; Franklin W. L., 1982, MAMMALIAN BIOL S AM, P457; Franklin WL, 1999, BIOL CONSERV, V90, P33, DOI 10.1016/S0006-3207(99)00008-7; Garcia C, 2008, J APPL ECOL, V45, P351, DOI 10.1111/j.1365-2664.2007.01388.x; Gonzalez BA, 2006, MAMMAL REV, V36, P157, DOI 10.1111/j.1365-2907.2006.00084.x; Gustafson LL, 1998, J WILDLIFE MANAGE, V62, P24, DOI 10.2307/3802261; Haight RG, 2000, CONSERV BIOL, V14, P1298, DOI 10.1046/j.1523-1739.2000.99414.x; IUCN, 2016, GUID REINTR OTHER CO; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Maguire L.A., 1987, P141, DOI 10.1017/CBO9780511623400.009; Marino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089060; Meretsky VJ, 2000, CONSERV BIOL, V14, P957, DOI 10.1046/j.1523-1739.2000.99113.x; Parlato EH, 2012, CONSERV BIOL, V26, P97, DOI 10.1111/j.1523-1739.2011.01794.x; Pia MV, 2013, MAMMALIA, V77, P273, DOI 10.1515/mammalia-2012-0096; Puig S, 1997, J ARID ENVIRON, V36, P343, DOI 10.1006/jare.1996.0186; Puig S., 2000, MANEJO SUSTENTABLE V, P57; Puig S, 1995, COMPORTAMIENTO ORG S, P97; Raedeke K.J., 1979, POPULATION DYNAMICS; RALLS K, 1988, Conservation Biology, V2, P185, DOI 10.1111/j.1523-1739.1988.tb00169.x; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Renison D, 2010, AUSTRAL ECOL, V35, P435, DOI 10.1111/j.1442-9993.2009.02055.x; RIO M., 1905, GEOGRAFIA PROVINCIA; Sarasqueta D, 2001, CRIA REPR GUAN CAUT; Sarno RJ, 1999, J APPL ECOL, V36, P937, DOI 10.1046/j.1365-2664.1999.00449.x; Sarno RJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P22, DOI 10.1007/s00265-003-0604-5; Sarno RJ, 1999, BEHAV ECOL, V10, P41, DOI 10.1093/beheco/10.1.41; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Seddon PJ, 1999, CONSERV BIOL, V13, P177, DOI 10.1046/j.1523-1739.1999.97414.x; Slotta-Bachmayr L, 2004, J WILDLIFE MANAGE, V68, P790, DOI 10.2193/0022-541X(2004)068[0790:UOPVAT]2.0.CO;2; Soorae P.S., 2013, GLOBAL RE INTRO PERS; Sosa RA, 2005, EUR J WILDLIFE RES, V51, P207, DOI 10.1007/s10344-005-0105-0; Tavarone EG, 2007, PROYECTO PILOTO REIN; Young JK, 2004, REV CHIL HIST NAT, V77, P617, DOI 10.4067/S0716-078X2004000400005	59	6	7	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164806	10.1371/journal.pone.0164806	http://dx.doi.org/10.1371/journal.pone.0164806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741302	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000067
J	Sanghvi, GV; Baskaran, P; Roseler, W; Sieriebriennikov, B; Rodelsperger, C; Sommer, RJ				Sanghvi, Gaurav V.; Baskaran, Praveen; Roeseler, Waltraud; Sieriebriennikov, Bogdan; Roedelsperger, Christian; Sommer, Ralf J.			Life History Responses and Gene Expression Profiles of the Nematode Pristionchus pacificus Cultured on Cryptococcus Yeasts	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PLASTICITY; DIVERSITY; EVOLUTION; BIOLOGY; SYSTEM; MODEL	Nematodes, the earth's most abundant metazoa are found in all ecosystems. In order to survive in diverse environments, they have evolved distinct feeding strategies and they can use different food sources. While some nematodes are specialists, including parasites of plants and animals, others such as Pristionchus pacificus are omnivorous feeders, which can live on a diet of bacteria, protozoans, fungi or yeast. In the wild, P. pacificus is often found in a necromenic association with beetles and is known to be able to feed on a variety of microbes as well as on nematode prey. However, in laboratory studies Escherichia coli OP50 has been used as standard food source, similar to investigations in Caenorhabditis elegans and it is unclear to what extent this biases the obtained results and how relevant findings are in real nature. To gain first insight into the variation in traits induced by a non-bacterial food source, we study Pristionchus- fungi interactions under laboratory conditions. After screening different yeast strains, we were able to maintain P. pacificus for at least 50- 60 generations on Cryptococcus albidus and Cryptococcus curvatus. We describe life history traits of P. pacificus on both yeast strains, including developmental timing, survival and brood size. Despite a slight developmental delay and problems to digest yeast cells, which are both reflected at a transcriptomic level, all analyses support the potential of Cryptococcus strains as food source for P. pacificus. In summary, our work establishes two Cryptococcus strains as alternative food source for P. pacificus and shows change in various developmental, physiological and morphological traits, including the transcriptomic profiles.	[Sanghvi, Gaurav V.; Baskaran, Praveen; Roeseler, Waltraud; Sieriebriennikov, Bogdan; Roedelsperger, Christian; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 37, Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 37, Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	Sanghvi, Gaurav/AIC-2480-2022; Sieriebriennikov, Bogdan/AAG-5293-2021; , roedelsberg/Q-3831-2019; Sanghvi, Gaurav/AAO-4605-2020	Sieriebriennikov, Bogdan/0000-0002-2948-7292; , roedelsberg/0000-0002-7905-9675; Baskaran, Praveen/0000-0003-2275-3516	Max-Planck Society	Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the core funding of the Max-Planck Society to RJS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Matthias Herrmann for critical comments on the manuscript and the Sommer lab for discussions. This work was funded by the Max-Planck Society to RJS.	Baskaran P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131136; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Bose N, 2012, ANGEW CHEM INT EDIT, V51, P12438, DOI 10.1002/anie.201206797; Bumbarger DJ, 2013, CELL, V152, P109, DOI 10.1016/j.cell.2012.12.013; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Ding X., 2013, CLIN CHEST MED, V16, P387, DOI DOI 10.1016/J.CMET.2012.08.002; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann M, 2010, BIOL J LINN SOC, V100, P170, DOI 10.1111/j.1095-8312.2010.01410.x; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Hugot JP, 2001, NEMATOLOGY, V3, P199, DOI 10.1163/156854101750413270; Koehnle TJ, 2003, J NUTR, V133, P2331, DOI 10.1093/jn/133.7.2331; Lightfoot James W., 2016, BMC Research Notes, V9, P142, DOI 10.1186/s13104-016-1886-9; Markov GV, 2015, J MOL EVOL, V80, P18, DOI 10.1007/s00239-014-9651-y; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; Munn E. A, 2002, FEEDING DIGESTION, P211; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Pigliucci M., 2001, SYN ECO EVO; Platt H. M., 1994, PHYLOGENETIC SYSTEMA; Rae R, 2008, J EXP BIOL, V211, P1927, DOI 10.1242/jeb.014944; Rae R, 2010, ENVIRON MICROBIOL, V12, P3007, DOI 10.1111/j.1462-2920.2010.02278.x; Ragsdale EJ, 2013, CELL, V155, P922, DOI 10.1016/j.cell.2013.09.054; Rodelsperger C, 2014, GENETICS, V196, P1153, DOI 10.1534/genetics.113.159855; Serobyan V, 2013, EVOL DEV, V15, P161, DOI 10.1111/ede.12030; Simpson SJ, 2000, ADV STUD BEHAV, V29, P1, DOI 10.1016/S0065-3454(08)60102-3; Sinha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044255; Sommer RJ, 2015, NEMATOL MONOGR PERSP, V11, P19; Sommer RJ, 2009, NAT REV GENET, V10, P416, DOI 10.1038/nrg2567; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Sudhaus Walter, 2010, Palaeodiversity, P117; Susoy V, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00023; Tian H, 2008, CURR BIOL, V18, P142, DOI 10.1016/j.cub.2007.12.048; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Witte H, 2015, DEV GENES EVOL, V225, P55, DOI 10.1007/s00427-014-0486-8	36	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164881	10.1371/journal.pone.0164881	http://dx.doi.org/10.1371/journal.pone.0164881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741297	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000078
J	Zhang, LW; Kang, K; Jiang, SC; Zhang, YN; Wang, TT; Zhang, J; Sun, L; Yang, YQ; Huang, CC; Jiang, LY; Ding, DG				Zhang, Long-Wa; Kang, Ke; Jiang, Shi-Chang; Zhang, Ya-Nan; Wang, Tian-Tian; Zhang, Jing; Sun, Long; Yang, Yun-Qiu; Huang, Chang-Chun; Jiang, Li-Ya; Ding, De-Gui			Analysis of the Antennal Transcriptome and Insights into Olfactory Genes in Hyphantria cunea (Drury)	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; EXPRESSION; LEPIDOPTERA; FAMILY; IDENTIFICATION; RECEPTORS; PHEROMONE; GENOME; SILKWORM; SNMP-1	Hyphantria cunea (Drury) (Lepidoptera: Arctiidae) is an invasive insect pest which, in China, causes unprecedented damage and economic losses due to its extreme fecundity and wide host range, including forest and shade trees, and even crops. Compared to the better known lepidopteran species which use Type-I pheromones, little is known at the molecular level about the olfactory mechanisms of host location and mate choice in H. cunea, a species using Type-II lepidopteran pheromones. In the present study, the H. cunea antennal transcriptome was constructed by Illumina Hiseq 2500 TM sequencing, with the aim of discovering olfaction-related genes. We obtained 64,020,776 clean reads, and 59,243 unigenes from the analysis of the transcriptome, and the putative gene functions were annotated using gene ontology (GO) annotation. We further identified 124 putative chemosensory unigenes based on homology searches and phylogenetic analysis, including 30 odorant binding proteins (OBPs), 17 chemosensory proteins (CSPs), 52 odorant receptors (ORs), 14 ionotropic receptors (IRs), nine gustatory receptors (GRs) and two sensory neuron membrane proteins (SNMPs). We also found many conserved motif patterns of OBPs and CSPs using a MEME system. Moreover, we systematically analyzed expression patterns of OBPs and CSPs based on reverse transcription PCR and quantitative real time PCR (RT-qPCR) with RNA extracted from different tissues and life stages of both sexes in H. cunea. The antennae-biased expression may provide a deeper further understanding of olfactory processing in H. cunea. The first ever identification of olfactory genes in H. cunea may provide new leads for control of this major pest.	[Zhang, Long-Wa; Kang, Ke; Jiang, Shi-Chang; Wang, Tian-Tian; Zhang, Jing; Sun, Long; Yang, Yun-Qiu] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Anhui Prov Key Lab Microbial Control, Hefei 230036, Peoples R China; [Zhang, Ya-Nan] Huaibei Normal Univ, Coll Life Sci, Huaibei 235000, Peoples R China; [Huang, Chang-Chun; Jiang, Li-Ya; Ding, De-Gui] Forest Pests Control & Quarantine Bur Anhui Prov, Hefei 230001, Peoples R China	Anhui Agricultural University; Huaibei Normal University	Zhang, LW (corresponding author), Anhui Agr Univ, Sch Forestry & Landscape Architecture, Anhui Prov Key Lab Microbial Control, Hefei 230036, Peoples R China.; Zhang, YN (corresponding author), Huaibei Normal Univ, Coll Life Sci, Huaibei 235000, Peoples R China.	zhanglw@ahau.edu.cn; ynzhang_insect@163.com		Zhang, Ya-Nan/0000-0001-7038-2292	Natural Science Foundation of Anhui Province [1508085SMC216]; National Natural Science Foundation of China [31170616, 31000304, 31200490]	Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of Anhui Province 1508085SMC216: L-WZ; National Natural Science Foundation of China 31170616: L-WZ; National Natural Science Foundation of China 31000304: Y-QY; and National Natural Science Foundation of China 31200490: Y-NZ. The funders had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abraham D, 2005, INSECT BIOCHEM MOLEC, V35, P1100, DOI 10.1016/j.ibmb.2005.05.002; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Ando T, 2004, CHEM PHEROMONES OTHE; Ando T, 2008, J PESTIC SCI, V33, P17, DOI 10.1584/jpestics.R07-06; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; do Nascimento ARB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2183-z; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Corcoran JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128596; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; De Biasio F, 2015, INSECT SCI, V22, P220, DOI 10.1111/1744-7917.12118; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Elfekih S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19112; Feng Bo, 2015, BMC Genomics, V16; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Gomi T, 2007, ECOL RES, V22, P855, DOI 10.1007/s11284-006-0327-y; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13800; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; Hatano E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0188-3; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hu P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26652; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Liu CQ, 2014, POLYM DEGRAD STABIL, V102, P180, DOI 10.1016/j.polymdegradstab.2014.01.013; Liu H J, 2006, FRONTIERS FORESTRY C, V1, P328, DOI DOI 10.1007/S11461-006-0025-5; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang RB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045597, 10.1371/journal.pone.0049256]; Tang R, 2012, CHINESE SCI BULL, V57, P4560, DOI 10.1007/s11434-012-5356-z; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; YANG Z, 1989, Entomotaxonomia, V11, P117; Yang ZQ, 2008, B ENTOMOL RES, V98, P293, DOI 10.1017/S0007485308005609; Yang ZQ, 2006, BIOCONTROL, V51, P401, DOI 10.1007/s10526-006-9010-z; Yang Zhong-Qi, 2004, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V77, P213; Yang Zhongqi, 2005, Scientia Silvae Sinicae, V41, P72; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18576; Zhang J., 2015, J NANOMATER, V2015, P7, DOI DOI 10.1371/J0URNAL.P0NE; Zhang SF, 2014, INSECT BIOCHEM MOLEC, V52, P69, DOI 10.1016/j.ibmb.2014.06.006; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148159	71	48	56	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164729	10.1371/journal.pone.0164729	http://dx.doi.org/10.1371/journal.pone.0164729			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741298	gold, Green Submitted, Green Published			2022-12-27	WOS:000385507000061
J	Brancia, C; Noli, B; Boido, M; Boi, A; Puddu, R; Borghero, G; Marrosu, F; Bongioanni, P; Orru, S; Manconi, B; D'Amatol, F; Messana, I; Vincenzoni, F; Vercelli, A; Ferri, GL; Cocco, C				Brancia, Carla; Noli, Barbara; Boido, Marina; Boi, Andrea; Puddu, Roberta; Borghero, Giuseppe; Marrosu, Francesco; Bongioanni, Paolo; Orru, Sandro; Manconi, Barbara; D'Amatol, Filomena; Messana, Irene; Vincenzoni, Federica; Vercelli, Alessandro; Ferri, Gian-Luca; Cocco, Cristina			VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model Studies	PLOS ONE			English	Article							INDUCIBLE GENE VGF; NEUROENDOCRINE CELLS; NEUROPEPTIDE VGF; SENSORY NEURONS; MOUSE MODEL; EXPRESSION; FIBROBLASTS; MODULATION	VGF mRNA is widely expressed in areas of the nervous system known to degenerate in Amyotrophic Lateral Sclerosis (ALS), including cerebral cortex, brainstem and spinal cord. Despite certain VGF alterations are reported in animal models, little information is available with respect to the ALS patients. We addressed VGF peptide changes in fibroblast cell cultures and in plasma obtained from ALS patients, in parallel with spinal cord and plasma samples from the G93A-SOD1 mouse model. Antisera specific for the C-terminal end of the human and mouse VGF proteins, respectively, were used in immunohistochemistry and enzyme-linked immunosorbent assay (ELISA), while gel chromatography and HPLC/ESI-MS/MS were used to identify the VGF peptides present. Immunoreactive VGF C-terminus peptides were reduced in both fibroblast and plasma samples from ALS patients in an advanced stage of the disease. In the G93A-SOD1 mice, the same VGF peptides were also decreased in plasma in the late-symptomatic stage, while showing an earlier downregulation in the spinal cord. In immunohistochemistry, a large number of gray matter structures were VGF C-terminus immunoreactive in control mice (including nerve terminals, axons and a few perikarya identified as motoneurons), with a striking reduction already in the pre-symptomatic stage. Through gel chromatography and spectrometry analysis, we identified one form likely to be the VGF precursor as well as peptides containing the NAPP-sequence in all tissues studied, while in the mice and fibroblasts, we revealed also AQEE- and TLQP-peptides. Taken together, selective VGF fragment depletion may participate in disease onset and/or progression of ALS.	[Brancia, Carla; Noli, Barbara; Boi, Andrea; D'Amatol, Filomena; Ferri, Gian-Luca; Cocco, Cristina] Univ Cagliari, NEF Lab, Dept Biomed Sci, Cagliari, Italy; [Boido, Marina; Vercelli, Alessandro] Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Dept Neurosci, Turin, Italy; [Puddu, Roberta; Borghero, Giuseppe; Marrosu, Francesco] Azienda Univ Osped Cagliari, Dept Neurol, Cagliari, Italy; [Puddu, Roberta; Borghero, Giuseppe; Marrosu, Francesco] Univ Cagliari, Cagliari, Italy; [Bongioanni, Paolo] Univ Pisa, Neurosci Dept, Neurorehabil Unit, Pisa, Italy; [Orru, Sandro] Univ Cagliari, Binaghi Hosp, Med Genet, Dept Med Sci, Cagliari, Italy; [Manconi, Barbara] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Messana, Irene] Catholic Univ, Inst Biochem & Clin Biochem, Rome, Italy; [Messana, Irene] CNR, Inst Chem Mol Recognit, Rome, Italy	University of Cagliari; University of Turin; University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari; University of Cagliari; University of Pisa; University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Brancia, C (corresponding author), Univ Cagliari, NEF Lab, Dept Biomed Sci, Cagliari, Italy.	cbrancia@unica.it	Ferri, Luca Angelo/AAC-5890-2022; bongioanni, paolo/K-4758-2016; Messana, Irene/L-2478-2019; Vercelli, Alessandro/A-1926-2012	Ferri, Luca Angelo/0000-0001-9031-6284; bongioanni, paolo/0000-0002-0767-1558; Messana, Irene/0000-0002-1436-6105; Vercelli, Alessandro/0000-0002-5909-2128; FERRI, Gian-Luca/0000-0003-2768-349X; Boido, Marina/0000-0003-1211-1552; BRANCIA, CARLA/0000-0002-0716-3983; ORRU, SANDRO/0000-0001-5085-7975; Vincenzoni, Federica/0000-0002-0124-2234	Autonomous Region of Sardinia; Sardinia PO FSE [2007-1013]	Autonomous Region of Sardinia(Regione Sardegna); Sardinia PO FSE	This work was supported by Autonomous Region of Sardinia, Sardinia PO FSE 2007-1013' funds (the L.R. 7/2007), and NEUROCARE onlus.	Alder J, 2003, J NEUROSCI, V23, P10800; Allen SP, 2015, NEUROBIOL AGING, V36, P2893, DOI 10.1016/j.neurobiolaging.2015.07.013; Boido M, 2014, CYTOTHERAPY, V16, P1059, DOI 10.1016/j.jcyt.2014.02.003; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Brancia C, 2005, J ENDOCRINOL, V186, P97, DOI 10.1677/joe.1.05992; Brancia C, 2010, J ENDOCRINOL, V207, P329, DOI 10.1677/JOE-10-0189; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen XP, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0689-x; Cocco C, 2003, APPL IMMUNOHISTO M M, V11, P274; D'Amato F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142333; DYCK PJ, 1975, NEUROLOGY, V25, P781, DOI 10.1212/WNL.25.8.781; Ekestern E, 2004, NEURODEGENER DIS, V1, P88, DOI 10.1159/000080049; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; FERRI GL, 1995, ENDOCRINOLOGY, V136, P2244, DOI 10.1210/en.136.5.2244; Guo YS, 2009, EXP MOL MED, V41, P140, DOI 10.3858/emm.2009.41.3.017; Isaacs JD, 2007, J NEUROL NEUROSUR PS, V78, P750, DOI 10.1136/jnnp.2006.098798; Kirk K, 2014, ANN NEUROL, V76, P620, DOI 10.1002/ana.24244; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; Lin WJ, 2015, J NEUROSCI, V35, P10343, DOI 10.1523/JNEUROSCI.0584-15.2015; Moss A, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-62; Noli B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108456; Onesto E, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0316-5; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Pugdahl K, 2007, J NEUROL NEUROSUR PS, V78, P746, DOI 10.1136/jnnp.2006.098533; Ren YT, 2015, INT J CLIN EXP PATHO, V8, P5419; Rindi G, 2007, J CLIN ENDOCR METAB, V92, P2811, DOI 10.1210/jc.2007-0035; Rozek W, 2013, TUMOR BIOL, V34, P1773, DOI 10.1007/s13277-013-0716-0; Sabatelli M, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.02.009; Shimazawa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015307; Snyder SE, 1998, J COMP NEUROL, V394, P91; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Watson E, 2005, ENDOCRINOLOGY, V146, P5151, DOI 10.1210/en.2005-0588; Wilson ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015133; Zhao Zhong, 2008, Int J Med Sci, V5, P92	35	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164689	10.1371/journal.pone.0164689	http://dx.doi.org/10.1371/journal.pone.0164689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737014	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800114
J	Franceschini, N; Carty, CL; Lu, YC; Tao, R; Sung, YJ; Manichaikul, A; Haessler, J; Fornage, M; Schwander, K; Zubair, N; Bien, S; Hindorff, LA; Guo, XQ; Bielinski, SJ; Ehret, G; Kaufman, JD; Rich, SS; Carlson, CS; Bottinger, EP; North, KE; Rao, DC; Chakravarti, A; Barrett, PQ; Loos, RJF; Buyske, S; Kooperberg, C				Franceschini, Nora; Carty, Cara L.; Lu, Yingchang; Tao, Ran; Sung, Yun Ju; Manichaikul, Ani; Haessler, Jeff; Fornage, Myriam; Schwander, Karen; Zubair, Niha; Bien, Stephanie; Hindorff, Lucia A.; Guo, Xiuqing; Bielinski, Suzette J.; Ehret, Georg; Kaufman, Joel D.; Rich, Stephen S.; Carlson, Christopher S.; Bottinger, Erwin P.; North, Kari E.; Rao, D. C.; Chakravarti, Aravinda; Barrett, Paula Q.; Loos, Ruth J. F.; Buyske, Steven; Kooperberg, Charles			Variant Discovery and Fine Mapping of Genetic Loci Associated with Blood Pressure Traits in Hispanics and African Americans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; POTASSIUM CHANNELS; HYPERTENSION; METAANALYSIS; PREVALENCE; AWARENESS; INDIVIDUALS; TRENDS	Despite the substantial burden of hypertension in US minority populations, few genetic studies of blood pressure have been conducted in Hispanics and African Americans, and it is unclear whether many of the established loci identified in European-descent populations contribute to blood pressure variation in non-European descent populations. Using the Metabochip array, we sought to characterize the genetic architecture of previously identified blood pressure loci, and identify novel cardiometabolic variants related to systolic and diastolic blood pressure in a multi-ethnic US population including Hispanics (n = 19,706) and African Americans (n = 18,744). Several known blood pressure loci replicated in African Americans and Hispanics. Fourteen variants in three loci (KCNK3, FGF5, ATXN2-SH2B3) were significantly associated with blood pressure in Hispanics. The most significant diastolic blood pressure variant identified in our analysis, rs2586886/KCNK3 (P = 5.2 x 10(-9)), also replicated in independent Hispanic and European-descent samples. African American and trans-ethnic meta-analysis data identified novel variants in the FGF5, ULK4 and HOXA-EVX1 loci, which have not been previously associated with blood pressure traits. Our identification and independent replication of variants in KCNK3, a gene implicated in primary hyperaldosteronism, as well as a variant in HOTTIP (HOXA-EVX1) suggest that further work to clarify the roles of these genes may be warranted. Overall, our findings suggest that loci identified in European descent populations also contribute to blood pressure variation in diverse populations including Hispanics and African Americans D populations that are understudied for hypertension genetic risk factors.	[Franceschini, Nora; North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Carty, Cara L.] George Washington Univ, Ctr Translat Sci, Washington, DC USA; [Carty, Cara L.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Lu, Yingchang; Bottinger, Erwin P.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, Genet Obes & Related Metab Traits Program, New York, NY 10029 USA; [Tao, Ran] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Sung, Yun Ju; Schwander, Karen; Rao, D. C.] Washington Univ, Div Biostat, St Louis, MO USA; [Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Haessler, Jeff; Zubair, Niha; Bien, Stephanie; Carlson, Christopher S.; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Hindorff, Lucia A.] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Guo, Xiuqing] Univ Calif Los Angeles, Med Ctr, LABiomed Harbor, Inst Translat Genom & Populat Sci, Torrance, CA USA; [Guo, Xiuqing] Univ Calif Los Angeles, Med Ctr, LABiomed Harbor, Dept Pediat, Torrance, CA USA; [Bielinski, Suzette J.] Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA; [Ehret, Georg; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Ehret, Georg] Univ Hosp Geneva, Dept Specialties Internal Med, Geneva, Switzerland; [Kaufman, Joel D.] Univ Washington, Dept Environm & Occupat Hlth Sci Epidemiol & Med, Seattle, WA 98195 USA; [Barrett, Paula Q.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Buyske, Steven] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA	University of North Carolina; University of North Carolina Chapel Hill; George Washington University; Children's National Health System; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); University of Virginia; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Mayo Clinic; Johns Hopkins University; University of Geneva; University of Washington; University of Washington Seattle; University of Virginia; Rutgers State University New Brunswick	Franceschini, N (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	noraf@unc.edu	EHRET, Georg B/A-9532-2009; Kaufman, Joel D/B-5761-2008; Loos, Ruth J F/Q-2862-2016; Barrett, Paula/AAY-1056-2021; Loos, Ruth/GON-5877-2022; Bielinski, Suzette/A-2238-2009	EHRET, Georg B/0000-0002-5730-0675; Kaufman, Joel D/0000-0003-4174-9037; Loos, Ruth J F/0000-0002-8532-5087; Buyske, Steven/0000-0001-8539-5416; Rich, Stephen/0000-0003-3872-7793; Bielinski, Suzette/0000-0002-2905-5430	Population Architecture Using Genomics and Epidemiology (PAGE) program - National Human Genome Research Institute (NHGRI) [U01HG004803, U01HG004798, U01HG004802, U01HG004790, U01HG004801]; Epidemiology of putative genetic variants: The Women's Health Initiative through the NHGRI PAGE program [U01HG004790]; National Heart, Lung, and Blood Institute (NHLBI) [R01HL089717, N02-HL-64278]; National Institutes of Health (NIH); U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; Genetic Epidemiology of Causal Variants Across the Life Course (CALiCo) program [U01HG004803]; National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; NHGRI [U01HG004402, R01 HG006124]; NIH [HHSN268200625226C]; PAGE Coordinating Center [UL1RR025005]; NIH National Center for Advancing Translational Sciences [UL1TR000075]; MESA [N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-001079, UL1-TR-000040]; National Center for Research Resources [UL1RR033176]; National Center for Advancing Translational Sciences [UL1TR000124]; STAR research assistance agreement [RD831697]; National Center for Advancing Translational Sciences, CTSI [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) [DK063491]; Andrea and Charles Bronfman Philanthropies;  [R21HL123677];  [5 R01 HL086694];  [R01HL071051];  [R01HL071205];  [R01HL071250];  [R01HL071251];  [R01HL071258];  [R01HL071259];  [R01HL98077];  [HL071205];  [P50ES015915]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089717] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	Population Architecture Using Genomics and Epidemiology (PAGE) program - National Human Genome Research Institute (NHGRI); Epidemiology of putative genetic variants: The Women's Health Initiative through the NHGRI PAGE program; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; Genetic Epidemiology of Causal Variants Across the Life Course (CALiCo) program; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PAGE Coordinating Center; NIH National Center for Advancing Translational Sciences; MESA; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); STAR research assistance agreement; National Center for Advancing Translational Sciences, CTSI; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC); Andrea and Charles Bronfman Philanthropies; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Population Architecture Using Genomics and Epidemiology (PAGE) program which is funded by the National Human Genome Research Institute (NHGRI) [U01HG004803 (to the Genetic Epidemiology of Causal Variants Across the Life Course (CALiCo) program, U01HG004798 (to the Epidemiologic Architecture of Genes Linked to Environment (EAGLE)), U01HG004802 (to the Multi-Ethnic Cohort (MEC)), U01HG004790 (to the Women's Health Initiative (WHI)), and U01HG004801 (to the PAGE Coordinating Center), and the irrespective NHGRI ARRA supplements. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The complete list of PAGE members can be found at http://www.pagestudy.org. The data and materials included in this report result from a collaboration between the following studies. Funding support for the "Epidemiology of putative genetic variants: The Women's Health Initiative" study is provided through the NHGRI PAGE program (U01HG004790 and its NHGRI ARRA supplement). The WHI program is funded by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. Funding support for the Genetic Epidemiology of Causal Variants Across the Life Course (CALiCo) program is provided through the NHGRI PAGE program [U01HG004803 and its NHGRI ARRA supplement]. The following CALiCo studies contributed to this manuscript and are funded by the following agencies: The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; NHGRI contract U01HG004402; and NIH contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the NIH and NIH Roadmap for Medical Research. Assistance with phenotype harmonization, SNP selection and annotation, data cleaning, data management, integration and dissemination, and general study coordination was provided by the PAGE Coordinating Center [U01HG004801-01 and its NHGRI ARRA supplement]. The National Institutes of Mental Health also contributes to the support for the PAGE Coordinating Center. Additional support for this work was provided by the NHGRI through [R01 HG006124]. CLC received support from UL1TR000075 from the NIH National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the NIH. NF receives support from R21HL123677. PQB receives support from NHLBI grant R01HL089717. Metabochip genotyping for the HyperGen and GenNet studies was supported by 5 R01 HL086694. MESA was conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-001079, and UL1-TR-000040. MESA Family is conducted and supported by the NHLBI in collaboration with MESA investigators.; Support is provided by grants and contracts R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071258, R01HL071259, by the National Center for Research Resources, Grant UL1RR033176, and the National Center for Advancing Translational Sciences, Grant UL1TR000124. This publication was developed under a STAR research assistance agreement, No. RD831697 (MESA Air), awarded by the U.S Environmental protection Agency (EPA). It has not been formally reviewed by the EPA. The views expressed in this document are solely those of the authors and the EPA does not endorse any products or commercial services mentioned in this publication. Metabochip genotyping data was supported in part by grants and contracts R01HL98077, N02-HL-64278, HL071205, UL1TR000124, DK063491, RD831697, and P50ES015915. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Genotyping was performed at Affymetrix (Santa Clara, California, USA) and the Broad Institute of Harvard and MIT (Boston, Massachusetts, USA) using the Affymetrix Genome-Wide Human SNP Array 6.0. The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR000124, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The Mount Sinai BioMe Biobank is supported by The Andrea and Charles Bronfman Philanthropies. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghatrif M, 2011, ANN EPIDEMIOL, V21, P15, DOI 10.1016/j.annepidem.2010.06.002; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Boerwinkle E, 2002, HYPERTENSION, V39, P3; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Ehret GB, 2011, NATURE, DOI DOI 10.1093/HMG/DDS555; Fishman PA, 2011, J CLIN HYPERTENS, V13, P821, DOI 10.1111/j.1751-7176.2011.00528.x; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Ganesh SK, 2014, AM J HUM GENET, V95, P49, DOI 10.1016/j.ajhg.2014.06.002; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Hopkins PN, 2003, GENET MED, V5, P413, DOI 10.1097/01.GIM.0000096375.88710.A6; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin DY, 2014, AM J HUM GENET, V95, P675, DOI 10.1016/j.ajhg.2014.11.005; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Manichaikul A, 2016, HYPERTENSION, V68, P356, DOI 10.1161/HYPERTENSIONAHA.116.07564; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Peterson LE, 2003, COMPUT METH PROG BIO, V70, P107, DOI 10.1016/S0169-2607(02)00009-3; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; Snieder H, 2003, HYPERTENSION, V41, P1196, DOI 10.1161/01.HYP.0000072269.19820.0D; Sorlie PD, 2014, AM J HYPERTENS, V27, P793, DOI 10.1093/ajh/hpu003; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Tragante V, 2014, AM J HUM GENET, V94, P349, DOI 10.1016/j.ajhg.2013.12.016; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	38	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164132	10.1371/journal.pone.0164132	http://dx.doi.org/10.1371/journal.pone.0164132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736895	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800042
J	Mali, VR; Pan, GD; Deshpande, M; Thandavarayan, RA; Xu, J; Yang, XP; Palaniyandi, SS				Mali, Vishal R.; Pan, Guodong; Deshpande, Mandar; Thandavarayan, Rajarajan A.; Xu, Jiang; Yang, Xiao-Ping; Palaniyandi, Suresh S.			Cardiac Mitochondrial Respiratory Dysfunction and Tissue Damage in Chronic Hyperglycemia Correlate with Reduced Aldehyde Dehydrogenase-2 Activity	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; DIABETIC COMPLICATIONS; HEART-FAILURE; INHIBITION; FIBROSIS; PATHOGENESIS; REPERFUSION; MELLITUS; DISEASE	Aldehyde dehydrogenase (ALDH) 2 is a mitochondrial isozyme of the heart involved in the metabolism of toxic aldehydes produced from oxidative stress. We hypothesized that hyperglycemia-mediated decrease in ALDH2 activity may impair mitochondrial respiration and ultimately result in cardiac damage. A single dose (65 mg/kg; i.p.) streptozotocin injection to rats resulted in hyperglycemia with blood glucose levels of 443 +/- 9 mg/dl versus 121 +/- 7 mg/dl in control animals, p<0.0001, N = 7-11. After 6 months of diabetes mellitus (DM) induction, the rats were sacrificed after recording the functionality of their hearts. Increase in the cardiomyocyte cross sectional area (446 +/- 32 mu m(2) Vs 221 +/- 10 mu m(2); p<0.0001) indicated cardiac hypertrophy in DM rats. Both diastolic and systolic dysfunctions were observed with DM rats compared to controls. Most importantly, myocardial ALDH2 activity and levels were reduced, and immunostaining for 4HNE protein adducts was increased in DM hearts compared to controls. The mitochondrial oxygen consumption rate (OCR), an index of mitochondrial respiration, was decreased in mitochondria isolated from DM hearts compared to controls (p<0.0001). Furthermore, the rate of mitochondrial respiration and the increase in carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP)-induced maximal respiration were also decreased with chronic hyperglycemia. Chronic hyperglycemia reduced mitochondrial OXPHOS proteins. Reduced ALDH2 activity was correlated with mitochondrial dysfunction, pathological remodeling and cardiac dysfunction, respectively. Our results suggest that chronic hyperglycemia reduces ALDH2 activity, leading to mitochondrial respiratory dysfunction and consequently cardiac damage and dysfunction.	[Mali, Vishal R.; Pan, Guodong; Deshpande, Mandar; Xu, Jiang; Yang, Xiao-Ping; Palaniyandi, Suresh S.] Henry Ford Hlth Syst, Dept Internal Med, Div Hypertens & Vasc Res, Detroit, MI 48202 USA; [Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Ctr Cardiovasc Regenerat, Dept Cardiovasc Sci, Houston, TX USA; [Palaniyandi, Suresh S.] Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; The Methodist Hospital System; The Methodist Hospital - Houston; Wayne State University	Palaniyandi, SS (corresponding author), Henry Ford Hlth Syst, Dept Internal Med, Div Hypertens & Vasc Res, Detroit, MI 48202 USA.; Palaniyandi, SS (corresponding author), Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA.	spalani2@hfhs.org	pan, guodong/F-3794-2017		Henry Ford Health System [A10249]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Henry Ford Health System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the internal grant from Henry Ford Health System (SSP) A10249.	Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Bach JF, 2000, CLIN REV ALLERG IMMU, V19, P217, DOI 10.1385/CRIAI:19:3:217; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Bosi E, 1998, J Pediatr Endocrinol Metab, V11 Suppl 2, P293; Bottino R, 2005, DIABETES, V54, pS79, DOI 10.2337/diabetes.54.suppl_2.S79; Brichac J, 2007, CHEM RES TOXICOL, V20, P887, DOI 10.1021/tx7000509; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2010, CARDIOVASC RES, V88, P51, DOI 10.1093/cvr/cvq192; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; ENGERMAN R, 1977, DIABETES, V26, P760, DOI 10.2337/diabetes.26.8.760; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Flarsheim CE, 1996, AM J PHYSIOL-HEART C, V271, pH192, DOI 10.1152/ajpheart.1996.271.1.H192; Geiss LS, NIH PUBLICATION, P233; Gonzalez-Salazar A, 2011, CARDIOVASC TOXICOL, V11, P357, DOI 10.1007/s12012-011-9128-9; Han HS, 2013, CLIN ORTHOP SURG, V5, P118, DOI 10.4055/cios.2013.5.2.118; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Lashin OM, 2006, FREE RADICAL BIO MED, V40, P886, DOI 10.1016/j.freeradbiomed.2005.10.040; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Liu XW, 2015, ARTERIOSCL THROM VAS, V35, P2196, DOI 10.1161/ATVBAHA.115.306012; Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; Mali VR, 2014, FREE RADICAL RES, V48, P251, DOI 10.3109/10715762.2013.864761; Mali VR, 2014, EXP BIOL MED, V239, P610, DOI 10.1177/1535370213520109; Mali VR NR, 2014, EXPT BIOL M IN PRESS; Mizuno Y, 2015, CIRCULATION, V131, P1665, DOI 10.1161/CIRCULATIONAHA.114.013120; Monami M, 2013, NUTR METAB CARDIOVAS, V23, P591, DOI 10.1016/j.numecd.2013.03.007; Palaniyandi SS, 2007, EXP BIOL MED, V232, P1213, DOI 10.3181/0703-RM-85; Palaniyandi SS, 2010, FASEB J, V24; Palaniyandi SS, 2011, J CELL MOL MED, V15, P1769, DOI 10.1111/j.1582-4934.2010.01174.x; Palaniyandi Suresh Selvaraj, 2010, Drug Discov Today Dis Mech, V7, pe95, DOI 10.1016/j.ddmec.2010.07.002; Rajesh M, 2012, DIABETES, V61, P716, DOI 10.2337/db11-0477; Selvakumar D, 2012, BIOCHEM J, V443, P463, DOI 10.1042/BJ20111255; Shi Q, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4062; Sun AJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000779; Wang C, 2016, J MOL MED, V94, P1229, DOI 10.1007/s00109-016-1449-5; Wang JL, 2011, MOL MED, V17, P172, DOI 10.2119/molmed.2010.00114; Yamazaki KG, 2012, J CARDIOVASC TRANSL, V5, P805, DOI 10.1007/s12265-012-9405-4; Zhang YM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-40	46	24	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163158	10.1371/journal.pone.0163158	http://dx.doi.org/10.1371/journal.pone.0163158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736868	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800012
J	Pan, ZY; He, JJ; Rasoul, LM; Liu, YY; Che, RX; Ding, Y; Guo, XC; Yang, JR; Zou, DH; Zhang, H; Li, DS; Cao, HW				Pan, Ziye; He, Jinjiao; Rasoul, Lubna M.; Liu, Yunye; Che, Ruixiang; Ding, Yun; Guo, Xiaocheng; Yang, Jiarui; Zou, Dehua; Zhang, Hua; Li, Deshan; Cao, Hongwei			Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect	PLOS ONE			English	Article							IMMUNE-RESPONSE; CANCER-THERAPY; NDV; STRAIN; INTERLEUKIN-2; CARCINOMA; CYTOKINES; VACCINE; PROTEIN	Recombinant Newcastle disease virus (rNDV) is tumor selective and intrinsically oncolytic, which has been developed as a vector to express exogenous genes to enhance its oncolytic efficacy. Our previous studies found that insertion sites of foreign gene in rNDV vector affected its expression and anti-tumor activities. However, the optimal insertion site for foreign genes remains unknown. In this study, we inserted the enhanced green fluorescence protein (EGFP) and IL2 genes into four different intergenic regions of the rNDV using reverse genetics technology. Recombinants rNDV-EGFPs and rNDV-IL2s were successfully rescued, which displayed the similar growth kinetics with parental virus. Both EGFP mRNA and protein levels were most abundant in HepG2 cells, when EGFP gene was inserted between the NP/P site of the rNDV. Similarly, the IL-2 expressed by HepG2 cells infected with rNDV-IL2 was highest, when IL2 was inserted into NP/P site. To test whether these rNDVs that express higher foreign genes could induce stronger anti-tumor response, we treated the H22-oxter-tumor-bearing C57BL/6J mice with rNDV-IL2s and then examined the oncolytic efficacy. The results showed that rNDV-IL2-NP/P had the strongest inhibition of murine hepatoma carcinoma tumors. The splenocytes isolated from the mice treated with rNDV-IL2-NP/P reached the highest degrees of CD4(+) T and CD8(+) T cells. In addition, animals' survival rate in rNDV-IL2-NP/P-treated group was higher than that of other groups. Taken together, these results demonstrate that NP and P gene junction in rNDV is the optimal insertion site for foreign genes expression to enhance rNDV's antitumor effects.	[Pan, Ziye; Ding, Yun; Zou, Dehua; Zhang, Hua; Cao, Hongwei] HeiLongJiang BaYi Agr Univ, Coll Life Sci & Technol, Daqing 163319, Peoples R China; [Pan, Ziye; He, Jinjiao; Rasoul, Lubna M.; Liu, Yunye; Che, Ruixiang; Ding, Yun; Guo, Xiaocheng; Yang, Jiarui; Zou, Dehua; Li, Deshan] Northeast Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China	Heilongjiang Bayi Agricultural University; Northeast Agricultural University - China	Cao, HW (corresponding author), HeiLongJiang BaYi Agr Univ, Coll Life Sci & Technol, Daqing 163319, Peoples R China.; Li, DS (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China.	deshanli@163.com; hettieluck@hotmail.com	Rasoul, Lubna Muhi/ABA-6811-2020	Rasoul, Lubna Muhi/0000-0001-9836-1151	Doctor's Research Foundation; HeiLongJiang BaYi Agricultural University [XDB2015-18]; National Natural Science Foundation of China (NSFC) [31200121, 31300145, 31570159]	Doctor's Research Foundation; HeiLongJiang BaYi Agricultural University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Doctor's Research Foundation, HeiLongJiang BaYi Agricultural University (XDB2015-18), and National Natural Science Foundation of China (NSFC, Nos. 31200121, 31300145, and 31570159). We are grateful to Prof. Paul Chu (Guest Professor of Institute of Microbiology, Chinese Academy of Sciences) and Dr. Zhenhua Yang (University of Alabama at Birmingham) for critical reading of the manuscript.	Atkins MB, 2004, CLIN CANCER RES, V10, p6342S, DOI 10.1158/1078-0432.CCR-040029; Bai FL, 2015, MOL BIOL+, V49, P171, DOI 10.1134/S0026893315020028; Bai FL, 2014, CANCER BIOL THER, V15, P1226, DOI 10.4161/cbt.29686; Buijs P, 2015, VIRUSES-BASEL, V7, P2980, DOI 10.3390/v7062756; Estevez C, 2007, VIRUS RES, V129, P182, DOI 10.1016/j.virusres.2007.07.008; Huang HY, 2011, CHEM RES CHINESE U, V27, P836; Ibrahim AS, 2013, VACCINE, V31, P5549, DOI 10.1016/j.vaccine.2013.09.016; King DJ, 1998, AVIAN DIS, V42, P507, DOI 10.2307/1592677; Krishnamurthy S, 2000, VIROLOGY, V278, P168, DOI 10.1006/viro.2000.0618; Lazar I, 2010, J VIROL, V84, P639, DOI 10.1128/JVI.00401-09; Liang W, 2003, WORLD J GASTROENTERO, V9, P495, DOI 10.3748/wjg.v9.i3.495; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv Z, 2013, ASIAN PAC J CANCER P, V14, P7489, DOI 10.7314/APJCP.2013.14.12.7489; McDermott DF, 2004, EXPERT OPIN BIOL TH, V4, P455, DOI 10.1517/eobt.4.4.455.29473; Mebatsion T, 2002, J VIROL, V76, P10138, DOI 10.1128/JVI.76.20.10138-10146.2002; Niu ZS, 2015, TECHNOL CANCER RES T, V14, P607, DOI 10.7785/tcrt.2012.500414; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Tayeb S, 2013, HUM GENE THER, V24, pA4; Wu YZ, 2014, TECHNOL CANCER RES T, V13, P169, DOI 10.7785/tcrt.2012.500356; Zhang CX, 2015, TUMOR BIOL, V36, P7121, DOI 10.1007/s13277-015-3433-z	20	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164723	10.1371/journal.pone.0164723	http://dx.doi.org/10.1371/journal.pone.0164723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736965	Green Published, gold			2022-12-27	WOS:000385505800120
J	Williams, BC; Kruse, GH; Dorn, MW				Williams, Benjamin C.; Kruse, Gordon H.; Dorn, Martin W.			Interannual and Spatial Variability in Maturity ofWalleye Pollock Gadus chalcogrammus and Implications for Spawning Stock Biomass Estimates in the Gulf of Alaska	PLOS ONE			English	Article							WALLEYE POLLOCK; THERAGRA-CHALCOGRAMMA; ATLANTIC COD; SEA; CLASSIFICATION; SIZE	Catch quotas for walleye pollock Gadus chalcogrammus, the dominant species in the groundfish fishery off Alaska, are set by applying harvest control rules to annual estimates of spawning stock biomass (SSB) from age-structured stock assessments. Adult walleye pollock abundance and maturity status have been monitored in early spring in Shelikof Strait in the Gulf of Alaska for almost three decades. The sampling strategy for maturity status is largely characterized as targeted, albeit opportunistic, sampling of trawl tows made during hydroacoustic surveys. Trawl sampling during pre-spawning biomass surveys, which do not adequately account for spatial patterns in the distribution of immature and mature fish, can bias estimated maturity ogives from which SSB is calculated. Utilizing these maturity data, we developed mixed-effects generalized additive models to examine spatial and temporal patterns in walleye pollock maturity and the influence of these patterns on estimates of SSB. Current stock assessment practice is to estimate SSB as the product of annual estimates of numbers at age, weight at age, and mean maturity at age for 1983-present. In practice, we found this strategy to be conservative for a time period from 2003-2013 as, on average, it underestimates SSB by a 4.7 to 11.9% difference when compared to our estimates of SSB that account for spatial structure or both temporal and spatial structure. Inclusion of spatially explicit information for walleye pollock maturity has implications for understanding stock reproductive biology and thus the setting of sustainable harvest rates used to manage this valuable fishery.	[Williams, Benjamin C.; Kruse, Gordon H.] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Juneau, AK 99775 USA; [Dorn, Martin W.] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Williams, Benjamin C.] Alaska Dept Fish & Game, Juneau, AK 99802 USA	University of Alaska System; University of Alaska Fairbanks; National Oceanic Atmospheric Admin (NOAA) - USA; Alaska Department of Fish & Game	Williams, BC (corresponding author), Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Juneau, AK 99775 USA.	ben.williams@alaska.gov		Williams, Benjamin/0000-0001-7295-2076	National Science Foundation's Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT program at the University of Alaska Fairbanks [DGE-0801720]; Pollock Conservation Cooperative Research Center at the University of Alaska Fairbanks	National Science Foundation's Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT program at the University of Alaska Fairbanks; Pollock Conservation Cooperative Research Center at the University of Alaska Fairbanks	Financial support for this research was provided by the National Science Foundation's Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT program at the University of Alaska Fairbanks (#DGE-0801720) to BCW (https://www.sfos.uaf.edu/mesas/), and from the Pollock Conservation Cooperative Research Center at the University of Alaska Fairbanks to GHK (https://www.uaf.edu/sfos/research/major-research-programs/pccrc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this research was provided by the National Science Foundation's Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT program at the University of Alaska Fairbanks (#DGE-0801720), and from the Pollock Conservation Cooperative Research Center at the University of Alaska Fairbanks. Special thanks are extended to Alaska Fisheries Science Center scientists D. Jones, T. Honkalehto, C. Wilson, and N. Williamson for providing data and explaining data collection methods and offering other advice. This manuscript was greatly improved by an initial review from K. Criddle, and by two anonymous reviews.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Bacheler NM, 2012, DEEP-SEA RES PT II, V65-70, P208, DOI 10.1016/j.dsr2.2012.02.001; Bacheler NM, 2009, MAR ECOL PROG SER, V391, P1, DOI 10.3354/meps08259; Brander K, 2005, SPAWNING LIFE HIST I; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clarke ED, 2003, J APPL ECOL, V40, P278, DOI 10.1046/j.1365-2664.2003.00802.x; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dorn M, 2010, STOCK ASSESSMENT FIS; Dorn M, 2013, STOCK ASSESSMENT FIS, P53; Dorn M, 2012, STOCK ASSESSMENT FIS; Farley JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083017; Fissel B, 2013, EC STATUS GROUNDFISH; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hay DE, 2008, PROG OCEANOGR, V77, P233, DOI 10.1016/j.pocean.2008.03.015; Hay D. E., 1985, CANADIAN J FISHERIES, V42, ps111, DOI DOI 10.1139/F85-267; HILBORN R, 1992; Hollowed AB, 2009, ICES J MAR SCI, V66, P1584, DOI 10.1093/icesjms/fsp057; Honkalehto TN, 2008, NMFSAFSC190 NOAA US, P53; Ianelli JN, 2011, ICES J MAR SCI, V68, P1297, DOI 10.1093/icesjms/fsr010; Lambert Yvan, 2009, Journal of Northwest Atlantic Fishery Science, V41, P93; Loh WY, 2011, WIRES DATA MIN KNOWL, V1, P14, DOI 10.1002/widm.8; Lynde C, 1986, REGIONAL TEMPORAL DI; Marshall CT, 1998, CAN J FISH AQUAT SCI, V55, P1766, DOI 10.1139/cjfas-55-7-1766; Marshall CT, 2009, IMPLEMENTING INFORM, P395, DOI [10.1002/9781444312133.ch11, DOI 10.1002/9781444312133.CH11]; Matta M.E., 2012, NOAA PROF PAP NMFS, V13, P97; NMFS, 2013, NOAA PROT FISH AC SU; NMFS (National Marine Fisheries Service), 2014, FISH US 2013; Olsen E, 2005, CAN J FISH AQUAT SCI, V62, P811, DOI 10.1139/F05-065; Olsen JB, 2002, FISH B-NOAA, V100, P752; Peterson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088906; Pinchuk AI, 2008, PROG OCEANOGR, V77, P203, DOI 10.1016/j.pocean.2008.03.012; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rideout RM, 2000, J FISH BIOL, V57, P1429, DOI 10.1111/j.1095-8649.2000.tb02222.x; Shuck CJ, 2000, SPATIAL TEMPORAL DIF; Silva A, 2006, ICES J MAR SCI, V63, P663, DOI 10.1016/j.icesjms.2006.01.005; Stahl JP, 2008, LOW WAKE FI, V24, P1, DOI 10.4027/rgsfcc.2008.01; Stahl JP, 2008, T AM FISH SOC, V137, P1543, DOI 10.1577/T07-099.1; Therneau T., 2014, RPART RECURSIVE PART; Thorsen A, 2010, FISH RES, V104, P45, DOI 10.1016/j.fishres.2010.03.020; Thorsteinson LK, 2002, FISHES ALASKA; Trippel Edward A., 1999, Journal of Northwest Atlantic Fishery Science, V25, P61, DOI 10.2960/J.v25.a6; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams Kresimir, 2007, ALASKA FISHERY RESEARCH BULLETIN, V12, P252; Winton MV, 2014, CAN J FISH AQUAT SCI, V71, P1279, DOI 10.1139/cjfas-2013-0617; Witherell D, 2000, ICES J MAR SCI, V57, P771, DOI 10.1006/jmsc.2000.0719; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yoneda M, 2004, MAR ECOL PROG SER, V276, P237, DOI 10.3354/meps276237	48	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164797	10.1371/journal.pone.0164797	http://dx.doi.org/10.1371/journal.pone.0164797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736982	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800130
J	Gao, WL; Qiao, XW; Wang, YH; Wan, LP; Wang, ZW; Wang, X; Di, ZX; Liu, XY				Gao, Wenlong; Qiao, Xiaowei; Wang, Yuhong; Wan, Liping; Wang, Zengwu; Wang, Xin; Di, Zhaoxin; Liu, Xiaoyu			The Interactive Association of General Obesity and Central Obesity with Prevalent Hypertension in Rural Lanzhou, China	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; ANTHROPOMETRIC INDICATORS; CARDIOVASCULAR-DISEASE; ABDOMINAL ADIPOSITY; RISK-FACTORS; PREDICTION; FATNESS; RATIO	Objective To evaluate the interactive association between obesity with different anthropometry indices and prevalence of hypertension in rural Lanzhou. Methods A cross-sectional survey was conducted in rural Lanzhou from April to July in 2013. The available information of 1275 rural residents aged more than 35 years was collected with a unified questionnaire and their blood pressure and anthropometry indices were measured in the field. The male-to-female ratio was 1:1.1. A generalized estimate equation (GEE) linear model was used to determine the association between obesity with different indexes and hypertension. Results There was a moderate prevalence of general obesity (similar to 11%) and very high prevalence of central obesity (53.2 similar to 67%) among the adults of rural Lanzhou. The prevalence of hypertension approximated 28%. GEE linear models showed that obesity with any one of anthropometry indices was associated significantly with the increased prevalence of hypertension among both males and females. In females, general obesity increased the prevalence of hypertension by 37% (0.37, 95% CI: 0.27,0.47) but in males by 23% (0.23, 95% CI: 0.12,0.35). The hypertensive effect of all central obesity was much lower than that of general obesity but approximately comparable to that of overweight. In addition, the interactions of the classified body mass index (BMI) and central obesity showed that when general obesity or overweight coexisted with any one of central obesity, the prevalence of hypertension was increased significantly, and this effect was a little higher than the corresponding main effect of general obesity or overweight in females but was much higher in males. In addition, general obesity or overweight which did not coexist with central obesity was not significantly associated with the increased prevalence of hypertension, nor were the other situations of central obesity in the normal weight or underweight except for the situation of central obesity with waist-to-hip ratio in the males of normal weight or underweight. Conclusion In rural Lanzhou, higher BMI had larger associations with the increased prevalence of hypertension than central obesity indices. Only when general obesity or overweight coexisted with central obesity, the prevalence of hypertension was significantly increased. So, central obesity indices should be used jointly with BMI in evaluating the risk of hypertension.	[Gao, Wenlong] Lanzhou Univ, Sch Publ Hlth, Inst Epidemiol & Hlth Stat, Lanzhou, Gansu, Peoples R China; [Qiao, Xiaowei; Wang, Yuhong; Wan, Liping; Di, Zhaoxin] Lanzhou Ctr Dis Prevent & Control, Lanzhou, Gansu, Peoples R China; [Wang, Zengwu; Wang, Xin] Fuwai Hosp, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Div Prevent & Community Hlth, Beijing, Peoples R China; [Wang, Zengwu; Wang, Xin] Chinese Acad Med Sci, Beijing, Peoples R China; [Liu, Xiaoyu] Yuzhong Cty Ctr Dis Prevent & Control, Lanzhou, Gansu, Peoples R China	Lanzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Gao, WL (corresponding author), Lanzhou Univ, Sch Publ Hlth, Inst Epidemiol & Hlth Stat, Lanzhou, Gansu, Peoples R China.	gaowl06@aliyun.com	wang, zengwu/AAS-9504-2021	wang, Zengwu/0000-0003-1613-5076	research of key technology integration and application demonstration for prevention and treatment of cardiovascular and cerebral diseases in rural areas, national "Twelfth Five Year Plan" science and technology support program [2012BAJ18B04]	research of key technology integration and application demonstration for prevention and treatment of cardiovascular and cerebral diseases in rural areas, national "Twelfth Five Year Plan" science and technology support program	Financial support came from a research of key technology integration and application demonstration for prevention and treatment of cardiovascular and cerebral diseases in rural areas, national "Twelfth Five Year Plan" science and technology support program (No. 2012BAJ18B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sharbatti SS, 2011, IRAN J PUBLIC HEALTH, V40, P33; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Chalmers J, 1999, J HYPERTENS, V17, P151; Chang JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145818; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Chuang SY, 2016, J GERONTOL A-BIOL, V71, P1049, DOI 10.1093/gerona/glv192; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Doll S, 2002, INT J OBESITY, V26, P48, DOI 10.1038/sj.ijo.0801854; Esmaillzadeh A, 2006, PUBLIC HEALTH NUTR, V9, P61, DOI 10.1079/PHN2005833; Falaschetti E, 2014, LANCET, V383, P1912, DOI 10.1016/S0140-6736(14)60688-7; Fan HM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21521; Feldstein CA, 2005, NUTR METAB CARDIOVAS, V15, P310, DOI 10.1016/j.numecd.2005.03.001; Foussas S, 2016, HELL J CARDIOL, V57, P63, DOI 10.1016/S1109-9666(16)30023-9; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Hallqvist T, 1996, J INTERN MED, V239, P377, DOI 10.1046/j.1365-2796.1996.431782000.x; Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3; KANNEL WB, 1967, ANN INTERN MED, V67, P48, DOI 10.7326/0003-4819-67-1-48; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Khan Rumana J, 2015, Integr Obes Diabetes, V1, P49; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Ling RE, 2011, PUBLIC HEALTH, V125, P9, DOI 10.1016/j.puhe.2010.10.009; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; Molarius A, 1998, INT J OBESITY, V22, P719, DOI 10.1038/sj.ijo.0800660; Mufunda T, 2000, J HUM HYPERTENS, V14, P65, DOI 10.1038/sj.jhh.1000886; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Ren Lin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P356; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; Shao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082446; Gutierrez CV, 2015, NUTR HOSP, V32, P1603, DOI 10.3305/nh.2015.32.4.9380; [王国栋 Wang Guodong], 2012, [中华流行病学杂志, Chinese Journal of Epidemiology], V33, P873; Wang YX, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003379; Wilding J, 2006, LANCET, V367, P1053, DOI 10.1016/S0140-6736(06)68463-8; World Health Organization,, 1998, WHO TECHN REP SER; Yalcin BM, 2005, FAM PRACT, V22, P541, DOI 10.1093/fampra/cmi043; Yan YX, 2012, J URBAN HEALTH, V89, P329, DOI 10.1007/s11524-011-9636-8; Zhou ZQ, 2009, PUBLIC HEALTH NUTR, V12, P1061, DOI 10.1017/S1368980008003601; Zhu S, 2013, CHINA J OF PUBLIC HE, V12, P98	39	7	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164409	10.1371/journal.pone.0164409	http://dx.doi.org/10.1371/journal.pone.0164409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732655	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505300054
J	Hopper, T; Meixler, MS				Hopper, Thomas; Meixler, Marcia S.			Modeling Coastal Vulnerability through Space and Time	PLOS ONE			English	Article							SEA-LEVEL RISE; NEW-YORK-CITY; JAMAICA-BAY; ECOSYSTEM SERVICES; PROTECTION; WETLANDS; IMPACTS; THREATS	Coastal ecosystems experience a wide range of stressors including wave forces, storm surge, sea-level rise, and anthropogenic modification and are thus vulnerable to erosion. Urban coastal ecosystems are especially important due to the large populations these limited ecosystems serve. However, few studies have addressed the issue of urban coastal vulnerability at the landscape scale with spatial data that are finely resolved. The purpose of this study was to model and map coastal vulnerability and the role of natural habitats in reducing vulnerability in Jamaica Bay, New York, in terms of nine coastal vulnerability metrics (relief, wave exposure, geomorphology, natural habitats, exposure, exposure with no habitat, habitat role, erodible shoreline, and surge) under past (1609), current (2015), and future (2080) scenarios using InVEST 3.2.0. We analyzed vulnerability results both spatially and across all time periods, by stakeholder (ownership) and by distance to damage from Hurricane Sandy. We found significant differences in vulnerability metrics between past, current and future scenarios for all nine metrics except relief and wave exposure. The marsh islands in the center of the bay are currently vulnerable. In the future, these islands will likely be inundated, placing additional areas of the shoreline increasingly at risk. Significant differences in vulnerability exist between stakeholders; the Breezy Point Cooperative and Gateway National Recreation Area had the largest erodible shoreline segments. Significant correlations exist for all vulnerability (exposure/surge) and storm damage combinations except for exposure and distance to artificial debris. Coastal protective features, ranging from storm surge barriers and levees to natural features (e.g. wetlands), have been promoted to decrease future flood risk to communities in coastal areas around the world. Our methods of combining coastal vulnerability results with additional data and across multiple time periods have considerable potential to provide valuable predictions that resource managers can effectively use to identify areas for restoration and protection.	[Hopper, Thomas; Meixler, Marcia S.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Hopper, T (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.	Tjhop1123@gmail.com	BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910	United States Department of the Interior, National Park Service [NPS-14-NERO-0152, P14AC01607]	United States Department of the Interior, National Park Service	This study was supported by funding from the United States Department of the Interior, National Park Service (NPS-14-NERO-0152, task agreement P14AC01607) to MM; https://www.nps.gov/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1910, NY TIMES; [Anonymous], THESIS; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Black FR, 1981, JAMAICA BAY HIST HIS; Boger R, 2012, ENVIRON MANAGE, V49, P229, DOI 10.1007/s00267-011-9752-y; Bolstad Paul., 2019, GIS FUNDAMENTALS 1 T, V6th; Brown AC, 2002, ENVIRON CONSERV, V29, P62, DOI 10.1017/S037689290200005X; Charlier RH, 2005, J COASTAL RES, V21, P79, DOI 10.2112/03561.1; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; de Groot R, 2012, ECOSYST SERV, V1, P50, DOI 10.1016/j.ecoser.2012.07.005; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Dugan J.E., 2006, SHORE BEACH, V74, P10, DOI DOI 10.1111/J.1439-0485.2008.00231.X; Englebright S., 1975, JAMAICA BAY CASE STU; Gomez-Baggethun E, 2013, ECOL ECON, V86, P235, DOI 10.1016/j.ecolecon.2012.08.019; Gordon A, 2004, P JAM BAYS DIS SALTM; Hammar-Klose ES, 2001, US GEOL SURV DAT SER; Hartig EK, 2002, WETLANDS, V22, P71, DOI 10.1672/0277-5212(2002)022[0071:AACCIO]2.0.CO;2; Hauser S, 2015, WETLANDS, V35, P1137, DOI 10.1007/s13157-015-0701-z; Jamaica Bay Watershed Advisory Committee, 2007, JAM BAY WAT PROT PLA, V1; Kirwan ML, 2016, NAT CLIM CHANGE, V6, P253, DOI 10.1038/NCLIMATE2909; Kopp RE, 2016, P NATL ACAD SCI USA, V113, pE1434, DOI 10.1073/pnas.1517056113; Mcinnes KL, 2003, NAT HAZARDS, V30, P187, DOI 10.1023/A:1026118417752; Morton RA, 2011, J COASTAL RES, V27, P27, DOI 10.2112/JCOASTRES-D-10-00185.1; New York City Panel on Climate Change, 2015, ANN NY ACAD SCI, V1336, P9, DOI DOI 10.1111/NYAS.12591; ONeil-Dunne J.P.M., 2014, URBAN ECOLOGICAL LAN; Pachauri R.K., 2014, 2014 IEEE STUDENTSCO; Pickett ST, 2008, URBAN ECOL, V32, P127; Pontee N, 2013, OCEAN COAST MANAGE, V84, P204, DOI 10.1016/j.ocecoaman.2013.07.010; Ramsey E, 2012, J COASTAL RES, V28, P457, DOI 10.2112/JCOASTRES-D-11-00052.1; Sanderson EW, 2016, NORTHEAST NAT, V23, P277, DOI 10.1656/045.023.0208; Sharp R., 2015, INVEST USERS GUIDE, P123; Street B., 2010, NAT PARK SERV NAT RE; Swanson RL, 2008, J COASTAL RES, V24, P1565, DOI 10.2112/07-0907.1; Tibbetts J, 2002, ENVIRON HEALTH PERSP, V110, pA674, DOI 10.1289/ehp.110-a674; Velinsky D, 2011, 1005 PCER U DEL AC N; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9	36	16	16	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163495	10.1371/journal.pone.0163495	http://dx.doi.org/10.1371/journal.pone.0163495			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732674	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300016
J	McLaren, ZM; Schnippel, K; Sharp, A				McLaren, Zoe M.; Schnippel, Kathryn; Sharp, Alana			A Data-Driven Evaluation of the Stop TB Global Partnership Strategy of Targeting Key Populations at Greater Risk for Tuberculosis	PLOS ONE			English	Article							SOUTH-AFRICA; HIV	Objective Identifying those infected with tuberculosis (TB) is an important component of any strategy for reducing TB transmission and population prevalence. The Stop TB Global Partnership recently launched an initiative with a focus on key populations at greater risk for TB infection or poor clinical outcomes, due to housing and working conditions, incarceration, low household income, malnutrition, co-morbidities, exposure to tobacco and silica dust, or barriers to accessing medical care. To achieve operational targets, the global health community needs effective, low cost, and large-scale strategies for identifying key populations. Using South Africa as a test case, we assess the feasibility and effectiveness of targeting active case finding to populations with TB risk factors identified from regularly collected sources of data. Our approach is applicable to all countries with TB testing and census data. It allows countries to tailor their outreach activities to the particular risk factors of greatest significance in their national context. Methods We use a national database of TB test results to estimate municipality-level TB infection prevalence, and link it to Census data to measure population risk factors for TB including rates of urban households, informal settlements, household income, unemployment, and mobile phone ownership. To examine the relationship between TB prevalence and risk factors, we perform linear regression analysis and plot the set of population characteristics against TB prevalence and TB testing rate by municipality. We overlay lines of best fit and smoothed curves of best fit from locally weighted scatter plot smoothing. Findings Higher TB prevalence is statistically significantly associated with more urban municipalities (slope coefficient beta(1) = 0.129, p < 0.0001, R-2 = 0.133), lower mobile phone access (beta(1) = -0.053, p < 0.001, R-2 = 0.089), lower unemployment rates (beta(1) = -0.020, p = 0.003, R-2 = 0.048), and a lower proportion of low-income households (beta(1) = -0.048, p < 0.0001, R-2 = 0.084). Municipalities with more low-income households also have marginally higher TB testing rates, however, this association is not statistically significant (beta(1) = -0.025, p = 0.676, R-2 = 0.001). There is no relationship between TB prevalence and the proportion of informal settlement households (beta(1) = 0.021, p = 0.136, R-2 = 0.014). Conclusions These analyses reveal that the set of characteristics identified by the Global Plan as defining key populations do not adequately predict populations with high TB burden. For example, we find that higher TB prevalence is correlated with more urbanized municipalities but not with informal settlements. We highlight several factors that are counter-intuitively those most associated with high TB burdens and which should therefore play a large role in any effective targeting strategy. Targeting active case finding to key populations at higher risk of infection or poor clinical outcomes may prove more cost effective than broad efforts. However, these results should increase caution in current targeting of active case finding interventions.	[McLaren, Zoe M.; Sharp, Alana] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Schnippel, Kathryn] Right Care, Res Dept, Centurion, South Africa; [Schnippel, Kathryn] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med,Clin HIV Res Unit, Johannesburg, South Africa	University of Michigan System; University of Michigan; University of Witwatersrand	McLaren, ZM (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA.	zmclaren@umich.edu		Schnippel, Kathryn/0000-0003-0757-4325; McLaren, Zoe/0000-0003-2515-9731				[Anonymous], 2016, 1 DEP HLTH S AFR NAT; [Anonymous], 2015, GLOB PLAN END TB PAR; [Anonymous], 2014, P03093 STAT S AFR; Azman AS, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0216-0; Bekker LG, 2010, CLIN INFECT DIS, V50, pS208, DOI 10.1086/651493; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Dowdy DW, 2013, INT J TUBERC LUNG D, V17, P866, DOI 10.5588/ijtld.12.0573; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Houben RMGJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0608-4; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Sekandi JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117009; South African National AIDS Council, 2015, S AFR COMM MASS TB S; Statistics South Africa, 2012, 030147 STAT S AFR; Stuckler D, 2013, INT J HEALTH SERV, V43, P639, DOI 10.2190/HS.43.4.c; Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587; World Health Organization, 2020, GLOBAL TUBERCULOSIS	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163083	10.1371/journal.pone.0163083	http://dx.doi.org/10.1371/journal.pone.0163083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732606	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300008
J	Owczarczak-Garstecka, SC; Burman, OHP				Owczarczak-Garstecka, Sara C.; Burman, Oliver H. P.			Can Sleep and Resting Behaviours Be Used as Indicators of Welfare in Shelter Dogs (Canis lupus familiaris)?	PLOS ONE			English	Article							CHRONIC MILD STRESS; PHYSIOLOGICAL INDICATORS; RAT; RESTRICTION; DEPRESSION; DISORDERS; RESPONSES; CORTISOL; DURATION; CATS	Previous research on humans and animals suggests that the analysis of sleep patterns may reliably inform us about welfare status, but little research of this kind has been carried out for non-human animals in an applied context. This study explored the use of sleep and resting behaviour as indicators of welfare by describing the activity patterns of dogs (Canis lupus familiaris) housed in rescue shelters, and comparing their sleep patterns to other behavioural and cognitive measures of welfare. Sleep and activity patterns were observed over five non-consecutive days in a population of 15 dogs. Subsequently, the characteristics of sleep and resting behaviour were described and the impact of activity on patterns of sleep and resting behaviour analysed. Shelter dogs slept for 2.8% of the day, 14.3% less than previously reported and experienced less sleep fragmentation at night (32 sleep bouts). There were no statistically significant relationships between behaviours exhibited during the day and sleep behaviour. A higher proportion of daytime resting behaviour was significantly associated with a positive judgement bias, less repetitive behaviour and increased time spent coded as 'relaxed' across days by shelter staff. These results suggest that, in the context of a busy shelter environment, the ability to rest more during the day could be a sign of improved welfare. Considering the non-linear relationship between sleep and welfare in humans, the relationship between sleep and behavioural indicators of welfare, including judgement bias, in shelter dogs may be more complex than this study could detect.	[Owczarczak-Garstecka, Sara C.] Univ Liverpool, Inst Risk & Uncertainty, Liverpool, Merseyside, England; [Owczarczak-Garstecka, Sara C.; Burman, Oliver H. P.] Lincoln Univ, Sch Life Sci, Lincoln, England	University of Liverpool; University of Lincoln	Owczarczak-Garstecka, SC (corresponding author), Univ Liverpool, Inst Risk & Uncertainty, Liverpool, Merseyside, England.; Owczarczak-Garstecka, SC (corresponding author), Lincoln Univ, Sch Life Sci, Lincoln, England.	s.owczarczak-garstecka@liverpool.ac.uk	Owczarczak-Garstecka, Sara/AAT-8927-2021	Owczarczak-Garstecka, Sara/0000-0001-5323-8117	BBSRC [BB/J00703X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J00703X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abou-Ismail UA, 2007, ANIM WELFARE, V16, P185; Abou-Ismail UA, 2008, APPL ANIM BEHAV SCI, V111, P329, DOI 10.1016/j.applanim.2007.06.019; ADAMS GJ, 1993, APPL ANIM BEHAV SCI, V36, P233, DOI 10.1016/0168-1591(93)90013-F; ADAMS GJ, 1994, APPL ANIM BEHAV SCI, V41, P115, DOI 10.1016/0168-1591(94)90056-6; Anderson C, 2011, BEHAV BRAIN RES, V217, P463, DOI 10.1016/j.bbr.2010.09.020; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Bolhuis JE, 2006, APPL ANIM BEHAV SCI, V101, P68, DOI 10.1016/j.applanim.2006.01.001; Bouyer JJ, 1997, NEUROSCI LETT, V225, P193, DOI 10.1016/S0304-3940(97)00218-8; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Burman O, 2011, APPL ANIM BEHAV SCI, V132, P160, DOI 10.1016/j.applanim.2011.04.001; Cafazzo S, 2014, PHYSIOL BEHAV, V133, P223, DOI 10.1016/j.physbeh.2014.05.046; Cheeta S, 1997, BIOL PSYCHIAT, V41, P419, DOI 10.1016/S0006-3223(96)00058-3; Clark CCA, 2012, VET REC, V170, P493, DOI 10.1136/vr.100524; Dalm S, 2009, BEHAV BRAIN RES, V196, P84, DOI 10.1016/j.bbr.2008.07.035; Denham HDC, 2014, PHYSIOL BEHAV, V128, P288, DOI 10.1016/j.physbeh.2014.01.007; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Hanninen L, 2010, RECENT ADV ANIMAL WE; Hennessy MB, 2002, J AM VET MED ASSOC, V221, P65, DOI 10.2460/javma.2002.221.65; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; Kamphuis J, 2012, SLEEP MED, V13, P327, DOI 10.1016/j.sleep.2011.12.006; Kis A, 2014, PHYSIOL BEHAV, V130, P149, DOI 10.1016/j.physbeh.2014.04.004; Langford FM, 2010, ANIM WELFARE, V19, P215; Lemola S, 2011, J SLEEP RES, V20, P12, DOI 10.1111/j.1365-2869.2010.00856.x; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; MASON G, 1993, ANIM WELFARE, V2, P301; Meagher RK, 2013, APPL ANIM BEHAV SCI, V144, P138, DOI 10.1016/j.applanim.2013.01.008; Meerlo P, 2001, PHYSIOL BEHAV, V73, P331, DOI 10.1016/S0031-9384(01)00451-6; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Nutt David, 2008, Dialogues Clin Neurosci, V10, P329; Part CE, 2014, PHYSIOL BEHAV, V133, P260, DOI 10.1016/j.physbeh.2014.05.018; Rochlitz I, 1998, VET REC, V143, P35, DOI 10.1136/vr.143.2.35; Ruckebusch Y., 1975, Applied Animal Ethology, V2, P3, DOI 10.1016/0304-3762(75)90061-9; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Stephen JM, 2006, PHYSIOL BEHAV, V87, P911, DOI 10.1016/j.physbeh.2006.02.015; Takeuchi T, 2002, BEHAV BRAIN RES, V136, P193, DOI 10.1016/S0166-4328(02)00123-7; Tilly SLC, 2010, ANIM BEHAV, V80, P363, DOI 10.1016/j.anbehav.2010.06.008; Titulaer M, 2013, APPL ANIM BEHAV SCI, V147, P149, DOI 10.1016/j.applanim.2013.05.001; Vandekerckhove M, 2010, SLEEP MED REV, V14, P219, DOI 10.1016/j.smrv.2010.01.002; Vandeputte M, 2003, SLEEP MED, V4, P343, DOI 10.1016/S1389-9457(03)00059-5; Voellmy IK, 2014, HORM BEHAV, V66, P759, DOI 10.1016/j.yhbeh.2014.08.008; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Wurbel H, 1998, BEHAV PROCESS, V42, P61, DOI 10.1016/S0376-6357(97)00062-4; Zanghi BM, 2013, J VET BEHAV, V8, P195, DOI 10.1016/j.jveb.2012.10.007; Zanghi BM, 2012, J VET BEHAV, V7, P339, DOI 10.1016/j.jveb.2012.01.004	48	38	39	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163620	10.1371/journal.pone.0163620	http://dx.doi.org/10.1371/journal.pone.0163620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732667	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000385505300024
J	Kawiak, A; Domachowska, A				Kawiak, Anna; Domachowska, Anna			Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKa-Mediated NF-kappa B Activation	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; SECONDARY METABOLITES; INDUCED APOPTOSIS; BONE METASTASIS; PATHWAY; KINASE; EXPRESSION; HER2; OVEREXPRESSION; MIGRATION	HER2-overexpressing breast cancers account for about 30% of breast cancer occurrences and have been correlated with increased tumor aggressiveness and invasiveness. The nuclear factor-kappa B (NF-kappa B) is overexpressed in a subset of HER2-positive breast cancers and its upregulation has been associated with the metastatic potential of HER2-overexpressing tumors. The present study aimed at determining the potential of plumbagin, a naturally occurring naphthoquinone, to inhibit the invasion of HER2-overexpressing breast cancer cells and determine the involvement of NF-kappa B inhibition in plumbagin-mediated cell invasion suppression. In the present research we showed that plumbagin inhibited the transcriptional activity of NF-kappa B in HER2-positive breast cancer cells. The suppression of NF-kappa B activation corresponded with the inhibition of NF-kappa B p65 phosphorylation and downregulation of NF-kappa B-regulated matrix metalloproteinase 9 (MMP-9) expression. Plumbagin suppressed the invasion of HER2-overexpressing breast cancer cells and the inhibition of cell invasion was associated with the ability of plumbagin to inhibit NF-kappa B transcriptional activity. The silencing of NF-kappa B p65 increased the sensitivity of HER2-overexpressing breast cancer cells to plumbagin-induced cell invasion inhibition. NF-kappa B inhibition was associated with I.B kinase a (IKKa) activity suppression and inhibition of I.Ba phosphorylation and degradation. The knockdown of IKKa resulted in increased sensitivity of HER2-positive cells to plumbagin-induced suppression of NF-kappa B transcriptional activity and expression of MMP-9. In conclusion, plumbagin inhibits the invasion of HER2-overexpressing breast cancer cells through the inhibition of IKKa-mediated NF-kappa B activation and downregulation of NF-kappa B-regulated MMP-9 expression.	[Kawiak, Anna; Domachowska, Anna] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Gdansk, Poland; [Kawiak, Anna; Domachowska, Anna] Med Univ Gdansk, Gdansk, Poland; [Kawiak, Anna] Med Univ Gdansk, Fac Hlth Sci Subfac Nursing, Lab Human Physiol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Kawiak, A (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Gdansk, Poland.; Kawiak, A (corresponding author), Med Univ Gdansk, Gdansk, Poland.; Kawiak, A (corresponding author), Med Univ Gdansk, Fac Hlth Sci Subfac Nursing, Lab Human Physiol, Gdansk, Poland.	anna.kawiak@biotech.ug.edu.pl	Kawiak, Anna/L-6060-2014	Kawiak, Anna/0000-0001-8105-2555	National Centre for Research and Development [Lider/15/217/L-3/11/NCBR/2012]; AK; European Union's Seventh Framework Programme for research [MOBI4Health, 316094]; Polish Ministry of Science and Higher Education	National Centre for Research and Development; AK; European Union's Seventh Framework Programme for research; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported were supported by grant no. Lider/15/217/L-3/11/NCBR/2012 from the National Centre for Research and Development (https://www.ncbr.gov.pl), funding received by AK. Cost of open access publication supported from the project MOBI4Health that has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 316094 and from the Polish Ministry of Science and Higher Education within the programme for international co-funded projects.	Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Ahmed KM, 2006, ANTICANCER RES, V26, P4235; Aziz MH, 2008, CANCER RES, V68, P9024, DOI 10.1158/0008-5472.CAN-08-2494; Bin Hafeez B, 2012, INT J CANCER, V131, P2175, DOI [10.1002/ijc.274781471, DOI 10.1002/IJC.27478]; Cao N, 2009, RADIAT RES, V171, P9, DOI 10.1667/RR1472.1; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; de Paiva SB, 2005, PHYTOCHEM ANALYSIS, V16, P278, DOI 10.1002/pca.841; Duru N, 2014, J CANCER RES CLIN, V140, P1, DOI 10.1007/s00432-013-1494-1; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Guo GZ, 2004, ONCOGENE, V23, P535, DOI 10.1038/sj.onc.1207149; Gupta P, 2014, MOL ONCOL, V8, P1532, DOI 10.1016/j.molonc.2014.06.006; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Joo MK, 2015, INT J ONCOL, V46, P2380, DOI 10.3892/ijo.2015.2935; Kawiak A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147718; Kawiak A, 2012, J NAT PROD, V75, P747, DOI 10.1021/np3000409; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Li Z, 2012, CURR MOL MED, V12, P967, DOI 10.2174/156652412802480871; Liu XJ, 2015, J NEURO-ONCOL, V121, P469, DOI 10.1007/s11060-014-1664-2; Manu KA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-107; Marczak L, 2005, PHYTOCHEM ANALYSIS, V16, P143, DOI 10.1002/pca.833; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Park JW, 2008, CLIN BREAST CANCER, V8, P392, DOI 10.3816/CBC.2008.n.047; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Shieh JM, 2010, MOL CELL BIOCHEM, V335, P181, DOI 10.1007/s11010-009-0254-7; Shih YW, 2009, HEPATOL RES, V39, P998, DOI 10.1111/j.1872-034X.2009.00540.x; Sung B, 2012, MOL CANCER THER, V11, P350, DOI 10.1158/1535-7163.MCT-11-0731; Thasni KA, 2013, MOL CARCINOGEN, V52, P392, DOI 10.1002/mc.21877; Wang CCC, 2008, CANCER LETT, V259, P82, DOI 10.1016/j.canlet.2007.10.005; Wang TY, 2014, FOOD CHEM TOXICOL, V64, P177, DOI 10.1016/j.fct.2013.11.027; Xia WL, 2010, MOL CANCER THER, V9, P292, DOI 10.1158/1535-7163.MCT-09-1041; Yan W, 2013, BONE RES, V1, P362, DOI 10.4248/BR201304007; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027	38	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164064	10.1371/journal.pone.0164064	http://dx.doi.org/10.1371/journal.pone.0164064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727280	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504400018
J	Mehlotra, RK; Hall, NB; Willie, B; Stein, CM; Weinberg, A; Zimmerman, PA; Vernon, LT				Mehlotra, Rajeev K.; Hall, Noemi B.; Willie, Barne; Stein, Catherine M.; Weinberg, Aaron; Zimmerman, Peter A.; Vernon, Lance T.			Associations of Toll-Like Receptor and beta-Defensin Polymorphisms with Measures of Periodontal Disease (PD) in HIV plus North American Adults: An Exploratory Study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; HUMAN BETA-DEFENSIN-3; ANTIMICROBIAL PEPTIDES; RISK-FACTORS; EXPRESSION; INDUCTION; TLR2; SUSCEPTIBILITY; PATHOGENESIS	Polymorphisms in toll-like receptor (TLR) and beta-defensin (DEFB) genes have been recognized as potential genetic factors that can influence susceptibility to and severity of periodontal diseases (PD). However, data regarding associations between these polymorphisms and PD are still scarce in North American populations, and are not available in HIV+ North American populations. In this exploratory study, we analyzed samples from HIV+ adults (n = 115), who received primary HIV care at 3 local outpatient HIV clinics and were monitored for PD status. We genotyped a total of 41 single nucleotide polymorphisms (SNPs) in 8 TLR genes and copy number variation (CNV) in DEFB4/103A. We performed regression analyses for levels of 3 periodontopathogens in subgingival dental plaques (Porphyromonas gingivalis [Pg], Treponema denticola [Td], and Tannerella forsythia [Tf]) and 3 clinical measures of PD (periodontal probing depth [PPD], gingival recession [REC], and bleeding on probing [BOP]). In all subjects combined, 2 SNPs in TLR1 were significantly associated with Td, and one SNP in TLR2 was significantly associated with BOP. One of the 2 SNPs in TLR1 was significantly associated with Td in Caucasians. In addition, another SNP in TLR1 and a SNP in TLR6 were also significantly associated with Td and Pg, respectively, in Caucasians. All 3 periodontopathogen levels were significantly associated with PPD and BOP, but none was associated with REC. Instrumental variable analysis showed that 8 SNPs in 6 TLR genes were significantly associated with the 3 periodontopathogen levels. However, associations between the 3 periodontopathogen levels and PPD or BOP were not driven by associations with these identified SNPs. No association was found between DEFB4/103A CNV and any periodontopathogen level or clinical measure in all samples, Caucasians, or African Americans. Our exploratory study suggests a role of TLR polymorphisms, particularly TLR1 and TLR6 polymorphisms, in PD in HIV+ North Americans.	[Mehlotra, Rajeev K.; Willie, Barne; Zimmerman, Peter A.] Case Western Reserve Univ, Sch Med, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Hall, Noemi B.; Stein, Catherine M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Stein, Catherine M.] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Weinberg, Aaron] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA; [Vernon, Lance T.] Case Western Reserve Univ, Sch Dent Med, Dept Pediat & Community Dent, Cleveland, OH 44106 USA; [Willie, Barne] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; PNG Institute Of Medical Research	Mehlotra, RK (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA.; Vernon, LT (corresponding author), Case Western Reserve Univ, Sch Dent Med, Dept Pediat & Community Dent, Cleveland, OH 44106 USA.	rkm@case.edu; ltv1@case.edu	MEHLOTRA, RAJEEV/AAG-1026-2020; Stein, Catherine/P-9498-2019	Stein, Catherine/0000-0002-9763-5023; Mehlotra, Rajeev/0000-0003-4205-750X; Weinberg, Aaron/0000-0002-9960-7181	National Institutes of Health [DE15746, DE21376, DE023740, T32HL007567, 1P01DE019759]; National Institutes of Health (through CFAR) [AI36219]; Fogarty International Center [D43TW007377]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (through CFAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Institutes of Health DE15746, DE21376, and DE023740 to L.T.V.; National Institutes of Health (through CFAR) AI36219 to L.T.V.; National Institutes of Health 1P01DE019759 to A.W., P.A.Z.; Fogarty International Center D43TW007377 to P.A.Z.; and National Institutes of Health T32HL007567 to C.M.S.	Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Burgess S, 2017, STAT METHODS MED RES, V26, P2333, DOI 10.1177/0962280215597579; Buzkova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056976; Carratelli CR, 2009, FEMS IMMUNOL MED MIC, V57, P116, DOI 10.1111/j.1574-695X.2009.00586.x; Checchi L, 2009, OPEN DENT J, V3, P154, DOI 10.2174/1874210600903010154; Costa Fernando O, 2009, J Oral Sci, V51, P199; Diamond G, 2011, ORAL DIS, V17, P628, DOI 10.1111/j.1601-0825.2011.01799.x; Dommisch H, 2015, PERIODONTOL 2000, V69, P96, DOI 10.1111/prd.12093; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Feghali K, 2011, J PERIODONTAL RES, V46, P147, DOI 10.1111/j.1600-0765.2010.01311.x; Feng P, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-84; Ferlin A, 2010, ENDOCR-RELAT CANCER, V17, P17, DOI 10.1677/ERC-09-0176; FLEISS JL, 1987, COMMUNITY DENT ORAL, V15, P221, DOI 10.1111/j.1600-0528.1987.tb00525.x; Folwaczny M, 2011, CLIN ORAL INVEST, V15, P435, DOI 10.1007/s00784-010-0396-8; Ford PJ, 2010, PERIODONTOL 2000, V53, P111, DOI 10.1111/j.1600-0757.2010.00349.x; Froy O, 2005, CELL MICROBIOL, V7, P1387, DOI 10.1111/j.1462-5822.2005.00590.x; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Funderburg NT, 2012, J LEUKOCYTE BIOL, V92, P1103, DOI 10.1189/jlb.1111555; Funderburg NT, 2011, IMMUNOLOGY, V134, P151, DOI 10.1111/j.1365-2567.2011.03475.x; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Grenier D, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.21517; Guncu GN, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00099; Hart BE, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/415057; Highfield J, 2009, AUST DENT J, V54, pS11, DOI 10.1111/j.1834-7819.2009.01140.x; Holla LI, 2010, J CLIN PERIODONTOL, V37, P152, DOI 10.1111/j.1600-051X.2009.01523.x; Jaradat SW, 2013, J DENT RES, V92, P1035, DOI 10.1177/0022034513504217; Junpee A, 2010, PARASITOL RES, V107, P807, DOI 10.1007/s00436-010-1932-9; Knight ET, 2016, PERIODONTOL 2000, V71, P22, DOI 10.1111/prd.12110; Kormann MSD, 2008, J ALLERGY CLIN IMMUN, V122, P86, DOI 10.1016/j.jaci.2008.04.039; Kornman KS, 2008, J PERIODONTOL, V79, P1560, DOI 10.1902/jop.2008.080213; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Laine ML, 2012, PERIODONTOL 2000, V58, P37, DOI 10.1111/j.1600-0757.2011.00415.x; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Loo WTY, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S9; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Martins MD, 2016, J DENT RES, V95, P215, DOI 10.1177/0022034515611876; Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231; Matsumoto C, 2012, BIOCHEM BIOPH RES CO, V428, P110, DOI 10.1016/j.bbrc.2012.10.016; Mehlotra RK, 2013, INT J IMMUNOGENET, V40, P261, DOI 10.1111/iji.12021; Morris Nathan J, 2009, BMC Proc, V3 Suppl 7, pS45; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ozturk A, 2009, J CLIN PERIODONTOL, V36, P279, DOI 10.1111/j.1600-051X.2009.01370.x; Platz J, 2004, J IMMUNOL, V173, P1219, DOI 10.4049/jimmunol.173.2.1219; Prakasam S, 2014, ORAL DIS, V20, P171, DOI 10.1111/odi.12085; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Richter GM, 2012, J CLIN PERIODONTOL, V39, P315, DOI 10.1111/j.1600-051X.2011.01846.x; Ryder MI, 2012, PERIODONTOL 2000, V60, P78, DOI 10.1111/j.1600-0757.2012.00445.x; Sahingur SE, 2011, J PERIODONTAL RES, V46, P184, DOI 10.1111/j.1600-0765.2010.01327.x; Sahingur SE, 2013, J PERIODONTOL, V84, pE48, DOI 10.1902/jop.2013.120739; Sarah S M, 2006, Indian J Dent Res, V17, P114; Savage A, 2009, J CLIN PERIODONTOL, V36, P458, DOI 10.1111/j.1600-051X.2009.01408.x; Schaefer AS, 2010, GENES IMMUN, V11, P45, DOI 10.1038/gene.2009.75; Scheres N, 2011, J PERIODONTAL RES, V46, P407, DOI 10.1111/j.1600-0765.2011.01353.x; Schroder NWJ, 2005, GENES IMMUN, V6, P448, DOI 10.1038/sj.gene.6364221; Shey MS, 2010, GENES IMMUN, V11, P561, DOI 10.1038/gene.2010.14; Shimizu S, 2015, J DENT RES, V94, P555, DOI 10.1177/0022034515570315; Song GG, 2013, MOL BIOL REP, V40, P5129, DOI 10.1007/s11033-013-2616-1; Stabholz A, 2010, PERIODONTOL 2000, V53, P138, DOI 10.1111/j.1600-0757.2010.00340.x; Sumikawa Y, 2006, MICROBES INFECT, V8, P1513, DOI 10.1016/j.micinf.2006.01.008; Theodoratou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037662; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Vernon LT, 2016, ORAL DIS, V22, P135, DOI 10.1111/odi.12412; Vernon LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076986; Vernon LT, 2011, AIDS RES HUM RETROV, V27, P1157, DOI [10.1089/aid.2010.0320, 10.1089/AID.2010.0320]; Vernon LT, 2009, COMMUNITY DENT ORAL, V37, P427, DOI 10.1111/j.1600-0528.2009.00485.x; Vieira AR, 2014, PERIODONTOL 2000, V65, P92, DOI 10.1111/prd.12021; von Hinke S, 2016, J HEALTH ECON, V45, P131, DOI 10.1016/j.jhealeco.2015.10.007; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wang P, 2015, J PERIODONTAL RES, V50, P113, DOI 10.1111/jre.12187; Wara-aswapati N, 2013, J PERIODONTOL, V84, P1010, DOI 10.1902/jop.2012.120362; Willie B, 2014, GENES IMMUN, V15, P569, DOI 10.1038/gene.2014.54; Wohfahrt JC, 2006, J PERIODONTOL, V77, P426, DOI 10.1902/jop.2006.050058; Zelkha SA, 2010, PERIODONTOL 2000, V54, P207, DOI 10.1111/j.1600-0757.2010.00358.x; Zhang JC, 2011, PERIODONTOL 2000, V56, P102, DOI 10.1111/j.1600-0757.2010.00371.x	75	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164075	10.1371/journal.pone.0164075	http://dx.doi.org/10.1371/journal.pone.0164075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727278	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400019
J	Ahn, S; Lee, H; Choi, W; Ahn, R; Hong, JS; Sohn, CH; Seo, DW; Lee, YS; Lim, KS; Kim, WY				Ahn, Shin; Lee, Hyeji; Choi, Wookjin; Ahn, Ryeok; Hong, Jung-Suk; Sohn, Chang Hwan; Seo, Dong Woo; Lee, Yoon-Seon; Lim, Kyung Soo; Kim, Won Young			Clinical Importance of the Heel Drop Test and a New Clinical Score for Adult Appendicitis	PLOS ONE			English	Article							MODIFIED ALVARADO SCORE; SUSPECTED APPENDICITIS; DIAGNOSTIC SCORE; VALIDATION; EPIDEMIOLOGY; APPENDECTOMY; MANAGEMENT; CHILDREN	Objective We tried to evaluate the accuracy of the heel drop test in patients with suspected appendicitis and tried to develop a new clinical score, which incorporates the heel drop test and other parameters, for the diagnosis of this condition. Methods We performed a prospective observational study on adult patients with suspected appendicitis at two academic urban emergency departments between January and August 2015. The predictive characteristics of each parameter, along with heel drop test results were calculated. A composite score was generated by logistic regression analysis. The performance of the generated score was compared to that of the Alvarado score. Results Of the 292 enrolled patients, 165 (56.5%) had acute appendicitis. The heel drop test had a higher predictive value than rebound tenderness. Variables and their points included in the new (MESH) score were pain migration (2), elevated white blood cell (WBC) > 10,000/mu L (3), shift to left (2), and positive heel drop test (3). The MESH score had a higher AUC than the Alvarado score (0.805 vs. 0.701). Scores of 5 and 11 were chosen as cut-off values; a MESH score >= 5 compared to an Alvarado score >= 5, and a MESH score >= 8 compared to an Alvarado score >= 7 showed better performance in diagnosing appendicitis. Conclusion MESH (migration, elevated WBC, shift to left, and heel drop test) is a simple clinical scoring system for assessing patients with suspected appendicitis and is more accurate than the Alvarado score. Further validation studies are needed.	[Ahn, Shin; Sohn, Chang Hwan; Seo, Dong Woo; Lee, Yoon-Seon; Lim, Kyung Soo; Kim, Won Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul, South Korea; [Lee, Hyeji; Choi, Wookjin; Ahn, Ryeok; Hong, Jung-Suk] Univ Ulsan, Dept Emergency Med, Coll Med, Ulsan Univ Hosp, Ulsan, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Ulsan University Hospital	Kim, WY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul, South Korea.	wonpia73@naver.com						ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; Andersson REB, 2004, BRIT J SURG, V91, P28, DOI 10.1002/bjs.4464; Bulus H, 2013, WIEN KLIN WOCHENSCHR, V125, P16, DOI 10.1007/s00508-012-0308-9; Han DG, 2010, MED HYPOTHESES, V74, P1084, DOI 10.1016/j.mehy.2010.01.012; KALAN M, 1994, ANN ROY COLL SURG, V76, P418; Kharbanda AB, 2014, ANN EMERG MED, V64, P373, DOI 10.1016/j.annemergmed.2014.05.002; Korner H, 1997, WORLD J SURG, V21, P313, DOI 10.1007/s002689900235; Kulik DM, 2013, J CLIN EPIDEMIOL, V66, P95, DOI 10.1016/j.jclinepi.2012.09.004; Lamparelli MJ, 2000, ANN ROY COLL SURG, V82, P192; Lawrence PFB, 2012, ESSENTIALS GEN SURG, DOI [10.1016/j.annemergmed.2014.05.002, DOI 10.1016/J.ANNEMERGMED.2014.05.002]; Lee JH, 2010, J EPIDEMIOL, V20, P97, DOI 10.2188/jea.JE20090011; Lintula H, 2010, LANGENBECK ARCH SURG, V395, P495, DOI 10.1007/s00423-010-0627-0; Malik AA, 1998, AUST NZ J SURG, V68, P504, DOI 10.1111/j.1445-2197.1998.tb04811.x; Man E, 2014, SURG ENDOSC, V28, P2398, DOI 10.1007/s00464-014-3488-8; MARKLE GB, 1985, ARCH SURG-CHICAGO, V120, P243; MARKLE GB, 1973, AM J SURG, V125, P721, DOI 10.1016/0002-9610(73)90171-2; Meltzer AC, 2013, ANN EMERG MED, V62, P126, DOI 10.1016/j.annemergmed.2013.01.021; Mentes O, 2010, EUROPEAN J SURG SCI, V1, P77; Ohle R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-139; OHMANN C, 1995, EUR J SURG, V161, P273; Sitter H, 2004, LANGENBECK ARCH SURG, V389, P213, DOI 10.1007/s00423-003-0436-9; Solomkin JS, 2010, SURG INFECT, V11, P79, DOI 10.1089/sur.2009.9930; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589; Zielke A, 1999, CHIRURG, V70, P777, DOI 10.1007/s001040050721	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164574	10.1371/journal.pone.0164574	http://dx.doi.org/10.1371/journal.pone.0164574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723842	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100075
J	Visuttijai, K; Pettersson, J; Azar, YM; van den Bout, I; Orndal, C; Marcickiewicz, J; Nilsson, S; Hornquist, M; Olsson, B; Ejeskar, K; Behboudi, A				Visuttijai, Kittichate; Pettersson, Jennifer; Azar, Yashar Mehrbani; van den Bout, Iman; Orndal, Charlotte; Marcickiewicz, Janusz; Nilsson, Staffan; Hornquist, Michael; Olsson, Bjorn; Ejeskar, Katarina; Behboudi, Afrouz			Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT	PLOS ONE			English	Article							GLUT4 TRANSLOCATION; OXIDATIVE STRESS; INSULIN; MOTOR; MEMBRANE; GENE; CANCER; DISTAL; ACTIN; PATHWAY	Myosin-1C (MYO1C) is a tumor suppressor candidate located in a region of recurrent losses distal to TP53. Myo1c can tightly and specifically bind to PIP2, the substrate of Phosphoinositide 3-kinase (PI3K), and to Rictor, suggesting a role for MYO1C in the PI3K pathway. This study was designed to examine MYO1C expression status in a panel of well-stratified endometrial carcinomas as well as to assess the biological significance of MYO1C as a tumor suppressor in vitro. We found a significant correlation between the tumor stage and lowered expression of MYO1C in endometrial carcinoma samples. In cell transfection experiments, we found a negative correlation between MYO1C expression and cell proliferation, and MYO1C silencing resulted in diminished cell migration and adhesion. Cells expressing excess of MYO1C had low basal level of phosphorylated protein kinase B (PKB, a. k. a. AKT) and cells with knocked down MYO1C expression showed a quicker phosphorylated AKT (pAKT) response in reaction to serum stimulation. Taken together the present study gives further evidence for tumor suppressor activity of MYO1C and suggests MYO1C mediates its tumor suppressor function through inhibition of PI3K pathway and its involvement in loss of contact inhibition.	[Visuttijai, Kittichate; Azar, Yashar Mehrbani; Olsson, Bjorn; Ejeskar, Katarina; Behboudi, Afrouz] Univ Skovde, Tumor Biol Res Grp, Sch Biosci, SE-54128 Skovde, Sweden; [Visuttijai, Kittichate] Univ Gothenburg, Sahlgrenska Acad, Dept Med & Clin Genet, SE-40530 Gothenburg, Sweden; [van den Bout, Iman] Univ Pretoria, Fac Hlth Sci, Dept Physiol, ZA-0007 Pretoria, South Africa; [Orndal, Charlotte] Sahlgrens Univ Hosp, Dept Pathol, SE-41345 Gothenburg, Sweden; [Marcickiewicz, Janusz] Halland Hosp Varberg, Dept Obstet & Gynecol, SE-43237 Varberg, Sweden; [Nilsson, Staffan] Chalmers Univ Technol, Inst Stat Math, SE-41296 Gothenburg, Sweden; [Hornquist, Michael] Linkoping Univ, ITN, Dept Sci & Technol, SE-60174 Norrkoping, Sweden	University of Skovde; University of Gothenburg; University of Pretoria; Sahlgrenska University Hospital; Chalmers University of Technology; Linkoping University	Behboudi, A (corresponding author), Univ Skovde, Tumor Biol Res Grp, Sch Biosci, SE-54128 Skovde, Sweden.	afrouz.behboudi@his.se	Visuttijai, Kittichate/S-4927-2019; Azar, Yashar Mehrbani/L-9453-2019; Olsson, Bjorn/N-2733-2014	Visuttijai, Kittichate/0000-0002-4800-8533; Azar, Yashar Mehrbani/0000-0002-2022-9182; Nilsson, Staffan/0000-0003-4748-0446; Olsson, Bjorn/0000-0001-6254-4335; Ejeskar, Katarina/0000-0001-8962-0860; Rosendahl, Jennifer/0000-0002-8849-1793; van den Bout, Iman/0000-0001-6333-1470	Royal Physiographic Society in Lund (Nilsson-Ehle Foundation) [30928, 32705, 36388]; Wilhelm and Martina Lundgren Foundation; Assar Gabrielsson Research Foundation for Clinical Cancer Research [FB11-15, FB12-26, FB13-05, FB14-46, FB15-45]; Sahlgrenska University Hospital Foundation [8181]; Knowledge Foundation [HOG12, 20120311]	Royal Physiographic Society in Lund (Nilsson-Ehle Foundation); Wilhelm and Martina Lundgren Foundation; Assar Gabrielsson Research Foundation for Clinical Cancer Research; Sahlgrenska University Hospital Foundation; Knowledge Foundation	Royal Physiographic Society in Lund (Nilsson-Ehle Foundation) with grant numbers 30928, 32705 and 36388: KV. Wilhelm and Martina Lundgren Foundation: KV, AB. Assar Gabrielsson Research Foundation for Clinical Cancer Research with grant numbers FB11-15, FB12-26, FB13-05, FB14-46 and FB15-45: KV. Sahlgrenska University Hospital Foundation with grant number 8181: KV. The Knowledge Foundation with grant number HOG12, 20120311: AB.	Aleskandarany MA, 2010, BREAST CANCER RES TR, V122, P45, DOI 10.1007/s10549-009-0508-9; Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Boguslavsky S, 2012, MOL BIOL CELL, V23, P4065, DOI 10.1091/mbc.E12-04-0263; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Brandstaetter H, 2012, J CELL SCI, V125, P1991, DOI 10.1242/jcs.097212; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chapuis N, 2010, HAEMATOL-HEMATOL J, V95, P415, DOI 10.3324/haematol.2009.010785; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Freemont AJ, 1996, J CLIN PATHOL-CL MOL, V49, pM321; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Grunberger G, 2002, INSULIN SIGNALING FR; Guan XY, 2003, CANCER GENET CYTOGEN, V140, P45, DOI 10.1016/S0165-4608(02)00654-4; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Holman GD, 2008, CELL METAB, V8, P344, DOI 10.1016/j.cmet.2008.10.006; Huang J, 2000, CARCINOGENESIS, V21, P2019, DOI 10.1093/carcin/21.11.2019; Huang J, 2005, J BIOL CHEM, V280, P42300, DOI 10.1074/jbc.M510920200; Ihnatovych I, 2012, CYTOSKELETON, V69, P555, DOI 10.1002/cm.21040; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Kato S, 2007, INT J CANCER, V121, P1771, DOI 10.1002/ijc.22890; Konishi H, 2003, ONCOGENE, V22, P1892, DOI 10.1038/sj.onc.1206304; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Matheny RW, 2010, CELL DEATH DIFFER, V17, P677, DOI 10.1038/cdd.2009.150; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Muders MH, 2009, CANCER RES, V69, P6042, DOI 10.1158/0008-5472.CAN-09-0552; Munnich S, 2014, J MOL BIOL, V426, P2070, DOI 10.1016/j.jmb.2014.03.004; Nair KS, 2005, J CLIN PATHOL, V58, P343, DOI 10.1136/jcp.2004.018036; Nakano T, 2005, GENE CHROMOSOME CANC, V43, P162, DOI 10.1002/gcc.20180; Nordlander C, 2007, INT J CANCER, V120, P1472, DOI 10.1002/ijc.22533; Okegawa T, 2002, J UROLOGY, V167, P1836, DOI 10.1016/S0022-5347(05)65245-7; Oldfors CH, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0238-4; Pande G, 2000, CURR OPIN CELL BIOL, V12, P569, DOI 10.1016/S0955-0674(00)00133-2; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; Roncuzzi L, 2005, ONCOL REP, V14, P471; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sarshad A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003397; Sielski NL, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-8; Summers SA, 1997, BIOCHEM SOC T, V25, P981, DOI 10.1042/bst0250981; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tiwari A, 2013, AM J PHYSIOL-HEART C, V304, pH687, DOI 10.1152/ajpheart.00744.2012; Toyoda T, 2011, J BIOL CHEM, V286, P4133, DOI 10.1074/jbc.M110.174938; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126; Yanaihara N, 2004, INT J CANCER, V112, P150, DOI 10.1002/ijc.20339; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10	57	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164063	10.1371/journal.pone.0164063	http://dx.doi.org/10.1371/journal.pone.0164063			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716847	gold, Green Published, Green Submitted			2022-12-27	WOS:000385698100017
J	Bainbridge, M; Kraft, J				Bainbridge, Melissa; Kraft, Jana			Lipid Encapsulation Provides Insufficient Total-Tract Digestibility to Achieve an Optimal Transfer Efficiency of Fatty Acids to Milk Fat	PLOS ONE			English	Article							LACTATING DAIRY-COWS; RUMINAL FERMENTATION; STEARIDONIC ACID; ECHIUM-OIL; DIGESTION; FEED; BIOHYDROGENATION; SUPPLEMENTATION; METABOLISM; FRACTIONS	Transfer efficiencies of rumen-protected n-3 fatty acids (FA) to milk are low, thus we hypothesized that rumen-protection technologies allow for biohydrogenation and excretion of n-3 FA. The objectives of this study were to i) investigate the ruminal protection and post-ruminal release of the FA derived from the lipid-encapsulated echium oil (EEO), and ii) assess the bioavailability and metabolism of the EEO-derived FA through measuring the FA content in plasma lipid fractions, feces, and milk. The EEO was tested for rumen stability using the in situ nylon bag technique, then the apparent total-tract digestibility was assessed in vivo using six Holstein dairy cattle. Diets consisted of a control (no EEO); 1.5% of dry matter (DM) as EEO and 1.5% DM as encapsulation matrix; and 3% DM as EEO. The EEO was rumen-stable and had no effect on animal production. EEO-derived FA were incorporated into all plasma lipid fractions, with the highest proportion of n-3 FA observed in cholesterol esters. Fecal excretion of EEO-derived FA ranged from 7-14%. Biohydrogenation products increased in milk, plasma, and feces with EEO supplementation. In conclusion, lipid-encapsulation provides inadequate digestibility to achieve an optimal transfer efficiency of n-3 FA to milk.	[Bainbridge, Melissa; Kraft, Jana] Univ Vermont, Dept Anim & Vet Sci, 570 Main St, Burlington, VT 05405 USA	University of Vermont	Kraft, J (corresponding author), Univ Vermont, Dept Anim & Vet Sci, 570 Main St, Burlington, VT 05405 USA.	Jana.Kraft@uvm.edu			USDA NIFA-VT [VT-H01913]; Dairy Center of Excellence at the University of Vermont	USDA NIFA-VT; Dairy Center of Excellence at the University of Vermont	This project was funded by the USDA NIFA-VT (PROJ NO: VT-H01913) and Dairy Center of Excellence at the University of Vermont.	American Heart Association, 2015, DIET GUID ADV; [Anonymous], 2001, NUTR REQ DIAR CATTL; Association of Official Analytical Chemists, 2000, OFFICIAL METHODS ANA, Vseventeenth; Bainbridge ML, 2015, J AGR FOOD CHEM, V63, P4827, DOI 10.1021/acs.jafc.5b00857; Bauman DE, 2001, LIVEST PROD SCI, V70, P15, DOI 10.1016/S0301-6226(01)00195-6; Bernal-Santos G, 2010, J DAIRY SCI, V93, P32, DOI 10.3168/jds.2009-2711; BRUMBY PE, 1972, J DAIRY RES, V39, P167, DOI 10.1017/S0022029900013960; Chilliard Y, 2001, LIVEST PROD SCI, V70, P31, DOI 10.1016/S0301-6226(01)00196-8; Cortes C, 2010, J DAIRY SCI, V93, P3146, DOI 10.3168/jds.2009-2905; Demeyer D. I., 1991, Rumen microbial metabolism and ruminant digestion., P217; FIRKINS JL, 1994, J DAIRY SCI, V77, P2357, DOI 10.3168/jds.S0022-0302(94)77178-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glasser F, 2008, ANIMAL, V2, P691, DOI 10.1017/S1751731108002036; Gressley TF, 2012, J DAIRY SCI, V95, P353; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Harfoot C, 1997, RUMEN MICROBIAL ECOS, P382; Hawkins A, 2013, J DAIRY SCI, V96, P3907, DOI 10.3168/jds.2012-6207; Jalc D, 2007, VET MED-CZECH, V52, P87, DOI 10.17221/2012-VETMED; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; Jenkins TC, 2007, EUR J LIPID SCI TECH, V109, P778, DOI 10.1002/ejlt.200700022; Kitessa SM, 2011, ANIM FEED SCI TECH, V170, P35, DOI 10.1016/j.anifeedsci.2011.08.007; Kliem KE, MANIPULATION MILK FA, P1; Lanier JS, 2013, LIPIDS, V48, P469, DOI 10.1007/s11745-013-3782-6; MACGIBBON AKH, 2006, ADV DAIRY CHEM, V2, P1, DOI DOI 10.1007/0-387-28813-9; Maia MRG, 2012, J ANIM SCI, V90, P900, DOI 10.2527/jas.2011-4118; Nobel RC, 1978, PROG LIPID RES, V17, P55; Offer NW, 2001, ANIM SCI, V73, P523, DOI 10.1017/S1357729800058495; Palmquist D.L., 2006, ADV DAIRY CHEM, P43, DOI DOI 10.1007/0-387-28813-9; PALMQUIST DL, 1993, J DAIRY SCI, V76, P1753, DOI 10.3168/jds.S0022-0302(93)77508-6; Palmquist DL, 2007, EUR J LIPID SCI TECH, V109, P737, DOI 10.1002/ejlt.200700146; Pantoja J, 1996, J DAIRY SCI, V79, P429, DOI 10.3168/jds.S0022-0302(96)76382-8; Pappritz J, 2011, EUR J LIPID SCI TECH, V113, P1443, DOI 10.1002/ejlt.201100170; Stamey JA, 2012, J DAIRY SCI, V95, P5269, DOI 10.3168/jds.2012-5412; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; VANSOEST PJ, 1968, J DAIRY SCI, V51, P1644, DOI 10.3168/jds.S0022-0302(68)87246-7; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Weiss WP, 2004, J DAIRY SCI, V87, P1446, DOI 10.3168/jds.S0022-0302(04)73295-6; Whelan J, 2009, J NUTR, V139, P5, DOI 10.3945/jn.108.094268	38	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164700	10.1371/journal.pone.0164700	http://dx.doi.org/10.1371/journal.pone.0164700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741299	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000059
J	Dinomais, M; Celle, S; Duval, GT; Roche, F; Henni, S; Bartha, R; Beauchet, O; Annweiler, C				Dinomais, Mickael; Celle, Sebastien; Duval, Guillaume T.; Roche, Frederic; Henni, Samir; Bartha, Robert; Beauchet, Olivier; Annweiler, Cedric			Anatomic Correlation of the Mini-Mental State Examination: A Voxel-Based Morphometric Study in Older Adults	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MEMORY COMPLAINT; SHORT-FORM; DEMENTIA; REGISTRATION; ASSOCIATION; VOLUMETRY; BRAINS; MMSE	The clinical utility of the Mini-Mental State Examination (MMSE) and its shorter version (SMMSE) is still debated. There is a need to better understand the neuroanatomical correlates of these cognitive tests. The objective of this cross-sectional study was to determine whether lower MMSE and SMMSE scores correlated with focal brain volume reduction in older adults. Participants from the GAIT study (n = 207; mean, 70.9 +/- 5.9 years; 57% female; mean MMSE 26.2 +/- 3.9; mean SMMSE 5.1 +/- 1.1) were evaluated using the MMSE and SMMSE and received a 1.5-Tesla MRI scan of the brain. Cortical gray and white matter subvolumes were automatically segmented using Statistical Parametric Mapping. Age, gender, education level, and total intracranial volume were included as potential confounders. We found correlations between the MMSE score and specific cortical regions of the limbic system including the hippocampus, amygdala, cingulate gyrus, and parahippocampal gyrus, independently of the diagnostic category (i.e., mild cognitive impairment or Alzheimer disease or controls). Regarding correlations with the SMMSE score, only one cluster in the left hippocampus was identified, which overlapped with the cluster that was positively correlated with the MMSE score. There were no correlations with the volume of white matter. In conclusion, worse MMSE and SMMSE scores were associated with gray matter atrophy mainly in the limbic system. This finding highlights that atrophy of specific brain regions are related to performance on the MMSE and the SMMSE tests, and provides new insights into the cognitive function probed by these tests.	[Dinomais, Mickael] Univ Angers, LARIS EA7315, F-49000 Angers, France; [Dinomais, Mickael] Univ Angers, CHU Angers, LUNAM, Dept Med Phys & Readaptat, F-49933 Angers, France; [Celle, Sebastien; Roche, Frederic] CHU, Serv Physiol Clin & Exercice, St Etienne, France; [Celle, Sebastien; Roche, Frederic] PRES Univ Lyon, Fac Med J Lisfranc UJM, SNA EPIS EA 4607, F-42023 Lyon, France; [Duval, Guillaume T.; Annweiler, Cedric] Univ Angers, Angers Univ Hosp, UNAM, Dept Neurosci,Div Geriatr Med & Memory Clin,UPRES, Angers, France; [Henni, Samir] Univ Hosp, Dept Sports Med & Vasc Investigat, Angers, France; [Bartha, Robert] Univ Western Ontario, Schulich Sch Med & Dent, Roberts Res Inst, Dept Med Biophys, London, ON, Canada; [Beauchet, Olivier] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Med, Div Geriatr Med, Montreal, PQ, Canada; [Beauchet, Olivier] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de St Etienne; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Western University (University of Western Ontario); McGill University; Lady Davis Institute; McGill University	Annweiler, C (corresponding author), Univ Angers, Angers Univ Hosp, UNAM, Dept Neurosci,Div Geriatr Med & Memory Clin,UPRES, Angers, France.	ceannweiler@chu-angers.fr	Beauchet, Olivier/AAP-8108-2020; Bartha, Robert/K-3611-2013	Bartha, Robert/0000-0002-7118-9096; Annweiler, Cedric/0000-0002-7199-8109; Roche, Frederic/0000-0001-6115-7958	French Ministry of Health (Projet Hospitalier de Recherche Clinique national) [2009-A00533-54]	French Ministry of Health (Projet Hospitalier de Recherche Clinique national)	The study was financially supported by the French Ministry of Health (Projet Hospitalier de Recherche Clinique national n 2009-A00533-54). The sponsor had no role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Acheson DJ, 2013, J COGNITIVE NEUROSCI, V25, P1664, DOI 10.1162/jocn_a_00430; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Annweiler C, 2014, EXP GERONTOL, V57, P256, DOI 10.1016/j.exger.2014.06.015; Arlt S, 2013, EUR ARCH PSY CLIN N, V263, P335, DOI 10.1007/s00406-012-0350-7; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Avila R, 2011, NEUROBIOL AGING, V32, P1857, DOI 10.1016/j.neurobiolaging.2009.11.004; Bartsch T., 2012, CLIN NEUROBIOL HIPPO, DOI [10.1093/acprof:oso/9780199592388.003.0011, DOI 10.1093/ACPROF:OSO/9780199592388.003.0011]; BRODATY H, 1994, MED J AUSTRALIA, V160, P10, DOI 10.5694/j.1326-5377.1994.tb138193.x; Creavin ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011145.pub2; Dubois B, 2004, LANCET NEUROL, V3, P246, DOI 10.1016/S1474-4422(04)00710-0; Dubois B., 2009, REV NEUROL-FRANCE, V165, P66, DOI [10.1016/S0035-3787(09)72632-72633, DOI 10.1016/S0035-3787(09)72632-72633]; Eichenbaum H, 2007, COMP COGN BEHAV REV, V2, P47; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Haubois G, 2013, EUR J NEUROL, V20, P588, DOI 10.1111/j.1468-1331.2012.03830.x; Haubois G, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-59; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kovacevic S, 2009, ALZ DIS ASSOC DIS, V23, P139, DOI 10.1097/WAD.0b013e318192e745; LAZARO L, 1995, INT J GERIATR PSYCH, V10, P603, DOI 10.1002/gps.930100711; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Nilsson FM, 2007, ACTA PSYCHIAT SCAND, V116, P156, DOI 10.1111/j.1600-0447.2007.01037.x; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Simard M, 1998, CANADIAN ALZHEIMERS, P10; Spreng RN, 2012, BRAIN RES, V1428, P43, DOI 10.1016/j.brainres.2010.12.024; Vogt BA, 2009, CINGULATE NEUROBIOLO, DOI DOI 10.1162/JOCN_A_00430	29	26	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0162889	10.1371/journal.pone.0162889	http://dx.doi.org/10.1371/journal.pone.0162889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741236	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000002
J	Friedrich, P; Lam, CG; Kaur, G; Itriago, E; Ribeiro, RC; Arora, RS				Friedrich, Paola; Lam, Catherine G.; Kaur, Geetinder; Itriago, Elena; Ribeiro, Raul C.; Arora, Ramandeep S.			Determinants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TREATMENT-RELATED MORTALITY; CARE PROVIDERS PERSPECTIVES; PEDIATRIC ACUTE-LEUKEMIA; WILMS-TUMOR; HODGKIN-LYMPHOMA; BURKITT-LYMPHOMA; CHILDREN; REFUSAL; PREDICTORS	Background Understanding and addressing treatment abandonment (TxA) is crucial for bridging the pediatric cancer survival gap between high-income (HIC) and low-and middle-income countries (LMC). In childhood cancer, TxA is defined as failure to start or complete curative cancer therapy and known to be a complex phenomenon. With rising interest on causes and consequences of TxA in LMC, this study aimed to establish the lay-of-the-land regarding determinants of TxA globally, perform and promote comparative research, and raise awareness on this subject. Methods Physicians (medical oncologists, surgeons, and radiation therapists), nurses, social workers, and psychologists involved in care of children with cancer were approached through an online survey February-May 2012. Queries addressed social, economic, and treatment-related determinants of TxA. Free-text comments were collected. Descriptive and qualitative analyses were performed. Appraisal of overall frequency, burden, and predictors of TxA has been reported separately. Results 581 responses from 101 countries were obtained (contact rate = 26%, cooperation rate = 70%). Most respondents were physicians (86%), practicing pediatric hematology/oncology (86%) for > 10 years (54%). Providers from LMC considered social/economic factors (families' low socioeconomic status, low education, and long travel time), as most influential in increasing risk of TxA. Treatment-related considerations such as preference for complementary and alternative medicine and concerns about treatment adverse effects and toxicity, were perceived to play an important role in both LMC and HIC. Perceived prognosis seemed to mediate the role of other determinants such as diagnosis and treatment phase on TxA risk. For example, high-risk of TxA was most frequently reported when prognosis clearly worsened (i.e. lack of response to therapy, relapse), or conversely when the patient appeared improved (i.e. induction completed, mass removed), as well as before aggressive/mutilating surgery. Provider responses allowed development of an expanded conceptual model of determinants of TxA; one which illustrates established and emerging individual, family, center, and context specific factors to be considered in order to tackle this problem. Emerging factors included vulnerability, family dynamics, perceptions, center capacity, public awareness, and governmental healthcare financing, among others. Conclusion TxA is a complex and multifactorial phenomenon. With increased recognition of the role of TxA on global pediatric cancer outcomes, factors beyond social/economic status and beliefs have emerged. Our results provide insights regarding the role of established determinants of TxA in different geographical and economic contexts, allow probing of key determinants by deliberating their mechanisms, and allow building an expanded conceptual model of established and emerging determinants TxA.	[Friedrich, Paola; Itriago, Elena] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02115 USA; [Friedrich, Paola; Lam, Catherine G.] St Jude Childrens Res Hosp, Dept Global Pediat Med, 332 N Lauderdale St, Memphis, TN 38105 USA; [Friedrich, Paola; Lam, Catherine G.; Ribeiro, Raul C.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kaur, Geetinder] Univ Liverpool, Inst Child Hlth, Liverpool, Merseyside, England; [Arora, Ramandeep S.] Max Healthcare, Dept Med Oncol, New Delhi, India	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Liverpool	Friedrich, P (corresponding author), Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02115 USA.	paola.friedrich@stjude.org	Friedrich, Paola/N-8145-2018; Lam, Catherine/K-6328-2014	Friedrich, Paola/0000-0002-5265-3113; Lam, Catherine/0000-0003-1363-5331	Program in Cancer Outcomes Research Training [R25 CA092203]; National Institutes of Health training grant; American Lebanese Syrian Associated Charities (ALSAC); Dana-Farber/ Boston Children's Cancer and Blood Disorders Center Global Health Initiative; St. Jude Children's Research Hospital International Outreach Program	Program in Cancer Outcomes Research Training; National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Dana-Farber/ Boston Children's Cancer and Blood Disorders Center Global Health Initiative; St. Jude Children's Research Hospital International Outreach Program	First author's effort was supported by the Program in Cancer Outcomes Research Training (R25 CA092203); a National Institutes of Health training grant. St. Jude Children's Research Hospital efforts are supported by the American Lebanese Syrian Associated Charities (ALSAC). Sponsors had no role in design, data collection analysis, decision to publish or preparation of the manuscript.; The authors gratefully acknowledge support from the Dana-Farber/ Boston Children's Cancer and Blood Disorders Center Global Health Initiative, St. Jude Children's Research Hospital International Outreach Program, and members from the SIOP (International Society of Paediatric Oncology) PODC (Paediatric Oncology in Developing Countries) Working Group on Treatment Abandonment, and the assistance provided by Dr. Yuri Quintana and Jay Knight, St. Jude Cure4Kids, in implementing the survey.	Abuidris DO, 2008, PEDIATR BLOOD CANCER, V50, P1135, DOI 10.1002/pbc.21547; Ahuja S, 2014, PEDIATR BLOOD CANCER, V61, pS159; Alessandri AJ, 2011, J PAEDIATR CHILD H, V47, P628, DOI 10.1111/j.1440-1754.2011.02170.x; American Association for Public Opinion Research, RESP RAT OV AAPOR RE; Antillon F, 2008, PEDIATR BLOOD CANCER, V50, P502, DOI 10.1002/pbc.21398; Arora RS, 2010, INDIAN PEDIATR, V47, P1005, DOI 10.1007/s13312-010-0172-5; Arora RS, 2007, PEDIATR BLOOD CANCER, V49, P941, DOI 10.1002/pbc.21127; Bonilla M, 2009, INT J CANCER, V125, P2144, DOI 10.1002/ijc.24534; Bustamante M, 2014, PEDIATR BLOOD CANCER, V61, pS403; De Pernillo M, 2014, PEDIATR BLOOD CANCER, V61, P2071, DOI 10.1002/pbc.25060; Delgado E, 2010, EUR J CANCER, V46, P2260, DOI 10.1016/j.ejca.2010.05.006; Demoly P, 2014, ALLERGY, V69, P559, DOI 10.1111/all.12386; Evans SC, 2013, INT J PSYCHOL, V48, P177, DOI 10.1080/00207594.2013.804189; Fadoo Zehra, 2010, J Pediatr Hematol Oncol, V32, pe14, DOI 10.1097/MPH.0b013e3181bdf1f3; Friedrich P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135230; Friedrich P, 2013, CANCER-AM CANCER SOC, V119, P871, DOI 10.1002/cncr.27816; Gao YJ, 2014, PEDIATR BLOOD CANCER, V61, P659, DOI 10.1002/pbc.24848; Gao YJ, 2013, BRIT J HAEMATOL, V160, P363, DOI 10.1111/bjh.12122; Gunawan S, 2014, ASIAN PAC J CANCER P, V15, P3593, DOI 10.7314/APJCP.2014.15.8.3593; Gupta S, 2009, BRIT J CANCER, V100, P1026, DOI 10.1038/sj.bjc.6604895; Gupta S, 2013, EUR J CANCER, V49, P2555, DOI 10.1016/j.ejca.2013.03.024; Gupta S, 2012, EUR J CANCER, V48, P1363, DOI 10.1016/j.ejca.2011.10.009; Gupta S, 2011, CANCER-AM CANCER SOC, V117, P4788, DOI 10.1002/cncr.26107; Halbert J, 2014, SOUTH ASIAN J CANCER, V3, P78, DOI 10.4103/2278-330X.126548; Israels T, 2008, PEDIATR BLOOD CANCER, V51, P639, DOI 10.1002/pbc.21703; Israels T, 2009, PEDIATR BLOOD CANCER, V53, P584, DOI 10.1002/pbc.22138; Israels T, 2009, PEDIATR BLOOD CANCER, V53, P47, DOI 10.1002/pbc.22032; Klünder-Klünder Miguel, 2012, Bol. Med. Hosp. Infant. Mex., V69, P226; Kulkarni KP, 2010, ASIAN PAC J CANCER P, V11, P1435; Kulkarni KP, 2011, J PEDIAT HEMATOL ONC, V33, P475, DOI 10.1097/MPH.0b013e31820e7361; Kumar A, 2013, PEDIATR BLOOD CANCER, V60, P771, DOI 10.1002/pbc.24454; Ladas EJ, 2014, PEDIATR BLOOD CANCER, V61, P687, DOI 10.1002/pbc.24791; Laengler A, 2011, PEDIAT BLOOD CANC; LAM C, 2012, J HEALTHCARE SCI HUM, V2, P81; Li EQ, 2012, LEUKEMIA RES, V36, pE193, DOI 10.1016/j.leukres.2012.05.017; Libes J, 2015, PEDIATR BLOOD CANCER, V62, P252, DOI 10.1002/pbc.25312; Luna-Fineman S, 2012, PEDIATR BLOOD CANCER, V58, P545, DOI 10.1002/pbc.23307; Madani A, 2006, PEDIATR BLOOD CANCER, V46, P472, DOI 10.1002/pbc.20436; Malhotra P, 2007, LEUKEMIA LYMPHOMA, V48, P1173, DOI 10.1080/10428190701343255; Castellanos EM, 2014, PEDIATR BLOOD CANCER, V61, P997, DOI 10.1002/pbc.24905; Metzger ML, 2003, LANCET, V362, P706, DOI 10.1016/S0140-6736(03)14228-6; Moleti ML, 2011, PEDIATR BLOOD CANCER, V56, P560, DOI 10.1002/pbc.22905; Mostert S, 2014, PSYCHO-ONCOLOGY, V23, P700, DOI 10.1002/pon.3571; Mostert S, 2014, PEDIATR BLOOD CANCER, V61, P913, DOI 10.1002/pbc.24896; Mostert S, 2013, PSYCHO-ONCOLOGY, V22, P2522, DOI 10.1002/pon.3314; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; Njuguna F, 2015, SUPPORT CARE CANCER, V23, P1251, DOI 10.1007/s00520-014-2475-x; Njuguna F, 2014, ARCH DIS CHILD, V99, P609, DOI 10.1136/archdischild-2013-305052; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Quintana Yuri, 2003, AMIA Annu Symp Proc, P978; Ramzan M, 2013, PEDIATR BLOOD CANCER, V60, P159, DOI 10.1002/pbc.24277; Ribeiro RC, 2005, NEW ENGL J MED, V352, P2158, DOI 10.1056/NEJMp048313; Rivera-Luna R, 2013, INT J CANCER, V132, P1646, DOI 10.1002/ijc.27771; Rodriguez-Galindo C, 2013, CURR OPIN PEDIATR, V25, P3, DOI 10.1097/MOP.0b013e32835c1cbe; Salaverria C, 2014, PEDIATR BLOOD CANCER, V61, pS252; Samudio A, 2013, PEDIATRIA-ASUNCION, V40, P119; Sandlund JT, 1997, LEUKEMIA, V11, P743, DOI 10.1038/sj.leu.2400609; Sitaresm MN, 2010, PSYCHO-ONCOLOGY, V19, P361, DOI 10.1002/pon.1578; Slone JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089102; Spinetta JJ, 2002, MED PEDIATR ONCOL, V38, P114, DOI 10.1002/mpo.1283; Sweet-Cordero A., 1999, MED PEDIATR ONCOL, V33, P151; Tang YM, 2008, PEDIATR BLOOD CANCER, V51, P380, DOI 10.1002/pbc.21629; The World Bank, COUNTR LEND GROUPS; Wang YR, 2011, LEUKEMIA RES, V35, P1628, DOI 10.1016/j.leukres.2011.07.004; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yeh CH, 1999, J ADV NURS, V30, P193, DOI 10.1046/j.1365-2648.1999.01064.x	66	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163090	10.1371/journal.pone.0163090	http://dx.doi.org/10.1371/journal.pone.0163090			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736871	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800010
J	Fujita, H; Gomori, A; Fujioka, Y; Kataoka, Y; Tanaka, K; Hashimoto, A; Suzuki, T; Ito, K; Haruma, T; Yamamoto-Yokoi, H; Harada, N; Sakuragi, M; Oda, N; Matsuo, K; Inada, M; Yonekura, K				Fujita, Hidenori; Gomori, Akira; Fujioka, Yayoi; Kataoka, Yuki; Tanaka, Kenji; Hashimoto, Akihiro; Suzuki, Takamasa; Ito, Kenjiro; Haruma, Tomonori; Yamamoto-Yokoi, Hiromi; Harada, Naomoto; Sakuragi, Motomu; Oda, Nobuyuki; Matsuo, Kenichi; Inada, Masaki; Yonekura, Kazuhiko			High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; PROSTATE-CANCER; OSTEOCLAST FORMATION; ZOLEDRONIC ACID; PATIENTS PTS; C-MET; M-CSF; METASTASIS; VEGF; RECEPTOR	Approximately 25-40% of patients with lung cancer show bone metastasis. Bone modifying agents reduce skeletal-related events (SREs), but they do not significantly improve overall survival. Therefore, novel therapeutic approaches are urgently required. In this study, we investigated the anti-tumor effect of TAS-115, a VEGFRs and HGF receptor (MET)-targeted kinase inhibitor, in a tumor-induced bone disease model. A549-Luc-BM1 cells, an osteo-tropic clone of luciferase-transfected A549 human lung adenocarcinoma cells (A549-Luc), produced aggressive bone destruction associated with tumor progression after intratibial (IT) implantation into mice. TAS-115 significantly reduced IT tumor growth and bone destruction. Histopathological analysis showed a decrease in tumor vessels after TAS-115 treatment, which might be mediated through VEGFRs inhibition. Furthermore, the number of osteoclasts surrounding the tumor was decreased after TAS-115 treatment. In vitro studies demonstrated that TAS-115 inhibited HGF-, VEGF-, and macrophage-colony stimulating factor (M-CSF)-induced signaling pathways in osteoclasts. Moreover, TAS-115 inhibited Feline McDonough Sarcoma oncogene (FMS) kinase, as well as M-CSF and receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast differentiation. Thus, VEGFRs/MET/FMS-triple inhibition in osteoclasts might contribute to the potent efficacy of TAS-115. The fact that concomitant dosing of sunitinib (VEGFRs/FMS inhibition) with crizotinib (MET inhibition) exerted comparable inhibitory efficacy for bone destruction to TAS-115 also supports this notion. In conclusion, TAS-115 inhibited tumor growth via VEGFR-kinase blockade, and also suppressed bone destruction possibly through VEGFRs/MET/FMS-kinase inhibition, which resulted in potent efficacy of TAS-115 in an A549-Luc-BM1 bone disease model. Thus, TAS-115 shows promise as a novel therapy for lung cancer patients with bone metastasis.	[Fujita, Hidenori; Gomori, Akira; Fujioka, Yayoi; Kataoka, Yuki; Tanaka, Kenji; Hashimoto, Akihiro; Suzuki, Takamasa; Ito, Kenjiro; Haruma, Tomonori; Yamamoto-Yokoi, Hiromi; Harada, Naomoto; Sakuragi, Motomu; Oda, Nobuyuki; Matsuo, Kenichi; Yonekura, Kazuhiko] Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan; [Inada, Masaki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan	Taiho Pharmaceutical; Tokyo University of Agriculture & Technology	Fujita, H (corresponding author), Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan.	hide-fujita@taiho.co.jp	Harada, Naomoto/Y-4591-2019; KATAOKA, Yuki/GRR-4808-2022; inada, masaki/D-1581-2013	KATAOKA, Yuki/0000-0001-7982-5213; inada, masaki/0000-0002-5066-8506; Harada, Naomoto/0000-0003-1083-7253	Taiho Pharmaceutical Co., Ltd.	Taiho Pharmaceutical Co., Ltd.	Taiho Pharmaceutical Co., Ltd. provided funding for the experiments and had a role in study design, data collection and analysis as well as the decision to publish the manuscript.	Adamopoulos IE, 2006, BIOCHEM BIOPH RES CO, V350, P478, DOI 10.1016/j.bbrc.2006.09.076; Aldridge SE, 2005, BIOCHEM BIOPH RES CO, V335, P793, DOI 10.1016/j.bbrc.2005.07.145; Bauml J, 2013, CLIN LUNG CANCER, V14, P581, DOI 10.1016/j.cllc.2013.05.002; Butowski N, 2015, NEUROONCOL; Cassier PA, 2015, LANCET ONCOL, V16, P949, DOI 10.1016/S1470-2045(15)00132-1; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Corey E, 2003, CLIN CANCER RES, V9, P295; Doti N, 2009, J BIOMOL SCREEN, V14, P1263, DOI 10.1177/1087057109345527; Duque JLF, 1999, UROLOGY, V54, P523, DOI 10.1016/S0090-4295(99)00167-3; El-Gamal MI, 2013, MED RES REV, V33, P599, DOI 10.1002/med.21258; Feeley BT, 2006, J BONE MINER RES, V21, P1571, DOI 10.1359/JBMR.060706; Feng X, 2013, BONE RES, V1, DOI 10.4248/BR201301003; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Fujita H, 2013, MOL CANCER THER, V12, P2685, DOI 10.1158/1535-7163.MCT-13-0459; FULLER K, 1995, BIOCHEM BIOPH RES CO, V212, P334, DOI 10.1006/bbrc.1995.1974; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Guan H, 2009, ONCOL RES, V18, P117, DOI 10.3727/096504009789954627; Heymann D, 2015, BONE CANCER: PRIMARY BONE CANCER AND BONE METASTASES, 2ND EDITION, pXIX; Hung JY, 2014, LAB INVEST, V94, P371, DOI 10.1038/labinvest.2014.1; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Katakami N, 2014, J THORAC ONCOL, V9, P231, DOI 10.1097/JTO.0000000000000051; Kawamoto T., 2012, ARCH HISTOL CYTOL, V1130, P149, DOI DOI 10.1007/978-1-62703-989-5_11; Knowles HJ, 2009, HISTOL HISTOPATHOL, V24, P337, DOI 10.14670/HH-24.337; Knudsen BS, 2002, UROLOGY, V60, P1113, DOI 10.1016/S0090-4295(02)01954-4; Masteller EL, 2014, DRUG DISCOV TODAY, V19, P1212, DOI 10.1016/j.drudis.2014.05.016; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mukai S, 2015, HUM CELL, V28, P44, DOI 10.1007/s13577-014-0101-3; Murray LJ, 2003, CLIN EXP METASTAS, V20, P757, DOI 10.1023/B:CLIN.0000006873.65590.68; Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9; Newman AC, 2013, ARTERIOSCL THROM VAS, V33, P513, DOI 10.1161/ATVBAHA.112.300782; Nobuhito Nango SK., 2014, MODERN BONE HISTOMOR, P143; Ono K, 2006, BONE, V39, P27, DOI 10.1016/j.bone.2005.12.006; Previdi S, 2012, MOL CANCER THER, V11, P214, DOI 10.1158/1535-7163.MCT-11-0277; Ries CH, 2015, CURR OPIN PHARMACOL, V23, P45, DOI 10.1016/j.coph.2015.05.008; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Skibinski G, 2001, IMMUNOLOGY, V102, P506, DOI 10.1046/j.1365-2567.2001.01186.x; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Smith MR, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.7_suppl.139; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Taylor RM, 2012, LAB INVEST, V92, P1398, DOI 10.1038/labinvest.2012.108; Varkaris A, 2015, CLIN CANC RES; Yang QL, 2008, MATRIX BIOL, V27, P589, DOI 10.1016/j.matbio.2008.06.005	44	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164830	10.1371/journal.pone.0164830	http://dx.doi.org/10.1371/journal.pone.0164830			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736957	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505800134
J	Marshall, JD; Heeke, DS; Rao, E; Maynard, SK; Hornigold, D; McCrae, C; Fraser, N; Tovchigrechko, A; Yu, L; Williams, N; King, S; Cooper, ME; Hajjar, AM; Woo, JC				Marshall, Jason D.; Heeke, Darren S.; Rao, Eileen; Maynard, Sean K.; Hornigold, David; McCrae, Christopher; Fraser, Neil; Tovchigrechko, Andrey; Yu, Li; Williams, Nicola; King, Sarah; Cooper, Martin E.; Hajjar, Adeline M.; Woo, Jennifer C.			A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation	PLOS ONE			English	Article							RECEPTOR 7 AGONISTS; STRUCTURAL BASIS; LIPID-A; TOLL; TOLL-LIKE-RECEPTOR-4; DERIVATIVES; LIPOPOLYSACCHARIDE; FRAGMENTS; ADJUVANTS; DELIVERY	The best-characterized Toll-like receptor 4 (TLR4) ligands are lipopolysaccharide (LPS) and its chemically modified and detoxified variant, monophosphoryl lipid A (MPL). Although both molecules are active for human TLR4, they demonstrate a potency preference for mouse TLR4 based on data from transfected cell lines and primary cells of both species. After a high throughput screening process of small molecule libraries, we have discovered a new class of TLR4 agonist with a species preference profile differing from MPL. Products of the 4-component Ugi synthesis reaction were demonstrated to potently trigger human TLR4-transfected HEK cells but not mouse TLR4, although inclusion of the human MD2 with mTLR4 was able to partially recover activity. Co-expression of CD14 was not required for optimal activity of Ugi compounds on transfected cells, as it is for LPS. The species preference profile for the panel of Ugi compounds was found to be strongly active for human and cynomolgus monkey primary cells, with reduced but still substantial activity for most Ugi compounds on guinea pig cells. Mouse, rat, rabbit, ferret, and cotton rat cells displayed little or no activity when exposed to Ugi compounds. However, engineering the human versions of TLR4 and MD2 to be expressed in mTLR4/MD2 deficient mice allowed for robust activity by Ugi compounds both in vitro and in vivo. These findings extend the range of compounds available for development as agonists of TLR4 and identify novel molecules which reverse the TLR4 triggering preference of MPL for mouse TLR4 over human TLR4. Such compounds may be amenable to formulation as more potent human-specific TLR4L-based adjuvants than typical MPL-based adjuvants.	[Marshall, Jason D.; Maynard, Sean K.] Medlmmune, Vaccine Platform Grp, Gaithersburg, MD 20878 USA; [Heeke, Darren S.; Rao, Eileen; Woo, Jennifer C.] Medlmmune, Translat Biol Grp, Mountain View, CA USA; [Hornigold, David] Medlmmune, Dept Cardiovasc & Metab Dis, Cambridge, England; [McCrae, Christopher; Cooper, Martin E.] AstraZeneca R&D, Translat Sci Resp Inflammat & Autoimmun Innovat M, Molndal, Sweden; [Fraser, Neil; Williams, Nicola] AstraZeneca R&D, Dept Biol, Charnwood, England; [Tovchigrechko, Andrey] Medlmmune, Res Bioinformat, Gaithersburg, MD USA; [Yu, Li] Medlmmune, Stat Sci, Gaithersburg, MD USA; [King, Sarah] AstraZeneca R&D, Dept Med Chem, Charnwood, England; [Hajjar, Adeline M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	AstraZeneca; AstraZeneca; AstraZeneca; University of Washington; University of Washington Seattle	Marshall, JD (corresponding author), Medlmmune, Vaccine Platform Grp, Gaithersburg, MD 20878 USA.	jdmarshall67@yahoo.com	McCrae, Christopher/C-7422-2018; Marshall, Jason/ABA-2542-2020	McCrae, Christopher/0000-0001-7184-9069; Marshall, Jason/0000-0002-7864-803X; Maynard, Sean/0000-0002-0953-4362; Hajjar, Adeline/0000-0002-4838-8070	MedImmune; global biologics R&D arm of AstraZeneca	MedImmune(AstraZenecaMedimmune); global biologics R&D arm of AstraZeneca	This study was sponsored/funded by MedImmune, the global biologics R&D arm of AstraZeneca. The funder provided support in the form of salaries for authors JDM, DSH, ER, SKM, DH, CM, NF, AT, LY, NW, SK, MEC, and JCW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Behzad H, 2012, J INFECT DIS, V205, P466, DOI 10.1093/infdis/jir769; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boelsterli UA, 2006, CURR DRUG METAB, V7, P715, DOI 10.2174/138920006778520606; Chan M, 2013, J MED CHEM; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foged C, 2011, THER DELIV, V2, P1057, DOI 10.4155/TDE.11.68; Gondokaryono SP, 2007, J LEUKOCYTE BIOL, V82, P657, DOI 10.1189/jlb.1206730; Graffner-Nordberg M, 1998, CHEM PHARM BULL, V46, P591; Hajjar AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002963; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ireton GC, 2013, EXPERT REV VACCINES, V12, P793, DOI 10.1586/14760584.2013.811204; Ishizaka ST, 2007, EXPERT REV VACCINES, V6, P773, DOI 10.1586/14760584.6.5.773; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Katritzky AR, 2003, J PHYS ORG CHEM, V16, P811, DOI 10.1002/poc.643; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Misquith A, 2014, COLLOID SURFACE B, V113, P312, DOI 10.1016/j.colsurfb.2013.09.006; Morefield GL, 2007, CLIN VACCINE IMMUNOL, V14, P1499, DOI 10.1128/CVI.00153-07; Nakamura T, 2013, BIOORG MED CHEM LETT, V23, P669, DOI 10.1016/j.bmcl.2012.11.114; Nour A, 2014, BIOORGANIC MED CHEM; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ohto U, 2012, J BIOL CHEM, V287, P40611, DOI 10.1074/jbc.M112.404608; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Orr MT, 2013, J CONTROL RELEASE, V172, P190, DOI 10.1016/j.jconrel.2013.07.030; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Purohit V, 2000, CHEM RES TOXICOL, V13, P673, DOI 10.1021/tx000002x; Pyrkov TV, 2009, ACTA NATURAE, V1, P124, DOI 10.32607/20758251-2009-1-1-124-127; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Russo C, 2011, BLOOD, V117, P5683, DOI 10.1182/blood-2010-12-328138; Scior T, 2013, COMPUT STRUCT BIOTEC, V5, DOI 10.5936/csbj.201302012; Steeghs L, 2008, INFECT IMMUN, V76, P3801, DOI 10.1128/IAI.00005-08; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unitt J, 2011, BIOCHEM PHARMACOL, V81, P1324, DOI 10.1016/j.bcp.2011.03.010; Wang Y, 2016, P NATL ACAD SCI USA, V113, pE884, DOI 10.1073/pnas.1525639113; Zhang D, 2013, J PHARM EXPT THERAPE; Zhang JX, 2009, SCI CHINA SER C, V52, P147, DOI 10.1007/s11427-009-0002-y; Zhang YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25130; Zhang YH, 2008, ORG BIOMOL CHEM, V6, P3371, DOI 10.1039/b809090d	51	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164632	10.1371/journal.pone.0164632	http://dx.doi.org/10.1371/journal.pone.0164632			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736941	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800101
J	van Hummel, A; Bi, M; Ippati, S; van der Hoven, J; Volkerling, A; Lee, WS; Tan, DCS; Bongers, A; Ittner, A; Ke, YD; Ittner, LM				van Hummel, Annika; Bi, Mian; Ippati, Stefania; van der Hoven, Julia; Volkerling, Alexander; Lee, Wei S.; Tan, Daniel C. S.; Bongers, Andre; Ittner, Arne; Ke, Yazi D.; Ittner, Lars M.			No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapt(tm1(EGFP)Kit) GFP Knockin Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; FUNCTIONAL DEFICITS; PROTEIN; IRON; PARKINSONISM; COGNITION; DEFECTS; NEURONS; MOTOR	Several mouse lines with knockout of the tau-encoding MAPT gene have been reported in the past; they received recent attention due to reports that tau reduction prevented A beta-induced deficits in mouse models of Alzheimer's disease. However, the effects of long-term depletion of tau in vivo remained controversial. Here, we used the tau-deficient GFP knockin line Mapt(tm1(EGFP)kit) on a pure C57Bl/6 background and subjected a large cohort of males and females to a range of motor, memory and behavior tests and imaging analysis, at the advanced age of over 16 months. Neither heterozygous nor homozygous Mapt(tm1(EGFP)kit) mice presented with deficits or abnormalities compared to wild-type litter-mates. Differences to reports using other tau knockout models may be due to different genetic backgrounds, respective gene targeting strategies or other confounding factors, such as nutrition. To this end, we report no functional or morphological deficits upon tau reduction or depletion in aged mice.	[van Hummel, Annika; Bi, Mian; Ippati, Stefania; van der Hoven, Julia; Volkerling, Alexander; Lee, Wei S.; Tan, Daniel C. S.; Ittner, Arne; Ittner, Lars M.] Univ New South Wales, Sch Med Sci, Dept Anat, Dementia Res Unit,Fac Med, Sydney, NSW, Australia; [Bongers, Andre] Univ New South Wales, Mark Wainright Analyt Ctr, Biol Resources Imaging Lab, Sydney, NSW, Australia; [Ke, Yazi D.] Univ New South Wales, Sch Med Sci, Dept Anat, Motor Neuron Dis Unit,Fac Med, Sydney, NSW, Australia; [Ittner, Lars M.] Neurosci Res Australia, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Neuroscience Research Australia	Ittner, LM (corresponding author), Univ New South Wales, Sch Med Sci, Dept Anat, Dementia Res Unit,Fac Med, Sydney, NSW, Australia.; Ittner, LM (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	l.ittner@unsm.edu.au	Ittner, Arne/ABD-3072-2021; Ke, Yazi/ABC-3052-2020	Ittner, Arne/0000-0001-5244-6897; Ke, Yazi/0000-0002-1423-0451; van Hummel, Annika/0000-0001-5192-6434; Bi, Mian/0000-0002-4383-3606; Tan, Daniel/0000-0003-4559-0115; Ittner, Lars/0000-0001-6738-3825	National Health and Medical Research Council [1037746, 1020562, 1069173, 1003083]; Australian Research Council [DP130102027, CE11000102]; UNSW Sydney; UNSW Sydney (Australia); National Health and Medical Research Council [1037746, 1020562, 1069173, 1003083]; Australian Research Council [DP130102027, CE11000102]; UNSW Sydney; UNSW Sydney (Australia)	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); UNSW Sydney; UNSW Sydney (Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); UNSW Sydney; UNSW Sydney (Australia)	This work was funded by National Health and Medical Research Council (#1037746, #1020562, #1069173, #1003083; nhmrc.gov.au), the Australian Research Council (#DP130102027, #CE11000102; arc.gov.au), and UNSW Sydney (unsw.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank the staff of the Biological Resources Centre animal facility for animal care. This work has been supported by the National Health and Medical Research Centre (#1037746, #1020562, #1069173), the Australian Research Council (#DP130102027, #CE11000102) and UNSW Sydney (Australia). L.M.I. is a NHMRC Senior Research Fellows (#1003083).	Ahmed T, 2014, NEUROBIOL AGING, V35, P2474, DOI 10.1016/j.neurobiolaging.2014.05.005; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Cantero JL, 2011, HIPPOCAMPUS, V21, P827, DOI 10.1002/hipo.20798; Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; Dawson HN, 2001, J CELL SCI, V114, P1179; Fujio K, 2007, NEUROREPORT, V18, P1049, DOI 10.1097/WNR.0b013e32818b2a0b; Gotz J, 2006, J NEUROCHEM, V98, P993, DOI 10.1111/j.1471-4159.2006.03955.x; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ittner LM, 2009, J BIOL CHEM, V284, P20909, DOI 10.1074/jbc.M109.014472; Ke YD, 2015, ACTA NEUROPATHOL, V130, P661, DOI 10.1007/s00401-015-1486-0; Ke Yazi D, 2012, Int J Alzheimers Dis, V2012, P873270, DOI 10.1155/2012/873270; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Lei P, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-29; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Li ZY, 2014, NEUROBIOL AGING, V35, P2617, DOI 10.1016/j.neurobiolaging.2014.05.001; Lopes S, 2016, AGING CELL, V15, P208, DOI 10.1111/acel.12391; Ma QL, 2014, J NEUROSCI, V34, P7124, DOI 10.1523/JNEUROSCI.3439-13.2014; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; van Eersel J, 2015, NEUROPATH APPL NEURO, V41, P906, DOI 10.1111/nan.12233; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	28	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163236	10.1371/journal.pone.0163236	http://dx.doi.org/10.1371/journal.pone.0163236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736877	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800015
J	Zheng, SW; Ng, TY; Li, HH; Tang, AL; Tan, TT; Tan, BH				Zheng, Shuwei; Ng, Tong Yong; Li, Huihua; Tang, Ai Ling; Thuan Tong Tan; Tan, Ban Hock			A dedicated fungal culture medium is useful in the diagnosis of fungemia: a retrospective cross-sectional study	PLOS ONE			English	Article							CANDIDA COLONIZATION; SPECIES DISTRIBUTION; BLOOD CULTURES; MYCOBACTERIA; EPIDEMIOLOGY; FLUCONAZOLE; INFECTIONS; MORTALITY; RECOVERY; BACTERIA	Background Mortality for candidemia ranges from 15% to 35%. Current guidelines recommend inoculating blood into three aerobic and three anaerobic blood culture bottles when candidemia is suspected, without mention of a fungal blood culture bottle. Objective To determine the value of the BACTEC Myco/F Lytic blood culture media in the diagnosis of fungemia. Methods A two-year retrospective cross-sectional study was performed for patients who had fungemia with submitted BACTEC Plus Aerobic/F (Aer), BACTEC Plus Anaerobic/F (Anaer) or Myco/F Lytic (Myco) blood culture bottles. Results The detection rate of fungemia was 77.4% in 93 patients with contemporaneously submitted blood culture bottles when limited to only Aer/Anaer culture results. The detection rate improved significantly with the addition of the Myco culture bottle results (p<0.0001). A logistic regression model showed that Myco culture bottle submissions were less useful for patients with appropriate anti-fungal therapy administered within 48 hours [OR = 0.18, 95% CI = (0.06, 0.49), p = 0.001] and those with fungal growth detected within 48 hours [OR = 0.33, 95% CI = (0.12, 0.89), p = 0.001]. Among a subset of patients with concordant blood culture results, those with Myco culture bottles submission allowed earlier fungal detection and speciation by at least one day in 27.5% and 25.0% of the cases respectively. Conclusion Our study highlights the importance of a dedicated fungal blood culture when fungemia is clinically suspected. Nearly a quarter of fungemias may be missed if a fungal blood culture is not performed.	[Zheng, Shuwei; Thuan Tong Tan; Tan, Ban Hock] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore; [Ng, Tong Yong; Tang, Ai Ling] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Li, Huihua] Singapore Gen Hosp, Div Res, Hlth Serv Res Biostat Unit, Singapore, Singapore	Singapore General Hospital; Singapore General Hospital; Singapore General Hospital	Zheng, SW (corresponding author), Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore.	shuwei.zheng@mohh.com.sg	Zhou, Erjun/D-6720-2012					Ananda-Rajah MR, 2012, CURR OPIN INFECT DIS, V25, P107, DOI 10.1097/QCO.0b013e32834e0680; [Anonymous], 2016, BD BACTECTM MYC F LY; [Anonymous], 2015, BD BACTECTM PLUS AER; Bassetti M, 2013, J CLIN MICROBIOL, V51, P4167, DOI 10.1128/JCM.01998-13; Bates D, 2015, R PROJECT STAT COMPU; Cuenca-Estrella M, 2012, CLIN MICROBIOL INFEC, V18, P9, DOI 10.1111/1469-0691.12038; Edwards John E., 2010, PRINCIPLES PRACTICES, V7th, P3225; Fernandez R, 2014, OPEN FORUM INFECT S1, V1, pS377; Fuller DD, 2001, J CLIN MICROBIOL, V39, P2933, DOI 10.1128/JCM.39.8.2933-2936.2001; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Hermsen ED, 2011, CRIT CARE, V15, DOI 10.1186/cc10366; Horvath LL, 2004, J CLIN MICROBIOL, V42, P115, DOI 10.1128/JCM.42.1.115-118.2004; Jekarl DW, 2012, J CLIN LAB ANAL, V26, P412, DOI 10.1002/jcla.21535; Kirby JE, 2009, ARCH PATHOL LAB MED, V133, P93, DOI 10.1043/1543-2165-133.1.93; Leon C, 2006, CRIT CARE MED, V34, P730, DOI 10.1097/01.CCM.0000202208.37364.7D; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Morrell RM, 1996, J CLIN MICROBIOL, V34, P3040, DOI 10.1128/JCM.34.12.3040-3043.1996; Mylonakis E, 2015, CLIN INFECT DIS, V60, P892, DOI 10.1093/cid/ciu959; Ostrosky-Zeichner L, 2011, MYCOSES, V54, P46, DOI 10.1111/j.1439-0507.2009.01756.x; PITTET D, 1994, ANN SURG, V220, P751, DOI 10.1097/00000658-199412000-00008; Rosner B, 2011, FUNDAMENTALS BIOSTAT, P352; StataCorp, 2013, STAT REL 13; Swinne D, 2009, EPIDEMIOL INFECT, V137, P1037, DOI 10.1017/S0950268808001763; Tan BH, 2015, CLIN MICROBIOL INFEC, V21, P946, DOI 10.1016/j.cmi.2015.06.010; Tortorano AM, 2013, INFECTION, V41, P655, DOI 10.1007/s15010-013-0455-6; Vetter E, 2001, J CLIN MICROBIOL, V39, P4380, DOI 10.1128/JCM.39.12.4380-4386.2001; Weinstein MP, 1996, J CLIN MICROBIOL, V34, P234, DOI 10.1128/JCM.34.1.234-235.1996; Weiss E, 2014, THER ADV INFECT DIS, V2, P105, DOI 10.1177/2049936114562586	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164668	10.1371/journal.pone.0164668	http://dx.doi.org/10.1371/journal.pone.0164668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736956	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505800107
J	Krzywanski, J; Mikulski, T; Krysztofiak, H; Mlynczak, M; Gaczynska, E; Ziemba, A				Krzywanski, Jaroslaw; Mikulski, Tomasz; Krysztofiak, Hubert; Mlynczak, Marcel; Gaczynska, Ewa; Ziemba, Andrzej			Seasonal Vitamin D Status in Polish Elite Athletes in Relation to Sun Exposure and Oral Supplementation	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; DIETARY-INTAKE; PERFORMANCE; GUIDELINES	Vitamin D does not only influence the musculoskeletal health and mineral homeostasis but it also affects cardiovascular, endocrine, nervous, immune and mental functions, thus it is of considerable importance for both physically active people and elite athletes. However, vitamin D deficiency is common worldwide and results from inadequate endogenous skin synthesis (insufficient ultraviolet B exposure) and diet. To improve the vitamin D status elite athletes often travel to lower latitude during winter. The aim of the study was to evaluate the seasonal vitamin D status in Polish elite athletes according to the sun exposure and oral supplementation. Serum concentration of 25-hydroxyvitamin D (25(OH)D) was measured in the years 2010-2014 in 409 elite athletes, who were divided into the following groups: OUTD-outdoor sports, represented by track and field athletes, who trained in Poland; IND-weightlifters, handball and volleyball players who trained indoors in Poland; SUN-track and field athletes who trained during Polish winter in lower latitude with high sunshine exposure; SUPL-track and field athletes who trained in Poland, had an inadequate vitamin D status (25(OH)D < 30 ng/ml) and were supplemented orally. Inadequate Vitamin D status was observed in 80% of OUTD and 84% of IND athletes in winter, whereas in summer the values amounted to 42% and 83%, respectively. The athletes exposed to sun in winter had significantly higher vitamin D concentration than OUTD group. Oral supplementation improved vitamin D concentration by 45%, whereas winter sun exposure caused its increase by 85%. Except for a few summer months an inadequate status of vitamin D was found in the majority of Polish elite athletes, with the deficiency level being similar to the one observed in non-athletic population. The most serious deficiency was observed in indoor disciplines. Adequate vitamin D status can be achieved by both increased sun exposure, especially in winter, and oral supplementation. Athletes should therefore routinely assess their vitamin D status and be educated how to approach their sunlight exposure, diet and supplementation.	[Krzywanski, Jaroslaw; Gaczynska, Ewa] Natl Ctr Sports Med, Warsaw, Poland; [Mikulski, Tomasz; Krysztofiak, Hubert; Ziemba, Andrzej] Mossakowski Med Res Ctr PAS, Dept Appl Physiol, Warsaw, Poland; [Mlynczak, Marcel] Warsaw Univ Technol, Inst Metrol & Biomed Engn, Fac Mech, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Warsaw University of Technology	Krysztofiak, H (corresponding author), Mossakowski Med Res Ctr PAS, Dept Appl Physiol, Warsaw, Poland.	hkrysztofiak@imdik.pan.pl	Młyńczak, Marcel/L-1509-2016; Krysztofiak, Hubert/L-8083-2019	Młyńczak, Marcel/0000-0001-8549-7973; Krysztofiak, Hubert/0000-0003-4567-1433; Ziemba, Andrzej/0000-0002-1987-3050				Al-Shaar L, 2014, J BONE MINER RES, V29, P944, DOI 10.1002/jbmr.2111; Biancuzzo RM, 2013, J CLIN ENDOCR METAB, V98, P973, DOI 10.1210/jc.2012-2114; Bischoff-Ferrari HA, 2012, J BONE MINER RES, V27, P160, DOI 10.1002/jbmr.551; Brot C, 2001, BRIT J NUTR, V86, pS97, DOI 10.1079/BJN2001345; Cannell JJ, 2009, MED SCI SPORT EXER, V41, P1102, DOI 10.1249/MSS.0b013e3181930c2b; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Cicarma E, 2009, ANTICANCER RES, V29, P3495; Dahlquist DT, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0093-8; Engelsen O, 2010, NUTRIENTS, V2, P482, DOI 10.3390/nu2050482; Farrokhyar F, 2015, SPORTS MED, V45, P365, DOI 10.1007/s40279-014-0267-6; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Ganji V, 2012, J NUTR, V142, P498, DOI 10.3945/jn.111.151977; Greene-Finestone LS, 2011, OSTEOPOROSIS INT, V22, P1389, DOI 10.1007/s00198-010-1362-7; Grigalavicius M, 2015, J PHOTOCH PHOTOBIO B, V147, P69, DOI 10.1016/j.jphotobiol.2015.03.009; Grigalavicius M, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.22941; Grober U, 2013, DERM-ENDOCRINOL, V5, P331, DOI 10.4161/derm.26738; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Hilger J, 2014, BRIT J NUTR, V111, P23, DOI 10.1017/S0007114513001840; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2012, J CLIN ENDOCR METAB, V97, P1153, DOI 10.1210/jc.2011-2601; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Kopec A, 2013, J HUM KINET, V38, P135, DOI 10.2478/hukin-2013-0053; Kroll MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118108; Lavie CJ, 2011, J AM COLL CARDIOL, V58, P1547, DOI 10.1016/j.jacc.2011.07.008; Lazzeroni M, 2013, ANTI-CANCER AGENT ME, V13, P118, DOI 10.2174/187152013804487281; Lovell G, 2008, CLIN J SPORT MED, V18, P159, DOI 10.1097/JSM.0b013e3181650eee; Miller JW, 2010, NEUROLOGY, V74, P13, DOI 10.1212/WNL.0b013e3181c719a2; Morton JP, 2012, APPL PHYSIOL NUTR ME, V37, P798, DOI [10.1139/H2012-037, 10.1139/h2012-037]; Ng K, 2014, AM J CLIN NUTR, V99, P587, DOI 10.3945/ajcn.113.067777; Ogan D, 2013, NUTRIENTS, V5, P1856, DOI 10.3390/nu5061856; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Pludowski P, 2014, STAND MED PEDIAT, P609, DOI DOI 10.5603/EP.2014.0015; Pludowski P, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/589587; Pludowski P, 2013, ENDOKRYNOL POL, V64, P319, DOI 10.5603/EP.2013.0012; Pramyothin P, 2012, CURR OPIN GASTROEN, V28, P139, DOI 10.1097/MOG.0b013e32835004dc; R Core Team, 2015, LANGUAGE ENV STAT CO; Romagnoli E, 2013, EUR J ENDOCRINOL, V169, pR59, DOI 10.1530/EJE-13-0435; Terushkin V, 2010, J AM ACAD DERMATOL, V62, P929, DOI 10.1016/j.jaad.2009.07.028; Vierucci F, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-54; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Willis KS, 2012, OPEN ACCESS J SPORTS, V3, P35, DOI 10.2147/OAJSM.S31022	43	44	44	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164395	10.1371/journal.pone.0164395	http://dx.doi.org/10.1371/journal.pone.0164395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732653	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300050
J	Lei, Z; Chen, XD; Mercade-Prieto, R				Lei, Zhao; Chen, Xiao Dong; Mercade-Prieto, Ruben			Effect of N-Ethylmaleimide as a Blocker of Disulfide Crosslinks Formation on the Alkali-Cold Gelation of Whey Proteins	PLOS ONE			English	Article							BETA-LACTOGLOBULIN GELS; GELLING PROPERTIES; PH; DISSOLUTION; AGGREGATION; ENVIRONMENT; CYSTEINE; BONDS; SIZE	N-ethylmaleimide (NEM) was used to verify that no new disulfide crosslinks were formed during the fascinating rheology of the alkali cold-gelation of whey proteins, which show Sol-Gel-Sol transitions with time at pH > 11.5. These dynamic transitions involve the formation and subsequent destruction of non-covalent interactions between soluble whey aggregates. Therefore, incubation of aggregates with NEM was expected not to affect much the rheology. Experiments show that very little additions of NEM, such as 0.5 mol per mol of protein, delayed and significantly strengthened the metastable gels formed. Interactions between whey protein aggregates were surprisingly enhanced during incubation with NEM as inferred from oscillatory rheometry at different protein concentrations, dynamic swelling, Trp fluorescence and SDS-PAGE measurements.	[Lei, Zhao; Chen, Xiao Dong; Mercade-Prieto, Ruben] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Sch Chem & Environm Engn, Suzhou Key Lab Green Chem Engn, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China	Mercade-Prieto, R (corresponding author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Sch Chem & Environm Engn, Suzhou Key Lab Green Chem Engn, Suzhou 215123, Jiangsu, Peoples R China.	ruben@suda.edu.cn	Chen, Xiao Dong/ADG-8612-2022; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022	Chen, Xiao Dong/0000-0002-0150-0491; Mercade Prieto, Ruben/0000-0003-0487-7400	Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; "Jiangsu Specially-Appointed Professors Program" of China; Youth Fund of Natural Science Foundation of Jiangsu Province of China [BK20140343]	Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; "Jiangsu Specially-Appointed Professors Program" of China; Youth Fund of Natural Science Foundation of Jiangsu Province of China	This work was supported by the project funding from the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions and the "Jiangsu Specially-Appointed Professors Program" of China, and the Youth Fund of Natural Science Foundation of Jiangsu Province of China (no. BK20140343)	Alting AC, 2000, J AGR FOOD CHEM, V48, P5001, DOI 10.1021/jf000474h; Alting AC, 2003, FOOD HYDROCOLLOID, V17, P469, DOI 10.1016/S0268-005X(03)00023-7; Altlng AC, 2003, J AGR FOOD CHEM, V51, P3150, DOI 10.1021/jf0209342; Betz M, 2012, SOFT MATTER, V8, P2477, DOI 10.1039/c2sm06976h; Boye JI, 2004, J DAIRY RES, V71, P207, DOI 10.1017/S0022029904000184; BREWER CF, 1967, ANAL BIOCHEM, V18, P248, DOI 10.1016/0003-2697(67)90007-3; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; Chihi ML, 2016, J AGR FOOD CHEM, V64, P2780, DOI 10.1021/acs.jafc.6b00087; Collini M, 2000, PROTEIN SCI, V9, P1968, DOI 10.1110/ps.9.10.1968; Creamer LK, 2004, J AGR FOOD CHEM, V52, P7660, DOI 10.1021/jf049388y; Delahaije RJBM, 2016, J AGR FOOD CHEM, V64, P4362, DOI 10.1021/acs.jafc.6b00816; Dissanayake M, 2010, J AGR FOOD CHEM, V58, P6825, DOI 10.1021/jf1009796; Foegeding EA, 2002, TRENDS FOOD SCI TECH, V13, P151, DOI 10.1016/S0924-2244(02)00111-5; Gosal WS, 2004, BIOMACROMOLECULES, V5, P2420, DOI 10.1021/bm049660c; Havea P, 2009, J AGR FOOD CHEM, V57, P1506, DOI 10.1021/jf802559z; Hua YF, 2005, FOOD RES INT, V38, P377, DOI 10.1016/j.foodres.2004.10.006; Kaneko R, 1999, J AGR FOOD CHEM, V47, P4950, DOI 10.1021/jf990267l; Kitabatake N, 2001, J AGR FOOD CHEM, V49, P4011, DOI 10.1021/jf001380a; Lei Z, 2016, RHEOL ACTA IN PRESS; Mercade-Prieto R, 2007, FOOD HYDROCOLLOID, V21, P1275, DOI 10.1016/j.foodhyd.2006.09.015; Mercade-Prieto R, 2007, BIOMACROMOLECULES, V8, P1162, DOI 10.1021/bm061100l; Mercade-Prieto R, 2007, BIOMACROMOLECULES, V8, P469, DOI 10.1021/bm060553n; Mercade-Prieto R, 2006, J AGR FOOD CHEM, V54, P5437, DOI 10.1021/jf0605650; Mercade-Prieto R, 2009, LANGMUIR, V25, P5793, DOI 10.1021/la804094n; Mercade-Prieto R, 2009, LANGMUIR, V25, P5785, DOI 10.1021/la804093d; Mercade-Prieto R, 2009, FOOD HYDROCOLLOID, V23, P1587, DOI 10.1016/j.foodhyd.2008.11.007; Nicolai T, 2011, FOOD HYDROCOLLOID, V25, P1945, DOI 10.1016/j.foodhyd.2011.02.006; Purwanti N, 2011, FOOD HYDROCOLLOID, V25, P1482, DOI 10.1016/j.foodhyd.2011.02.027; Qin BY, 1998, BIOCHEMISTRY-US, V37, P14014, DOI 10.1021/bi981016t; Rabiey L, 2009, FOOD HYDROCOLLOID, V23, P973, DOI 10.1016/j.foodhyd.2008.07.009; Renard D, 1998, INT J BIOL MACROMOL, V22, P41, DOI 10.1016/S0141-8130(97)00086-X; Ryan KN, 2013, J FOOD SCI, V78, pR1105, DOI 10.1111/1750-3841.12207; Simons JWFA, 2002, ARCH BIOCHEM BIOPHYS, V406, P143, DOI 10.1016/S0003-9861(02)00429-0; Smyth DG, 1960, J AM CHEM SOC, V82, P4600, DOI 10.1021/ja01502a039; Taulier N, 2001, J MOL BIOL, V314, P873, DOI 10.1006/jmbi.2001.5188; Wada R, 2001, J AGR FOOD CHEM, V49, P4971, DOI 10.1021/jf001457v; XIONG YL, 1993, J DAIRY SCI, V76, P70, DOI 10.3168/jds.S0022-0302(93)77324-5; Zhang YH, 2010, FOOD HYDROCOLLOID, V24, P266, DOI 10.1016/j.foodhyd.2009.10.002; Zhu D, 2008, J AGR FOOD CHEM, V56, P7113, DOI 10.1021/jf800909w	39	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164496	10.1371/journal.pone.0164496	http://dx.doi.org/10.1371/journal.pone.0164496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732644	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300061
J	Mbizah, MM; Steenkamp, G; Groom, RJ				Mbizah, Moreangels M.; Steenkamp, Gerhard; Groom, Rosemary J.			Evaluation of the Applicability of Different Age Determination Methods for Estimating Age of the Endangered African Wild Dog (Lycaon Pictus)	PLOS ONE			English	Article							TOOTH-WEAR; GRAY WOLVES; DENTAL RADIOGRAPHS; CEMENTUM LAYERS; ACCURACY; CANINE; POPULATIONS; PRECISION; ZIMBABWE; COYOTES	African wild dogs (Lycaon pictus) are endangered and their population continues to decline throughout their range. Given their conservation status, more research focused on their population dynamics, population growth and age specific mortality is needed and this requires reliable estimates of age and age of mortality. Various age determination methods from teeth and skull measurements have been applied in numerous studies and it is fundamental to test the validity of these methods and their applicability to different species. In this study we assessed the accuracy of estimating chronological age and age class of African wild dogs, from dental age measured by (i) counting cementum annuli (ii) pulp cavity/tooth width ratio, (iii) tooth wear (measured by tooth crown height) (iv) tooth wear (measured by tooth crown width/crown height ratio) (v) tooth weight and (vi) skull measurements (length, width and height). A sample of 29 African wild dog skulls, from opportunistically located carcasses was analysed. Linear and ordinal regression analysis was done to investigate the performance of each of the six age determination methods in predicting wild dog chronological age and age class. Counting cementum annuli was the most accurate method for estimating chronological age of wild dogs with a 79% predictive capacity, while pulp cavity/tooth width ratio was also a reliable method with a 68% predictive capacity. Counting cementum annuli and pulp cavity/tooth width ratio were again the most accurate methods for separating wild dogs into three age classes (6-24 months; 25-60 months and > 60 months), with a McFadden's Pseudo-R-2 of 0.705 and 0.412 respectively. The use of the cementum annuli method is recommended when estimating age of wild dogs since it is the most reliable method. However, its use is limited as it requires tooth extraction and shipping, is time consuming and expensive, and is not applicable to living individuals. Pulp cavity/tooth width ratio is a moderately reliable method for estimating both chronological age and age class. This method gives a balance between accuracy, cost and practicability, therefore it is recommended when precise age estimations are not paramount.	[Mbizah, Moreangels M.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford, England; [Steenkamp, Gerhard] Univ Pretoria, Fac Vet Sci, Dept Compan Anim Clin Studies, Onderstepoort, South Africa; [Groom, Rosemary J.] Univ Johannesburg, Dept Zool, Auckland Pk, South Africa; [Groom, Rosemary J.] African Wildlife Conservat Fund, Chishakwe Ranch, Birchenough Bri, Zimbabwe	University of Oxford; University of Pretoria; University of Johannesburg	Mbizah, MM (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford, England.	moreangelsm@gmail.com	Steenkamp, Gerhard/AAP-3362-2021	Steenkamp, Gerhard/0000-0001-8428-7309	National Geographic Conservation Trust; Columbus Zoo and Aquarium; Disney Worldwide Conservation Fund; Rufford Foundation	National Geographic Conservation Trust(National Geographic Society); Columbus Zoo and Aquarium; Disney Worldwide Conservation Fund; Rufford Foundation	This work was funded by grants awarded to RJG from National Geographic Conservation Trust, Columbus Zoo and Aquarium, Disney Worldwide Conservation Fund and The Rufford Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Bingham J, 2003, AFR ZOOL, V38, P153; Boertje RD, 2015, WILDLIFE SOC B, V39, P383, DOI 10.1002/wsb.537; Bosmans N, 2005, FORENSIC SCI INT, V153, P208, DOI 10.1016/j.forsciint.2004.08.017; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calvert W, 1998, URSUS-SERIES, V10, P449; Christensen-Dalsgaard SN, 2010, POLAR BIOL, V33, P589, DOI 10.1007/s00300-009-0734-y; Clauss M, 2007, J ZOO WILDLIFE MED, V38, P433, DOI 10.1638/06-032.1; CRAIGHEAD JJ, 1970, J WILDLIFE MANAGE, V34, P353, DOI 10.2307/3799022; Delahay RJ, 2011, J ZOOL, V284, P183, DOI 10.1111/j.1469-7998.2011.00796.x; DIX LM, 1986, WILDLIFE SOC B, V14, P275; GAILLARD JM, 1994, EVOLUTION, V48, P509, DOI 10.1111/j.1558-5646.1994.tb01329.x; Gay SW, 1996, J MAMMAL, V77, P191, DOI 10.2307/1382720; GILBERT FF, 1970, J WILDLIFE MANAGE, V34, P532, DOI 10.2307/3798858; Gipson PS, 2000, J WILDLIFE MANAGE, V64, P752, DOI 10.2307/3802745; GOODWIN EA, 1985, J WILDLIFE MANAGE, V49, P313, DOI 10.2307/3801522; GRIMSDELL J J R, 1973, East African Wildlife Journal, V11, P31; HARRIS S, 1992, J ZOOL, V228, P679, DOI 10.1111/j.1469-7998.1992.tb04467.x; Karanth K. Ullas, 2003, Journal of the Bombay Natural History Society, V100, P169; Kerley LL, 2003, J MAMMAL, V84, P288, DOI 10.1644/1545-1542(2003)084<0288:RPOWFA>2.0.CO;2; KLEIN RG, 1981, J ARCHAEOL SCI, V8, P1, DOI 10.1016/0305-4403(81)90010-8; Knowlton FF, 2001, WILDLIFE SOC B, V29, P239; Krebs CJ, 1999, ECOLOGICAL METHODOLO, P1; Kuehn D.W., 1983, Wildlife Society Bulletin, V11, P68; KVAAL SI, 1995, FORENSIC SCI INT, V74, P175, DOI 10.1016/0379-0738(95)01760-G; Landon DB, 1998, J WILDLIFE MANAGE, V62, P674, DOI 10.2307/3802343; Laundre JW, 2000, WILDLIFE SOC B, V28, P963; LINHART SB, 1967, J WILDLIFE MANAGE, V31, P362, DOI 10.2307/3798334; Mbizah MM, 2014, BIODIVERS CONSERV, V23, P1441, DOI 10.1007/s10531-014-0675-9; Mbizah MM, 2012, S AFR J WILDL RES, V42, P94, DOI 10.3957/056.042.0213; McFadden D., 1974, FRONTIERS ECONOMETRI, P105; POOLE KG, 1994, ANN ZOOL FENN, V31, P329; RCoreTeam, 2015, R LANG ENV STAT COMP; ROBINSON PT, 1979, J ZOO ANIM MED, V10, P57, DOI 10.2307/20094419; Schaller G. B., 1972, SERENGETI LION; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; SPINAGE C. A., 1967, EAST AFR WILDLIFE J, V5, P1; SPINAGE C A, 1973, East African Wildlife Journal, V11, P165; Spinage C.A., 1972, AFR J ECOL, V10, P273, DOI [10.1111/j.1365-2028.1972.tb00871.x, DOI 10.1111/J.1365-2028.1972.TB00871.X]; SPINAGE CA, 1988, AFR J ECOL, V26, P221; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; Stansfield FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124980; Taylor LA, 2014, CONTRIB ZOOL, V83, P107, DOI 10.1163/18759866-08302002; THOMSON PC, 1992, WILDLIFE RES, V19, P597, DOI 10.1071/WR9920597; WILLIAMS BK, 2002, ANAL MANAGEMENT WILD	45	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164676	10.1371/journal.pone.0164676	http://dx.doi.org/10.1371/journal.pone.0164676			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732663	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300075
J	Nakashima, Y; Egami, Y; Kimura, M; Wakimoto, T; Abe, I				Nakashima, Yu; Egami, Yoko; Kimura, Miki; Wakimoto, Toshiyuki; Abe, Ikuro			Metagenomic Analysis of the Sponge Discodermia Reveals the Production of the Cyanobacterial Natural Product Kasumigamide by 'Entotheonella'	PLOS ONE			English	Article							PYROPHOSPHATE PROTOXIN; ADENYLATION DOMAINS; LYNGBYA-MAJUSCULA; TUMOR PROMOTERS; GENE CLUSTERS; BIOSYNTHESIS; POLYKETIDE; PEPTIDE; CALYX; DNA	Sponge metagenomes are a useful platform to mine cryptic biosynthetic gene clusters responsible for production of natural products involved in the sponge-microbe association. Since numerous sponge-derived bioactive metabolites are biosynthesized by the symbiotic bacteria, this strategy may concurrently reveal sponge-symbiont produced compounds. Accordingly, a metagenomic analysis of the Japanese marine sponge Discodermia calyx has resulted in the identification of a hybrid type I polyketide synthase-nonribosomal peptide synthetase gene (kas). Bioinformatic analysis of the gene product suggested its involvement in the biosynthesis of kasumigamide, a tetrapeptide originally isolated from freshwater free-living cyanobacterium Microcystis aeruginosa NIES-87. Subsequent investigation of the sponge metabolic profile revealed the presence of kasumigamide in the sponge extract. The kasumigamide producing bacterium was identified as an 'Entotheonella' sp. Moreover, an in silico analysis of kas gene homologs uncovered the presence of kas family genes in two additional bacteria from different phyla. The production of kasumigamide by distantly related multiple bacterial strains implicates horizontal gene transfer and raises the potential for a wider distribution across other bacterial groups.	[Nakashima, Yu; Kimura, Miki; Abe, Ikuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan; [Egami, Yoko; Wakimoto, Toshiyuki] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido, Japan	University of Tokyo; Hokkaido University	Abe, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan.; Wakimoto, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido, Japan.	wakimoto@pharm.hokudai.ac.jp; abei@mol.f.u-tokyo.ac.jp	Abe, Ikuro/E-4449-2010; Wakimoto, Toshiyuki/Q-3278-2019	Abe, Ikuro/0000-0002-3640-888X; 	Takeda Science Foundation; Sumitmo Foundation; Naito Foundation; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (JSPS KAKENHI) [JP16H06443, JP16H06448, JP16K13084, JP15H01836, JP15H03112, JP15K12740, JP26303005]; JSPS Fellowship for Young Scientist; Grants-in-Aid for Scientific Research [16H06448, 15H05996] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitmo Foundation; Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (JSPS KAKENHI); JSPS Fellowship for Young Scientist(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Takeda Science Foundation, the Sumitmo Foundation, the Naito Foundation, the Bilateral Program between Japan and Switzerland from the Japan Society for the Promotion of Science (JSPS), and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (JSPS KAKENHI Grant Numbers JP16H06443, JP16H06448, JP16K13084, JP15H01836, JP15H03112, JP15K12740, and JP26303005). Y.N. is a recipient of the JSPS Fellowship for Young Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. J. Piel (ETH Zurich), Dr. M. F. Freeman (University of Minnesota), and Prof. Taifo Mahmud (Oregon State University) for valuable discussions, Prof. S. Matsunaga and Dr. K. Takada (University of Tokyo) for assistance with the sponge collection. This work was carried out in part as a joint-research in Japanese Association for Marine Biology (JAMBIO) and partly supported by the Takeda Science Foundation, the Sumitmo Foundation, the Naito Foundation, the Bilateral Program between Japan and Switzerland from the Japan Society for the Promotion of Science (JSPS), and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (JSPS KAKENHI Grant Numbers JP16H06443, JP16H06448, JP16K13084, JP15H01836, JP15H03112, JP15K12740, and JP26303005). Y.N. is a recipient of the JSPS Fellowship for Young Scientist.	AIMI N, 1990, J NAT PROD, V53, P1593, DOI 10.1021/np50072a035; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Beyer S, 1999, BBA-GENE STRUCT EXPR, V1445, P185, DOI 10.1016/S0167-4781(99)00041-X; Brown SD, 2012, J BACTERIOL, V194, P5991, DOI 10.1128/JB.01243-12; CARDELLINA JH, 1979, SCIENCE, V204, P193, DOI 10.1126/science.107586; Chevreux B., 1999, COMPUTER SCI BIOL P, P45; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Doderlein L, 1883, Z WISS ZOOL, V40, P62; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; DUL L, 2010, NAT PROD REP, V27, P255, DOI DOI 10.1039/B912037H; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Egami Y, 2014, BIOORG MED CHEM LETT, V24, P5150, DOI 10.1016/j.bmcl.2014.10.002; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; FUJIKI H, 1981, P NATL ACAD SCI-BIOL, V78, P3872, DOI 10.1073/pnas.78.6.3872; Ginolhac A, 2004, APPL ENVIRON MICROB, V70, P5522, DOI 10.1128/AEM.70.9.5522-5527.2004; Hackett JD, 2013, MOL BIOL EVOL, V30, P70, DOI 10.1093/molbev/mss142; He R, 2012, MOL BIOSYST, V8, P2334, DOI 10.1039/c2mb25169h; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; HITOTSUYANAGI Y, 1984, CHEM PHARM BULL, V32, P3774; HITOTSUYANAGI Y, 1984, CHEM PHARM BULL, V32, P4233; Hrvatin S, 2007, J MICROBIOL METH, V68, P434, DOI 10.1016/j.mimet.2006.09.009; Ichimura T, 1979, 2 ISOLATION CULTURE, P294; Ishida K, 2000, J ORG CHEM, V65, P5898, DOI 10.1021/jo991918f; Ishida K, 2009, APPL ENVIRON MICROB, V75, P2017, DOI 10.1128/AEM.02258-08; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Kadi N, 2009, METHOD ENZYMOL, V458, P431, DOI 10.1016/S0076-6879(09)04817-4; Kampa A, 2013, P NATL ACAD SCI USA, V110, pE3129, DOI 10.1073/pnas.1305867110; KATO Y, 1986, J AM CHEM SOC, V108, P2780, DOI 10.1021/ja00270a061; Kevany BM, 2009, APPL ENVIRON MICROB, V75, P1144, DOI 10.1128/AEM.02518-08; Kimura M, 2012, J NAT PROD, V75, P290, DOI 10.1021/np2009187; Makris TM, 2013, BIOCHEMISTRY-US, V52, P6662, DOI 10.1021/bi400845b; McQuade TJ, 2009, ANAL BIOCHEM, V386, P244, DOI 10.1016/j.ab.2008.12.014; Moffitt MC, 2003, J MOL EVOL, V56, P446, DOI 10.1007/s00239-002-2415-0; Morin N, 2010, J MICROBIOL METH, V80, P148, DOI 10.1016/j.mimet.2009.11.012; NINOMIYA M, 1986, JPN J CANCER RES, V77, P222; Piel J, 2004, ENVIRON MICROBIOL, V6, P921, DOI 10.1111/j.1462-2920.2004.00531.x; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Ross AC, 2013, J AM CHEM SOC, V135, P1155, DOI 10.1021/ja3119674; Schirmer A, 2005, APPL ENVIRON MICROB, V71, P4840, DOI 10.1128/AEM.71.8.4840-4849.2005; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Ueoka R, 2015, NAT CHEM BIOL, V11, P705, DOI [10.1038/NCHEMBIO.1870, 10.1038/nchembio.1870]; Wakimoto T, 2014, NAT CHEM BIOL, V10, P648, DOI [10.1038/NCHEMBIO.1573, 10.1038/nchembio.1573]; Wiese M, 2010, MAR DRUGS, V8, P2185, DOI 10.3390/md8072185; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959	46	23	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164468	10.1371/journal.pone.0164468	http://dx.doi.org/10.1371/journal.pone.0164468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732651	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505300058
J	Kizaki, H; Omae, Y; Tabuchi, F; Saito, Y; Sekimizu, K; Kaito, C				Kizaki, Hayato; Omae, Yosuke; Tabuchi, Fumiaki; Saito, Yuki; Sekimizu, Kazuhisa; Kaito, Chikara			Cell-Surface Phenol Soluble Modulins Regulate Staphylococcus aureus Colony Spreading	PLOS ONE			English	Article							GENE-EXPRESSION; DELTA-TOXIN; VIRULENCE; AGR; INFECTION; BIOFILMS; SEQUENCE; DNA	Staphylococcus aureus produces phenol-soluble modulins (PSMs), which are amphipathic small peptides with lytic activity against mammalian cells. We previously reported that PSM alpha 1-4 stimulate S. aureus colony spreading, the phenomenon of S. aureus colony expansion on the surface of soft agar plates, whereas delta-toxin (Hld, PSM gamma) inhibits colony-spreading activity. In this study, we revealed the underlying mechanism of the opposing effects of PSM alpha 1-4 and delta-toxin in S. aureus colony spreading. PSM alpha 1-4 and delta-toxin are abundant on the S. aureus cell surface, and account for 18% and 8.5% of the total amount of PSM alpha 1-4 and delta-toxin, respectively, in S. aureus overnight cultures. Knockout of PSM alpha 1-4 did not affect the amount of cell surface delta-toxin. In contrast, knockout of d-toxin increased the amount of cell surface PSM alpha 1-4, and decreased the amount of culture supernatant PSM alpha 1-4. The d-toxin inhibited PSM alpha 3 and PSM alpha 2 binding to the S. aureus cell surface in vitro. A double knockout strain of PSM alpha 1-4 and delta-toxin exhibited decreased colony spreading compared with the parent strain. Expression of cell surface PSM alpha 1-4, but not culture supernatant PSM alpha 1-4, restored the colony-spreading activity of the PSM alpha 1-4/delta-toxin double knockout strain. Expression of delta-toxin on the cell surface or in the culture supernatant did not restore the colony-spreading activity of the PSMa1-4/delta-toxin double knockout strain. These findings suggest that cell surface PSM alpha 1-4 promote S. aureus colony spreading, whereas delta-toxin suppresses colony-spreading activity by inhibiting PSM alpha 1-4 binding to the S. aureus cell surface.	[Kizaki, Hayato; Omae, Yosuke; Tabuchi, Fumiaki; Saito, Yuki; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	 [25117507];  [15H04727];  [15H05783]	; ; 	This work was supported by Grants-in-Aid for Scientific Research to CK (25117507, 15H04727, 15H05783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi T, 2014, CLIN MICROBIOL INFEC, V20, P912, DOI 10.1111/1469-0691.12575; Berube BJ, 2014, INFECT IMMUN, V82, P3350, DOI 10.1128/IAI.00089-14; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cheung GYC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18023; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Dastgheyb SS, 2015, INFECT IMMUN, V83, P2966, DOI 10.1128/IAI.00394-15; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003269; Kaito C, 2011, MICROB PATHOGENESIS, V51, P142, DOI 10.1016/j.micpath.2011.04.007; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Lin MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25233; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Omae Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097670; Omae Y, 2012, J BIOL CHEM, V287, P15570, DOI 10.1074/jbc.M112.357848; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Pollitt EJG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17698; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; THIAUDIERE E, 1991, EUR J BIOCHEM, V195, P203, DOI 10.1111/j.1432-1033.1991.tb15696.x; Tsompanidou E, 2013, APPL ENVIRON MICROB, V79, P886, DOI 10.1128/AEM.03157-12; Tsompanidou E, 2011, J BACTERIOL, V193, P1267, DOI 10.1128/JB.01276-10; Ueda T, 2011, MICROB PATHOGENESIS, V51, P178, DOI 10.1016/j.micpath.2011.04.003; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Yoshikai H, 2016, J INFECT DIS, V213, P295, DOI 10.1093/infdis/jiv376	40	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164523	10.1371/journal.pone.0164523	http://dx.doi.org/10.1371/journal.pone.0164523			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723838	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100071
J	Stubbington, R; Dole-Olivier, MJ; Galassi, DMP; Hogan, JP; Wood, PJ				Stubbington, Rachel; Dole-Olivier, Marie-Jose; Galassi, Diana M. P.; Hogan, John-Paul; Wood, Paul J.			Characterization of Macroinvertebrate Communities in the Hyporheic Zone of River Ecosystems Reflects the Pump-Sampling Technique Used	PLOS ONE			English	Article							BOU-ROUCH METHOD; ASSESSING INVERTEBRATE ASSEMBLAGES; GRAVEL-BED STREAM; ECOLOGICAL QUALITY; SPECIES RICHNESS; SUBSURFACE ZONE; BETA DIVERSITY; LAND-USE; BIODIVERSITY; SEDIMENTS	The hyporheic zone of river ecosystems provides a habitat for a diverse macroinvertebrate community that makes a vital contribution to ecosystem functioning and biodiversity. However, effective methods for sampling this community have proved difficult to establish, due to the inaccessibility of subsurface sediments. The aim of this study was to compare the two most common semi-quantitative macroinvertebrate pump-sampling techniques: Bou-Rouch and vacuum-pump sampling. We used both techniques to collect replicate samples in three contrasting temperate-zone streams, in each of two biogeographical regions (Atlantic region, central England, UK; Continental region, southeast France). Results were typically consistent across streams in both regions: Bou-Rouch samples provided significantly higher estimates of taxa richness, macroinvertebrate abundance, and the abundance of all UK and eight of 10 French common taxa. Seven and nine taxa which were rare in Bou-Rouch samples were absent from vacuum-pump samples in the UK and France, respectively; no taxon was repeatedly sampled exclusively by the vacuum pump. Rarefaction curves (rescaled to the number of incidences) and non-parametric richness estimators indicated no significant difference in richness between techniques, highlighting the capture of more individuals as crucial to Bou-Rouch sampling performance. Compared to assemblages in replicate vacuum-pump samples, multivariate analyses indicated greater distinction among Bou-Rouch assemblages from different streams, as well as significantly greater consistency in assemblage composition among replicate Bou-Rouch samples collected in one stream. We recommend Bou-Rouch sampling for most study types, including rapid biomonitoring surveys and studies requiring acquisition of comprehensive taxon lists that include rare taxa. Despite collecting fewer macroinvertebrates, vacuum-pump sampling remains an important option for inexpensive and rapid sample collection.	[Stubbington, Rachel; Hogan, John-Paul] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, Notts, England; [Dole-Olivier, Marie-Jose] Univ Lyon 1, Villeurbanne, France; [Galassi, Diana M. P.] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Wood, Paul J.] Univ Loughborough, Dept Geog, Ctr Hydrol & Ecosyst Sci, Loughborough, Leics, England	Nottingham Trent University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of L'Aquila; Loughborough University	Stubbington, R (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham, Notts, England.	rachel.stubbington@ntu.ac.uk	Stubbington, Rachel/ABI-3913-2020; Galassi, Diana M.P./N-1674-2015	Stubbington, Rachel/0000-0001-8475-5109; Galassi, Diana M.P./0000-0002-6448-2710	Nottingham trent University (NTU); ZABR (Zone Atelier Bassin du Rhone); Natural Environment Research Council [ceh010010] Funding Source: researchfish	Nottingham trent University (NTU); ZABR (Zone Atelier Bassin du Rhone); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	UK data collection was supported by a Nottingham trent University (NTU; http://www.ntu.ac.uk/) 'Scholarship Project for Undergraduate Researchers' award to RS and a NTU Biosciences Undergraduate Researcher award to RS. France data collection was financially supported by the ZABR (Zone Atelier Bassin du Rhone), a group managing Long Term Ecological Research sites on the Rhone River (http://www.graie,org/zabr). Ben Stephens also contributed to UK data collection (field sampling and sample processing), as recipient of the NTU Biosciences Undergraduate Researcher bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; BOU C, 1967, CR ACAD SCI D NAT, V265, P369; Boulton A, 2004, EXP APPL ACAROL, V34, P149, DOI 10.1023/B:APPA.0000044445.30246.b2; Boulton AJ, 1997, NEW ZEAL J MAR FRESH, V31, P609, DOI 10.1080/00288330.1997.9516793; Boulton AJ, 1998, ANNU REV ECOL SYST, V29, P59, DOI 10.1146/annurev.ecolsys.29.1.59; Boulton AJ, 2004, ARCH HYDROBIOL, V159, P327, DOI 10.1127/0003-9136/2004/0159-0327; BOULTON AJ, 1992, ARCH HYDROBIOL, V125, P37; Boulton AJ, 2003, ARCH HYDROBIOL, V156, P431, DOI 10.1127/0003-9136/2003/0156-0431; Boulton AJ, 2008, INVERTEBR SYST, V22, P103, DOI 10.1071/IS07024; Boulton AJ, 2014, AQUAT CONSERV, V24, P733, DOI 10.1002/aqc.2537; Bruno MC, 2012, ANN LIMNOL-INT J LIM, V48, P371, DOI 10.1051/limn/2012025; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Colwell R. K, 2013, ESTIMATES 9 10 USERS; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Corti R, 2013, HYDROBIOLOGIA, V717, P13, DOI 10.1007/s10750-013-1563-0; Datry T, 2007, FRESHWATER BIOL, V52, P1452, DOI 10.1111/j.1365-2427.2007.01775.x; Datry T, 2012, FRESHWATER BIOL, V57, P563, DOI 10.1111/j.1365-2427.2011.02725.x; Davy-Bowker J, 2006, HYDROBIOLOGIA, V563, P109, DOI 10.1007/s10750-005-1482-9; Deharveng L, 2009, FRESHWATER BIOL, V54, P709, DOI 10.1111/j.1365-2427.2008.01972.x; Dole-Olivier MJ, 2014, WATER RESOUR RES, V50, P9124, DOI 10.1002/2014WR015843; Dole-Olivier MJ, 2014, WATER RESOUR RES, V50, P453, DOI 10.1002/2012WR013207; Dole-Olivier MJ, 2011, MAR FRESHWATER RES, V62, P1281, DOI 10.1071/MF11084; European Environment Agency, 2015, EUR BIOD BIOG REG SE; Flint R. F., 1971, GLACIAL QUATERNARY G; Fraser BG, 1997, CAN J FISH AQUAT SCI, V54, P1135, DOI 10.1139/cjfas-54-5-1135; Gordon ND, 2004, STREAM HYDROLOGY INT; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griebler C, 2014, CURR OPIN BIOTECH, V27, P159, DOI 10.1016/j.copbio.2014.01.018; HELTSHE JF, 1983, BIOMETRICS, V39, P1, DOI 10.2307/2530802; Hering D, 2004, HYDROBIOLOGIA, V516, P1, DOI 10.1023/B:HYDR.0000025255.70009.a5; HULTIN L, 1971, OIKOS, V22, P329, DOI 10.2307/3543856; Hunt GW, 2000, CAN J FISH AQUAT SCI, V57, P1545, DOI 10.1139/cjfas-57-8-1545; International Organization for Standardization, 16772 FPREN ISO; Jacobi GZ, 1996, J N AM BENTHOL SOC, V15, P690, DOI 10.2307/1467816; Kibichii S, 2009, MAR FRESHWATER RES, V60, P83, DOI 10.1071/MF08172; Leigh C, 2013, ECOL INDIC, V32, P62, DOI 10.1016/j.ecolind.2013.03.006; Malard F, 1996, GROUND WATER MONIT R, V16, P103, DOI 10.1111/j.1745-6592.1996.tb00130.x; MARIDET L, 1992, Regulated Rivers Research and Management, V7, P45, DOI 10.1002/rrr.3450070107; Marmonier P, 2013, ECOL ENG, V57, P118, DOI 10.1016/j.ecoleng.2013.04.009; Marmonier P, 2010, FUND APPL LIMNOL, V176, P303, DOI 10.1127/1863-9135/2010/0176-0303; McDermott MJ, 2010, CAN J FISH AQUAT SCI, V67, P304, DOI 10.1139/F09-179; Moldovan OT, 2013, ECOL INDIC, V24, P412, DOI 10.1016/j.ecolind.2012.07.019; Mondy CP, 2012, ECOL INDIC, V18, P452, DOI 10.1016/j.ecolind.2011.12.013; Olsen DA, 2003, FRESHWATER BIOL, V48, P1363, DOI 10.1046/j.1365-2427.2003.01097.x; Orghidan T., 1959, ARCH HYDROBIOL, V55, P393; Pacioglu O, 2016, ENVIRON SCI POLLUT R, V23, P4729, DOI 10.1007/s11356-015-5703-0; PALMER MA, 1993, J N AM BENTHOL SOC, V12, P84, DOI 10.2307/1467689; Paril P, 2008, BIOLOGIA, V63, P574, DOI 10.2478/s11756-008-0087-y; Pospisil P., 1992, NATURAL HIST BIOSPEL, P107; Reyjol Y, 2014, SCI TOTAL ENVIRON, V497, P332, DOI 10.1016/j.scitotenv.2014.07.119; Robertson AL, 2010, FUND APPL LIMNOL, V176, P279, DOI 10.1127/1863-9135/2010/0176-0279; Robertson AL, 2009, Q J ENG GEOL HYDROGE, V42, P359, DOI 10.1144/1470-9236/08-046; Rode M., 2015, ECOSYSTEM SERVICES R, P57, DOI [DOI 10.1007/978-94-017-9846-4_4, 10.1007/979-94-017-9846-4]; Roy JW, 2014, WATER RESOUR RES, V50, P9120, DOI 10.1002/2014WR015571; Scarsbrook MR, 2002, NEW ZEAL J MAR FRESH, V36, DOI 10.1080/00288330.2002.9517099; Semprucci F, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4493-7; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; STOCKER ZSJ, 1972, LIMNOL OCEANOGR, V17, P136, DOI 10.4319/lo.1972.17.1.0136; Stubbington R, 2012, MAR FRESHWATER RES, V63, P293, DOI 10.1071/MF11196; Stubbington R, 2011, AQUAT SCI, V73, P499, DOI 10.1007/s00027-011-0203-x; Stubbington R, 2011, ECOHYDROLOGY, V4, P500, DOI 10.1002/eco.168; Tockner K, 2009, RIVERS OF EUROPE, 1ST EDITION, P1, DOI 10.1016/B978-0-12-369449-2.00001-1; Tomilson M, 2007, HYDROGEOL J, V15, P1317, DOI 10.1007/s10040-007-0211-z; Vander Vorste R, 2016, FRESHWATER BIOL, V61, P1276, DOI 10.1111/fwb.12658; WILLIAMS DD, 1981, HYDROBIOLOGIA, V83, P257, DOI 10.1007/BF00008275; WILLIAMS DD, 1974, FRESHWATER BIOL, V4, P233; Wolman M. G., 1954, T AM GEOPHYS UNION, V35, P951, DOI DOI 10.1029/TR035I006P00951; Wood PJ, 2010, FUND APPL LIMNOL, V176, P377, DOI 10.1127/1863-9135/2010/0176-0377; Zagmajster M, 2014, GLOBAL ECOL BIOGEOGR, V23, P1135, DOI 10.1111/geb.12200	70	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164372	10.1371/journal.pone.0164372	http://dx.doi.org/10.1371/journal.pone.0164372			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723819	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000385504100047
J	Zhang, BW; Zou, CH; Hu, QB				Zhang, Bowen; Zou, Chunhua; Hu, Qiongbo			Effects of Isaria fumosorosea on TYLCV (Tomato Yellow Leaf Curl Virus) Accumulation and Transmitting Capacity of Bemisia tabaci	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; ENTOMOPATHOGENIC FUNGUS; TRIALEURODES-VAPORARIORUM; METARHIZIUM-ANISOPLIAE; HEMIPTERA ALEYRODIDAE; PATHOGENICITY; SUSCEPTIBILITY; INSECTICIDES; INFECTION; TOXIN	Tomato yellow leaf curl virus (TYLCV) is transmitted by the Bemisia tabaci pest Middle East-Asia Minor 1 (MEAM1) in China. Isaria fumosorosea is a fungal pathogen of B. tabaci. However, the effects of fungal infection on TYLCV expression and transmission by MEAM1 are unclear. In this study, potted tomatoes containing second instar nymphs of MEAM1 were treated with I. fumosorosea IfB01 strain and the relationship between fungal infection in MEAM1 and its TYLCV transmission capacity was investigated. The results indicated that a significantly (p < 0.05) decreased incidence of transmission of TYLCV-infected plants (ITYPs) transmitted by second instar nymphs of MEAM1 infected with fungus. Further, we found a negative correlation between fungal conidial concentrations and eclosion rates of MEAM1, and a positive correlation between ITYPs and eclosion. In addition, when each plant was exposed to three adults treated with fungus, a significantly decreased transmission of TYLCV (TYTE) was observed in the infected group. However, the incidence of TYLCV-carrying MEAM1 adults (ITYAs) was not significantly different in the infected and control groups (p < 0.05). Nevertheless, a significant decrease in viral accumulation using TYLCV AC2 gene as a marker was observed in the fungus-infected MEAM1. In conclusion, the results suggested that I. fumosorosea infection decreases TYLCV accumulation in MEAM1 and subsequently reduces its transmission. Our study provides new insights into the relationship between host plant, plant virus, insect vector, and entomopathogenic fungus.	[Zhang, Bowen; Zou, Chunhua; Hu, Qiongbo] South China Agr Univ, Coll Agr, Key Lab Biopesticide Innovat & Applicat Guangdong, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Hu, QB (corresponding author), South China Agr Univ, Coll Agr, Key Lab Biopesticide Innovat & Applicat Guangdong, Guangzhou 510642, Guangdong, Peoples R China.	hqbscau@126.com			National Natural Science Foundation of China [31272057]; National Department of Public Benefit Research Foundation [201003065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department of Public Benefit Research Foundation	This research was supported by the National Natural Science Foundation of China (31272057) and the National Department of Public Benefit Research Foundation (201003065).	Ali S, 2011, BIOCONTROL SCI TECHN, V21, P1457, DOI 10.1080/09583157.2011.635784; Asaff A, 2005, APPL MICROBIOL BIOT, V68, P542, DOI 10.1007/s00253-005-1909-2; BER R, 1990, ARCH VIROL, V112, P169, DOI 10.1007/BF01323162; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; Lopez DC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103891, 10.1371/journal.pone.0093811]; Chan-Cupul W, 2010, AGROCIENCIA-MEXICO, V44, P587; Chen XR, 2014, INSECT SCI, V21, P31, DOI 10.1111/1744-7917.12028; Cuthbertson AGS, 2005, MYCOPATHOLOGIA, V160, P35, DOI 10.1007/s11046-005-6835-4; Czosnek H, 2012, J INTEGR AGR, V11, P225, DOI 10.1016/S2095-3119(12)60007-0; Fargues J, 2002, MYCOL RES, V106, P1066, DOI 10.1017/S0953756202006408; Faria M, 2001, CROP PROT, V20, P767, DOI 10.1016/S0261-2194(01)00110-7; Gong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096170; Huang Z, 2010, INSECT SCI, V17, P140, DOI 10.1111/j.1744-7917.2009.01299.x; Islam MT, 2011, AFR J MICROBIOL RES, V5, P3409; Li Chang-Bao, 2012, Yichuan, V34, P366, DOI 10.3724/SP.J.1005.2012.00366; Li M, 2011, INSECT SCI, V18, P40, DOI 10.1111/j.1744-7917.2010.01354.x; Lin Ming, 2013, China Vegetables, P20; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Liu BL, 2012, BIOTECHNOL ADV, V30, P1242, DOI 10.1016/j.biotechadv.2011.10.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez DC, 2015, BIOL CONTROL, V89, P53, DOI 10.1016/j.biocontrol.2015.03.010; Malsam O, 2002, BIOCONTROL SCI TECHN, V12, P337, DOI 10.1080/09583150220128121; NAVOT N, 1991, VIROLOGY, V185, P151, DOI 10.1016/0042-6822(91)90763-2; Pan HP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02230; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034817; Parsa S, 2013, JOVE-J VIS EXP, DOI 10.3791/50360; Pineda S, 2007, SOUTHWEST ENTOMOL, V32, P43, DOI 10.3958/0147-1724-32.1.43; Quesada-Moraga E, 2006, BIOL CONTROL, V36, P274, DOI 10.1016/j.biocontrol.2005.09.022; Rios-Velasco C, 2014, SOUTHWEST ENTOMOL, V39, P739, DOI 10.3958/059.039.0405; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Vidal S, 2015, CURR SCI INDIA, V109, P46; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Wang LD, 2007, PEST MANAG SCI, V63, P381, DOI 10.1002/ps.1359; Zhang WM, 2014, J ECON ENTOMOL, V107, P98, DOI 10.1603/EC13348; Zhu H, 2011, BIOCONTROL SCI TECHN, V21, P1471, DOI 10.1080/09583157.2011.636482; Zou CH, 2014, BIOCONTROL SCI TECHN, V24, P315, DOI 10.1080/09583157.2013.860427	36	6	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164356	10.1371/journal.pone.0164356	http://dx.doi.org/10.1371/journal.pone.0164356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716852	Green Submitted, Green Published, gold			2022-12-27	WOS:000385698100047
J	Jiang, JY; Ouyang, JH; Liu, HT				Jiang, Jingyang; Ouyang, Jinghui; Liu, Haitao			Can Learning a Foreign Language Foster Analytic Thinking?-Evidence from Chinese EFL Learners' Writings	PLOS ONE			English	Article							BILINGUAL-CHILDREN; EXECUTIVE CONTROL; WORDS; TASK; STYLES	Language is not only the representation of thinking, but also shapes thinking. Studies on bilinguals suggest that a foreign language plays an important and unconscious role in thinking. In this study, a software D Linguistic Inquiry and Word Count 2007 D was used to investigate whether the learning of English as a foreign language (EFL) can foster Chinese high school students' English analytic thinking (EAT) through the analysis of their English writings with our self-built corpus. It was found that: (1) learning English can foster Chinese learners' EAT. Chinese EFL learners' ability of making distinctions, degree of cognitive complexity and degree of thinking activeness have all improved along with the increase of their English proficiency and their age; (2) there exist differences in Chinese EFL learners' EAT and that of English native speakers, i.e. English native speakers are better in the ability of making distinctions and degree of thinking activeness. These findings suggest that the best EFL learners in high schools have gained native-like analytic thinking through six years' English learning and are able to switch their cognitive styles as needed.	[Jiang, Jingyang; Ouyang, Jinghui; Liu, Haitao] Zhejiang Univ, Dept Linguist, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Haitao] Zhejiang Univ, Ningbo Inst Technol, CN-315100 Ningbo, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Liu, HT (corresponding author), Zhejiang Univ, Dept Linguist, Hangzhou 310058, Zhejiang, Peoples R China.; Liu, HT (corresponding author), Zhejiang Univ, Ningbo Inst Technol, CN-315100 Ningbo, Zhejiang, Peoples R China.	lhtzju@yeah.net	Jiang, Jingyang/U-9103-2017; Liu, Haitao/HIR-1601-2022; Liu, Haitao/A-6053-2011	Jiang, Jingyang/0000-0003-3019-3918; Liu, Haitao/0000-0003-1724-4418	National Social Science Foundation of China [11, ZD188]	National Social Science Foundation of China	This work was supported by National Social Science Foundation of China (Grant No. 11&ZD188), URL: http://www.nponss.cn.gov.cn/.	Adesope OO, 2010, REV EDUC RES, V80, P207, DOI 10.3102/0034654310368803; Bialystok E, 1998, APPL PSYCHOLINGUIST, V19, P69, DOI 10.1017/S0142716400010584; Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E, 1999, CHILD DEV, V70, P636, DOI 10.1111/1467-8624.00046; Bialystok E., 2005, INT J BILINGUAL, V9, P103, DOI [10.1177/13670069050090010701, DOI 10.1177/13670069050090010701]; Bialystok E., 2005, HDB BILINGUALISM PSY, P417; Bialystok Ellen, 2009, Psychol Sci Public Interest, V10, P89, DOI 10.1177/1529100610387084; Bialystok E, 2009, BRAIN LANG, V109, P93, DOI 10.1016/j.bandl.2008.09.001; Bowers B, 1993, J Nurs Educ, V32, P107; Choi I, 2007, PERS SOC PSYCHOL B, V33, P691, DOI 10.1177/0146167206298568; Cumins J., 1976, WORKING PAPERS BILIN, V9, P1; Duncan S., 1979, NABE J, V4, P15; Elder L, 2007, THINKERS GUIDE ANAL, P26; Feist GregoryJ., 1991, CREATIVITY RES J, V4, P145, DOI [DOI 10.1080/10400419109534382, 10.1080/10400419109534382]; Foy JG, 2014, INT J BILINGUAL, V18, P717, DOI 10.1177/1367006912472263; Ghonsooly B., 2012, ENGLISH LANGUAGE TEA, V5, P161, DOI DOI 10.1111/lang.12009; Jiang J, 2015, FOREIGN LANGUAGE TEA, V38, P29; Lin MH, 2009, SUNWAY ACAD J, V6, P17; Ljungberg JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073029; Lonka K, 1995, EUR J PSYCHOL EDUC, V10, P351, DOI 10.1007/BF03172926; Luo L, 2013, PSYCHOL AGING, V28, P28, DOI 10.1037/a0030875; Ma HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106468; Munro DJ, 1985, INDIVIDUALISM HOLISM, P1; Nakamura H., 1964, WAYS THINKING E PEOP; Newman ML, 2003, PERS SOC PSYCHOL B, V29, P665, DOI 10.1177/0146167203029005010; Nisbett R.E, 2003, GEOGRAPHY THOUGHT AS; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Niu B., 1997, J SICHUAN INT STUDIE, P55; Pasupathi M, 2007, MEMORY, V15, P258, DOI 10.1080/09658210701256456; Peng K, 2009, PSYCHOL CROSS CULTUR; Pennebaker, 2011, SECRET LIFE PRONOUNS, DOI 10.1387/gogoa.17916; Pennebaker J. W., 2007, DEV PSYCHOMETRIC PRO; Pennebaker JW, 2003, J PERS SOC PSYCHOL, V85, P291, DOI 10.1037/0022-3514.85.2.291; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Pennebaker JW, 1999, J CLIN PSYCHOL, V55, P1243, DOI 10.1002/(SICI)1097-4679(199910)55:10<1243::AID-JCLP6>3.0.CO;2-N; Pennebaker JW, 2007, OPERATORS MANUAL LIN; RAMIREZ M, 1974, INTERAM J PSYCHOL, V8, P93; RICCIARDELLI LA, 1992, J PSYCHOLINGUIST RES, V21, P301, DOI 10.1007/BF01067515; Ringbom H, 1998, LANG COMPUT, P191; Sanders Ted, 2005, COHERENCE CAUSALITY; Simonton DK, 2008, INTRO BILINGUALISM P, P147; Sullivan MD, 2014, BRAIN LANG, V139, P84, DOI 10.1016/j.bandl.2014.10.004; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Wang L, 2007, FOREIGN LANGUAGE TEA, V39, P110; Whorf Benjamin Lee, 2012, LANGUAGE THOUGHT REA, V2nd, DOI DOI 10.2307/411163; [吴嵩 Wu Song], 2012, [心理科学进展, Advances in Psychological Science], V20, P457	46	3	3	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164448	10.1371/journal.pone.0164448	http://dx.doi.org/10.1371/journal.pone.0164448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DZ0DG	27741270	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000034
J	Lee, YJ; Kim, JH; Park, JJ; Youn, YH; Park, H; Kim, JW; Choi, SH; Noh, SH				Lee, Yoo Jin; Kim, Jie-Hyun; Park, Jae Jun; Youn, Young Hoon; Park, Hyojin; Kim, Jong Won; Choi, Seung Ho; Noh, Sung Hoon			The Implications of Endoscopic Ulcer in Early Gastric Cancer: Can We Predict Clinical Behaviors from Endoscopy?	PLOS ONE			English	Article								Background The presence of ulcer in early gastric cancer (EGC) is important for the feasibility of endoscopic resection, only a few studies have examined the clinicopathological implications of endoscopic ulcer in EGC. Objectives To determine the role of endoscopic ulcer as a predictor of clinical behaviors in EGC. Methods Data of 3,270 patients with EGC who underwent surgery between January 2005 and December 2012 were reviewed. Clinicopathological characteristics were analyzed in relation to the presence and stage of ulcer in EGC. Based on endoscopic findings, the stage of ulcer was categorized as active, healing, or scar. Logistic regression analysis was performed to analyze factors associated with lymph node metastasis (LNM). Results 2,343 (71.7%) patients had endoscopic findings of ulceration in EGC. Submucosal (SM) invasion, LNM, lymphovascular invasion (LVI), perineural invasion, and undifferentiated-type histology were significantly higher in ulcerative than non-ulcerative EGC. Comparison across different stages of ulcer revealed that SM invasion, LNM, and LVI were significantly associated with the active stage, and that these features exhibited significant stage-based differences, being most common at the active stage, and least common at the scar stage. The presence of endoscopic ulcer and active status of the ulcer were identified as independent risk factors for LNM. Conclusions Ulcerative EGC detected by endoscopy exhibited more aggressive behaviors than nonulcerative EGC. Additionally, the endoscopic stage of ulcer may predict the clinicopathological behaviors of EGC. Therefore, the appearance of ulcers should be carefully evaluated to determine an adequate treatment strategy for EGC.	[Lee, Yoo Jin; Kim, Jie-Hyun; Park, Jae Jun; Youn, Young Hoon; Park, Hyojin] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Jong Won; Choi, Seung Ho] Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea; [Noh, Sung Hoon] Yonsei Univ, Dept Surg, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, JH (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.	doctorlyj@naver.com; otilia94@yuhs.ac	Kim, Jie-Hyun/Q-9061-2019; Lee, Yoojin/AAB-9799-2022	Kim, Jie-Hyun/0000-0002-9198-3326; Lee, Yoojin/0000-0003-1799-0146; Noh, Sung Hoon/0000-0003-4386-6886; Youn, Young Hoon/0000-0002-0071-229X; park, hyojin/0000-0003-4814-8330; Choi, Seung Ho/0000-0002-9872-3594	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A1042417]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work received approval by the Yonsei University College of Medicine Institutional Review Board on January 2013. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1042417).	Choi JH, 2015, GASTROINTEST ENDOSC, V82, P299, DOI 10.1016/j.gie.2015.01.019; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Horiuchi Y, 2015, GASTRIC CANC OFFICIA; Im JP, 2009, SURG ENDOSC, V23, P2509, DOI 10.1007/s00464-009-0434-2; JAPANESE G, 2011, GASTRIC CANCER, V14, P113, DOI DOI 10.1007/S10120-011-0042-4]; Jung DH, 2013, SURG ENDOSC, V27, P3690, DOI 10.1007/s00464-013-2947-y; Kang HJ, 2010, GASTROINTEST ENDOSC, V72, P508, DOI 10.1016/j.gie.2010.03.1077; Kim YY, 2013, SURG ENDOSC, V27, P4656, DOI 10.1007/s00464-013-3099-9; Lee HL, 2011, WORLD J GASTROENTERO, V17, P2597, DOI 10.3748/wjg.v17.i21.2597; Lee JH, 2014, EJSO-EUR J SURG ONC, V40, P1771, DOI 10.1016/j.ejso.2014.07.042; Lee JI, 2012, J GASTROEN HEPATOL, V27, P1718, DOI 10.1111/j.1440-1746.2012.07233.x; Nakajima Takeshi, 2006, Gastric Cancer, V9, P93, DOI 10.1007/s10120-006-0372-9; Ohnita K, 2009, SURG ENDOSC, V23, P2713, DOI 10.1007/s00464-009-0473-8; Okada K, 2011, SURG ENDOSC, V25, P841, DOI 10.1007/s00464-010-1279-4; SAKITA T, 1971, GASTROENTEROLOGY, V60, P835; Sakita T, 1971, ENDOSCOPIC DIAGNOSIS; Sekiguchi M, 2015, J GASTROENTEROL, V50, P424, DOI 10.1007/s00535-014-0991-6; SHIMIZU S, 1995, ENDOSCOPY, V27, P27, DOI 10.1055/s-2007-1005628; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Yeomans ND, 2008, ALIMENT PHARM THERAP, V27, P465, DOI 10.1111/j.1365-2036.2008.03610.x	22	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164339	10.1371/journal.pone.0164339	http://dx.doi.org/10.1371/journal.pone.0164339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741275	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000026
J	Simonsen, M; Fregnani, JHTG; Resende, JCP; Antoniazzi, M; Longatto, A; Scapulatempo-Neto, C				Simonsen, Marcelo; Tavares Guerreiro Fregnani, Jose Humberto; Possati Resende, Julio Cesar; Antoniazzi, Marcio; Longatto-Filho, Adhemar; Scapulatempo-Neto, Cristovam			Comparison of the Cervex-Brush (R) Combi and the Cytobrush plus Ayres Spatula Combination for Cervical Sampling in Liquid-Based Cytology	PLOS ONE			English	Article							ENDOCERVICAL BRUSH; PAPANICOLAOU TEST; CELL COLLECTION; CERVEX-BRUSH; PAP TEST; CANCER; ACCURACY; COLPOSCOPY; SMEARS; DEVICES	Objectives To compare the performance of two cervical collection devices (Cytobrush+Ayres spatula and Cervex-Brush (R) Combi) for cellular sampling, transformation zone representation and accuracy in diagnosing cervical intraepithelial neoplasia (CIN)2+. Methods Cervical samples were collected from patients referred to the colposcopy unit of the Barretos Cancer Hospital between September 2013 and October 2014 using one of the two sampling devices. Additionally, colposcopy was performed with or without cervical biopsy and/ or endocervical curettage. Results Biopsy was performed in 670 of the 1,235 patients submitted to colposcopy (54.2%). The Cervex-Brush (R) Combi was more effective than the Cytobrush with respect to endocervical cells sampling (82.7% versus 74.6%; p = 0.001). Sensitivity was also higher with the Cervex-Brush (R) Combi (48.6% versus 33.9%; p = 0.023) for predicting CIN2+ when high-grade squamous intraepithelial lesions were detected at cytology. Conclusions Cervex-Brush (R) Combi was more effective than Cytobrush+Ayres Spatula for endocervical cells sampling and also had a slightly higher accuracy in predicting histologically CIN2+ lesions in patients with diagnosis of HSIL in cytology.	[Simonsen, Marcelo] Santa Casa Sao Paulo, Dept Gynecol, Sao Paulo, Brazil; [Tavares Guerreiro Fregnani, Jose Humberto] Barretos Canc Hosp, Res & Teaching Inst, Barretos, Brazil; [Possati Resende, Julio Cesar; Antoniazzi, Marcio] Barretos Canc Hosp, Canc Prevent Dept, Barretos, Brazil; [Longatto-Filho, Adhemar; Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Ctr Mol Oncol, Barretos, SP, Brazil; [Longatto-Filho, Adhemar] Univ Sao Paulo, Lab Med Invest LIM 14, Sch Med, Sao Paulo, Brazil; [Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Dept Pathol, Barretos, SP, Brazil	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade de Sao Paulo; Hospital de Cancer de Barretos	Simonsen, M (corresponding author), Santa Casa Sao Paulo, Dept Gynecol, Sao Paulo, Brazil.	msimonsen@ig.com.br	Fregnani, José H/H-4238-2012; longatto-filho, adhemar/D-7039-2013; Simonsen, Marcelo/J-4817-2019; Longatto-Filho, Adhemar/N-3397-2019; Possati-Resende, Julio Cesar/C-8575-2016	Fregnani, José H/0000-0002-5235-6469; longatto-filho, adhemar/0000-0002-5779-9752; Longatto-Filho, Adhemar/0000-0002-5779-9752; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Possati-Resende, Julio Cesar/0000-0002-7869-3885; Simonsen, Marcelo/0000-0002-9022-415X				Adad S J, 1999, Sao Paulo Med J, V117, P81; ALLINGHAM JD, 1985, J FAM PRACTICE, V20, P185; [Anonymous], 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001036; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Boicea A, 2012, ROM J MORPHOL EMBRYO, V53, P735; BUNTINX F, 1993, BRIT J GEN PRACT, V43, P194; CANNON JM, 1993, OBSTET GYNECOL, V82, P569; Davey E, 2006, LANCET, V367, P122, DOI 10.1016/S0140-6736(06)67961-0; Davis-Devine S, 2009, CYTOJOURNAL, V6, DOI 10.4103/1742-6413.45495; Depuydt CE, 2006, CYTOPATHOLOGY, V17, P374, DOI 10.1111/j.1365-2303.2006.00386.x; DUGUID HLD, 1985, LANCET, V2, P1053; GERMAIN M, 1994, OBSTET GYNECOL, V84, P168; Ghosh I, 2014, AUST NZ J OBSTET GYN, V54, P570, DOI 10.1111/ajo.12282; HARRISON DD, 1993, J REPROD MED, V38, P285; Hoda RS, 2013, DIAGN CYTOPATHOL, V41, P257, DOI 10.1002/dc.22842; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; INCA, 2014, PREC CANC UT; Johnson T, 2000, DIAGN CYTOPATHOL, V22, P86, DOI 10.1002/(SICI)1097-0339(200002)22:2<86::AID-DC5>3.0.CO;2-4; KAVAK ZN, 1995, AUST NZ J OBSTET GYN, V35, P446, DOI 10.1111/j.1479-828X.1995.tb02165.x; Kohlberger PD, 1999, ACTA CYTOL, V43, P1023, DOI 10.1159/000331348; Kothari A, 2006, INT J GYNECOL CANCER, V16, P1579, DOI 10.1111/j.1525-1438.2006.00629.x; Kuramoto H, 2013, ACTA CYTOL, V57, P153, DOI 10.1159/000345798; Lazcano-Ponce EC, 1998, CANCER CAUSE CONTROL, V9, P241, DOI 10.1023/A:1008875818033; Lee KR, 1997, OBSTET GYNECOL, V90, P278, DOI 10.1016/S0029-7844(97)00228-7; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Palma PD, 2008, AM J CLIN PATHOL, V129, P75, DOI 10.1309/EWYGWFRRM8798U5P; PARKIN DM, 1985, BRIT J OBSTET GYNAEC, V92, P150, DOI 10.1111/j.1471-0528.1985.tb01067.x; Repse-Fokter A, 2011, INT J GYNECOL OBSTET, V112, P65, DOI 10.1016/j.ijgo.2010.08.008; Risberg B, 1997, J REPROD MED, V42, P405; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sankaranarayanan R, 2004, J MED SCREEN, V11, P77, DOI 10.1258/096914104774061056; Scapulatempo C, 2013, ACTA CYTOL, V57, P489, DOI 10.1159/000351789; Solomon D, 2005, SISTEMA BETHESDA CIT; SZAREWSKI A, 1993, ACTA CYTOL, V37, P457; Underwood M, 2012, BJOG-INT J OBSTET GY, V119, P1293, DOI 10.1111/j.1471-0528.2012.03444.x	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164077	10.1371/journal.pone.0164077	http://dx.doi.org/10.1371/journal.pone.0164077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741238	Green Submitted, gold, Green Published			2022-12-27	WOS:000385507000016
J	Forgacs, A; Jonsson, HP; Dahlbom, M; Daver, F; DiFranco, MD; Opposits, G; Krizsan, AK; Garai, I; Czernin, J; Varga, J; Tron, L; Balkay, L				Forgacs, Attila; Jonsson, Hermann Pall; Dahlbom, Magnus; Daver, Freddie; DiFranco, Matthew D.; Opposits, Gabor; Krizsan, Aron K.; Garai, Ildiko; Czernin, Johannes; Varga, Jozsef; Tron, Lajos; Balkay, Laszlo			A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TUMOR TEXTURE ANALYSIS; CELL LUNG-CANCER; STANDARDIZED UPTAKE VALUES; FDG-PET; VOLUME MEASUREMENTS; MALIGNANT-TUMORS; FEATURES; CARCINOMA; REPRODUCIBILITY	Textural analysis might give new insights into the quantitative characterization of metabolically active tumors. More than thirty textural parameters have been investigated in former F18-FDG studies already. The purpose of the paper is to declare basic requirements as a selection strategy to identify the most appropriate heterogeneity parameters to measure textural features. Our predefined requirements were: a reliable heterogeneity parameter has to be volume independent, reproducible, and suitable for expressing quantitatively the degree of heterogeneity. Based on this criteria, we compared various suggested measures of homogeneity. A homogeneous cylindrical phantom was measured on three different PET/CT scanners using the commonly used protocol. In addition, a custom-made inhomogeneous tumor insert placed into the NEMA image quality phantom was imaged with a set of acquisition times and several different reconstruction protocols. PET data of 65 patients with proven lung lesions were retrospectively analyzed as well. Four heterogeneity parameters out of 27 were found as the most attractive ones to characterize the textural properties of metabolically active tumors in FDG PET images. These four parameters included Entropy, Contrast, Correlation, and Coefficient of Variation. These parameters were independent of delineated tumor volume (bigger than 25-30 ml), provided reproducible values (relative standard deviation<10%), and showed high sensitivity to changes in heterogeneity. Phantom measurements are a viable way to test the reliability of heterogeneity parameters that would be of interest to nuclear imaging clinicians.	[Forgacs, Attila; Garai, Ildiko] Scanomed Nucl Med Ctr, Debrecen, Hungary; [Forgacs, Attila; Jonsson, Hermann Pall; Opposits, Gabor; Krizsan, Aron K.; Garai, Ildiko; Varga, Jozsef; Tron, Lajos; Balkay, Laszlo] Univ Debrecen, Dept Nucl Med, Fac Med, Debrecen, Hungary; [Dahlbom, Magnus; Czernin, Johannes] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Ahmanson Biol Imaging Ctr, Los Angeles, CA 90095 USA; [Daver, Freddie] Univ Southern Calif, Alfred Mann Inst Biomed Engn, Los Angeles, CA USA; [DiFranco, Matthew D.] Med Univ Vienna, Quantitat Imaging & Med Phys, Vienna, Austria	Scanomed; University of Debrecen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; Medical University of Vienna	Forgacs, A (corresponding author), Scanomed Nucl Med Ctr, Debrecen, Hungary.; Forgacs, A (corresponding author), Univ Debrecen, Dept Nucl Med, Fac Med, Debrecen, Hungary.	attilaforgacsem@gmail.com	Opposits, Gabor/AAO-2526-2020; Varga, József/B-8314-2008; Opposits, Gábor/AAD-6265-2020	Opposits, Gabor/0000-0002-0065-224X; Varga, József/0000-0001-5797-9625; 				Aerts HJWL, 2014, IMAGING USING QUANTI; Alic L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110300; [Anonymous], 2014, J NUCL MED, V55; Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Brooks FJ, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-294; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Brooks FJ, 2013, EUR J NUCL MED MOL I, V40, P1292, DOI 10.1007/s00259-013-2430-y; Brooks FJ, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-7; Brooks FJ, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-69; Bundschuh RA, 2014, J NUCL MED, V55, P891, DOI 10.2967/jnumed.113.127340; Buvat I, 2015, J NUCL MED, V56, P1642, DOI 10.2967/jnumed.115.163469; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Dong XZ, 2013, NUCL MED COMMUN, V34, P40, DOI 10.1097/MNM.0b013e32835ae50c; Forgacs A, 2013, EUR J NUCL MED MOL I, V40, pS407; Frings V, 2010, J NUCL MED, V51, P1870, DOI 10.2967/jnumed.110.077255; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Hatt M, 2016, EUR J NUCL MED MOL I; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Hatt M, 2010, J NUCL MED, V51, P1368, DOI 10.2967/jnumed.110.078501; Kinahan PE, 2010, SEMIN ULTRASOUND CT, V31, P496, DOI 10.1053/j.sult.2010.10.001; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Miwa K, 2014, EUR J RADIOL, V83, P715, DOI 10.1016/j.ejrad.2013.12.020; Nahmias C, 2008, J NUCL MED, V49, P1804, DOI 10.2967/jnumed.108.054239; Nakajima EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102452; Nyflot MJ, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.041002; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Rajendran JG, 2006, CLIN CANCER RES, V12, P5435, DOI 10.1158/1078-0432.CCR-05-1773; Soussan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094017; Tixier F, 2014, J NUCL MED, V55, P1235, DOI 10.2967/jnumed.113.133389; Tixier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099567; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Weber WA, 1999, J NUCL MED, V40, P1771; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Yang F, 2013, EUR J NUCL MED MOL I, V40, P716, DOI 10.1007/s00259-012-2332-4	40	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164113	10.1371/journal.pone.0164113	http://dx.doi.org/10.1371/journal.pone.0164113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736888	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800040
J	Gilfillan, C; Naidu, P; Gunawan, F; Hassan, F; Tian, P; Elwood, N				Gilfillan, Christopher; Naidu, Pratyusha; Gunawan, Florence; Hassan, Fadwa; Tian, Pei; Elwood, Ngaire			Leukocyte Telomere Length in the Neonatal Offspring of Mothers with Gestational and Pre-Gestational Diabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; PATERNAL AGE; MELLITUS; SHORTER; WOMEN; ASSOCIATION; PREGNANCIES; ADULTHOOD	Aims Telomeres undergo shortening with cell division, accelerated by increased oxidative stress. We aimed to demonstrate shortened telomeres in the offspring of mothers who have diabetes as a consequence of exposure to increased oxidative stress during intrauterine development. Methods We examined the level of glycaemia (glucose, HbA1c, fructosamine), oxidative stress (lipid peroxidation) and the levels of antioxidant enzymes (Superoxide dismutase (SOD) and Selenium dependent glutathione peroxidase) and correlate these findings with mean telomere length (TL) in maternal and foetal blood in groups of pregnant women with pre-gestational diabetes (PGD), gestational diabetes (GD) and a euglycaemic control group. Results Foetal and maternal glucose, maternal HbA1c, and foetal insulin and C-peptide were higher in the PGD group with the GD group being intermediate. Markers of oxidative stress did not vary between groups with the exception of foetal SOD activity that was highest in the GD group. There were no detectable differences in maternal or foetal TL between study groups. An exploratory analysis looking at correlations between glycaemic and oxidative stress parameters and TL revealed a negative correlation between maternal and foetal glucose and TL across the whole study population. This relationship held for the short-term marker of glycaemic control, fructosamine. Conclusions We were unable to show significant telomere shortening in the offspring of mothers with PGD or GD. Exploratory analysis revealed a relationship between foetal TL and short-term glycaemia particularly in PGD. It is possible that increased telomerase activity can compensate for long-term increased oxidative stress but not for short-term dysglycaemia.	[Gilfillan, Christopher; Naidu, Pratyusha; Gunawan, Florence] Monash Univ, Eastern Hlth Clin Sch, Box Hill, Vic, Australia; [Hassan, Fadwa] Peninsula Hlth, Frankston, Vic, Australia; [Tian, Pei; Elwood, Ngaire] Murdoch Childrens Res Inst, Cord Blood Stem Cell Res, Parkville, Vic, Australia	Monash University; Murdoch Children's Research Institute	Gilfillan, C (corresponding author), Monash Univ, Eastern Hlth Clin Sch, Box Hill, Vic, Australia.	chris.gilfillan@easternhealth.org.au	Gilfillan, Christopher/O-4310-2019	Gilfillan, Christopher/0000-0002-8193-8994; Elwood, Ngaire/0000-0002-4740-2416	internal funds arising from private practice billings of the principle investigator held within the organization (Peninsula Health) for the purposes of education and research	internal funds arising from private practice billings of the principle investigator held within the organization (Peninsula Health) for the purposes of education and research	This project was funded by internal funds arising from private practice billings of the principle investigator held within the organization (Peninsula Health) for the purposes of education and research. This research received no specific grant from any funding agency in the public, commercial or not for-profit sectors.	Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Biron-Shental T, 2015, PLACENTA, V36, P199, DOI 10.1016/j.placenta.2014.11.011; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cross JA, 2010, DIABETIC MED, V27, P1264, DOI 10.1111/j.1464-5491.2010.03099.x; Cross JA, 2009, DIABETOLOGIA, V52, P226, DOI 10.1007/s00125-008-1207-5; De Meyer T, 2007, HUM MOL GENET, V16, P3097, DOI 10.1093/hmg/ddm271; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Guo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017858; Hashimoto K, 2015, WORLD J DIABETES, V6, P1045, DOI 10.4239/wjd.v6.i8.1045; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Leach L, 2011, MICROCIRCULATION, V18, P253, DOI 10.1111/j.1549-8719.2011.00097.x; Ma D, 2013, J ENDOCRINOL INVEST, V36, P1032, DOI 10.3275/9036; Makino N, 2010, EXP CLIN CARDIOL, V15, pE128; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P1345, DOI 10.1038/ijo.2010.49; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Orhan Hilmi, 2003, Archives of Gynecology and Obstetrics, V267, P189; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Willeit P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112483; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086161; Yilmaz G, 2007, J CLIN LAB ANAL, V21, P260, DOI 10.1002/jcla.20181; Zee RYL, 2011, ATHEROSCLEROSIS, V218, P144, DOI 10.1016/j.atherosclerosis.2011.05.013; Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012; Zhao JY, 2014, DIABETES, V63, P354, DOI 10.2337/db13-0744; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385	30	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							0163824	10.1371/journal.pone.0163824	http://dx.doi.org/10.1371/journal.pone.0163824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736899	Green Published, gold			2022-12-27	WOS:000385505800026
J	Kobayashi, H; Brozman, M; Kyselova, K; Viszlayova, D; Morimoto, T; Roubec, M; Skoloudik, D; Petrovicova, A; Juskanic, D; Strauss, J; Halaj, M; Kurray, P; Hranai, M; Harada, KH; Inoue, S; Yoshida, Y; Habu, T; Herzig, R; Youssefian, S; Koizumi, A				Kobayashi, Hatasu; Brozman, Miroslav; Kyselova, Katerina; Viszlayova, Dasa; Morimoto, Takaaki; Roubec, Martin; Skoloudik, David; Petrovicova, Andrea; Juskanic, Dominik; Strauss, Jozef; Halaj, Marian; Kurray, Peter; Hranai, Marian; Harada, Kouji H.; Inoue, Sumiko; Yoshida, Yukako; Habu, Toshiyuki; Herzig, Roman; Youssefian, Shohab; Koizumi, Akio			RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; GENE	RNF213/Mysterin has been identified as a susceptibility gene for moyamoya disease, a cerebrovascular disease characterized by occlusive lesions in the circle of Willis. The p. R4810K (rs112735431) variant is a founder polymorphism that is strongly associated with moyamoya disease in East Asia. Many non-p. R4810K rare variants of RNF213 have been identified in white moyamoya disease patients, although the ethnic mutations have not been investigated in this population. In the present study, we screened for RNF213 variants in 19 Slovakian and Czech moyamoya disease patients. A total of 69 RNF213 coding exons were directly sequenced in 18 probands and one relative who suffered from moyamoya disease in Slovakia and the Czech Republic. We previously reported one proband harboring RNF213 p.D4013N. Results from the present study identified four rare variants other than p.D4013N (p.R4019C, p.E4042K, p.V4146A, and p.W4677L) in four of the patients. P.V4146A was determined to be a novel de novo mutation, and p.R4019C and p.E4042K were identified as double mutations inherited on the same allele. P.W4677L, found in two moyamoya disease patients and an unaffected subject in the same pedigree, was a rare single nucleotide polymorphism. Functional analysis showed that RNF213 p. D4013N, p.R4019C and p.V4146A-transfected human umbilical vein endothelial cells displayed significant lowered migration, and RNF213 p.V4146A significantly reduced tube formation, indicating that these are disease-causing mutations. Results from the present study identified RNF213 rare variants in 22.2% (4/18 probands) of Slovakian and Czech moya-moya disease patients, confirming that RNF213 may also be a major causative gene in a relative large population of white patients.	[Kobayashi, Hatasu; Morimoto, Takaaki; Harada, Kouji H.; Inoue, Sumiko; Koizumi, Akio] Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto 6068501, Japan; [Brozman, Miroslav; Viszlayova, Dasa; Petrovicova, Andrea] Constantine Philosopher Univ, Fac Hosp Nitra, Dept Neurol, Nitra 94901, Slovakia; [Kyselova, Katerina] Ctr Med Genet, Frydek Mystek 37008, Czech Republic; [Morimoto, Takaaki] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan; [Roubec, Martin] Univ Ostrava, Fac Med, Comprehens Stroke Ctr, Dept Neurol, Ostrava 70852, Czech Republic; [Roubec, Martin] Univ Hosp, Ostrava 70852, Czech Republic; [Skoloudik, David] Palacky Univ, Fac Hlth Sci, Ctr Res & Sci, Dept Nursing, Olomouc 77515, Czech Republic; [Juskanic, Dominik; Strauss, Jozef; Halaj, Marian] Constantine Philosopher Univ, Fac Hosp Nitra, Dept Radiol, Nitra 94901, Slovakia; [Kurray, Peter; Hranai, Marian] Constantine Philosopher Univ, Fac Hosp Nitra, Cardio Ctr, Nitra 94901, Slovakia; [Yoshida, Yukako; Habu, Toshiyuki] Mukogawa Womens Univ, Dept Food Sci & Nutr, Lab Nutr Sci, Nishinomiya, Hyogo 6638121, Japan; [Herzig, Roman] Charles Univ Prague, Comprehens Stroke Ctr, Dept Neurol, Hradec Kralove 50038, Czech Republic; [Herzig, Roman] Univ Hosp, Hradec Kralove 50038, Czech Republic; [Youssefian, Shohab] Kyoto Univ, Grad Sch Med, Lab Mol Biosci, Kyoto 6068501, Japan	Kyoto University; Constantine the Philosopher University in Nitra; Kyoto University; University of Ostrava; University Hospital Ostrava; Palacky University Olomouc; Constantine the Philosopher University in Nitra; Constantine the Philosopher University in Nitra; Mukogawa Women's University; Charles University Prague; University Hospital Hradec Kralove; Kyoto University	Koizumi, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hlth & Environm Sci, Kyoto 6068501, Japan.	koizumi.akio.5v@kyoto-u.ac.jp	Habu, Toshiyuki/ABC-6644-2021; Herzig, Roman/O-8901-2017; Kobayashi, Hatasu/R-8012-2019	Habu, Toshiyuki/0000-0003-4131-3938; Herzig, Roman/0000-0001-7238-7724; Kobayashi, Hatasu/0000-0002-5664-6869	Japan Society for the Promotion of Science KAKENHI [25253047, 15K19243]; Research Committee on Spontaneous Occlusion of the circle of Willis of the Ministry of Health, Labour and Welfare of Japan [H26-Nanjito-Ippan-078]; Grants-in-Aid for Scientific Research [15K07044] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Committee on Spontaneous Occlusion of the circle of Willis of the Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by The Japan Society for the Promotion of Science KAKENHI (Grants-In-Aid for Scientific Research (A): 25253047 to AK and for Encouragement of Young Scientists (B): 15K19243 to HK) (http://www.jsps.go.jp/english/) and by a grant from the Research Committee on Spontaneous Occlusion of the circle of Willis of the Ministry of Health, Labour and Welfare of Japan (No. H26-Nanjito-Ippan-078) (http://www.mhlw.go.jp/english/policy/other/research-projects/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cecchi AC, 2014, STROKE, V45, P3200, DOI 10.1161/STROKEAHA.114.006244; Harel T, 2015, AM J MED GENET A, V167, P2742, DOI 10.1002/ajmg.a.37230; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V438, P13, DOI 10.1016/j.bbrc.2013.07.004; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kobayashi H, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002146; Koizumi A, 2016, ENVIRON HEALTH PREV, V21, P55, DOI 10.1007/s12199-015-0498-7; KUDO T, 1968, NEUROLOGY, V18, P485, DOI 10.1212/WNL.18.5.485; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Morito D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04442; Murohara T, 1999, ARTERIOSCL THROM VAS, V19, P1156, DOI 10.1161/01.ATV.19.5.1156; Ohkubo K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13191; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Takeuchi K., 1957, BRAIN NERVE, V9, P37	14	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164759	10.1371/journal.pone.0164759	http://dx.doi.org/10.1371/journal.pone.0164759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736983	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800126
J	Strojny, B; Grodzik, M; Sawosz, E; Winnicka, A; Kurantowicz, N; Jaworski, S; Kutwin, M; Urbanska, K; Hotowy, A; Wierzbicki, M; Chwalibog, A				Strojny, Barbara; Grodzik, Marta; Sawosz, Ewa; Winnicka, Anna; Kurantowicz, Natalia; Jaworski, Slawomir; Kutwin, Marta; Urbanska, Kaja; Hotowy, Anna; Wierzbicki, Mateusz; Chwalibog, Andre			Diamond Nanoparticles Modify Curcumin Activity: In Vitro Studies on Cancer and Normal Cells and In Ovo Studies on Chicken Embryo Model	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HEPATIC STELLATE CELLS; GROWTH-FACTOR; CARBON NANOPARTICLES; NANODIAMONDS; TOXICITY; BIODISTRIBUTION; EXPRESSION; BIOCOMPATIBILITY; NANOFORMULATIONS	Curcumin has been studied broadly for its wide range of biological activities, including anticancer properties. The major problem with curcumin is its poor bioavailability, which can be improved by the addition of carriers, such as diamond nanoparticles (DN). They are carbon allotropes, and are therefore biocompatible and easily taken up by cells. DN are non-toxic and have antiangiogenic properties with potential applications in cancer therapy. Their large surface makes them promising compounds in a drug delivery system for bioactive agents, as DN create bio-complexes in a fast and simple process of self-organisation. We investigated the cytotoxicity of such bio-complexes against liver cancer cells and normal fibroblasts, revealing that conjugation of curcumin with DN significantly improves its activity. The experiment performed in a chicken embryo model demonstrated that neither curcumin nor DN nor bio-complexes affect embryo development, even though DN can form deposits in tissues. Preliminary results confirmed the applicability of DN as an efficient carrier of curcumin, which improves its performance against cancer cells in vitro, yet is not toxic to an organism, which makes the bio-complex a promising anticancer agent.	[Strojny, Barbara; Grodzik, Marta; Sawosz, Ewa; Kurantowicz, Natalia; Jaworski, Slawomir; Kutwin, Marta; Hotowy, Anna; Wierzbicki, Mateusz] Warsaw Univ Life Sci, Fac Anim Sci, Div Nanobiotechnol, PL-02786 Warsaw, Poland; [Winnicka, Anna] Warsaw Univ Life Sci, Fac Vet Med, Div Histol & Embryol, PL-02786 Warsaw, Poland; [Urbanska, Kaja] Warsaw Univ Life Sci, Fac Vet Med, Dept Pathol & Vet Diagnost, PL-02786 Warsaw, Poland; [Chwalibog, Andre] Univ Copenhagen, Div Nanonutr, Fac Hlth & Med Sci, DK-1870 Frederiksberg, Denmark	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Warsaw University of Life Sciences; University of Copenhagen	Chwalibog, A (corresponding author), Univ Copenhagen, Div Nanonutr, Fac Hlth & Med Sci, Groennegaardsvej 3, DK-1870 Frederiksberg, Denmark.	ach@sund.ku.dk	Grodzik, Marta/AAO-4319-2021; Jaworski, Sławomir/AAI-2313-2020; Wierzbicki, Mateusz/ABF-5482-2020; Grodzik, Marta/J-9404-2015	Grodzik, Marta/0000-0001-5359-1885; Jaworski, Sławomir/0000-0002-4619-941X; Wierzbicki, Mateusz/0000-0003-3623-8929; Grodzik, Marta/0000-0001-5359-1885; Kutwin, Marta/0000-0001-7059-7875; Kurantowicz, Natalia/0000-0002-7036-1325; Hotowy, Anna/0000-0002-0596-1201; Urbanska, Kaja/0000-0001-8600-4130; Sawosz Chwalibog, Ewa/0000-0002-0016-4721; Winnicka, Anna/0000-0001-9918-3430; Strojny, Barbara/0000-0002-2642-5491; Chwalibog, Andre/0000-0001-8150-2392	National Science Centre (Poland) [NN311 540840]	National Science Centre (Poland)	This study was supported by grant NN311 540840 from the National Science Centre (Poland) (MG). The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Chen C, 2010, HAZARDOUS EFFECTS CU, V0067, P2839, DOI 10.3390/ijms11082839; Ema M, 2016, TOXICOL APPL PHARM, V299, P47, DOI 10.1016/j.taap.2015.12.015; Fan HJ, 2014, TARGET ONCOL, V9, P279, DOI 10.1007/s11523-013-0286-5; Ganiger S, 2007, FOOD CHEM TOXICOL, V45, P64, DOI 10.1016/j.fct.2006.07.016; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Grodzik M, 2013, INT J MOL SCI, V14, P23033, DOI 10.3390/ijms141123033; Grodzik M, 2011, INT J NANOMED, V6, P3041, DOI 10.2147/IJN.S25528; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Howells LM, 2007, INT J CANCER, V121, P175, DOI 10.1002/ijc.22645; Johnson JJ, 2007, CANCER LETT, V255, P170, DOI 10.1016/j.canlet.2007.03.005; Kulakova II, 2004, PHYS SOLID STATE+, V46, P636, DOI 10.1134/1.1711440; Kurantowicz N, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1107-9; Lundvig DMS, 2015, EXP CELL RES, V330, P429, DOI 10.1016/j.yexcr.2014.10.006; Mazurkiewicz M., 2011, CHOROBY DROBIU; Prasek M, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-251; Puzyr AP, 2007, DIAM RELAT MATER, V16, P2124, DOI 10.1016/j.diamond.2007.07.025; Qi W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04352; Sa G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-14; Sawosz E, 2014, INT J NANOMED, V9, P3913, DOI 10.2147/IJN.S65633; Schrand AM, 2007, DIAM RELAT MATER, V16, P2118, DOI 10.1016/j.diamond.2007.07.020; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Strojny B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144821; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Wang M, 2011, EUR J PHARMACOL, V650, P41, DOI 10.1016/j.ejphar.2010.09.049; Wierzbicki M, 2013, INT J NANOMED, V8, P3427, DOI 10.2147/IJN.S49745; Wierzbicki M, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-195; Wu JY, 2007, BIOL PHARM BULL, V30, P1336, DOI 10.1248/bpb.30.1336; Yallapu MM, 2012, DRUG DISCOV TODAY, V17, P71, DOI 10.1016/j.drudis.2011.09.009; Yallapu MM, 2011, INT J NANOMED, V6, P2779, DOI 10.2147/IJN.S25534; Yuan Y, 2009, DIAM RELAT MATER, V18, P95, DOI 10.1016/j.diamond.2008.10.031; Zakrzewska KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122579; Zhang F, 2014, J CELL SCI, V127, P305, DOI 10.1242/jcs.128306; Zhang JF, 2014, FOOD CHEM, V145, P57, DOI 10.1016/j.foodchem.2013.08.025; Zhang XY, 2010, TOXICOL LETT, V198, P237, DOI 10.1016/j.toxlet.2010.07.001; Zheng SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG113, DOI 10.1152/ajpgi.00200.2006; Zhou XJ, 2014, J PHARMACOL SCI, V126, P344, DOI 10.1254/jphs.14173FP; Zhu Y, 2012, THERANOSTICS, V2, P302, DOI 10.7150/thno.3627; Zielinska M, 2012, ARCH ANIM NUTR, V66, P1, DOI 10.1080/1745039X.2011.644918	41	21	23	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164637	10.1371/journal.pone.0164637	http://dx.doi.org/10.1371/journal.pone.0164637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736939	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800103
J	Abdur-Rahim, J; Morales, Y; Gupta, P; Umata, I; Watanabe, A; Even, J; Suyama, T; Ishii, S				Abdur-Rahim, Jamilah; Morales, Yoichi; Gupta, Pankaj; Umata, Ichiro; Watanabe, Atsushi; Even, Jani; Suyama, Takayuki; Ishii, Shin			Multi-Sensor Based State Prediction for Personal Mobility Vehicles	PLOS ONE			English	Article							VALENCE FOCUS; STRESS; HABITUATION; AROUSAL; PASSENGER; FEATURES; MODEL	This paper presents a study on multi-modal human emotional state detection while riding a powered wheelchair (PMV; Personal Mobility Vehicle) in an indoor labyrinth-like environment. The study reports findings on the habituation of human stress response during self-driving. In addition, the effects of "loss of controllability", change in the role of the driver to a passenger, are investigated via an autonomous driving modality. The multi-modal emotional state detector sensing framework consists of four sensing devices: electroencephalograph (EEG), heart inter-beat interval (IBI), galvanic skin response (GSR) and stressor level lever (in the case of autonomous riding). Physiological emotional state measurement characteristics are organized by time-scale, in terms of capturing slower changes (long-term) and quicker changes from moment-to-moment. Experimental results with fifteen participants regarding subjective emotional state reports and commercial software measurements validated the proposed emotional state detector. Short-term GSR and heart signal characterizations captured moment-to-moment emotional state during autonomous riding (Spearman correlation;. rho= 0.6, p < 0.001). Short-term GSR and EEG characterizations reliably captured moment-to-moment emotional state during self-driving (Classification accuracy; 69.7). Finally, long-term GSR and heart characterizations were confirmed to reliably capture slow changes during autonomous riding and also of emotional state during participant resting state. The purpose of this study and the exploration of various algorithms and sensors in a structured framework is to provide a comprehensive background for multi-modal emotional state prediction experiments and/or applications. Additional discussion regarding the feasibility and utility of the possibilities of these concepts are given.	[Abdur-Rahim, Jamilah; Gupta, Pankaj; Suyama, Takayuki; Ishii, Shin] Adv Telecommun Res Inst Int, Dept Dynam Brain Imaging, Cognit Mech Labs, Kyoto, Japan; [Morales, Yoichi; Umata, Ichiro; Watanabe, Atsushi; Even, Jani] Adv Telecommun Res Inst Int, Intelligent Robot & Commun Labs, Kyoto, Japan; [Umata, Ichiro] Natl Inst Informat & Commun Technol, Universal Commun Res Inst, Multisensory Cognit & Computat Lab, Kyoto, Japan; [Ishii, Shin] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Kyoto, Japan	Advanced Telecommunications Research Institute International; Advanced Telecommunications Research Institute International; National Institute of Information & Communications Technology (NICT) - Japan; Kyoto University	Abdur-Rahim, J (corresponding author), Adv Telecommun Res Inst Int, Dept Dynam Brain Imaging, Cognit Mech Labs, Kyoto, Japan.	j622amilah@gmail.com	Watanabe, Atsushi/AAU-8018-2020	Gupta, Pankaj/0000-0001-6814-2812; Foucher, Jamilah/0000-0002-9682-0307; Ishii, Shin/0000-0001-9385-8230	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); Ministry of Internal Affairs and Communications	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); Ministry of Internal Affairs and Communications	This research was supported by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), and by a contract with the Ministry of Internal Affairs and Communications entitled, 'Novel and innovative R&D making use of brain structures.'; This research was supported by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan), and by a contract with the Ministry of Internal Affairs and Communications entitled, "Novel and innovative R&D making use of brain structures".	Barrett LF, 1998, COGNITION EMOTION, V12, P579, DOI 10.1080/026999398379574; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P5, DOI 10.1016/S0167-8760(97)00753-8; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brouwer A, 2011, JCR-J CLIN RHEUMATOL, V4, P83; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Critchley HD, 2000, J NEUROSCI, V20, P3033; Crowley Katie, 2010, 2010 IEEE 10th International Conference on Advanced Learning Technologies (ICALT 2010), P276, DOI 10.1109/ICALT.2010.81; Dehais F, 2011, APPL ERGON, V42, P785, DOI 10.1016/j.apergo.2010.12.005; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Elbanhawi M, 2015, IEEE INTEL TRANSP SY, V7, P4, DOI 10.1109/MITS.2015.2405571; Fehr L, 2000, J REHABIL RES DEV, V37, P353; FELDMAN LA, 1995, J PERS SOC PSYCHOL, V69, P153, DOI 10.1037/0022-3514.69.1.153; Geuter S, 2014, PAIN, V155, P994, DOI 10.1016/j.pain.2014.02.005; Gulati S, 2008, IEEE INT CONF ROBOT, P3932, DOI 10.1109/ROBOT.2008.4543815; Harbert T., 2015, IEEE SPECTRUM, V52, P11, DOI [10.1109/MSPEC.2015.7095186, DOI 10.1109/MSPEC.2015.7095186]; Healey JA, 2005, IEEE T INTELL TRANSP, V6, P156, DOI 10.1109/TITS.2005.848368; Hendricks J, 2013, ALTERNATIVE WHEELCHA; Iida S., 1991, Proceedings IROS '91. IEEE/RSJ International Workshop on Intelligent Robots and Systems '91. Intelligence for Mechanical Systems (Cat. No.91TH0375-6), P212, DOI 10.1109/IROS.1991.174452; Inc N., 2009, BRAIN WAV SIGN EEG N; Kehoe EG, 2013, NEUROBIOL AGING, V34, P809, DOI 10.1016/j.neurobiolaging.2012.07.006; Lazarus R. S., 1984, STRESS APPRAISAL COP; Le Vine S, 2015, TRANSPORT RES C-EMER, V52, P1, DOI 10.1016/j.trc.2015.01.002; Lewis RS, 2007, BIOL PSYCHOL, V75, P239, DOI 10.1016/j.biopsycho.2007.03.004; Lim Chee-Keong Alfred, 2015, International Journal of Computer Theory and Engineering, V7, P149, DOI 10.7763/IJCTE.2015.V7.947; Lin Y, 2015, FRONT ARCHIT RES, V4, P220, DOI 10.1016/j.foar.2015.06.003; Melillo P, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-96; Morales Y, 2015, IEEE INT CONF ROBOT, P6153, DOI 10.1109/ICRA.2015.7140063; Morales Y, 2014, IEEE INT C INT ROBOT, P3284, DOI 10.1109/IROS.2014.6943019; Morales Y, 2014, IEEE INT CONF ROBOT, P2197, DOI 10.1109/ICRA.2014.6907162; Morales Y, 2013, IEEE INT C INT ROBOT, P2737, DOI 10.1109/IROS.2013.6696743; Myers D., 2008, PSYCHOLOGY; Nourbakhsh N, 2013, LECT NOTES COMPUT SC, V8117, P159; Pavlenko VB, 2009, NEUROPHYSIOLOGY+, V41, P337, DOI 10.1007/s11062-010-9111-2; Ramshur J.T., 2010, THESIS U MEMPHIS MEM, DOI [10.13140/RG.2.2.33667.81444, DOI 10.13140/RG.2.2.33667.81444]; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Rodriguez M., 2012, INFORMATIKTAGE S, VS-11, P163; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P848, DOI 10.1037/0022-3514.57.5.848; Schleicher R., 2005, SIMPLEEDA EMG MATLAB, DOI DOI 10.1186/1475-925X-10-96; Selye H., 1978, STRESS LIFE; Smith H., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; Snodgrass LT, 1986, AM PSYCH ASS CONV 94, P514; Spielberger CD, 1983, MANUAL STAT IN PRESS; Storm H, 2000, CLIN NEUROPHYSIOL, V111, P1889, DOI 10.1016/S1388-2457(00)00421-1; Storm H, CLIN NEUROPHYSIOL; Thoma MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070156; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Thompson RF, 2009, NEUROBIOL LEARN MEM, V92, P127, DOI 10.1016/j.nlm.2008.07.011; Verona E, 2009, J ABNORM PSYCHOL, V118, P131, DOI 10.1037/a0014376; ZEIER H, 1979, ERGONOMICS, V22, P799, DOI 10.1080/00140137908924658	50	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0162593	10.1371/journal.pone.0162593	http://dx.doi.org/10.1371/journal.pone.0162593			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732589	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300001
J	Eisele, JF; Fassler, F; Burgel, PF; Chaban, C				Eisele, Jochen F.; Faessler, Florian; Buergel, Patrick F.; Chaban, Christina			A Rapid and Simple Method for Microscopy-Based Stomata Analyses	PLOS ONE			English	Article							GUARD-CELLS; ABSCISIC-ACID; RHODAMINE 6G; ARABIDOPSIS; CLOSURE; CONDUCTANCE; APERTURE; STRESS	There are two major methodical approaches with which changes of status in stomatal pores are addressed: indirectly by measurement of leaf transpiration, and directly by measurement of stomatal apertures. Application of the former method requires special equipment, whereas microscopic images are utilized for the direct measurements. Due to obscure visualization of cell boundaries in intact leaves, a certain degree of invasive leaf manipulation is often required. Our aim was to develop a protocol based on the minimization of leaf manipulation and the reduction of analysis completion time, while still producing consistent results. We applied rhodamine 6G staining of Arabidopsis thaliana leaves for stomata visualization, which greatly simplifies the measurement of stomatal apertures. By using this staining protocol, we successfully conducted analyses of stomatal responses in Arabidopsis leaves to both closure and opening stimuli. We performed long-term monitoring of living stomata and were able to document the same leaf before and after treatment. Moreover, we developed a protocol for rapid-fixation of epidermal peels, which enables high throughput data analysis. The described method allows analysis of stomatal apertures with minimal leaf manipulation and usage of the same leaf for sequential measurements, and will facilitate the analysis of several lines in parallel.	[Eisele, Jochen F.; Faessler, Florian; Buergel, Patrick F.; Chaban, Christina] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Plant Physiol, Tubingen, Germany; [Eisele, Jochen F.] Lonza Ltd, Visp, Switzerland; [Faessler, Florian] Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Dev Genet, Tubingen, Germany	Eberhard Karls University of Tubingen; Lonza Group; Eberhard Karls University of Tubingen	Chaban, C (corresponding author), Univ Tubingen, Ctr Plant Mol Biol ZMBP, Dept Plant Physiol, Tubingen, Germany.	christina.chaban@zmbp.uni-tuebingen.de			European Union, Marie Curie Actions FP7-People-ITN (MERIT) [264474]; Deutsche Forschungsgemeinschaft through seed funding of the CRC [1101]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen	European Union, Marie Curie Actions FP7-People-ITN (MERIT); Deutsche Forschungsgemeinschaft through seed funding of the CRC; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	This work was supported by European Union, Marie Curie Actions FP7-People-2010-ITN (http://ec.europa.eu/research/mariecurieactions/index_en.htm) (MERIT, Grant agreement #264474) and by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) through seed funding of the CRC 1101 to CC. We also acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen (http://www.uni-tuebingen.de/de/58988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; Chitrakar Reejana, 2010, J Vis Exp, DOI 10.3791/2185; Cvetkovska M, 2014, NEW PHYTOL, V203, P449, DOI 10.1111/nph.12773; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Desikan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002491; Engineer CB, 2016, TRENDS PLANT SCI, V21, P16, DOI 10.1016/j.tplants.2015.08.014; Kollist H, 2014, NEW PHYTOL, V203, P44, DOI 10.1111/nph.12832; Larcher L, 2015, NEW PHYTOL, V206, P141, DOI 10.1111/nph.13154; LEVITT LK, 1987, PLANT PHYSIOL, V85, P318, DOI 10.1104/pp.85.2.318; Lind C, 2015, CURR BIOL, V25, P928, DOI 10.1016/j.cub.2015.01.067; Magde D, 2002, PHOTOCHEM PHOTOBIOL, V75, P327, DOI 10.1562/0031-8655(2002)075<0327:FQYATR>2.0.CO;2; Monda K, 2016, PLANT PHYSIOL, V170, P1435, DOI 10.1104/pp.15.01450; Munemasa S, 2015, CURR OPIN PLANT BIOL, V28, P154, DOI 10.1016/j.pbi.2015.10.010; Murata Y, 2015, ANNU REV PLANT BIOL, V66, P369, DOI 10.1146/annurev-arplant-043014-114707; Song YW, 2014, NEW PHYTOL, V201, P1121, DOI 10.1111/nph.12565; Upadhyay RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101995; Virlouvet L, 2015, NEW PHYTOL, V205, P596, DOI 10.1111/nph.13080; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Zehentbauer FM, 2014, SPECTROCHIM ACTA A, V121, P147, DOI 10.1016/j.saa.2013.10.062; Zhang X, 2001, CELL RES, V11, P37, DOI 10.1038/sj.cr.7290064; Zimmerli C, 2012, PLANT J, V72, P199, DOI 10.1111/j.1365-313X.2012.05058.x	21	42	42	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164576	10.1371/journal.pone.0164576	http://dx.doi.org/10.1371/journal.pone.0164576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732636	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300065
J	Hansen, NC; Vuust, P; Pearce, M				Hansen, Niels Chr.; Vuust, Peter; Pearce, Marcus			"If You Have to Ask, You'll Never Know": Effects of Specialised Stylistic Expertise on Predictive Processing of Music	PLOS ONE			English	Article							MELODIC EXPECTATION; TONAL HIERARCHIES; HESCHLS GYRUS; PERCEPTION; RESPONSES; ENCULTURATION; RECOGNITION; PERFORMANCE; SEQUENCES; KNOWLEDGE	Musical expertise entails meticulous stylistic specialisation and enculturation. Even so, research on musical training effects has focused on generalised comparisons between musicians and non-musicians, and cross-cultural work addressing specialised expertise has traded cultural specificity and sensitivity for other methodological limitations. This study aimed to experimentally dissociate the effects of specialised stylistic training and general musical expertise on the perception of melodies. Non-musicians and professional musicians specialising in classical music or jazz listened to sampled renditions of saxophone solos improvised by Charlie Parker in the bebop style. Ratings of explicit uncertainty and expectedness for different continuations of each melodic excerpt were collected. An information- theoretic model of expectation enabled selection of stimuli affording highly certain continuations in the bebop style, but highly uncertain continuations in the context of general tonal expectations, and vice versa. The results showed that expert musicians have acquired probabilistic characteristics of music influencing their experience of expectedness and predictive uncertainty. While classical musicians had internalised key aspects of the bebop style implicitly, only jazz musicians' explicit uncertainty ratings reflected the computational estimates, and jazz-specific expertise modulated the relationship between explicit and inferred uncertainty data. In spite of this, there was no evidence that non-musicians and classical musicians used a stylistically irrelevant cognitive model of general tonal music providing support for the theory of cognitive firewalls between stylistic models in predictive processing of music.	[Hansen, Niels Chr.; Vuust, Peter] Aarhus Univ, Dept Clin Med, Ctr Mus Brain, Aarhus, Denmark; [Hansen, Niels Chr.; Vuust, Peter] Royal Acad Mus Aarhus Aalborg, Aarhus, Denmark; [Hansen, Niels Chr.] Aarhus Univ, Sch Commun & Culture, Aarhus, Denmark; [Hansen, Niels Chr.; Pearce, Marcus] Queen Mary Univ London, Cognit Sci Res Grp, London, England; [Hansen, Niels Chr.; Pearce, Marcus] Queen Mary Univ London, Ctr Digital Mus, London, England; [Hansen, Niels Chr.] Ohio State Univ, Sch Mus, Cognit & Systemat Musicol Lab, Columbus, OH 43210 USA	Aarhus University; Aarhus University; University of London; Queen Mary University London; University of London; Queen Mary University London; University System of Ohio; Ohio State University	Hansen, NC (corresponding author), Aarhus Univ, Dept Clin Med, Ctr Mus Brain, Aarhus, Denmark.; Hansen, NC (corresponding author), Royal Acad Mus Aarhus Aalborg, Aarhus, Denmark.; Hansen, NC (corresponding author), Aarhus Univ, Sch Commun & Culture, Aarhus, Denmark.; Hansen, NC (corresponding author), Queen Mary Univ London, Cognit Sci Res Grp, London, England.; Hansen, NC (corresponding author), Queen Mary Univ London, Ctr Digital Mus, London, England.; Hansen, NC (corresponding author), Ohio State Univ, Sch Mus, Cognit & Systemat Musicol Lab, Columbus, OH 43210 USA.	hansen.491@osu.edu	Hansen, Niels Chr./AAE-8484-2021	Hansen, Niels Chr./0000-0003-2142-6484	Ministry of Culture Denmark; Royal Academy of Music Aarhus/Aalborg; Aarhus University; Ministry of Higher Education and Science Denmark; UK Engineering and Physical Sciences Research Council (EPSRC) [EP/D038855/1]; Danish National research Foundation [DNRF117]; Engineering and Physical Sciences Research Council [EP/D038855/1] Funding Source: researchfish; EPSRC [EP/D038855/1] Funding Source: UKRI	Ministry of Culture Denmark; Royal Academy of Music Aarhus/Aalborg; Aarhus University; Ministry of Higher Education and Science Denmark; UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Danish National research Foundation(Danmarks Grundforskningsfond); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	During the preparation of this manuscript, NCH was supported by a PhD stipend from The Ministry of Culture Denmark, The Royal Academy of Music Aarhus/Aalborg, and Aarhus University, as well as by an Elite Forsk Travel Grant from The Ministry of Higher Education and Science Denmark. Part of this research was supported by the UK Engineering and Physical Sciences Research Council (EPSRC) via grant number EP/D038855/1 (www.epsrc.ac.uk). Center for Music in the Brain is funded by the Danish National research Foundation (DNRF117) (www.dg.dk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarden BJ, 2003, DYNAMIC MELODIC EXPE; Ayari M, 2003, MUSIC PERCEPT, V21, P159, DOI 10.1525/mp.2003.21.2.159; Baker D., 1988, D BAKERS JAZZ IMPROV; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Bigand E, 2003, ANN NY ACAD SCI, V999, P304, DOI 10.1196/annals.1284.041; Burunat I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138238; CASTELLANO MA, 1984, J EXP PSYCHOL GEN, V113, P394, DOI 10.1037/0096-3445.113.3.394; Cenkerova Z, 2015, MUSIC PERCEPT, V33, P110, DOI 10.1525/MP.2015.33.1.110; Coker J., 1997, J COKERS COMPLETE ME; CONKLIN D, 1995, J NEW MUSIC RES, V24, P51, DOI 10.1080/09298219508570672; Cosmides L., 2000, METAREPRESENTATIONS, P53; Demorest SM, 2008, MUSIC PERCEPT, V25, P213, DOI 10.1525/MP.2008.25.3.213; Drake C, 2003, ANN NY ACAD SCI, V999, P429, DOI 10.1196/annals.1284.053; Eerola T, 2009, MUSIC SCI, V13, P231, DOI 10.1177/102986490901300203; Eerola Tuomas, 2006, PSYCHOL MUSIC, V34, P337, DOI DOI 10.1177/0305735606064842; Finkelman J., 1997, JAZZFORSCHUNGJAZZ RE, V29, P159; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Friberg A, 1997, SPEECH MUSIC HEARING, V38, P19; Gingras B, 2016, J EXP PSYCHOL HUMAN, V42, P594, DOI 10.1037/xhp0000141; Gjerdingen R, 2008, J NEW MUSIC RES, V37, P93, DOI 10.1080/09298210802479268; Goldman A., 2013, PSYCHOMUSICOLOGY, V23, P210, DOI [10.1037/pmu0000020, DOI 10.1037/pmu0000020, DOI 10.1037/PMU0000020]; Hannon EE, 2012, J EXP PSYCHOL HUMAN, V38, P543, DOI 10.1037/a0027225; Hansen N, 2014, FRONT NEUROL, V5, DOI [10.3389/fneur.2014.00080, 10.3389/fpsyg.2014.01052]; Hughson AL, 2001, AUST J PSYCHOL, V53, P103, DOI 10.1080/00049530108255130; Huron D.B., 2006, SWEET ANTICIPATION M; JARVINEN T, 1995, MUSIC PERCEPT, V12, P415; Kalender B, 2013, PSYCHOL RES-PSYCH FO, V77, P196, DOI 10.1007/s00426-012-0427-y; Kenny B., 1999, ANN REV JAZZ STUDIES, P163; KESSLER EJ, 1984, MUSIC PERCEPT, V2, P131; KNOPOFF L, 1983, J MUSIC THEORY, V27, P75, DOI 10.2307/843561; Koelsch S, 2003, NEUROREPORT, V14, P709, DOI 10.1097/00001756-200304150-00010; KRUMHANSL CL, 1987, MUSIC PERCEPT, V5, P31; Krumhansl CL, 2000, COGNITION, V76, P13, DOI 10.1016/S0010-0277(00)00068-8; Krumhansl CL, 1999, MUSIC PERCEPT, V17, P151; KRUMHANSL CL, 1995, MUSIC THEOR SPECTRUM, V17, P53, DOI 10.1525/mts.1995.17.1.02a00030; KRUMHANSL CL, 1979, J EXP PSYCHOL HUMAN, V5, P579, DOI 10.1037/0096-1523.5.4.579; Laukka P, 2013, EMOTION, V13, P434, DOI 10.1037/a0031388; Lerdahl F., 1992, CONTEMP MUSIC REV, V6, P97, DOI [10.1080/07494469200640161, DOI 10.1080/07494469200640161]; Loui P, 2010, MUSIC PERCEPT, V27, P377, DOI 10.1525/mp.2010.27.5.377; LYNCH MP, 1991, J EXP PSYCHOL HUMAN, V17, P967, DOI 10.1037/0096-1523.17.4.967; Margulis EH, 2009, HUM BRAIN MAPP, V30, P267, DOI 10.1002/hbm.20503; McAuley JD, 2011, MUSIC PERCEPT, V28, P505, DOI 10.1525/MP.2011.28.5.505; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Munte TF, 2003, ANN NY ACAD SCI, V999, P131, DOI 10.1196/annals.1284.014; Munte TF, 2001, NATURE, V409, P580, DOI 10.1038/35054668; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Neuhaus C, 2006, J COGNITIVE NEUROSCI, V18, P472, DOI 10.1162/089892906775990642; Norgaard M, 2014, MUSIC PERCEPT, V31, P271, DOI 10.1525/MP.2014.31.3.271; Norgaard Martin, 2013, PSYCHOL MUSIC MIND B, V23, P243, DOI DOI 10.1037/PMU0000018; Owens T., 1974, THESIS; Pachet F., 2012, COMPUTERS CREATIVITY, P115, DOI DOI 10.1007/978-3-642-31727-9; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Parker C., 1978, C PARKER OMNIBOOK TR; Pearce MT, 2006, MUSIC PERCEPT, V23, P377, DOI 10.1525/mp.2006.23.5.377; Pearce MT, 2012, TOP COGN SCI, V4, P625, DOI 10.1111/j.1756-8765.2012.01214.x; Pearce MT, 2010, NEUROIMAGE, V50, P302, DOI 10.1016/j.neuroimage.2009.12.019; Pearce MT., 2005, THESIS; Pecenka N, 2011, EXP BRAIN RES, V211, P505, DOI 10.1007/s00221-011-2616-0; Proverbio AM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05866; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; SCHMUCKLER MA, 1989, MUSIC PERCEPT, V7, P109; Schneider P, 2005, ANN NY ACAD SCI, V1060, P387, DOI 10.1196/annals.1360.033; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simon SJ, 2005, THESIS; Steedman M., 1996, MENTAL MODELS COGNIT, P305; STEEDMAN MJ, 1984, MUSIC PERCEPT, V2, P52; Strait DL, 2012, CORTEX, V48, P360, DOI 10.1016/j.cortex.2011.03.015; Sun R, 2001, COGNITIVE SCI, V25, P203, DOI 10.1016/S0364-0213(01)00035-0; Tervaniemi M, 2009, ANN NY ACAD SCI, V1169, P151, DOI 10.1111/j.1749-6632.2009.04591.x; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Ulrich JW, 1977, P INT JOINT C ART IN, V2, P865; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Vuust P, 2012, ANN NY ACAD SCI, V1252, P139, DOI 10.1111/j.1749-6632.2011.06409.x; Waters A.J., 1998, PSYCHOL MUSIC, V26, P46, DOI [10.1177/0305735698261005, DOI 10.1177/0305735698261005]; Weisberg RW, 2004, P C INT MUS; Wiggins Geraint A., 2009, OXFORD HDB COMPUTER, P383; Wikioo, 2021, THINKING JAZZ INFINI; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Wong PCM, 2009, MUSIC PERCEPT, V27, P81, DOI 10.1525/MP.2009.27.2.81; Wopereis I.G., 2013, PSYCHOMUSICOL MUSIC, V23, P222, DOI 10.1037/pmu0000021	83	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163584	10.1371/journal.pone.0163584	http://dx.doi.org/10.1371/journal.pone.0163584			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DZ0CQ	27732612	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300021
J	Derks, NAV; Krugers, HJ; Hoogenraad, CC; Joels, M; Sarabdjitsingh, RA				Derks, Nienke A. V.; Krugers, Harm J.; Hoogenraad, Casper C.; Joels, Marian; Sarabdjitsingh, R. Angela			Effects of Early Life Stress on Synaptic Plasticity in the Developing Hippocampus of Male and Female Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEVELOPMENTAL SWITCH; MATERNAL SEPARATION; SIGNALING CASCADES; CHILDHOOD TRAUMA; ADULT; CORTICOSTERONE; BRAIN; EXPRESSION; DISORDERS	Introduction Early life stress (ELS) increases the risk for developing psychopathology in adulthood. When these effects occur is largely unknown. We here studied at which time during development ELS affects hippocampal synaptic plasticity, from early life to adulthood, in a rodent ELS model. Moreover, we investigated whether the sensitivity of synaptic plasticity to the stress-hormone corticosterone is altered by exposure to ELS. Materials & Methods Male and female Wistar rats were exposed to maternal deprivation (MD) for 24h on postnatal day (P)3 or left undisturbed with their mother (control). On P8-9, 22-24 and P85-95, plasma corticosterone (CORT) levels, body weight, and thymus and adrenal weights were determined to validate the neuroendocrine effects of MD. Field potentials in the CA1 hippocampus were recorded in vitro before and after high frequency stimulation. Brain slices were incubated for 20 min with 100nM CORT or vehicle 1-4h prior to high frequency stimulation, to mimic high-stress conditions in vitro. Results & Discussion Body weight was decreased by MD only at P4 (p = 0.02). There were minimal effects on P89, 22-24 or 85-95 thymus and adrenal weight and basal CORT levels. Glutamate transmission underwent strong developmental changes: half-maximal signal size strongly increased (p<0.0001) while the required half-maximal stimulation intensity concomitantly decreased with age (p = 0.04). Synaptic plasticity developed from long-term depression at P8-9 to increasing levels of long-term potentiation at later ages (p = 0.0001). MD caused a significant increase in long-term potentiation of P22-24 males (p = 0.03) and P85-95 females (p = 0.04). Bayesian modeling strongly supported the age-dependent development, with some evidence for accelerated maturation after MD in males (Bayes factor 1.23). CORT suppressed LTP in adult males; synaptic plasticity at other ages and in females remained unaffected. Thus, MD affects the development of synaptic plasticity in the CA1 hippocampus in a sex-dependent manner, with some support for the notion that maturation is accelerated in MD males.	[Derks, Nienke A. V.; Joels, Marian; Sarabdjitsingh, R. Angela] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Krugers, Harm J.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, Dept Biol, Cell Biol, Utrecht, Netherlands; [Joels, Marian] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Utrecht University; University of Groningen	Derks, NAV (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands.	nderks@umcutrecht.nl	Joëls, Marian/P-6415-2016	Joels, Marian/0000-0002-4826-6209; Hoogenraad, Casper/0000-0002-2666-0758	ZonMw Top [91213017]	ZonMw Top	ZonMw Top Grant #91213017 has been received by Prof. Dr. Marian Joels, Prof. Dr. Casper C. Hoogenraad and Dr. Harm J. Krugers together. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarez DN, 2002, NEUROSCIENCE, V115, P1119, DOI 10.1016/S0306-4522(02)00483-9; Bagot RC, 2010, J AM ACAD CHILD PSY, V49, P752, DOI 10.1016/j.jaac.2010.06.001; Bagot RC, 2009, NEUROBIOL LEARN MEM, V92, P292, DOI 10.1016/j.nlm.2009.03.004; Bangasser DA, 2014, FRONT NEUROENDOCRIN, V35, P303, DOI 10.1016/j.yfrne.2014.03.008; Bath KG, 2016, HORM BEHAV, V82, P64, DOI 10.1016/j.yhbeh.2016.04.010; Cellot G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00136; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Cuijpers P, 2011, CHILD ABUSE NEGLECT, V35, P937, DOI 10.1016/j.chiabu.2011.06.005; Doom JR, 2014, J AM ACAD CHILD PSY, V53, P1206, DOI 10.1016/j.jaac.2014.08.006; Dumas TC, 2005, HIPPOCAMPUS, V15, P562, DOI 10.1002/hipo.20077; Dupuis JP, 2014, EMBO J, V33, P842, DOI 10.1002/embj.201386356; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fiala JC, 1998, J NEUROSCI, V18, P8900; Gomez-Gonzalez B, 2011, INT J DEV NEUROSCI, V29, P839, DOI 10.1016/j.ijdevneu.2011.08.003; Gomez-Gonzalez B, 2010, ACTA NEUROPATHOL, V119, P303, DOI 10.1007/s00401-009-0590-4; Gunnar MR, 2009, DEV PSYCHOPATHOL, V21, P69, DOI 10.1017/S0954579409000054; Gutman David A, 2002, Semin Clin Neuropsychiatry, V7, P89, DOI 10.1053/scnp.2002.31781; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Huang CC, 2005, J PHYSIOL-LONDON, V569, P789, DOI 10.1113/jphysiol.2005.098160; Joels M, 2012, PHARMACOL REV, V64, P901, DOI 10.1124/pr.112.005892; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kuhlman KR, 2015, PSYCHONEUROENDOCRINO, V54, P103, DOI 10.1016/j.psyneuen.2015.01.020; Lehmann J, 1999, PHARMACOL BIOCHEM BE, V64, P705, DOI 10.1016/S0091-3057(99)00150-1; Lehmann J, 2002, PHARMACOL BIOCHEM BE, V73, P141, DOI 10.1016/S0091-3057(02)00788-8; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; Loi M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00013; Luchkina NV, 2014, P NATL ACAD SCI USA, V111, P4321, DOI 10.1073/pnas.1315769111; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Marco EM, 2015, NEUROSCI BIOBEHAV R, V51, P151, DOI 10.1016/j.neubiorev.2015.01.015; Marco EM, 2013, NEUROPHARMACOLOGY, V68, P223, DOI 10.1016/j.neuropharm.2012.08.014; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; McLaughlin KA, 2010, ARCH GEN PSYCHIAT, V67, P124, DOI 10.1001/archgenpsychiatry.2009.187; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Mills R, 2013, CHILD ABUSE NEGLECT, V37, P292, DOI 10.1016/j.chiabu.2012.11.008; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Mulder J, 2012, J STAT SOFTW, V46, P1; Mulkey RM, 1991, NEURON, V9, P687; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Oomen CA, 2009, PLOS ONE, P4; Oomen CA, 2011, PSYCHOPHARMACOLOGY, V214, P249, DOI 10.1007/s00213-010-1922-8; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Qiao HF, 2006, LIFE SCI, V79, P8, DOI 10.1016/j.lfs.2005.12.025; Romeo RD, 2010, FRONT NEUROENDOCRIN, V31, P232, DOI 10.1016/j.yfrne.2010.02.004; Sarabdjitsingh RA, 2014, P NATL ACAD SCI USA, V111, P14265, DOI 10.1073/pnas.1411216111; Schiess ARB, 2010, EUR J NEUROSCI, V31, P1377, DOI 10.1111/j.1460-9568.2010.07180.x; Schmidt MV, 2011, PSYCHONEUROENDOCRINO, V36, P330, DOI 10.1016/j.psyneuen.2010.07.001; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Teicher MH, 2016, J CHILD PSYCHOL PSYC, V57, P241, DOI 10.1111/jcpp.12507; Turner DA, 1998, PROG NEUROBIOL, V55, P537, DOI 10.1016/S0301-0082(98)00019-7; van Hasselt FN, 2012, J NEUROENDOCRINOL, V24, P331, DOI 10.1111/j.1365-2826.2011.02233.x; van Hasselt FN, 2012, HIPPOCAMPUS, V22, P255, DOI 10.1002/hipo.20892; van Rossum M, 2013, METHODOLOGY-EUR, V9, P13, DOI 10.1027/1614-2241/a000050; Warren SG, 1995, BRAIN RES, V703, P26, DOI 10.1016/0006-8993(95)01059-9; Wiegert O, 2005, NEUROSCIENCE, V135, P403, DOI 10.1016/j.neuroscience.2005.05.039; Yang YP, 2009, NEUROPHARMACOLOGY, V56, P56, DOI 10.1016/j.neuropharm.2008.08.013; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Zhou JZ, 2000, BRAIN RES, V885, P182, DOI 10.1016/S0006-8993(00)02934-6	61	40	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164551	10.1371/journal.pone.0164551	http://dx.doi.org/10.1371/journal.pone.0164551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723771	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100073
J	Li, T; Ali, J; Marcaida, M; Angeles, O; Franje, NJ; Revilleza, JE; Manalo, E; Redona, E; Xu, JL; Li, ZK				Li, Tao; Ali, Jauhar; Marcaida, Manuel, III; Angeles, Olivyn; Franje, Neil Johann; Revilleza, Jastin Edrian; Manalo, Emmali; Redona, Edilberto; Xu, Jianlong; Li, Zhikang			Combining Limited Multiple Environment Trials Data with Crop Modeling to Identify Widely Adaptable Rice Varieties	PLOS ONE			English	Article							DROUGHT-STRESS; IRRIGATED RICE; CLIMATE-CHANGE; UPLAND RICE; YIELD; OPTIMIZATION; SIMULATION; PROGRESS; OPTIONS; BRAZIL	Multi-Environment Trials (MET) are conventionally used to evaluate varietal performance prior to national yield trials, but the accuracy of MET is constrained by the number of test environments. A modeling approach was innovated to evaluate varietal performance in a large number of environments using the rice model ORYZA (v3). Modeled yields representing genotype by environment interactions were used to classify the target population of environments (TPE) and analyze varietal yield and yield stability. Eight Green Super Rice (GSR) and three check varieties were evaluated across 3796 environments and 14 seasons in Southern Asia. Based on drought stress imposed on rainfed rice, environments were classified into nine TPEs. Relative to the check varieties, all GSR varieties performed well except GSR-IR1-5-S14-S2-Y2, with GSR-IR1-1-Y4-Y1, and GSR-IR1-8-S6-S3-Y2 consistently performing better in all TPEs. Varietal evaluation using ORYZA (v3) significantly corresponded to the evaluation based on actual MET data within specific sites, but not with considerably larger environments. ORYZA-based evaluation demonstrated the advantage of GSR varieties in diverse environments. This study substantiated that the modeling approach could be an effective, reliable, and advanced approach to complement MET in the assessment of varietal performance on spatial and temporal scales whenever quality soil and weather information are accessible. With available local weather and soil information, this approach can also be adopted to other rice producing domains or other crops using appropriate crop models.	[Li, Tao; Marcaida, Manuel, III; Angeles, Olivyn; Manalo, Emmali] Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Laguna, Philippines; [Ali, Jauhar; Franje, Neil Johann; Revilleza, Jastin Edrian; Redona, Edilberto] Int Rice Res Inst, Div Plant Breeding, Los Banos, Laguna, Philippines; [Redona, Edilberto] Mississippi State Univ, Delta Res & Extens Ctr, Stoneville, MS USA; [Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China	CGIAR; International Rice Research Institute (IRRI); CGIAR; International Rice Research Institute (IRRI); Mississippi State University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, T (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Laguna, Philippines.; Ali, J (corresponding author), Int Rice Res Inst, Div Plant Breeding, Los Banos, Laguna, Philippines.	t.li@irri.org; j.ali@irri.org	Marcaida, Manuel/HGC-6363-2022; Xu, Jianlong/AAI-8310-2020; Ali, Jauhar Ali or A. Jauhar/E-4432-2012; Li, Tao/N-2730-2019	Marcaida, Manuel/0000-0002-4954-6704; Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607; Li, Tao/0000-0002-1360-1396	Bill & Melinda Gates Foundation; allocation of the research fund of International Rice Research Institute	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); allocation of the research fund of International Rice Research Institute	This study is partially funded by Bill & Melinda Gates Foundation through two research projects: Green Super Rice (GSR) and Stress-Tolerant Rice for Africa and South Asia (STRASA). Other funding was from the allocation of the research fund of International Rice Research Institute donated by countries through the network of Multiple Environment Trials.; This study was a collaboration between the Green Super Rice (GSR) and the Stress-Tolerant Rice for Africa and South Asia (STRASA) projects. The GSR and STRASA projects were funded by the Bill & Melinda Gates Foundation. Field experiments and data collection were supported by the IRRI Multiple Environment Trials (MET) Team.	Ali J., 2012, P 12 SABRAO C PLANT, P16; Ali J., 2013, INT DIALOGUE PERCEPT, P60; Ali J, 2011, RICE TODAY; Anantha MS, 2016, CROP SCI, V56, P408, DOI 10.2135/cropsci2015.06.0344; Bandillo N, 2013, RICE, V6, DOI 10.1186/1939-8433-6-11; Batjes N. H., 2006, 200602 ISRIC WISE; Belder P, 2007, AGR SYST, V92, P91, DOI 10.1016/j.agsy.2006.03.001; Bouman B., 2001, ORYZA2000 MODELING L; Chapman S, 2003, AGRON J, V95, P99, DOI 10.2134/agronj2003.0099; Chapman SC, 2002, AUST J AGR RES, V53, P379, DOI 10.1071/AR01070; Chapman SC, 2000, AUST J AGR RES, V51, P209, DOI 10.1071/AR99021; Cooper M., 1996, P5; Guan YS, 2010, J EXP BOT, V61, P4145, DOI 10.1093/jxb/erq212; Heinemann AB, 2008, EUPHYTICA, V162, P395, DOI 10.1007/s10681-007-9579-z; Heinemann AB, 2015, J EXP BOT, V66, P3625, DOI 10.1093/jxb/erv126; International Rice Research Institute, 2013, ANN REPORT; Jing Q, 2008, AGR SYST, V98, P177, DOI 10.1016/j.agsy.2008.06.005; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; Li T., 2009, CALIBRATION VALIDATI; Li T, 2015, CLIMATIC CHANGE, V133, P709, DOI 10.1007/s10584-015-1487-y; Li T, 2015, GLOBAL CHANGE BIOL, V21, P1328, DOI 10.1111/gcb.12758; Li T, 2013, FIELD CROP RES, V149, P312, DOI 10.1016/j.fcr.2013.05.006; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Marcaida M, 2014, FIELD CROP RES, V162, P30, DOI 10.1016/j.fcr.2014.03.013; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Perkins J., 2011, GREEN REVOLUTION; Poulton PL, 2015, EXP AGR, V51, P264, DOI 10.1017/S0014479714000271; Soundharajan B, 2013, PADDY WATER ENVIRON, V11, P59, DOI 10.1007/s10333-011-0293-z; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tayefe M., 2013, Journal of Biodiversity and Environmental Sciences (JBES), V3, P77; Wang WG, 2012, PROCEDIA ENGINEER, V28, P341, DOI 10.1016/j.proeng.2012.01.730; Yadav S., 2011, FIELD CROPS RES, V122, P104; Yorobe JM, 2016, AGR ECON-BLACKWELL, V47, P261, DOI 10.1111/agec.12227; Zhang TY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27355	34	17	17	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164456	10.1371/journal.pone.0164456	http://dx.doi.org/10.1371/journal.pone.0164456			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723774	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504100062
J	Menze, BD; Riveron, JM; Ibrahim, SS; Irving, H; Antonio-Nkondjio, C; Awono-Ambene, PH; Wondji, CS				Menze, Benjamin D.; Riveron, Jacob M.; Ibrahim, Sulaiman S.; Irving, Helen; Antonio-Nkondjio, Christophe; Awono-Ambene, Parfait H.; Wondji, Charles S.			Multiple Insecticide Resistance in the Malaria Vector Anopheles funestus from Northern Cameroon Is Mediated by Metabolic Resistance Alongside Potential Target Site Insensitivity Mutations	PLOS ONE			English	Article							PYRETHROID RESISTANCE; GENE; CULICIDAE; DIPTERA; DDT; IDENTIFICATION; TRANSMISSION; POPULATIONS; SEQUENCE; IMPACT	Background Despite the recent progress in establishing the patterns of insecticide resistance in the major malaria vector Anopheles funestus, Central African populations of this species remain largely uncharacterised. To bridge this important gap and facilitate the implementation of suitable control strategies against this vector, we characterised the resistance patterns of An. funestus population from northern Cameroon. Methods and Findings Collection of indoor-resting female mosquitoes in Gounougou (northern Cameroon) in 2012 and 2015 revealed a predominance of An. funestus during dry season. WHO bioas-says performed using F-1 An. funestus revealed that the population was multiple resistant to several insecticide classes including pyrethroids (permethrin, deltamethrin, lambda-cyhalothrin and etofenprox), carbamates (bendiocarb) and organochlorines (DDT and dieldrin). However, a full susceptibility was observed against the organophosphate malathion. Bioassays performed with 2015 collection revealed that resistance against pyrethroids and DDT is increasing. PBO synergist assays revealed a significant recovery of susceptibility for all pyrethroids but less for DDT. Analysis of the polymorphism of a portion of the voltage-gated sodium channel gene (VGSC) revealed the absence of the L1014F/S kdr mutation but identified 3 novel amino acid changes I877L, V881L and A1007S. However, no association was established between VGSC polymorphism and pyrethroid/DDT resistance. The DDT resistant 119F-GSTe2 allele (52%) and the dieldrin resistant 296S-RDL allele (45%) were detected in Gounougou. Temporal analysis between 2006, 2012 and 2015 collections revealed that the 119F-GSTe2 allele was relatively stable whereas a significant decrease is observed for 296S-RDL allele. Conclusion This multiple resistance coupled with the temporal increased in resistance intensity high-lights the need to take urgent measures to prolong the efficacy of current insecticide-based interventions against An. funestus in this African region.	[Menze, Benjamin D.; Riveron, Jacob M.; Ibrahim, Sulaiman S.; Irving, Helen; Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England; [Menze, Benjamin D.; Riveron, Jacob M.; Antonio-Nkondjio, Christophe; Awono-Ambene, Parfait H.; Wondji, Charles S.] Org Coordinat Lutte Endemies Afrique Cent, LSTM OCEAC Res Unit, Yaounde, Centre Region, Cameroon; [Ibrahim, Sulaiman S.] Bayero Univ, Dept Biochem, Kano, Kano State, Nigeria	Liverpool School of Tropical Medicine; Bayero University	Wondji, CS (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England.; Wondji, CS (corresponding author), Org Coordinat Lutte Endemies Afrique Cent, LSTM OCEAC Res Unit, Yaounde, Centre Region, Cameroon.	charles.wondji@lstmed.ac.uk	Ibrahim, Sulaiman S/R-5466-2019; Wondji, Charles/AAG-1510-2020	Ibrahim, Sulaiman S/0000-0003-0744-802X; Wondji, Charles S./0000-0003-0791-3673; Antonio Nkondjio, Christophe/0000-0003-0073-1578	Wellcome Trust Master Fellowship in Public Health and Tropical Medicine [096437/Z/11/Z]; Wellcome Trust Research Career Development Fellowship [083515/Z/07/Z]; Wellcome Trust Senior Research Fellowship in Biomedical Sciences [101893/Z/13/Z]	Wellcome Trust Master Fellowship in Public Health and Tropical Medicine(Wellcome Trust); Wellcome Trust Research Career Development Fellowship(Wellcome Trust); Wellcome Trust Senior Research Fellowship in Biomedical Sciences(Wellcome Trust)	This work was supported by a Wellcome Trust Master Fellowship in Public Health and Tropical Medicine to BDM (096437/Z/11/Z); a Wellcome Trust Research Career Development Fellowship (083515/Z/07/Z) and a Wellcome Trust Senior Research Fellowship in Biomedical Sciences to CSW (101893/Z/13/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, WHOCDCMAL98; Antonio-Nkondjio C, 2008, T ROY SOC TROP MED H, V102, P352, DOI 10.1016/j.trstmh.2007.12.010; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Antonio-Nkondjio C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0675-6; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Christian RN, 2011, PESTIC BIOCHEM PHYS, V99, P140, DOI 10.1016/j.pestbp.2010.11.010; Coetzee M, 2013, ANNU REV ENTOMOL, V58, P393, DOI 10.1146/annurev-ento-120811-153628; Cohuet A, 2005, GENETICS, V169, P301, DOI 10.1534/genetics.103.025031; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; Cuamba N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011010; Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x; Djouaka R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027760; Etang J, 2003, J MED ENTOMOL, V40, P491, DOI 10.1603/0022-2585-40.4.491; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIVAK KJ, 1984, GENETICS, V107, P611; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Michel AP, 2005, MOL ECOL, V14, P4235, DOI 10.1111/j.1365-294X.2005.02754.x; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Mulamba C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110058; Mulamba C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-71; NMCP, 2012, NAT STRAT PLAN MAL C, P1; Nwane P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-41; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Platt N, 2015, HEREDITY, V115, P243, DOI 10.1038/hdy.2015.33; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Riveron JM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1787-8; Riveron JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0877-y; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tene BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061408; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099822; Vezenegho SB, 2013, T ROY SOC TROP MED H, V107, P753, DOI 10.1093/trstmh/trt089; WHO, 2013, TEST PROC INS RES MA; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Wondji CS, 2011, INSECT BIOCHEM MOLEC, V41, P484, DOI 10.1016/j.ibmb.2011.03.012; World Health Organization, 2012, WHO GLOB MAL PROGR G	44	52	54	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163261	10.1371/journal.pone.0163261	http://dx.doi.org/10.1371/journal.pone.0163261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723825	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000385504100005
J	Pollack, CE; Ross, ME; Armstrong, K; Branas, CC; Rhodes, KV; Bekelman, JE; Wentz, A; Stillson, C; Radhakrishnan, A; Oyeniran, E; Grande, D				Pollack, Craig Evan; Ross, Michelle E.; Armstrong, Katrina; Branas, Charles C.; Rhodes, Karin V.; Bekelman, Justin E.; Wentz, Alicia; Stillson, Christian; Radhakrishnan, Archana; Oyeniran, Enny; Grande, David			Using a Mystery-Caller Approach to Examine Access to Prostate Cancer Care in Philadelphia	PLOS ONE			English	Article								Purpose Prior work suggests that access to health care may influence the diagnosis and treatment of prostate cancer. Mystery-caller methods have been used previously to measure access to care for health services such as primary care, where patients' self-initiate requests for care. We used a mystery-caller survey for specialized prostate cancer care to assess dimensions of access to prostate cancer care. Materials and Methods We created an inventory of urology and radiation oncology practices in southeastern Pennsylvania. Using a 'mystery caller' approach, a research assistant posing as a medical office scheduler in a primary care office, attempted to make a new patient appointment on behalf of a referred patient. Linear regression was used to determine the association between time to next available appointment with practice and census tract characteristics. Results We successfully obtained information on new patient appointments from 198 practices out of the 223 in the region (88.8%). Radiation oncology practices were more likely to accept Medicaid compared to urology practices (91.3% vs 36.4%) and had shorter mean wait times for new patient appointments (9.0 vs 12.8 days). We did not observe significant differences in wait times according to census tract characteristics including neighborhood socioeconomic status and the proportion of male African American residents. Conclusions Mystery-caller methods that reflect real-world referral processes from primary care offices can be used to measure access to specialized cancer care. We observed significant differences in wait times and insurance acceptance between radiation oncology and urology practices.	[Pollack, Craig Evan; Radhakrishnan, Archana] Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA; [Pollack, Craig Evan; Radhakrishnan, Archana] Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Ross, Michelle E.; Branas, Charles C.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Armstrong, Katrina] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Rhodes, Karin V.] Northwell Hlth Hofstra Med Sch, Off Populat Hlth Management, Great Neck, NY USA; [Bekelman, Justin E.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Wentz, Alicia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Stillson, Christian; Grande, David] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Oyeniran, Enny] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grande, David] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital; Northwell Health; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Pollack, CE (corresponding author), Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA.; Pollack, CE (corresponding author), Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	Cpollac2@jhmi.edu	Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735	National Institute on Minority Health and Health Disparities [P60MD006900]; National Cancer Institute (NCI); Office of Behavioral and Social Sciences [K07CA151910]; NATIONAL CANCER INSTITUTE [K07CA151910] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Behavioral and Social Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was provided by the National Institute on Minority Health and Health Disparities (P60MD006900) and Dr. Craig Evan Pollack's (CP) salary is supported by the National Cancer Institute (NCI) and Office of Behavioral and Social Sciences (K07CA151910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisgaier J, 2011, NEW ENGL J MED, V364, P2324, DOI 10.1056/NEJMsa1013285; DesRoches CM, 2015, J GEN INTERN MED, V30, P595, DOI 10.1007/s11606-015-3380-9; Holmes JA, 2012, J UROLOGY, V187, P883, DOI 10.1016/j.juro.2011.10.156; Polsky D, 2015, NEW ENGL J MED, V372, P537, DOI 10.1056/NEJMsa1413299; Rhodes KV, 2014, JAMA INTERN MED, V174, P861, DOI 10.1001/jamainternmed.2014.20; Richards MR, 2014, MED CARE, V52, P818, DOI 10.1097/MLR.0000000000000184; Skolarus TA, 2013, CANCER-AM CANCER SOC, V119, P3629, DOI 10.1002/cncr.28275	7	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164411	10.1371/journal.pone.0164411	http://dx.doi.org/10.1371/journal.pone.0164411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723780	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504100057
J	Barnighausen, T; Bloom, DE; Humair, S				Barnighausen, Till; Bloom, David E.; Humair, Salal			Human Resources for Treating HIV/AIDS: Are the Preventive Effects of Antiretroviral Treatment a Game Changer?	PLOS ONE			English	Article							SOUTH-AFRICA; INTERNATIONAL RECRUITMENT; HIV TRANSMISSION; HEALTH PERSONNEL; GLOBAL CODE; SCALE-UP; THERAPY; ACCESS; CARE; ACQUISITION	Shortages of human resources for treating HIV/AIDS (HRHA) are a fundamental barrier to reaching universal antiretroviral treatment (ART) coverage in developing countries. Previous studies suggest that recruiting HRHA to attain universal ART coverage poses an insurmountable challenge as ART significantly increases survival among HIV-infected individuals. While new evidence about ART's prevention benefits suggests fewer infections may mitigate the challenge, new policies such as treatment-as-prevention (TasP) will exacerbate it. We develop a mathematical model to analytically study the net effects of these countervailing factors. Using South Africa as a case study, we find that contrary to previous results, universal ART coverage is achievable even with current HRHA numbers. However, larger health gains are possible through a surge-capacity policy that aggressively recruits HRHA to reach universal ART coverage quickly. Without such a policy, TasP roll-out can increase health losses by crowding out sicker patients from treatment, unless a surge capacity exclusively for TasP is also created.	[Barnighausen, Till; Bloom, David E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Barnighausen, Till] AHRI, Mtubatuba, Kwazulu Natal, South Africa; [Barnighausen, Till] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Humair, Salal] Amazon Com Inc, Seattle, WA 98109 USA	Harvard University; Harvard T.H. Chan School of Public Health; Africa Health Research Institute; Ruprecht Karls University Heidelberg; Amazon.com	Humair, S (corresponding author), Amazon Com Inc, Seattle, WA 98109 USA.	salal@alum.mit.edu	Bärnighausen, Till/Y-2388-2019	Humair, Salal/0000-0002-9354-5389				Alistar SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000423; [Anonymous], 2014, GLOB UPD HLTH SECT R; Atun RA, 2008, DO VERTICAL STAND AL; Atun R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009656; Baernighausen T, 2011, NEW ENGL J MED, V364, P2181, DOI 10.1056/NEJMp1014255; Barnighausen T, 2010, B WORLD HEALTH ORGAN, V88, P951, DOI 10.2471/BLT.09.073890; Barnighausen T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-86; Barnighausen T, 2009, SOC SCI MED, V68, P544, DOI 10.1016/j.socscimed.2008.11.009; Bajunirwe F, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002875; Barnighausen T, 2011, OXFORD HDB HLTH EC; Barnighausen T, 2009, 15517 NBER; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Bongaarts J, 2010, SCIENCE, V328, P1359, DOI 10.1126/science.1191804; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bossert T, 2007, ASSESSING FINANCING; Bowser D, 2013, HLTH POLICY PLANNING; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; Brundage SC., 2011, TERRA NOVA ACHIEVE S; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colvin CJ, 2010, SAMJ S AFR MED J, V100, P210, DOI 10.7196/SAMJ.4124; Cometto G, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001514; de Vries E, 2010, SAMJ S AFR MED J, V100, P227, DOI 10.7196/SAMJ.3856; DFID, 2007, TAK ACT HIV STIGM DI; Di Giorgio L, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0653-z; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; ECONEX, 2010, HLTH REFORM NOTE; Edge JS, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-60; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Filler SJ, 2011, JAIDS-J ACQ IMM DEF, V57, pE1, DOI 10.1097/QAI.0b013e3182158980; Geldsetzer P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0675-6; George G, 2009, HUMAN RESOURCES HLTH; George G, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-15; GH Tech, 2011, 1101530 USAID GH TEC; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hagopian A, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-3; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; Hontelez JAC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158015; Hontelez JAC, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-39; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; HPCSA, 2012, HPCSA 2012 DATA SPRE; HSRC, 2008, MULT SOURC ID VER SC; IOM (Institute of Medicine), 2013, EV PEPFAR; Jack A., 2010, FINANCIAL TIMES; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; Johnson L., 2011, S AFR J HIV MED, V13, P22; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Kalichman SC, 2010, AIDS PATIENT CARE ST, V24, P271, DOI 10.1089/apc.2009.0309; Kasper J, 2012, ARCH DIS CHILD, V97, P973, DOI 10.1136/archdischild-2012-301900; Katz IT, 2013, NEW ENGL J MED, V369, P1385, DOI 10.1056/NEJMp1310982; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Leahy B, MOVING FORWARD TREAT; Levine R, 2009, JAIDS-J ACQ IMM DEF, V52, pS3, DOI 10.1097/QAI.0b013e3181bbc807; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Malaza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070126; McNairy ML, 2014, CLIN INFECT DIS, V58, P1003, DOI 10.1093/cid/ciu018; Mills EJ, 2011, AIDS, V25, P851, DOI 10.1097/QAD.0b013e32834564e9; Mullan F, 2007, JAMA-J AM MED ASSOC, V297, P744, DOI 10.1001/jama.297.7.744; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Ooms G, 2007, PLOS MED, V4, P605, DOI 10.1371/journal.pmed.0040128; Over M., 2008, PREVENTION FAILURE B; PEPFAR, 2011, PARTN FRAM SUPP S AF; Pfeiffer J, 2010, ANNU REV ANTHROPOL, V39, P149, DOI 10.1146/annurev.anthro.012809.105101; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Rosenberg NE, 2014, JAIDS-J ACQ IMM DEF, V65, pE162, DOI 10.1097/QAI.0000000000000066; Schoffelen AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058526; Senthilingam M, 2015, NATURE NEWS, V10, DOI [10.1038/nature.2015.18017., DOI 10.1038/NATURE.2015.18017]; Sheikh A, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-43; Sidibe M, 2011, 4 DECADE AIDS WHAT I, VXLVIII; Slomski A, 2013, JAMA-J AM MED ASSOC, V309, P1672, DOI 10.1001/jama.2013.3394; South Africa. Department of Health, 2014, NAT CONS GUID PREV M; South Africa Department of Health, 2013, FOR WORKF MAN S AFR; South Africa Department of Labor, 2009, SKILLS SHORT S AFRIC; South Africa Department of Labor, 2008, SHORT DOCT S AFR SCA; Stilwell Barbara, 2003, Hum Resour Health, V1, P8, DOI 10.1186/1478-4491-1-8; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Stover J, 2007, HEALTH AFFAIR, V26, P1147, DOI 10.1377/hlthaff.26.4.1147; Stover J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/738271; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tankwanchi ABS, 2014, LANCET GLOB HEALTH, V2, pE390, DOI 10.1016/S2214-109X(14)70240-2; Tankwanchi ABS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001513; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Uebel KE, 2013, JAIDS-J ACQ IMM DEF, V63, pE94, DOI 10.1097/QAI.0b013e318291cd08; UNAIDS, 2015, TREATMENT 2015, DOI [10.1097/QAI.0000000000000066, DOI 10.1097/QAI.0000000000000066]; UNAIDS, 2014, AMB TREATM TARG WRIT; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; Vandormael A, 2014, LANCET GLOB HEALTH, V2, pE209, DOI 10.1016/S2214-109X(14)70018-X; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185; Wadee H, 2007, S AFRICAN HLTH REV 2; Waning B, 2010, J GENERIC MED BUSINE, V7, P159, DOI [DOI 10.1057/JGM.2010.6, 10.1057/jgm.2010.6]; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WHO, 2012, WHO HIV DRUG RESISTA; WHO, 2008, FIN EC ASP HLTH WORK; WHO, 2010, INCR ACC HLTH REM RU; WHO UNAIDS UNICEF, 2013, GLOB UPD HIV TREAT 2; WHO UNAIDS UNICEF, 2011, 2011 WHO UNAIDS UNIC; World Health Organisation, 2012, ANT TREATM PREV TASP; World Health Organization, 2008, TASK SHIFT RAT RED T; Yu DB, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-8	102	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163960	10.1371/journal.pone.0163960	http://dx.doi.org/10.1371/journal.pone.0163960			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UW	27716813	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100014
J	De Henau, O; Degroot, GN; Imbault, V; Robert, V; De Poorter, C; Mcheik, S; Gales, C; Parmentier, M; Springael, JY				De Henau, Olivier; Degroot, Gaetan-Nagim; Imbault, Virginie; Robert, Virginie; De Poorter, Cedric; Mcheik, Saria; Gales, Celine; Parmentier, Marc; Springael, Jean-Yves			Signaling Properties of Chemerin Receptors CMKLR1, GPR1 and CCRL2	PLOS ONE			English	Article							HUMAN CHEMOKINE RECEPTOR; DENDRITIC CELLS; EXPRESSION; TRAFFICKING; ACTIVATION; LIGAND; INFLAMMATION; SECRETION; RESPONSES; CASCADES	Chemerin is a small chemotactic protein originally identified as the natural ligand of CMKLR1. More recently, two other receptors, GPR1 and CCRL2, have been reported to bind chemerin but their functional relevance remains poorly understood. In this study, we compared the binding and signaling properties of the three human chemerin receptors and showed differences in mode of chemerin binding and receptor signaling. Chemerin binds to all three receptors with low nanomolar affinities. However, the contribution of the chemerin C-terminus to binding efficiency varies greatly amongst receptors. By using BRET-based biosensors monitoring the activation of various G proteins, we showed that binding of chemerin and the chemerin 9 nonapeptide (149 YFPGQFAFS 157) to CMKLR1 activates the three Gai subtypes (Gai1, Gai2 and Gai3) and the two Gao isoforms (Gaoa and Gaob) with potencies correlated to binding affinities. In contrast, no significant activation of G proteins was detected upon binding of chemerin to GPR1 or CCRL2. Binding of chemerin and the chemerin 9 peptide also induced the recruitment of beta-arrestin1 and 2 to CMKLR1 and GPR1, though to various degree, but not to CCRL2. However, the propensity of chemerin 9 to activate beta-arrestins relative to chemerin is higher when bound to GPR1. Finally, we showed that binding of chemerin to CMKLR1 and GPR1 promotes also the internalization of the two receptors and the phosphorylation of ERK1/2 MAP kinases, although with a different efficiency, and that phosphorylation of ERK1/2 requires both Gai/o and beta-arrestin2 activation but not beta-arrestin1. Collectively, these data support a model in which each chemerin receptor displays selective signaling properties.	[De Henau, Olivier; Degroot, Gaetan-Nagim; Imbault, Virginie; Robert, Virginie; De Poorter, Cedric; Mcheik, Saria; Parmentier, Marc; Springael, Jean-Yves] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; [Gales, Celine] Univ Toulouse III Paul Sabatier, INSERM, Inst Malad Metab & Cardiovasc, Toulouse, France; [Parmentier, Marc] Walloon Excellence Life Sci & Biotechnol Welbio, Wavre, Belgium	Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; WELBIO	Parmentier, M (corresponding author), Univ Libre Bruxelles, IRIBHM, Brussels, Belgium.; Parmentier, M (corresponding author), Walloon Excellence Life Sci & Biotechnol Welbio, Wavre, Belgium.	mparment@ulb.ac.be		Robert, Virginie/0000-0001-9998-6890; GALES, Celine/0000-0002-4938-1583	Fonds National de le Recherche Scientifique (FNRS/FRIA); Televie Stundenship; Fonds de la Recherche Scientifique Medicale of Belgium; Actions de Recherche Concertees; Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy [IAP7-40]	Fonds National de le Recherche Scientifique (FNRS/FRIA)(Fonds de la Recherche Scientifique - FNRS); Televie Stundenship; Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees(University of Liege); Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office)	OD and CD hold a studentship from the Fonds National de le Recherche Scientifique (FNRS/FRIA). SM is the recipient of a Televie Stundenship. This work was supported by the Fonds de la Recherche Scientifique Medicale of Belgium, the Actions de Recherche Concertees, and the Interuniversity Attraction Poles Programme (IAP7-40), Belgian State, Belgian Science Policy.	Banas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117830; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Biber K, 2003, J LEUKOCYTE BIOL, V74, P243, DOI 10.1189/jlb.0802415; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Catusse J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-297; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; de Poorter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058075; Del PA, 2013, EUR J IMMUNOL, V43, P1418, DOI [10.1002/eji.201243179, DOI 10.1002/EJI.201243179]; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Fan P, 1998, BIOCHEM BIOPH RES CO, V243, P264, DOI 10.1006/bbrc.1997.7981; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gonzalvo-Feo S, 2014, J IMMUNOL, V192, P2366, DOI 10.4049/jimmunol.1302028; Guillabert A, 2008, J LEUKOCYTE BIOL, V84, P1530, DOI 10.1189/jlb.0508322; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kendall RT, 2009, CELL MOL LIFE SCI, V66, P2953, DOI 10.1007/s00018-009-0088-1; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Leick M, 2010, IMMUNOLOGY, V129, P536, DOI 10.1111/j.1365-2567.2009.03209.x; Li L, 2014, J ENDOCRINOL, V220, P155, DOI 10.1530/JOE-13-0275; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; MARCHESE A, 1994, BIOCHEM BIOPH RES CO, V205, P1952, DOI 10.1006/bbrc.1994.2899; MARCHESE A, 1994, GENOMICS, V23, P609, DOI 10.1006/geno.1994.1549; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Migeotte I, 2002, EUR J IMMUNOL, V32, P494, DOI 10.1002/1521-4141(200202)32:2<494::AID-IMMU494>3.0.CO;2-Y; Otero K, 2010, BLOOD, V116, P2942, DOI 10.1182/blood-2009-12-259903; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Reverchon M, 2012, HUM REPROD, V27, P1790, DOI 10.1093/humrep/des089; Rourke JL, 2013, OBES REV, V14, P245, DOI 10.1111/obr.12009; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300	36	95	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164179	10.1371/journal.pone.0164179	http://dx.doi.org/10.1371/journal.pone.0164179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716822	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100029
J	Means, AR; Risher, KA; Ujeneza, EL; Maposa, I; Nondi, J; Bellan, SE				Means, Arianna R.; Risher, Kathryn A.; Ujeneza, Eva L.; Maposa, Innocent; Nondi, Joseph; Bellan, Steven E.			Impact of Age and Sex on CD4+Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment Database	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4 CELL COUNTS; INFECTED PATIENTS; VIRAL-LOAD; RECOVERY; WOMEN; MORTALITY; SURVIVAL; INCREASE; GREATER	Objective New guidelines recommend that all HIV-infected individuals initiate antiretroviral treatment (ART) immediately following diagnosis. This study describes how immune reconstitution varies by gender and age to help identify poorly reconstituting subgroups and inform targeted testing initiatives. Design Longitudinal data from the outpatient monitoring system of the National AIDS Control Program in Tanzania. Methods An asymptotic nonlinear mixed effects model was fit to post-treatment CD4+ cell count trajectories, allowing for fixed effects of age and sex, and an age by sex interaction. Results Across 220,544 clinic visits from 32,069 HIV-infected patients, age-and sex-specific average CD4+ cell count at ART initiation ranged from 83 +/- 136 cells/mm(3), long term asymptotic CD4+ cell count ranged from 301 +/- 389 cells/mm(3), and time to half of maximal CD4+ reconstitution ranged from 3.57 +/- 5.68 months. CD4+ cell count at ART initiation and asymptotic CD4+ cell count were 1.28 (95% CI: 1.18-1.40) and 1.25 (95% CI: 1.20-1.31) times higher, respectively, for females compared to males in the youngest age group (19-29 years). Older patients started treatment at higher CD4+ counts but experienced slower CD4+ recovery than younger adults. Treatment initiation at greater CD4+ cell counts was correlated with greater asymptotic CD4+ cell counts within all sex and age groups. Conclusion Older adults should initiate care early in disease progression because total immune reconstitution potential and rate of reconstitution appears to decrease with age. Targeted HIV testing and care linkage remains crucial for patient populations who tend to initiate treatment at lower CD4+ cell counts, including males and younger adults.	[Means, Arianna R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Risher, Kathryn A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ujeneza, Eva L.] Univ Stellenbosch, Natl Res Fdn Ctr Excellence Epidemiol Modelling &, South African Dept Sci & Technol, ZA-7600 Stellenbosch, South Africa; [Maposa, Innocent] Polytech Namibia, Sch Hlth & Appl Sci, Dept Math & Stat, Windhoek, Namibia; [Nondi, Joseph] Minist Hlth & Social Welf MOHSW, Natl AIDS Control Program, Dar Es Salaam, Tanzania; [Bellan, Steven E.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA	University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Research Foundation - South Africa; Stellenbosch University; Namibia University of Science & Technology; University System of Georgia; University of Georgia	Bellan, SE (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.	steve.bellan@gmail.com		Ujeneza, Eva Liliane/0000-0002-5760-4847; Risher, Kathryn/0000-0002-9588-1693	Clinic on the Meaningful Modeling of Epidemiological Data (MMED); NIH; South African Centre for Epidemiological Modelling and Analysis (SACEMA); African Institute for Mathematical Sciences (AIMS) [NIH NIGMS R25GM102149]; National Institutes of Health [T32AI102623]; Schlumberger Foundation; National Institute of General Medical Sciences MIDAS [U01GM087719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM111274, R25GM102149] Funding Source: NIH RePORTER	Clinic on the Meaningful Modeling of Epidemiological Data (MMED); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African Centre for Epidemiological Modelling and Analysis (SACEMA); African Institute for Mathematical Sciences (AIMS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schlumberger Foundation(Schlumberger); National Institute of General Medical Sciences MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All authors gratefully acknowledge support from the Clinic on the Meaningful Modeling of Epidemiological Data (MMED) where this work was initiated; MMED is an NIH-funded joint initiative under the University of Florida, the South African Centre for Epidemiological Modelling and Analysis (SACEMA), and the African Institute for Mathematical Sciences (AIMS) (NIH NIGMS R25GM102149 to Juliet RC Pulliam and Alex Welte). KR has been supported by the National Institutes of Health (T32AI102623). ELU received funding from the Schlumberger Foundation. SEB was supported by a National Institute of General Medical Sciences MIDAS grant to Lauren Ancel Meyers and Alison P Galvani (U01GM087719).	Moro-Garcia MA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00107; Bastard M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-27; Chu HT, 2005, AM J EPIDEMIOL, V162, P787, DOI 10.1093/aje/kwi268; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; De Beaudrap P, 2008, JAIDS-J ACQ IMM DEF, V49, P70, DOI 10.1097/QAI.0b013e3181831847; De Beaudrap P, 2009, AM J TROP MED HYG, V80, P1047, DOI 10.4269/ajtmh.2009.80.1047; Ezeamama AE, 2015, INT J INFECT DIS, V35, P73, DOI 10.1016/j.ijid.2015.04.008; Franco RA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-147; Geng EH, 2012, CLIN INFECT DIS, V55, P1690, DOI 10.1093/cid/cis750; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Hoffmann CJ, 2013, JAIDS-J ACQ IMM DEF, V63, P34, DOI 10.1097/QAI.0b013e318287c1fe; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koethe JR, 2016, JAIDS-J ACQ IMM DEF, V73, P197, DOI 10.1097/QAI.0000000000001035; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Lovvorn AE, 2010, INT J STD AIDS, V21, P342, DOI 10.1258/ijsa.2009.009020; Luz PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093039; Malaza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070126; Mangal T., 2015, JOINT ESTIMATION HIV; Maskew M, 2013, J WOMENS HEALTH, V22, P113, DOI 10.1089/jwh.2012.3585; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Naftalin CM, 2015, INT J STD AIDS, V26, P803, DOI 10.1177/0956462414553826; National Guidelines For the Management of HIV and AIDS, 2009, NATIONAL GUIDELINES; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; PHILLIPS AN, 1995, NATURE, V375, P195, DOI 10.1038/375195a0; Picat MQ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001542; Pinheiro J., 2013, NLME LINEAR NONLINEA; Rickabaugh TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016459; Saharia KK, 2013, CELL, V155, P505, DOI 10.1016/j.cell.2013.09.045; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; UNAIDS, 2014, THE GAP REP; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; WHO, 2015, GUID START ANTR RAP; Wright ST, 2013, HIV MED, V14, P208, DOI 10.1111/j.1468-1293.2012.01053.x	39	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164148	10.1371/journal.pone.0164148	http://dx.doi.org/10.1371/journal.pone.0164148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716818	Green Published, gold, Green Accepted			2022-12-27	WOS:000385698100027
J	De Witte, NAJ; Sutterlin, S; Braet, C; Mueller, SC				De Witte, Nele A. J.; Sutterlin, Stefan; Braet, Caroline; Mueller, Sven C.			Getting to the Heart of Emotion Regulation in Youth: The Role of Interoceptive Sensitivity, Heart Rate Variability, and Parental Psychopathology	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; CARDIOVASCULAR AUTONOMIC FUNCTION; VAGAL TONE; INDIVIDUAL-DIFFERENCES; HOSPITAL ANXIETY; CHILDREN; AWARENESS; TRAJECTORIES; STRESS; MODEL	Emotion regulation and associated autonomic activation develop throughout childhood and adolescence under the influence of the family environment. Specifically, physiological indicators of autonomic nervous system activity such as interoceptive sensitivity and vagally mediated heart rate variability (HRV) can inform on emotion regulation. Although the effect of parental emotion socialization on emotion regulation appears to be influenced by autonomic processes, research on physiological regulation and the influence of parental factors remains scarce. This study investigated the relationship between self-reported habitual emotion regulation strategies and HRV at rest as well as interoceptive sensitivity in forty-six youngsters (27 female; age: M = 13.00, SD = 2.13). Secondly, the association between these autonomic correlates and parental psychopathology was also studied. Whereas better interoceptive sensitivity was related to reduced maladaptive emotion regulation, specifically rumination, high HRV was related to more use of external emotion regulation strategies (i.e., support seeking). In addition, increased HRV and decreased interoceptive sensitivity were associated with maternal internalizing and there was evidence for a possible mediation effect of HRV in the relationship between maternal internalizing and child external emotion regulation. This study elucidates the link between cognitive emotion regulation strategies and underlying physiological regulation in adolescents but also indicates a putative influence of maternal internalizing symptoms on emotion regulation in their offspring.	[De Witte, Nele A. J.; Mueller, Sven C.] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium; [Sutterlin, Stefan] Lillehammer Univ Coll, Psychol Sect, Lillehammer, Norway; [Sutterlin, Stefan] Oslo Univ Hosp, Rikshosp, Dept Neurobiol Med, Oslo, Norway; [Braet, Caroline] Univ Ghent, Dept Dev Personal & Social Psychol, Ghent, Belgium	Ghent University; Inland Norway University of Applied Sciences; University of Oslo; National Hospital Norway; Ghent University	De Witte, NAJ (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.	neledewitte@gmail.com		Mueller, Sven/0000-0003-1661-3840; Sutterlin, Stefan/0000-0002-4337-1296; Braet, Caroline/0000-0003-2458-287X; De Witte, Nele A. J./0000-0001-6313-7256	Ghent University (Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control")	Ghent University (Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control")	SCM and NDW are supported by Ghent University (Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SCM and NDW are supported by Ghent University (Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control").	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Ashman SB, 2008, DEV PSYCHOPATHOL, V20, P55, DOI 10.1017/S0954579408000035; Bariola E, 2011, CLIN CHILD FAM PSYCH, V14, P198, DOI 10.1007/s10567-011-0092-5; Beauchaine T, 2001, DEV PSYCHOPATHOL, V13, P183, DOI 10.1017/S0954579401002012; Beauchaine TP, 2007, BIOL PSYCHOL, V74, P174, DOI 10.1016/j.biopsycho.2005.08.008; Bechara A, 2004, NAT NEUROSCI, V7, P102, DOI 10.1038/nn0204-102; Blandon AY, 2008, DEV PSYCHOL, V44, P1110, DOI 10.1037/0012-1649.44.4.1110; Blandon AY, 2010, DEV PSYCHOL, V46, P1089, DOI 10.1037/a0020678; Blom EH, 2009, EUR J APPL PHYSIOL, V106, P877, DOI 10.1007/s00421-009-1089-3; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Braet C., 2013, VRAGENLIJST EMOTIERE; Calkins SD, 2007, BIOL PSYCHOL, V74, P144, DOI 10.1016/j.biopsycho.2006.09.005; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Camm AJ, 1996, EUR HEART J, V17, P354; Chapman HA, 2010, BIOL PSYCHOL, V84, P296, DOI 10.1016/j.biopsycho.2010.03.001; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Demaree HA, 2004, BRAIN COGNITION, V56, P14, DOI 10.1016/j.bandc.2004.05.001; Dunn BD, 2012, COGN AFFECT BEHAV NE, V12, P419, DOI 10.3758/s13415-012-0092-z; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P1, DOI 10.1017/S095457941000060X; Fabes RA, 1997, J PERS SOC PSYCHOL, V73, P1107, DOI 10.1037/0022-3514.73.5.1107; Faulkner MS, 2003, HEART LUNG, V32, P10, DOI 10.1067/mhl.2003.6; Field T, 2008, INFANT BEHAV DEV, V31, P361, DOI 10.1016/j.infbeh.2007.12.008; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; Furman DJ, 2013, J AFFECT DISORDERS, V151, P780, DOI 10.1016/j.jad.2013.06.044; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Garfinkel SN, 2013, SOC COGN AFFECT NEUR, V8, P231, DOI 10.1093/scan/nss140; Geisler FCM, 2013, BIOL PSYCHOL, V93, P279, DOI 10.1016/j.biopsycho.2013.02.013; Gentzler AL, 2012, DEV PSYCHOBIOL, V54, P556, DOI 10.1002/dev.20614; Gentzler AL, 2009, BIOL PSYCHOL, V82, P156, DOI 10.1016/j.biopsycho.2009.07.002; Gillie BL, 2015, PSYCHOPHYSIOLOGY, V52, P1149, DOI 10.1111/psyp.12443; Grob A., 2005, FRAGEBOGEN ERHEBUNG; Hayes AF, 2013, PSYCHOL SCI, V24, P1918, DOI 10.1177/0956797613480187; Herbert BM, 2014, EAT BEHAV, V15, P445, DOI 10.1016/j.eatbeh.2014.06.002; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; Hibberd EE, 2015, J PEDIATR ENDOCR MET, V28, P381, DOI 10.1515/jpem-2014-0187; Hien D., 1994, STRUCTURED CLIN INTE; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; Koch A, 2014, PSYCHOPHYSIOLOGY, V51, P932, DOI 10.1111/psyp.12233; Koenig J, 2014, J NUTR HEALTH AGING, V18, P300, DOI 10.1007/s12603-014-0022-6; Kok BE, 2010, BIOL PSYCHOL, V85, P432, DOI 10.1016/j.biopsycho.2010.09.005; Koval P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081536; Kowalewski M, 2007, PEDIATR RES, V62, P710, DOI 10.1203/PDR.0b013e3181598836; Krautwurst S, 2014, J BEHAV THER EXP PSY, V45, P303, DOI 10.1016/j.jbtep.2014.02.001; Kushki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059730; Lin Y, 2015, WORLD J BIOL PSYCHIA, V16, P323, DOI 10.3109/15622975.2015.1017603; Marroquin B, 2011, CLIN PSYCHOL REV, V31, P1276, DOI 10.1016/j.cpr.2011.09.005; McLaughlin KA, 2011, BEHAV RES THER, V49, P544, DOI 10.1016/j.brat.2011.06.003; Mcrae K, 2012, SOC COGN AFFECT NEUR, V7, P11, DOI 10.1093/scan/nsr093; Meessen J, 2016, J PSYCHOPHYSIOL, V30, P76, DOI 10.1027/0269-8803/a000157; Milicevic G, 2003, COLLEGIUM ANTROPOL, V27, P335; Mussgay L, 1999, J PSYCHOPHYSIOL, V13, P27, DOI 10.1027//0269-8803.13.1.27; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Pappens M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105054; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pollatos O, 2007, J ANXIETY DISORD, V21, P931, DOI 10.1016/j.janxdis.2006.12.004; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pu J, 2010, BIOL PSYCHOL, V84, P531, DOI 10.1016/j.biopsycho.2009.07.006; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schmitt K, 2012, Z KINDER JUG-PSYCH, V40, P95, DOI 10.1024/1422-4917/a000156; Scott BG, 2014, PSYCHOPHYSIOLOGY, V51, P718, DOI 10.1111/psyp.12218; Segerstrom SC, 2007, PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-9280.2007.01888.x; Shanahan L, 2014, DEV PSYCHOPATHOL, V26, P1353, DOI 10.1017/S0954579414001072; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Singh JP, 2001, AUTON NEUROSCI-BASIC, V90, P122, DOI 10.1016/S1566-0702(01)00277-6; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Srinivasan K, 2002, DEPRESS ANXIETY, V15, P159, DOI 10.1002/da.10046; Sulik MJ, 2013, BIOL PSYCHOL, V92, P241, DOI 10.1016/j.biopsycho.2012.10.009; Tanaka H, 2000, J PEDIATR-US, V137, P63, DOI 10.1067/mpd.2000.108098; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Vasilev CA, 2009, J CHILD PSYCHOL PSYC, V50, P1357, DOI 10.1111/j.1469-7610.2009.02172.x; Weckx M., 1998, NEDERLANDSE VERTALIN; Williams DP, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00261; Williams SR, 2015, CHILD PSYCHIAT HUM D, V46, P512, DOI 10.1007/s10578-014-0492-0; Zeman J, 2006, J DEV BEHAV PEDIATR, V27, P155, DOI 10.1097/00004703-200604000-00014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	85	20	20	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164615	10.1371/journal.pone.0164615	http://dx.doi.org/10.1371/journal.pone.0164615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741261	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000045
J	Kolola, T; Ekubay, M; Tesfa, E; Morka, W				Kolola, Tufa; Ekubay, Meseret; Tesfa, Endalamaw; Morka, Wogene			Determinants of Neonatal Mortality in North Shoa Zone, Amhara Regional State, Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; TRENDS; CARE; INITIATION; CHILDREN; INFANTS; DEATHS	In Ethiopia, neonatal mortality has been declined since the declaration of Millennium Developmental Goals, but the rate was slower since 2006. Thus, this study was designed to assess the determinants of neonatal mortality (NM) in North Shoa Zone. A community based case-control study was conducted on 84 cases and 252 controls. Cases were deceased new-borns within 28 days of birth while controls were infants survived beyond the first 28 days. Data were collected from mothers of the cases and controls using interviewer administered questionnaires. Multivariate analysis was done to examine determinants of NM. Variables significantly associated with NM in bivariate analysis were selected for multivariate analysis. Neonates whose mothers not attended antenatal care (AOR: 3.47; 95% CI: 1.44-8.32), delivered at home (AOR: 2.86; 95% CI: 1.56-5.26), and not received postnatal care services (AOR: 3.09; 95% CI: 1.73-5.51) were more likely to die. The odds of neonatal death was higher among neonates not breastfed within the first hour of delivery than those who breastfed within the first hour of delivery (AOR: 23.48; 95% CI: 8.43-65.37). Likewise, no-colostrum intake was positively associated with neonatal death. Neonates born to mothers who not received or received a single dose of tetanus toxoid injection (TTI) were more likely to experience death than those neonates born to mothers who received two or more doses of TTI (AOR: 2.05; 95% CI: 1.14-3.70). Furthermore, being small in size at birth (AOR: 2.66; 95% CI: 1.33-5.33) and male in sex (AOR: 1.85; 95% CI: 1.06-3.26) were risk factors for NM. In conclusion, neonatal mortality was significantly associated with factors that are modifiable through addressing the continuum-ofcare approach in healthcare services in North Shoa. This implies that ensuring a continuity of health care services for maternal and new-borns from antenatal to postnatal care will improve neonatal survival.	[Kolola, Tufa; Ekubay, Meseret; Morka, Wogene] Debre Berhan Univ, Inst Med & Hlth Sci, Debre Berhan, Ethiopia; [Tesfa, Endalamaw] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University	Kolola, T (corresponding author), Debre Berhan Univ, Inst Med & Hlth Sci, Debre Berhan, Ethiopia.	tufabest@gmail.com	Damtie, Endalamaw Tesfa/GPF-8119-2022	Damtie, Endalamaw Tesfa/0000-0002-1554-2190	Debre Berhan University	Debre Berhan University	This study was funded by Debre Berhan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyemi JO, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0349-0; [Anonymous], 2011, ETHIOPIA DEMOGRAPHIC, P452; Bashir AO, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-287; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Dhaded SM, 2015, REPROD HLTH S2, V12, P56; do Nascimento RM, 2012, CAD SAUDE PUBLICA, V28, P559, DOI 10.1590/S0102-311X2012000300016; Drevenstedt GL, 2008, P NATL ACAD SCI USA, V105, P5016, DOI 10.1073/pnas.0800221105; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; El Awour I, 2012, LANCET, V380, P25; Ghosh R, 2010, J BIOSOC SCI, V42, P511, DOI 10.1017/S0021932010000040; Gizaw M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-64; GREEN MS, 1992, INT J EPIDEMIOL, V21, P381, DOI 10.1093/ije/21.2.381; Hogan D., 2015, LANCET, V385, P430, DOI DOI 10.1016/S0140-6736(14)61698-6; Jehan I, 2009, B WORLD HEALTH ORGAN, V87, P130, DOI 10.2471/BLT.08.050963; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kayode GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-165; Khan AA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-322; Lambo JA, 2013, INT J INFECT DIS, V17, pE1100, DOI 10.1016/j.ijid.2013.05.016; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Malqvist M, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.5724; Mekonnen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-483; Mullany LC, 2008, J NUTR, V138, P599, DOI 10.1093/jn/138.3.599; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Onwuanaku Caroline A, 2011, BMC Res Notes, V4, P562, DOI 10.1186/1756-0500-4-562; Moura PMSS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-11; Singh A, 2013, PEERJ, V75, P4; Singh A K, 2013, RES REV J ECOLOGY EN, V1, P1, DOI DOI 10.1145/2463209.2488734; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048891; Singh Kiran, 1992, Health and Population Perspectives and Issues, V15, P94; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; UN, 2015, MILLENNIUM DEV GOALS; UNICEF, 2010, 9 UNICEF; Uthman O, 2008, INT J EPIDEMIOL, V6, P1; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Waldron I, 1998, SEX DIFFERENCES INFA, P64; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; World Health Organization, 2006, NEON PER MORT COUNTR; Yasmin S, 2001, B WORLD HEALTH ORGAN, V79, P608; Yego F, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0389-8	40	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164472	10.1371/journal.pone.0164472	http://dx.doi.org/10.1371/journal.pone.0164472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741284	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000037
J	Koh, W; Gonzalez, V; Natarajan, S; Carter, R; Brown, PO; Gawad, C				Koh, Winston; Gonzalez, Veronica; Natarajan, Sivaraman; Carter, Robert; Brown, Patrick O.; Gawad, Charles			Dynamic ASXL1 Exon Skipping and Alternative Circular Splicing in Single Human Cells	PLOS ONE			English	Article							GENE; RNAS; EXPRESSION; TRANSCRIPTS; TESTIS	Circular RNAs comprise a poorly understood new class of noncoding RNA. In this study, we used a combination of targeted deletion, high-resolution splicing detection, and single-cell sequencing to deeply probe ASXL1 circular splicing. We found that efficient circular splicing required the canonical transcriptional start site and inverted AluSx elements. Sequencing-based interrogation of isoforms after ASXL1 overexpression identified promiscuous linear splicing between all exons, with the two most abundant non-canonical linear products skipping the exons that produced the circular isoforms. Single-cell sequencing revealed a strong preference for either the linear or circular ASXL1 isoforms in each cell, and found the predominant exon skipping product is frequently co-expressed with its reciprocal circular isoform. Finally, absolute quantification of ASXL1 isoforms confirmed our findings and suggests that standard methods overestimate circRNA abundance. Taken together, these data reveal a dynamic new view of circRNA genesis, providing additional framework for studying their roles in cellular biology.	[Gonzalez, Veronica; Natarajan, Sivaraman; Carter, Robert; Gawad, Charles] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Gonzalez, Veronica; Natarajan, Sivaraman; Carter, Robert; Gawad, Charles] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Koh, Winston] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Koh, Winston] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Brown, Patrick O.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Gawad, C (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA.; Gawad, C (corresponding author), St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA.	Charles.Gawad@stjude.org	Koh, Lian Chye Winston/GYD-5873-2022; Gawad, Charles/AAP-5448-2021; Natarajan, Sivaraman/I-3513-2019; Gawad, Charles/N-8073-2018	Koh, Lian Chye Winston/0000-0003-4611-6490; Natarajan, Sivaraman/0000-0003-2608-2887; Gawad, Charles/0000-0002-4728-8203	Burroughs Wellcome Fund; Leukemia and Lymphoma Society; American Society of Hematology; American Lebanese Syrian Associated Charities; A*STAR, agency of science, technology and research, Singapore; Howard Hughes Medical Institute	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Society of Hematology; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); A*STAR, agency of science, technology and research, Singapore(Agency for Science Technology & Research (A*STAR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by funding to CG from the Burroughs Wellcome Fund (http://www.bwfund.org/grant-programs/biomedicalsciences/career-awards-medical-scientists), Leukemia and Lymphoma Society (http://www.lls. org), American Society of Hematology (http://www.hematology.org/Awards/Career-Training/463.aspx), and American Lebanese Syrian Associated Charities (Fund raiser for St. Jude Children's Hospital-https://www.stjude.org/about-st-jude/leadership/alsac-leadership.html). WK was also supported by A*STAR, agency of science, technology and research, Singapore (https://www.a-star.edu.sg). Some of these studies were supported by the Howard Hughes Medical Institute (http://www.hhmi.org) by funding from P.O.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Barrett SP, 2015, ELIFE, V4, DOI 10.7554/eLife.07540; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Fan XY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0706-1; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Gualandi F, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e100; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kelly S, 2015, J MOL BIOL, V427, P2414, DOI 10.1016/j.jmb.2015.02.018; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Zaphiropoulos PG, 1997, MOL CELL BIOL, V17, P2985, DOI 10.1128/MCB.17.6.2985	22	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164085	10.1371/journal.pone.0164085	http://dx.doi.org/10.1371/journal.pone.0164085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736885	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800038
J	O'Sullivan, S; Tay, ML; Lin, JM; Bava, U; Callon, K; Cornish, J; Naot, D; Grey, A				O'Sullivan, Susannah; Tay, Mei Lin; Lin, Jian-Ming; Bava, Usha; Callon, Karen; Cornish, Jillian; Naot, Dorit; Grey, Andrew			Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFR beta	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; PATIENTS RECEIVING IMATINIB; MESENCHYMAL STEM-CELLS; C-FMS; SECONDARY HYPERPARATHYROIDISM; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; ALTERED BONE; MESYLATE; OSTEOCLASTOGENESIS	Nilotinib and imatinib are tyrosine kinase inhibitors (TKIs) used in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). In vitro, imatinib and nilotinib inhibit osteoclastogenesis, and in patients they reduce levels of bone resorption. One of the mechanisms that might underlie these effects is an increase in the production of osteoprotegerin (OPG). In the current work we report that platelet-derived growth factor receptor beta (PDGFR beta) signaling regulates OPG production in vitro. In addition, we have shown that TKIs have effects on RANKL signaling through inhibition of the PDGFR beta and other target receptors. These findings have implications for our understanding of the mechanisms by which TKIs affect osteoclastogenesis, and the role of PDGFR beta signaling in regulating osteoclastogenesis. Further studies are indicated to confirm the clinical effects of PDGFR beta-inhibitors and to elaborate the intracellular pathways that underpin these effects.	[O'Sullivan, Susannah] Univ Auckland, Dept Pharmacol, Auckland, New Zealand; [Tay, Mei Lin; Lin, Jian-Ming; Bava, Usha; Callon, Karen; Cornish, Jillian; Naot, Dorit; Grey, Andrew] Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland; University of Auckland	O'Sullivan, S (corresponding author), Univ Auckland, Dept Pharmacol, Auckland, New Zealand.	s.osullivan@auckland.ac.nz	Tay, Mei/AAH-7288-2021	Tay, Mei Lin/0000-0002-1704-120X; Lin, Jian/0000-0002-8362-6951	Auckland Medical Research Foundation; Health Research Council; University of Auckland The Auckland Medical Research Foundation	Auckland Medical Research Foundation; Health Research Council; University of Auckland The Auckland Medical Research Foundation	The Auckland Medical Research Foundation provided funding for salary for SO and reagents for the research described in this manuscript. The Health Research Council provided funding for salary for UB and reagents for the research described in this manuscript. The University of Auckland The Auckland Medical Research Foundation provided funding for salary for MLT and reagents for the research described in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando W, 2006, J BONE MINER METAB, V24, P274, DOI 10.1007/s00774-006-0684-1; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; Brownlow N, 2008, LEUKEMIA, V22, P649, DOI 10.1038/sj.leu.2404944; Buchdunger E, 1996, CANCER RES, V56, P100; BUCHDUNGER E, 1995, P NATL ACAD SCI USA, V92, P2558, DOI 10.1073/pnas.92.7.2558; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Dewar AL, 2006, BLOOD, V107, P4334, DOI 10.1182/blood-2005-09-3568; Dib IE, 2006, EUR J PHARMACOL, V551, P27, DOI 10.1016/j.ejphar.2006.09.007; Fierro F, 2007, CELL PROLIFERAT, V40, P355, DOI 10.1111/j.1365-2184.2007.00438.x; Fitter S, 2008, BLOOD, V111, P2538, DOI 10.1182/blood-2007-07-104281; Gambacorti-Passerini C, 2003, LANCET, V361, P1954, DOI 10.1016/S0140-6736(03)13554-4; Grey A, 2006, NEW ENGL J MED, V355, P2494, DOI 10.1056/NEJMc062388; GROOT CG, 1985, CELL BIOL INT REP, V9, P528, DOI 10.1016/0309-1651(85)90015-3; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Herrmann-Erlee MPM, 1986, INT CONF IX ON CALCI; Hiraga T, 2009, INT J CANCER, V124, P215, DOI 10.1002/ijc.23903; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Joensuu H, 2006, NEW ENGL J MED, V355, P628; Jonsson S, 2008, HAEMATOL-HEMATOL J, V93, P1101, DOI 10.3324/haematol.12373; Jonsson S, 2012, AM J HEMATOL, V87, P550, DOI 10.1002/ajh.23155; Jonsson S, 2012, J BONE MINER METAB, V30, P119, DOI 10.1007/s00774-011-0323-3; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim SD, 2013, BIOCHEM PHARMACOL, V86, P782, DOI 10.1016/j.bcp.2013.07.015; Middleton-Hardie C, 2006, J BONE MINER RES, V21, P438, DOI 10.1359/JBMR.051104; Montemurro M, 2009, EUR J CANCER, V45, P2293, DOI 10.1016/j.ejca.2009.04.030; Nilsson B, 2007, BRIT J CANCER, V96, P1656, DOI 10.1038/sj.bjc.6603797; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; O'Sullivan S, 2013, LEUKEMIA LYMPHOMA, V54, P1783, DOI 10.3109/10428194.2012.760734; O'Sullivan S, 2011, BONE, V49, P281, DOI 10.1016/j.bone.2011.04.014; O'Sullivan S, 2011, CALCIFIED TISSUE INT, V88, P16, DOI 10.1007/s00223-010-9429-1; O'Sullivan S, 2009, J CLIN ENDOCR METAB, V94, P1131, DOI 10.1210/jc.2008-2324; Osorio S, 2007, AM J HEMATOL, V82, P394, DOI 10.1002/ajh.20778; Owen S, 2006, NEW ENGL J MED, V355, P627; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Paniagua RT, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2940; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Tibullo D, 2012, HEMATOL ONCOL, V30, P27, DOI 10.1002/hon.988; Tibullo D, 2009, EXP HEMATOL, V37, P461, DOI 10.1016/j.exphem.2008.12.008; Tsao AS, 2003, CANCER, V98, P2483, DOI 10.1002/cncr.11812; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007	41	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164727	10.1371/journal.pone.0164727	http://dx.doi.org/10.1371/journal.pone.0164727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737004	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505800121
J	Ossa, H; Aquino, J; Pereira, R; Ibarra, A; Ossa, RH; Perez, LA; Granda, JD; Lattig, MC; Groot, H; de Carvalho, EF; Gusmao, L				Ossa, Humberto; Aquino, Juliana; Pereira, Rui; Ibarra, Adriana; Ossa, Rafael H.; Adriana Perez, Luz; David Granda, Juan; Claudia Lattig, Maria; Groot, Helena; de Carvalho, Elizeu Fagundes; Gusmao, Leonor			Outlining the Ancestry Landscape of Colombian Admixed Populations	PLOS ONE			English	Article							DNA MTDNA HAPLOGROUPS; MITOCHONDRIAL-DNA; Y-CHROMOSOME; UNRELATED INDIVIDUALS; AMERICAN POPULATIONS; GENETIC ANCESTRY; ADMIXTURE; SUBSTRUCTURE; ASSOCIATION; COMMUNITIES	The ancestry of the Colombian population comprises a large number of well differentiated Native communities belonging to diverse linguistic groups. In the late fifteenth century, a process of admixture was initiated with the arrival of the Europeans, and several years later, Africans also became part of the Colombian population. Therefore, the genepool of the current Colombian population results from the admixture of Native Americans, Europeans and Africans. This admixture occurred differently in each region of the country, producing a clearly stratified population. Considering the importance of population substructure in both clinical and forensic genetics, we sought to investigate and compare patterns of genetic ancestry in Colombia by studying samples from Native and non-Native populations living in its 5 continental regions: the Andes, Caribe, Amazonia, Orinoquia, and Pacific regions. For this purpose, 46 AIM-Indels were genotyped in 761 non-related individuals from current populations. Previously published genotype data from 214 Colombian Natives from five communities were used for population comparisons. Significant differences were observed between Native and non-Native populations, among non-Native populations from different regions and among Native populations from different ethnic groups. The Pacific was the region with the highest African ancestry, Amazonia harboured the highest Native ancestry and the Andean and Orinoquian regions showed the highest proportion of European ancestry. The Andean region was further sub-divided into 6 sub-regions: North East, Central West, Central East, West, South West and South East. Among these regions, the South West region showed a significantly lower European admixture than the other regions. Hardy-Weinberg equilibrium and variance values of ancestry among individuals within populations showed a potential stratification of the Pacific population.	[Ossa, Humberto] Pontificia Univ Javeriana, Fac Ciencias, Bogota, Colombia; [Ossa, Humberto; Ossa, Rafael H.] Lab Genet & Biol Mol, Bogota, Colombia; [Aquino, Juliana; de Carvalho, Elizeu Fagundes; Gusmao, Leonor] State Univ Rio de Janeiro UERJ, DNA Diagnost Lab, Rio De Janeiro, Brazil; [Pereira, Rui] Univ Porto, i3S, Oporto, Portugal; [Pereira, Rui; Gusmao, Leonor] Univ Porto, IPATIMUP Inst Patol Imunol Mol, Oporto, Portugal; [Ibarra, Adriana; David Granda, Juan] Univ Antioquia, Sch Nat & Exact Sci FCEN, Inst Biol, IdentiGEN Genet Identificat Lab, Medellin, Antioquia, Colombia; [Ibarra, Adriana; David Granda, Juan] Univ Antioquia, Sch Nat & Exact Sci FCEN, Inst Biol, Res Grp Genet Identificat, Medellin, Antioquia, Colombia; [Ossa, Rafael H.] Univ Bosque, Fac Med, Bogota, Colombia; [Adriana Perez, Luz; Claudia Lattig, Maria; Groot, Helena] Univ Los Andes, Lab Genet Humana, Bogota, Colombia	Pontificia Universidad Javeriana; Universidade do Estado do Rio de Janeiro; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidad de Antioquia; Universidad de Antioquia; Universidad El Bosque; Universidad de los Andes (Colombia)	Gusmao, L (corresponding author), State Univ Rio de Janeiro UERJ, DNA Diagnost Lab, Rio De Janeiro, Brazil.; Gusmao, L (corresponding author), Univ Porto, IPATIMUP Inst Patol Imunol Mol, Oporto, Portugal.	Igusmao@ipatimup.pt	Gusmao, Leonor/B-3122-2013; Pereira, Rui/B-1656-2013; Gusmão, Leonor/L-8931-2019; DE CARVALHO, ELIZEU F/B-8525-2013	Gusmao, Leonor/0000-0003-0432-6481; Pereira, Rui/0000-0002-3889-798X; Gusmão, Leonor/0000-0003-0432-6481; DE CARVALHO, ELIZEU F/0000-0003-4620-7253; lattig, claudia/0000-0003-2113-9266; Ossa Trujillo, Rafael Humberto/0000-0003-3112-8712; Groot, Helena/0000-0002-9152-2175	DNA Program State University and Justice Court of Rio de Janeiro (UERJ/TJRJ/MPRJ), Brazil; FCT, Portugal [SFRH/BPD/81986/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil; Portuguese Foundation for Science and Technology	DNA Program State University and Justice Court of Rio de Janeiro (UERJ/TJRJ/MPRJ), Brazil; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	Financial support was granted by DNA Program State University and Justice Court of Rio de Janeiro (UERJ/TJRJ/MPRJ), Brazil. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and is partially supported by FCT, the Portuguese Foundation for Science and Technology. JA was supported through a Doctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil. RP is supported by a postdoctoral fellowship from FCT (SFRH/BPD/81986/2011), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alonso LA, 2013, HOMO, V64, P71, DOI 10.1016/j.jchb.2012.11.006; Aquino JG, 2015, FORENS SCI INT-GEN S, V5, pE34, DOI 10.1016/j.fsigss.2015.09.014; Arango Ochoa Raul., 2004, PUEBLOS INDIGENAS CO; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Briceno I, 1996, EUR J IMMUNOGENET, V23, P235, DOI 10.1111/j.1744-313X.1996.tb00118.x; Builes JJ, 2006, INT C SERIES, V1288, P174; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Casas-Vargas A, 2011, AM J PHYS ANTHROPOL, V146, P637, DOI 10.1002/ajpa.21626; Noguera MC, 2014, ANN HUM BIOL, V41, P453, DOI 10.3109/03014460.2013.852244; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gonzales De Perez MS, 2000, LENGUAS INDIGENAS CO; Homburger JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005602; Ibarra A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087202; Ibarra A, 2014, INT J LEGAL MED, V128, P19, DOI 10.1007/s00414-013-0858-z; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Manta FSN, 2013, ANN HUM BIOL, V40, P94, DOI 10.3109/03014460.2012.742138; Oliveros D. E., 1996, GEOGRAFIA HUMANA COL, V2, P153; Ossa H, 2015, FORENS SCI INT-GEN S, V5, pE332, DOI 10.1016/j.fsigss.2015.09.132; Pereira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029684; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rodas C, 2003, HUM BIOL, V75, P13, DOI 10.1353/hub.2003.0026; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salzano FM, 2014, GENET MOL BIOL, V37, P151, DOI 10.1590/S1415-47572014000200003; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Usme-Romero S, 2013, GENET MOL BIOL, V36, P149, DOI 10.1590/S1415-47572013005000011; Vullo C, 2015, INT J LEGAL MED, V129, P673, DOI 10.1007/s00414-014-1025-x; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Xavier C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120155; Yunis JJ, 2005, FORENSIC SCI INT, V151, P307, DOI 10.1016/j.forsciint.2005.02.005; Yunis JJ, 2013, GENET MOL BIOL, V36, P329, DOI 10.1590/S1415-47572013000300005; Zhivotovsky LA, 2001, FORENSIC SCI INT, V119, P269, DOI 10.1016/S0379-0738(00)00442-4	37	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164414	10.1371/journal.pone.0164414	http://dx.doi.org/10.1371/journal.pone.0164414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736937	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800064
J	Warren, DT; Donelson, JM; McCormick, MI; Ferrari, MCO; Munday, PL				Warren, Donald T.; Donelson, Jennifer M.; McCormick, Mark I.; Ferrari, Maud C. O.; Munday, Philip L.			Duration of Exposure to Elevated Temperature Affects Competitive Interactions in Juvenile Reef Fishes	PLOS ONE			English	Article							THERMAL-ACCLIMATION; DEVELOPMENTAL PLASTICITY; HABITAT DEGRADATION; CLIMATE-CHANGE; PERFORMANCE; TOLERANCE; RESPONSES; RECRUITMENT; PHYSIOLOGY; CAPACITY	Climate change will affect key ecological processes that structure natural communities, but the outcome of interactions between individuals and species will depend on their thermal plasticity. We tested how short-and long-term exposure to projected future temperatures affects intraspecific and interspecific competitive interactions in two species of coral reef damselfishes. In conspecific contests, juvenile Ambon damselfish, Pomacentrus amboinensis, exhibited no change in aggressive interactions after 4d exposure to higher temperatures. However, after 90d of exposure, fish showed a nonadaptive reduction in aggression at elevated temperatures. Conversely, 4d exposure to higher temperature increased aggression towards conspecifics in the lemon damselfish, Pomacentrus moluccensis. 90d exposure began to reduce this pattern, but overall there was little effect of temperature. Aggression in interspecific contests increased with short-term exposure, but was significantly lower after long-term exposure indicative of acclimation. Our results show how the length of exposure to elevated temperature can affect the outcome of competitive interactions. Furthermore, we illustrate that results from intraspecific contests may not accurately predict interspecific interactions, which will challenge our ability to generalise the effects of warming on competitive interactions.	[Warren, Donald T.; McCormick, Mark I.] James Cook Univ, Dept Marine Biol & Aquaculture, Townsville, Qld 4811, Australia; [Warren, Donald T.; Donelson, Jennifer M.; McCormick, Mark I.; Munday, Philip L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Donelson, Jennifer M.] Univ Technol Sydney, Sch Life Sci, POB 123, Broadway, NSW 2007, Australia; [Ferrari, Maud C. O.] Univ Saskatchewan, WCVM, Dept Biomed Sci, Saskatoon, SK, Canada	James Cook University; James Cook University; University of Technology Sydney; University of Saskatchewan	Warren, DT (corresponding author), James Cook Univ, Dept Marine Biol & Aquaculture, Townsville, Qld 4811, Australia.; Warren, DT (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	donald.warren@my.jcu.edu.au	McCormick, Mark I/J-8301-2014; Munday, Philip L/F-5443-2011; Donelson, Jennifer/M-5531-2018	McCormick, Mark I/0000-0001-9289-1645; Munday, Philip L/0000-0001-9725-2498; Donelson, Jennifer/0000-0002-0039-5300	Ian Potter Foundation [20140154]; University of Technology Sydney; NSERC DG; Australian Research Council; Centre of Excellence for Coral Reef Studies [CE140100020]; College of Marine and Environmental Sciences at James Cook University	Ian Potter Foundation; University of Technology Sydney; NSERC DG(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council(Australian Research Council); Centre of Excellence for Coral Reef Studies; College of Marine and Environmental Sciences at James Cook University	JMD was supported by the Ian Potter Foundation (grant #: 20140154) and The University of Technology Sydney. MCOF was supported by an NSERC DG. MIM and PLM were supported by the Australian Research Council, Centre of Excellence for Coral Reef Studies (grant #: CE140100020) and the College of Marine and Environmental Sciences at James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058520; Allen G. R., 1991, DAMSELFISHES WORLD, P271; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Andersen IL, 2011, BEHAV ECOL SOCIOBIOL, V65, P1159, DOI 10.1007/s00265-010-1128-4; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Australian Institute of Marine Science, 2014, WAT TEMP JAN 2014 AR; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Donelson JM, 2012, NAT CLIM CHANGE, V2, P30, DOI 10.1038/NCLIMATE1323; Donelson JM, 2011, GLOBAL CHANGE BIOL, V17, P1712, DOI 10.1111/j.1365-2486.2010.02339.x; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Gardiner NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013299; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Grenchik MK, 2013, CORAL REEFS, V32, P85, DOI 10.1007/s00338-012-0949-1; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HOFFMANN AA, 1995, TRENDS ECOL EVOL, V10, P1; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Huey R.B., 1996, Society for Experimental Biology Seminar Series, V59, P205; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; Huey RB, 1999, AM ZOOL, V39, P323; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Intergovernmental Panel on Climate Change, 2013, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Johansen JL, 2011, GLOBAL CHANGE BIOL, V17, P2971, DOI 10.1111/j.1365-2486.2011.02436.x; JOHNSON TP, 1995, J EXP BIOL, V198, P2165; Killen SS, 2014, FUNCT ECOL, V28, P1367, DOI 10.1111/1365-2435.12296; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; LEROI AM, 1994, P NATL ACAD SCI USA, V91, P1917, DOI 10.1073/pnas.91.5.1917; LEVINS R, 1969, AM NAT, V103, P483, DOI 10.1086/282616; McCormick MI, 2010, CORAL REEFS, V29, P537, DOI 10.1007/s00338-010-0620-7; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; McCormick MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042590; McCormick MI, 2012, P ROY SOC B-BIOL SCI, V279, P3899, DOI 10.1098/rspb.2012.0854; McCormick MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007096; Milazzo M, 2013, J ANIM ECOL, V82, P468, DOI 10.1111/j.1365-2656.2012.02034.x; Moksnes PO, 2004, MAR ECOL PROG SER, V281, P181, DOI 10.3354/meps281181; Mora C, 2001, MAR BIOL, V139, P765; Munday PL, 2013, ECOL LETT, V16, P1488, DOI 10.1111/ele.12185; Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, P23, DOI 10.1098/rspb.2015.1005; Newman RA, 1998, OECOLOGIA, V115, P9, DOI 10.1007/s004420050485; Nilsson GE, 2010, COMP BIOCHEM PHYS A, V156, P389, DOI 10.1016/j.cbpa.2010.03.009; Nilsson GE, 2009, GLOBAL CHANGE BIOL, V15, P1405, DOI 10.1111/j.1365-2486.2008.01767.x; Nilsson JA, 2001, ANIM BEHAV, V61, P357, DOI 10.1006/anbe.2000.1602; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Poulos DE, 2014, ANIM BEHAV, V90, P305, DOI 10.1016/j.anbehav.2014.02.003; Precht H., 1958, PHYSIOLOGICAL ADAPTA, P50; Schaefer J, 2006, J FISH BIOL, V69, P722, DOI 10.1111/j.1095-8649.2006.01145.x; Schulte PM, 2011, INTEGR COMP BIOL, V51, P691, DOI 10.1093/icb/icr097; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; Seebacher F, 2012, FUNCT ECOL, V26, P1418, DOI 10.1111/j.1365-2435.2012.02052.x; Sentis A, 2015, GLOBAL CHANGE BIOL, V21, P3290, DOI 10.1111/gcb.12931; Taniguchi Y, 1998, CAN J FISH AQUAT SCI, V55, P1894, DOI 10.1139/cjfas-55-8-1894; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Tracy RL, 2001, J COMP PHYSIOL B, V171, P669, DOI 10.1007/s003600100218; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; West-Eberhard Mary Jane, 2003, pi; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; Woods AH, 2001, BENEFICIAL HYPOTHESI, V74, P32, DOI [10.1086/319302, DOI 10.1086/319302]; Woods HA, 2002, EVOLUTION, V56, P1863	63	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164505	10.1371/journal.pone.0164505	http://dx.doi.org/10.1371/journal.pone.0164505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736924	Green Published, gold, Green Accepted			2022-12-27	WOS:000385505800076
J	Comas, M; Mendivil, J; Andreu, M; Hernandez, C; Castells, X				Comas, Merce; Mendivil, Joan; Andreu, Montserrat; Hernandez, Cristina; Castells, Xavier			Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program	PLOS ONE			English	Article							OCCULT BLOOD-TEST; BOWEL-CANCER; COST-EFFECTIVENESS; CAPACITY; IMPACT	Objective To estimate the long-term need for colonoscopies after a positive fecal immunochemical test (FIT) and post-polypectomy surveillance in the context of a population-based colorectal cancer (CRC) screening program. Methods A discrete-event simulation model was built to reproduce the process of CRC screening and post-polypectomy surveillance following European guidelines in a population of 100,000 men and women aged 50-69 years over a 20-year period. Screening consisted of biennial FIT and colonoscopy in participants with positive results. The model was mainly fed using data from the first and second rounds of a Spanish program (2010-2013). Data on post-polypectomy surveillance results were obtained from the literature. A probabilistic multivariate sensitivity analysis was performed on the effect of participation, FIT positivity, and adherence to surveillance colonoscopies. The main outcome variables were the number of colonoscopies after a positive FIT, surveillance colonoscopies, and the overall number of colonoscopies. Results An average yearly number of 1,200 colonoscopies after a positive FIT were predicted per 100,000 inhabitants with a slight increase to 1,400 at the end of the 20-year period. Surveillance colonoscopies increased to an average of 1,000 per 100,000 inhabitants in the long-term, showing certain stabilization in the last years of the 20-year simulation horizon. The results were highly sensitive to FIT positivity. Conclusions Implementing a population-based CRC screening program will increase the demand for colonoscopies, which is expected to double in 20 years, mainly due to an increase in surveillance colonoscopies.	[Comas, Merce; Hernandez, Cristina; Castells, Xavier] Hosp Mar, Epidemiol & Evaluat Dept, Barcelona, Spain; [Comas, Merce; Andreu, Montserrat; Hernandez, Cristina; Castells, Xavier] Hosp Mar, Med Res Inst, IMM, Barcelona, Spain; [Comas, Merce; Castells, Xavier] Red Invest Serv Salud Enfermedades Cronicas REDIS, Barcelona, Spain; [Mendivil, Joan] Roche Diagnost Int Ltd, CPS Market Access, Rotkreuz, Switzerland; [Andreu, Montserrat] Hosp Mar, Dept Gastroenterol, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Roche Holding; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Comas, M (corresponding author), Hosp Mar, Epidemiol & Evaluat Dept, Barcelona, Spain.; Comas, M (corresponding author), Hosp Mar, Med Res Inst, IMM, Barcelona, Spain.; Comas, M (corresponding author), Red Invest Serv Salud Enfermedades Cronicas REDIS, Barcelona, Spain.	mcomas@parcdesalutmar.cat	Serrano, Merce Comas/O-3825-2014; Buron, Andrea/E-5705-2016; Castells, Xavier/S-7798-2016	Serrano, Merce Comas/0000-0003-1926-2740; Buron, Andrea/0000-0003-3590-1303; Castells, Xavier/0000-0002-2528-0382; Mendivil, Joan/0000-0003-1139-0078	Instituto de Salud Carlos III-FEDER [PI07/90357]; Fundacion Mutua Madrilena [AP94422011]	Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	Financial support for this study was provided to MC by grant number PI07/90357 from Instituto de Salud Carlos III-FEDER (www.isciii.es/) and number AP94422011 from Fundacion Mutua Madrilena (www.fundacionmutua.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Roche Diagnostics International Ltd., a commercial company, provided support in the form of salaries for JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Brailsford S, 2011, EUR J OPER RES, V212, P223, DOI 10.1016/j.ejor.2010.10.026; Campbell L, 2014, THESIS; Cenin DR, 2014, MED J AUSTRALIA, V201, P456, DOI 10.5694/mja13.00112; Digby J, 2013, J MED SCREEN, V20, P80, DOI 10.1177/0969141313497197; European Commission, 2010, EUROPEAN GUIDELINES; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Grazzini G, 2008, J MED SCREEN, V15, P175, DOI 10.1258/jms.2008.008032; Grobbee EJ, 2015, AM J GASTROENTEROL, V110, P1072, DOI 10.1038/ajg.2015.157; Guy GP, 2014, CANCER-AM CANCER SOC, V120, P2308, DOI 10.1002/cncr.28724; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Karnon J, 2012, VALUE HEALTH, V15, P821, DOI 10.1016/j.jval.2012.04.013; Lansdorp-Vogelaar I, 2011, EPIDEMIOL REV, V33, P88, DOI 10.1093/epirev/mxr004; Nnoaham KE, 2008, GUT, V57, P1238, DOI 10.1136/gut.2007.146050; Parente F, 2013, ENDOSCOPY, V45, P27, DOI 10.1055/s-0032-1325800; Parente F, 2011, AM J GASTROENTEROL, V106, P1986, DOI 10.1038/ajg.2011.185; Pignone MP, 2011, MED J AUSTRALIA, V194, P180, DOI 10.5694/j.1326-5377.2011.tb03766.x; Rodriguez-Moranta Francisco, 2008, Gastroenterol Hepatol, V31, P405, DOI 10.1157/13125585; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Sharp L, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-105; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Tinmouth J, 2015, GUT, V64, P1327, DOI 10.1136/gutjnl-2014-308074; van Hees F, 2015, GUT, V64, P1985, DOI 10.1136/gutjnl-2015-309316; Wilschut JA, 2011, JNCI-J NATL CANCER I, V103, P1741, DOI 10.1093/jnci/djr385; Zorzi M, 2016, GUT, V65, P1822, DOI 10.1136/gutjnl-2015-310139	24	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164666	10.1371/journal.pone.0164666	http://dx.doi.org/10.1371/journal.pone.0164666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732635	gold, Green Published			2022-12-27	WOS:000385505300074
J	Jolly, SP; Rahman, M; Afsana, K; Yunus, FM; Chowdhury, AM				Jolly, Saira Parveen; Rahman, Mahfuzar; Afsana, Kaosar; Yunus, Fakir Md; Chowdhury, Ahmed M. R.			Evaluation of Maternal Health Service Indicators in Urban Slum of Bangladesh	PLOS ONE			English	Article							NEONATAL-MORTALITY; BIRTH ATTENDANTS; CARE SERVICES; DELIVERY; DHAKA; INTERVENTIONS; CHILDBIRTH; STRATEGIES; PREGNANCY; COVERAGE	Background A continuous influx of poor people to urban slums poses a challenge to Bangladesh's health system as it has failed to tackle maternal morbidity and mortality. BRAC is the largest non-governmental organisation in Bangladesh. BRAC has been working to reduce maternal, neonatal and under-five children morbidity and mortality of slum dwellers in cities. BRAC has been doing this work for a decade through a programme called MANOSHI. This programme provides door-to-door services to its beneficiaries through community health workers (CHWs) and normal delivery service through its delivery and maternity centres. BRAC started the 'MANOSHI' programme in Narayanganj City Corporation during 2011 to address maternal, neonatal and child health problems facing slum dwellers. We investigated the existing maternal health-service indicators in the slums of Narayanganj City Corporation and compared the findings with a non-intervention area. Methods This cross-sectional study was conducted during 2012, in 47 slums of Narayanganj City Corporation as intervention and 10 slums of Narsingdi Sadar Municipality as comparison area. A total of 1206 married women, aged 15-49 years, with a pregnancy outcome in the previous year were included for interview. Data on socio-demographic characteristics, reproductive and maternal health-care practices like use of contraceptive methods, antenatal care (ANC), delivery care, postnatal care (PNC) were collected through a structured questionnaire. The chi-square test, Student t test, Mann Whitney U-test, factor analysis and log-binominal test were performed by using STATA statistical software for analysing data. Results The activities of BRAC CHWs significantly improved four or more ANC (47% vs. 21%; p< 0.000) and PNC (48% vs. 39%; p< 0.01) coverage in the intervention slums compared to comparison slums. Still, about half of the deliveries in both areas were attended at home by unskilled birth attendants, of which a very few received PNC within 48 hours after delivery. The poorest and illiterate women received fewer maternal health services from medically trained providers (MTPs). The poorest had a lower likelihood of receiving services from MTPs during delivery complications. Conclusion The MANOSHI programme service coverage for delivery care and PNC-checkup for women who prefer home delivery needs to be improved. For sustainable improvement of maternal health outcomes in urban slums, the programme needs to facilitate access to services for poor and illiterate women.	[Jolly, Saira Parveen; Rahman, Mahfuzar; Yunus, Fakir Md] BRAC, Res & Evaluat Div, Dhaka 1212, Bangladesh; [Afsana, Kaosar] BRAC, Hlth Nutr & Populat Program, Dhaka 1212, Bangladesh; [Chowdhury, Ahmed M. R.] BRAC, Corp Off, Dhaka 1212, Bangladesh	Bangladesh Rural Advancement Committee BRAC; Bangladesh Rural Advancement Committee BRAC; Bangladesh Rural Advancement Committee BRAC	Jolly, SP (corresponding author), BRAC, Res & Evaluat Div, Dhaka 1212, Bangladesh.	sairaparveenjolly@gmail.com	Yunus, Fakir Md/H-3170-2019	Yunus, Fakir Md/0000-0002-0614-000X; Jolly, Saira/0000-0003-4709-9071; Afsana, Kaosar/0000-0002-5197-8151	BRAC	BRAC	This research activity was funded by the strategic partnership arrangement of BRAC.; The Research and Evaluation Division of BRAC, acknowledges with gratitude the commitment of the BRAC to its research effort. We are also thankful to Mrs Moragh Loose for editing this manuscript. This research activity was funded by the strategic partnership arrangement of BRAC. Research and Evaluation Division acknowledges with gratitude their effort.	Adams AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123817; Adams AM, 2015, HEALTH POLICY PLANN, V30, pi32, DOI 10.1093/heapol/czu094; Adams AM, 2013, LANCET, V382, P2027, DOI 10.1016/S0140-6736(13)62060-7; Adams AM, 2013, LANCET, V382, P2104, DOI 10.1016/S0140-6736(13)62150-9; Afsana K, 2011, LANCET, V377, P2178, DOI 10.1016/S0140-6736(11)60960-4; Afsana K, 2010, ONE MANY SCALING HLT; Ahmed SM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-663; Alam K, 2012, SOC SCI MED, V75, P511, DOI 10.1016/j.socscimed.2012.03.039; Alam N, 2000, J BIOSOC SCI, V32, P229, DOI 10.1017/S0021932000002297; [Anonymous], 2013, BANGL URB HLTH SURV; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS29, DOI 10.1038/sj.jp.7211269; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38; Bonu S, 2009, HEALTH POLICY PLANN, V24, P445, DOI 10.1093/heapol/czp032; Brown W, 2015, SEMIN PERINATOL, V39, P338, DOI 10.1053/j.semperi.2015.06.006; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Centers for Disease Control and Prevention National Center for Health Statistics, 1997, STAT DEF REP REQ LIV; Choudhury N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-791; Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; de Bernis L, 2016, LANCET, V387, P703, DOI 10.1016/S0140-6736(15)00954-X; Diaz-Quijano FA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-14; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1; Filippi V, 2016, REPROD MATERNAL NEWB, V2; Fotso JC, 2008, J URBAN HEALTH, V85, P428, DOI 10.1007/s11524-008-9263-1; Freeman JV, 2005, PAEDIATR PERINAT EP, V19, P323, DOI 10.1111/j.1365-3016.2005.00652.x; Fronczak N, 2007, J HEALTH POPUL NUTR, V25, P479; Haerty A, 2005, MONATSSCHR KINDERH, V153, P114, DOI 10.1007/s00112-005-1084-7; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Lassi ZS, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0106-y; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; MANOSHI, 2011, 118 MANOSHI ICDDR BR; MANOSHI, 2010, 113 MANOSHI ICDDR BR; Ministry of Health and Family Welfare, 2012, HEALTH POPULATION AN; Nahar S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-11; National Institute of Population Research and Training, 2006, BANGL URB HLTH SURV; National Institute of Population Research and Training (NIPORT), 2012, BANGL MAT MORT HLTH; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) Mitra and Associates ICF International, 2011, BANGL DEM HLTH SURV; Paul BK, 2002, SOC SCI MED, V54, P1755, DOI 10.1016/S0277-9536(01)00148-4; Population & Housing Census, 2011, POP HOUS CENS PREL R; Prakash R, 2013, J BIOSOC SCI, V45, P433, DOI 10.1017/S0021932012000831; Quayyum Z, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-22; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Rebecca Chalker, 1992, WOMANS BOOK CHOICES; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sanneving L, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19145; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; Titaley CR, 2009, J EPIDEMIOL COMMUN H, V63, P827, DOI 10.1136/jech.2008.081604; TRUSSELL J, 1983, DEMOGRAPHY, V20, P1, DOI 10.2307/2060898; Westoff C., 2005, DHS ANAL STUDIES; WHO/UNICEF, 2003, ANALYSIS OF TRENDS L; World Health Organization, 1998, THE WORLD HEALTH REP; Yanagisawa S, 2006, TROP MED INT HEALTH, V11, P238, DOI 10.1111/j.1365-3156.2005.01547.x; Yuan BB, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19542	60	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0162825	10.1371/journal.pone.0162825	http://dx.doi.org/10.1371/journal.pone.0162825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732596	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300007
J	Raccuia, L				Raccuia, Livio			Single-Target Implicit Association Tests (ST-IAT) Predict Voting Behavior of Decided and Undecided Voters in Swiss Referendums	PLOS ONE			English	Article							EXPLICIT ATTITUDES; COGNITION; VALIDITY	Undecided voters represent a major challenge to political pollsters. Recently, political psychologists have proposed the use of implicit association tests (IAT) to measure implicit attitudes toward political parties and candidates and predict voting behavior of undecided voters. A number of studies have shown that both implicit and explicit (i.e., self-reported) attitudes contribute to the prediction of voting behavior. More importantly, recent research suggests that implicit attitudes may be more useful for predicting the vote of undecided voters in the case of specific political issues rather than elections. Due to its direct-democratic political system, Switzerland represents an ideal place to investigate the predictive validity of IATs in the context of political votes. In this article, I present evidence from three studies in which both explicit and implicit measures were used ahead of the vote on four different referendums. Explicit measures predicted voting better than implicit attitudes for decided voters while implicit and explicit attitudes were equally good predictors among undecided voters. In addition, implicit attitudes predicted voting behavior descriptively, but not significantly better for undecided voters while, also from a descriptive point of view, explicit attitudes predicted voting better for decided respondents. In sum, results suggest that, as argued in previous research, the predictive value of implicit attitudes may be higher in the context of issue-related votes but still not as high as initially hoped-for.	[Raccuia, Livio] Univ Zurich, Dept Polit Sci, Zurich, Switzerland	University of Zurich	Raccuia, L (corresponding author), Univ Zurich, Dept Polit Sci, Zurich, Switzerland.	raccuia@ipz.uzh.ch						Arcuri L, 2008, POLIT PSYCHOL, V29, P369, DOI 10.1111/j.1467-9221.2008.00635.x; Bluemke M, 2008, EUR J SOC PSYCHOL, V38, P977, DOI 10.1002/ejsp.487; Cadinu M., 2011, SOCIAL PERCEPTION CO, P203; Dotsch R, 2011, J PERS SOC PSYCHOL, V100, P999, DOI 10.1037/a0023026; Dovidio JF, 1997, J EXP SOC PSYCHOL, V33, P510, DOI 10.1006/jesp.1997.1331; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Friese M, 2007, EXP PSYCHOL, V54, P247, DOI 10.1027/1618-3169.54.4.247; Friese M, 2016, SOC PERSONAL PSYCHOL, V10, P188, DOI 10.1111/spc3.12246; Friese M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044130; Galdi S, 2008, SCIENCE, V321, P1100, DOI 10.1126/science.1160769; Galdi S, 2012, PERS SOC PSYCHOL B, V38, P559, DOI 10.1177/0146167211435981; Gawronski B, 2006, CONSCIOUS COGN, V15, P485, DOI 10.1016/j.concog.2005.11.007; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Karpinski A, 2005, PERS SOC PSYCHOL B, V31, P949, DOI 10.1177/0146167204273007; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Lemm K. M., 2008, PSYCHOL MODERN PREJU, P123; Lundberg KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085680; Nosek B. A., 2010, HDB IMPLICIT SOCIAL, P548; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Perugini M, 2005, BRIT J SOC PSYCHOL, V44, P29, DOI 10.1348/014466604X23491; Roccato M, 2010, POLIT PSYCHOL, V31, P249, DOI 10.1111/j.1467-9221.2009.00751.x; Visser P., 2000, ELECTION POLLS NEWS, P224	25	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163872	10.1371/journal.pone.0163872	http://dx.doi.org/10.1371/journal.pone.0163872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732617	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300032
J	Wass, M; Hitz, F; Schaffrath, J; Muller-Tidow, C; Muller, LP				Wass, Maxi; Hitz, Friederike; Schaffrath, Judith; Mueller-Tidow, Carsten; Mueller, Lutz P.			Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							ELDERLY-PATIENTS; INTENSIVE CHEMOTHERAPY; EARLY DEATH; MYELODYSPLASTIC SYNDROMES; COMPLETE REMISSION; PROGNOSTIC MODEL; OLDER PATIENTS; SURVIVAL; AGE; SCORE	Age is a dominant predictor of outcome in acute myeloid leukemia (AML). However, it is not clear to which extent comorbidities contribute to this effect. The objective of this study was to determine the impact of pretreatment comorbidities on survival of AML patients. In a single-center retrospective study 194 adult AML patients were included. The Hematopoietic cell transplantation comorbidity index (HCT-CI), the Adult Comorbidity Evaluation-27 (ACE-27) score and the Cumulative Illness Rating Scale for Geriatrics (CIRS-G) as well as data on demographics, cytogenetics, treatment and outcome were evaluated at the time of initial diagnosis by univariate and multivariate analysis. The study included 102 male and 92 female (median age 60.9 years) of which 173 (89.2%) received intensive chemotherapy. Median overall survival (OS) was 17 months. In univariate analysis, cardiovascular disease (26 vs 12 months, p = .005), severe hepatic disease (19 vs 4 months, p = .013) and renal impairment (17 vs 7 months, p = .016) was associated with inferior OS. For each index, the highest comorbidity burden was associated with reduced OS. However, in multivariate analysis only the ACE-27 score was associated with outcome. Besides ECOG >= 2 and poor cytogenetics only the ACE-27 score but not higher age was associated with OS in the group of patients receiving intensive therapy. Adjusted hazard ratios were 3.1, 3.5 and 4.0 for mild, moderate and severe ACE-27-assessed comorbidities, respectively (p = .012). Our study confirms that comorbidities significantly impact survival of AML patients and a pretreatment assessment of comorbidities may help to identify patients with poor outcome.	[Wass, Maxi; Hitz, Friederike; Schaffrath, Judith; Mueller-Tidow, Carsten; Mueller, Lutz P.] Univ Hosp Halle, Dept Hematol & Oncol, Halle, Germany	Martin Luther University Halle Wittenberg	Wass, M (corresponding author), Univ Hosp Halle, Dept Hematol & Oncol, Halle, Germany.	maxi.wass@uk-halle.de	Müller, Lutz/ABE-2941-2020; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232				Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bullinger L, 2010, BLOOD, V115, P636, DOI 10.1182/blood-2009-03-211003; Chen CC, 2005, ANN ONCOL, V16, P1366, DOI 10.1093/annonc/mdi259; Damm F, 2011, BLOOD, V117, P4561, DOI 10.1182/blood-2010-08-303479; Daver N, 2014, AM J HEMATOL, V89, P509, DOI 10.1002/ajh.23675; Deschler B, 2013, HAEMATOLOGICA, V98, P208, DOI 10.3324/haematol.2012.067892; Djunic I, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0394-6; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Eichhorst B, 2009, LEUKEMIA LYMPHOMA, V50, P171, DOI 10.1080/10428190802688517; Etienne A, 2007, CANCER, V109, P1376, DOI 10.1002/cncr.22537; Extermann Martine, 2007, Cancer Control, V14, P13; Giles FJ, 2007, BRIT J HAEMATOL, V136, P624, DOI 10.1111/j.1365-2141.2006.06476.x; Gupta V, 2005, CANCER-AM CANCER SOC, V103, P2082, DOI 10.1002/cncr.21006; Juliusson G, 2009, BLOOD, V113, P4179, DOI 10.1182/blood-2008-07-172007; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1090, DOI 10.1002/cncr.21723; Krug U, 2010, LANCET, V376, P2000, DOI 10.1016/S0140-6736(10)62105-8; Malfuson JV, 2008, HAEMATOL-HEMATOL J, V93, P1806, DOI 10.3324/haematol.13309; Mohammadi M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1857-x; Naqvi K, 2011, J CLIN ONCOL, V29, P2240, DOI 10.1200/JCO.2010.31.3353; Newberry KJ, 2014, CANCER-AM CANCER SOC, V120, P2996, DOI 10.1002/cncr.28857; Ostgard LSG, 2015, LEUKEMIA, V29, P548, DOI 10.1038/leu.2014.234; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Pollyea DA, 2011, BRIT J HAEMATOL, V152, P524, DOI 10.1111/j.1365-2141.2010.08470.x; Rollig C, 2011, J CLIN ONCOL, V29, P2758, DOI 10.1200/JCO.2010.32.8500; Rollig C, 2010, BLOOD, V116, P971, DOI 10.1182/blood-2010-01-267302; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Savic A, 2012, LEUKEMIA RES, V36, P479, DOI 10.1016/j.leukres.2011.11.021; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Sorror ML, 2007, BLOOD, V110, P4606, DOI 10.1182/blood-2007-06-096966; Tawfik B, 2016, J GERIATR ONCOL, V7, P24, DOI 10.1016/j.jgo.2015.10.182; Wheatley K, 2009, BRIT J HAEMATOL, V145, P598, DOI 10.1111/j.1365-2141.2009.07663.x; Williams GR, 2015, J GERIATR ONCOL	33	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164587	10.1371/journal.pone.0164587	http://dx.doi.org/10.1371/journal.pone.0164587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732646	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300066
J	Thomas, AS; Milfont, TL; Gavin, MC				Thomas, Alyssa S.; Milfont, Taciano L.; Gavin, Michael C.			A New Approach to Identifying the Drivers of Regulation Compliance Using Multivariate Behavioural Models	PLOS ONE			English	Article							PLANNED BEHAVIOR; RANDOMIZED-RESPONSE; SOCIAL-INFLUENCE; FISHERIES; NORMS; NONCOMPLIANCE; CONSERVATION; METAANALYSIS; ENFORCEMENT; LEGITIMACY	Non-compliance with fishing regulations can undermine management effectiveness. Previous bivariate approaches were unable to untangle the complex mix of factors that may influence fishers' compliance decisions, including enforcement, moral norms, perceived legitimacy of regulations and the behaviour of others. We compared seven multivariate behavioural models of fisher compliance decisions using structural equation modeling. An online survey of over 300 recreational fishers tested the ability of each model to best predict their compliance with two fishing regulations (daily and size limits). The best fitting model for both regulations was composed solely of psycho-social factors, with social norms having the greatest influence on fishers' compliance behaviour. Fishers' attitude also directly affected compliance with size limit, but to a lesser extent. On the basis of these findings, we suggest behavioural interventions to target social norms instead of increasing enforcement for the focal regulations in the recreational blue cod fishery in the Marlborough Sounds, New Zealand. These interventions could include articles in local newspapers and fishing magazines highlighting the extent of regulation compliance as well as using respected local fishers to emphasize the benefits of compliance through public meetings or letters to the editor. Our methodological approach can be broadly applied by natural resource managers as an effective tool to identify drivers of compliance that can then guide the design of interventions to decrease illegal resource use.	[Thomas, Alyssa S.; Gavin, Michael C.] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand; [Milfont, Taciano L.] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand; [Gavin, Michael C.] Colorado State Univ, Human Dimens Nat Resources, Ft Collins, CO 80523 USA	Victoria University Wellington; Victoria University Wellington; Colorado State University	Thomas, AS (corresponding author), Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand.	choiceofluthien@gmail.com	Thomas, Alyssa/AAD-8783-2022; Thomas, Alyssa/AAH-6854-2021; Milfont, Taciano L/GCA-0840-2022	Thomas, Alyssa/0000-0002-1207-4344; Milfont, Taciano L/0000-0001-6838-6307; Gavin, Michael/0000-0002-2169-4668	School of Psychology at Victoria University of Wellington [93432/2207]	School of Psychology at Victoria University of Wellington	AT was funded by a grant from The School of Psychology at Victoria University of Wellington (grant #93432/2207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2013, GLOBAL ENVIRON CHANG, V23, P1773, DOI 10.1016/j.gloenvcha.2013.07.029; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Akpalu W., 2011, Journal of Socio-Economics, V40, P172, DOI 10.1016/j.socec.2010.12.014; [Anonymous], 1998, OCEAN DEV INT LAW, V29, P339, DOI [10.1080/00908329809546131, DOI 10.1080/00908329809546131]; Arias A, 2015, J ENVIRON MANAGE, V153, P134, DOI 10.1016/j.jenvman.2015.02.013; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bamberg S, 2007, J ENVIRON PSYCHOL, V27, P14, DOI 10.1016/j.jenvp.2006.12.002; Batstone C., 2009, MARLBOROUGH SOUNDS R, P63; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Blewitt E, 1987, FISHERIES LAW ENFORC, P170; Borsari B, 2003, J STUD ALCOHOL, V64, P331, DOI 10.15288/jsa.2003.64.331; Bose S, 2009, MAR POLICY, V33, P248, DOI 10.1016/j.marpol.2008.07.004; Byrne B.M., 2012, STRUCTURAL EQUATION; Chen XD, 2009, P NATL ACAD SCI USA, V106, P11812, DOI 10.1073/pnas.0809980106; Cialdini RB, 2003, CURR DIR PSYCHOL SCI, V12, P105, DOI 10.1111/1467-8721.01242; Cialdini RB, 2007, PSYCHOMETRIKA, V72, P263, DOI 10.1007/s11336-006-1560-6; De Leeuw E., 2008, INT HDB SURVEY METHO, P113, DOI DOI 10.4324/9780203843123.CH7; Diogo H, 2016, MAR POLICY, V63, P92, DOI 10.1016/j.marpol.2015.10.007; Free CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143960; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; Gezelius SS, 2002, ACTA SOCIOL, V45, P305, DOI 10.1177/000169930204500404; Heard M, 2016, MAR POLICY, V64, P168, DOI 10.1016/j.marpol.2015.11.019; Jagers SC, 2012, MAR POLICY, V36, P969, DOI 10.1016/j.marpol.2012.02.004; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; King DM, 2010, MAR POLICY, V34, P7, DOI 10.1016/j.marpol.2009.04.023; Kuperan K, 1998, LAW SOC REV, V32, P309, DOI 10.2307/827765; Ministry of Primary Industries, CHALL AR FISH RUL; Ministry of Primary Industries [Internet], 2015, REV FISH RUL MARLB S; Nielsen JR, 2003, MAR POLICY, V27, P409, DOI 10.1016/S0308-597X(03)00024-1; Oh CO, 2013, LEISURE SCI, V35, P256, DOI 10.1080/01490400.2013.780534; Pieraccini M, 2017, AQUAT CONSERV, V27, P177, DOI 10.1002/aqc.2632; Slater MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089156; Solomon JN, 2015, BIOL CONSERV, V189, P1, DOI 10.1016/j.biocon.2015.04.028; St John FAV, 2012, P ROY SOC B-BIOL SCI, V279, P804, DOI 10.1098/rspb.2011.1228; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; SUTINEN JG, 1990, OCEAN DEV INT LAW, V21, P335, DOI 10.1080/00908329009545942; SUTINEN JG, 1985, LAND ECON, V61, P387, DOI 10.2307/3146156; Thomas AS, 2015, BIOL CONSERV, V189, P24, DOI 10.1016/j.biocon.2014.09.048; Thomas AS, 2015, WHAT DETERMINES FISH, P547; Tyler T.R., 1990, WHY PEOPLE OBEY LAW; van der Heijden PGM, 2000, SOCIOL METHOD RES, V28, P505, DOI 10.1177/0049124100028004005; Viteri C, 2007, OCEAN COAST MANAGE, V50, P253, DOI 10.1016/j.ocecoaman.2006.05.002; White KM, 2009, BRIT J SOC PSYCHOL, V48, P135, DOI 10.1348/014466608X295207; Zubair M, 2006, AGROFOREST SYST, V66, P217, DOI 10.1007/s10457-005-8846-z	44	30	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163868	10.1371/journal.pone.0163868	http://dx.doi.org/10.1371/journal.pone.0163868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CI	27727292	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504400012
J	Zhang, Y; Prins, HHT; Versluijs, M; Wessels, R; Cao, L; de Boer, WF				Zhang, Yong; Prins, Herbert H. T.; Versluijs, Martijn; Wessels, Rick; Cao, Lei; de Boer, Willem Frederik			Experimental Evidence Shows the Importance of Behavioural Plasticity and Body Size under Competition in Waterfowl	PLOS ONE			English	Article							GEESE BRANTA-LEUCOPSIS; LESSER SNOW GEESE; BARNACLE GEESE; FUNCTIONAL-RESPONSE; FORAGE QUALITY; SWARD HEIGHT; BRENT GEESE; HERBIVOROUS ANATIDAE; MAMMALIAN HERBIVORES; NITROGEN-CONTENT	When differently sized species feed on the same resources, interference competition may occur, which may negatively affect their food intake rate. It is expected that competition between species also alters behaviour and feeding patch selection. To assess these changes in behaviour and patch selection, we applied an experimental approach using captive birds of three differently sized Anatidae species: wigeon (Anas penelope) (similar to 600 g), swan goose (Anser cygnoides) (similar to 2700 g) and bean goose (Anser fabalis) (similar to 3200 g). We quantified the functional response for each species and then recorded their behaviour and patch selection with and without potential competitors, using different species combinations. Our results showed that all three species acquired the highest nitrogen intake at relatively tall swards (6, 9 cm) when foraging in single species flocks in the functional response experiment. Goose species were offered foraging patches differing in sward height with and without competitors, and we tested for the effect of competition on foraging behaviour. The mean percentage of time spent feeding and being vigilant did not change under competition for all species. However, all species utilized strategies that increased their peck rate on patches across different sward heights, resulting in the same instantaneous and nitrogen intake rate. Our results suggest that variation in peck rate over different swards height permits Anatidae herbivores to compensate for the loss of intake under competition, illustrating the importance of behavioural plasticity in heterogeneous environments when competing with other species for resources.	[Zhang, Yong] Nanjing Forestry Univ, Coll Biol & Environm, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Zhang, Yong; Prins, Herbert H. T.; Versluijs, Martijn; Wessels, Rick; de Boer, Willem Frederik] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Cao, Lei] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Nanjing Forestry University; Wageningen University & Research; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Zhang, Y (corresponding author), Nanjing Forestry Univ, Coll Biol & Environm, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.; Zhang, Y (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.; Cao, L (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.	zyong@mail.ustc.edu.cn; leicao@rcees.ac.cn	Versluijs, Martijn/I-5521-2019	Versluijs, Martijn/0000-0001-8156-9124; Prins, Herbert/0000-0003-1131-5107	National Basic Research Program of China (973 Program) [2012CB956104]; National Natural Science Foundation of China [31370416]; State Science and Technology Service Network Initiative Project of the Chinese Academy of Sciences [KFJ-EW-ZY-004-6]; Open Project of State Key Laboratory of Urbanand Regional Ecology [SKLURE2014-2-3]; Chinese Academy of Sciences; CAS-KNAW Joint PhD Training Programme	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Science and Technology Service Network Initiative Project of the Chinese Academy of Sciences; Open Project of State Key Laboratory of Urbanand Regional Ecology; Chinese Academy of Sciences(Chinese Academy of Sciences); CAS-KNAW Joint PhD Training Programme	National Basic Research Program of China (973 Program, Grant No. 2012CB956104), www.nsfc.gov.cn, LC; National Natural Science Foundation of China (Grant No. 31370416), www.nsfc.gov.cn, LC; State Science and Technology Service Network Initiative Project of the Chinese Academy of Sciences (KFJ-EW-ZY-004-6), http://www.cas.cn, LC; Open Project of State Key Laboratory of Urbanand Regional Ecology (No. SKLURE2014-2-3), Chinese Academy of Sciences, http://dse.rcees.cas.cn, LC; CAS-KNAW Joint PhD Training Programme, www.knaw.nl, YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK JM, 1992, ANIM BEHAV, V44, P41, DOI 10.1016/S0003-3472(05)80752-3; Bos D, 2004, OIKOS, V107, P485, DOI 10.1111/j.0030-1299.2004.13273.x; Cope DR, 2003, J ZOOL, V260, P65, DOI 10.1017/S0952836903003509; Cramp S, 1998, COMPLETE BIRDS W PAL; Cresswell W, 1997, J ANIM ECOL, V66, P461, DOI 10.2307/5941; Durant D, 2006, J ORNITHOL, V147, P367, DOI 10.1007/s10336-005-0029-1; Durant D, 2004, J AVIAN BIOL, V35, P144, DOI 10.1111/j.0908-8857.2004.03166.x; Durant D, 2003, J ANIM ECOL, V72, P220, DOI 10.1046/j.1365-2656.2003.00689.x; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Fox A.D., 1981, Wildfowl, V32, P48; Fox AD, 1998, IBIS, V140, P676, DOI 10.1111/j.1474-919X.1998.tb04714.x; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Gauvin S, 2004, OECOLOGIA, V139, P150, DOI 10.1007/s00442-003-1482-2; Hassall M, 2001, OECOLOGIA, V127, P97, DOI 10.1007/s004420000563; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Heuermann N, 2011, OECOLOGIA, V166, P659, DOI 10.1007/s00442-010-1894-8; HIROSE T, 1989, ECOLOGY, V70, P1610, DOI 10.2307/1938094; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Huntingford F. A., 1987, ANIMAL CONFLICT, DOI [10.1007/978-94-009-3145-9, DOI 10.1007/978-94-009-3145-9]; Hupp JW, 1996, OECOLOGIA, V108, P232, DOI 10.1007/BF00334646; Jonsson JE, 2008, WILSON J ORNITHOL, V120, P725, DOI 10.1676/07-124.1; Kristiansen JN, 2002, ARDEA, V90, P1; MADSEN J, 1985, ORNIS SCAND, V16, P140, DOI 10.2307/3676479; MANSEAU M, 1993, ECOLOGY, V74, P2045, DOI 10.2307/1940850; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; MOORE FR, 1978, BEHAV ECOL SOCIOBIOL, V3, P173, DOI 10.1007/BF00294988; Nersesian CL, 2012, BEHAV ECOL SOCIOBIOL, V66, P47, DOI 10.1007/s00265-011-1250-y; Newton I., 1998, POPULATION LIMITATIO; NOVOZAMSKY I, 1983, COMMUN SOIL SCI PLAN, V14, P239, DOI 10.1080/00103628309367359; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Prins H, 1998, SPECIES RICHNESS AFR; Prins HHT, 2006, AFR J ECOL, V44, P186, DOI 10.1111/j.1365-2028.2006.00619.x; PRINS HHT, 1985, OECOLOGIA, V66, P122, DOI 10.1007/BF00378563; PROP J, 1992, FUNCT ECOL, V6, P180, DOI 10.2307/2389753; Randler C, 2004, J FIELD ORNITHOL, V75, P404, DOI 10.1648/0273-8570-75.4.404; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; SEDINGER JS, 1984, J WILDLIFE MANAGE, V48, P1128, DOI 10.2307/3801773; SEDINGER JS, 1984, AUK, V101, P295, DOI 10.1093/auk/101.2.295; Smith RD, 2001, BEHAV ECOL, V12, P475, DOI 10.1093/beheco/12.4.475; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; SPALINGER DE, 1992, AM NAT, V140, P325, DOI 10.1086/285415; Stillman RA, 1997, J ANIM ECOL, V66, P692, DOI 10.2307/5922; SUMMERS RW, 1990, J APPL ECOL, V27, P834, DOI 10.2307/2404380; Vahl WK, 2006, INTERFERENCE COMPETI; van der Graaf AJ, 2006, J ORNITHOL, V147, P479, DOI 10.1007/s10336-005-0041-5; van der Wal R, 1998, OIKOS, V82, P123, DOI 10.2307/3546922; van Dijk JGB, 2012, ETHOLOGY, V118, P169, DOI 10.1111/j.1439-0310.2011.01994.x; van Langevelde F, 2008, ECOL MODEL, V213, P273, DOI 10.1016/j.ecolmodel.2007.12.009; Wang X, 2013, IBIS, V155, P576, DOI 10.1111/ibi.12039; Wiens J. A, 1989, ECOLOGY BIRD COMMUNI, V2; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; WILMSHURST JF, 1995, BEHAV ECOL, V6, P209, DOI 10.1093/beheco/6.2.209; YDENBERG RC, 1981, J APPL ECOL, V18, P443, DOI 10.2307/2402405; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124972; Zhao Mei Juan, 2010, Wildfowl, V60, P52; Zhao MJ, 2012, BIRD CONSERV INT, V22, P135, DOI 10.1017/S0959270911000542	57	8	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164606	10.1371/journal.pone.0164606	http://dx.doi.org/10.1371/journal.pone.0164606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727315	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504400044
J	Collinson-Pautz, MR; Slawin, KM; Levitt, JM; Spencer, DM				Collinson-Pautz, Matthew R.; Slawin, Kevin M.; Levitt, Jonathan M.; Spencer, David M.			MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; CD8(+) T-CELLS; IN-VIVO; CROSS-PRESENTATION; PLASMID ELECTROPORATION; IMMUNE-RESPONSES; PROSTATE-CANCER; TUMOR-ANTIGEN; SKIN-DISEASE; EXPRESSION	Therapeutic DNA-based vaccines aim to prime an adaptive host immune response against tumor-associated antigens, eliminating cancer cells primarily through CD8(+) cytotoxic T cell-mediated destruction. To be optimally effective, immunological adjuvants are required for the activation of tumor-specific CD8(+) T cells responses by DNA vaccination. Here, we describe enhanced anti-tumor efficacy of an in vivo electroporation-delivered DNA vaccine by inclusion of a genetically encoded chimeric MyD88/CD40 (MC) adjuvant, which integrates both innate and adaptive immune signaling pathways. When incorporated into a DNA vaccine, signaling by the MC adjuvant increased antigen-specific CD8(+) T cells and promoted elimination of pre-established tumors. Interestingly, MC-enhanced vaccine efficacy did not require direct-expression of either antigen or adjuvant by local antigen-presenting cells, but rather our data supports a key role for MC function in "atypical" antigen-presenting cells of skin. In particular, MC adjuvant-modified keratinocytes increased inflammatory cytokine secretion, upregulated surface MHC class I, and were able to increase in vitro and in vivo priming of antigen-specific CD8(+) T cells. Furthermore, in the absence of critical CD8 alpha(+)/CD103(+) cross-priming dendritic cells, MC was still able to promote immune priming in vivo, albeit at a reduced level. Altogether, our data support a mechanism by which MC signaling activates an inflammatory phenotype in atypical antigen-presenting cells within the cutaneous vaccination site, leading to an enhanced CD8(+) T cell response against DNA vaccine-encoded antigens, through both CD8 alpha(+)/CD103(+) dendritic cell-dependent and independent pathways.	[Collinson-Pautz, Matthew R.; Levitt, Jonathan M.] Baylor Coll Med, Interdepartmental Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Collinson-Pautz, Matthew R.; Levitt, Jonathan M.; Spencer, David M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Slawin, Kevin M.; Spencer, David M.] Bellicum Pharmaceut, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Levitt, JM (corresponding author), Baylor Coll Med, Interdepartmental Program Translat Biol & Mol Med, Houston, TX 77030 USA.; Levitt, JM; Spencer, DM (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.; Spencer, DM (corresponding author), Bellicum Pharmaceut, Houston, TX 77030 USA.	JLevitt@BCM.edu; DSpencer@Bellicum.com			Cancer Prevention and Research Institute of Texas [RP100728]; Bellicum Pharmaceuticals; National Institute of General Medical Sciences of the National Institutes of Health [T32GM088129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; Bellicum Pharmaceuticals; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was in part supported by an award from the Cancer Prevention and Research Institute of Texas, grant number RP100728, awarded to DMS. Additionally, a gift to Baylor College of Medicine from Bellicum Pharmaceuticals partly funded this study. Lastly, research reported in this publication was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T32GM088129. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [KS, DMS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amante DH, 2015, HUM GENE THER METHOD, V26, P134, DOI 10.1089/hgtb.2015.020; Antonarakis ES, 2010, CURR OPIN UROL, V20, P241, DOI 10.1097/MOU.0b013e3283381793; Azukizawa H, 2003, EUR J IMMUNOL, V33, P1879, DOI 10.1002/eji.200323630; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Black APB, 2007, EUR J IMMUNOL, V37, P1485, DOI 10.1002/eji.200636915; Bloy N, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026531; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Butterfield LH, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h988; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Desrichard A, 2016, CLIN CANCER RES, V22, P807, DOI 10.1158/1078-0432.CCR-14-3175; Di Meglio P, 2011, IMMUNITY, V35, P857, DOI 10.1016/j.immuni.2011.12.003; Didovic S, 2015, EUR J IMMUNOL, P1; Durward M, 2010, JOVE-J VIS EXP, P4; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; European Organisation of Research and Treatment of Cancer, 2016, PHAS 2 CLIN TRIAL CH; Fan L, 2003, P NATL ACAD SCI USA, V100, P3386, DOI 10.1073/pnas.0437899100; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Flingai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00354; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gutowska-Owsiak D, 2012, J INVEST DERMATOL, V132, P940, DOI 10.1038/jid.2011.398; Hanks BA, 2005, NAT MED, V11, P130, DOI 10.1038/nm1183; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Juckem LK, 2008, J IMMUNOL, V180, P4965, DOI 10.4049/jimmunol.180.7.4965; Kalat M, 2002, CANCER RES, V62, P5489; Kemnade JO, 2012, MOL THER, V20, P1462, DOI 10.1038/mt.2012.48; Kim JJ, 1997, NAT BIOTECHNOL, V15, P641; Kim JJ, 2001, CLIN CANCER RES, V7, p882S; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Klinman DM, 1997, J IMMUNOL, V158, P3635; Kutzler MA, 2016, MUCOSAL IMMUNOL, V9, P13, DOI 10.1038/mi.2015.31; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Li LJ, 2012, P NATL ACAD SCI USA, V109, P12716, DOI 10.1073/pnas.1203468109; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; Narayanan P, 2011, J CLIN INVEST, V121, P1524, DOI 10.1172/JCI44327; Perales MA, 2008, MOL THER, V16, P2022, DOI 10.1038/mt.2008.196; Qu CF, 2009, J IMMUNOL, V182, P3650, DOI 10.4049/jimmunol.0801532; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Shore ND, 2014, IMMUNOTHERAPY-UK, V6, P235, DOI 10.2217/imt.13.176; Smith TRF, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.54; Subang MC, 2015, CURR GENE THER, V15, P3; Tan ACL, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0093-x; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Villarreal DO, 2015, VACCINE, V33, P4313, DOI 10.1016/j.vaccine.2015.03.086; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Zhan YF, 2011, EUR J IMMUNOL, V41, P2585, DOI 10.1002/eji.201141540; Zhou QH, 2013, J IMMUNOL, V190, P6579, DOI 10.4049/jimmunol.1202993; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	53	2	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164547	10.1371/journal.pone.0164547	http://dx.doi.org/10.1371/journal.pone.0164547			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741278	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000042
J	Li, JG; Hao, CY; Ren, LL; Xiao, Y; Wang, JW; Qin, XM				Li, Jianguo; Hao, Chunyan; Ren, Lili; Xiao, Yan; Wang, Jianwei; Qin, Xuemei			Data Mining of Lung Microbiota in Cystic Fibrosis Patients	PLOS ONE			English	Article							GUT MICROBIOTA; DISEASE; METAANALYSES; PATHOGENESIS; INFLAMMATION; RESISTANCE; BACTERIA; HEALTHY; SAMPLES	The major therapeutic strategy used to treat exacerbated cystic fibrosis (CF) is antibiotic treatment. As this approach easily generates antibiotic-resistant strains of opportunistic bacteria, optimized antibiotic therapies are required to effectively control chronic and recurrent bacterial infections in CF patients. A promising future for the proper use of antibiotics is the management of lung microbiota. However, the impact of antibiotic treatments on CF microbiota and vice versa is not fully understood. This study analyzed 718 sputum samples from 18 previous studies to identify differences between CF and uninfected lung microbiota and to evaluate the effects of antibiotic treatments on exacerbated CF microbiota. A reference-based OTU (operational taxonomic unit) picking method was used to combine analyses of data generated using different protocols and platforms. Findings show that CF microbiota had greater richness and lower diversity in the community structure than uninfected control (NIC) microbiota. Specifically, CF microbiota showed higher levels of opportunistic bacteria and dramatically lower levels of commensal bacteria. Antibiotic treatment affected exacerbated CF microbiota notably but only transiently during the treatment period. Limited decrease of the dominant opportunistic bacteria and a dramatic decrease of commensal bacteria were observed during the antibiotic treatment for CF exacerbation. Simultaneously, low abundance opportunistic bacteria were thriving after the antibiotic treatment. The inefficiency of the current antibiotic treatment against major opportunistic bacteria and the detrimental effects on commensal bacteria indicate that the current empiric antibiotic treatment on CF exacerbation should be reevaluated and optimized.	[Li, Jianguo; Qin, Xuemei] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan 030006, Peoples R China; [Hao, Chunyan] Taiyuan Univ Sci Technol, Coll Chem & Biol Engn, Taiyuan 030021, Peoples R China; [Ren, Lili; Xiao, Yan; Wang, Jianwei] Chinese Acad Med Sci, MOH Key Lab Syst Pathogen Biol, Beijing 100730, Peoples R China; [Ren, Lili; Xiao, Yan; Wang, Jianwei] Chinese Acad Med Sci, Christophe Merieux Lab, IPB, CAMS Fdn Merieux, Beijing 100730, Peoples R China; [Ren, Lili; Xiao, Yan; Wang, Jianwei] Peking Union Med Coll, Beijing 100730, Peoples R China	Shanxi University; Taiyuan University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qin, XM (corresponding author), Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan 030006, Peoples R China.	qinxm001@126.com	Wang, Jianwei/AAW-9499-2020; Li, Jianguo/T-3372-2019; Wang, Jianwei/W-5916-2019	Wang, Jianwei/0000-0002-1116-4559; Li, Jianguo/0000-0002-2251-8308; 	Youth Project of the National Natural Science Foundation of China [81301441]	Youth Project of the National Natural Science Foundation of China	This study was supported by the Youth Project of the National Natural Science Foundation of China (Project No. 81301441). (URL:http://www.nsfc.gov.cn/)	Ashish A, 2012, J CYST FIBROS, V11, P173, DOI 10.1016/j.jcf.2011.11.004; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Beck James M, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS3, DOI 10.1513/AnnalsATS.201306-188MG; Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Boutin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116029; Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Cernadas M, 2011, AM J RESP CRIT CARE, V184, P149, DOI 10.1164/rccm.201105-0828ED; Conrad D, 2013, AM J RESP CELL MOL, V48, P150, DOI 10.1165/rcmb.2012-0059PS; Cuthbertson L, 2015, J CYST FIBROS, V14, P464, DOI 10.1016/j.jcf.2014.10.004; Cuthbertson L, 2014, J CLIN MICROBIOL, V52, P3011, DOI 10.1128/JCM.00764-14; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Flight WG, 2015, J CLIN MICROBIOL, V53, P2022, DOI 10.1128/JCM.00432-15; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Hampton TH, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-14; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Hurley MN, 2012, PAEDIATR RESPIR REV, V13, P160, DOI 10.1016/j.prrv.2012.04.005; Jain K, 2012, EXPERT REV RESP MED, V6, P407, DOI [10.1586/ERS.12.39, 10.1586/ers.12.39]; Kosiewicz MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00180; Kramer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117436; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Lobo J, 2012, CLIN CHEST MED, V33, P307, DOI 10.1016/j.ccm.2012.02.006; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Maughan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045791; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Narasimhan Mangala, 2011, Ther Adv Respir Dis, V5, P275, DOI 10.1177/1753465811398267; Nelson A, 2012, INNATE IMMUN-LONDON, V18, P774, DOI 10.1177/1753425912439910; Nguyen LDN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00089; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Pressler T, 2011, PEDIATR DRUGS, V13, P141, DOI 10.2165/11588150-000000000-00000; Price KE, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-27; Rabin HR, 2012, CURR OPIN PULM MED, V18, P622, DOI 10.1097/MCP.0b013e328358d49a; Rutebemberwa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111150; Saiman L, 2011, CURR OPIN INFECT DIS, V24, P390, DOI 10.1097/QCO.0b013e32834748ff; Segal Leopoldo N, 2014, Ann Am Thorac Soc, V11, P108, DOI 10.1513/AnnalsATS.201310-339FR; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sherrard LJ, 2014, LANCET, V384, P703, DOI 10.1016/S0140-6736(14)61137-5; Sloane PA, 2010, CURR OPIN PULM MED, V16, P591, DOI 10.1097/MCP.0b013e32833f1d00; Smith DJ, 2014, EUR RESPIR J, V44, P922, DOI 10.1183/09031936.00203013; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Tildy BE, 2015, PHARMACOLOGY, V95, P117, DOI 10.1159/000377638; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2; Zemanick ET, 2014, ANN AM THORAC SOC, V12, P221, DOI DOI 10.1513/ANNALSATS.2014073100C; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	57	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164510	10.1371/journal.pone.0164510	http://dx.doi.org/10.1371/journal.pone.0164510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741283	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000039
J	Nam, EJ; Kang, JH; Sa, KH; Sung, S; Park, JY; Jo, DG; Park, JH; Kim, IS; Kang, YM				Nam, Eon Jeong; Kang, Jin Hee; Sa, Keum Hee; Sung, Shijin; Park, Jae Yong; Jo, Dong-Gyu; Park, Jae Hyung; Kim, In San; Kang, Young Mo			Robust Therapeutic Efficacy of Matrix Metalloproteinase-2-Cleavable Fas-1-RGD Peptide Complex in Chronic Inflammatory Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; INDUCIBLE GENE H3; RHEUMATOID-ARTHRITIS; ALPHA-V-BETA-3 INTEGRIN; ARRIVE GUIDELINES; ANGIOGENESIS; ACTIVATION; DELIVERY; DISEASE; CELLS	Objective Therapeutic agents that are transformable via introducing cleavable linkage by locally enriched MMP-2 within inflamed synovium would enhance therapeutic efficacy on chronic inflammatory arthritis. Transforming growth factor-beta-inducible gene-h3 (beta ig-h3), which consists of four fas-1 domains and an Arg-Gly-Asp (RGD) motif, intensifies inflammatory processes by facilitating adhesion and migration of fibroblast-like synoviocyte in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to investigate whether a MMP-2-cleavable peptide complex consisting of a fas-1 domain and an RGD peptide blocks the interaction between beta ig-h3 and resident cells and leads to the amelioration of inflammatory arthritis. Methods We designed beta ig-h3-derivatives, including the fourth fas-1 domain truncated for H1 and H2 sequences of mouse (MFK00) and MMP-2-cleavable peptide complex (MFK902). MMP-2 selectivity was examined by treatment with a series of proteases. MFK902 efficacy was determined by the adhesion and migration assay with NIH3T3 cells in vitro and collagen-induced arthritis (CIA) model using male DBA/1J mice in vivo. The mice were treated intra-peritoneally with MFK902 at different dosages. Results MFK902 was specifically cleaved by active MMP-2 in a concentration-dependent manner, and beta ig-h3-mediated adhesion and migration were more effectively inhibited by MFK902, compared with RGD or MFK00 peptides. The arthritis activity of murine CIA, measured by clinical arthritis index and incidence of arthritic paws, was significantly ameliorated after treatment with all dosages of MFK902 (1, 10, and 30 mg/kg). MFK902 ameliorated histopathologic deterioration and reduced the expression of inflammatory mediators simultaneously with improvement of clinical features. In addition, a favorable safety profile of MFK902 was demonstrated in vivo. Conclusion The present study revealed that MMP-2-cleavable peptide complex based on beta ig-h3 structure is a potent and safe therapeutic agent for chronic inflammatory arthritis, thus providing reliable evidence for a MMP-2-cleavable mechanism as a tissue-targeted strategy for treatment of RA.	[Nam, Eon Jeong; Kang, Jin Hee; Sa, Keum Hee; Sung, Shijin; Kang, Young Mo] Kyungpook Natl Univ, Sch Med, Div Rheumatol, Dept Internal Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea; [Nam, Eon Jeong; Park, Jae Yong; Kang, Young Mo] Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, 680 Gukchaebosang Ro, Daegu 41944, South Korea; [Park, Jae Yong] Kyungpook Natl Univ, Div Pulmonol, Dept Internal Med, Sch Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea; [Jo, Dong-Gyu] Sungkyunkwan Univ, Sch Pharm, 2066 Seobu Ro, Suwon 16419, South Korea; [Park, Jae Hyung] Sungkyunkwan Univ, Dept Polymer Sci & Engn, Coll Engn, 2066 Seobu Ro, Suwon 16419, South Korea; [Kim, In San] Korea Inst Sci & Technol, Biomed Res Inst, 5,Hwarang Ro 14 Gil, Seoul 02792, South Korea; [Kang, Young Mo] Kyungpook Natl Univ, Dept Biochem & Cellular Biol, Sch Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Korea Institute of Science & Technology (KIST); Kyungpook National University	Kang, YM (corresponding author), Kyungpook Natl Univ, Sch Med, Div Rheumatol, Dept Internal Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea.; Kang, YM (corresponding author), Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, 680 Gukchaebosang Ro, Daegu 41944, South Korea.; Kang, YM (corresponding author), Kyungpook Natl Univ, Dept Biochem & Cellular Biol, Sch Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea.	ymkang@knu.ac.kr	Kim, In-San/D-3956-2017; 김, 인산/I-8988-2014; Park, Jae Hyung/B-5967-2018; Jo, Dong-Gyu/AAN-9278-2021	Jo, Dong-Gyu/0000-0003-2271-1076	Basic Research Program of the National Research Foundation; Republic of Korea [NRF-2014R1A1A4A01007662]; Korean Healthcare Technology RD Project [HI14C0381]	Basic Research Program of the National Research Foundation; Republic of Korea; Korean Healthcare Technology RD Project	This work was supported by the Basic Research Program of the National Research Foundation, Republic of Korea (No. NRF-2014R1A1A4A01007662, http://www.nrf.re.kr) and the Korean Healthcare Technology R&D Project (Grant No. HI14C0381, https://www.htdream.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2014, ACTA PHYSIOL, V212, P306, DOI 10.1111/apha.12398; Bae JS, 2014, AM J RESP CRIT CARE, V189, P779, DOI 10.1164/rccm.201311-2033OC; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Crielaard BJ, 2012, J CONTROL RELEASE, V161, P225, DOI 10.1016/j.jconrel.2011.12.014; Crisp JL, 2014, MOL CANCER THER, V13, P1514, DOI 10.1158/1535-7163.MCT-13-1067; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P145, DOI 10.1186/ar79; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Kang JH, 2014, J CONTROL RELEASE, V183, P9, DOI 10.1016/j.jconrel.2014.03.029; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D; Konttinen YT, 1998, MATRIX BIOL, V17, P585, DOI 10.1016/S0945-053X(98)90110-X; Lee GY, 2007, EUR J PHARM BIOPHARM, V67, P646, DOI 10.1016/j.ejpb.2007.03.023; Mateos J, 2012, J PROTEOMICS, V75, P2869, DOI 10.1016/j.jprot.2011.12.042; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mebrahtu E, 2013, NUCL MED BIOL, V40, P190, DOI 10.1016/j.nucmedbio.2012.10.003; Mohammed FF, 2003, ANN RHEUM DIS, V62, P43; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nam EJ, 2006, ARTHRITIS RHEUM-US, V54, P2734, DOI 10.1002/art.22076; Nam EJ, 2013, ARTHRITIS RHEUM-US, V65, P1753, DOI 10.1002/art.37932; Nam JO, 2005, CANCER RES, V65, P4153, DOI 10.1158/0008-5472.CAN-04-2705; Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200; Park KS, 2012, MOL IMAGING, V11, P389, DOI 10.2310/7290.2011.00056; Rannou FO, 2006, JOINT BONE SPINE, V73, P29, DOI 10.1016/j.jbspin.2004.12.013; Rupp PA, 2008, MOL BIOL CELL, V19, P5529, DOI 10.1091/mbc.E07-05-0480; Son HN, 2013, BBA-MOL CELL RES, V1833, P2378, DOI 10.1016/j.bbamcr.2013.06.012; Steffensen B, 1998, J BIOL CHEM, V273, P20622, DOI 10.1074/jbc.273.32.20622; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Storgard CM, 1999, J CLIN INVEST, V103, P47, DOI 10.1172/JCI3756; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Szekanecz Z, 2007, NAT CLIN PRACT RHEUM, V3, P635, DOI 10.1038/ncprheum0647; Takada Y, 2010, J AUTOIMMUN, V34, P453, DOI 10.1016/j.jaut.2009.11.017; Vartak DG, 2007, J DRUG TARGET, V15, P1, DOI 10.1080/10611860600968967; Welf ES, 2012, BIOPHYS J, V103, P1379, DOI 10.1016/j.bpj.2012.08.021; Wythe SE, 2013, ANN RHEUM DIS, V72, P129, DOI 10.1136/annrheumdis-2012-201457; Zhou M, 2014, INT J CLIN EXP PATHO, V7, P3048	44	6	6	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164102	10.1371/journal.pone.0164102	http://dx.doi.org/10.1371/journal.pone.0164102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741237	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000018
J	Sugawara, S; Maeno, M; Lee, C; Nagai, S; Kim, DM; Da Silva, J; Nagai, M; Kondo, H				Sugawara, Shiho; Maeno, Masahiko; Lee, Cliff; Nagai, Shigemi; Kim, David M.; Da Silva, John; Nagai, Masazumi; Kondo, Hisatomo			Establishment of Epithelial Attachment on Titanium Surface Coated with Platelet Activating Peptide	PLOS ONE			English	Article							PERI-IMPLANT; JUNCTIONAL EPITHELIUM; EXPRESSION PATTERN; DENTAL IMPLANT; LAMININ-5; ADHESION; CELLS; ROUGHNESS; GROWTH	The aim of this study was to produce epithelial attachment on a typical implant abutment surface of smooth titanium. A challenging complication that hinders the success of dental implants is peri-implantitis. A common cause of peri-implantitis may results from the lack of epithelial sealing at the peri-implant collar. Histologically, epithelial sealing is recognized as the attachment of the basement membrane (BM). BM-attachment is promoted by activated platelet aggregates at surgical wound sites. On the other hand, platelets did not aggregate on smooth titanium, the surface typical of the implant abutment. We then hypothesized that epithelial BM-attachment was produced when titanium surface was modified to allow platelet aggregation. Titanium surfaces were coated with a protease activated receptor 4-activating peptide (PAR4-AP). PAR4-AP coating yielded rapid aggregation of platelets on the titanium surface. Platelet aggregates released robust amount of epithelial chemoattractants (IGF-I, TGF-beta) and growth factors (EGF, VEGF) on the titanium surface. Human gingival epithelial cells, when they were co-cultured on the platelet aggregates, successfully attached to the PAR4-AP coated titanium surface with spread laminin5 positive BM and consecutive staining of the epithelial tight junction component ZO1, indicating the formation of complete epithelial sheet. These in-vitro results indicate the establishment of epithelial BM-attachment to the titanium surface.	[Sugawara, Shiho; Maeno, Masahiko; Lee, Cliff; Nagai, Shigemi; Da Silva, John] Harvard Sch Dent Med, Dept Restorat Dent & Biomat Sci, Boston, MA USA; [Kim, David M.; Nagai, Masazumi] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Sugawara, Shiho; Kondo, Hisatomo] Iwate Med Univ, Sch Dent Med, Dept Prosthodont & Oral Implantol, Morioka, Iwate, Japan; [Maeno, Masahiko] Nippon Dent Univ Tokyo, Dept Adhes Dent, Chiyoda Ku, Tokyo, Japan	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; Iwate Medical University; Nippon Dental University	Nagai, M (corresponding author), Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA.	Masazumi_Nagai@hms.harvard.edu	Kondo, Hisatomo/AAA-9939-2021; Maeno, Masahiko/AAW-9849-2020; kim, david/AAA-4537-2020	Lee, Cliff/0000-0001-7987-3493				Almaguer-Flores A, 2010, J BIOMED MATER RES B, V92B, P196, DOI 10.1002/jbm.b.31506; Atsuta I, 2005, BIOMATERIALS, V26, P6280, DOI 10.1016/j.biomaterials.2005.03.046; Atsuta I, 2005, BIOMATERIALS, V26, P1751, DOI 10.1016/j.biomaterials.2004.05.033; Atsuta I, 2013, J BIOMED MATER RES A, V101, P2896, DOI 10.1002/jbm.a.34608; Atsuta I, 2012, CLIN ORAL IMPLAN RES, V23, P459, DOI 10.1111/j.1600-0501.2011.02163.x; Da Silva JD, 2014, J AM DENT ASSOC, V145, P704, DOI 10.14219/jada.2014.27; Dantas Andrea Abi Rached, 2012, J Contemp Dent Pract, V13, P332; de Waal YC, 2015, CLIN ORAL IMPLAN RES, V00, P1, DOI [10.1111/cir.12584, DOI 10.1111/CIR.12584]; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Fujiseki Masatsugu, 2003, Bull Tokyo Dent Coll, V44, P185, DOI 10.2209/tdcpublication.44.185; Fujita T, 2012, J PERIODONTAL RES, V47, P55, DOI 10.1111/j.1600-0765.2011.01404.x; Hatakeyama S, 2006, J PERIODONTAL RES, V41, P322, DOI 10.1111/j.1600-0765.2006.00875.x; Hosokawa I, 2006, CLIN EXP IMMUNOL, V146, P218, DOI 10.1111/j.1365-2249.2006.03200.x; Iglhaut G, 2014, J ESTHET RESTOR DENT, V26, P324, DOI 10.1111/jerd.12097; Ikeda H, 2002, CLIN ORAL IMPLAN RES, V13, P243, DOI 10.1034/j.1600-0501.2002.130303.x; Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961; Jiang Q, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-30; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; Lee HK, 2006, INVEST OPHTH VIS SCI, V47, P873, DOI 10.1167/iovs.05-0826; Lindhe J, 2008, J CLIN PERIODONTOL, V35, P282, DOI 10.1111/j.1600-051X.2008.01283.x; Linkevicius Tomas, 2008, Stomatologija, V10, P27; Mishra SK, 2016, J PROSTHODONT, V25, P185, DOI 10.1111/jopr.12310; Ofosu FA, 2009, BIOCHEMISTRY-US, V48, P1562, DOI 10.1021/bi801399c; Papaspyridakos P, 2012, J DENT RES, V91, P242, DOI 10.1177/0022034511431252; Sawada T, 1996, ANAT RECORD, V246, P317; Silva Aline Cristina, 2016, Braz. Dent. J., V27, P160, DOI 10.1590/0103-6440201600427; Taha M, 2016, ANGLE ORTHOD, V86, P285, DOI 10.2319/122814-947.1; Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004; Xiao Y, 2001, J PERIODONTOL, V72, P849, DOI 10.1902/jop.2001.72.7.849	30	17	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164693	10.1371/journal.pone.0164693	http://dx.doi.org/10.1371/journal.pone.0164693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741287	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000057
J	Hess, BM; Amidan, BG; Anderson, KK; Hutchison, JR				Hess, Becky M.; Amidan, Brett G.; Anderson, Kevin K.; Hutchison, Janine R.			Evaluating Composite Sampling Methods of Bacillus Spores at Low Concentrations	PLOS ONE			English	Article							ANTHRACIS DELTA-STERNE; NONPOROUS SURFACES; RECOVERY; DECONTAMINATION; COLLECTION; PROTOCOL	Restoring all facility operations after the 2001 Amerithrax attacks took years to complete, highlighting the need to reduce remediation time. Some of the most time intensive tasks were environmental sampling and sample analyses. Composite sampling allows disparate samples to be combined, with only a single analysis needed, making it a promising method to reduce response times. We developed a statistical experimental design to test three different composite sampling methods: 1) single medium single pass composite (SM-SPC): a single cellulose sponge samples multiple coupons with a single pass across each coupon; 2) single medium multi-pass composite: a single cellulose sponge samples multiple coupons with multiple passes across each coupon (SM-MPC); and 3) multi-medium post-sample composite (MM-MPC): a single cellulose sponge samples a single surface, and then multiple sponges are combined during sample extraction. Five spore concentrations of Bacillus atrophaeus Nakamura spores were tested; concentrations ranged from 5 to 100 CFU/coupon (0.00775 to 0.155 CFU/cm(2)). Study variables included four clean surface materials (stainless steel, vinyl tile, ceramic tile, and painted dry wallboard) and three grime coated/dirty materials (stainless steel, vinyl tile, and ceramic tile). Analysis of variance for the clean study showed two significant factors: composite method (p<0.0001) and coupon material (p = 0.0006). Recovery efficiency (RE) was higher overall using the MM-MPC method compared to the SM-SPC and SM-MPC methods. RE with the MM-MPC method for concentrations tested (10 to 100 CFU/coupon) was similar for ceramic tile, dry wall, and stainless steel for clean materials. RE was lowest for vinyl tile with both composite methods. Statistical tests for the dirty study showed RE was significantly higher for vinyl and stainless steel materials, but lower for ceramic tile. These results suggest post-sample compositing can be used to reduce sample analysis time when responding to a Bacillus anthracis contamination event of clean or dirty surfaces.	[Hess, Becky M.; Amidan, Brett G.; Anderson, Kevin K.; Hutchison, Janine R.] Pacific Northwest Natl Lab, Natl Secur Directorate, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Hutchison, JR (corresponding author), Pacific Northwest Natl Lab, Natl Secur Directorate, Richland, WA 99352 USA.	Janine.Hutchison@pnnl.gov			Chemical and Biological Research; Development Branch of the Chemical and Biological Division in the Science and Technology Directorate of the Department of Homeland Security (DHS)	Chemical and Biological Research; Development Branch of the Chemical and Biological Division in the Science and Technology Directorate of the Department of Homeland Security (DHS)	The Pacific Northwest National Laboratory (PNNL) work was funded by the Chemical and Biological Research and Development Branch of the Chemical and Biological Division in the Science and Technology Directorate of the Department of Homeland Security (DHS). PR#: RSRD-14-XXXX, https://www.dhs.gov/science-and-technology/st-cbd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker RA, 1988, NEW S LANGUAGE PROGR; Brown GS, 2007, APPL ENVIRON MICROB, V73, P706, DOI 10.1128/AEM.01082-06; Budowle B, 2006, APPL ENVIRON MICROB, V72, P6431, DOI 10.1128/AEM.01165-06; Buhr TL, 2008, J APPL MICROBIOL, V105, P1604, DOI 10.1111/j.1365-2672.2008.03899.x; Buhr TL, 2012, J APPL MICROBIOL, V113, P1037, DOI 10.1111/j.1365-2672.2012.05423.x; Buhr TL, 2011, J APPL MICROBIOL, V111, P1057, DOI 10.1111/j.1365-2672.2011.05122.x; Centers for Disease Control and Prevention, 2006, FACTS LAB RESP NETW; Centers for Disease Control and Prevention,, 2012, SURF SAMPL PROC BAC; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Chambers JM., 1992, ANAL VARIANCE DESIGN; Council NR, 2005, REOP PUBL FAC BIOL A; Da Silva SM, 2013, J APPL MICROBIOL, V114, P807, DOI 10.1111/jam.12090; France B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145799; Hodges LR, 2006, APPL ENVIRON MICROB, V72, P4429, DOI 10.1128/AEM.02923-05; Hutchison JR, 2015, PNNL24204; Krauter PA, 2012, APPL ENVIRON MICROB, V78, P846, DOI 10.1128/AEM.07403-11; Patil Ganapati P, 2011, COMPOSITE SAMPLING, DOI [10.1007/978-1-4419-7628-4, DOI 10.1007/978-1-4419-7628-4]; Piepel GF, 2012, J APPL MICROBIOL, V113, P1287, DOI 10.1111/j.1365-2672.2012.05381.x; Piepel GF, 2015, PNNL23955; Probst A, 2011, APPL ENVIRON MICROB, V77, P1628, DOI 10.1128/AEM.02037-10; Prokop EJ, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0021-3; Rose L, 2004, EMERG INFECT DIS, V10, P1023, DOI 10.3201/eid1006.030716; Rose LJ, 2011, APPL ENVIRON MICROB, V77, P8355, DOI 10.1128/AEM.05377-11; STEWART GSAB, 1981, BIOCHEM J, V198, P101, DOI 10.1042/bj1980101; Tufts JAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114082	25	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164582	10.1371/journal.pone.0164582	http://dx.doi.org/10.1371/journal.pone.0164582			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736999	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800089
J	Jeong, H; Chang, YS; Baek, SY; Kim, SW; Eun, YH; Kim, IY; Lee, J; Koh, EM; Cha, HS				Jeong, Hyemin; Chang, Young-Soo; Baek, Sun Young; Kim, Seon Woo; Eun, Yeong Hee; Kim, In Young; Lee, Jaejoon; Koh, Eun-Mi; Cha, Hoon-Suk			Evaluation of Audiometric Test Results to Determine Hearing Impairment in Patients with Rheumatoid Arthritis: Analysis of Data from the Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							BRAIN-STEM RESPONSE; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; EAR INVOLVEMENT; OCCUPATIONAL NOISE; OLDER-ADULTS; RISK-FACTORS; PREVALENCE; ESTROGEN; COCHLEA	This study aimed to evaluate the association between rheumatoid arthritis (RA) and hearing impairment in the Korean adult population. Audiometric and laboratory test data from the 2010-2012 Korean National Health and Nutrition Examination Survey (KNHANES) were used for analysis. The relationship between RA and hearing impairment was analyzed, adjusting for various known risk factors associated with hearing impairment. RA was defined in the questionnaire as "RA diagnosed by a physician (yes/no) through a standardized interview." We defined hearing impairment according to 2 categories of frequency (low/mid and high) as follows (average values in kHz): low/mid frequency, 0.5, 1.0, and 2.0, and high frequency, 3.0, 4.0, and 6.0. Of the subjects, 15,158 (weighted n = 32,035,996) completed the audiometric tests. The overall weighted prevalence of RA was 1.5%. The prevalence of hearing impairment was higher in the subjects with RA than in those without RA, in both, the low/mid- and high-frequency categories (21.1% vs 7.5%, p < 0.001 and 43.3% vs. 26.2%, p < 0.001, respectively). In the multivariable logistic analysis, RA (odds ratios [OR] 1.47, 95% confidence interval [CI] 1.05-2.06, p = 0.025) was an independent risk factor of low/mid-frequency hearing impairment along with age (OR 1.12, 95% CI 1.12-1.13, p < 0.001), current smoking (OR 1.27, 95% CI 1.03-1.56, p = 0.026), and college graduation (OR 0.53, 95% CI 0.39-0.72, p < 0.001). In the multivariable analysis of high-frequency hearing impairment, RA did not show any association with hearing impairment. This study suggests that RA is associated with low/mid-frequency hearing impairment after adjustment for various known risk factors. Further study is needed to verify the hearing impairment in RA.	[Jeong, Hyemin; Eun, Yeong Hee; Kim, In Young; Lee, Jaejoon; Koh, Eun-Mi; Cha, Hoon-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Div Rheumatol, Seoul, South Korea; [Chang, Young-Soo] Armed Forces Daejeon Hosp, Dept Otorhinolaryngol, Daejeon, South Korea; [Baek, Sun Young; Kim, Seon Woo] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Cha, HS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Div Rheumatol, Seoul, South Korea.	hoonsuk.cha@samsung.com						Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Akdag M, 2015, CLIN EXP OTORHINOLAR, V8, P183, DOI 10.3342/ceo.2015.8.3.183; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Batuecas-Caletrio A, 2013, LUPUS, V22, P437, DOI 10.1177/0961203313477223; Celik Onur, 1996, Auris Nasus Larynx, V23, P127; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Chang TY, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-35; Dagli M, 2008, AURIS NASUS LARYNX, V35, P333, DOI 10.1016/j.anl.2007.09.003; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; DAVIS H, 1964, J SPEECH HEAR RES, V7, P7, DOI 10.1044/jshr.0701.07; Dobie RA, 2001, MED LEGAL EVALUATION; Erbek SS, 2006, AUDIOL NEURO-OTOL, V11, P294, DOI 10.1159/000094078; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Friedland DR, 2009, LARYNGOSCOPE, V119, P473, DOI 10.1002/lary.20130; Gasparyan AY, 2011, RHEUMATOL INT, V31, P153, DOI 10.1007/s00296-010-1446-x; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Gibofsky Allan, 2012, Am J Manag Care, V18, pS295; Gordon-Salant S, 2005, J REHABIL RES DEV, V42, P9, DOI 10.1682/JRRD.2005.01.0006; Halligan CS, 2006, LARYNGOSCOPE, V116, P2044, DOI 10.1097/01.mlg.0000241365.54017.32; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; HULTCRANTZ M, 1994, HEARING RES, V76, P127, DOI 10.1016/0378-5955(94)90094-9; Hwang JH, 2009, OBESITY, V17, P1796, DOI 10.1038/oby.2009.66; JERGER J, 1980, ARCH OTOLARYNGOL, V106, P387; JUNG TTK, 1993, OTOLARYNG CLIN N AM, V26, P791; KAKANI RS, 1990, J OTOLARYNGOL, V19, P100; Kakarlapudi V, 2003, OTOL NEUROTOL, V24, P382, DOI 10.1097/00129492-200305000-00006; Kang JW, 2014, AM J CLIN NUTR, V99, P1407, DOI 10.3945/ajcn.113.072793; KASTANIOUDAKIS I, 1995, J LARYNGOL OTOL, V109, P713, DOI 10.1017/S0022215100131135; Kilicdag EB, 2004, AM J OBSTET GYNECOL, V190, P77, DOI 10.1016/j.ajog.2003.06.001; Konrad-Martin D, 2015, EAR HEARING, V36, P381, DOI 10.1097/AUD.0000000000000137; Kurmis Andrew P., 2007, International Journal of Occupational Medicine and Environmental Health, V20, P127, DOI 10.2478/v10001-007-0016-2; Lamb EJ, 2005, ANN CLIN BIOCHEM, V42, P321, DOI 10.1258/0004563054889936; Lindhardsen J, 2011, ANN RHEUM DIS, V70, P929, DOI 10.1136/ard.2010.143396; Listing J, 2015, ANN RHEUM DIS, V74, P415, DOI 10.1136/annrheumdis-2013-204021; Maia Clícia Adriana S., 2005, Rev. Bras. Otorrinolaringol., V71, P208, DOI 10.1590/S0034-72992005000200015; Marioni G, 2004, ACTA OTO-LARYNGOL, V124, P603, DOI 10.1080/00016480410016225; MCCABE BF, 1979, ANN OTO RHINOL LARYN, V88, P585, DOI 10.1177/000348947908800501; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mizoue T, 2003, OCCUP ENVIRON MED, V60, P56, DOI 10.1136/oem.60.1.56; Murdin L, 2008, CLIN RHEUMATOL, V27, P637, DOI 10.1007/s10067-007-0802-z; Ozcan M, 2002, RHEUMATOL INT, V22, P16, DOI 10.1007/s00296-002-0185-z; Park YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150783; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; Raut VV, 2001, J OTOLARYNGOL, V30, P289, DOI 10.2310/7070.2001.19580; Rho YH, 2009, ARTHRIT RHEUM-ARTHR, V61, P1580, DOI 10.1002/art.25009; Rink Timothy L, 2004, Occup Health Saf, V73, P179; Rosenhall Ulf, 2006, Noise Health, V8, P88; Satar B, 2001, OTOL NEUROTOL, V22, P786, DOI 10.1097/00129492-200111000-00012; Seckin U, 2000, RHEUMATOL INT, V19, P203, DOI 10.1007/s002960000054; Surucu Gulseren Dost, 2016, J CLIN EXP INVEST, V7, P63; Symmons D, 2002, RHEUMATOLOGY, V41, P793, DOI 10.1093/rheumatology/41.7.793; TACHIBANA M, 1984, ACTA OTO-LARYNGOL, V97, P257, DOI 10.3109/00016488409130987; Takatsu M, 2005, OTOL NEUROTOL, V26, P755, DOI 10.1097/01.mao.0000178138.19848.bd; Ursini F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002552; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; WACKYM PA, 1986, AM J OTOL, V7, P176; Wang L, 2001, P NATL ACAD SCI USA, V98, P2792, DOI 10.1073/pnas.041617498; WHARTON JA, 1990, AUDIOLOGY, V29, P196; Yildirim A, 2016, CLIN RHEUMATOL, V35, P309, DOI 10.1007/s10067-015-3129-1	62	9	10	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164591	10.1371/journal.pone.0164591	http://dx.doi.org/10.1371/journal.pone.0164591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736998	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505800092
J	Nourmohammadi, Z; Joshi, S; Vengallatore, S				Nourmohammadi, Zahra; Joshi, Surabhi; Vengallatore, Srikar			Analysis of Nonlinear Thermoelastic Dissipation in Euler-BernoulliBeam Resonators	PLOS ONE			English	Article							BEAM RESONATORS; MICRO-BEAM; VIBRATION	The linear theory of thermoelastic damping (TED) has been extensively developed over the past eight decades, but relatively little is known about the different types of nonlinearities that are associated with this fundamental mechanism of material damping. Here, we initiate the study of a dissipative nonlinearity (also called thermomechanical nonlinearity) whose origins reside at the heart of the thermomechanical coupling that gives rise to TED. The finite difference method is used to solve the nonlinear governing equation and estimate nonlinear TED in Euler-Bernoulli beams. The maximum difference between the nonlinear and linear estimates ranges from 0.06% for quartz and 0.3% for silicon to 7% for aluminum and 28% for zinc.	[Nourmohammadi, Zahra; Joshi, Surabhi; Vengallatore, Srikar] McGill Univ, Dept Mech Engn, Montreal, PQ, Canada	McGill University	Vengallatore, S (corresponding author), McGill Univ, Dept Mech Engn, Montreal, PQ, Canada.	srikar.vengallatore@mcgill.ca		, Surabhi/0000-0002-2037-4822	Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada	Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the Canada Research Chairs program (SV) (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and the Natural Sciences and Engineering Research Council of Canada (SV) (http://www.nserc-crsng. gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JE, 1997, INT J SOLIDS STRUCT, V34, P1075, DOI 10.1016/S0020-7683(96)00085-6; Cagnoli G, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.174111; CHANG WP, 1986, INT J NONLINEAR MECH, V21, P375, DOI 10.1016/0020-7462(86)90021-1; Clayton J.D., 2011, NONLINEAR MECH CRYST; De SK, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144305; Guo X, 2014, J SOUND VIB, V333, P1079, DOI 10.1016/j.jsv.2013.09.041; Hendou RH, 2014, J SOUND VIB, V333, P6224, DOI 10.1016/j.jsv.2014.07.002; Joshi S, 2014, EPJ TECH INSTRUM, V1, DOI 10.1140/epjti5; Lifshitz R, 2000, PHYS REV B, V61, P5600, DOI 10.1103/PhysRevB.61.5600; Mendez C, 2009, NONLINEAR ANAL-REAL, V10, P1579, DOI 10.1016/j.nonrwa.2008.02.002; Mohammadi AK, 2014, J MECH, V30, P219, DOI 10.1017/jmech.2014.12; Nayfeh AH, 2004, J MICROMECH MICROENG, V14, P1711, DOI 10.1088/0960-1317/14/12/016; Nourmohammadi Z, 2014, THESIS; Nowick A. S., 1972, ANELASTIC RELAXATION; Salajeghe S, 2012, APPL MATH MODEL, V36, P5991, DOI 10.1016/j.apm.2012.01.027; Tunvir K, 2012, J THERM STRESSES, V35, P1076, DOI 10.1080/01495739.2012.720474; Vengallatore S, 2005, J MICROMECH MICROENG, V15, P2398, DOI 10.1088/0960-1317/15/12/023; Weiner, 1960, THEORY THERMAL STRES; Zener C, 1937, PHYS REV, V52, P0230, DOI 10.1103/PhysRev.52.230	20	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164669	10.1371/journal.pone.0164669	http://dx.doi.org/10.1371/journal.pone.0164669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736951	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800108
J	Wang, SX; Zhang, SY; Xu, C; Barron, A; Galiano, F; Patel, D; Lee, YJ; Caldwell, GA; Caldwell, KA; Witt, SN				Wang, Shaoxiao; Zhang, Siyuan; Xu, Chuan; Barron, Addie; Galiano, Floyd; Patel, Dhaval; Lee, Yong Joo; Caldwell, Guy A.; Caldwell, Kim A.; Witt, Stephan N.			Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PERMEABILITY TRANSITION; CAENORHABDITIS-ELEGANS; SUBSTANTIA-NIGRA; ARACHIDONIC-ACID; CELL-DEATH; PHOSPHATIDYLETHANOLAMINE; INHIBITION; CYCLOSPORINE; BRAIN	We have been investigating the role that phosphatidylethanolamine (PE) and phosphatidylcholine (PC) content plays in modulating the solubility of the Parkinson's disease protein alpha-synuclein (alpha-syn) using Saccharomyces cerevisiae and Caenorhabditis elegans. One enzyme that synthesizes PE is the conserved enzyme phosphatidylserine decarboxylase (Psd1/yeast; PSD-1/worms), which is lodged in the inner mitochondrial membrane. We previously found that decreasing the level of PE due to knockdown of Psd1/psd-1 affects the homeostasis of alpha-syn in vivo. In S. cerevisiae, the co-occurrence of low PE and alpha-syn in psd1 Delta cells triggers mitochondrial defects, stress in the endoplasmic reticulum, misprocessing of glycosylphosphatidylinositol-anchored proteins, and a 3-fold increase in the level of alpha-syn. The goal of this study was to identify drugs that rescue this phenotype. We screened the Prestwick library of 1121 Food and Drug Administration-approved drugs using psd1 Delta + alpha-syn cells and identified cyclosporin A, meclofenoxate hydrochloride, and sulfaphenazole as putative protective compounds. The protective activity of these drugs was corroborated using C. elegans in which a-syn is expressed specifically in the dopaminergic neurons, with psd-1 depleted by RNAi. Worm populations were examined for dopaminergic neuron survival following psd-1 knockdown. Exposure to cyclosporine, meclofenoxate, and sulfaphenazole significantly enhanced survival at day 7 in alpha-syn-expressing worm populations whereby 50-55% of the populations displayed normal neurons, compared to only 10-15% of untreated animals. We also found that all three drugs rescued worms expressing alpha-syn in dopaminergic neurons that were deficient in the phospholipid cardiolipin following cardiolipin synthase (crls-1) depletion by RNAi. We discuss how these drugs might block a-syn pathology in dopaminergic neurons.	[Wang, Shaoxiao; Barron, Addie; Galiano, Floyd; Patel, Dhaval; Lee, Yong Joo; Witt, Stephan N.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Zhang, Siyuan; Xu, Chuan; Caldwell, Guy A.; Caldwell, Kim A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Witt, Stephan N.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Alabama System; University of Alabama Tuscaloosa; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Witt, SN (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.; Witt, SN (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA.	switt1@lsuhsc.edu	Witt, Stephan N/M-7922-2013; Xu, Chuan/AAR-6290-2021; Zhang, Siyuan/AAY-8845-2020	Witt, Stephan N/0000-0002-6462-2840; Xu, Chuan/0000-0003-4291-3820; Caldwell, Kim/0000-0003-1580-6122; Caldwell, Guy/0000-0002-8283-9090	National Institute of Neurological Disorders and Stroke [R01NS057656, R15NS075684]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS075684, R01NS057656] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded in part by funds from the National Institute of Neurological Disorders and Stroke (http/www.ninds.nih.gov/) grants R01NS057656 (SNW) and R15NS075684 (GAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Baker CD, 2016, MOL BIOL CELL, V27, P2161, DOI 10.1091/mbc.E15-12-0865; Berkowitz L. A., 2008, JOVE-J VIS EXP, V835, DOI [10.3791/835, DOI 10.3791/835]; Bir A, 2014, J NEUROCHEM, V131, P868, DOI 10.1111/jnc.12966; Burke D, 2000, METHODS YEAST GENETI, P103; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chang Q, 2014, J BIOL CHEM, V289, P8337, DOI 10.1074/jbc.M113.507152; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Depaz IMB, 2015, DRUG METAB DISPOS, V43, P353, DOI 10.1124/dmd.114.061242; Eichmann C, 2016, J BIOL CHEM, V291, P8516, DOI 10.1074/jbc.M115.707968; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Granville DJ, 2004, P NATL ACAD SCI USA, V101, P1321, DOI 10.1073/pnas.0308185100; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Harrington AJ, 2012, J NEUROSCI, V32, P2142, DOI 10.1523/JNEUROSCI.2606-11.2012; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Kainu V, 2013, BBA-MOL CELL BIOL L, V1831, P429, DOI 10.1016/j.bbalip.2012.11.003; Kara E, 2013, NEUROSCI LETT, V546, P67, DOI 10.1016/j.neulet.2013.04.058; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Malanga Gabriela, 2012, DRUG METAB LETT, V6, P54; MANYAM BV, 1988, ARCH NEUROL-CHICAGO, V45, P48, DOI 10.1001/archneur.1988.00520250054021; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nehru B, 2008, BRAIN RES, V1201, P122, DOI 10.1016/j.brainres.2008.01.074; PARTHASARATHY S, 1981, BIOCHIM BIOPHYS ACTA, V665, P345, DOI 10.1016/0005-2760(81)90020-5; PARTHASARATHY S, 1978, LIPIDS, V13, P161, DOI 10.1007/BF02533260; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Petrosillo G, 2004, J BIOL CHEM, V279, P53103, DOI 10.1074/jbc.M407500200; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Ray A, 2014, J NEUROSCI, V34, P16076, DOI 10.1523/JNEUROSCI.1945-14.2014; RIEKKINEN P, 1975, ARCH NEUROL-CHICAGO, V32, P25, DOI 10.1001/archneur.1975.00490430047006; Ross BM, 2001, NEUROSCIENCE, V102, P899, DOI 10.1016/S0306-4522(00)00501-7; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; SEMSEI I, 1985, Journal of Free Radicals in Biology and Medicine, V1, P403, DOI 10.1016/0748-5514(85)90153-9; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Verma R, 2009, NEUROCHEM INT, V55, P369, DOI 10.1016/j.neuint.2009.04.001; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wang SX, 2014, P NATL ACAD SCI USA, V111, pE3976, DOI 10.1073/pnas.1411694111; Warne J, 2016, J BIOL CHEM, V291, P4356, DOI 10.1074/jbc.M115.700385; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZSNAGY I, 1994, ANN NY ACAD SCI, V717, P102, DOI 10.1111/j.1749-6632.1994.tb12077.x	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164465	10.1371/journal.pone.0164465	http://dx.doi.org/10.1371/journal.pone.0164465			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736935	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800067
J	Ziganshina, EE; Sharifullina, DM; Lozhkin, AP; Khayrullin, RN; Ignatyev, IM; Ziganshin, AM				Ziganshina, Elvira E.; Sharifullina, Dilyara M.; Lozhkin, Andrey P.; Khayrullin, Rustem N.; Ignatyev, Igor M.; Ziganshin, Ayrat M.			Bacterial Communities Associated with Atherosclerotic Plaques from Russian Individuals with Atherosclerosis	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; RALSTONIA-PICKETTII; VASCULAR-DISEASE; INFECTION; WATER; NOV.; ENDOCARDITIS; INFLAMMATION; MECHANISMS; CHALLENGES	Atherosclerosis is considered a chronic disease of the arterial wall and is the major cause of severe disease and death among individuals all over the world. Some recent studies have established the presence of bacteria in atherosclerotic plaque samples and suggested their possible contribution to the development of cardiovascular disease. The main objective of this preliminary pilot study was to better understand the bacterial diversity and abundance in human atherosclerotic plaques derived from common carotid arteries of individuals with atherosclerosis (Russian nationwide group) and contribute towards the further identification of a main group of atherosclerotic plaque bacteria by 454 pyrosequencing their 16S ribosomal RNA (16S rRNA) genes. The applied approach enabled the detection of bacterial DNA in all atherosclerotic plaques. We found that distinct members of the order Burkholderiales were present at high levels in all atherosclerotic plaques obtained from patients with atherosclerosis with the genus Curvibacter being predominant in all plaque samples. Moreover, unclassified Burkholderiales as well as members of the genera Propionibacterium and Ralstonia were typically the most significant taxa for all atherosclerotic plaques. Other genera such as Burkholderia, Corynebacterium and Sediminibacterium as well as unclassified Comamonadaceae, Oxalobacteraceae, Rhodospirillaceae, Bradyrhizobiaceae and Burkholderiaceae were always found but at low relative abundances of the total 16S rRNA gene population derived from all samples. Also, we found that some bacteria found in plaque samples correlated with some clinical parameters, including total cholesterol, alanine aminotransferase and fibrinogen levels. Finally, our study indicates that some bacterial agents at least partially may be involved in affecting the development of cardiovascular disease through different mechanisms.	[Ziganshina, Elvira E.; Ziganshin, Ayrat M.] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan 420008, The Republic Of, Russia; [Sharifullina, Dilyara M.; Lozhkin, Andrey P.; Khayrullin, Rustem N.; Ignatyev, Igor M.] Interreg Clin & Diagnost Ctr, Kazan 420101, The Republic Of, Russia	Kazan Federal University	Ziganshin, AM (corresponding author), Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan 420008, The Republic Of, Russia.	a.ziganshin06@fulbrightmail.org	Sharifullina, Dilyara/AAF-4389-2021; Ziganshin, Ayrat M/A-7013-2014; Ziganshina, Elvira E/G-3068-2016	Sharifullina, Dilyara/0000-0001-5493-9644; Ziganshin, Ayrat M/0000-0001-6296-8955; Ziganshina, Elvira E/0000-0003-2777-843X; Khayrullin, Rustem/0000-0002-2160-7720	Investment and Venture Fund of the Republic of Tatarstan, Russia	Investment and Venture Fund of the Republic of Tatarstan, Russia	Partial financial support was provided by the Investment and Venture Fund of the Republic of Tatarstan, Russia (DMS).	Alviar CL, 2011, MED HYPOTHESES, V76, P517, DOI 10.1016/j.mehy.2010.12.006; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Armingohar Z, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23408; BROOK I, 1991, REV INFECT DIS, V13, P819; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Budzynski J, 2016, INT J ANGIOL, V25, P3, DOI 10.1055/s-0035-1547385; Budzynski J, 2014, CLIN RES CARDIOL, V103, P855, DOI 10.1007/s00392-014-0720-4; Calandrini CA, 2014, ORAL DIS, V20, pe128, DOI 10.1111/odi.12205; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cargill JS, 2012, J MED MICROBIOL, V61, P755, DOI 10.1099/jmm.0.039693-0; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1075, DOI 10.1099/ijs.0.02555-0; Ding LX, 2010, J GEN APPL MICROBIOL, V56, P267, DOI 10.2323/jgam.56.267; Ding LX, 2004, INT J SYST EVOL MICR, V54, P2223, DOI 10.1099/ijs.0.02975-0; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Falcone-Dias MF, 2012, WATER RES, V46, P3612, DOI 10.1016/j.watres.2012.04.007; Gaspar JM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0532-1; GUNTHARD H, 1994, J CLIN MICROBIOL, V32, P3043; Haidar R, 2010, SCAND J INFECT DIS, V42, P405, DOI 10.3109/00365540903582459; Hansen GM, 2016, AM J CARDIOL, V118, P489, DOI 10.1016/j.amjcard.2016.05.036; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Hansson GK, 2009, J THROMB HAEMOST, V7, P328, DOI 10.1111/j.1538-7836.2009.03416.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Lee J, 2010, WATER RES, V44, P5050, DOI 10.1016/j.watres.2010.07.027; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Lundberg AM, 2010, CLIN IMMUNOL, V134, P5, DOI 10.1016/j.clim.2009.07.016; Matthaiou D.K., 2011, RESP MED CME, V4, P144, DOI [10.1016/j.rmedc.2010.11.002, DOI 10.1016/J.RMEDC.2010.11.002]; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mitra S, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0100-y; Neuwirth C, 2006, EMERG INFECT DIS, V12, P1737, DOI 10.3201/eid1211.060143; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Peplinski K, 2010, MICROBIOL-SGM, V156, P2136, DOI 10.1099/mic.0.038380-0; Pierce D, 2012, AM FAM PHYSICIAN, V85, P981; Quillard T, 2015, EUR HEART J, V36, P1394, DOI 10.1093/eurheartj/ehv044; Rafferty B, 2011, J ATHEROSCLER THROMB, V18, P72, DOI 10.5551/jat.5207; Rasmussen RV, 2011, FUTURE MICROBIOL, V6, P43, DOI 10.2217/FMB.10.155; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; Rune I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146439; Ryan MP, 2013, J MED MICROBIOL, V62, P1025, DOI 10.1099/jmm.0.054759-0; Ryan MP, 2006, J HOSP INFECT, V62, P278, DOI 10.1016/j.jhin.2005.08.015; Safni I, 2014, INT J SYST EVOL MICR, V64, P3087, DOI 10.1099/ijs.0.066712-0; Scannapieco Frank A, 2004, Compend Contin Educ Dent, V25, P16; Silva WSE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109761; Sgrelli A, 2012, NEW MICROBIOL, V35, P245; Sharifullina D. M., 2015, Kazanskii Meditsinskii Zhurnal, V96, P979, DOI 10.17750/KMJ2015-979; Shindo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100045; VAFIDIS G, 1991, BRIT J OPHTHALMOL, V75, P706, DOI 10.1136/bjo.75.12.706; Vankov PY, 2016, BIONANOSCIENCE, V6, P490, DOI 10.1007/s12668-016-0270-5; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Voronina OL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/680210; Wolcott R. D., 2012, J BACTERIOL PARASITO, V3, P127; Zakharkina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068302; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141310; Ziganshin AM, 2012, ACTA NATURAE, V4, P91, DOI 10.32607/20758251-2012-4-4-91-97; Ziganshina EE, 2016, BIOLOGIA, V71, P70, DOI 10.1515/biolog-2016-0014; Ziganshina EE, 2015, MICROB ECOL, V70, P948, DOI 10.1007/s00248-015-0635-2; Ziganshina EE, 2014, J MICROBIOL BIOTECHN, V24, P1464, DOI 10.4014/jmb.1404.04043; Zong ZY, 2011, EUR RESPIR J, V38, P1482, DOI 10.1183/09031936.00046011	59	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164836	10.1371/journal.pone.0164836	http://dx.doi.org/10.1371/journal.pone.0164836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736997	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800135
J	Nordlund, LM; Koch, EW; Barbier, EB; Creed, JC				Nordlund, Lina Mtwana; Koch, Evamaria W.; Barbier, Edward B.; Creed, Joel C.			Seagrass Ecosystem Services and Their Variability across Genera and Geographical Regions	PLOS ONE			English	Article							ZOSTERA-MARINA; ECONOMIC VALUATION; HALOPHILA-OVALIS; CARBON STORAGE; BLUE CARBON; COASTAL; MANAGEMENT; CONSERVATION; HABITAT; EELGRASS	Threats to and loss of seagrass ecosystems globally, impact not only natural resources but also the lives of people who directly or indirectly depend on these systems. Seagrass ecosystems play a multi-functional role in human well-being, e. g. food through fisheries, control of erosion and protection against floods. Quantifying these services reveals their contributions to human well-being and helps justify seagrass conservation. There has been no comprehensive assessment as to whether seagrass ecosystem services are perceived to vary over the globe or amongst genera. Our study compiles the most complete list of ecosystem services provided by seagrasses so far, including bioregional-and genus-specific information from expert opinion and published studies. Several seagrass ecosystem services vary considerably in their (known) provision across genera and over the globe. Seagrasses genera are clearly not all equal with regard to the ecosystem services they provide. As seagrass genera are not evenly distributed over all bioregions, the presence of an ecosystem service sometimes depends on the genera present. Larger sized seagrass genera (e. g. Posidonia, Enhalus) are perceived to provide more substantial and a wider variety of ecosystem services than smaller species (e. g. Halophila, Lepilaena). Nevertheless, smaller species provide important services. Our findings point out data gaps, provide new insight for more efficient management and recommend caution in economic valuation of seagrass services worldwide.	[Nordlund, Lina Mtwana] Stockholm Univ, Dept Ecol Environm & Plant Sci, SE-10691 Stockholm, Sweden; [Koch, Evamaria W.] Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA; [Barbier, Edward B.] Univ Wyoming, Dept Econ & Finance, 1000 E Univ Ave, Laramie, WY 82071 USA; [Creed, Joel C.] Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Dept Ecol, Lab Ecol Marinha Bent, PHLC Sala 220,Rua Sao Francisco Xavier 524, BR-20559900 Rio De Janeiro, RJ, Brazil	Stockholm University; University System of Maryland; University of Maryland Center for Environmental Science; University of Wyoming; Universidade do Estado do Rio de Janeiro	Nordlund, LM (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, SE-10691 Stockholm, Sweden.	lina.mtwana.nordlund@su.se	Creed, Joel Christopher/C-4764-2013; Nordlund, Lina/A-2282-2011	Creed, Joel Christopher/0000-0002-1722-0806; Nordlund, Lina/0000-0002-4450-2331				Albano PG, 2012, SCI MAR, V76, P721, DOI 10.3989/scimar.03396.02C; Alonso Aller E, 2014, MAR BIOL, V161, P2395, DOI 10.1007/s00227-014-2514-7; Ambo-Rappe Rohani, 2013, Open Journal of Ecology, V3, P331; Anton A, 2011, ECOL APPL, V21, P991, DOI 10.1890/09-0841.1; Armitage AR, 2016, BIOGEOSCIENCES, V13, P313, DOI 10.5194/bg-13-313-2016; Ban SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135465; Bandeira S., 2003, WORLD ATLAS SEAGRASS, P93; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P403; Barbier EB, 2012, REV ENV ECON POLICY, V6, P1, DOI 10.1093/reep/rer017; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Barry SC, 2013, J EXP MAR BIOL ECOL, V444, P73, DOI 10.1016/j.jembe.2013.03.012; Beaumont NJ, 2008, MAR POLLUT BULL, V56, P386, DOI 10.1016/j.marpolbul.2007.11.013; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bostrom C, 2006, J EXP MAR BIOL ECOL, V335, P52, DOI 10.1016/j.jembe.2006.02.015; Bostrom C, 2014, AQUAT CONSERV, V24, P410, DOI 10.1002/aqc.2424; Buapet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083804; Burgman M., 2005, RISKS DECISIONS CONS; Campagne CS, 2015, MAR POLLUT BULL, V97, P391, DOI 10.1016/j.marpolbul.2015.05.061; Champenois W, 2012, LIMNOL OCEANOGR, V57, P347, DOI 10.4319/lo.2012.57.1.0347; Christianen MJA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2890; Christianen MJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062413; Cocozza C, 2011, WASTE MANAGE, V31, P78, DOI 10.1016/j.wasman.2010.08.016; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cullen-Unsworth LC, 2016, J APPL ECOL; Cullen-Unsworth LC, 2014, MAR POLLUT BULL, V83, P387, DOI 10.1016/j.marpolbul.2013.06.001; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; de la Torre-Castro M, 2004, OCEAN COAST MANAGE, V47, P361, DOI 10.1016/j.ocecoaman.2004.07.005; Dewsbury BM, 2016, ECOSYST SERV, V18, P68, DOI 10.1016/j.ecoser.2016.02.010; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Do VT, 2012, MAR POLLUT BULL, V64, P2340, DOI 10.1016/j.marpolbul.2012.08.025; Dos Santos VM, 2012, AQUAT BOT, V100, P41, DOI 10.1016/j.aquabot.2012.03.009; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; DUARTE CM, 1991, MAR ECOL PROG SER, V77, P289, DOI 10.3354/meps077289; Durlak JA, 2010, HDB CLIN PSYCHOL COM, P483; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P107, DOI 10.1016/0022-0981(95)00085-2; Eklof JS, 2006, MAR ECOL PROG SER, V325, P73, DOI 10.3354/meps325073; El Shaffai A., 2011, FIELD GUIDE SEAGRASS, VFirst, DOI DOI 10.1017/S0030605309990342; Fernandes M, 2009, MAR POLLUT BULL, V58, P303, DOI 10.1016/j.marpolbul.2008.10.006; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Frazier MR, 2014, WETL ECOL MANAG, V22, P451, DOI 10.1007/s11273-014-9346-6; Fredriksen S, 2004, SARSIA, V89, P218, DOI 10.1080/00364820410005593; Giakoumi S, 2015, CONSERV BIOL, V29, P1228, DOI 10.1111/cobi.12468; Gobert Sylvie, 2002, BMC Ecol, V2, P9, DOI 10.1186/1472-6785-2-9; Govers LL, 2014, ENVIRON POLLUT, V195, P210, DOI 10.1016/j.envpol.2014.08.028; Grassi F, 2015, AGRON SUSTAIN DEV, V35, P679, DOI 10.1007/s13593-014-0268-8; Grech A, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024006; Green BN, 2001, J SPORT CHIROPR REH, V15, P5, DOI 10.1016/S0899-3467(07)60142-6; Green E.P., 2003, WORLD ATLAS SEAGRASS; Gullstrom M, 2012, MAR BIOL, V159, P413, DOI 10.1007/s00227-011-1819-z; Gustafsson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064064; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; HEMMINGA MA, 1990, ESTUAR COAST SHELF S, V31, P499, DOI 10.1016/0272-7714(90)90040-X; Jackson EL, 2015, CONSERV BIOL, V29, P899, DOI 10.1111/cobi.12436; Kaewsrikhaw R, 2014, AQUAT BOT, V116, P69, DOI 10.1016/j.aquabot.2014.01.009; Kannan RRR, 2013, INT J BIOL MACROMOL, V62, P30, DOI 10.1016/j.ijbiomac.2013.08.005; Kenworthy WJ, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P595; Knudby A, 2011, INT J REMOTE SENS, V32, P2227, DOI 10.1080/01431161003692057; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; KOCH EW, 1988, AQUAT BOT, V31, P321, DOI 10.1016/0304-3770(88)90020-4; Krueger T, 2012, ENVIRON MODELL SOFTW, V36, P4, DOI 10.1016/j.envsoft.2012.01.011; Lavesque N, 2009, J EXP MAR BIOL ECOL, V368, P101, DOI 10.1016/j.jembe.2008.09.017; Lebreton B, 2012, MAR BIOL, V159, P1537, DOI 10.1007/s00227-012-1940-7; Lebreton B, 2011, ESTUAR COAST SHELF S, V92, P140, DOI 10.1016/j.ecss.2010.12.027; Lee KS, 2004, AQUAT BOT, V78, P197, DOI 10.1016/j.aquabot.2003.09.010; Luisetti T, 2013, MAR POLLUT BULL, V71, P101, DOI 10.1016/j.marpolbul.2013.03.029; Lutz S. J., 2014, FISH CARBON EXPLORIN; Macia S, 2005, MAR ECOL PROG SER, V303, P113, DOI 10.3354/meps303113; Macreadie PI, 2014, MAR BIOL, V161, P2939, DOI 10.1007/s00227-014-2558-8; Martin P, 2010, ESTUAR COAST SHELF S, V87, P357, DOI 10.1016/j.ecss.2010.01.016; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Mateo MA, 2003, ESTUAR COAST SHELF S, V56, P85, DOI 10.1016/S0272-7714(02)00123-3; Michel LN, 2014, MARINE ECOLOGY; Milcu AI, 2013, ECOL SOC, V18, DOI 10.5751/ES-05790-180344; Moran KL, 2007, MAR BIOL, V150, P1083, DOI 10.1007/s00227-006-0427-9; Nakamura Y, 2004, FISHERIES SCI, V70, P788, DOI 10.1111/j.1444-2906.2004.00872.x; Newell RIE, 2004, ESTUARIES, V27, P793, DOI 10.1007/BF02912041; Nordlund L, 2010, AQUAT LIVING RESOUR, V23, P399, DOI 10.1051/alr/2011006; Nordlund LM, 2013, MAR POLICY, V41, P110, DOI 10.1016/j.marpol.2012.12.018; Nordlund LM, 2014, AMBIO, V43, P1006, DOI 10.1007/s13280-013-0465-8; Nordlund LM, 2013, ESTUAR COAST SHELF S, V135, P231, DOI 10.1016/j.ecss.2013.10.019; Ochieng C A, 2003, WORLD ATLAS SEAGRASS, P82; ORTH RJ, 1986, AQUAT BOT, V24, P335, DOI 10.1016/0304-3770(86)90100-2; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Patterson J, 2009, AUST J ADULT LEARN, V49, P382; Paul M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006797; Pautasso M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003149; Prendergast HDV, 2002, ECON BOT, V56, P110, DOI 10.1663/0013-0001(2002)056[0110:UMMCTD]2.0.CO;2; Qi SH, 2008, BOT MAR, V51, P441, DOI 10.1515/BOT.2008.054; Richir J, 2015, J ENVIRON MANAGE, V151, P486, DOI 10.1016/j.jenvman.2014.11.015; Richir J, 2013, AQUAT TOXICOL, V140, P157, DOI 10.1016/j.aquatox.2013.05.018; Roberts PD, 2006, BIOL CONSERV, V132, P409, DOI 10.1016/j.biocon.2006.04.034; Samonte-Tan GPB, 2007, COAST MANAGE, V35, P319, DOI 10.1080/08920750601169634; Satz D, 2013, AMBIO, V42, P675, DOI 10.1007/s13280-013-0386-6; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P5, DOI 10.1016/B978-044450891-1/50002-5; Sinclair Elizabeth A., 2013, Ecological Management & Restoration, V14, P68, DOI 10.1111/emr.12028; Spash CL, 2015, BIOL CONSERV, V192, P541, DOI 10.1016/j.biocon.2015.07.037; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; Unsworth R, 2011, PACIFIC ECOLOGSI WIN, P51; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Unsworth RKF, 2013, FEASIBILITY ESTABLIS; van Keulen M, 2003, ESTUAR COAST SHELF S, V57, P587, DOI 10.1016/S0272-7714(02)00394-3; Virnstein RW, 2009, MAR ECOL PROG SER, V385, P97, DOI 10.3354/meps08039; Wagner E, 2012, MAR ECOL PROG SER, V468, P149, DOI 10.3354/meps09952; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wyllie-Echeverria S, 1999, ECON BOT, V53, P419, DOI 10.1007/BF02866721; Wyllie-Echeverria S., 1999, PAC CONSERV BIOL, V5, P329; Yamamuro M, 2005, J OCEANOGR, V61, P183, DOI 10.1007/s10872-005-0030-6; Yuvaraj N, 2012, PHARM BIOL, V50, P458, DOI 10.3109/13880209.2011.611948	112	191	193	9	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163091	10.1371/journal.pone.0163091	http://dx.doi.org/10.1371/journal.pone.0163091			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732600	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300009
J	Rannamae, E; Lougas, L; Speller, CF; Valk, H; Maldre, L; Wilczynski, J; Mikhailov, A; Saarma, U				Rannamae, Eve; Lougas, Lembi; Speller, Camilla F.; Valk, Heiki; Maldre, Liina; Wilczynski, Jaroslaw; Mikhailov, Aleksandr; Saarma, Urmas			Three Thousand Years of Continuity in the Maternal Lineages of Ancient Sheep (Ovis aries) in Estonia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC DIVERSITY; SEQUENCE DATA; BRONZE-AGE; DOMESTICATION; BREEDS; POLYMORPHISM; NETWORKS; SOFTWARE; PATTERNS	Although sheep (Ovis aries) have been one of the most exploited domestic animals in Estonia since the Late Bronze Age, relatively little is known about their genetic history. Here, we explore temporal changes in Estonian sheep populations and their mitochondrial genetic diversity over the last 3000 years. We target a 558 base pair fragment of the mitochondrial hypervariable region in 115 ancient sheep from 71 sites in Estonia (c. 1200 BC-AD 1900s), 19 ancient samples from Latvia, Russia, Poland and Greece (6800 BC-AD 1700), as well as 44 samples of modern Kihnu native sheep breed. Our analyses revealed: (1) 49 mitochondrial haplotypes, associated with sheep haplogroups A and B; (2) high haplotype diversity in Estonian ancient sheep; (3) continuity in mtDNA haplotypes through time; (4) possible population expansion during the first centuries of the Middle Ages (associated with the establishment of the new power regime related to 13th century crusades); (5) significant difference in genetic diversity between ancient populations and modern native sheep, in agreement with the beginning of large-scale breeding in the 19th century and population decline in local sheep. Overall, our results suggest that in spite of the observed fluctuations in ancient sheep populations, and changes in the natural and historical conditions, the utilisation of local sheep has been constant in the territory of Estonia, displaying matrilineal continuity from the Middle Bronze Age through the Modern Period, and into modern native sheep.	[Rannamae, Eve; Valk, Heiki] Univ Tartu, Inst Hist & Archaeol, Dept Archaeol, Tartu, Estonia; [Lougas, Lembi; Maldre, Liina] Tallinn Univ, Archaeol Res Collect, Tallinn, Estonia; [Speller, Camilla F.] Univ York, Dept Archaeol, York, N Yorkshire, England; [Wilczynski, Jaroslaw] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland; [Mikhailov, Aleksandr] Archaeol Ctr Pskov Reg, Pskov, Russia; [Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia	University of Tartu; Tallinn University; University of York - UK; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia.	urmas.saarma@ut.ee	Lõugas, Lembi/G-6063-2016; Saarma, Urmas/AAC-9813-2019; Lõugas, Lembi/N-2409-2019; Valk, Heiki/H-5913-2018; Speller, Camilla/GLV-4769-2022; Speller, Camilla/D-2830-2014	Lõugas, Lembi/0000-0003-2011-2141; Saarma, Urmas/0000-0002-3222-571X; Lõugas, Lembi/0000-0003-2011-2141; Valk, Heiki/0000-0003-4059-896X; Speller, Camilla/0000-0001-7128-9903; Wilczynski, Jaroslaw/0000-0002-9786-0693; Rannamae, Eve/0000-0003-1186-5512	Estonian Science Foundation (ETF) [8525, 8526]; Estonian Ministry of Education and Research [IUT20-7, IUT20-32]; European Union through the European Regional Development Fund; European Social Fund's Doctoral Studies and Internationalisation Programme DoRa; national scholarship program Kristjan Jaak; Archimedes Foundation in collaboration with the Ministry of Education and Research	Estonian Science Foundation (ETF); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union through the European Regional Development Fund(European Commission); European Social Fund's Doctoral Studies and Internationalisation Programme DoRa; national scholarship program Kristjan Jaak; Archimedes Foundation in collaboration with the Ministry of Education and Research	This research was supported by the Estonian Science Foundation (ETF grants 8525 and 8526), institutional research funding IUT20-7 and IUT20-32 of the Estonian Ministry of Education and Research, the European Union through the European Regional Development Fund (Centre of Excellence in Biodiversity Research, and Centre of Excellence in Cultural Theory), European Social Fund's Doctoral Studies and Internationalisation Programme DoRa, and national scholarship program Kristjan Jaak, which is funded and managed by Archimedes Foundation in collaboration with the Ministry of Education and Research. The funders had no role in study design, ata collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2010, THESIS; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bar-Gal GK, 2003, INT J OSTEOARCHAEOL, V13, P120, DOI 10.1002/oa.666; Brandt LO, 2011, ARCHAEOL ANTHROP SCI, V3, P209, DOI 10.1007/s12520-011-0055-2; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Bruns F., 1967, HANSISCHE HANDELSSTR; Cai DW, 2007, J ARCHAEOL SCI, V34, P1347, DOI 10.1016/j.jas.2006.10.020; Cai DW, 2011, J ARCHAEOL SCI, V38, P896, DOI 10.1016/j.jas.2010.11.019; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Cinkulov M, 2008, J ANIM BREED GENET, V125, P417, DOI 10.1111/j.1439-0388.2008.00742.x; Cooper A, 2000, SCIENCE, V289, P1139; Demirci S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081952; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gabbianelli F, 2015, ANIM GENET, V46, P329, DOI 10.1111/age.12289; Goslar T, 2016, SARAKENOS CAVE AKRAE, P18; Guo J, 2005, ANIM GENET, V36, P331, DOI 10.1111/j.1365-2052.2005.01310.x; Haak A., 2014, CASTLE SOCIAL SPACE, P139; Haak A., 2012, LIETUVOS ARCHAEOLOGI, V38, P295; Hadjigeorgiou I, 2011, PASTORALISM, V1, DOI 10.1186/2041-7136-1-24; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Horsburgh KA, 2010, J ARCHAEOL SCI, V37, P2906, DOI 10.1016/j.jas.2010.06.035; Jaama K., 1959, EESTI TUMEDAPEALINE; Karelson M., 1981, LEHEKULGI EESTI JA T; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Lancioni H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073712; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lougas L., 1994, STILUS EESTI ARHEOLO, V5, P71; Lougas L, 2007, ARCHAEOFAUNA, V16, P21; Luik H, 2011, LAMBAKASVATUSE VALDK; Lv FH, 2015, MOL BIOL EVOL, V32, P2515, DOI 10.1093/molbev/msv139; Maldre L., 2008, LOODUS INIMENE JA TE, V17, P263; Maldre L., 2008, LOODUS INIMENE JA TE, P277; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Michelson A., 2013, TRADITIONAL SHEEP KE, P60; Niemi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123821; Niemi M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-2; Olivieri C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033792; Palli H., FESTI RAKVASTIKU AJA; Palli H., 1996, EESTI RAHVASTIKU AJA; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Peets J, 1995, KLEIO AJALOO AJAKIRI, V1, P3; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Piirsalu P., LAMBAKASVATUS; Pluskowski A, QUELLEN STUDIEN GESC; Pluskowski A, 2016, ROUTLEDGE WORLDS, P568; Poinar HN, 2003, INT CONGR SER, V1239, P575, DOI 10.1016/S0531-5131(02)00624-6; Prost S, 2011, METHODS ECOL EVOL, V2, P663, DOI 10.1111/j.2041-210X.2011.00129.x; Rammo R., 2015, THESIS; Rannamae E., 2010, THESIS; Rannamae E., 2013, ARCHAEOLOGIA BALTICA, V20, P47, DOI [10.15181/ab.v20i0.807, DOI 10.15181/AB.V20I0.807]; Rannamae E, 2016, ANIM GENET, V47, P208, DOI 10.1111/age.12407; Rannamde E, ECOLOGY CRUSADING CO; Rast-Eicher A, 2013, J ARCHAEOL SCI, V40, P1224, DOI 10.1016/j.jas.2012.09.030; REYNOLDS J, 1983, GENETICS, V105, P767; Ryder M.L., 1983, SHEEP AND MAN; Saarma U, 2009, PARASITOLOGY, V136, P317, DOI 10.1017/S0031182008005453; Soom A., 1954, HERRENHOF ESTLAND 17; TAJIMA F, 1989, GENETICS, V123, P585; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Tapio M, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-76; Tarvel E, 2005, HEINRICI CHRONICON L; Valk H, 2012, ARCHAEOLOGICAL FIELD, V2013, P73; Viinalass H, TEADMATA PARITOLUGA; Wilczyski J, 2016, SARAKENOS CAVE AKRAE, VII, P81; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x; Yang DY, 2005, J ARCHAEOL SCI, V32, P331, DOI 10.1016/j.jas.2004.09.008; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; Zeder Melinda A., 2006, P87; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105	74	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163676	10.1371/journal.pone.0163676	http://dx.doi.org/10.1371/journal.pone.0163676			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DZ0CQ	27732668	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300025
J	Wang, PF				Wang, Pengfei			Forward Period Analysis Method of the Periodic Hamiltonian System	PLOS ONE			English	Article							SYMPLECTIC INTEGRATORS; CHAOTIC SOLUTIONS; SIMULATION	Using the forward period analysis (FPA), we obtain the period of a Morse oscillator and mathematical pendulum system, with the accuracy of 100 significant digits. From these results, the long-term [0, 10 60] (time unit) solutions, ranging from the Planck time to the age of the universe, are computed reliably and quickly with a parallel multiple-precision Taylor series (PMT) scheme. The application of FPA to periodic systems can greatly reduce the computation time of long-term reliable simulations. This scheme provides an efficient way to generate reference solutions, against which long-term simulations using other schemes can be tested.	[Wang, Pengfei] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modeling Atmospher Sci & Geop, Beijing, Peoples R China; [Wang, Pengfei] Chinese Acad Sci, Inst Atmospher Phys, Ctr Monsoon Syst Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Wang, PF (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modeling Atmospher Sci & Geop, Beijing, Peoples R China.; Wang, PF (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, Ctr Monsoon Syst Res, Beijing, Peoples R China.	wpf@mail.iap.ac.cn	Wang, Pengfei/K-5757-2013		National Natural Sciences Foundation of China [41375112, 41530426]; CAS Key Technology Talent Program	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Key Technology Talent Program	This study is supported by the National Natural Sciences Foundation of China (41375112 and 41530426) and the CAS Key Technology Talent Program.	Barrio R, 2005, APPL MATH COMPUT, V163, P525, DOI 10.1016/j.amc.2004.02.015; Barrio R, 2015, COMPUT PHYS COMMUN, V194, P76, DOI 10.1016/j.cpc.2015.04.007; Bin W, 1995, SCI CHINA SER A, V38, P1211; Feng K, 2010, SYMPLECTIC GEOMETRIC ALGORITHMS FOR HAMILTONIAN SYSTEMS, P1, DOI 10.1007/978-3-642-01777-3; Feng K., 1984, P BEIJ S DIFF GEOM D, P42; Gladman B, 1991, CELEST MECH DYN ASTR, V52, P221, DOI 10.1007/BF00048485; Haier E., 2000, SOLVING ORDINARY DIF; Hairer E., 2005, GEOMETRIC NUMERICAL; Liao SJ, 2014, SCI CHINA PHYS MECH, V57, P330, DOI 10.1007/s11433-013-5375-z; Liao SJ, 2014, COMMUN NONLINEAR SCI, V19, P601, DOI 10.1016/j.cnsns.2013.07.008; Liao SJ, 2013, CHAOS SOLITON FRACT, V47, P1, DOI 10.1016/j.chaos.2012.11.009; Liao SJ, 2009, TELLUS A, V61, P550, DOI 10.1111/j.1600-0870.2009.00402.x; Moore R.E., 1966, INTERVAL ANAL; NEAMTAN SM, 1946, J METEOROL, V3, P53, DOI 10.1175/1520-0469(1946)003<0053:TMOHWI>2.0.CO;2; Qin M, 1991, J COMPUT MATH, V9, P211; Quispel GRW, 1998, PHYS LETT A, V242, P25, DOI 10.1016/S0375-9601(98)00154-6; RUTH RD, 1983, IEEE T NUCL SCI, V30, P2669, DOI 10.1109/TNS.1983.4332919; SANZSERNA JM, 1988, BIT, V28, P877, DOI 10.1007/BF01954907; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Wang PF, 2014, CHINESE SCI BULL, V59, P4465, DOI 10.1007/s11434-014-0412-5; Wang PF, 2012, NUMER ALGORITHMS, V59, P147, DOI 10.1007/s11075-011-9481-6; YOSHIDA H, 1990, PHYS LETT A, V150, P262, DOI 10.1016/0375-9601(90)90092-3	23	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163303	10.1371/journal.pone.0163303	http://dx.doi.org/10.1371/journal.pone.0163303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727295	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504400006
J	Stellavato, A; Corsuto, L; D'Agostino, A; La Gatta, A; Diana, P; Bernini, P; De Rosa, M; Schiraldi, C				Stellavato, Antonietta; Corsuto, Luisana; D'Agostino, Antonella; La Gatta, Annalisa; Diana, Paola; Bernini, Patrizia; De Rosa, Mario; Schiraldi, Chiara			Hyaluronan Hybrid Cooperative Complexes as a Novel Frontier for Cellular Bioprocesses Re-Activation	PLOS ONE			English	Article							DERMAL FILLERS; CROSS-LINKING; SKIN; ACID; COLLAGEN; MATRIX; BIOSYNTHESIS; FIBROBLASTS; EXPRESSION; MODEL	Hyaluronic Acid (HA)-based dermal formulations have rapidly gained a large consensus in aesthetic medicine and dermatology. HA, highly expressed in the Extracellular Matrix (ECM), acts as an activator of biological cascades, stimulating cell migration and proliferation, and operating as a regulator of the skin immune surveillance, through specific interactions with its receptors. HA may be used in topical formulations, as dermal inducer, for wound healing. Moreover, intradermal HA formulations (injectable HA) provide an attractive tool to counteract skin aging (e.g., facial wrinkles, dryness, and loss of elasticity) and restore normal dermal functions, through simple and minimally invasive procedures. Biological activity of a commercially available hyaluronic acid, Profhilo (R), based on NAHYCO (TM) technology, was compared to H-HA or L-HA alone. The formation of hybrid cooperative complexes was confirmed by the sudden drop in eta(0) values in the rheological measurements. Besides, hybrid cooperative complexes proved stable to hyaluronidase (BTH) digestion. Using in vitro assays, based on keratinocytes, fibroblasts cells and on the Phenion (R) Full Thickness Skin Model 3D, hybrid cooperative complexes were compared to H-HA, widely used in biorevitalization procedures, and to L-HA, recently proposed as the most active fraction modulating the inflammatory response. Quantitative real-time PCR analyses were accomplished for the transcript quantification of collagens and elastin. Finally immunofluorescence staining permitted to evaluate the complete biosynthesis of all the molecules investigated. An increase in the expression levels of type I and type III collagen in fibroblasts and type IV and VII collagen in keratinocytes were found with the hybrid cooperative complexes, compared to untreated cells (CTR) and to the H-HA and L-HA treatments. The increase in elastin expression found in both cellular model and in the Phenion (R) Full Thickness Skin Model 3D also at longer time (up to 7 days), supports the clinically observed improvement of skin elasticity. The biomarkers analyzed suggest an increase of tissue remodeling in the presence of Profhilo (R), probably due to the long lasting release and the concurrent action of the two HA components.	[Stellavato, Antonietta; Corsuto, Luisana; D'Agostino, Antonella; La Gatta, Annalisa; Diana, Paola; De Rosa, Mario; Schiraldi, Chiara] Univ Naples 2, Sect Biotechnol Med Histol & Mol Biol, Dept Expt Med, Naples, Italy; [Bernini, Patrizia] IBSA Farmaceut Italia Srl, Lodi, Italy	Universita della Campania Vanvitelli	Schiraldi, C (corresponding author), Univ Naples 2, Sect Biotechnol Med Histol & Mol Biol, Dept Expt Med, Naples, Italy.	chiara.schiraldi@unina2.it	La Gatta, Annalisa/X-5317-2018	La Gatta, Annalisa/0000-0002-4723-5865; STELLAVATO, Antonietta/0000-0003-1635-2724; De Rosa, Mario/0000-0002-2976-0818	MIUR [PON03PE_00060_3]; IBSA Farmaceutici Italia Srl, Lodi, Italy, Europe	MIUR(Ministry of Education, Universities and Research (MIUR)); IBSA Farmaceutici Italia Srl, Lodi, Italy, Europe	This research work was funded by MIUR PON03PE_00060_3: "design and development of molecules with nutraceutical and cosmeceutical function". In addition it was supported by IBSA Farmaceutici Italia Srl, Lodi, Italy, Europe, that provided the pharmaceutical grade products and API used in the experiments and provided support for the English copyediting of the final manuscript.	Andre Pierre, 2008, J Cosmet Dermatol, V7, P251, DOI 10.1111/j.1473-2165.2008.00402.x; Baumann L, 2007, J PATHOL, V211, P241, DOI 10.1002/path.2098; Bellas E, 2012, MACROMOL BIOSCI, V12, P1627, DOI 10.1002/mabi.201200262; Bentov I, 2014, BIOGERONTOLOGY, V15, P329, DOI 10.1007/s10522-014-9501-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Croce MA, 2001, TISSUE CELL, V33, P326, DOI 10.1054/tice.2001.0180; D'Agostino A, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0064-6; Damodarasamy M, 2014, WOUND REPAIR REGEN, V22, P521, DOI 10.1111/wrr.12192; De Rosa M, WOPatent, Patent No. [WO/2012/032,151, 2012/]; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; Donejko M, 2015, DRUG DES DEV THER, V9, P6225, DOI 10.2147/DDDT.S91968; Espada J, 2015, INT J COSMETIC SCI, V37, P41, DOI 10.1111/ics.12167; Fakhari A, 2013, ACTA BIOMATER, V9, P7081, DOI 10.1016/j.actbio.2013.03.005; Farwick M, 2011, SKIN PHARMACOL PHYS, V24, P210, DOI 10.1159/000324296; Funt D, 2013, CLIN COSMET INVESTI, V6, P295, DOI 10.2147/CCID.S50546; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Girardeau-Hubert S, 2015, EUR J DERMATOL, V25, P312, DOI 10.1684/ejd.2015.2563; Hiramoto K, 2012, EXP DERMATOL, V21, P911, DOI 10.1111/exd.12032; Kage M, 2014, INT J COSMETIC SCI, V36, P109, DOI 10.1111/ics.12105; Kim ZH, 2015, J MICROBIOL BIOTECHN, V25, P399, DOI 10.4014/jmb.1411.11029; La Gatta A, 2016, MAT SCI ENG C-MATER, V68, P565, DOI 10.1016/j.msec.2016.06.008; La Gatta A, 2016, J BIOMED MATER RES B, V104, P9, DOI 10.1002/jbm.b.33329; La Gatta A, 2013, CARBOHYD POLYM, V96, P536, DOI 10.1016/j.carbpol.2013.04.022; La Gatta A, 2011, POLYM DEGRAD STABIL, V96, P630, DOI 10.1016/j.polymdegradstab.2010.12.025; La Gatta A, 2010, ANAL BIOCHEM, V404, P21, DOI 10.1016/j.ab.2010.04.014; Laurino Carmen, 2015, Eplasty, V15, pe46; Oh JH, 2011, J DERMATOL SCI, V62, P192, DOI 10.1016/j.jdermsci.2011.02.007; Paliwal S, 2014, PLAST RECONSTR SURG, V134, P1224, DOI 10.1097/PRS.0000000000000753; Papakonstantinou E, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.21923; Schante CE, 2011, CARBOHYD POLYM, V85, P469, DOI 10.1016/j.carbpol.2011.03.019; Stellavato A, 2016, J CELL BIOCHEM, V117, P2158, DOI 10.1002/jcb.25556; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; Symonette CJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/727459; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Varma SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145921; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Wang TW, 2006, BIOMATERIALS, V27, P5059, DOI 10.1016/j.biomaterials.2006.05.004; Williams S, 2009, J COSMET DERMATOL-US, V8, P216, DOI 10.1111/j.1473-2165.2009.00447.x	38	36	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163510	10.1371/journal.pone.0163510	http://dx.doi.org/10.1371/journal.pone.0163510			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723763	Green Published, gold			2022-12-27	WOS:000385504100008
J	Yuan, G; Yu, Y; Ji, L; Jie, X; Yue, L; Kang, Y; Gong, JP; Liu, ZJ				Yuan, Guo; Yu, You; Ji, Li; Jie, Xu; Yue, Li; Kang, Yang; Gong Jianping; Liu Zuojin			Down-Regulated Receptor Interacting Protein 140 Is Involved in Lipopolysaccharide-Preconditioning-Induced Inactivation of Kupffer Cells and Attenuation of Hepatic Ischemia Reperfusion Injury	PLOS ONE			English	Article							LIVER ISCHEMIA/REPERFUSION INJURY; ENDOTOXIN TOLERANCE; SIGNALING PATHWAY; CARBON-MONOXIDE; TRANSPLANTATION; RIP140; ACTIVATION; RESPONSES; RATS; REGENERATION	Background Lipopolysaccharide (LPS) preconditioning is known to attenuate hepatic ischemia/reperfusion injury (I/RI); however, the precise mechanism remains unclear. This study investigated the role of receptor-interacting protein 140 (RIP140) on the protective effect of LPS preconditioning in hepatic I/RI involving Kupffer cells (KCs). Methods Sprague-Dawley rats underwent 70% hepatic ischemia for 90 minutes. LPS (100 mu g/kg) was injected intraperitoneally 24 hours before ischemia. Hepatic injury was observed using serum and liver samples. The LPS/NF-kappa B (nuclear factor-kappa B) pathway and hepatic RIP140 expression in isolated KCs were investigated. Results LPS preconditioning significantly inhibited hepatic RIP140 expression, NF-kappa B activation, and serum proinflammatory cytokine expression after I/RI, with an observation of remarkably reduced serum enzyme levels and histopathologic scores. Our experiments showed that protection effects could be effectively induced in KCs by LPS preconditioning, but couldn't when RIP140 was overexpressed in KCs. Conversely, even without LPS preconditioning, protective effects were found in KCs if RIP140 expression was suppressed with siRNA. Conclusions Down-regulated RIP140 is involved in LPS-induced inactivation of KCs and hepatic I/RI attenuation.	[Yuan, Guo] Chongqing Med Univ, Dept Infect, Affiliated Hosp 2, Chongqing 400010, Peoples R China; [Yu, You; Ji, Li; Jie, Xu; Yue, Li; Kang, Yang; Gong Jianping; Liu Zuojin] Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing 400010, Peoples R China	Chongqing Medical University; Chongqing Medical University	Liu, ZJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing 400010, Peoples R China.	Liuzuojin66@163.com	Linong, Ji/AAB-6543-2020		National Science Foundation of China [81170442, 81470899]; Important Scientific Research Project of Ministry of Education [211153]; National Scholarship Foundation [201208505116]; Outsatanding Young Talent Fund	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important Scientific Research Project of Ministry of Education; National Scholarship Foundation; Outsatanding Young Talent Fund	This project was supported by the National Science Foundation of China (No. 81170442 and 81470899), the Important Scientific Research Project of the Ministry of Education (No. 211153), the National Scholarship Foundation (No. 201208505116), and the Outsatanding Young Talent Fund of the Second Hospital of CQMU (2011).	Bhogal RH, 2011, LIVER TRANSPLANT, V17, P95, DOI 10.1002/lt.22205; Bohannon JK, 2013, SHOCK, V40, P451, DOI 10.1097/SHK.0000000000000042; Chen WH, 2012, CELL MOL IMMUNOL, V9, P195, DOI 10.1038/cmi.2012.9; Chung HT, 2013, CELL MOL IMMUNOL, V10, P7, DOI 10.1038/cmi.2012.53; He K, 2014, KIDNEY INT, V85, P276, DOI 10.1038/ki.2013.342; Ho PC, 2012, NAT IMMUNOL, V13, P379, DOI 10.1038/ni.2238; Ho PC, 2011, FASEB J, V25, P1758, DOI 10.1096/fj.10-179267; Ji HF, 2014, HEPATOLOGY, V60, P2052, DOI 10.1002/hep.27334; Kim HJ, 2015, BBA-MOL BASIS DIS, V1852, P1550, DOI 10.1016/j.bbadis.2015.04.017; Kitagawa T, 2013, AM J PHYSIOL-GASTR L, V304, pG346, DOI 10.1152/ajpgi.00391.2012; Liu ZJ, 2006, ACTA PHARMACOL SIN, V27, P1479, DOI 10.1111/j.1745-7254.2006.00413.x; Lopez-Collazo E, 2013, CRIT CARE, V17, DOI 10.1186/cc13110; Luo HY, 2015, HEPATOB PANCREAT DIS, V14, P56, DOI 10.1016/S1499-3872(14)60291-5; Morris M, 2012, ARCH IMMUNOL THER EX, V60, P13, DOI 10.1007/s00005-011-0155-9; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Perry BC, 2011, J INVEST SURG, V24, P178, DOI 10.3109/08941939.2011.568594; Quesnelle KM, 2015, ARCH TOXICOL, V89, P651, DOI 10.1007/s00204-014-1437-x; Rao J, 2015, AM J TRANSPLANT, V15, P76, DOI 10.1111/ajt.12954; Rao JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065568; Saidi RF, 2014, J INVEST SURG, V27, P366, DOI 10.3109/08941939.2014.932473; Sano T, 2011, TRANSPLANTATION, V91, P1082, DOI 10.1097/TP.0b013e31821457cb; Sano T, 2010, HPB, V12, P538, DOI 10.1111/j.1477-2574.2010.00211.x; Shin HJ, 2014, J ANESTH, V28, P898, DOI 10.1007/s00540-014-1850-6; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Teoh NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104376; Tomiyama K, 2008, HEPATOLOGY, V48, P1608, DOI 10.1002/hep.22482; Tsoulfas G, 2002, TRANSPLANTATION, V74, P7, DOI 10.1097/00007890-200207150-00003; van der Heijden KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108453; Vasilescu C, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-55; von Heesen M, 2015, ANN TRANSPL, V20, P160, DOI 10.12659/AOT.893031; Wang HY, 2013, MOL CELL BIOCHEM, V379, P153, DOI 10.1007/s11010-013-1637-3; Xiao ZY, 2015, LIVER TRANSPLANT, V21, P468, DOI 10.1002/lt.24059; Yang K, 2013, J SURG RES, V183, P922, DOI 10.1016/j.jss.2013.02.033; You Y, 2015, IMMUNOL RES, V62, P292, DOI 10.1007/s12026-015-8660-2; Zeng WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070832; Zhang QY, 2014, J SURG RES, V189, P152, DOI 10.1016/j.jss.2014.01.061; Zschiedrich I, 2008, BLOOD, V112, P264, DOI 10.1182/blood-2007-11-121699	37	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164217	10.1371/journal.pone.0164217	http://dx.doi.org/10.1371/journal.pone.0164217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723769	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100030
J	Zhang, HZ; Liu, DH; Zhang, DK; Wang, YH; Li, G; Yan, GL; Cao, LJ; Xiao, XH; Huang, LQ; Wang, JB				Zhang, Hai-zhu; Liu, Da-hui; Zhang, Ding-kun; Wang, Yan-hui; Li, Gang; Yan, Gui-lin; Cao, Li-juan; Xiao, Xiao-he; Huang, Lu-qi; Wang, Jia-bo			Quality Assessment of Panax notoginseng from Different Regions through the Analysis of Marker Chemicals, Biological Potency and Ecological Factors	PLOS ONE			English	Article							PROTOPANAXATRIOL-TYPE SAPONINS; SMOOTH-MUSCLE-CELLS; ROOTS; RATS; CHROMATOGRAPHY; RAW	Panax notoginseng (Burk.) F.H. Chen, called Sanqi in China, is a perennial herb that has been used as a medicinal herb in traditional Chinese medicine for more than 400 years. Because notoginseng is included in many proprietary Chinese medicines, the quality of notoginseng directly affects its efficacy and safety. However, considering the complex and special growth environment requirements of notoginseng, it is insufficient to evaluate its quality based solely on the analysis of marker chemicals. Thus, in this study, we tried to evaluate the quality of notoginseng with integrated indicators: (1) the concentration of five marker chemicals, notoginsenoside R1, ginsenoside Rg1, ginsenoside Re, ginsenoside Rb1 and ginsenoside Rd; (2) the anticoagulant activity (ACA); and (3) twenty-one ecological factors (e.g., longitude, latitude, elevation and soil data). Using these 27 parameters, notoginseng from different regions could be distinguished effectively, indicating a remarkable divergence of quality. A correlation analysis showed that variations of the ecological factors were closely associated with the saponins content and biopotency. For instance, the total nitrogen (TN), alkali hydrolysis nitrogen (AHN) and rapidly available potassium (RAPT) were significantly correlated with ACA, and RAPT was significantly correlated with the content of ginsenoside Rd and notoginsenoside R1. The results demonstrated that the high-quality notoginseng was produced from the emerging regions such as Kunming, Qujing and Honghe, which had higher ACA and saponin content than the notoginseng produced in traditional regions such as Wenshan and Baise.	[Zhang, Hai-zhu; Zhang, Ding-kun; Xiao, Xiao-he; Wang, Jia-bo] Chengdu Univ Tradit Chinese Med, Chengdu 611137, Peoples R China; [Zhang, Hai-zhu; Zhang, Ding-kun; Wang, Yan-hui; Xiao, Xiao-he; Wang, Jia-bo] 302 Mil Hosp, China Mil Inst Chinese Med, Beijing 100039, Peoples R China; [Zhang, Hai-zhu] Dali Univ, Dali 671003, Peoples R China; [Liu, Da-hui] Kunming Univ Sci & Technol, Yunnan Genuine Med Mat Res & Dev Ctr, Kunming 650500, Peoples R China; [Li, Gang; Yan, Gui-lin; Cao, Li-juan] China Med Corp, Int Bldg 811,Guang Qu Men St 80, Beijing 100062, Peoples R China; [Huang, Lu-qi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing 100700, Peoples R China	Chengdu University of Traditional Chinese Medicine; Fifth Medical Center of Chinese PLA General Hospital; Dali University; Kunming University of Science & Technology; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS	Xiao, XH; Wang, JB (corresponding author), Chengdu Univ Tradit Chinese Med, Chengdu 611137, Peoples R China.; Xiao, XH; Wang, JB (corresponding author), 302 Mil Hosp, China Mil Inst Chinese Med, Beijing 100039, Peoples R China.	Pharmacy302xxh@126.com; wjb0128@126.com	xiao, xiang/GWU-6035-2022; Zhang, Ding-kun/AAF-1142-2020		National Natural Science Foundation of China [81274026, 81403126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China (No. 81274026, 81403126).; This research is supported by the National Natural Science Foundation of China (No. 81274026, 81403126).	[安娜 AN Na], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P1086; Chan ECY, 2007, RAPID COMMUN MASS SP, V21, P519, DOI 10.1002/rcm.2864; Chan P, 2002, ACTA PHARMACOL SIN, V23, P1157; Chan RYK, 2002, J CLIN ENDOCR METAB, V87, P3691, DOI 10.1210/jc.87.8.3691; Chen SW, 2004, ACTA PHARMACOL SIN, V25, P1151; Cicero AFG, 2003, PHYTOTHER RES, V17, P174, DOI 10.1002/ptr.1262; Cui Xiu-Ming, 2014, Zhongguo Zhong Yao Za Zhi, V39, P553; Dong TTX, 2003, J AGR FOOD CHEM, V51, P4617, DOI 10.1021/jf034229k; Du QZ, 2003, J CHROMATOGR A, V1008, P173, DOI 10.1016/S0021-9673(03)00988-9; Guan YY, 2006, EUR J PHARMACOL, V548, P129, DOI 10.1016/j.ejphar.2006.08.001; Guo XC, 2007, ECOL ECON, V1, P114; Han J, 1999, Zhongguo Zhong Xi Yi Jie He Za Zhi, V19, P227; Huang Chun-mei, 2015, Zhongguo Zhong Yao Za Zhi, V40, P2930; Ji W, 2007, J ETHNOPHARMACOL, V113, P318, DOI 10.1016/j.jep.2007.06.022; Jia Y., 2008, J MED COLL PLA, V23, P38; Lau AJ, 2003, J CHROMATOGR A, V1011, P77, DOI 10.1016/S0021-9673(03)01135-X; LI XH, 1999, CHIN TRADIT HERBAL D, V30, P514; Ling SH, 2008, INT J CARDIOL, V128, P350, DOI 10.1016/j.ijcard.2007.05.111; Liu Da-Hui, 2014, Zhongguo Zhong Yao Za Zhi, V39, P572; [刘莉 Liu Li], 2013, [西南农业学报, Southwest China Journal of Agricultural Sciences], V26, P1946; Liu Y, 2003, SPECTROCHIM ACTA A, V59, P2747, DOI 10.1016/S1386-1425(03)00055-6; Low M, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0525-7; MA LY, 1998, CHIN PHARM J, V33, P467; MA LY, 1998, CHIN PHARM J, V33, P143; Ma WG, 1999, PHYTOCHEMISTRY, V52, P1133, DOI 10.1016/S0031-9422(99)00364-7; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; Sun HX, 2006, INT IMMUNOPHARMACOL, V6, P14, DOI 10.1016/j.intimp.2005.07.003; Wan JB, 2007, J SEP SCI, V30, P825, DOI 10.1002/jssc.200600359; Wang D, 2013, PHYTOCHEMISTRY, V93, P88, DOI 10.1016/j.phytochem.2013.03.007; Wei J.X., 1996, MODERN SCI RES APPL, P426; Xu L, 2011, J ETHNOPHARMACOL, V137, P226, DOI 10.1016/j.jep.2011.05.020; Xu QF, 2003, J ETHNOPHARMACOL, V84, P187, DOI 10.1016/S0378-8741(02)00317-3; ZHANG GQ, 1998, CHIN J NEPHROL, V14, P93; Zhang Y, 2013, MOLECULES, V18, P10352, DOI 10.3390/molecules180910352; Zheng Dong-Mei, 2014, Zhongguo Zhong Yao Za Zhi, V39, P558; Zheng GZ, 1994, BIOL PANAX NOTOGINSE; Zhu XX, 1998, CHIN J BIOCH PHARM, V19, P28	37	15	19	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164384	10.1371/journal.pone.0164384	http://dx.doi.org/10.1371/journal.pone.0164384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723805	Green Submitted, gold, Green Published			2022-12-27	WOS:000385504100052
J	Kinoshita, M; Sakai, M; Arita, H; Shofuda, T; Chiba, Y; Kagawa, N; Watanabe, Y; Hashimoto, N; Fujimoto, Y; Yoshimine, T; Nakanishi, K; Kanemura, Y				Kinoshita, Manabu; Sakai, Mio; Arita, Hideyuki; Shofuda, Tomoko; Chiba, Yasuyoshi; Kagawa, Naoki; Watanabe, Yoshiyuki; Hashimoto, Naoya; Fujimoto, Yasunori; Yoshimine, Toshiki; Nakanishi, Katsuyuki; Kanemura, Yonehiro			Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas	PLOS ONE			English	Article							IDH1 MUTATIONS; TUMORS; 2-HYDROXYGLUTARATE; SPECTROSCOPY	Reports have suggested that tumor textures presented on T2-weighted images correlate with the genetic status of glioma. Therefore, development of an image analyzing framework that is capable of objective and high throughput image texture analysis for large scale image data collection is needed. The current study aimed to address the development of such a framework by introducing two novel parameters for image textures on T2-weighted images, i.e., Shannon entropy and Prewitt filtering. Twenty-two WHO grade 2 and 28 grade 3 glioma patients were collected whose pre-surgical MRI and IDH1 mutation status were available. Heterogeneous lesions showed statistically higher Shannon entropy than homogenous lesions (p = 0.006) and ROC curve analysis proved that Shannon entropy on T2WI was a reliable indicator for discrimination of homogenous and heterogeneous lesions (p = 0.015, AUC = 0.73). Lesions with well-defined borders exhibited statistically higher Edge mean and Edge median values using Prewitt filtering than those with vague lesion borders (p = 0.0003 and p = 0.0005 respectively). ROC curve analysis also proved that both Edge mean and median values were promising indicators for discrimination of lesions with vague and well defined borders and both Edge mean and median values performed in a comparable manner (p = 0.0002, AUC = 0.81 and p < 0.0001, AUC = 0.83, respectively). Finally, IDH1 wild type gliomas showed statistically lower Shannon entropy on T2WI than IDH1 mutated gliomas (p = 0.007) but no difference was observed between IDH1 wild type and mutated gliomas in Edge median values using Prewitt filtering. The current study introduced two image metrics that reflect lesion texture described on T2WI. These two metrics were validated by readings of a neuro-radiologist who was blinded to the results. This observation will facilitate further use of this technique in future large scale image analysis of glioma.	[Kinoshita, Manabu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Neurosurg, Osaka, Japan; [Sakai, Mio; Nakanishi, Katsuyuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiol, Osaka, Japan; [Arita, Hideyuki; Chiba, Yasuyoshi; Kagawa, Naoki; Hashimoto, Naoya; Fujimoto, Yasunori; Yoshimine, Toshiki] Osaka Univ, Dept Neurosurg, Grad Sch Med, Suita, Osaka, Japan; [Shofuda, Tomoko] Osaka Natl Hosp, Inst Clin Res, Div Stem Cell Res, Osaka, Japan; [Watanabe, Yoshiyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka, Japan; [Hashimoto, Naoya] Kyoto Prefectural Univ, Dept Neurosurg, Grad Sch Med Sci, Kyoto, Japan; [Kanemura, Yonehiro] Osaka Natl Hosp, Div Regenerat Med, Inst Clin Res, Osaka, Japan; [Kanemura, Yonehiro] Osaka Natl Hosp, Dept Neurosurg, Osaka, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Osaka National Hospital; Osaka University; Kyoto Prefectural University; Osaka National Hospital; Osaka National Hospital	Kinoshita, M (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Neurosurg, Osaka, Japan.	mail@manabukinoshita.com	Kagawa, Naoki/AAF-7079-2019; Sakai, Mio/AAZ-5540-2021; Arita, Hideyuki/AAH-2301-2019	Arita, Hideyuki/0000-0002-1126-8155; Sakai, Mio/0000-0002-6415-3191; Kinoshita, Manabu/0000-0001-7923-6902	JSPS KAKENHI [25462256]; Osaka Medical Research Foundation for Intractable Diseases; Terumo Foundation for Life Sciences and Arts; Japan Brain Foundation; Grants-in-Aid for Scientific Research [15K10331, 16K10778, 26670642] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Osaka Medical Research Foundation for Intractable Diseases; Terumo Foundation for Life Sciences and Arts; Japan Brain Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI 25462256 (https://www.jsps.go.jp/english/index.html); Osaka Medical Research Foundation for Intractable Diseases (http://www.nanbyo.or.jp/zaidan/info2013.html); Terumo Foundation for Life Sciences and Arts (https://www.terumozaidan.or.jp); and Japan Brain Foundation (http://jbf.or.jp//).	Aihara K, 2014, NEURO-ONCOLOGY, V16, P140, DOI 10.1093/neuonc/not144; Andronesi OC, 2013, J CLIN INVEST, V123, P3659, DOI 10.1172/JCI67229; Andronesi OC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002693; Arita H, 2015, BRAIN TUMOR PATHOL, V32, P79, DOI 10.1007/s10014-014-0197-x; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Canny J, 1986, MACH INTELL, V8, P679, DOI DOI 10.1109/TPAMI.1986.4767851; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Ellingson BM, 2013, AM J NEURORADIOL, V34, P533, DOI 10.3174/ajnr.A3253; Ellingson BM, 2012, NEUROIMAGE, V59, P908, DOI 10.1016/j.neuroimage.2011.09.076; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kijima N, 2012, NEURO-ONCOLOGY, V14, P1254, DOI 10.1093/neuonc/nor202; Kim JW, 2011, J NEUROL NEUROSUR PS, V82, P224, DOI 10.1136/jnnp.2009.178806; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Ryu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108335; Shinozaki N, 2011, J NEUROSURG, V114, P1640, DOI 10.3171/2010.11.JNS10553; Sonoda Y, 2015, BRAIN TUMOR PATHOL, V32, P99, DOI 10.1007/s10014-014-0211-3; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273	19	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164268	10.1371/journal.pone.0164268	http://dx.doi.org/10.1371/journal.pone.0164268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716832	gold, Green Published, Green Submitted			2022-12-27	WOS:000385698100038
J	Schliemann, C; Gerss, J; Wiebe, S; Mikesch, JH; Knoblauch, N; Sauer, T; Angenendt, L; Kewitz, T; Urban, M; Butterfass-Bahloul, T; Edemir, S; Vehring, K; Muller-Tidow, C; Berdel, WE; Krug, U				Schliemann, Christoph; Gerss, Joachim; Wiebe, Stefanie; Mikesch, Jan-Henrik; Knoblauch, Nicola; Sauer, Tim; Angenendt, Linus; Kewitz, Tobias; Urban, Marc; Butterfass-Bahloul, Trude; Edemir, Sabine; Vehring, Kerstin; Mueller-Tidow, Carsten; Berdel, Wolfgang E.; Krug, Utz			A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OLDER PATIENTS; BONE-MARROW; MYELODYSPLASTIC SYNDROME; AUTOCRINE STIMULATION; OPEN-LABEL; TRIAL; INDUCTION; SURVIVAL; CELLS	Nintedanib (BIBF 1120), a potent multikinase inhibitor of VEGFR-1/-2/-3, FGFR-1/-2/-3 and PDGFR-alpha/-beta, exerts growth inhibitory and pro-apoptotic effects in myeloid leukemic cells, especially when used in combination with cytarabine. This phase I study evaluated nintedanib in combination with low-dose cytarabine (LDAC) in elderly patients with untreated or relapsed/refractory acute myeloid leukemia (AML) ineligible for intensive chemotherapy in a 3+ 3 design. Nintedanib (dose levels 100, 150, and 200 mg orally twice daily) and LDAC (20 mg subcutaneous injection twice daily for 10 days) were administered in 28-day cycles. Dose-limiting toxicity (DLT) was defined as non-hematological severe adverse reaction CTC grade >= 4 with possible or definite relationship to nintedanib. Between April 2012 and October 2013, 13 patients (median age 73 [range: 62-86] years) were enrolled. One patient did not receive study medication and was replaced. Nine (69%) patients had relapsed or refractory disease and 6 (46%) patients had unfavorable cytogenetics. The most frequently reported treatment-related adverse events (AE) were gastrointestinal events. Twelve SAEs irrespective of relatedness were reported. Two SUSARs were observed, one fatal hypercalcemia and one fatal gastrointestinal infection. Two patients (17%) with relapsed AML achieved a complete remission (one CR, one CRi) and bone marrow blast reductions without fulfilling PR criteria were observed in 3 patients (25%). One-year overall survival was 33%. Nintedanib combined with LDAC shows an adequate safety profile and survival data are promising in a difficult-to-treat patient population. Continuation of this trial with a phase II recommended dose of 2 x 200 mg nintedanib in a randomized, placebo-controlled phase II study is planned. The trial is registered to EudraCT as 2011-001086-41.	[Schliemann, Christoph; Wiebe, Stefanie; Mikesch, Jan-Henrik; Knoblauch, Nicola; Sauer, Tim; Angenendt, Linus; Edemir, Sabine; Vehring, Kerstin; Mueller-Tidow, Carsten; Berdel, Wolfgang E.; Krug, Utz] Univ Hosp Muenster, Dept Med A, Munster, Germany; [Gerss, Joachim] Univ Hosp Muenster, Inst Biostat & Clin Res, Munster, Germany; [Kewitz, Tobias; Urban, Marc; Butterfass-Bahloul, Trude] Univ Hosp Muenster, Ctr Clin Trials, Munster, Germany; [Mueller-Tidow, Carsten] Univ Hosp Halle, Dept Med 4, Halle, Saale, Germany; [Krug, Utz] Klinikum Leverkusen, Dept Med 3, Leverkusen, Germany	University of Munster; University of Munster; University of Munster; Martin Luther University Halle Wittenberg	Krug, U (corresponding author), Univ Hosp Muenster, Dept Med A, Munster, Germany.; Krug, U (corresponding author), Klinikum Leverkusen, Dept Med 3, Leverkusen, Germany.	utz.krug@klinikum-lev.de	Müller-Tidow, Carsten/O-7207-2018; Gerß, Joachim WO/B-5702-2013; A, L/K-2711-2017	Müller-Tidow, Carsten/0000-0002-7166-5232; A, L/0000-0003-2502-9910	Boehringer Ingelheim Pharma GmbH Co. KG; German Federal Ministry of Education and Research (BMBF) [01KN1105]	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was funded by Boehringer Ingelheim Pharma GmbH & Co. KG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Center for Clinical Trials Muenster was supported by the German Federal Ministry of Education and Research (BMBF, 01KN1105).	Aguayo A, 1999, BLOOD, V94, P3717, DOI 10.1182/blood.V94.11.3717.423k09_3717_3721; Bieker R, 2003, CANCER RES, V63, P7241; Buchner T, 2006, J CLIN ONCOL, V24, P2480, DOI 10.1200/JCO.2005.04.5013; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Burnett AK, 2013, BLOOD, V122, P1384, DOI 10.1182/blood-2013-04-496596; Dennis M, 2015, BLOOD, V125, P2923, DOI 10.1182/blood-2014-10-608117; Dias S, 2001, P NATL ACAD SCI USA, V98, P10857, DOI 10.1073/pnas.191117498; Dias S, 2000, J CLIN INVEST, V106, P511, DOI 10.1172/JCI8978; Dohner H, 2014, BLOOD, V124, P1426, DOI 10.1182/blood-2014-03-560557; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fenaux P, 2008, ECANCERMEDICALSCIENC, V2, DOI 10.3332/ecancer.2008.121; Fiedler W, 1997, BLOOD, V89, P1870, DOI 10.1182/blood.V89.6.1870; Fiedler W, 2010, LEUKEMIA RES, V34, P196, DOI 10.1016/j.leukres.2009.07.020; Foss B, 2001, EUR J HAEMATOL, V67, P267, DOI 10.1034/j.1600-0609.2001.0430a.x; Giles FJ, 2006, LEUKEMIA RES, V30, P801, DOI 10.1016/j.leukres.2005.10.024; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Juliusson G, 2009, BLOOD, V113, P4179, DOI 10.1182/blood-2008-07-172007; Kantarjian HM, 2012, J CLIN ONCOL, V30, P2670, DOI 10.1200/JCO.2011.38.9429; Karajannis MA, 2006, LEUKEMIA, V20, P979, DOI 10.1038/sj.leu.2404203; Kulimova E, 2006, MOL CANCER THER, V5, P3105, DOI 10.1158/1535-7163.MCT-06-0323; Okamoto I, 2010, MOL CANCER THER, V9, P2825, DOI 10.1158/1535-7163.MCT-10-0379; Ossenkoppele GJ, 2012, BLOOD, V120, P4706, DOI 10.1182/blood-2012-04-420596; Padro T, 2002, LEUKEMIA, V16, P1302, DOI 10.1038/sj.leu.2402534; Padro T, 2000, BLOOD, V95, P2637, DOI 10.1182/blood.V95.8.2637.008k07_2637_2644; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Shah CA, 2013, J BIOL CHEM, V288, P32490, DOI 10.1074/jbc.M113.496109; Veiga JP, 2006, EXP HEMATOL, V34, P610, DOI 10.1016/j.exphem.2006.01.013; Wierzbowska A, 2003, EUR CYTOKINE NETW, V14, P149; Zahiragic L, 2007, LEUKEMIA, V21, P1310, DOI 10.1038/sj.leu.2404632	33	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164499	10.1371/journal.pone.0164499	http://dx.doi.org/10.1371/journal.pone.0164499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716819	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100059
J	Biranjia-Hurdoyal, SD; Seetulsingh-Goorah, SP				Biranjia-Hurdoyal, Susheela D.; Seetulsingh-Goorah, Sharmila P.			Performances of Four Helicobacter pylori Serological Detection Kits Using Stool Antigen Test as Gold Standard	PLOS ONE			English	Article							THROMBOCYTOPENIC PURPURA; IGA ANTIBODIES; INFECTION; ERADICATION; DIAGNOSIS; VACA; CAGA; POPULATION; IMMUNOBLOT; ACCURACY	The aim was to determine the performances of four Helicobacter pylori serological detection kits in different target groups, using Amplified IDEIA (TM) Hp StAR (TM) as gold standard. Kits studied were Rapid Immunochromatoghraphic Hexagon, Helicoblot 2.1, an EIA IgG kit and EIA IgA kit. Methods: Stool and blood samples were collected from 162 apparently healthy participants (control) and 60 Type 2 diabetes mellitus (T2DM) patients. Results: The performances of the four serological detection kits were found to be affected by gender, age, health status and ethnicity of the participants. In the control group, the Helicoblot 2.1 kit had the best performance (AUC = 0.85; p<0.05, accuracy = 86.4%), followed by EIA IgG (AUC = 0.75; p<0.05, accuracy = 75.2%). The Rapid Hexagon and EIA IgA kits had relatively poor performances. In the T2DM subgroup, the kits H2.1 and EIA IgG had best performances, with accuracies of 96.5% and 93.1% respectively. The performance of EIA IgG improved with adjustment of its cut-off value. Conclusion: The performances of the detection kits were affected by various factors which should be taken into consideration.	[Biranjia-Hurdoyal, Susheela D.; Seetulsingh-Goorah, Sharmila P.] Univ Mauritius, Dept Hlth Sci, Moka, Mauritius; [Seetulsingh-Goorah, Sharmila P.] Univ Technol Mauritius, Moka, Mauritius	University of Mauritius	Biranjia-Hurdoyal, SD (corresponding author), Univ Mauritius, Dept Hlth Sci, Moka, Mauritius.	s.biranjia@uom.ac.mu		Biranjia-Hurdoyal, Susheela/0000-0003-1920-0128	University of Mauritius	University of Mauritius	University of Mauritius funded the experimental part of this study as part of an MPhil/PhD study.	Annibale B, 2007, HELICOBACTER, V12, P23, DOI 10.1111/j.1523-5378.2007.00467.x; Arinton I Gede, 2011, Acta Med Indones, V43, P88; Barton SGRG, 1998, CLIN EXP IMMUNOL, V112, P490; Emilia G, 2001, BLOOD, V97, P812, DOI 10.1182/blood.V97.3.812; Fock MK, 2009, J GASTROEN HEPATOL, V24, P1587, DOI [10.1111/j.1440-1746.2009.05982.x, DOI 10.1111/J.1440-1746.2009.05982.X]; Garcia-Gomez E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/928290; GOOSSENS H, 1992, J CLIN MICROBIOL, V30, P176, DOI 10.1128/JCM.30.1.176-180.1992; GRANBERG C, 1993, J CLIN MICROBIOL, V31, P1450, DOI 10.1128/JCM.31.6.1450-1453.1993; Gulcelik NE, 2005, J ENDOCRINOL INVEST, V28, P214, DOI 10.1007/BF03345375; Ho B, 2000, GASTROENTEROL CLIN N, V29, P853, DOI 10.1016/S0889-8553(05)70152-7; Hoang TTH, 2006, CLIN MICROBIOL INFEC, V12, P1112, DOI 10.1111/j.1469-0691.2006.01514.x; Huang XL, 2010, POSTGRAD MED J, V86, P272, DOI 10.1136/pgmj.2009.089987; Kidd M, 1999, GUT, V45, P499, DOI 10.1136/gut.45.4.499; Koehler CI, 2003, J CLIN PATHOL-MOL PA, V56, P36, DOI 10.1136/mp.56.1.36; KOSUNEN TU, 1992, LANCET, V339, P893, DOI 10.1016/0140-6736(92)90929-W; LABENZ J, 1994, GUT, V35, P19, DOI 10.1136/gut.35.1.19; Lee SY, 2014, WORLD J GASTROENTERO, V20, P1493, DOI 10.3748/wjg.v20.i6.1493; Lim LG, 2005, WORLD J GASTROENTERO, V11, P6681, DOI 10.3748/wjg.v11.i42.6681; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Marchildon PA, 2003, J CLIN MICROBIOL, V41, P1480, DOI 10.1128/JCM.41.4.1480-1485.2003; Marchildon PA, 1996, J CLIN MICROBIOL, V34, P1147, DOI 10.1128/JCM.34.5.1147-1152.1996; Michel M, 2004, BLOOD, V103, P890, DOI 10.1182/blood-2003-03-0900; Moayyedi P, 1998, GUT, V43, pS51, DOI 10.1136/gut.43.2008.S51; Montalban C, 2001, HAEMATOLOGICA, V86, P609; Oluwasola A O, 2002, West Afr J Med, V21, P138; Pietroiusti A, 2002, CIRCULATION, V106, P580, DOI 10.1161/01.CIR.0000023894.10871.2F; Salomaa-Rasanen A, 2006, CLIN MICROBIOL INFEC, V12, P236, DOI 10.1111/j.1469-0691.2005.01357.x; Veijola L, 2008, CLIN VACCINE IMMUNOL, V15, P1705, DOI 10.1128/CVI.00165-08; Wilcox MH, 1996, J CLIN PATHOL, V49, P373, DOI 10.1136/jcp.49.5.373; Wu CC, 2005, J CLIN MICROBIOL, V43, P2913, DOI 10.1128/JCM.43.6.2913-2915.2005; Xia HHX, 2001, AM J GASTROENTEROL, V96, P1039, DOI 10.1111/j.1572-0241.2001.03604.x; Yeo Marie, 2005, Korean J Gastroenterol, V46, P181; Zapatier Jorge A., 2007, Acta Gastroenterologica Latinoamericana, V37, P104	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163834	10.1371/journal.pone.0163834	http://dx.doi.org/10.1371/journal.pone.0163834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736910	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800027
J	Blokker, BM; Weustink, AC; Hunink, MGM; Oosterhuis, JW				Blokker, Britt M.; Weustink, Annick C.; Hunink, M. G. Myriam; Oosterhuis, J. Wolter			Autopsy of Adult Patients Deceased in an Academic Hospital: Considerations of Doctors and Next-of-Kin in the Consent Process	PLOS ONE			English	Article							DIAGNOSTIC ERRORS; RATES; ATTITUDES; DEATH; PERCEPTIONS; ANGIOGRAPHY; PERFORMANCE; RELATIVES; MEDICINE	Introduction Hospital autopsies, vanishing worldwide, need to be requested by clinicians and consented to by next-of-kin. The aim of this prospective observational study was to examine how often and why clinicians do not request an autopsy, and for what reasons next-of-kin allow, or refuse it. Methods Clinicians at the Erasmus University Medical Centre were asked to complete a questionnaire when an adult patient had died. Questionnaires on 1000 consecutive naturally deceased adults were collected. If possible, missing data in the questionnaires were retrieved from the electronic patient record. Results Data from 958 (96%) questionnaires was available for analysis. In 167/958 (17.4%) cases clinicians did not request an autopsy, and in 641/791 (81.0%) cases next-of-kin did not give consent. The most important reason for both clinicians (51.5%) and next-of-kin (51.0%) to not request or consent to an autopsy was an assumed known cause of death. Their second reason was that the deceased had gone through a long illness (9.6% and 29.5%). The third reason for next-of-kin was mutilation of the deceased's body by the autopsy procedure (16.1%). Autopsy rates were highest among patients aged 30-39 years, Europeans, suddenly and/or unexpectedly deceased patients, and tissue and/or organ donors. The intensive care and emergency units achieved the highest autopsy rates, and surgical wards the lowest. Conclusion The main reason for not requesting or allowing an autopsy is the assumption that the cause of death is known. This is a dangerous premise, because it is a self-fulfilling prophecy. Clinicians should be aware, and communicate with the next of kin, that autopsies not infrequently disclose unexpected findings, which might have changed patient management. Mutilation of the deceased's body seems a minor consideration of next-of-kin, though how it really affects autopsy rates, should be studied by offering minimally or non-invasive autopsy methods.	[Blokker, Britt M.; Oosterhuis, J. Wolter] Erasmus Univ, Med Ctr, Dept Pathol, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Blokker, Britt M.; Weustink, Annick C.; Hunink, M. G. Myriam] Erasmus Univ, Med Ctr, Dept Radiol, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Hunink, M. G. Myriam] Erasmus Univ, Med Ctr, Dept Clin Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health	Oosterhuis, JW (corresponding author), Erasmus Univ, Med Ctr, Dept Pathol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.w.oosterhuis@erasmusmc.nl			Erasmus MC Health Care Efficiency/Cost-Effectiveness Research [2010-10112]; Stichting Coolsingel Rotterdam [255]; Erasmus MC Vriendenfonds [104117]	Erasmus MC Health Care Efficiency/Cost-Effectiveness Research; Stichting Coolsingel Rotterdam; Erasmus MC Vriendenfonds	This study was made possible by grants from the Erasmus MC Health Care Efficiency/Cost-Effectiveness Research, http/www.erasmusmc.nl/research/over-research/subsidies/subsidies/?lang=en (project number 2010-10112), Stichting Coolsingel Rotterdam, http//stichtingcoolsingel.nl (project number 255), and Erasmus MC Vriendenfonds, littps://www. erasmusmcvrienden.nl/het-fonds/vriendenfonds (project number 104117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub T, 2008, J ROY SOC MED, V101, P177, DOI 10.1258/jrsm.2008.070479; Blokker BM, 2015, EUR RADIOL; BROWN HG, 1990, HUM PATHOL, V21, P154, DOI 10.1016/0046-8177(90)90123-M; Burton EC, 2004, AM J MED, V117, P255, DOI 10.1016/j.amjmed.2004.01.028; Burton JL, 2003, J CLIN PATHOL, V56, P537, DOI 10.1136/jcp.56.7.537; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; CHARLTON R, 1994, J ROY SOC MED, V87, P232; Gaensbacher S, 2012, EUR J EPIDEMIOL, V27, P577, DOI 10.1007/s10654-012-9709-3; GATRAD AR, 1994, BRIT MED J, V309, P521, DOI 10.1136/bmj.309.6953.521; HINCHLIFFE SA, 1994, POSTGRAD MED J, V70, P292, DOI 10.1136/pgmj.70.822.292; Hull MJ, 2007, HUM PATHOL, V38, P342, DOI 10.1016/j.humpath.2006.08.011; Jeganathan VS, 2006, ANZ J SURG, V76, P205, DOI 10.1111/j.1445-2197.2006.03703.x; Kuijpers CCHJ, 2014, J CLIN PATHOL, V67, P512, DOI 10.1136/jclinpath-2013-202122; Loughrey MB, 2000, ULSTER MED J, V69, P83; MCPHEE SJ, 1986, AM J MED, V80, P665, DOI 10.1016/0002-9343(86)90822-3; Murken DR, 2012, AM J ROENTGENOL, V199, P394, DOI 10.2214/AJR.11.8386; Oluwasola OA, 2009, ARCH PATHOL LAB MED, V133, P78, DOI 10.1043/1543-2165-133.1.78; Saunders SL, 2013, J CLIN PATHOL, V66, P326, DOI 10.1136/jclinpath-2012-201250; Scordi-Bello IA, 2010, MODERN PATHOL, V23, P1225, DOI 10.1038/modpathol.2010.107; Shojania KG, 2008, NEW ENGL J MED, V358, P873, DOI 10.1056/NEJMp0707996; Shojania KG, 2005, QUAL SAF HEALTH CARE, V14, P408, DOI 10.1136/qshc.2004.011973; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Sinard JH, 2001, EXP MOL PATHOL, V70, P333, DOI 10.1006/exmp.2001.2371; Thayyil S, 2010, EUR J RADIOL, V75, pE142, DOI 10.1016/j.ejrad.2009.10.007; Tsitsikas DA, 2011, J CLIN PATHOL, V64, P412, DOI 10.1136/jcp.2010.086645; van den Tweel JG, 2015, VIRCHOWS ARCH; van der Linden A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115675; Wichmann D, 2014, ANN INTERN MED, V160, P534, DOI 10.7326/M13-2211; Winters B, 2012, BMJ QUAL SAF, V21, P894, DOI 10.1136/bmjqs-2012-000803; Wittschieber D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037460	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163811	10.1371/journal.pone.0163811	http://dx.doi.org/10.1371/journal.pone.0163811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736974	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800025
J	Hsu, KC; Wang, FS				Hsu, Kai-Cheng; Wang, Feng-Sheng			Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine Deficiency	PLOS ONE			English	Article							PARKINSONS-DISEASE; SYSTEMS BIOLOGY; MOUSE MODEL; OPTIMIZATION; DISCOVERY; PRINCIPLES; MICE	Model-based optimization approaches are valuable in developing new drugs for human metabolic disorders. The core objective in most optimal drug designs is positive therapeutic effects. In this study, we considered the effects of therapeutic, adverse, and target variation simultaneously. A fuzzy optimization method was applied to formulate a multiobjective drug design problem for detecting enzyme targets in the presynaptic dopamine metabolic network to remedy two types of enzymopathies caused by deficiencies of vesicular monoamine transporter 2 (VMAT2) and tyrosine hydroxylase (TH). The fuzzy membership approach transforms a two-stage drug discovery problem into a unified decision-making problem. We developed a nested hybrid differential evolution algorithm to efficiently identify a set of potential drug targets. Furthermore, we also simulated the effects of current clinical drugs for Parkinson's disease (PD) in this model and tried to clarify the possible causes of neurotoxic and neuroprotective effects. The optimal drug design could yield 100% satisfaction grade when both therapeutic effect and the number of targets were considered in the objective. This scenario required regulating one to three and one or two enzyme targets for 50%-95% and 50%-100% VMAT2 and TH deficiencies, respectively. However, their corresponding adverse and target variation effect grades were less satisfactory. For the most severe deficiencies of VMAT2 and TH, a compromise design could be obtained when the effects of therapeutic, adverse, and target variation were simultaneously applied to the optimal drug discovery problem. Such a trade-off design followed the no free lunch theorem for optimization; that is, a more serious dopamine deficiency required more enzyme targets and lower satisfaction grade. In addition, the therapeutic effects of current clinical medications for PD could be enhanced in combination with new enzyme targets. The increase of toxic metabolites after treatment might be the cause of neurotoxic effects of some current PD medications.	[Hsu, Kai-Cheng; Wang, Feng-Sheng] Natl Chung Cheng Univ, Dept Chem Engn, Chiayi 62102, Taiwan	National Chung Cheng University	Wang, FS (corresponding author), Natl Chung Cheng Univ, Dept Chem Engn, Chiayi 62102, Taiwan.	chmfsw@ccu.edu.tw	Hsu, Kai-Cheng/AAF-8231-2019		Ministry of Science of Technology, Taiwan, ROC [MOST103-2221-E-194-045-MY3, MOST104-2627-B-194-001, MOST105-2627-M-194-001]	Ministry of Science of Technology, Taiwan, ROC	This work was financially supported by the Ministry of Science of Technology, Taiwan, ROC (https://www.most.gov.tw/) through grants MOST103-2221-E-194-045-MY3, MOST104-2627-B-194-001, and MOST105-2627-M-194-001, grant recipient Prof. Feng-ShengWang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussieck MR, 2011, MINLP SOLVER SOFTWAR, P95; Caslake R, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006661.pub2; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Che YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153503; Colebrooke RE, 2006, EUR J NEUROSCI, V24, P2622, DOI 10.1111/j.1460-9568.2006.05143.x; FILLOON TG, 1995, STAT MED, V14, P925, DOI 10.1002/sim.4780140911; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Guillen-Gosalbez G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-386; Hsu KC, 2013, BIOINFORMATICS, V29, P3191, DOI 10.1093/bioinformatics/btt564; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Marin-Sanguino A, THEORETICAL BIOL MED, V74, P38; Materi W, 2007, DRUG DISCOV TODAY, V12, P295, DOI 10.1016/j.drudis.2007.02.013; Melamed E, 2000, J NEUROL S2, V247; Mooslehner KA, 2001, MOL CELL BIOL, V21, P5321, DOI 10.1128/MCB.21.16.5321-5331.2001; Muller I, 2004, J NEUROL S6, V251; Nakano T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000670; Nicolaou Christos A, 2013, Drug Discov Today Technol, V10, pe427, DOI 10.1016/j.ddtec.2013.02.001; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; PARDO B, 1995, BRAIN RES, V682, P133, DOI 10.1016/0006-8993(95)00341-M; Pavlides A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004609; Penney JB, 1996, ANN NEUROL, V39, P37; Pharmaceutical Research and Manufacturers of America, 2015, BIOPH RES DEV PROC N; Polisetty PK, 2008, BIOTECHNOL BIOENG, V99, P1154, DOI 10.1002/bit.21679; Pozo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043487; Qi Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002444; Rangaiah GP, 2013, MULTI-OBJECTIVE OPTIMIZATION IN CHEMICAL ENGINEERING: DEVELOPMENTS AND APPLICATIONS, P1, DOI 10.1002/9781118341704; Rascol O, 2003, ANN NEUROL, V53, pS3, DOI 10.1002/ana.10513; Rodgers KJ, 2006, J NEUROCHEM, V98, P1061, DOI 10.1111/j.1471-4159.2006.03941.x; Sakawa M, 1993, FUZZY SETS INTERACTI, P308; Sawaragi Y., 1985, THEORY MULTIOBJECTIV, DOI 10.1016/s0076-5392(09)x6017-0; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305; Shoulson I, 1996, ANN NEUROL, V39, P29; Stone JA, 2010, J CLIN PHARMACOL, V50, p20S, DOI 10.1177/0091270010377628; Strovel J, 2012, EARLY DRUG DISCOVERY; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; Vera J, 2007, BIOINFORMATICS, V23, P2281, DOI 10.1093/bioinformatics/btm326; Vera J, 2010, COMPUT OPER RES, V37, P1427, DOI 10.1016/j.cor.2009.02.021; Voit E. O., 2013, ISRN BIOMATH, V2013, P53, DOI [10.1155/2013/897658, DOI 10.1155/2013/897658]; Voit EO, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004012; Voit EO, 2002, DRUG DISCOV TODAY, V7, P621, DOI 10.1016/S1359-6446(02)02280-8; Voit EO, 2001, BIOTECHNOL BIOENG, V74, P443, DOI 10.1002/bit.1135; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; WALKINSHAW G, 1995, J CLIN INVEST, V95, P2458, DOI 10.1172/JCI117946; Wang FS, 2015, J TAIWAN INST CHEM E, V54, P57, DOI 10.1016/j.jtice.2015.03.015; Wu WH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-145; Zou Q, 2013, J COMPUT THEOR NANOS, V10, P1038, DOI 10.1166/jctn.2013.2804	50	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164589	10.1371/journal.pone.0164589	http://dx.doi.org/10.1371/journal.pone.0164589			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736960	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800091
J	Iseki, K; Takahashi, Y; Muto, C; Naito, K; Tomooka, N				Iseki, Kohtaro; Takahashi, Yu; Muto, Chiaki; Naito, Ken; Tomooka, Norihiko			Diversity and Evolution of Salt Tolerance in the Genus Vigna	PLOS ONE			English	Article							PHYSIOLOGICAL-BASIS; WHEAT; DOMESTICATION; DROUGHT; STRESS; PLANTS	Breeding salt tolerant plants is difficult without utilizing a diversity of wild crop relatives. Since the genus Vigna (family Fabaceae) is comprised of many wild relatives adapted to various environmental conditions, we evaluated the salt tolerance of 69 accessions of this genus, including that of wild and domesticated accessions originating from Asia, Africa, Oceania, and South America. We grew plants under 50 mM and 200 mM NaCl for two weeks and then measured the biomass, relative quantum yield of photosystem II, leaf Na+ concentrations, and leaf K+ concentrations. The accessions were clustered into four groups: the most tolerant, tolerant, moderately susceptible, and susceptible. From the most tolerant group, we selected six accessions, all of which were wild accessions adapted to coastal environments, as promising sources of salt tolerance because of their consistently high relative shoot biomass and relative quantum yield. Interestingly, variations in leaf Na+ concentration were observed between the accessions in the most tolerant group, suggesting different mechanisms were responsible for their salt tolerance. Phylogenetic analysis with nuclear DNA sequences revealed that salt tolerance had evolved independently at least four times in the genus Vigna, within a relatively short period. The findings suggested that simple genetic changes in a few genes might have greatly affected salt tolerances. The elucidation of genetic mechanisms of salt tolerances in the selected accessions may contribute to improving the poor salt tolerance in legume crops.	[Iseki, Kohtaro] Japan Int Res Ctr Agr Sci, Biol Resources & Postharvest Div, Tsukuba, Ibaraki, Japan; [Takahashi, Yu; Muto, Chiaki; Naito, Ken; Tomooka, Norihiko] Natl Agr & Food Sci Org, Genet Resources Ctr, Tsukuba, Ibaraki, Japan	Japan International Research Center for Agricultural Sciences	Iseki, K (corresponding author), Japan Int Res Ctr Agr Sci, Biol Resources & Postharvest Div, Tsukuba, Ibaraki, Japan.; Naito, K (corresponding author), Natl Agr & Food Sci Org, Genet Resources Ctr, Tsukuba, Ibaraki, Japan.	iseki83@affrc.go.jp; knaito@affrc.go.jp		Naito, Ken/0000-0002-0273-7837; Iseki, Kohtaro/0000-0001-8721-1553	JST, PRESTO; Grants-in-Aid for Scientific Research [26850006] Funding Source: KAKEN	JST, PRESTO(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported JST, PRESTO for Ken Naito.	AKITA S, 1990, PLANT SOIL, V123, P277, DOI 10.1007/BF00011281; Chankaew S, 2014, THEOR APPL GENET, V127, P691, DOI 10.1007/s00122-013-2251-1; Costa JH, 2007, J PLANT PHYSIOL, V164, P718, DOI 10.1016/j.jplph.2006.04.001; FAO Corporate Document Repository, ANN 1 CROP SALTT DAT; Farooq S, 2006, J PLANT PHYSIOL, V163, P629, DOI 10.1016/j.jplph.2005.06.006; Fatokun C. A., 1997, Advances in cowpea research, P50; Flowers T, DATABASE EHALOPH HAL; Gogile A, 2013, Pak J Biol Sci, V16, P671, DOI 10.3923/pjbs.2013.671.679; Kang YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08069; Katerji N, 2006, AGR WATER MANAGE, V85, P184, DOI 10.1016/j.agwat.2006.04.006; Khan MIR, 2014, PLANT PHYSIOL BIOCH, V80, P67, DOI 10.1016/j.plaphy.2014.03.026; Mala JM, 2010, BIOL PLANTARUM, V54, P159; Mano Y, 1998, EUPHYTICA, V103, P137, DOI 10.1023/A:1018302910661; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Murillo-Amador B, 2006, SCI HORTIC-AMSTERDAM, V108, P423, DOI 10.1016/j.scienta.2006.02.010; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Palmgren MG, 2015, TRENDS PLANT SCI, V20, P155, DOI 10.1016/j.tplants.2014.11.003; Sakai H, 2015, SCI REP-UK, V5, DOI 10.1038/srep16780; Schrire B. D., 2005, LEGUMES WORLD, P393, DOI DOI 10.1017/S0960428606190198; Shabala S, 2013, ANN BOT-LONDON, V112, P1209, DOI 10.1093/aob/mct205; Sumithra K, 2006, PLANT GROWTH REGUL, V50, P11, DOI 10.1007/s10725-006-9121-7; Takahashi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147568; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Tomooka N, 2014, PLANT GENET RESOUR-C, V12, pS168, DOI 10.1017/S1479262114000483; Tomooka N, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: LEGUME CROPS AND FORAGES, P291, DOI 10.1007/978-3-642-14387-8_15; Trifilo P, 2013, FUNCT PLANT BIOL, V40, P459, DOI 10.1071/FP12287; Voigt EL, 2009, BIOL PLANTARUM, V53, P764, DOI 10.1007/s10535-009-0140-x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Win KT, 2016, J PLANT PHYSIOL, V193, P71, DOI 10.1016/j.jplph.2016.02.013; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Yoshida Y, 2016, GENET RESOUR CROP EV, V63, P627, DOI 10.1007/s10722-015-0272-0	36	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164711	10.1371/journal.pone.0164711	http://dx.doi.org/10.1371/journal.pone.0164711			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736995	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505800118
J	Lee, CJ; Lee, JY; Oum, CY; Youn, JC; Kang, SM; Choi, D; Jang, Y; Park, S; Jee, SH; Lee, SH				Lee, Chan Joo; Lee, Ji-Young; Oum, Chi-Yoon; Youn, Jong-Chan; Kang, Seok-Min; Choi, Donghoon; Jang, Yangsoo; Park, Sungha; Jee, Sun Ha; Lee, Sang-Hak			The Effect of FLT1 Variant on Long-Term Cardiovascular Outcomes: Validation of a Locus Identified in a Previous Genome-Wide Association Study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; RECURRENT MYOCARDIAL-INFARCTION; CHROMOSOME 9P21 POLYMORPHISM; GENETIC-VARIATION; SECONDARY PREVENTION; COMMON VARIANT; HEART-DISEASE; RISK; POPULATION; MORTALITY	Background Data on genetic variants that can predict follow-up cardiovascular events are highly limited, particularly for Asians. The aim of this study was to validate the effects of two variants in FLT1 and 9p21 on long-term cardiovascular outcomes in high-risk Korean patients. Methods We examined the prognostic values of the rs9508025 and rs1333049 variants that were found to be associated with coronary artery disease (CAD) risk in a previous Korean genome-wide association study. A total of 2693 patients (mean age: 55.2 years; male: 55.2%) with CAD or its risk factors at baseline were enrolled and followed for major adverse cardiac events (MACE). Results During the mean follow-up of 8.8 years, 15.4% of the patients experienced MACE. Kaplan-Meier curves showed that MACE-free survival was different according to the genotype of rs9508025 (log rank p = 0.02), whereas rs1333049 genotype did not correlate with the prognosis. Multivariate Cox proportional hazard analysis showed that C-allele of rs9508025 was significantly associated with a high rate of MACE, while rs1333049 was not. Further analyses demonstrated that the association of the rs9508025 variant with MACE was mainly due to its relation to coronary revascularization, which was also associated with the rs1333049 variant. In an additional analysis, rs9508025 was found to be an independent determinant of the outcome only in the subgroup with history of CAD. Conclusions rs9508025 in FLT1 was significantly associated with long-term cardiovascular events, particularly in patients with prior CAD. The association of rs1333049 in 9p21 was not significant.	[Lee, Chan Joo; Youn, Jong-Chan; Kang, Seok-Min; Choi, Donghoon; Jang, Yangsoo; Park, Sungha; Lee, Sang-Hak] Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul, South Korea; [Lee, Chan Joo; Lee, Ji-Young; Youn, Jong-Chan; Kang, Seok-Min; Choi, Donghoon; Jang, Yangsoo; Park, Sungha; Lee, Sang-Hak] Yonsei Coll Med, Cardiovasc Res Inst, Seoul, South Korea; [Lee, Chan Joo; Lee, Ji-Young; Youn, Jong-Chan; Kang, Seok-Min; Choi, Donghoon; Jang, Yangsoo; Park, Sungha; Lee, Sang-Hak] Yonsei Coll Med, Cardiovasc Genome Ctr, Seoul, South Korea; [Oum, Chi-Yoon] Yonsei Univ, Dept Biostat & Comp, Grad Sch, Seoul, South Korea; [Jee, Sun Ha] Yonsei Univ, Inst Hlth Promot, Grad Sch Publ Hlth, Seoul, South Korea; [Youn, Jong-Chan] Hallym Univ, Div Cardiol, Dongtan Sacred Heart Hosp, Hwaseong, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Hallym University	Lee, SH (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul, South Korea.	shpark0530@yuhs.ac; jsunha@yuhs.ac; shl1106@yuhs.ac	Youn, Jong-Chan/AAS-1405-2020	Jee, Sun Ha/0000-0001-9519-3068; Park, Sungha/0000-0001-5362-478X; Lee, Chan Joo/0000-0002-8756-409X; Jang, Yangsoo/0000-0002-2169-3112; Youn, Jong-Chan/0000-0003-0998-503X; Choi, Donghoon/0000-0002-2009-9760; Kang, Seok-Min/0000-0001-9856-9227	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012R1A4A1029061, 2014R1A1A2056104]; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3A9B6029138]; Creative Allied Project (CAP) grant - Korean Research Council of Fundamental Science and Technology (KRCF)	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; Creative Allied Project (CAP) grant - Korean Research Council of Fundamental Science and Technology (KRCF)	This research was financially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A4A1029061 and 2014R1A1A2056104), the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (2015M3A9B6029138), and the Creative Allied Project (CAP) grant funded by the Korean Research Council of Fundamental Science and Technology (KRCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Barth AS, 2016, TRENDS CARDIOVAS MED, V26, P260, DOI 10.1016/j.tcm.2015.07.003; Blankenberg S, 2003, J AM COLL CARDIOL, V41, P1983, DOI 10.1016/S0735-1097(03)00408-X; Chan K, 2013, J AM COLL CARDIOL, V61, P957, DOI 10.1016/j.jacc.2012.10.051; Chappell JC, 2013, ARTERIOSCL THROM VAS, V33, P1952, DOI 10.1161/ATVBAHA.113.301805; Dandona S, 2010, J AM COLL CARDIOL, V56, P479, DOI 10.1016/j.jacc.2009.10.092; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Ellis KL, 2011, CIRC-CARDIOVASC GENE, V4, P636, DOI 10.1161/CIRCGENETICS.111.960336; Ellis KL, 2010, CIRC-CARDIOVASC GENE, V3, P286, DOI 10.1161/CIRCGENETICS.109.917443; Ganna A, 2013, ARTERIOSCL THROM VAS, V33, P2267, DOI 10.1161/ATVBAHA.113.301218; Guo J, 2013, MOL BIOL REP, V40, P337, DOI 10.1007/s11033-012-2066-1; Hara M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005438; Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4; Hoppmann P, 2009, JACC-CARDIOVASC INTE, V2, P1149, DOI 10.1016/j.jcin.2009.08.021; Huang J, 2011, BIOINFORMATICS, V27, P1201, DOI 10.1093/bioinformatics/btr116; Jee SH, 2014, EUR J PREV CARDIOL, V21, P1484, DOI 10.1177/2047487313497602; Karvanen J, 2009, GENET EPIDEMIOL, V33, P237, DOI 10.1002/gepi.20374; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Koerselman J, 2003, CIRCULATION, V107, P2507, DOI 10.1161/01.CIR.0000065118.99409.5F; Konta A, 2016, J HUM GENET, V61, P435, DOI 10.1038/jhg.2015.171; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; Matsuoka R, 2015, INT J MOL MED, V35, P1451, DOI 10.3892/ijmm.2015.2115; Moon Jeonggeun, 2010, Korean Circ J, V40, P348, DOI 10.4070/kcj.2010.40.7.348; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Olivi L, 2015, J HUM HYPERTENS, V29, P167, DOI 10.1038/jhh.2014.66; Owen LA, 2014, INVEST OPHTH VIS SCI, V55, P3543, DOI 10.1167/iovs.14-14047; Parry RG, 1999, EUR J IMMUNOGENET, V26, P321, DOI 10.1046/j.1365-2370.1999.00161.x; Peng WH, 2009, CLIN CHEM LAB MED, V47, P917, DOI 10.1515/CCLM.2009.215; Rambod M, 2014, ATHEROSCLEROSIS, V236, P360, DOI 10.1016/j.atherosclerosis.2014.07.026; Regieli JJ, 2011, ATHEROSCLEROSIS, V218, P457, DOI 10.1016/j.atherosclerosis.2011.07.008; Regieli JJ, 2009, J AM COLL CARDIOL, V54, P1238, DOI 10.1016/j.jacc.2009.05.061; Roberts R, 2014, CIRC RES, V114, P1890, DOI 10.1161/CIRCRESAHA.114.302692; Rodrigues P, 2013, MOL CELL BIOCHEM, V379, P181, DOI 10.1007/s11010-013-1640-8; Slattery ML, 2014, MOL CARCINOGEN, V53, pE140, DOI 10.1002/mc.22058; Virani SS, 2012, CIRC J, V76, P950, DOI 10.1253/circj.CJ-11-1166; Wang H, 2014, MUTAGENESIS, V29, P311, DOI 10.1093/mutage/geu020; Wang W, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-33; Wauters E, 2013, EUR HEART J, V34, P993, DOI 10.1093/eurheartj/ehs389; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; Ye S, 2008, J AM COLL CARDIOL, V52, P378, DOI 10.1016/j.jacc.2007.11.087	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164705	10.1371/journal.pone.0164705	http://dx.doi.org/10.1371/journal.pone.0164705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736948	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800116
J	Olabarrial, C; Gestoso, I; Lima, FP; Vazquez, E; Comeau, LA; Gomes, F; Seabra, R; Babarro, JMF				Olabarrial, Celia; Gestoso, Ignacio; Lima, Fernando P.; Vazquez, Elsa; Comeau, Luc A.; Gomes, Filipa; Seabra, Rui; Babarro, Jose M. F.			Response of Two Mytilids to a Heatwave: The Complex Interplay of Physiology, Behaviour and Ecological Interactions	PLOS ONE			English	Article							INTERTIDAL MUSSELS; ENVIRONMENTAL-STRESS; THERMAL PHYSIOLOGY; BODY-TEMPERATURE; AERIAL EXPOSURE; MORTALITY; LIMPET; GALLOPROVINCIALIS; PATTERNS; LIMITS	Different combinations of behavioural and physiological responses may play a crucial role in the ecological success of species, notably in the context of biological invasions. The invasive mussel Xenostrobus securis has successfully colonised the inner part of the Galician Rias Baixas (NW Spain), where it co-occurs with the commercially-important mussel Mytilus galloprovincialis. This study investigated the effect of a heatwave on the physiological and behavioural responses in monospecific or mixed aggregations of these species. In a mesocosm experiment, mussels were exposed to simulated tidal cycles and similar temperature conditions to those experienced in the field during a heat-wave that occurred in the summer of 2013, when field robo-mussels registered temperatures up to 44.5 degrees C at low tide. The overall responses to stress differed markedly between the two species. In monospecific aggregations M. galloprovincialis was more vulnerable than X. securis to heat exposure during emersion. However, in mixed aggregations, the presence of the invader was associated with lower mortality in M. galloprovincialis. The greater sensitivity of M. galloprovincialis to heat exposure was reflected in a higher mortality level, greater induction of Hsp70 protein and higher rates of respiration and gaping activity, which were accompanied by a lower heart rate (bradycardia). The findings show that the invader enhanced the physiological performance of M. galloprovincialis, highlighting the importance of species interactions in regulating responses to environmental stress. Understanding the complex interactions between ecological factors and physiological and behavioural responses of closely-related species is essential for predicting the impacts of invasions in the context of future climate change.	[Olabarrial, Celia; Vazquez, Elsa] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain; [Gestoso, Ignacio] MARE Marine & Environm Sci Ctr, P-9200044 Canical, Madeira, Portugal; [Lima, Fernando P.; Gomes, Filipa; Seabra, Rui] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, P-4485661 Vairao, Portugal; [Comeau, Luc A.] Gulf Fisheries Ctr, Sci Branch, Dept Fisheries & Oceans, Moncton, NB E1C 9B6, Canada; [Babarro, Jose M. F.] Inst Invest Marinas CSIC, Dept Biotechnol & Aquaculture, Vigo 36208, Spain	Universidade de Vigo; Universidade do Porto; Fisheries & Oceans Canada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Olabarrial, C (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain.	colabarria@uvigo.es	Lima, Fernando P./C-1398-2008; Olabarria, Celia/ABB-5554-2020; Gestoso, Ignacio/E-8742-2015; Vázquez, Elsa/D-7082-2013; Babarro, Jose MF/F-1175-2016; Gomes, Filipa/GXF-4696-2022; Olabarria, Celia/R-8555-2018; Seabra, Rui/J-7814-2012	Lima, Fernando P./0000-0001-9575-9834; Olabarria, Celia/0000-0001-8332-5924; Gestoso, Ignacio/0000-0001-5521-3255; Olabarria, Celia/0000-0001-8332-5924; Seabra, Rui/0000-0002-0240-3992; Babarro, Jose/0000-0001-6352-1944	Autonomous government Xunta de Galicia-FEDER [GRC2013-004]; Spanish government [AGL2010-16464, AGL2013-45945-R]; University of Vigo [P.P. 00VI 131H 64103]; FEDER [FCOMP-01-0124-FEDER-020817]; FCT [PTDC/MAR/117568/2010, SFRH/BD/68521/2010, IF/00043/2012]	Autonomous government Xunta de Galicia-FEDER; Spanish government(Spanish GovernmentEuropean Commission); University of Vigo; FEDER(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was supported by the Autonomous government Xunta de Galicia-FEDER (GRC2013-004) and the Spanish government (AGL2010-16464 and AGL2013-45945-R). IG was supported by a pre-doctoral contract funded by the University of Vigo (P.P. 00VI 131H 64103). FPL and RS were funded by FEDER (FCOMP-01-0124-FEDER-020817) and FCT (PTDC/MAR/117568/2010, SFRH/BD/68521/2010 and IF/00043/2012).	Abele D, 2002, J EXP BIOL, V205, P1831; Anestis A, 2010, J EXP MAR BIOL ECOL, V394, P123, DOI 10.1016/j.jembe.2010.08.008; [Anonymous], 2014, R LANG ENV STAT COMP; Babarro JMF, 2013, MAR ECOL PROG SER, V476, P115, DOI 10.3354/meps10122; Babarro JMF, 2011, AQUAT LIVING RESOUR, V24, P303, DOI 10.1051/alr/2011142; BANNISTER JV, 1974, COMP BIOCHEM PHYSIOL, V49, P407, DOI 10.1016/0300-9629(74)90131-5; Barbieri Michele, 2011, Marine Biodiversity Records, V4; BAYNE BL, 1976, OECOLOGIA, V22, P211, DOI 10.1007/BF00344793; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; BERTNESS MD, 1981, ECOLOGY, V62, P411, DOI 10.2307/1936715; Bjelde BE, 2013, J EXP BIOL, V216, P2858, DOI 10.1242/jeb.084178; Braby CE, 2006, J EXP BIOL, V209, P2554, DOI 10.1242/jeb.02259; Buckley BA, 2001, J EXP BIOL, V204, P3571; Burnett NP, 2013, LIMNOL OCEANOGR-METH, V11, P91, DOI 10.4319/lom.2013.11.91; Carefoot T.H., 1977, PACIFIC SEASHORES GU; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Comeau LA, 2014, AQUACULT INT, V22, P1215, DOI 10.1007/s10499-013-9742-6; Comeau LA, 2012, MAR BIOL, V159, P2269, DOI 10.1007/s00227-012-2012-8; Crawley MJ, 2012, R BOOK, DOI [10.1002/9781118448908, DOI 10.1002/9781118448908]; Darrigran Gustavo, 2002, Biological Invasions, V4, P145, DOI 10.1023/A:1020521811416; De Pirro M, 1999, J COMP PHYSIOL B, V169, P501, DOI 10.1007/s003600050248; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; Denny MW, 2006, J EXP BIOL, V209, P2420, DOI 10.1242/jeb.02258; Dowd WW, 2013, J EXP BIOL, V216, P502, DOI 10.1242/jeb.076620; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gandra M, 2015, LIMNOL OCEANOGR-METH, V13, P115, DOI 10.1002/lom3.10012; Gestoso I, 2016, J EXP MAR BIOL ECOL, V474, P116, DOI 10.1016/j.jembe.2015.10.006; Gestoso I, 2015, J SEA RES, V97, P66, DOI 10.1016/j.seares.2014.12.006; Gestoso I, 2014, MAR ECOL PROG SER, V506, P163, DOI 10.3354/meps10828; Gestoso I, 2013, MAR ENVIRON RES, V90, P85, DOI 10.1016/j.marenvres.2013.05.015; Gestoso I, 2012, CAH BIOL MAR, V53, P391; Halpin PM, 2004, MAR ECOL PROG SER, V276, P137, DOI 10.3354/meps276137; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harley CDG, 2008, MAR ECOL PROG SER, V371, P37, DOI 10.3354/meps07711; Helmuth B, 1999, ECOLOGY, V80, P15; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Helmuth BST, 2001, BIOL BULL-US, V201, P374, DOI 10.2307/1543615; Helmuth BST, 1998, ECOL MONOGR, V68, P51, DOI 10.1890/0012-9615(1998)068[0051:IMMPTB]2.0.CO;2; Hicks DW, 2003, B MAR SCI, V72, P135; Jansen JM, 2009, COMP BIOCHEM PHYS A, V153, P399, DOI 10.1016/j.cbpa.2009.03.013; Kimura Taeko, 1999, Venus the Japanese Journal of Malacology, V58, P101; Lima FP, 2016, GLOBAL CHANGE BIOL, V22, P254, DOI [10.1111/gcb.13115, 10.1111/gcb.13321]; Lima FP, 2009, LIMNOL OCEANOGR-METH, V7, P347, DOI 10.4319/lom.2009.7.347; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; Marsden ID, 1998, J EXP MAR BIOL ECOL, V230, P15, DOI 10.1016/S0022-0981(98)00067-7; Marshall DJ, 2011, J EXP BIOL, V214, P3649, DOI 10.1242/jeb.059899; MARSHALL DJ, 1993, J EXP MAR BIOL ECOL, V171, P225, DOI 10.1016/0022-0981(93)90005-9; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Miller LP, 2009, FUNCT ECOL, V23, P756, DOI 10.1111/j.1365-2435.2009.01567.x; Mislan KAS, 2015, ECOLOGY, V96, P902, DOI 10.1890/14-1219.1; Nicastro KR, 2008, MAR ECOL PROG SER, V372, P119, DOI 10.3354/meps07671; Nicastro KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047382; Nicastro Katy R., 2010, BMC Ecology, V10, P17, DOI 10.1186/1472-6785-10-17; OKAMURA B, 1986, OECOLOGIA, V69, P341, DOI 10.1007/BF00377054; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Petes LE, 2008, OECOLOGIA, V156, P671, DOI 10.1007/s00442-008-1018-x; Sabelli B., 1994, Bollettino Malacologico, V29, P311; Sagarin RD, 2006, J BIOGEOGR, V33, P622, DOI 10.1111/j.1365-2699.2005.01403.x; Schneider KR, 2008, BIOL BULL-US, V215, P253, DOI 10.2307/25470709; Schob C, 2013, J ECOL, V101, P753, DOI 10.1111/1365-2745.12062; Seabra R, 2011, J EXP MAR BIOL ECOL, V400, P200, DOI 10.1016/j.jembe.2011.02.010; Sokolova IM, 2003, J EXP BIOL, V206, P195, DOI 10.1242/jeb.00054; Sokolova IM, 2001, MAR ECOL PROG SER, V224, P171, DOI 10.3354/meps224171; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Sorte CJB, 2005, MAR BIOL, V146, P985, DOI 10.1007/s00227-004-1508-2; Stillman JH, 1996, J EXP BIOL, V199, P1845; SUTHERLA.JP, 1970, ECOL MONOGR, V40, P169, DOI 10.2307/1942294; Tagliarolo M, 2015, MAR ECOL PROG SER, V535, P145, DOI 10.3354/meps11434; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Tomanek L, 2003, BIOL BULL-US, V205, P276, DOI 10.2307/1543291; Tomanek L, 2002, INTEGR COMP BIOL, V42, P771, DOI 10.1093/icb/42.4.771; Tomanek L, 2010, J EXP BIOL, V213, P3559, DOI 10.1242/jeb.041228; TSUCHIYA M, 1983, J EXP MAR BIOL ECOL, V66, P101, DOI 10.1016/0022-0981(83)90032-1; WETHEY DS, 1984, BIOL BULL, V167, P176, DOI 10.2307/1541346; WETHEY DS, 1983, BIOL BULL-US, V165, P330, DOI 10.2307/1541373; WIDDOWS J, 1985, MAR BIOL, V85, P217, DOI 10.1007/BF00393242; Williams GA, 2011, FUNCT ECOL, V25, P101, DOI 10.1111/j.1365-2435.2010.01760.x; Wilson R, 2005, MAR BIOL, V147, P1165, DOI 10.1007/s00227-005-0021-6; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	80	25	25	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164330	10.1371/journal.pone.0164330	http://dx.doi.org/10.1371/journal.pone.0164330			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736896	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800052
J	Silva, SCR; Messias, AM; Abi-Rached, FD; de Souza, RF; Reis, JMDN				Rodolfo Silva, Stephania Caroline; Messias, Aion Mangino; Abi-Rached, Filipe de Oliveira; de Souza, Raphael Freitas; dos Santos Nunes Reis, Jose Mauricio			Accuracy of Gypsum Casts after Different Impression Techniques and Double Pouring	PLOS ONE			English	Article							2-STEP PUTTY; FABRICATION	This study evaluated the accuracy of gypsum casts after different impression techniques and double pouring. Ten patients were selected and for each one it was obtained 5 partial putty/wash impressions with vinyl polysiloxane (VPS) material from teeth #13 to #16 with partial metal stock trays. The following techniques were performed: (1) one-step; two-step relief with: (2) PVC film; (3) slow-speed tungsten carbide bur and scalpel blade, (4) small movements of the tray and (5) without relief-negative control. The impressions were disinfected with 0.5% sodium hypochlorite for 10 minutes and stored during 110 and 230 minutes for the first and second pouring, respectively, with type IV gypsum. Three intra-oral lateral photographs of each patient were taken using a tripod and a customized radiographic positioner. The images were imported into ImageJ software and the total area of the buccal surface from teeth #13 to #16 was measured. A 4.0% coefficient of variance was criterion for using these measurements as Baseline values. The casts were photographed and analyzed using the same standardization for the clinical images. The area (mm 2) obtained from the difference between the measurements of each gypsum cast and the Baseline value of the respective patient were calculated and analyzed by repeated-measures two way-ANOVA and Mauchly's Sphericity test (a = 0.05). No significant effect was observed for Impression technique (P = 0.23), Second pouring (P = 0.99) and their interaction (P = 0.25). The impression techniques and double pouring did not influence the accuracy of the gypsum casts.	[Rodolfo Silva, Stephania Caroline; Messias, Aion Mangino; Abi-Rached, Filipe de Oliveira; dos Santos Nunes Reis, Jose Mauricio] Unesp Univ Estadual Paulista, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil; [de Souza, Raphael Freitas] McGill Univ, Div Oral Hlth & Soc, Fac Dent, Montreal, PQ, Canada	Universidade Estadual Paulista; McGill University	Reis, JMDN (corresponding author), Unesp Univ Estadual Paulista, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil.	reis@foar.unesp.br	Messias, Aion Mangino/AAM-2516-2021; de Souza, Raphael F/D-2345-2009; Silva, Stephania/F-8852-2017	de Souza, Raphael F/0000-0001-8437-9991; Silva, Stephania/0000-0001-6530-234X; Reis, Jose Mauricio/0000-0002-1910-2360	Sao Paulo Research Foundation-FAPESP [2011/19165-4, 2011/19314-0]	Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was granted by Sao Paulo Research Foundation-FAPESP, grant numbers: 2011/19165-4 and 2011/19314-0.	Al-Abidi Khalid, 2006, J Contemp Dent Pract, V7, P17; Bakenhol M, 2010, J PROSTHET DENT, V103, P288, DOI [10.1016/S0022-3913(10)60060-1, DOI 10.1016/S0022-3913(10)60060-1]; Brosky ME, 2002, J PROSTHET DENT, V87, P204, DOI 10.1067/mpr.2002.121240; CHEE WWL, 1992, J PROSTHET DENT, V68, P728, DOI 10.1016/0022-3913(92)90192-D; Chen SY, 2004, J DENT, V32, P603, DOI 10.1016/j.jdent.2004.04.002; Cho SH, 2015, J PROSTHET DENT, V113, P310, DOI 10.1016/j.prosdent.2014.09.027; Donovan TE, 2004, DENT CLIN N AM, V48, P445, DOI [10.1016/j.cden.2003.12.014, DOI 10.1016/J.CDEN.2003.12.014]; FANO V, 1992, DENT MATER, V8, P105, DOI 10.1016/0109-5641(92)90064-J; Faria Adriana Cláudia Lapria, 2008, Braz. oral res., V22, P293, DOI 10.1590/S1806-83242008000400002; Gottlieb Marc, 2011, Todays FDA, V23, P57; Haim M, 2009, INT J PROSTHODONT, V22, P296; Hamalian TA, 2011, J PROSTHODONT, V20, P153, DOI 10.1111/j.1532-849X.2010.00673.x; HUNG SH, 1992, J PROSTHET DENT, V67, P583, DOI 10.1016/0022-3913(92)90151-Y; JOHNSON GH, 1985, J PROSTHET DENT, V53, P484, DOI 10.1016/0022-3913(85)90630-4; Kahn R L, 1989, Int J Prosthodont, V2, P342; Kang AH, 2009, J PROSTHET DENT, V101, P332, DOI 10.1016/S0022-3913(09)60066-4; Kumar Dheeraj, 2011, J Contemp Dent Pract, V12, P272; LEE IK, 1995, OPER DENT, V20, P246; Leong Elvin W J, 2007, Singapore Dent J, V29, P46; Luthardt RG, 2006, DENT MATER, V22, P69, DOI 10.1016/j.dental.2005.02.015; Mandikos MN, 1998, AUST DENT J, V43, P428, DOI 10.1111/j.1834-7819.1998.tb00204.x; Mann K, 2015, J PROSTHET DENT, V113, P316, DOI 10.1016/j.prosdent.2014.09.014; Michalakis KX, 2012, J PROSTHET DENT, V108, P189, DOI 10.1016/S0022-3913(12)60146-2; MORGANO SM, 1995, J PROSTHET DENT, V73, P333, DOI 10.1016/S0022-3913(05)80327-0; Nissan J, 2000, J PROSTHET DENT, V83, P161, DOI 10.1016/S0022-3913(00)80007-4; NOONAN JE, 1985, OPER DENT, V10, P46; Patill SB, 2008, GERODONTOLOGY, V25, P57, DOI 10.1111/j.1741-2358.2007.00171.x; Schaefer O, 2012, J PROSTHET DENT, V108, P165, DOI 10.1016/S0022-3913(12)60141-3; Stober T, 2010, J PROSTHET DENT, V103, P228, DOI 10.1016/S0022-3913(10)60035-2; Tanomaru M, 2011, INT ENDOD J, V44, P1019, DOI 10.1111/j.1365-2591.2011.01910.x; Wadhwani CPK, 2005, J PROSTHET DENT, V93, P530, DOI 10.1016/j.prosdent.2005.03.007	31	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164825	10.1371/journal.pone.0164825	http://dx.doi.org/10.1371/journal.pone.0164825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736967	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800133
J	Slawinska, A; Hsieh, JC; Schmidt, CJ; Lamont, SJ				Slawinska, Anna; Hsieh, John C.; Schmidt, Carl J.; Lamont, Susan J.			Heat Stress and Lipopolysaccharide Stimulation of Chicken Macrophage-Like Cell Line Activates Expression of Distinct Sets of Genes	PLOS ONE			English	Article							DANGER SIGNAL; SHOCK PROTEINS; CANCER-CELLS; FEED-INTAKE; HSP70; TEMPERATURE; ENVIRONMENT; INDUCTION; MECHANISM; APOPTOSIS	Acute heat stress requires immediate adjustment of the stressed individual to sudden changes of ambient temperatures. Chickens are particularly sensitive to heat stress due to development of insufficient physiological mechanisms to mitigate its effects. One of the symptoms of heat stress is endotoxemia that results from release of the lipopolysaccharide (LPS) from the guts. Heat-related cytotoxicity is mitigated by the innate immune system, which is comprised mostly of phagocytic cells such as monocytes and macrophages. The objective of this study was to analyze the molecular responses of the chicken macrophage-like HD11 cell line to combined heat stress and lipopolysaccharide treatment in vitro. The cells were heat-stressed and then allowed a temperature-recovery period, during which the gene expression was investigated. LPS was added to the cells to mimic the heat-stress-related endotoxemia. Semi high-throughput gene expression analysis was used to study a gene panel comprised of heat shock proteins, stress-related genes, signaling molecules and immune response genes. HD11 cell line responded to heat stress with increased mRNA abundance of the HSP25, HSPA2 and HSPH1 chaperones as well as DNAJA4 and DNAJB6 co-chaperones. The anti-apoptotic gene BAG3 was also highly up-regulated, providing evidence that the cells expressed pro-survival processes. The immune response of the HD11 cell line to LPS in the heat stress environment (up-regulation of CCL4, CCL5, IL1B, IL8 and iNOS) was higher than in thermoneutral conditions. However, the peak in the transcriptional regulation of the immune genes was after two hours of temperature-recovery. Therefore, we propose the potential influence of the extracellular heat shock proteins not only in mitigating effects of abiotic stress but also in triggering the higher level of the immune responses. Finally, use of correlation networks for the data analysis aided in discovering subtle differences in the gene expression (i.e. the role of the CASP3 and CASP9 genes).	[Slawinska, Anna; Hsieh, John C.; Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Slawinska, Anna] UTP Univ Sci & Technol, Dept Anim Biochem & Biotechnol, Bydgoszcz, Poland; [Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA	Iowa State University; Bydgoszcz University of Science & Technology; University of Delaware	Lamont, SJ (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	sjlamont@iastate.edu	Slawinska, Anna/B-3781-2016	Slawinska, Anna/0000-0002-5706-6145; Schmidt, Carl/0000-0002-8386-4781	USDA-NIFA-AFRI Climate Change Award [2011-67003-30228]; Polish-American Fulbright Commission	USDA-NIFA-AFRI Climate Change Award; Polish-American Fulbright Commission	The study was conducted with support of USDA-NIFA-AFRI Climate Change Award #2011-67003-30228. The Polish-American Fulbright Commission is acknowledged for supporting a 2014/2015 Senior Advanced Research Award of Dr. Slawinska at Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; Campisi J, 2003, CELL STRESS CHAPERON, V8, P272, DOI 10.1379/1466-1268(2003)008<0272:SEHIAF>2.0.CO;2; Chen W, 1999, J IMMUNOL, V162, P3212; Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; Coble DJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1084; DALE NM, 1980, POULTRY SCI, V59, P1434, DOI 10.3382/ps.0591434; Davies EL, 2006, CLIN EXP IMMUNOL, V145, P183, DOI 10.1111/j.1365-2249.2006.03109.x; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; Ebeid TA, 2012, POULTRY SCI, V91, P2282, DOI 10.3382/ps.2011-01898; Gu ZT, 2014, SCI REP-UK, V4, DOI 10.1038/srep04469; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Li C, 2011, POULTRY SCI, V90, P1028, DOI 10.3382/ps.2010-01144; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Luo QB, 2014, GENE, V546, P200, DOI 10.1016/j.gene.2014.06.017; Marnbula SS, 2007, METHODS, V43, P168, DOI 10.1016/j.ymeth.2007.06.009; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; NATHAN D B, 1976, British Poultry Science, V17, P481, DOI 10.1080/00071667608416303; Ofenstein JP, 2000, ANN CLIN LAB SCI, V30, P92; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Prohaszka Z, 2002, CELL STRESS CHAPERON, V7, P17, DOI 10.1379/1466-1268(2002)007<0017:HSPIAP>2.0.CO;2; Rashmi R, 2003, FEBS LETT, V538, P19, DOI 10.1016/S0014-5793(03)00099-1; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; SAKAKIBARA Y, 1992, INT J HYPERTHER, V8, P329, DOI 10.3109/02656739209021788; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Shi L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10142; SMITH MO, 1993, J AGR SCI, V121, P421, DOI 10.1017/S0021859600085610; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Sun L, 2015, CELL STRESS CHAPERON, V20, P939, DOI 10.1007/s12192-015-0621-0; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Wang SH, 2013, THERIOGENOLOGY, V79, P374, DOI 10.1016/j.theriogenology.2012.10.010; White MG, 2003, J NEUROCHEM, V87, P958, DOI 10.1046/j.1471-4159.2003.02077.x; Whitley D, 1999, J VASC SURG, V29, P748, DOI 10.1016/S0741-5214(99)70329-0; Xie JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102204; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4; Zhang ZY, 2012, POULTRY SCI, V91, P2931, DOI 10.3382/ps.2012-02255; ZULKIFLI I, 1995, WORLD POULTRY SCI J, V51, P63, DOI 10.1079/WPS19950006	50	32	33	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164575	10.1371/journal.pone.0164575	http://dx.doi.org/10.1371/journal.pone.0164575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736938	Green Published, gold			2022-12-27	WOS:000385505800088
J	Eikendal, ALM; Bots, ML; Haaring, C; Saam, T; van der Geeset, RJ; Westenberg, JJM; den Ruijter, HM; Hoefer, IE; Leiner, T				Eikendal, Anouk L. M.; Bots, Michiel L.; Haaring, Cees; Saam, Tobias; van der Geeset, Rob J.; Westenberg, Jos J. M.; den Ruijter, Hester M.; Hoefer, Imo E.; Leiner, Tim			Reference Values for Cardiac and Aortic Magnetic Resonance Imaging in Healthy, Young Caucasian Adults	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; CARDIOVASCULAR RISK; WALL THICKNESS; THORACIC AORTA; SURFACE-AREA; VESSEL WALL; ATHEROSCLEROSIS; MRI; REPRODUCIBILITY; DISTENSIBILITY	Background Reference values for morphological and functional parameters of the cardiovascular system in early life are relevant since they may help to identify young adults who fall outside the physiological range of arterial and cardiac ageing. This study provides age and sex specific reference values for aortic wall characteristics, cardiac function parameters and aortic pulse wave velocity (PWV) in a population-based sample of healthy, young adults using magnetic resonance (MR) imaging. Materials and Methods In 131 randomly selected healthy, young adults aged between 25 and 35 years (mean age 31.8 years, 63 men) of the general-population based Atherosclerosis-Monitoring-and-Biomarker-measurements-In-The-YOuNg (AMBITYON) study, descending thoracic aortic dimensions and wall thickness, thoracic aortic PWV and cardiac function parameters were measured using a 3.0T MR-system. Age and sex specific reference values were generated using dedicated software. Differences in reference values between two age groups (25-30 and 30-35 years) and both sexes were tested. Results Aortic diameters and areas were higher in the older age group (all p<0.007). Moreover, aortic dimensions, left ventricular mass, left and right ventricular volumes and cardiac output were lower in women than in men (all p<0.001). For mean and maximum aortic wall thickness, left and right ejection fraction and aortic PWV we did not observe a significant age or sex effect. Conclusion This study provides age and sex specific reference values for cardiovascular MR parameters in healthy, young Caucasian adults. These may aid in MR guided pre-clinical identification of young adults who fall outside the physiological range of arterial and cardiac ageing.	[Eikendal, Anouk L. M.; Haaring, Cees; Leiner, Tim] Univ Med Ctr, Dept Radiol, Utrecht, Netherlands; [Bots, Michiel L.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Saam, Tobias] Ludwig Maximilians Univ Hosp, Inst Clin Radiol, Munich, Germany; [van der Geeset, Rob J.; Westenberg, Jos J. M.] Leiden Univ, Med Ctr, Dept Radiol, Div Image Proc, Leiden, Netherlands; [den Ruijter, Hester M.] Univ Med Ctr, Lab Expt Cardiol, Utrecht, Netherlands; [Hoefer, Imo E.] Univ Med Ctr, Lab Clin Chem & Haematol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Eikendal, ALM (corresponding author), Univ Med Ctr, Dept Radiol, Utrecht, Netherlands.	a.l.m.eikendal@umcutrecht.nl	Westenberg, Jos/T-6122-2019; van der Geest, Rob/J-8193-2015	den Ruijter, Hester/0000-0001-9762-014X; van der Geest, Rob/0000-0002-9084-5597	ZonMw Klinische Fellows Programme [40-00703-98-11432]	ZonMw Klinische Fellows Programme	This study was funded by a grant from the ZonMw Klinische Fellows Programme 2011 (40-00703-98-11432). Funding recipient: Tim Leiner. URL: http://www.google.nl/url?uril=http://www.zonmw.nl.programmas/programma-detail/klinischefellows/algemeen/&rct=j&from=1&q&esrc=s&sa=U&ved=OahUKEwil4ZaEievLAhXDcg8KHbLubcQEggUMAA&usg=AFQjCNIbL0zndCgwtTW7UFMq5OHNSIt400.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akosah KO, 2003, J AM COLL CARDIOL, V41, P1475, DOI 10.1016/S0735-1097(03)00187-6; Berger JS, 2010, J AM COLL CARDIOL, V55, P1169, DOI 10.1016/j.jacc.2009.09.066; Corti R, 2011, EUR HEART J, V32, P1709, DOI 10.1093/eurheartj/ehr068; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Devos DGH, 2015, J MAGN RESON IMAGING, V41, P765, DOI 10.1002/jmri.24592; Du Bois D, 1989, Nutrition, V5, P303; Eikendal ALM, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0237-2; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Grotenhuis HB, 2009, J MAGN RESON IMAGING, V30, P521, DOI 10.1002/jmri.21886; Kawel-Boehm N, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0111-7; Li AE, 2004, AM J ROENTGENOL, V182, P593, DOI 10.2214/ajr.182.3.1820593; Lorbeer R, 2015, J VASC INTERV RADIOL, V26, P635, DOI 10.1016/j.jvir.2014.12.022; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Mani V, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-10; Mensel B, 2016, EUR RADIOL, V26, P969, DOI 10.1007/s00330-015-3926-6; Mensel B, 2014, EUR RADIOL, V24, P2038, DOI 10.1007/s00330-014-3188-8; Mensel B, 2013, ACAD RADIOL, V20, P1004, DOI 10.1016/j.acra.2013.03.014; Mihai G, 2015, J MAGN RESON IMAGING, V41, P202, DOI 10.1002/jmri.24545; Mooiweer R, 2016, MAGN RESON MED, V75, P547, DOI 10.1002/mrm.25599; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Pepine CJ, 2006, CIRC RES, V99, P459, DOI 10.1161/01.RES.0000241056.84659.59; Prakken N., 2008, OPEN MAGN RESON J, V1, P104, DOI DOI 10.2174/1874769800801010104; Prakken NH, 2010, EUR J CARDIOV PREV R, V17, P198, DOI 10.1097/HJR.0b013e3283347fdb; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; Shah PK, 2010, J AM COLL CARDIOL, V56, P98, DOI 10.1016/j.jacc.2009.09.081; Takano K, 2012, EUR J RADIOL, V81, pE304, DOI 10.1016/j.ejrad.2011.10.012; Urbina EM, 2009, HYPERTENSION, V54, P919, DOI 10.1161/HYPERTENSIONAHA.109.192639; van der Geest RJ, 1999, J MAGN RESON IMAGING, V10, P602, DOI 10.1002/(SICI)1522-2586(199911)10:5<602::AID-JMRI3>3.0.CO;2-C; Voges I, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-77; WISSLER RW, 1993, ARTERIOSCLER THROMB, V13, P1291; Wong SK, 2014, WORLD J RADIOL, V6, P192, DOI 10.4329/wjr.v6.i5.192; Zhang ZL, 2009, INVEST RADIOL, V44, P619, DOI 10.1097/RLI.0b013e3181b4c218	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164480	10.1371/journal.pone.0164480	http://dx.doi.org/10.1371/journal.pone.0164480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732640	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300059
J	Liu, H; Chen, S; Huang, K; Kim, J; Mo, H; Iovine, R; Gendre, J; Pascal, P; Li, Q; Sun, YP; Done, ZQ; Arkin, M; Guo, S; Huang, B				Liu, Harrison; Chen, Steven; Huang, Kevin; Kim, Jeffrey; Mo, Han; Iovine, Raffael; Gendre, Julie; Pascal, Pauline; Li, Qiang; Sun, Yaping; Done, Zhiqiang; Arkin, Michelle; Guo, Su; Huang, Bo			A High-Content Larval Zebrafish Brain Imaging Method for Small Molecule Drug Discovery	PLOS ONE			English	Article							HIGH-THROUGHPUT; VERTEBRATE; ABLATION; BEHAVIOR; NITROREDUCTASE; PLATFORM; SCREENS	Drug discovery in whole-organisms such as zebrafish is a promising approach for identifying biologically-relevant lead compounds. However, high content imaging of zebrafish at cellular resolution is challenging due to the difficulty in orienting larvae en masse such that the cell type of interest is in clear view. We report the development of the multi-pose imaging method, which uses 96-well round bottom plates combined with a standard liquid handler to repose the larvae within each well multiple times, such that an image in a specific orientation can be acquired. We have validated this method in a chemo-genetic zebrafish model of dopaminergic neuron degeneration. For this purpose, we have developed an analysis pipeline that identifies the larval brain in each image and then quantifies neuronal health in CellProfiler. Our method achieves a SSMD* score of 6.96 (robust Z'-factor of 0.56) and is suitable for screening libraries up to 10(5) compounds in size.	[Liu, Harrison] Univ Calif San Francisco, Joint Grad Program Bioengn, Berkeley, CA USA; [Liu, Harrison] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Chen, Steven; Arkin, Michelle] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94143 USA; [Chen, Steven; Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Huang, Kevin; Kim, Jeffrey; Mo, Han; Iovine, Raffael; Gendre, Julie; Pascal, Pauline; Li, Qiang; Sun, Yaping; Done, Zhiqiang; Guo, Su] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Huang, Bo] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, B (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.; Guo, S (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Huang, B (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	su.guo@ucsf.edu; bo.huang@ucsf.edu	Arkin, Michelle/AAO-2009-2021; arkin, michelle/AAN-4298-2021	arkin, michelle/0000-0002-9366-6770	NIH [R21 NS082938]; Mary Anne Koda-Kimble Seed Award for Innovation from the UCSF School of Pharmacy; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS082938] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Anne Koda-Kimble Seed Award for Innovation from the UCSF School of Pharmacy; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R21 NS082938 and the Mary Anne Koda-Kimble Seed Award for Innovation from the UCSF School of Pharmacy. HL is supported by the National Science Foundation Graduate Research Fellowship. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang TY, 2012, LAB CHIP, V12, P711, DOI 10.1039/c1lc20849g; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Guo S, 2009, EXPERT OPIN DRUG DIS, V4, P715, DOI 10.1517/17460440902988464; Gut P, 2013, NAT CHEM BIOL, V9, P97, DOI [10.1038/NCHEMBIO.1136, 10.1038/nchembio.1136]; Kadam Prashant, 2010, Int J Ayurveda Res, V1, P55, DOI 10.4103/0974-7788.59946; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; MacRae CA, 2015, NAT REV DRUG DISCOV, V14, P721, DOI 10.1038/nrd4627; McCammon JM, 2015, DIS MODEL MECH, V8, P647, DOI 10.1242/dmm.019620; McGown A, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0122-3; Niihori M, 2015, TRANSL RES, V166, P440, DOI 10.1016/j.trsl.2015.05.002; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Rennekamp AJ, 2015, CURR OPIN CHEM BIOL, V24, P58, DOI 10.1016/j.cbpa.2014.10.025; Rinaldi G, 2015, INT J PARASITOL-DRUG, V5, P141, DOI 10.1016/j.ijpddr.2015.07.002; Scott CA, 2016, DEV DYNAM, V245, P605, DOI [10.1002/DVDY.24398, 10.1002/dvdy.24398]; Sun YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035645; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Walker SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029916; Wang GL, 2015, ELIFE, V4, DOI 10.7554/eLife.08261; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851; Zhang XHD, 2010, J BIOMOL SCREEN, V15, P1116, DOI 10.1177/1087057110381783; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	27	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164645	10.1371/journal.pone.0164645	http://dx.doi.org/10.1371/journal.pone.0164645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732643	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300073
J	Asenbaum, U; Nolz, R; Karanikas, G; Furtner, J; Woitek, R; Staudenherz, A; Senn, D; Raderer, M; Weber, M; Simonitsch-Klupp, I; Mayerhoefer, ME				Asenbaum, Ulrika; Nolz, Richard; Karanikas, Georgios; Furtner, Julia; Woitek, Ramona; Staudenherz, Anton; Senn, Daniela; Raderer, Markus; Weber, Michael; Simonitsch-Klupp, Ingrid; Mayerhoefer, Marius E.			Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; WHOLE-BODY MRI; FDG-PET/CT; RESPONSE ASSESSMENT; MALIGNANT-LYMPHOMA; INFILTRATION; METASTASES; DISEASE	The purpose of our study was to determine the value of different hybrid imaging combinations for the detection of focal and diffuse bone marrow infiltration in lymphoma. Patients with histologically proven lymphoma, who underwent both [18F]-FDG-PET/CT and whole-body MRI (including T1- and diffusion-weighted [DWI] sequences) within seven days, and a subsequent bone marrow biopsy, were retrospectively included. Three hybrid imaging combinations were evaluated: (1) [18F]-FDG-PET/CT; (2) [18F]-FDG-PET/T1; and (3) [18F]-FDG-PET/DWI. The presence of focal or diffuse bone marrow infiltration was assessed by two rater teams. Sensitivity, specificity, and accuracy for the detection of overall, focal, and diffuse bone marrow involvement were compared between the three hybrid imaging combinations. Overall, lymphomatous bone marrow involvement was found in 16/60 patients (focal, 8; diffuse, 8). Overall sensitivity, specificity, and accuracy were 81.3%, 95.5%, and 91.7% for [18F]-FDG-PET/CT; 81.3%, 97.7%, and 93.3% for [18F]-FDG-PET/T1; and 81.3%, 95.5%, and 91.7% for [18F]-FDG-PET/DWI. No statistically significant differences between the three imaging combinations were observed, based on overall bone marrow involvement, focal involvement, or diffuse involvement. The sensitivity of all three imaging combinations for detecting diffuse bone marrow involvement was only moderate (62.5% for all three combinations). Although the combination of [18F]-FDG-PET and T1-weighted MRI generally showed the best diagnostic performance for the detection of bone marrow involvement in lymphoma, it was not significantly superior to the two other hybrid imaging combinations. Since the sensitivity of all imaging combinations for the detection of diffuse bone marrow involvement was only moderate, bone marrow biopsy cannot be replaced by imaging as yet.	[Asenbaum, Ulrika; Nolz, Richard; Karanikas, Georgios; Furtner, Julia; Woitek, Ramona; Staudenherz, Anton; Senn, Daniela; Weber, Michael; Mayerhoefer, Marius E.] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Simonitsch-Klupp, Ingrid] Med Univ Vienna, Div Oncol, Dept Internal Med 1, Vienna, Austria; [Raderer, Markus] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Asenbaum, U (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	ulrika.asenbaum@meduniwien.ac.at	Mayerhoefer, Marius/AAD-2156-2021; Weber, Michael/L-9836-2016	Mayerhoefer, Marius/0000-0001-8786-8686; Nolz, Richard/0000-0002-7030-5972; Weber, Michael/0000-0002-8507-2219; Furtner, Julia/0000-0001-8258-3681; Woitek, Ramona/0000-0002-9146-9159; Asenbaum, Ulrika/0000-0002-5850-7598				Abdulqadhr G, 2011, ACTA RADIOL, V52, P173, DOI 10.1258/ar.2010.100246; Adams HJA, 2013, EUR RADIOL, V23, P2271, DOI 10.1007/s00330-013-2835-9; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; COLLER BS, 1977, AM J HEMATOL, V3, P105, DOI 10.1002/ajh.2830030201; CONLAN MG, 1990, J CLIN ONCOL, V8, P1163, DOI 10.1200/JCO.1990.8.7.1163; Eiber M, 2014, J NUCL MED, V55, P191, DOI 10.2967/jnumed.113.123646; Grankvist J, 2012, EUR J RADIOL, V81, pE13, DOI 10.1016/j.ejrad.2010.10.024; Jiang XX, 2013, CLIN RADIOL, V68, pE143, DOI 10.1016/j.crad.2012.11.002; Kwee TC, 2010, BRIT J HAEMATOL, V149, P628, DOI 10.1111/j.1365-2141.2010.08093.x; Lin C, 2010, EUR RADIOL, V20, P2027, DOI 10.1007/s00330-010-1758-y; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Mayerhoefer ME, 2016, CLIN NUCL MED, V41, P101, DOI 10.1097/RLU.0000000000001005; Mayerhoefer ME, 2015, CLIN CANCER RES, V21, P2506, DOI 10.1158/1078-0432.CCR-14-2454; Mayerhoefer ME, 2014, CLIN CANCER RES, V20, P2984, DOI 10.1158/1078-0432.CCR-13-3355; Murata Y, 2006, NUCL MED BIOL, V33, P999, DOI 10.1016/j.nucmedbio.2006.09.005; Paes FM, 2010, RADIOGRAPHICS, V30, P269, DOI 10.1148/rg.301095088; Ribrag V, 2008, EUR J RADIOL, V66, P325, DOI 10.1016/j.ejrad.2007.06.014; Salaun PY, 2009, EUR J NUCL MED MOL I, V36, P1813, DOI 10.1007/s00259-009-1183-0; Takenaka D, 2009, J MAGN RESON IMAGING, V30, P298, DOI 10.1002/jmri.21858	19	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164118	10.1371/journal.pone.0164118	http://dx.doi.org/10.1371/journal.pone.0164118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723817	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100021
J	Bak, N; Hansen, LK				Bak, Nikolaj; Hansen, Lars K.			Data Driven Estimation of Imputation Error-A Strategy for Imputation with a Reject Option	PLOS ONE			English	Article							MISSING DATA ESTIMATION; REGRESSION	Missing data is a common problem in many research fields and is a challenge that always needs careful considerations. One approach is to impute the missing values, i. e., replace missing values with estimates. When imputation is applied, it is typically applied to all records with missing values indiscriminately. We note that the effects of imputation can be strongly dependent on what is missing. To help make decisions about which records should be imputed, we propose to use a machine learning approach to estimate the imputation error for each case with missing data. The method is thought to be a practical approach to help users using imputation after the informed choice to impute the missing data has been made. To do this all patterns of missing values are simulated in all complete cases, enabling calculation of the "true error" in each of these new cases. The error is then estimated for each case with missing values by weighing the "true errors" by similarity. The method can also be used to test the performance of different imputation methods. A universal numerical threshold of acceptable error cannot be set since this will differ according to the data, research question, and analysis method. The effect of threshold can be estimated using the complete cases. The user can set an a priori relevant threshold for what is acceptable or use cross validation with the final analysis to choose the threshold. The choice can be presented along with argumentation for the choice rather than holding to conventions that might not be warranted in the specific dataset.	[Bak, Nikolaj] Copenhagen Univ Hosp, Mental Hlth Serv, CNSR, Glostrup, Denmark; [Bak, Nikolaj] Copenhagen Univ Hosp, Mental Hlth Serv, Ctr Clin Intervent & Neuropsychiat Schizophrenia, Psychiat Ctr Glostrup, Glostrup, Denmark; [Hansen, Lars K.] Tech Univ Denmark, Dept Appl Math & Comp Sci, DTU Compute, Cognit Syst, Kongens Lyngby, Denmark	University of Copenhagen; University of Copenhagen; Technical University of Denmark	Bak, N (corresponding author), Copenhagen Univ Hosp, Mental Hlth Serv, CNSR, Glostrup, Denmark.; Bak, N (corresponding author), Copenhagen Univ Hosp, Mental Hlth Serv, Ctr Clin Intervent & Neuropsychiat Schizophrenia, Psychiat Ctr Glostrup, Glostrup, Denmark.	Nikolaj@cnsr.dk			Mental Health Services, The Capital Region, Denmark; Lundbeck Foundation [R155-2013-16337]	Mental Health Services, The Capital Region, Denmark; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Mental Health Services, The Capital Region, Denmark; and The Lundbeck Foundation (R155-2013-16337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M, 2006, PATTERN RECOGNITION; Brown CM, 2012, SYST BIOL, V61, P941, DOI 10.1093/sysbio/sys047; Chapelle O., 2006, IEEE T NEURAL NETWOR, V20, P542; Clavel J, 2014, SYST BIOL, V63, P203, DOI 10.1093/sysbio/syt100; Dekel O, 2010, MACH LEARN, V81, P149, DOI 10.1007/s10994-009-5124-8; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; EFRON B, 1994, J AM STAT ASSOC, V89, P463, DOI 10.2307/2290846; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Hansen LK, 1999, NEUROIMAGE, V9, P534, DOI 10.1006/nimg.1998.0425; Hughes RA, 2016, STAT METHODS MED RES, V25, P2541, DOI 10.1177/0962280214526216; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; KAN G, 1986, BRIT HEART J, V56, P422; Lichman M, 2013, UCI MACHINE LEARNING; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Musil CM, 2002, WESTERN J NURS RES, V24, P815, DOI 10.1177/019394502762477004; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Schneider JW, 2007, J AM SOC INF SCI TEC, V58, P1596, DOI 10.1002/asi.20642; Strauss RE, 2003, J VERTEBR PALEONTOL, V23, P284, DOI 10.1671/0272-4634(2003)023[0284:EOTPAE]2.0.CO;2; TOUSSAINT GT, 1974, IEEE T INFORM THEORY, V20, P472, DOI 10.1109/TIT.1974.1055260; Zhou Zhi- Hua, 2016, ARXIV160509082	21	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164464	10.1371/journal.pone.0164464	http://dx.doi.org/10.1371/journal.pone.0164464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723782	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100064
J	Luznik, Z; Hawlina, M; Malicev, E; Bertolin, M; Koptar, AN; Ihan, A; Ferrari, S; Schollmayer, P				Luznik, Zala; Hawlina, Marko; Malicev, Elvira; Bertolin, Marina; Koptar, Andreja Natasa; Ihan, Alojz; Ferrari, Stefano; Schollmayer, Petra			Effect of Cryopreserved Amniotic Membrane Orientation on the Expression of Limbal Mesenchymal and Epithelial Stem Cell Markers in Prolonged Limbal Explant Cultures	PLOS ONE			English	Article							PROGENITOR CELLS; CORNEAL EPITHELIUM; AUTOLOGOUS LIMBAL; TRANSPLANTATION; INTACT; REGENERATION; THERAPY; SERUM	Purpose To evaluate the effect of prolonged limbal explants cultured without any scaffolds or on amniotic membrane (AM) on the viability, proliferation and differentiation potential of putative phenotypically defined cultured limbal mesenchymal (LMSC) and epithelial stem cells (LESC). Methods Limbal explants were cultivated on cryopreserved intact AM or plastic plates using medium supplemented with only human serum. AM was positioned with either the epithelial or stromal side up. The outgrowing cells were immunophenotyped for the co-expression of mesenchymal stem cell markers (CD73/CD90/CD105 positive and CD45 negative), proliferation and putative progenitor markers (CXCR4, CD117), epithelial markers and antigen presenting cell markers (CD80, CD83, CD86) by flow cytometry. Immunohistochemistry on limbal cultures cultivated on AM was carried out with antibodies against pan-cytokeratin, p63, Ki67. Results Morphological and immunostaining analyses revealed two distinct stem cell population types, which could be identified over prolonged culturing time periods. Expression of LMSC markers and CXCR4 was significantly higher (p < 0.05) in cultures cultivated without AM. However, no statistically significant difference was observed in CD117 expression. The cells cultivated on AM retained an epithelial cell structure, which was further confirmed by histology examination. Histology revealed limbal epithelial growth and p63, Ki67 positive cells on both sides of AM. Conclusion Limbal cells cultivated on AM exhibited a lower expression profile of LMSC and CXCR4 markers as limbal cells cultivated on plastic culture plates. However, CD117 expression was similar. Histology confirmed limbal epithelial cell growth on both sides of AM, with no morphological differences, or positivity of cells for p63 and Ki67.	[Luznik, Zala; Hawlina, Marko; Schollmayer, Petra] Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia; [Malicev, Elvira] Blood Transfus Ctr Slovenia, Ljubljana, Slovenia; [Bertolin, Marina; Ferrari, Stefano] Veneto Eye Bank Fdn, Zelarino Venice, Italy; [Koptar, Andreja Natasa; Ihan, Alojz] Univ Ljubljana Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana	Luznik, Z (corresponding author), Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia.	zala_luznik@yahoo.com	Lužnik Marzidovšek, Zala/AFL-4910-2022; Hawlina, Marko/AAZ-8084-2020	Ferrari, Stefano/0000-0003-3983-3328; Bertolin, Marina/0000-0002-6941-8419; Luznik Marzidovsek, Zala/0000-0002-3164-1586	European Union; European Social Fund; Republic of Slovenia, Ministry for Education, Science and Sport; ARRS [P3-0333]; UKC [TP 2014-0297]	European Union(European Commission); European Social Fund(European Social Fund (ESF)); Republic of Slovenia, Ministry for Education, Science and Sport; ARRS(Slovenian Research Agency - Slovenia); UKC	This research work is a result of doctoral research, in part financed by the European Union, European Social Fund and the Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational programme for human resources development for the period 2007-2013 and by ARRS Grant P3-0333, UKC Grant TP 2014-0297.; This research work is a result of doctoral research, in part financed by the European Union, European Social Fund and the Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational programme for human resources development for the period 2007-2013 and by ARRS Grant P3-0333, UKC Grant TP 2014-0297.	Ainscough SL, 2011, EXP EYE RES, V92, P10, DOI 10.1016/j.exer.2010.10.004; Bakhtiari P, 2010, MIDDLE EAST AFR J OP, V17, P9, DOI 10.4103/0974-9233.61211; Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028; Bray LJ, 2014, CYTOTHERAPY, V16, P64, DOI 10.1016/j.jcyt.2013.07.006; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Cvenkel B, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/939602; Di Iorio E, 2006, MICROSC RES TECHNIQ, V69, P983, DOI 10.1002/jemt.20375; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dziasko MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094283; Galindo EEH, 2009, OPHTHALMIC RES, V41, P83, DOI 10.1159/000187624; Garfias Y, 2012, MOL VIS, V18, P2087; Hashmani K, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt226; Higa K, 2006, CORNEA, V25, P715, DOI 10.1097/01.ico.0000214227.36485.9b; Jeon S, 2013, MOL VIS, V19, P2542; Jirsova K, 2011, INVEST OPHTH VIS SCI, V52, P5892, DOI 10.1167/iovs.10-6748; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3; Li W, 2007, INVEST OPHTH VIS SCI, V48, P605, DOI 10.1167/iovs.06-0514; Meller D, 2002, BRIT J OPHTHALMOL, V86, P463, DOI 10.1136/bjo.86.4.463; Pathak M, 2013, ACTA OPHTHALMOL, V91, P769, DOI 10.1111/j.1755-3768.2012.02521.x; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Polisetti N, 2010, MOL VIS, V16, P1227; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Sato H., 1998, IOVS, V39, pS428; Shandadfar A, 2012, EXP EYE RES, V97, P1, DOI 10.1016/j.exer.2012.01.013; Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444; Subramaniam SV, 2013, INDIAN J OPHTHALMOL, V61, P202, DOI 10.4103/0301-4738.99840; Szabo DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143053; Zakaria N, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-58; Zakaria N, 2010, TISSUE ENG PART C-ME, V16, P921, DOI [10.1089/ten.tec.2009.0634, 10.1089/ten.TEC.2009.0634]	31	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164408	10.1371/journal.pone.0164408	http://dx.doi.org/10.1371/journal.pone.0164408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723792	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100056
J	Jacob, H; Kreifelts, B; Nizielski, S; Schutz, A; Wildgruber, D				Jacob, Heike; Kreifelts, Benjamin; Nizielski, Sophia; Schuetz, Astrid; Wildgruber, Dirk			Effects of Emotional Intelligence on the Impression of Irony Created by the Mismatch between Verbal and Nonverbal Cues	PLOS ONE			English	Article							COMMUNICATION; DOMINANCE; SIGNALS; ATTITUDES	Emotional information is conveyed through verbal and nonverbal signals, with nonverbal cues often being considered the decisive factor in the judgment of others' emotional states. The aim of the present study was to examine how verbal and nonverbal cues are integrated by perceivers. More specifically, we tested whether the mismatch between verbal and nonverbal information was perceived as an expression of irony. Moreover, we investigated the effects of emotional intelligence on the impression of irony. The findings revealed that the mismatch between verbal and nonverbal information created the impression of irony. Furthermore, participants higher in emotional intelligence were faster at rating such stimuli as ironic expressions.	[Jacob, Heike; Kreifelts, Benjamin; Wildgruber, Dirk] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Nizielski, Sophia] Tech Univ Chemnitz, Dept Psychol, Chemnitz, Germany; [Schuetz, Astrid] Univ Bamberg, Dept Psychol, Bamberg, Germany	Eberhard Karls University of Tubingen; Technische Universitat Chemnitz; Otto Friedrich University Bamberg	Jacob, H (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	HeikeJacob@gmx.de	Schütz, Astrid/U-4113-2018	Schütz, Astrid/0000-0002-6358-167X; Kreifelts, Benjamin/0000-0002-9233-3800	University of Tubingen [2176-0-0, 2294-0-0, 2294-0-1]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen	University of Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	This work was supported by the fortune program of the University of Tubingen under Grant (number 2176-0-0, 2294-0-0, 2294-0-1). We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta S, 2013, ALCOHOL CLIN EXP RES, V37, P339, DOI 10.1111/j.1530-0277.2012.01909.x; ARGYLE M, 1970, BRIT J SOC CLIN PSYC, V9, P222, DOI 10.1111/j.2044-8260.1970.tb00668.x; ARGYLE M, 1971, EUR J SOC PSYCHOL, V1, P385, DOI 10.1002/ejsp.2420010307; Attardo S, 2003, HUMOR, V16, P243, DOI 10.1515/humr.2003.012; Bryant GA, 2011, PRAGMAT COGN, V19, P291, DOI 10.1075/pc.19.2.06bry; Burgoon JK., 1996, NONVERBAL COMMUNICAT; DEWS S, 1995, DISCOURSE PROCESS, V19, P347, DOI 10.1080/01638539509544922; DEWS S, 1995, METAPHOR SYMB ACT, V10, P3, DOI 10.1207/s15327868ms1001_2; Ekman P, 2016, PERSPECT PSYCHOL SCI, V11, P31, DOI 10.1177/1745691615596992; Filik R, 2015, ACTA PSYCHOL, V156, P114, DOI 10.1016/j.actpsy.2014.08.007; Filik R, 2014, J EXP PSYCHOL LEARN, V40, P811, DOI 10.1037/a0035658; Gibbs R.W., 2000, METAPHOR SYMBOL, V15, P5, DOI [DOI 10.1080/10926488.2000.9678862, 10.1207/S15327868MS1512_2, DOI 10.1207/S15327868MS1512_2]; Jacob H, 2013, COGNITION EMOTION, V27, P783, DOI 10.1080/02699931.2012.739999; Jacob H, 2012, NEUROIMAGE, V61, P738, DOI 10.1016/j.neuroimage.2012.03.085; Mayer J., 2002, MAYER SALOVEY CARUSO; Mayer J. D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; Mayer JD, 2004, PSYCHOL INQ, V15, P197, DOI 10.1207/s15327965pli1503_02; Mehrabian A., 1971, SILENT MESSAGES; Nicholson A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00691; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Riva G., 2001, SAY NOT SAY NEW PERS, P141; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Scharrer L, 2011, LANG SPEECH, V54, P435, DOI 10.1177/0023830911402608; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061; Steinmayr R., 2011, MAYER SALOVEY CARUSO; TRIMBOLI A, 1987, J NONVERBAL BEHAV, V11, P180, DOI 10.1007/BF00990236	26	9	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163211	10.1371/journal.pone.0163211	http://dx.doi.org/10.1371/journal.pone.0163211			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UW	27716831	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100006
J	Linton, L; Taylor, M; Dunn, S; Martin, L; Chavez, S; Stanitz, G; Huszti, E; Minkin, S; Boyd, N				Linton, Linda; Taylor, Monica; Dunn, Sheila; Martin, Lisa; Chavez, Sonia; Stanitz, Greg; Huszti, Ella; Minkin, Salomon; Boyd, Norman			Associations of Serum Levels of Sex Hormones in Follicular and Luteal Phases of the Menstrual Cycle with Breast Tissue Characteristics in Young Women	PLOS ONE			English	Article							BINDING GLOBULIN LEVELS; MAMMOGRAPHIC DENSITY; MAGNETIC-RESONANCE; CANCER RISK; ESTROGEN; TESTOSTERONE; MITOGENS	Background In previous work in young women aged 15-30 years we measured breast water and fat using MR and obtained blood for hormone assays on the same day in the follicular phase of the menstrual cycle. Only serum growth hormone levels and sex hormone binding globulin (SHBG) were significantly associated with percent breast water after adjustment for covariates. The sex hormones estradiol, progesterone and testosterone were not associated with percent water in the breast in the follicular phase of the menstrual cycle. In the present study we have examined the association of percent breast water with serum levels of sex hormones in both follicular and luteal phase of the menstrual cycle. Methods In 315 healthy white Caucasian young women aged 15-30 with regular menstrual cycles who had not used oral contraceptives or other hormones in the previous 6 months, we used MR to determine percent breast water, and obtained blood samples for hormone assays within 10 days of the onset of the most recent menstrual cycle (follicular phase) of the cycle on the same day as the MR scan, and a second blood sample on days 19-24 of the cycle. Serum progesterone levels of > = 5 mmol/L in days 19-24 were used to define the 225 subjects with ovulatory menstrual cycles, whose data are the subject of the analyses shown here. Results SHBG was positively associated with percent water in both follicular and luteal phases of the menstrual cycle. Total and free estradiol and total and free testosterone were not associated with percent water in the follicular phase, but in young women with ovulatory cycles, were all negatively associated with percent water in the luteal phase. Conclusions Our results from young women aged 15-30 years add to the evidence that the extent of fibroglandular tissue in the breast that is reflected in both mammographic density and breast water is associated positively with higher serum levels of SHBG, but not with higher levels of sex hormones.	[Linton, Linda; Taylor, Monica; Martin, Lisa; Huszti, Ella; Boyd, Norman] Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Chavez, Sonia; Stanitz, Greg] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Minkin, Salomon] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Dunn, Sheila] Womens Coll Hosp, Family Practice Hlth Ctr, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Womens College Hospital	Boyd, N (corresponding author), Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.	boyd@uhnres.utoronto.ca	Taylor, Monica/D-1494-2019	Taylor, Monica/0000-0001-5333-2955	National Institutes of Health [R01 CA135101-01A2]; Canadian Breast Cancer Research lnitiative/NCIC	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Breast Cancer Research lnitiative/NCIC	This work was supported by the 2010-2015: Determinants of breast tissue composition in young women. National Institutes of Health. US $3,431,252. (R01 CA135101-01A2) Principal Investigators: Boyd NF and Rommens JM with Martin LJ, Paterson AD, Bronskill MJ, Friedenreich CM, Minkin S, Tamimi R, Vachon CM, Hopper JL, John EM, Andrulis IL and the 2003-2006 Determinants of breast tissue composition in young women. Canadian Breast Cancer Research lnitiative/NCIC. $1,309,434. $394,648 for 2003-2004; $550,649 for 2004-2005; $364,137 for 2005-2006; no cost extension for 2006-2007. Principal Investigator: NF Boyd with M Bronskill, K Bukhanov, E Fishell, C Friedenreich, P Harper, RA Jong, S Minkin, B Wright, MJ Yaffe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello EJ, 2005, CANCER EPIDEM BIOMAR, V14, P662, DOI 10.1158/1055-9965.EPI-04-0327; APTER D, 1984, ACTA ENDOCRINOL-COP, V107, P413, DOI 10.1530/acta.0.1070413; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Boyd NF, 2002, BRIT J CANCER, V87, P876, DOI 10.1038/sj.bjc.6600537; Boyd N, 2009, LANCET ONCOL, V10, P569, DOI 10.1016/S1470-2045(09)70078-6; Bremnes Y, 2007, INT J CANCER, V121, P2506, DOI 10.1002/ijc.22971; Chavez S, 2014, J MAGN RESON IMAGING, V40, P890, DOI 10.1002/jmri.24452; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; Cuzick J, 2011, J NATL CANCER I, V103, P744, DOI 10.1093/jnci/djr079; DOWSETT M, 1985, CLIN ENDOCRINOL, V23, P303, DOI 10.1111/j.1365-2265.1985.tb00228.x; EDMUNDS SEJ, 1990, J STEROID BIOCHEM, V37, P733, DOI 10.1016/0960-0760(90)90358-R; Graham SJ, 1997, MAGNET RESON MED, V38, P669, DOI 10.1002/mrm.1910380422; Graham SJ, 1995, JMRI-J MAGN RESON IM, V5, P695, DOI 10.1002/jmri.1880050613; Greendale GA, 1999, ANN INTERN MED, V130, P262, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00003; Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593; Hennessey S, 2014, CANCER CAUSE CONTROL, V25, P491, DOI 10.1007/s10552-014-0351-0; Iversen A, 2016, EUR J CANCER PREV, V25, P9, DOI 10.1097/CEJ.0000000000000130; Jung S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0581-4; Key TJ, 2013, LANCET ONCOL, V14, P1009, DOI 10.1016/S1470-2045(13)70301-2; Key TJ, 2011, BRIT J CANCER, V105, P709, DOI 10.1038/bjc.2011.254; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Noh JJ, 2006, BREAST, V15, P20, DOI 10.1016/j.breast.2005.04.014; PLYMATE SR, 1985, J CLIN ENDOCR METAB, V61, P993, DOI 10.1210/jcem-61-5-993; POON CS, 1992, J NATL CANCER I, V84, P777, DOI 10.1093/jnci/84.10.777; SCHIJF CPT, 1993, ACTA ENDOCRINOL-COP, V129, P130, DOI 10.1530/acta.0.1290130; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; Sorensen K, 2009, DIABETES CARE, V32, P909, DOI 10.2337/dc08-1618; Sprague Brian L., 2011, Hormones & Cancer, V2, P62, DOI 10.1007/s12672-010-0056-0; Stone J, 2009, J CLIN ENDOCR METAB, V94, P4793, DOI 10.1210/jc.2009-0713; Tamimi RM, 2005, CANCER EPIDEM BIOMAR, V14, P2641, DOI 10.1158/1055-9965.EPI-05-0558; Thompson DJ, 2008, CANCER EPIDEM BIOMAR, V17, P3490, DOI 10.1158/1055-9965.EPI-08-0734; Varghese JS, 2012, CANCER RES, V72, P1478, DOI 10.1158/0008-5472.CAN-11-3295; Verheus M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1758; Warren R, 2006, CANCER EPIDEM BIOMAR, V15, P1502, DOI 10.1158/1055-9965.EPI-05-0828; Yaghjyan L, 2016, BREAST CANCER RES TR, V158, P351, DOI 10.1007/s10549-016-3884-y; Yong M, 2009, CANCER CAUSE CONTROL, V20, P1039, DOI 10.1007/s10552-009-9321-3	37	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163865	10.1371/journal.pone.0163865	http://dx.doi.org/10.1371/journal.pone.0163865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716810	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100011
J	Fukai, K; Harada, S; Iida, M; Kurihara, A; Takeuchi, A; Kuwabara, K; Sugiyama, D; Okamura, T; Akiyama, M; Nishiwaki, Y; Oguma, Y; Suzuki, A; Suzuki, C; Hirayama, A; Sugimoto, M; Soga, T; Tomita, M; Takebayashi, T				Fukai, Kota; Harada, Sei; Iida, Miho; Kurihara, Ayako; Takeuchi, Ayano; Kuwabara, Kazuyo; Sugiyama, Daisuke; Okamura, Tomonori; Akiyama, Miki; Nishiwaki, Yuji; Oguma, Yuko; Suzuki, Asako; Suzuki, Chizuru; Hirayama, Akiyoshi; Sugimoto, Masahiro; Soga, Tomoyoshi; Tomita, Masaru; Takebayashi, Toru			Metabolic Profiling of Total Physical Activity and Sedentary Behavior in Community-Dwelling Men	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; DOSE-RESPONSE METAANALYSIS; CHAIN AMINO-ACIDS; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; HEALTH-BENEFITS; ACTIVITY LEVEL; RISK; JAPANESE; DISEASE	Objective Physical activity is known to be preventive against various non-communicable diseases. We investigated the relationship between daily physical activity level and plasma metabo-lites using a targeted metabolomics approach in a population-based study. Methods A total of 1,193 participants (male, aged 35 to 74 years) with fasting blood samples were selected from the baseline survey of a cohort study. Information on daily total physical activity, classified into four levels by quartile of metabolic equivalent scores, and sedentary behavior, defined as hours of sitting per day, was collected through a self-administered questionnaire. Plasma metabolite concentrations were quantified by capillary electrophoresis mass spectrometry method. We performed linear regression analysis models with multi-variable adjustment and corrected p-values for multiple testing in the original population (n = 808). The robustness of the results was confirmed by replication analysis in a separate population (n = 385) created by random allocation. Results Higher levels of total physical activity were associated with various metabolite concentrations, including lower concentrations of amino acids and their derivatives, and higher concentrations of pipecolate (FDR p <0.05 in original population). The findings persisted after adjustment for age, body mass index, smoking, alcohol intake, and energy intake.	[Fukai, Kota; Harada, Sei; Kurihara, Ayako; Takeuchi, Ayano; Kuwabara, Kazuyo; Sugiyama, Daisuke; Okamura, Tomonori; Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Fukai, Kota; Harada, Sei; Kurihara, Ayako; Akiyama, Miki; Suzuki, Asako; Suzuki, Chizuru; Hirayama, Akiyoshi; Sugimoto, Masahiro; Soga, Tomoyoshi; Tomita, Masaru; Takebayashi, Toru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Iida, Miho] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Akiyama, Miki; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan; [Nishiwaki, Yuji] Toho Univ, Fac Med, Dept Social Med, Div Environm & Occupat Hlth, Tokyo, Japan; [Oguma, Yuko] Keio Univ, Sports Med Res Ctr, Yokohama, Kanagawa, Japan; [Oguma, Yuko; Takebayashi, Toru] Keio Univ, Grad Sch Hlth Management, Fujisawa, Kanagawa, Japan	Keio University; Keio University; Keio University; Keio University; Toho University; Keio University; Keio University	Takebayashi, T (corresponding author), Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan.; Takebayashi, T (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.; Takebayashi, T (corresponding author), Keio Univ, Grad Sch Hlth Management, Fujisawa, Kanagawa, Japan.	ttakebayashi@keio.jp	Takebayashi, Toru/K-7526-2013; Soga, Tomoyoshi/B-8105-2014; Okamura, Tomonori/L-1693-2013; Takebayashi, Toru/AAB-9356-2019; Sugiyama, Daisuke/L-4347-2013; Fukai, Kota/P-9046-2017; Harada, Sei/ABA-5975-2020; Takeuchi, Ayano/C-3130-2019	Takebayashi, Toru/0000-0002-8268-8026; Soga, Tomoyoshi/0000-0001-9502-2509; Okamura, Tomonori/0000-0003-0488-0351; Takebayashi, Toru/0000-0002-8268-8026; Sugiyama, Daisuke/0000-0002-6487-8934; Fukai, Kota/0000-0002-8319-8467; Harada, Sei/0000-0003-2666-4932; Takeuchi, Ayano/0000-0002-0908-1850; Sugimoto, Masahiro/0000-0003-3316-2543	Yamagata Prefectural Government; city of Tsuruoka; Japan Society for the Promotion of Science [24390168, 15H04778]	Yamagata Prefectural Government; city of Tsuruoka; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research funds from the Yamagata Prefectural Government and the city of Tsuruoka and by the Grant-in-Aid for Scientific Research (grant numbers 24390168 and 15H04778) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Aune D, 2015, EUR J EPIDEMIOL, V30, P529, DOI 10.1007/s10654-015-0056-z; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Benjamini Y, 2001, ANN STAT, V29, P1165; Berg A, 1997, Eur J Med Res, V2, P259; Berger MA, 2013, J EPIDEMIOL, V23, P411, DOI 10.2188/jea.JE20120151; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; CONSOLI A, 1990, J CLIN INVEST, V86, P2038, DOI 10.1172/JCI114940; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Harada S, 2016, ENVIRON HEALTH PREV, V21, P18, DOI 10.1007/s12199-015-0494-y; Hirayama A, 2015, ELECTROPHORESIS, V36, P2148, DOI 10.1002/elps.201400600; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Imaeda N, 2007, J EPIDEMIOL, V17, P100, DOI 10.2188/jea.17.100; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; Kaino W, 2013, ENDOCR J, V60, P617, DOI 10.1507/endocrj.EJ12-0351; Kim AM, 2010, NATURE, V465, P688, DOI 10.1038/465688a; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leskinen T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012609; Lustgarten MS, 2014, J GERONTOL A-BIOL, V69, P717, DOI 10.1093/gerona/glt152; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ohkawara K, 2007, INT J OBESITY, V31, P1786, DOI 10.1038/sj.ijo.0803683; Oshima Y, 2010, GAIT POSTURE, V31, P370, DOI 10.1016/j.gaitpost.2010.01.005; Patel MJ, 2013, OMICS, V17, P627, DOI 10.1089/omi.2013.0031; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qin LQ, 2011, J NUTR, V141, P249, DOI 10.3945/jn.110.128520; Ramautar R, 2013, CURR OPIN CHEM BIOL, V17, P841, DOI 10.1016/j.cbpa.2013.06.015; Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shimomura Y, 2004, J NUTR, V134, p1583S, DOI 10.1093/jn/134.6.1583S; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; vanHall G, 1996, J PHYSIOL-LONDON, V494, P899, DOI 10.1113/jphysiol.1996.sp021542; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wientzek A, 2014, INT J SPORT NUTR EXE, V24, P215, DOI 10.1123/ijsnem.2013-0048	52	43	43	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164877	10.1371/journal.pone.0164877	http://dx.doi.org/10.1371/journal.pone.0164877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741291	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000076
J	Singh, A; Varela, C; Bhatt, K; Veerapen, N; Lee, OYC; Wu, HHT; Besra, GS; Minnikin, DE; Fujiwara, N; Teramoto, K; Bhatt, A				Singh, Albel; Varela, Cristian; Bhatt, Kiranmai; Veerapen, Natacha; Lee, Oona Y. C.; Wu, Houdini H. T.; Besra, Gurdyal S.; Minnikin, David E.; Fujiwara, Nagatoshi; Teramoto, Kanae; Bhatt, Apoorva			Identification of a Desaturase Involved in Mycolic Acid Biosynthesis in Mycobacterium smegmatis	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CYCLOPROPANE SYNTHETASE; FATTY-ACID; BOVIS BCG; TUBERCULOSIS; SYNTHASE; CATALYZES; REDUCTASE; BACILLUS; LEADS	Mycolic acids are unique long chain fatty acids found in the cell walls of mycobacteria including the tubercle bacillus, Mycobacterium tuberculosis. The introduction of double bonds in mycolic acids remains poorly understood, however, genes encoding two potential aerobic desaturases have been proposed to be involved in this process. Here we show that one of these genes, desA1, is essential for growth of the saprophytic Mycobacterium smegmatis. Depletion of desA1 in a M. smegmatis conditional mutant led to reduction of mycolic acid biosynthesis and loss of viability. The DesA1-depleted cells exhibited two other phenotypes: using (14)[C]-labelling, we detected the accumulation of minor mycolic acid-related species that migrated faster in a silver TLC plate. Spiral Time of Flight Mass Spectroscopic analysis suggested the presence of species with sizes corresponding to what were likely monoenoic derivatives of alpha-mycolic acids. Additionally, conditional depletion led to the presence of free fatty acyl species of lengths similar to C-26-C-48 in the lysing cells. Cell viability could be rescued in the conditional mutant by Mycobacterium tuberculosis desA1, highlighting the potential of desA1 as a new drug target in pathogenic mycobacteria.	[Singh, Albel; Varela, Cristian; Veerapen, Natacha; Lee, Oona Y. C.; Wu, Houdini H. T.; Besra, Gurdyal S.; Minnikin, David E.; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Singh, Albel; Varela, Cristian; Veerapen, Natacha; Lee, Oona Y. C.; Wu, Houdini H. T.; Besra, Gurdyal S.; Minnikin, David E.; Bhatt, Apoorva] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Bhatt, Kiranmai] Heart England NHS Trust, Birmingham, W Midlands, England; [Fujiwara, Nagatoshi] Tezukayama Gakuin Univ, Fac Contemporary Human Life Sci, Dept Food & Nutr, Nara, Nara 6318585, Japan; [Teramoto, Kanae] JEOL Ltd, Adv & Fundamental Technol Ctr, Akishima, Tokyo 1968558, Japan	University of Birmingham; University of Birmingham; Heart of England NHS Foundation Trust; Jeol Ltd; JEOL Japan	Bhatt, A (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.; Bhatt, A (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.	a.bhatt@bham.ac.uk		Besra, Gurdyal/0000-0002-5605-0395	Medical Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/N01314X/1] Funding Source: researchfish; Medical Research Council [MR/K00042X/1, G0600105, MR/K012118/1] Funding Source: researchfish; BBSRC [BB/N01314X/1] Funding Source: UKRI; MRC [MR/K00042X/1, G0600105, MR/K012118/1] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KT is an employee of Jeol Ltd. The funder provided support in the form of salaries for author KT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. AB received grant funding from the Medical Research Council (UK). The funder provided support did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	ASSELINE.CP, 1970, EUR J BIOCHEM, V14, P406, DOI 10.1111/j.1432-1033.1970.tb00304.x; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bernut A, 2016, MOL MICROBIOL, V99, P866, DOI 10.1111/mmi.13283; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2008, CHEM BIOL, V15, P930, DOI 10.1016/j.chembiol.2008.07.007; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Bhatt Apoorva, 2008, V465, P325, DOI 10.1007/978-1-59745-207-6_22; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dobson G., 1985, CHEM METHODS BACTERI, P237; Dubnau E, 1997, MOL MICROBIOL, V23, P313, DOI 10.1046/j.1365-2958.1997.2301589.x; Dyer DH, 2005, PROTEIN SCI, V14, P1508, DOI 10.1110/ps.041288005; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; HAGEN SR, 1995, J CHROMATOGR A, V692, P167, DOI 10.1016/0021-9673(94)00743-S; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Nataraj V, 2015, MOL MICROBIOL, V98, P7, DOI 10.1111/mmi.13101; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Slayden RA, 1996, ANTIMICROB AGENTS CH, V40, P2813, DOI 10.1128/AAC.40.12.2813; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Teramoto Kanae, 2015, Mass Spectrom (Tokyo), V4, pA0035, DOI 10.5702/massspectrometry.A0035; Teramoto K, 2013, J ANTIBIOT, V66, P713, DOI 10.1038/ja.2013.79; Watanabe M, 2002, MICROBIOL-SGM, V148, P1881, DOI 10.1099/00221287-148-6-1881; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200	33	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164253	10.1371/journal.pone.0164253	http://dx.doi.org/10.1371/journal.pone.0164253			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741286	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000023
J	Cyril, S; Green, J; Nicholson, JM; Agho, K; Renzaho, AMN				Cyril, Sheila; Green, Julie; Nicholson, Jan M.; Agho, Kingsley; Renzaho, Andre M. N.			Exploring Service Providers' Perspectives in Improving Childhood Obesity Prevention among CALD Communities in Victoria, Australia	PLOS ONE			English	Article							HEALTH LITERACY; INTERGENERATIONAL DIFFERENCES; SOCIOECONOMIC INEQUALITIES; MIGRANT FAMILIES; AFRICAN MIGRANTS; CHILDRENS HEALTH; INTERVENTION; STRATEGIES; EDUCATION; PROGRAM	Background Childhood obesity rates have been increasing disproportionately among disadvantaged communities including culturally and linguistically diverse (CALD) migrant groups in Australia due to their poor participation in the available obesity prevention initiatives. We sought to explore service providers' perceptions of the key factors influencing the participation of CALD communities in the existing obesity prevention services and the service requirements needed to improve CALD communities' participation in these services. Methods We conducted a qualitative study using focus group discussions involving fifty-nine service providers from a range of services, who are involved in the health and wellbeing of children from CALD groups living in four socioeconomically disadvantaged areas in Victoria, Australia. Results Thematic analysis of the data showed three major themes including community-level barriers to CALD engagement in childhood obesity prevention services; service-level barriers to the delivery of these services; and proposed changes to current childhood obesity prevention approaches. Integrating obesity prevention messages within existing programs, better coordination between prevention and treatment services and the establishment of a childhood obesity surveillance system, were some of the important changes suggested by service providers. Conclusion This study has found that low CALD health literacy, lack of knowledge of cultural barriers among service providers and co-existing deficiencies in the structure and delivery of obesity prevention services negatively impacted the participation of CALD communities in obesity prevention services. Cultural competency training of service providers would improve their understanding of the cultural influences of childhood obesity and incorporate them into the design and development of obesity prevention initiatives. Service providers need to be educated on the pre-migratory health service experiences and health conditions of CALD communities to ensure equitable delivery of care. Collaborative approaches between health systems, immigrant services, early years' services and community health services are urgently needed to address obesity-related disparities in Australia.	[Cyril, Sheila] Univ Western Sydney, Sch Social Sci & Psychol, Locked Bag 1797, Penrith, NSW, Australia; [Cyril, Sheila] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Prahran, Vic, Australia; [Green, Julie] Murdoch Childrens Res Inst, Raising Children Network, Level 5-232 Victoria Parade, East Melbourne, Vic, Australia; [Green, Julie] Univ Melbourne, Parenting Res Ctr, Dept Paediat, Level 5-232 Victoria Parade, East Melbourne, Vic, Australia; [Nicholson, Jan M.] La Trobe Univ, Judith Lumley Ctr, Level 3, Melbourne, Vic, Australia; [Agho, Kingsley] Univ Western Sydney, Sch Sci & Hlth, Locked Bag 1797, Penrith, NSW, Australia; [Renzaho, Andre M. N.] Univ Western Sydney, Sch Social Sci & Psychol, Locked Bag 1797, Penrith, NSW, Australia	Western Sydney University; Monash University; Murdoch Children's Research Institute; University of Melbourne; La Trobe University; Western Sydney University; Western Sydney University	Cyril, S (corresponding author), Univ Western Sydney, Sch Social Sci & Psychol, Locked Bag 1797, Penrith, NSW, Australia.; Cyril, S (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Prahran, Vic, Australia.	sheila.cyril@monash.edu	Agho, Kingsley/AAW-5622-2021; Renzaho, Andre M.N./AAH-7679-2021; Agho, Kingsley/AAE-9971-2020	Agho, Kingsley/0000-0003-4111-3207; RENZAHO, ANDRE/0000-0002-6844-0833; Nicholson, Jan/0000-0002-0305-0017	Australian Research Council [130100485]	Australian Research Council(Australian Research Council)	This study was funded by the Australian Research Council as a Linkage Grant No. 130100485. The grant recipient is AR.	Abad PJB, 2014, J COMMUN GENET, V5, P399, DOI 10.1007/s12687-014-0193-1; ABS, 2015, NAT HLTH SURV 1 RES; ABS, 2013, COMM PROF; ABS, 2015, 34120 ABS; ABS, 2011, NAT REG PROF GREAT D; ABS (Australian Bureau of Statistics), 2013, PROGR INT ASS AD COM; AIHW, 2014, AUSTR HLTH 2014 6 6; Australian Bureau of Statistics (ABS), 2011, CENS POP HOUS 2011; Australian Bureau of Statistics (ABS), 2008, AD LIT LIF SKILLS SU; Australian Bureau of Statistics (ABS), 1999, 12890 ABS; Australian Institute of Health and Welfare, 2014, AUSTR HLTH SER, V14, P10; Backholer K, 2014, AM J PUBLIC HEALTH, V104, pE43, DOI 10.2105/AJPH.2014.302066; Barkin SL, 2012, PEDIATRICS, V130, P445, DOI 10.1542/peds.2011-3762; Barlow-Stewart K, 2006, GENET MED, V8, P24, DOI 10.1097/01.gim.0000195884.86201.a0; Beach MC, 2006, PATIENT EDUC COUNS, V62, P347, DOI 10.1016/j.pec.2006.06.004; Beauchamp A, 2014, OBES REV, V15, P541, DOI 10.1111/obr.12161; Bender MS, 2013, CHILD OBES, V9, P157, DOI 10.1089/chi.2012.0118; Bender Melinda S, 2011, Calif J Health Promot, V9, P40; Birch LL, 2001, PEDIATR CLIN N AM, V48, P893, DOI 10.1016/S0031-3955(05)70347-3; Black JA, 2015, BRIT J GEN PRACT, V65, pE234, DOI 10.3399/bjgp15X684385; Bornhorst C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1793-3; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Callinicos Alex, 2004, MAKING HIST AGENCY S; Campbell K., 2001, Australian Journal of Nutrition and Dietetics, V58, P19; Caprio S, 2008, DIABETES CARE, V31, P2211, DOI 10.2337/dc08-9024; Carter L, 2016, CLIN PSYCHOL PSYCHOT; Chung A, 2016, OBES REV, V17, P276, DOI 10.1111/obr.12360; Commonwealth of Australia, 2014, OB PREV TRENDS AUSTR; de Silva-Sanigorski AM, 2010, AM J CLIN NUTR, V91, P831, DOI 10.3945/ajcn.2009.28826; Delavari M, 2013, ETHNIC HEALTH, V18, P66, DOI 10.1080/13557858.2012.698255; Della Torre SB, 2010, J SCHOOL HEALTH, V80, P233, DOI 10.1111/j.1746-1561.2010.00495.x; Department of Immigration and Multicultural Affairs, 2001, GUID IMPL STAND STAT; DeWalt D, 2010, HLTH LITERACY UNIVER; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Drenowatz C, 2014, OBESITY FACTS, V7, P388, DOI 10.1159/000369984; Fialkowski MK, 2014, MATERN CHILD HLTH J, V18, P2261, DOI 10.1007/s10995-013-1353-3; Ganter C, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140371; Garcia-Dominic O, 2010, HEALTH PROMOT PRACT, V11, P703, DOI 10.1177/1524839909331909; Gibbs L, 2011, FUN N HLTH MORELAND; Gill T, 2005, BEST OPTIONS PROMOTI; Glaser Barney G., 1967, DISCOV GROUNDED THEO; Green J, 2008, PARENT CTR CULTURALL; Haby Michelle M, 2012, BMC Res Notes, V5, P20, DOI 10.1186/1756-0500-5-20; Halliday JA, 2014, FAM COMMUNITY HEALTH, V37, P60, DOI 10.1097/FCH.0000000000000011; Hannah CT, 2012, RURAL REMOTE HEALTH, V12; Harris MF, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-104; He M, 2007, CAN FAM PHYSICIAN, V53, P1493; Hearn LA, 2008, MED J AUSTRALIA, V188, pS87; Howard-Drake EJ, 2015, J PUBLIC HLTH, V5; Javadzade SH, 2012, IRAN J ED HLTH PROMO, V1, DOI DOI 10.4103/2277-9531.100160; Jirojwong Sansnee, 2002, Health Care Women Int, V23, P197, DOI 10.1080/073993302753429068; Jones VF, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00137; Katz DL, 2008, INT J OBESITY, V32, P1780, DOI 10.1038/ijo.2008.158; Kickbusch, 2009, POLICY INNOVATIONS H; Kimbrough JB, 2012, J HLTH DISPARITIES R, V1, P6; Kreps GL, 2008, PATIENT EDUC COUNS, V71, P328, DOI 10.1016/j.pec.2008.03.001; Kumanyika S, 2012, PREV MED, V55, P371, DOI 10.1016/j.ypmed.2012.07.002; Lacy KE, 2015, AUST J PRIM HEALTH, V21, P369, DOI 10.1071/PY15052; Linchey J, 2011, PREV CHRONIC DIS, V8; Maneze D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/506269; Mellor D, 2012, AUST NZ J PUBL HEAL, V36, P317, DOI 10.1111/j.1753-6405.2012.00894.x; Minas H, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-34; Minihan PM, 2011, PREV CHRONIC DIS, V8; Moore L, 2010, PREVENTING CHILDHOOD, P157, DOI DOI 10.1002/9781444318517.CH19; MORGAN DL, 1988, FOCUS GROUPS QUALITA; National Obesity Taskforce, 2011, HLTH WEIGHT 2008 AUS; National Preventative Health Taskforce, 2010, TAK PREV ACT RESP AU; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Nimmon LE, 2007, CAN J PUBLIC HEALTH, V98, P337, DOI 10.1007/BF03405414; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Parent M, 2000, INFORM MANAGE, V38, P47, DOI 10.1016/S0378-7206(00)00053-7; Peeters A, 2015, LANCET DIABETES ENDO, V3, P838, DOI 10.1016/S2213-8587(15)00373-3; Pena MM, 2012, CHILD OBES, V8, P23, DOI 10.1089/chi.2011.0109; Poureslami Iraj, 2007, MedGenMed, V9, P12; Preventive Health Taskforce, 2010, AUSTR HLTH COUNTR 20; Public Health England, 2013, NAT CHILD MEAS PROGR; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Renzaho A. M. N., 2006, Nutrition & Dietetics, V63, P91, DOI 10.1111/j.1747-0080.2006.00055.x; Renzaho A, 2010, INT J MIGR HEALTH SO, V6, P34, DOI 10.5042/ijmhsc.2010.0448; Renzaho AMN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1628-2; Renzaho AMN, 2014, MATERN CHILD HLTH J, V18, P1391, DOI 10.1007/s10995-013-1378-7; Renzaho AMN, 2012, QUAL HEALTH RES, V22, P740, DOI 10.1177/1049732311425051; Renzaho AMN, 2011, CHILD FAM SOC WORK, V16, P228, DOI 10.1111/j.1365-2206.2010.00736.x; Renzaho AMN, 2009, NUTR DIET, V66, P145, DOI 10.1111/j.1747-0080.2009.01358.x; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Scott TL, 2002, MED CARE, V40, P395, DOI 10.1097/00005650-200205000-00005; Staten LK, 2004, J WOMENS HEALTH, V13, P547, DOI 10.1089/1540999041281133; Stewart D.W., 2007, FOCUS GROUPS THEORY, V20; Suphanchaimat R, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1065-z; Swinburn B, 2013, OBES REV, V14, P60, DOI 10.1111/obr.12103; Swinburn Boyd, 2007, Pac Health Dialog, V14, P139; Sylvetsky-Meni AC, 2015, J OBES, V2015, DOI 10.1155/2015/307381; Taylor RW, 2007, AM J CLIN NUTR, V86, P735, DOI 10.1093/ajcn/86.3.735; Tovar A, 2014, CURR OBES REP, V3, P206, DOI 10.1007/s13679-014-0101-3; van Smeerdijk James, 2015, WEIGHING COST OBESIT; Warr D, 2013, AUST J EARLY CHILD, V38, P41, DOI 10.1177/183693911303800108; Wilson A, 2010, HEALTH PLACE, V16, P969, DOI 10.1016/j.healthplace.2010.06.001; Wilson A, 2015, PUBLIC HEALTH NUTR, V18, P176, DOI 10.1017/S1368980013003467; World Health Organization, 2012, POP BAS APPR CHILDH; Zanchetta MS, 2006, CAN J PUBLIC HEALTH, V97, pS26	101	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0162184	10.1371/journal.pone.0162184	http://dx.doi.org/10.1371/journal.pone.0162184			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736864	Green Published, gold			2022-12-27	WOS:000385505800004
J	Danilovic, DLS; Ferraz-de-Souza, B; Fabri, AW; Santana, NO; Kulcsar, MA; Cernea, CR; Marui, S; Hoff, AO				Seguro Danilovic, Debora Lucia; Ferraz-de-Souza, Bruno; Fabri, Amanda Wictky; Santana, Nathalie Oliveira; Kulcsar, Marco Aurelio; Cernea, Claudio Roberto; Marui, Suemi; Hoff, Ana Oliveira			25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; BREAST-CANCER; PROSTATE-CANCER; RECEPTOR EXPRESSION; GROWTH-FACTOR; SERUM; CELLS; COLON; THYROTROPIN; DIFFERENTIATION	Objective The increasing incidence of thyroid nodules demands identification of risk factors for malignant disease. Several studies suggested the association of higher TSH levels with cancer, but influence of 25-hydroxyvitamin D (25OHD) is controversial. This study aimed to identify the relationship of thyroid cancer with higher TSH levels and hypovitaminosis D and to evaluate their influence on prognostic characteristics of papillary thyroid carcinomas (PTC). Methods We retrospectively evaluated 433 patients submitted to thyroidectomy for thyroid nodules. Patients were categorized according to quartiles of TSH and 25OHD levels. Clinicopathological features were analyzed. Results Subjects with thyroid carcinomas were more frequently male and younger compared to those with benign disease. Their median TSH levels were higher and adjusted odds-ratio (OR) for cancer in the highest-quartile of TSH (> 2.4 mUI/mL) was 2.36 (1.36-4.09). Although vitamin D deficiency/insufficiency was prevalent in our cohort (84%), no significant differences in 25OHD levels or quartile distribution were observed between benign and malignant cases. Among 187 patients with PTC, analyses of prognostic features revealed increased risk of lymph nodes metastases for subjects with highest-quartile TSH levels (OR = 3.7, p = 0.029). Decreased 25OHD levels were not overtly associated with poor prognosis in PTC. Conclusions In this cross-sectional cohort, higher TSH levels increased the risk of cancer in thyroid nodules and influenced its prognosis, particularly favoring lymph nodes metastases. On theother hand, no association was found between 25OHD levels and thyroid carcinoma risk or prognosis, suggesting that serum 25OHD determination may not contribute to risk assessment workup of thyroid nodules.	[Seguro Danilovic, Debora Lucia; Hoff, Ana Oliveira] Inst Canc Estado Sao Paulo, Endocrinol, Sao Paulo, Brazil; [Seguro Danilovic, Debora Lucia; Fabri, Amanda Wictky; Santana, Nathalie Oliveira; Marui, Suemi] Univ Sao Paulo, Fac Med, Lab Endocrinol Celular & Mol LIM25, Sao Paulo, Brazil; [Ferraz-de-Souza, Bruno] Univ Sao Paulo, Fac Med, LIM 18, Sao Paulo, Brazil; [Kulcsar, Marco Aurelio; Cernea, Claudio Roberto] Inst Canc Estado Sao Paulo, Head & Neck Surg, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Danilovic, DLS (corresponding author), Inst Canc Estado Sao Paulo, Endocrinol, Sao Paulo, Brazil.	deboradanilovic@usp.br	Danilovic, Debora L. S./H-1429-2015; Danilovic, Debora/AAB-9259-2019; de Oliveira Hoff, Ana Amélia Fialho/A-5753-2013; Kulcsar, Marco Aurelio Vamondes/L-8779-2013; Santana, Nathalie Oliveira/CAG-2168-2022; Ferraz-de-Souza, Bruno/G-1069-2010; Cernea, Claudio Roberto/F-5610-2016; Marui, Suemi/D-3660-2012	Danilovic, Debora L. S./0000-0002-4058-8027; Danilovic, Debora/0000-0002-4058-8027; Kulcsar, Marco Aurelio Vamondes/0000-0002-4751-0476; Santana, Nathalie Oliveira/0000-0003-1447-1754; Ferraz-de-Souza, Bruno/0000-0003-4863-2544; Cernea, Claudio Roberto/0000-0001-5899-0535; Marui, Suemi/0000-0002-0744-3942	CNPq (National Counsel of Technological and Scientific Development) [USP1676]	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AWF received study grants from CNPq (National Counsel of Technological and Scientific Development, grant number USP1676, 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; Ahn HY, 2016, THYROID, V26, P429, DOI 10.1089/thy.2015.0516; Akslen LA, 1998, BRIT J CANCER, V77, P1174, DOI 10.1038/bjc.1998.195; Bade B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112863; Bauer SR, 2013, MEDICINE, V92, P123, DOI 10.1097/MD.0b013e3182943bc2; Ben-Shoshan M, 2007, MOL CANCER THER, V6, P1433, DOI 10.1158/1535-7163.MCT-06-0677; Bises G, 2004, J HISTOCHEM CYTOCHEM, V52, P985, DOI 10.1369/jhc.4B6271.2004; Blutt SE, 2000, ENDOCRINOLOGY, V141, P10, DOI 10.1210/en.141.1.10; Chailurkit LO, 2013, THYROID, V23, P25, DOI 10.1089/thy.2012.0001; Chen W, 2007, BRIT J CANCER, V97, P123, DOI 10.1038/sj.bjc.6603834; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Chung KW, 2006, CLIN ENDOCRINOL, V65, P660, DOI 10.1111/j.1365-2265.2006.02646.x; Cipriani C, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/841248; EISMAN JA, 1979, LANCET, V2, P1335; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Fiore E, 2009, ENDOCR-RELAT CANCER, V16, P1251, DOI 10.1677/ERC-09-0036; Fraser A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013882; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Gilbert R, 2011, CANCER CAUSE CONTROL, V22, P319, DOI 10.1007/s10552-010-9706-3; Gissel T, 2008, J STEROID BIOCHEM, V111, P195, DOI 10.1016/j.jsbmb.2008.06.002; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Haugen BR, 2016, THYROID, V26, P1, DOI [DOI 10.1089/THY.2015.0020, 10.1089/thy.2015.0020]; Haymart MR, 2009, CLIN ENDOCRINOL, V71, P434, DOI 10.1111/j.1365-2265.2008.03489.x; HOELTING T, 1993, BIOCHEM BIOPH RES CO, V195, P1230, DOI 10.1006/bbrc.1993.2176; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hsieh TC, 1996, BIOCHEM BIOPH RES CO, V223, P141, DOI 10.1006/bbrc.1996.0859; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Izkhakov E, 2016, J STEROID BIOCHEM, V159, P26, DOI 10.1016/j.jsbmb.2016.02.016; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; Jonklaas J, 2013, THYROID, V23, P1079, DOI 10.1089/thy.2012.0548; Kim JR, 2014, THYROID, V24, P1618, DOI 10.1089/thy.2014.0090; Kim SS, 2011, ENDOCRINE, V39, P259, DOI 10.1007/s12020-010-9430-5; Kmiec P, 2015, EXP CLIN ENDOCR DIAB, V123, P386, DOI 10.1055/s-0035-1554714; Krishnan AV, 2010, ENDOCRINOLOGY, V151, P32, DOI 10.1210/en.2009-0855; Laney N, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/805716; Lee HJ, 2014, CANCER-AM CANCER SOC, V120, P521, DOI 10.1002/cncr.28368; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Leyssens C, 2013, ENDOCR-RELAT CANCER, V20, pR31, DOI 10.1530/ERC-12-0381; Li MA, 2014, J CLIN ENDOCR METAB, V99, P2327, DOI 10.1210/jc.2013-4320; McLeod DSA, 2012, J CLIN ENDOCR METAB, V97, P2682, DOI 10.1210/jc.2012-1083; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Morand GB, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00309; Moreno J, 2005, CANCER RES, V65, P7917, DOI 10.1158/0008-5472.CAN-05-1435; Muenstedt K, 2010, BREAST CARE, V5, P383, DOI 10.1159/000322651; O'Grady TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110886; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Peppone LJ, 2012, ANN SURG ONCOL, V19, P2590, DOI 10.1245/s10434-012-2297-3; Pereira F, 2012, ENDOCR-RELAT CANCER, V19, pR51, DOI 10.1530/ERC-11-0388; Ray R, 2012, ANTICANCER RES, V32, P727; Roskies M, 2012, J OTOLARYNGOL-HEAD N, V41, P160, DOI 10.2310/7070.2011.110174; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sahin M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0589-5; Shin DY, 2014, ENDOCR-RELAT CANCER, V21, P715, DOI 10.1530/ERC-14-0259; SKOWRONSKI RJ, 1993, ENDOCRINOLOGY, V132, P1952, DOI 10.1210/en.132.5.1952; Stepien T, 2010, ARCH MED RES, V41, P190, DOI 10.1016/j.arcmed.2010.04.004; Swami S, 2016, ENDOCR-RELAT CANCER, V23, P251, DOI 10.1530/ERC-15-0557; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Unger MD, 2010, CLIN NUTR, V29, P784, DOI 10.1016/j.clnu.2010.06.009; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wang LL, 2004, J STEROID BIOCHEM, V89-90, P127, DOI 10.1016/j.jsbmb.2004.03.091	61	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164550	10.1371/journal.pone.0164550	http://dx.doi.org/10.1371/journal.pone.0164550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737011	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800082
J	Chen, LH; Chen, JQ; Peng, QY; Chen, JJ; Zou, YC; Liu, G				Chen, Lianghua; Chen, Junqi; Peng, Qiyuan; Chen, Jingjie; Zou, Yucong; Liu, Gang			Effect of Sling Exercise Training on Balance in Patients with Stroke: A Meta-Analysis	PLOS ONE			English	Article							TRUNK STABILIZATION EXERCISES; LOW-BACK-PAIN; VALIDATION; GAIT; THERAPY; SCALE	Objective This study aims to evaluate the effect of sling exercise training (SET) on balance in patients with stroke. Methods PubMed, Cochrane Library, Ovid LWW, CBM, CNKI, WanFang, and VIP databases were searched for randomized controlled trials of the effect of SET on balance in patients with stroke. The study design and participants were subjected to metrological analysis. Berg balance Scale (BBS), Barthel index score (BI), and Fugl-Meyer Assessment (FMA) were used as independent parameters for evaluating balance function, activities of daily living (ADL) and motor function after stroke respectively, and were subjected to meta-analysis by RevMan5.3 software. Results Nine studies with 460 participants were analyzed. Results of meta-analysis showed that the SET treatment combined with conventional rehabilitation was superior to conventional rehabilitation treatments, with increased degrees of BBS (WMD = 3.81, 95% CI [0.15, 7.48], P = 0.04), BI (WMD = 12.98, 95% CI [8.39, 17.56], P < 0.00001), and FMA (SMD = 0.76, 95% CI [0.41, 1.11], P < 0.0001). Conclusion Based on limited evidence from 9 trials, the SET treatment combined with conventional rehabilitation was superior to conventional rehabilitation treatments, with increased degrees of BBS, BI and FMA, So the SET treatment can improvement of balance function after stroke, but the interpretation of our findings is required to be made with caution due to limitations in included trials such as small sample sizes and the risk of bias. Therefore, more multi-center and large-sampled randomized controlled trials are needed to confirm its clinical applications.	[Chen, Lianghua; Chen, Junqi; Peng, Qiyuan; Chen, Jingjie; Zou, Yucong; Liu, Gang] Southern Med Univ, Affiliated Hosp 3, Dept Rehabil Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Liu, G (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Rehabil Med, Guangzhou, Guangdong, Peoples R China.	13580350999@126.com		chen, jun-qi/0000-0001-6847-0891	Tianhe District Science and Technology Projects of Guangdong, China [201404KW021]	Tianhe District Science and Technology Projects of Guangdong, China	This work was supported by Tianhe District Science and Technology Projects of Guangdong, China (No. 201404KW021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2005, CAN J APPL PHYSIOL, V30, P33, DOI 10.1139/h05-103; Anderson KG, 2004, J STRENGTH COND RES, V18, P637; Bae SH, 2013, J PHYS THER SCI, V25, P741, DOI 10.1589/jpts.25.741; Benaim C, 1999, STROKE, V30, P1862, DOI 10.1161/01.STR.30.9.1862; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Cabanas-Valdes R, 2013, NEUROREHABILITATION, V33, P575, DOI 10.3233/NRE-130996; Chen C, 2012, AM J CLIN ONCOL-CANC, V27, P27, DOI DOI 10.5301/JBM.2011.8736; Chinese society for neuroscience and Chinese society of department of neurosurgery, 1996, CHINESE J NEUROLOGY, V29, P379; [崔贵祥 CUI Guixiang], 2009, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V24, P530; Duffy L, 2013, STROKE, V44, P462, DOI 10.1161/STROKEAHA.112.678615; French B, 2010, J REHABIL MED, V42, P9, DOI 10.2340/16501977-0473; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gu Shaohua, 2012, CHINESE J REHABILITA, V28, P452; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hu Chuan, 2015, CHINESE J REHABILITA, V30, P114; Kirkesola G, 2009, J FYSIOTERAPEUTEN, V76, P16; Krutulyte Grazina, 2003, Medicina (Kaunas), V39, P889; Lee JS, 2014, J PHYS THER SCI, V26, P655, DOI 10.1589/jpts.26.655; Lee JS, 2014, J PHYS THER SCI, V26, P1301, DOI 10.1589/jpts.26.1301; Li Ziqiang, 2013, CHINESE J COAL IND M, V16, P1835; Liu Gang, 2014, BASIC CLIN SLING EXE; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Mao HF, 2002, STROKE, V33, P1022, DOI 10.1161/01.STR.0000012516.63191.C5; [缪亚萍 Miao Yaping], 2011, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V33, P285; Miller CE, 2009, STROKE, V40, P1973, DOI 10.1161/STROKEAHA.108.539528; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; O'Sullivan PB, 1997, SPINE, V22, P2959, DOI 10.1097/00007632-199712150-00020; Park JH, 2014, J PHYS THER SCI, V26, P219, DOI 10.1589/jpts.26.219; Qian JG, 2015, J PHYS THER SCI, V27, P3541, DOI 10.1589/jpts.27.3541; Rathore SS, 2002, STROKE, V33, P2718, DOI 10.1161/01.STR.0000035286.87503.31; ROSSITERFORNOFF JE, 1995, J GERONTOL A-BIOL, V50, pM291, DOI 10.1093/gerona/50A.6.M291; Sawacha Z, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-95; Sorinola IO, 2014, NEUROREHABILITATION, V35, P205, DOI 10.3233/NRE-141123; Spaich EG, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-81; Sun ZX., 2012, EFFECT SLING EXERCIS; Verheyden G, 2004, CLIN REHABIL, V18, P326, DOI 10.1191/0269215504cr733oa; [杨国梁 Yang Guoliang], 2011, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V33, P281; Yavuzer G, 2006, CLIN REHABIL, V20, P960, DOI 10.1177/0269215506070315; You YL, 2015, J PHYS THER SCI, V27, P2591, DOI 10.1589/jpts.27.2591; Yue YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099307; 傅建明, 2012, [中华物理医学与康复杂志, Chinese Journal of Physical Medicine and Rehabilitation], V34, P926	41	11	18	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163351	10.1371/journal.pone.0163351	http://dx.doi.org/10.1371/journal.pone.0163351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727288	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504400007
J	Ding, N; Berry, HL; Bennett, CM				Ding, Ning; Berry, Helen L.; Bennett, Charmian M.			The Importance of Humidity in the Relationship between Heat and Population Mental Health: Evidence from Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; IMPACT; DROUGHT; WEATHER; MOOD	Despite many studies on the effects of heat on mental health, few studies have examined humidity. In order to investigate the relationship among heat, humidity and mental health, we matched data from the Social, Economic and Environmental Factors (SEEF) project with gridded daily temperature and water vapour pressure data from the Australian Bureau of Meteorology. Logit models were employed to describe the associations among heat (assessed using temperature, degrees C), humidity (assessed using vapour pressure, hPa) and two measures of mental health, (i) high or very high distress (assessed using K10 scores >= 22) and (ii) having been treated for depression or anxiety. We found a one-unit increase in temperature and vapour pressure was associated with an increase in the occurrence of high or very high distress by 0.2% (p < 0.001, 99% CI: 0.1 - 0.3%) and 0.1% (p < 0.001, 99% CI: 0.0 - 0.3%) respectively. However, when humidity rose to the 99th percentile of the sample, the estimated marginal effect of heat was more than doubled (0.5%, p < 0.001, 99% CI: 0.2 - 0.7%). Neither heat nor humidity was related to having been treated for depression or anxiety in the last month. Humidity compounds the negative association between hot weather and mental health and thus should be taken into account when reforming the health care system to respond to the challenge of climate change.	[Ding, Ning] China Med Univ, Res Ctr Med Educ, Shenyang, Liaoning Provin, Peoples R China; [Berry, Helen L.] Australian Natl Univ, ANU Climate Change Inst, Canberra, ACT, Australia; [Bennett, Charmian M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Res Sch Populat Hlth, Canberra, ACT, Australia	China Medical University; Australian National University; Australian National University	Ding, N (corresponding author), China Med Univ, Res Ctr Med Educ, Shenyang, Liaoning Provin, Peoples R China.	nding@cmu.edu.cn						Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Australian Institute of Health and Welfare, 2007, RUR REG REM HLTH STU; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Berry Helen L, 2015, BJPsych Int, V12, P31; Berry HL, 2010, INT J PUBLIC HEALTH, V55, P123, DOI 10.1007/s00038-009-0112-0; Blashki G, 2011, ASIA-PAC J PUBLIC HE, V23, p133S, DOI 10.1177/1010539510395121; Blunden J, 2013, B AM METEOROL SOC, V94, pS1, DOI 10.1175/2013BAMSStateoftheClimate.1; Brereton F, 2008, ECOL ECON, V65, P386, DOI 10.1016/j.ecolecon.2007.07.008; Connolly M, 2013, J HAPPINESS STUD, V14, P457, DOI 10.1007/s10902-012-9338-2; Davis RE, 2016, ENVIRON RES, V144, P106, DOI 10.1016/j.envres.2015.10.014; Denissen JJA, 2008, EMOTION, V8, P662, DOI 10.1037/a0013497; Ding N, 2015, INT J EPIDEMIOL, V44, P64; Every-Palmer S, 2016, AUST NZ J PSYCHIAT, V50, P16, DOI 10.1177/0004867415615946; Feddersen J, 2015, J ROYAL STAT SOC A; Friel S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1102; Frijters P, 1998, CLIMATIC CHANGE, V39, P61, DOI 10.1023/A:1005347721963; Hansen A, 2008, ENVIRON HEALTH PERSP, V116, P1369, DOI 10.1289/ehp.11339; Jones DA, 2009, AUST METEOROL OCEAN, V58, P233, DOI 10.22499/2.5804.003; Kaiser R, 2001, AM J FOREN MED PATH, V22, P303, DOI 10.1097/00000433-200109000-00022; Keller MC, 2005, PSYCHOL SCI, V16, P724, DOI 10.1111/j.1467-9280.2005.01602.x; Maddison D, 2011, ECOL ECON, V70, P2437, DOI 10.1016/j.ecolecon.2011.07.027; Maughan Daniel L, 2015, BJPsych Int, V12, P29; OBrien LV, 2014, ENVIRON RES, V131, P181, DOI 10.1016/j.envres.2014.03.014; Paranjothy S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-145; Rehdanz K, 2005, ECOL ECON, V52, P111, DOI 10.1016/j.ecolecon.2004.06.015; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Slade T., 2009, MENTAL HLTH AUSTR 2; Slade T, 2009, AUST NZ J PSYCHIAT, V43, P594, DOI 10.1080/00048670902970882; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; United Nations, 2002, WORLD POP AG 1950 20; Vardoulakis S, 2014, ENVIRON HEALTH PERSP, V122, P1285, DOI 10.1289/ehp.1307524; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209	33	31	32	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164190	10.1371/journal.pone.0164190	http://dx.doi.org/10.1371/journal.pone.0164190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CI	27727320	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504400020
J	Wang, SH; Chou, YC; Shangkuan, WC; Wei, KY; Pan, YH; Lin, HC				Wang, Sheng-Huei; Chou, Yu-Ching; Shangkuan, Wei-Chuan; Wei, Kuang-Yu; Pan, Yu-Han; Lin, Hung-Che			Relationship between Plasma Triglyceride Level and Severity of Hypertriglyceridemic Pancreatitis	PLOS ONE			English	Article							PERSISTENT ORGAN FAILURE; CLINICAL-ASSESSMENT; INSULIN; HYPERLIPEMIA; DIAGNOSIS; THERAPY; HEPARIN	Background Hypertriglyceridemia is the third most common cause of acute pancreatitis, but whether the level of triglyceride (TG) is related to severity of pancreatitis is unclear. Aim To evaluate the effect of TG level on the severity of hypertriglyceridemic pancreatitis (HTGP). Design Retrospective cohort study. Methods We reviewed the records of 144 patients with HTGP from 1999 to 2013 at Tri-Service General Hospital. Patients with possible etiology of pancreatitis, such as gallstones, those consuming alcohol or drugs, or those with infections were excluded. The classification of severity of pancreatitis was based on the revised Atlanta classification. We allocated the patients into high-TG and low-TG groups based on the optimal cut-off value (2648 mg/dL), which was derived from the receiver operating characteristic (ROC) curve between TG level and severity of HTGP. We then compared the clinical characteristics, pancreatitis severity, and mortality rates of the groups. Results There were 66 patients in the low-TG group and 78 patients in the high-TG group. There was no significant difference in the age, sex ratio, body mass index, and comorbidity between the 2 groups. The high-TG group had significantly higher levels of glucose (P = 0.022), total cholesterol (P = 0.002), and blood urea nitrogen (P = 0.037), and lower levels of sodium (P = 0.003) and bicarbonate (P = 0.002) than the low-TG group. The incidences of local complication (P = 0.002) and severe and moderate form of pancreatitis (P = 0.004) were significantly higher in the high-TG group than in the low-TG group. The mortality rate was higher in the high-TG group than in the low-TG group (P = 0.07). Conclusions Higher TG level in patients with HTGP may be associated with adverse prognosis, but randomized and prospective studies are needed in the future verify this relationship.	[Wang, Sheng-Huei] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Shangkuan, Wei-Chuan] Natl Def Med Ctr, Taipei, Taiwan; [Wei, Kuang-Yu] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Pan, Yu-Han] Natl Def Med Ctr, Triserv Gen Hosp, Dept Nursing, Taipei, Taiwan; [Lin, Hung-Che] Natl Def Med Ctr, Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Lin, HC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan.	lhj50702@gmail.com		Lin, Hung-Che/0000-0002-0138-1904; Wang, Sheng-Huei/0000-0002-5267-0618				Alagozlu H, 2006, DIGEST DIS SCI, V51, P931, DOI 10.1007/s10620-005-9006-z; Anderson F, 2011, S AFR J SURG, V49, P82; Anderson F, 2009, PANCREATOLOGY, V9, P252, DOI 10.1159/000212091; Armario A, 1996, PSYCHONEUROENDOCRINO, V21, P17, DOI 10.1016/0306-4530(95)00048-8; Athyros VG, 2002, J CLIN GASTROENTEROL, V34, P472, DOI 10.1097/00004836-200204000-00020; Balachandra S, 2006, INT J CLIN PRACT, V60, P156, DOI 10.1111/j.1368-5031.2005.00645.x; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Berger Z, 2001, REV MED CHILE, V129, P1373; Buter A, 2002, BRIT J SURG, V89, P298, DOI 10.1046/j.0007-1323.2001.02025.x; Cappell MS, 2008, MED CLIN N AM, V92, P889, DOI 10.1016/j.mcna.2008.04.013; Chang C C, 1998, Zhonghua Yi Xue Za Zhi (Taipei), V61, P85; Deng LH, 2008, WORLD J GASTROENTERO, V14, P4558, DOI 10.3748/wjg.14.4558; FORTSON MR, 1995, AM J GASTROENTEROL, V90, P2134; Isenmann R, 2001, PANCREAS, V22, P274, DOI 10.1097/00006676-200104000-00008; Ivanova R, 2012, HEPATOB PANCREAT DIS, V11, P96, DOI 10.1016/S1499-3872(11)60131-8; Jabbar MA, 1998, J AM COLL NUTR, V17, P458, DOI 10.1080/07315724.1998.10718794; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Kim Gheun-Ho, 2006, Electrolyte Blood Press, V4, P77, DOI 10.5049/EBP.2006.4.2.77; Kimura W, 1996, INT J PANCREATOL, V20, P177, DOI 10.1007/BF02803766; LADENSON JH, 1981, ANN INTERN MED, V95, P707, DOI 10.7326/0003-4819-95-6-707; Linares CL, 2008, PANCREAS, V37, P13, DOI 10.1097/MPA.0b013e31816074a1; Mounzer R, 2012, GASTROENTEROLOGY, V142, P1476, DOI 10.1053/j.gastro.2012.03.005; Murphy MJ, 2013, JAMA INTERN MED, V173, P162, DOI 10.1001/2013.jamainternmed.477; SAHARIA P, 1977, SURGERY, V82, P60; Saligram S, 2012, CLIN GASTROENTEROL H, V10, P805, DOI 10.1016/j.cgh.2012.03.025; Scherer J, 2014, J CLIN GASTROENTEROL, V48, P195, DOI 10.1097/01.mcg.0000436438.60145.5a; Stefanutti C, 2011, TRANSFUS APHER SCI, V45, P3, DOI 10.1016/j.transci.2011.06.013; Tai WP, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/6263095; Tamas Baranyai, 2010, Orvosi Hetilap, V151, P1869, DOI 10.1556/OH.2010.28966; Valdivielso P, 2014, EUR J INTERN MED, V25, P689, DOI 10.1016/j.ejim.2014.08.008; Wang X, 2013, PANCREAS, V42, P1255, DOI 10.1097/MPA.0b013e3182a5d6a7; Zeng Y, 2012, HEPATO-GASTROENTEROL, V59, P2318, DOI 10.5754/hge12042; Zhang XL, 2015, CHINESE MED J-PEKING, V128, P2045, DOI 10.4103/0366-6999.161361	34	32	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163984	10.1371/journal.pone.0163984	http://dx.doi.org/10.1371/journal.pone.0163984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727299	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504400016
J	Van Belle, V; Van Calster, B; Van Huffel, S; Suykens, JAK; Lisboa, P				Van Belle, Vanya; Van Calster, Ben; Van Huffel, Sabine; Suykens, Johan A. K.; Lisboa, Paulo			Explaining Support Vector Machines: A Color Based Nomogram	PLOS ONE			English	Article							RULE EXTRACTION; VISUALIZATION; SELECTION; MODELS	Problem setting Support vector machines (SVMs) are very popular tools for classification, regression and other problems. Due to the large choice of kernels they can be applied with, a large variety of data can be analysed using these tools. Machine learning thanks its popularity to the good performance of the resulting models. However, interpreting the models is far from obvious, especially when non-linear kernels are used. Hence, the methods are used as black boxes. As a consequence, the use of SVMs is less supported in areas where interpretability is important and where people are held responsible for the decisions made by models. Objective In this work, we investigate whether SVMs using linear, polynomial and RBF kernels can be explained such that interpretations for model-based decisions can be provided. We further indicate when SVMs can be explained and in which situations interpretation of SVMs is (hitherto) not possible. Here, explainability is defined as the ability to produce the final decision based on a sum of contributions which depend on one single or at most two input variables. Results Our experiments on simulated and real-life data show that explainability of an SVM depends on the chosen parameter values (degree of polynomial kernel, width of RBF kernel and regularization constant). When several combinations of parameter values yield the same cross-validation performance, combinations with a lower polynomial degree or a larger kernel width have a higher chance of being explainable. Conclusions This work summarizes SVM classifiers obtained with linear, polynomial and RBF kernels in a single plot. Linear and polynomial kernels up to the second degree are represented exactly. For other kernels an indication of the reliability of the approximation is presented. The complete methodology is available as an R package and two apps and a movie are provided to illustrate the possibilities offered by the method.	[Van Belle, Vanya; Van Huffel, Sabine; Suykens, Johan A. K.] Katholieke Univ Leuven, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Dept Elect Engn ESAT, Leuven, Belgium; [Van Belle, Vanya; Van Huffel, Sabine; Suykens, Johan A. K.] iMinds Med IT, Leuven, Belgium; [Van Calster, Ben] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Lisboa, Paulo] Liverpool John Moores Univ, Dept Appl Math, Liverpool, Merseyside, England	KU Leuven; IMEC; KU Leuven; Liverpool John Moores University	Van Belle, V (corresponding author), Katholieke Univ Leuven, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Dept Elect Engn ESAT, Leuven, Belgium.; Van Belle, V (corresponding author), iMinds Med IT, Leuven, Belgium.; Van Calster, B (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium.	vanya.vanbelle@esat.kuleuven.be; ben.vancalster@kuleuven.be	Suykens, Johan A.K./C-9781-2014; Van Calster, Ben/F-9150-2010	Suykens, Johan A.K./0000-0002-8846-6352; Van Calster, Ben/0000-0003-1613-7450	postdoctoral fellow of the Research foundation Flanders (FWO); Center of Excellence (CoE): (OPTEC) [PFV/10/002]; iMinds Medical Information Technologies; Belgian Federal Science Policy Office: (DYSCO, 'Dynamical systems, control and optimization') [IUAP P7/19/]; European Research Council: ERC Advanced Grant, BIOTENSORS [339804]; ERC AdG A-DATADRIVE-B [FWO G.0377.12, G.088114N]	postdoctoral fellow of the Research foundation Flanders (FWO)(FWO); Center of Excellence (CoE): (OPTEC); iMinds Medical Information Technologies; Belgian Federal Science Policy Office: (DYSCO, 'Dynamical systems, control and optimization')(Belgian Federal Science Policy Office); European Research Council: ERC Advanced Grant, BIOTENSORS; ERC AdG A-DATADRIVE-B	V. Van Belle is a postdoctoral fellow of the Research foundation Flanders (FWO). This research was supported by: Center of Excellence (CoE): PFV/10/002 (OPTEC); iMinds Medical Information Technologies; Belgian Federal Science Policy Office: IUAP P7/19/ (DYSCO, 'Dynamical systems, control and optimization, 20122017); European Research Council: ERC Advanced Grant, (339804) BIOTENSORS. This paper reflects only the authors views and the Union is not liable for any use that may be made of the contained information. JS acknowledges support of ERC AdG A-DATADRIVE-B, FWO G.0377.12, G.088114N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Balfer J, 2014, J CHEM INF MODEL, V54, P2451, DOI 10.1021/ci500410g; Barakat N, 2010, NEUROCOMPUTING, V74, P178, DOI 10.1016/j.neucom.2010.02.016; Bjork J, 2012, J CLIN EPIDEMIOL, V65, P335, DOI 10.1016/j.jclinepi.2011.06.019; Caragea D, 2008, LECT NOTES COMPUT SC, V4404, P136, DOI 10.1007/978-3-540-71080-6_10; Cho BH, 2008, IEEE T INF TECHNOL B, V12, P247, DOI 10.1109/TITB.2007.902300; Dea PO, COMBINING FEATURE SE; Decoste D, 2002, MACH LEARN, V46, P161, DOI 10.1023/A:1012454411458; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Gallier J, 2011, UNIVERSITEXT, P365, DOI 10.1007/978-1-4419-8047-2_6; Gunn SR, 2002, MACH LEARN, V48, P137, DOI 10.1023/A:1013903804720; Hansen K, 2011, MOL INFORM, V30, P817, DOI 10.1002/minf.201100059; Harrell FE, 2001, REGRESSION MODELING; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Jakulin Aleks, 2005, P 11 ACM SIGKDD INT, P108, DOI DOI 10.1145/1081870.1081886; Joachims T., 2002, LEARNING CLASSIFY TE, DOI [10.1007/978-1-4615-0907-3, DOI 10.1007/978-1-4615-0907-3]; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kohonen T., 1995, SELF ORG MAPS, V30, DOI [10.1007/978-3-642-97610-0, DOI 10.1007/978-3-642-97610-0]; Krooshof PWT, 2010, ANAL CHEM, V82, P7000, DOI 10.1021/ac101338y; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lichman M, 2013, UCI MACHINE LEARNING; Lisboa PJG, 2015, EXPERT SYST APPL, V42, P8982, DOI 10.1016/j.eswa.2015.07.054; Martens D, 2008, STUD COMPUT INTELL, V80, P33; Moghaddam B, 2002, IEEE T PATTERN ANAL, V24, P707, DOI 10.1109/34.1000244; Navia-Vazquez A, 2006, NEUROCOMPUTING, V69, P1754, DOI 10.1016/j.neucom.2005.12.118; Nguyen TTT, 2011, LECT NOTES COMPUT SC, V6676, P94, DOI 10.1007/978-3-642-21090-7_11; Pelckmans K., 2005, ARTIFICIAL NEURAL NE; Platt JC, 2000, ADV NEUR IN, P61; Romero E, 2012, PATTERN RECOGN, V45, P1436, DOI 10.1016/j.patcog.2011.09.025; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Stitson M, 1999, SUPPORT VECTOR REGRE, P285; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Suykens JAK., 2002, LEAST SQUARES SUPPOR, DOI [DOI 10.1142/5089, 10.1142/5089]; Usdun B, 2007, ANAL CHIM ACTA, V595, P299, DOI 10.1016/j.aca.2007.03.023; Van Belle V, 2013, P EUR S ART NEUR NET, P533; Van Belle V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132614; Van Belle V, 2014, ARTIF INTELL MED, V60, P53, DOI 10.1016/j.artmed.2013.10.001; Van Belle V, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P26, DOI 10.1109/CIDM.2013.6597213; Vapnik V., 1998, STAT LEARNING THEORY; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Verikas A, 2002, PATTERN RECOGN LETT, V23, P1323, DOI 10.1016/S0167-8655(02)00081-8; Wang XH, 2006, LECT NOTES COMPUT SC, V3971, P968; Zadrozny B., 2002, P 8 ACM SIGKDD INT C, P694, DOI [10.1145/775047.775151, DOI 10.1145/775047.775151]	43	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164568	10.1371/journal.pone.0164568	http://dx.doi.org/10.1371/journal.pone.0164568			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723811	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100074
J	Duckworth, S; Chappell, LC; Seed, PT; Mackillop, L; Shennan, AH; Hunter, R				Duckworth, Suzy; Chappell, Lucy C.; Seed, Paul T.; Mackillop, Lucy; Shennan, Andrew H.; Hunter, Rachael			Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks' Gestation: A Budget Impact Analysis	PLOS ONE			English	Article							ANGIOGENIC FACTORS; PAYER PERSPECTIVE; MODELING ANALYSIS; PREDICTION; ACCURACY; TRIAGE	Objective To model the resource implications of placental growth factor (PlGF) testing in women with suspected pre-eclampsia prior to 35 weeks' gestation as part of a management algorithm, compared with current practice. Methods Data on resource use from 132 women with suspected pre-eclampsia prior to 35 weeks' gestation, enrolled in a prospective observational cohort study evaluating PlGF measurement within antenatal assessment units within two UK consultant-led maternity units was extracted by case note review. A decision analytic model was developed using these data to establish the budget impact of managing women with suspected pre-eclampsia for two weeks from the date of PlGF testing, using a clinical management algorithm and reference cost tariffs. The main outcome measures of resource use (numbers of outpatient appointments, ultrasound investigations and hospital admissions) were correlated to final diagnosis and used to calculate comparative management regimes. Results The mean cost saving associated with the PlGF test (in the PlGF plus management arm) was pound 35,087 (95% CI - pound 33,181 to - pound 36,992) per 1,000 women. This equated to a saving of pound 582 (95% CI-552 to - pound 613) per woman tested. In 94% of iterations, PlGF testing was associated with cost saving compared to current practice. Conclusions This analysis suggests PlGF used as part of a clinical management algorithm in women presenting with suspected pre-eclampsia prior to 35 weeks' gestation could provide cost savings by reducing unnecessary resource use. Introduction of PlGF testing could be used to direct appropriate resource allocation and overall would be cost saving.	[Duckworth, Suzy; Chappell, Lucy C.; Seed, Paul T.; Shennan, Andrew H.] Kings Coll London, Womens Hlth Acad Ctr, London, England; [Mackillop, Lucy] Oxford Univ Hosp NHS Trust, Oxford, England; [Hunter, Rachael] UCL, Res Dept Primary Care & Populat Hlth, London, England	University of London; King's College London; Oxford University Hospitals NHS Foundation Trust; University of London; University College London	Chappell, LC (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, London, England.	lucy.chappell@kcl.ac.uk	Hunter, Rachael Maree/H-7846-2019; Seed, Paul T/C-4435-2008; Chappell, Lucy/U-4778-2018	Hunter, Rachael Maree/0000-0002-7447-8934; Seed, Paul T/0000-0001-7904-7933; Chappell, Lucy/0000-0001-6219-3379; Mackillop, Lucy/0000-0002-1927-1594; Shennan, Andrew/0000-0001-5273-3132	Tommy's Charity [1060508, SC039280]; National Institute for Health Research Research Professorship [RP-2014-05-019]; National Institute for Health Research [PB-PG-0214-33054, 15/59/06, RP-2014-05-019] Funding Source: researchfish	Tommy's Charity; National Institute for Health Research Research Professorship; National Institute for Health Research(National Institute for Health Research (NIHR))	We acknowledge funding support from Tommy's Charity (registered charity no 1060508 and SC039280) and Alere (San Diego, CA). This was an investigator-led study; neither funder had any role in study design, patient recruitment, data collection, analysis, interpretation, nor in writing of the manuscript or decision to submit for publication. LC is supported by the National Institute for Health Research Research Professorship, RP-2014-05-019. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chaiworapongsa T, 2011, J MATERN-FETAL NEO M, V24, P1187, DOI 10.3109/14767058.2011.589932; Chappell LC, 2013, CIRCULATION, V128, P2121, DOI 10.1161/CIRCULATIONAHA.113.003215; Curtis L, 2013, UNIT COSTS HLTH SOCI; Department of Health, 2013, PAYM RES NHS TANFF 2; Department of Health, 2016, NHS REF COSTS 2013 2; Hadker N, 2013, HYPERTENS PREGNANCY, V32, P105, DOI 10.3109/10641955.2011.638958; Hadker Nandini, 2010, J Med Econ, V13, P728, DOI 10.3111/13696998.2010.535285; Knudsen UB, 2012, PREGNANCY HYPERTENS, V2, P8, DOI 10.1016/j.preghy.2011.08.117; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Meads CA, 2008, HEALTH TECHNOL ASSES, V12, P1; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; National Institute for Health and Clinical Excellence, 2016, NICE DIAGN GUID DG23; National Institute for Health and Clinical Excellence: Guidance, 2010, HYP PREGN MAN HYP DI; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Schnettler WT, 2013, BJOG-INT J OBSTET GY, V120, P1224, DOI 10.1111/1471-0528.12259; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6	18	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164276	10.1371/journal.pone.0164276	http://dx.doi.org/10.1371/journal.pone.0164276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741259	Green Submitted, gold, Green Published			2022-12-27	WOS:000385507000024
J	Mazurkewich, S; Seah, SYK				Mazurkewich, Scott; Seah, Stephen Y. K.			Investigation into the Mode of Phosphate Activation in the 4-Hydroxy-4-Methyl-2-Oxoglutarate/4-Carboxy-4-Hydroxy-2-Oxoadipate Aldolase from Pseudomonas putida F1	PLOS ONE			English	Article							SPHINGOMONAS-PAUCIMOBILIS SYK-6; CLASS-II ALDOLASE; PROTOCATECHUATE 4,5-CLEAVAGE PATHWAY; SP STRAIN F274; CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; KINETIC CHARACTERIZATION; DEGRADATION PATHWAY; ESCHERICHIA-COLI; PYRUVATE-KINASE	The 4-hydroxy-4-methyl-2-oxoglutarate (HMG)/4-carboxy-4-hydroxy-2-oxoadipate (CHA) aldolase is the last enzyme of both the gallate and protocatechuate 4,5-cleavage pathways which links aromatic catabolism to central cellular metabolism. The enzyme is a class II, divalent metal dependent, aldolase which is activated in the presence of inorganic phosphate (P-i), increasing its turnover rate >10-fold. This phosphate activation is unique for a class II aldolase. The aldolase pyruvate methyl proton exchange rate, a probe of the general acid half reaction, was increased 300-fold in the presence of 1 mM P-i and the rate enhancement followed saturation kinetics giving rise to a K-M of 397 +/- 30 mu M. Docking studies revealed a potential P-i binding site close to, or overlapping with, the proposed general acid water site. Putative P-i binding residues were substituted by site-directed mutagenesis which resulted in reductions of P-i activation. Significantly, the active site residue Arg-123, known to be critical for the catalytic mechanism of the enzyme, was also implicated in supporting P-i mediated activation.	[Mazurkewich, Scott; Seah, Stephen Y. K.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada	University of Guelph	Seah, SYK (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	sseah@uoguelph.ca		Mazurkewich, Scott/0000-0002-9238-0615	Natural Science and Engineering Research Council of Canada [2015-05366]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Grant 2015-05366 from the Natural Science and Engineering Research Council of Canada (to S. Y. K. S.). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker P, 2009, BIOCHEMISTRY-US, V48, P6551, DOI 10.1021/bi9006644; Barry KP, 2013, BIOCHEMISTRY-US, V52, P6724, DOI 10.1021/bi400665t; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burmeister WP, 2000, J BIOL CHEM, V275, P39385, DOI 10.1074/jbc.M006796200; Chastain CJ, 2002, PLANT PHYSIOL, V128, P1368, DOI 10.1104/pp.010806; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; CUNNINGHAM BA, 1966, J AM CHEM SOC, V88, P551, DOI 10.1021/ja00955a029; Fish D. C., 1966, METHOD ENZYMOL, V9, P529; GRIFOLI M, 1995, APPL ENVIRON MICROB, V61, P3490, DOI 10.1128/AEM.61.9.3490-3493.1995; Hara H, 2003, J BACTERIOL, V185, P41, DOI 10.1128/JB.185.1.41-50.2003; Hara H, 2000, J BACTERIOL, V182, P6950, DOI 10.1128/JB.182.24.6950-6957.2000; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Hobbs ME, 2012, BIOCHEMISTRY-US, V51, P3497, DOI 10.1021/bi300307b; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; MARUYAMA K, 1990, J BIOCHEM-TOKYO, V108, P334, DOI 10.1093/oxfordjournals.jbchem.a123202; Masai E, 2000, J BACTERIOL, V182, P6651, DOI 10.1128/JB.182.23.6651-6658.2000; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; MATSUURA K, 1987, BIOCHIM BIOPHYS ACTA, V912, P270, DOI 10.1016/0167-4838(87)90097-5; Mazurkewich S, 2016, J BIOL CHEM, V291, P7669, DOI 10.1074/jbc.M115.682054; Mazurkewich S, 2014, BIOCHEMISTRY-US, V53, P542, DOI 10.1021/bi401486g; Nelson D, 2004, LEHNINGER PRINCIPLES, P497; Nogales J, 2005, J BIOL CHEM, V280, P35382, DOI 10.1074/jbc.M502585200; OKABAYASHI K, 1984, J BIOCHEM, V95, P1625, DOI 10.1093/oxfordjournals.jbchem.a134775; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rea D, 2008, BIOCHEMISTRY-US, V47, P9955, DOI 10.1021/bi800943g; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; Sakai H, 2004, J BIOCHEM, V136, P471, DOI 10.1093/jb/mvh152; Seo JS, 2007, BIODEGRADATION, V18, P123, DOI 10.1007/s10532-006-9048-8; SETZKE E, 1994, EUR J BIOCHEM, V220, P139, DOI 10.1111/j.1432-1033.1994.tb18608.x; Shikita M, 1999, BIOCHEM J, V341, P725, DOI 10.1042/0264-6021:3410725; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Suzuki K, 2008, J BIOCHEM, V144, P305, DOI 10.1093/jb/mvn069; TRENZ SP, 1994, J BACTERIOL, V176, P789, DOI 10.1128/jb.176.3.789-795.1994; VANBELLE H, 1976, CLIN CHEM, V22, P972; Wang WJ, 2008, FEBS LETT, V582, P3385, DOI 10.1016/j.febslet.2008.08.032; Wang WJ, 2010, J BIOL CHEM, V285, P36608, DOI 10.1074/jbc.M110.159509; Wang WJ, 2005, BIOCHEMISTRY-US, V44, P9447, DOI 10.1021/bi050607y; Wattiau P, 2001, RES MICROBIOL, V152, P861, DOI 10.1016/S0923-2508(01)01269-4	46	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164556	10.1371/journal.pone.0164556	http://dx.doi.org/10.1371/journal.pone.0164556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741265	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000043
J	Ahn, C; Lee, D; Lee, JH; Yang, H; An, BS; Jeung, EB				Ahn, Changhwan; Lee, Dongoh; Lee, Jae-Hwan; Yang, Hyun; An, Beum-Soo; Jeung, Eui-Bae			Calbindin-D9k Ablation Disrupt Glucose/Pancreatic Insulin Homeostasis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; APOPTOSIS; CALCIUM; SECRETION; PANCREAS; ISLETS; CELLS; MITOCHONDRIAL; RECEPTOR	It has been proposed that cellular Ca2+ signals activate hormone secretion. In pancreatic beta cells, which produce insulin, Ca2+ signals have been known to contribute to insulin secretion. Prior to this study, we confirmed that insulin-secreting beta cells express CaBP-9k, and assumed that CaBP-9k play a role in beta cell insulin synthesis or secretion. Using CaBP-9k knock out (KO) mice, we demonstrated that ablation of CaBP-9k causes reducing insulin secretion and increasing serum glucose. To compare the role of CaBP-9k with pathophysiological conditions, we exposed wild-type and CaBP-9k KO mice to hypoxic conditions for 10 days. Hypoxia induced endoplasmic reticulum (ER) stress, increasing both insulin signaling and insulin resistance. By exposing hypoxia, CaBP-9k KO mice showed an increased level of ER stress marker protein relative to wild type mice. Without hypoxic conditions, CaBP-9K ablation regulates calcium channels and causes ER stress in a CaBP-9K specific manner. Ablation of CaBP-9k also showed decreased levels of sulfonylurea receptor1 (SUR1) and inward-rectifier potassium ion channel 6.2 (K(ir)6.2), which are insulin secretion marker genes. Overall, the results of the present study demonstrated that CaBP-9k regulates synthesis of insulin and is part of the insulin-secreting calcium signaling.	[Ahn, Changhwan; Lee, Dongoh; Lee, Jae-Hwan; Yang, Hyun; Jeung, Eui-Bae] Chungbuk Natl Univ, Ctr Vet Med, Lab Vet Biochem & Mol Biol, Cheongju 28644, Chungbuk, South Korea; [Ahn, Changhwan; Lee, Dongoh; Lee, Jae-Hwan; Yang, Hyun; Jeung, Eui-Bae] Chungbuk Natl Univ, Coll Vet Med, Cheongju 28644, Chungbuk, South Korea; [An, Beum-Soo] Pusan Natl Univ, Coll Natl Resources & Life Sci, Dept Biomat Sci, Miryang 627706, Gyeongsangnam D, South Korea	Chungbuk National University; Chungbuk National University; Pusan National University	Jeung, EB (corresponding author), Chungbuk Natl Univ, Ctr Vet Med, Lab Vet Biochem & Mol Biol, Cheongju 28644, Chungbuk, South Korea.; Jeung, EB (corresponding author), Chungbuk Natl Univ, Coll Vet Med, Cheongju 28644, Chungbuk, South Korea.	ebjeung@chungbuk.ac.kr		Ahn, Changhwan/0000-0002-7176-7108	National Research Foundation of Korea (NRF) grant of Korean government (MEST) [2013-010514, 2015R1A6A1A04020885]	National Research Foundation of Korea (NRF) grant of Korean government (MEST)	This work was supported by the National Research Foundation of Korea (NRF) grant of Korean government (MEST) (No. 2013-010514 and 2015R1A6A1A04020885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C, 2015, MOL CELL ENDOCRINOL, V412, P302, DOI 10.1016/j.mce.2015.05.017; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Botta A, 2013, GENES-BASEL, V4, P275, DOI 10.3390/genes4020275; Bousette N, 2014, J CELL PHYSIOL, V229, P374, DOI 10.1002/jcp.24459; CHRISTAKOS S, 1979, BIOCHEM BIOPH RES CO, V89, P56, DOI 10.1016/0006-291X(79)90942-2; DEFRONZO RA, 1975, J CLIN INVEST, V55, P845, DOI 10.1172/JCI107996; FaureDussert AG, 1997, STEROIDS, V62, P554, DOI 10.1016/S0039-128X(97)00041-X; Herchuelz A, 2012, DIABETES OBES METAB, V14, P136, DOI 10.1111/j.1463-1326.2012.01649.x; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hong EJ, 2013, INT J MOL SCI, V14, P23330, DOI 10.3390/ijms141223330; Jiang L, 2010, J BIOL CHEM, V285, P30634, DOI 10.1074/jbc.M110.116681; Kang HS, 2014, J PHYSIOL PHARMACOL, V65, P273; Liang CP, 2012, DIABETES, V61, P2609, DOI 10.2337/db11-1415; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Ma ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067498; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; MUALLEM S, 1985, P NATL ACAD SCI USA, V82, P4433, DOI 10.1073/pnas.82.13.4433; PETERSEN OH, 1987, PHYSIOL REV, V67, P1054, DOI 10.1152/physrev.1987.67.3.1054; Ritzel RA, 2004, J CLIN ENDOCR METAB, V89, P795, DOI 10.1210/jc.2003-031120; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Yoo YM, 2009, J PINEAL RES, V47, P301, DOI 10.1111/j.1600-079X.2009.00714.x; Zeitz U, 2003, FASEB J, V17, P509, DOI 10.1096/fj.02-0424fje	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164527	10.1371/journal.pone.0164527	http://dx.doi.org/10.1371/journal.pone.0164527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736926	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800079
J	Andorsen, OF; Ahmed, LA; Emaus, N; Kleuman, E				Andorsen, Ole Fredrik; Ahmed, Luai Awad; Emaus, Nina; Kleuman, Elise			Musculoskeletal Complaints (Pain and/or Stiffness) and Their Impact on Mortality in the General Population. The Tromso Study	PLOS ONE			English	Article							WIDESPREAD BODY PAIN; FOLLOW-UP; EPIDEMIOLOGY; FIBROMYALGIA; RISK; PREVALENCE; BENEFITS; SMOKING; CANCER; COHORT	Background The long-term consequences of chronic pain and/or stiffness from the musculoskeletal system (musculoskeletal complaints: MSCs) have not been well explored. The aims of this study were to investigate whether MSCs reported at baseline influence all-cause and cause-specific mortality during 21 years follow-up of a general Northern Norwegian adult population. Methods A total of 26,977 men and women aged 25-97 years who participated in the 1994-1995 survey of the Tromso study (response rate 77%) were included in the present prospective cohort study. Baseline data were collected from the 1994-1995 survey and information on death and emigration was taken from the National Register of Norway. Cox regression analyses were performed to examine if MSCs predicted risk of mortality. Results 5693 (21.1%) participants died during follow-up. Mean time between entry into the survey and death or emigration was 18.6 years (standard deviation 4.87) for all-cause mortality. There was an increased risk of death among those with MSCs at baseline in the crude Cox regression model. However, the multivariable model revealed no significant association between MSCs at baseline and all-cause mortality by sex (women: hazard ratio [HR] = 0.93, 95% confidence interval [CI]: 0.85-1.01; men: HR = 0.93, 95% CI: 0.85-1.01). Furthermore, no significant associations were found between widespread MSCs at baseline and all-cause mortality in multivariable models (women: HR = 0.90, 95% CI: 0.80-1.01; men HR = 0.87, 95% CI: 0.76-1.00). Analyses on cause-specific mortality did not reveal any significant results. Conclusion MSCs are not independently associated with increased risk of death from cardiovascular disease, cancer, or death from all causes.	[Andorsen, Ole Fredrik; Kleuman, Elise] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Ahmed, Luai Awad; Emaus, Nina] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway; [Ahmed, Luai Awad] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; United Arab Emirates University	Andorsen, OF (corresponding author), Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway.	ole.anciorsen@yahoo.no	Ahmed, Luai A./J-7225-2013	Ahmed, Luai A./0000-0001-5292-8212	UiT - The Arctic University of Norway	UiT - The Arctic University of Norway	This study was funded by an internal grant from UiT - The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson HI, 2009, DISABIL REHABIL, V31, P1980, DOI 10.3109/09638280902874154; Andorsen Ole Fredrik, 2014, BMC Res Notes, V7, P506, DOI 10.1186/1756-0500-7-506; Asberg AN, 2016, PAIN, V157, P1443, DOI 10.1097/j.pain.0000000000000537; Bergman S, 2001, J RHEUMATOL, V28, P1369; Brage S, 2009, MEDISINSKE ARSAKER U; Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012; Dreyer L, 2010, ARTHRITIS RHEUM-US, V62, P3101, DOI 10.1002/art.27623; Eggen AE, 2013, SCAND J PUBLIC HEALT, V41, P65, DOI 10.1177/1403494812469851; Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602; Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001; Goodson NJ, 2013, PAIN, V154, P1595, DOI 10.1016/j.pain.2013.04.043; Hagen K, 2011, PAIN MED, V12, P1657, DOI 10.1111/j.1526-4637.2011.01240.x; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Jimenez-Sanchez S, 2010, J PAIN, V11, P612, DOI 10.1016/j.jpain.2009.09.015; Kvalheim S, 2013, PAIN, V154, P1073, DOI 10.1016/j.pain.2013.03.015; Macfarlane GJ, 2007, RHEUMATOLOGY, V46, P805, DOI 10.1093/rheumatology/kel403; Macfarlane GJ, 2001, BRIT MED J, V323, P662, DOI 10.1136/bmj.323.7314.662; McBeth J, 2009, RHEUMATOLOGY, V48, P74, DOI 10.1093/rheumatology/ken424; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; Morseth B, 2012, EUR J EPIDEMIOL, V27, P463, DOI 10.1007/s10654-012-9665-y; Nitter AK, 2013, SCAND J PAIN, V4, P86, DOI 10.1016/j.sjpain.2012.12.002; Sjogren P, 2010, CLIN J PAIN, V26, P763, DOI 10.1097/AJP.0b013e3181f15daf; Smith BH, 2003, BRIT J GEN PRACT, V53, P45; Smith D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099048; Sogaard AJ, 2003, NOR EPIDEMIOL, V13, P279, DOI DOI 10.5324/NJE.V13I2.296; Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2011, ARTHRIT CARE RES, V63, P94, DOI 10.1002/acr.20301	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164341	10.1371/journal.pone.0164341	http://dx.doi.org/10.1371/journal.pone.0164341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736952	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800053
J	Banar, M; Emaneini, M; Satarzadeh, M; Abdellahi, N; Beigverdi, R; van Leeuwen, WB; Jabalameli, F				Banar, Maryam; Emaneini, Mohammad; Satarzadeh, Mhboubeh; Abdellahi, Nafiseh; Beigverdi, Reza; van Leeuwen, Willem B.; Jabalameli, Fereshteh			Evaluation of Mannosidase and Trypsin Enzymes Effects on Biofilm Production of Pseudomonas aeruginosa Isolated from Burn Wound Infections	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANTI-BIOFILM; CYTOTOXICITY; MATRIX; ASSAY; DNASE	Biofilm is an important virulence factor in Pseudomonas aeruginosa and has a substantial role in antibiotic resistance and chronic burn wound infections. New therapeutic agents against P. aeruginosa, degrading biofilms in burn wounds and improving the efficacy of current antimicrobial agents, are required. In this study, the effects of alpha-mannosidase, beta-mannosidase and trypsin enzymes on the degradation of P. aeruginosa biofilms and on the reduction of ceftazidime minimum biofilm eliminating concentrations (MBEC) were evaluated. All tested enzymes, destroyed the biofilms and reduced the ceftazidime MBECs. However, only trypsin had no cytotoxic effect on A-431 human epidermoid carcinoma cell lines. In conclusion, since trypsin had better features than mannosidase enzymes, it can be a promising agent in combatting P. aeruginosa burn wound infections.	[Banar, Maryam; Emaneini, Mohammad; Abdellahi, Nafiseh; Beigverdi, Reza; Jabalameli, Fereshteh] Univ Tehran Med Sci, Sch Med, Dept Microbiol, Tehran, Iran; [Satarzadeh, Mhboubeh] Shahid Motahari Burns Hosp, Microbiol Lab, Tehran, Iran; [van Leeuwen, Willem B.] Univ Appl Sci, Erasmus Med Ctr, Dept Med Microbiol & Infect Dis, Leiden, Netherlands	Tehran University of Medical Sciences; Erasmus University Rotterdam; Erasmus MC	Jabalameli, F (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Microbiol, Tehran, Iran.	jabalamf@tums.ac.ir	Emaneini, Mohammad/AAB-1003-2019; Emaneini, Mohammad/K-3545-2016	Emaneini, Mohammad/0000-0002-0208-7264; Emaneini, Mohammad/0000-0002-0208-7264	Tehran University of Medical Sciences and Health Services;  [25137/93-01-30]	Tehran University of Medical Sciences and Health Services(Tehran University of Medical Sciences); 	This research has been supported by Tehran University of Medical Sciences and Health Services. Study grant no: 25137/93-01-30.	Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43; Anvarinejad M, 2014, ARCH TRAUMA RES, V3, DOI 10.5812/atr.18182; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Douglas MW, 2001, BURNS, V27, P131, DOI 10.1016/S0305-4179(00)00084-X; Ghadaksaz A, 2015, J APPL BIOMED, V13, P61, DOI 10.1016/j.jab.2014.05.002; Jabalameli F, 2012, BURNS, V38, P1192, DOI 10.1016/j.burns.2012.07.030; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kimura Y, 1999, EUR J BIOCHEM, V264, P168, DOI 10.1046/j.1432-1327.1999.00598.x; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Velazquez-Velazquez JL, 2015, MAT SCI ENG C-MATER, V49, P604, DOI 10.1016/j.msec.2014.12.084; Martins M, 2012, MYCOSES, V55, P80, DOI 10.1111/j.1439-0507.2011.02047.x; MCCLEARY BV, 1983, CARBOHYD RES, V119, P191, DOI 10.1016/0008-6215(83)84056-7; Metcalf DG, 2013, BURNS TRAUMA, V1, DOI 10.4103/2321-3868.113329; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Nidadavolu P, 2012, J MED MICROBIOL, V61, P662, DOI 10.1099/jmm.0.038638-0; Nikokar I, 2013, IRAN J MICROBIOL, V5, P36; Payne Wyatt G, 2008, Eplasty, V8, pe17; Pettit RK, 2005, ANTIMICROB AGENTS CH, V49, P2612, DOI 10.1128/AAC.49.7.2612-2617.2005; Rafla K, 2011, BURNS, V37, P5, DOI 10.1016/j.burns.2009.06.198; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; Roy V, 2013, APPL MICROBIOL BIOT, V97, P2627, DOI 10.1007/s00253-012-4404-6; Sepandj F, 2004, PERITON DIALYSIS INT, V24, P65; Sharma G, 2014, BIOLOGICALS, V42, P1, DOI 10.1016/j.biologicals.2013.11.001; Taylor PK, 2014, J BIOTECHNOL, V191, P121, DOI 10.1016/j.jbiotec.2014.09.003; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Turner KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004518; Vasiljevic Z, 2014, ARCH BIOL SCI, V66, P117, DOI 10.2298/ABS1401117V; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; Zaranza AV, 2013, ANTIMICROBIAL SUSCEP	31	38	38	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164622	10.1371/journal.pone.0164622	http://dx.doi.org/10.1371/journal.pone.0164622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736961	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800099
J	Bortolotto, GA; Danilewicz, D; Andriolo, A; Secchi, ER; Zerbini, AN				Bortolotto, Guilherme A.; Danilewicz, Daniel; Andriolo, Artur; Secchi, Eduardo R.; Zerbini, Alexandre N.			Whale, Whale, Everywhere: Increasing Abundance of Western South Atlantic Humpback Whales (Megaptera novaeangliae) in Their Wintering Grounds	PLOS ONE			English	Article							VITORIA-TRINDADE CHAIN; SPATIAL MODELS; AERIAL SURVEYS; WATERS; COAST; CONSERVATION	The western South Atlantic (WSA) humpback whale population inhabits the coast of Brazil during the breeding and calving season in winter and spring. This population was depleted to near extinction by whaling in the mid-twentieth century. Despite recent signs of recovery, increasing coastal and offshore development pose potential threats to these animals. Therefore, continuous monitoring is needed to assess population status and support conservation strategies. The aim of this work was to present ship-based line-transect estimates of abundance for humpback whales in their WSA breeding ground and to investigate potential changes in population size. Two cruises surveyed the coast of Brazil during August-September in 2008 and 2012. The area surveyed in 2008 corresponded to the currently recognized population breeding area; effort in 2012 was limited due to unfavorable weather conditions. WSA humpback whale population size in 2008 was estimated at 16,410 (CV = 0.228, 95% CI = 10,563-25,495) animals. In order to compare abundance between 2008 and 2012, estimates for the area between Salvador and Cabo Frio, which were consistently covered in the two years, were computed at 15,332 (CV = 0.243, 95% CI = 9,595-24,500) and 19,429 (CV = 0.101, 95% CI = 15,958-23,654) whales, respectively. The difference in the two estimates represents an increase of 26.7% in whale numbers in a 4-year period. The estimated abundance for 2008 is considered the most robust for the WSA humpback whale population because the ship survey conducted in that year minimized bias from various sources. Results presented here indicate that in 2008, the WSA humpback whale population was at least around 60% of its estimated pre-modern whaling abundance and that it may recover to its pre-exploitation size sooner than previously estimated.	[Bortolotto, Guilherme A.; Danilewicz, Daniel] Univ Estadual Santa Cruz, Posgrad Zool, BR-45662900 Ilheus, BA, Brazil; [Bortolotto, Guilherme A.; Danilewicz, Daniel; Andriolo, Artur; Zerbini, Alexandre N.] Inst Aqualie, Av Dr Paulo Japiassu Coelho 714,Sala 202, BR-36033310 Juiz De Fora, MG, Brazil; [Bortolotto, Guilherme A.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit SMRU, St Andrews KY16 8LB, Fife, Scotland; [Danilewicz, Daniel] GEMARS, Av Tramandai 976, BR-95625000 Imbe, RS, Brazil; [Andriolo, Artur] Univ Fed Juiz De Fora, Inst Ciencias Biol, Dept Zool, Lab Ecol Comportamental & Bioacost LABEC, BR-36036900 Juiz De Fora, MG, Brazil; [Secchi, Eduardo R.] Univ Fed Rio Grande, Inst Oceanog, Lab Ecol & Conservacao Megafauna Marinha EcoMega, Av Italia,Km 8, BR-96203900 Rio Grande, RS, Brazil; [Zerbini, Alexandre N.] NOAA Fisheries, Alaska Fisheries Sci Ctr, Marine Mammal Lab, 7600 Sand Point Way NE, Seattle, WA 98115 USA; [Zerbini, Alexandre N.] Cascadia Res Collect, 218 1-2 4th Ave W, Olympia, WA 98501 USA	Universidade Estadual de Santa Cruz; University of St Andrews; Universidade Federal de Juiz de Fora; Universidade Federal do Rio Grande; National Oceanic Atmospheric Admin (NOAA) - USA	Bortolotto, GA (corresponding author), Univ Estadual Santa Cruz, Posgrad Zool, BR-45662900 Ilheus, BA, Brazil.; Bortolotto, GA (corresponding author), Inst Aqualie, Av Dr Paulo Japiassu Coelho 714,Sala 202, BR-36033310 Juiz De Fora, MG, Brazil.; Bortolotto, GA (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit SMRU, St Andrews KY16 8LB, Fife, Scotland.	bartolotto.vet@gmail.com	Bortolotto, Guilherme Augusto/AAC-6615-2019; Danilewicz, Daniel/O-5024-2014; Andriolo, Artur/K-5624-2013; Secchi, Eduardo R./ABF-1191-2020; Zerbini, Alexandre/ABH-3916-2020	Bortolotto, Guilherme Augusto/0000-0002-5343-6575; Andriolo, Artur/0000-0002-5582-0183; Secchi, Eduardo R./0000-0001-9087-9909; Zerbini, Alexandre/0000-0002-9776-6605	Whale Satellite Monitoring Project (Projeto Monitoramento de Baleias por Satellite, PMBS); Cetacean Society International; Conselho Nacional para Desenvolvimento Cientifico e Tecnologico (CNPq, Brazilian Science, Technology and Innovation Ministry) [311474/2013-6, 307843/2014-0]; National Research Council, National Academies of Sciences, Engineering, and Medicine	Whale Satellite Monitoring Project (Projeto Monitoramento de Baleias por Satellite, PMBS); Cetacean Society International; Conselho Nacional para Desenvolvimento Cientifico e Tecnologico (CNPq, Brazilian Science, Technology and Innovation Ministry)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Research Council, National Academies of Sciences, Engineering, and Medicine	Shell Brasil (http://www.shell.com.br/) sponsored the Whale Satellite Monitoring Project (Projeto Monitoramento de Baleias por Satellite, PMBS; http://www.aqualie.org.br/2013/projetos/home-pmbs/) research cruises. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; http://www.capes.gov.br/) provided GAB with a scholarship during his master's studies. Cetacean Society International (http://csiwhalesalive.org/) awarded GAB with a small grant during the development of this work. Conselho Nacional para Desenvolvimento Cientifico e Tecnologico (CNPq, Brazilian Science, Technology and Innovation Ministry; http://cnpq.br/) provided Research Fellowships to AA (#311474/2013-6) and ERS (#307843/2014-0). ANZ was funded by National Research Council, National Academies of Sciences, Engineering, and Medicine (http://www.nationalacademies.org/nrc/) during the 2008 cruise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriolo A., 2006, Journal of Cetacean Research and Management, V8, P307; Andriolo A, 2014, ZOOLOGIA-CURITIBA, V31, P105, DOI 10.1590/S1984-46702014000200001; Andriolo Artur, 2010, Endangered Species Research, V11, P233, DOI 10.3354/esr00282; Angliss R.P., 2005, NOAA TECHNICAL MEMOR; Barlow J, 1997, ECOLOGY, V78, P535; BARLOW J, 1996, NMFSSWFSC233 NOAA; Bezamat C, 2015, AQUAT CONSERV, V25, P712, DOI 10.1002/aqc.2523; Bortolotto GA, 2016, ZOOL, V33, P1; Bortolotto GA, 2016, MAR BIODIVERS REC MA, P9; Brasil. Ministe A rio de Minas e Energia, NAC PETR GAS NAT BIO; BROWN MR, 1995, P ROY SOC B-BIOL SCI, V259, P229, DOI 10.1098/rspb.1995.0034; Buckland S.T., 2001, pi; Buckland ST, 2015, METH STAT ECOL, P1, DOI 10.1007/978-3-319-19219-2; Burnham KP, 1987, AM FISHERIES SOC MON; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J, 2008, AB133F03RP0078 US DE; Cartwright R, 2012, PLOS ONE, P7; Childerhouse S, 2008, IUCN RED LIST THREAT; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Clapham Phillip J., 1999, Mammalian Species, V604, P1; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Craig AS, 2014, BEHAVIOUR, V151, P613, DOI 10.1163/1568539X-00003151; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; Danilewicz Daniel, 2009, Marine Biodiversity Records, V2, pe88, DOI 10.1017/S1755267209000943; Engel MH, 2009, MAR MAMMAL SCI, V25, P964, DOI 10.1111/j.1748-7692.2009.00301.x; Findlay KP., 2000, MEM QUEENSL MUSEUM, V47, P411; Freitas Ana C., 2004, Journal of Cetacean Research and Management, V6, P225; Grunkorn T, 2004, P WORKSH EST G 0 LIN, P26; Hammond Philip S., 2010, P42; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Heide-Jorgensen M. P., 2008, Journal of Cetacean Research and Management, V10, P119; IWC, 2007, ANN REP INT WHAL COM; Kinas PG, 1998, 48 INT WHAL COMM, V48; Laake JL, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P108; Lerczak JA, 1998, MAR MAMMAL SCI, V14, P590, DOI 10.1111/j.1748-7692.1998.tb00745.x; Lodi L., 1994, BIOTEMAS, V7, P123; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Martins CCA, 2013, OCEAN COAST MANAGE, V75, P63, DOI 10.1016/j.ocecoaman.2013.02.006; Martins CCA., 2001, MEMOIRS QUEENSLAND M, V47, P563; Meirelles ACO, 2009, J MAR BIOL ASSOC UK, V89, P1083, DOI 10.1017/S0025315409002215; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Mobley J., 2001, REPORT HAWAIIAN ISLA, V9; Morais IOB, 2016, MAMM REV; Pavanato HJ, 2013, ABUNDANCIA DISTRIBUI; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; Pomilla C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114162; Pretto DJ, 2009, BRAZ J BIOL, V69, P1207, DOI 10.1590/S1519-69842009000500029; Reilly SB, 2008, IUCN RED LIST THREAT; Rocha-Campos CC, 2011, SERIE ESPECIES AMEAC, V14; Siciliano S, 2011, 63 INT WHAL COMM, V63; Siciliano S, 2012, BRAZ J OCEANOGR, V60, P455, DOI 10.1590/S1679-87592012000300016; Stevick PT, 2003, MAR ECOL PROG SER, V258, P263, DOI 10.3354/meps258263; Strindberg S, 2004, J AGR BIOL ENVIR ST, V9, P443, DOI 10.1198/108571104X15601; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thomas PO, 2016, MAR MAMMAL SCI, V32, P682, DOI 10.1111/mms.12281; Tonnessen JN., 1982, HIST MODERN WHALING; Ward Eric, 2011, Journal of Cetacean Research and Management, P145; Wedekin LL, 2014, BRAZ J BIOL, V74, P137, DOI 10.1590/1519-6984.21812; Wedekin LL, 2011, ECOLOGIA POPULACIONA; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zerbini Alexandre N., 2004, Journal of Cetacean Research and Management, V6, P101; Zerbini Alexandre N., 2011, Journal of Cetacean Research and Management, P131; Zerbini AN, 2010, MAR BIOL, V157, P1225, DOI 10.1007/s00227-010-1403-y; Zerbini AN, 1998, 48 INT WHAL COMM, V48	65	23	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164596	10.1371/journal.pone.0164596	http://dx.doi.org/10.1371/journal.pone.0164596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736958	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800094
J	Popko, J; Herrfurth, C; Feussner, K; Ischebeck, T; Iven, T; Haslam, R; Hamilton, M; Sayanova, O; Napier, J; Khozin-Goldberg, I; Feussner, I				Popko, Jennifer; Herrfurth, Cornelia; Feussner, Kirstin; Ischebeck, Till; Iven, Tim; Haslam, Richard; Hamilton, Mary; Sayanova, Olga; Napier, Jonathan; Khozin-Goldberg, Inna; Feussner, Ivo			Metabolome Analysis Reveals Betaine Lipids as Major Source for Triglyceride Formation, and the Accumulation of Sedoheptulose during Nitrogen-Starvation of Phaeodactylum tricornutum	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; MASS-SPECTROMETRY; ACYL-COENZYME; FATTY-ACIDS; MICROALGAE; BIOSYNTHESIS; STRESS; EVOLUTION; DIATOMS; PATHWAY	Oleaginous microalgae are considered as a promising resource for the production of biofuels. Especially diatoms arouse interest as biofuel producers since they are most productive in carbon fixation and very flexible to environmental changes in the nature. Naturally, triacylglycerol (TAG) accumulation in algae only occurs under stress conditions like nitrogenlimitation. We focused on Phaeodactylum strain Pt4 (UTEX 646), because of its ability to grow in medium with low salinity and therefore being suited when saline water is less available or for wastewater cultivation strategies. Our data show an increase in neutral lipids during nitrogen-depletion and predominantly 16: 0 and 16: 1(n-7) accumulated in the TAG fraction. The molecular species composition of TAG suggests a remodeling primarily from the betaine lipid diacylglyceroltrimethylhomoserine (DGTS), but a contribution of the chloroplast galactolipid monogalactosyldiacylglycerol (MGDG) cannot be excluded. Interestingly, the acyl-CoA pool is rich in 20: 5(n-3) and 22: 6(n-3) in all analyzed conditions, but these fatty acids are almost excluded from TAG. Other metabolites most obviously depleted under nitrogen-starvation were amino acids, lyso-phospholipids and tricarboxylic acid (TCA) cycle intermediates, whereas sulfur-containing metabolites as dimethylsulfoniopropionate, dimethylsulfoniobutyrate and methylsulfate as well as short acyl chain carnitines, propanoyl-carnitine and butanoyl-carnitine increased upon nitrogen-starvation. Moreover, the Calvin cycle may be de-regulated since sedoheptulose accumulated after nitrogen-depletion. Together the data provide now the basis for new strategies to improve lipid production and storage in Phaeodactylum strain Pt4.	[Popko, Jennifer; Herrfurth, Cornelia; Feussner, Kirstin; Ischebeck, Till; Iven, Tim; Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst Plant Sci, Justus von Liebig Weg 11, D-37077 Gottingen, Germany; [Haslam, Richard; Hamilton, Mary; Sayanova, Olga; Napier, Jonathan] Rothamsted Res, Biol Chem, Harpenden AL5 2JQ, Herts, England; [Khozin-Goldberg, Inna] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Microalgal Biotechnol Lab, Midreshet Ben Gurion, Israel; [Feussner, Ivo] Univ Gottingen, Goettingen Ctr Mol Biosci GZMB, Dept Plant Biochem, D-37077 Gottingen, Germany; [Feussner, Ivo] Univ Gottingen, ICASEC, Dept Plant Biochem, D-37077 Gottingen, Germany	University of Gottingen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Ben Gurion University; University of Gottingen; University of Gottingen	Feussner, I (corresponding author), Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst Plant Sci, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ifeussn@uni-goettingen.de	Khozin-Goldberg, Inna/F-2300-2012; Feussner, Ivo/H-9320-2013; Ischebeck, Till/AAM-4327-2020	Khozin-Goldberg, Inna/0000-0001-8618-0687; Feussner, Ivo/0000-0002-9888-7003; Ischebeck, Till/0000-0003-0737-3822; Napier, Johnathan/0000-0003-3580-3607; Haslam, Richard/0000-0001-6226-5643; Sayanova, Olga/0000-0002-8484-2322	European Commission's Seventh Framework Program for Research and Technology Development (FP7), project GIAVAP [266401]; BBSRC [BB/N010388/1, BBS/E/C/00005207] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005207, BB/N010388/1] Funding Source: researchfish	European Commission's Seventh Framework Program for Research and Technology Development (FP7), project GIAVAP; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was financially supported by the European Commission's Seventh Framework Program for Research and Technology Development (FP7), project GIAVAP, grant no. 266401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abida H, 2015, PLANT PHYSIOL, V167, P118, DOI 10.1104/pp.114.252395; Alipanah L, 2015, J EXP BOT, V66, P6281, DOI 10.1093/jxb/erv340; Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Allen JW, 2015, ALGAL RES, V10, P110, DOI 10.1016/j.algal.2015.04.019; Armada I, 2013, PHYTOCHEMISTRY, V95, P224, DOI 10.1016/j.phytochem.2013.07.024; Bellaire A, 2014, NEW PHYTOL, V202, P322, DOI 10.1111/nph.12631; Borowitzka MA, 2013, MITIG ADAPT STRAT GL, V18, P13, DOI 10.1007/s11027-010-9271-9; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Bromke MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138965; Bromke MA, 2015, PLANT J, V81, P529, DOI 10.1111/tpj.12739; Bromke MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067340; Bucciarelli E, 2003, LIMNOL OCEANOGR, V48, P2256, DOI 10.4319/lo.2003.48.6.2256; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Ceusters J, 2013, J EXP BOT, V64, P1497, DOI 10.1093/jxb/ert010; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; Danielewicz MA, 2011, J LIPID RES, V52, P2101, DOI 10.1194/jlr.D018408; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; Dembitsky VM, 1996, PROG LIPID RES, V35, P1, DOI 10.1016/0163-7827(95)00009-7; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Gebser B, 2013, MAR DRUGS, V11, P2168, DOI 10.3390/md11062168; GIROUD C, 1988, PLANT CELL PHYSIOL, V29, P587; Gong YM, 2013, FEBS LETT, V587, P481, DOI 10.1016/j.febslet.2013.01.015; Guiheneuf F, 2011, FEBS J, V278, P3651, DOI 10.1111/j.1742-4658.2011.08284.x; Guschina IA, 2013, ALGAE BIOFUELS ENERG, P17, DOI DOI 10.1016/j.aquaculture.2012.04.028; Guschina IA, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2_1; Hamilton ML, 2014, METAB ENG, V22, P3, DOI 10.1016/j.ymben.2013.12.003; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Hildebrand M, 2012, BIOFUELS-UK, V3, P221, DOI 10.4155/bfs.11.157; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hornung E, 2002, EUR J BIOCHEM, V269, P4852, DOI 10.1046/j.1432-1033.2002.03184.x; James GO, 2011, BIORESOURCE TECHNOL, V102, P3343, DOI 10.1016/j.biortech.2010.11.051; Kaever A, 2015, METABOLOMICS, V11, P764, DOI 10.1007/s11306-014-0734-y; Kaever A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-92; Kim J, 2016, PLANT J, V85, P161, DOI 10.1111/tpj.13081; Kim SH, 2015, J AGR FOOD CHEM, V63, P880, DOI 10.1021/jf502967k; Konig S, 2014, NEW PHYTOL, V202, P823, DOI 10.1111/nph.12709; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Legeret B, 2016, PLANT CELL ENVIRON, V39, P834, DOI 10.1111/pce.12656; Lenky CC, 2012, ANAL BIOCHEM, V420, P7, DOI 10.1016/j.ab.2011.09.013; Levitan O, 2014, TRENDS BIOTECHNOL, V32, P117, DOI 10.1016/j.tibtech.2014.01.004; Li S, 2014, AQUACULTURE, V428, P104, DOI 10.1016/j.aquaculture.2014.02.032; Li-Beisson Y, 2013, OCL OILS FAT CROP LI, V20, DOI 10.1051/ocl/2013031; Liu BS, 2013, CURR OPIN BIOTECH, V24, P300, DOI 10.1016/j.copbio.2012.08.008; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Canavate JP, 2016, PHYTOCHEMISTRY, V124, P68, DOI 10.1016/j.phytochem.2016.02.007; QIAN KX, 1993, APPL BIOCHEM BIOTECH, V38, P93; Rashed MS, 1997, CLIN CHEM, V43, P1129; Reich M, 2009, NEW PHYTOL, V182, P950, DOI 10.1111/j.1469-8137.2009.02819.x; Rezanka T, 2014, PHYTOCHEMISTRY, V100, P34, DOI 10.1016/j.phytochem.2014.01.017; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Rohn H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-139; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; Solovchenko A. E., 2008, Moscow University Biological Sciences Bulletin, V63, P44; Solovchenko AE, 2009, J APPL PHYCOL, V21, P361, DOI 10.1007/s10811-008-9377-6; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Xue J, 2015, METAB ENG, V27, P1, DOI 10.1016/j.ymben.2014.10.002; Yang ZK, 2014, J APPL PHYCOL, V26, P73, DOI 10.1007/s10811-013-0050-3; Zhekisheva M, 2002, J PHYCOL, V38, P325, DOI 10.1046/j.1529-8817.2002.01107.x; Zienkiewicz K, 2016, BBA-MOL CELL BIOL L, V1861, P1269, DOI 10.1016/j.bbalip.2016.02.008	60	48	50	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164673	10.1371/journal.pone.0164673	http://dx.doi.org/10.1371/journal.pone.0164673			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736949	Green Published, gold			2022-12-27	WOS:000385505800110
J	Reyer, H; Ponsuksili, S; Kanitz, E; Pohland, R; Wimmers, K; Murani, E				Reyer, Henry; Ponsuksili, Siriluck; Kanitz, Ellen; Poehland, Ralf; Wimmers, Klaus; Murani, Eduard			A Natural Mutation in Helix 5 of the Ligand Binding Domain of Glucocorticoid Receptor Enhances Receptor-Ligand Interaction	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTOR; CORTICOSTEROID RECEPTORS; MOLECULAR-GRAPHICS; LIMBIC AREAS; EVOLUTION; HORMONE; STRESS; PROGESTERONE; PROTEINS; PIGS	The glucocorticoid receptor (GR) is a central player in the neuroendocrine stress response; it mediates feedback regulation of the hypothalamus-pituitary-adrenal (HPA) axis and physiological actions of glucocorticoids in the periphery. Despite intensive investigations of GR in the context of receptor-ligand interaction, only recently the first naturally occurring gain-of-function substitution, Ala610Val, of the ligand binding domain was identified in mammals. We showed that this mutation underlies a major quantitative trait locus for HPA axis activity in pigs, reducing cortisol production by about 40-50 percent. To unravel the molecular mechanisms behind this gain of function, receptor-ligand interactions were evaluated in silico, in vitro and in vivo. In accordance with previously observed phenotypic effects, the mutant Val610 GR showed significantly increased activation in response to glucocorticoid and non-glucocorticoid steroids, and, as revealed by GR-binding studies in vitro and in pituitary glands, enhanced ligand binding. Concordantly, the protein structure prediction depicted reduced binding distances between the receptor and ligand, and altered interactions in the ligand binding pocket. Consequently, the Ala610Val substitution opens up new structural information for the design of potent GR ligands and to examine effects of the enhanced GR responsiveness to glucocorticoids on the entire organism.	[Reyer, Henry; Ponsuksili, Siriluck; Wimmers, Klaus; Murani, Eduard] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Kanitz, Ellen] Leibniz Inst Farm Anim Biol FBN, Inst Behav Physiol, Dummerstorf, Germany; [Poehland, Ralf] Leibniz Inst Farm Anim Biol FBN, Inst Reprod Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Murani, E (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany.	murani@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020	Pohland, Ralf/0000-0003-2521-6126; Wimmers, Klaus/0000-0002-9523-6790	Federal Ministry of Education and Research (BMBF) as part of the PHENOMICS project [0315536F]; Leibniz Institute for Farm Animal Biology (FBN)	Federal Ministry of Education and Research (BMBF) as part of the PHENOMICS project; Leibniz Institute for Farm Animal Biology (FBN)	This work was partly funded by the Federal Ministry of Education and Research (BMBF; www.brnbf.de) as part of the PHENOMICS project (supportcode: 0315536F; www.phaenomics.auf.uni-rostock.de). The Leibniz Institute for Farm Animal Biology (FBN) provided own matched funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM GE, 1971, J CLIN ENDOCR METAB, V32, P619, DOI 10.1210/jcem-32-5-619; Attardi BJ, 2002, MOL CELL ENDOCRINOL, V188, P111, DOI 10.1016/S0303-7207(01)00743-2; Bledsoe RK, 2004, VITAM HORM, V68, P49; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Boonyaratanakornkit BB, 2002, BBA-PROTEIN STRUCT M, V1595, P235, DOI 10.1016/S0167-4838(01)00347-8; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Carroll SM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002117; Carson MW, 2014, J MED CHEM, V57, P849, DOI 10.1021/jm401616g; Charmandari E, 2010, EUR J CLIN INVEST, V40, P932, DOI 10.1111/j.1365-2362.2010.02336.x; Chittavong M, 2013, TROP ANIM HEALTH PRO, V45, P1477, DOI 10.1007/s11250-013-0385-4; de Carvalho AP, 2004, KIDNEY INT, V65, P403, DOI 10.1111/j.1523-1755.2004.00392.x; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; He YZ, 2014, CELL RES, V24, P713, DOI 10.1038/cr.2014.52; Henderson TA, 2003, J CLIN ENDOCR METAB, V88, P440, DOI 10.1210/jc.2002-021174; Kanitz E, 1998, BRAIN RES, V804, P311, DOI 10.1016/S0006-8993(98)00712-4; Kanitz E, 2003, J VET MED A, V50, P132, DOI 10.1046/j.1439-0442.2003.00513.x; Kino T, 2001, J CLIN ENDOCR METAB, V86, P5600, DOI 10.1210/jc.86.11.5600; Kohn JA, 2012, J BIOL CHEM, V287, P16267, DOI 10.1074/jbc.M112.346411; Liu YF, 2015, J NANOMATER, V2015, DOI 10.1155/2015/792095; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murani E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045518; Rosmond R, 2000, OBES RES, V8, P211, DOI 10.1038/oby.2000.24; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Seitz T, 2010, J MOL BIOL, V403, P562, DOI 10.1016/j.jmb.2010.08.048; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; SZEFLER SJ, 1986, EUR J CLIN PHARMACOL, V30, P323, DOI 10.1007/BF00541537; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; von Langen J, 2005, CHEMBIOCHEM, V6, P1110, DOI 10.1002/cbic.200400361; WARRIAR N, 1994, J BIOL CHEM, V269, P29010; Zhang JH, 2005, P NATL ACAD SCI USA, V102, P2707, DOI 10.1073/pnas.0409663102; Zhang JH, 2009, J BIOL CHEM, V284, P6249, DOI 10.1074/jbc.M807997200	40	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164628	10.1371/journal.pone.0164628	http://dx.doi.org/10.1371/journal.pone.0164628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736993	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800100
J	Rutherford, GW; Horvath, H				Rutherford, George W.; Horvath, Hacsi			Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review	PLOS ONE			English	Review							ONCE-DAILY DOLUTEGRAVIR; NAIVE ADULTS; DOUBLE-BLIND; INFECTION; SAFETY; RALTEGRAVIR; RESISTANCE; EFFICACY	Background Dolutegravir (DTG) is a once-daily unboosted second-generation integrase-inhibitor that along with two nucleoside reverse transcriptase inhibitors is one of several regimens recommended by the United States, United Kingdom and European Union for first-line antiretroviral treatment of people with HIV infection. Our objective was to review the evidence for the efficacy and safety of DTG-based first-line regimens compared to efavirenz (EFV)based regimens. Methods We conducted a systematic review. We comprehensively searched a range of databases as well as conference abstracts and a trials registry. We used Cochrane methods in screening and data collection and assessed each study's risk of bias with the Cochrane tool. We meta-analyzed data using a fixed-effects model. We used GRADE to assess evidence quality. Results From 492 search results, we identified two randomized controlled trials, reported in five peer-reviewed articles and one conference abstract. One trial tested two DTG-based regimens (DTG+ abacavir (ABC)+ lamivudine (3TC) or DTG + tenofovir + emtricitabine) against an EFV-based regimen (EFV+ABC+3TC). The other trial tested DTG+ABC+3TC against EFV+ABC+3TC. In meta-analysis, DTG-containing regimens were superior to EFV-containing regimens at 48 weeks and at 96 weeks (RR = 1.10, 95% CI 1.04-1.16; and RR = 1.12, 95% CI 1.04-1.21, respectively). In one trial, the DTG-containing regimen was superior at 144 weeks (RR = 1.13, 95% CI 1.02-1.24). DTG-containing regimens were superior in reducing treatment discontinuation compared to those containing EFV at 96 weeks and at 144 weeks (RR = 0.27, 95% CI 0.15-0.50; and RR = 0.28, 95% CI 0.16-0.48, respectively). Risk of serious adverse events was similar in each regimen at 96 weeks (RR = 1.15, 95% CI 0.80-1.63) and 144 weeks (RR = 0.93, 95% CI 0.68-1.29). Risk of bias was moderate overall, as was GRADE evidence quality. Conclusions DTG-based regimens should be considered in future World Health Organization guidelines for initial HIV treatment.	[Rutherford, George W.; Horvath, Hacsi] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rutherford, GW (corresponding author), Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA.	george.rutherford@ucsf.edu		Horvath, Hacsi/0000-0001-7569-3524	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		British HIV Association (BHIVA), 2015, BHIVA GUID TREATM HI; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Curtis L, 2014, HIV CLIN TRIALS, V15, P199, DOI 10.1310/hct1505-199; European AIDS Clinical Society, 2015, GUID 8 0; Ford N, 2015, JAIDS-J ACQ IMM DEF, V69, P422, DOI 10.1097/QAI.0000000000000606; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Kandel CE, 2015, DRUG DES DEV THER, V9, P3547, DOI 10.2147/DDDT.S84850; Llibre JM, 2015, AIDS REV, V17, P56; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Raffi F, 2015, AIDS, V29, P167, DOI 10.1097/QAD.0000000000000519; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Sinclair D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063715; Stellbrink HJ, 2013, AIDS, V27, P1771, DOI 10.1097/QAD.0b013e3283612419; Taha H, 2015, INFECT DRUG RESIST, V8, P339, DOI 10.2147/IDR.S68396; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Walmsley S, 2014, 21 C RETR OPP INF BO; Walmsley S, 2015, JAIDS-J ACQ IMM DEF, V70, P515, DOI 10.1097/QAI.0000000000000790; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Weinberg MA, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00090; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2014, WHO HDB GUID DEV, V2nd	25	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0162775	10.1371/journal.pone.0162775	http://dx.doi.org/10.1371/journal.pone.0162775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736859	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800005
J	Ruttle, JE; Cressman, EK; 't Hart, BM; Henriques, DYP				Ruttle, Jennifer E.; Cressman, Erin K.; 't Hart, Bernard Marius; Henriques, Denise Y. P.			Time Course of Reach Adaptation and Proprioceptive Recalibration during Visuomotor Learning	PLOS ONE			English	Article							MOTOR WORKING-MEMORY; SENSORIMOTOR ADAPTATION; INTERFERENCE; TRANSFORMATIONS; EXPLICIT; CONSOLIDATION; LOCALIZATION; DISTORTIONS; PLASTICITY; INPUT	Training to reach with rotated visual feedback results in adaptation of hand movements, which persist when the perturbation is removed (reach aftereffects). Training also leads to changes in felt hand position, which we refer to as proprioceptive recalibration. The rate at which motor and proprioceptive changes develop throughout training is unknown. Here, we aim to determine the timescale of these changes in order to gain insight into the processes that may be involved in motor learning. Following six rotated reach training trials (30 degrees rotation), at three radially located targets, we measured reach aftereffects and perceived hand position (proprioceptive guided reaches). Participants trained with opposing rotations one week apart to determine if the original training led to any retention or interference. Results suggest that both motor and proprioceptive recalibration occurred in as few as six rotated-cursor training trials (7.57 degrees & 3.88 degrees E respectively), with no retention or interference present one week after training. Despite the rapid speed of both motor and sensory changes, these shifts do not saturate to the same degree. Thus, different processes may drive these changes and they may not constitute a single implicit process.	[Ruttle, Jennifer E.; 't Hart, Bernard Marius; Henriques, Denise Y. P.] York Univ, Ctr Vis Res, Toronto, ON, Canada; [Ruttle, Jennifer E.; Henriques, Denise Y. P.] York Univ, Dept Psychol, Toronto, ON, Canada; [Henriques, Denise Y. P.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Cressman, Erin K.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada	York University - Canada; York University - Canada; York University - Canada; University of Ottawa	Ruttle, JE (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.; Ruttle, JE (corresponding author), York Univ, Dept Psychol, Toronto, ON, Canada.	jennruttle@gmail.com	't Hart, Bernard/AHD-9519-2022	't Hart, Bernard/0000-0002-0045-3769; Ruttle, Jennifer/0000-0002-6610-2662	German Research Foundation (DFG) [HA 6861/2-1]; NSERC Operating grant (DYPH and EKC)	German Research Foundation (DFG)(German Research Foundation (DFG)); NSERC Operating grant (DYPH and EKC)	This work was supported by the German Research Foundation (DFG) under grant no. HA 6861/2-1 (BMtH) and a NSERC Operating grant (DYPH and EKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkley V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00705; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Bock O, 2001, EXP BRAIN RES, V138, P359, DOI 10.1007/s002210100704; Clayton HA, 2014, EXP BRAIN RES, V232, P2073, DOI 10.1007/s00221-014-3896-y; Cressman EK, 2010, J NEUROPHYSIOL, V103, P1888, DOI 10.1152/jn.01002.2009; Cressman EK, 2009, J NEUROPHYSIOL, V102, P3505, DOI 10.1152/jn.00514.2009; Jones SAH, 2012, NEUROPSYCHOLOGIA, V50, P1462, DOI 10.1016/j.neuropsychologia.2012.02.031; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Krakauer JW, 2009, ADV EXP MED BIOL, V629, P405, DOI 10.1007/978-0-387-77064-2_21; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Mattar AAG, 2013, J NEUROPHYSIOL, V109, P782, DOI 10.1152/jn.00734.2011; McDougle SD, 2015, J NEUROSCI, V35, P9568, DOI 10.1523/JNEUROSCI.5061-14.2015; Miall RC, 2004, EXP BRAIN RES, V154, P201, DOI 10.1007/s00221-003-1630-2; Neva JL, 2013, EXP BRAIN RES, V226, P363, DOI 10.1007/s00221-013-3444-1; Nourouzpour N, 2015, EXP BRAIN RES, V233, P1019, DOI 10.1007/s00221-014-4176-6; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Salomonczyk D, 2013, EXP BRAIN RES, V228, P313, DOI 10.1007/s00221-013-3564-7; Salomonczyk D, 2012, EXP BRAIN RES, V217, P187, DOI 10.1007/s00221-011-2985-4; Salomonczyk D, 2011, NEUROPSYCHOLOGIA, V49, P3053, DOI 10.1016/j.neuropsychologia.2011.07.006; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; Taylor JA, 2014, PROG BRAIN RES, V210, P217, DOI 10.1016/B978-0-444-63356-9.00009-1; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Taylor JA, 2011, J NEUROPHYSIOL, V106, P3157, DOI 10.1152/jn.01008.2010; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; Werner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123321; Wigmore V, 2002, J EXP PSYCHOL HUMAN, V28, P447, DOI 10.1037//0096-1523.28.2.447; Yamamoto K, 2006, J NEUROPHYSIOL, V96, P2797, DOI 10.1152/jn.00209.2006; Yin PB, 2001, EXP BRAIN RES, V141, P250, DOI 10.1007/s002210100892; Zbib B, 2016, EXP BRAIN RES, V234, P2201, DOI 10.1007/s00221-016-4624-6	34	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163695	10.1371/journal.pone.0163695	http://dx.doi.org/10.1371/journal.pone.0163695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732595	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300026
J	Sanokawa-Akakura, R; Akakura, S; Tabibzadeh, S				Sanokawa-Akakura, Reiko; Akakura, Shin; Tabibzadeh, Siamak			Replicative Senescence in Human Fibroblasts Is Delayed by Hydrogen Sulfide in a NAMPT/SIRT1 Dependent Manner	PLOS ONE			English	Article							VEIN ENDOTHELIAL-CELLS; CAENORHABDITIS-ELEGANS; TELOMERASE ACTIVITY; SIRT1 ACTIVITY; LIFE-SPAN; NAD(+); ASSOCIATION; ACTIVATION; PATHWAY; CANCER	Recent evidence suggests that hydrogen sulfide (H2S) has cytoprotective and anti-aging effects. However, the mechanisms for such properties are not fully understood. Here, we show that the expression of the main H2S producing enzyme, CBS, and production of H2S are coordinately diminished in replicative senescent adult human dermal fibroblasts. The reduced production of H2S falls within the same time-frame that the hallmarks of replicative senescence appear including accumulation of SA-beta-Gal, enhanced expression of p16, p21, and RRM2B while the expression of RRM2, hTERT, SIRT1, NAMPT, and NAD/NADH ratio all fall. Exogenous H2S increases the expression of hTERT, NAMPT, SIRT1 and NAD/NADH ratio in treated cells. Moreover, H2S safeguards the expression of hTERT in a NAMPT and SIRT1 dependent manner and delays the onset of replicative senescence as evidenced by reduced accumulation of age associated SA-beta-Gal and cessation of proliferation. Postponement of loss of cell proliferative capacity without risk of mutagenesis shows implications for use of H2S in delaying the adverse effects of senescence in organisms.	[Sanokawa-Akakura, Reiko; Akakura, Shin; Tabibzadeh, Siamak] Frontiers Biosci Res Inst Aging & Canc, Irvine, CA 92618 USA		Tabibzadeh, S (corresponding author), Frontiers Biosci Res Inst Aging & Canc, Irvine, CA 92618 USA.	fbs@bioscience.org						Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Greenwood SK, 2004, ENVIRON MOL MUTAGEN, V43, P36, DOI 10.1002/em.10207; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Huang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113305; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Imai S, 2009, BBA-GEN SUBJECTS, V1790, P997, DOI 10.1016/j.bbagen.2009.03.005; Imai S, 2009, FRONT BIOSCI-LANDMRK, V14, P2983, DOI 10.2741/3428; KERY V, 1994, J BIOL CHEM, V269, P25283; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kuo ML, 2012, SCI REP-UK, V2, DOI 10.1038/srep00822; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Ostrakhovitch EA, 2015, EXP CELL RES, V330, P135, DOI 10.1016/j.yexcr.2014.09.027; Qabazard B, 2014, ANTIOXID REDOX SIGN, V20, P2621, DOI 10.1089/ars.2013.5448; Qabazard B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080135; Rehan L, 2014, LIFE SCI, V105, P1, DOI 10.1016/j.lfs.2014.03.015; Sanokawa-Akakura R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108537; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Suo R, 2013, MOL MED REP, V7, P1865, DOI 10.3892/mmr.2013.1417; Szabo C, 2014, BRIT J PHARMACOL, V171, P2099, DOI 10.1111/bph.12369; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Wei YH, 2016, P NATL ACAD SCI USA, V113, pE2832, DOI 10.1073/pnas.1524727113; Yamashita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101864; Yamashita S, 2012, BIOCHEM BIOPH RES CO, V417, P630, DOI 10.1016/j.bbrc.2011.12.021; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zheng MH, 2014, MOL CELL BIOCHEM, V393, P59, DOI 10.1007/s11010-014-2046-y	35	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164710	10.1371/journal.pone.0164710	http://dx.doi.org/10.1371/journal.pone.0164710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732642	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505300077
J	Navarathna, DHMLP; Pathirana, RU; Lionakis, MS; Nickerson, KW; Roberts, DD				Navarathna, Dhammika H. M. L. P.; Pathirana, Ruvini U.; Lionakis, Michail S.; Nickerson, Kenneth W.; Roberts, David D.			Candida albicans ISW2 Regulates Chlamydospore Suspensor Cell Formation and Virulence In Vivo in a Mouse Model of Disseminated Candidiasis	PLOS ONE			English	Article							SCANNING ELECTRON-MICROSCOPY; GENE DISRUPTION; CHANGING EPIDEMIOLOGY; GIANT BLASTOCONIDIA; EXPRESSION; URA3; DUBLINIENSIS; FARNESOL; GROWTH; PATHOGENICITY	Formation of chlamydospores by Candida albicans was an established medical diagnostic test to confirm candidiasis before the molecular era. However, the functional role and pathological relevance of this in vitro morphological transition to pathogenesis in vivo remain unclear. We compared the physical properties of in vitro-induced chlamydospores with those of large C. albicans cells purified by density gradient centrifugation from Candida-infected mouse kidneys. The morphological and physical properties of these cells in kidneys of mice infected intravenously with wild type C. albicans confirmed that chlamydospores can form in infected kidneys. A previously reported chlamydospore-null Delta isw2/Delta isw2 mutant was used to investigate its role in virulence and chlamydospore induction. Virulence of the Delta isw2/Delta isw2 mutant strain was reduced 3.4-fold compared to wild type C. albicans or the ISW2 reconstituted strain. Altered host inflammatory reactions to the null mutant further indicate that ISW2 is a virulence factor in C. albicans. ISW2 deletion abolished chlamydospore formation within infected mouse kidneys, whereas the reconstituted strain restored chlamydospore formation in kidneys. Under chlamydospore inducing conditions in vitro, deletion of ISW2 significantly delayed chlamydospore formation, and those late induced chlamydospores lacked associated suspensor cells while attaching laterally to hyphae via novel spore-hypha septa. Our findings establish the induction of chlamydospores by C. albicans during mouse kidney colonization. Our results indicate that ISW2 is not strictly required for chlamydospores formation but is necessary for suspensor cell formation. The importance of ISW2 in chlamydospore morphogenesis and virulence may lead to additional insights into morphological differentiation and pathogenesis of C. albicans in the host microenvironment.	[Navarathna, Dhammika H. M. L. P.; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Pathirana, Ruvini U.; Nickerson, Kenneth W.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Lionakis, Michail S.] NIAID, Fungal Pathogenesis Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Nebraska System; University of Nebraska Lincoln; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Navarathna, DHMLP; Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	dhammika.h.navarathna.civ@mail.mil; droberts@helix.nih.gov	Navarathna, Dhammika/GXM-8674-2022; Pathirana, Ruvini/AAX-7637-2020; Roberts, David D./A-9699-2008; Pathirana, Ruvini/ABF-2475-2020; Nickerson, Kenneth/V-9979-2019; Lionakis, Michail/J-8840-2017	Pathirana, Ruvini/0000-0001-9847-2185; Roberts, David D./0000-0002-2481-2981; Lionakis, Michail/0000-0003-4994-9500	Intramural Research Program of National Institute of Allergy and Infectious Diseases; Intramural Research Program of National Cancer Institute; Intramural Research Program of National Institutes of Health (NIH) [A1001175-01, ZIA SC 009173]; Farnesol and Candida albicans Research Fund; University of Nebraska Foundation; Blair Paxton Udale Scholarship from UNL School of Biological Sciences; NATIONAL CANCER INSTITUTE [ZIASC009173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001175] Funding Source: NIH RePORTER	Intramural Research Program of National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of National Cancer Institute; Intramural Research Program of National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Farnesol and Candida albicans Research Fund; University of Nebraska Foundation; Blair Paxton Udale Scholarship from UNL School of Biological Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Intramural Research Programs of the National Institute of Allergy and Infectious Diseases and the National Cancer Institute, National Institutes of Health (NIH) (M.S.L., A1001175-01; D.D.R., ZIA SC 009173), Ann L. Kelsall and the Farnesol and Candida albicans Research Fund, University of Nebraska Foundation (to K.W.N.), and the Blair Paxton Udale Scholarship for Life Sciences from UNL School of Biological Sciences (to R.U.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hedaithy SSA, 2002, MED MYCOL, V40, P301, DOI 10.1080/mmy.40.3.301.306; Alasio TM, 2003, ARCH PATHOL LAB MED, V127, P868; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; BAKERSPIGEL A, 1974, MYCOPATH MYCOL APPL, V54, P147, DOI 10.1007/BF02055984; Barelle CJ, 2003, EUKARYOT CELL, V2, P398, DOI 10.1128/EC.2.3.398-410.2003; Bottone EJ, 1999, DIAGN MICR INFEC DIS, V34, P27, DOI 10.1016/S0732-8893(99)00013-9; BRAKKE MK, 1951, J AM CHEM SOC, V73, P1847, DOI 10.1021/ja01148a508; CANNON RD, 1994, J BACTERIOL, V176, P2640, DOI 10.1128/JB.176.9.2640-2647.1994; CARETTA G, 1982, MYCOPATHOLOGIA, V77, P159, DOI 10.1007/BF00518801; CHABASSE D, 1988, ANN BIOL CLIN-PARIS, V46, P817; Cheng SJ, 2003, INFECT IMMUN, V71, P6101, DOI 10.1128/IAI.71.10.6101-6103.2003; Chibana H, 2005, MICROBIOL IMMUNOL, V49, P937, DOI 10.1111/j.1348-0421.2005.tb03686.x; Citiulo F, 2009, FEMS YEAST RES, V9, P1051, DOI 10.1111/j.1567-1364.2009.00533.x; COLE GT, 1991, CAN J MICROBIOL, V37, P637, DOI 10.1139/m91-108; Dang W, 2014, CELL METAB, V19, P952, DOI 10.1016/j.cmet.2014.04.004; DAROCZY J, 1988, MYCOSES, V31, P523, DOI 10.1111/j.1439-0507.1988.tb04404.x; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; Dumitru R, 2007, EUKARYOT CELL, V6, P465, DOI 10.1128/EC.00316-06; Fabry W, 2003, MED MYCOL, V41, P53, DOI 10.1080/mmy.41.1.53.58; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Grawitz P, 1877, DTSCH Z PRAKT MED, V20, P209; HEINEMAN HS, 1961, ARCH INTERN MED, V108, P570, DOI 10.1001/archinte.1961.03620100062008; HO PC, 1981, BRIT J OPHTHALMOL, V65, P333, DOI 10.1136/bjo.65.5.333; Hornby JM, 2004, J MICROBIOL METH, V56, P119, DOI 10.1016/j.mimet.2003.09.021; IRVING SG, 1990, NUCLEIC ACIDS RES, V18, P3261, DOI 10.1093/nar/18.11.3261; JANSONS VK, 1970, J BACTERIOL, V104, P922, DOI 10.1128/JB.104.2.922-932.1970; JANSONS VK, 1970, J BACTERIOL, V104, P910, DOI 10.1128/JB.104.2.910-921.1970; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kebaara BW, 2008, EUKARYOT CELL, V7, P980, DOI 10.1128/EC.00357-07; KIRSCH DR, 1991, INFECT IMMUN, V59, P3297, DOI 10.1128/IAI.59.9.3297-3300.1991; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Labelle AJ, 2008, CRIT CARE MED, V36, P2967, DOI 10.1097/CCM.0b013e31818b3477; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Lionakis MS, 2014, MED MYCOL, V52, P555, DOI 10.1093/mmy/myu029; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; LOURIA D. B., 1963, Sabouraudia, V2, P271; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Martin SW, 2005, EUKARYOT CELL, V4, P1191, DOI 10.1128/EC.4.7.1191-1202.2005; Martin-Manso G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048775; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; Nakamoto Sachiko, 1998, Yonago Acta Medica, V41, P65; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P4006, DOI 10.1128/IAI.00397-07; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P1609, DOI 10.1128/IAI.01182-06; Navarathna DHMLP, 2013, NMR BIOMED, V26, P1125, DOI 10.1002/nbm.2926; Navarathna DHMLP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048475; Navarathna DHMLP, 2011, MICROBIOL-SGM, V157, P270, DOI 10.1099/mic.0.045005-0; Navarathna DHMLP, 2010, FREE RADICAL BIO MED, V49, P1561, DOI 10.1016/j.freeradbiomed.2010.08.020; Navarathna DHMLP, 2005, J ANTIMICROB CHEMOTH, V56, P1156, DOI 10.1093/jac/dki383; Nobile CJ, 2003, MICROBIOL-SGM, V149, P3629, DOI 10.1099/mic.0.26640-0; Palige K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061940; Palmer GE, 2004, CURR GENET, V46, P343, DOI 10.1007/s00294-004-0538-0; Palmer GE, 2004, MICROBIOL-SGM, V150, P1911, DOI 10.1099/mic.0.26910-0; Pande K, 2013, NAT GENET, V45, P1088, DOI 10.1038/ng.2710; Pendrak ML, 2004, EUKARYOT CELL, V3, P764, DOI 10.1128/EC.3.3.764-775.2004; Pfaller MA, 1998, DIAGN MICR INFEC DIS, V30, P121, DOI 10.1016/S0732-8893(97)00192-2; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Riedel CG, 2013, NAT CELL BIOL, V15, P491, DOI 10.1038/ncb2720; Sasse Christoph, 2012, Methods Mol Biol, V845, P3, DOI 10.1007/978-1-61779-539-8_1; SCHONBORN C, 1971, Mykosen, V14, P119; Sipsas NV, 2009, CANCER-AM CANCER SOC, V115, P4745, DOI 10.1002/cncr.24507; Slavin MA, 2010, J ANTIMICROB CHEMOTH, V65, P1042, DOI 10.1093/jac/dkq053; Sonneborn A, 1999, INFECT IMMUN, V67, P5514, DOI 10.1128/IAI.67.10.5514-5517.1999; Staib P, 1999, MYCOSES, V42, P521, DOI 10.1046/j.1439-0507.1999.00516.x; Staib P, 2005, MOL MICROBIOL, V55, P637, DOI 10.1111/j.1365-2958.2004.04414.x; Staib P, 2005, MYCOSES, V48, P50, DOI 10.1111/j.1439-0507.2004.01085.x; Staib P, 2007, MYCOSES, V50, P1, DOI 10.1111/j.1439-0507.2006.01308.x; SULLIVAN DJ, 1995, MICROBIOL-UK, V141, P1507, DOI 10.1099/13500872-141-7-1507; Trachtulcova P, 2000, YEAST, V16, P35, DOI 10.1002/(SICI)1097-0061(20000115)16:1<35::AID-YEA504>3.0.CO;2-0; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Vidotto V, 1996, MICROBIOLOGICA, V19, P327; WILBORN WH, 1980, JAMA-J AM MED ASSOC, V244, P2294; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhang Hong, 2004, Methods Mol Biol, V241, P77	80	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164449	10.1371/journal.pone.0164449	http://dx.doi.org/10.1371/journal.pone.0164449			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727302	Green Published, gold			2022-12-27	WOS:000385504400032
J	Melo, CFOR; de Oliveira, DN; Lima, ED; Guerreiro, TM; Esteves, CZ; Beck, RM; Padilla, MA; Milanez, GP; Arns, CW; Proenca-Modena, JL; Souza-Neto, JA; Catharino, RR				Odir Rodrigues Melo, Carlos Fernando; de Oliveira, Diogo Noin; Lima, Estela de Oliveira; Guerreiro, Tatiane Melina; Esteves, Cibele Zanardi; Beck, Raissa Marques; Padilla, Marina Aiello; Milanez, Guilherme Paier; Arns, Clarice Weis; Proenca-Modena, Jose Luiz; Souza-Neto, Jayme Augusto; Catharino, Rodrigo Ramos			A Lipidomics Approach in the Characterization of Zika-Infected Mosquito Cells: Potential Targets for Breaking the Transmission Cycle	PLOS ONE			English	Article							C VIRUS-INFECTION; DENGUE VIRUS; PHOSPHATIDYLSERINE RECEPTORS; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLETHANOLAMINE; APOPTOSIS; PHOSPHATIDYLCHOLINE; REPLICATION; ENTRY; ASYMMETRY	Recent outbreaks of Zika virus in Oceania and Latin America, accompanied by unexpected clinical complications, made this infection a global public health concern. This virus has tropism to neural tissue, leading to microcephaly in newborns in a significant proportion of infected mothers. The clinical relevance of this infection, the difficulty to perform accurate diagnosis and the small amount of data in literature indicate the necessity of studies on Zika infection in order to characterize new biomarkers of this infection and to establish new targets for viral control in vertebrates and invertebrate vectors. Thus, this study aims at establishing a lipidomics profile of infected mosquito cells compared to a control group to define potential targets for viral control in mosquitoes. Thirteen lipids were elected as specific markers for Zika virus infection (Brazilian strain), which were identified as putatively linked to the intracellular mechanism of viral replication and/or cell recognition. Our findings bring biochemical information that may translate into useful targets for breaking the transmission cycle.	[Odir Rodrigues Melo, Carlos Fernando; de Oliveira, Diogo Noin; Lima, Estela de Oliveira; Guerreiro, Tatiane Melina; Esteves, Cibele Zanardi; Catharino, Rodrigo Ramos] Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, BR-13083877 Campinas, SP, Brazil; [Beck, Raissa Marques; Padilla, Marina Aiello; Arns, Clarice Weis] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Anim Viruses Lab, BR-13083862 Campinas, SP, Brazil; [Milanez, Guilherme Paier; Proenca-Modena, Jose Luiz] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Emerging Viruses Study Lab, BR-13083862 Campinas, SP, Brazil; [Souza-Neto, Jayme Augusto] Sao Paulo State Univ, UNESP Inst Biotechnol, Vector Funct Genom & Microbiol Lab, Alameda Tecomarias S-N, BR-18607440 Botucatu, SP, Brazil; [Souza-Neto, Jayme Augusto] Sao Paulo State Univ, Fac Agron Sci, Dept Bioproc & Biotechnol, Rua Jose Barbosa 1780, BR-18610307 Botucatu, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade Estadual Paulista	Catharino, RR (corresponding author), Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, BR-13083877 Campinas, SP, Brazil.	rrc@fcm.unicamp.br	Catharino, Rodrigo/G-1487-2013; Souza-Neto, Jayme A/E-7841-2010; Lima, Estela/W-5105-2019; Catharino, Rodrigo/AAH-4333-2021; de Oliveira Lima, Estela/G-7375-2015; Proenca-Modena, Jose Luiz/C-8231-2014; Arns, Clarice W/G-7525-2012; de Oliveira, Diogo Noin/C-3939-2013; Milanez, Guilherme/G-6457-2016	Catharino, Rodrigo/0000-0001-7219-2644; Souza-Neto, Jayme A/0000-0001-9281-894X; Lima, Estela/0000-0003-0479-0364; Catharino, Rodrigo/0000-0001-7219-2644; de Oliveira Lima, Estela/0000-0003-0479-0364; Proenca-Modena, Jose Luiz/0000-0002-4996-3153; Arns, Clarice W/0000-0002-7308-460X; de Oliveira, Diogo Noin/0000-0002-2725-476X; Milanez, Guilherme/0000-0002-8599-1098; Guerreiro, Tatiane/0000-0002-4114-1243; Melo, Carlos/0000-0003-0334-1065	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Sao Paulo Research Foundation) [2011/50400-0, 2015/06809-1, 2014/00084-2, 2014/00302-0, 2013/11343-6]; CPAES; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CPAES; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We acknowledge funding from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Sao Paulo Research Foundation), under the following grant numbers: 2011/50400-0 and 2015/06809-1 for RRC, 2014/00084-2 for DNO, 2014/00302-0 for CZE, 2013/11343-6 for JASN) JANS is a FAPESP Young Investigator. We also thank CPAES and CNPq for the fellowships for CFORM, EOL and TMG. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya F, 2008, J INFECT DIS, V197, P361, DOI 10.1086/525287; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Barathan M, 2015, APOPTOSIS, V20, P466, DOI 10.1007/s10495-014-1084-y; Boumann HA, 2004, FEBS LETT, V569, P173, DOI 10.1016/j.febslet.2004.05.043; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brunner M, 2004, CURR ORG CHEM, V8, P1629, DOI 10.2174/1385272043369638; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15; Carocci M, 2015, ANTIMICROB AGENTS CH, V59, P85, DOI 10.1128/AAC.04177-14; Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006; de Oliveira DN, 2013, MATERIALS, V6, P1000, DOI 10.3390/ma6031000; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012; GLIEDMAN JB, 1975, J VIROL, V16, P913, DOI 10.1128/JVI.16.4.913-926.1975; Hematian Ali, 2016, Osong Public Health Res Perspect, V7, P77, DOI 10.1016/j.phrp.2015.11.011; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Liang TB, 2016, J AM COLL SURGEONS, V222, P269, DOI 10.1016/j.jamcollsurg.2015.12.009; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Maulik N, 1998, AM J PHYSIOL-HEART C, V274, pH242, DOI 10.1152/ajpheart.1998.274.1.H242; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974; Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; Soulages JL, 2015, INSECT BIOCHEM MOLEC, V62, P194, DOI 10.1016/j.ibmb.2014.09.007; Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; To KKW, 2015, J INFECTION, V70, P433, DOI 10.1016/j.jinf.2015.02.011; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085; Verkleij A, 1984, CIBA FDN S; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zhang JT, 2016, P NATL ACAD SCI USA, V113, pE1064, DOI 10.1073/pnas.1519730113; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	48	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164377	10.1371/journal.pone.0164377	http://dx.doi.org/10.1371/journal.pone.0164377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723844	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504100050
J	Sagara, A; Igarashi, K; Otsuka, M; Karasawa, T; Gotoh, N; Narita, M; Kuzumaki, N; Narita, M; Kato, Y				Sagara, Atsunobu; Igarashi, Katsuhide; Otsuka, Maky; Karasawa, Takeshi; Gotoh, Noriko; Narita, Michiko; Kuzumaki, Naoko; Narita, Minoru; Kato, Yoshinori			Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR	PLOS ONE			English	Article							COMBINATION; EXPRESSION; BCL2A1; GENES; BFL-1	Although drug resistance is often observed in metastatic recurrence of breast cancer, little is known about the intrinsic drug resistance in such metastases. In the present study, we found, for the first time, that MDA-MB-231BR, a brain metastatic variant of a human breast cancer cell line, was refractory to treatment with 5-fluorouracil (5-FU) even without chronic drug exposure, compared to its parent cell line, MDA-MB-231, and a bone metastatic variant, MDA-MB-231SCP2. Both the mRNA and protein levels of COX-2 and BCL2A1 in MDA-MB-231BR were significantly higher than those in MDA-MB-231 or MDA-MB-231SCP2. Neither the COX-2 inhibitor celecoxib nor the NF-kappa B inhibitor BAY11-7082 could sensitize MDA-MB-231BR to 5-FU, indicating that COX-2 plays little, if any, role in the resistance of MDA-MB-231BR to 5-FU. Although BCL2-family inhibitor ABT-263 failed to sensitize MDA-MB-231BR to 5-FU at a dose at which ABT-263 is considered to bind to BCL2, BCL2-xL, and BCL2-w, but not to BCL2A1, ABT-263 did sensitize MDA-MB-231BR to 5-FU to a level comparable to that in MDA-MB-231 at a dose of 5 mu M, at which ABT-263 may disrupt intracellular BCL2A1 protein interactions. More importantly, BCL2A1 siRNA sensitized MDA-MB-231BR to 5-FU, whereas the overexpression of BCL2A1 conferred 5-FU-resistance on MDA-MB-231. These results indicate that BCL2A1 is a key contributor to the intrinsic 5-FU-resistance in MDA-MB-231BR. It is interesting to note that the drug sensitivity of MDA-MB-231BR was distinct from that of MDA-MB-231SCP2 even though they have the same origin (MDA-MB-231). Further investigations pertinent to the present findings may provide valuable insight into the breast cancer brain metastasis.	[Sagara, Atsunobu; Karasawa, Takeshi; Narita, Michiko; Kuzumaki, Naoko; Narita, Minoru] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Shinagawa Ku, 2-4-41 Ebara, Tokyo, Japan; [Igarashi, Katsuhide; Otsuka, Maky; Narita, Minoru; Kato, Yoshinori] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, 2-4-41 Ebara, Tokyo, Japan; [Gotoh, Noriko] Kanazawa Univ, Div Canc Cell Biol, Canc Res Inst, Kakuma Machi, Kanazawa, Ishikawa, Japan	Hoshi University; Hoshi University; Kanazawa University	Narita, M (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Shinagawa Ku, 2-4-41 Ebara, Tokyo, Japan.; Narita, M; Kato, Y (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, 2-4-41 Ebara, Tokyo, Japan.	narita@hoshi.ac.jp; y-kato@hoshi.ac.jp	Sagara, Atsunobu/AAM-5106-2020	Gotoh, Noriko/0000-0003-3733-260X; Kato, Yoshinori/0000-0002-6218-8710	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [S1411019]; Cancer Research Institute, Kanazawa University	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cancer Research Institute, Kanazawa University	Support was provided by The Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities [http://www.mext.go.jp/english/], S1411019 (MN); Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University [http://ganken.cri. kanazawa-u.ac.jp/eng/], (YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Cheng QW, 2000, ONCOGENE, V19, P4936, DOI 10.1038/sj.onc.1203861; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Gopalan A, 2013, CANCER LETT, V328, P285, DOI 10.1016/j.canlet.2012.10.003; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Hiraga T, 2011, ONCOL REP, V25, P289, DOI 10.3892/or_00001073; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V332, P433, DOI 10.1016/j.bbrc.2005.04.143; Kim SJ, 2011, NEOPLASIA, V13, P286, DOI 10.1593/neo.11112; Lee MS, 2012, BBA-MOL CELL RES, V1823, P514, DOI 10.1016/j.bbamcr.2011.11.017; Okamura H, 2013, ANTICANCER RES, V33, P537; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sierra A, 1997, LAB INVEST, V77, P357; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wang Yifan, 2011, Chin J Cancer, V30, P603, DOI 10.5732/cjc.011.10226; Yamauchi K, 2008, CANCER RES, V68, P516, DOI 10.1158/0008-5472.CAN-07-3063; Yoon HS, 2003, J KOREAN MED SCI, V18, P225, DOI 10.3346/jkms.2003.18.2.225	21	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164250	10.1371/journal.pone.0164250	http://dx.doi.org/10.1371/journal.pone.0164250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723829	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100033
J	Sasaoka, S; Matsui, T; Hane, Y; Abe, J; Ueda, N; Motooka, Y; Hatahira, H; Fukuda, A; Naganuma, M; Hasegawa, S; Kinosada, Y; Nakamura, M				Sasaoka, Sayaka; Matsui, Toshinobu; Hane, Yuuki; Abe, Junko; Ueda, Natsumi; Motooka, Yumi; Hatahira, Haruna; Fukuda, Akiho; Naganuma, Misa; Hasegawa, Shiori; Kinosada, Yasutomi; Nakamura, Mitsuhiro			Time-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug Events	PLOS ONE			English	Article							TORSADES-DE-POINTES; INTERVAL PROLONGATION; QUINIDINE; ARRHYTHMIAS; DATABASE; PHARMACOGENETICS; THERAPY	Long QT syndrome (LQTS) is a disorder of the heart's electrical activity that infrequently causes severe ventricular arrhythmias such as a type of ventricular tachycardia called torsade de pointes (TdP) and ventricular fibrillation, which can be fatal. There have been no previous reports on the time-to-onset for LQTS based on data from spontaneous reporting systems. The aim of this study was to assess the time-to-onset of LQTS according to drug treatment. We analyzed the association between 113 drugs in 37 therapeutic categories and LQTS including TdP using data obtained from the Japanese Adverse Drug Event Report database. For signal detection, we used the reporting odds ratio (ROR). Furthermore, we analyzed the time-to-onset data and assessed the hazard type using the Weibull shape parameter. The RORs (95% confidence interval) for bepridil, amiodarone, pilsicainide, nilotinib, disopyramide, arsenic trioxide, clarithromycin, cibenzoline, donepezil, famotidine, sulpiride, and nifekalant were 174.4 (148.6-204.6), 17.3 (14.7-20.4), 52.0 (43.4- 62.4), 13.9 (11.5-16.7), 69.3 (55.3-86.8), 54.2 (43.2-68.0), 4.7 (3.8-5.8), 19.9 (15.9- 25.0), 8.1 (6.5-10.1), 3.2 (2.5-4.1), 7.1 (5.5-9.2), and 254.8 (168.5-385.4), respectively. The medians and quartiles of time-to-onset for aprindine (oral) and bepridil were 20.0 (11.0-35.8) and 18.0 (6.0-43.0) days, respectively. The lower 95% confidence interval of the shape parameter beta of bepridil was over 1 and the hazard was considered to increase over time. Our study indicated that the pattern of LQTS onset might differ among drugs. Based on these results, careful long-term observation is recommended, especially for specific drugs such as bepridil and aprindine. This information may be useful for the prevention of sudden death following LQTS and for efficient therapeutic planning.	[Sasaoka, Sayaka; Matsui, Toshinobu; Hane, Yuuki; Abe, Junko; Ueda, Natsumi; Motooka, Yumi; Hatahira, Haruna; Fukuda, Akiho; Naganuma, Misa; Hasegawa, Shiori; Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Lab Drug Informat, Gifu, Gifu, Japan; [Abe, Junko] Med Database Co LTD, Shibuya Ku, Tokyo, Japan; [Kinosada, Yasutomi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Gifu, Japan; [Ueda, Natsumi] Ehime Univ Hosp, Div Pharm, Toon, Ehime, Japan	Gifu Pharmaceutical University; Gifu University; Ehime University	Nakamura, M (corresponding author), Gifu Pharmaceut Univ, Lab Drug Informat, Gifu, Gifu, Japan.	mnakamura@gifu-pu.ac.jp		Nakamura, Mitsuhiro/0000-0002-5062-5522; Hasegawa, Shiori/0000-0003-0444-7945	JSPS KAKENHI [24390126]; Medical Database Co., LTD	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Database Co., LTD	This research was partially supported by JSPS KAKENHI Grant Number, 24390126. JA was an employee of Medical Database Co., LTD during the time of the study and received a salary. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2016, J PHARM HEALTH CARE, V2, DOI 10.1186/s40780-016-0048-5; Aberg K, 2012, PHARMACOGENOMICS J, V12, P165, DOI 10.1038/tpj.2010.76; Benton RE, 2000, CLIN PHARMACOL THER, V67, P413, DOI 10.1067/mcp.2000.105761; Curtis LH, 2003, AM J MED, V114, P135, DOI 10.1016/S0002-9343(02)01455-9; De Bruin ML, 2006, PHARMACOEPIDEM DR S, V15, P99, DOI 10.1002/pds.1194; Deremer David L, 2011, Cancer Manag Res, V3, P65, DOI 10.2147/CMR.S11948; Fujita T., 2009, JPN J PHARMACOEPIDEM, V14, P27, DOI [10.3820/jjpe.14.27, DOI 10.3820/JJPE.14.27]; Goldenberg I, 2008, CURR PROB CARDIOLOGY, V33, P629, DOI 10.1016/j.cpcardiol.2008.07.002; Haverkamp W, 2000, CARDIOVASC RES, V47, P219, DOI 10.1016/S0008-6363(00)00119-X; Heist EK, 2010, CIRCULATION, V122, P1426, DOI 10.1161/CIRCULATIONAHA.109.894725; HOHNLOSER SH, 1994, ANN INTERN MED, V121, P529, DOI 10.7326/0003-4819-121-7-199410010-00009; Holbrook Mark, 2009, Journal of Pharmacological and Toxicological Methods, V59, P21, DOI 10.1016/j.vascn.2008.09.001; Ikeno Takashi, 2013, Nihon Shinkei Seishin Yakurigaku Zasshi, V33, P179; International Council for Harmonisation, 2016, INTR GUID MEDDRA VER; International Council on Harmonisation, 2005, GUID IND E14 CLIN EV; Iribarren Carlos, 2013, Pharmacoepidemiol Drug Saf, V22, P1222, DOI 10.1002/pds.3479; Itoh H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P511, DOI 10.1161/CIRCEP.109.862649; Lehtonen A, 2007, HEART RHYTHM, V4, P603, DOI 10.1016/j.hrthm.2007.01.019; Letsas Konstantinos P, 2007, Hellenic J Cardiol, V48, P296; Lin JC, 1997, PHARMACOTHERAPY, V17, P626; MedDRA MSSO, 2016, INTR GUID STAND MEDD; Ministry of Health, 2009, LAB AND WELF; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; MORGANROTH J, 1985, AM J CARDIOL, V56, P585, DOI 10.1016/0002-9149(85)91015-X; Moriya M, 2007, PACE, V30, P1522, DOI 10.1111/j.1540-8159.2007.00901.x; Nakamura M, 2015, J PHARM HEALTH CARE, V1, DOI 10.1186/s40780-015-0035-2; Niemeijer MN, 2015, DRUG SAFETY, V38, P855, DOI 10.1007/s40264-015-0316-6; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Poluzzi E, 2012, DATA MINING APPLICATIONS IN ENGINEERING AND MEDICINE, P265, DOI 10.5772/50095; Poluzzi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119551; Poluzzi E, 2013, DRUG SAFETY, V36, P467, DOI 10.1007/s40264-013-0032-z; Raschi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081208; Roboz GJ, 2014, J CLIN ONCOL, V32, P3723, DOI 10.1200/JCO.2013.51.2913; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; Rufke Cornelia, 2006, Med Monatsschr Pharm, V29, P22; Sauzet O, 2013, DRUG SAFETY, V36, P995, DOI 10.1007/s40264-013-0061-7; Shaffer D, 2002, CLIN INFECT DIS, V35, P197, DOI 10.1086/340861; Shin JG, 2007, BRIT J CLIN PHARMACO, V63, P206, DOI 10.1111/j.1365-2125.2006.02793.x; SOYKA LF, 1990, AM J CARDIOL, V65, pA74; Suzuki Y, 2015, BIOL PHARM BULL, V38, P680, DOI 10.1248/bpb.b14-00191; Takaya T, 2009, J CARDIOL, V54, P507, DOI 10.1016/j.jjcc.2009.03.011; The Japanese Circulation Society (JCS) joint study group, 2012, GUID DIAGN MAN PAT L; Ueda N, 2015, BIOL PHARM BULL, V38, P1638, DOI 10.1248/bpb.b15-00253; Umetsu R, 2015, BIOL PHARM BULL, V38, P1689, DOI 10.1248/bpb.b15-00243; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; Wisniowska B, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0053-1; Yamada M, 2014, JPN J PHARMACOEPIDEM, V19, P23, DOI DOI 10.3820/JJPE.19.23	48	31	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164309	10.1371/journal.pone.0164309	http://dx.doi.org/10.1371/journal.pone.0164309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723808	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504100042
J	Jang, WS; Kim, LHC; Yoon, CY; Rha, KH; Choi, YD; Hong, SJ; Ham, WS				Jang, Won Sik; Kim, Lawrence H. C.; Yoon, Cheol Yong; Rha, Koon Ho; Choi, Young Deuk; Hong, Sung Joon; Ham, Won Sik			Effect of Preoperative Risk Group Stratification on Oncologic Outcomes of Patients with Adverse Pathologic Findings at Radical Prostatectomy	PLOS ONE			English	Article							CANCER-SPECIFIC MORTALITY; RANDOMIZED CLINICAL-TRIAL; SURGICAL MARGIN STATUS; ADJUVANT RADIOTHERAPY; RADIATION-THERAPY; POSTOPERATIVE RADIOTHERAPY; ANTIGEN; MANAGEMENT; IMPACT	Background Current National Comprehensive Cancer Network guidelines recommend postoperative radiation therapy based only on adverse pathologic findings (APFs), irrespective of preoperative risk group. We assessed whether a model incorporating both the preoperative risk group and APFs could predict long-term oncologic outcomes better than a model based on APFs alone. Methods We retrospectively reviewed 4,404 men who underwent radical prostatectomy (RP) at our institution between 1992 and 2014. After excluding patients receiving neoadjuvant therapy or with incomplete pathological or follow-up data, 3,092 men were included in the final analysis. APFs were defined as extraprostatic extension (EPE), seminal vesicle invasion (SVI), or a positive surgical margin (PSM). The adequacy of model fit to the data was compared using the likelihood-ratio test between the models with and without risk groups, and model discrimination was compared with the concordance index (c-index) for predicting biochemical recurrence (BCR) and prostate cancer-specific mortality (PCSM). We performed multivariate Cox proportional hazard model and competing risk regression analyses to identify predictors of BCR and PCSM in the total patient group and each of the risk groups. Results Adding risk groups to the model containing only APFs significantly improved the fit to the data (likelihood-ratio test, p < 0.001) and the c-index increased from 0.693 to 0.732 for BCR and from 0.707 to 0.747 for PCSM. A RP Gleason score (GS) >= 8 and a PSM were independently associated with BCR in the total patient group and also each risk group. However, only a GS >= 8 and SVI were associated with PCSM in the total patient group (GS >= 8: hazard ratio [HR]5.39 and SVI: HR 3.36) and the high-risk group (GS >= 8: HR 6.31 and SVI: HR 4.05). Conclusion The postoperative estimation of oncologic outcomes in men with APFs at RP was improved by considering preoperative risk group stratification. Although a PSM was an independent predictor for BCR, only a RP GS >= 8 and SVI were associated with PCSM in the total patient and high-risk groups.	[Jang, Won Sik; Kim, Lawrence H. C.; Yoon, Cheol Yong; Rha, Koon Ho; Choi, Young Deuk; Hong, Sung Joon; Ham, Won Sik] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea	Yonsei University; Yonsei University Health System	Ham, WS (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea.	uroham@yuhs.ac		Rha, Koon Ho/0000-0001-8588-7584; Ham, Won Sik/0000-0003-2246-8838; Choi, Young Deuk/0000-0002-8545-5797; Hong, Sung Joon/0000-0001-9869-065X; Jang, Won Sik/0000-0002-9082-0381				Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Chalfin HJ, 2012, BJU INT, V110, P1684, DOI 10.1111/j.1464-410X.2012.11371.x; Cooperberg MR, 2004, J CLIN ONCOL, V22, P2141, DOI 10.1200/JCO.2004.10.062; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Edge SB, 2010, AJCC CANC STAGING MA; Imnadze M, 2016, EUR UROL, V69, P143, DOI 10.1016/j.eururo.2015.03.044; Kang JH, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-30; Kim SP, 2013, UROLOGY, V82, P807, DOI 10.1016/j.urology.2013.04.060; Knoedler JJ, 2014, PROSTATE CANCER P D, V17, P144, DOI 10.1038/pcan.2013.61; Koo KC, 2015, ANN SURG ONCOL, V22, P693, DOI 10.1245/s10434-014-4057-z; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lee JY, 2014, ANN SURG ONCOL, V21, P4026, DOI 10.1245/s10434-014-3780-9; Schroder FH, 2008, EUR UROL, V53, P468, DOI 10.1016/j.eururo.2007.10.047; Scrucca L, 2010, BONE MARROW TRANSPL, V45, P1388, DOI 10.1038/bmt.2009.359; Showalter TN, 2012, INT J RADIAT ONCOL, V82, pe233, DOI DOI 10.1016/J.IJR0BP.2011.04.003; Soloway MS, 2012, CAN J UROL, V19, P6280; Stephenson AJ, 2009, J CLIN ONCOL, V27, P4300, DOI 10.1200/JCO.2008.18.2501; Swanson GP, 2007, UROL ONCOL-SEMIN ORI, V25, P110, DOI 10.1016/j.urolonc.2006.06.003; Thompson IM, 2013, J UROLOGY, V190, P441, DOI 10.1016/j.juro.2013.05.032; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Wright JL, 2010, J UROLOGY, V183, P2213, DOI 10.1016/j.juro.2010.02.017	24	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164497	10.1371/journal.pone.0164497	http://dx.doi.org/10.1371/journal.pone.0164497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716842	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100057
J	Sunder, R; Jeyasekharan, AD; Pang, B; Soong, RCT; Kumarakulasinghe, NB; Ow, SGW; Ho, JS; Si, J; Lim, J; Tan, DSP; Wilder-Smith, EPV; Bandla, A; Tan, SSH; Asuncion, BR; Fazreen, Z; Hoppe, MM; Putti, TC; Poh, LM; Goh, BC; Lee, SC				Sunder, Raghav; Jeyasekharan, Anand D.; Pang, Brendan; Soong, Richie Chuan Teck; Kumarakulasinghe, Nesaretnam Barr; Ow, Samuel Guan Wei; Ho, Jingshan; Si, Joline; Lim, Jing; Tan, David Shao Peng; Wilder-Smith, Einar P. V.; Bandla, Aishwarya; Tan, Stacey Sze Hui; Asuncion, Bernadette Reyna; Fazreen, Zul; Hoppe, Michel Marek; Putti, Thomas Choudary; Poh, Lay Mui; Goh, Boon Cher; Lee, Soo-Chin			Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED NEUROPATHY; CLINICAL-PRACTICE GUIDELINE; PERIPHERAL NEUROPATHY; AMERICAN SOCIETY; CANCER PATIENTS; GENE; DIFFERENTIATION; GROWTH; COSTS	Introduction Sensory peripheral neuropathy caused by paclitaxel is a common and dose limiting toxicity, for which there are currently no validated predictive biomarkers. We investigated the relationship between the Charcot-Marie-Tooth protein NDRG1 and paclitaxel-induced neuropathy. Methods/Materials Archived mammary tissue specimen blocks of breast cancer patients who received weekly paclitaxel in a single centre were retrieved and NDRG1 immunohistochemistry was performed on normal nerve tissue found within the sample. The mean nerve NDRG1 score was defined by an algorithm based on intensity of staining and percentage of stained nerve bundles. NDRG1 scores were correlated with paclitaxel induced neuropathy Results 111 patients were studied. 17 of 111 (15%) developed severe paclitaxel-induced neuropathy. The mean nerve NDRG1 expression score was 5.4 in patients with severe neuropathy versus 7.7 in those without severe neuropathy (p = 0.0019). A Receiver operating characteristic (ROC) curve analysis of the mean nerve NDRG1 score revealed an area under the curve of 0.74 (p = 0.0013) for the identification of severe neuropathy, with a score of 7 being most discriminative. 13/54 (24%) subjects with an NDRG1 score < = 7 developed severe neuropathy, compared to only 4/57 (7%) in those with a score > 7 (p = 0.017). Conclusion Low NDRG1 expression in nerve tissue present within samples of surgical resection may identify subjects at risk for severe paclitaxel-induced neuropathy. Since nerve biopsies are not routinely feasible for patients undergoing chemotherapy for early breast cancer, this promising biomarker strategy is compatible with current clinical workflow.	[Sunder, Raghav; Jeyasekharan, Anand D.; Kumarakulasinghe, Nesaretnam Barr; Ow, Samuel Guan Wei; Ho, Jingshan; Si, Joline; Lim, Jing; Goh, Boon Cher; Lee, Soo-Chin] Natl Univ Hlth Syst, Dept Haematol Oncol, Natl Univ Canc Inst, Singapore, Singapore; [Jeyasekharan, Anand D.; Pang, Brendan; Soong, Richie Chuan Teck; Asuncion, Bernadette Reyna; Fazreen, Zul; Hoppe, Michel Marek; Goh, Boon Cher; Lee, Soo-Chin] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Pang, Brendan; Soong, Richie Chuan Teck; Putti, Thomas Choudary] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore; [Wilder-Smith, Einar P. V.; Bandla, Aishwarya; Tan, Stacey Sze Hui] Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, Singapore, Singapore; [Wilder-Smith, Einar P. V.] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Wilder-Smith, Einar P. V.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Bandla, Aishwarya] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Poh, Lay Mui] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Pharm, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lee, SC (corresponding author), Natl Univ Hlth Syst, Dept Haematol Oncol, Natl Univ Canc Inst, Singapore, Singapore.; Lee, SC (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore.	csilsc@nus.edu.sg	Bandla, Aishwarya/AAN-5685-2020; Jeyasekharan, Anand/O-3398-2019; Bandla, Aishwarya/AAQ-5441-2020; Tan, David/HIR-2214-2022; Sundar, Raghav/S-2898-2019; Lee, Soo Chin/S-9111-2016	Sundar, Raghav/0000-0001-9423-1368; Lee, Soo Chin/0000-0002-5835-6419; Hoppe, Michal Marek/0000-0002-0364-6080; Bandla, Aishwarya/0000-0002-6705-1318; OW, Samuel GW/0000-0002-2229-7971; Tan, David/0000-0001-9087-5262; Wilder-Smith, Einar/0000-0003-3402-7503	National University Cancer Institute, Singapore Centre Grant Seeding Funding Program - National Medical Research Council, Singapore [NMRC/CG/012/2013]; National Medical Research Council, Singapore [NMRC/CG/012/2013]	National University Cancer Institute, Singapore Centre Grant Seeding Funding Program - National Medical Research Council, Singapore(National Medical Research Council, Singapore); National Medical Research Council, Singapore(National Medical Research Council, Singapore)	This work was supported by a grant from the National University Cancer Institute, Singapore Centre Grant Seeding Funding Program, awarded by the National Medical Research Council, Singapore (Grant No: NMRC/CG/012/2013) [http://www.nmrc.gov.sg/index.html] to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the patients who have participated in our study. This study was supported by a grant provided from the National Medical Research Council, Singapore. Grant number: NMRC/CG/012/2013.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Baldwin RM, 2012, CLIN CANCER RES, V18, P5099, DOI 10.1158/1078-0432.CCR-12-1590; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Berger A, 2004, J PAIN, V5, P143, DOI 10.1016/j.jpain.2003.12.004; Boora GK, 2016, CANCER MED-US, V5, P631, DOI 10.1002/cam4.625; Calhoun EA, 2001, ONCOLOGIST, V6, P441, DOI 10.1634/theoncologist.6-5-441; Cavaletti G, 2014, J PERIPHER NERV SYST, V19, P66, DOI 10.1111/jns5.12073; Farahani RM, 2011, J COMP NEUROL, V519, P3306, DOI 10.1002/cne.22701; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Hesketh PJ, 2015, J CLIN ONCOL, DOI [10.1200/JCO.2015, DOI 10.1200/JCO.2015]; Hunter M, 2003, HUM MUTAT, V22, P129, DOI 10.1002/humu.10240; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; King RHM, 2011, NEUROBIOL DIS, V42, P368, DOI 10.1016/j.nbd.2011.01.030; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Melli G, 2006, NEUROBIOL DIS, V24, P525, DOI 10.1016/j.nbd.2006.08.014; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Smith TJ, 2015, J CLIN ONCOL, V33, P3199, DOI 10.1200/JCO.2015.62.3488; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Sundar R, 2014, ASCO M, V32, P1054; Theiss C, 2000, CELL TISSUE RES, V299, P213, DOI 10.1007/s004419900120; vanBelzen N, 1997, LAB INVEST, V77, P85; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; Won HH, 2012, CANCER-AM CANCER SOC, V118, P2828, DOI 10.1002/cncr.26614	28	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164319	10.1371/journal.pone.0164319	http://dx.doi.org/10.1371/journal.pone.0164319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716814	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100043
J	Lanas, F; Bazzano, L; Rubinstein, A; Calandrelli, M; Chen, CS; Elorriaga, N; Gutierrez, L; Manfredi, JA; Seron, P; Mores, N; Poggio, R; Ponzo, J; Olivera, H; He, J; Irazola, VE				Lanas, Fernando; Bazzano, Lydia; Rubinstein, Adolfo; Calandrelli, Matias; Chen, Chung-Shiuan; Elorriaga, Natalia; Gutierrez, Laura; Manfredi, Jose A.; Seron, Pamela; Mores, Nora; Poggio, Rosana; Ponzo, Jacqueline; Olivera, Hector; He, Jiang; Irazola, Vilma E.			Prevalence, Distributions and Determinants of Obesity and Central Obesity in the Southern Cone of America	PLOS ONE			English	Article							RISK-FACTORS; LATIN-AMERICA; MYOCARDIAL-INFARCTION; ABDOMINAL OBESITY; HEART-DISEASE; INTERHEART	Background Obesity is a major determinant of cardiovascular disease in South America. However, population- based data are limited. Methods A total of 7,524 women and men, aged 35 to 74 years old, were randomly selected from 4 cities in the Southern Cone of Latin America between February 2010 and December 2011. Obesity clinical measurements and cardiovascular risk factors were measured using standard methodology. Results The prevalence of obesity and central obesity were 35.7% and 52.9%, respectively. The prevalence of obesity and central obesity were higher in women, and even higher in women with lower education compared with women with higher education. In men and women obesity was associated with a higher prevalence of diabetes, odds ratio (OR) 2.38 (95% Confidence Interval [CI]: 1.86 to 3.05) and 3.01 (95% CI 2.42 to 3.74) respectively, hypertension (OR 2.79 (95% CI 2.32 to 3.36) and 2.40 (95% CI 2.05 to 2.80) respectively, dyslipidemia (OR 1.83 (95% CI 1.50 to 2.24) and 1.69 (95% CI 1.45 to 1.98), respectively, low physical activity (OR 1.38(95% CI 1.14 to 1.68) and 1.38 (95% CI 1.18 to 1.62) respectively and a lower prevalence of smoking (OR, 0.65 (95% CI 0.53 to 0.80) and 0.58(95% CI 0.48 to 0.70) respectively. Conclusions Obesity and central obesity are highly prevalent in the general population in the Southern Cone of Latin America and are strongly associated with cardiovascular risk factor prevalence. These data suggest that efforts toward prevention, treatment, and control of obesity should be a public health priority in the Southern Cone of Latin America.	[Lanas, Fernando; Seron, Pamela; Irazola, Vilma E.] CIGES Univ La Frontera UFRO, Temuco, Chile; [Bazzano, Lydia; Chen, Chung-Shiuan; He, Jiang] Tulane Univ, Tulane Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Rubinstein, Adolfo; Elorriaga, Natalia; Gutierrez, Laura; Poggio, Rosana] Ctr Excelencia Salud Cardiovasc El Cono Sur CESCA, IECS, Buenos Aires, DF, Argentina; [Calandrelli, Matias] Sanatorio San Carlos, San Carlos De Bariloche, Rio Negro, Argentina; [Manfredi, Jose A.; Ponzo, Jacqueline] Univ Republica, Dept Med Familiar, Montevideo, Uruguay; [Mores, Nora; Olivera, Hector] Municipalidad Marcos Paz, Pcia De Buenos Aires, Argentina	Tulane University; Universidad de la Republica, Uruguay	Lanas, F (corresponding author), CIGES Univ La Frontera UFRO, Temuco, Chile.	fernando.lanas@ufrontera.cl	He, Jiang/AAF-5303-2020; Seron, Pamela/AAN-3304-2021; Lanas, Fernando/AAE-8842-2022; Ponzo, Jacqueline/B-5303-2019	He, Jiang/0000-0002-8286-9652; Seron, Pamela/0000-0003-0190-8988; Lanas, Fernando/0000-0003-3595-9759; Elorriaga, Natalia/0000-0001-5496-9835; Calandrelli, Matias/0000-0002-8303-5078; Ponzo, Jacqueline/0000-0002-8329-7430	National Heart, Lung, and Blood Institute [268200900029C]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Award Number 268200900029C from the National Heart, Lung, and Blood Institute, www.nhlbi.nih.gov. The funders aprove study design, but did not participate in data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2000, 31 GPE WHO; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coutinho T, 2013, J AM COLL CARDIOL, V61, P553, DOI 10.1016/j.jacc.2012.10.035; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daviglus ML, 2014, PROG CARDIOVASC DIS, V57, P230, DOI 10.1016/j.pcad.2014.07.006; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Elorriaga N, 2015, PUBLIC HEALTH NUTR, V18, P59, DOI 10.1017/S1368980013003431; Fernando L, 2014, PROG CARDIOVASC DIS, V57, P262, DOI 10.1016/j.pcad.2014.07.007; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gruson E, 2010, HEART, V96, P136, DOI 10.1136/hrt.2009.171447; Hernandez-Hernandez R, 2010, J HYPERTENS, V28, P24, DOI 10.1097/HJH.0b013e328332c353; Miranda JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054056; Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552; Lee CD, 2007, AM J CLIN NUTR, V86, P48, DOI 10.1093/ajcn/86.1.48; Logue J, 2011, HEART, V97, P564, DOI 10.1136/hrt.2010.211201; Rubinstein AL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000126; de Souza MDM, 2012, HEART, V98, P1207, DOI 10.1136/heartjnl-2012-301828; National Risk Factor Survey Uruguay, 2013, NAT RISK FACT SURV U; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Rubinstein AL, 2015, INT J CARDIOL, V183, P82, DOI 10.1016/j.ijcard.2015.01.062; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2000, WHO TECHN REP SER, V894; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	29	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163727	10.1371/journal.pone.0163727	http://dx.doi.org/10.1371/journal.pone.0163727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741247	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000004
J	Ward, JD; Sutton, PC; Werner, AD; Costanza, R; Mohr, SH; Simmons, CT				Ward, James D.; Sutton, Paul C.; Werner, Adrian D.; Costanza, Robert; Mohr, Steve H.; Simmons, Craig T.			Is Decoupling GDP Growth from Environmental Impact Possible?	PLOS ONE			English	Article							ECONOMIC-GROWTH; SUSTAINABLE DEVELOPMENT; CLIMATE-CHANGE; RESOURCE USE; LIMITS; REALITY; ENERGY	The argument that human society can decouple economic growth D defined as growth in Gross Domestic Product (GDP) D from growth in environmental impacts is appealing. If such decoupling is possible, it means that GDP growth is a sustainable societal goal. Here we show that the decoupling concept can be interpreted using an easily understood model of economic growth and environmental impact. The simple model is compared to historical data and modelled projections to demonstrate that growth in GDP ultimately cannot be decoupled from growth in material and energy use. It is therefore misleading to develop growth-oriented policy around the expectation that decoupling is possible. We also note that GDP is increasingly seen as a poor proxy for societal wellbeing. GDP growth is therefore a questionable societal goal. Society can sustainably improve wellbeing, including the wellbeing of its natural assets, but only by discarding GDP growth as the goal in favor of more comprehensive measures of societal wellbeing.	[Ward, James D.] Univ South Australia, Sch Nat & Built Environm, GPO Box 2471, Adelaide, SA 5001, Australia; [Sutton, Paul C.] Univ Denver, Dept Geog, Denver, CO 80208 USA; [Werner, Adrian D.; Simmons, Craig T.] Flinders Univ S Australia, Sch Environm, GPO Box 2100, Adelaide, SA 5001, Australia; [Werner, Adrian D.; Simmons, Craig T.] Flinders Univ S Australia, Natl Ctr Groundwater Res & Training, GPO Box 2100, Adelaide, SA 5001, Australia; [Costanza, Robert] Australian Natl Univ, Crawford Sch Publ Policy, Acton, ACT 2601, Australia; [Mohr, Steve H.] Univ Technol Sydney, Inst Sustainable Futures, POB 123, Broadway, NSW 2007, Australia	University of South Australia; University of Denver; Flinders University South Australia; Flinders University South Australia; Australian National University; University of Technology Sydney	Ward, JD (corresponding author), Univ South Australia, Sch Nat & Built Environm, GPO Box 2471, Adelaide, SA 5001, Australia.	james.ward@unisa.edu.au	Sutton, Paul/K-9802-2019; Costanza, Robert/AAJ-3546-2021; Costanza, Robert/A-4912-2008; Hopeward, James David/GLS-9445-2022; Simmons, Craig T/H-7458-2015; Werner, Adrian/F-2222-2015	Sutton, Paul/0000-0002-4961-026X; Costanza, Robert/0000-0001-6348-8734; Hopeward, James David/0000-0003-4847-841X; Simmons, Craig T/0000-0001-5399-6292; Werner, Adrian/0000-0002-1190-1301; Sutton, Paul/0000-0001-6972-3256				Anderson K, 2015, NAT GEOSCI, V8, P898, DOI 10.1038/ngeo2559; [Anonymous], 2016, NEW YORK TIMES; Antal M, 2013, ENVIRON INNOV SOC TR, V6, P47, DOI 10.1016/j.eist.2013.01.002; Baker D., 2007, GAP PRODUCTIVITY WAG; Beckerman W., 1974, DEFENCE EC GROWTH SP, V7619, P19; Behrens A, 2007, ECOL ECON, V64, P444, DOI 10.1016/j.ecolecon.2007.02.034; Bringezu S, 2004, ECOL ECON, V51, P97, DOI 10.1016/j.ecolecon.2004.04.010; Chapin FS, 2009, NATURE, V461, P472, DOI [10.1038/461472a, DOI 10.1038/461472A]; Chertow MR, 2014, J IND ECOL, V4, P13; Commoner B, 1972, POPULATION RESOURCES, P339; Costanza R, 2016, SOLUTIONS, V7, P20; Costanza R, 2014, NATURE, V505, P283, DOI 10.1038/505283a; Csereklyei Z, 2015, ENERG ECON, V51, P633, DOI 10.1016/j.eneco.2015.08.029; Donella H, 1972, LIMITS GROWTH REPORT; Drews S, 2016, GLOBAL ENVIRON CHANG, V39, P1, DOI 10.1016/j.gloenvcha.2016.04.001; Eastin J, 2011, FUTURES, V43, P16, DOI 10.1016/j.futures.2010.03.001; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Fischer-Kowalski M., 2011, DECOUPLING NATURAL R; Giljum Stefan, 2005, International Journal of Sustainable Development, V8, P31, DOI 10.1504/IJSD.2005.007373; Gupta S, 2015, INT J SUST DEV WORLD, V22, P510, DOI 10.1080/13504509.2015.1088485; Hatfield-Dodds S., 2015, AUSTR NATL OUTLOOK 2; Hatfield-Dodds S, 2015, NATURE, V527, P49, DOI 10.1038/nature16065; Klein Naomi, 2014, THIS CHANGES EVERYTH; Krautkramer J., 1995, HDB ENV EC, P139; Kubiszewski I, 2013, ECOL ECON, V93, P57, DOI 10.1016/j.ecolecon.2013.04.019; Looney B., 2020, STAT REV WORLD EN 20, V69; Lutter S, 2016, GLOBAL MAT FLOW DATA; Meadowcroft J, 2013, ENVIRON PLANN C, V31, P988, DOI 10.1068/c1338j; Meadows D., 2004, LIMITS GROWTH 30 YEA; Meadows D. H., 1992, LIMITS CONFRONTING G; Meyer Robinson, 2016, ATLANTIC; O'Rourke D, 2015, ANNU REV ENV RESOUR, V40, P233, DOI 10.1146/annurev-environ-102014-021224; Ockwell DG, 2008, ENERG POLICY, V36, P4600, DOI 10.1016/j.enpol.2008.09.005; OECD, 2011, OECD OBSER; OECD Secretariat, 2002, IND MEAS DEC ENV PRE, V1, P2002; PESSOA J. P, 2013, WAGE GROWTH PRODUCTI; Pulselli FM, 2015, GLOBAL ENVIRON CHANG, V35, P41, DOI 10.1016/j.gloenvcha.2015.08.002; Simon J. L, 1981, ULTIMATE RESOURCE; Smulders S, 2014, OXFORD REV ECON POL, V30, P423, DOI 10.1093/oxrep/gru027; Stern DI, 2011, ANN NY ACAD SCI, V1219, P6; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; Turner GM, 2008, GLOBAL ENVIRON CHANG, V18, P397, DOI 10.1016/j.gloenvcha.2008.05.001; World Bank, 2020, WORLD BANK OPEN DATA; World Bank, 2012, WORLD BANK INCL GREE	44	198	199	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164733	10.1371/journal.pone.0164733	http://dx.doi.org/10.1371/journal.pone.0164733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741300	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000062
J	Chen, D; Halberstam, Y; Yu, ACL				Chen, Daniel; Halberstam, Yosh; Yu, Alan C. L.			Perceived Masculinity Predicts US Supreme Court Outcomes	PLOS ONE			English	Article							SEXUAL ORIENTATION; VOICE PITCH; ATTRACTIVENESS; PERCEPTION; SPEECH; WOMEN; TRUST; RECOGNITION; ELECTIONS; JUDGMENTS	Previous studies suggest a significant role of language in the court room, yet none has identified a definitive correlation between vocal characteristics and court outcomes. This paper demonstrates that voice-based snap judgments based solely on the introductory sentence of lawyers arguing in front of the Supreme Court of the United States predict outcomes in the Court. In this study, participants rated the opening statement of male advocates arguing before the Supreme Court between 1998 and 2012 in terms of masculinity, attractiveness, confidence, intelligence, trustworthiness, and aggressiveness. We found significant correlation between vocal characteristics and court outcomes and the correlation is specific to perceived masculinity even when judgment of masculinity is based only on less than three seconds of exposure to a lawyer's speech sample. Specifically, male advocates are more likely to win when they are perceived as less masculine. No other personality dimension predicts court outcomes. While this study does not aim to establish any causal connections, our findings suggest that vocal characteristics may be relevant in even as solemn a setting as the Supreme Court of the United States.	[Chen, Daniel] Toulouse Sch Econ, Inst Adv Study, Toulouse, France; [Halberstam, Yosh] Univ Toronto, Dept Econ, Toronto, ON, Canada; [Yu, Alan C. L.] Univ Chicago, Phonol Lab, Dept Linguist, Chicago, IL 60637 USA	Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics; University of Toronto; University of Chicago	Yu, ACL (corresponding author), Univ Chicago, Phonol Lab, Dept Linguist, Chicago, IL 60637 USA.	aclyu@uchicago.edu			Social Sciences and Humanities Research Council of Canada; European Research Council, Humanities Division of the University of Chicago; Connaught Fund at the University of Toronto; Swiss National Science Foundation; Agence Nationale de la Recherche	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); European Research Council, Humanities Division of the University of Chicago; Connaught Fund at the University of Toronto; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was partially supported by the Social Sciences and Humanities Research Council of Canada, the European Research Council, Humanities Division of the University of Chicago, the Connaught Fund at the University of Toronto, Swiss National Science Foundation, and Agence Nationale de la Recherche.	AMBADY N, 1992, PSYCHOL BULL, V111, P256, DOI 10.1037/0033-2909.111.2.256; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Babel M, 2013, P INT, P426; Babel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088616; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; Benor S, 2005, JEWISH SOC STUD, V11, P147, DOI [10.2979/JSS.2004.11.1.147, DOI 10.2979/JSS.2004.11.1.147]; Berdejo A C, 2010, PRIMING IDEOLOGY ELE; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Bestelmeyer PEG, 2010, COGNITION, V117, P217, DOI 10.1016/j.cognition.2010.08.008; Bucholtz Mary, 2001, J LINGUIST ANTHROPOL, V11, P84, DOI DOI 10.1525/JLIN.2001.11.1.84; Butler Judith, 1990, GENDER TROUBLE FEMIN; Cameron CM, 1993, C POL EC PUBL LAW; Campbell-Kibler K, 2010, LANG LINGUIST COMPAS, V4, P377, DOI 10.1111/j.1749-818x.2010.00201.x; CHAIKEN S, 1979, J PERS SOC PSYCHOL, V37, P1387, DOI 10.1037/0022-3514.37.8.1387; Chen DL, 2014, THIS MORNINGS BREAKF; Chen DL, 2016, DECISION MAKING GAMB; Clopper Cynthia G, 2004, Lang Var Change, V16, P31; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Cristian Danescu-Niculescu-Mizil, 2012, P 21 INT C WORLD WID, P699, DOI DOI 10.1145/2187836.2187931; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Eckert P, 2008, J SOCIOLING, V12, P453, DOI 10.1111/j.1467-9841.2008.00374.x; Eckert Penelope, 2003, LANGUAGE GENDER; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; Juslin P. N., 2005, NEW HDB METHODS NONV, P65, DOI DOI 10.1093/ACPROF:OSO/9780198529620.003.0003; Kessler SJ., 1978, GENDER ETHNOMETHODOL; Kiesling S, 2007, LANG LINGUIST COMPAS, V1, P653, DOI 10.1111/j.1749-818x.2007.00035.x; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Kornhauser LA, 1999, ENCY LAW EC, V5, P27; Latinus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041384; Levon E, 2007, LANG SOC, V36, P533, DOI 10.1017/S0047404507070431; LEWIS JD, 1985, SOC FORCES, V63, P967, DOI 10.2307/2578601; Linville SE, 1998, FOLIA PHONIATR LOGO, V50, P35, DOI 10.1159/000021447; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Locke J., 2011, DUELS DUETS WHY MEN; Mayew WJ, 2012, J FINANC, V67, P1, DOI 10.1111/j.1540-6261.2011.01705.x; McAleer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090779; Nass C, 2001, J EXP PSYCHOL-APPL, V7, P171, DOI 10.1037//1076-898X.7.3.171; O'Barr W, 1980, WOMEN LANGUAGE LIT S, P93; O'Barr WM, 1982, STUDIES LAW SOCIAL C; Peresie JL, 2005, YALE LAW J, V114, P1759; Perrachione TK, 2011, SCIENCE, V333, P595, DOI 10.1126/science.1207327; Pierrehumbert JB, 2004, J ACOUST SOC AM, V116, P1905, DOI 10.1121/1.1788729; Podesva RJ, 2002, LANGUAGE AND SEXUALITY: CONTESTING MEANING IN THEORY AND PRACTICE, P175; Podesva RJ, 2015, LANG VAR CHANGE, V27, P59, DOI 10.1017/S0954394514000192; POSNER RA, 1973, J LEGAL STUD, V2, P399, DOI 10.1086/467503; Purnell T, 1999, J LANG SOC PSYCHOL, V18, P10, DOI 10.1177/0261927X99018001002; Puts DA, 2011, P ROYAL SOC LONDON B; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Riding D, 2006, J NONVERBAL BEHAV, V30, P55, DOI 10.1007/s10919-006-0005-3; Ross W, 1996, INT J CONFL MANAGE, V7, P314, DOI 10.1108/eb022786; Saxton TK, 2006, ETHOLOGY, V112, P1179, DOI 10.1111/j.1439-0310.2006.01278.x; Scharinger M, 2011, NEUROIMAGE, V56, P2329, DOI 10.1016/j.neuroimage.2011.04.007; SCHERER KR, 1973, J RES PERS, V7, P31, DOI 10.1016/0092-6566(73)90030-5; Scherer KR, 1979, THE SOCIAL PSYCHOLOG, P88; Schroeder J, 2015, PSYCHOL SCI, V26, P877, DOI 10.1177/0956797615572906; Schubert JN, 2002, RISKY T TRUST KINSHI, P304; Smyth R, 2003, LANG SOC, V32, P329, DOI 10.1017/S0047404503323024; Sunstein Cass R., 2006, ARE JUDGES POLITICAL; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	63	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164324	10.1371/journal.pone.0164324	http://dx.doi.org/10.1371/journal.pone.0164324			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27737008	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800050
J	Kopprasch, S; Dheban, S; Schuhmann, K; Xu, AM; Schulte, KM; Simeonovic, CJ; Schwarz, PEH; Bornstein, SR; Shevchenko, A; Graessler, J				Kopprasch, Steffi; Dheban, Srirangan; Schuhmann, Kai; Xu, Aimin; Schulte, Klaus-Martin; Simeonovic, Charmaine J.; Schwarz, Peter E. H.; Bornstein, Stefan R.; Shevchenko, Andrej; Graessler, Juergen			Detection of Independent Associations of Plasma Lipidomic Parameters with Insulin Sensitivity Indices Using Data Mining Methodology	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; CARDIOVASCULAR-DISEASE; SHOTGUN LIPIDOMICS; GLUCOSE-TOLERANCE; RESISTANCE; PROFILE; GLUCOLIPOTOXICITY; LIPOTOXICITY; PREDICTION; CERAMIDES	Objective Glucolipotoxicity is a major pathophysiological mechanism in the development of insulin resistance and type 2 diabetes mellitus (T2D). We aimed to detect subtle changes in the circulating lipid profile by shotgun lipidomics analyses and to associate them with four different insulin sensitivity indices. Methods The cross-sectional study comprised 90 men with a broad range of insulin sensitivity including normal glucose tolerance (NGT, n = 33), impaired glucose tolerance (IGT, n = 32) and newly detected T2D (n = 25). Prior to oral glucose challenge plasma was obtained and quantitatively analyzed for 198 lipid molecular species from 13 different lipid classes including triacylglycerls (TAGs), phosphatidylcholine plasmalogen/ether (PC O-s), sphingomyelins (SMs), and lysophosphatidylcholines (LPCs). To identify a lipidomic signature of individual insulin sensitivity we applied three data mining approaches, namely least absolute shrinkage and selection operator (LASSO), Support Vector Regression (SVR) and Random Forests (RF) for the following insulin sensitivity indices: homeostasis model of insulin resistance (HOMA-IR), glucose insulin sensitivity index (GSI), insulin sensitivity index (ISI), and disposition index (DI). The LASSO procedure offers a high prediction accuracy and and an easier interpretability than SVR and RF. Results After LASSO selection, the plasma lipidome explained 3% (DI) to maximal 53% (HOMA-IR) variability of the sensitivity indexes. Among the lipid species with the highest positive LASSO regression coefficient were TAG 54:2 (HOMA-IR), PC O-32:0 (GSI), and SM 40: 3:1 (ISI). The highest negative regression coefficient was obtained for LPC 22:5 (HOMA-IR), TAG 51:1 (GSI), and TAG 58:6 (ISI). Conclusion Although a substantial part of lipid molecular species showed a significant correlation with insulin sensitivity indices we were able to identify a limited number of lipid metabolites of particular importance based on the LASSO approach. These few selected lipids with the closest connection to sensitivity indices may help to further improve disease risk prediction and disease and therapy monitoring.	[Kopprasch, Steffi; Schwarz, Peter E. H.; Bornstein, Stefan R.; Graessler, Juergen] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Dresden, Germany; [Dheban, Srirangan] Tech Univ Dresden, Inst Med Informat & Biometry, Fac Med Carl Gustav Carus, Dresden, Germany; [Schuhmann, Kai; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Xu, Aimin] Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Schulte, Klaus-Martin] NHS Fdn Trust, Kings Coll Hosp, Dept Endocrine Surg, London, England; [Simeonovic, Charmaine J.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Max Planck Society; University of Hong Kong; King's College Hospital NHS Foundation Trust; King's College Hospital; Oxford University Hospitals NHS Foundation Trust; Australian National University; John Curtin School of Medical Research	Kopprasch, S (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Dresden, Germany.	Steffi.Kopprasch@uniklinikum-dresden.de	Schulte, Klaus-Martin/D-9066-2019; Simeonovic, Charmaine/AAG-9945-2020; Schulte, Klaus-Martin/AAS-7015-2020	Schulte, Klaus-Martin/0000-0002-9091-0512; Simeonovic, Charmaine/0000-0002-7161-5825				Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Boulesteix AL, 2008, CANCER INFORM, V6, P77; Corpeleijn E, 2006, DIABETOLOGIA, V49, P2392, DOI 10.1007/s00125-006-0383-4; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Fan FL, 2015, INFLAMM BOWEL DIS, V21, P1511, DOI 10.1097/MIB.0000000000000394; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garbarino J, 2009, CURR OPIN CLIN NUTR, V12, P110, DOI 10.1097/MCO.0b013e32832182ee; Gonzalez-Covarrubias V, 2013, AGING CELL, V12, P426, DOI 10.1111/acel.12064; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; Hanley AJG, 2003, DIABETES, V52, P463, DOI 10.2337/diabetes.52.2.463; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Kazama Y, 2008, DIABETES RES CLIN PR, V79, P24, DOI 10.1016/j.diabres.2007.05.005; Kopprasch S, 2016, CLIN ENDOCRINOL, V84, P48, DOI 10.1111/cen.12811; Kotronen A, 2009, DIABETOLOGIA, V52, P684, DOI 10.1007/s00125-009-1282-2; Kulkarni H, 2013, HYPERTENSION, V62, P621, DOI 10.1161/HYPERTENSIONAHA.113.01396; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Liu R, 2014, DIABETES RES CLIN PR; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Meikle PJ, 2014, PHARMACOL THERAPEUT, V143, P12, DOI 10.1016/j.pharmthera.2014.02.001; Meikle PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074341; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Renner S, 2012, DIABETES, V61, P2166, DOI 10.2337/db11-1133; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Scholkopf B., 2001, LEARNING KERNELS; Schuhmann K, 2012, J MASS SPECTROM, V47, P96, DOI 10.1002/jms.2031; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Stegemann C, 2014, CIRCULATION, V129, P1821, DOI 10.1161/CIRCULATIONAHA.113.002500; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Veret J, 2011, BIOCHEM J, V438, P177, DOI 10.1042/BJ20101386; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Wong G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076577	42	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164173	10.1371/journal.pone.0164173	http://dx.doi.org/10.1371/journal.pone.0164173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736893	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000385505800044
J	Mahato, AK; Sharma, N; Singh, A; Srivastav, M; Jaiprakash; Singh, SK; Singh, AK; Sharma, TR; Singh, NK				Mahato, Ajay Kumar; Sharma, Nimisha; Singh, Akshay; Srivastav, Manish; Jaiprakash; Singh, Sanjay Kumar; Singh, Anand Kumar; Sharma, Tilak Raj; Singh, Nagendra Kumar			Leaf Transcriptome Sequencing for Identifying Genic-SSR Markers and SNP Heterozygosity in Crossbred Mango Variety 'Amrapali' (Mangifera indica L.)	PLOS ONE			English	Article							GENERATION; DIVERSITY; GENES; TOOL; MICROSATELLITES; TECHNOLOGY; ANNOTATION; MECHANISMS; CULTIVARS; DISCOVERY	Mango (Mangifera indica L.) is called "king of fruits " due to its sweetness, richness of taste, diversity, large production volume and a variety of end usage. Despite its huge economic importance genomic resources in mango are scarce and genetics of useful horticultural traits are poorly understood. Here we generated deep coverage leaf RNA sequence data for mango parental varieties 'Neelam', 'Dashehari' and their hybrid 'Amrapali' using next generation sequencing technologies. De-novo sequence assembly generated 27,528, 20,771 and 35,182 transcripts for the three genotypes, respectively. The transcripts were further assembled into a non-redundant set of 70,057 unigenes that were used for SSR and SNP identification and annotation. Total 5,465 SSR loci were identified in 4,912 unigenes with 288 type I SSR (n >= 20 bp). One hundred type I SSR markers were randomly selected of which 43 yielded PCR amplicons of expected size in the first round of validation and were designated as validated genic-SSR markers. Further, 22,306 SNPs were identified by aligning high quality sequence reads of the three mango varieties to the reference unigene set, revealing significantly enhanced SNP heterozygosity in the hybrid Amrapali. The present study on leaf RNA sequencing of mango varieties and their hybrid provides useful genomic resource for genetic improvement of mango.	[Mahato, Ajay Kumar; Singh, Akshay; Sharma, Tilak Raj; Singh, Nagendra Kumar] ICAR Natl Res Ctr Plant Biotechnol, New Delhi, India; [Sharma, Nimisha; Srivastav, Manish; Jaiprakash; Singh, Sanjay Kumar; Singh, Anand Kumar] ICAR Indian Agr Res Inst, Div Fruits & Hort Technol, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Singh, NK (corresponding author), ICAR Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India.	nksingh4@gmail.com	Singh, Akshay/AAZ-8886-2020; Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; Singh, Akshay/0000-0001-7599-6699; MAHATO, AJAY KUMAR/0000-0003-1359-6643	Indian Council of Agriculture Research-Network Project on Transgenics in Crops [ICAR-NPTC-2001-3059]; ICAR-Indian Agricultural Research Institute, New Delhi; ICAR- National Research Centre on Plant Biotechnology, New Delhi, India; Division of Fruits and Horticultural Technology, ICAR-Indian Agricultural Research Institute, Pusa, New Delhi, India	Indian Council of Agriculture Research-Network Project on Transgenics in Crops; ICAR-Indian Agricultural Research Institute, New Delhi; ICAR- National Research Centre on Plant Biotechnology, New Delhi, India; Division of Fruits and Horticultural Technology, ICAR-Indian Agricultural Research Institute, Pusa, New Delhi, India	This work was supported by the Indian Council of Agriculture Research-Network Project on Transgenics in Crops (ICAR-NPTC-2001-3059) NKS, ICAR-Indian Agricultural Research Institute, New Delhi, AKS.; We are thankful to ICAR- National Research Centre on Plant Biotechnology, New Delhi, India and The Division of Fruits and Horticultural Technology, ICAR-Indian Agricultural Research Institute, Pusa, New Delhi, India for facilities and support.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Azim MK, 2014, PLANT MOL BIOL, V85, P193, DOI 10.1007/s11103-014-0179-8; Barabaschi D, 2012, MOL BIOTECHNOL, V50, P250, DOI 10.1007/s12033-011-9443-1; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Dautt-Castro M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00062; DEGANI C, 1992, HORTSCIENCE, V27, P252, DOI 10.21273/HORTSCI.27.3.252; Degani C., 1993, Acta Horticulturae, P78; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dutta S, 2012, PLANT BREEDING, V132, P1439; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Egan AN, 2012, AM J BOT, V99, P175, DOI 10.3732/ajb.1200020; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Hirano R, 2010, GENOME, V53, P321, DOI [10.1139/g10-005, 10.1139/G10-005]; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Khan IA, 2011, PLANT SYST EVOL, V292, P249, DOI 10.1007/s00606-011-0424-4; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lal S., 2016, THESIS, P1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Luria N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-957; Mahattanatawee K, 2006, J AGR FOOD CHEM, V54, P7355, DOI 10.1021/jf060566s; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; MUKHERJEE S. K., 1950, PROC NATION INST SCI INDIA, V16, P287; Ravishankar KV, 2011, AM J BOT, V98, pE96, DOI 10.3732/ajb.1000263; Ribeiro SMR, 2007, PLANT FOOD HUM NUTR, V62, P13, DOI 10.1007/s11130-006-0035-3; SCHNELL RJ, 1992, HORTSCIENCE, V27, P174, DOI 10.21273/HORTSCI.27.2.174; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Singh N, 2014, PLANT AN GEN 22 C; Singh N.K., 2016, INDIAN J HIST SCI, V51, DOI [10.16943/ijhs/2016/v51i2.2/48449, DOI 10.16943/IJHS/2016/V51I2.2/48449]; Souza IGB, 2011, GENET MOL RES, V10, P3080, DOI 10.4238/2011.December.14.1; Srivastava N, 2012, J ENVIRON BIOL, V33, P159; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tharanathan RN, 2006, FOOD REV INT, V22, P95, DOI 10.1080/87559120600574493; Truscott M., 1992, Inligtingsbulletin - Instituut vir Tropiese en Subtropiese Gewasse, P17; Van Deynze A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-125; Van Deynze A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-465; Wu HX, 2014, J PROTEOMICS, V105, P19, DOI 10.1016/j.jprot.2014.03.030; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	53	16	17	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164325	10.1371/journal.pone.0164325	http://dx.doi.org/10.1371/journal.pone.0164325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736892	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800051
J	Morinobu, A; Tanaka, S; Nishimura, K; Takahashi, S; Kageyama, G; Miura, Y; Kurosaka, M; Saegusa, J; Kumagai, S				Morinobu, Akio; Tanaka, Shino; Nishimura, Keisuke; Takahashi, Soshi; Kageyama, Goichi; Miura, Yasushi; Kurosaka, Masahiro; Saegusa, Jun; Kumagai, Shunichi			Expression and Functions of Immediate Early Response Gene X-1 (IEX-1) in Rheumatoid Arthritis Synovial Fibroblasts	PLOS ONE			English	Article							HISTONE DEACETYLASES; APOPTOSIS; PATHOGENESIS; INHIBITORS; SURVIVAL; CANCER; CELLS; TH17	In rheumatoid arthritis (RA), synovial fibroblasts (RA-SFs) accumulate in affected joints, where they play roles in inflammation and joint destruction. RA-SFs exhibit tumor-like proliferation and are resistant to apoptosis. Although RA-SF activation is well described, negative regulators of RA-SF activation are unknown. We previously reported that histone deacetylase (HDAC) inhibitors facilitate apoptosis in RA-SFs. Here we found that RA-SFs treated with the HDAC inhibitor Trichostatin A (TSA) exhibited an upregulation of the immediate early response gene X- 1 (IEX- 1). IEX- 1 has roles in apoptosis sensitivity, cell-cycle progression, and proliferation, and is reported to be involved in immune responses, inflammation, and tumorigenesis, and to have anti-arthritic properties. To investigate IEX- 1's role in RA-SFs, we used in vitro-cultured synovial fibroblasts from RA and osteoarthritis (OA) patients. We confirmed that TSA upregulated the IEX- 1 protein and mRNA expressions in RA-SFs by western blotting and quantitative RT-PCR. Inhibiting HDAC1, 2, and 3 (but not 6 or 8) also upregulated IEX- 1. The IEX- 1 mRNA levels were higher in RA-SFs than in OASFs, and were further upregulated in RA-SFs by the pro-inflammatory cytokines TNF alpha and IL- 1 beta. The staining of surgical specimens showed that IEX- 1 was present in the pannus from affected RA joints. Si-RNA-mediated IEX- 1 knockdown upregulated the lipopolysaccharide (LPS)-induced expression of TNFa and various chemokine mRNAs, indicating that IEX- 1 downregulates TNF alpha and chemokines. Furthermore, apoptosis analysis showed that IEX- 1 knockdown protected RA-SFs from apoptosis induced by TSA or by an anti-Fas mAb, indicating that IEX- 1 is pro-apoptotic in RA-SFs. Collectively, our results showed that IEX- 1 is induced by TNFa and IL- 1 beta in RA-SFs, in which it suppresses TNFa and chemokine production and induces apoptosis; thus, IEX- 1 negatively regulates RA-SF activation. Further investigation of IEX1's functions in RA-SFs may lead to new therapeutic approaches for RA.	[Morinobu, Akio; Tanaka, Shino; Nishimura, Keisuke; Takahashi, Soshi; Kageyama, Goichi; Saegusa, Jun] Kobe Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan; [Miura, Yasushi; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Orthoped Surg, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan; [Saegusa, Jun; Kumagai, Shunichi] Kobe Univ Hosp, Clin Lab, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan; [Kumagai, Shunichi] Shinko Hosp, Ctr Rheumat Dis, Chuo Ku, 1-4-47 Wakinohama Cho, Kobe, Hyogo 6510072, Japan	Kobe University; Kobe University; Kobe University	Morinobu, A (corresponding author), Kobe Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	morinobu@med.koberu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [16590981, 21591265]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for scientific research KAKENHI (16590981, 21591265) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (https://www.jsps.go.jp/j-grantsinaid/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt A, 2008, BBA-MOL CELL RES, V1783, P941, DOI 10.1016/j.bbamcr.2007.12.010; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Grabiec AM, 2011, CRIT REV IMMUNOL, V31, P233, DOI 10.1615/CritRevImmunol.v31.i3.40; Horiuchi M, 2009, J RHEUMATOL, V36, P1580, DOI 10.3899/jrheum.081115; Korb A, 2009, APOPTOSIS, V14, P447, DOI 10.1007/s10495-009-0317-y; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Morinobu A, 2006, J RHEUMATOL, V33, P1052; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Shen L, 2009, CELL DEATH DIFFER, V16, P603, DOI 10.1038/cdd.2008.184; Shen L, 2006, J BIOL CHEM, V281, P15304, DOI 10.1074/jbc.M600054200; Turner JD, 2015, CURR OPIN RHEUMATOL, V27, P175, DOI 10.1097/BOR.0000000000000148; Ustyugova IV, 2012, MOL CANCER RES, V10, P760, DOI 10.1158/1541-7786.MCR-11-0556; Ustyugova IV, 2012, INFLAMM BOWEL DIS, V18, P333, DOI 10.1002/ibd.21772; Wu MX, 2013, EXPERT OPIN THER TAR, V17, P593, DOI 10.1517/14728222.2013.768234; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Zhi L, 2012, J IMMUNOL, V189, P1639, DOI 10.4049/jimmunol.1200528	18	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164350	10.1371/journal.pone.0164350	http://dx.doi.org/10.1371/journal.pone.0164350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736946	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800055
J	Wang, YW; Wu, CS; Zhang, GY; Chang, CH; Cheng, KS; Yao, WJ; Chang, YK; Chien, TW; Lin, LC; Lin, KR				Wang, Yu-Wen; Wu, Chin-Shun; Zhang, Guo-Yi; Chang, Chih-Han; Cheng, Kuo-Sheng; Yao, Wei-Jen; Chang, Yu-Kang; Chien, Tsair-Wei; Lin, Li-Ching; Lin, Keng-Ren			Can Parameters Other than Minimal Axial Diameter in MRI and PET/CT Further Improve Diagnostic Accuracy for Equivocal Retropharyngeal Lymph Nodes in Nasopharyngeal Carcinoma?	PLOS ONE			English	Article							BARR-VIRUS DNA; METASTASIS; PATTERNS; NECK; CANCERS; HEAD	Purpose Minimal axial diameter (MIAD) in magnetic resonance imaging (MRI) was recognized as the most useful parameter in diagnosing lateral retropharyngeal lymph (LRPL) nodes in nasopharyngeal carcinoma (NPC). This study aims to explore the additional nodal parameters in MRI and positron emission tomography-computed tomography for increasing the prediction accuracy. Materials and Methods A total of 663 LRPL nodes were retrospectively collected from 335 patients with NPC. The LRPL nodes ascertained on follow-up MRI were considered positive for metastases. First, the optimal cutoff value of each parameter was derived for each parameter. In addition, neural network (NN) nodal evaluation was tested for all combinations of three parameters, namely MIAD, maximal axial diameter (MAAD), and maximal coronal diameter (MACD). The optimal approach was determined through brute force attack, and the results of two methods were compared using a bootstrap sampling method. Second, the mean standard uptake value (NSUVmean) was added as the fourth parameter and tested in the same manner for 410 nodes in 219 patients. Results In first and second analysis, the accuracy rate (percentage) for the MIAD was 89.0% (590/663) and 89.0% (365/410), with the optimal cutoff values being 6.1 mm and 6.0 mm, respectively. With the combination of all three and four parameters, the accuracy rate of the NN was 89% (288/332) and 88.8% (182/205), respectively. In prediction, the optimal combinations of the three and four parameters resulted in correct identification of three (accuracy: 593/663, 89.4%) and six additional nodes (371/410, 90.5%), representing 4% (3/73) and 13.3% (6/45) decreases in incorrect prediction, respectively. Conclusion NPC LRPL nodes with an MIAD >= 6.1 mm are positive. Among nodes with an MIAD < 6.1 mm, if the NSUVmean >= 2.6 or MACD >= 25 mm and MAAD >= 8 mm, the nodes are positive; otherwise, they are negative.	[Wang, Yu-Wen; Chang, Chih-Han; Cheng, Kuo-Sheng; Lin, Keng-Ren] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Wang, Yu-Wen] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Wang, Yu-Wen] Min Hwei Jr Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Wu, Chin-Shun] Chi Mei Med Ctr, Div Nucl Med, Dept Med Imaging, Tainan, Taiwan; [Zhang, Guo-Yi] Sun Yat Sen Univ, Foshan Hosp, Ctr Canc, Foshan, Peoples R China; [Yao, Wei-Jen] Natl Cheng Kung Univ Hosp, Dept Nucl Med, Tainan, Taiwan; [Chang, Yu-Kang] Chi Mei Med Ctr, Dept Med Imaging, Tainan, Taiwan; [Chien, Tsair-Wei] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lin, Li-Ching] Chi Mei Fdn Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Lin, Li-Ching] Chung Hwa Univ Med Technol, Dept Optometry, Tainan, Taiwan; [Lin, Keng-Ren] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan	National Cheng Kung University; Chi Mei Hospital; Chi Mei Hospital; Sun Yat Sen University; National Cheng Kung University; National Cheng Kung University Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chung Hua University; National Cheng Kung University	Lin, KR (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.; Lin, KR (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan.	krlin213@gmail.com	, kscheng/M-9373-2019; smile, chien/AAA-1053-2022	Wang, Yu-Wen/0000-0002-4588-2591; Lin, Keng-Ren/0000-0002-3720-8054	Chi Medical Center, Liouying [CLFHR10206, CLFHR10536]	Chi Medical Center, Liouying	This work (YWW) was sponsored by Chi Medical Center, Liouying (grants CLFHR10206 and CLFHR10536).We ensure that no additional external funding was received for this study. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130677; Chan JYW, 2013, HEAD NECK-J SCI SPEC, V35, P1726, DOI 10.1002/hed.23214; Chang JTC, 2005, INT J RADIAT ONCOL, V62, P501, DOI 10.1016/j.ijrobp.2004.09.057; DIFFIE W, 1977, COMPUTER, V10, P74, DOI 10.1109/C-M.1977.217750; Du Y, 2013, J NUCL CARDIOL, V20, P84, DOI 10.1007/s12350-012-9649-z; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fraum TJ, 2016, ACAD RADIOL, V23, P220, DOI 10.1016/j.acra.2015.09.008; Hoetjes NJ, 2010, EUR J NUCL MED MOL I, V37, P1679, DOI 10.1007/s00259-010-1472-7; King AD, 2000, HEAD NECK-J SCI SPEC, V22, P275; Lai V, 2014, ORAL ONCOL, V50, P539, DOI 10.1016/j.oraloncology.2013.05.005; Lee CC, 2011, INT J RADIAT ONCOL, V81, pE833, DOI 10.1016/j.ijrobp.2010.11.036; Li H, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140126; Li JJ, 2015, ENDOSCOPY, V47, pE449, DOI 10.1055/s-0034-1392652; Li Y, 2014, CHIN J NAT MEDICINES, V12, P204, DOI 10.1016/S1875-5364(14)60034-0; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lin YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125283; Liu LZ, 2006, INT J RADIAT ONCOL, V66, P721, DOI 10.1016/j.ijrobp.2006.05.054; Ma J, 2007, CLIN CANCER RES, V13, P1445, DOI 10.1158/1078-0432.CCR-06-2059; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Ng LKY, 2011, HEAD NECK-J SCI SPEC, V33, P1335, DOI 10.1002/hed.21627; Ng SH, 2004, EUR J NUCL MED MOL I, V31, P1073, DOI 10.1007/s00259-004-1498-9; Ng WT, 2007, RADIOTHER ONCOL, V82, P70, DOI 10.1016/j.radonc.2006.11.010; Queiroz MA, 2015, SEMIN NUCL MED, V45, P248, DOI 10.1053/j.semnuclmed.2014.12.005; Sharma M, 2010, EXPERT REV ANTICANC, V10, P1703, DOI 10.1586/ERA.10.159; Shi Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103153; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Su Yong, 2010, Chin J Cancer, V29, P768; Tang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122965; Tauzin M, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-70; Tsai MC, 2016, HEAD NECK-J SCI SPEC, V38, pE84, DOI 10.1002/hed.24205; Varoquaux A, 2015, RADIOGRAPHICS, V35, P1502, DOI 10.1148/rg.2015140029; Vriens D, 2010, EUR J NUCL MED MOL I, V37, P1408, DOI 10.1007/s00259-009-1306-7; Wang WY, 2013, CANCER-AM CANCER SOC, V119, P963, DOI 10.1002/cncr.27853; Wang XS, 2009, INT J RADIAT ONCOL, V73, P194, DOI 10.1016/j.ijrobp.2008.03.067; Wang YW, 2015, J MED BIOL ENG, V35, P218, DOI 10.1007/s40846-015-0023-x; Wang YW, 2011, RADIOLOGY, V259, P612, DOI 10.1148/radiol.11102415; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yu E, 2010, EXPERT REV ANTICANC, V10, P365, DOI 10.1586/ERA.10.9; Zhang F, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1669-z; Zhang Gu-yi, 2006, Zhonghua Zhongliu Zazhi, V28, P381; Zhang GY, 2010, RADIOLOGY, V255, P605, DOI 10.1148/radiol.10090289	42	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163741	10.1371/journal.pone.0163741	http://dx.doi.org/10.1371/journal.pone.0163741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736927	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800021
J	Yamani, Y; Horrey, WJ; Liang, YL; Fisher, DL				Yamani, Yusuke; Horrey, William J.; Liang, Yulan; Fisher, Donald L.			Age-Related Differences in Vehicle Control and Eye Movement Patterns at Intersections: Older and Middle-Aged Drivers	PLOS ONE			English	Article							DRIVING PERFORMANCE; TRAINING STRATEGIES; SELECTIVE ATTENTION; FAILURES; PERCEPTION; MODELS	Older drivers are at increased risk of intersection crashes. Previous work found that older drivers execute less frequent glances for detecting potential threats at intersections than middle-aged drivers. Yet, earlier work has also shown that an active training program doubled the frequency of these glances among older drivers, suggesting that these effects are not necessarily due to age-related functional declines. In light of findings, the current study sought to explore the ability of older drivers to coordinate their head and eye movements while simultaneously steering the vehicle as well as their glance behavior at intersections. In a driving simulator, older (M = 76 yrs) and middle-aged (M = 58 yrs) drivers completed different driving tasks: (1) travelling straight on a highway while scanning for peripheral information (a visual search task) and (2) navigating intersections with areas potential hazard. The results replicate that the older drivers did not execute glances for potential threats to the sides when turning at intersections as frequently as the middle-aged drivers. Furthermore, the results demonstrate costs of performing two concurrent tasks, highway driving and visual search task on the side displays: the older drivers performed more poorly on the visual search task and needed to correct their steering positions more compared to the middle-aged counterparts. The findings are consistent with the predictions and discussed in terms of a decoupling hypothesis, providing an account for the effects of the active training program.	[Yamani, Yusuke] Old Dominion Univ, Dept Psychol, Norfolk, VA 23529 USA; [Horrey, William J.; Liang, Yulan] Liberty Mutual Res Inst Safety, Ctr Behav Sci, Hopkinton, MA USA; [Fisher, Donald L.] Univ Massachusetts, Dept Ind & Mech Engn, Amherst, MA 01003 USA; [Fisher, Donald L.] Volpe Natl Transportat Ctr, Cambridge, MA USA	Old Dominion University; Liberty Mutual Research Institute for Safety; University of Massachusetts System; University of Massachusetts Amherst	Yamani, Y (corresponding author), Old Dominion Univ, Dept Psychol, Norfolk, VA 23529 USA.	yyamani@odu.edu	Yamani, Yusuke/J-8506-2019	Yamani, Yusuke/0000-0001-8990-0010	Arbella Insurance Charitable Foundation; New England University Transportation Center; Liberty Mutual-UMass Amherst Post-Doctoral Research Fellowship award; LMRIS	Arbella Insurance Charitable Foundation; New England University Transportation Center; Liberty Mutual-UMass Amherst Post-Doctoral Research Fellowship award; LMRIS	Portions of this research were funded by a gift from the Arbella Insurance Charitable Foundation and by the New England University Transportation Center to Donald Fisher and Liberty Mutual-UMass Amherst Post-Doctoral Research Fellowship awarded to Yusuke Yamani. The co-authors WJ Hand YL, who are employed by the Liberty Mutual Research Institute for Safety, played a role in the study design, data analysis, decision to publish, and preparation of the manuscript. Additionally, LMRIS provided partial financial support for a postdoctoral fellowship awarded to the lead author [YY].	Ball K. K., 1988, J OPT SOC AM A, P2210; Bao S, 2008, TRANSPORT RES REC, P26, DOI 10.3141/2069-04; Boer E. R., 2011, P DRIV ASS 2011 6 IN, P17; Borowsky A, 2010, ACCIDENT ANAL PREV, V42, P1240, DOI 10.1016/j.aap.2010.02.001; Brown SC, 2003, GERONTOLOGIST, V43, P57, DOI 10.1093/geront/43.suppl_1.57; Bryer T., 2000, MOBILITY TRANSPORTAT, P157; Caird JK, 2005, HUM FACTORS, V47, P235, DOI 10.1518/0018720054679542; Eck RW, 2002, TRANSPORT RES REC, P70; Gstalter H, 2010, ACCIDENT ANAL PREV, V42, P225, DOI 10.1016/j.aap.2009.07.021; Insurance Institute for Highway safety, 2012, FAT FACTS 2012 OLD P; Kasneci E, 2015, ARTIFICIAL NEURAL NETWORKS, P411, DOI 10.1007/978-3-319-09903-3_20; Kramer AF, 1999, PSYCHOL AGING, V14, P135, DOI 10.1037/0882-7974.14.1.135; Lombardi D. A., AGE RELATED IN PRESS; Mackay M., 1988, TRANSPORTATION AGING, V218, P158; Madden D, 2008, HDB AGING COGNITION; McKnight AJ, 1999, ACCIDENT ANAL PREV, V31, P445, DOI 10.1016/S0001-4575(98)00082-7; Pollatsek A, 2006, CURR DIR PSYCHOL SCI, V15, P255, DOI 10.1111/j.1467-8721.2006.00447.x; Pollatsek A, 2012, CURR DIR PSYCHOL SCI, V21, P3, DOI 10.1177/0963721411429459; Pradhan AK, 2005, HUM FACTORS, V47, P840, DOI 10.1518/001872005775570961; Reimer B, 2012, HUM FACTORS, V54, P454, DOI 10.1177/0018720812437274; Romoser MRE, 2013, HUM FACTORS, V55, P278, DOI 10.1177/0018720812457566; Romoser MRE, 2013, TRANSPORT RES F-TRAF, V16, P104, DOI 10.1016/j.trf.2012.08.004; Romoser MRE, 2009, HUM FACTORS, V51, P652, DOI 10.1177/0018720809352654; Samuel S., LARGE REDUC IN PRESS; Samuel S., 2016, CLIN EXPT OPTPMETRY; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Senders JW, 1983, VISUAL SAMPLING PROC; Shope J.T., 1998, 9824 UMTRI; Staplin L., 1991, TRANSPORT RES REC, V1325, P23; SZLYK JP, 1995, HUM FACTORS, V37, P430, DOI 10.1518/001872095779064645; Vaportzis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060265; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Yamani Y., 2015, P HUM FACT ERG SOC A, P1636; Zacks R. T., 2000, HDB AGING COGNITION, V2nd, P293, DOI DOI 10.3758/S13423-011-0086-9	34	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164124	10.1371/journal.pone.0164124	http://dx.doi.org/10.1371/journal.pone.0164124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736887	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800041
J	Chatzievangelou, D; Doya, C; Thomsen, L; Purser, A; Aguzzi, J				Chatzievangelou, Damianos; Doya, Carolina; Thomsen, Laurenz; Purser, Autun; Aguzzi, Jacopo			High-Frequency Patterns in the Abundance of Benthic Species near a Cold-Seep - An Internet Operated Vehicle Application	PLOS ONE			English	Article							BURROW EMERGENCE RHYTHMS; NEPTUNE CANADA NETWORK; GULF-OF-MEXICO; DEEP-SEA; TIME-SERIES; ANOPLOPOMA-FIMBRIA; BARKLEY CANYON; CHRONOBIOLOGICAL APPROACH; CABLED OBSERVATORIES; NEPHROPS-NORVEGICUS	Three benthic megafaunal species (i.e. sablefish Anoplopoma fimbria; pacific hagfish Eptatretus stoutii and a group of juvenile crabs) were tested for diel behavioral patterns at the methane hydrates site of Barkley Canyon (890 m depth), off Vancouver Island (BC, Canada). Fluctuations of animal counts in linear video-transects conducted with the Internet Operated Deep-Sea Crawler "Wally" in June, July and December of 2013, were used as proxy of population activity rhythms. Count time series and environmental parameters were analyzed under the hypothesis that the environmental conditioning of activity rhythms depends on the life habits of particular species (i.e. movement type and trophic level). Nonlinear least squares modeling of biological time series revealed significant diel periods for sablefish in summer and for hagfish and crabs in December. Combined cross-correlation and redundancy (RDA) analyses showed strong relationships among environmental fluctuations and detected megafauna. In particular, sablefish presence during summer months was related to flow magnitude, while the activity of pacific hagfish and juvenile crabs in December correlated with change in chemical parameters (i.e. chlorophyll and oxygen concentrations, respectively). Waveform analyses of animal counts and environmental variables confirmed the phase delay during the 24 h cycle. The timing of detection of sablefish occurred under low flow velocities, a possible behavioral adaptation to the general hypoxic conditions. The proposed effect of chlorophyll concentrations on hagfish counts highlights the potential role of phytodetritus as an alternative food source for this opportunistic feeder. The juvenile crabs seemed to display a cryptic behavior, possibly to avoid predation, though this was suppressed when oxygen levels were at a minimum. Our results highlight the potential advantages such mobile observation platforms offer in multiparametric deep-sea monitoring in terms of both spatial and temporal resolution and add to the vastly understudied field of diel rhythms of deep-sea megafauna.	[Chatzievangelou, Damianos; Thomsen, Laurenz] Jacobs Univ Bremen, Bremen, Germany; [Doya, Carolina; Aguzzi, Jacopo] Inst Ciencias Mar ICM CSIC, Barcelona, Spain; [Purser, Autun] AWI, Bremerhaven, Germany	Jacobs University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Chatzievangelou, D (corresponding author), Jacobs Univ Bremen, Bremen, Germany.	d.hatzievangelou@jacobs-university.de	Doya, Carolina/AAK-3441-2021; Chatzievangelou, Damianos/AAE-4039-2020; Aguzzi, Jacopo/D-6574-2012	Chatzievangelou, Damianos/0000-0001-7512-5105; Purser, Autun/0000-0001-5427-0151; Doya Le Besnerais, Carolina/0000-0003-0083-7348; Aguzzi, Jacopo/0000-0002-1484-8219	Robotic Exploration of Extreme Environments (ROBEX) project by Helmholtz Alliance [HA-304]; RITFIM project of the Spanish national RTD program [CTM2010-16274]; Ocean Networks Canada; Neptune Canada	Robotic Exploration of Extreme Environments (ROBEX) project by Helmholtz Alliance; RITFIM project of the Spanish national RTD program; Ocean Networks Canada; Neptune Canada	This work was supported by Robotic Exploration of Extreme Environments (ROBEX) project by Helmholtz Alliance (HA-304), http://www.helmholtz.de/ (DC and AP); RITFIM project (ref. CTM2010-16274) of the Spanish national RTD program (CD). Development and deployment of the crawler was co-funded by Ocean Networks Canada and Neptune Canada, http://www.oceannetworks.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C, 2013, CIRCULAR STATISTICS; Aguzzi J, 2015, REV FISH BIOL FISHER, V25, P463, DOI 10.1007/s11160-015-9387-9; Aguzzi J, 2012, MAR ECOL PROG SER, V458, P247, DOI 10.3354/meps09758; Aguzzi J, 2010, MAR ECOL PROG SER, V418, P47, DOI 10.3354/meps08835; Aguzzi Jacopo, 2006, J Circadian Rhythms, V4, P6, DOI 10.1186/1740-3391-4-6; Aguzzi J, 2015, DEEP-SEA RES PT I, V95, P1, DOI 10.1016/j.dsr.2014.10.003; Aguzzi J, 2012, OCEANOGR MAR BIOL, V50, P235; Aguzzi J, 2011, FRONT BIOSCI-LANDMRK, V16, P131, DOI 10.2741/3680; Aguzzi J, 2010, ADV MAR BIOL, V58, P155, DOI 10.1016/S0065.2881(10)58003.9; Aiken CM, 2014, ECOLOGY, V95, P2289, DOI 10.1890/13-0472.1; [Anonymous], MATLAB R2014B; Azzurro E, 2013, J MAR BIOL ASSOC UK, V93, P461, DOI 10.1017/S0025315412001166; Bahamon N, 2011, SENSORS-BASEL, V11, P11251, DOI 10.3390/s111211251; Bahamon N, 2009, ICES J MAR SCI, V66, P2211, DOI 10.1093/icesjms/fsp190; Barss W.H., 1993, MAR FISH REV, V55, P19; Boetius A, 2013, NAT GEOSCI, V6, P725, DOI [10.1038/ngeo1926, 10.1038/NGEO1926]; Bosiger YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111723; Bozzano A, 2005, FISH RES, V73, P29, DOI 10.1016/j.fishres.2005.01.006; Bucking C, 2011, PHYSIOL BIOCHEM ZOOL, V84, P607, DOI 10.1086/662630; Chapman R., 2004, EOS T AM GEOPHYS UN, V85, P361, DOI [10.1029/2004EO380001, DOI 10.1029/2004EO380001]; Colmenero AI, 2010, MAR ECOL PROG SER, V416, P255, DOI 10.3354/meps08766; Cordes EE, 2010, MAR ECOL-EVOL PERSP, V31, P51, DOI 10.1111/j.1439-0485.2009.00334.x; Cox GK, 2011, J COMP PHYSIOL B, V181, P361, DOI 10.1007/s00360-010-0532-4; Davies S, 2006, CAN FIELD NAT, V120, P363, DOI 10.22621/cfn.v120i3.329; Doya C, 2014, J MARINE SYST, V130, P69, DOI 10.1016/j.jmarsys.2013.04.003; Doya C, YEARLY EPIBENTHIC ME; Doya C, 2016, J MARINE SYST, V154, P280, DOI 10.1016/j.jmarsys.2015.09.005; Drew CA, 2006, LANDSCAPE ECOL, V21, P917, DOI 10.1007/s10980-005-5568-6; FERNHOLM B, 1974, MAR BIOL, V27, P351, DOI 10.1007/BF00394371; Gervais F., 2012, MARINE LIFE FIELD GU; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Hart TD, 2010, FISH B-NOAA, V108, P466; Haselmair A, 2010, MAR ECOL PROG SER, V414, P195, DOI 10.3354/meps08657; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Juniper SK, 2013, DEEP-SEA RES PT II, V92, P114, DOI 10.1016/j.dsr2.2013.03.038; Kimura DK, 1998, FISH B-NOAA, V96, P462; King JR, 2001, PROG OCEANOGR, V49, P619, DOI 10.1016/S0079-6611(01)00044-1; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Laidig Thomas E., 1997, NOAA Technical Report NMFS, V130, P65; Lemon J., 2006, R R NEWS; Levin LA, 2000, MAR ECOL PROG SER, V208, P21, DOI 10.3354/meps208021; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P94, DOI 10.1111/j.1439-0485.2009.00335.x; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; LOKKEBORG S, 1995, J FISH BIOL, V46, P142, DOI 10.1111/j.1095-8649.1995.tb05953.x; LOKKEBORG S, 1989, CAN J FISH AQUAT SCI, V46, P1478, DOI 10.1139/f89-189; Lundsten EM, 2014 FALL MEETING; MacAvoy SE, 2005, MAR ECOL PROG SER, V292, P51, DOI 10.3354/meps292051; MacAvoy SE, 2003, CHEM GEOL, V201, P229, DOI 10.1016/S0009-2541(03)00204-3; MacAvoy SE, 2002, MAR ECOL PROG SER, V225, P65, DOI 10.3354/meps225065; Martini FH, 1998, BIOLOGY OF HAGFISHES, P57; Matabos M, 2014, J MARINE SYST, V130, P56, DOI 10.1016/j.jmarsys.2013.05.002; McLeod RJ, 2007, ECOLOGY, V88, P809, DOI 10.1890/06-1342; Miyashita T, 2014, BIOL BULL-US, V226, P111, DOI 10.1086/BBLv226n2p111; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Orlov Alexei M., 1997, Russian Journal of Aquatic Ecology, V6, P59; Purser A., 2013, METHODS OCEANOGR, V5, P1, DOI 10.1016/j.mio.2013.07.001; R Core Team, 2018, R LANG ENV STAT COMP; Refinetti R, 2004, J THEOR BIOL, V227, P571, DOI 10.1016/j.jtbi.2003.11.032; Riedel B, 2014, BIOGEOSCIENCES, V11, P1491, DOI 10.5194/bg-11-1491-2014; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; Ruhl HA, 2011, PROG OCEANOGR, V91, P1, DOI 10.1016/j.pocean.2011.05.001; Rummer JL, 2010, J EXP BIOL, V213, P1503, DOI 10.1242/jeb.038844; Sahling H, 2003, DEEP-SEA RES PT I, V50, P1391, DOI 10.1016/j.dsr.2003.08.004; Sbragaglia V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141893; Sbragaglia V, 2015, MAR BIOL, V162, P2007, DOI 10.1007/s00227-015-2726-5; Sbragaglia V, 2013, SCI MAR, V77, P641, DOI 10.3989/scimar.03902.28C; Schimmel M, 2001, BIOL RHYTHM RES, V32, P341, DOI 10.1076/brhm.32.3.341.1340; Schmidt K, 2011, LIMNOL OCEANOGR, V56, P1411, DOI 10.4319/lo.2011.56.4.1411; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; STEPHENS GC, 1968, AM ZOOL, V8, P95; Thomsen L, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052462; Wagner HJ, 2007, DEEP-SEA RES PT I, V54, P1944, DOI 10.1016/j.dsr.2007.08.005; Zeileis A, 2005, J STAT SOFTW, V14; Zintzen V, 2013, MAR ECOL PROG SER, V485, P223, DOI 10.3354/meps10341; Zintzen V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00131	76	21	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163808	10.1371/journal.pone.0163808	http://dx.doi.org/10.1371/journal.pone.0163808			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732626	Green Published, gold			2022-12-27	WOS:000385505300030
J	Garcia, CR; Bonilla, VV; Marin, IR; Mascaros, SM				Roldan Garcia, Clodoaldo; Villaverde Bonilla, Valentin; Rodenas Marin, Isabel; Murcia Mascaros, Sonia			A Unique Collection of Palaeolithic Painted Portable Art: Characterization of Red and Yellow Pigments from the Parpallo Cave (Spain)	PLOS ONE			English	Article							ROCK-PAINTINGS; SPECTROMETRY; COLOR	In this work we analyze the pigments used in the decoration of red and yellow motifs present in the portable art of the Parpallo A Cave (Gandia, Spain), one of the most important Palaeolithic sites in the Spanish Mediterranean region. Energy dispersive X-ray fluorescence spectrometry (EDXRF) and spectrophotometry in the visible region (CIEL*a*b* color coordinates and spectral reflectance curves) were used to perform in situ fast analyses of the red and yellow motifs with portable equipment and to characterize their elemental composition and their colorimetric perception, respectively. According to the elemental composition, the intensity of the fluorescence iron signals in red and yellow motifs are higher than average values in the rock substrates. As expected, red motifs possess high values of the chromatic coordinate a* and yellow motifs possess high values of b*. This characterization was complemented with FT-IR analyses of microsamples detached from the red and yellow colored zones of a small set of plaquettes. Our results show that the artists used red and yellow pigments in the decoration likely derived from natural iron oxides as hematite and goethite.	[Roldan Garcia, Clodoaldo; Rodenas Marin, Isabel; Murcia Mascaros, Sonia] Univ Valencia, Inst Mat Sci ICMUV, Valencia, Spain; [Villaverde Bonilla, Valentin] Univ Valencia, Dept Prehist & Archaeol, Valencia, Spain	University of Valencia; University of Valencia	Garcia, CR (corresponding author), Univ Valencia, Inst Mat Sci ICMUV, Valencia, Spain.	clodoaldo.roldan@uv.es	Murcia-Mascarós, Sonia/L-1183-2014; Roldán, Clodoaldo/K-5095-2014; Villaverde, Valentin/L-2153-2015	Murcia-Mascarós, Sonia/0000-0001-5224-8938; Roldán, Clodoaldo/0000-0001-5988-1189; Villaverde, Valentin/0000-0002-2876-0306	Ministry of Economy and Competitiveness (Spain) [HAR2011-24878, HAR2014-52671]; Conselleria d'Educacio, Investigacio, Cultura i Esport (Generalitat Valenciana) [PROMETEOII/2013/016]; Museo de Prehistoria of Valencia	Ministry of Economy and Competitiveness (Spain); Conselleria d'Educacio, Investigacio, Cultura i Esport (Generalitat Valenciana); Museo de Prehistoria of Valencia	This research was supported by the Ministry of Economy and Competitiveness (Spain) projects, HAR2011-24878 and HAR2014-52671 (http://www.mineco.gob.es/), and by the Conselleria d'Educacio, Investigacio, Cultura i Esport (Generalitat Valenciana) project PROMETEOII/2013/016 (http://www.ceice.gva.es/inicio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express thanks to Museo de Prehistoria of Valencia for their support and to Dr. Marius Vendrell (Barcelona University) for their help with FTIR analysis and to Dr. Nuria Garro (ICMUV) for proof-reading the final manuscript.	[Anonymous], 1986, CIE PUBLICATION, V15.2; Arias P, 2011, ANTHROPOLOGIE, V115, P425, DOI 10.1016/j.anthro.2011.05.005; Beck L, 2011, X-RAY SPECTROM, V40, P219, DOI 10.1002/xrs.1321; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; d'Errico F, 2016, J ARCHAEOL SCI, V70, P48, DOI 10.1016/j.jas.2016.03.007; d'Errico F, 2010, J ARCHAEOL SCI, V37, P3099, DOI 10.1016/j.jas.2010.07.011; Dayet L, 2013, J ARCHAEOL SCI, V40, P3492, DOI 10.1016/j.jas.2013.01.025; Derrick M. R., 1999, INFRARED SPECTROSCOP; Elias M, 2006, MAT SCI ENG B-SOLID, V127, P70, DOI 10.1016/j.mseb.2005.09.061; Gil M, 2007, NUCL INSTRUM METH A, V580, P728, DOI 10.1016/j.nima.2007.05.131; Helwig K., 2007, ARTISTS PIGMENTS HDB, V4, P38; Hernanz A, 2008, J RAMAN SPECTROSC, V39, P972, DOI 10.1002/jrs.1940; Jezequel P, 2011, J ARCHAEOL SCI, V38, P1165, DOI 10.1016/j.jas.2010.12.014; Johnston-Feller R., 2001, COLOR SCI EXAMINATIO; Lahlil S, 2012, J RAMAN SPECTROSC, V43, P1637, DOI 10.1002/jrs.4115; Olivares M, 2013, J ARCHAEOL SCI, V40, P1354, DOI 10.1016/j.jas.2012.10.008; Resano M, 2007, ANAL CHEM, V79, P8947, DOI 10.1021/ac0712953; Rifkin RF, 2016, J ARCHAEOL SCI-REP, V5, P336, DOI 10.1016/j.jasrep.2015.11.028; Roldan C, 2013, J ARCHAEOL SCI, V40, P744, DOI 10.1016/j.jas.2012.07.015; Roldan C, 2010, X-RAY SPECTROM, V39, P243, DOI 10.1002/xrs.1254; Ruiz JF, 2014, J ARCHAEOL SCI, V50, P338, DOI 10.1016/j.jas.2014.06.023; Sanoit J., 2005, ARCHEOSCIENCES-REV A, V29, P61; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Torrent J, 2006, ENCY SURFACE COLLOID; Tournie A, 2011, J RAMAN SPECTROSC, V42, P399, DOI 10.1002/jrs.2682; Villaverde V., 2005, MAT GUAJE PREHISTORI, P67; Villaverde V, 2010, PALEOLITICO SUPERIOR, P85; Villaverde V., 1994, ARTE PALEOLITICO COV, VI	28	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163565	10.1371/journal.pone.0163565	http://dx.doi.org/10.1371/journal.pone.0163565			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DZ0CQ	27732605	gold, Green Published			2022-12-27	WOS:000385505300020
J	Damian-Zamacona, S; Toledo-Ibelles, P; Ibarra-Abundis, MZ; Uribe-Figueroa, L; Hernandez-Lemus, E; Macedo-Alcibia, KP; Delgado-Coello, B; Mas-Oliva, J; Reyes-Grajeda, JP				Damian-Zamacona, Salvador; Toledo-Ibelles, Paola; Ibarra-Abundis, Mabel Z.; Uribe-Figueroa, Laura; Hernandez-Lemus, Enrique; Paola Macedo-Alcibia, Karla; Delgado-Coello, Blanca; Mas-Oliva, Jaime; Pablo Reyes-Grajeda, Juan			Early Transcriptomic Response to LDL and oxLDL in Human Vascular Smooth Muscle Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; SUBCLASS ABC TRANSPORTER; OXIDATIVE STRESS; ATHEROSCLEROTIC LESIONS; MIGRATION; PROLIFERATION; ACTIVATION; MECHANISMS; DISEASE; GROWTH	Background Although nowadays it is well known that the human transcriptome can importantly vary according to external or environmental condition, the reflection of this concept when studying oxidative stress and its direct relationship with gene expression profiling during the process of atherogenesis has not been thoroughly achieved. Objective The ability to analyze genome-wide gene expression through transcriptomics has shown that the genome responds dynamically to diverse stimuli. Here, we describe the transcriptome of human vascular smooth muscle cells (hVSMC) stimulated by native and oxidized low-density lipoprotein (nLDL and oxLDL respectively), with the aim of assessing the early molecular changes that induce a response in this cell type resulting in a transcriptomic transformation. This expression has been demonstrated in atherosclerotic plaques in vivo and in vitro, particularly in the light of the oxidative modification hypothesis of atherosclerosis. Approach and Results Total RNA was isolated with TRIzol reagent (Life Technologies) and quality estimated using an Agilent 2100 bioanalyzer. The transcriptome of hVSMC under different experimental conditions (1,5 and 24 hours for nLDL and oxLDL) was obtained using the GeneChip Human Gene 1.0 ST (Affymetrix) designed to measure gene expression of 28,869 well-annotated genes. A fixed fold-change cut-off corresponding to +/- 2 was used to identify genes exhibiting the most significant variation and statistical significance (P< 0.05), and 8 genes validated by qPCR using Taqman probes. Conclusions 10 molecular processes were significantly affected in hVSMC: Apoptosis and cell cycle, extracellular matrix remodeling, DNA repair, cholesterol efflux, cGMP biosynthesis, endocytic mechanisms, calcium homeostasis, redox balance, membrane trafficking and finally, the immune response to inflammation. The evidence we present supporting the hypothesis for the involvement of oxidative modification of several processes and metabolic pathways in atherosclerosis is strengthen by the fact that gene expression patterns obtained when hVSMC are incubated for a long period of time in the presence of nLDL, correspond very much the same as when cells are incubated for a short period of time in the presence of chemically modified oxLDL. Our results indicate that under physiological conditions and directly related to specific environmental conditions, LDL particles most probably suffer chemical modifications that initially serve as an alert signal to overcome a harmful stimulus that with time might get transformed to a pathological pattern and therefore consolidate a pathological condition.	[Damian-Zamacona, Salvador; Toledo-Ibelles, Paola; Delgado-Coello, Blanca; Mas-Oliva, Jaime] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City, DF, Mexico; [Ibarra-Abundis, Mabel Z.; Uribe-Figueroa, Laura; Hernandez-Lemus, Enrique; Paola Macedo-Alcibia, Karla; Pablo Reyes-Grajeda, Juan] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Uribe-Figueroa, Laura] Affymetrix, Santa Clara, CA USA	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Affymetrix	Mas-Oliva, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City, DF, Mexico.; Reyes-Grajeda, JP (corresponding author), Inst Nacl Med Genom, Mexico City, DF, Mexico.	jmas@ifc.unam.mx; jreyes@inmegen.gob.mx	DELGADO-COELLO, BLANCA/HDO-2038-2022	DELGADO-COELLO, BLANCA/0000-0002-6822-3302; Reyes, Juan Pablo/0000-0001-6498-3286; Hernandez-Lemus, Enrique/0000-0002-1872-1397	CONACYT-Consejo Nacional de Ciencia y Tecnologia [180726]; Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM) [IN205814-13]; Inatituto Nacional de Medicina Genomica (INMEGEN) [25/2011/1]	CONACYT-Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM)(Universidad Nacional Autonoma de Mexico); Inatituto Nacional de Medicina Genomica (INMEGEN)	This study was supported by grants from CONACYT-Consejo Nacional de Ciencia y Tecnologia (180726 granted to JMO); Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM) (IN205814-13) granted to JMO); and Inatituto Nacional de Medicina Genomica (INMEGEN - 25/2011/1) granted to JPRG).	Aguilar-Gaytan R, 2003, BIOCHEM BIOPH RES CO, V305, P510, DOI 10.1016/S0006-291X(03)00796-4; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BLACKWOOD EM, 1991, COLD SPRING HARB SYM, V56, P109; Bochkov VN, 2003, J MOL MED, V81, P613, DOI 10.1007/s00109-003-0467-2; Bolanos-Garcia VM, 1998, BBA-PROTEIN STRUCT M, V1384, P7, DOI 10.1016/S0167-4838(97)00156-8; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Charles RL, 2008, PROTEOM CLIN APPL, V2, P823, DOI 10.1002/prca.200780104; CHATTERJEE S, 1992, MOL CELL BIOCHEM, V111, P143; Chistiakov DA, 2015, ACTA PHYSIOL, V214, P33, DOI 10.1111/apha.12466; Christen T, 1999, CIRC RES, V85, P99; Felty Q, 2005, BIOCHEMISTRY-US, V44, P6900, DOI 10.1021/bi047629p; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Garcia-Sanchez C, 2011, CLIN CHIM ACTA, V412, P292, DOI 10.1016/j.cca.2010.10.021; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Guo J, 2013, AM J CHINESE MED, V41, P1283, DOI 10.1142/S0192415X13500869; Hansen-Hagge TE, 2008, ATHEROSCLEROSIS, V197, P602, DOI 10.1016/j.atherosclerosis.2007.08.029; Innerarity T L, 1986, Methods Enzymol, V129, P542; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Jimenez-Corona AE, 2012, ARCH MED RES, V43, P102, DOI 10.1016/j.arcmed.2012.03.001; Kaminski WE, 2001, BIOCHEM BIOPH RES CO, V285, P1295, DOI 10.1006/bbrc.2001.5326; KATSUDA S, 1992, AM J PATHOL, V140, P907; Kuhn H, 1997, J CLIN INVEST, V99, P888, DOI 10.1172/JCI119253; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Libby P, 1997, CIRCULATION, V96, P4095; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MAHLEY RW, 1977, AM J PATHOL, V87, P205; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; Manzano-Leon N, 2013, J BIOCHEM MOL TOXIC, V27, P69, DOI 10.1002/jbt.21452; Mendoza-Espinosa P, 2008, BIOCHEM BIOPH RES CO, V365, P8, DOI 10.1016/j.bbrc.2007.10.112; Mesquita FS, 2010, BIOL REPROD, V82, P341, DOI 10.1095/biolreprod.108.075887; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Minta Joe, 2010, Cell Biol Int Rep (2010), V17, pe00007, DOI 10.1042/CBR20100006; Morrissey JJ, 1997, P ASSOC AM PHYSICIAN, V109, P51; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Patel S, 2000, CIRCULATION, V101, P524, DOI 10.1161/01.CIR.101.5.524; Pezuk JA, 2013, CANCER BIOTHER RADIO, V28, P516, DOI 10.1089/cbr.2012.1415; Pfanzagl B, 2006, ATHEROSCLEROSIS, V187, P292, DOI 10.1016/j.atherosclerosis.2005.09.024; Piehler A, 2002, BIOCHEM BIOPH RES CO, V295, P408, DOI 10.1016/S0006-291X(02)00659-9; PITAS RE, 1980, J BIOL CHEM, V255, P5454; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Qi XQ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/756426; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rizzo M, 2006, QJM-INT J MED, V99, P1, DOI 10.1093/qjmed/hci154; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; Schachter M, 1997, INT J CARDIOL, V62, pS85, DOI 10.1016/S0167-5273(97)00245-3; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; SCHWENKE DC, 1989, ARTERIOSCLEROSIS, V9, P908, DOI 10.1161/01.ATV.9.6.908; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Sundell CL, 2003, J PHARMACOL EXP THER, V305, P1116, DOI 10.1124/jpet.102.048132; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; Tsimikas S, 2006, AM J CARDIOL, V98, p9P, DOI 10.1016/j.amjcard.2006.09.015; Vora DK, 1997, CIRC RES, V80, P810; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Xu JF, 2009, J BIOL CHEM, V284, P20593, DOI 10.1074/jbc.M109.021477; Zheng JY, 1998, J CELL SCI, V111, P1061	65	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163924	10.1371/journal.pone.0163924	http://dx.doi.org/10.1371/journal.pone.0163924			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727291	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400013
J	Domanski, D; Zegrocka-Stendeli, O; Perzanowska, A; Dutkiewicz, M; Kowalewska, M; Grabowska, I; Maciejko, D; Fogtman, A; Dadlez, M; Koziak, K				Domanski, Dominik; Zegrocka-Stendeli, Oliwia; Perzanowska, Anna; Dutkiewicz, Malgorzata; Kowalewska, Magdalena; Grabowska, Iwona; Maciejko, Dorota; Fogtman, Anna; Dadlez, Michel; Koziak, Katarzyna			Molecular Mechanism for Cellular Response to beta-Escin and Its Therapeutic Implications	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CHRONIC VENOUS INSUFFICIENCY; AESCULUS-HIPPOCASTANUM L.; ACTIN CYTOSKELETON; HORSE-CHESTNUT; SEED EXTRACT; CHOLESTEROL; SAPONINS; CELLS; ORGANIZATION	beta-escin is a mixture of triterpene saponins isolated from the horse chestnut seeds (Aesculus hippocastanum L.). The anti-edematous, anti-inflammatory and venotonic properties of beta-escin have been the most extensively clinically investigated effects of this plant-based drug and randomized controlled trials have proved the efficacy of beta-escin for the treatment of chronic venous insufficiency. However, despite the clinical recognition of the drug its pharmacological mechanism of action still remains largely elusive. To determine the cellular and molecular basis for the therapeutic effectiveness of beta-escin we performed discovery and targeted proteomic analyses and in vitro evaluation of cellular and molecular responses in human endothelial cells under inflammatory conditions. Our results demonstrate that in endothelial cells beta-escin potently induces cholesterol synthesis which is rapidly followed with marked fall in actin cytoskeleton integrity. The concomitant changes in cell functioning result in a significantly diminished responses to TNF-alpha stimulation. These include reduced migration, alleviated endothelial monolayer permeability, and inhibition of NF kappa B signal transduction leading to down-expression of TNF-alpha D induced effector proteins. Moreover, the study provides evidence for novel therapeutic potential of beta-escin beyond the current vascular indications.	[Domanski, Dominik; Perzanowska, Anna; Dadlez, Michel] Polish Acad Sci, Inst Biochem & Biophys, Lab Mass Spectrometry, Warsaw, Poland; [Zegrocka-Stendeli, Oliwia; Dutkiewicz, Malgorzata; Maciejko, Dorota; Koziak, Katarzyna] Med Univ Warsaw, Ctr Preclin Res & Technol, Dept Immunol Biochem & Nutr, Warsaw, Poland; [Kowalewska, Magdalena] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Mol & Translat Oncol, Warsaw, Poland; [Grabowska, Iwona] Univ Warsaw, Fac Biol, Dept Cytol, Miecznikowa 1, PL-02096 Warsaw, Poland; [Fogtman, Anna] Polish Acad Sci, Lab Microarray Anal CORELAB, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Medical University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Koziak, K (corresponding author), Med Univ Warsaw, Ctr Preclin Res & Technol, Dept Immunol Biochem & Nutr, Warsaw, Poland.	katarzyna.koziak@wum.edu.pl	Zegrocka-Stendel, Oliwia/T-8148-2018; Dutkiewicz, Malgorzata/T-9898-2018; Koziak, Katarzyna/V-2323-2019; Grabowska, Iwona/AAY-8564-2021	Zegrocka-Stendel, Oliwia/0000-0001-6481-372X; Dutkiewicz, Malgorzata/0000-0002-5701-7490; Grabowska, Iwona/0000-0001-6455-9434; Fogtman, Anna/0000-0002-5331-7840; Kowalewska, Magdalena/0000-0002-3413-9612; Domanski, Dominik/0000-0003-2549-1064; Dadlez, Michal/0000-0001-8811-5176	European Union under the Operational Programme "Innovative Economy" [POIG.01.01.02-14-072/09]; Homing Plus for the project HOMING from the Foundation for Polish Science (FNP) [PLUS/2011-3/1]; EU structural funds within Action 1.2 "Strengthening the personnel potential of science" POIG of the Innovative Economy Operational Programme (DD); funds for the project "beta-escin-a new agent in the skeletal muscle regeneration improvement?" [Bridge/2013-8/8]; European Union Operational Programme "Innovative Economy" [POIG.01.01.02-14-072/09]; Foundation for Polish Science [Bridge/2013-8/8, HOMING PLUS/2011-3/1]	European Union under the Operational Programme "Innovative Economy"; Homing Plus for the project HOMING from the Foundation for Polish Science (FNP); EU structural funds within Action 1.2 "Strengthening the personnel potential of science" POIG of the Innovative Economy Operational Programme (DD); funds for the project "beta-escin-a new agent in the skeletal muscle regeneration improvement?"; European Union Operational Programme "Innovative Economy"; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was funded by the European Union under the Operational Programme "Innovative Economy" grant no. POIG.01.01.02-14-072/09 entitled "Search of innovative endothelial drug in a group of new escin derivatives" (KK). Funding was also provided by the Homing Plus for the project HOMING PLUS/2011-3/1 "Development of targeted mass spectrometry-based proteomic assays for the discovery of a novel endothelium-specific pharmaceutical for the treatment of human vascular diseases" from the Foundation for Polish Science (FNP) co-financed from EU structural funds within Action 1.2 "Strengthening the personnel potential of science" POIG 2007-2013 of the Innovative Economy Operational Programme (DD). Foundation for Polish Science supported the project by providing funds for the project Bridge/2013-8/8 "beta-escin-a new agent in the skeletal muscle regeneration improvement?" (KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the below mentioned funders provided support in form of salaries, but also all the materials for the study were purchased with the obtained funding: 1. European Union Operational Programme "Innovative Economy" Award Number: POIG.01.01.02-14-072/09. The funder provided support in the form of salaries for OZ-S, IG, MDu, MK, DM, KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. 2. Foundation for Polish Science, Award Number: HOMING PLUS/2011-3/1. The funder provided support in the form of salaries for DD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. 3. Foundation for Polish Science, Award Number: Bridge/2013-8/8. The funder provided support in the form of salaries for IG and KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Arnould T, 1996, EUR J PHARMACOL, V315, P227, DOI 10.1016/S0014-2999(96)00645-0; Atkinson SJ, 2004, FEBS LETT, V566, P65, DOI 10.1016/j.febslet.2004.04.040; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bottger S, 2013, BIOORGAN MED CHEM, V21, P7118, DOI 10.1016/j.bmc.2013.09.008; Boncler M, 2014, J PHARMACOL TOX MET, V69, P9, DOI 10.1016/j.vascn.2013.09.003; Breen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034516; Burger K, 2000, CELL MOL LIFE SCI, V57, P1577, DOI 10.1007/PL00000643; Chauhan NB, 2003, J LIPID RES, V44, P2019, DOI 10.1194/jlr.R300010-JLR200; Debruin EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108881; Deng D, 2009, BBA-BIOMEMBRANES, V1788, P470, DOI 10.1016/j.bbamem.2008.11.018; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; FACINO RM, 1995, ARCH PHARM, V328, P720, DOI 10.1002/ardp.19953281006; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Frick RW, 2000, ANGIOLOGY, V51, P197, DOI 10.1177/000331970005100303; Galbete JL, 2000, BIOCHEM J, V348, P307, DOI 10.1042/0264-6021:3480307; GUILLAUME M, 1994, ARZNEIMITTELFORSCH, V44-1, P25; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; Habegger KM, 2012, DIABETOLOGIA, V55, P457, DOI 10.1007/s00125-011-2334-y; Hannaford J, 2013, OBESITY, V21, P1586, DOI 10.1002/oby.20136; Harikumar KB, 2010, MOL PHARMACOL, V77, P818, DOI 10.1124/mol.109.062760; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Kaczmarek E, 2005, THROMB HAEMOSTASIS, V93, P735, DOI 10.1160/TH04-09-0576; Khatibzadeh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057147; Kilarski WW, 2003, EXP CELL RES, V291, P70, DOI 10.1016/S0014-4827(03)00374-4; Kim JY, 2010, BIOCHEM PHARMACOL, V79, P431, DOI 10.1016/j.bcp.2009.09.016; Kucukkurt I, 2010, J ETHNOPHARMACOL, V129, P18, DOI 10.1016/j.jep.2010.02.017; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Malinowska A, 2012, J PROTEOMICS, V75, P4062, DOI 10.1016/j.jprot.2012.05.030; Marquer C, 2011, FASEB J, V25, P1295, DOI 10.1096/fj.10-168633; Matsuda H, 1997, BIOL PHARM BULL, V20, P1092, DOI 10.1248/bpb.20.1092; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Montopoli M, 2007, PLANTA MED, V73, P285, DOI 10.1055/s-2007-967118; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Pittler MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003230.pub4; Pittler MH, 1998, ARCH DERMATOL, V134, P1356, DOI 10.1001/archderm.134.11.1356; Qiao J, 2013, INFLAMM RES, V62, P461, DOI 10.1007/s00011-013-0598-z; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SAKAKIBARA K, 1975, CHEM PHARM BULL, V23, P1009; Schnittler H, 2014, CELL TISSUE RES, V355, P529, DOI 10.1007/s00441-014-1856-2; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sirtori CR, 2001, PHARMACOL RES, V44, P183, DOI 10.1006/phrs.2001.0847; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Hammerness Paul, 2002, Journal of Herbal Pharmacotherapy, V2, P71; Wang T, 2014, TOXICOL MECH METHOD, V24, P560, DOI 10.3109/15376516.2014.951815; Wang XH, 2008, VASC PHARMACOL, V49, P158, DOI 10.1016/j.vph.2008.07.005; Winiarska M, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050064; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Zeng CB, 2001, AM J PHYSIOL-CELL PH, V281, pC932, DOI 10.1152/ajpcell.2001.281.3.C932; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	52	28	31	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164365	10.1371/journal.pone.0164365	http://dx.doi.org/10.1371/journal.pone.0164365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727329	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504400029
J	Bu, HL; Wang, F; McShea, WJ; Lu, Z; Wang, DJ; Li, S				Bu, Hongliang; Wang, Fang; McShea, William J.; Lu, Zhi; Wang, Dajun; Li, Sheng			Spatial Co-Occurrence and Activity Patterns of Mesocarnivores in the Temperate Forests of Southwest China	PLOS ONE			English	Article							CAT PRIONAILURUS-BENGALENSIS; MESOPREDATOR RELEASE; MARTES-FLAVIGULA; SMALL CARNIVORES; TROPICAL FOREST; DIETARY SHIFTS; PAGUMA-LARVATA; HABITAT USE; CONSERVATION; WILD	Understanding the interactions between species and their coexistence mechanisms will help explain biodiversity maintenance and enable managers to make sound conservation decisions. Mesocarnivores are abundant and diverse mid-sized carnivores and can have profound impacts on the function, structure and dynamics of ecosystem after the extirpation of apex predators in many ecosystems. The moist temperate forests of Southwest China harbor a diverse community of mesocarnivores in the absence of apex predators. Sympatric species tend to partition limited resources along time, diet and space to facilitate coexistence. We determined the spatial and temporal patterns for five species of mesocarnivores. We used detection histories from a large camera-trap dataset collected from 2004-2015 with an extensive effort of 23,313 camera-days from 495 camera locations. The five mesocarnivore species included masked palm civet Paguma larvata, leopard cat Prionailurus bengalensis, hog badger Arctonyx collaris, yellow-throated marten Martes flavigula, and Siberian weasel Mustela sibirica. Only the masked palm civet and hog badger tended to avoid each other; while for other pairs of species, they occurred independently of each other, or no clear pattern observed. With regard to seasonal activity, yellow-throated marten was most active in winter, opposite the pattern observed for masked palm civet, leopard cat and hog badger. For diel activity, masked palm civet, leopard cat and hog badger were primarily nocturnal and crepuscular; yellow-throated marten was diurnal, and Siberian weasel had no clear pattern for most of the year (March to November), but was nocturnal in the winter (December to February). The seasonal shift of the Siberian weasel may be due to the high diet overlap among species in winter. Our results provided new facts and insights into this unique community of mesocarnivores of southwest China, and will facilitate future studies on the mechanism determining coexistence of animal species within complex system.	[Bu, Hongliang; Lu, Zhi; Wang, Dajun; Li, Sheng] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Wang, Fang] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA; [McShea, William J.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA	Peking University; Michigan State University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Wang, DJ; Li, S (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	djwang@pku.edu.cn; shengli@pku.edu.cn	Wang, Fang/AIC-7698-2022	McShea, William/0000-0002-8102-0200; Wang, Fang/0000-0002-3922-5851	Sichuan Nature Conservancy Foundation [SNCF/PU092013]	Sichuan Nature Conservancy Foundation	This work was funded by the Sichuan Nature Conservancy Foundation, grant number: SNCF/PU092013	[Anonymous], OVERLAP ESTIMATES CO; Austin Sean C., 2007, Acta Zoologica Sinica, V53, P1; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; CASE TJ, 1991, TRENDS ECOL EVOL, V6, P135, DOI 10.1016/0169-5347(91)90093-D; Chen MT, 2009, MAMMALIA, V73, P20, DOI 10.1515/MAMM.2009.006; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chiang PJ, 2012, ZOOL STUD, V51, P500; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gehrt SD, 2003, WILDLIFE SOC B, V31, P836; Gerber BD, 2012, J MAMMAL, V93, P667, DOI 10.1644/11-MAMM-A-265.1; Grassman LI, 2000, ACTA THERIOL, V45, P421, DOI 10.4098/AT.arch.00-41; Grassman LI, 2005, J ZOOL, V266, P45, DOI 10.1017/S095283690500659X; Grassman LI, 2005, WILDLIFE BIOL, V11, P49, DOI 10.2981/0909-6396(2005)11[49:RHUAAP]2.0.CO;2; Henke SE, 1999, J WILDLIFE MANAGE, V63, P1066, DOI 10.2307/3802826; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hines J., 2006, PRESENCE2 SOFTWARE E; Johnson A, 2009, ORYX, V43, P626, DOI 10.1017/S0030605309990238; Kang M., 1997, J HUNAN AGR U, V23, P366; King C.M., 2007, NATURAL HIST WEASELS; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Laguardia A, 2017, ORYX, V51, P153, DOI 10.1017/S0030605315000988; Li S, 2012, DIVERS DISTRIB, V18, P1166, DOI 10.1111/j.1472-4642.2012.00907.x; Li S, 2010, IBIS, V152, P299, DOI 10.1111/j.1474-919X.2009.00989.x; Linkie M, 2011, J ZOOL, V284, P224, DOI 10.1111/j.1469-7998.2011.00801.x; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manly B.F.J., 2002, RESOURCE SELECTION A; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nouvellet P, 2012, J ZOOL, V286, P179, DOI 10.1111/j.1469-7998.2011.00864.x; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; R Core Team, 2015, R LANG ENV STAT COMP; RABINOWITZ A, 1990, BIOTROPICA, V22, P397, DOI 10.2307/2388557; Rajaratnam R., 2000, ECOLOGY LEOPARD CAT; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; SCHMITT RJ, 1986, OECOLOGIA, V69, P1, DOI 10.1007/BF00399030; SCHOENER TW, 1974, P NATL ACAD SCI USA, V71, P4169, DOI 10.1073/pnas.71.10.4169; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P1628, DOI 10.2193/2009-571; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Smith AT, 2010, GUIDE ESTIMATES PRB; Tilson R, 2004, ORYX, V38, P40, DOI 10.1017/S0030605304000079; Tilson R, 1997, ORYX, V31, P243, DOI 10.1046/j.1365-3008.1997.d01-123.x; Wang F, 2015, BIOL CONSERV, V186, P319, DOI 10.1016/j.biocon.2015.03.032; Wang Jia-jia, 2014, Shengtaixue Zazhi, V33, P352; Wang YW, 2015, BIOL CONSERV, V190, P23, DOI 10.1016/j.biocon.2015.05.007; Xiong MY, 2016, J MAMMAL, V97, P1054, DOI 10.1093/jmammal/gyw061; Zhou YB, 2011, J MAMMAL, V92, P611, DOI 10.1644/10-MAMM-A-296.1; Zhou YB, 2008, J MAMMAL, V89, P435, DOI 10.1644/07-MAMM-A-048R1.1; Zhou YB, 2015, EUR J WILDLIFE RES, V61, P125, DOI 10.1007/s10344-014-0881-5; Zhou YB, 2014, J MAMMAL, V95, P534, DOI 10.1644/13-MAMM-A-185	61	45	63	6	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164271	10.1371/journal.pone.0164271	http://dx.doi.org/10.1371/journal.pone.0164271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723772	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100038
J	Nita, A; Rozylowicz, L; Manolache, S; Ciocanea, CM; Miu, IV; Popescu, VD				Nita, Andreea; Rozylowicz, Laurentiu; Manolache, Steluta; Ciocanea, Cristiana Maria; Miu, Iulia Viorica; Popescu, Viorel Dan			Collaboration Networks in Applied Conservation Projects across Europe	PLOS ONE			English	Article							GOVERNANCE; IMPLEMENTATION; IMPACT; KEY	The main funding instrument for implementing EU policies on nature conservation and supporting environmental and climate action is the LIFE Nature programme, established by the European Commission in 1992. LIFE Nature projects (>1400 awarded) are applied conservation projects in which partnerships between institutions are critical for successful conservation outcomes, yet little is known about the structure of collaborative networks within and between EU countries. The aim of our study is to understand the nature of collaboration in LIFE Nature projects using a novel application of social network theory at two levels: (1) collaboration between countries, and (2) collaboration within countries using six case studies: Western Europe (United Kingdom and Netherlands), Eastern Europe (Romania and Latvia) and Southern Europe (Greece and Portugal). Using data on 1261 projects financed between 1996 and 2013, we found that Italy was the most successful country not only in terms of awarded number of projects, but also in terms of overall influence being by far the most influent country in the European LIFE Nature network, having the highest eigenvector (0.989) and degree centrality (0.177). Another key player in the network is Netherlands, which ensures a fast communication flow with other network members (closeness-0.318) by staying connected with the most active countries. Although Western European countries have higher centrality scores than most of the Eastern European countries, our results showed that overall there is a lower tendency to create partnerships between different organization categories. Also, the comparisons of the six case studies indicates significant differences in regards to the pattern of creating partnerships, providing valuable information on collaboration on EU nature conservation. This study represents a starting point in predicting the formation of future partnerships within LIFE Nature programme, suggesting ways to improve transnational cooperation and communication.	[Nita, Andreea; Rozylowicz, Laurentiu; Manolache, Steluta; Ciocanea, Cristiana Maria; Miu, Iulia Viorica; Popescu, Viorel Dan] Univ Bucharest, Ctr Environm Res & Impact Studies, Bucharest, Romania; [Popescu, Viorel Dan] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University of Bucharest; University System of Ohio; Ohio University	Nita, A (corresponding author), Univ Bucharest, Ctr Environm Res & Impact Studies, Bucharest, Romania.	andreea.nita@cc.unibuc.ro	Popescu, Viorel/AAP-4699-2021; Nita, Andreea/W-2056-2018; Nita, Andreea/AAY-6874-2021; Miu, Iulia Viorica/U-4431-2017; Rozylowicz, Laurentiu/B-4540-2009; Ciocanea, Cristiana-Maria/AAM-2915-2020; CIOCANEA, CRISTIANA M/E-4859-2017	Nita, Andreea/0000-0002-0661-608X; Nita, Andreea/0000-0002-0661-608X; Miu, Iulia Viorica/0000-0002-5060-537X; Rozylowicz, Laurentiu/0000-0001-7174-032X; Ciocanea, Cristiana-Maria/0000-0001-6060-2749; CIOCANEA, CRISTIANA M/0000-0001-6060-2749	grant of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PN-II-RU-TE-2014-4-1039]	grant of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	The authors were supported by a grant of the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://uefiscdi.gov.ro), PN-II-RU-TE-2014-4-1039.	Apostolopoulou E, 2014, INT J SUST DEV WORLD, V21, P481, DOI 10.1080/13504509.2014.979904; Berardo R, 2014, POLICY STUD J, V42, P197, DOI 10.1111/psj.12056; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bodin O, 2016, ECOL SOC, V21, DOI 10.5751/ES-08368-210140; Bodin O, 2014, CONSERV BIOL, V28, P1371, DOI 10.1111/cobi.12306; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Borgatti S., 2002, UCINET WINDOWS SOFTW; Borgatti S.P., 2018, ANAL SOCIAL NETWORKS; Borgatti SP, 1997, SOC NETWORKS, V19, P243, DOI 10.1016/S0378-8733(96)00301-2; Borrass L, 2015, ENVIRON POLIT, V24, P788, DOI 10.1080/09644016.2015.1027056; Brandes U, 2005, NETWWORK ANAL METHOL; Carrington P. J., 2005, MODELS METHODS SOCIA; Cent J, 2013, ENVIRON CONSERV, V40, P119, DOI 10.1017/S0376892912000380; Chen MH, 2015, APPL MATH COMPUT, V251, P192, DOI 10.1016/j.amc.2014.11.052; COWI, 2009, EXP EV PROJ ACT FI 4; Directive Council 92/43/EEC. Council Directive 92/43/EEC, 1992, OFFICIAL JOURNAL EEC, pL206; European Commission, 2016, LIFE PROJ DAT; Evans D, 2012, NAT CONSERV-BULGARIA, P11, DOI 10.3897/natureconservation.1.1808; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gruber B, 2012, NAT CONSERV-BULGARIA, P45, DOI 10.3897/natureconservation.3.3732; Guerrero AM, 2015, CONSERV LETT, V8, P107, DOI 10.1111/conl.12112; Hermoso V, 2017, CONSERV LETT, V10, P231, DOI 10.1111/conl.12248; Hermoso V, 2015, NATURE, V528, P193, DOI 10.1038/528193b; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Ioja CI, 2010, BIOL CONSERV, V143, P2468, DOI 10.1016/j.biocon.2010.06.013; Ioja IC, 2016, PROCEDIA ENVIRON SCI, V32, P4, DOI 10.1016/j.proenv.2016.03.007; Kark S, 2015, CURR OPIN ENV SUST, V12, P12, DOI 10.1016/j.cosust.2014.08.005; Kati V, 2015, CONSERV BIOL, V29, P260, DOI 10.1111/cobi.12366; Koontz TM, 2014, POLICY STUD J, V42, P416, DOI 10.1111/psj.12067; Koskinen J., 2013, EXPONENTIAL RANDOM G, P141; Lazega E, 2016, MULTILEVEL NETWORK A, DOI [10.1007/978-3-319-24520-1, DOI 10.1007/978-3-319-24520-1]; Lu E L, 2016, PHYS REP; Lubell M, 2014, ECOL SOC, V19, DOI 10.5751/ES-06880-190423; Fernandez AM, 2010, ENVIRON POLIT, V19, P557, DOI 10.1080/09644016.2010.489711; McAllister RRJ, 2015, POLICY STUD J, V43, P379, DOI 10.1111/psj.12103; McAllister RRJ, 2015, CURR OPIN ENV SUST, V12, P86, DOI 10.1016/j.cosust.2015.01.001; Muller A, 2015, NAT CONSERV-BULGARIA, P1, DOI 10.3897/natureconservation.12.4848; Nita A, 2015, LAND USE POLICY, V44, P145, DOI 10.1016/j.landusepol.2014.12.006; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Parau CE, 2015, POSTCOMMUNIST ROMANI, V12, P241; Popescu VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113648; Rauschmayer F, 2009, ENVIRON PLANN C, V27, P42, DOI 10.1068/c0703j; Rootes Christopher, 2003, ENV PROTEST W EUROPE; Silva JP, 2015, LIFE NEW PARTNERSHIP, DOI [10.2779/193419, DOI 10.2779/193419]; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Stanciu E, 2013, GOVERNANCE PROTECTED; Sun SW, 2016, PHYS LETT A, V380, P1912, DOI 10.1016/j.physleta.2016.03.048; Valente TW, 2010, SOC NETWORKS, V32, P212, DOI 10.1016/j.socnet.2010.03.003; Wang L, 2014, CHINESE SCI BULL, V59, P430, DOI 10.1007/s11434-013-0029-0; Wang P., 2009, PNET PROGRAM ESTIMAT; Wang P, 2013, SOC NETWORKS, V35, P211, DOI 10.1016/j.socnet.2011.12.004; Wang P, 2009, SOC NETWORKS, V31, P12, DOI 10.1016/j.socnet.2008.08.002; Wang Peng., 2013, EXPONENTIAL RANDOM G, P115; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Young JC, 2012, BIODIVERS CONSERV, V21, P1095, DOI 10.1007/s10531-012-0243-0	57	37	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164503	10.1371/journal.pone.0164503	http://dx.doi.org/10.1371/journal.pone.0164503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723834	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100067
J	Yang, XX; Duan, J; Fisher, J				Yang, Xiaoxia; Duan, John; Fisher, Jeffrey			Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; SINGLE-DOSE PHARMACOKINETICS; DL-THREO-METHYLPHENIDATE; HEALTHY-VOLUNTEERS; INTACT CAPSULE; DELIVERY-SYSTEMS; FORMULATIONS; DRUGS; BIOAVAILABILITY	A previously presented physiologically-based pharmacokinetic model for immediate release (IR) methylphenidate (MPH) was extended to characterize the pharmacokinetic behaviors of oral extended release (ER) MPH formulations in adults for the first time. Information on the anatomy and physiology of the gastrointestinal (GI) tract, together with the biopharmaceutical properties of MPH, was integrated into the original model, with model parameters representing hepatic metabolism and intestinal non-specific loss recalibrated against in vitro and in vivo kinetic data sets with IR MPH. A Weibull function was implemented to describe the dissolution of different ER formulations. A variety of mathematical functions can be utilized to account for the engineered release/dissolution technologies to achieve better model performance. The physiological absorption model tracked well the plasma concentration profiles in adults receiving a multilayer-release MPH formulation or Metadate CD, while some degree of discrepancy was observed between predicted and observed plasma concentration profiles for Ritalin LA and Medikinet Retard. A local sensitivity analysis demonstrated that model parameters associated with the GI tract significantly influenced model predicted plasma MPH concentrations, albeit to varying degrees, suggesting the importance of better understanding the GI tract physiology, along with the intestinal non-specific loss of MPH. The model provides a quantitative tool to predict the biphasic plasma time course data for ER MPH, helping elucidate factors responsible for the diverse plasma MPH concentration profiles following oral dosing of different ER formulations.	[Yang, Xiaoxia; Fisher, Jeffrey] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Duan, John] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Yang, XX (corresponding author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	xiaoxia.yang@fda.hhs.gov		Duan, John/0000-0002-6319-0599	U.S. Food and Drug Administration; National Center for the Toxicological Research	U.S. Food and Drug Administration; National Center for the Toxicological Research	This study was supported by U.S. Food and Drug Administration/National Center for the Toxicological Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented in the current paper do not necessarily represent the views of the FDA.	Abdul S, 2004, J CONTROL RELEASE, V97, P393, DOI 10.1016/j.jconrel.2004.03.034; Adjei A, 2014, J CHILD ADOL PSYCHOP, V24, P570, DOI 10.1089/cap.2013.0135; Adjei A, 2014, CLIN DRUG INVEST, V34, P795, DOI 10.1007/s40261-014-0234-x; Almukainzi M., 2014, DIABETES METAB, V5, P353; Argikar UA, 2016, AAPS J, V18, P1391, DOI 10.1208/s12248-016-9962-6; Avdeef A, 2007, ADV DRUG DELIVER REV, V59, P568, DOI 10.1016/j.addr.2007.05.008; Babiskin AH, 2015, J PHARM SCI-US, V104, P3170, DOI 10.1002/jps.24474; CHAN YM, 1980, CLIN BIOCHEM, V13, P266, DOI 10.1016/S0009-9120(80)80007-5; CLEMENTS SD, 1962, ARCH GEN PSYCHIAT, V6, P185; Clewell HJ, 2000, ENVIRON HEALTH PERSP, V108, P283, DOI 10.1289/ehp.00108s2283; CLEWELL HJ, 1994, RISK ANAL, V14, P521, DOI 10.1111/j.1539-6924.1994.tb00268.x; Coghill D, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-237; Covington TR, 2007, REGUL TOXICOL PHARM, V47, P1, DOI 10.1016/j.yrtph.2006.06.008; Di L, 2013, DRUG METAB DISPOS, V41, P1975, DOI 10.1124/dmd.113.054031; Edginton AN, 2009, ENVIRON HEALTH PERSP, V117, P645, DOI 10.1289/ehp.0800073; FARAJ BA, 1974, J PHARMACOL EXP THER, V191, P535; FDA, FDA DAT SET RIT LA M; FDA, 2001, FDA MED REV DEXM HCI; FDA, 2002, GUID IND BIOAV BIOEQ GUID IND BIOAV BIOEQ; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; Fenneteau F, 2010, J PHARM SCI-US, V99, P486, DOI 10.1002/jps.21802; Fischer R, 2006, INT J CLIN PHARM TH, V44, P135; Frolich J, 2014, EXPERT OPIN DRUG MET, V10, P1169, DOI 10.1517/17425255.2014.922542; Fu Y, 2010, EXPERT OPIN DRUG DEL, V7, P429, DOI 10.1517/17425241003602259; Gonzalez MA, 2002, INT J CLIN PHARM TH, V40, P175; Haessler F, 2008, INT J CLIN PHARM TH, V46, P466; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Hoeppner J, 2008, J NEURAL TRANSM, V115, P777, DOI 10.1007/s00702-007-0008-1; Hosenbocus S, 2009, J CAN ACAD CHILD ADO, V18, P331; IPCHP IPoCHP, 2010, 9 WHO; Khalil F, 2014, AAPS J, V16, P226, DOI 10.1208/s12248-013-9555-6; Kimko H, 2012, J PHARMACOKINET PHAR, V39, P161, DOI 10.1007/s10928-011-9238-9; King Cynthia R, 2003, Clin J Oncol Nurs, V7, P458; Lee L, 2003, BIOPHARM DRUG DISPOS, V24, P233, DOI 10.1002/bdd.358; Li J, 2015, CLIN PHARMACOKINET, V54, P179, DOI 10.1007/s40262-014-0192-8; Liu F, 2005, PSYCHIAT QUART, V76, P259, DOI 10.1007/s11126-005-2979-0; Maldonado R, 2013, EXPERT OPIN DRUG MET, V9, P1001, DOI 10.1517/17425255.2013.786041; Markowitz JS, 2003, PHARMACOTHERAPY, V23, P1281, DOI 10.1592/phco.23.12.1281.32697; Markowitz JS, 2003, CLIN PHARMACOKINET, V42, P393, DOI 10.2165/00003088-200342040-00007; Mithani SD, 1996, PHARMACEUT RES, V13, P163, DOI 10.1023/A:1016062224568; Moodley K, 2012, INT J MOL SCI, V13, P18, DOI 10.3390/ijms13010018; NTP-CERHR, 2005, NTP CERHR MON, pv; NTP-CERHR, 2005, NTP CERHR MON, pv; NTP-CERHR, 2005, NTP CERHR MON; Parrott N, 2009, AAPS J, V11, P45, DOI 10.1208/s12248-008-9079-7; Patrick KS, 2007, CLIN PHARMACOL THER, V81, P346, DOI 10.1038/sj.clpt.6100082; Patrick Kennerly S, 2005, Expert Opin Drug Deliv, V2, P121; Patrick KS, 2014, J PHARM SCI-US, V103, P3834, DOI 10.1002/jps.24202; Patrick KS, 2013, DRUG METAB DISPOS, V41, P197, DOI 10.1124/dmd.112.048595; Patrick KS, 1997, HUM PSYCHOPHARM CLIN, V12, P527, DOI 10.1002/(SICI)1099-1077(199711/12)12:6<527::AID-HUP932>3.0.CO;2-U; Pentikis HS, 2002, J AM ACAD CHILD PSY, V41, P443, DOI 10.1097/00004583-200204000-00017; Quinn D, 2007, J CLIN PHARMACOL, V47, P760, DOI 10.1177/0091270007299759; Quinney SK, 2005, J PHARMACOL EXP THER, V313, P1011, DOI 10.1124/jpet.104.081265; Reiz JL, 2008, CLIN THER, V30, P59, DOI 10.1016/j.clinthera.2008.01.002; Sager JE, 2015, DRUG METAB DISPOS, V43, P1823, DOI 10.1124/dmd.115.065920; Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488; Schutz H, 2009, INT J CLIN PHARM TH, V47, P761; Shankaran H, 2013, TOXICOL APPL PHARM, V273, P464, DOI 10.1016/j.taap.2013.05.024; Singh BN, 2005, DRUG DEVELOP RES, V65, P55, DOI 10.1002/ddr.20008; SRINIVAS NR, 1993, PHARMACEUT RES, V10, P14, DOI 10.1023/A:1018956526016; SRINIVAS NR, 1992, J PHARM SCI, V81, P747, DOI 10.1002/jps.2600810805; Sterner TR, 2013, ARCH TOXICOL, V87, P661, DOI 10.1007/s00204-012-0987-z; Sun ZJ, 2004, J PHARMACOL EXP THER, V310, P469, DOI 10.1124/jpet.104.067116; Swanson J, 1999, CLIN PHARMACOL THER, V66, P295, DOI 10.1016/S0009-9236(99)70038-X; Swanson J, 2011, NEUROPSYCHOPHARMACOL, V36, P207, DOI 10.1038/npp.2010.160; Swanson JM, 2002, J AM ACAD CHILD PSY, V41, P1306, DOI 10.1097/00004583-200211000-00011; Taketani M, 2007, LIFE SCI, V81, P924, DOI 10.1016/j.lfs.2007.07.026; Tan YM, 2006, J TOXICOL ENV HEAL A, V69, P1727, DOI 10.1080/15287390600631367; VALENTIN J, 2003, J ANN ICRP, V89; Wang YF, 2004, BIOPHARM DRUG DISPOS, V25, P91, DOI 10.1002/bdd.390; Wong YN, 1998, J CLIN PHARMACOL, V38, P276, DOI 10.1002/j.1552-4604.1998.tb04425.x; Xu L, 2009, DRUG METAB DISPOS, V37, P2330, DOI 10.1124/dmd.108.025494; Yang XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106101; Zhang HF, 2014, AAPS PHARMSCITECH, V15, P400, DOI 10.1208/s12249-014-0075-1; Zhang XY, 2011, AAPS J, V13, P59, DOI 10.1208/s12248-010-9250-9; Zhu LQ, 2016, EUR J DRUG METAB PH, V41, P395, DOI 10.1007/s13318-015-0271-8; Zhu LQ, 2015, KOREAN J PHYSIOL PHA, V19, P99, DOI 10.4196/kjpp.2015.19.2.99	77	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164641	10.1371/journal.pone.0164641	http://dx.doi.org/10.1371/journal.pone.0164641			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723791	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100077
J	Yoon, HJ; Shin, SR; Cha, JM; Lee, SH; Kim, JH; Do, JT; Song, H; Bae, H				Yoon, Hee Jeong; Shin, Su Ryon; Cha, Jae Min; Lee, Soo-Hong; Kim, Jin-Hoi; Do, Jeong Tae; Song, Hyuk; Bae, Hojae			Cold Water Fish Gelatin Methacryloyl Hydrogel for Tissue Engineering Application	PLOS ONE			English	Article							BIOMEDICAL APPLICATIONS; CROSS-LINKING; COMPLEX; SCAFFOLDS; FABRICATION; EXTRACTION; MICROGELS; STIFFNESS; ACID; SKIN	Gelatin methacryloyl (GelMA) is a versatile biomaterial that has been used in various biomedical fields. Thus far, however, GelMA is mostly obtained from mammalian sources, which are associated with a risk of transmission of diseases, such as mad cow disease, as well as certain religious restrictions. In this study, we synthesized GelMA using fish-derived gelatin by a conventional GelMA synthesis method, and evaluated its physical properties and cell responses. The lower melting point of fish gelatin compared to porcine gelatin allowed larger-scale synthesis of GelMA and enabled hydrogel fabrication at room temperature. The properties (mechanical strength, water swelling degree and degradation rate) of fish GelMA differed from those of porcine GelMA, and could be tuned to suit diverse applications. Cells adhered, proliferated, and formed networks with surrounding cells on fish GelMA, and maintained high initial cell viability. These data suggest that fish GelMA could be utilized in a variety of biomedical fields as a substitute for mammalian-derived materials.	[Yoon, Hee Jeong; Bae, Hojae] Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 05029, South Korea; [Shin, Su Ryon] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Cha, Jae Min] Samsung Med Ctr, Res Inst Future Med, Med Device Res Ctr, Seoul, South Korea; [Cha, Jae Min] Samsung Elect Co Ltd, Samsung Biomed Res Inst, Samsung Adv Inst Technol, Seoul, South Korea; [Lee, Soo-Hong] CHA Univ, Dept Biomed Sci, Gyeonggi Do, South Korea; [Kim, Jin-Hoi; Do, Jeong Tae; Song, Hyuk] Konkuk Univ, Dept Stem Cell & Regenerat Biol, Coll Anim Biosci & Technol, Seoul 05029, South Korea	Konkuk University; Harvard University; Brigham & Women's Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Pochon Cha University; Konkuk University	Bae, H (corresponding author), Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 05029, South Korea.	hojaebae@konkuk.ac.kr	Shin, Su Ryon/GRO-3950-2022	Shin, Su Ryon/0000-0003-0864-6482; Do, Jeong Tae/0000-0001-6721-1441; kim, jin-hoi/0000-0003-1232-5307; bae, hojae/0000-0003-3057-4999	Korean HealthTechnology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI13C1256]	Korean HealthTechnology R&D Project, Ministry of Health and Welfare, Republic of Korea	This article was supported by a grant from the Korean HealthTechnology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C1256).The authors declare no conflicts of interest related to the content of this article.The funder provided support in the form of salaries for authors [J. M. Cha], but did not have any additional role in the study design, data collection and analysis,decision to publish,or preparation of the manuscript.The specific roles of the seauthors are articulated in the 'author contributions' section The Samsung Electronics (Commercial affiliation) provided support in the form of salaries for author [J. M. Cha], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This article was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C1256). The authors declare no conflicts of interest related to the content of this article.	Abd Elgadir M, 2013, J FOOD AGRIC ENVIRON, V11, P73; Ahearne M, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0038; Annabi N, 2013, ADV FUNCT MATER, V23, P4950, DOI 10.1002/adfm.201300570; [Anonymous], [No title captured], DOI [10.1088/1758-5082/6/3/035020, DOI 10.1088/1758-5082/6/3/035020]; Araghi M, 2015, FOOD SCI NUTR, V3, P370, DOI 10.1002/fsn3.230; Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056; Badii F, 2006, FOOD HYDROCOLLOID, V20, P630, DOI 10.1016/j.foodhyd.2005.06.006; Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]; Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g; Coutinho DF, 2012, J MATER CHEM, V22, P17262, DOI 10.1039/c2jm31374j; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; EASTOE JE, 1957, BIOCHEM J, V65, P363, DOI 10.1042/bj0650363; Eng G, 2013, P NATL ACAD SCI USA, V110, P4551, DOI 10.1073/pnas.1300569110; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Farris S, 2009, TRENDS FOOD SCI TECH, V20, P316, DOI 10.1016/j.tifs.2009.04.003; Ganji F, 2010, IRAN POLYM J, V19, P375; Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048; Gomez-Guillen MC, 2009, TRENDS FOOD SCI TECH, V20, P3, DOI 10.1016/j.tifs.2008.10.002; Gudmundsson M, 1997, J FOOD SCI, V62, P37, DOI 10.1111/j.1365-2621.1997.tb04363.x; Gudmundsson M, 2002, J FOOD SCI, V67, P2172, DOI 10.1111/j.1365-2621.2002.tb09522.x; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Heo DN, 2014, J MATER CHEM B, V2, P1584, DOI 10.1039/c3tb21246g; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI 10.1089/ten.tea.2010.0666; Irwandi J., 2009, International Food Research Journal, V16, P381; Karim AA, 2009, FOOD HYDROCOLLOID, V23, P563, DOI 10.1016/j.foodhyd.2008.07.002; Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64; KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431; Kittiphattanabawon P, 2016, LWT-FOOD SCI TECHNOL, V66, P186, DOI 10.1016/j.lwt.2015.10.029; Klotz BJ, 2016, TRENDS BIOTECHNOL, V34, P394, DOI 10.1016/j.tibtech.2016.01.002; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003; Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e; Muyonga JH, 2004, FOOD HYDROCOLLOID, V18, P581, DOI 10.1016/j.foodhyd.2003.08.009; Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064; Okay O, 2009, SPRINGER SER CHEM SE, V6, P1, DOI 10.1007/978-3-540-75645-3_1; Omidian H., 1994, POLYM SCI TECHNOL, V3, P115; Padrao J, 2014, SOFT MATER, V12, P247, DOI 10.1080/1539445X.2013.873466; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Rose JB, 2014, MATERIALS, V7, P3106, DOI 10.3390/ma7043106; Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471; Selimovic S, 2012, POLYMERS-BASEL, V4, P1554, DOI 10.3390/polym4031554; Shin SR, 2013, ADV MATER, V25, P6385, DOI 10.1002/adma.201301082; Shin SR, 2012, ACS NANO, V6, P362, DOI 10.1021/nn203711s; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Somboon N., 2014, International Food Research Journal, V21, P485; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Yue K, 2015, BIOMATERIALS, V73, P254, DOI 10.1016/j.biomaterials.2015.08.045; Zhao X, 2016, ADV HEALTHC MATER, V5, P108, DOI 10.1002/adhm.201500005; Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]	50	69	70	8	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163902	10.1371/journal.pone.0163902	http://dx.doi.org/10.1371/journal.pone.0163902			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723807	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100012
J	Cordeau, M; Belounis, A; Lelaidier, M; Cordeiro, P; Sartelet, H; Herblot, S; Duval, M				Cordeau, Martine; Belounis, Assila; Lelaidier, Martin; Cordeiro, Paulo; Sartelet, Herve; Herblot, Sabine; Duval, Michel			Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; STEM-CELLS; GENE-EXPRESSION; BONE-MARROW; NK-CELLS; INDUCTION; CANCER; INTERLEUKIN-2; TRAIL; CHEMORESISTANCE	High-risk neuroblastoma ( NB) remains a major therapeutic challenge despite the recent advent of disialoganglioside (GD2)-antibody treatment combined with interleukin (IL)-2 and granulocyte monocyte-colony stimulating factor (GM-CSF). Indeed, more than one third of the patients still die from this disease. Here, we developed a novel approach to improve the current anti-GD2 immunotherapy based on NK cell stimulation using toll-like receptor (TLR)activated plasmacytoid dendritic cells (pDCs). We demonstrated that this strategy led to the efficient killing of NB cells. When the expression of GD2 was heterogeneous on NB cells, the combination of pDC-mediated NK-cell activation and anti-GD2 treatment significantly increased the cytotoxicity of NK cells against NB cells. Activation by pDCs led to a unique NK-cell phenotype characterized by increased surface expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), with increased expression of CD69 on CD56(dim) cytotoxic cells, and strong interferon-gamma production. Additionally, NB-cell killing was mediated by the TRAIL death-receptor pathway, as well as by the release of cytolytic granules via the DNAX accessory molecule 1 pathway. NK-cell activation and lytic activity against NB was independent of cell contact, depended upon type I IFN produced by TLR-9-activated pDCs, but was not reproduced by IFN-alpha stimulation alone. Collectively, these results highlighted the therapeutic potential of activated pDCs for patients with high-risk NB.	[Cordeau, Martine; Belounis, Assila; Lelaidier, Martin; Cordeiro, Paulo; Herblot, Sabine; Duval, Michel] CHU St Justine, Ctr Rech, Ctr Cancerol Charles Bruneau, GRETISC, Montreal, PQ, Canada; [Cordeau, Martine; Belounis, Assila; Lelaidier, Martin; Duval, Michel] Univ Montreal, Dept Microbiol & Immunol, Quebec City, PQ, Canada; [Herblot, Sabine; Duval, Michel] Univ Montreal, Dept Pediat, Quebec City, PQ, Canada; [Duval, Michel] Univ Montreal, Dept Biomed Sci, Quebec City, PQ, Canada; [Sartelet, Herve] CHU Grenoble, Dept Anat & Cytol Pathol, F-38043 Grenoble 9, France	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; Universite de Montreal; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Herblot, S (corresponding author), CHU St Justine, Ctr Rech, Ctr Cancerol Charles Bruneau, GRETISC, Montreal, PQ, Canada.; Herblot, S (corresponding author), Univ Montreal, Dept Pediat, Quebec City, PQ, Canada.	sabine.herblot@umontreal.ca			Fondation Centre de Cancerologie Charles-Bruneau; Fonds de recherche du Quebec - Sante; Fondation Centre hospitalier Universitaire Ste-Justine - Fondation des Etoiles; Canadian Institutes of Health Research; Foundation Centre de Cancerologie Charles-Bruneau; Fonds de recherche du Quebec en Sante; Fondation CHU Sainte-Justine-Fondation des Etoiles	Fondation Centre de Cancerologie Charles-Bruneau; Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Fondation Centre hospitalier Universitaire Ste-Justine - Fondation des Etoiles; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation Centre de Cancerologie Charles-Bruneau; Fonds de recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); Fondation CHU Sainte-Justine-Fondation des Etoiles	This work was supported by Fondation Centre de Cancerologie Charles-Bruneau: operating grant, MD; Fonds de recherche du Quebec - Sante: operating grant, MD; and Fondation Centre hospitalier Universitaire Ste-Justine - Fondation des Etoiles: fellowship, MC.; This work was supported by the Canadian Institutes of Health Research, The Foundation Centre de Cancerologie Charles-Bruneau, the Fonds de recherche du Quebec en Sante, the Fondation CHU Sainte-Justine-Fondation des Etoiles. The authors thank Dr. Pierre Teira for critical reading of this manuscript and helpful comments and Lubomir Alexandrov for his help with statistical analyses. We would like to thank Editage (www.editage.com) for English language editing.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; ALVARADO CS, 1989, CANCER, V63, P83, DOI 10.1002/1097-0142(19890101)63:1<83::AID-CNCR2820630114>3.0.CO;2-A; Aranda F, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29179; BARKER E, 1991, CANCER RES, V51, P144; Bayer AL, 2011, EUR J IMMUNOL, V41, P3467, DOI 10.1002/eji.201141611; Bottino C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00056; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Castriconi R, 2007, EUR J IMMUNOL, V37, P3190, DOI 10.1002/eji.200737546; Castriconi R, 2007, CANCER IMMUNOL IMMUN, V56, P1733, DOI 10.1007/s00262-007-0317-0; Charrier E, 2014, BIOL BLOOD MARROW TR, V20, P1501, DOI 10.1016/j.bbmt.2014.06.007; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Coulon A, 2011, NEOPLASIA, V13, P991, DOI 10.1593/neo.11800; Cournoyer S, 2012, GENE CHROMOSOME CANC, V51, P792, DOI 10.1002/gcc.21964; Delgado DC, 2010, CANCER RES, V70, P9554, DOI 10.1158/0008-5472.CAN-10-2211; Forlenza CJ, 2016, J CLIN ONCOL, V34, P2443, DOI 10.1200/JCO.2015.64.9558; Garner EF, 2016, CANCERS, V8, DOI 10.3390/cancers8010005; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Grossenbacher SK, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0124-2; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Iannello A, 2016, CURR OPIN IMMUNOL, V38, P52, DOI 10.1016/j.coi.2015.11.001; Institute NC, 2015, NEUR TREATM HLTH PRO, DOI 1016/j.molimm.2004.12.018; Johnsen JI, 2004, INT J ONCOL, V25, P1849; Kamijo T, 2012, PEDIATR RES, V71, P511, DOI 10.1038/pr.2011.54; Khalil MA, 2012, NEOPLASMA, V59, P737, DOI 10.4149/neo_2012_093; Ladenstein R, 1998, J CLIN ONCOL, V16, P953, DOI 10.1200/JCO.1998.16.3.953; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Lelaidier M, 2015, ONCOTARGET, V6, P29440, DOI 10.18632/oncotarget.4984; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lode HN, 1998, BLOOD, V91, P1706, DOI 10.1182/blood.V91.5.1706.1706_1706_1715; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lou YY, 2007, J IMMUNOL, V178, P1534, DOI 10.4049/jimmunol.178.3.1534; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Neal ZC, 2004, CLIN CANCER RES, V10, P4839, DOI 10.1158/1078-0432.CCR-03-0799; Perez-Martinez A, 2011, BIOL BLOOD MARROW TR, V17, P598, DOI 10.1016/j.bbmt.2010.10.019; Pinto NR, 2015, J CLIN ONCOL, V33, P3008, DOI 10.1200/JCO.2014.59.4648; Pisegna S, 2002, J IMMUNOL, V169, P68, DOI 10.4049/jimmunol.169.1.68; Reid GSD, 2009, CLIN CANCER RES, V15, P6602, DOI 10.1158/1078-0432.CCR-09-0829; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rong XX, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1086060; Ross RA, 2015, STEM CELL RES, V15, P419, DOI 10.1016/j.scr.2015.08.008; Sartelet H, 2012, HISTOPATHOLOGY, V60, P1144, DOI 10.1111/j.1365-2559.2012.04191.x; Sartelet H, 2012, IN VIVO, V26, P19; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Schrey D, 2015, J PEDIAT HEMATOL ONC, V37, pE150, DOI 10.1097/MPH.0000000000000308; Sheard MA, 2013, J IMMUNOTHER, V36, P319, DOI 10.1097/CJI.0b013e31829b4493; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Terzic T, 2014, EXPRESSION DIS UNPUB; Tong QS, 2008, WORLD J PEDIATR, V4, P58, DOI 10.1007/s12519-008-0012-z; Wagner LM, 2009, J CELL BIOCHEM, V107, P46, DOI 10.1002/jcb.22094; Wei F, 2015, ONCOTARGET, V6, P35023, DOI 10.18632/oncotarget.5280; Xing LL, 2015, WORLD J PEDIATR, V11, P54, DOI 10.1007/s12519-014-0529-2; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375; Zeng Y, 2005, MOL IMMUNOL, V42, P1311, DOI 10.1016/j.molimm.2004.12.018; Zhang LB, 2009, NEOPLASIA, V11, P426, DOI 10.1593/neo.09166	61	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164401	10.1371/journal.pone.0164401	http://dx.doi.org/10.1371/journal.pone.0164401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716850	Green Submitted, Green Published, gold			2022-12-27	WOS:000385698100049
J	Haile, D; Takele, A; Gashaw, K; Demelash, H; Nigatu, D				Haile, Demewoz; Takele, Abulie; Gashaw, Ketema; Demelash, Habtamu; Nigatu, Dabere			Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; HIV-1-INFECTED ADULTS; IMMUNOLOGICAL FAILURE; GENDER-DIFFERENCES; CIGARETTE-SMOKING; DRUG-RESISTANCE; THERAPY; DETERMINANTS; SURVIVAL; COHORT	Background Treatment failure defined as progression of disease after initiation of ART or when the anti-HIV medications can't control the infection. One of the major concerns over the rapid scaling up of ART is the emergence and transmission of HIV drug resistant strains at the population level due to treatment failure. This could lead to the failure of basic ART programs. Thus this study aimed to investigate the predictors of treatment failure among adult ART clients in Bale Zone Hospitals, South east Ethiopia. Methods Retrospective cohort study was employed in four hospitals of Bale zone named Goba, Robe, Ginir and Delomena. A total of 4,809 adult ART clients were included in the analysis from these four hospitals. Adherence was measured by pill count method. The Kaplan Meier (KM) curve was used to describe the survival time of ART patients without treatment failure. Bivariate and multivariable Cox proportional hazards regression models were used for identifying associated factors of treatment failure. Result The incidence rate of treatment failure was found 9.38 (95% CI 7.79-11.30) per 1000 person years. Male ART clients were more likely to experience treatment failure as compared to females [AHR = 4.49; 95% CI: (2.61-7.73)]. Similarly, lower CD4 count (<100 m(3)/dl) at initiation of ART was found significantly associated with higher odds of treatment failure [AHR = 3.79; 95% CI: (2.46-5.84). Bedridden [AHR = 5.02; 95% CI: (1.98-12.73)] and ambulatory [AHR = 2.12; 95% CI: (1.08-4.07)] patients were more likely to experience treatment failure as compared to patients with working functional status. TB co-infected clients had also higher odds to experience treatment failure [AHR = 3.06; 95% CI: (1.72-5.44)]. Those patients who had developed TB after ART initiation had higher odds to experience treatment failure as compared to their counter parts [AHR = 4.35; 95% CI: (1.99-9.54]. Having other opportunistic infection during ART initiation was also associated with higher odds of experiencing treatment failure [AHR = 7.0, 95% CI: (3.19-15.37)]. Similarly having fair [AHR = 4.99 95% CI: (1.90-13.13)] and poor drug adherence [AHR = 2.56; 95% CI: (1.12-5.86)] were significantly associated with higher odds of treatment failure as compared to clients with good adherence. Conclusion The rate of treatment failure in Bale zone hospitals needs attention. Prevention and control of TB and other opportunistic infections, promotion of ART initiation at higher CD4 level, and better functional status, improving drug adherence are important interventions to reduce treatment failure among ART clients in Southeastern Ethiopia.	[Haile, Demewoz] Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Takele, Abulie; Gashaw, Ketema; Nigatu, Dabere] Madda Walabu Univ, Dept Nursing, Coll Med & Hlth Sci, Bale Goba, Ethiopia; [Demelash, Habtamu] Debre Tabor Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Debre Tabor, Ethiopia	Addis Ababa University	Haile, D (corresponding author), Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia.	demewozhaile@yahoo.com	Nigatu, Dabere/Q-9332-2018	Nigatu, Dabere/0000-0001-7303-6723; Haile, Demewoz/0000-0003-0047-4276; Demelash Enyew, Habtamu/0000-0002-9381-2184	Madda Walabu University	Madda Walabu University	This study was supported by Madda Walabu University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Madda Walabu University for financing this study.	Abebe N, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.88.3262; Agarwal A, 2013, J AIDS CLIN RES, V4, P210, DOI [10.4172/2155-6113.1000210, DOI 10.4172/2155-6113.1000210]; Aldous JL, 2009, CURR OPIN HIV AIDS, V4, P459, DOI 10.1097/COH.0b013e328331dea5; Amenyah R, 2006, 16 INT AIDS C; Amuron B, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-39; [Anonymous], ETHIOPIAN J HLTH SCI; [Anonymous], 2012, WORLD J AIDS, DOI DOI 10.4236/WJA.2012.24036; Austin PC, 2004, J CLIN EPIDEMIOL, V57, P1138, DOI 10.1016/j.jclinepi.2004.04.003; Bacha T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-197; BAJUNIRWE F, 2007, 4 IAS C HIV PATH TRE; Bale zone Health Office, 2013, ANN REP ANT REP BAL; Bhatta L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-604; Biadgilign S, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-15; Cozzi-Lepri A, 2008, AIDS, V22, P2187, DOI 10.1097/QAD.0b013e328310e04f; Deeks SG, 2009, CLIN INFECT DIS, V49, P1582, DOI 10.1086/644768; Dragsted UB, 2004, J INFECT DIS, V190, P148, DOI 10.1086/420786; Federal Ministry of Health, 2007, NAT GUID ANT TREATM; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hymowitz N, 1997, Tob Control, V6 Suppl 2, pS57, DOI 10.1136/tc.6.suppl_2.S57; Jagoe K, 2002, TOB CONTROL, V11, P210, DOI 10.1136/tc.11.3.210; Kapesa Anthony, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS620; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Laprise C, 2013, CLIN INFECT DIS, V57, P1489, DOI 10.1093/cid/cit529; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Mageda K, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/843598; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-28; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Palladino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082718; Penot P, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18646; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Poka-Mayap V, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003210; Reda AA, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-39; Rudatsikira E, 2008, SINGAP MED J, V49, P57; Steyn K, 2002, J CARDIOVASC RISK, V9, P161, DOI 10.1097/00043798-200206000-00005; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; Tsegaye E, 2011, ETHIOPIAN J HLTH DEV, V25; World Health Organization, HIV DRUG RES REP 201; Yayehirad Alemu Melsew, 2013, Journal of AIDS and Clinical Research, V4, P211	41	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164299	10.1371/journal.pone.0164299	http://dx.doi.org/10.1371/journal.pone.0164299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716827	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100041
J	Jerath, G; Hazam, PK; Shekhar, S; Ramakrishnan, V				Jerath, Gaurav; Hazam, Prakash Kishore; Shekhar, Shashi; Ramakrishnan, Vibin			Mapping the Geometric Evolution of Protein Folding Motor	PLOS ONE			English	Article							ACID SUBSTITUTION MATRICES; DESIGN; PATHWAYS; DATABASE; SIMULATION; STABILITY; KINETICS; HAIRPIN	Polypeptide chain has an invariant main-chain and a variant side-chain sequence. How the side-chain sequence determines fold in terms of its chemical constitution has been scrutinized extensively and verified periodically. However, a focussed investigation on the directive effect of side-chain geometry may provide important insights supplementing existing algorithms in mapping the geometrical evolution of protein chains and its structural preferences. Geometrically, folding of protein structure may be envisaged as the evolution of its geometric variables:phi, and. dihedral angles of polypeptide main-chain directed by chi(1), and chi(2) of side chain. In this work, protein molecule is metaphorically modelled as a machine with 4 rotors phi, psi chi(1) and chi(2), with its evolution to the functional fold is directed by combinations of its rotor directions. We observe that differential rotor motions lead to different secondary structure formations and the combinatorial pattern is unique and consistent for particular secondary structure type. Further, we found that combination of rotor geometries of each amino acid is unique which partly explains how different amino acid sequence combinations have unique structural evolution and functional adaptation. Quantification of these amino acid rotor preferences, resulted in the generation of 3 substitution matrices, which later on plugged in the BLAST tool, for evaluating their efficiency in aligning sequences. We have employed BLOSUM62 and PAM30 as standard for primary evaluation. Generation of substitution matrices is a logical extension of the conceptual framework we attempted to build during the development of this work. Optimization of matrices following the conventional routines and possible application with biologically relevant data sets are beyond the scope of this manuscript, though it is a part of the larger project design.	[Jerath, Gaurav; Hazam, Prakash Kishore; Shekhar, Shashi; Ramakrishnan, Vibin] Indian Inst Technol, Dept Biosci & Bioengn, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Ramakrishnan, V (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Gauhati, Assam, India.	vibin@iitg.ernet.in	Jerath, Gaurav/AAS-5621-2021; Vibin, Ramakrishnan/AAO-6868-2021	Jerath, Gaurav/0000-0001-6584-6048; Vibin, Ramakrishnan/0000-0002-8048-3211	Department of Biotechnology, Govt. of India [BT/350/NE/TBP/2012]; Indian Institute of Technology Guwahati, India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Indian Institute of Technology Guwahati, India	This study was jointly funded by Department of Biotechnology, Govt. of India (Grant number: BT/350/NE/TBP/2012), and Indian Institute of Technology Guwahati, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Beauchamp KA, 2012, P NATL ACAD SCI USA, V109, P17807, DOI 10.1073/pnas.1201810109; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogatyreva NS, 2009, NUCLEIC ACIDS RES, V37, pD342, DOI 10.1093/nar/gkn696; Chakrabarti P, 2001, PROG BIOPHYS MOL BIO, V76, P1, DOI 10.1016/S0079-6107(01)00005-0; Cole BJ, 2009, PROTEIN SCI, V18, P1602, DOI 10.1002/pro.182; Dahiyat BI, 1996, PROTEIN SCI, V5, P895, DOI 10.1002/pro.5560050511; Dayhoff M., 1978, ATLAS PROTEIN SEQUEN; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Flory P., 1989, STAT MECH CHAIN MOL; Fulton KF, 2005, NUCLEIC ACIDS RES, V33, pD279, DOI 10.1093/nar/gki016; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Karle IL, 2000, P NATL ACAD SCI USA, V97, P3034, DOI 10.1073/pnas.070042697; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lapidus LJ, 2014, BIOPHYS J, V107, P947, DOI 10.1016/j.bpj.2014.06.037; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; Lin CY, 2012, BIOPHYS J, V103, P99, DOI 10.1016/j.bpj.2012.05.029; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; LOVEJOY B, 1993, SCIENCE, V259, P1288, DOI 10.1126/science.8446897; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Novotny M, 2005, J MOL BIOL, V347, P231, DOI 10.1016/j.jmb.2005.01.037; Pancsa R, 2016, BIOPHYS J, V110, P572, DOI 10.1016/j.bpj.2015.12.028; Park H, 2016, PROTEINS, V84, P314, DOI 10.1002/prot.24862; Ramakrishnan V, 2012, PROTEINS, V80, P920, DOI 10.1002/prot.23249; Shapovalov Maxim V, STRUCTURE, V19, P844, DOI [10.1016/j.str.2011.03.019, DOI 10.1016/J.STR.2011.03.019]; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yang JY, 2016, PROTEINS, V84, P233, DOI 10.1002/prot.24918; Yu YK, 2005, BIOINFORMATICS, V21, P902, DOI 10.1093/bioinformatics/bti070	31	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163993	10.1371/journal.pone.0163993	http://dx.doi.org/10.1371/journal.pone.0163993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716851	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100015
J	Feng, J; Shi, SL; Pei, LY; Lv, JP; Liu, Q; Xie, SL				Feng, Jia; Shi, Shengli; Pei, Liangyu; Lv, Junping; Liu, Qi; Xie, Shulian			Preparation of Activated Carbon From Polygonum orientale Linn. to Remove the Phenol in Aqueous Solutions	PLOS ONE			English	Article							WASTE-WATER; MALACHITE GREEN; METHYLENE-BLUE; ADSORPTION; 2,4-DICHLOROPHENOL; KINETICS; DYE; WOOD	Phenol components are major industry contaminants of aquatic environment. Among all practical methods for removing phenol substances from polluted water, activated carbon absorption is the most effective way. Here, we have produced low-cost activated carbon using Polygonum orientale Linn, a wide spreading species with large biomass. The phenol adsorption ability of this activated carbon was evaluated at different physico-chemical conditions. Average equilibrium time for adsorption was 120 min. The phenol adsorption ability of the P. orientale activated carbon was increased as the pH increases and reached to the max at pH 9.00. By contrast, the ionic strength had little effect on the phenol absorption. The optimum dose for phenol adsorption by the P. orientale activated carbon was 20.00 g/L. The dominant adsorption mechanism of the P. orientale activated carbon was chemisorption as its phenol adsorption kinetics matched with the pseudo-second-order kinetics. In addition, the equilibrium data were fit to the Langmuir model, with the negative standard free energy and the positive enthalpy, suggesting that adsorption was spontaneous and endothermic.	[Feng, Jia; Shi, Shengli; Pei, Liangyu; Lv, Junping; Liu, Qi; Xie, Shulian] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China	Shanxi University	Xie, SL (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China.	xiesl@sxu.edu.cn			Social Development Foundation of Shanxi [201603D321001]	Social Development Foundation of Shanxi	The work was supported by Social Development Foundation of Shanxi (no. 201603D321001 to Jia Feng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2003, APPL CATAL B-ENVIRON, V46, P229, DOI 10.1016/S0926-3373(03)00229-7; Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006; BANERJI SK, 1994, J HAZARD MATER, V39, P19, DOI 10.1016/0304-3894(94)00044-1; BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0; Busca G, 2008, J HAZARD MATER, V160, P265, DOI 10.1016/j.jhazmat.2008.03.045; Chen CL, 2007, APPL GEOCHEM, V22, P436, DOI 10.1016/j.apgeochem.2006.11.010; Cheung WH, 2007, BIORESOURCE TECHNOL, V98, P2897, DOI 10.1016/j.biortech.2006.09.045; Coniglio MS, 2008, CHEMOSPHERE, V72, P1035, DOI 10.1016/j.chemosphere.2008.04.003; Dabrowski A, 2005, CHEMOSPHERE, V58, P1049, DOI 10.1016/j.chemosphere.2004.09.067; Das S, 2008, CHEM ENG J, V138, P215, DOI 10.1016/j.cej.2007.06.030; El-Hendawy ANA, 2003, CARBON, V41, P713, DOI 10.1016/S0008-6223(03)00029-0; Ferrero A, 1998, INT S CROP, V50, P833; Freundlich H, 1906, J PHYS CHEM, V40, P1361; Garg VK, 2004, DYES PIGMENTS, V62, P1, DOI 10.1016/j.dyepig.2003.10.016; Graham N, 2003, CHEMOSPHERE, V51, P237, DOI 10.1016/S0045-6535(02)00815-9; Guo J, 2003, MATER CHEM PHYS, V80, P114, DOI 10.1016/S0254-0584(02)00383-8; Gupta VK, 2004, SEP PURIF TECHNOL, V40, P87, DOI 10.1016/j.seppur.2004.01.008; HAUKOS DA, 1993, WILDLIFE SOC B, V21, P288; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Jha P, 2013, INT BIODETER BIODEGR, V77, P106, DOI 10.1016/j.ibiod.2012.11.001; Kalavathy MH, 2005, J COLLOID INTERF SCI, V292, P354, DOI 10.1016/j.jcis.2005.05.087; Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0; Karthikeyan T, 2005, J HAZARD MATER, V124, P192, DOI 10.1016/j.jhazmat.2005.05.003; Kavitha D, 2007, BIORESOURCE TECHNOL, V98, P14, DOI 10.1016/j.biortech.2005.12.008; Kulkarni Sunil J., 2013, INT J SCI RES PUBL, V3, P1; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Lim WC, 2010, J ANAL APPL PYROL, V88, P181, DOI 10.1016/j.jaap.2010.04.004; Lutzenkirchen J, 1997, J COLLOID INTERF SCI, V195, P149, DOI 10.1006/jcis.1997.5160; Mall ID, 2005, COLLOID SURFACE A, V264, P17, DOI 10.1016/j.colsurfa.2005.03.027; Moreno-Castilla C, 2004, CARBON, V42, P83, DOI 10.1016/j.carbon.2003.09.022; Nakbanpote W, 2000, MINER ENG, V13, P391, DOI 10.1016/S0892-6875(00)00021-2; Nath K, 2013, ENVIRON SCI POLLUT R, V20, P4030, DOI 10.1007/s11356-012-1325-y; Ozer A, 2006, DYES PIGMENTS, V71, P83, DOI 10.1016/j.dyepig.2005.06.004; Pavan FA, 2008, DYES PIGMENTS, V76, P64, DOI 10.1016/j.dyepig.2006.08.027; POOTS VJP, 1978, J WATER POLLUT CON F, V50, P926; Rajeshwarisivaraj, 2001, BIORESOURCE TECHNOL, V80, P233, DOI 10.1016/S0960-8524(00)00179-6; Rengaraj S, 2002, WASTE MANAGE, V22, P543, DOI 10.1016/S0956-053X(01)00016-2; Sathishkumar M, 2009, CHEM ENG J, V147, P265, DOI 10.1016/j.cej.2008.07.020; Sathishkumar M, 2007, BIORESOURCE TECHNOL, V98, P866, DOI 10.1016/j.biortech.2006.03.002; Vimonses V, 2009, CHEM ENG J, V148, P354, DOI 10.1016/j.cej.2008.09.009; Wang K, 2014, ENVIRON MONIT ASSESS, V186, P8667, DOI 10.1007/s10661-014-4034-9; Wang L, 2011, DESALINATION, V254, P68; Wang L, 2011, DESALINATION, V266, P175, DOI 10.1016/j.desal.2010.08.022; Wang L, 2010, BIORESOURCE TECHNOL, V101, P5808, DOI 10.1016/j.biortech.2010.02.099; WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Wu FC, 2005, J COLLOID INTERF SCI, V283, P49, DOI 10.1016/j.jcis.2004.08.037; [杨志云 Yang Zhiyun], 2008, [中国野生植物资源, Chinese Wild Plant Resources], V27, P11	48	7	8	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164744	10.1371/journal.pone.0164744	http://dx.doi.org/10.1371/journal.pone.0164744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741305	Green Submitted, Green Published, gold			2022-12-27	WOS:000385507000063
J	Kim, H; Park, CM; Lee, M; Park, SJ; Song, YS; Lee, JH; Hwang, EJ; Goo, JM				Kim, Hyungjin; Park, Chang Min; Lee, Myunghee; Park, Sang Joon; Song, Yong Sub; Lee, Jong Hyuk; Hwang, Eui Jin; Goo, Jin Mo			Impact of Reconstruction Algorithms on CT Radiomic Features of Pulmonary Tumors: Analysis of Intra- and Inter-Reader Variability and Inter-Reconstruction Algorithm Variability	PLOS ONE			English	Article							TEXTURE ANALYSIS; ITERATIVE RECONSTRUCTION; QUANTITATIVE FEATURES; LUNG; NODULES; HETEROGENEITY; REDUCTION; VOLUMETRY; COMPONENT; PHANTOM	Purpose To identify the impact of reconstruction algorithms on CT radiomic features of pulmonary tumors and to reveal and compare the intra- and inter-reader and inter-reconstruction algorithm variability of each feature. Methods Forty-two patients (M:F = 19: 23; mean age, 60.43 +/- 10.56 years) with 42 pulmonary tumors (22.56 +/- 8.51mm) underwent contrast-enhanced CT scans, which were reconstructed with filtered back projection and commercial iterative reconstruction algorithm (level 3 and 5). Two readers independently segmented the whole tumor volume. Fifteen radiomic features were extracted and compared among reconstruction algorithms. Intra-and inter-reader variability and inter-reconstruction algorithm variability were calculated using coefficients of variation (CVs) and then compared. Results Among the 15 features, 5 first-order tumor intensity features and 4 gray level co-occurrence matrix (GLCM)-based features showed significant differences (p<0.05) among reconstruction algorithms. As for the variability, effective diameter, sphericity, entropy, and GLCM entropy were the most robust features (CV <= 5%). Inter-reader variability was larger than intra-reader or inter-reconstruction algorithm variability in 9 features. However, for entropy, homogeneity, and 4 GLCM-based features, inter-reconstruction algorithm variability was significantly greater than inter-reader variability (p<0.013). Conclusions Most of the radiomic features were significantly affected by the reconstruction algorithms. Inter-reconstruction algorithm variability was greater than inter-reader variability for entropy, homogeneity, and GLCM-based features.	[Kim, Hyungjin; Park, Chang Min; Lee, Myunghee; Park, Sang Joon; Song, Yong Sub; Lee, Jong Hyuk; Hwang, Eui Jin; Goo, Jin Mo] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Park, Chang Min; Park, Sang Joon; Goo, Jin Mo] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Park, Chang Min; Park, Sang Joon; Goo, Jin Mo] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, CM (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.; Park, CM (corresponding author), Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea.; Park, CM (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	cmpark.morphius@gmail.com	Hwang, Eui Jin/X-4415-2018	Hwang, Eui Jin/0000-0002-3697-5542; Lee, Jong Hyuk/0000-0002-9594-683X	Seoul National University Hospital (SNUH) Research Fund [05-2016-0050]	Seoul National University Hospital (SNUH) Research Fund	This study was supported by grant no. 05-2016-0050 from the Seoul National University Hospital (SNUH) Research Fund, www.snuh.org/pub/; CMP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Ahn SY, 2015, INVEST RADIOL, V50, P719, DOI 10.1097/RLI.0000000000000174; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Fletcher JG, 2012, J COMPUT ASSIST TOMO, V36, P560, DOI 10.1097/RCT.0b013e318263cc1b; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Goodman LR, 2006, AM J ROENTGENOL, V186, P989, DOI 10.2214/AJR.04.1821; Kim H, 2015, INVEST RADIOL, V50, P571, DOI 10.1097/RLI.0000000000000152; Lee KH, 2014, J THORAC ONCOL, V9, P74, DOI 10.1097/JTO.0000000000000019; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Mattonen SA, 2014, J THORAC DIS, V6, P375, DOI 10.3978/j.issn.2072-1439.2013.11.09; McErlean Aoife, 2013, Radiology, V269, P451, DOI 10.1148/radiol.13122665; Ravanelli M, 2013, EUR RADIOL, V23, P3450, DOI 10.1007/s00330-013-2965-0; Sieren JP, 2014, MED PHYS, V41, DOI 10.1118/1.4893498; Solomon J, 2016, RADIOLOGY, V279, P185, DOI 10.1148/radiol.2015150892; Song YS, 2014, RADIOLOGY, V273, P276, DOI 10.1148/radiol.14132324; Wielputz MO, 2013, EUR J RADIOL, V82, P1577, DOI 10.1016/j.ejrad.2013.04.035; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y; Willemink MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058053; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Young S, 2015, MED PHYS, V42, P2679, DOI 10.1118/1.4918919; Zhao BS, 2014, TRANSL ONCOL, V7, P88, DOI 10.1593/tlo.13865	24	54	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164924	10.1371/journal.pone.0164924	http://dx.doi.org/10.1371/journal.pone.0164924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741289	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000083
J	Schuck, S; Emmerson, N; Ziv, H; Collins, P; Arastoo, S; Warschauer, M; Crinella, F; Lakes, K				Schuck, Sabrina; Emmerson, Natasha; Ziv, Hadar; Collins, Penelope; Arastoo, Sara; Warschauer, Mark; Crinella, Francis; Lakes, Kimberley			Designing an iPad App to Monitor and Improve Classroom Behavior for Children with ADHD: iSelfControl Feasibility and Pilot Studies	PLOS ONE			English	Article							DEVELOPMENTAL-DISABILITIES; STUDENTS; TECHNOLOGY; INDIVIDUALS; AUTISM; SKILLS	Children with Attention Deficit/Hyperactivity Disorder (ADHD) receive approximately 80% of instruction in the general education classroom, where individualized behavioral management strategies may be difficult for teachers to consistently deliver. Mobile device apps provide promising platforms to manage behavior. This pilot study evaluated the utility of a web-based application (iSelfControl) designed to support classroom behavior management. iSelfControl prompted students every 'Center' (30-minutes) to self-evaluate using a universal token-economy classroom management system focused on compliance, productivity, and positive relationships. Simultaneously, the teacher evaluated each student on a separate iPad. Using Multi Level Modeling, we examined 13 days of data gathered from implementation with 5(th) grade students (N = 12) at a school for children with ADHD and related executive function difficulties. First, an unconditional growth model evaluated the overall amount of change in aggregated scores over time as well as the degree of systematic variation in scores within and across teacher-student dyads. Second, separate intercepts and slopes were estimated for teacher and student to estimate degree of congruency between trajectories. Finally, differences between teacher and student scores were tested at each time-point in separate models to examine unique 'Center' effects. 51% of the total variance in scores was attributed to differences between dyads. Trajectories of student and teacher scores remained relatively stable across seven time-points each day and did not statistically differ from each other. On any given day, students tended to evaluate their behaviors more positively (entered higher scores for themselves) compared to corresponding teacher scores. In summary, iSelfControl provides a platform for self and teacher evaluation that is an important adjunct to conventional classroom management strategies. The application captured teacher/student discrepancies and significant variations across the day. Future research with a larger, clinically diagnosed sample in multiple classrooms is needed to assess generalizability to a wider variety of classroom settings.	[Schuck, Sabrina; Arastoo, Sara; Crinella, Francis; Lakes, Kimberley] Univ Calif Irvine, Dept Pediat, Child Dev Sch, Sch Med, Irvine, CA 92717 USA; [Ziv, Hadar] Univ Calif Irvine, Dept Informat & Comp Sci, Irvine, CA 92717 USA; [Collins, Penelope; Warschauer, Mark] Univ Calif Irvine, Sch Educ, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Schuck, S (corresponding author), Univ Calif Irvine, Dept Pediat, Child Dev Sch, Sch Med, Irvine, CA 92717 USA.	sabrina@uci.edu	Collins, Penelope/AAV-1096-2020	Collins, Penelope/0000-0002-0818-3230; Lakes, Kimberley/0000-0003-3698-274X				Alzrayer N, 2014, REV J AUTISM DEV DIS, V1, P179, DOI 10.1007/s40489-014-0018-5; Bryant BR, 2015, J BEHAV EDUC, V24, P255, DOI 10.1007/s10864-015-9218-z; Campigotto R, 2013, COMPUT EDUC, V60, P74, DOI 10.1016/j.compedu.2012.08.002; Chai Z, 2015, J SPEC EDUC, V48, P268, DOI 10.1177/0022466913517554; Conley J., 2012, SOC INF TECHN TEACH, P3986; Edyburn DL, 2013, EXCEPT CHILDREN, V80, P7, DOI 10.1177/001440291308000107; Eldar E, 2010, INT J INCLUSIVE EDUC, V14, P97, DOI 10.1080/13603110802504150; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Harlacher JE, 2006, TEACH EXCEPT CHILD, V39, P6, DOI 10.1177/004005990603900202; Haydon T, 2012, BEHAV DISORDERS, V37, P232; Herbert M, 2010, IPAD BREAKING NEW GR; Hooker KE, 2008, GESTALT REV, V12; Kagohara DM, 2013, RES DEV DISABIL, V34, P147, DOI 10.1016/j.ridd.2012.07.027; Kamens M. W., 2003, ACTION TEACHER ED, V25, P20, DOI [10.1080/01626620.2003.10463289, DOI 10.1080/01626620.2003.10463289]; Kashy D.A., 2008, MODELING DYADIC INTE, P165; Kenny D. A., 2006, DYADIC DATA ANAL; Kiger D, 2012, J RES TECHNOL EDUC, V45, P61, DOI 10.1080/15391523.2012.10782597; Neely L, 2013, RES AUTISM SPECT DIS, V7, P509, DOI 10.1016/j.rasd.2012.12.004; Nowacek EJ, 2007, PREV SCH FAIL, V51, P28, DOI 10.3200/PSFL.51.3.28-35; Pavri S., 2004, TEACH EDUC SPEC EDUC, V27, P433, DOI [10.1177/088840640402700410, DOI 10.1177/088840640402700410]; Shah N., 2011, ED WEEK, V30, P1; Shoni E., 2011, SCREEN ED, V8, P60; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spooner F, 2015, RES PRACT PERS SEV D, V40, P52, DOI 10.1177/1540796915586190; Warschauer M., 2011, LEARNING CLOUD WHY T	25	14	14	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164229	10.1371/journal.pone.0164229	http://dx.doi.org/10.1371/journal.pone.0164229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741257	gold, Green Published			2022-12-27	WOS:000385507000020
J	Avila-Rios, S; Garcia-Morales, C; Matias-Florentino, M; Tapia-Trejo, D; Hernandez-Alvarez, BF; Moreira-Lopez, SE; Quant-Duran, CJ; Porras-Cortes, G; Reyes-Teran, G				Avila-Rios, Santiago; Garcia-Morales, Claudia; Matias-Florentino, Margarita; Tapia-Trejo, Daniela; Hernandez-Alvarez, Bismarck F.; Moreira-Lopez, Sumaya E.; Quant-Duran, Carlos J.; Porras-Cortes, Guillermo; Reyes-Teran, Gustavo			HIV Drug Resistance in Antiretroviral Treatment-Naive Individuals in the Largest Public Hospital in Nicaragua, 2011-2015	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; REVERSE-TRANSCRIPTASE; GENOTYPIC-RESISTANCE; TRANSMISSION; MUTATIONS; SURVEILLANCE; CLUSTER; TOOL	Background Increasing HIV pre-treatment drug resistance (PDR) levels have been observed in regions with increasing antiretroviral treatment (ART) coverage. However, data is lacking for several low/middle-income countries. We present the first PDR survey in Nicaragua since ART introduction in the country in 2003. Methods HIV-infected, ART-naive Nicaraguan individuals were enrolled at Roberto Caldero A n Hospital, the largest national HIV referral center, from 2011 to 2015. HIV pol sequences were obtained at a WHO-accredited laboratory in Mexico by Sanger and next generation sequencing (NGS). PDR was assessed using the WHO surveillance drug resistance mutation (SDRM) list and the Stanford HIVdb tool. Results 283 individuals were enrolled in the study. The overall PDR prevalence based on the list of SDRMs was 13.4%. Using the Stanford HIVdb tool, overall PDR reached 19.4%; with both nucleoside and non-nucleoside reverse transcriptase inhibitor (NRTI and NNRTI) PDR levels independently reaching moderate levels (6.7% and 11.3% respectively). Protease inhibitor PDR was low (2.8%). Using NGS with 2% threshold to detect SDRMs, PDR increased to 25.3%. K103N and M41L were the most frequent SDRMs and were present mostly in proportions > 20% in each individual. A significant temporal increase in NNRTI PDR was observed (p = 0.0422), with no apparent trends for other drug classes. Importantly, PDR to zidovudine + lamivudine + efavirenz and tenofovir + emtricitabine + efavirenz, the most widely used first-line regimens in Nicaragua, reached 14.6% and 10.4% respectively in 2015. Of note, a higher proportion of females was observed among individuals with PDR compared to individuals without PDR (OR 14.2; 95% CI: 7.1-28.4; p< 0.0001). Conclusions Overall PDR in the Nicaraguan cohort was high (19.4%), with a clear increasing temporal trend in NNRTI PDR. Current HIVDR to the most frequently used first-line ART regimens in Nicaragua reached levels > 10%. These observations are worrisome and need to be evidenced to strengthen the national HIV program. Also, our observations warrant further nationally representative HIVDR surveillance studies and encourage other countries to perform national surveys. Cost-effectiveness studies are suggested to analyze the feasibility of implementation of baseline HIV genotyping as well as to review the choice of first-line ART regimens in Nicaragua.	[Avila-Rios, Santiago; Garcia-Morales, Claudia; Matias-Florentino, Margarita; Tapia-Trejo, Daniela; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico; [Hernandez-Alvarez, Bismarck F.; Quant-Duran, Carlos J.] Hosp Dr Roberto Calderon Gutierrez, Managua, Nicaragua; [Moreira-Lopez, Sumaya E.; Quant-Duran, Carlos J.; Porras-Cortes, Guillermo] Hosp Metropolitano Vivian Pellas, Managua, Nicaragua		Reyes-Teran, G (corresponding author), Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico.; Porras-Cortes, G (corresponding author), Hosp Metropolitano Vivian Pellas, Managua, Nicaragua.	memopo2002@yahoo.com; gustavo.reyesteran@gmail.com	Avila-Rios, Santiago/AAB-4383-2020	Reyes-Teran, Gustavo/0000-0002-4115-4888	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); Consejo Nacional de Ciencia y Tecnologia [CONACyT SALUD-2013-01-202475]	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from the Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana) to GRT and Consejo Nacional de Ciencia y Tecnologia (CONACyT SALUD-2013-01-202475) to SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M., 2015, CLIN MICROBIOL INFEC, V21, p104., DOI [DOI 10.1016/J.CMI.2014.08.005, 10.1016/j.cmi.2014.08.005]; [Anonymous], 2016, INF MENS TAR HOSP R; Avila-Rios S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158560; Avila-Rios S, 2015, AIDS RES HUM RETROV, V31, P401, DOI 10.1089/aid.2014.0057; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Calvez V, 2016, ANTIVIR THER, V21, P405, DOI 10.3851/IMP3024; Cecchini D, 2015, MEDICINA-BUENOS AIRE, V75, P163; Frentz D, 2012, AIDS REV, V14, P17; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hofstra LM, 2013, J ANTIMICROB CHEMOTH, V68, P1246, DOI 10.1093/jac/dkt038; Ji H, 2013, CAN J INFECT DIS MED; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; LANL, LOS AL HIV DAT; Lindstrom A, 2006, ANTIVIR THER, V11, P1031; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lorio Marco, 2014, J Int Assoc Provid AIDS Care, V13, P466, DOI 10.1177/2325957414535978; Martinez-Prats L, 2011, AIDS RES HUM RETROV, V27, P41, DOI 10.1089/aid.2010.0104; McMahon JH, 2013, B WHO; Mehta SR, 2015, EBIOMEDICINE, V2, P1456, DOI 10.1016/j.ebiom.2015.07.024; MINSA, 2014, EST VIG COMP SEX PRE; MINSA, 2009, GUIA TER ANT AD CON; Msimanga PW, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0244-1; PAHO/WHO, 2014, ANT TREATM SPOTL PUB; PAHO/WHO, 2012, TRAT ANT BAJ LUP AN; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; Pineda-Pena AC, 2012, AIDS REV, V14, P256; Porter DP, 2016, HIV CLIN TRIALS, V17, P29, DOI 10.1080/15284336.2015.1115585; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Sluis-Cremer N, 2014, ANTIVIR RES, V107, P31, DOI 10.1016/j.antiviral.2014.04.001; Stanford-University, HIV DRUG RES DAT; Theys K, 2016, AIDS RES HUM RETROV, V32, P427, DOI [10.1089/aid.2015.0095, 10.1089/AID.2015.0095]; UNAIDS, 2014, SIT EP VIH TARV NIC; UNAIDS, 2015, INT GLOB EP SIDA NIC; UNAIDS, UNAIDS NIC; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Witaningrum AM, 2016, AIDS RES HUM RETROV, V32, P812, DOI [10.1089/aid.2016.0054, 10.1089/AID.2016.0054]; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; World Health Organization, WHO HIV DRUG RES REP	42	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164156	10.1371/journal.pone.0164156	http://dx.doi.org/10.1371/journal.pone.0164156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736898	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800043
J	Coristine, AJ; Yerly, J; Stuber, M				Coristine, Andrew J.; Yerly, Jerome; Stuber, Matthias			A Cylindrical, Inner Volume Selecting 2D-T(2-)Prep Improves GRAPPA-Accelerated Image Quality in MRA of the Right Coronary Artery	PLOS ONE			English	Article							K-SPACE; VESSEL WALL; INITIAL-EXPERIENCE; LOCAL EXCITATION; PARALLEL MRI; 3 T; ANGIOGRAPHY; HEART; INVERSION; PULSES	Background Two-dimensional (2D) spatially selective radiofrequency (RF) pulses may be used to excite restricted volumes. By incorporating a "pencil beam" 2D pulse into a T-2-Prep, one may create a "2D-T-2-Prep" that combines T-2-weighting with an intrinsic outer volume suppression. This may particularly benefit parallel imaging techniques, where artefacts typically originate from residual foldover signal. By suppressing foldover signal with a 2D-T-2-Prep, image quality may therefore improve. We present numerical simulations, phantom and in vivo validations to address this hypothesis. Methods A 2D-T-2-Prep and a conventional T-2-Prep were used with GRAPPA-accelerated MRI (R = 1.6). The techniques were first compared in numerical phantoms, where per pixel maps of SNR (SNRmulti), noise, and g-factor were predicted for idealized sequences. Physical phantoms, with compartments doped to mimic blood, myocardium, fat, and coronary vasculature, were scanned with both T-2-Preparation techniques to determine the actual SNRmulti and vessel sharpness. For in vivo experiments, the right coronary artery (RCA) was imaged in 10 healthy adults, using accelerations of R = 1,3, and 6, and vessel sharpness was measured for each. Results In both simulations and phantom experiments, the 2D-T-2-Prep improved SNR relative to the conventional T-2-Prep, by an amount that depended on both the acceleration factor and the degree of outer volume suppression. For in vivo images of the RCA, vessel sharpness improved most at higher acceleration factors, demonstrating that the 2D-T-2- Prep especially benefits accelerated coronary MRA. Conclusion Suppressing outer volume signal with a 2D-T-2-Prep improves image quality particularly well in GRAPPA-accelerated acquisitions in simulations, phantoms, and volunteers, demonstrating that it should be considered when performing accelerated coronary MRA.	[Coristine, Andrew J.; Yerly, Jerome; Stuber, Matthias] Univ Lausanne UNIL, Univ Hosp CHUV, Dept Radiol, Lausanne, VD, Switzerland; [Coristine, Andrew J.; Yerly, Jerome; Stuber, Matthias] Ctr BioMed Imaging CIBM, CardioVasc Magnet Resonance CVMR Res Ctr, Lausanne, VD, Switzerland; [Coristine, Andrew J.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Case Western Reserve University	Stuber, M (corresponding author), Univ Lausanne UNIL, Univ Hosp CHUV, Dept Radiol, Lausanne, VD, Switzerland.; Stuber, M (corresponding author), Ctr BioMed Imaging CIBM, CardioVasc Magnet Resonance CVMR Res Ctr, Lausanne, VD, Switzerland.	matthias.stuber@chuv.ch		Yerly, Jerome/0000-0003-4347-8613	Swiss National Science Foundation [320030-143923, P2LAP3_164909]; Centre d'Imagerie BioMedical (CIBM) of the UNIL; EPFL; UNIGE; CHUV; HUG; Jeantet Foundation; Leenaards Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre d'Imagerie BioMedical (CIBM) of the UNIL; EPFL; UNIGE; CHUV; HUG; Jeantet Foundation; Leenaards Foundation	This work was in part supported by the Swiss National Science Foundation (www.snf.ch), through grants 320030-143923 and P2LAP3_164909. Additional support was provided in part by the Centre d'Imagerie BioMedical (CIBM) of the UNIL, EPFL, UNIGE, CHUV, and HUG, as well as the Jeantet and Leenaards Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was in part supported by the Swiss National Science Foundation grants #320030-143923 and #P2LAP3_164909. Additional support was provided in part by the Centre d'Imagerie BioMedical (CIBM) of the UNIL, EPFL, UNIGE, CHUV, and HUG, as well as the Jeantet and Leenaards Foundations.	Abd-Elmoniem KZ, 2012, MAGN RESON MED, V68, P822, DOI 10.1002/mrm.23305; Aja-Fernandez S, 2009, MAGN RESON IMAGING, V27, P1397, DOI 10.1016/j.mri.2009.05.025; Blaimer M, 2006, MAGN RESON MED, V56, P1359, DOI 10.1002/mrm.21071; Bornstedt A, 2008, MAGN RESON MED, V59, P1207, DOI 10.1002/mrm.21590; Botnar RM, 2000, JMRI-J MAGN RESON IM, V11, P389, DOI 10.1002/(SICI)1522-2586(200004)11:4<389::AID-JMRI6>3.0.CO;2-T; Botnar RM, 1999, JMRI-J MAGN RESON IM, V10, P821, DOI 10.1002/(SICI)1522-2586(199911)10:5<821::AID-JMRI29>3.0.CO;2-7; Botnar RM, 2000, CIRCULATION, V102, P2582; Botnar RM, 1999, CIRCULATION, V99, P3139, DOI 10.1161/01.CIR.99.24.3139; Botnar RM, 2001, MAGNET RESON MED, V46, P848, DOI 10.1002/mrm.1268; BOTTOMLEY PA, 1987, J APPL PHYS, V62, P4284, DOI 10.1063/1.339103; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Breuer FA, 2006, MAGN RESON MED, V55, P549, DOI 10.1002/mrm.20787; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; Breuer FA, 2009, MAGN RESON MED, V62, P739, DOI 10.1002/mrm.22066; BRITTAIN JH, 1995, MAGNET RESON MED, V33, P689, DOI 10.1002/mrm.1910330515; Coppo S, 2014, J MAGNETIC RESONANCE; Coppo S, 2014, MAGNETIC RESONANCE M; Coristine AJ, 2014, MAGNETIC RESONANCE M; Coristine AJ, 2014, MAGN RESON MED, V72, P763, DOI 10.1002/mrm.24961; Davies NP, 2003, MAGNET RESON MED, V49, P1133, DOI 10.1002/mrm.10475; Deshmane A, 2012, J MAGN RESON IMAGING, V36, P55, DOI 10.1002/jmri.23639; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; FEINBERG DA, 1985, RADIOLOGY, V156, P743, DOI 10.1148/radiology.156.3.4023236; FRAHM J, 1987, J MAGN RESON, V72, P502, DOI 10.1016/0022-2364(87)90154-5; George AK, 2012, MAGN RESON MED, V67, P1013, DOI 10.1002/mrm.23078; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hwang TL, 1998, J MAGN RESON, V133, P200, DOI 10.1006/jmre.1998.1441; Katoh M, 2005, RADIOLOGY, V236, P1047, DOI 10.1148/radiol.2363040865; Katoh M, 2008, J MAGN RESON IMAGING, V27, P913, DOI 10.1002/jmri.21319; Kim WY, 2007, CIRCULATION, V115, P228, DOI 10.1161/CIRCULATIONAHA.106.633339; Kim WY, 2002, CIRCULATION, V106, P296, DOI 10.1161/01.CIR.0000025629.85631.1E; KRAFT KA, 1987, MAGNET RESON MED, V5, P555, DOI 10.1002/mrm.1910050606; Luo J, 2014, MAGNETIC RESONANCE M; Lustig M, 2010, MAGN RESON MED, V64, P457, DOI 10.1002/mrm.22428; Ma D, 2013, NATURE, V495, P187, DOI 10.1038/nature11971; McConnell MV, 1997, MAGN RESON MED, V37, P148, DOI 10.1002/mrm.1910370121; Mooiweer R, 2015, MAGNETIC RESONANCE M; Nehrke K, 1999, MAGN RESON IMAGING, V17, P1173, DOI 10.1016/S0730-725X(99)00043-0; Nezafat R, 2009, MAGN RESON MED, V61, P1326, DOI 10.1002/mrm.21742; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Oshinski JN, 1996, RADIOLOGY, V201, P737, DOI 10.1148/radiology.201.3.8939224; PAULY J, 1989, J MAGN RESON, V82, P571, DOI 10.1016/0022-2364(89)90219-9; PAULY J, 1989, J MAGN RESON, V81, P43, DOI 10.1016/0022-2364(89)90265-5; Piccini D, 2014, RADIOLOGY, V270, P378, DOI 10.1148/radiol.13132045; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Smith TB, 2012, MAGN RESON MED, V67, P1316, DOI 10.1002/mrm.23116; Spuentrup E, 2002, RADIOLOGY, V225, P589, DOI 10.1148/radiol.2252011366; Stehning C, 2005, MAGN RESON MED, V54, P476, DOI 10.1002/mrm.20557; Stuber M, 2002, MAGNET RESON MED, V47, P322, DOI 10.1002/mrm.10042; Stuber M, 1999, J AM COLL CARDIOL, V34, P524, DOI 10.1016/S0735-1097(99)00223-5; Thunberg P, 2007, MAGN RESON IMAGING, V25, P1089, DOI 10.1016/j.mri.2006.11.003; Tsai CM, 2000, MAGNET RESON MED, V43, P452, DOI 10.1002/(SICI)1522-2594(200003)43:3<452::AID-MRM18>3.0.CO;2-B; van Heeswijk RB, 2012, CRITICAL REV BIOMEDI, P40; van Heeswijk RB, 2015, MAGN RESON MED, V73, P1549, DOI 10.1002/mrm.25258; van Heeswijk RB, 2012, JACC-CARDIOVASC IMAG, V5, P1231, DOI 10.1016/j.jcmg.2012.06.010; WANG Y, 1995, MAGNET RESON MED, V33, P713, DOI 10.1002/mrm.1910330517; Weavers PT, 2014, MAGN RESON MED, V71, P672, DOI 10.1002/mrm.24700; Weavers PT, 2014, MAGNETIC RESONANCE M	60	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163618	10.1371/journal.pone.0163618	http://dx.doi.org/10.1371/journal.pone.0163618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736866	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800019
J	Leitner, L; Walter, M; Sammer, U; Knupfer, SC; Mehnert, U; Kessler, TM				Leitner, Lorenz; Walter, Matthias; Sammer, Ulla; Knupfer, Stephanie C.; Mehnert, Ulrich; Kessler, Thomas M.			Urodynamic Investigation: A Valid Tool to Define Normal Lower Urinary Tract Function?	PLOS ONE			English	Article							YOUNG HEALTHY-VOLUNTEERS; PRESSURE-FLOW; FEMALE VOLUNTEERS; BLADDER; WOMEN; QUESTIONNAIRE; PARAMETERS; INCONTINENCE; CYSTOMETRY; FORM	Objectives To evaluate whether urodynamic investigation (UDI), the gold standard to assess refractory lower urinary tract symptoms (LUTS), is appropriate to select healthy volunteers with apparent normal lower urinary tract function as control subjects for comparative studies. Subjects and Methods 42 healthy subjects (22 women, mean age 32 +/- 10 years; 20 men, mean age 37 +/- 12 years) without LUTS were included into this prospective single-centre cohort study. All subjects recorded a 3-day bladder diary, completed validated questionnaires regarding LUTS, and underwent neuro-urological assessment as well as free uroflowmetry. Same session repeat UDI was performed according to "Good Urodynamic Practice "recommended by the International Continence Society, but using an air-charged instead of a water-filled catheter, and evaluated by a blinded investigator. Results All 3-day bladder diaries, LUTS questionnaires, neuro-urological assessments and free uroflowmetries were within normal limits. Overall (either during the first or second UDI), same session repeat UDI revealed pathological findings in 71% (30/42): Detrusor overactivity was detected in 14% (3/22) and 30% (6/20), post void residual >100mL in 14% (3/22) and 25% (5/20), bladder outlet obstruction in 9% (2/22) and 20% (4/20) and detrusor sphincter dyssynergia in 77% (17/22) and 65% (13/20) of our women and men, respectively. Repeatability of detrusor overactivity (k = 0.78, 95% CI: 0.54-1.02) and detrusor sphincter dyssynergia (k = 0.77,95% CI: 0.55-0.98) showed substantial agreement between both UDIs. All other assessed urodynamic parameters had wide 95% limits of agreement for differences in the parameters indicating poor repeatability. Conclusions More than 70% of our healthy subjects showed pathological urodynamic findings. Although UDI is the gold standard to assess refractory LUTS, it seems not to be applicable in healthy subjects to define normal lower urinary tract function. Therefore, we do not recommend using UDI to select healthy control subjects.	[Leitner, Lorenz; Walter, Matthias; Sammer, Ulla; Knupfer, Stephanie C.; Mehnert, Ulrich; Kessler, Thomas M.] Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr & Res, Neurourol, Zurich, Switzerland; [Leitner, Lorenz] Univ Basel Hosp, Dept Urol, Basel, Switzerland	University of Zurich; University of Basel	Kessler, TM (corresponding author), Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr & Res, Neurourol, Zurich, Switzerland.	tkessler@gmx.ch	Walter, M/ABB-9592-2020	Walter, M/0000-0001-5347-1584; Leitner, Lorenz/0000-0001-5764-3494	Wings for Life [WFL-CHE-035/14]; Swiss National Science Foundation; Emily Dorothy Lagemann Stiftung; Swiss Continence Foundation	Wings for Life; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Emily Dorothy Lagemann Stiftung; Swiss Continence Foundation	We would like to acknowledge Wings for Life (www winngsforlife.com) (WFL-CHE-035/14 to Lorenz Leitner), Swiss National Science Foundation (www.snf.ch) (to Ulrich Mehnert), Emily Dorothy Lagemann Stiftung (to Thomas M. Kessler), and Swiss Continence Foundation (www.swisscontnencefoundation.ch) (to Thomas M. Kessler) for financial support. The supporters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2006, J UROLOGY, V175, P1063, DOI 10.1016/S0022-5347(05)00348-4; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Bellucci CHS, 2012, J UROLOGY, V187, P1318, DOI 10.1016/j.juro.2011.11.107; Blaivas JG, 2001, NEUROUROL URODYNAM, V20, P141, DOI 10.1002/1520-6777(2001)20:2<141::AID-NAU16>3.3.CO;2-G; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brookes ST, 2004, AM J OBSTET GYNECOL, V191, P73, DOI 10.1016/j.ajog.2003.12.027; Clement KD, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011179.pub2; Cooper MA, 2011, NEUROUROL URODYNAM, V30, P329, DOI 10.1002/nau.20991; Coyne KS, 2015, NEUROUROL URODYNAM, V34, P255, DOI 10.1002/nau.22559; Defreitas GA, 2004, UROLOGY, V64, P675, DOI 10.1016/j.urology.2004.04.089; Digesu GA, 2014, INT UROGYNECOL J, V25, P123, DOI 10.1007/s00192-013-2182-z; Donovan JL, 2000, J UROLOGY, V164, P1948, DOI 10.1016/S0022-5347(05)66926-1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gammie A, 2016, NEUROUROL URODYNAM, V35, P926, DOI 10.1002/nau.22827; *INT C HARM, GOOD CLIN PRACT GUID; International organization for standardization, ISO 14155 2011; KATZ GP, 1983, J UROLOGY, V129, P1170, DOI 10.1016/S0022-5347(17)52625-7; Kessler TM, 2008, JAMA-J AM MED ASSOC, V300, P283, DOI 10.1001/jama.2008.30; Kessler TM, 2004, UROLOGE A, V43, P542, DOI 10.1007/s00120-004-0564-z; Kirby AC, 2011, NEUROUROL URODYNAM, V30, P1591, DOI 10.1002/nau.21080; LIM CS, 1995, WORLD J UROL, V13, P34; Mahfouz W, 2012, INT UROGYNECOL J, V23, P269, DOI 10.1007/s00192-011-1585-y; Panicker JN, 2015, LANCET NEUROL, V14, P720, DOI 10.1016/S1474-4422(15)00070-8; Pfisterer MHD, 2007, NEUROUROL URODYNAM, V26, P356, DOI 10.1002/nau.20381; Rosario DJ, 2008, NEUROUROL URODYNAM, V27, P388, DOI 10.1002/nau.20537; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Suskind AM, 2015, UROLOGY, V85, P547, DOI 10.1016/j.urology.2014.11.001; VANDOORN ESCV, 1992, J UROLOGY, V147, P1319, DOI 10.1016/S0022-5347(17)37553-5; VANDOORN ESCV, 1992, J UROLOGY, V147, P1326; Walter M, 2016, WORLD J UROL, V34, P391, DOI 10.1007/s00345-015-1589-1; Wyndaele JJ, 2002, EUR UROL, V42, P34, DOI 10.1016/S0302-2838(02)00221-X; Wyndaele JJ, 1999, J UROLOGY, V161, P899, DOI 10.1016/S0022-5347(01)61801-9; Wyndaele JJ, 1998, J UROLOGY, V160, P479, DOI 10.1016/S0022-5347(01)62929-X; Zehnder P, 2008, J UROLOGY, V180, P1013, DOI 10.1016/j.juro.2008.05.028; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	24	24	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163847	10.1371/journal.pone.0163847	http://dx.doi.org/10.1371/journal.pone.0163847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736908	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000385505800028
J	Mendez, S; Watanabe, L; Hill, R; Owens, M; Moraczewski, J; Rowe, GC; Riddle, NC; Reed, LK				Mendez, Sean; Watanabe, Louis; Hill, Rachel; Owens, Meredith; Moraczewski, Jason; Rowe, Glenn C.; Riddle, Nicole C.; Reed, Laura K.			The TreadWheel: A Novel Apparatus to Measure Genetic Variation in Response to Gently Induced Exercise for Drosophila	PLOS ONE			English	Article							PUTATIVE CONTRIBUTORS; ENDURANCE EXERCISE; BODY-COMPOSITION; SEDENTARY TIME; RISK-FACTORS; WEIGHT-LOSS; EXPRESSION; OBESITY; METABOLISM; INCREASE	Obesity is one of the dramatic health issues affecting developed and developing nations, and exercise is a well-established intervention strategy. While exercise-by-genotype interactions have been shown in humans, overall little is known. Using the natural negative geotaxis of Drosophila melanogaster, an important model organism for the study of genetic interactions, a novel exercise machine, the TreadWheel, can be used to shed light on this interaction. The mechanism for inducing exercise with the TreadWheel is inherently gentle, thus minimizing possible confounding effects of other stressors. Using this machine, we were able to assess large cohorts of adult flies from eight genetic lines for their response to exercise after one week of training. We measured their triglyceride, glycerol, protein, glycogen, glucose content, and body weight, as well as their climbing ability and feeding behavior in response to exercise. Exercised flies showed decreased stored triglycerides, glycogen, and body weight, and increased stored protein and climbing ability. In addition to demonstrating an overall effect of TreadWheel exercise on flies, we found significant interactions of exercise with genotype, sex, or genotype-by-sex effects for most of the measured phenotypes. We also observed interaction effects between exercise, genotype, and tissue (abdomen or thorax) for metabolite profiles, and those differences can be partially linked to innate differences in the flies' persistence in maintaining activity during exercise bouts. In addition, we assessed gene expression levels for a panel of 13 genes known to be associated with respiratory fitness and found that many responded to exercise. With this study, we have established the TreadWheel as a useful tool to study the effect of exercise in flies, shown significant genotype-specific and sex-specific impacts of exercise, and have laid the ground work for more extensive studies of how genetics, sex, environment, and aging interact with exercise to influence metabolic fitness in Drosophila.	[Mendez, Sean; Hill, Rachel; Owens, Meredith; Reed, Laura K.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Watanabe, Louis; Riddle, Nicole C.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Moraczewski, Jason; Rowe, Glenn C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Reed, LK (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	lreed1@ua.edu	Rowe, Glenn/N-5314-2019	Riddle, Nicole/0000-0003-1827-9145; Reed, Laura/0000-0002-4381-494X; Rowe, Glenn/0000-0002-8195-9605	National Institutes of General Medicine [R01GM098856]; National Institutes of Arthritis and Musculoskeletal and Skin Diseases [K01AR062128]; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK056336]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR062128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, P30DK056336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098856] Funding Source: NIH RePORTER	National Institutes of General Medicine; National Institutes of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by R01GM098856, National Institutes of General Medicine (www.niams.nih.gov) to LKR; K01AR062128, National Institutes of Arthritis and Musculoskeletal and Skin Diseases (www.niams.nih.gov) to GCR, and by P30DK056336, National Institute of Diabetes and Digestive and Kidney Diseases (www.niddk.nih.gov) pilot grant to NCR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institutes of General Medicine, the National Institutes of Arthritis and Musculoskeletal and Skin Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2014, BRAIN BEHAV IMMUN, V39, P130, DOI 10.1016/j.bbi.2013.10.023; Aoi W, 2013, MED SCI SPORT EXER, V45, P245, DOI 10.1249/MSS.0b013e31826f3107; Babbar Mansi, 2013, Mol Cell Pharmacol, V5, P109; Bellou E, 2013, APPL PHYSIOL NUTR ME, V38, P823, DOI 10.1139/apnm-2012-0468; Bengtsson J, 2001, PFLUG ARCH EUR J PHY, V443, P61, DOI 10.1007/s004240100628; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; BOUCHARD C, 1989, METABOLISM, V38, P364, DOI 10.1016/0026-0495(89)90126-1; Bouchard C, 2015, PROG CARDIOVASC DIS, V57, P337, DOI 10.1016/j.pcad.2014.08.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breen EC, 1996, J APPL PHYSIOL, V81, P355, DOI 10.1152/jappl.1996.81.1.355; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Cutler DM, 2002, CITESEERX WHY HAVE A; Desgorces FD, 2015, HORM METAB RES, V47, P473, DOI 10.1055/s-0034-1387704; Dijk W, 2016, CURR OPIN LIPIDOL, V27, P249, DOI 10.1097/MOL.0000000000000290; Edison AS, 2016, METABOLITES, V6, DOI 10.3390/metabo6010008; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gordon B, 2014, CURR SPORT MED REP, V13, P253, DOI 10.1249/JSR.0000000000000073; Hansen JS, 2015, DIABETOLOGIA, V58, P1845, DOI 10.1007/s00125-015-3584-x; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Honda T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1307; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Joseph AM, 2006, ESSAYS BIOCHEM, V42, P13, DOI 10.1042/bse0420013; Karoly HC, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/540563; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Khoo J, 2015, INT J SPORT NUTR EXE, V25, P566, DOI 10.1123/ijsnem.2015-0025; Kolwicz SC, 2016, BBA-MOL CELL BIOL L, V1861, P1472, DOI 10.1016/j.bbalip.2016.03.028; Kruger NJ, 1994, NEW PROTEIN TECHNIQU, V32, P9, DOI DOI 10.1385/0-89603-268-X:9; Laughlin MH, 2015, J APPL PHYSIOL, V119, P583, DOI 10.1152/japplphysiol.00316.2015; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McLean CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127089; Michell V, 2014, J SPORT MED PHYS FIT, V54, P441; Nehrenberg DL, 2009, OBESITY, V17, P1402, DOI 10.1038/oby.2009.51; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Reed LK, 2010, GENETICS, V185, P1009, DOI 10.1534/genetics.109.113571; Ro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101107; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Sato T, 2015, BIOCHEM BIOPH RES CO, V457, P653, DOI 10.1016/j.bbrc.2015.01.043; Schneider D, 2000, NAT REV GENET, V1, P218, DOI 10.1038/35042080; Sisnowski J, 2015, HEALTH POLICY, V119, P720, DOI 10.1016/j.healthpol.2015.04.013; Stephens NA, 2015, J CLIN ENDOCR METAB, V100, P43, DOI 10.1210/jc.2014-2545; Sujkowski A, 2015, AGING-US, V7, P535, DOI 10.18632/aging.100789; Tanaka M, 2016, PHYSIOL GENOMICS, V48, P173, DOI 10.1152/physiolgenomics.00009.2016; Tinkerhess MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031633; Tipton KD, 1998, ACTA PHYSIOL SCAND, V162, P377, DOI 10.1046/j.1365-201X.1998.00306.x; Upala S, 2015, INT J OBESITY, V39, P1197, DOI 10.1038/ijo.2015.64; van der Bliek AM, 2000, J CELL BIOL, V151, pF1, DOI 10.1083/jcb.151.2.F1; van Gemert WAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127520; Wack SR, 2014, J APPL BEHAV ANAL, V47, P181, DOI 10.1002/jaba.108	53	26	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164706	10.1371/journal.pone.0164706	http://dx.doi.org/10.1371/journal.pone.0164706			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736996	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800117
J	Ptaszynska, AA; Paleolog, J; Borsuk, G				Ptaszynska, Aneta A.; Paleolog, Jerzy; Borsuk, Grzegorz			Nosema ceranae Infection Promotes Proliferation of Yeasts in Honey Bee Intestines	PLOS ONE			English	Article							APIS-MELLIFERA; HYMENOPTERA-APIDAE; WORKER BEES; COLONIES; MICROSPORIDIA; IMPACT; VIRULENCE; TESTS; SPP.	Background Nosema ceranae infection not only damages honey bee (Apis melifera) intestines, but we believe it may also affect intestinal yeast development and its seasonal pattern. In order to check our hypothesis, infection intensity versus intestinal yeast colony forming units (CFU) both in field and cage experiments were studied. Methods/Findings Field tests were carried out from March to October in 2014 and 2015. N. ceranae infection intensity decreased more than 100 times from 7.6 x 10(8) in March to 5.8 x 10(6) in October 2014. A similar tendency was observed in 2015. Therefore, in the European eastern limit of its range, N. ceranae infection intensity showed seasonality (spring peak and subsequent decline in the summer and fall), however, with an additional mid-summer peak that had not been recorded in other studies. Due to seasonal changes in the N. ceranae infection intensity observed in honey bee colonies, we recommend performing studies on new therapeutics during two consecutive years, including colony overwintering. A natural decrease in N. ceranae spore numbers observed from March to October might be misinterpreted as an effect of Nosema spp. treatment with new compounds. A similar seasonal pattern was observed for intestinal yeast population size in field experiments. Furthermore, cage experiments confirmed the size of intestinal yeast population to increase markedly together with the increase in the N. ceranae infection intensity. Yeast CFUs amounted to respectively 2,025 (CV = 13.04) and 11,150 (CV = 14.06) in uninfected and N. ceranae-infected workers at the end of cage experiments. Therefore, honey bee infection with N. ceranae supported additional opportunistic yeast infections, which may have resulted in faster colony depopulations.	[Ptaszynska, Aneta A.] Marie Curie Sklodowska Univ, Fac Biol & Biotechnol, Inst Biol & Biochem, Dept Bot & Mycol, Akad 19, PL-20033 Lublin, Poland; [Paleolog, Jerzy] Univ Life Sci Lublin, Dept Zool Ecol & Wildlife Management, Akad 13, PL-20950 Lublin, Poland; [Borsuk, Grzegorz] Univ Life Sci Lublin, Fac Biol & Anim Breeding, Dept Biol Basis Anim Prod, Akad 13, PL-20950 Lublin, Poland	Maria Curie-Sklodowska University; University of Life Sciences in Lublin; University of Life Sciences in Lublin	Ptaszynska, AA (corresponding author), Marie Curie Sklodowska Univ, Fac Biol & Biotechnol, Inst Biol & Biochem, Dept Bot & Mycol, Akad 19, PL-20033 Lublin, Poland.	aneta.ptaszynska@paczta.umcs.lublin.pl	Paleolog, Jerzy/U-5290-2018; Ptaszynska, Aneta/AAG-7172-2021; Borsuk, Grzegorz/AAD-3268-2021	Paleolog, Jerzy/0000-0002-4447-4318; Ptaszynska, Aneta/0000-0001-6413-6028; Borsuk, Grzegorz/0000-0002-8407-3383	Individual Research Grant of Vice-rector for Research and International Relations of UMCS (Lublin, Poland)	Individual Research Grant of Vice-rector for Research and International Relations of UMCS (Lublin, Poland)	This research was supported by the Individual Research Grant of Vice-rector for Research and International Relations of UMCS (Lublin, Poland). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript PONE-D-16-10261.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Borsuk G, 2013, MED WETER, V69, P726; Borsuk G, 2011, J APIC SCI, V55, P59; Borsuk G, 2011, J APIC SCI, V55, P53; Bradley TJ, 2008, J EXP BIOL, V211, P835, DOI 10.1242/jeb.009589; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Chauzat MP, 2006, P 2 EUR C AP 10 14 S, P30; Chen YP, 2009, J EUKARYOT MICROBIOL, V56, P142, DOI 10.1111/j.1550-7408.2008.00374.x; Copley TR, 2012, J APPL MICROBIOL, V112, P15, DOI 10.1111/j.1365-2672.2011.05192.x; DADE H A, 2009, ANATOMY DISSECTION H; El-leithy MA, 1992, EGYPT J MICROBIOL, V75, P679; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; FRIES I, 1988, APIDOLOGIE, V19, P319, DOI 10.1051/apido:19880310; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gatschenberger H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066415; Gajger IT, 2009, AM BEE J, V149, P485; GILLIAM M, 1974, J INVERTEBR PATHOL, V24, P349, DOI 10.1016/0022-2011(74)90143-8; GILLIAM M, 1973, ANN ENTOMOL SOC AM, V66, P1176, DOI 10.1093/aesa/66.5.1176; GILLIAM M, 1976, J INVERTEBR PATHOL, V28, P275, DOI 10.1016/0022-2011(76)90137-3; GILLIAM M, 1974, J INVERTEBR PATHOL, V23, P38, DOI 10.1016/0022-2011(74)90069-X; GILLIAM M, 1972, J INVERTEBR PATHOL, V20, P101, DOI 10.1016/0022-2011(72)90087-0; GILLIAM M, 1991, J INVERTEBR PATHOL, V58, P286, DOI 10.1016/0022-2011(91)90077-4; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Greene H., 2003, ECONOMETRIC ANAL; Grzybek M, 2015, PARASITOLOGY, V142, P1722, DOI 10.1017/S0031182015001225; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; Hornitzky M, 2008, NOSEMA DIS LIT REV 2; HUANG WF, 2005, 38 ANN M SOC INV PAT; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Lach L, 2015, J INVERTEBR PATHOL, V130, P64, DOI 10.1016/j.jip.2015.06.003; Levy S, 2011, NATURE, V479, P164, DOI 10.1038/479164a; Martin HR, 2006, P 2 EUR C AP PRAG 10, P34; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2012, ENVIRON MICROBIOL, V14, P2127, DOI 10.1111/j.1462-2920.2011.02645.x; Martin-Hernandez R, 2009, APPL ENVIRON MICROB, V75, P2554, DOI 10.1128/AEM.02908-08; MILNE CP, 1985, J APICULT RES, V24, P237, DOI 10.1080/00218839.1985.11100679; Mirjanic G., 2013, 43 INT AP C AP KYIV, P113; Mulholland Grace E., 2012, Insects, V3, P1143, DOI 10.3390/insects3041143; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Ptaszynska AA, 2016, MED WETER, V72, P430, DOI 10.21521/mw.5534; Ptaszynska AA, 2016, PARASITOL RES, V115, P397, DOI 10.1007/s00436-015-4761-z; Ptaszynska AA, 2014, J APICULT RES, V53, P537, DOI 10.3896/IBRA.1.53.5.02; Ptaszynska AA, 2013, MED WETER, V69, P736; SAS/STAT, 2014, US GUID REL 9 13; Shafer ABA, 2009, J PARASITOL, V95, P198, DOI 10.1645/GE-1724.1; Somerville D, 2005, DAI124 NSW AGR; Strachecka A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1192, DOI 10.1134/S0006297914110066; Strachecka AJ, 2008, J APIC SCI, V52, P49; Strachecka AJ, 2015, J APIC SCI, V59, P129, DOI 10.1515/jas-2015-0014; Tapaszti Z, 2009, ACTA VET HUNG, V57, P383, DOI 10.1556/AVet.57.2009.3.4; Traver BE, 2012, J INVERTEBR PATHOL, V109, P187, DOI 10.1016/j.jip.2011.11.001; Tysset C., 1991, CONTRIBUTION STUDY I; Williams GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099465; Yefimenko TM, 2014, NOSEMA CERANAE FRIES, V2, P70; Zander E., 1909, M NCH BIENENZ, V31, P196, DOI DOI 10.1016/J.BBAGEN.2015.01.008	59	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164477	10.1371/journal.pone.0164477	http://dx.doi.org/10.1371/journal.pone.0164477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736915	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800072
J	Schoville, BJ; Browne, KS; Harris, JA; Wilkins, J				Schoville, Benjamin J.; Browne, Kyle S.; Harris, Jacob A.; Wilkins, Jayne			New Experiments and a Model-Driven Approach for Interpreting Middle Stone Age Lithic Point Function Using the Edge Damage Distribution Method	PLOS ONE			English	Article							WESTERN CAPE PROVINCE; KELDERS CAVE 1; 13B MOSSEL BAY; INVESTIGATING MICROWEAR POLISHES; MODERN HUMAN-BEHAVIOR; USE-WEAR METHOD; KATHU PAN 1; PINNACLE POINT; SOUTH-AFRICA; DIE KELDERS	The Middle Stone Age (MSA) is associated with early evidence for symbolic material culture and complex technological innovations. However, one of the most visible aspects of MSA technologies are unretouched triangular stone points that appear in the archaeological record as early as 500,000 years ago in Africa and persist throughout the MSA. How these tools were being used and discarded across a changing Pleistocene landscape can provide insight into how MSA populations prioritized technological and foraging decisions. Creating inferential links between experimental and archaeological tool use helps to establish prehistoric tool function, but is complicated by the overlaying of post-depositional damage onto behaviorally worn tools. Taphonomic damage patterning can provide insight into site formation history, but may preclude behavioral interpretations of tool function. Here, multiple experimental processes that form edge damage on unretouched lithic points from taphonomic and behavioral processes are presented. These provide experimental distributions of wear on tool edges from known processes that are then quantitatively compared to the archaeological patterning of stone point edge damage from three MSA lithic assemblages-Kathu Pan 1, Pinnacle Point Cave 13B, and Die Kelders Cave 1. By using a model-fitting approach, the results presented here provide evidence for variable MSA behavioral strategies of stone point utilization on the landscape consistent with armature tips at KP1, and cutting tools at PP13B and DK1, as well as damage contributions from post-depositional sources across assemblages. This study provides a method with which landscape-scale questions of early modern human tool-use and site-use can be addressed.	[Schoville, Benjamin J.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Schoville, Benjamin J.; Browne, Kyle S.; Wilkins, Jayne] Univ Cape Town, Dept Archaeol, Human Evolut Res Inst, ZA-7701 Rondebosch, South Africa; [Harris, Jacob A.] Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, Tempe, AZ 85287 USA	University of Cape Town; University of Cape Town; Arizona State University; Arizona State University-Tempe	Schoville, BJ (corresponding author), Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa.; Schoville, BJ (corresponding author), Univ Cape Town, Dept Archaeol, Human Evolut Res Inst, ZA-7701 Rondebosch, South Africa.	Benjamin.Schoville@uct.ac.za	Wilkins, Jayne/ABF-9501-2020	Wilkins, Jayne/0000-0003-2586-107X; Schoville, Benjamin/0000-0002-0124-7959	NSF Doctoral Dissertation Improvement Grant [1444133]; NSF grants [BCS 1138073, BCS 9912465, BCS 0130713, BCS 0524087]; Elizabeth H. Harmon Research Endowment through the Institute of Human Origins; Hyde Family Foundation; Social Science and Humanities Research Council of Canada; University of Toronto	NSF Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); NSF grants(National Science Foundation (NSF)); Elizabeth H. Harmon Research Endowment through the Institute of Human Origins; Hyde Family Foundation; Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); University of Toronto(University of Toronto)	This research was funded by a NSF Doctoral Dissertation Improvement Grant (No. 1444133), and NSF grants BCS 1138073, BCS 9912465, BCS 0130713, and BCS 0524087, the Elizabeth H. Harmon Research Endowment through the Institute of Human Origins,the Hyde Family Foundation. Funding for the analysis of KP1 was provided to JW by the Social Science and Humanities Research Council of Canada and the University of Toronto.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akoshima Kaoru., 1987, HUMAN USES FLINT CHE, P71; Andrefsky W, 2008, LITHIC TECHNOLOGY: MEASURES OF PRODUCTION, USE, AND CURATION, P195, DOI 10.1017/CBO9780511499661.010; [Anonymous], 1989, THESIS; [Anonymous], 2011, PRINC PRACT GROUP; ARGAST S, 1987, GEOLOGY, V15, P927, DOI 10.1130/0091-7613(1987)15<927:TAOFRT>2.0.CO;2; Avery G, 1997, J FIELD ARCHAEOL, V24, P263, DOI 10.1179/009346997792208131; BAMFORTH DB, 1988, J ARCHAEOL SCI, V15, P11, DOI 10.1016/0305-4403(88)90015-5; Barham L, 2013, HAND HANDLE 1 IND RE, DOI [10.1093/acprof:osobl/9780199604715.001.0001, DOI 10.1093/ACPROF:OSOBL/9780199604715.001.0001]; Barton CM, 2002, GEOARCHAEOLOGY, V17, P155, DOI 10.1002/gea.10008; Beaumont PB., 1990, GUIDE ARCHAEOLOGICAL; Bernatchez JA, 2010, J HUM EVOL, V59, P274, DOI 10.1016/j.jhevol.2010.07.005; Binford L.R., 2001, CONSTRUCTING FRAMES; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Bird C, 2007, J ARCHAEOL SCI, V34, P771, DOI 10.1016/j.jas.2006.08.005; Bird R, 1999, EVOL ANTHROPOL, V8, P65, DOI 10.1002/(SICI)1520-6505(1999)8:2<65::AID-EVAN5>3.3.CO;2-V; Brink J.S., 1988, Palaeoecology of Africa and the Surrounding Islands, V19, P169; Brooks AS, 2006, INTERD CONTRIB ARCH, P233, DOI 10.1007/0-387-24661-4_13; Brown KS, 1999, THESIS; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chambers JC, 2003, LITHICS NEWSL LITHIC, V24, P66; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; Dibble Harold L., 2006, Paleoanthropology, V2006, P1; Metin IE, 2010, J ARCHAEOL SCI, V37, P3010, DOI 10.1016/j.jas.2010.06.024; Evans AA, 2014, J ARCHAEOL SCI, V48, P1, DOI 10.1016/j.jas.2014.03.002; Faith JT, 2008, J HUM EVOL, V55, P24, DOI 10.1016/j.jhevol.2007.11.005; Fisher EC, 2010, QUATERNARY SCI REV, V29, P1382, DOI 10.1016/j.quascirev.2010.01.015; Flenniken J. J., 1979, NW ANTHR RES NOTES, V13, P208; GIFFORDGONZALEZ DP, 1985, AM ANTIQUITY, V50, P803, DOI 10.2307/280169; Goldberg P, 2000, J HUM EVOL, V38, P43, DOI 10.1006/jhev.1999.0350; Grace R., 1996, ARCHAEOMETRY, V38, P209, DOI [10.1111/j.1475-4754.1996.tb00771.x, DOI 10.1111/J.1475-4754.1996.TB00771.X]; Greaves RD, 1997, INTERD CONT, P287; GRINE FE, 1991, J HUM EVOL, V21, P363, DOI 10.1016/0047-2484(91)90113-A; Gurven M, 2000, EVOL HUM BEHAV, V21, P263, DOI 10.1016/S1090-5138(00)00032-5; Hardy B. L., 1994, THESIS; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2011, CURR ANTHROPOL, V52, P361, DOI 10.1086/660022; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Hilborn Ray, 1997, V28; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Iovita R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029029; Jacobs Z, 2010, J HUM EVOL, V59, P289, DOI 10.1016/j.jhevol.2010.07.010; Jerardino A, 2010, J HUM EVOL, V59, P412, DOI 10.1016/j.jhevol.2010.07.003; Kaplan J., 1997, ARCHAEOLOGICAL STUDY; Karkanas P, 2010, J HUM EVOL, V59, P256, DOI 10.1016/j.jhevol.2010.07.001; Klein R. G., 1999, HUMAN CAREER HUMAN B; Klein RG, 2000, J HUM EVOL, V38, P169, DOI 10.1006/jhev.1999.0355; Kuhn R.P., 1989, BAR INT SERIES, P33; Lazuen T, 2014, J ARCHAEOL SCI, V46, P1, DOI 10.1016/j.jas.2014.02.023; Lerner H, 2007, J ARCHAEOL SCI, V34, P711, DOI 10.1016/j.jas.2006.07.009; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Lombard M, 2007, S AFR ARCHAEOL BULL, V62, P62, DOI 10.2307/20474947; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lyman R.L., 1994, VERTEBRATE TAPHONOMY, DOI [10.1017/CBO9781139878302, DOI 10.1017/CBO9781139878302, 10.1017/cbo9781139878302]; Macdonald DA, 2014, J ARCHAEOL SCI, V48, P26, DOI 10.1016/j.jas.2013.10.003; Marean C.W., 2004, PALEOANTHROPOL, P14; Marean C. W., 2007, RETHINKING HUMAN REV, P367; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; Marean CW, 2010, J HUM EVOL, V59, P234, DOI 10.1016/j.jhevol.2010.07.007; Marean CW, 2000, J HUM EVOL, V38, P7, DOI 10.1006/jhev.1999.0349; Marean CW, 2000, J HUM EVOL, V38, P3, DOI 10.1006/jhev.1999.0348; Marean CW, 2000, J HUM EVOL, V38, P197, DOI 10.1006/jhev.1999.0356; Marean CW, 1999, EVOL ANTHROPOL, V8, P22, DOI 10.1002/(SICI)1520-6505(1999)8:1<22::AID-EVAN7>3.0.CO;2-F; Marreiros J, 2015, MAN ARCHAEOL METH, P5, DOI 10.1007/978-3-319-08257-8_2; Matthews T, 2011, PALAEOGEOGR PALAEOCL, V302, P213, DOI 10.1016/j.palaeo.2011.01.014; McBrearty S, 1998, AM ANTIQUITY, V63, P108, DOI 10.2307/2694779; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McPherron SP, 2014, J ARCHAEOL SCI, V49, P70, DOI 10.1016/j.jas.2014.04.003; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Milo RG, 1998, J ARCHAEOL SCI, V25, P99, DOI 10.1006/jasc.1997.0233; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; NEWCOMER M, 1986, J ARCHAEOL SCI, V13, P203, DOI 10.1016/0305-4403(86)90059-2; NIELSEN AE, 1991, AM ANTIQUITY, V56, P483, DOI 10.2307/280897; Noone HVV, 1949, MAN, V49, P111, DOI 10.2307/2792763; O'Driscoll CA, 2012, THESIS; O'Driscoll CA, 2014, J ARCHAEOL SCI, V49, P398, DOI 10.1016/j.jas.2014.05.036; Odell G.H., 1980, J FIELD ARCHAEOL, V7, P87, DOI DOI 10.1179/009346980791505545; Odell GH, 1996, STONE TOOLS MOBILITY; Oswalt W. H, 1976, ANTHR ANAL FOOD GETT; Pargeter J, 2011, ANTIQUITY, V85, P327; Pargeter J, 2011, J ARCHAEOL SCI, V38, P2882, DOI 10.1016/j.jas.2011.04.018; Patton JQ, 2005, EVOL HUM BEHAV, V26, P137, DOI 10.1016/j.evolhumbehav.2004.08.008; Pickering R, 2013, QUATERNARY SCI REV, V65, P39, DOI 10.1016/j.quascirev.2012.12.016; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Pryor JH., 1988, LITHIC TECHNOL, V17, P45, DOI DOI 10.1080/01977261.1988.11754525; Riel-Salvatore J, 2008, J ANTHROPOL ARCHAEOL, V27, P399, DOI 10.1016/j.jaa.2008.02.002; Rots V, 2006, J ARCHAEOL SCI, V33, P935, DOI 10.1016/j.jas.2005.10.018; Rots V, 2014, J ARCHAEOL SCI, V48, P154, DOI 10.1016/j.jas.2013.10.027; Rots V, 2013, J ARCHAEOL SCI, V40, P497, DOI 10.1016/j.jas.2012.06.042; Rots V, 2011, J HUM EVOL, V60, P637, DOI 10.1016/j.jhevol.2011.01.001; Schoville B.J., 2010, VIS VIS EXPLOR ANTHR, V10, P34; Schoville BJ, 2014, J ARCHAEOL SCI, V48, P84, DOI 10.1016/j.jas.2013.10.002; Schoville BJ, 2010, J HUM EVOL, V59, P378, DOI 10.1016/j.jhevol.2010.07.015; SCHWEITZER F R, 1979, Annals of the South African Museum, V78, P101; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Shea J, 2001, J ARCHAEOL SCI, V28, P807, DOI 10.1006/jasc.2000.0590; Shea J.J., 1987, LITHIC TECHNOL, V16, P44, DOI DOI 10.1080/01977261.1987.11720882; Shea J. J., 1993, ARCHAEOLOGICAL PAPER, V4, P189, DOI DOI 10.1525/AP3A.1993.4.1.189; SHEA JJ, 1993, J ARCHAEOL SCI, V20, P175, DOI 10.1006/jasc.1993.1013; Shea JJ, 1991, BEHAV SIGNIFICANCE L; Shea JJ, 2011, EVOL ANTHROPOL, V20, P48, DOI 10.1002/evan.20290; Shea JJ, 2011, CURR ANTHROPOL, V52, P1, DOI 10.1086/658067; Sisk Matthew L, 2011, Int J Evol Biol, V2011, P968012, DOI 10.4061/2011/968012; Smith AM, 2003, EARTH-SCI REV, V63, P1, DOI 10.1016/S0012-8252(02)00164-2; Speth JD, 2010, INTERD CONTRIB ARCH, P149, DOI 10.1007/978-1-4419-6733-6_12; Stemp WJ, 2014, J ARCHAEOL SCI, V48, P15, DOI 10.1016/j.jas.2013.04.027; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Thackeray AI, 2000, J HUM EVOL, V38, P147, DOI 10.1006/jhev.1999.0354; Thompson E, 2010, J HUM EVOL, V59, P358, DOI 10.1016/j.jhevol.2010.07.009; Thompson J. C., 2008, THESIS; Thompson JC, 2014, J ARCHAEOL SCI, V41, P214, DOI 10.1016/j.jas.2013.08.017; Thompson JC, 2011, J HUM EVOL, V60, P746, DOI 10.1016/j.jhevol.2011.01.013; Tindale Norman., 1965, RECORDS S AUSTR MUSE, V15, P131; Tomasso S., 2015, NOTAE PRAEHISTORICAE, V35, P239; Tringham R., 1974, J FIELD ARCHAEOL, V1, P171, DOI 10.1179/jfa.1974.1.1-2.171; Vaughan P.C., 1985, USE WEAR ANAL FLAKED; Villa P., 2006, SOUTH AFR HUMANIT, V18, P89; Villa P, 2009, J ARCHAEOL SCI, V36, P850, DOI 10.1016/j.jas.2008.11.012; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Wadley L, 2005, J HUM EVOL, V49, P587, DOI 10.1016/j.jhevol.2005.06.007; Wadley L, 2004, J ARCHAEOL SCI, V31, P1491, DOI 10.1016/j.jas.2004.03.010; Wadley L, 2010, J ARCHAEOL SCI, V37, P2397, DOI 10.1016/j.jas.2010.04.012; Wadley L, 2010, J HUM EVOL, V58, P179, DOI 10.1016/j.jhevol.2009.10.004; Watts I, 2016, CURR ANTHROPOL, V57, P287, DOI 10.1086/686484; Wilkins J, 2016, VERTEBR PALEOBIOL PA, P101, DOI 10.1007/978-94-017-7602-8_7; Wilkins J, 2015, J ARCHAEOL SCI, V54, P294, DOI 10.1016/j.jas.2014.12.003; Wilkins J, 2012, SCIENCE, V338, P942, DOI 10.1126/science.1227608; Wilkins J, 2012, J ARCHAEOL SCI, V39, P1883, DOI 10.1016/j.jas.2012.01.031; Zipkin AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112560	134	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164088	10.1371/journal.pone.0164088	http://dx.doi.org/10.1371/journal.pone.0164088			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736886	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800039
J	Tang, YY; Wang, YK; Chen, JY; Li, XB				Tang, Yinyin; Wang, Yueke; Chen, Jianyun; Li, Xianbin			Uplink Scheduling of Navigation Constellation Based on Immune Genetic Algorithm	PLOS ONE			English	Article							PHYSICAL IMPAIRMENTS; SATELLITE; RANGE; MODEL	The uplink of navigation data as satellite ephemeris is a complex satellite range scheduling problem. Large-scale optimal problems cannot be tackled using traditional heuristic methods, and the efficiency of standard genetic algorithm is unsatisfactory. We propose a multi-objective immune genetic algorithm (IGA) for uplink scheduling of navigation constellation. The method focuses on balance traffic and maximum task objects based on satellite-ground index encoding method, individual diversity evaluation and memory library. Numerical results show that the multi-hierarchical encoding method can improve the computation efficiency, the fuzzy deviation toleration method can speed up convergence, and the method can achieve the balance target with a negligible loss in task number (approximately 2.98%). The proposed algorithm is a general method and thus can be used in similar problems.	[Tang, Yinyin; Wang, Yueke; Chen, Jianyun] Natl Univ Def Technol, Coll Mechatron Engn & Automat, Changsha, Hunan, Peoples R China; [Li, Xianbin] Troop 69222, Luntai, Xinjiang, Peoples R China	National University of Defense Technology - China	Wang, YK (corresponding author), Natl Univ Def Technol, Coll Mechatron Engn & Automat, Changsha, Hunan, Peoples R China.	814211180@163.com						Ahrabi SS, 2014, 14 INT C HYBR INT SY; Barbulescu L., 2002, Parallel Problem Solving from Nature - PPSN VII. 7th International Conference. Proceedings (Lecture Notes in Computer Science Vol.2439), P611; Barbulescu L, 2004, J SCHEDULING, V7, P7, DOI 10.1023/B:JOSH.0000013053.32600.3c; Dai YS, 2007, J SYST ENG ELECTRON, V18, P655, DOI 10.1016/S1004-4132(07)60144-3; Dou H, 2015, 2015 INTERNATIONAL CONFERENCE ON IDENTIFICATION, INFORMATION, AND KNOWLEDGE IN THE INTERNET OF THINGS (IIKI), P210, DOI 10.1109/IIKI.2015.52; Fernandez FA, 2011, ADV SPACE RES, V47, P786, DOI 10.1016/j.asr.2010.10.002; Huang W, 2003, TRANSM DISTR C EXP, V1, P186; Javanmardi S, 2015, INT J GRID UTIL COMP, V6, P57, DOI 10.1504/IJGUC.2015.066397; Kaplan E., 2005, UNDERSTANDING GPS PR; Karapetyan D, 2015, OMEGA-INT J MANAGE S, V53, P115, DOI 10.1016/j.omega.2015.01.001; Li XB, 2014, IEICE T COMMUN, VE97B, P915, DOI 10.1587/transcom.E97.B.915; Li YQ, 2015, CHINESE J AERONAUT, V28, P789, DOI 10.1016/j.cja.2015.04.012; Liu JN, 2011, SURV REV, V43, P333, DOI 10.1179/003962611X13055561708542; Long YJ, 2011, SURV REV, V43, P333; Marinelli F, 2011, COMPUT OPER RES, V38, P1572, DOI 10.1016/j.cor.2011.01.016; Sanchez M, 2008, P 21 INT TECHN M SAT; Simoes A, 2003, SPRING COMP SCI, P168; Song H., 2011, P IEEE GLOB COMM C H, P1; Song HB, 2013, IEEE GLOB COMM CONF, P2394, DOI 10.1109/GLOCOM.2013.6831432; Song HB, 2013, J LIGHTWAVE TECHNOL, V31, P846, DOI 10.1109/JLT.2012.2235409; Song HB, 2012, J LIGHTWAVE TECHNOL, V30, P713, DOI 10.1109/JLT.2011.2180360; Song Huaiming, 2011, P IEEE INT C COMM KY, P1, DOI [DOI 10.1145/2063384.2063407, 10.1145/2063384.2063407]; Sun ZY, 2017, WIREL NETW, V23, P1201, DOI 10.1007/s11276-016-1213-3; Wu J. H., 1999, Journal of Grey System, V11, P7; Xhafa F, 2012, MOB INF SYST, V8, P351, DOI 10.1155/2012/717658; Xie G., 2009, PRINCIPLES GPS RECEI; XU DT, 2016, IET COMMUN, V10, P292, DOI DOI 10.1049/IET-C0M.2015.0229	27	0	1	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164730	10.1371/journal.pone.0164730	http://dx.doi.org/10.1371/journal.pone.0164730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736986	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800123
J	Ikeda, T; Uchida, K; Matsuura, Y; Takahashi, H; Yoshida, T; Kaji, K; Koizumi, I				Ikeda, Takashi; Uchida, Kenta; Matsuura, Yukiko; Takahashi, Hiroshi; Yoshida, Tsuyoshi; Kaji, Koichi; Koizumi, Itsuro			Seasonal and Diel Activity Patterns of Eight Sympatric Mammals in Northern Japan Revealed by an Intensive Camera-Trap Survey	PLOS ONE			English	Article							BIALOWIEZA-NATIONAL-PARK; FOX VULPES-VULPES; PUMA-CONCOLOR; ACTIVITY PERIODS; MARTES-MARTES; PANTHERA-ONCA; CANIS-LUPUS; RAIN-FOREST; HOME-RANGE; DEER	The activity patterns of mammals are generally categorized as nocturnal, diurnal, crepuscular (active at twilight), and cathemeral (active throughout the day). These patterns are highly variable across regions and seasons even within the same species. However, quantitative data is still lacking, particularly for sympatric species. We monitored the seasonal and diel activity patterns of terrestrial mammals in Hokkaido, Japan. Through an intensive camera-trap survey a total of 13,279 capture events were recorded from eight mammals over 20,344 camera-trap days, i.e., two years. Diel activity patterns were clearly divided into four categories: diurnal (Eurasian red squirrels), nocturnal (raccoon dogs and raccoons), crepuscular (sika deer and mountain hares), and cathemeral (Japanese martens, red foxes, and brown bears). Some crepuscular and cathemeral mammals shifted activity peaks across seasons. Particularly, sika deer changed peaks from twilight during spring-autumn to day-time in winter, possibly because of thermal constraints. Japanese martens were cathemeral during winter-summer, but nocturnal in autumn. We found no clear indication of predator-prey and competitive interactions, suggesting that animal densities are not very high or temporal niche partitioning is absent among the target species. This long-term camera-trap survey was highly cost-effective and provided one of the most detailed seasonal and diel activity patterns in multiple sympatric mammals under natural conditions.	[Ikeda, Takashi; Koizumi, Itsuro] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Uchida, Kenta; Koizumi, Itsuro] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido, Japan; [Matsuura, Yukiko] Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan; [Takahashi, Hiroshi] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Kyoto, Kyoto, Japan; [Yoshida, Tsuyoshi] Rakuno Gakuen Univ, Wildlife Management Lab, Ebetsu, Hokkaido, Japan; [Kaji, Koichi] Tokyo Univ Agr & Technol, Lab Wildlife Management, Fuchu, Tokyo, Japan	Hokkaido University; Hokkaido University; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Rakuno Gakuen University; Tokyo University of Agriculture & Technology	Ikeda, T (corresponding author), Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan.	wild_wolf_traveler@yahoo.co.jp	Koichi, Kaji/C-8355-2013; Yoshida, Tsuyoshi/N-4049-2018; Uchida, Kenta/AAJ-5940-2021	Koichi, Kaji/0000-0001-6578-9995; Yoshida, Tsuyoshi/0000-0001-9297-8716; Ikeda, Takashi/0000-0003-3217-3275; Uchida, Kenta/0000-0001-7998-1363	Japan Ministry of the Environment Research and Technology Development Fund [4D-1103]; Japan Society for the Promotion of Science (JSPS) [14J01402]	Japan Ministry of the Environment Research and Technology Development Fund; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Japan Ministry of the Environment Research and Technology Development Fund (4D-1103) to TY and the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for JSPS Fellows (14J01402) to TI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abi-Said MR, 2014, VERTEBR ZOOL, V64, P127; Akbaba B, 2012, MAMMALIA, V76, P43, DOI [10.1515/MAMM.2011.102, 10.1515/mamm.2011.102]; Angerbjorn Anders, 1995, Mammalian Species, V495, P1; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold W, 2004, AM J PHYSIOL-REG I, V286, pR174, DOI 10.1152/ajpregu.00593.2002; Azlan JM, 2006, ORYX, V40, P36, DOI 10.1017/S0030605306000147; Bartnick TD, 2013, CAN J ZOOL, V91, P82, DOI 10.1139/cjz-2012-0147; BEIER P, 1990, WILDLIFE MONOGR, P5; Bennie JJ, 2014, P NATL ACAD SCI USA, V111, P13727, DOI 10.1073/pnas.1216063110; Bisi F, 2013, MAMM BIOL, V78, P28, DOI 10.1016/j.mambio.2012.05.004; Bridges AS, 2004, WILDLIFE BIOL, V10, P277, DOI 10.2981/wlb.2004.033; Di Cerbo AR, 2013, ACTA THERIOL, V58, P279, DOI 10.1007/s13364-012-0122-9; Diaz-Ruiz F, 2016, J ZOOL, V298, P128, DOI 10.1111/jzo.12294; Doncaster CP, 1997, J ZOOL, V241, P73, DOI 10.1111/j.1469-7998.1997.tb05500.x; Feierabend D, 2014, J MAMMAL, V95, P525, DOI 10.1644/13-MAMM-A-199; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Foster VC, 2013, BIOTROPICA, V45, P373, DOI 10.1111/btp.12021; Georgiev Dilian, 2015, ZooNotes, V69, P1; GILLINGHAM MP, 1992, CAN J ZOOL, V70, P293, DOI 10.1139/z92-044; Gomez H, 2005, STUD NEOTROP FAUNA E, V40, P91, DOI 10.1080/01650520500129638; GREEN RA, 1990, J WILDLIFE MANAGE, V54, P272, DOI 10.2307/3809041; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Ikeda T., 1999, ANN REPORT CULTURAL, P149; Ikeda T, 2015, MAMM STUDY, V40, P199; Ikeda Tohru, 2004, Global Environmental Research, V8, P125; Kaas J. H., 2004, VISUAL NEUROSCIENCES, P1563; Kaczensky P, 2006, J ZOOL, V269, P474, DOI 10.1111/j.1469-7998.2006.00114.x; Katona K, 2002, ACTA THERIOL, V47, P45, DOI 10.1007/BF03193565; Kilgo JC, 1998, CONSERV BIOL, V12, P1359, DOI 10.1046/j.1523-1739.1998.97223.x; Kirk EC, 2006, FOLIA PRIMATOL, V77, P27, DOI 10.1159/000089694; Koprowski JL, 2005, J MAMMAL, V86, P947, DOI 10.1644/1545-1542(2005)86[947:TBAPAB]2.0.CO;2; Kortello AD, 2007, ECOSCIENCE, V14, P214, DOI 10.2980/1195-6860(2007)14[214:IBCPCA]2.0.CO;2; Koshey YS, 2008, ACTA ZOOL BULGAR, P149; Linkie M, 2011, J ZOOL, V284, P224, DOI 10.1111/j.1469-7998.2011.00801.x; Macdonald D.W., 2004, CANIDS FOXES WOLVES, P129; Manzo E, 2012, ACTA THERIOL, V57, P165, DOI 10.1007/s13364-011-0055-8; Meek PD, 2012, AUST MAMMAL, V34, P223, DOI 10.1071/AM11032; Ramesh T, 2012, J ZOOL, V287, P269, DOI 10.1111/j.1469-7998.2012.00908.x; Rehnus Maik, 2014, Zoologische Garten, V83, P140; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Saitoh T, 2015, WILD MAMMALS JAPAN, V2nd; Salvatori V, 1999, J MAMMAL, V80, P980, DOI 10.2307/1383268; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Symmank ME, 2014, SW NAT, V13, P172, DOI [10.1656/058.013.s501, DOI 10.1656/058.013.S501]; Takeuchi M, 1992, MAMM STUDY, V17, P95, DOI DOI 10.11238/JMAMMSOCJAPAN.17.95; vanSchaik CP, 1996, BIOTROPICA, V28, P105, DOI 10.2307/2388775; Wong ST, 2004, BIOL CONSERV, V119, P169, DOI 10.1016/j.biocon.2003.10.029; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zalewski A, 2000, J ZOOL, V251, P439, DOI 10.1111/j.1469-7998.2000.tb00799.x; Zalewski A, 2001, ACTA THERIOL, V46, P295, DOI 10.1007/BF03192436; Zoller H, 2013, FOLIA ZOOL, V62, P290	52	50	56	3	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163602	10.1371/journal.pone.0163602	http://dx.doi.org/10.1371/journal.pone.0163602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732611	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300022
J	Kaushik, DK; Yong, HYF; Hahn, JN; Silva, C; Casha, S; Hurlbert, RJ; Jacques, FH; Lisak, R; Khan, O; Ionete, C; Larochelle, C; Prat, A; Bar-Or, A; Yong, VW				Kaushik, Deepak K.; Yong, Heather Y. F.; Hahn, Jennifer N.; Silva, Claudia; Casha, Steven; Hurlbert, R. John; Jacques, Francois H.; Lisak, Robert; Khan, Omar; Ionete, Carolina; Larochelle, Catherine; Prat, Alex; Bar-Or, Amit; Yong, V. Wee			Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; IMMUNOGLOBULIN SUPERFAMILY; MATRIX METALLOPROTEINASES; NERVOUS-SYSTEM; EXPRESSION; SURFACE; CD147; INDUCER; BASIGIN; LACTATE	Extracellular matrix metalloproteinase inducer (EMMPRIN, CD147) is an inducer of matrix metalloproteinases and has roles in leukocyte activation and migration. We reported previously that in MS and its animal model, experimental autoimmune encephalomyelitis, cell surface-associated EMMPRIN was significantly elevated in leukocytes around inflammatory perivascular cuffs in the CNS. In this study we report that activated T-cells can secrete soluble form of EMMPRIN (sEMMPRIN) upon activation. As sEMMPRIN is also present in biological fluids, we determined whether sEMMPRIN is altered in the CSF and sera of MS subjects. Sera from individuals without neurological conditions served as controls, while CSFs collected from subjects undergoing discectomy, and without evidence of CNS pathology, were used as a comparator group. We found that serum levels of sEMMPRIN from clinically stable MS patients or other inflammatory conditions did not differ from control subjects. Paired serum and CSF samples demonstrated poor correlation of sEMMPRIN. Interestingly, sEMMPRIN levels were approximately 60% higher in CSFs compared to sera. sEMMPRIN CSF levels were significantly higher in secondary progressive compared to primary progressive subjects. Thus we conclude that measurement of sEMMPRIN in serum is not informative for disease activity in MS. The differential expression of sEMMPRIN in the CSF of primary and secondary progressive MS invites hypotheses of the still undefined roles of EMMPRIN in the CNS.	[Kaushik, Deepak K.; Yong, Heather Y. F.; Hahn, Jennifer N.; Silva, Claudia; Casha, Steven; Hurlbert, R. John; Yong, V. Wee] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Jacques, Francois H.] CSSSG Hull Pavil, Gatineau, PQ, Canada; [Lisak, Robert; Khan, Omar] Wayne State Univ, Sch Med, Multiple Sclerosis Ctr, Detroit, MI USA; [Ionete, Carolina] Univ Massachusetts, Multiple Sclerosis Ctr, Worcester, MA 01605 USA; [Larochelle, Catherine; Prat, Alex] Univ Montreal, Montreal, PQ, Canada; [Bar-Or, Amit] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	University of Calgary; Wayne State University; University of Massachusetts System; University of Massachusetts Worcester; Universite de Montreal; McGill University	Yong, VW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	vyong@ucalgary.ca	Bar-Or, Amit/AIC-1416-2022	Jacques, Francois Henri/0000-0002-6530-9370; Yong, V. Wee/0000-0002-2600-3563	Canadian Institutes of Health Research (CIHR); Alberta Innovates [201500719] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This study was funded by an operating grant from the Canadian Institutes of Health Research (CIHR).	Agrawal SM, 2013, BRAIN, V136, P1760, DOI 10.1093/brain/awt093; Agrawal SM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-64; Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; Archelos JJ, 1999, TRENDS NEUROSCI, V22, P30, DOI 10.1016/S0166-2236(98)01287-9; Arnorini AM, 2014, BBA-MOL BASIS DIS, V1842, P1137, DOI 10.1016/j.bbadis.2014.04.005; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Burggraf D, 2005, EUR J NEUROSCI, V22, P273, DOI 10.1111/j.1460-9568.2005.04187.x; Comabella M, 2006, J NEUROL, V253, P701, DOI 10.1007/s00415-006-0090-6; Curtin KD, 2005, J CELL SCI, V118, P2649, DOI 10.1242/jcs.02408; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Fainardi E, 2006, MULT SCLER J, V12, P294, DOI 10.1191/135248506ms1274oa; Fainardi E, 2009, MULT SCLER J, V15, P547, DOI 10.1177/1352458509102372; Fan QW, 1998, NEUROSCI RES, V30, P53, DOI 10.1016/S0168-0102(97)00119-3; Giovannoni G, 2006, DIS MARKERS, V22, P187, DOI 10.1155/2006/509476; Hahn JN, 2015, J LEUKOCYTE BIOL, V98, P33, DOI 10.1189/jlb.3RU0215-045R; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hatanaka M, 2014, ANTICANCER RES, V34, P7091; Igakura T, 1996, BIOCHEM BIOPH RES CO, V224, P33, DOI 10.1006/bbrc.1996.0980; Ilzecka J, 2011, ACTA NEUROL SCAND, V124, P424, DOI 10.1111/j.1600-0404.2011.01519.x; Kaushik DK, 2015, MATRIX BIOL, V44-46, P138, DOI 10.1016/j.matbio.2015.01.018; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; NAKAJIMA H, 1994, J EXP MED, V179, P1145, DOI 10.1084/jem.179.4.1145; Naruhashi K, 1997, BIOCHEM BIOPH RES CO, V236, P733, DOI 10.1006/bbrc.1997.6993; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Regenold WT, 2008, J NEUROL SCI, V275, P106, DOI 10.1016/j.jns.2008.07.032; REVESZ T, 1994, BRAIN, V117, P759, DOI 10.1093/brain/117.4.759; RISAU W, 1986, EMBO J, V5, P3179, DOI 10.1002/j.1460-2075.1986.tb04627.x; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sameshima T, 2000, INT J CANCER, V88, P21, DOI 10.1002/1097-0215(20001001)88:1<21::AID-IJC4>3.0.CO;2-S; Sidhu SS, 2004, ONCOGENE, V23, P956, DOI 10.1038/sj.onc.1207070; Steiner O, 2010, J IMMUNOL, V185, P4846, DOI 10.4049/jimmunol.0903732; Stuendl A, 2016, BRAIN, V139, P481, DOI 10.1093/brain/awv346; Tian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058069; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Yanaba K, 2012, CLIN RHEUMATOL, V31, P835, DOI 10.1007/s10067-012-1949-9; Yong VW, 1998, TRENDS NEUROSCI, V21, P75; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163802	10.1371/journal.pone.0163802	http://dx.doi.org/10.1371/journal.pone.0163802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727297	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504400010
J	Choi, S; Han, KM; Kang, J; Won, E; Chang, HS; Tae, WS; Son, KR; Kim, SJ; Lee, MS; Ham, BJ				Choi, Sunyoung; Han, Kyu-Man; Kang, June; Won, Eunsoo; Chang, Hun Soo; Tae, Woo Suk; Son, Kyu Ri; Kim, Su-Jin; Lee, Min-Soo; Ham, Byung-Joo			Effects of a Polymorphism of the Neuronal Amino Acid Transporter SLC6A15 Gene on Structural Integrity of White Matter Tracts in Major Depressive Disorder	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; MILD COGNITIVE IMPAIRMENT; MICROSTRUCTURAL ABNORMALITIES; FRACTIONAL ANISOTROPY; POSTERIOR CINGULUM; TREATMENT-NAIVE; BDNF VAL66MET; YOUNG-ADULTS; METAANALYSIS; 1ST-EPISODE	Background The SLC6A15 gene has been identified as a novel candidate gene for major depressive disorder (MDD). It is presumed to be involved in the pathophysiology of MDD through regulation of glutamate transmission in the brain. However, the involvement of this gene in microstructural changes in white matter (WM) tracts remains unclear. We aimed to investigate the influence of a polymorphism of this gene (rs1545853) on the structural integrity of WM tracts in the cortico-limbic network. Methods Eighty-six patients with MDD and 64 healthy controls underwent T1-weighted structural magnetic resonance imaging, including diffusion tensor imaging (DTI), and genotype analysis. We selected the genu of the corpus callosum, the uncinate fasciculus, cingulum, and fornix as regions of interest, and extracted fractional anisotropy (FA) values using the FMRIB Diffusion Toolbox software. Results FA values for the left parahippocampal cingulum (PHC) was significantly reduced in the patients with MDD compared to healthy control participants (p = 0.004). We also found that MDD patients with the A allele showed reduced FA values for the left PHC than did healthy controls with the A allele (p = 0.012). There was no significant difference in the FA value of left PHC for the comparison between the G homozygotes of MDD and healthy control group. Conclusions We observed an association between the risk allele of the SLC6A15 gene rs1545843 and the WM integrity of the PHC in MDD patients, which is known to play an important role in the neural circuit involved in emotion processing.	[Choi, Sunyoung] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Han, Kyu-Man; Won, Eunsoo; Lee, Min-Soo; Ham, Byung-Joo] Korea Univ, Dept Psychiat, Coll Med, Seoul, South Korea; [Kang, June] Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Chang, Hun Soo] Soonchunhyang Univ, Grad Sch, Dept Med Biosci, Bucheon, South Korea; [Tae, Woo Suk; Ham, Byung-Joo] Korea Univ, Anam Hosp, Brain Convergence Res Ctr, Seoul, South Korea; [Son, Kyu Ri] Korea Univ, Coll Med, Anam Hosp, Dept Radiol, Seoul, South Korea; [Kim, Su-Jin] Korea Univ, Coll Med, Dept Emergency Med, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Soonchunhyang University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Ham, BJ (corresponding author), Korea Univ, Dept Psychiat, Coll Med, Seoul, South Korea.; Ham, BJ (corresponding author), Korea Univ, Anam Hosp, Brain Convergence Res Ctr, Seoul, South Korea.	hambj@korea.ac.kr	LEE, MINSOO/HGE-5845-2022; Kang, June/ABG-5999-2020; Ham, Byung-Joo/S-9982-2019	Han, Kyu-Man/0000-0002-1982-4216; Kang, June/0000-0003-3625-0856; Ham, Byung Joo/0000-0002-0108-2058	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120004]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	Thid work was supported by Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120004).	Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benedetti F, 2015, GENES BRAIN BEHAV, V14, P238, DOI 10.1111/gbb.12206; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carballedo A, 2012, AM J MED GENET B, V159B, P537, DOI 10.1002/ajmg.b.32060; Chen LP, 2013, PSYCHIAT RES-NEUROIM, V212, P201, DOI 10.1016/j.pscychresns.2012.05.009; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Choi S, 2015, J AFFECT DISORDERS, V172, P74, DOI 10.1016/j.jad.2014.09.042; Fani N, 2014, NEUROPSYCHOPHARMACOL, V39, P1206, DOI 10.1038/npp.2013.322; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Forde NJ, 2014, NEUROIMAGE, V90, P280, DOI 10.1016/j.neuroimage.2013.12.050; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Guo WB, 2012, NEUROSCI LETT, V522, P139, DOI 10.1016/j.neulet.2012.06.027; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hayashi K, 2014, NEUROPSYCH DIS TREAT, V10, P1183, DOI [10.2147/NDT.S61275, 10.2147/NDT.561275]; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Ito K, 2015, PSYCHIAT RES-NEUROIM, V231, P346, DOI 10.1016/j.pscychresns.2015.01.020; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Jiang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134142; Jonassen R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00019; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kohli MA, 2011, NEURON, V70, P252, DOI 10.1016/j.neuron.2011.04.005; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Li M, 2013, AM J PSYCHIAT, V170, P805, DOI 10.1176/appi.ajp.2013.12111458; Liu XD, 2016, BRIT J PSYCHIAT, V208, P585, DOI 10.1192/bjp.bp.114.155689; Martinot MLP, 2014, MOL PSYCHIATR, V19, P462, DOI 10.1038/mp.2013.44; Murphy ML, 2012, BIOL PSYCHIAT, V72, P663, DOI 10.1016/j.biopsych.2012.04.015; Murphy ML, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-3; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Quast C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068645; Santarelli S, 2016, STRESS, V19, P83, DOI 10.3109/10253890.2015.1105211; Santarelli S, 2015, J PSYCHIATR RES, V68, P261, DOI 10.1016/j.jpsychires.2015.07.012; Schuhmacher A, 2013, INT J NEUROPSYCHOPH, V16, P83, DOI 10.1017/S1461145712000223; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Steffens DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022697; Taylor WD, 2014, J AFFECT DISORDERS, V162, P8, DOI 10.1016/j.jad.2014.03.031; Ugwu ID, 2015, BRAIN STRUCT FUNCT, V220, P1997, DOI 10.1007/s00429-014-0769-x; Won E, 2016, PROG NEURO-PSYCHOPH, V64, P311, DOI 10.1016/j.pnpbp.2015.03.014; Yang Q, 2007, INT PSYCHOGERIATR, V19, P757, DOI 10.1017/S1041610207004875; Zeng LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044248; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhu XL, 2011, BRAIN RES, V1369, P223, DOI 10.1016/j.brainres.2010.10.104	46	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164301	10.1371/journal.pone.0164301	http://dx.doi.org/10.1371/journal.pone.0164301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723767	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100041
J	Colli, A; Fraquelli, M; Prati, D; Riva, A; Berzuini, A; Conte, D; Aghemo, A; Colombo, M; Casazza, G				Colli, Agostino; Fraquelli, Mirella; Prati, Daniele; Riva, Alessia; Berzuini, Alessandra; Conte, Dario; Aghemo, Alessio; Colombo, Massimo; Casazza, Giovanni			Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; FIBROSIS; BIOPSY; ARCHITECTURE; VARIABILITY; PATIENT	Introduction In a perspective of economic constraints the prioritizing of patients to IFN-free regimens is mainly based on the determination of liver stiffness by transient elastography (TE). Being a continuous variable the interpretation of TE results requires the identification of cut-off values, to date set to maximize diagnostic accuracy even if such values should be better based on more helpful outcome prediction endpoints. Aim To define the TE cut-off values in different clinical scenarios, including new IFN-free regimens, and to balance the clinical benefits versus harms in treated and untreated patients. Methods We assessed the accuracy of TE in staging 728 consecutive HCV patients and the distribution of TE values in 1,001 blood donors. Ten experts quantified the expected harm/ benefit ratio for 6 scenarios resulting from 2 stages of liver disease (F >= 2 or F >= 3) and 3 treatment regimens: PEGIFN+ribavirin, PEGIFN+RBV+first-generation protease inhibitor, and IFN-free regimens. The optimal TE cut-off values were identified using the Metz equation. Results The estimated mean expected harm/ benefit ratio for IFN-free regimens was 1/8.3 in patients with F >= 2 and 1/10 in those with F >= 3. The resulting optimal cut-off values were respectively 4.5 kPa with sensitivity at 99% and specificity at 12%, and 6.8 kPa with sensitivity at 94% and specificity at 41%. These cut-off values are lower than those maximizing accuracy and allow to reduce the number of false negative results. Conclusions The optimal TE cut-off values to prioritize patients for IFN-free regimens, are sensibly lower than those used to maximize diagnostic accuracy.	[Colli, Agostino; Riva, Alessia] Osped A Manzoni, Dept Internal Med, Lecce, Italy; [Fraquelli, Mirella; Conte, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gastroenterol & Endoscopy Unit, Milan, Italy; [Prati, Daniele; Berzuini, Alessandra] Osped A Manzoni, Dept Transfus Med & Hematol, Lecce, Italy; [Aghemo, Alessio; Colombo, Massimo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gastroenterol & Hepatol Unit, Milan, Italy; [Casazza, Giovanni] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Fraquelli, M (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Gastroenterol & Endoscopy Unit, Milan, Italy.	a.colli@ospedale.lecco.it; mfraquelli@yahoo.it	Aghemo, Alessio/ABE-5976-2021; Prati, Daniele/P-8215-2019; Casazza, Giovanni/G-3661-2012	Aghemo, Alessio/0000-0003-0941-3226; Prati, Daniele/0000-0002-2281-7498; Casazza, Giovanni/0000-0003-3718-1784				[Anonymous], 2014, REC TEST MAN TREAT H; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chunilal SD, 2003, JAMA-J AM MED ASSOC, V290, P2849, DOI 10.1001/jama.290.21.2849; Colli A, 2014, HEPATOLOGY, V60, P408, DOI 10.1002/hep.26948; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Guido M, 2004, SEMIN LIVER DIS, V24, P89; Khan MH, 2000, HEPATOLOGY, V31, P513, DOI 10.1002/hep.510310236; Koretz RL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7809; Leidner AJ, 2015, HEPATOLOGY, V61, P1860, DOI 10.1002/hep.27736; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Patel K, 2004, J HEPATOL, V41, P935, DOI 10.1016/j.jhep.2004.08.008; Petta S., 2016, GASTROENTEROLOGY, V150, P145, DOI [DOI 10.1053/J.GASTRO.2015.09.007, DOI 10.1053/J.GASTR0.2015.09.007, 10.1053/j.gastro.2015.09.007]; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sox H., 2013, MED DECIS MAKING, V2nd ed, DOI [10.1002/9781118341544, DOI 10.1002/9781118341544]; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Trowbridge RL, 2003, JAMA-J AM MED ASSOC, V289, P80, DOI 10.1001/jama.289.1.80; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164452	10.1371/journal.pone.0164452	http://dx.doi.org/10.1371/journal.pone.0164452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723770	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100061
J	Cha, SA; Yun, JS; Lim, TS; Min, K; Song, KH; Yoo, KD; Park, YM; Ahn, YB; Ko, SH				Cha, Seon-Ah; Yun, Jae-Seung; Lim, Tae-Seok; Min, Kyoungil; Song, Ki-Ho; Yoo, Ki-Dong; Park, Yong-Moon; Ahn, Yu-Bae; Ko, Seung-Hyun			Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes	PLOS ONE			English	Article							SILENT-MYOCARDIAL-ISCHEMIA; MELLITUS; RISK; ASSOCIATION; MORTALITY; STROKE; EPIDEMIOLOGY; INFARCTION; STATEMENT; INDIVIDUALS	Cardiovascular autonomic neuropathy (CAN) is a risk factor for cardiovascular disease (CVD) and mortality in patients with type 2 diabetes. This study evaluated the relationship between CAN and recurrent CVD in type 2 diabetes. A total of 206 patients with type 2 diabetes who had a history of CVD within 3 years of enrollment were consecutively recruited from January 2001 to December 2009 and followed-up until December 2015. Cardiovascular autonomic function tests were performed using the following heart rate variability parameters: expiration-to-inspiration ratio, response to Valsalva maneuver and standing. We estimated the recurrence of CVD events during the follow-up period. A total of 159 (77.2%) of the 206 patients enrolled completed the follow up, and 78 (49.1%) patients had recurrent episodes of CVD, with an incidence rate of 75.6 per 1,000 patient-years. The mean age and diabetes duration were 62.5 +/- 8.7 and 9.2 +/- 6.9 years, respectively. Patients who developed recurrent CVD also exhibited hypertension (P = 0.004), diabetic nephropathy (P = 0.012), higher mean systolic blood pressure (P = 0.006), urinary albumin excretion (P = 0.015), and mean triglyceride level (P = 0.035) than did patients without recurrent CVD. Multivariable Cox hazard regression analysis revealed that definite CAN was significantly associated with an increased risk of recurrent CVD (hazard ratio [HR] 3.03; 95% confidence interval [CI] 1.39-6.60; P = 0.005). Definite CAN was an independent predictor for recurrent CVD in patients with type 2 diabetes who had a known prior CVD event.	[Cha, Seon-Ah; Yun, Jae-Seung; Lim, Tae-Seok; Min, Kyoungil; Song, Ki-Ho; Ahn, Yu-Bae; Ko, Seung-Hyun] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul, South Korea; [Yoo, Ki-Dong] Catholic Univ Korea, Div Cardiol, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, Yong-Moon] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA	Catholic University of Korea; Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Ko, SH (corresponding author), Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul, South Korea.	kosh@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Cha, Seon-Ah/0000-0001-6533-3082; Ko, Seung-Hyun/0000-0003-3703-1479; MIN, KYOUNG IL/0000-0002-8089-3800				Adeghate E, 2006, ANN NY ACAD SCI, V1084, P1, DOI 10.1196/annals.1372.029; Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Ahmed Amany H, 2007, Exp Clin Cardiol, V12, P189; [Anonymous], 1994, Diabetes Care, V17, P1357; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Callahan A, 2011, ARCH NEUROL-CHICAGO, V68, P1245, DOI 10.1001/archneurol.2011.146; Chyun DA, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312114568476; Cohen JA, 2003, AUTON NEUROSCI-BASIC, V108, P73, DOI 10.1016/j.autneu.2003.07.001; EWING DJ, 1986, DIABETES CARE, V9, P648, DOI 10.2337/diacare.9.6.648; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Giorda CB, 2008, DIABETES CARE, V31, P2154, DOI 10.2337/dc08-1013; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Honda T, 2014, J CARDIOL, V63, P358, DOI 10.1016/j.jjcc.2013.10.007; Jung JH, 2015, DIABETES METAB J, V39, P307, DOI 10.4093/dmj.2015.39.4.307; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Ko SH, 2008, DIABETIC MED, V25, P1171, DOI 10.1111/j.1464-5491.2008.02567.x; Ko SH, 2014, DIABETES METAB J, V38, P51, DOI 10.4093/dmj.2014.38.1.51; Korea Centers for Disease Control and Prevention, 2014, KOR HLTH STAT 2014 K; Korea Statistics, FACT SHEET CAUS DEAT; Korean Diabetes Association National Health Insurance Service, 2015, KOR DIAB FACT SHEET; Leiter LA, 2013, CAN J DIABETES, V37, P82, DOI 10.1016/j.jcjd.2013.02.055; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895; Orchard TJ, 1996, DIABETES RES CLIN PR, V34, pS165, DOI 10.1016/S0168-8227(96)01321-6; Pop-Busui R, 2010, DIABETES CARE, V33, P1578, DOI 10.2337/dc10-0125; Roh E, 2013, DIABETES METAB J, V37, P433, DOI 10.4093/dmj.2013.37.6.433; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Toyry JP, 1996, STROKE, V27, P1316, DOI 10.1161/01.STR.27.8.1316; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Valensi P, 2001, DIABETES CARE, V24, P339, DOI 10.2337/diacare.24.2.339; van der Heijden AAWA, 2013, DIABETES CARE, V36, P3498, DOI 10.2337/dc12-2691; Vincent JL, 2008, CRIT CARE, V12, DOI 10.1186/cc6975; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Wackers FJT, 2004, DIABETES CARE, V27, P1954, DOI 10.2337/diacare.27.8.1954; Yun JS, 2016, J CLIN LIPIDOL, V10, P426, DOI 10.1016/j.jacl.2015.12.030; Yun JS, 2015, DIABETES METAB J, V39, P498, DOI 10.4093/dmj.2015.39.6.498; ZIEGLER D, 1993, DIABETES METAB, V19, P143	42	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164807	10.1371/journal.pone.0164807	http://dx.doi.org/10.1371/journal.pone.0164807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741306	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000068
J	Jones, AR; Meshulam, T; Oliveira, MF; Burritt, N; Corkey, BE				Jones, Albert R.; Meshulam, Tova; Oliveira, Marcus F.; Burritt, Nathan; Corkey, Barbara E.			Extracellular Redox Regulation of Intracellular Reactive Oxygen Generation, Mitochondrial Function and Lipid Turnover in Cultured Human Adipocytes	PLOS ONE			English	Article							THIOL/DISULFIDE REDOX; ADIPOSE-TISSUE; KETONE-BODIES; GLUTATHIONE TRANSPORTERS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; OPTIMIZED ROS; FATTY-ACIDS; ACETOACETATE; STATE	Background Many tissues play an important role in metabolic homeostasis and the development of diabetes and obesity. We hypothesized that the circulating redox metabolome is a master metabolic regulatory system that impacts all organs and modulates reactive oxygen species (ROS) production, lipid peroxidation, energy production and changes in lipid turnover in many cells including adipocytes. Methods Differentiated human preadipocytes were exposed to the redox couples, lactate (L) and pyruvate (P), beta-hydroxybutyrate (beta OHB) and acetoacetate (Acoc), and the thiol-disulfides cysteine/cystine (Cys/CySS) and GSH/GSSG for 1.5-4 hours. ROS measurements were done with CM-H(2)DCFDA. Lipid peroxidation (LPO) was assessed by a modification of the thiobarbituric acid method. Lipolysis was measured as glycerol release. Lipid synthesis was measured as 14 C-glucose incorporated into lipid. Respiration was assessed using the SeaHorse XF24 analyzer and the proton leak was determined from the difference in respiration with oligomycin and antimycin A. Results Metabolites with increasing oxidation potentials (GSSG, CySS, Acoc) increased adipocyte ROS. In contrast, P caused a decrease in ROS compared with L. Acoc also induced a significant increase in both LPO and lipid synthesis. L and Acoc increased lipolysis. beta OHB increased respiration, mainly due to an increased proton leak. GSSG, when present throughout 14 days of differentiation significantly increased fat accumulation, but not when added later. Conclusions We demonstrated that in human adipocytes changes in the external redox state impacted ROS production, LPO, energy efficiency, lipid handling, and differentiation. A more oxidized state generally led to increased ROS, LPO and lipid turnover and more reduction led to increased respiration and a proton leak. However, not all of the redox couples were the same suggesting compartmentalization. These data are consistent with the concept of the circulating redox metabolome as a master metabolic regulatory system.	[Jones, Albert R.; Meshulam, Tova; Oliveira, Marcus F.; Burritt, Nathan; Corkey, Barbara E.] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA; [Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Bioquim Resposta Estresse, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil	Boston University; Universidade Federal do Rio de Janeiro	Corkey, BE (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA.	bcorkey@bu.edu	Oliveira, Marcus/G-3158-2011	Oliveira, Marcus/0000-0002-9890-8425	NIH [DK56690, DK46200]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by NIH grants (DK56690) and (DK46200).	Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Bachhawat AK, 2013, BBA-GEN SUBJECTS, V1830, P3154, DOI 10.1016/j.bbagen.2012.11.018; Ballatori N, 2009, MOL ASPECTS MED, V30, P13, DOI 10.1016/j.mam.2008.08.004; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; BJORNTORP P, 1966, J LIPID RES, V7, P621; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Chaiswing L, 2010, ANTIOXID REDOX SIGN, V13, P449, DOI 10.1089/ars.2009.3020; Corkey BE, 2012, TRENDS ENDOCRIN MET, V23, P594, DOI 10.1016/j.tem.2012.07.006; Cortassa S, 2014, BBA-BIOENERGETICS, V1837, P287, DOI 10.1016/j.bbabio.2013.11.007; Droge W, 2002, AGEING RES REV, V1, P257, DOI 10.1016/S1568-1637(01)00008-3; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; GEELEN MJH, 1983, FEBS LETT, V163, P269, DOI 10.1016/0014-5793(83)80833-3; Giandomenico AR, 1997, FREE RADICAL BIO MED, V23, P426, DOI 10.1016/S0891-5849(97)00113-5; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Go YM, 2011, FREE RADICAL BIO MED, V50, P495, DOI 10.1016/j.freeradbiomed.2010.11.029; Ha J, 1997, J PHARMACOL EXP THER, V281, P1457; Imhoff BR, 2010, DIFFERENTIATION, V80, P31, DOI 10.1016/j.diff.2010.04.005; Imhoff BR, 2009, BIOCHEM J, V424, P491, DOI 10.1042/BJ20091286; Jain SK, 1998, FREE RADICAL BIO MED, V25, P1083, DOI 10.1016/S0891-5849(98)00140-3; Jain SK, 1998, FREE RADICAL BIO MED, V24, P175, DOI 10.1016/S0891-5849(97)00213-X; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jonas CR, 2002, FREE RADICAL BIO MED, V33, P1499, DOI 10.1016/S0891-5849(02)01081-X; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jones DP, 2006, REJUV RES, V9, P169, DOI 10.1089/rej.2006.9.169; Jones DP, 2015, REDOX BIOL, V5, P71, DOI 10.1016/j.redox.2015.03.004; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; KISSEBAH AH, 1974, DIABETOLOGIA, V10, P69, DOI 10.1007/BF00421416; Krawczyk SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034904; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee MJ, 2014, METHOD ENZYMOL, V538, P49, DOI 10.1016/B978-0-12-800280-3.00004-9; Lee MJ, 2012, OBESITY, V20, P2334, DOI 10.1038/oby.2012.116; LOPESCARDOZO M, 1986, J NEUROCHEM, V46, P773, DOI 10.1111/j.1471-4159.1986.tb13039.x; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Mallet RT, 2002, J MOL CELL CARDIOL, V34, P1173, DOI 10.1006/jmcc.2002.2050; METZ SHM, 1972, FEBS LETT, V21, P203, DOI 10.1016/0014-5793(72)80137-6; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; MURPHY ME, 1992, EUR J BIOCHEM, V210, P139, DOI 10.1111/j.1432-1033.1992.tb17401.x; Nocito L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122818; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; PATEL MS, 1976, BIOCHEM J, V156, P603, DOI 10.1042/bj1560603; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Roede JR, 2013, REDOX BIOL, V1, P387, DOI 10.1016/j.redox.2013.06.003; Saadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030200; Scholz RW, 1996, BIOCHEM BIOPH RES CO, V226, P475, DOI 10.1006/bbrc.1996.1380; Stipanuk M, 2013, BIOCH PHYSL MOL ASPE; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang T, 2003, OBES RES, V11, P880, DOI 10.1038/oby.2003.121; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Watson JD, 2014, LANCET, V383, P841, DOI 10.1016/S0140-6736(13)62365-X; Zang Y, 2005, OBES RES, V13, P1530, DOI 10.1038/oby.2005.188	54	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164011	10.1371/journal.pone.0164011	http://dx.doi.org/10.1371/journal.pone.0164011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741233	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000015
J	Urano, H; Iwatsuki, K; Yamamoto, M; Ohnisi, T; Kurimoto, S; Endo, N; Hirata, H				Urano, Hideki; Iwatsuki, Katsuyuki; Yamamoto, Michiro; Ohnisi, Tetsuro; Kurimoto, Shigeru; Endo, Nobuyuki; Hirata, Hitoshi			Novel Anti-Adhesive CMC-PE Hydrogel Significantly Enhanced Morphological and Physiological Recovery after Surgical Decompression in an Animal Model of Entrapment Neuropathy	PLOS ONE			English	Article							CHRONIC NERVE COMPRESSION; CARPAL-TUNNEL-SYNDROME; SCIATIC-NERVE; RAT MODEL; NEUROLYSIS; ADHESION; SCAR	We developed a novel hydrogel derived from sodium carboxymethylcellulose (CMC) in which phosphatidylethanolamine (PE) was introduced into the carboxyl groups of CMC to prevent perineural adhesions. This hydrogel has previously shown excellent anti-adhesive effects even after aggressive internal neurolysis in a rat model. Here, we confirmed the effects of the hydrogel on morphological and physiological recovery after nerve decompression. We prepared a rat model of chronic sciatic nerve compression using silicone tubing. Morphological and physiological recovery was confirmed at one, two, and three months after nerve decompression by assessing motor conduction velocity (MCV), the wet weight of the tibialis anterior muscle and morphometric evaluations of nerves. Electrophysiology showed significantly quicker recovery in the CMC-PE group than in the control group (24.0 +/- 3.1 vs. 21.0 +/- 2.1 m/s (p < 0.05) at one months and MCV continued to be significantly faster thereafter. Wet muscle weight at one month significantly differed between the CMC-PE (BW) and control groups (0.148 +/- 0.020 vs. 0.108 +/- 0.019% BW). The mean wet muscle weight was constantly higher in the CMC-PE group than in the control group throughout the experimental period. The axon area at one month was twice as large in the CMC-PE group compared with the control group (24.1 +/- 17.3 vs. 12.3 +/- 9 mu m(2)) due to the higher ratio of axons with a larger diameter. Although the trend continued throughout the experimental period, the difference decreased after two months and was not statistically significant at three months. Although anti-adhesives can reduce adhesion after nerve injury, their effects on morphological and physiological recovery after surgical decompression of chronic entrapment neuropathy have not been investigated in detail. The present study showed that the new anti-adhesive CMC-PE gel can accelerate morphological and physiological recovery of nerves after decompression surgery.	[Urano, Hideki] Yokkaichi Municipal Hosp, Dept Orthopaed Surg, 2-2-37 Shibata Cho, Yokaichi, Mie 5108567, Japan; [Urano, Hideki; Iwatsuki, Katsuyuki; Yamamoto, Michiro; Ohnisi, Tetsuro; Kurimoto, Shigeru; Hirata, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hand Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan; [Endo, Nobuyuki] Teijin Ltd, Healthcare Business Dev, 4-3-2 Asahigaoka Hino, Tokyo 1918512, Japan	Nagoya University; Teijin Limited	Urano, H (corresponding author), Yokkaichi Municipal Hosp, Dept Orthopaed Surg, 2-2-37 Shibata Cho, Yokaichi, Mie 5108567, Japan.; Urano, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Hand Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	jingarimituki@yahoo.co.jp			Teijin Limited; JSPS KAKENHI Grant [25861309]	Teijin Limited; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We received financial and/or technical supported from Teijin Limited and a grant in aid for Japan society for the promotion of science KAKENHI Grant Number 25861309. The funder provided support in the form of salaries for authors [N.E.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by JSPS KAKENHI Grant Number 25861309.	ABITBOL JJ, 1994, SPINE, V19, P1809, DOI 10.1097/00007632-199408150-00004; AGUAYO A, 1971, ARCH NEUROL-CHICAGO, V24, P358, DOI 10.1001/archneur.1971.00480340090010; Dam-Hieu Phong, 2005, Neurosurgery, V56, P425, DOI 10.1227/01.NEU.0000156845.41626.E9; Dumanian GA, 1999, J HAND SURG-AM, V24A, P30; Gupta R, 2004, EXP NEUROL, V187, P500, DOI 10.1016/j.expneurol.2004.02.009; Gupta R, 2012, MUSCLE NERVE, V45, P231, DOI 10.1002/mus.22276; Ikeda K, 2010, BR J PLAST SURG, V56, P342; Ikeda Kazuo, 2002, Hand Surg, V7, P11, DOI 10.1142/S0218810402000911; Isla A, 2003, J Neurosurg Sci, V47, P195; Iwatsuki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057721; Mackinnon SE, 2002, HAND CLIN, V18, P231, DOI 10.1016/S0749-0712(01)00012-9; MACKINNON SE, 1986, HAND CLIN, V2, P639; Mazal PR, 2005, ACT NEUR S, V92, P3; McCall TD, 2001, NEUROSURG CLIN N AM, V12, P329, DOI 10.1016/S1042-3680(18)30058-5; Miillesi H, 1990, ANN HNAD SURG, V9, P87; MILLESI H, 1993, MICROSURG, V14, P430, DOI 10.1002/micr.1920140703; Nishimura T, 2008, HISTOL HISTOPATHOL, V23, P157, DOI 10.14670/HH-23.157; OBRIEN JP, 1987, ANN PLAS SURG, V19, P430, DOI 10.1097/00000637-198711000-00008; Ohsumi H, 2005, PLAST RECONSTR SURG, V116, P823, DOI 10.1097/01.prs.0000176893.44656.8e; Okui N, 2012, MICROSURG, V32, P466, DOI 10.1002/micr.21998; Okui N, 2010, MUSCLE NERVE, V42, P570, DOI 10.1002/mus.21727; Petersen J, 1996, NEUROSURGERY, V38, P976, DOI 10.1097/00006123-199605000-00025; Pham K, 2009, NEUROSCI LETT, V465, P194, DOI 10.1016/j.neulet.2009.09.014; SUNDERLAND S, 1976, J NEUROL NEUROSUR PS, V39, P615, DOI 10.1136/jnnp.39.7.615; Watanabe M, 2001, J HAND SURG-AM, V26A, P663, DOI 10.1053/jhsu.2001.24142; Xu JM, 2000, J HAND SURG-AM, V25A, P93; Yamamoto M, 2010, J ORTHOP RES, V28, P284, DOI 10.1002/jor.21004; Yamamoto T, 2014, MICROSURG, V34, P145, DOI 10.1002/micr.22135; [No title captured]	29	6	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164572	10.1371/journal.pone.0164572	http://dx.doi.org/10.1371/journal.pone.0164572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741280	Green Submitted, Green Published, gold			2022-12-27	WOS:000385507000044
J	Lions, C; Bocci, MP; Bonnet, C				Lions, Cynthia; Bocci, Maria Pia; Bonnet, Cedrick			Postural Control Can Be Well Maintained by Healthy, Young Adults in Difficult Visual Task, Even in Sway-Referenced Dynamic Conditions	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; ATTENTIONAL DEMANDS; DUAL-TASK; CHILDREN; STABILIZATION; BALANCE; FOCUS	Purpose To challenge the validity of existing cognitive models of postural control, we recorded eye movements and postural sway during two visual tasks (a control free-viewing task and a difficult searching task), and two postural tasks (one static task in which the platform was maintained stable and a dynamic task in which the platform moved in a sway-referenced manner.) We expected these models to be insufficient to predict the results in postural control both in static-as already shown in the literature reports-and in dynamic platform conditions. Methods Twelve healthy, young adults (17.3 to 34.1 years old) participated in this study. Postural performances were evaluated using the Multitest platform (Framiral (R)) and ocular recording was performed with Mobile T2 (e(ye) BRAIN (R)). In the free-viewing task, the participants had to look at an image, without any specific instruction. In the searching task, the participants had to look at an image and also to locate the position of an object in the scene. Results Postural sway was only significantly higher in the dynamic free-viewing condition than in the three other conditions with no significant difference between these three other conditions. Visual task performance was slightly higher in dynamic than in static conditions. Discussion As expected, our results did not confirm the main assumption of the current cognitive models of postural control-i.e. that the limited attentional resources of the brain should explain changes in postural control in our conditions. Indeed, 1) the participants did not sway significantly more in the sway-referenced dynamic searching condition than in any other condition; 2) the participants swayed significantly less in both static and dynamic searching conditions than in the dynamic free-viewing condition. We suggest that a new cognitive model illustrating the adaptive, functional role of the brain to control upright stance is necessary for future studies.	[Lions, Cynthia; Bocci, Maria Pia] Univ Paris 07, Robert Debre Univ Hosp, INSERM, UMR 1141, Paris, France; [Lions, Cynthia; Bocci, Maria Pia] Robert Debre Univ Hosp, ENT Dept, Vestibular & Oculomotor Evaluat Unit, Paris, France; [Lions, Cynthia] Univ Lyon 1, CNRS UMR 5292, INSERM U1028, Lyon Neurosci Res Ctr, Lyon, France; [Lions, Cynthia] Hosp Civils Lyon, Dept Audiol & Otoneurol Evaluat, Lyon, France; [Bonnet, Cedrick] Univ Lille, UMR CNRS 9193, SCALab, Lab Sci Cognit & Sci Affect, Lille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille	Lions, C (corresponding author), Univ Paris 07, Robert Debre Univ Hosp, INSERM, UMR 1141, Paris, France.; Lions, C (corresponding author), Robert Debre Univ Hosp, ENT Dept, Vestibular & Oculomotor Evaluat Unit, Paris, France.; Lions, C (corresponding author), Univ Lyon 1, CNRS UMR 5292, INSERM U1028, Lyon Neurosci Res Ctr, Lyon, France.; Lions, C (corresponding author), Hosp Civils Lyon, Dept Audiol & Otoneurol Evaluat, Lyon, France.	Cyntho.lions.graud@gmail.com		Bonnet, Cedrick/0000-0001-5143-1933				Andersson G, 1998, AM J OTOL, V19, P632; Belenkii VE, 1967, CONTROL ELEMENTS VOL; Bernard-Demanze L, 2009, Curr Aging Sci, V2, P139; Bonnet CT, 2016, GAIT POSTURE, V48, P57, DOI 10.1016/j.gaitpost.2016.04.016; Bonnet CT, 2010, J MOTOR BEHAV, V42, P85, DOI 10.1080/00222890903498521; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Delerue C, 2010, NEUROSCI LETT, V482, P245, DOI 10.1016/j.neulet.2010.07.048; Fetter M, 1996, VESTIBULAR TESTS EVO, P256; Ghulyan V, 2005, ACTA OTO-LARYNGOL, V125, P607, DOI 10.1080/00016480510026908; Giveans MR, 2011, ECOL PSYCHOL, V23, P247, DOI 10.1080/10407413.2011.617215; Gouleme N, 2014, INT J DEV NEUROSCI, V38, P169, DOI 10.1016/j.ijdevneu.2014.08.011; Gurfinkel V. S., 1973, MOTOR CONTROL, P217; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Ionescu E, 2006, INT J PEDIATR OTORHI, V70, P1457, DOI 10.1016/j.ijporl.2006.03.012; Kahneman D., 1973, ATTENTION EFFORT; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Legrand A, 2013, EXP BRAIN RES, V227, P397, DOI 10.1007/s00221-013-3519-z; Lions C, 2013, INVEST OPHTH VIS SCI, V54, P620, DOI 10.1167/iovs.12-10526; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; PAILLARD J, 1971, CAH PSYCHOL COGN, V0014, P00261; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; RICCIO GE, 1988, HUM MOVEMENT SCI, V7, P265, DOI 10.1016/0167-9457(88)90014-0; Rodrigues ST, 2013, MOTRIZ, V19, P614, DOI 10.1590/S1980-65742013000300012; Rougier P, 2007, MOTOR CONTROL, V11, P213, DOI 10.1123/mcj.11.3.213; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Stoffregen TA, 2007, MOTOR CONTROL, V11, P86; Stoffregen TA, 2006, ECOL PSYCHOL, V18, P191, DOI 10.1207/s15326969eco1803_3; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Vuillerme N, 2004, BRAIN RES BULL, V63, P161, DOI 10.1016/j.brainresbull.2004.02.006; Wickens CD, 2008, HUM FACTORS, V50, P397, DOI 10.1518/001872008X288420; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wulf G, 2001, PSYCHON B REV, V8, P648, DOI 10.3758/BF03196201; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118	34	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164400	10.1371/journal.pone.0164400	http://dx.doi.org/10.1371/journal.pone.0164400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736934	Green Published, gold			2022-12-27	WOS:000385505800063
J	Loh, CYY; Wang, AYL; Kao, HK; Cardona, E; Chuang, SH; Wei, FC				Loh, Charles Yuen Yung; Wang, Aline Yen Ling; Kao, Huang-Kai; Cardona, Esteban; Chuang, Sheng-Hao; Wei, Fu-Chan			Episomal Induced Pluripotent Stem Cells Promote Functional Recovery of Transected Murine Peripheral Nerve	PLOS ONE			English	Article							IN-VITRO; NEUROTROPHIN-3; REGENERATION; NEURONS; GENERATION; GROWTH; DIFFERENTIATION; TRANSPLANTATION; SURVIVAL; REPAIR	Traumatic peripheral nerve neurotmesis occurs frequently and functional recovery is often slow and impaired. Induced pluripotent stem cells (iPSCs) have shown much promise in recent years due to its regenerative properties similar to that of embryonic stem cells. However, the potential of iPSCs in promoting the functional recovery of a transected peripheral nerve is largely unknown. This study is the first to investigate in vivo effects of episomal iPSCs (EiPSCs) on peripheral nerve regeneration in a murine sciatic nerve transection model. Episomal iPSCs refer to iPSCs that are generated via Oct3/4-Klf4-Sox2 plasmid reprogramming instead of the conventional viral insertion techniques. It represents a relatively safer form of iPSC production without permanent transgene integration which may raise questions regarding risks of genomic mutation. A minimal number of EiPSCs were added directly to the transected nerve. Functional recovery of the EiPSC group was significantly improved compared to the negative control group when assessed via serial five-toe spread measurement and gait analysis of ankle angles. EiPSC promotion of nerve regeneration was also evident on stereographic analysis of axon density, myelin thickness, and axonal cross-sectional surface area. Most importantly, the results observed in EiPSCs are similar to that of the embryonic stem cell group. A roughly ten-fold increase in neurotrophin-3 levels was seen in EiPSCs which could have contributed to peripheral nerve regeneration and recovery. No abnormal masses or adverse effects were noted with EiPSC administration after one year of follow-up. We have hence shown that functional recovery of the transected peripheral nerve can be improved with the use of EiPSC therapy, which holds promise for the future of nerve regeneration.	[Loh, Charles Yuen Yung; Wang, Aline Yen Ling; Cardona, Esteban; Chuang, Sheng-Hao; Wei, Fu-Chan] Chang Gung Mem Hosp, Vascularized Composite Allotransplantat Ctr, Taoyuan, Taiwan; [Loh, Charles Yuen Yung; Kao, Huang-Kai; Cardona, Esteban; Wei, Fu-Chan] Chang Gung Mem Hosp, Dept Plast Surg, Taoyuan, Taiwan; [Loh, Charles Yuen Yung] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Loh, Charles Yuen Yung] UCL, Div Surg & Intervent Sci, London, England; [Kao, Huang-Kai; Wei, Fu-Chan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; University of London; University College London; Chang Gung University	Wei, FC (corresponding author), Chang Gung Mem Hosp, Vascularized Composite Allotransplantat Ctr, Taoyuan, Taiwan.	fuchanwei@gmail.com	Wang, Aline/ABE-7593-2021; Loh, Charles Yuen Yung/AAA-3762-2020; Loh, Charles Yuen Yung/AAZ-1783-2021	Wang, Aline/0000-0001-6272-6948; Loh, Charles Yuen Yung/0000-0003-2646-0358; 	Chang Gung Memorial Hospital, Taiwan, ROC [CMRPG1D0022, CMRPG1F0081, CMRPG3F1431]	Chang Gung Memorial Hospital, Taiwan, ROC(Chang Gung Memorial Hospital)	We would like to express our gratitude to Hon-Chung Yu and Chin-Ming Lee for their assistance in conducting various aspects of the experiments in this study. This work was supported by Chang Gung Memorial Hospital, Taiwan, ROC (CMRPG1D0022, CMRPG1F0081 & CMRPG3F1431). We also thank Chang Gung Microscopy Core Laboratory for Laser Scanning Confocal Microscopy (Leica TCS SP8X), toluidine blue staining and electron microscopy experiments.; This work was supported by Chang Gung Memorial Hospital, Taiwan, ROC (CMRPG1D0022, CMRPG1F0081 & CMRPG3F1431). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDE YA, 1978, NATURE, V274, P818, DOI 10.1038/274818a0; Canan S, 2008, NEUROPATH APPL NEURO, V34, P638, DOI 10.1111/j.1365-2990.2008.00938.x; Craff MN, 2007, PLAST RECONSTR SURG, V119, P235, DOI 10.1097/01.prs.0000244863.71080.f0; Devlin AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6999; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; Fairbairn NG, 2015, WORLD J STEM CELLS, V7, P11, DOI 10.4252/wjsc.v7.i1.11; FU SY, 1995, J NEUROSCI, V15, P3876; Garcia ML, 2009, J NEUROSCI, V29, P1277, DOI 10.1523/JNEUROSCI.3765-08.2009; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Gordon T, 2016, HAND CLIN, V32, P103, DOI 10.1016/j.hcl.2015.12.001; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Griffin JW, 2010, EXP NEUROL, V223, P60, DOI 10.1016/j.expneurol.2009.12.033; GUENARD V, 1992, J NEUROSCI, V12, P3310; Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748; Ikeda M, 2014, J BIOMED MATER RES A, V102, P1370, DOI 10.1002/jbm.a.34816; Jones J, 2015, MOL THER, V23, P130, DOI 10.1038/mt.2014.143; Jortner BS, 2011, TOXICOL PATHOL, V39, P66, DOI 10.1177/0192623310387618; Kim KS, 2014, CELL TRANSPLANT, V23, P1585, DOI 10.3727/096368913X673450; Kubo T, 2009, PLAST RECONSTR SURG, V123, p139S, DOI 10.1097/PRS.0b013e3181923d07; Lee JY, 2013, PLAST RECONSTR SURG, V132, P1173, DOI 10.1097/PRS.0b013e3182a3bfeb; Lin C, 2008, STEM CELLS, V26, P1356, DOI 10.1634/stemcells.2007-0333; Lin S, 2012, J INT MED RES, V40, P1449, DOI 10.1177/147323001204000423; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Schweizer R, 2015, CURR OPIN ORGAN TRAN, V20, P608, DOI 10.1097/MOT.0000000000000247; Toli D, 2015, NEUROBIOL DIS, V82, P269, DOI 10.1016/j.nbd.2015.06.011; Trehan SK, 2016, HAND CLIN, V32, P119, DOI 10.1016/j.hcl.2015.12.002; Uemura T, 2012, BIOCHEM BIOPH RES CO, V419, P130, DOI 10.1016/j.bbrc.2012.01.154; Varas F, 2009, STEM CELLS, V27, P300, DOI 10.1634/stemcells.2008-0696; Wang XY, 2015, NEURAL REGEN RES, V10, P1865, DOI 10.4103/1673-5374.170318; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu GW, 2012, NEURAL REGEN RES, V7, P1483, DOI 10.3969/j.issn.1673-5374.2012.19.006	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164696	10.1371/journal.pone.0164696	http://dx.doi.org/10.1371/journal.pone.0164696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736950	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800115
J	Estrada-Contreras, I; Equihua, M; Laborde, J; Meyer, EM; Sanchez-Velasquez, LR				Estrada-Contreras, Israel; Equihua, Miguel; Laborde, Javier; Martinez Meyer, Enrique; Sanchez-Velasquez, Lazaro R.			Current and Future Distribution of the Tropical Tree Cedrela odorata L. in Mexico under Climate Change Scenarios Using MaxLike	PLOS ONE			English	Article							PRESENCE-ONLY DATA; SPECIES DISTRIBUTIONS; PREDICTION; MODELS; AREA	Climate change is recognized as an important threat to global biodiversity because it increases the risk of extinction of many species on the planet. Mexico is a megadiverse country and native tree species such as red cedar (Cedrela odorata) can be used to maintain forests while helping mitigate climate change, because it is considered a fast growing pioneer species with great economic potential in the forestry industry. In order to assess possible shifts in areas suitable for C. odorata plantations in Mexico with ecological niche models, we used the MaxLike algorithm, climate variables, the geo-referenced records of this species, three general circulation models and three scenarios of future emissions. Results show a current potential distribution of 573,079 km(2) with an average probability of occurrence of 0.93 (+/- 0.13). The potential distribution area could increase up to 650,356 km(2) by 2060 according to the general circulation model HADCM3 B2, with an average probability of occurrence of 0.86 (+/- 0.14). Finally, we delimited an area of 35,377 km(2) that has a high potential for the establishment of C. odorata plantations, by selecting those sites with optimal conditions for its growth that are outside protected areas and are currently devoid of trees. C. odorata has a significant potential to help in the mitigation of the effects of climate change. Using MaxLike we identified extense areas in Mexico suitable to increase carbon sequestration through plantations of this highly valued native tree species.	[Estrada-Contreras, Israel; Equihua, Miguel] Inst Ecol AC, Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico; [Laborde, Javier] Inst Ecol AC, Ecol Func, Xalapa, Veracruz, Mexico; [Martinez Meyer, Enrique] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City, DF, Mexico; [Sanchez-Velasquez, Lazaro R.] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Veracruzana	Equihua, M (corresponding author), Inst Ecol AC, Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico.	miguel.equihua@inecol.mx	Laborde, Javier/GLT-9497-2022; Sánchez-Velásquez, Lázaro Rafael/O-9911-2018; Eq, Miguel/Q-6786-2018; Laborde, Javier/B-5542-2017	Laborde, Javier/0000-0001-5401-4182; Sánchez-Velásquez, Lázaro Rafael/0000-0002-6014-8731; Eq, Miguel/0000-0001-5306-7397; Laborde, Javier/0000-0001-5401-4182; Martinez-Meyer, Enrique/0000-0003-1184-9264; Estrada Contreras, Israel/0000-0001-7706-0931	Consejo Nacional de Ciencia y Tecnologia (CONACYT scholarship) [212532]; Institute de Ecologia, A.C. [20030-10024, 20030-10281]	Consejo Nacional de Ciencia y Tecnologia (CONACYT scholarship)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Institute de Ecologia, A.C.	This study was partially supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT scholarship #212532, to IEC) and by the Institute de Ecologia, A.C. (projects 20030-10024 and 20030-10281). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 2006, MEX TERC COM NAC ANT; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2009, TECHN SER SECR CONV, V41; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; BARVE N, 2008, TOOL PARTIAL ROC VER; Bertoni VR, 1978, REUN NAC PLANT FOR, P287; Broadhead J, 2009, EFTRN NEWS, P57; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Challenger A, 1998, UTILIZACION CONSERVA; Cintron B, 1990, AGR HDB DEP AGR FOR, V654, P250; Cornelius JP, 2003, FOREST ECOL MANAG, V183, P341, DOI 10.1016/S0378-1127(03)00142-7; Dorazio RM, 2012, BIOMETRICS, V68, P1303, DOI 10.1111/j.1541-0420.2012.01779.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fearnside Philip Martin, 2009, Acta Amaz., V39, P1003, DOI 10.1590/S0044-59672009000400030; Fearnside PM, 2009, TERRAS PRETAS INDIO; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Franklin J., 2010, MAPPING SPECIES DIST, DOI [10.1017/CBO9780511810602, DOI 10.1017/CBO9780511810602]; Galan-Larrea R, 2008, MADERA BOSQUES, V14, P65; Gomez JD, 2007, MADERA BOSQUES, V13; Halpin PN, 1997, ECOL APPL, V7, P828; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Laurance WF, 2007, BIOTROPICA, V39, P20, DOI 10.1111/j.1744-7429.2006.00229.x; Le Treut H, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P93; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Mendizabal-Hernandez LC, 2009, FORESTA VERACRUZANA, V11, P13; Merow C, 2014, METHODS ECOL EVOL, V5, P215, DOI 10.1111/2041-210X.12152; Morales ER, 2009, CEDRO CEDRELA ODORAT; Nakicenovic N, 2000, ESCENARIOSS EMISIONE; Niembro A., 2010, ARBOLES VERACRUZ 100; Pennington TD, 1998, ARBOLES TROPICALES M; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pistorius T., 2009, FORESTS CLIMATE CHAN, P11; Putz F, 2009, FORESTS CLIMATE CHAN, P19; Ramirez-Garcia C., 2008, Agricultura Tecnica en Mexico, V34, P243; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Saenz-Romero C, 2010, CLIMATIC CHANGE, V102, P595, DOI 10.1007/s10584-009-9753-5; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Sistema Nacional de Informacion Forestal (SIRE), CEDR OD L; Stocker TF, 2013, RESUMEN RESPONSABLES; Vazquez-Yanes C., 1999, J084 CONABIO UNAM I; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Warton DI, 2010, ANN APPL STAT, V4, P1383, DOI 10.1214/10-AOAS331; Xu D., 2001, MITIG ADAPT STRAT GL, V6, P213	50	15	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164178	10.1371/journal.pone.0164178	http://dx.doi.org/10.1371/journal.pone.0164178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732622	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300041
J	Gunther, F; Marelli, M				Guenther, Fritz; Marelli, Marco			Understanding Karma Police: The Perceived Plausibility of Noun Compounds as Predicted by Distributional Models of Semantic Representation	PLOS ONE			English	Article							WORD COOCCURRENCE STATISTICS; CONCEPTUAL COMBINATION; RELATION AVAILABILITY; ENGLISH; FAMILIARITY; GAGNE	Noun compounds, consisting of two nouns (the head and the modifier) that are combined into a single concept, differ in terms of their plausibility: school bus is a more plausible compound than saddle olive. The present study investigates which factors influence the plausibility of attested and novel noun compounds. Distributional Semantic Models (DSMs) are used to obtain formal (vector) representations of word meanings, and compositional methods in DSMs are employed to obtain such representations for noun compounds. From these representations, different plausibility measures are computed. Three of those measures contribute in predicting the plausibility of noun compounds: The relatedness between the meaning of the head noun and the compound (Head Proximity), the relatedness between the meaning of modifier noun and the compound (Modifier Proximity), and the similarity between the head noun and the modifier noun (Constituent Similarity). We find non-linear interactions between Head Proximity and Modifier Proximity, as well as between Modifier Proximity and Constituent Similarity. Furthermore, Constituent Similarity interacts non-linearly with the familiarity with the compound. These results suggest that a compound is perceived as more plausible if it can be categorized as an instance of the category denoted by the head noun, if the contribution of the modifier to the compound meaning is clear but not redundant, and if the constituents are sufficiently similar in cases where this contribution is not clear. Furthermore, compounds are perceived to be more plausible if they are more familiar, but mostly for cases where the relation between the constituents is less clear.	[Guenther, Fritz] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Marelli, Marco] Univ Ghent, Dept Expt Psychol, Ghent, Belgium	Eberhard Karls University of Tubingen; Ghent University	Gunther, F (corresponding author), Univ Tubingen, Dept Psychol, Tubingen, Germany.	fritz.guenther@uni-tuebingen.de	marelli, marco/AAC-9941-2022	marelli, marco/0000-0001-5831-5441	DAAD (German Academic Exchange Service) short-term scholarship [57044996]; ERC (European Research Council) Starting Independent Research [283554]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen	DAAD (German Academic Exchange Service) short-term scholarship(Deutscher Akademischer Austausch Dienst (DAAD)); ERC (European Research Council) Starting Independent Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	This project was supported by the DAAD (German Academic Exchange Service) short-term scholarship n. 57044996 (first author, (https://www.daad.de/de/)), and the ERC (European Research Council) 2011 Starting Independent Research Grant n. 283554 (COMPOSES) (second author, https://erc.europa.eu/). We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen (http://www.dfg.de/foerderung/programme/infrastruktur/lis/lis_awbi/open_access/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Allen Margaret, 1978, THESIS; Amenta S, 2015, J EXP PSYCHOL LEARN, V41, P1587, DOI 10.1037/xlm0000104; Andrews M, 2009, PSYCHOL REV, V116, P463, DOI 10.1037/a0016261; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Baroni M., 2014, LINGUISTIC ISSUES LA, V9, P5, DOI DOI 10.33011/LILT.V9I.1321; Baroni M, 2010, NOUNS ARE VECTORS AD, P1183; Baroni M, 2008, ITAL J LINGUIST, V20, P55; Baroni M, 2010, COGNITIVE SCI, V34, P222, DOI 10.1111/j.1551-6709.2009.01068.x; Bauer L., 2009, OXFORD HDB COMPOUNDI, P343, DOI 10.1093/oxfordhb/9780199695720.013.0017; Bauer L., 1998, ENGL LANG LINGUIST, V2, P65, DOI [10.1017/S1360674300000691, DOI 10.1017/S1360674300000691]; Benczes Reka, 2006, CREATIVE COMPOUNDING; Bisetto A, 2005, LINGUE LINGUAGGIO, V4, P319, DOI 10.1418/20728; Bloomfield L., 1933, LANGUAGE; Booij G., 2005, COMPOUNDING DERIVATI, P109; Booij Geert, 2009, OXFORD HDB COMPOUNDI, P201, DOI DOI 10.1093/OXFORDHB/9780199695720.013.0010; Brinton LaurelJ., 2005, LEXICALIZATION LANGU; Brugmann K., 1900, BERICHTE VERHANDLU P, V52, P359; Bruni E, 2014, J ARTIF INTELL RES, V49, P1, DOI 10.1613/jair.4135; Brysbaert M, 2013, BEHAV RES METHODS, V45, P422, DOI 10.3758/s13428-012-0270-5; Bullinaria JA, 2007, BEHAV RES METHODS, V39, P510, DOI 10.3758/BF03193020; Bullinaria JA, 2012, BEHAV RES METHODS, V44, P890, DOI 10.3758/s13428-011-0183-8; CHURCH KW, 1990, 27TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P76; COHEN B, 1984, COGNITIVE SCI, V8, P27, DOI 10.1207/s15516709cog0801_2; Connell L, 2006, COGNITIVE SCI, V30, P95, DOI 10.1207/s15516709cog0000_53; Connell L, 2003, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, PTS 1 AND 2, P264; Connell L, 2004, MEM COGNITION, V32, P185, DOI 10.3758/BF03196851; Costello FJ, 2000, COGNITIVE SCI, V24, P299, DOI 10.1207/s15516709cog2402_4; Di Sciullo A.-M, 1987, DEFINITION WORD; Di Sciullo AnnaMaria., 2009, OXFORD HDB COMPOUNDI, P145; Dinu G, 2010, MEASURING DISTRIBUTI, P1162; Dinu G, 2013, DISSECT DISTRIBUTION, P31; Dirven R, 1998, COGNITIVE LINGUISTIC, V1; DiSciullo A. -M., 2005, ASYMMETRY MORPHOLOGY; DOWNING P, 1977, LANGUAGE, V53, P810, DOI 10.2307/412913; Estes Z, 2000, MEM COGNITION, V28, P28, DOI 10.3758/BF03211572; Gagn? C.L., 2006, SKASE J THEORETICAL, V3, P9; Gagne C. L., 2006, REPRESENTATION PROCE, P145; Gagne CL, 2006, J EXP PSYCHOL LEARN, V32, P1431, DOI 10.1037/0278-7393.32.6.1431; Gagne CL, 2004, BRAIN LANG, V90, P478, DOI 10.1016/S0093-934X(03)00459-0; Gagne CL, 2000, J MEM LANG, V42, P365, DOI 10.1006/jmla.1999.2683; Gagne CL, 1997, J EXP PSYCHOL LEARN, V23, P71; Gagne CL, 2001, J EXP PSYCHOL LEARN, V27, P236, DOI 10.1037/0278-7393.27.1.236; Giegerich H., 2009, OXFORD HDB COMPOUNDI, P178; Graves WW, 2013, BEHAV RES METHODS, V45, P463, DOI 10.3758/s13428-012-0256-3; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Guevara E., 2010, REGRESSION MODEL ADJ, P33; Gunther F, LATENT SEMANTIC ANAL; HAMPTON J, 1991, PSYCHOLOGY OF WORD MEANINGS, P91; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Hart B., 1995, MEANINGFUL DIFFERENC; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hutchinson S, 2014, PSYCHON B REV, V21, P470, DOI 10.3758/s13423-013-0492-2; Jackendoff R., 1990, SEMANTIC STRUCTURES; Jackendoff RS, OXFORD HDB COMPOUNDI; Jespersen Otto, 1942, MODERN ENGLISH GRAMM; Jones MN, 2006, J MEM LANG, V55, P534, DOI 10.1016/j.jml.2006.07.003; Jones MichaelN., 2015, OXFORD HDB MATH COMP, P232, DOI DOI 10.1093/OXFORDHB/9780199957996.013.11; Kastovsky D., 2009, OXFORD HDB COMPOUNDI, P323; Kavka S., 2009, THE OXFORD HANDBOOK, P3; Kuperman V, 2009, J EXP PSYCHOL HUMAN, V35, P876, DOI 10.1037/a0013484; Kuperman V, 2008, LANG COGNITIVE PROC, V23, P1089, DOI 10.1080/01690960802193688; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Langacker R.W., 1987, FDN COGNITIVE GRAMMA; Lapata M, 1999, DETERMINANTS ADJECTI, P30; Lazaridou A, 2013, FISH TRANSPORTERS MI, P1908; Lees Robert, 1960, GRAMMAR ENGLISH NOMI; Lenci A, 2008, ITAL J LINGUIST, V20, P1; Levi Judith N, 1978, SYNTAX SEMANTICS COM; Libben G, 2003, BRAIN LANG, V84, P50, DOI 10.1016/S0093-934X(02)00520-5; Lieber R., 2009, OXFORD HDB COMPOUNDI, P78; Lieber R., 2009, OXFORD HDB COMPOUNDI; Lieber Rochelle., 2004, MORPHOLOGY LEXICAL S; Lieber Rochelle, 2009, OXFORD HDB COMPOUNDI, P3; Louwerse M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00385; Louwerse MM, 2011, TOP COGN SCI, V3, P273, DOI 10.1111/j.1756-8765.2010.01106.x; Louwerse MM, 2009, COGNITIVE SCI, V33, P51, DOI 10.1111/j.1551-6709.2008.01003.x; Lund K, PRODUCING HIGH DIMEN; Lynott D., 2001, P 12 IR C ART INT CO, P1; Marchand H, 1969, CATEGORIES TYPES PRE; Marelli M, 2015, APPL PSYCHOLINGUIST, V36, P1421, DOI 10.1017/S0142716414000332; Marelli M, 2015, PSYCHOL REV, V122, P485, DOI 10.1037/a0039267; Marelli M, 2013, PSYCHON B REV, V20, P534, DOI 10.3758/s13423-012-0363-2; Marelli M, 2012, J MEM LANG, V66, P644, DOI 10.1016/j.jml.2012.01.003; Martin D. I., 2007, HDB LATENT SEMANTIC, P35, DOI [10.4324/9780203936399, DOI 10.4324/9780203936399]; Mitchell J., 2008, P ASS COMP LING HUM, P236, DOI DOI 10.1039/9781847558633-00236; Mitchell J, 2010, COGNITIVE SCI, V34, P1388, DOI 10.1111/j.1551-6709.2010.01106.x; Mondini S, 2005, BRAIN LANG, V94, P178, DOI 10.1016/j.bandl.2004.12.005; Murphy G. L., 2002, BIG BOOK CONCEPTS, P443; MURPHY GL, 1990, J MEM LANG, V29, P259, DOI 10.1016/0749-596X(90)90001-G; MURPHY GL, 1988, COGNITIVE SCI, V12, P529, DOI 10.1207/s15516709cog1204_2; Murphy GL, 2006, J EXP PSYCHOL LEARN, V32, P1438, DOI 10.1037/0278-7393.32.6.143; Plag I, 2006, ENGL LANG LINGUIST, V10, P143, DOI 10.1017/S1360674306001821; Plag Ingo, 2003, WORD FORMATION ENGLI; R Core Team, 2013, R LANG ENV STAT COMP; Radiohead. Karma Police, 1997, RADIOHEAD KARMA POLI; Ramscar M, 2010, COGNITIVE SCI, V34, P909, DOI 10.1111/j.1551-6709.2009.01092.x; Ran B., 2009, COGNITIVE PSYCHOL RE, P39; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; Sahlgren M, 2008, ITAL J LINGUIST, V20, P33; Schmid H., 1995, IMPROVEMENTS PART OF; Shaoul C, 2007, A USENET CORPUS; SMITH EE, 1988, COGNITIVE SCI, V12, P485, DOI 10.1207/s15516709cog1204_1; SMITH EE, 1984, COGNITIVE SCI, V8, P337, DOI 10.1016/S0364-0213(84)80006-3; Spalding T. L., 2010, LINGUISTISCHE BERICH, V17, P283; Thagard P., 1984, PSA, V1, P3; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; van Heuven WJ, SUBTLEX UK NEW IMPRO; Vecchi EM, 2011, LINEAR MAPS IMPOSSIB, P1; Vecchi EM, COGN SCI IN PRESS; WILLIAMS E, 1981, LINGUIST INQ, V12, P245; Wisniewski EJ, 1997, PSYCHON B REV, V4, P167, DOI 10.3758/BF03209392; Wisniewski EJ, 1998, J MEM LANG, V38, P177, DOI 10.1006/jmla.1997.2550; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN., 2019, MGCV MIXED GAM COMPU	118	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163200	10.1371/journal.pone.0163200	http://dx.doi.org/10.1371/journal.pone.0163200			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732599	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300012
J	de Medina, CRBL; Geronazzo, LL; Otero, C				Lopez de Medina, Carlos Raul Belotti; Lopez Geronazzo, Lautaro; Otero, Clarisa			At the Feet of the Fortress: Analysis of Inka Period (ca. AD 1430-1536) Archaeofaunal Assemblages from Residential Unit 1 (RU1), Pucara de Tilcara (Jujuy, Argentina)	PLOS ONE			English	Article							STRUCTURAL DENSITY; CUT MARKS; HUMAHUACA; QUEBRADA; SOCIETIES; ZOOARCHAEOLOGY; SURVIVORSHIP; PERSPECTIVES; CONSUMPTION; TECHNOLOGY	This paper reports the results of a zooarchaeological analysis conducted on the occupation layer of a compound structure (Residential Unit 1) of the Pucara de Tilcara archaeological site (Jujuy Province, northwestern Argentina). Its occupation span extends between the 13th and 15th centuries AD, but evidence diagnostic of the Inka Period (AD 1430-1536) is predominant. Residential Unit 1 was a house-workshop that hosted specialized crafts like metallurgy and lapidary during the Inka Period. It was proposed in previous works that artisans living at Pucara de Tilcara were provisioned with agropastoral products by the Inka administration. This paper aims to test that hypothesis against the zooarchaeological evidence of Residential Unit 1. Three variables were used as proxies for state-sponsored distribution: taxonomic diversity (family and species ranks), and skeletal and age profiles of the predominant zoological family (Camelidae) in the assemblage. The results show a high degree of continuity with the regional record, characterized by a herding-hunting strategy focused on domestic and wild species of Camelidae and a mixed mortality pattern. The skeletal profile shows a strong and negative correlation with the desiccation potential of elements, which could be indicative of local production of chalona. Overall, faunal evidence does not show any sign of centralized distribution.	[Lopez de Medina, Carlos Raul Belotti] Univ Buenos Aires, CONICET, Inst Cultures IDECU, Museo Etnog JB Ambrosetti FFyL, Buenos Aires, DF, Argentina; [Lopez Geronazzo, Lautaro; Otero, Clarisa] Univ Nacl Jujuy, CONICET, Inst Ecorreg Andinas INECOA, San Salvador De Jujuy, Jujuy Province, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	de Medina, CRBL (corresponding author), Univ Buenos Aires, CONICET, Inst Cultures IDECU, Museo Etnog JB Ambrosetti FFyL, Buenos Aires, DF, Argentina.	crbelotti@gmail.com		Belotti Lopez de Medina, Carlos Raul/0000-0002-1643-7261	Program for Institutional Recognition; "Procesos sociales, paisaje y cultura material del sector Central de la Quebrada de Humahuaca. Organizacion estatal de una provincial del Collasuyu" [(D) 1806/15]; Faculty of Philosophy; Letters of the University of Buenos Aires	Program for Institutional Recognition; "Procesos sociales, paisaje y cultura material del sector Central de la Quebrada de Humahuaca. Organizacion estatal de una provincial del Collasuyu"; Faculty of Philosophy; Letters of the University of Buenos Aires	The Faculty of Philosophy and Letters of the University of Buenos Aires funded lab analyses with a grant from the Program for Institutional Recognition, awarded to the research project "Procesos sociales, paisaje y cultura material del sector Central de la Quebrada de Humahuaca. Organizacion estatal de una provincial del Collasuyu" -Res. (D) 1806/15-, under direction by CO (http://www.filo.uba.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present research was funded by the Faculty of Philosophy and Letters of the University of Buenos Aires and conducted at the Dr. E. Casanova Archaeological Museum. Activities at Til1 were executed according to current laws on archaeological heritage (National law No 25.743, Regulation decree 1022/2004, and Provincial law No 3866/66). The Deanship of the Faculty of Philosophy and Letters (University of Buenos Aires) endorsed and authorized research activities directed by C. Otero (Resolution (D) No 1806/15). Resolution No 241 of the Secretariat of Culture of Jujuy Province authorized research for a three-year term. The RU1 faunal collection is currently curated at the Dr. E. Casanova Archaeological Museum of the Interdisciplinary Institute of Tilcara, FFyL-UBA. Applications for access to the RU1 collections must be addressed to Clarisa Otero, who is in charge of current research undertaken by the Institute at Til1.	ACUTO FÉLIX A, 2007, Estud. atacam., P71, DOI 10.4067/S0718-10432007000200005; Adaro LA, 1990, AVANCES CIENCIAS VET, V5, P76; ALBECK ME, 2000, NUEVA HIST ARGENTINA, V1, P187; Alvarez MR, 2004, PRODUCCION LITICA PU, P25; Zaburlin MA, 2009, INTERSECCIONES ANTRO, V10, P89; Ambrosetti J. B, 1908, EXPLORACIONES ARQUEO; [Anonymous], HIST ARCHAEOLOGY; Aschero C. A., 2000, NUEVA HIST ARGENTINA, P17; Bailey G, 2007, J ANTHROPOL ARCHAEOL, V26, P198, DOI 10.1016/j.jaa.2006.08.002; Cremonte MB, 2009, RELACIONES, V34, P75; Belotti Lopez de Medina C. R., 2011, REV MUSEO ANTROPOLOG, V4, P3; Belotti Lopez de Medina CR, 2013, USOS EC RITUALES FAU; Benavente Antonia M., 1993, CONTRIBUCION DETERMI; Binford L.R., 1981, BONES ANCIENT MEN MO; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; Binford LR., 1984, FAUNAL REMAINS KLASI; Burger R., 2003, 1912 YALE PERUVIAN S; Casanova E, 1950, RESTAURACION PUCARA; Casanova E., 1976, ACT MEM 4 C NAC ARQ, P21; CHAIX L, 2005, MANUAL ARQUEOZOOLOGI; Chaplin RE., 1971, STUDY ANIMAL BONES A; Church RR, 2003, J ARCHAEOL SCI, V30, P1077, DOI 10.1016/S0305-4403(03)00010-4; Cicala B, 1998, DESARROLLOS LOCALES, P305; Costin Cathy L., 1996, CRAFT SPECIALIZATION, P211; Crabtree Pam, 1990, ARCHAEOLOGICAL METHO, V2, P155, DOI DOI 10.2307/20170207; Cremonte M., 2013, AI BORDE IMPERIO PAI, P311; De Nigris M., 2004, CONSUMO GRUPOS CAZAD; De Nigris M. E., 2002, ZOOARCHAEOLOGY MILK, P160; Debenedetti S., 1930, RUINAS PUCARA TILCAR; deFrance SD, 2009, J ARCHAEOL RES, V17, P105, DOI 10.1007/s10814-008-9027-1; DeMarrais E, 2013, CAMB ARCHAEOL J, V23, P345, DOI 10.1017/S0959774313000474; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P884, DOI 10.1016/j.jas.2008.11.007; Egeland CP, 2003, PLAINS ANTHROPOL, V48, P39, DOI 10.1080/2052546.2003.11949279; Elkin D., 1996, THESIS U BUENOS AIRE; Escola P., 2002, RELACIONES SOC ARGEN, V27, P233; Espinosa Soriano W., 2008, EC PREHISPANICA, P315; Fisher J.W., 1995, J ARCHAEOL METHOD TH, V2, P7, DOI [10.1007/bf02228434, DOI 10.1007/BF02228434]; Galan AB, 2013, ARCHAEOMETRY, V55, P1132, DOI 10.1111/j.1475-4754.2012.00730.x; Galotta D. R., 1988, Revista de Ciencias Agrarias y de Tecnologia de los Alimentos, V9, P19; Giardina M., 2010, ZOOARQUEOLOGIA PRINC, P273; Gobel B., 1994, ZOOARQUEOLOGIA DE CA, P43; Gonzalez L., 2004, BRONCES SIN NOMBRE M; Gonzalez L., 2000, NUEVA HIST ARGENTINA, P301; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Greco C, 2015, CHRONOLOGY SETTLEMEN; Gumerman G, 1997, J ARCHAEOL METHOD TH, V4, P105, DOI 10.1007/BF02428056; Hernandez A, 2015, ANUARIO ARQUEOLOGIA, V7, P95; Hillson S., 2005, TEETH; Izeta A., 2004, THESIS; Izeta A. D., 2012, GUIA OSTEOMETRICA CA; Izeta A. D., 2007, BRIT ARCHAEOLOGICAL; Izeta AD, 2005, J ARCHAEOL SCI, V32, P1159, DOI 10.1016/j.jas.2005.02.013; Izeta AD, 2010, ZOOARQUEOLOGIA PRINC, P29; Izeta AD, 2008, QUATERN INT, V180, P135, DOI 10.1016/j.quaint.2007.08.026; Izeta Andres D., 2009, REV MUSEO ANTROPOLOG, V2, P169, DOI DOI 10.31048/1852.4826.V2.N1.5416; Kent JD, 1982, THESIS; Klein R.G., 1984, ANAL ANIMAL BONES AR; Krapovickas P., 1958, RUNA, V9, P137; Kuznar LA, 1990, THESIS; Lafon CR, 1969, ETNIA, V9, P15; Lagiglia H. A., 2001, HIST ARGENTINA PREHI, VI, P41; Leoni JB, 2012, INTERSECCIONES ANTRO, V13, P117; Linnaeus C, 1788, SYSTEMA NATURAE REGN; Llago MA, 2009, ZARANSA IDEAS REV JO, V5, P185; Lonnberg E, 1913, ARK ZOOL, V8, P1, DOI DOI 10.5962/BHL.PART.1065; de Medina CRBL, 2015, J ARCHAEOL SCI-REP, V4, P461, DOI 10.1016/j.jasrep.2015.10.016; Lopez Geronazzo LN, 2015, THESIS; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Lyman RL, 2005, J ARCHAEOL SCI, V32, P1722, DOI 10.1016/j.jas.2005.06.003; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; Madero C., 1993, INKA ARQUEOLOGIA HIS, P145; Madero C., 1993, RELAC SOC ARGENT ANT, VXIX, P145; Madero CM, 1994, ZOOARQUEOLOGIA CAMEL, P73; Madrazo G. B., 1969, ETNIA, V9, P21; Madrazo G. B., 1966, TIPOS INSTALACION PR; Marean CW, 1997, AM ANTIQUITY, V62, P698, DOI 10.2307/281887; Mayer E., 2004, CASA CHACRA DINERO E; Menegaz A., 1988, PROCESOS CONTEXTOS O, P53; Mengoni Gonalons G, 1999, CAZADORES GUANACOS E; Mengoni Gonalons Guillermo, 1991, ARQUEOLOGIA-ARGENTIN, V1, P179; Gonalons GLM, 2008, QUATERN INT, V185, P59, DOI 10.1016/j.quaint.2007.05.022; Mengoni Gorialons GL, 1996, ZOOARQUEOLOGIA CAMEL, P33; Mercolli PH, 2011, ARQUEOLOGIA, V17, P81; Mercolli PH, 2014, CUADERNOS I NACL ANT, V2, P24; Mercolli PH, 2004, THESIS; MILLER GR, 1995, AM ANTIQUITY, V60, P421, DOI 10.2307/282258; Miller Rory, 1979, THESIS; Molina GI, 1810, SAGGIO STORIA NATURA; MORLAN RE, 1994, J ARCHAEOL SCI, V21, P797, DOI 10.1006/jasc.1994.1077; Muria JV, 2002, REBANOS PASTORES EC, P308; Murra John V., 1978, ORG EC ESTADO INCA; Nielsen A., 2007, CELEBRANDO CON ANTEP; Nielsen A. E., 2001, HIST ARGENTINA PREHI, P171; Nielsen AE, 2009, NOMAD PEOPLES, V13, P17, DOI 10.3167/np.2009.130202; Nielsen Axel E, 2006, Estud. atacam., V0, P63, DOI 10.4067/S0718-10432006000100006; Nilssen P., 2000, THESIS; Norton CJ, 2008, J HUM EVOL, V55, P164, DOI 10.1016/j.jhevol.2008.02.006; Olivera D. E., 1997, AVANCES ARQUEOLOGIA, V3, P77; Olivera D. E., 1997, ESTUD ATACAMENOS, V14, P29; Otero C., 2013, THESIS; Otero C, 2006, THESIS; Otero C, 2015, CHUNGARA, V47, P401; Otero C, 2015, INTERSECCIONES ANTRO, V16, P145; Otero C, 2014, J ANTHROPOL ARCHAEOL, V33, P108, DOI 10.1016/j.jaa.2013.11.001; Carbonelli JP, 2011, INTERSECCIONES ANTRO, V12, P31; Pacheco Torres V. A., 1979, GUIA OSTEOLOGICA CAM; Palma J., 1992, CUADERNOS INSTITUTO, V14, P237; Perez J. A, 1972, ARGENTINA INDIGENA V; Price M, 2016, AM ANTIQUITY, V81, P157, DOI 10.7183/0002-7316.81.1.157; RAUP D M, 1975, Paleobiology, V1, P333; Reitz EJ., 1999, ZOOARCHAEOLOGY; Rodriguez Loredo C., 1997, RELACIONES SOC ARGEN, VXXII-XXIII, P203; Rostworowski de Diez Canseco Mar?a., 1999, HIST TAHUANTINSUYU; Scattolin M. Cristina, 2006, B ARQUEOLOGIA PUCP, V10, P357; Seldes V., 2007, PRODUCCION CIRCULACI, P259; Sotomayor Berrie MA, 1984, ALLPANCHIS, V20, P97; Stahl P. W., 1990, LAT AM ANTIQ, V1, P150, DOI DOI 10.2307/971985; Stahl PW, 1999, J ARCHAEOL SCI, V26, P1347, DOI 10.1006/jasc.1998.0389; Tarrago M., 1998, SOCIEDADES LOCALES S, P179; Tarrago M. N., 1992, CUADERNOS, V3, P64; Tarrago M. N., 2000, NUEVA HIST ARGENTINA, V1, P257; Tarrago M.N., 2011, ESTUDIOS SOCIALES NO, V11, P33; Tarrago M. N., 1997, AVANCES ARQUEOLOGIA, V3, P101; THOMAS DH, 1969, AM ANTIQUITY, V34, P392, DOI 10.2307/277736; TIPPER JC, 1979, PALEOBIOLOGY, V5, P423, DOI 10.1017/S0094837300016924; Valcarcel LE, 1964, HIST PERU ANTIGUO; Valda P, 2012, ARQUEOANTROPOLOGICAS, V2, P163; Valda PA, 2008, ANALISIS ZOOARQUEOLO; Vila B., 2014, ETNOECOLOGICA, V10, P1; Vila B., 2012, CAMELIDOS SUDAMERICA; WAPNISH P, 1988, J NEAR EASTERN STUD, V47, P81, DOI 10.1086/373259; WHEELER J, 1982, LLAMA WORLD, V1, P12; White TE, 1953, AM ANTIQUITY, V18, P396, DOI 10.2307/277116; Wing E. S., 1975, ALLPANCHIS PHUTURINQ, V8, P25; Yacobaccio H. D., 1998, ETNOARQUEOLOGIA PAST; Yacobaccio H.D., 2010, ZOOARQUEOLOGIA PRINC, VXXI, P65; Yacobaccio H. D., 2001, HIST ARGENTINA PREHI, V1, P7; Yacobaccio HD, 2006, ACT 4 C MUND CAM; Yacobaccio Hugo, 1997, RELACIONES SOC ARGEN, VXXII, P389; Yacobaccio Hugo D, 2012, Comechingonia, V16, P31; Yacobaccio Hugo D., 2007, Anthropozoologica, V42, P143	141	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163766	10.1371/journal.pone.0163766	http://dx.doi.org/10.1371/journal.pone.0163766			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732648	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300028
J	Stone, S; La Flamme, AC				Stone, Sarrabeth; La Flamme, Anne Camille			Type II Activation of Macrophages and Microglia by Immune Complexes Enhances Th17 Biasing in an IL-6-Independent Manner	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; T-CELLS; CYTOKINE PRODUCTION; IL-10; EXPRESSION; INTERLEUKIN-10; PROLIFERATION; INFLAMMATION; RECEPTOR	Macrophages can be activated into several distinct activation states. One of these states, type II activation, has a regulatory phenotype characterized by decreased IL-12 and increased IL-10, and has been shown to bias naive CD4(+) T cells to a Th2 response. Microglia, the resident macrophage-like cells in the central nervous system ( CNS), are important contributors to neuroinflammation and, thus, we investigated if type II activated microglia could bias CD4(+) T cell responses in a similar manner as type II activated macrophages. Using immune complex ligation in the presence of LPS to induce type II activation, we found that both type II macrophages and type II microglia biased CD4(+) T cell responses in vitro to express increased levels of IL-17A and CD124. The enhanced IL-17A production occurred independently of IL-6, and IL-10 and IL-12, which were key regulators of IFN-(Y) production, but were not involved in the increased IL-17A. Finally, we found that another type II-activating compound, glatiramer acetate, did not bias CD4(+) T cells to produce enhanced IL-17A. Taken together, this study demonstrates that microglia can be type II activated and, similarly to type II macrophages, can bias CD4(+) T cell responses; however, depending on the type II stimulus, the effect on CD4(+) T cell subset differentiation may vary.	[Stone, Sarrabeth; La Flamme, Anne Camille] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [La Flamme, Anne Camille] Malaghan Inst Med Res, Wellington, New Zealand	Victoria University Wellington; Malaghan Institute; Victoria University Wellington	La Flamme, AC (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.; La Flamme, AC (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	anne.laflamme@vuw.ac.nz		Stone, Sarrabeth/0000-0001-7866-8228	Neurological Foundation of New Zealand [1029-PG]; New Zealand Lottery Grants Board	Neurological Foundation of New Zealand; New Zealand Lottery Grants Board	This work was funded by the Neurological Foundation of New Zealand (1029-PG to ACL) and New Zealand Lottery Grants Board (to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Neurological Foundation of New Zealand (1029-PG to ACL) and New Zealand Lottery Grants Board (to SS) for funding.	Aharoni R, 2010, J NEUROIMMUNOL, V225, P100, DOI 10.1016/j.jneuroim.2010.04.022; Aloisi F, 2000, J IMMUNOL, V164, P1705, DOI 10.4049/jimmunol.164.4.1705; Aloisi F, 1997, J IMMUNOL, V159, P1604; Anderson CF, 2002, J IMMUNOL, V168, P3697, DOI 10.4049/jimmunol.168.8.3697; Becher B, 2003, J CLIN INVEST, V112, P1186, DOI 10.1172/JCI200319079; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; DING L, 1993, J IMMUNOL, V151, P1224; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fortier Anne H, 2001, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s11; Green L.C., 1982, BIOCHEMISTRY-US, V126, P131, DOI DOI 10.1016/0003-2697(82)90118-X; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Kobayashi T, 2012, J IMMUNOL, V189, P1792, DOI 10.4049/jimmunol.1200042; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moussaud S, 2010, J NEUROSCI METH, V187, P243, DOI 10.1016/j.jneumeth.2010.01.017; Naundorf S, 2009, EUR J IMMUNOL, V39, P1066, DOI 10.1002/eji.200838773; Ponomarev ED, 2005, J IMMUNOL METHODS, V300, P32, DOI 10.1016/j.jim.2005.02.011; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tao X, 1997, J IMMUNOL, V159, P5956; Tierney JB, 2009, IMMUNOL CELL BIOL, V87, P235, DOI 10.1038/icb.2008.99; van der Veen RC, 2000, CELL IMMUNOL, V199, P43, DOI 10.1006/cimm.1999.1597; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164454	10.1371/journal.pone.0164454	http://dx.doi.org/10.1371/journal.pone.0164454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732670	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505300057
J	Xiao, QK; Song, R				Xiao, Qinkun; Song, Ren			Human Motion Retrieval Based on Statistical Learning and Bayesian Fusion	PLOS ONE			English	Article								A novel motion retrieval approach based on statistical learning and Bayesian fusion is presented. The approach includes two primary stages. (1) In the learning stage, fuzzy clustering is utilized firstly to get the representative frames of motions, and the gesture features of the motions are extracted to build a motion feature database. Based on the motion feature database and statistical learning, the probability distribution function of different motion classes is obtained. (2) In the motion retrieval stage, the query motion feature is extracted firstly according to stage (1). Similarity measurements are then conducted employing a novel method that combines category-based motion similarity distances with similarity distances based on canonical correlation analysis. The two motion distances are fused using Bayesian estimation, and the retrieval results are ranked according to the fused values. The effectiveness of the proposed method is verified experimentally.	[Xiao, Qinkun; Song, Ren] Xian Technol Univ, Dept Elect Informat Engn, Xian 710032, Shaanxi Provinc, Peoples R China	Xi'an Technological University	Xiao, QK (corresponding author), Xian Technol Univ, Dept Elect Informat Engn, Xian 710032, Shaanxi Provinc, Peoples R China.	xiaoginkun10000@163.com			National Natural Science Foundation [60972095, 61271362]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation (Grant Nos. 60972095 and 61271362), http://www.nsfc.gov.cn/.	Baak A., 2008, ACM C MULT INF RETR, P451, DOI [10.1145/1460096.1460169, DOI 10.1145/1460096.1460169]; Chen C, 2011, IEEE T VIS COMPUT GR, V17, P1676, DOI 10.1109/TVCG.2010.272; Euachongprasit W., 2008, 30 EUR C IR RES ECIR, P506; Fu AWC, 2008, VLDB J, V17, P899, DOI 10.1007/s00778-006-0040-z; Hsu E, 2005, ACM T GRAPHIC, V24, P1082, DOI 10.1145/1073204.1073315; Jain HP, 2011, LECT NOTES COMPUT SC, V6930, P227; Jan Baumann, 2014, INT C COMP GRAPH THE; Junejo IN, 2011, IEEE T PATTERN ANAL, V33, P172, DOI 10.1109/TPAMI.2010.68; Keogh E., 2002, Proceedings of the Twenty-eighth International Conference on Very Large Data Bases, P406; Kruager B., 2010, P 2010 ACM SIGGRAPH, P1, DOI DOI 10.2312/SCA/SCA10/001-010; Lab Graphics, MOT CAPT DAT; Meng Li, 2015, COMPUT GRAPH-UK, V54, P104; Muller M, 2005, ACM T GRAPHIC, V24, P677, DOI 10.1145/1073204.1073247; Muller M., 2009, P ACM SIGGRAPH EUR S; Muller M., 2007, TECHNICAL REPORT; Rao C, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P939; Shapiro A, 2006, PROC GRAPH INTERF, P33; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; Tam GKL, 2007, IEEE INT SYM MULTIM, P210, DOI 10.1109/ISM.2007.15; Vogele A, 2014, ACM SIGGRAPH EUR S C; Wang PJ, 2014, COMPUT GRAPH-UK, V38, P255, DOI 10.1016/j.cag.2013.11.008; Xiao J, 2015, SIGNAL PROCESS, V113, P1, DOI 10.1016/j.sigpro.2015.01.004; Zhan XW, 2006, IEEE T GEOSCI REMOTE, V44, P1534, DOI 10.1109/TGRS.2005.863319; Zhou F, 2013, IEEE T PATTERN ANAL, V35, P582, DOI 10.1109/TPAMI.2012.137; Zhou F, 2012, PROC CVPR IEEE, P1282, DOI 10.1109/CVPR.2012.6247812	25	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164610	10.1371/journal.pone.0164610	http://dx.doi.org/10.1371/journal.pone.0164610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732673	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300068
J	Martino, L; Holland, L; Christodoulou, E; Kunzelmann, S; Esposito, D; Rittinger, K				Martino, Luigi; Holland, Louise; Christodoulou, Evangelos; Kunzelmann, Simone; Esposito, Diego; Rittinger, Katrin			The Biophysical Characterisation and SAXS Analysis of Human NLRP1 Uncover a New Level of Complexity of NLR Proteins	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INNATE IMMUNITY; INFLAMMASOME ACTIVATION; CED-4-CED-9 COMPLEX; DOMAIN; MECHANISMS; INSIGHTS; REVEALS; TUMORIGENESIS; RECOGNITION	NOD-like receptors represent an important class of germline-encoded pattern recognition receptors that play key roles in the regulation of inflammatory signalling pathways. They function as danger sensors and initiate inflammatory responses and the production of cyto-kines. Since NLR malfunction results in chronic inflammation and auto-immune diseases, there is a great interest in understanding how they work on a molecular level. To date, a lot of insight into the biological functions of NLRs is available but biophysical and structural studies have been hampered by the difficulty to produce soluble and stable recombinant NLR proteins. NLRP1 is an inflammasome forming NLR that is believed to be activated by binding to MDP and induces activation of caspase 1. Here, we report the identification of a soluble fragment of NLRP1 that contains the NACHT oligomerization domain and the putative MDP-sensing LRR domain. We describe the biophysical and biochemical characterization of this construct and a SEC-SAXS analysis that allowed the calculation of a low resolution molecular envelope. Our data indicate that the protein is constitutively bound to ATP with a negligible ability to hydrolyse the triphosphate nucleotide and that it adopts a monomeric extended conformation that is reminiscent of the structure adopted by NLRC4 in the inflammasome complex. Furthermore, we show that the presence of MDP is not sufficient to promote self-oligomerization of the NACHT-LRR fragment suggesting that MDP may either bind to regions outside the NACHT-LRR module or that it may not be the natural ligand of NLRP1. Taken together, our data suggest that the NLRP1 mechanism of action differs from that recently reported for other NLRs.	[Martino, Luigi; Holland, Louise; Esposito, Diego; Rittinger, Katrin] Francis Crick Inst, Mol Struct Cell Signalling Lab, 1 Midland Rd, London NW1 1AT, England; [Christodoulou, Evangelos; Kunzelmann, Simone] Francis Crick Inst, Struct Biol Sci Technol Platform, 1 Midland Rd, London NW1 1AT, England; [Holland, Louise] Immunocore Ltd, 101 Pk Dr,Milton Pk, Abingdon OX14 4RY, Oxon, England	Francis Crick Institute; Francis Crick Institute	Rittinger, K (corresponding author), Francis Crick Inst, Mol Struct Cell Signalling Lab, 1 Midland Rd, London NW1 1AT, England.	katrin.rittinger@crick.ac.uk	Rittinger, Katrin/N-3344-2019	Rittinger, Katrin/0000-0002-7698-4435; Martino, Luigi/0000-0001-5871-3124; Esposito, Diego/0000-0003-4042-8856; Christodoulou, Evangelos/0000-0001-8464-1558	Medical Research Council [U117565398]; Francis Crick Institute; Cancer Research UK [FC001142]; UK Medical Research Council [FC001142]; Wellcome Trust [FC001142]; MRC [MC_U117565398] Funding Source: UKRI; Medical Research Council [MC_U117565398] Funding Source: researchfish; The Francis Crick Institute [10015, 10142] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Medical Research Council, grant U117565398, to K.R., and by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001142), the UK Medical Research Council (FC001142), and the Wellcome Trust (FC001142). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00169; Bleda S, 2014, INT J CARDIOL, V172, pE282, DOI 10.1016/j.ijcard.2013.12.201; Chavarria-Smith J, 2015, IMMUNOL REV, V265, P22, DOI 10.1111/imr.12283; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Diebolder CA, 2015, STRUCTURE, V23, P2349, DOI 10.1016/j.str.2015.10.001; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Huang WJ, 2013, GENE DEV, V27, P2039, DOI 10.1101/gad.224428.113; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin TC, 2013, PROTEINS, V81, P1266, DOI 10.1002/prot.24287; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Le HT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00275; Lechtenberg BC, 2014, CURR OPIN STRUC BIOL, V29, P17, DOI 10.1016/j.sbi.2014.08.011; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Nunes T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/654963; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Reubold TF, 2014, FEBS LETT, V588, P3327, DOI 10.1016/j.febslet.2014.07.017; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rosenstiel P, 2007, MICROBES INFECT, V9, P648, DOI 10.1016/j.micinf.2007.01.015; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Williams TM, 2015, J IMMUNOL, V194, P3369, DOI 10.4049/jimmunol.1402098; Yan N, 2006, CELL CYCLE, V5, P31, DOI 10.4161/cc.5.1.2263; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	45	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164662	10.1371/journal.pone.0164662	http://dx.doi.org/10.1371/journal.pone.0164662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727326	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504400048
J	Mogensen, H; Moller, J; Hultin, H; Mittendorter-Rutz, E				Mogensen, Hanna; Moller, Jette; Hultin, Hanna; Mittendorter-Rutz, Ellenor			Death of a Close Relative and the Risk of Suicide in Sweden-A Large Scale Register-Based Case-Crossover Study	PLOS ONE			English	Article							BEREAVEMENT; MORTALITY; SPOUSE; LIFE	Background Bereavement is thought to be a risk factor for suicide but the association has not been thoroughly investigated according to specific sensitive time periods and risk groups using a self-matched design. We aimed to 1) determine the risk of suicide within the first year after death of a close relative, 2) investigate if and how the risk changes within this time window and 3) determine if sex, age, and type of relationship, affect this association. Methods A self-matched, case-crossover study was performed by linking Swedish registers. In total, 31 059 individuals with suicide between 1990 and 2011 were included. Different periods within the year prior to the suicide were compared with corresponding periods one year earlier in the same individual's life. Conditional logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for suicide after death of a close relative. Results Increased ORs of suicide were seen during the first month, OR 1.77 (95% CI 1.35-2.34), and the first half-year, 1.27 (1.13-1.43). An even higher OR was found within the first week, 3.43 (1.89-6.22). Patterns were similar for women and men and across age groups. Death of a partner or child but not death of a sibling or parent was associated with a significantly increased suicide risk. The strongest association was seen after death of a partner in individuals aged 45 and older. Discussion These findings provide knowledge of sensitive time periods and at-risk groups in the early period of bereavement. Due to the use of a self-matched study design, methodological challenges of unmeasured residual confounding could be overcome.	[Mogensen, Hanna; Moller, Jette; Hultin, Hanna] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Mogensen, Hanna] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Mittendorter-Rutz, Ellenor] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Mittendorter-Rutz, E (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	Ellenor.mittendorfer-rutz@ki.se		Hultin, Hanna/0000-0002-4531-4885; Moller, Jette/0000-0001-9513-5896; Mogensen, Hanna/0000-0001-5195-8065	Swedish Research Council [522-2007-5681]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Support was provided by the Swedish Research Council, grant number: 522-2007-5681 to JM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbo E, 2005, J EPIDEMIOL COMMUN H, V59, P407, DOI 10.1136/jech.2004.024950; Agerbo E, 2002, BMJ-BRIT MED J, V325, P74, DOI 10.1136/bmj.325.7355.74; Ajdacic-Gross V, 2008, PSYCHOL MED, V38, P673, DOI 10.1017/S0033291708002754; Bolton JM, 2013, JAMA PSYCHIAT, V70, P158, DOI 10.1001/jamapsychiatry.2013.275; Erlangsen A, 2004, AGE AGEING, V33, P378, DOI 10.1093/ageing/afh128; Fang F, 2012, NEW ENGL J MED, V366, P1310, DOI 10.1056/NEJMoa1110307; Grenklo TB, 2013, JAMA PEDIATR, V167, P133, DOI 10.1001/jamapediatrics.2013.430; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Jakobsen IS, 2011, J CHILD PSYCHOL PSYC, V52, P176, DOI 10.1111/j.1469-7610.2010.02298.x; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; Mittendorfer-Rutz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051585; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; Mostofsky E, 2012, CIRCULATION, V125, P491, DOI 10.1161/CIRCULATIONAHA.111.061770; Niederkrotenthaler T, 2012, J EPIDEMIOL COMMUN H, V66, P233, DOI 10.1136/jech.2010.109595; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Rostila M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002618; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; Simon NM, 2013, JAMA-J AM MED ASSOC, V310, P416, DOI 10.1001/jama.2013.8614; Statistics Sweden, 2010, BACKGR FACTS POP WEL; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Wilcox HC, 2015, SOC PSYCH PSYCH EPID, V50, P1249, DOI 10.1007/s00127-014-0997-7	24	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164274	10.1371/journal.pone.0164274	http://dx.doi.org/10.1371/journal.pone.0164274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CI	27727324	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400024
J	Bertrand, S; Ceyssens, PJ; Yde, M; Dierick, K; Boyen, F; Vanderpas, J; Vanhoof, R; Mattheus, W				Bertrand, S.; Ceyssens, P. J.; Yde, M.; Dierick, K.; Boyen, F.; Vanderpas, J.; Vanhoof, R.; Mattheus, W.			Diversity of Listeria monocytogenes Strains of Clinical and Food Chain Origins in Belgium between 1985 and 2014	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED LISTERIOSIS; RESISTANCE; INFECTION; FOODBORNE; ENGLAND; WALES; EPIDEMIOLOGY; MOXIFLOXACIN; PERSISTENT; COUNTRIES	Listeriosis is a rare but severe disease, mainly caused by Listeria monocytogenes. This study shows the results of the laboratory-based surveillance of Listeriosis in Belgium over the period 1985-2014. Besides the incidence and some demographic data we present also more detailed microbiological and molecular characteristics of human strains isolated since 2000. The strains from the latter period were compared to food and animal strains from the same period. Our study shows that different food matrices were commonly contaminated with L. monocytogenes presenting the same PFGE profile as in patient's isolates. Since 1985, we observed a significant decrease in incidence of the Materno-Neonatal cases (from 0.15 to 0.04 cases /100,000 inhabitants-year), which is probably to be attributed to active prevention campaigns targeting pregnant women. Despite the strengthening of different control measures by the food industry, the incidence of non-Materno-Neonatal listeriosis increased in Belgium (from 0.3 to 0.7 cases /100,000 inhabitants-year), probably due to the rise of highly susceptible patients in an aging population. This significant increase found in non-Materno-Neonatal cases (slope coefficient 7.42%/year, P< 0.0001) can be attributed to significant increase in incidence of isolates belonging to serovars 1/2a (n = 393, slope coefficient 6.62%/year, P< 0.0001). Although resistance to antimicrobials is rare among L. monocytogenes isolates, a trend to increasing MIC values is evident with chloramphenicol, amoxicillin, tetracycline and ciprofloxacin. We show that fluoroquinolone resistance is not linked to chromosomal mutations, but caused by a variety of efflux pumps. Our study also shows that huge majority of known underlying pathologies (426 out of 785 cases) were cancers (185/426, 43.1%) and haematological malignancies (75/185, 40.5%). Moreover the risk population is susceptible to low levels of contamination in food stressing the need of prevention campaigns specifically targeting these persons.	[Bertrand, S.; Ceyssens, P. J.; Yde, M.; Vanhoof, R.; Mattheus, W.] Sci Inst Publ Hlth, NRC Listeria, Sect Bacterial Dis, Brussels, Belgium; [Dierick, K.] Sci Inst Publ Hlth, Sect Foodborne Pathogens, NRL Listeria Monocytogenes, Brussels, Belgium; [Boyen, F.] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium; [Vanderpas, J.] Sci Inst Publ Hlth, Med Microbiol Lab, Brussels, Belgium	Ghent University	Bertrand, S (corresponding author), Sci Inst Publ Hlth, NRC Listeria, Sect Bacterial Dis, Brussels, Belgium.	sophie.bertrand@wiv-isp.be	Boyen, Filip/AAF-6109-2020	Boyen, Filip/0000-0002-4777-6880; Ceyssens, Pieter-Jan/0000-0001-7735-8316; Jean, Vanderpas/0000-0003-0623-5612	Belgian Ministry of Social Affairs through a fund within the Health Insurance System	Belgian Ministry of Social Affairs through a fund within the Health Insurance System	The authors received no specific funding for this work. The national reference center is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System	Abreu C, 2013, J CROHNS COLITIS, V7, P175, DOI [10.1016/j.crohns.2012.04.018, 10.1016/j.crohns.2013.03.004]; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Althaus D, 2014, FOODBORNE PATHOG DIS, V11, P753, DOI 10.1089/fpd.2014.1747; Ammon A, 2010, INT J FOOD MICROBIOL, V139, pS43, DOI 10.1016/j.ijfoodmicro.2010.03.002; [Anonymous], 2013, VITAL SIGNS LISTERIA; Awofisayo A, 2015, EPIDEMIOL INFECT, V143, P249, DOI 10.1017/S0950268814000594; Bertsch D, 2014, MICROBIOLOGYOPEN, V3, P118, DOI 10.1002/mbo3.155; Bockwel P, 2010, INTRO TIME SERIES FO; Carryn S, 2003, J ANTIMICROB CHEMOTH, V51, P1051, DOI 10.1093/jac/dkg189; Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI [10.3201/eid1901.120393, 10.3201/eid1908.121511]; Coetzee N, 2011, EUROSURVEILLANCE, V16, P2; Curtis D, 2014, J FOOD SCI, V79, pR1871, DOI 10.1111/1750-3841.12646; de Valk H, 2005, Euro Surveill, V10, P9, DOI 10.2807/esm.10.10.00572-en; den Bakker HC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-277; Elinav H, 2014, CLIN INFECT DIS, V59, P953, DOI 10.1093/cid/ciu504; Fagerlund A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151117; Gillespie IA, 2006, EMERG INFECT DIS, V12, P1361, DOI 10.3201/eid1209.051657; Girard D, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.38.20909; Godreuil S, 2003, ANTIMICROB AGENTS CH, V47, P704, DOI 10.1128/AAC.47.2.704-708.2003; Goulet V, 2008, EMERG INFECT DIS, V14, P734, DOI 10.3201/eid1405.071395; Grayo S, 2008, ANTIMICROB AGENTS CH, V52, P1697, DOI 10.1128/AAC.01211-07; Guerin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106340; Haase JK, 2014, ENVIRON MICROBIOL, V16, P405, DOI 10.1111/1462-2920.12342; Heiman KE, 2016, EPIDEMIOL INFECT, V144, P2698, DOI 10.1017/S095026881500117X; Jensen AK, 2016, EMERG INFECT DIS, V22, P625, DOI 10.3201/eid2204.150998; Jiang XB, 2016, INT J FOOD MICROBIOL, V217, P141, DOI 10.1016/j.ijfoodmicro.2015.10.022; JONES EM, 1995, EUR J CLIN MICROBIOL, V14, P165, DOI 10.1007/BF02310351; Knabel SJ, 2012, J CLIN MICROBIOL, V50, P1748, DOI 10.1128/JCM.06185-11; Koch J, 2006, Euro Surveill, V11, P7, DOI 10.2807/esm.11.06.00631-en; Magalhaes R, 2016, FOOD MICROBIOL, V57, P103, DOI 10.1016/j.fm.2016.02.005; Martin P, 2006, FOODBORNE PATHOG DIS, V3, P303, DOI 10.1089/fpd.2006.3.303; Maury MM, 2016, NAT GENET, V48, P308, DOI 10.1038/ng.3501; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Montero D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00384; Mook P, 2010, EUROSURVEILLANCE, V15, P17; Morvan A, 2010, ANTIMICROB AGENTS CH, V54, P2728, DOI 10.1128/AAC.01557-09; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Ruppitsch W, 2015, J CLIN MICROBIOL, V53, P2869, DOI 10.1128/JCM.01193-15; Safdar A, 2003, J CLIN MICROBIOL, V41, P483, DOI 10.1128/JCM.41.1.483-485.2003; Schmid D, 2014, CLIN MICROBIOL INFEC, V20, P431, DOI 10.1111/1469-0691.12638; SEELIGER HPR, 1989, INT J FOOD MICROBIOL, V8, P245, DOI 10.1016/S0168-1605(00)00348-2; Stahlmann R, 2013, EXPERT OPIN DRUG SAF, V12, P497, DOI 10.1517/14740338.2013.796362; Stasiewicz MJ, 2015, APPL ENVIRON MICROB, V81, P6024, DOI 10.1128/AEM.01049-15; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; TAPPERO JW, 1995, JAMA-J AM MED ASSOC, V273, P1118, DOI 10.1001/jama.273.14.1118; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Viale P, 2007, DIAGN MICR INFEC DIS, V58, P137, DOI 10.1016/j.diagmicrobio.2006.11.010; WINSLOW DL, 1982, ANTIMICROB AGENTS CH, V22, P51, DOI 10.1128/AAC.22.1.51; WINSLOW DL, 1983, ANTIMICROB AGENTS CH, V23, P555, DOI 10.1128/AAC.23.4.555; Yde M, 2012, EURO SURVEILL, V17; [No title captured]	52	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164283	10.1371/journal.pone.0164283	http://dx.doi.org/10.1371/journal.pone.0164283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723768	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504100040
J	Chang, M; Womer, FY; Bai, C; Zhou, Q; Wei, SN; Jiang, XW; Geng, HY; Zhou, YF; Tang, YQ; Wang, F				Chang, Miao; Womer, Fay Y.; Bai, Chuan; Zhou, Qian; Wei, Shengnan; Jiang, Xiaowei; Geng, Haiyang; Zhou, Yifang; Tang, Yanqing; Wang, Fei			Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis	PLOS ONE			English	Article							HIGH FAMILIAL RISK; ULTRA-HIGH-RISK; 1ST-EPISODE SCHIZOPHRENIA; MULTISENSORY INTEGRATION; BRAIN STRUCTURE; POSTURAL SWAY; CEREBELLUM; TRANSITION; VARIANTS; NETWORKS	Background Understanding morphologic changes in vulnerable and early disease state of schizophrenia (SZ) may provide further insight into the development of psychosis. Method Whole brain voxel-based morphometry was performed to identify gray matter (GM) regional differences in 60 individuals with SZ during their first psychotic episode (FE-SZ), 31 individuals at genetic high risk for SZ (GHR-SZ) individuals, and 71 healthy controls. Results Significant differences were found in several regions including the prefrontal cortex, parietal lobe, temporal lobe, hippocampus, occipital lobe, and cerebellum among the three groups (p<0.05, corrected). Compared to the HC group, the FE-SZ group had significantly decreased GM volumes in several regions including the cerebellum, hippocampus, fusiform gyrus, lingual gyrus, supramarginal gyrus, and superior, middle, and inferior temporal gyri and significantly increased GM volumes in the middle frontal gyrus and inferior operculum frontal gyrus (p<0.05). The GHR-SZ group had significant decreases in GM volumes in the supramaginal gyrus, precentral gyrus, and rolandic operculum and significant increases in GM volumes in the cerebellum, fusiform gyrus, middle frontal gyrus, inferior operculum frontal gyrus, and superior, middle, and inferior temporal gyri when compared to the HC group (p<0.05). Compared to the GHR-SZ group, the FE-SZ group had significant decreases in GM volumes in several regions including the cerebellum, fusiform gyrus, supramarginal gyrus, and superior, middle, and inferior temporal gyri (p<0.05). Conclusions The findings herein implicate the involvement of multisensory integration in SZ development and pathophysiology. Additionally, the patterns of observed differences suggest possible indicators of disease, vulnerability, and resiliency in SZ.	[Chang, Miao; Bai, Chuan; Wei, Shengnan; Jiang, Xiaowei; Geng, Haiyang; Wang, Fei] China Med Univ, Dept Radiol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Chang, Miao; Bai, Chuan; Zhou, Qian; Tang, Yanqing; Wang, Fei] China Med Univ, Brain Funct Res Sect, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Womer, Fay Y.; Zhou, Qian; Zhou, Yifang; Tang, Yanqing; Wang, Fei] China Med Univ, Dept Psychiat, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Wei, Shengnan; Jiang, Xiaowei] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Wang, Fei] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	China Medical University; China Medical University; China Medical University; Washington University (WUSTL); Yale University	Wang, F (corresponding author), China Med Univ, Dept Radiol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China.; Wang, F (corresponding author), China Med Univ, Brain Funct Res Sect, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China.; Wang, F (corresponding author), China Med Univ, Dept Psychiat, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China.; Wang, F (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA.	fei.wang@mail.cmu.edu.cn			National Natural Science Foundation of China [81071099, 81271499, 81101012]; Liaoning Education Foundation; Liaoning Science and Technology Foundation [2008225010, 2011225018]; National Institutes of Health [K01MH086621]; National Alliance for Research on Schizophrenia and Depression; Klingenstein Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Education Foundation; Liaoning Science and Technology Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); Klingenstein Foundation(Klingenstein Philanthropies)	The authors were supported by research grants from the National Natural Science Foundation of China (81071099, 81271499, Yanqing Tang and 81101012, Feng Wu), Liaoning Education Foundation (Pandeng Scholar, Fei Wang), the Liaoning Science and Technology Foundation (2008225010, Yanqing Tang and 2011225018, Fei Wang), National Institutes of Health (K01MH086621, Fei Wang), the National Alliance for Research on Schizophrenia and Depression (Fei Wang) and the Klingenstein Foundation (Fei Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Bernard JA, 2014, HUM BRAIN MAPP, V35, P4064, DOI 10.1002/hbm.22458; Bois C, 2015, J PSYCHOPHARMACOL, V29, P144, DOI 10.1177/0269881114541015; Bois C, 2015, SCHIZOPHR RES, V165, P45, DOI 10.1016/j.schres.2015.03.024; Brent BK, 2013, CHILD ADOL PSYCH CL, V22, P689, DOI 10.1016/j.chc.2013.06.003; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Chang EF, 2015, J NEUROSURG, V122, P250, DOI 10.3171/2014.10.JNS132647; Chung Y, 2015, J NERV MENT DIS, V203, P336, DOI 10.1097/NMD.0000000000000286; Dean DJ, 2015, SCHIZOPHR RES, V162, P86, DOI 10.1016/j.schres.2014.12.039; Gong QY, 2015, SCHIZOPHRENIA BULL, V41, P1266, DOI 10.1093/schbul/sbv109; Gurung R, 2015, PSYCHOL MED, V45, P2461, DOI 10.1017/S0033291715000537; Kent JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041808; Konarski JZ, 2005, J PSYCHIATR NEUROSCI, V30, P178; Li T, 2017, SCHIZOPHRENIA BULL, V43, P436, DOI 10.1093/schbul/sbw099; Lindgren M, 2014, SCHIZOPHR RES, V158, P1, DOI 10.1016/j.schres.2014.06.028; Mayer AR, 2015, BRIT J PSYCHIAT, V207, P420, DOI 10.1192/bjp.bp.114.155499; Nakamura Kazue, 2013, Front Psychiatry, V4, P16, DOI 10.3389/fpsyt.2013.00016; Nenadic I, 2015, SCHIZOPHR RES, V161, P169, DOI 10.1016/j.schres.2014.10.041; O'Halloran CJ, 2012, J CLIN EXP NEUROPSYC, V34, P35, DOI 10.1080/13803395.2011.614599; Pasternak O, 2016, SCHIZOPHR RES, V173, P200, DOI 10.1016/j.schres.2015.05.034; Raz N, 2001, AM J NEURORADIOL, V22, P1161; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ronconi L, 2017, CEREB CORTEX, V27, P2041, DOI 10.1093/cercor/bhw049; Rubinov Mikail, 2013, Dialogues Clin Neurosci, V15, P339; Sprooten E, 2013, SCHIZOPHR RES, V151, P259, DOI 10.1016/j.schres.2013.09.024; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Thermenos HW, 2013, AM J MED GENET B, V162, P604, DOI 10.1002/ajmg.b.32170; Thorsen AL, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00103; Torii Y, 2012, SCHIZOPHR RES, V134, P137, DOI 10.1016/j.schres.2011.10.024; Tseng HH, 2015, NEUROSCI BIOBEHAV R, V55, P444, DOI 10.1016/j.neubiorev.2015.04.019; van den Heuvel MP, 2014, NEUROPSYCHOL REV, V24, P32, DOI 10.1007/s11065-014-9248-7; Wheeler AL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00653; Williams LE, 2010, NEUROPSYCHOLOGIA, V48, P3128, DOI 10.1016/j.neuropsychologia.2010.06.028; Witthaus H, 2009, PSYCHIAT RES-NEUROIM, V173, P163, DOI 10.1016/j.pscychresns.2008.08.002; Womer FY, 2016, SCHIZOPHR RES, V176, P164, DOI 10.1016/j.schres.2016.06.028; Wynn JK, 2014, COGN NEUROPSYCHIATRY, V19, P319, DOI 10.1080/13546805.2013.866892	37	30	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163749	10.1371/journal.pone.0163749	http://dx.doi.org/10.1371/journal.pone.0163749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723806	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100010
J	Francis, KB; Howard, C; Howard, IS; Gummerum, M; Ganis, G; Anderson, G; Terbeck, S				Francis, Kathryn B.; Howard, Charles; Howard, Ian S.; Gummerum, Michaela; Ganis, Giorgio; Anderson, Grace; Terbeck, Sylvia			Virtual Morality: Transitioning from Moral Judgment to Moral Action?	PLOS ONE			English	Article							BEHAVIOR; PERSONALITY; DIMENSIONS	The nature of moral action versus moral judgment has been extensively debated in numerous disciplines. We introduce Virtual Reality (VR) moral paradigms examining the action individuals take in a high emotionally arousing, direct action-focused, moral scenario. In two studies involving qualitatively different populations, we found a greater endorsement of utilitarian responses-killing one in order to save many others-when action was required in moral virtual dilemmas compared to their judgment counterparts. Heart rate in virtual moral dilemmas was significantly increased when compared to both judgment counterparts and control virtual tasks. Our research suggests that moral action may be viewed as an independent construct to moral judgment, with VR methods delivering new prospects for investigating and assessing moral behaviour.	[Francis, Kathryn B.; Gummerum, Michaela; Ganis, Giorgio; Anderson, Grace; Terbeck, Sylvia] Univ Plymouth, Sch Psychol, Plymouth PL1 4AA, Devon, England; [Howard, Charles; Howard, Ian S.] Univ Plymouth, Ctr Robot & Neural Syst, Plymouth PL1 4AA, Devon, England	University of Plymouth; University of Plymouth	Francis, KB (corresponding author), Univ Plymouth, Sch Psychol, Plymouth PL1 4AA, Devon, England.	kathryn.francis@plymouth.ac.uk		Francis, Kathryn/0000-0002-3875-8904; Howard, Ian/0000-0002-6041-9669; Ganis, Giorgio/0000-0001-6175-2618; Terbeck, Sylvia/0000-0003-0417-7527	Seventh Framework Programme [FP7-PEOPLE-2013-ITN-604764]; Plymouth University; ESRC [ES/K000942/1] Funding Source: UKRI; Economic and Social Research Council [ES/K000942/1] Funding Source: researchfish	Seventh Framework Programme(European Commission); Plymouth University; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The authors received funding from Plymouth University and Seventh Framework Programme (FP7-PEOPLE-2013-ITN-604764).	Ashton MC, 2005, J PERS, V73, P1321, DOI 10.1111/j.1467-6494.2005.00351.x; Ashton MC, 2009, J PERS ASSESS, V91, P340, DOI 10.1080/00223890902935878; Cima M, 2010, SOC COGN AFFECT NEUR, V5, P59, DOI 10.1093/scan/nsp051; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Cushman F, 2013, PERS SOC PSYCHOL REV, V17, P273, DOI 10.1177/1088868313495594; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Djeriouat H, 2014, PERS INDIV DIFFER, V67, P11, DOI 10.1016/j.paid.2013.12.026; Ellemers N, 2013, EUR REV SOC PSYCHOL, V24, P160, DOI 10.1080/10463283.2013.841490; Everett JAC, 2016, J EXP PSYCHOL GEN, V145, P772, DOI 10.1037/xge0000165; FeldmanHall O, 2012, COGNITION, V123, P434, DOI 10.1016/j.cognition.2012.02.001; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Foot Philippa, 1978, VIRTUES VICES, DOI [10.1093/0199252866.003.0002, DOI 10.1093/0199252866.003.0002]; Glenn AL, 2009, J PERS DISORD, V23, P384, DOI 10.1521/pedi.2009.23.4.384; Greene J., 2014, MORAL TRIBES EMOTION; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Iachini T, 2015, ACTA PSYCHOL, V161, P131, DOI 10.1016/j.actpsy.2015.09.003; Kastner R. M., 2010, CHRESTOMATHY ANN REV, V9, P114; Kiehl Kent A., 2008, MORAL PSYCHOL, V3, P119; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Navarrete CD, 2012, EMOTION, V12, P364, DOI 10.1037/a0025561; Patil I, 2014, SOC NEUROSCI-UK, V9, P94, DOI 10.1080/17470919.2013.870091; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Shakespeare W., 2005, OTHELLO; Shaver, 2011, SOCIAL PSYCHOL MORAL, V1, P167, DOI [DOI 10.1037/13091-009, 10.1037/13091-009]; Skulmowski A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00426; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Tassy S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00229; Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250; Terbeck S, 2012, PSYCHOPHARMACOLOGY, V222, P419, DOI 10.1007/s00213-012-2657-5; Thoma S., 1994, MORAL DEV PROFESSION, P199; Wai M, 2012, PERS INDIV DIFFER, V52, P794, DOI 10.1016/j.paid.2012.01.008; Zhong CB, 2010, J EXP SOC PSYCHOL, V46, P859, DOI 10.1016/j.jesp.2010.04.003	35	64	64	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164374	10.1371/journal.pone.0164374	http://dx.doi.org/10.1371/journal.pone.0164374			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723826	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000385504100049
J	Gaba, A; Dygryn, J; Mitas, J; Jakubec, L; Fromel, K				Gaba, Ales; Dygryn, Jan; Mitas, Josef; Jakubec, Lukas; Fromel, Karel			Effect of Accelerometer Cut-Off Points on the Recommended Level of Physical Activity for Obesity Prevention in Children	PLOS ONE			English	Article							BODY-COMPOSITION; ACTIVITY MONITOR; YOUTH; CALIBRATION; ADOLESCENTS; ADIPOSITY; ASSOCIATIONS; VALIDATION; OVERWEIGHT; VALIDITY	There is no general consensus regarding which accelerometer cut-off point (CoP) is most acceptable to estimate the time spent in moderate-to-vigorous physical activity (MVPA) in children and choice of an appropriate CoP primarily remains a subjective decision. Therefore, this study aimed to analyze the influence of CoP selection on the mean MVPA and to define the optimal thresholds of MVPA derived from different accelerometer CoPs to avoid overweight/obesity and adiposity in children aged 7 to 12 years. Three hundred six children participated. Physical activity (PA) was monitored for seven consecutive days using an ActiGraph accelerometer (model GT3X) and the intensity of PA was estimated using the five most frequently published CoPs. Body adiposity was assessed using a multi-frequency bioelectrical impedance analysis. There was found a wide range of mean levels of MVPA that ranged from 27 (Puyau CoP) to 231 min center dot d(-1) (Freedson 2005 CoP). A receiver operating characteristic curve analysis indicated that the optimal thresholds for counts per minute (cpm) and MVPA derived from the Puyau CoP was the most useful in classifying children according to their body mass index (BMI) and fat mass percentage (FM%). In the total sample, the optimal thresholds of the MVPA derived from the Puyau CoP were 22 and 23 min center dot d(-1) when the categories based on BMI and FM%, respectively, were used. The children who did not meet these optimal thresholds had a significantly increased risk of being overweight/obese (OR = 2.88, P < 0.01) and risk of having excess fat mass (OR = 2.41, P < 0.01). In conclusion, the decision of selecting among various CoPs significantly influences the optimal levels of MVPA. The Puyau CoP of 3 200 cmp seems to be the most useful for defining the optimal level of PA for pediatric obesity prevention.	[Gaba, Ales; Dygryn, Jan; Mitas, Josef; Jakubec, Lukas; Fromel, Karel] Palacky Univ Olomouc, Fac Phys Culture, Trida Miru 117, Olomouc 77111, Czech Republic	Palacky University Olomouc	Gaba, A (corresponding author), Palacky Univ Olomouc, Fac Phys Culture, Trida Miru 117, Olomouc 77111, Czech Republic.	ales.gaba@upol.cz	Mitáš, Josef/K-1760-2015; Frömel, Karel/AAU-2222-2020; Frömel, Karel/L-9865-2017; Gába, Aleš/D-2090-2011; Jakubec, Lukas/P-8652-2016; Dygryn, Jan/E-4760-2017	Mitáš, Josef/0000-0001-7219-931X; Frömel, Karel/0000-0001-7848-3418; Frömel, Karel/0000-0001-7848-3418; Gába, Aleš/0000-0002-7236-9072; Jakubec, Lukas/0000-0003-2332-8693; Dygryn, Jan/0000-0003-1026-1784	Czech Science Foundation [14-28696S, 13-32935S]; Palacky University Olomouc [FTK_2013_003]	Czech Science Foundation(Grant Agency of the Czech Republic); Palacky University Olomouc	This study was supported by the research projects of the Czech Science Foundation, "Multifactorial research on built environment, active lifestyle and physical fitness in Czech adolescents" (No. 14-28696S) and "Objectification of comprehensive monitoring of school mental and physical strain in adolescents in the context of physical and mental condition" (No. 13-32935S), as well as an institutional grant of Palacky University Olomouc (FTK_2013_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bassett DR, 2015, MED SCI SPORT EXER, V47, P833, DOI 10.1249/MSS.0000000000000468; Beets MW, 2011, PEDIATRICS, V127, P658, DOI 10.1542/peds.2010-2021; BERK RA, 1976, J EXP EDUC, V45, P4, DOI 10.1080/00220973.1976.11011567; Bornstein DB, 2011, J SCI MED SPORT, V14, P404, DOI 10.1016/j.jsams.2011.03.013; Brage S, 2003, PEDIATR EXERC SCI, V15, P277, DOI 10.1123/pes.15.3.277; Brazendale K, 2016, J SCI MED SPORT, V19, P242, DOI 10.1016/j.jsams.2015.02.006; Cain KL, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-51; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Vries SI, 2006, J CLIN EPIDEMIOL, V59, P670, DOI 10.1016/j.jclinepi.2005.11.020; Department of Health & Aging, 2004, AUSTR PHYS ACT REC 5; Ekelund U, 2004, AM J CLIN NUTR, V80, P584; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson P.S., 1997, MED SCI SPORT EXER S, V29, P45, DOI DOI 10.1097/00005768-199705001-00256; Guinhouya BC, 2013, PUBLIC HEALTH, V127, P301, DOI 10.1016/j.puhe.2013.01.020; Guinhouya CB, 2006, OBESITY, V14, P774, DOI 10.1038/oby.2006.89; Guinhouya CB, 2009, PEDIATR INT, V51, P568, DOI 10.1111/j.1442-200X.2008.02801.x; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Javed A, 2015, PEDIATR OBES, V10, P234, DOI 10.1111/ijpo.242; Jensky-Squires NE, 2008, BRIT J NUTR, V100, P859, DOI 10.1017/S0007114508925460; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Kahlmeier S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1412-3; Kim Y, 2012, J SCI MED SPORT, V15, P311, DOI 10.1016/j.jsams.2011.12.001; Laguna M, 2013, PEDIATR OBES, V8, P62, DOI 10.1111/j.2047-6310.2012.00086.x; Lim JS, 2009, PEDIATR INT, V51, P263, DOI 10.1111/j.1442-200X.2008.02698.x; Loprinzi PD, 2012, RES Q EXERCISE SPORT, V83, P422; Mellor JM, 2008, EVALUATION REV, V32, P298, DOI 10.1177/0193841X07312682; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Rowlands AV, 2006, J EXERC SCI FIT, V4, P96, DOI DOI 10.1177/0193841X07312682; Sigmund E, 2015, INT J ENV RES PUB HE, V12, P11848, DOI 10.3390/ijerph120911848; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	42	15	15	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164282	10.1371/journal.pone.0164282	http://dx.doi.org/10.1371/journal.pone.0164282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723835	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100039
J	Haasnoot, AMJW; Vernie, LA; Rothova, A; van der Doe, P; Los, LI; Schalij-Delfos, NE; de Boer, JH				Haasnoot, Anne-Mieke J. W.; Vernie, Lenneke A.; Rothova, Aniki; van der Doe, Patricia; Los, Leonoor I.; Schalij-Delfos, Nicoline E.; de Boer, Joke H.			Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood	PLOS ONE			English	Article							TERM-FOLLOW-UP; RHEUMATOID-ARTHRITIS; RISK-FACTORS; METHOTREXATE; CHILDREN; CHILDHOOD; THERAPY	Background Typically juvenile idiopathic arthritis (JIA)-associated uveitis (further referred as 'JIA-uveitis') has its onset in childhood, but some patients suffer its, sometimes visual threatening, complications or ongoing disease activity in adulthood. The objective of this study was to analyze uveitis activity, complications and visual prognosis in adulthood. Methods In this multicenter study, 67 adult patients (129 affected eyes) with JIA-uveitis were retrospectively studied for best corrected visual acuity, visual fields, uveitis activity, topical/systemic treatments, ocular complications, and ocular surgeries during their 18th, 22nd and 30th year of life. Because treatment strategies changed after the year 1990, outcomes were stratified for onset of uveitis before and after 1990. Results Sixty-two of all 67 included patients (93%) had bilateral uveitis. During their 18th life year, 4/52 patients (8%) had complete remission, 28/52 (54%) had uveitis activity and 37/51 patients (73%) were on systemic immunomodulatory treatment. Bilateral visual impairment or legal blindness occurred in 2/51 patients (4%); unilateral visual impairment or legal blindness occurred in 17/51 patients (33%) aged 18 years. The visual prognosis appeared to be slightly better for patients with uveitis onset after the year 1990 (for uveitis onset before 1990 (n = 7) four patients (58%) and for uveitis onset after 1990 (n = 44) 13 patients (30%) were either visual impaired or blind). At least one ocular surgery was performed in 10/24 patients (42%) between their 18th and 22nd year of life. Conclusions Bilateral visual outcome in early adulthood in patients with JIA-uveitis appears to be fairly good, although one third of the patients developed one visually impaired or blind eye. However, a fair amount of the patients suffered from ongoing uveitis activity and needed ongoing treatment as well as surgical interventions. Awareness of these findings is important for ophthalmologists and rheumatologists treating patients with JIA-uveitis, as well as for the patients themselves.	[Haasnoot, Anne-Mieke J. W.; Vernie, Lenneke A.; de Boer, Joke H.] Univ Utrecht, Med Ctr, Dept Ophthalmol, Utrecht, Netherlands; [Rothova, Aniki] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands; [Schalij-Delfos, Nicoline E.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Haasnoot, AMJW (corresponding author), Univ Utrecht, Med Ctr, Dept Ophthalmol, Utrecht, Netherlands.	a.j.w.haasnoot@umcutrecht.nl			Dr. F.P. Fischer Stichting, Amersfoort; ODAS Stichting; Landslijke Stichting Voor Blinden en Slechtzienden, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek (SNOO), Rotterdam, the Netherlands	Dr. F.P. Fischer Stichting, Amersfoort; ODAS Stichting; Landslijke Stichting Voor Blinden en Slechtzienden, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek (SNOO), Rotterdam, the Netherlands(Netherlands Government)	This study was funded by the combined grants from the Dr. F.P. Fischer Stichting, Amersfoort; The ODAS Stichting, the Landslijke Stichting Voor Blinden en Slechtzienden, Utrecht; the Stichting Nederlands Oogheelkundig Onderzoek (SNOO), Rotterdam, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles-Han Sheila T, 2013, Int J Clin Rheumtol, V8, DOI 10.2217/ijr.12.83; [Anonymous], 2014, INT STAT CLASSIFICAT; Ayuso VK, 2010, AM J OPHTHALMOL, V149, P987, DOI 10.1016/j.ajo.2010.01.014; Berntson L, 2001, J RHEUMATOL, V28, P2737; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Camuglia JE, 2009, OCUL IMMUNOL INFLAMM, V17, P330, DOI 10.3109/09273940903118626; Cassidy J, 2006, PEDIATRICS, V117, P1843, DOI 10.1542/peds.2006-0421; Dana MR, 1997, OPHTHALMOLOGY, V104, P236, DOI 10.1016/S0161-6420(97)30329-7; Edelsten C, 2002, BRIT J OPHTHALMOL, V86, P51, DOI 10.1136/bjo.86.1.51; Foster CS, 2000, ACTA OPHTHALMOL SCAN, V78, P576, DOI 10.1034/j.1600-0420.2000.078005576.x; GARE BA, 1992, PEDIATRICS, V90, P950; GIANNINI EH, 1992, NEW ENGL J MED, V326, P1043, DOI 10.1056/NEJM199204163261602; Gregory AC, 2013, OPHTHALMOLOGY, V120, P186, DOI 10.1016/j.ophtha.2012.07.052; Haasnoot AJW, 2015, AM J OPHTHALMOL, V159, P372, DOI 10.1016/j.ajo.2014.11.007; Hoeve M, 2012, BRIT J OPHTHALMOL, V96, P852, DOI 10.1136/bjophthalmol-2011-301023; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; KANSKI J J, 1988, Eye (London), V2, P641; KANSKI JJ, 1989, BRIT J OPHTHALMOL, V73, P225, DOI 10.1136/bjo.73.3.225; Kesen Muge R, 2008, Int Ophthalmol Clin, V48, P21, DOI 10.1097/IIO.0b013e31817d998f; Kotaniemi K, 1999, CLIN EXP RHEUMATOL, V17, P119; Kotaniemi K, 2005, ANN RHEUM DIS, V64, P871, DOI 10.1136/ard.2004.026955; Kotaniemi K, 2001, OPHTHALMOLOGY, V108, P2071, DOI 10.1016/S0161-6420(01)00773-4; Kotaniemi K, 2007, CLIN OPHTHALMOL, V1, P455; Lovell DJ, 2008, NEW ENGL J MED, V359, P810, DOI 10.1056/NEJMoa0706290; Lovell DJ, 2000, NEW ENGL J MED, V342, P763, DOI 10.1056/NEJM200003163421103; Oray M, 2016, GRAEF ARCH CLIN EXP, V254, P1841, DOI 10.1007/s00417-016-3340-z; Ozdal PC, 2005, OCUL IMMUNOL INFLAMM, V13, P33, DOI 10.1080/09273940590909220; Packham JC, 2002, RHEUMATOLOGY, V41, P1428, DOI 10.1093/rheumatology/41.12.1428; Petty RE, 2004, J RHEUMATOL, V31, P390; Sen ES, 2015, NAT REV RHEUMATOL, V11, P338, DOI 10.1038/nrrheum.2015.20; Sijssens KM, 2007, AM J OPHTHALMOL, V144, P574, DOI 10.1016/j.ajo.2007.06.030; Skarin A, 2009, OCUL IMMUNOL INFLAMM, V17, P104, DOI 10.1080/09273940802650398; Tappeiner C, 2016, ARTHRIT CARE RES, V68, P46, DOI 10.1002/acr.22649; TRUCKENBRODT H, 1986, ARTHRITIS RHEUM, V29, P801, DOI 10.1002/art.1780290616; YANCEY C, 1993, PEDIATRICS, V92, P295; Zak M, 2003, ACTA OPHTHALMOL SCAN, V81, P211, DOI 10.1034/j.1600-0420.2003.00066.x	36	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164312	10.1371/journal.pone.0164312	http://dx.doi.org/10.1371/journal.pone.0164312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723840	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100043
J	Murgatroyd, M; Underhill, LG; Bouten, W; Amar, A				Murgatroyd, Megan; Underhill, Les G.; Bouten, Willem; Amar, Arjun			Ranging Behaviour of Verreaux's Eagles during the Pre-Breeding Period Determined through the Use of High Temporal Resolution Tracking	PLOS ONE			English	Article							KESTREL FALCO-TINNUNCULUS; ADULT GOLDEN EAGLES; GPS TRACKING; HOME-RANGE; AQUILA-VERREAUXII; HABITAT SELECTION; FORAGING HABITAT; CAPE GANNETS; BLACK EAGLES; CONSERVATION	Information on movement ecology is key in understanding the drivers and limitations of life history traits and has a potential role in indicating environmental change. Currently we have a limited understanding of the parameters of movement of territory-bound raptors, which are sensitive to environmental change. In this study we used GPS tracking technology to obtain spatially (within 3 m) and temporally (c. 3 mins) high-resolution movement data on a small sample of Verreaux's eagle Aquila verreauxii during the pre-laying period (n = 4) with one additional example during the chick rearing period. We present GPS-derived home range estimates for this species and we examine temporal (timing, duration, frequency and speed) and spatial (total path length and maximum distance from nest) patterns of trips away from the nest. For eagles tagged in the agriculturally developed Sandveld region (n = 3), which is made up of a mosaic of land use types, we also undertook a habitat selection analysis. Home ranges were small and largely mutually exclusive. Trip activity was centred around midday, which is likely to be related to lift availability. Our habitat selection analysis found that eagles selected for near-natural and degraded habitat over natural or completely modified areas, suggesting that these eagles may have benefitted from some of the agricultural development in this region. Although our sample sizes are small, the resolution of our tracking data was essential in deriving this data over a relatively short time period and paves the way for future research.	[Murgatroyd, Megan; Underhill, Les G.] Univ Cape Town, Dept Biol Sci, Anim Demog Unit, ZA-7701 Rondebosch, South Africa; [Murgatroyd, Megan; Amar, Arjun] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Dept Biol Sci, ZA-7701 Rondebosch, South Africa; [Bouten, Willem] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Cape Town; University of Cape Town; University of Amsterdam	Murgatroyd, M (corresponding author), Univ Cape Town, Dept Biol Sci, Anim Demog Unit, ZA-7701 Rondebosch, South Africa.; Murgatroyd, M (corresponding author), Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Dept Biol Sci, ZA-7701 Rondebosch, South Africa.	verreauxs@gmail.com	Amar, Arjun/L-4493-2019; Bouten, Willem/G-4383-2018	Bouten, Willem/0000-0002-5250-8872; Murgatroyd, Megan/0000-0002-9673-8418; Underhill, Les/0000-0002-8758-1527	LGU via the Harry Oppenheimer Fellowship Award from the Oppenheimer Memorial Trust; National Birds of Prey Trust; National Research Foundation; Cape Leopard Trust; NLeSC; SURF Foundation; Cape Nature; Driehoek Farm in the Cederberg	LGU via the Harry Oppenheimer Fellowship Award from the Oppenheimer Memorial Trust; National Birds of Prey Trust; National Research Foundation; Cape Leopard Trust; NLeSC; SURF Foundation; Cape Nature; Driehoek Farm in the Cederberg	GPS tags were funded by LGU via the Harry Oppenheimer Fellowship Award from the Oppenheimer Memorial Trust. MM received grants from the National Birds of Prey Trust (www.nationalbirdsofpreytrust.net), the National Research Foundation (www.nrf.ac.za) and the Cape Leopard Trust (www.capeleopard.org.za). These all contributed to field work, data analysis and write up costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; UvA-BiTS studies are facilitated by infrastructures for e-Science, developed with support of the NLeSC (www.esciencecenter.com), carried out on the Dutch national e-infrastructure with support of SURF Foundation. Victor Garcia (Spanish Ministry of Environment) assisted MM in developing capture techniques. Patrick Banville, Jess Berndt, Lucia Rodrigues, Hank Chalmers and the team at Eagle Encounters contributed their time to assisting with fieldwork. Theoni Photopoulou and Marc Burman helped with R programming. Land access and support was provided by Cape Nature and Driehoek Farm in the Cederberg, and private landowners in the Sandveld.	ADAMS NJ, 1992, S AFR J MARINE SCI, V12, P959; Amar A, 2005, IBIS, V147, P37, DOI 10.1111/j.1474-919x.2004.00314.x; Amar A, 2011, J APPL ECOL, V48, P220, DOI 10.1111/j.1365-2664.2010.01896.x; [Anonymous], 2014, QGIS GEOGR INF SYST; Archer E, 2009, J INTEGR ENVIRON SCI, V6, P139, DOI 10.1080/19438150902916589; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; BirdLife International, 2014, IUCN RED LIST THREAT; Bivand R, 2016, PACKAGE MAPTOOLS TOO; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; BOSHOFF AF, 1991, OSTRICH, V62, P59, DOI 10.1080/00306525.1991.9639642; Bouten W, 2013, J ORNITHOL, V154, P571, DOI 10.1007/s10336-012-0908-1; BROWN CJ, 1988, S AFR J WILDL RES, V18, P120; BUEHLER DA, 1995, J FIELD ORNITHOL, V66, P173; Camacho C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104974; Cardador L, 2011, ANIM CONSERV, V14, P382, DOI 10.1111/j.1469-1795.2011.00449.x; Chiweshe N, 2007, OSTRICH, V78, P381, DOI 10.2989/OSTRICH.2007.78.2.42.122; Costantini D, 2014, IBIS, V156, P768, DOI 10.1111/ibi.12181; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Cumming GS, 2012, DIVERS DISTRIB, V18, P1057, DOI 10.1111/j.1472-4642.2012.00908.x; Davies R.A.G., 1994, THESIS; Demsar U, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0032-y; DONAZAR JA, 1993, J APPL ECOL, V30, P515, DOI 10.2307/2404191; Duerr AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035548; Duriez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084887; Fairbanks DHK, 2002, ANIM CONSERV, V5, P61, DOI 10.1017/S1367943002001087; Franke AC, 2011, AGR SYST, V104, P297, DOI 10.1016/j.agsy.2010.12.001; Gargett V., 1990, BLACK EAGLE STUDY; Gil JA, 2014, ARDEOLA, V61, P379, DOI 10.13157/arla.61.2.2014.379; Godfrey JD, 2003, BIOL CONSERV, V114, P35, DOI 10.1016/S0006-3207(02)00416-0; Goodwin W.J., 2000, P395; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Heydenrych B., 1993, 933 FFC BOT SOC S AF; Irvine RJ, 2007, WILDLIFE BIOL, V13, P238, DOI 10.2981/0909-6396(2007)13[238:COCRTA]2.0.CO;2; Jeltsch F, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-6; Jenkins AR, 2005, OSTRICH, V76, P175, DOI 10.2989/00306520509485490; Katzner TE, 2012, J APPL ECOL, V49, P1178, DOI 10.1111/j.1365-2664.2012.02185.x; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kirkwood D, 2010, GIS METADATA DETAILE; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Lockhart JM, 1978, UNPUB; Loftie-Eaton M, 2014, THESIS; Low AB, 2004, GREATER CEDERBERG BI; Magioli M, 2015, ANIM CONSERV, V18, P499, DOI 10.1111/acv.12201; Perez-Garcia JM, 2013, J ORNITHOL, V154, P63, DOI 10.1007/s10336-012-0871-x; Maree K., 2010, BIODIVERSITY SECTOR; Marzluff JM, 1997, AUK, V114, P673, DOI 10.2307/4089287; MASMAN D, 1988, J ANIM ECOL, V57, P411, DOI 10.2307/4914; Mellone U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039833; Moseley C, 2012, J EXP MAR BIOL ECOL, V422, P29, DOI 10.1016/j.jembe.2012.04.002; Moss EHR, 2014, J RAPTOR RES, V48, P93, DOI 10.3356/JRR-13-00044.1; Murgatroyd M, 2016, J AVIAN BIOL, V47, P834, DOI 10.1111/jav.00944; Murgatroyd M, 2016, CONDOR, V118, P238, DOI 10.1650/CONDOR-15-142.1; Murgatroyd Megan, 2013, GABAR, V24, P16; Murgatroyd SM, 2016, THESIS; Newton I., 1979, POPULATION ECOLOGY R; Orians G.H., 1979, P155; PAINE RT, 1980, J ANIM ECOL, V49, P667; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; PRESTON CR, 1990, CONDOR, V92, P107, DOI 10.2307/1368388; R Core Team, 2013, R LANG ENV STAT COMP; Reid T, 2015, J APPL ECOL, V52, P881, DOI 10.1111/1365-2664.12468; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050336; Rodriguez-Estrella R, 1998, CONSERV BIOL, V12, P921, DOI 10.1046/j.1523-1739.1998.97044.x; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Sergio F, 2015, J APPL ECOL, V52, P1665, DOI 10.1111/1365-2664.12520; Shepard ELC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0612; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Smolla M, 2014, MOVE VISUALIZING ANA; Stephens D.W., 1986, pi; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Symes CT, 2012, S AFR J WILDL RES, V42, P45, DOI 10.3957/056.042.0109; Taylor MR, 2015, ESKOM RED DATA BOOK; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; Thaxter CB, 2016, IBIS, V158, P279, DOI 10.1111/ibi.12340; Treep J, 2016, B AM METEOROL SOC, V97, P951, DOI 10.1175/BAMS-D-14-00234.1; Trierweiler C, 2013, J ANIM ECOL, V82, P107, DOI 10.1111/j.1365-2656.2012.02036.x; Ursua E, 2005, BIOL CONSERV, V122, P643, DOI 10.1016/j.biocon.2004.10.002; VERNON C J, 1972, Ostrich, V43, P206, DOI 10.1080/00306525.1972.9632603; Watson JW, 2014, J WILDLIFE MANAGE, V78, P1012, DOI 10.1002/jwmg.745; Weston ED, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-42; Wolak M., 2015, FACILITATING ESTIMAT	82	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163378	10.1371/journal.pone.0163378	http://dx.doi.org/10.1371/journal.pone.0163378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723832	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100007
J	Sharma, D; Tiwari, BK; Mehto, S; Antony, C; Kak, G; Singh, Y; Natarajan, K				Sharma, Deepika; Tiwari, Brijendra Kumar; Mehto, Subhash; Antony, Cecil; Kak, Gunjan; Singh, Yogendra; Natarajan, Krishnamurthy			Suppression of Protective Responses upon Activation of L-Type Voltage Gated Calcium Channel in Macrophages during Mycobacterium bovis BCG Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; T-CELL-ACTIVATION; DENDRITIC CELLS; MICROBIAL PATHOGENS; IMMUNE-RESPONSE; REACTIVE OXYGEN; TUBERCULOSIS; AUTOPHAGY; SURVIVAL; APOPTOSIS	The prevalence of Mycobacterium tuberculosis (M. tb) strains eliciting drug resistance has necessitated the need for understanding the complexities of host pathogen interactions. The regulation of calcium homeostasis by Voltage Gated Calcium Channel (VGCCs) upon M. tb infection has recently assumed importance in this area. We previously showed a suppressor role of VGCC during M. tb infections and recently reported the mechanisms of its regulation by M. tb. Here in this report, we further characterize the role of VGCC in mediating defence responses of macrophages during mycobacterial infection. We report that activation of VGCC during infection synergistically downmodulates the generation of oxidative burst (ROS) by macrophages. This attenuation of ROS is regulated in a manner which is dependent on Toll like Receptor (TLR) and also on the route of calcium influx, Protein Kinase C (PKC) and by Mitogen Activation Protein Kinase (MAPK) pathways. VGCC activation during infection increases cell survival and downmodulates autophagy. Concomitantly, pro-inflammatory responses such as IL-12 and IFN-gamma secretion and the levels of their receptors on cell surface are inhibited. Finally, the ability of phagosomes to fuse with lysosomes in M. bovis BCG and M. tb H37Rv infected macrophages is also compromised when VGCC activation occurs during infection. The results point towards a well-orchestrated strategy adopted by mycobacteria to supress protective responses mounted by the host. This begins with the increase in the surface levels of VGCCs by mycobacteria and their antigens by well-controlled and regulated mechanisms. Subsequent activation of the upregulated VGCC following tweaking of calcium levels by molecular sensors in turn mediates suppressor responses and prepare the macrophages for long term persistent infection.	[Sharma, Deepika; Tiwari, Brijendra Kumar; Mehto, Subhash; Antony, Cecil; Kak, Gunjan; Natarajan, Krishnamurthy] Univ Delhi, Infect Dis Immunol Lab, Dr BR Ambedkar Ctr Biomed Res, Delhi, India; [Singh, Yogendra] Univ Delhi, Dept Zool, Delhi, India	University of Delhi; University of Delhi	Sharma, D; Natarajan, K (corresponding author), Univ Delhi, Infect Dis Immunol Lab, Dr BR Ambedkar Ctr Biomed Res, Delhi, India.	deepika2sharma@gmail.com; knatarajan@acbr.du.ac.in	Antony, Cecil/AFE-5951-2022; Tiwari, Brijesh Kumar/K-6227-2013; Antony, Cecil/O-7733-2017	Tiwari, Brijesh Kumar/0000-0002-4834-6831; Antony, Cecil/0000-0001-7622-4586; Mehto, Subhash/0000-0002-5351-7850	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The study was funded by grants from the Department of Biotechnology, Ministry of Science and Technology, Government of India to KN and YS. DS is a recipient of UGC-SRF. BKT is a recipient of UGC-DSK-PDF. The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Adolfo RBV, 2006, EUR J IMMUNOL, V36, P345, DOI 10.1002/eji.200535202; Ando K, 2013, INT J MED SCI, V10, P1209, DOI 10.7150/ijms.5508; Antony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124263; Balkhi MY, 2004, J INFECT DIS, V189, P1598, DOI 10.1086/383328; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Catterall WA, 2011, COLD SPRING HARB PER, V3, DOI [10.1007/0-387-27526-6, DOI 10.1007/0-387-27526-6]; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fracchia KM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00324; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Garrett WS, 2001, BOOK DENDRITIC CELLS, V1098, DOI [10.1111/j.1462-5822.2007.00914.x, DOI 10.1111/J.1462-5822.2007.00914.X]; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Goldberg MF, 2014, MOL GENET MYCOBACTER, P747, DOI [10.1128/9781555818845.ch36, DOI 10.1128/9781555818845.CH36]; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2009, TRANSBOUND EMERG DIS, V56, P248, DOI 10.1111/j.1865-1682.2009.01069.x; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; JACONI MEE, 1990, J CELL BIOL, V110, P1555, DOI 10.1083/jcb.110.5.1555; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kelm MK, 2010, NEUROPHARMACOLOGY, V58, P1179, DOI 10.1016/j.neuropharm.2010.02.018; Khan N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00328; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Mehto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131767; MODLIN RL, 1993, CURR OPIN IMMUNOL, V5, P511, DOI 10.1016/0952-7915(93)90031-M; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Netea MG, 2004, J LEUKOCYTE BIOL, V75, P749, DOI 10.1189/jlb.1103543; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; Selvakumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096427; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Singhal J, 2012, J BIOL CHEM, V287, P11108, DOI 10.1074/jbc.M111.300319; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; THOMAS G, 1985, CIRC RES, V56, P87, DOI 10.1161/01.RES.56.1.87; Uplekar M, 2006, STOP TB STRATEGY BUI; Vashishta M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133601; Wieder N, 2015, BIOPHYS J, V108, P557, DOI 10.1016/j.bpj.2014.11.3458; Wieland H, 2006, FEMS IMMUNOL MED MIC, V47, P296, DOI 10.1111/j.1574-695X.2006.00092.x; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x; World Health Organization, 2020, GLOBAL TUBERCULOSIS; ZHANG M, 1995, INFECT IMMUN, V63, P3231, DOI 10.1128/IAI.63.8.3231-3234.1995; Zlobina MV, 2015, EUROPE PMC, V57, P269, DOI DOI 10.1134/S1990519X15040124	57	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163845	10.1371/journal.pone.0163845	http://dx.doi.org/10.1371/journal.pone.0163845			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723836	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100011
J	Singh, GB; Ann, SH; Park, J; Chung, HC; Lee, JS; Kim, ES; Choi, JI; Lee, J; Kim, SJ; Shin, ES				Singh, Gillian Balbir; Ann, Soe Hee; Park, Jongha; Chung, Hyun Chul; Lee, Jong Soo; Kim, Eun-Sook; Choi, Jung Il; Lee, Jiho; Kim, Shin-Jae; Shin, Eun-Seok			Remote Ischemic Preconditioning for the Prevention of Contrast-Induced Acute Kidney Injury in Diabetics Receiving Elective Percutaneous Coronary Intervention	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; INDUCED NEPHROPATHY; RISK; DISEASE; SURGERY	Objective Remote ischemic preconditioning (RIPC) induces transient episodes of ischemia by the occlusion of blood flow in non-target tissue, before a subsequent ischemia-reperfusion injury. When RIPC is applied before percutaneous coronary intervention (PCI), the kidneys may be protected against ischemia-reperfusion injury and subsequently contrast-induced acute kidney injury (CI-AKI). The aim of this study was to evaluate the efficacy of RIPC for the prevention of CI-AKI in patients with diabetes with pre-existing chronic kidney disease (CKD) undergoing elective PCI. Methods This randomized, double-blind, sham-controlled study enrolled patients with diabetes scheduled for elective PCI with eGFR <= 60 ml/min/1.73 m(2) or urinary albumin creatinine ratio of >300 mg/g to receive either RIPC or the sham ischemic preconditioning. Results One hundred and two patients (68.9 +/- 8.2 years old, 47.1% men) were included. Baseline eGFR, creatinine and serum NGAL was similar between RIPC and control groups (48.5 +/- 12 ml/min vs. 46.6 +/- 10 ml/min, p = 0.391; 1.42 +/- 0.58 mg/dl vs. 1.41 +/- 0.34 mg/dl, p = 0.924; and 136.0 +/- 45.0 ng/ml vs. 137.6 +/- 43.3 ng/ml, p = 0.961, respectively). CI-AKI occurred in 13.7% (14/102) of the total subjects, with both RIPC and control groups having an equal incidence of 13.7% (7/51). No significant differences were seen in creatinine, NGAL, cardiac enzymes (troponin T, CKMB) and hs-CRP between the groups postprocedure. Conclusions In this study, RIPC applied prior to elective PCI was not effective in preventing CI-AKI in patients with diabetes with pre-existing CKD.	[Singh, Gillian Balbir; Ann, Soe Hee; Kim, Shin-Jae; Shin, Eun-Seok] Univ Ulsan, Coll Med, Dept Cardiol, Ulsan Univ Hosp, Ulsan, South Korea; [Park, Jongha; Chung, Hyun Chul; Lee, Jong Soo] Univ Ulsan, Coll Med, Div Nephrol, Ulsan Univ Hosp, Ulsan, South Korea; [Kim, Eun-Sook; Choi, Jung Il] Univ Ulsan, Coll Med, Div Endocrinol, Ulsan Univ Hosp, Ulsan, South Korea; [Lee, Jiho] Univ Ulsan, Coll Med, Dept Occupat & Environm Med, Ulsan Univ Hosp, Ulsan, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Shin, ES (corresponding author), Univ Ulsan, Coll Med, Dept Cardiol, Ulsan Univ Hosp, Ulsan, South Korea.	sesim1989@gmail.com	Kim, Shin-Jae/CAE-9456-2022					Bachorzewska-Gajewska H, 2006, AM J NEPHROL, V26, P287, DOI 10.1159/000093961; Bachorzewska-Gajewska H, 2009, ADV MED SCI-POLAND, V54, P221, DOI 10.2478/v10039-009-0036-1; Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Brar SS, 2014, LANCET, V383, P1814, DOI 10.1016/S0140-6736(14)60689-9; Chaykovska L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145723; Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056; Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Er F, 2012, CIRCULATION, V126, P296, DOI 10.1161/CIRCULATIONAHA.112.096370; Evans RG, 2013, CLIN EXP PHARMACOL P, V40, P106, DOI 10.1111/1440-1681.12031; Gassanov N, 2014, J AM SOC NEPHROL, V25, P216, DOI 10.1681/ASN.2013070708; Harjai KJ, 2008, AM J CARDIOL, V101, P812, DOI 10.1016/j.amjcard.2007.10.051; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; James MT, 2013, CIRC-CARDIOVASC INTE, V6, P37, DOI 10.1161/CIRCINTERVENTIONS.112.974493; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Katzberg RW, 1997, RADIOLOGY, V204, P297, DOI 10.1148/radiology.204.2.9240511; Kharbanda RK, 2009, LANCET, V374, P1557, DOI 10.1016/S0140-6736(09)61421-5; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; McCullough PA, 2006, REV CARDIOVASC MED, V7, P177; McCullough PA, 2012, AM J NEPHROL, V35, P509, DOI 10.1159/000339163; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Menting TP, 2015, EUR J VASC ENDOVASC, V50, P527, DOI 10.1016/j.ejvs.2015.04.002; Panchapakesan U, 2011, CLIN EXP PHARMACOL P, V38, P84, DOI 10.1111/j.1440-1681.2010.05472.x; Park J, 2014, HEART VESSELS, V29, P58, DOI 10.1007/s00380-013-0329-y; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Savaj S, 2014, IRAN J KIDNEY DIS, V8, P457; Venugopal V, 2010, AM J KIDNEY DIS, V56, P1043, DOI 10.1053/j.ajkd.2010.07.014	30	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164256	10.1371/journal.pone.0164256	http://dx.doi.org/10.1371/journal.pone.0164256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723839	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100034
J	Xiang, SN; Liu, K; Yan, ZM; Zhang, Y; Sun, ZR				Xiang, Shunian; Liu, Ke; Yan, Zhangming; Zhang, Yaou; Sun, Zhirong			RNAMethPre: A Web Server for the Prediction and Query of mRNA m(6)A Sites	PLOS ONE			English	Article							N-6-METHYLADENOSINE; METHYLATION; REVEALS; IDENTIFICATION; M6A	N-6-Methyladenosine (m(6)A) is the most common mRNA modification; it occurs in a wide range of taxon and is associated with many key biological processes. High-throughput experiments have identified m(6)A-peaks and sites across the transcriptome, but studies of m(6)A sites at the transcriptome-wide scale are limited to a few species and tissue types. Therefore, the computational prediction of mRNA m(6)A sites has become an important strategy. In this study, we integrated multiple features of mRNA (flanking sequences, local secondary structure information, and relative position information) and trained a SVM classifier to predict m(6)A sites in mammalian mRNA sequences. Our method achieves ideal performance in both cross-validation tests and rigorous independent dataset tests. The server also provides a comprehensive database of predicted transcriptome-wide m(6)A sites and curated m(6)A-seq peaks from the literature for both human and mouse, and these can be queried and visualized in a genome browser. The RNAMethPre web server provides a user-friendly tool for the prediction and query of mRNA m(6)A sites, which is freely accessible for public use at http://bioinfo.tsinghua.edu.cn/RNAMethPre/index.html.	[Xiang, Shunian; Liu, Ke; Yan, Zhangming; Sun, Zhirong] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zhang, Yaou] Tsinghua Univ, Key Lab Hlth Sci & Technol, Div Life Sci, Grad Sch Shenzhen, Beijing 518055, Peoples R China; [Liu, Ke] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University of California System; University of California Berkeley	Sun, ZR (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.; Zhang, Y (corresponding author), Tsinghua Univ, Key Lab Hlth Sci & Technol, Div Life Sci, Grad Sch Shenzhen, Beijing 518055, Peoples R China.	zhangyo@sz.tsinghua.edu.cn; sunzhr@mail.tsinghua.edu.cn	Yan, Zhangming/N-1574-2018	Yan, Zhangming/0000-0001-5373-8496	National Natural Science Foundation of China (NSFC) [31171274]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC) (No.31171274)	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen W, 2015, ANAL BIOCHEM, V490, P26, DOI 10.1016/j.ab.2015.08.021; Chen W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13859; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Grosjean H., 2005, FINE TUNING RNA FUNC, Vxxiv, DOI [10.1007/b95147, DOI 10.1007/B95147]; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Madera M, 2010, BIOINFORMATICS, V26, P596, DOI 10.1093/bioinformatics/btq020; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Zhou Y, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw104	24	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0162707	10.1371/journal.pone.0162707	http://dx.doi.org/10.1371/journal.pone.0162707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723837	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100002
J	Fu, LY; Zhang, MX; Mastrantoni, K; Pertetto, M; Wei, S; Yao, JB				Fu, Liyuan; Zhang, Mingxiang; Mastrantoni, Kristen; Pertetto, Mark; Wei, Shuo; Yao, Jianbo			Bovine Lhx8, a Germ Cell-Specific Nuclear Factor, Interacts with Figla	PLOS ONE			English	Article							EARLY EMBRYONIC-DEVELOPMENT; OOCYTE-SPECIFIC GENE; LIM DOMAIN; TRANSCRIPTION FACTORS; BINDING-PROTEIN; EXPRESSION; FAMILY; FOLLICULOGENESIS; TRANSPORT; COMPLEX	LIM homeobox 8 (Lhx8) is a germ cell-specific transcription factor essential for the development of oocytes during early oogenesis. In mice, Lhx8 deficiency causes postnatal oocyte loss and affects the expression of many oocyte-specific genes. The aims of this study were to characterize the bovine Lhx8 gene, determine its mRNA expression during oocyte development and early embryogenesis, and evaluate its interactions with other oocyte-specific transcription factors. The bovine Lhx8 gene encodes a protein of 377 amino acids. A splice variant of Lhx8 (Lhx8_v1) was also identified. The predicted bovine Lhx8 protein contains two LIM domains and one homeobox domain. However, one of the LIM domains in Lhx8_v1 is incomplete due to deletion of 83 amino acids near the N terminus. Both Lhx8 and Lhx8_v1 transcripts were only detected in the gonads but none of the somatic tissues examined. The expression of Lhx8 and Lhx8_v1 appears to be restricted to oocytes as none of the transcripts was detectable in granulosa or theca cells. The maternal Lhx8 transcript is abundant in GV and MII stage oocytes as well as in early embryos but disappear by morula stage. A nuclear localization signal that is required for the import of Lhx8 into nucleus was identified, and Lhx8 is predominantly localized in the nucleus when ectopically expressed in mammalian cells. Finally, a novel interaction between Lhx8 and Figla, another transcription factor essential for oogenesis, was detected. The results provide new information for studying the mechanisms of action for Lhx8 in oocyte development and early embryogenesis.	[Fu, Liyuan; Zhang, Mingxiang; Mastrantoni, Kristen; Yao, Jianbo] West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [Pertetto, Mark; Wei, Shuo] West Virginia Univ, Dept Biol, Morgantown, WV USA	West Virginia University; West Virginia University	Yao, JB (corresponding author), West Virginia Univ, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	jianbo.yao@mail.wvu.edu		Wei, Shuo/0000-0001-8203-4922; Perfetto, Mark/0000-0001-8546-0839	Agriculture and Food Research Initiative Competitive Grant from the US Department of Agriculture National Institute of Food and Agriculture [2009-65203-05706, 2016-67015-24919]	Agriculture and Food Research Initiative Competitive Grant from the US Department of Agriculture National Institute of Food and Agriculture	This work was supported by Agriculture and Food Research Initiative Competitive Grant No. 2009-65203-05706 and 2016-67015-24919 from the US Department of Agriculture National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bettegowda A, 2007, P NATL ACAD SCI USA, V104, P17602, DOI 10.1073/pnas.0706383104; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mizuno K, 1997, Tanpakushitsu Kakusan Koso, V42, P2061; Moriguchi H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00537; MURDOCH WJ, 1981, J ANIM SCI, V53, P192, DOI 10.2527/jas1981.531192x; Pangas SA, 2006, P NATL ACAD SCI USA, V103, P8090, DOI 10.1073/pnas.0601083103; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; RICHARDSON C, 1990, VET REC, V126, P279; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tripurani SK, 2011, ENDOCRINOLOGY, V152, P1013, DOI 10.1210/en.2010-1134; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239; Zheng P, 2007, SEMIN REPROD MED, V25, P243, DOI 10.1055/s-2007-980218	31	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164671	10.1371/journal.pone.0164671	http://dx.doi.org/10.1371/journal.pone.0164671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716808	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100064
J	Piniak, WED; Mann, DA; Harms, CA; Jones, TT; Eckert, SA				Piniak, Wendy E. D.; Mann, David A.; Harms, Craig A.; Jones, T. Todd; Eckert, Scott A.			Hearing in the Juvenile Green Sea Turtle (Chelonia mydas): A Comparison of Underwater and Aerial Hearing Using Auditory Evoked Potentials	PLOS ONE			English	Article							CARETTA-CARETTA; LOGGERHEAD; SENSITIVITY	Sea turtles spend much of their life in aquatic environments, but critical portions of their life cycle, such as nesting and hatching, occur in terrestrial environments, suggesting that it may be important for them to detect sounds in both air and water. In this study we compared underwater and aerial hearing sensitivities in five juvenile green sea turtles (Chelonia mydas) by measuring auditory evoked potential responses to tone pip stimuli. Green sea turtles detected acoustic stimuli in both media, responding to underwater stimuli between 50 and 1600 Hz and aerial stimuli between 50 and 800 Hz, with maximum sensitivity between 200 and 400 Hz underwater and 300 and 400 Hz in air. When underwater and aerial hearing sensitivities were compared in terms of pressure, green sea turtle aerial sound pressure thresholds were lower than underwater thresholds, however they detected a wider range of frequencies underwater. When thresholds were compared in terms of sound intensity, green sea turtle sound intensity level thresholds were 2-39 dB lower underwater particularly at frequencies below 400 Hz. Acoustic stimuli may provide important environmental cues for sea turtles. Further research is needed to determine how sea turtles behaviorally and physiologically respond to sounds in their environment.	[Piniak, Wendy E. D.] Duke Univ, Marine Lab, Div Marine Sci & Conservat, Beaufort, NC 28516 USA; [Mann, David A.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Harms, Craig A.] North Carolina State Univ, Coll Vet Med, Ctr Marine Sci & Technol, Morehead City, NC USA; [Jones, T. Todd] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Eckert, Scott A.] Wider Caribbean Sea Turtle Conservat Network, Ballwin, MO USA; [Eckert, Scott A.] Principia Coll, Dept Biol & Nat Resources, Elsah, IL USA; [Piniak, Wendy E. D.] Gettysburg Coll, Dept Environm Studies, Gettysburg, PA 17325 USA; [Mann, David A.] Loggerhead Instruments, Sarasota, FL USA; [Jones, T. Todd] Pacific Isl Fisheries Sci Ctr, NOAA Fisheries, Honolulu, HI USA	Duke University; State University System of Florida; University of South Florida; University of North Carolina; North Carolina State University; University of British Columbia; Gettysburg College; National Oceanic Atmospheric Admin (NOAA) - USA	Piniak, WED (corresponding author), Duke Univ, Marine Lab, Div Marine Sci & Conservat, Beaufort, NC 28516 USA.	wpiniak@gettysburg.edu			National Oceanic and Atmospheric Administration - NOAA Fisheries Service; NSERC Discovery Grant	National Oceanic and Atmospheric Administration - NOAA Fisheries Service; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the National Oceanic and Atmospheric Administration - NOAA Fisheries Service (http//www.nmfs.noaa.gov/)) and a NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2008, MODERN ACOUSTICS SIG; Bartol SM, 1999, COPEIA, P836, DOI 10.2307/1447625; Brill R, 2006, SEA TURTLE PELAGIC F, P98; Casper BM, 2006, ENVIRON BIOL FISH, V76, P101, DOI 10.1007/s10641-006-9012-9; Christensen-Dalsgaard J, 2012, P ROY SOC B-BIOL SCI, V279, P2816, DOI 10.1098/rspb.2012.0290; DeRuiter Stacy L., 2012, Endangered Species Research, V16, P55, DOI 10.3354/esr00396; Egner SA, 2005, MAR ECOL PROG SER, V285, P213, DOI 10.3354/meps285213; GATZ RN, 1987, J APPL PHYSIOL, V62, P459, DOI 10.1152/jappl.1987.62.2.459; Harms C. A., 2009, Journal of Herpetological Medicine and Surgery, V19, P8; Hetherington T, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P183; Ketten D. R., 2008, BIOACOUSTICS, V17, P312, DOI [10.1080/09524622.2008.9753860, DOI 10.1080/09524622.2008.9753860]; Lavender AL, 2014, J EXP BIOL, V217, P2580, DOI 10.1242/jeb.096651; LENHARDT M L, 1985, Journal of Auditory Research, V25, P66; LENHARDT M L, 1983, Journal of Auditory Research, V23, P251; LENHARDT M L, 1983, Journal of Auditory Research, V23, P119; Martin KJ, 2012, J EXP BIOL, V215, P3001, DOI 10.1242/jeb.066324; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; Mooney TA, 2010, J EXP BIOL, V213, P3748, DOI 10.1242/jeb.048348; OHARA J, 1990, COPEIA, P564; Patterson W. C., 1966, J AUD RES, V6, P453; RIDGWAY SH, 1969, P NATL ACAD SCI USA, V64, P884, DOI 10.1073/pnas.64.3.884; Wever E.., 1978, REPTILE EAR ITS STRU; WEVER EG, 1956, P NATL ACAD SCI USA, V42, P292, DOI 10.1073/pnas.42.5.292; Yost W. A., 2007, FUNDAMENTALS HEARING	24	11	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0159711	10.1371/journal.pone.0159711	http://dx.doi.org/10.1371/journal.pone.0159711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741231	gold, Green Submitted, Green Published			2022-12-27	WOS:000385507000001
J	Sugi, Y; Takahashi, K; Kurihara, K; Nakata, K; Narabayashi, H; Hamamoto, Y; Suzuki, M; Tsuda, M; Hanazawa, S; Hosono, A; Kaminogawa, S				Sugi, Yutaka; Takahashi, Kyoko; Kurihara, Kenta; Nakata, Kazuaki; Narabayashi, Hikari; Hamamoto, Yuji; Suzuki, Makoto; Tsuda, Masato; Hanazawa, Shigemasa; Hosono, Akira; Kaminogawa, Shuichi			Post-Transcriptional Regulation of Toll-Interacting Protein in the Intestinal Epithelium	PLOS ONE			English	Article							INTRACELLULAR TRAFFICKING; CELLS; HOST; GUT; MICROBIOTA; AUTOPHAGY; DIFFERENTIATION; SUSCEPTIBILITY; EXPRESSION; RECEPTORS	Immune responses against gut microbiota should be minimized to avoid unnecessary inflammation at mucosal surface. In this study, we analyzed the expression patterns of Toll-interacting protein (Tollip), an inhibitor of TLRs and IL-1 family cytokine-related intracellular signaling, in intestinal epithelial cells (IECs). Comparable mRNA expression was observed in murine small and large IECs (S-IECs and L-IECs). However, Tollip protein was only detected in L-IECs, but not in S-IECs. Similar results were obtained in germ-free mice, indicating that L-IEC-specific TOLLIP expression does not depend on bacterial colonization. Next, to understand the mechanisms underlying the post-transcriptional repression of Tollip, 3'-UTR-mediated translational regulation was evaluated. The region +1876/+2398 was responsible for the repression of Tollip expression. This region included the target sequence of miR-31. The inhibition of miR-31 restored the 3'-UTR-meditaed translational repression. In addition, miR-31 expression was significantly higher in S-IECs than in L-IECs, suggesting that miR-31 represses the translation of Tollip mRNA in S-IECs. Collectively, we conclude that the translation of Tollip is inhibited in S-IECs, at least in part, by miR-31 to yield L-IEC-specific high-level expression of the Tollip protein, which may contribute to the maintenance of intestinal homeostasis.	[Sugi, Yutaka; Takahashi, Kyoko; Kurihara, Kenta; Nakata, Kazuaki; Hamamoto, Yuji; Suzuki, Makoto; Tsuda, Masato; Hosono, Akira; Kaminogawa, Shuichi] Nihon Univ, Coll Bioresource Sci, Dept Food Biochem & Biotechnol, Kanagawa, Japan; [Takahashi, Kyoko; Nakata, Kazuaki; Narabayashi, Hikari; Hanazawa, Shigemasa] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Kanagawa, Japan	Nihon University; Nihon University	Takahashi, K (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Food Biochem & Biotechnol, Kanagawa, Japan.; Takahashi, K (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Kanagawa, Japan.	ktaka@brs.nihon-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [26450165]; Institute for Fermentation, Osaka; Strategic Research Base Development Program, "International joint research and training of young researchers for zoonosis control in a globalized world"; Ministry of Education, Culture, Sports, Science and Technology of Japan [S0991023, S1491007]; Grants-in-Aid for Scientific Research [26292065] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Strategic Research Base Development Program, "International joint research and training of young researchers for zoonosis control in a globalized world"; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from the Japan Society for the Promotion of Science (KAKENHI 26450165, to K.T.) and the Institute for Fermentation, Osaka (K.T.). This work was also supported by the Strategic Research Base Development Program, "International joint research and training of young researchers for zoonosis control in a globalized world", and a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S0991023 and S1491007).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Amr KS, 2016, RHEUMATOL INT, V36, P1617, DOI 10.1007/s00296-016-3550-z; Asada R, 2012, J BIOL CHEM, V287, P8144, DOI 10.1074/jbc.M111.332593; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Blanco FF, 2014, MOL CELL BIOL, V34, P180, DOI 10.1128/MCB.01020-13; Brandao I, 2015, GUT MICROBES, V6, P202, DOI 10.1080/19490976.2015.1034417; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Carames C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060878; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Hino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088048; Hormann N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113080; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Inoue J, 2012, ARCH BIOCHEM BIOPHYS, V521, P95, DOI 10.1016/j.abb.2012.03.019; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18174; Liu SR, 2016, CELL HOST MICROBE, V19, P32, DOI 10.1016/j.chom.2015.12.005; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782; Maillard MH, 2014, INFLAMM BOWEL DIS, V20, P660, DOI 10.1097/MIB.0000000000000006; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Melmed G, 2003, J IMMUNOLOGY BALTIM, P170; Mlcochova J, 2015, ONCOTARGET, V6, P38695, DOI 10.18632/oncotarget.5735; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakato G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150379; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramasamy S, 2011, INFLAMM BOWEL DIS, V17, P532, DOI 10.1002/ibd.21377; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schaefer JS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0069-0; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Shifrin DA, 2012, CURR BIOL, V22, P627, DOI 10.1016/j.cub.2012.02.022; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Sugi Y, 2011, BIOCHEM BIOPH RES CO, V412, P704, DOI 10.1016/j.bbrc.2011.08.035; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Tateishi Y, 2015, PATHOL INT, V65, P513, DOI 10.1111/pin.12334; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Weilner S, 2016, AGING CELL, V15, P744, DOI 10.1111/acel.12484; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; Yan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8652; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010; Zhang LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8639; Zhu L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388009	69	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164858	10.1371/journal.pone.0164858	http://dx.doi.org/10.1371/journal.pone.0164858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741296	Green Submitted, Green Published, gold			2022-12-27	WOS:000385507000075
J	Xiao, J; Moon, Y; Li, LH; Rustchenko, E; Wakabayashi, H; Zhao, XY; Feng, CY; Gill, SR; McLaren, S; Malmstrom, H; Ren, YF; Quivey, R; Koo, H; Kopycka-Kedzierawski, DT				Xiao, Jin; Moon, Yonghwi; Li, Lihua; Rustchenko, Elena; Wakabayashi, Hironao; Zhao, Xiaoyi; Feng, Changyong; Gill, Steven R.; McLaren, Sean; Malmstrom, Hans; Ren, Yanfang; Quivey, Robert; Koo, Hyun; Kopycka-Kedzierawski, Dorota T.			Candida albicans Carriage in Children with Severe Early Childhood Caries (S-ECC) and Maternal Relatedness	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; HORIZONTAL TRANSMISSION; GLUCOSYLTRANSFERASE B; DENTAL-CARIES; GENOMIC DNA; ORAL RINSE; DIVERSITY; ACQUISITION; BIOFILMS; STRAINS	Introduction Candida albicans has been detected together with Streptococcus mutans in high numbers in plaque-biofilm from children with early childhood caries (ECC). The goal of this study was to examine the C. albicans carriage in children with severe early childhood caries (SECC) and the maternal relatedness. Methods Subjects in this pilot cross-sectional study were recruited based on a convenient sample. DMFT(S)/dmft(s) caries and plaque scores were assessed during a comprehensive oral exam. Social-demographic and related background information was collected through a questionnaire. Saliva and plaque sample from all children and mother subjects were collected. C. albicans were isolated by BBL (TM) CHROMagar (TM) and also identified using germ tube test. S. mutans was isolated using Mitis Salivarius with Bacitracin selective medium and identified by colony morphology. Genetic relatedness was examined using restriction endonuclease analysis of the C. albicans genome using BssHII (REAG-B). Multilocus sequence typing was used to examine the clustering information of isolated C. albicans. Spot assay was performed to examine the C. albicans Caspofungin susceptibility between S-ECC children and their mothers. All statistical analyses (power analysis for sample size, Spearman's correlation coefficient and multiple regression analyses) were implemented with SAS 9.4 Results A total of 18 S-ECC child-mother pairs and 17 caries free child-mother pairs were enrolled in the study. Results indicated high C. albicans carriage rate in the oral cavity (saliva and plaque) of both S-ECC children and their mothers (> 80%). Spearman's correlation coefficient also indicated a significant correlation between salivary and plaque C. albicans and S. mutans carriage (p< 0.01) and caries severity (p< 0.05). The levels of C. albicans in the prepared saliva and plaque sample (1ml resuspension) of S-ECC children were 1.3 +/- 4.5 x10(4) cfu/ml and 1.2 +/- 3.5 x10(4) cfu/ml (similar to 3-log higher vs. caries-free children). Among 18 child-mother pairs, > 60% of them demonstrated identical C. albicans REAG-B pattern. C. albicans isolated from > 65% of child-mother pairs demonstrated similar susceptibility to caspofungin in spot assay, while no caspofungin resistant strains were seen when compared with C. albicans wild-type strain SC5314. Interestingly, the regression analysis showed that factors such as antibiotic usage, birth weight, inhaler use, brushing frequency, and daycare attendance had no significant effect on the oral carriage of C. albicans in the S-ECC children. Conclusions Our results reveal that both the child with S-ECC and the mother were highly infected with C. albicans, while most of the strains were genetically related, suggesting that the mother might be a source for C. albicans acquisition in the oral cavity of children affected by the disease.	[Xiao, Jin; Moon, Yonghwi; McLaren, Sean; Malmstrom, Hans; Ren, Yanfang; Quivey, Robert; Kopycka-Kedzierawski, Dorota T.] Univ Rochester, Med Ctr, Eastman Inst Oral Hlth, Rochester, NY 14642 USA; [Li, Lihua] North Sichuan Med Univ, Dept Dent, Nanchong, Sichuan, Peoples R China; [Rustchenko, Elena; Wakabayashi, Hironao] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Zhao, Xiaoyi] Peking Univ, Sch Dent, Beijing, Peoples R China; [Feng, Changyong] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Gill, Steven R.] Univ Rochester, Med Ctr, Genom Res Ctr, Rochester, NY 14642 USA; [Koo, Hyun] Univ Penn, Sch Dent Med, Dept Orthodont, Philadelphia, PA 19104 USA; [Koo, Hyun] Univ Penn, Sch Dent Med, Pediat Dent Div, Philadelphia, PA 19104 USA; [Koo, Hyun] Univ Penn, Sch Dent Med, Community Oral Hlth Div, Philadelphia, PA 19104 USA	University of Rochester; North Sichuan Medical University; University of Rochester; Peking University; University of Rochester; University of Rochester; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Xiao, J (corresponding author), Univ Rochester, Med Ctr, Eastman Inst Oral Hlth, Rochester, NY 14642 USA.	jin_xiao@urmc.rochester.edu	Ren, Yan-Fang/N-9369-2019	Ren, Yan-Fang/0000-0001-6428-2252	National Institute for Dental and Craniofacial Research, National Institutes of Health (NIDCR, NIH) [1R01DE025220-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013683] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research, National Institutes of Health (NIDCR, NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Dr. Hyun Koo's research in this area was supported in part by research grant 1R01DE025220-01 from the National Institute for Dental and Craniofacial Research, National Institutes of Health (NIDCR, NIH).	American Academy of Pediatric Dentistry Council on Clinical Affairs, 2005, Pediatr Dent, V27, P34; American Academy on Pediatric Dentistry, 2008, Pediatr Dent, V30, P40; Berkowitz RJ, 2009, J PUBLIC HEALTH DENT, V69, P163, DOI 10.1111/j.1752-7325.2009.00118.x; Bliss JM, 2008, PEDIATR INFECT DIS J, V27, P231, DOI 10.1097/INF.0b013e31815bb69d; Bougnoux ME, 2004, INFECT GENET EVOL, V4, P243, DOI 10.1016/j.meegid.2004.06.002; Bougnoux ME, 2003, J CLIN MICROBIOL, V41, P5265, DOI 10.1128/JCM.41.11.5265-5266.2003; Caufield Page W, 2005, Compend Contin Educ Dent, V26, P10; CAUFIELD PW, 1993, J DENT RES, V72, P37, DOI 10.1177/00220345930720010501; Chen KW, 2005, J MED MICROBIOL, V54, P249, DOI 10.1099/jmm.0.45829-0; Colak Hakan, 2013, J Nat Sci Biol Med, V4, P29, DOI 10.4103/0976-9668.107257; de Carvalho FG, 2006, ARCH ORAL BIOL, V51, P1024, DOI 10.1016/j.archoralbio.2006.06.001; Dye BA, 2007, VITAL HLTH STAT, V2007, P1; Dye BA, 2015, PEDIATR DENT, V37, P200; Falsetta ML, 2014, INFECT IMMUN, V82, P1968, DOI 10.1128/IAI.00087-14; Gregoire S, 2011, APPL ENVIRON MICROB, V77, P6357, DOI 10.1128/AEM.05203-11; Hajishengallis E, 2017, MOL ORAL MICROBIOL, V32, P24, DOI 10.1111/omi.12152; Heo Seok-Mo, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.6362; Hossain H, 2003, ORAL MICROBIOL IMMUN, V18, P302, DOI 10.1034/j.1399-302X.2003.00086.x; Hwang G, 2015, J DENT RES, V94, P1310, DOI 10.1177/0022034515592859; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Klein MN, 2004, J CLIN MICROBIOL, V42, P4620, DOI 10.1128/JCM.42.10.4620-4626.2004; Klinke T, 2014, CARIES RES, V48, P24, DOI 10.1159/000351673; Klinke T, 2011, CARIES RES, V45, P100, DOI 10.1159/000324809; Klinke T, 2009, CARIES RES, V43, P83, DOI 10.1159/000204911; Koo H, 2014, FUTURE MICROBIOL, V9, P1295, DOI 10.2217/fmb.14.92; Krawczyk B, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-177; Leung WK, 2000, J CLIN MICROBIOL, V38, P2219; LEVERETT DH, 1993, J DENT RES, V72, P529, DOI 10.1177/00220345930720021001; Li Y, 2005, J DENT RES, V84, P806, DOI 10.1177/154405910508400905; LITTLE WA, 1977, J CLIN MICROBIOL, V5, P578; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; McEllistrem MC, 2000, J CLIN MICROBIOL, V38, P4367, DOI 10.1128/JCM.38.12.4367-4372.2000; Metwalli KH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003616; ODDS FC, 1994, J CLIN MICROBIOL, V32, P1923, DOI 10.1128/JCM.32.8.1923-1929.1994; Qiu RM, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0134-3; Raja M, 2010, CARIES RES, V44, P272, DOI 10.1159/000314675; RIBEIRO AA, 2002, PESQUI ODONTOL BRAS, V16, P144; Rozkiewicz D, 2006, Adv Med Sci, V51 Suppl 1, P187; Saghrouni F, 2013, J APPL MICROBIOL, V114, P1559, DOI 10.1111/jam.12132; SAMARANAYAKE LP, 1986, J ORAL PATHOL MED, V15, P386, DOI 10.1111/j.1600-0714.1986.tb00646.x; Schuetzer-Muehlbauer M, 2003, MOL MICROBIOL, V48, P225, DOI 10.1046/j.1365-2958.2003.03430.x; Shin JH, 2005, J MICROBIOL, V43, P546; Shin JH, 2004, J CLIN MICROBIOL, V42, P4025, DOI 10.1128/JCM.42.9.4025-4031.2004; Shin JH, 2011, J CLIN MICROBIOL, V49, P2572, DOI 10.1128/JCM.02153-10; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Slayton Rebecca L, 2011, J Evid Based Dent Pract, V11, P27, DOI 10.1016/j.jebdp.2010.11.014; Srivastava Binita, 2012, Int J Clin Pediatr Dent, V5, P108, DOI 10.5005/jp-journals-10005-1146; Sztajer H, 2014, ISME J, V8, P2256, DOI 10.1038/ismej.2014.73; VOSS A, 1995, J CLIN MICROBIOL, V33, P576, DOI 10.1128/JCM.33.3.576-580.1995; WaggonerFountain LA, 1996, CLIN INFECT DIS, V22, P803, DOI 10.1093/clinids/22.5.803; White PL, 2004, J CLIN MICROBIOL, V42, P2101, DOI 10.1128/JCM.42.5.2101-2107.2004; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19; Xu H, 2014, MOL ORAL MICROBIOL, V29, P99, DOI 10.1111/omi.12049; Yang F, 2013, ANTIMICROB AGENTS CH, V57, P5026, DOI 10.1128/AAC.00516-13; Yang XQ, 2012, ARCH ORAL BIOL, V57, P1048, DOI 10.1016/j.archoralbio.2012.05.012; Zhan Ling, 2012, Pediatr Dent, V34, pe86	56	46	54	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164242	10.1371/journal.pone.0164242	http://dx.doi.org/10.1371/journal.pone.0164242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741258	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000021
J	Budhathoki, S; Yamaji, T; Iwasaki, M; Sawada, N; Shimazu, T; Sasazuki, S; Yoshida, T; Tsugane, S				Budhathoki, Sanjeev; Yamaji, Taiki; Iwasaki, Motoki; Sawada, Norie; Shimazu, Taichi; Sasazuki, Shizuka; Yoshida, Teruhiko; Tsugane, Shoichiro			Vitamin D Receptor Gene Polymorphism and the Risk of Colorectal Cancer: A Nested Case-Control Study	PLOS ONE			English	Article							BINDING PROTEIN GC; 25-HYDROXYVITAMIN D; COLON-CANCER; DIETARY CALCIUM; PROSTATE-CANCER; ASSOCIATIONS; POPULATION; VARIANTS; VDR; JPHC	Epidemiological and experimental evidence suggest that vitamin D is protective against the risk of colorectal cancer. Polymorphisms in the gene encoding vitamin D receptor (VDR), which mediates most of the known cellular effects of vitamin D, have been suggested to alter this association. Here, using a tag SNP approach, we comprehensively evaluated the role of common genetic variants in VDR and their interaction with plasma vitamin D levels in relation to colorectal cancer risk in Japanese populations. A total of 356 colorectal cancer cases and 709 matched control subjects were selected from the participants of the Japan Public Health Center-based Prospective Cohort Study. Among these subjects, 29 VDR single nucleotide polymorphisms (SNPs) were selected and genotyped, and plasma vitamin D concentrations were measured. Conditional logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of colorectal cancer, with adjustment for potential confounding factors. Among the results, eight VDR SNPs, namely rs2254210, rs1540339, rs2107301, rs11168267, rs11574113, rs731236, rs3847987 and rs11574143, the latter 5 of which were located in the 30 region, were nominally associated with the risk of colorectal cancer (P = 0.01-0.048). Furthermore, of the above 5 30 region SNPs, the inverse associations for 3 SNPs (rs11574113, rs3847987 and rs11574143) appeared to be evident only in those with high plasma vitamin D concentration. However, neither of these direct and suggestive interaction analysis associations was significant after multiple testing adjustment. Overall, the findings of this study provide only limited support for an association between common genetic variations in VDR and colorectal cancer risk in the Japanese population.	[Budhathoki, Sanjeev; Yamaji, Taiki; Iwasaki, Motoki; Sawada, Norie; Shimazu, Taichi; Sasazuki, Shizuka; Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Div Genet, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan	Iwasaki, M (corresponding author), Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan.	moiwasak@ncc.go.jp	Budhathoki, Sanjeev/C-7358-2015; Shimazu, Taichi/A-4470-2015; Budhathoki, sanjieev/Y-1972-2019; Tsugane, Shoichiro/A-2424-2015	Budhathoki, Sanjeev/0000-0003-1662-3109; Shimazu, Taichi/0000-0001-6000-9830; Tsugane, Shoichiro/0000-0003-4105-2774	National Cancer Center Research and Development Fund [23-A-31, 26-A-2]; Ministry of Health, Labour and Welfare of Japan; Integrated Promotion of Social System Reform and Research and Development from the Japan Science and Technology Agency [37201101-01]; Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development [15Ack0106095h0002]; Japan Society for the Promotion of Science [15K08722]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Integrated Promotion of Social System Reform and Research and Development from the Japan Science and Technology Agency; Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a National Cancer Center Research and Development Fund (23-A-31[toku] and 26-A-2 since 2011), a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010), Funds for the Integrated Promotion of Social System Reform and Research and Development (37201101-01 from 2011 to 2013) from the Japan Science and Technology Agency, the Practical Research for Innovative Cancer Control (15Ack0106095h0002 since 2015) from the Japan Agency for Medical Research and Development, and a Grant-in-Aid for Scientific Research C (15K08722 since 2015) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Ashmore JH, 2015, CANCER EPIDEM BIOMAR, V24, P1635, DOI 10.1158/1055-9965.EPI-15-0284; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Garland CF, 2006, INT J EPIDEMIOL, V35, P217, DOI 10.1093/ije/dyi229; Hao K, 2007, BIOINFORMATICS, V23, P3178, DOI 10.1093/bioinformatics/btm496; Hibler EA, 2014, CANCER PREV RES, V7, P426, DOI 10.1158/1940-6207.CAPR-13-0269; Hibler EA, 2012, CANCER EPIDEM BIOMAR, V21, P368, DOI 10.1158/1055-9965.EPI-11-0916; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Hughes David J, 2011, J Gastrointest Cancer, V42, P149, DOI 10.1007/s12029-010-9168-6; Ishihara J, 2008, AM J CLIN NUTR, V88, P1576, DOI 10.3945/ajcn.2008.26195; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kupfer SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026123; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Mahmoudi T, 2014, ASIAN PAC J CANCER P, V15, P957, DOI 10.7314/APJCP.2014.15.2.957; Maneechay Wanwisa, 2015, Asian Pac J Cancer Prev, V16, P3339; McCullough ML, 2009, ANNU REV NUTR, V29, P111, DOI 10.1146/annurev-nutr-080508-141248; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Ochs-Balcom HM, 2008, CARCINOGENESIS, V29, P1788, DOI 10.1093/carcin/bgn166; Osborne JE, 2002, BRIT J DERMATOL, V147, P197, DOI 10.1046/j.1365-2133.2002.04960.x; Otani T, 2007, BRIT J CANCER, V97, P446, DOI 10.1038/sj.bjc.6603892; Poynter JN, 2010, CANCER EPIDEM BIOMAR, V19, P525, DOI 10.1158/1055-9965.EPI-09-0662; Slattery ML, 2001, CANCER CAUSE CONTROL, V12, P359, DOI 10.1023/A:1011280518278; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Takeshige Nobuyuki, 2015, Asian Pac J Cancer Prev, V16, P2019; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Tsubono Y, 2003, J EPIDEMIOL, V13, pS125; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Ukaji M, 2007, DRUG METAB PHARMACOK, V22, P462, DOI 10.2133/dmpk.22.462; VANDEWALLE B, 1994, CANCER LETT, V86, P67, DOI 10.1016/0304-3835(94)90181-3; Yamaji T, 2012, AM J EPIDEMIOL, V175, P236, DOI 10.1093/aje/kwr295; Zhou LQ, 2012, INT J CLIN EXP MED, V5, P72	35	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164648	10.1371/journal.pone.0164648	http://dx.doi.org/10.1371/journal.pone.0164648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736940	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800105
J	Indik, JH; Nair, V; Rafikov, R; Nyotowidjojo, IS; Bisla, J; Kansal, M; Parikh, DS; Robinson, M; Desai, A; Oberoi, M; Gupta, A; Abbasi, T; Khalpey, Z; Patel, AR; Lane, RM; Dudley, SC; Choi, BR; Garcia, JGN; Machado, RF; Desai, AA				Indik, Julia H.; Nair, Vineet; Rafikov, Ruslan; Nyotowidjojo, Iwan S.; Bisla, Jaskanwal; Kansal, Mayank; Parikh, Devang S.; Robinson, Melissa; Desai, Anand; Oberoi, Megha; Gupta, Akash; Abbasi, Taimur; Khalpey, Zain; Patel, Amit R.; Lane, Roberto M.; Dudley, Samuel C.; Choi, Bum-Rak; Garcia, Joe G. N.; Machado, Roberto F.; Desai, Ankit A.			Associations of Prolonged QTc in Sickle Cell Disease	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; Q-T INTERVAL; MYOCARDIAL-INFARCTION; ADULT PATIENTS; ECHOCARDIOGRAPHY; ABNORMALITIES; VELOCITY; CHILDREN; RISK	Sudden death is a leading cause of mortality in sickle cell disease, implicating ventricular tachyarrhythmias. Prolonged QTc on an electrocardiogram (ECG), commonly seen with myocardial ischemia, is a known risk for polymorphic ventricular tachycardia (VT). We hypothesized that prolonged QTc is associated with mortality in sickle cell disease. ECG were analyzed from a cohort of 224 sickle patients (University of Illinois at Chicago, UIC) along with available laboratory, and echocardiographic findings, and from another cohort of 38 patients (University of Chicago, UC) for which cardiac MRI and free heme values were also measured. In the UIC cohort, QTc was potentially related to mortality with a hazard ratio (HR) of 1.22 per 10ms, (P = 0.015), and a HR = 3.19 (P = 0.045) for a QTc>480ms. In multivariate analyses, QTc remained significantly associated with survival after adjusting for inpatient ECG status (HR 1.26 per 10ms interval, P = 0.010) and genotype status [HR 1.21 per 10ms interval, P = 0.037). QTc trended toward association with mortality after adjusting for both LDH and hydroxyurea use (HR 1.21 per 10ms interval, P = 0.062) but was not significant after adjusting for TRV. In univariate analyses, QTc was related to markers of hemolysis including AST (P = 0.031), hemoglobin (P = 0.014), TR velocity (P = 0.036), higher in inpatients (P<0.001) and those with an SS compared to SC genotype (P<0.001) in the UIC cohort as well as to free heme in the UC cohort (P = 0.002). These findings support a relationship of prolonged QTc with hemolysis and potentially mortality in sickle cell disease.	[Indik, Julia H.; Nair, Vineet; Rafikov, Ruslan; Nyotowidjojo, Iwan S.; Bisla, Jaskanwal; Gupta, Akash; Garcia, Joe G. N.; Desai, Ankit A.] Univ Arizona, Dept Med, Tucson, AZ 85721 USA; [Indik, Julia H.; Nair, Vineet; Rafikov, Ruslan; Nyotowidjojo, Iwan S.; Bisla, Jaskanwal; Gupta, Akash; Khalpey, Zain; Garcia, Joe G. N.; Desai, Ankit A.] Univ Arizona, Arizona Hlth Sci Ctr, Tucson, AZ 85721 USA; [Kansal, Mayank; Parikh, Devang S.; Machado, Roberto F.] Univ Illinois Hosp & Hlth Sci Syst, Dept Med, Chicago, IL USA; [Robinson, Melissa] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Desai, Anand] Creighton Univ, Med Ctr, Dept Family Med, Omaha, NE 68178 USA; [Oberoi, Megha] Oakhill Hosp, Dept Med, Brooksville, FL USA; [Abbasi, Taimur] Mercy Hosp & Hlth Ctr, Dept Med, Chicago, IL USA; [Khalpey, Zain] Univ Arizona, Dept Surg, Tucson, AZ USA; [Patel, Amit R.; Lane, Roberto M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Dudley, Samuel C.; Choi, Bum-Rak] Lifespan Cardiovasc Inst, Providence, RI USA; [Dudley, Samuel C.; Choi, Bum-Rak] Brown Univ, Providence, RI 02912 USA	University of Arizona; University of Arizona; University of Arizona Health Sciences; University of Washington; University of Washington Seattle; Creighton University; University of Arizona; University of Chicago; Lifespan Health Rhode Island; Brown University	Desai, AA (corresponding author), Univ Arizona, Dept Med, Tucson, AZ 85721 USA.	adesai@shc.arizona.edu	Dudley, Samuel C/A-7085-2009; Dudley, Samuel/AAR-7950-2021; Rafikov, Ruslan/AAG-9352-2019; Patel, Amit/B-2464-2014	Dudley, Samuel/0000-0001-5843-5961; Desai, Ankit/0000-0001-6427-616X; Gupta, Akash/0000-0001-7305-055X; Patel, Amit/0000-0001-7621-6463; Rafikov, Ruslan/0000-0001-5950-4076; Kansal, Mayank/0000-0003-2552-8744; Machado, Roberto/0000-0002-3722-5954	NIH NCRR/NCATS [UL1RR029879]; American Heart Association (AHA) [14CRP18910051]; American Thoracic Society Foundation/Pulmonary Hypertension Association; NIH/NHLBI [R01 HL127342, R01 HL111656]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111656] Funding Source: NIH RePORTER	NIH NCRR/NCATS; American Heart Association (AHA)(American Heart Association); American Thoracic Society Foundation/Pulmonary Hypertension Association; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by NIH NCRR/NCATS UL1RR029879 (MD), American Heart Association (AHA) 14CRP18910051 (MD), the American Thoracic Society Foundation/Pulmonary Hypertension Association (MD), and NIH/NHLBI R01 HL127342 and R01 HL111656 (RFM).	Adegoke SA, 2016, CARDIOVASC J AFR, V27, P16, DOI 10.5830/CVJA-2015-059; Ahmad H, 2012, ECHOCARDIOGR-J CARD, V29, P962, DOI 10.1111/j.1540-8175.2012.01710.x; Akgul F, 2007, ACTA HAEMATOL-BASEL, V118, P1, DOI 10.1159/000100929; Al-Zaiti SS, 2014, HEART LUNG, V43, P527, DOI 10.1016/j.hrtlng.2014.05.008; CINCA J, 1981, AM J CARDIOL, V48, P1023, DOI 10.1016/0002-9149(81)90315-5; Darbari DS, 2006, AM J HEMATOL, V81, P858, DOI 10.1002/ajh.20685; Desai AA, 2014, CIRC-CARDIOVASC IMAG, V7, P431, DOI 10.1161/CIRCIMAGING.113.001420; Desai AA, 2012, AM J RESP CRIT CARE, V186, P359, DOI 10.1164/rccm.201201-0057OC; DOROGHAZI RM, 1978, AM J CARDIOL, V41, P684, DOI 10.1016/0002-9149(78)90818-4; Fitzhugh CD, 2010, AM J HEMATOL, V85, P36, DOI 10.1002/ajh.21569; Fontaine JM, 2008, J NATL MED ASSOC, V100, P360, DOI 10.1016/S0027-9684(15)31268-2; Gladwin MT, 2012, J AM COLL CARDIOL, V59, P1123, DOI 10.1016/j.jacc.2011.10.900; Graham JK, 2007, AM J FOREN MED PATH, V28, P168, DOI 10.1097/01.paf.0000257397.92466.50; Hamideh D, 2013, PEDIATR BLOOD CANCER, V60, P1482, DOI 10.1002/pbc.24557; Harmon KG, 2014, CIRC-ARRHYTHMIA ELEC, V7, P198, DOI 10.1161/CIRCEP.113.001376; HOLLOMAN KL, 1987, J NATL MED ASSOC, V79, P809; Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Liem RI, 2009, PEDIATR BLOOD CANCER, V52, P842, DOI 10.1002/pbc.21973; Lorenz CH, 1999, J CARDIOVASC MAGN R, V1, P7, DOI 10.3109/10976649909080829; Manci EA, 2003, BRIT J HAEMATOL, V123, P359, DOI 10.1046/j.1365-2141.2003.04594.x; Meyer JS, 2003, AM FAM PHYSICIAN, V68, P483; Mueller BU, 2006, PEDIATR BLOOD CANCER, V47, P831, DOI 10.1002/pbc.20539; NAPOLITANO C, 1994, DRUGS, V47, P51, DOI 10.2165/00003495-199447010-00004; Oguanobi NI, 2010, AFR HEALTH SCI, V10, P235; Remme CA, 2013, CARDIOVASC DRUG THER, V27, P91, DOI 10.1007/s10557-012-6433-x; Sara JD, 2016, J ELECTROCARDIOL, V49, P87, DOI 10.1016/j.jelectrocard.2015.10.006; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; Upadhya B, 2014, ACTA HAEMATOL-BASEL, V132, P152, DOI 10.1159/000357393; Upadhya B, 2013, EUR J HAEMATOL, V91, P170, DOI 10.1111/ejh.12127	30	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164526	10.1371/journal.pone.0164526	http://dx.doi.org/10.1371/journal.pone.0164526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736922	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800078
J	Lewallen, EA; Bohonak, AJ; Bonin, CA; van Wijnen, AJ; Pitmans, RL; Lovejoy, NR				Lewallen, Eric A.; Bohonak, Andrew J.; Bonin, Carolina A.; van Wijnen, Andre J.; Pitmans, Robert L.; Lovejoy, Nathan R.			Population Genetic Structure of the Tropical Two-Wing Flyingfish (Exocoetus volitans)	PLOS ONE			English	Article							HISTORICAL DEMOGRAPHY; MARINE FISHES; CONNECTIVITY; TUNA; DISPERSAL; PATTERNS; PHYLOGEOGRAPHY; POLYMORPHISM; EVOLUTION; VARIANCE	Delineating populations of pantropical marine fish is a difficult process, due to widespread geographic ranges and complex life history traits in most species. Exocoetus volitans, a species of two-winged flyingfish, is a good model for understanding large-scale patterns of epipelagic fish population structure because it has a circumtropical geographic range and completes its entire life cycle in the epipelagic zone. Buoyant pelagic eggs should dictate high local dispersal capacity in this species, although a brief larval phase, small body size, and short lifespan may limit the dispersal of individuals over large spatial scales. Based on these biological features, we hypothesized that E. volitans would exhibit statistically and biologically significant population structure defined by recognized oceanographic barriers. We tested this hypothesis by analyzing cytochrome b mtDNA sequence data (1106 bps) from specimens collected in the Pacific, Atlantic and Indian oceans (n = 266). AMOVA, Bayesian, and coalescent analytical approaches were used to assess and interpret population-level genetic variability. A parsimony-based haplotype network did not reveal population subdivision among ocean basins, but AMOVA revealed limited, statistically significant population structure between the Pacific and Atlantic Oceans (Phi(ST) = 0.035, p<0.001). A spatially-unbiased Bayesian approach identified two circumtropical population clusters north and south of the Equator (Phi(ST) = 0.026, p<0.001), a previously unknown dispersal barrier for an epipelagic fish. Bayesian demographic modeling suggested the effective population size of this species increased by at least an order of magnitude similar to 150,000 years ago, to more than 1 billion individuals currently. Thus, high levels of genetic similarity observed in E. volitans can be explained by high rates of gene flow, a dramatic and recent population expansion, as well as extensive and consistent dispersal throughout the geographic range of the species.	[Lewallen, Eric A.; Lovejoy, Nathan R.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada; [Lewallen, Eric A.; Lovejoy, Nathan R.] Mayo Clin, Dept Biochem, Rochester, MN 55905 USA; [Lewallen, Eric A.; van Wijnen, Andre J.] Mayo Clin, Dept Mol Biol, Rochester, MN 55905 USA; [Lewallen, Eric A.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Bohonak, Andrew J.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Bonin, Carolina A.] Univ St Thomas, St Paul, MN USA; [Pitmans, Robert L.] NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA	University of Toronto; University Toronto Scarborough; Mayo Clinic; Mayo Clinic; Mayo Clinic; California State University System; San Diego State University; University of St Thomas Minnesota; National Oceanic Atmospheric Admin (NOAA) - USA	Lewallen, EA; Lovejoy, NR (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada.; Lewallen, EA; Lovejoy, NR (corresponding author), Mayo Clin, Dept Biochem, Rochester, MN 55905 USA.; Lewallen, EA (corresponding author), Mayo Clin, Dept Mol Biol, Rochester, MN 55905 USA.; Lewallen, EA (corresponding author), Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.	lewallen.eric.@mayo.edu; lovejoy@utsc.utoronto.ca	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Lewallen, Eric/0000-0002-0777-7336; Bonin Lewallen, Carolina/0000-0003-1162-7290	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant; National Institute of Arthritis and Musculoskeletal and Skin Diseases [T32 AR56950, R01 AR049069]	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for the study was provided by The Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to NRL. We also acknowledge funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32 AR56950 to EAL; R01 AR049069 to AJVW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bohonak AJ, 2001, ISR J ZOOL, V47, P367, DOI 10.1560/HM51-9Y1V-QCRQ-CJP5; Bowen BW, 2001, EVOLUTION, V55, P1029, DOI 10.1554/0014-3820(2001)055[1029:POTTAR]2.0.CO;2; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; Buonaccorsi VP, 2001, MOL ECOL, V10, P1179, DOI 10.1046/j.1365-294X.2001.01270.x; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Chou C-H, 2015, NUCLEIC ACIDS RES, V2015, P1, DOI DOI 10.1186/S40555-014-0085-4; Chow S, 2007, MAR BIOL, V152, P87, DOI 10.1007/s00227-007-0662-8; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collette B.B., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P335; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Crandall Keith A., 1994, Systematics Association Special Volume Series, V52, P273; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ely B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-19; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; FU YX, 1993, GENETICS, V133, P693; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Gaither MR, 2015, FISH FISHERIES; Gomes C, 1998, MOL ECOL, V7, P1029, DOI 10.1046/j.1365-294x.1998.00427.x; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Graves JE, 2006, B MAR SCI, V79, P469; Grudtsev M, 1987, J ICHTHYOL, V27, P39; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; Klanten OS, 2007, MAR BIOL, V150, P659, DOI 10.1007/s00227-006-0372-7; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lewallen EA, 2011, BIOL J LINN SOC, V102, P161, DOI 10.1111/j.1095-8312.2010.01550.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longhurst AR, 1987, ECOLOGY TROPICAL OCE; Ludt WB, 2015, J BIOGEOGR, V42, P25, DOI 10.1111/jbi.12416; Martinez P, 2006, MOL PHYLOGENET EVOL, V39, P404, DOI 10.1016/j.ympev.2005.07.022; McDowell JR, 2008, CAN J FISH AQUAT SCI, V65, P1307, DOI 10.1139/F08-054; Norton EL, 2013, LIMNOL OCEANOGR, V58, P1581, DOI 10.4319/lo.2013.58.5.1581; Parin N., 1968, ICHTHYOFAUNA OCEANIC; Parin N.V., 2002, Journal of Ichthyology, V42, pS23; Parin N.V., 2000, Journal of Ichthyology, V40, pS31; Planes S, 2002, MOL ECOL, V11, P1515, DOI 10.1046/j.1365-294X.2002.01521.x; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; Rocha LA, 2007, CORAL REEFS, V26, P501, DOI 10.1007/s00338-007-0261-7; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Shakhovskoy IB, 2013, J ICHTHYOL+, V53, P509, DOI [10.1134/s0032945213050093, DOI 10.1134/S0032945213050093]; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1995, GENETICS, V140, P767; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	55	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163198	10.1371/journal.pone.0163198	http://dx.doi.org/10.1371/journal.pone.0163198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736863	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800013
J	Morioka, S; Osumi, M; Shiotani, M; Nobusako, S; Maeoka, H; Okada, Y; Hiyamizu, M; Matsuo, A				Morioka, Shu; Osumi, Michihiro; Shiotani, Mayu; Nobusako, Satoshi; Maeoka, Hiroshi; Okada, Yohei; Hiyamizu, Makoto; Matsuo, Atsushi			Incongruence between Verbal and Non-Verbal Information Enhances the Late Positive Potential	PLOS ONE			English	Article							FACE	Smooth social communication consists of both verbal and non-verbal information. However, when presented with incongruence between verbal information and nonverbal information, the relationship between an individual judging trustworthiness in those who present the verbal-nonverbal incongruence and the brain activities observed during judgment for trustworthiness are not clear. In the present study, we attempted to identify the impact of incongruencies between verbal information and facial expression on the value of trustworthiness and brain activity using event-related potentials (ERP). Combinations of verbal information [positive/negative] and facial expressions [smile/angry] expressions were presented randomly on a computer screen to 17 healthy volunteers. The value of trustworthiness of the presented facial expression was evaluated by the amount of donation offered by the observer to the person depicted on the computer screen. In addition, the time required to judge the value of trustworthiness was recorded for each trial. Using electroen-cephalography, ERP were obtained by averaging the wave patterns recorded while the participants judged the value of trustworthiness. The amount of donation offered was significantly lower when the verbal information and facial expression were incongruent, particularly for [negative x smile]. The amplitude of the early posterior negativity (EPN) at the temporal lobe showed no significant difference between all conditions. However, the amplitude of the late positive potential (LPP) at the parietal electrodes for the incongruent condition [negative x smile] was higher than that for the congruent condition [positive x smile]. These results suggest that the LPP amplitude observed from the parietal cortex is involved in the processing of incongruence between verbal information and facial expression.	[Morioka, Shu; Osumi, Michihiro; Nobusako, Satoshi; Maeoka, Hiroshi; Okada, Yohei; Hiyamizu, Makoto; Matsuo, Atsushi] Kio Univ, Neurorehabil Res Ctr, 4-2-2 Umaminaka, Koryo, Nara 6350832, Japan; [Shiotani, Mayu] Higashisumiyoshi Morimoto Hosp, Dept Rehabil, 3-2-66 Takaai, Osaka, Osaka 5460014, Japan		Morioka, S (corresponding author), Kio Univ, Neurorehabil Res Ctr, 4-2-2 Umaminaka, Koryo, Nara 6350832, Japan.	s.morioka@kio.ac.jp	Morioka, Shu/AAH-9229-2019	Morioka, Shu/0000-0003-2853-1789; Okada, Yohei/0000-0001-7860-3440; nobusako, satoshi/0000-0001-7183-5054				Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Breton A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091451; Bublatzky F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00493; Clark VP, 1998, J NEUROPHYSIOL, V79, P3257, DOI 10.1152/jn.1998.79.6.3257; Dieguez-Risco T, 2015, BIOL PSYCHOL, V112, P27, DOI 10.1016/j.biopsycho.2015.09.012; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Ekman P., 2002, FACIAL ACTION CODING; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Frith CD, 1999, SCIENCE, V286; Guerra P, 2012, INT J PSYCHOPHYSIOL, V85, P79, DOI 10.1016/j.ijpsycho.2011.06.004; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Holmes A, 2008, BIOL PSYCHOL, V77, P159, DOI 10.1016/j.biopsycho.2007.10.003; Jemel B, 2003, NEUROREPORT, V14; Kaufmann JM, 2009, J COGNITIVE NEUROSCI, V21, P625, DOI 10.1162/jocn.2009.21080; Krumhuber E, 2007, EMOTION, V7, P730, DOI 10.1037/1528-3542.7.4.730; Liddell BJ, 2004, J COGNITIVE NEUROSCI, V16, P479, DOI 10.1162/089892904322926809; Luo QL, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00810; Morioka S, 2015, INT J BRAIN SCI, DOI [10.1155/2015/719213, DOI 10.1155/2015/719213]; Mouchetant-Rostaing Y, 2003, J COGNITIVE NEUROSCI, V15, P900, DOI 10.1162/089892903322370816; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Paller KA, 2000, NEUROIMAGE, V11, P98, DOI 10.1006/nimg.1999.0521; Righart R, 2006, CEREB CORTEX, V16, P1249, DOI 10.1093/cercor/bhj066; Ritter W, 1992, ANN N Y ACAD SCI, V658; Rossion B, 1999, CLIN NEUROPHYSIOL, V110, P449, DOI 10.1016/S1388-2457(98)00037-6; Sabatinelli D, 2007, CEREB CORTEX, V17, P1085, DOI 10.1093/cercor/bhl017; Sato W, 2001, NEUROREPORT, V12, P709, DOI 10.1097/00001756-200103260-00019; Scharlemann JPW, 2001, J ECON PSYCHOL, V22, P617, DOI 10.1016/S0167-4870(01)00059-9; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Thiruchselvam R, 2011, BIOL PSYCHOL, V87, P84, DOI 10.1016/j.biopsycho.2011.02.009; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; VANDERPLOEG RD, 1987, INT J PSYCHOPHYSIOL, V5, P193, DOI 10.1016/0167-8760(87)90006-7; Wangelin BC, 2012, BIOL PSYCHOL, V91, P103, DOI 10.1016/j.biopsycho.2012.05.002; Werheid K, 2007, BIOL PSYCHOL, V76, P100, DOI 10.1016/j.biopsycho.2007.06.008; Wieser MJ, 2014, NEUROIMAGE, V92, P74, DOI 10.1016/j.neuroimage.2014.01.022; Williams LM, 2006, NEUROIMAGE, V31, P458, DOI 10.1016/j.neuroimage.2005.12.009; Xu Q, 2015, BRAIN RES, V1608, P138, DOI 10.1016/j.brainres.2015.02.047; Zaki J, 2010, J NEUROSCI, V30, P8481, DOI 10.1523/JNEUROSCI.0382-10.2010	44	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164633	10.1371/journal.pone.0164633	http://dx.doi.org/10.1371/journal.pone.0164633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736931	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800102
J	Nishi, T; Ueda, T; Mizusawa, Y; Shinomiya, K; Semba, K; Mitamura, Y; Sonoda, S; Uchino, E; Sakamoto, T; Ogata, N				Nishi, Tomo; Ueda, Tetsuo; Mizusawa, Yuutaro; Shinomiya, Kayo; Semba, Kentaro; Mitamura, Yoshinori; Sonoda, Shozo; Uchino, Eisuke; Sakamoto, Taiji; Ogata, Nahoko			Choroidal Structure in Children with Anisohypermetropic Amblyopia Determined by Binarization of Optical Coherence Tomographic Images	PLOS ONE			English	Article							HYPEROPIC ANISOMETROPIC AMBLYOPIA; HEALTHY-SUBJECTS; THICKNESS; EYES; MEMBRANE; PRIMATE; ADULTS; CELLS; YOUNG	Purpose To compare the choroidal structure of the subfoveal area in the eyes of children with anisohypermetropic amblyopia to that of the fellow eyes and to age-matched controls using a binarization method of the images obtained by enhanced depth imaging optical coherence tomography (EDI-OCT). Methods This study was performed at Nara Medical University Hospital, Tokushima University Hospital, and Kagoshima University Hospital, Japan. Forty amblyopic eyes with anisohypermetropic amblyopia and their fellow eyes (5.9 +/- 2.1 years, mean +/- standard deviation), and 103 age-matched controls (6.7 +/- 2.4 years) were studied. The control eyes were divided into myopic, emmetropic, and hyperopic eyes. The total choroidal area, luminal area and stromal area of the subfoveal choroid were measured by the binarization method. The luminal/stromal ratio and the axial length of the amblyopic eyes were compared to that of the control eyes. Results The total choroidal area in the amblyopic eyes was significantly larger than that of the fellow eyes (P = 0.005). The luminal/stromal ratio was significantly larger in the amblyopic eyes than that of the fellow eyes (P<0.001) and the control hyperopic eyes (P<0.001). There was a significant negative correlation between the luminal/stromal ratio and the axial length in the control eyes (r = -0.30, P = 0.001), but no significant correlation was found in the amblyopic eyes. Conclusions The choroidal structure of the amblyopic eyes was different from that of the fellow and the control hyperopic eyes. The choroidal changes are related to amblyopia.	[Nishi, Tomo; Ueda, Tetsuo; Mizusawa, Yuutaro; Ogata, Nahoko] Nara Med Univ, Dept Ophthalmol, Kashihara, Nara, Japan; [Shinomiya, Kayo; Semba, Kentaro; Mitamura, Yoshinori] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Kuramoto, Tokushima, Japan; [Sonoda, Shozo; Uchino, Eisuke; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Sakuragaoka, Kagoshima, Japan	Nara Medical University; Tokushima University; Kagoshima University	Nishi, T (corresponding author), Nara Med Univ, Dept Ophthalmol, Kashihara, Nara, Japan.	tomon@naramed-u.ac.jp						Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Brown JS, 2009, INVEST OPHTH VIS SCI, V50, P5, DOI 10.1167/iovs.08-1779; Celik E, 2016, INT OPHTHALMOL, V36, P515, DOI 10.1007/s10792-015-0157-4; Croft MA, 2013, INVEST OPHTH VIS SCI, V54, P5049, DOI 10.1167/iovs.12-10847; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Duan L, 2013, OPT EXPRESS, V21, P15787, DOI 10.1364/OE.21.015787; Kantarci FA, 2015, EUR J OPHTHALMOL, V25, P437, DOI 10.5301/ejo.5000594; Kumar A, 2014, INVEST OPHTH VIS SCI, V55, P1787, DOI 10.1167/iovs.13-13522; Manh V, 2015, INVEST OPHTH VIS SCI, V56, P1193, DOI 10.1167/iovs.14-14948; May CA, 2005, J ANAT, V207, P381, DOI 10.1111/j.1469-7580.2005.00460.x; Nishi T, 2014, BRIT J OPHTHALMOL, V98, P228, DOI 10.1136/bjophthalmol-2013-303938; Park KA, 2014, AM J OPHTHALMOL, V33, P1971; Park KA, 2013, RETINA-J RET VIT DIS, V33, P1971, DOI 10.1097/IAE.0b013e3182923477; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P3586, DOI 10.1167/iovs.13-11732; Ruiz-Moreno JM, 2012, INVEST OPHTH VIS SCI, V54, P353; Schrodl F, 2003, INVEST OPHTH VIS SCI, V44, P3705, DOI 10.1167/iovs.03-0232; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Troilo D, 2000, INVEST OPHTH VIS SCI, V41, P1249; Woodman-Pieterse EC, 2015, INVEST OPHTH VIS SCI, V56, P6414, DOI 10.1167/iovs.15-17102; Xu JL, 2014, INVEST OPHTH VIS SCI, V55, P7361, DOI 10.1167/iovs.14-14439	24	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164672	10.1371/journal.pone.0164672	http://dx.doi.org/10.1371/journal.pone.0164672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736947	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800109
J	Silverwood, RJ; Williamson, L; Grundy, EM; De Stavola, BL				Silverwood, Richard J.; Williamson, Lee; Grundy, Emily M.; De Stavola, Bianca L.			Pathways between Socioeconomic Disadvantage and Childhood Growth in the Scottish Longitudinal Study, 1991-2001	PLOS ONE			English	Article							PRIMARY-SCHOOL-CHILDREN; MILLENNIUM-COHORT; BIRTH-WEIGHT; SOCIAL DETERMINANTS; CAUSAL INFERENCE; RISK-FACTORS; OBESITY; HEIGHT; OVERWEIGHT; MEDIATION	Socioeconomically disadvantaged children are more likely to be of shorter stature and overweight, leading to greater risk of obesity in adulthood. Disentangling the mediatory pathways between socioeconomic disadvantage and childhood size may help in the development of appropriate policies aimed at reducing these health inequalities. We aimed to elucidate the putative mediatory role of birth weight using a representative sample of the Scottish population born 1991-2001 (n = 16,628). Estimated height and overweight/ obesity at age 4.5 years were related to three measures of socioeconomic disadvantage (mother's education, Scottish Index of Multiple Deprivation, synthetic weekly income). Mediation was examined using two approaches: a 'traditional' mediation analysis and a counterfactual-based mediation analysis. Both analyses identified a negative effect of each measure of socioeconomic disadvantage on height, mediated to some extent by birth weight, and a positive 'direct effect' of mother's education and Scottish Index of Multiple Deprivation on overweight/ obesity, which was partly counterbalanced by a negative ` indirect effect'. The extent of mediation estimated when adopting the traditional approach was greater than when adopting the counterfactual-based approach because of inappropriate handling of intermediate confounding in the former. Our findings suggest that higher birth weight in more disadvantaged groups is associated with reduced social inequalities in height but also with increased inequalities in overweight/ obesity.	[Silverwood, Richard J.; De Stavola, Bianca L.] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Silverwood, Richard J.; De Stavola, Bianca L.] London Sch Hyg & Trop Med, Ctr Stat Methodol, London, England; [Williamson, Lee] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Grundy, Emily M.] London Sch Econ & Polit Sci, Dept Social Policy, Ageing Lifecourse & Populat Hlth Anal Res Unit, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh; University of London; London School Economics & Political Science	Silverwood, RJ (corresponding author), London Sch Hyg & Trop Med, Dept Med Stat, London, England.; Silverwood, RJ (corresponding author), London Sch Hyg & Trop Med, Ctr Stat Methodol, London, England.	Richard.Silverwood@lshtm.ac.uk	Silverwood, Richard/A-1249-2014; Grundy, Emily/AAC-3260-2019	Silverwood, Richard/0000-0002-2744-1194; Grundy, Emily/0000-0002-9633-1116; De Stavola, Bianca Lucia/0000-0001-7853-0528	UK Economic and Social Research Council [ES/1025561/1, ES/1025561/2, ES/1025561/3]; ESRC/JISC; Scottish Funding Council; Chief Scientist's Office; Scottish Government; Economic and Social Research Council [ES/K000454/2, ES/I025561/3, ES/I025561/1, ES/K000454/1, ES/I025561/2] Funding Source: researchfish; ESRC [ES/I025561/3, ES/I025561/2, ES/I025561/1, ES/K000454/2, ES/K000454/1] Funding Source: UKRI	UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC/JISC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Scottish Funding Council; Chief Scientist's Office; Scottish Government; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the UK Economic and Social Research Council (National Centre for Research Methods Pathways node ES/1025561/1, ES/1025561/2 and ES/1025561/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The help provided by staff of the Longitudinal Studies Centre-Scotland (LSCS) is acknowledged. The LSCS is supported by the ESRC/JISC, the Scottish Funding Council, the Chief Scientist's Office and the Scottish Government. The authors alone are responsible for the interpretation of the data. Census output is Crown copyright and is reproduced with the permission of the Controller of HMSO and the Queen's Printer for Scotland.	ALWIN DF, 1975, AM SOCIOL REV, V40, P37, DOI 10.2307/2094445; Armstrong J, 2003, ARCH DIS CHILD, V88, P671, DOI 10.1136/adc.88.8.671; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BERKEY CS, 1987, HUM BIOL, V59, P973; Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B; Boyle PJ, 2009, INT J EPIDEMIOL, V38, P385, DOI 10.1093/ije/dyn087; Brophy S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-467; Cameron N, 2001, HUMAN GROWTH DEV, P1; Cecil JE, 2005, INT J OBESITY, V29, P1199, DOI 10.1038/sj.ijo.0803055; Clemens T, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-59; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Conrad D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000463; Daniel RM, 2013, STAT MED, V32, P1584, DOI 10.1002/sim.5686; Daniel RM, 2011, STATA J, V11, P479, DOI 10.1177/1536867X1101100401; Emerson E, 2009, PUBLIC HEALTH, V123, P130, DOI 10.1016/j.puhe.2008.10.020; Fairley L, 2005, PAEDIATR PERINAT EP, V19, P342, DOI 10.1111/j.1365-3016.2005.00665.x; Finch BK, 2011, ECON HUM BIOL, V9, P272, DOI 10.1016/j.ehb.2011.02.005; Galobardes B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029118; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Greenland S, 1999, STAT SCI, V14, P29; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Hawkins SS, 2009, J EPIDEMIOL COMMUN H, V63, P147, DOI 10.1136/jech.2008.077917; Hernan MA, 2004, J EPIDEMIOL COMMUN H, V58, P265, DOI 10.1136/jech.2002.006361; Howe LD, 2012, J EPIDEMIOL COMMUN H, V66, P143, DOI 10.1136/jech.2010.113068; Information Services Division Scotland, CHILD HLTH SYST PROG; Jebb SA, 2004, PUBLIC HEALTH NUTR, V7, P461, DOI 10.1079/PHN2003539; Jiang ZC, 2015, AM J EPIDEMIOL, V182, P105, DOI 10.1093/aje/kwv059; Kaufman Jay S, 2004, Epidemiol Perspect Innov, V1, P4, DOI 10.1186/1742-5573-1-4; Keating DP, 1999, DEV HLTH WEALTH NATI; Kimbro RT, 2007, AM J PUBLIC HEALTH, V97, P298, DOI 10.2105/AJPH.2005.080812; Kinra S, 2000, J EPIDEMIOL COMMUN H, V54, P456, DOI 10.1136/jech.54.6.456; Li JH, 2009, HEALTH SOCIOL REV, V18, P3, DOI 10.5172/hesr.18.1.3; Little R.J.A., 2002, STAT ANAL MISSING DA; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Merialdi M, 2003, J NUTR, V133, p1626S, DOI 10.1093/jn/133.5.1626S; Morrison JA, 2008, J PEDIATR-US, V152, P201, DOI 10.1016/j.jpeds.2007.09.010; Naimi AI, 2014, INT J EPIDEMIOL, V43, P1656, DOI 10.1093/ije/dyu107; Ness AR, 2006, INT J PEDIATR OBES, V1, P59, DOI 10.1080/17477160600569339; *OFF CHIEF STAT SC, SCOTT IND MULT DEPR; Palmer M, 2014, SOCIOECONOMIC DISADV; Pearl J., 2001, P 17 C UNC ART INT; Petersen ML, 2006, EPIDEMIOLOGY, V17, P276, DOI 10.1097/01.ede.0000208475.99429.2d; Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; RONA RJ, 1991, ANN HUM BIOL, V18, P441, DOI 10.1080/03014469100001742; RONA RJ, 1978, J EPIDEMIOL COMMUN H, V32, P147, DOI 10.1136/jech.32.3.147; Samani-Radia D, 2011, INT J OBESITY, V35, P128, DOI 10.1038/ijo.2010.116; Sayers A, STAT METHOD IN PRESS; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Simkiss D, 2014, PAEDIAT CHILD HLTH, V24, P103; Smith SM, 2013, ARCH DIS CHILD, V98, P269, DOI 10.1136/archdischild-2012-302391; Stamatakis E, 2005, ARCH DIS CHILD, V90, P999, DOI 10.1136/adc.2004.068932; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; StataCorp, 2011, STAT STAT SOFTW REL, P173; Townsend N, 2012, INT J OBESITY, V36, P45, DOI 10.1038/ijo.2011.191; VanderWeele TJ, 2009, STAT INTERFACE, V2, P457; Ward C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-81; Weightman AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000964; Williams J, 2005, JAMA-J AM MED ASSOC, V293, P70, DOI 10.1001/jama.293.1.70	63	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164853	10.1371/journal.pone.0164853	http://dx.doi.org/10.1371/journal.pone.0164853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736963	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000385505800137
J	Silvilairat, S; Charoenkwan, P; Saekho, S; Tantiworawit, A; Phrommintikul, A; Srichairatanakool, S; Chattipakorn, N				Silvilairat, Suchaya; Charoenkwan, Pimlak; Saekho, Suwit; Tantiworawit, Adisak; Phrommintikul, Arintaya; Srichairatanakool, Somdet; Chattipakorn, Nipon			Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia	PLOS ONE			English	Article							T2-ASTERISK-MAGNETIC RESONANCE; MAGNETIC-RESONANCE; CHELATION-THERAPY; OVERLOAD; CARDIOMYOPATHY; SURVIVAL; MRI	Background Iron overload cardiomyopathy remains the major cause of death in patients with transfusion- dependent thalassemia. Cardiac T2* magnetic resonance imaging is costly yet effective in detecting cardiac iron accumulation in the heart. Heart rate variability (HRV) has been used to evaluate cardiac autonomic function and is depressed in cases of thalassemia. We evaluated whether HRV could be used as an indicator for early identification of cardiac iron deposition. Methods One hundred and one patients with transfusion-dependent thalassemia were enrolled in this study. The correlation between recorded HRV and hemoglobin, non-transferrin bound iron (NTBI), serum ferritin and cardiac T2* were evaluated. Results The median age was 18 years (range 8-59 years). The patient group with a 5-year mean serum ferritin >5,000 ng/mL included significantly more homozygous beta-thalassemia and splenectomized patients, had lower hemoglobin levels, and had more cardiac iron deposit than all other groups. Anemia strongly influenced all domains of HRV. After adjusting for anemia, neither serum ferritin nor NTBI impacted the HRV. However cardiac T2* was an independent predictor of HRV, even after adjusting for anemia. For receiver operative characteristic (ROC) curve analysis of cardiac T2* <= 20 ms, only mean ferritin in the last 12 months and the average of the standard deviation of all R-R intervals for all five-minute segments in the 24-hour recording were predictors for cardiac T2* <= 20 ms, with area under the ROC curve of 0.961 (p<0.0001) and 0.701 (p = 0.05), respectively. Conclusions Hemoglobin and cardiac T2* as significant predictors for HRV indicate that anemia and cardiac iron deposition result in cardiac autonomic imbalance. The mean ferritin in the last 12 months could be useful as the best indicator for further evaluation of cardiac risk. The ability of serum ferritin to predict cardiac risk is stronger than observed in other thalassemia cohorts. HRV might be a stronger predictor of cardiac iron in study populations with lower somatic iron burdens and greater prevalence of cardiac iron deposition.	[Silvilairat, Suchaya; Charoenkwan, Pimlak] Chiang Mai Univ, Dept Pediat, Fac Med, Chiang Mai, Thailand; [Saekho, Suwit] Chiang Mai Univ, Fac Associated Med Sci, Dept Radiol Technol, Chiang Mai, Thailand; [Saekho, Suwit] Chiang Mai Univ, Ctr Biomed Engn, Fac Engn, Chiang Mai, Thailand; [Tantiworawit, Adisak; Phrommintikul, Arintaya] Chiang Mai Univ, Dept Internal Med, Fac Med, Chiang Mai, Thailand; [Srichairatanakool, Somdet] Chiang Mai Univ, Dept Biochem, Fac Med, Chiang Mai, Thailand; [Chattipakorn, Nipon] Chiang Mai Univ, Cardiac Electrophysiol Res & Training Ctr, Fac Med, Chiang Mai, Thailand; [Chattipakorn, Nipon] Chiang Mai Univ, Dept Physiol, Cardiac Electrophysiol Unit, Fac Med, Chiang Mai, Thailand; [Chattipakorn, Nipon] Chiang Mai Univ, Ctr Excellence Cardiac Electrophysiol Res, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Silvilairat, S (corresponding author), Chiang Mai Univ, Dept Pediat, Fac Med, Chiang Mai, Thailand.	asilvilairat@gmail.com	Phrommintikul, Arintaya/X-1881-2019; Charoenkwan, Pimlak/AGL-9582-2022; Charoenkwan, Pimlak/AAP-5905-2021; Chattipakorn, Nipon/AAJ-4049-2021	Phrommintikul, Arintaya/0000-0003-3986-1951; Charoenkwan, Pimlak/0000-0002-9123-9177; tantiworawit, adisak/0000-0002-2381-9292; Srichairatanakool, Somdet/0000-0002-5706-8781; Chattipakorn, Nipon/0000-0003-3026-718X	Thailand Research Fund [RSA5680014]; National Science and Technology Development Agency of Thailand (NSTDA); Research Chair grant	Thailand Research Fund(Thailand Research Fund (TRF)); National Science and Technology Development Agency of Thailand (NSTDA); Research Chair grant	This work was supported by the Thailand Research Fund, grant RSA5680014 to SSi, and by the Research Chair grant, to NC, from National Science and Technology Development Agency of Thailand (NSTDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp A, 2014, CARDIOL YOUNG, V24, P263, DOI 10.1017/S1047951113000036; Anderson LJ, 2011, PROG CARDIOVASC DIS, V54, P287, DOI 10.1016/j.pcad.2011.07.004; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Baksi AJ, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00217; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Carpenter JP, 2011, CIRCULATION, V123, P1519, DOI 10.1161/CIRCULATIONAHA.110.007641; De Chiara B, 2005, EUR J HAEMATOL, V74, P517; Fernandes JL, 2012, TRANSFUSION, V52, P2256, DOI 10.1111/j.1537-2995.2012.03580.x; Inthawong K, 2015, HEMATOLOGY, V20, P610, DOI 10.1179/1607845415Y.0000000014; Kardelen F, 2008, PEDIATR CARDIOL, V29, P935, DOI 10.1007/s00246-008-9240-1; Kirk P, 2009, CIRCULATION, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487; Koonrungsesomboon N, 2015, HEMOGLOBIN, V39, P281, DOI 10.3109/03630269.2015.1043059; Lekawanvijit S, 2009, CAN J CARDIOL, V25, P213, DOI 10.1016/S0828-282X(09)70064-9; Marsella M, 2014, HEMATOL ONCOL CLIN N, V28, P703, DOI 10.1016/j.hoc.2014.04.004; Martin A, 2013, PEDIATR CLIN N AM, V60, P1383, DOI 10.1016/j.pcl.2013.08.008; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Piga A, 2009, AM J HEMATOL, V84, P29, DOI 10.1002/ajh.21317; Poggiali E, 2012, BLOOD TRANSFUS-ITALY, V10, P411, DOI 10.2450/2012.0008-12; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Saekho S, 2013, P INT SOC MAG RES ME; Silvilairat S, 2008, EUR J ECHOCARDIOGR, V9, P368, DOI 10.1016/j.euje.2007.06.003; SINGH S, 1990, ANAL BIOCHEM, V186, P320, DOI 10.1016/0003-2697(90)90088-Q; Walker JM, 2013, HEART, V99, P827, DOI 10.1136/heartjnl-2012-302857; Ware HM, 2013, PEDIATR CLIN N AM, V60, P1393, DOI 10.1016/j.pcl.2013.09.003; Wijarnpreecha K, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.P0NE.0130837; Wood JC, 2015, BRIT J HAEMATOL, V170, P15, DOI 10.1111/bjh.13374; Wood JC, 2014, HEMATOL ONCOL CLIN N, V28, P747, DOI 10.1016/j.hoc.2014.04.002; Wood JC, 2011, HEMATOL-AM SOC HEMAT, P443, DOI 10.1182/asheducation-2011.1.443; Wood JC, 2010, ANN NY ACAD SCI, V1202, P173, DOI 10.1111/j.1749-6632.2010.05571.x; Wood John C, 2009, Hemoglobin, V33 Suppl 1, pS81, DOI 10.3109/03630260903347526; Yetimakman AF, 2014, PEDIATR HEMAT ONCOL, V31, P597, DOI 10.3109/08880018.2014.891681	32	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164300	10.1371/journal.pone.0164300	http://dx.doi.org/10.1371/journal.pone.0164300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737009	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800049
J	Luciano, MS; Wang, CL; Ortega, RA; Yu, QP; Boschung, S; Soto-Valencia, J; Bressman, SB; Lipton, RB; Pullman, S; Saunders-Pullman, R				Luciano, Marta San; Wang, Cuiling; Ortega, Roberto A.; Yu, Qiping; Boschung, Sarah; Soto-Valencia, Jeannie; Bressman, Susan B.; Lipton, Richard B.; Pullman, Seth; Saunders-Pullman, Rachel			Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson's Disease	PLOS ONE			English	Article							ESSENTIAL TREMOR; CLINICAL-TRIALS; HANDEDNESS; QUANTIFICATION; VALIDATION; DISORDERS; ASYMMETRY; SECTION; TABLET	Introduction Pre-clinical markers of Parkinson's Disease (PD) are needed, and to be relevant in pre-clinical disease, they should be quantifiably abnormal in early disease as well. Handwriting is impaired early in PD and can be evaluated using computerized analysis of drawn spirals, capturing kinematic, dynamic, and spatial abnormalities and calculating indices that quantify motor performance and disability. Digitized spiral drawing correlates with motor scores and may be more sensitive in detecting early changes than subjective ratings. However, whether changes in spiral drawing are abnormal compared with controls and whether changes are detected in early PD are unknown. Methods 138 PD subjects (50 with early PD) and 150 controls drew spirals on a digitizing tablet, generating x, y, z (pressure) data-coordinates and time. Derived indices corresponded to overall spiral execution (severity), shape and kinematic irregularity (second order smoothness, first order zero-crossing), tightness, mean speed and variability of spiral width. Linear mixed effect adjusted models comparing these indices and cross-validation were performed. Receiver operating characteristic analysis was applied to examine discriminative validity of combined indices. Results All indices were significantly different between PD cases and controls, except for zero-crossing. A model using all indices had high discriminative validity (sensitivity = 0.86, specificity = 0.81). Discriminative validity was maintained in patients with early PD. Conclusion Spiral analysis accurately discriminates subjects with PD and early PD from controls supporting a role as a promising quantitative biomarker. Further assessment is needed to determine whether spiral changes are PD specific compared with other disorders and if present in pre-clinical PD.	[Luciano, Marta San; Ortega, Roberto A.; Soto-Valencia, Jeannie; Bressman, Susan B.; Saunders-Pullman, Rachel] Mt Sinai Beth Israel Med Ctr, Dept Neurol, New York, NY 10003 USA; [Luciano, Marta San] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Wang, Cuiling] Albert Einstein Coll Med Bronx, Dept Epidemiol & Populat Hlth, New York, NY USA; [Yu, Qiping; Boschung, Sarah; Pullman, Seth] Columbia Univ, Dept Neurol, New York, NY USA; [Bressman, Susan B.; Lipton, Richard B.; Saunders-Pullman, Rachel] Albert Einstein Coll Med Bronx, Dept Neurol, New York, NY USA; [Bressman, Susan B.; Saunders-Pullman, Rachel] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA	University of California System; University of California San Francisco; Yeshiva University; Columbia University; Yeshiva University; Icahn School of Medicine at Mount Sinai	Luciano, MS (corresponding author), Mt Sinai Beth Israel Med Ctr, Dept Neurol, New York, NY 10003 USA.; Luciano, MS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	Marta.SanLucianoPalenzuela@ucsf.edu	Lipton, Richard B/B-5060-2011; Lipton, Richard Bruce/AAY-2818-2021	San Luciano, Marta/0000-0002-9885-704X	NIH [K02 NS073836, AG03949]; NIA [2 P01 AG03949]; CTSA [1UL1TR001073]; National Center for Advancing Translational Sciences (NCATS); Leonard and Sylvia Marx Foundation; Czap Foundation; Marcleod and Bigglesworth Foundations; Michael J Fox Foundation; Smart Family Foundation; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS073836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Leonard and Sylvia Marx Foundation; Czap Foundation; Marcleod and Bigglesworth Foundations; Michael J Fox Foundation; Smart Family Foundation; Parkinson's Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIH K02 NS073836 (RSP), NIH AG03949 (RSP, RBL, CW), NIA 2 P01 AG03949 (RBL, CW), CTSA 1UL1TR001073 (RBL, CW), the National Center for Advancing Translational Sciences (NCATS)(RBL, CW), the Leonard and Sylvia Marx Foundation (RBL, CW), and the Czap Foundation (RBL, CW); it was also supported by Marcleod and Bigglesworth Foundations (RSP, RO, CW, MSL), the Michael J Fox Foundation (RSP, RO, CW, MSL), the Smart Family Foundation (MSL) and the Parkinson's Disease Foundation (SB, QY, SLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett MJ, 2011, J NEUROL NEUROSUR PS, V82, P1122, DOI 10.1136/jnnp.2010.209783; ELBLE RJ, 1990, J NEUROSCI METH, V32, P193, DOI 10.1016/0165-0270(90)90140-B; Fahn S, 1987, RECENT DEV PARKINSON; Galli M, 2014, J APPL BIOMATER FUNC, V12, P107, DOI 10.5301/JABFM.2012.9265; Giuffrida JP, 2009, MOVEMENT DISORD, V24, P723, DOI 10.1002/mds.22445; Goetz CG, 2004, MOVEMENT DISORD, V19, P1453, DOI 10.1002/mds.20220; Haubenberger D, 2011, MOVEMENT DISORD, V26, P2073, DOI 10.1002/mds.23808; Hess CW, 2012, MOV DISORD SS1, V27, pS283; Hoff JI, 2001, CLIN NEUROPHARMACOL, V24, P280, DOI 10.1097/00002826-200109000-00004; Hsu AW, 2009, MOVEMENT DISORD, V24, P1984, DOI 10.1002/mds.22744; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Lakke J P, 1996, Parkinsonism Relat Disord, V2, P225, DOI 10.1016/S1353-8020(96)00023-5; Louis ED, 2012, CEREBELLUM, V11, P872, DOI 10.1007/s12311-011-0352-4; MAYEUX R, 1995, AM J EPIDEMIOL, V142, P820, DOI 10.1093/oxfordjournals.aje.a117721; Mera TO, 2012, J NEUROSCI METH, V203, P152, DOI 10.1016/j.jneumeth.2011.09.019; Mostile G, 2010, MOVEMENT DISORD, V25, P1938, DOI 10.1002/mds.23201; Muller T, 2000, CAN J NEUROL SCI, V27, P311; Nutt JG, 1997, MOVEMENT DISORD, V12, P285, DOI 10.1002/mds.870120304; O'Suilleabhain PE, 2001, MOVEMENT DISORD, V16, P265, DOI 10.1002/mds.1064; Olanow CW, 2011, MOVEMENT DISORD, V26, P1003, DOI 10.1002/mds.23727; Pullman SL, 1998, MOVEMENT DISORD, V13, P85; Saunders-Pullman R, 2008, MOVEMENT DISORD, V23, P531, DOI 10.1002/mds.21874; Smits EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097614; Stanley K, 2010, PARKINSONISM RELAT D, V16, P233, DOI 10.1016/j.parkreldis.2009.12.007; Stebbins GT, 1998, MOVEMENT DISORD, V13, P633, DOI 10.1002/mds.870130404; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; Van Gemmert AWA, 2006, HUM MOVEMENT SCI, V25, P447, DOI 10.1016/j.humov.2006.07.002; Vingerhoets FJG, 1997, ANN NEUROL, V41, P58, DOI 10.1002/ana.410410111; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Yust-Katz S, 2008, PARKINSONISM RELAT D, V14, P633, DOI 10.1016/j.parkreldis.2008.01.017	31	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0162799	10.1371/journal.pone.0162799	http://dx.doi.org/10.1371/journal.pone.0162799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732597	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505300006
J	Stephens, JL; Dinger, EC; Alexander, JD; Mohren, SR; Ralph, CJ; Sarr, DA				Stephens, Jaime L.; Dinger, Eric C.; Alexander, John D.; Mohren, Sean R.; Ralph, C. John; Sarr, Daniel A.			Bird Communities and Environmental Correlates in Southern Oregon and Northern California, USA	PLOS ONE			English	Article							KLAMATH-SISKIYOU ECOREGION; UNITED-STATES; FOREST; SCALE; CONSERVATION; BIODIVERSITY; HABITAT; PRECIPITATION; BIOGEOGRAPHY; ECOSYSTEMS	We examined avian community ecology in the Klamath Ecoregion and determined that individual bird species co-exist spatially to form 29 statistically distinguishable bird groups. We identified climate, geography, and vegetation metrics that are correlated with these 29 bird groups at three scales: Klamath Ecoregion, vegetation formation (agriculture, conifer, mixed conifer/hardwood, shrubland), and National Park Service unit. Two climate variables (breeding season mean temperature and temperature range) and one geography variable (elevation) were correlated at all scales, suggesting that for some vegetation formations and park units there is sufficient variation in climate and geography to be an important driver of bird communities, a level of variation we expected only at the broader scale. We found vegetation to be important at all scales, with coarse metrics (environmental site potential and existing vegetation formation) meaningful across all scales and structural vegetation patterns (e.g. succession, disturbance) important only at the scale of vegetation formation or park unit. Additionally, we examined how well six National Park Service units represent bird communities in the broader Klamath Ecoregion. Park units are inclusive of most bird communities with the exception of the oak woodland community; mature conifer forests are well represented, primarily associated with conifer canopy and lacking multi-layered structure. Identifying environmental factors that shape bird communities at three scales within this region is important; such insights can inform local and regional land management decisions necessary to ensure bird conservation in this globally significant region.	[Stephens, Jaime L.; Alexander, John D.; Ralph, C. John] Klamath Bird Observ, Ashland, OR 97520 USA; [Dinger, Eric C.; Mohren, Sean R.; Sarr, Daniel A.] Klamath Network, Natl Pk Serv, Ashland, OR USA; [Mohren, Sean R.] Crater Lake Natl Pk, Crater Lake, OR USA; [Ralph, C. John] USDA Forest Serv, Pacific Southwest Res Stn, Redwood Sci Lab, Arcata, CA USA	United States Department of the Interior; United States Department of Agriculture (USDA); United States Forest Service	Stephens, JL (corresponding author), Klamath Bird Observ, Ashland, OR 97520 USA.	jlh@klamathbird.org	Alexander, John/GVS-7271-2022	Stephens, Jaime/0000-0002-4929-5263	United States Department of Interior National Park Service [P13AC01404]	United States Department of Interior National Park Service	Funding for this paper was provided to Klamath Bird Observatory by the United States Department of Interior National Park Service through Task Agreement P13AC01404. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the opinions or policies of the U.S. Government. Mention of trade names or commercial products does not constitute their endorsement by the U.S. Government.	Alexander J.S., 2011, THESIS, P77; Allen T. F. H., 1982, HIERARCHY PERSPECTIV; Anderson MP, 1902, P ACAD NAT SCI PA, V55, P4; Arnold D, 2014, NATL MAP HYDROGRAPHY; Blondel J, 2003, OIKOS, V100, P223, DOI 10.1034/j.1600-0706.2003.12152.x; Canterbury GE, 2000, CONSERV BIOL, V14, P544, DOI 10.1046/j.1523-1739.2000.98235.x; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coblentz DD, 2004, J BIOGEOGR, V31, P1125, DOI 10.1111/j.1365-2699.2004.00981.x; Contreras, 2006, BIRDS OREGON GEN REF; Cushman SA, 2004, ECOL APPL, V14, P1090, DOI 10.1890/03-5131; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; DEGRAAF RM, 1985, ENVIRON MANAGE, V9, P493, DOI 10.1007/BF01867324; DellaSala DA, 1999, NAT AREA J, V19, P300; Di Luzio M, 2008, J APPL METEOROL CLIM, V47, P475, DOI 10.1175/2007JAMC1356.1; Diaz L, 2006, FOREST ECOL MANAG, V223, P54, DOI 10.1016/j.foreco.2005.10.061; Dietz RW, 2005, CONSERV BIOL, V19, P1478, DOI 10.1111/j.1523-1739.2005.00114.x; Diller JS, 1902, TOPOGRAPHIC DEV KLAM; Franklin J.F., 1988, US DEP AGR FOR SERV, P8; Grinnell J, 1914, AM NAT, V48, P248, DOI 10.1086/279402; JOHNSON NK, 1978, GREAT BASIN NAT, V2, P137; Knick ST, 2008, ECOGRAPHY, V31, P389, DOI 10.1111/j.0906-7590.2008.05391.x; KNOPF FL, 1994, CONSERV BIOL, V8, P669, DOI 10.1046/j.1523-1739.1994.08030669.x; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Manly BFJ, 1997, RANDOMIZATION BOOTST; MAURER BA, 1985, ECOL MONOGR, V55, P295, DOI 10.2307/1942579; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MITCHELL VL, 1976, J APPL METEOROL, V15, P920, DOI 10.1175/1520-0450(1976)015<0920:TROCIT>2.0.CO;2; MODIS, 2012, MOD LAI FPAR PROD US; Monahan W. B., 2012, NPSNRSSNRTR2012578; NASA Land Processes Distributed Active Archive Center, 2001, MCD15A2 NASA EROS LA; National Park Service, 2014, NPSCAPE MON LANDSC D; O'Connor Raymond J., 1996, Biodiversity Letters, V3, P97, DOI 10.2307/2999723; Olsen AR, 2012, DESIGN ANAL LONG TER, DOI [10.1017/CBO9781139022422, DOI 10.1017/CBO9781139022422]; PRISM Climate Group, 2010, 800M 30 YEAR NORM MA; Ralph C.J., 1993, PSWGTR144WWW USDA; Robinson WD, 2000, ECOL MONOGR, V70, P209, DOI 10.1890/0012-9615(2000)070[0209:FBCSIC]2.0.CO;2; Sawyer JO, 2006, NW CALIFORNIA NATURA; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Seavy NE, 2011, J WILDLIFE MANAGE, V75, P344, DOI 10.1002/jwmg.37; Sellars R.W., 2009, PRESERVING NATURE NA; Siegel Rodney B., 2012, Northwestern Naturalist, V93, P23; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Strittholt JR, 2001, CONSERV BIOL, V15, P1742, DOI 10.1046/j.1523-1739.2001.99577.x; SWIFT BL, 1984, WATER RESOUR BULL, V20, P223; TERBORGH J, 1985, ECOLOGY, V66, P1237, DOI 10.2307/1939177; TERBORGH J, 1970, ECOLOGY, V52, P23; Trail PW, 1997, P 1 C SISK EC CAV JU; U. S. Geological Survey, 2013, NAT HYDR GEOD; U. S. Geological Survey, 2013, LANDFIRE; Udvardy M.D.F., 1975, CLASSIFICATION BIOGE; Vance-Borland Ken, 1995, Wild Earth, V5, P52; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Wiens J., 1989, ECOLOGY BIRD COMMUNI, DOI [10.1017/CBO9780511608568, DOI 10.1017/CBO9780511608568]; WIENS JA, 1981, AM NAT, V117, P90, DOI 10.1086/283689; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x	59	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163906	10.1371/journal.pone.0163906	http://dx.doi.org/10.1371/journal.pone.0163906			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732625	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505300033
J	Zhao, B; Ata-Ul-Karim, ST; Yao, X; Tian, YC; Cao, WX; Zhu, Y; Liu, XJ				Zhao, Ben; Ata-Ul-Karim, Syed Tahir; Yao, Xia; Tian, YongChao; Cao, WeiXing; Zhu, Yan; Liu, XiaoJun			A New Curve of Critical Nitrogen Concentration Based on Spike Dry Matter for Winter Wheat in Eastern China	PLOS ONE			English	Article							DILUTION CURVE; USE EFFICIENCY; GRAIN-YIELD; CHLOROPHYLL MEASUREMENTS; NUTRITION INDEX; ACCUMULATION; CROP; CORN; MANAGEMENT; RICE	Diagnosing the status of crop nitrogen (N) helps to optimize crop yield, improve N use efficiency, and reduce the risk of environmental pollution. The objectives of the present study were to develop a critical N (N-c) dilution curve for winter wheat (based on spike dry matter [SDM] during the reproductive growth period), to compare this curve with the existing N-c dilution curve (based on plant dry matter [DM] of winter wheat), and to explore its ability to reliably estimate the N status of winter wheat. Four field experiments, using varied N fertilizer rates (0-375 kg ha(-1)) and six cultivars (Yangmai16, Ningmai13, Ningmai9, Aikang58, Yangmai12, Huaimai 17), were conducted in the Jiangsu province of eastern China. Twenty plants from each plot were sampled to determine the SDM and spike N concentration (SNC) during the reproductive growth period. The spike N-c curve was described by N-c = 2.85xSDM(-0.17), with SDM ranging from 0.752 to 7.233 t ha(-1). The newly developed curve was lower than the N-c curve based on plant DM. The N nutrition index (NNI) for spike dry matter ranged from 0.62 to 1.1 during the reproductive growth period across the seasons. Relative yield (RY) increased with increasing NNI; however, when NNI was greater than 0.96, RY plateaued and remained stable. The spike N-c dilution curve can be used to correctly identify the N nutrition status of winter wheat to support N management during the reproductive growth period for winter wheat in eastern China.	[Zhao, Ben; Ata-Ul-Karim, Syed Tahir; Yao, Xia; Tian, YongChao; Cao, WeiXing; Zhu, Yan; Liu, XiaoJun] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Jiangsu Key Lab Informat Agr, Natl Engn & Technol Ctr Informat Agr, Nanjing, Jiangsu, Peoples R China; [Zhao, Ben] Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Minist Agr, Key Lab Crop Water Use & Regulat, Xinxiang, Henan, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, XJ (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Jiangsu Key Lab Informat Agr, Natl Engn & Technol Ctr Informat Agr, Nanjing, Jiangsu, Peoples R China.	liuxj@njau.edu.cn	Ata-Ul-Karim, Syed Tahir/AAB-6257-2020; Zhu, Yan/AAK-6927-2020; Ata-Ul-Karim, Syed Tahir/F-7468-2017	Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502; Zhu, Yan/0000-0002-8912-3888; Ata-Ul-Karim, Syed Tahir/0000-0001-5233-4502	National Key Research & Development Program of China [2016YFD0300604, 2016YFD0200602]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Henan Province [162300410154]; Special Program for Agriculture Science and Technology from the Ministry of Agriculture in China [201303109]; National High-Tech Research and Development Program of China [2013AA100404]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China (PAPD); 111 project [B16026]	National Key Research & Development Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Henan Province; Special Program for Agriculture Science and Technology from the Ministry of Agriculture in China; National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions of China (PAPD); 111 project(Ministry of Education, China - 111 Project)	The work was supported by the National Key Research & Development Program of China (2016YFD0300604; 2016YFD0200602), the Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Henan Province (162300410154), the Special Program for Agriculture Science and Technology from the Ministry of Agriculture in China (201303109), the National High-Tech Research and Development Program of China (2013AA100404), the Priority Academic Program Development of Jiangsu Higher Education Institutions of China (PAPD) and the 111 project (B16026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arduini I, 2006, EUR J AGRON, V25, P309, DOI 10.1016/j.eja.2006.06.009; Ata-Ul-Karim ST, 2016, FIELD CROP RES, V195, P1, DOI 10.1016/j.fcr.2016.04.027; Ata-Ul-Karim ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104540; Ata-Ul-Karim ST, 2013, FIELD CROP RES, V149, P149, DOI 10.1016/j.fcr.2013.03.012; BARNEIX AJ, 1992, PHYSIOL PLANTARUM, V86, P609, DOI 10.1111/j.1399-3054.1992.tb02177.x; BINFORD GD, 1992, AGRON J, V84, P53, DOI 10.2134/agronj1992.00021962008400010012x; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; Chen PF, 2010, REMOTE SENS ENVIRON, V114, P1987, DOI 10.1016/j.rse.2010.04.006; Ciampitti IA, 2013, CROP SCI, V53, P366, DOI 10.2135/cropsci2012.07.0439; Confalonieri R, 2011, J AGR SCI-CAMBRIDGE, V149, P633, DOI 10.1017/S0021859611000177; Cui ZL, 2009, AGRON J, V101, P159, DOI 10.2134/agronj2008.0102; Demotes-Mainard S, 2004, FIELD CROP RES, V87, P221, DOI 10.1016/j.fcr.2003.11.014; Dobemann AR, 2005, NITROGEN USE EFFICIE; Duan YH, 2014, FIELD CROP RES, V157, P47, DOI 10.1016/j.fcr.2013.12.012; Enquist BJ, 2007, INT J PLANT SCI, V168, P729, DOI 10.1086/513479; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; Gayler S, 2002, GEODERMA, V105, P367, DOI 10.1016/S0016-7061(01)00113-6; Guarda G, 2004, EUR J AGRON, V21, P181, DOI 10.1016/j.eja.2003.08.001; Hoogmoed M, 2016, FIELD CROP RES, V193, P196, DOI 10.1016/j.fcr.2016.04.009; Jing Q, 2009, J AGR SCI, V147, P303, DOI 10.1017/S0021859609008466; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Kage H, 2002, PLANT SOIL, V246, P201, DOI 10.1023/A:1020627723616; Khan A, 2014, J PLANT NUTR, V37, P723, DOI 10.1080/01904167.2013.867989; LEMAIRE G, 1984, AGRONOMIE, V4, P423, DOI 10.1051/agro:19840503; Lemaire G., 1997, DIAGNOSIS NITROGEN S, P3, DOI [DOI 10.1007/978-3-642-60684-7, 10.1007/978-3-642-60684-7, DOI 10.1007/978-3-642-60684-7_1]; Lemaire G, 2008, EUR J AGRON, V28, P614, DOI 10.1016/j.eja.2008.01.005; Lemaire G, 2007, FIELD CROP RES, V100, P91, DOI 10.1016/j.fcr.2006.05.009; Li X, 2011, ACTA ECOLOGICA SINIC, V31, P31, DOI DOI 10.1002/SIM.4341; Lu ZengGen, 2006, Journal of Triticeae Crops, V26, P75; MACKOWN CT, 1992, PLANT PHYSIOL, V99, P1469, DOI 10.1104/pp.99.4.1469; Martre P, 2003, PLANT PHYSIOL, V133, P1959, DOI 10.1104/pp.103.030585; Mead R., 1983, STAT METAHODS AGR EX, P157; Pan Q. M., 1999, ACTA AGRON SIN, V25, P540; Penning de Vries F.W.T, 1982, SIMULATION MONOGRAPH; Plenet D., 1997, DIAGNOSIS NITROGEN S, P93; Reyes J, 2015, AGRON SUSTAIN DEV, V35, P1561, DOI 10.1007/s13593-015-0321-2; Ritchie J.T., 1988, CERES WHEAT; [史天昊 Shi Tianhao], 2015, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V21, P1496; Statistical Bureau of China, 2014, CHINA STATISTICAL YE; Stockle CO, 1997, EUR J AGRON, V7, P161, DOI 10.1016/S1161-0301(97)00038-5; Wang FH, 2009, FIELD CROP RES, V111, P181, DOI 10.1016/j.fcr.2008.12.004; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Xue XiaoPing, 2007, Acta Agronomica Sinica, V33, P669; Yao X, 2014, FIELD CROP RES, V159, P33, DOI 10.1016/j.fcr.2013.12.007; Yuan ZF, 2016, FIELD CROP RES, V185, P12, DOI 10.1016/j.fcr.2015.10.003; Yue SC, 2012, AGRON J, V104, P523, DOI 10.2134/agronj2011.0258; Zhao B, 2016, FIELD CROP RES, V185, P59, DOI 10.1016/j.fcr.2015.10.021; Zhao B, 2014, AGRON J, V106, P379, DOI 10.2134/agronj2013.0213; Ziadi N, 2008, AGRON J, V100, P1264, DOI 10.2134/agronj2008.0016; Ziadi N, 2009, AGRON J, V101, P947, DOI 10.2134/agronj2008.0172x	51	24	29	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164545	10.1371/journal.pone.0164545	http://dx.doi.org/10.1371/journal.pone.0164545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732634	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300064
J	Delgado-Balbuena, L; Bello-Lopez, JM; Navarro-Noya, YE; Rodriguez-Valentin, A; Luna-Guido, ML; Dendooven, L				Delgado-Balbuena, Laura; Bello-Lopez, Juan M.; Navarro-Noya, Yendi E.; Rodriguez-Valentin, Analine; Luna-Guido, Marco L.; Dendooven, Luc			Changes in the Bacterial Community Structure of Remediated Anthracene-Contaminated Soils	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; POLLUTED SOIL; AGED DIESEL; REMOVAL; BIOREMEDIATION; BIODEGRADATION; DEGRADATION; EARTHWORMS; BIOAVAILABILITY; CULTIVATION	Mixing soil or adding earthworms (Eisenia fetida (Savigny, 1826)) accelerated the removal of anthracene, a polycyclic aromatic hydrocarbon, from a pasture and an arable soil, while a non-ionic surfactant (Surfynol((R)) 485) inhibited the removal of the contaminant compared to the untreated soil. It was unclear if the treatments affected the soil bacterial community and consequently the removal of anthracene. Therefore, the bacterial community structure was monitored by means of 454 pyrosequencing of the 16S rRNA gene in the pasture and arable soil mixed weekly, amended with Surfynol((R)) 485, E. fetida or organic material that served as food for the earthworms for 56 days. In both soils, the removal of anthracene was in the order: mixing soil weekly (100%) > earthworms applied (92%) > organic material applied (77%) > untreated soil (57%) > surfactant applied (34%) after 56 days. There was no clear link between removal of anthracene from soil and changes in the bacterial community structure. On the one hand, application of earthworms removed most of the contaminant from the arable soil and had a strong effect on the bacterial community structure, i.e. a decrease in the relative abundance of the Acidobacteria, Chloroflexi and Gemmatimonadetes, and an increase in that of the Proteobacteria compared to the unamended soil. Mixing the soil weekly removed all anthracene from the arable soil, but had little or no effect on the bacterial community structure. On the other hand, application of the surfactant inhibited the removal of anthracene from the arable soil compared to the untreated soil, but had a strong effect on the bacterial community structure, i.e. a decrease in the relative abundance of Cytophagia (Bacteroidetes), Chloroflexi, Gemmatimonadetes and Planctomycetes and an increase in that of the Flavobacteria (Bacteroidetes) and Proteobacteria. Additionally, the removal of anthracene was similar in the different treatments of both the arable and pasture soil, but the effect of application of carrot residue, earthworms or the surfactant on the bacterial community structure was more accentuated in the arable soil than in the pasture soil. It was found that removal of anthracene was not linked to changes in the bacterial community structure.	[Delgado-Balbuena, Laura; Bello-Lopez, Juan M.; Navarro-Noya, Yendi E.; Rodriguez-Valentin, Analine; Luna-Guido, Marco L.; Dendooven, Luc] CINVESTAV, ABACUS, Lab Soil Ecol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Dendooven, L (corresponding author), CINVESTAV, ABACUS, Lab Soil Ecol, Mexico City, DF, Mexico.	dendooven@me.com	Navarro-Noya, Yendi E/A-7703-2012; Bello-López, Juan Manuel JMBL/A-9681-2017	Navarro-Noya, Yendi E/0000-0002-7191-7815; 	Cinvestav; 'Instituto de Ciencia y Tecnologia del Distrito Federal' (ICTyDF, Mexico); 'Consejo Nacional de Ciencia y Tecnologia' (CONACyT, Mexico) [205945]; 'Sistema Nacional de Investigadores' (SNI)	Cinvestav; 'Instituto de Ciencia y Tecnologia del Distrito Federal' (ICTyDF, Mexico); 'Consejo Nacional de Ciencia y Tecnologia' (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 'Sistema Nacional de Investigadores' (SNI)	The research was funded by 'Cinvestav', 'Instituto de Ciencia y Tecnologia del Distrito Federal' (ICTyDF, Mexico), project 'Infraestructura 205945' and 'Apoyo Especial para Fortalecimiento de Doctorado PNPC 2013' from 'Consejo Nacional de Ciencia y Tecnologia' (CONACyT, Mexico). LD-B and JMB-L received grant-aided support from 'Consejo Nacional de Ciencia y Tecnologia' (CONACyT, Mexico), while AR-V from 'Sistema Nacional de Investigadores' (SNI). The authors thank ABACUS (CONACyT) for providing time on their computer for denoising the DNA sequences.	Blouin M, 2013, EUR J SOIL SCI, V64, P161, DOI 10.1111/ejss.12025; Book AJ, 2014, APPL ENVIRON MICROB, V80, P4692, DOI 10.1128/AEM.01133-14; Brinch UC, 2002, APPL ENVIRON MICROB, V68, P1808, DOI 10.1128/AEM.68.4.1808-1816.2002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cardenas-Aquino MR, 2014, PEDOSPHERE, V24, P783, DOI 10.1016/S1002-0160(14)60065-5; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Castro-Silva C, 2015, J ENVIRON BIOL, V36, P229; Ceja-Navarro JA, 2010, APPL ENVIRON MICROB, V76, P3685, DOI 10.1128/AEM.02726-09; Chen M, 2015, BIOTECHNOL ADV, V33, P745, DOI 10.1016/j.biotechadv.2015.05.003; Das Nilanjana, 2011, Biotechnol Res Int, V2011, P941810, DOI 10.4061/2011/941810; Delgado-Balbuena L, 2013, ECOTOX ENVIRON SAFE, V96, P238, DOI 10.1016/j.ecoenv.2013.06.034; Delgado-Balbuena L, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1420-1; Dias RL, 2012, INT BIODETER BIODEGR, V75, P96, DOI 10.1016/j.ibiod.2012.07.020; Dumova VA, 2009, MICROBIOLOGY+, V78, P234, DOI 10.1134/S0026261709020155; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Franzetti A, 2010, ADV EXP MED BIOL, V672, P121; Ghanem A, 2013, CLEAN-SOIL AIR WATER, V41, P1222, DOI 10.1002/clen.201200601; Goodwin KD, 2005, APPL ENVIRON MICROB, V71, P3495, DOI 10.1128/AEM.71.7.3495-3503.2005; Gutierrez T, 2011, APPL ENVIRON MICROB, V77, P7856, DOI 10.1128/AEM.06200-11; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harris KL, 2013, EXPERT OPIN DRUG MET, V9, P1465, DOI 10.1517/17425255.2013.823157; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hosokawa R, 2009, WORLD J MICROB BIOT, V25, P1519, DOI 10.1007/s11274-009-0044-0; Huang K, 2014, BIORESOURCE TECHNOL, V170, P45, DOI 10.1016/j.biortech.2014.07.058; Jing YP, 2013, PEDOSPHERE, V23, P523, DOI 10.1016/S1002-0160(13)60045-4; Leys NMEJ, 2004, APPL ENVIRON MICROB, V70, P1944, DOI 10.1128/AEM.70.4.1944-1955.2004; Li XZ, 2012, SOIL BIOL BIOCHEM, V47, P191, DOI 10.1016/j.soilbio.2012.01.001; Llado S, 2013, SOIL BIOL BIOCHEM, V67, P114, DOI 10.1016/j.soilbio.2013.08.010; Llado S, 2013, J HAZARD MATER, V248, P407, DOI 10.1016/j.jhazmat.2013.01.020; Martinez-Lavanchy PM, 2015, APPL ENVIRON MICROB, V81, P6241, DOI 10.1128/AEM.01822-15; Martinez-Martinez M, 2014, MICROB BIOTECHNOL, V7, P184, DOI 10.1111/1751-7915.12107; Musselman SW, 2002, J COLLOID INTERF SCI, V256, P91, DOI 10.1006/jcis.2001.7987; Naether A, 2012, APPL ENVIRON MICROB, V78, P7398, DOI 10.1128/AEM.01325-12; Navarro-Noya YE, 2013, SOIL BIOL BIOCHEM, V65, P86, DOI 10.1016/j.soilbio.2013.05.009; Negassa WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123999; O'Neill T, 2013, POLAR BIOL, V36, P985, DOI 10.1007/s00300-013-1322-8; Qi W, 2011, J BIOBASED MATER BIO, V5, P75, DOI 10.1166/jbmb.2011.1123; Rodrigues A, 2013, INT BIODETER BIODEGR, V83, P48, DOI 10.1016/j.ibiod.2013.04.001; Rodriguez-Campos J, 2014, APPL SOIL ECOL, V79, P10, DOI 10.1016/j.apsoil.2014.02.010; Sambrook J., 2001, MOL CLONING LAB MANU; *SAS I, 1989, STAT GUID PERS COMP; Somtrakoon K, 2014, INT J PHYTOREMEDIAT, V16, P415, DOI 10.1080/15226514.2013.803024; Song Y. F., 1995, CHIN J APPL ECOL, V6, P92; Sun HM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01059; Sutton NB, 2013, BIODEGRADATION, V24, P487, DOI 10.1007/s10532-012-9605-2; Uhlik O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040653; van Dorst J, 2014, APPL ENVIRON MICROB, V80, P4021, DOI 10.1128/AEM.03939-13; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu GZ, 2014, CHEMOSPHERE, V107, P43, DOI 10.1016/j.chemosphere.2014.03.035; Wu YR, 2014, INT BIODETER BIODEGR, V86, P382, DOI 10.1016/j.ibiod.2013.10.015; Wust PK, 2011, ISME J, V5, P92, DOI 10.1038/ismej.2010.99; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0; Zhang XZ, 2014, CURR MICROBIOL, V68, P756, DOI 10.1007/s00284-014-0535-6	55	9	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0160991	10.1371/journal.pone.0160991	http://dx.doi.org/10.1371/journal.pone.0160991			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727277	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504400001
J	Gilbey, J; Cauwelier, E; Coulson, MW; Stradmeyer, L; Sampayo, JN; Armstrong, A; Verspoor, E; Corrigan, L; Shelley, J; Middlemas, S				Gilbey, John; Cauwelier, Eef; Coulson, Mark W.; Stradmeyer, Lee; Sampayo, James N.; Armstrong, Anja; Verspoor, Eric; Corrigan, Laura; Shelley, Jonathan; Middlemas, Stuart			Accuracy of Assignment of Atlantic Salmon (Salmo salar L.) to Rivers and Regions in Scotland and Northeast England Based on Single Nucleotide Polymorphism (SNP) Markers	PLOS ONE			English	Article							GENETIC STOCK IDENTIFICATION; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; LIFE-HISTORY; SOCKEYE-SALMON; PACIFIC SALMON; OCEAN CLIMATE; BERING-SEA; LOCI; MICROSATELLITE	Understanding the habitat use patterns of migratory fish, such as Atlantic salmon (Salmo salar L.), and the natural and anthropogenic impacts on them, is aided by the ability to identify individuals to their stock of origin. Presented here are the results of an analysis of informative single nucleotide polymorphic (SNP) markers for detecting genetic structuring in Atlantic salmon in Scotland and NE England and their ability to allow accurate genetic stock identification. 3,787 fish from 147 sites covering 27 rivers were screened at 5,568 SNP markers. In order to identify a cost-effective subset of SNPs, they were ranked according to their ability to differentiate between fish from different rivers. A panel of 288 SNPs was used to examine both individual assignments and mixed stock fisheries and eighteen assignment units were defined. The results improved greatly on previously available methods and, for the first time, fish caught in the marine environment can be confidently assigned to geographically coherent units within Scotland and NE England, including individual rivers. As such, this SNP panel has the potential to aid understanding of the various influences acting upon Atlantic salmon on their marine migrations, be they natural environmental variations and/or anthropogenic impacts, such as mixed stock fisheries and interactions with marine power generation installations.	[Gilbey, John; Cauwelier, Eef; Stradmeyer, Lee; Sampayo, James N.; Armstrong, Anja; Verspoor, Eric; Middlemas, Stuart] Freshwater Fisheries Lab, Marine Scotland Sci, Faskally PH16 5LB, Pitlochry, Scotland; [Coulson, Mark W.] Rivers & Fisheries Trusts Scotland, Suite 1F40,2 Commercial St, Edinburgh EH6 6JA, Midlothian, Scotland; [Corrigan, Laura; Shelley, Jonathan] Environm Agcy, Tyneside House,Newcastle Business Pk, Newcastle Upon Tyne NE4 7AR, Tyne & Wear, England; [Coulson, Mark W.; Verspoor, Eric] Univ Highlands & Isl, Inverness Coll, Rivers & Lochs Inst, Inverness IV1 1SA, Scotland	Marine Scotland Science (MSS); UHI Millennium Institute	Gilbey, J (corresponding author), Freshwater Fisheries Lab, Marine Scotland Sci, Faskally PH16 5LB, Pitlochry, Scotland.	John.Gilbey@gov.scot	Verspoor, Eric/AAI-2362-2019		Marine Scotland Science; Environment Agency	Marine Scotland Science; Environment Agency	This work was funded by Marine Scotland Science and the Environment Agency.	Ackerman MW, 2011, T AM FISH SOC, V140, P865, DOI 10.1080/00028487.2011.588137; ALLENDORF FW, 1981, CAN J FISH AQUAT SCI, V38, P1507, DOI 10.1139/f81-203; ALTUKHOV YP, 1981, CAN J FISH AQUAT SCI, V38, P1523, DOI 10.1139/f81-205; Anderson EC, 2010, MOL ECOL RESOUR, V10, P701, DOI 10.1111/j.1755-0998.2010.02846.x; Anderson EC, 2008, CAN J FISH AQUAT SCI, V65, P1475, DOI 10.1139/F08-049; [Anonymous], 2011, ADV UNDERSTANDING AT; [Anonymous], 2012, SALMONID FRESHWATER; [Anonymous], 2015, STATUS SCOTTISH SALM; [Anonymous], 2014, SALMON SEA TROUT CAT; Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Beacham TD, 2012, MAR COAST FISH, V4, P1, DOI 10.1080/19425120.2011.649391; Begg GA, 1999, FISH RES, V43, P1, DOI 10.1016/S0165-7836(99)00062-4; Bourret V, 2013, MOL ECOL, V22, P532, DOI 10.1111/mec.12003; CARVALHO GR, 1993, J FISH BIOL, V43, P53, DOI 10.1111/j.1095-8649.1993.tb01179.x; Clancy B, J NEUROSCI METH, V83, P97, DOI [10.1016/S0165-0270(98)00066-1, DOI 10.1016/S0165-0270(98)00066-1, DOI 10.1016/S0165-7836(99)00066-1]; Crozier WW, 2004, ICES J MAR SCI, V61, P1344, DOI 10.1016/j.icesjms.2004.08.013; Davidsen JG, 2009, J FISH BIOL, V75, P1700, DOI 10.1111/j.1095-8649.2009.02423.x; Dieckmann U, 2009, ICES INSIGHT, V9, P33; Dufresne F, 2016, MOL ECOL RESOUR, V16, P7, DOI 10.1111/1755-0998.12477; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Ellis JS, 2011, GENETICA, V139, P353, DOI 10.1007/s10709-011-9554-4; Enberg K, 2009, EVOL APPL, V2, P394, DOI 10.1111/j.1752-4571.2009.00077.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Friedland KD, 1998, CAN J FISH AQUAT SCI, V55, P119, DOI 10.1139/cjfas-55-S1-119; FRIEDLAND KD, 1994, CAN J FISH AQUAT SCI, V51, P91, DOI 10.1139/f94-011; Friedland KD, 2000, ICES J MAR SCI, V57, P419, DOI 10.1006/jmsc.1999.0639; Gidskehaug L, 2011, BIOINFORMATICS, V27, P303, DOI 10.1093/bioinformatics/btq673; Gilbey J, 2005, ICES J MAR SCI, V62, P1609, DOI 10.1016/j.icesjms.2005.07.001; Gilbey J., 2012, GENETIC INVESTIGATIO, V4; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Griffiths AM, 2011, BIOL CONSERV, V144, P2733, DOI 10.1016/j.biocon.2011.07.017; Griffiths AM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-31; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hansen LP, 2003, ICES J MAR SCI, V60, P110, DOI 10.1006/jmsc.2002.1324; Hess JE, 2011, MOL ECOL RESOUR, V11, P137, DOI 10.1111/j.1755-0998.2010.02958.x; Houston RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-90; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Hutchings JA, 1998, CAN J FISH AQUAT SCI, V55, P22, DOI 10.1139/cjfas-55-S1-22; ICES, 2014, REP WORK GROUP N ATL; ICES, 2008, WORKSH SALM HIST INF; Ikediashi C, 2012, ECOL EVOL, V2, P2532, DOI 10.1002/ece3.353; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Johnston SE, 2014, MOL ECOL, V23, P3452, DOI 10.1111/mec.12832; Johnston SE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-439; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Kalinowski S.T., 2007, ONCOR COMPUTER PROGR; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; King TL, 2001, MOL ECOL, V10, P807, DOI 10.1046/j.1365-294X.2001.01231.x; Koljonen ML, 1996, J FISH BIOL, V49, P998, DOI 10.1111/j.1095-8649.1996.tb00096.x; Larson WA, 2014, CAN J FISH AQUAT SCI, V71, P698, DOI 10.1139/cjfas-2013-0502; Larson WA, 2013, CAN J FISH AQUAT SCI, V70, P128, DOI 10.1139/cjfas-2012-0233; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Limborg MT, 2016, MOL ECOL, V25, P2117, DOI 10.1111/mec.13601; MacKenzie KM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00021; Malcolm I. A., 2010, REV MIGRATORY ROUTES, DOI [10.1093/icesjms/2.1.38, DOI 10.1093/ICESJMS/2.1.38]; Malcolm IA, 2013, 0513 MAR SCOTL SCI; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Moriya S, 2007, MAR BIOTECHNOL, V9, P179, DOI 10.1007/s10126-006-6079-4; Narum SR, 2008, MOL ECOL, V17, P3464, DOI 10.1111/j.1365-294X.2008.03851.x; Naswa S, 2014, 10 WORLD C GEN APPL; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Olafsson K, 2010, MOL ECOL RESOUR, V10, P533, DOI 10.1111/j.1755-0998.2009.02781.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PALS N, 1982, NETH J ZOOL, V32, P479; Palstra FP, 2007, MOL ECOL, V16, P4504, DOI 10.1111/j.1365-294X.2007.03541.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Potter E.C.E., 2000, P19; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2013, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RICKER WE, 1981, CAN J FISH AQUAT SCI, V38, P1636, DOI 10.1139/f81-213; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Seeb LW, 2011, MOL ECOL RESOUR, V11, P195, DOI 10.1111/j.1755-0998.2010.02966.x; Seeb LW, 2011, T AM FISH SOC, V140, P734, DOI 10.1080/00028487.2011.584493; Selmecki AM, 2015, NATURE, V519, P349, DOI 10.1038/nature14187; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smith CT, 2005, N AM J FISH MANAGE, V25, P944, DOI 10.1577/M04-143.1; Sokal R.R., 2012, BIOMETRY; Storer CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049018; Theriault V, 2008, EVOL APPL, V1, P409, DOI 10.1111/j.1752-4571.2008.00022.x; Thorstad Eva B., 2011, P1; Toke D, 2011, ENERG POLICY, V39, P526, DOI 10.1016/j.enpol.2010.08.043; UTTER FM, 1974, BIOCH BIOPHYSICAL PE, V1, P213; Vaha JP, 2011, EVOL APPL, V4, P39, DOI 10.1111/j.1752-4571.2010.00131.x; Verspoor E, 1997, ICES J MAR SCI, V54, P965, DOI 10.1016/S1054-3139(97)80001-X; Waples RS, 2008, FISHERIES, V33, P76; Waples RS, 2010, MOL ECOL, V19, P2599, DOI 10.1111/j.1365-294X.2010.04675.x; WAPLES RS, 1990, FISHERIES, V15, P19, DOI 10.1577/1548-8446(1990)015&lt;0019:GATTMO&gt;2.0.CO;2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wennevik V, 2004, ENVIRON BIOL FISH, V69, P143, DOI 10.1023/B:EBFI.0000022890.15512.29; Whitlock MC, 2015, AM NAT, V186, pS24, DOI 10.1086/682949; Williams H.H., 1992, Reviews in Fish Biology and Fisheries, V2, P144, DOI 10.1007/BF00042882	98	28	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164327	10.1371/journal.pone.0164327	http://dx.doi.org/10.1371/journal.pone.0164327			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723810	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100044
J	Onyango, MA; Burkhardt, G; Scott, J; Rouhani, S; Haider, S; Greiner, A; Albutt, K; Mullen, C; VanRooyen, M; Bartels, S				Onyango, Monica Adhiambo; Burkhardt, Gillian; Scott, Jennifer; Rouhani, Shada; Haider, Sadia; Greiner, Ashley; Albutt, Katherine; Mullen, Colleen; VanRooyen, Michael; Bartels, Susan			A Qualitative Analysis of Disclosure Patterns among Women with Sexual Violence-Related Pregnancies in Eastern Democratic Republic of Congo	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; MENTAL-HEALTH; ABORTION	The Democratic Republic of the Congo (DRC) has experienced nearly two decades of civil conflict in the Eastern regions of North and South Kivu. This conflict has been notorious for the use of sexual violence as a weapon of war, leading in many cases to pregnancy after rape. The objectives of this analysis were: 1) to describe patterns of sexual violence-related pregnancy (SVRP) disclosure; 2) to consider why survivors chose to disclose to particular individuals; and 3) to examine the dialogue around SVRPs between women with SVRPs and their confidants. In South Kivu Province, Democratic Republic of Congo, two subgroups of sexual violence survivors completed qualitative interviews, those currently raising a child from an SVRP (parenting group, N = 38) and those who had terminated an SVRP (termination group, N = 17). The findings show that a majority of SVRPs were conceived when participants were held in sexual captivity for prolonged periods of time. The SVRPs were disclosed to friends, family members, other sexual violence survivors, community members, spouses, health care providers, or perpetrators. The confidants were most often chosen because they were perceived by the participants as being discreet, trusted, and supportive. The confidants often provided advice about continuing or terminating the SVRP. Trust and discretion are the most important factors determining to whom women with SVRPs disclose their pregnancies. The vital role of confidants in giving support after disclosure cannot be overlooked. Providing opportunities for survivors to safely disclose their SVRPs, including to health care providers, is a necessary first step in allowing them to access safe and comprehensive post-assault care and services.	[Onyango, Monica Adhiambo] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA; [Burkhardt, Gillian; Scott, Jennifer; Rouhani, Shada; Greiner, Ashley; Albutt, Katherine; VanRooyen, Michael; Bartels, Susan] Harvard Humanitarian Initiat, Cambridge, MA USA; [Burkhardt, Gillian] Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA; [Scott, Jennifer] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Scott, Jennifer] Brigham & Womens Hosp, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA; [Scott, Jennifer; Rouhani, Shada; Albutt, Katherine; VanRooyen, Michael; Bartels, Susan] Harvard Med Sch, Boston, MA USA; [Rouhani, Shada; VanRooyen, Michael] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Haider, Sadia] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA; [Greiner, Ashley; Bartels, Susan] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Albutt, Katherine] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Mullen, Colleen] Boston Med Ctr, Dept Psychiat, Boston, MA USA; [VanRooyen, Michael] Harvard Sch Publ Hlth, Boston, MA USA; [Bartels, Susan] Queens Univ, Dept Emergency Med, Kingston, ON, Canada	Boston University; Harvard University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Boston Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Queens University - Canada	Onyango, MA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.	monyango@bu.edu	Bartels, Susan/Q-8756-2019	Bartels, Susan/0000-0003-2782-3480; Rouhani, Shada/0000-0002-2801-192X; Onyango, Monica Adhiambo/0000-0003-4998-1682	Eleanor Miles Shore Foundation [GL Dept] [01025283]; Harvard Humanitarian Initiative; Eleanor Miles Shore Foundation at the Harvard Medical School	Eleanor Miles Shore Foundation [GL Dept]; Harvard Humanitarian Initiative; Eleanor Miles Shore Foundation at the Harvard Medical School	This work was supported by Eleanor Miles Shore Foundation [GL Dept ID 01025283] and the Harvard Humanitarian Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to our partners: Centre d'Assistance Medico-Psychosociale (CAMPS), Acteurs Dans le Development et Droit a la Sante Pour Tous (ADES) and Action Pour la Lutte Contre L'Ignorance du SIDA (ALCIS). We would like to thank colleagues at the Harvard Humanitarian Initiative (HHI) as well as Daisy Njebenje, Amani Baro and Ideumbo Kasigwa. This study was funded by the Eleanor Miles Shore Foundation at the Harvard Medical School and by generous donations to Harvard Humanitarian Initiative (HHI).	Ahrens CE, 2010, VIOLENCE VICTIMS, V25, P631, DOI 10.1891/0886-6708.25.5.631; Albutt K, 2017, DISASTERS, V41, P211, DOI 10.1111/disa.12202; Bartels S, 2010, J INT WOMENS STUD, V11, P37, DOI DOI 10.1186/1752-1505-4-9; Bartels S, 2010, CONFL HLTH, V4; Bartels S, 2013, J INTERPERS VIOLENCE, V28, P340, DOI 10.1177/0886260512454742; Black BO, 2014, OBSTET GYNAECOL, V16, P153, DOI 10.1111/tog.12114; BUSTAN MN, 1994, AM J PUBLIC HEALTH, V84, P411, DOI 10.2105/AJPH.84.3.411; CARE. (n. d.), SUPP ACC FAM PLANN P; Casey SE, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-S3; Glaser B.G., 1968, DISCOV GROUNDED THEO; Greiner AL, 2014, AM J EPIDEMIOL; Guo XX, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1100, DOI 10.1109/ISBI.2012.6235751; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Kalonda J C Omba, 2012, Rev Med Brux, V33, P482; Kelly J, 2011, WORKING PAPER; Kelly J., 2009, CHARACTERIZING SEXUA; Kelly J, 2012, GLOB PUBLIC HEALTH, V7, P285, DOI 10.1080/17441692.2011.585344; Marlow HM, 2014, REPROD HEALTH MATTER, V22, P149, DOI 10.1016/S0968-8080(14)43758-3; Miles M. B., 2019, SAGE, DOI DOI 10.1080/1034912X.2016.1228856; Nations United, 2011, WORLD AB POL 2011; Orchowski LM, 2012, VIOLENCE AGAINST WOM, V18, P264, DOI 10.1177/1077801212442917; Orchowski LM, 2005, J INTERPERS VIOLENCE, V28, P2005, DOI [10.1177/088626051247.1085, DOI 10.1177/088626051247.1085]; Perry R, 2016, WOMEN HEALTH ISS, V26, P67, DOI 10.1016/j.whi.2015.10.006; Perry R, 2015, WOMEN HEALTH ISS, V25, P470, DOI 10.1016/j.whi.2015.05.004; Peterman A, 2011, AM J PUBLIC HEALTH, V101, P1060, DOI 10.2105/AJPH.2010.300070; Rouhani SA, 2015, AM ACAD PEDIAT, P2014; Rouhani SA, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0073-x; Scott J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007057; SINGH Susheela, 2009, ABORTION WORLDWIDE D; SocioCultural Research Consultants, 2014, DED WEB APPL MAN AN; Starzynski LL, 2005, VIOLENCE VICT, V20; Tanabe M, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-S2; Ullman S., 2010, SOCIAL CONTEXT TALKI, V1st ed.; Ullman SE, 2001, J TRAUMA STRESS, V14, P369, DOI 10.1023/A:1011125220522; Verelst A, 2014, CHILD ABUSE NEGLECT, P1; Verelst A, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-106; Wang D., 2013, ARCHITECTURAL RES ME	37	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164631	10.1371/journal.pone.0164631	http://dx.doi.org/10.1371/journal.pone.0164631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741262	Green Submitted, gold, Green Published			2022-12-27	WOS:000385507000049
J	Tran, DM; Clement-Demange, A; Deon, M; Garcia, D; Le Guen, V; Clement-Vidal, A; Soumahoro, M; Masson, A; Label, P; Le, MT; Pujade-Renaud, V				Dinh Minh Tran; Clement-Demange, Andre; Deon, Marine; Garcia, Dominique; Le Guen, Vincent; Clement-Vidal, Anne; Soumahoro, Mouman; Masson, Aurelien; Label, Philippe; Mau Tuy Le; Pujade-Renaud, Valerie			Genetic Determinism of Sensitivity to Corynespora cassiicola Exudates in Rubber Tree (Hevea brasiliensis)	PLOS ONE			English	Article							EFFECTOR-TRIGGERED SUSCEPTIBILITY; BLIGHT MICROCYCLUS-ULEI; LEAF FALL DISEASE; QUANTITATIVE TRAITS; LINKAGE MAPS; RESISTANCE; DIVERSITY; PLANTATIONS; MARKERS; RFLP	An indirect phenotyping method was developed in order to estimate the susceptibility of rubber tree clonal varieties to Corynespora Leaf Fall (CLF) disease caused by the ascomycete Corynespora cassiicola. This method consists in quantifying the impact of fungal exudates on detached leaves by measuring the induced electrolyte leakage (EL%). The tested exudates were either crude culture filtrates from diverse C. cassiicola isolates or the purified cassiicolin (Cas1), a small secreted effector protein produced by the aggressive isolate CCP. The test was found to be quantitative, with the EL% response proportional to toxin concentration. For eight clones tested with two aggressive isolates, the EL% response to the filtrates positively correlated to the response induced by conidial inoculation. The toxicity test applied to 18 clones using 13 toxinic treatments evidenced an important variability among clones and treatments, with a significant additional clone x treatment interaction effect. A genetic linkage map was built using 306 microsatellite markers, from the F1 population of the PB260 x RRIM600 family. Phenotyping of the population for sensitivity to the purified Cas1 effector and to culture filtrates from seven C. cassiicola isolates revealed a polygenic determinism, with six QTL detected on five chromosomes and percentages of explained phenotypic variance varying from 11 to 17%. Two common QTL were identified for the CCP filtrate and the purified cassiicolin, suggesting that Cas1 may be the main effector of CCP filtrate toxicity. The CCP filtrate clearly contrasted with all other filtrates. The toxicity test based on Electrolyte Leakage Measurement offers the opportunity to assess the sensitivity of rubber genotypes to C. cassiicola exudates or purified effectors for genetic investigations and early selection, without risk of spreading the fungus in plantations. However, the power of this test for predicting field susceptibility of rubber clones to CLF will have to be further investigated.	[Dinh Minh Tran; Mau Tuy Le] Rubber Res Inst Vietnam, Ho Chi Minh City, Vietnam; [Dinh Minh Tran; Clement-Demange, Andre; Garcia, Dominique; Le Guen, Vincent; Clement-Vidal, Anne] CIRAD, UMR AGAP, F-34398 Montpellier, France; [Deon, Marine; Label, Philippe] UCA, INRA, UMR PIAF, F-63000 Clermont Ferrand, France; [Soumahoro, Mouman] Soc Africaine Plantat Heveas, 01 BP 1322, Abidjan 01, Cote Ivoire; [Masson, Aurelien] Soc Caoutchoucs Grand Bereby, Grand Bereby, Cote Ivoire; [Pujade-Renaud, Valerie] CIRAD, UMR AGAP, F-63000 Clermont Ferrand, France	CIRAD; Universite de Montpellier; INRAE; CIRAD	Pujade-Renaud, V (corresponding author), CIRAD, UMR AGAP, F-63000 Clermont Ferrand, France.	valerie.pujade-renaud@cirad.fr	Le Guen, Vincent/I-2229-2012; Clément-Demange, André/AAU-7265-2021	Garcia, Dominique/0000-0002-0034-1927; Label, Philippe/0000-0001-7852-5868	IFC ("Institut Francais du Caoutchouc"); SIPH ("Societe Internationale de Plantations d'Hevea"); SOCFIN; RRIV ("Rubber Research Institute of Vietnam"); Michelin	IFC ("Institut Francais du Caoutchouc"); SIPH ("Societe Internationale de Plantations d'Hevea"); SOCFIN; RRIV ("Rubber Research Institute of Vietnam"); Michelin	This research was supported by IFC ("Institut Francais du Caoutchouc"), the companies Michelin (http://www.michelin.com/), SIPH ("Societe Internationale de Plantations d'Hevea", http://www.siph.com/) and SOCFIN (http://www.socfin.com/) and RRIV ("Rubber Research Institute of Vietnam", http://rriv.org.vn/). This support includes wages for MD and an allocation for DMT. The plantations SOGB ("Societe de Grand Bereby", belonging to the SOCFIN group) and SAPH-Toupah ("Societe Africaine de Plantation d'Hevea", belonging to the SIPH group), provided access and logistic assistance for field and lab experiments in Cote d'Ivoire. RRIV provided an allocation to DMT and contributed to the creation of the family analyzed in this study. The funders had no role in study design, data collection and analysis, other than those stated above. All funders have read the manuscript and agreed to its publication.	Barthe P, 2007, J MOL BIOL, V367, P89, DOI 10.1016/j.jmb.2006.11.086; Breton F., 2000, Journal of Rubber Research, V3, P115; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chee KH, 1988, STUDIES SPORULATION, V3, P21; Chen JY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0508-3; CHURCHILL GA, 1994, GENETICS, V138, P963; Cubry P, 2014, PLANT BREEDING, V133, P419, DOI 10.1111/pbr.12158; da Hora BT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104750; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; de Lamotte F, 2007, J CHROMATOGR B, V849, P357, DOI 10.1016/j.jchromb.2006.10.051; de Liyanage AS, 1986, J RUBB RES I SRI LAN, V65, P47; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Deighton F., 1936, KEW B, V7, P397; Deon M, 2014, FUNGAL BIOL-UK, V118, P32, DOI 10.1016/j.funbio.2013.10.011; Deon M, 2012, FUNGAL DIVERS, V54, P87, DOI 10.1007/s13225-012-0169-6; Deon M, 2012, PLANT SCI, V185, P227, DOI 10.1016/j.plantsci.2011.10.017; Dixon LJ, 2009, PHYTOPATHOLOGY, V99, P1015, DOI 10.1094/PHYTO-99-9-1015; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Fernando THPS, 2010, J PLANT DIS PROTECT, V117, P24, DOI 10.1007/BF03356329; Friesen TL, 2007, PLANT J, V51, P681, DOI 10.1111/j.1365-313X.2007.03166.x; Gao Y, 2015, MOL PLANT MICROBE IN, V28, P615, DOI 10.1094/MPMI-12-14-0396-R; Halle A F, 1968, ADANSONIA, V8, P475; Heil M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00578; Herbette S, 2005, BBA-GEN SUBJECTS, V1724, P108, DOI 10.1016/j.bbagen.2005.04.018; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; Jayasinghe CK, 2000, CORYNESPORA LEAF FAL, V42, P56; Jayasinghe CK, 2002, CORYNESPORA LEAF FAL, P5; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Keller H, 2016, MOL PLANT PATHOL, V17, P475, DOI 10.1111/mpp.12371; Kim J, 2012, MOL CELLS, V33, P385, DOI 10.1007/s10059-012-0003-8; LANDER ES, 1989, GENETICS, V121, P185; Le Guen V, 2011, PLANT BREEDING, V130, P294, DOI 10.1111/j.1439-0523.2010.01774.x; Le Guen V, 2003, THEOR APPL GENET, V108, P160, DOI 10.1007/s00122-003-1407-9; Le Guen V, 2008, CROP PROT, V27, P1498, DOI 10.1016/j.cropro.2008.07.012; Le Guen V, 2013, TREE GENET GENOMES, V9, P805, DOI 10.1007/s11295-013-0599-7; Le Guen V, 2011, TREE GENET GENOMES, V7, P877, DOI 10.1007/s11295-011-0381-7; Lespinasse D, 2000, THEOR APPL GENET, V100, P975, DOI 10.1007/s001220051379; Lespinasse D, 2000, THEOR APPL GENET, V100, P127, DOI 10.1007/s001220050018; Liu ZH, 2015, MOL PLANT PATHOL, V16, P188, DOI 10.1111/mpp.12172; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; Mai J, 2009, TREES-STRUCT FUNCT, V23, P863, DOI 10.1007/s00468-009-0328-x; Manju M. J., 2010, Journal of Mycology and Plant Pathology, V40, P603; MORTON NE, 1955, AM J HUM GENET, V7, P277; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Newsam A, 1961, PLANT PATHOLOGY DIVI, P63; Nghia NA, 2008, MYCOPATHOLOGIA, V166, P189, DOI 10.1007/s11046-008-9138-8; Hieu ND, 2014, J RUBBER RES, V17, P187; Perazzolli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083844; Qi YX, 2009, MOL BIOTECHNOL, V41, P145, DOI 10.1007/s12033-008-9109-9; Ramakirishnan T.S., 1961, RUBBER BOARD B, V5, P52; Rattanawong R, 2011, IRRDB INT RUBB C 14; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; RITTER E, 1990, GENETICS, V125, P645; Safiah Atan, 2003, Journal of Rubber Research, V6, P58; Seguin M, 1997, PLANT AN GEN 5 C SAN, P66; Shuib SS, 2015, J RUBBER RES, V18, P109; Silva WPK, 2003, MYCOL RES, V107, P567, DOI 10.1017/S0953756203007755; Silva WPK, 1998, PLANT PATHOL, V47, P267, DOI 10.1046/j.1365-3059.1998.00245.x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Sweat TA, 2007, PLANT CELL, V19, P673, DOI 10.1105/tpc.106.047563; Van Ooijen J., 2006, JOINMAP 4 SOFTWARE M; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Walton JD, 2006, PHYTOCHEMISTRY, V67, P1406, DOI 10.1016/j.phytochem.2006.05.033; Wen CL, 2015, THEOR APPL GENET, V128, P2495, DOI 10.1007/s00122-015-2604-z; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yang LM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-53; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	69	13	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0162807	10.1371/journal.pone.0162807	http://dx.doi.org/10.1371/journal.pone.0162807			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736862	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800007
J	Lo Cascio, CM; Goetze, O; Latshang, TD; Bluemel, S; Frauenfelder, T; Bloch, KE				Lo Cascio, Christian M.; Goetze, Oliver; Latshang, Tsogyal D.; Bluemel, Sena; Frauenfelder, Thomas; Bloch, Konrad E.			Gastrointestinal Dysfunction in Patients with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							GASTRIC-EMPTYING RATE; ACID BREATH TEST; RATIO MASS-SPECTROMETRY; CARDINAL SYMPTOM INDEX; OROCECAL TRANSIT-TIME; COLONIC TRANSIT; NITRIC-OXIDE; VALIDATION; SCINTIGRAPHY; SOLIDS	Background In adult patients with Duchenne muscular dystrophy (DMD) life-threatening constipation has been reported. Since gastrointestinal function in DMD has not been rigorously studied we investigated objective and subjective manifestations of gastrointestinal disturbances in DMD patients. Methods In 33 patients with DMD, age 12-41 years, eating behavior and gastrointestinal symptoms were evaluated by questionnaires. Gastric emptying half time (T-1/2) and oro-cecal transit time (OCTT) were evaluated by analyzing (CO2)-C-13 exhalation curves after ingestion of C-13 labeled test meals. Colonic transit time (CTT) was measured by abdominal radiography following ingestion of radiopaque markers. Results The median (quartiles) T-1/2 was 187 (168, 220) minutes, the OCTT was 6.3 (5.0, 7.9) hours, both substantially longer than normal data (Goetze 2005, T-1/2: 107 +/- 10; Geypens 1999, OCTT 4.3 +/- 0.1 hours). The median CTT was 60 (48, 82) hours despite extensive use of laxative measures (Meier 1995, upper limit of normal: 60 hours). T-1/2 and OCTT did not correlate with symptoms evaluated by the Gastroparesis Cardinal Symptom Index (GCSI) (Spearman r = -0.3, p = 0.1; and r = -0.15, p = 0.4, respectively). CTT was not correlated with symptoms of constipation assessed by ROME III criteria (r = 0.12, p = 0.5). Conclusions DMD patients have a markedly disturbed gastrointestinal motor function. Since objective measures of impaired gastrointestinal transport are not correlated with symptoms of gastroparesis or constipation our findings suggest that measures assuring adequate intestinal transport should be taken independent of the patient's perception in order to prevent potentially life threatening constipation, particularly in older DMD patients.	[Lo Cascio, Christian M.; Latshang, Tsogyal D.; Bloch, Konrad E.] Univ Zurich Hosp, Neuromuscular & Sleep Disorders Ctr, Div Pulm, Zurich, Switzerland; [Lo Cascio, Christian M.; Latshang, Tsogyal D.; Bloch, Konrad E.] Univ Zurich, Ctr Human Integrat Physiol, Zurich, Switzerland; [Goetze, Oliver; Bluemel, Sena] Univ Zurich Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland; [Goetze, Oliver] Univ Hosp Wurzburg, Div Hepatol, Dept Med 2, Wurzburg, Germany; [Frauenfelder, Thomas] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; University of Wurzburg; University of Zurich; University Zurich Hospital	Bloch, KE (corresponding author), Univ Zurich Hosp, Neuromuscular & Sleep Disorders Ctr, Div Pulm, Zurich, Switzerland.; Bloch, KE (corresponding author), Univ Zurich, Ctr Human Integrat Physiol, Zurich, Switzerland.	konrad.bloch@usz.ch	Frauenfelder, Thomas/O-1734-2016	Frauenfelder, Thomas/0000-0002-3295-6619; Lo Cascio, Christian M./0000-0002-2163-4219	Zurich Lung League	Zurich Lung League	This work was supported by Zurich Lung League (http://mtvw.lunge-zuerich.ch, no grant number available), CML, KEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek RJ, 1999, Z GASTROENTEROL, V37, P1139; BAROHN RJ, 1988, NEW ENGL J MED, V319, P15, DOI 10.1056/NEJM198807073190103; BLAKE DJ, 1995, P NATL ACAD SCI USA, V92, P3697, DOI 10.1073/pnas.92.9.3697; Borrelli O, 2005, AM J GASTROENTEROL, V100, P695, DOI 10.1111/j.1572-0241.2005.41303.x; Bromer MQ, 2002, DIGEST DIS SCI, V47, P1657, DOI 10.1023/A:1015856211261; BROOKE MH, 1989, NEUROLOGY, V39, P475, DOI 10.1212/WNL.39.4.475; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; BUSHBY KMD, 1992, J INHERIT METAB DIS, V15, P551, DOI 10.1007/BF01799614; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; Choi MG, 1998, AM J GASTROENTEROL, V93, P92, DOI 10.1111/j.1572-0241.1998.092_c.x; Dickman R, 2013, EUR J GASTROEN HEPAT, V25, P291, DOI 10.1097/MEG.0b013e32835c075d; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Fraser A, 2007, ALIMENT PHARM THER, V25, P477, DOI 10.1111/j.1365-2036.2006.03233.x; Geypens B, 1999, J NUCL MED, V40, P1451; GHOOS YF, 1993, GASTROENTEROLOGY, V104, P1640, DOI 10.1016/0016-5085(93)90640-X; Goetze O, 2007, ALIMENT PHARM THER, V26, P305, DOI 10.1111/j.1365-2036.2007.03360.x; Goetze O, 2005, NEUROSCI LETT, V375, P170, DOI 10.1016/j.neulet.2004.11.007; Goetze O, 2008, BRIT J NUTR, V100, P1077, DOI 10.1017/S0007114508960918; GOTTRAND F, 1991, ARCH DIS CHILD, V66, P1262, DOI 10.1136/adc.66.10.1262-b; HEATON KW, 1991, GUT, V32, P73, DOI 10.1136/gut.32.1.73; HEINE WE, 1995, AM J GASTROENTEROL, V90, P93; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Huizinga JD, 2001, AM J PHYSIOL-GASTR L, V281, pG1129, DOI 10.1152/ajpgi.2001.281.5.G1129; JAFFE KM, 1990, ARCH PHYS MED REHAB, V71, P742; Kohler M, 2005, AM J RESP CRIT CARE, V172, P1032, DOI 10.1164/rccm.200503-322OC; Kohler M, 2009, J NEUROL NEUROSUR PS, V80, P320, DOI 10.1136/jnnp.2007.141721; KORMAN SH, 1991, ARCH DIS CHILD, V66, P143, DOI 10.1136/adc.66.1.143; Lo Cascio CM, 2014, RESPIRATION, V87, P499, DOI 10.1159/000358439; MAES BD, 1994, DIGEST DIS SCI, V39, pS104, DOI 10.1007/BF02300385; MEIER R, 1995, SCHWEIZ MED WSCHR, V125, P1830; Metcalf AM, 1987, GASTROENTEROLOGY, V92, P40, DOI 10.1016/0016-5085(87)90837-7; Mule F, 2001, AM J PHYSIOL-GASTR L, V281, pG1264, DOI 10.1152/ajpgi.2001.281.5.G1264; Palit S, 2012, DIGEST DIS SCI, V57, P1445, DOI 10.1007/s10620-012-2071-1; Revicki DA, 2004, QUAL LIFE RES, V13, P833, DOI 10.1023/B:QURE.0000021689.86296.e4; Revicki DA, 2003, ALIMENT PHARM THER, V18, P141, DOI 10.1046/j.1365-2036.2003.01612.x; Sanaka Masaki, 2007, Journal of Smooth Muscle Research, V43, P201, DOI 10.1540/jsmr.43.201; Shah V, 2004, GASTROENTEROLOGY, V126, P903, DOI 10.1053/j.gastro.2003.11.046; SMITH PEM, 1987, NEW ENGL J MED, V316, P1197, DOI 10.1056/NEJM198705073161906; Vannucchi MG, 2002, NEUROSCI LETT, V326, P191, DOI 10.1016/S0304-3940(02)00338-5; Wutzke KD, 1997, EUR J CLIN NUTR, V51, P11, DOI 10.1038/sj.ejcn.1600353	41	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163779	10.1371/journal.pone.0163779	http://dx.doi.org/10.1371/journal.pone.0163779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736891	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000385505800024
J	Zhang, LX; Qian, H; Sha, M; Luan, ZY; Lin, M; Yuan, DL; Li, XK; Huang, JX; Ye, LH				Zhang, Lixin; Qian, Hua; Sha, Min; Luan, Zhengyun; Lin, Mei; Yuan, Donglan; Li, Xiaokang; Huang, Junxing; Ye, Lihua			Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; NONCODING RNA HOTAIR; POOR-PROGNOSIS; CYCLOOXYGENASE-2	Artesunate (ART) has anti-cancer activities for a variety of solid tumors. The aim of this study was to investigate the anti-metastatic effect of ART on cervical cancer cells. In vivo anti-metastatic effect of ART was investigated in mice with the lung metastasis model by the subcutaneous injection of ART. The interaction of HOTAIR and COX-2 was measured by RNA immunoprecipitation and RNA pull-down assay. The effect of ART on metastasis of CaSki and Hela cells was evaluated by invasion and migration assay. We found that ART inhibited cervical cancer metastasis and HOTAIR expression. HOTAIR overexpression partially abolished the anti-metastatic effect of ART on cervical cancer cells. In addition, HOTAIR can interact with COX-2 to positively regulate COX-2 expression and catalytic activity. Finally, overexpression of COX-2 reversed the effect of HOTAIR knockdown on Hela cell migration and invasion. Taken together, our data revealed that ART may elicit anti-metastatic effect against cervical cancer by inhibition of HOTAIR expression, which resulted in the decrease of COX-2 expression.	[Zhang, Lixin; Li, Xiaokang] Nantong Univ Med, Dept Reprod Med, Taizhou Peoples Hosp, Taizhou 225300, Peoples R China; [Zhang, Lixin; Qian, Hua; Yuan, Donglan; Ye, Lihua] Nantong Univ Med, Dept Gynecol, Taizhou Peoples Hosp, Taizhou 225300, Peoples R China; [Sha, Min; Luan, Zhengyun; Lin, Mei] Nantong Univ Med, Inst Clin Med, Taizhou Peoples Hosp, Taizhou 225300, Peoples R China; [Huang, Junxing] Nantong Univ Med, Inst Oncol, Taizhou Peoples Hosp, Taizhou 225300, Peoples R China	Nantong University; Nantong University; Nantong University; Nantong University	Zhang, LX (corresponding author), Nantong Univ Med, Dept Reprod Med, Taizhou Peoples Hosp, Taizhou 225300, Peoples R China.; Zhang, LX (corresponding author), Nantong Univ Med, Dept Gynecol, Taizhou Peoples Hosp, Taizhou 225300, Peoples R China.	lixinzhang4152@163.com						Bhan A, 2015, BBA-REV CANCER, V1856, P151, DOI 10.1016/j.bbcan.2015.07.001; Cai B, 2014, TUMOR BIOL, V35, P8445, DOI 10.1007/s13277-014-2311-4; Catarino R, 2015, WORLD J CLIN ONCOL, V6, P281, DOI 10.5306/wjco.v6.i6.281; Chen X, 2015, INT J CLIN EXP PATHO, V8, P13261; Ferreira JFS, 2010, MOLECULES, V15, P3135, DOI 10.3390/molecules15053135; He RR, 2008, CHIN J INTEGR MED, V14, P312, DOI 10.1007/s11655-008-0312-0; Ho WE, 2014, PHARMACOL THERAPEUT, V142, P126, DOI 10.1016/j.pharmthera.2013.12.001; Huang ML, 2013, INT J CANCER, V132, P363, DOI 10.1002/ijc.27686; Jeong DE, 2015, ONCOTARGET, V6, P33046, DOI 10.18632/oncotarget.5422; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kim HJ, 2015, INT J ONCOL, V46, P521, DOI 10.3892/ijo.2014.2758; Liu HD, 2011, MICROVASC RES, V82, P131, DOI 10.1016/j.mvr.2011.04.011; Pawar K, 2016, SCI REP-UK, V6, DOI 10.1038/srep19416; Peiretti M, 2012, SURG ONCOL, V21, pE59, DOI 10.1016/j.suronc.2011.12.008; Sun NX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100340; Suprasert P, 2005, INT J GYNECOL CANCER, V15, P995, DOI 10.1111/j.1525-1438.2005.00259.x; Yang L, 2015, EUR REV MED PHARMACO, V19, P3187; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Young JL, 2008, GYNECOL ONCOL, V109, P140, DOI 10.1016/j.ygyno.2008.01.008; Zengel P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-92; Zhang H, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/175940; Zhang LX, 2014, CELL BIOL INT, V38, P639, DOI 10.1002/cbin.10244; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002; Zhou WQ, 2015, EUR J GYNAECOL ONCOL, V36, P62	24	29	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164838	10.1371/journal.pone.0164838	http://dx.doi.org/10.1371/journal.pone.0164838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736969	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800136
J	Ford, L; Glass, K; Veitch, M; Wardell, R; Polkinghorne, B; Dobbins, T; Lal, A; Kirk, MD				Ford, Laura; Glass, Kathryn; Veitch, Mark; Wardell, Rebecca; Polkinghorne, Ben; Dobbins, Timothy; Lal, Aparna; Kirk, Martyn D.			Increasing Incidence of Salmonella in Australia, 2000-2013	PLOS ONE			English	Article							SOURCE ATTRIBUTION; FOODBORNE ILLNESS; SURVEILLANCE; INFECTIONS; PATHOGENS; FOOD; OUTCOMES	Salmonella is a key cause of foodborne gastroenteritis in Australia and case numbers are increasing. We used negative binomial regression to analyze national surveillance data for 2000-2013, for Salmonella Typhimurium and non-Typhimurium Salmonella serovars. We estimated incidence rate ratios adjusted for sex and age to show trends over time. Almost all states and territories had significantly increasing trends of reported infection for S. Typhimurium, with states and territories reporting annual increases as high as 12% (95% confidence interval 10-14%) for S. Typhimurium in the Australian Capital Territory and 6% (95% CI 5-7%) for non-Typhimurium Salmonella in Victoria. S. Typhimurium notification rates were higher than non-Typhimurium Salmonella rates in most age groups in the south eastern states of Australia, while non-Typhimurium rates were higher in most age groups elsewhere. The S. Typhimurium notification rate peaked at 12-23 months of age and the non-Typhimurium Salmonella notification rate peaked at 0-11 months of age. The age-specific pattern of S. Typhimurium cases suggests a foodborne origin, while the age and geographic pattern for non-Typhimurium may indicate that other transmission routes play a key role for these serovars.	[Ford, Laura; Glass, Kathryn; Wardell, Rebecca; Dobbins, Timothy; Lal, Aparna; Kirk, Martyn D.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Veitch, Mark] Dept Hlth & Human Serv, Hobart, Tas, Australia; [Polkinghorne, Ben] Australian Govt Dept Hlth, OzFoodNet, Canberra, ACT, Australia	Australian National University	Ford, L (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	laura.ford@anu.edu.au	Dobbins, Timothy/AAS-1422-2020; Ford, Laura/O-9354-2019	Dobbins, Timothy/0000-0003-1841-9056; Ford, Laura/0000-0002-6253-9672; lal, aparna/0000-0001-7062-1468; Kirk, Martyn/0000-0001-5432-5984; Glass, Kathryn/0000-0001-5905-1310; Polkinghorne, Benjamin/0000-0002-6330-9588	Australian Research Council (ARC) [LP110200431]	Australian Research Council (ARC)(Australian Research Council)	This work was funded by the Australian Research Council (ARC Linkage Grant LP110200431).	Ashbolt R, 2006, EPIDEMIOL INFECT, V134, P1257, DOI 10.1017/S0950268806006224; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Cronquist AB, 2012, CLIN INFECT DIS, V54, pS432, DOI 10.1093/cid/cis267; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; Ford L, 2014, EMERG INFECT DIS, V20, P1865, DOI 10.3201/eid2011.131316; Fullerton K, 2008, COMMUN DIS INTELL Q, V32, P400; Gilbert Gwendolyn L, 2008, N S W Public Health Bull, V19, P29, DOI 10.1071/NB07116; Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283; Glass K, 2016, RISK ANAL, V36, P561, DOI 10.1111/risa.12444; Hald T, 2004, RISK ANAL, V24, P255, DOI 10.1111/j.0272-4332.2004.00427.x; Hall G, 2008, EMERG INFECT DIS, V14, P1601, DOI 10.3201/eid1410.071042; Iwamoto M, 2015, MMWR-MORBID MORTAL W, V64, P252; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Kirk M, 2014, EMERG INFECT DIS, V20, P1857, DOI 10.3201/eid2011.131315; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Moffatt CRM, 2016, FOODBORNE PATHOG DIS, V13, P379, DOI 10.1089/fpd.2015.2110; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Nesbitt A, 2012, EPIDEMIOL INFECT, V140, P1757, DOI 10.1017/S0950268811002548; OzFoodNet Working Group, 2015, COMMUN DIS INTELL Q, V39, pE236; OzFoodNet Working Group, 2012, COMMUN DIS INTELL Q, V36, pE213; Queensland OzFoodNet Site, 2010, ANNUAL REPORT 2010 Q; Ran L, 2011, FOODBORNE PATHOG DIS, V8, P921, DOI 10.1089/fpd.2010.0827; The Department of Health, 2004, CANBERRA ACT COMMONW; The Department of Health, CANBERRA ACT COMMONW; Vally H, 2014, FOODBORNE PATHOG DIS, V11, P727, DOI 10.1089/fpd.2014.1746; Williams S, 2015, J INFECTION, V71, P642, DOI 10.1016/j.jinf.2015.09.011	28	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163989	10.1371/journal.pone.0163989	http://dx.doi.org/10.1371/journal.pone.0163989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732615	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300035
J	Gollner, S; Stuckas, H; Kihara, TC; Laurent, S; Kodami, S; Arbizu, PM				Gollner, Sabine; Stuckas, Heiko; Kihara, Terue C.; Laurent, Stefan; Kodami, Sahar; Arbizu, Pedro Martinez			Mitochondrial DNA Analyses Indicate High Diversity, Expansive Population Growth and High Genetic Connectivity of Vent Copepods (Dirivultidae) across Different Oceans	PLOS ONE			English	Article							SEA HYDROTHERMAL VENTS; SHRIMP RIMICARIS-EXOCULATA; MID-ATLANTIC RIDGE; PATTERNS; COMMUNITIES; SIPHONOSTOMATOIDA; COLONIZATION; BIOGEOGRAPHY; HEMOGLOBIN; SELECTION	Communities in spatially fragmented deep-sea hydrothermal vents rich in polymetallic sulfides could soon face major disturbance events due to deep-sea mineral mining, such that unraveling patterns of gene flow between hydrothermal vent populations will be an important step in the development of conservation policies. Indeed, the time required by deep-sea populations to recover following habitat perturbations depends both on the direction of gene flow and the number of migrants available for re-colonization after disturbance. In this study we compare nine dirivultid copepod species across various geological settings. We analyze partial nucleotide sequences of the mtCOI gene and use divergence estimates (F-ST) and haplotype networks to infer intraspecific population connectivity between vent sites. Furthermore, we evaluate contrasting scenarios of demographic population expansion/decline versus constant population size (using, for example, Tajima's D). Our results indicate high diversity, population expansion and high connectivity of all copepod populations in all oceans. For example, haplotype diversity values range from 0.89 to 1 and F-ST values range from 0.001 to 0.11 for Stygiopontius species from the Central Indian Ridge, Mid Atlantic Ridge, East Pacific Rise, and Eastern Lau Spreading Center. We suggest that great abundance and high site occupancy by these species favor high genetic diversity. Two scenarios both showed similarly high connectivity: fast spreading centers with little distance between vent fields and slow spreading centers with greater distance between fields. This unexpected result may be due to some distinct frequency of natural disturbance events, or to aspects of individual life histories that affect realized rates of dispersal. However, our statistical performance analyses showed that at least 100 genomic regions should be sequenced to ensure accurate estimates of migration rate. Our demography parameters demonstrate that dirivultid populations are generally large and continuously undergoing population growth. Benthic and pelagic species abundance data support these findings.	[Gollner, Sabine; Kihara, Terue C.; Kodami, Sahar; Arbizu, Pedro Martinez] German Ctr Marine Biodivers Res DZMB, Wilhelmshaven, Germany; [Gollner, Sabine] Royal Netherlands Inst Sea Res NIOZ, Ocean Syst Sci OCS, T Horntje, Texel, Netherlands; [Stuckas, Heiko] Museum Zool, Senckenberg Nat Hist Collect Dresden, Dresden, Germany; [Laurent, Stefan] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Laurent, Stefan] SIB, Lausanne, Switzerland	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Senckenberg Gesellschaft fur Naturforschung (SGN); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Gollner, S (corresponding author), German Ctr Marine Biodivers Res DZMB, Wilhelmshaven, Germany.; Gollner, S (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Ocean Syst Sci OCS, T Horntje, Texel, Netherlands.	sabine.gollner@senckenberg.de	Stuckas, Heiko/AFM-0009-2022	Stuckas, Heiko/0000-0002-5690-0994; Gollner, Sabine/0000-0001-9322-9258	European Union Seventh Framework Programme (FP7) under the MIDAS project [603418]; National Science Foundation (NSF) from the Division of Ocean Sciences to C.R. Fisher [07-32333]; Austrian FWF [P20190-B17]	European Union Seventh Framework Programme (FP7) under the MIDAS project; National Science Foundation (NSF) from the Division of Ocean Sciences to C.R. Fisher(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Austrian FWF(Austrian Science Fund (FWF))	The project received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under the MIDAS project, Grant agreement no. 603418.r We thank Kirsten Irwin for writing assistance. We thank U. Schampera for invitations to cruises on CIR were we collected copepods during exploratory cruises of the BGR (Bundesanstalt fuer Geowissenschaften und Rohstoffe, Hannover). Collections from ELSC were supported by National Science Foundation (NSF) grant 07-32333 from the Division of Ocean Sciences to C.R. Fisher. Collections from EPR were funded by the Austrian FWF (Grant P20190-B17) to M. Bright. Collections from MAR were provided by F. Pradillon and were made possible by Ifremer and BICOSE cruise 2014. We warmly thank U. Schampera (BGR), C. R. Fisher (PSU), M. Bright (University Vienna), and F. Pradillon (IFREMER) for their generosity to share samples and dive-time, and the crews, pilots and science parties on board of the research cruises for their support during sample collections. Pictures and samples presented in this study from CIR originate from the INDEX exploration project for marine polymetallic sulphides by the Federal Institute for Geosciences and Natural Resources (BGR) on behalf of the German Federal Ministry for Economic Affairs and Energy. Exploration activities are carried out in the framework and under the regulations of an exploration license with the International Seabed Authority.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Beaulieu SE, 2015, DEEP-SEA RES PT II, V121, P202, DOI 10.1016/j.dsr2.2015.05.001; Beaulieu SE, 2009, LIMNOL OCEANOGR-METH, V7, P235, DOI 10.4319/lom.2009.7.235; Beedessee G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081570; Boschen RE, 2013, OCEAN COAST MANAGE, V84, P54, DOI 10.1016/j.ocecoaman.2013.07.005; Breusing C, 2015, CONSERV GENET, V16, P1415, DOI 10.1007/s10592-015-0750-0; Carbotte SM, 1994, J GEOPHYS RES, V97, P6959; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clement M., 2002, P 16 INT PARALLEL DI, P7; Cuvelier D, 2014, DEEP-SEA RES PT I, V87, P70, DOI 10.1016/j.dsr.2014.02.008; Desbruyeres D, 2006, HANDBOOK OF HYDROTHE; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing GB, 2016, MOL ECOL, V25, P135, DOI 10.1111/mec.13390; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher CR, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.75; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gerdes K, 2013, CATALOGUE OF INDEX 2; GERLACH SA, 1971, OECOLOGIA, V6, P176, DOI 10.1007/BF00345719; Gollner S, 2006, CAH BIOL MAR, V47, P397; Gollner S, 2015, DEEP-SEA RES PT I, V106, P167, DOI 10.1016/j.dsr.2015.10.008; Gollner S, 2015, MAR ECOL PROG SER, V520, P57, DOI 10.3354/meps11078; Gollner S, 2013, ORG DIVERS EVOL, V13, P349, DOI 10.1007/s13127-012-0122-2; Gollner S, 2011, MAR BIOL, V158, P221, DOI 10.1007/s00227-010-1553-y; Gollner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009801; Gollner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012321; Gramling C, 2014, SCIENCE, V344, P463, DOI 10.1126/science.344.6183.463; Gregory TR, 2000, HEREDITY, V84, P201, DOI 10.1046/j.1365-2540.2000.00661.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Heptner M. V., 2002, Arthropoda Selecta, V11, P117; Hilario A, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00006; Hourdez S, 2000, BIOL BULL-US, V199, P95, DOI 10.2307/1542868; Humes AG, 1996, B MAR SCI, V58, P609; HUNTLEY ME, 1992, AM NAT, V140, P201, DOI 10.1086/285410; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Ivanenko VN, 1998, ZOOL ZH, V77, P1249; Ivanenko VN, 2007, MARINE ECOLOGY, V28; JOLLIVET D, 1995, HEREDITY, V74, P376, DOI 10.1038/hdy.1995.56; Kahilainen A, 2014, GLOB ECOL CONSERV, V2, P315, DOI 10.1016/j.gecco.2014.10.013; Klose Julia, 2015, Proc Natl Acad Sci U S A, V112, P11300, DOI 10.1073/pnas.1501160112; Laurent S, 2016, MOL ECOL, V25, P306, DOI 10.1111/mec.13385; Le Bris N, 2007, REV ENVIRON SCI BIO, V6, P167; Lehmkoester J, 2014, WORLD OCEAN REVIEW 3; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Limen H, 2008, MAR ECOL PROG SER, V359, P161, DOI 10.3354/meps07344; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Moalic Y, 2012, SYST BIOL, V61, P127, DOI 10.1093/sysbio/syr088; Mullineaux LS, 2010, P NATL ACAD SCI USA, V107, P7829, DOI 10.1073/pnas.0913187107; Mullineaux LS, 2005, MAR ECOL PROG SER, V293, P1, DOI 10.3354/meps293001; Mullineaux LS, 1995, SEAFLOOR HYDROTHERMA, P408; Nei M., 1987, MOL EVOLUTIONARY GEN; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Plum C, DEEP SEA RES 2, VII; Pradillon F, 2001, NATURE, V413, P698, DOI 10.1038/35099674; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rubin KH, 2012, OCEANOGRAPHY, V25, P142, DOI 10.5670/oceanog.2012.12; Sell AF, 2000, P ROY SOC B-BIOL SCI, V267, P2323, DOI 10.1098/rspb.2000.1286; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Sousa V, 2013, NAT REV GENET, V14, P404, DOI 10.1038/nrg3446; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Thaler AD, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-372; Tolstoy M, 2006, SCIENCE, V314, P1920, DOI 10.1126/science.1133950; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; TUNNICLIFFE V, 1992, Palaios, V7, P338, DOI 10.2307/3514820; Van Dover CL, 2014, MAR ENVIRON RES, V102, P59, DOI 10.1016/j.marenvres.2014.03.008; Van Dover CL, 2000, THE ECOLOGY OF HYDRO; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zbinden M, 2004, MAR ECOL PROG SER, V284, P237, DOI 10.3354/meps284237	76	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163776	10.1371/journal.pone.0163776	http://dx.doi.org/10.1371/journal.pone.0163776			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732624	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300029
J	Lucky, AB; Sakaguchi, M; Katakai, Y; Kawai, S; Yahata, K; Templeton, TJ; Kaneko, O				Lucky, Amuza Byaruhanga; Sakaguchi, Miako; Katakai, Yuko; Kawai, Satoru; Yahata, Kazuhide; Templeton, Thomas J.; Kaneko, Osamu			Plasmodium knowlesi Skeleton-Binding Protein 1 Localizes to the 'Sinton and Mulligan' Stipplings in the Cytoplasm of Monkey and Human Erythrocytes	PLOS ONE			English	Article							ZOONOTIC MALARIA PARASITE; RED-BLOOD-CELLS; FALCIPARUM-INFECTED ERYTHROCYTES; TARGETED MUTAGENESIS; ANTIGENIC VARIATION; MEMBRANE-PROTEINS; VARIANT ANTIGEN; EXPRESSION; VIRULENCE; TRAFFICKING	The malaria parasite, Plasmodium, exports protein products to the infected erythrocyte to introduce modifications necessary for the establishment of nutrient acquisition and surface display of host interaction ligands. Erythrocyte remodeling impacts parasite virulence and disease pathology and is well documented for the human malaria parasite Plasmodium falciparum, but has been less described for other Plasmodium species. For P. falciparum, the exported protein skeleton-binding protein 1 (PfSBP1) is involved in the trafficking of erythrocyte surface ligands and localized to membranous structures within the infected erythrocyte, termed Maurer's clefts. In this study, we analyzed SBP1 orthologs across the Plasmodium genus by BLAST analysis and conserved gene synteny, which were also recently described by de Niz et al. (2016). To evaluate the localization of an SBP1 ortholog, we utilized the zoonotic malaria parasite, Plasmodium knowlesi. Immunofluorescence assay of transgenic P. knowlesi parasites expressing epitope-tagged recombinant PkSBP1 revealed a punctate staining pattern reminiscent of Maurer's clefts, following infection of either monkey or human erythrocytes. The recombinant PkSBP1-positive puncta co-localized with Giemsa-stained structures, known as 'Sinton and Mulligan' stipplings. Immunoelectron microscopy also showed that recombinant PkSBP1 localizes within or on the membranous structures akin to the Maurer's clefts. The recombinant PkSBP1 expressed in P. falciparum-infected erythrocytes co-localized with PfSBP1 at the Maurer's clefts, indicating an analogous trafficking pattern. A member of the P. knowlesi 2TM protein family was also expressed and localized to membranous structures in infected monkey erythrocytes. These results suggest that the trafficking machinery and induced erythrocyte cellular structures of P. knowlesi are similar following infection of both monkey and human erythrocytes, and are conserved with P. falciparum.	[Lucky, Amuza Byaruhanga; Yahata, Kazuhide; Templeton, Thomas J.; Kaneko, Osamu] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 8528523, Japan; [Lucky, Amuza Byaruhanga; Kaneko, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Leading program, Nagasaki 8528523, Japan; [Sakaguchi, Miako] Nagasaki Univ, Inst Trop Med NEKKEN, Cent Lab, Nagasaki 8528523, Japan; [Katakai, Yuko] Corp Prod & Res Lab Primates, Tsukuba, Ibaraki 3050843, Japan; [Kawai, Satoru] Dokkyo Med Univ, Dept Trop Med & Parasitol, Mibu, Tochigi 3210293, Japan; [Templeton, Thomas J.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Nagasaki University; Nagasaki University; Nagasaki University; Dokkyo Medical University; Cornell University	Kaneko, O (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 8528523, Japan.; Kaneko, O (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Leading program, Nagasaki 8528523, Japan.	okaneko@nagasaki-u.ac.jp	Singh, Balbir/A-3610-2009	Kaneko, Osamu/0000-0003-0675-8296; lucky, amuza/0000-0001-6779-1888	MEXT, Japan [25670203, 15K15125, 23117008]; National Bio-Resource Project at Primate Research Institute, Kyoto University, AMED, Japan; National Bio-Resource Project at Primate Research Institute, Kyoto University from Agency for Medical Research and Development (AMED), Japan; MEXT Ph.D. scholarship, Japan; Institute of Tropical Medicine, Nagasaki University, Japan; Grants-in-Aid for Scientific Research [15K08444] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Bio-Resource Project at Primate Research Institute, Kyoto University, AMED, Japan; National Bio-Resource Project at Primate Research Institute, Kyoto University from Agency for Medical Research and Development (AMED), Japan(Japan Agency for Medical Research and Development (AMED)); MEXT Ph.D. scholarship, Japan; Institute of Tropical Medicine, Nagasaki University, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported in part by Grants-in-Aid for Scientific Research 25670203 and 15K15125 (O.K.) and for Scientific Research on Innovative Areas 23117008 (O.K.), MEXT, Japan and National Bio-Resource Project at Primate Research Institute, Kyoto University, AMED, Japan. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Reiko Tanaka, Ms. Mika Takeda, and Ms. Nana Matsumoto for technical assistance. This work was conducted at the Joint Usage / Research Center for Tropical Disease, Institute of Tropical Medicine, Nagasaki University, Japan and was partially supported by National Bio-Resource Project at Primate Research Institute, Kyoto University from Agency for Medical Research and Development (AMED), Japan. ABL is a recipient of MEXT Ph.D. scholarship, Japan. TJT was supported by a visiting professorship at the Institute of Tropical Medicine, Nagasaki University, Japan.	AIKAWA M, 1990, ADV PARASIT, V29, P151, DOI 10.1016/S0065-308X(08)60106-2; AIKAWA M, 1975, AM J PATHOL, V79, P285; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Ansari HR, 2016, INT J PARASITOL, V46, P685, DOI 10.1016/j.ijpara.2016.05.009; ATKINSON CT, 1988, EUR J CELL BIOL, V45, P192; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; BARNWELL JW, 1982, J IMMUNOL, V128, P224; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; BROWN KN, 1965, NATURE, V208, P1286, DOI 10.1038/2081286a0; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Cox-Singh J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-10; Dankwa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11187; De Niz M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11659; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Hanssen E, 2008, MOL MICROBIOL, V69, P938, DOI 10.1111/j.1365-2958.2008.06329.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HOWARD RJ, 1983, P NATL ACAD SCI-BIOL, V80, P4129, DOI 10.1073/pnas.80.13.4129; Kats LM, 2015, BBA-BIOMEMBRANES, V1848, P1619, DOI 10.1016/j.bbamem.2015.03.038; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033; Lavazec C, 2007, MOL MICROBIOL, V64, P1621, DOI 10.1111/j.1365-2958.2007.05767.x; Lim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2612; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MILLER LH, 1971, AM J TROP MED HYG, V20, P816, DOI 10.4269/ajtmh.1971.20.816; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Moon RW, 2016, P NATL ACAD SCI USA, V113, P7231, DOI 10.1073/pnas.1522469113; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Nakazawa S, 2011, INT J PARASITOL, V41, P317, DOI 10.1016/j.ijpara.2010.10.003; Pachlatko E, 2010, MOL MICROBIOL, V77, P1136, DOI 10.1111/j.1365-2958.2010.07278.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petersen W, 2015, MOL BIOCHEM PARASIT, V200, P25, DOI 10.1016/j.molbiopara.2015.04.005; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Sakaguchi M, 2016, J STRUCT BIOL, V193, P162, DOI 10.1016/j.jsb.2016.01.003; Sakura T, 2013, PARASITOL INT, V62, P157, DOI 10.1016/j.parint.2012.12.002; Sam-Yellowe TY, 2009, TRENDS PARASITOL, V25, P277, DOI 10.1016/j.pt.2009.03.009; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Sinton J. A., 1933, Records of the Malaria Survey of India, V3, P381; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; Ta TH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-68; Templeton TJ, 2009, MOL BIOCHEM PARASIT, V166, P109, DOI 10.1016/j.molbiopara.2009.04.003; Tsarukyanova I, 2009, PARASITOL RES, V104, P875, DOI 10.1007/s00436-008-1270-3; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392	52	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164272	10.1371/journal.pone.0164272	http://dx.doi.org/10.1371/journal.pone.0164272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732628	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300044
J	Carrada, CF; Scalioni, FAR; Cesar, DE; Devito, KL; Ribeiro, LC; Ribeiro, RA				Carrada, Camila Faria; Ribeiro Scalioni, Flavia Almeida; Cesar, Dioneia Evangelista; Devito, Karina Lopes; Ribeiro, Luiz Claudio; Ribeiro, Rosangela Almeida			Salivary Periodontopathic Bacteria in Children and Adolescents with Down Syndrome	PLOS ONE			English	Article							SITU HYBRIDIZATION FISH; DIRECT VISUALIZATION; GINGIVITIS; BIOFILM; COLONIZATION; MICROBIOTA; DISEASE; CARIES	Objective To assess and compare salivary periodontopathic bacteria between groups of Down syndrome and non-Down syndrome children and adolescents. Materials and Methods This study included a sample of 30 Down syndrome children and adolescents (G-DS) and 30 age-and sex-matched non-Down syndrome subjects (G-ND). Clinical examination determined the gingival bleeding index (GBI) and plaque index. Unstimulated whole saliva samples were collected from all participants. The fluorescence in situ hybridization (FISH) technique identified the presence and density of eight periodontopathic bacteria in saliva. The statistical analysis included chi-square and Mann-Whitney U tests. Results In the G-DS group, bleeding on probing was more frequent (p = 0.037) and higher densities of Campylobacter rectus (p = 0.013), Porphyromonas gingivalis (p = 0.025), Treponema denticola (p = 0.026), Fusobacterium nucleatum (p = 0.013), Prevotella intermedia (p = 0.001) and Prevotella nigrescens (p = 0.008) were observed. Besides, in the G-DS, the densities of bacteria from the orange complex were significantly higher in the age group 3-7 years for F. nucleatum (p = 0.029), P. intermedia (p = 0.001) and P. nigrescens (p = 0.006). C. rectus was higher in the age group 8-12 years (p = 0.045). Conclusion The results showed that children and adolescents with Down syndrome have higher susceptibility to periodontal disease and number of periodontopathic bacteria.	[Carrada, Camila Faria] Univ Fed Juiz de Fora, Sch Dent, Juiz De Fora, MG, Brazil; [Ribeiro Scalioni, Flavia Almeida; Ribeiro, Rosangela Almeida] Univ Fed Juiz de Fora, Sch Dent, Dept Pediat Dent, Juiz De Fora, MG, Brazil; [Cesar, Dioneia Evangelista] Univ Fed Juiz de Fora, Inst Biol Sci, Dept Ecol & Mol Biol Microorganisms, Juiz De Fora, MG, Brazil; [Devito, Karina Lopes] Univ Fed Juiz de Fora, Dept Dent Clin, Sch Dent, Juiz De Fora, MG, Brazil; [Ribeiro, Luiz Claudio] Univ Fed Juiz de Fora, Dept Stat, Inst Exact Sci, Juiz De Fora, MG, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora	Carrada, CF (corresponding author), Univ Fed Juiz de Fora, Sch Dent, Juiz De Fora, MG, Brazil.	camilacarrada_89@hotmail.com	Devito, Karina/N-7276-2019; Cesar, Dionéia Evangelista/V-5038-2019; Devito, Karina L/P-6030-2014	Devito, Karina/0000-0001-5037-5466; Devito, Karina L/0000-0001-5037-5466; Faria Carrada, Camila/0000-0002-3173-2904	Brazilian Coordination of Higher Education (CAPES); Minas Gerais State Research Foundation (FAPEMIG); National Council of Scientific and Technological Development (CNPq)	Brazilian Coordination of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Minas Gerais State Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Brazilian Coordination of Higher Education (CAPES http://www.capes.gov.br), the Minas Gerais State Research Foundation (FAPEMIG http://www.fapemig.br), the National Council of Scientific and Technological Development (CNPq http://www.cnpq.br). The funders had no role in the study design, data collection and analysis, decisions to publish, or preparation of the manuscript	AINAMO J, 1975, INT DENT J, V25, P229; Amano A, 2000, J PERIODONTOL, V71, P249, DOI 10.1902/jop.2000.71.2.249; Areias C, 2012, CLINICS, V67, P1007, DOI 10.6061/clinics/2012(09)04; BARRAGHOLME M, 1992, ORAL MICROBIOL IMMUN, V7, P244, DOI 10.1111/j.1399-302X.1992.tb00033.x; CHOI BK, 1994, INFECT IMMUN, V62, P1889, DOI 10.1128/IAI.62.5.1889-1895.1994; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Davidovich E, 2010, INT J PAEDIATR DENT, V20, P235, DOI 10.1111/j.1365-263X.2010.01045.x; Desai SS, 1997, ORAL SURG ORAL MED O, V84, P279, DOI 10.1016/S1079-2104(97)90343-7; Frydman Alon, 2012, Compend Contin Educ Dent, V33, P356; Gmur R, 2004, EUR J ORAL SCI, V112, P33, DOI 10.1111/j.0909-8836.2004.00103.x; Gmur R, 2002, MICROBIOL-SGM, V148, P1379, DOI 10.1099/00221287-148-5-1379; Haffajee AD, 2008, ORAL MICROBIOL IMMUN, V23, P196, DOI 10.1111/j.1399-302X.2007.00411.x; Haririan H, 2014, J PERIODONTOL, V85, P819, DOI 10.1902/jop.2013.130306; Kaur R, 2013, INT J PAEDIATR DENT, V23, P32, DOI 10.1111/j.1365-263X.2011.01220.x; Khocht A, 2012, J PERIODONTAL RES, V47, P500, DOI 10.1111/j.1600-0765.2011.01459.x; Kulekci G, 2008, ANAEROBE, V14, P49, DOI 10.1016/J.anaerobe.2007.08.001; Lyko K, 2013, ANAEROBE, V24, P32, DOI 10.1016/j.anaerobe.2013.09.005; Machado FC, 2012, BRAZ ORAL RES, V26, P443, DOI 10.1590/S1806-83242012000500011; Martinez-Martinez RE, 2013, J CLIN PEDIATR DENT, V37, P289, DOI 10.17796/jcpd.37.3.d70710016518p58n; Mathias MF, 2011, EUR J PAEDIATR DENT, V12, P37; Morinushi T, 1997, J PERIODONTOL, V68, P626, DOI 10.1902/jop.1997.68.7.626; Morinushi T, 2006, SPEC CARE DENT, V26, P13, DOI 10.1111/j.1754-4505.2006.tb01504.x; Moter A, 1998, J CLIN MICROBIOL, V36, P1399, DOI 10.1128/JCM.36.5.1399-1403.1998; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Perez-Chaparro PJ, 2014, J DENT RES, V93, P846, DOI 10.1177/0022034514542468; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Sakellari D, 2005, J CLIN PERIODONTOL, V32, P684, DOI 10.1111/j.1600-051X.2005.00737.x; Saygun I, 2011, J PERIODONTAL RES, V46, P235, DOI 10.1111/j.1600-0765.2010.01335.x; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; SZWERINSKI H, 1985, APPL MICROBIOL BIOT, V21, P125; Tanaka MH, 2015, EUR J CLIN MICROBIOL, V34, P601, DOI 10.1007/s10096-014-2268-7; Thurnheer T, 2014, ARCH ORAL BIOL, V59, P977, DOI 10.1016/j.archoralbio.2014.05.023; Umeda M, 1998, J PERIODONTOL, V69, P828, DOI 10.1902/jop.1998.69.7.828	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0162988	10.1371/journal.pone.0162988	http://dx.doi.org/10.1371/journal.pone.0162988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727287	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400004
J	Liska, F; Peterkova, R; Peterka, M; Landa, V; Zidek, V; Mlejnek, P; Silhavy, J; Simakova, M; Kren, V; Starker, CG; Voytas, DF; Izsvak, Z; Pravenec, M				Liska, Frantisek; Peterkova, Renata; Peterka, Miroslav; Landa, Vladimir; Zidek, Vaclav; Mlejnek, Petr; Silhavy, Jan; Simakova, Miroslava; Kren, Vladimir; Starker, Colby G.; Voytas, Daniel F.; Izsvak, Zsuzsanna; Pravenec, Michal			Targeting of the Plzf Gene in the Rat by Transcription Activator-Like Effector Nuclease Results in Caudal Regression Syndrome in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							CELL SELF-RENEWAL; BLOOD-PRESSURE; LIMB; CHROMOSOME-8	Recently, it has been found that spontaneous mutation Lx (polydactyly-luxate syndrome) in the rat is determined by deletion of a conserved intronic sequence of the Plzf (Promyelocytic leukemia zinc finger protein) gene. In addition, Plzf is a prominent candidate gene for quantitative trait loci (QTLs) associated with cardiac hypertrophy and fibrosis in the spontaneously hypertensive rat (SHR). In the current study, we tested the effects of Plzf gene targeting in the SHR using TALENs (transcription activator-like effector nucleases). SHR ova were microinjected with constructs pTAL438/439 coding for a sequence-specific endonuclease that binds to target sequence in the first coding exon of the Plzf gene. Out of 43 animals born after microinjection, we detected a single male founder. Sequence analysis revealed a deletion of G that resulted in frame shift mutation starting in codon 31 and causing a premature stop codon at position of amino acid 58. The Plzf(tm1Ipcv) allele is semi-lethal since approximately 95% of newborn homozygous animals died perinatally. All homozygous animals exhibited manifestations of a caudal regression syndrome including tail anomalies and serious size reduction and deformities of long bones, and oligo-or polydactyly on the hindlimbs. The heterozygous animals only exhibited the tail anomalies. Impaired development of the urinary tract was also revealed: one homozygous and one heterozygous rat exhibited a vesico-ureteric reflux with enormous dilatation of ureters and renal pelvis. In the homozygote, this was combined with a hypoplastic kidney. These results provide evidence for the important role of Plzf gene during development of the caudal part of a body-column vertebrae, hindlimbs and urinary system in the rat.	[Liska, Frantisek; Kren, Vladimir; Pravenec, Michal] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Peterkova, Renata; Peterka, Miroslav; Pravenec, Michal] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic; [Landa, Vladimir; Zidek, Vaclav; Mlejnek, Petr; Silhavy, Jan; Simakova, Miroslava; Kren, Vladimir] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic; [Starker, Colby G.; Voytas, Daniel F.] Univ Minnesota, Minneapolis, MN USA; [Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, Berlin, Germany	Charles University Prague; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of Minnesota System; University of Minnesota Twin Cities; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Pravenec, M (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.; Pravenec, M (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic.	pravenec@biomed.cas.cz	Pravenec, Michal/B-1666-2012; Simakova, Miroslava/B-7493-2012; Mlejnek, Petr/C-2305-2012; Simakova, Miroslava/R-5367-2019; Liska, Frantisek/N-9192-2017; Silhavy, Jan/B-5292-2014; Peterka, Miroslav/H-7852-2014	Pravenec, Michal/0000-0001-9197-5871; Mlejnek, Petr/0000-0002-4218-8983; Simakova, Miroslava/0000-0003-1468-5832; Liska, Frantisek/0000-0002-9588-806X; Silhavy, Jan/0000-0001-8042-5890; Peterka, Miroslav/0000-0002-9687-193X; Izsvak, Zsuzsanna/0000-0002-2053-2384; Starker, Colby/0000-0002-6774-7227; Voytas, Daniel/0000-0002-4944-1224	Czech Science Foundation [15-04871S, 14-37368G]; European Regional Development Fund (ERDF); Operational Program Prague Competitiveness (OPPC) Biomodels [CZ.2.16/3.1.00/24017]	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund (ERDF)(European Commission); Operational Program Prague Competitiveness (OPPC) Biomodels	This study was funded by grants from the Czech Science Foundation (15-04871S, to Frantisek Liska) (14-37368G, to Renata Peterkova) and the European Regional Development Fund (ERDF), Operational Program Prague Competitiveness (OPPC) Biomodels (CZ.2.16/3.1.00/24017, to Dr. Michal Pravenec). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Fischer S, 2008, J MED GENET, V45, P731, DOI 10.1136/jmg.2008.059451; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; Kren V, 1997, J CLIN INVEST, V99, P577, DOI 10.1172/JCI119198; Kren V, 1995, FOLIA BIOL-PRAGUE, V41, P284; Liska F, 2014, AM J HYPERTENS, V27, P99, DOI 10.1093/ajh/hpt156; Liska F, 2009, DEV DYNAM, V238, P673, DOI 10.1002/dvdy.21859; Liu TM, 2016, STEM CELLS, V34, P277, DOI 10.1002/stem.2270; Mancini M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0316-y; Murawski IJ, 2006, CLIN GENET, V69, P105, DOI 10.1111/j.1399-0004.2005.00562.x; Singh SK, 2005, PEDIATR SURG INT, V21, P578, DOI 10.1007/s00383-005-1451-4; Torre M, 2008, J PEDIATR SURG, V43, P530, DOI 10.1016/j.jpedsurg.2007.10.036; van Eerde AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031327; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035632; Wollmann HA, 1998, HORM RES, V49, P1, DOI 10.1159/000053079	17	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164206	10.1371/journal.pone.0164206	http://dx.doi.org/10.1371/journal.pone.0164206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727328	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000385504400022
J	Luis, IM; Alexandre, BM; Oliveira, MM; Abreu, IA				Luis, Ines M.; Alexandre, Bruno M.; Margarida Oliveira, M.; Abreu, Isabel A.			Selection of an Appropriate Protein Extraction Method to Study the Phosphoproteome of Maize Photosynthetic Tissue	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; PHENOL EXTRACTION; PHOSPHORYLATION	Often plant tissues are recalcitrant and, due to that, methods relying on protein precipitation, such as TCA/acetone precipitation and phenol extraction, are usually the methods of choice for protein extraction in plant proteomic studies. However, the addition of precipitation steps to protein extraction methods may negatively impact protein recovery, due to problems associated with protein re-solubilization. Moreover, we show that when working with non-recalcitrant plant tissues, such as young maize leaves, protein extraction methods with precipitation steps compromise the maintenance of some labile post-translational modifications (PTMs), such as phosphorylation. Therefore, a critical issue when studying PTMs in plant proteins is to ensure that the protein extraction method is the most appropriate, both at qualitative and quantitative levels. In this work, we compared five methods for protein extraction of the C4-photosynthesis related proteins, in the tip of fully expanded third-leaves. These included: TCA/Acetone Precipitation; Phenol Extraction; TCA/Acetone Precipitation followed by Phenol Extraction; direct extraction in Lysis Buffer (a urea-based buffer); and direct extraction in Lysis Buffer followed by Cleanup with a commercial kit. Protein extraction in Lysis Buffer performed better in comparison to the other methods. It gave one of the highest protein yields, good coverage of the extracted proteome and phosphoproteome, high reproducibility, and little protein degradation. This was also the easiest and fastest method, warranting minimal sample handling. We also show that this method is adequate for the successful extraction of key enzymes of the C4-photosynthetic metabolism, such as PEPC, PPDK, PEPCK, and NADP-ME. This was confirmed by MALDI-TOF/TOF MS analysis of excised spots of 2DE analyses of the extracted protein pools. Staining for phosphorylated proteins in 2DE revealed the presence of several phosphorylated isoforms of PEPC, PPDK, and PEPCK.	[Luis, Ines M.; Margarida Oliveira, M.; Abreu, Isabel A.] Univ Nova Lisboa, ITQB, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal; [Alexandre, Bruno M.; Abreu, Isabel A.] Inst Biol Expt & Tecnol, Oeiras, Portugal	Universidade Nova de Lisboa	Abreu, IA (corresponding author), Univ Nova Lisboa, ITQB, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal.; Abreu, IA (corresponding author), Inst Biol Expt & Tecnol, Oeiras, Portugal.	abreu@itqb.uni.pt	Oliveira, M. Margarida/H-9318-2012; Alexandre, Bruno/A-9028-2016; Abreu, Isabel A/I-5081-2013	Oliveira, M. Margarida/0000-0002-0095-1952; Alexandre, Bruno/0000-0002-7381-9258; Abreu, Isabel A/0000-0002-5566-2146; Luis, Ines Matias/0000-0001-8925-8857	Fundacao para a Ciencia e Tecnologia (FCT) [1ML (PD/BD/113982/2015)]; BMA [SFRH/BPD/98619/2013]; IAA (FCT); POPH (QREN); GREEN-it "Bioresources for Sustainability" [UID/Multi/04551/2013];  [FP7-KBBE-2011-5];  [289582]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); BMA; IAA (FCT); POPH (QREN); GREEN-it "Bioresources for Sustainability"; ; 	Fundacao para a Ciencia e Tecnologia (FCT, http://www.fct.pt) supported 1ML (PD/BD/113982/2015), BMA (SFRH/BPD/98619/2013), and IAA (FCT Investigator, financed by POPH (QREN)). Work was supported by the Research unit GREEN-it "Bioresources for Sustainability" (UID/Multi/04551/2013, http//www/itqb.unl.pt/green-it); and 3to4 (FP7-KBBE-2011-5, Collaborative Project n.289582, http://www3to4.org). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2009, SPRINGER PROTOC HAND, P579, DOI 10.1007/978-1-59745-198-7_54; Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; Bi YD, 2011, PLANTA, V233, P383, DOI 10.1007/s00425-010-1291-x; Boex-Fontvieille E, 2014, PLANT BIOLOGY, V16, P550, DOI 10.1111/plb.12100; Chao Q, 2014, PLANT MOL BIOL, V85, P95, DOI 10.1007/s11103-014-0171-3; Chastain CJ, 2008, PLANT J, V53, P854, DOI 10.1111/j.1365-313X.2007.03366.x; Faurobert Mireille, 2007, V355, P9; Han C, 2016, METHODS MOL BIOL, V1355, P213, DOI 10.1007/978-1-4939-3049-4_14; JIAO JA, 1991, PLANT PHYSIOL, V96, P297, DOI 10.1104/pp.96.1.297; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Mechin Valerie, 2007, V355, P1; Ning DL, 2016, PLANTA, V243, P501, DOI 10.1007/s00425-015-2420-3; Pick TR, 2011, PLANT CELL, V23, P4208, DOI 10.1105/tpc.111.090324; Rabilloud T, 1996, ELECTROPHORESIS, V17, P813, DOI 10.1002/elps.1150170503; Rabilloud T, 2014, METHODS MOL BIOL, V1072, P43, DOI 10.1007/978-1-62703-631-3_4; Silva-Sanchez C, 2015, PROTEOMICS, V15, P1127, DOI 10.1002/pmic.201400410; Wang Y, 2014, J EXP BOT, V65, P3567, DOI 10.1093/jxb/eru058; Wu XL, 2014, PROTEOMICS, V14, P645, DOI 10.1002/pmic.201300239; Wu XL, 2014, NAT PROTOC, V9, P362, DOI 10.1038/nprot.2014.022	19	8	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164387	10.1371/journal.pone.0164387	http://dx.doi.org/10.1371/journal.pone.0164387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727304	Green Submitted, gold, Green Published			2022-12-27	WOS:000385504400030
J	Taylor, AJ; Granwehr, J; Lesbats, C; Krupa, JL; Six, JS; Pavlovskaya, GE; Thomas, NR; Auer, DP; Meersmann, T; Faas, HM				Taylor, Alexander J.; Granwehr, Josef; Lesbats, Clementine; Krupa, James L.; Six, Joseph S.; Pavlovskaya, Galina E.; Thomas, Neil R.; Auer, Dorothee P.; Meersmann, Thomas; Faas, Henryk M.			Probe-Specific Procedure to Estimate Sensitivity and Detection Limits for F-19 Magnetic Resonance Imaging	PLOS ONE			English	Article							TO-NOISE RATIO; MRI PROBE; INFLAMMATION; TRACKING; RELAXATION; RESOLUTION	Due to low fluorine background signal in vivo, F-19 is a good marker to study the fate of exogenous molecules by magnetic resonance imaging (MRI) using equilibrium nuclear spin polarization schemes. Since F-19 MRI applications require high sensitivity, it can be important to assess experimental feasibility during the design stage already by estimating the minimum detectable fluorine concentration. Here we propose a simple method for the calibration of MRI hardware, providing sensitivity estimates for a given scanner and coil configuration. An experimental "calibration factor" to account for variations in coil configuration and hardware set-up is specified. Once it has been determined in a calibration experiment, the sensitivity of an experiment or, alternatively, the minimum number of required spins or the minimum marker concentration can be estimated without the need for a pilot experiment. The definition of this calibration factor is derived based on standard equations for the sensitivity in magnetic resonance, yet the method is not restricted by the limited validity of these equations, since additional instrument-dependent factors are implicitly included during calibration. The method is demonstrated using MR spectroscopy and imaging experiments with different F-19 samples, both paramagnetically and susceptibility broadened, to approximate a range of realistic environments.	[Taylor, Alexander J.; Lesbats, Clementine; Six, Joseph S.; Pavlovskaya, Galina E.; Auer, Dorothee P.; Meersmann, Thomas; Faas, Henryk M.] Univ Nottingham, Sch Med, Sir Peter Mansfield Imaging Ctr, Nottingham, England; [Granwehr, Josef] Forschungszentrum Julich, Inst Energy & Climate Res, Fundamental Electrochem IEK9, D-52425 Julich, Germany; [Krupa, James L.; Thomas, Neil R.] Univ Nottingham, Sch Chem, Nottingham, England	University of Nottingham; Helmholtz Association; Research Center Julich; University of Nottingham	Faas, HM (corresponding author), Univ Nottingham, Sch Med, Sir Peter Mansfield Imaging Ctr, Nottingham, England.	henryk.faas@nottinghan.ac.uk	pavlovskaya, galina/AAA-3732-2021	pavlovskaya, galina/0000-0003-4352-3269; Meersmann, Thomas/0000-0003-0243-0672; Auer, Dorothee P./0000-0002-4745-3635; Lesbats, Clementine/0000-0002-8168-6926; Krupa, James/0000-0002-2525-1709	EPSRC Research Development Fund award; MRC Doctoral Training Program PhD Studentship; Biotechnology and Biological Sciences Research Council [1094590] Funding Source: researchfish; Medical Research Council [1222719] Funding Source: researchfish; MRC [MC_PC_13072] Funding Source: UKRI	EPSRC Research Development Fund award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC Doctoral Training Program PhD Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the following: EPSRC Research Development Fund award; MRC Doctoral Training Program PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Gaudet JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118544; Giraudeau C, 2010, MAGN RESON MED, V63, P1119, DOI 10.1002/mrm.22269; Goette MJ, 2015, J MAGN RESON IMAGING, V42, P488, DOI 10.1002/jmri.24812; Granwehr J, 2007, APPL MAGN RESON, V32, P113, DOI 10.1007/s00723-007-0006-3; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; HAASE A, 1990, MAGN RESON MED, V13, P77, DOI 10.1002/mrm.1910130109; Hidalgo SS, 2012, J APPL PHYS, V112, DOI 10.1063/1.4740222; HOULT DI, 1979, J MAGN RESON, V34, P425, DOI 10.1016/0022-2364(79)90019-2; HOULT DI, 1976, J MAGN RESON, V24, P71, DOI 10.1016/0022-2364(76)90233-X; Jacoby C, 2014, NMR BIOMED, V27, P261, DOI 10.1002/nbm.3059; Kadjane P, 2014, CHEM-EUR J, V20, P7351, DOI 10.1002/chem.201400159; Keliris A, 2012, CONTRAST MEDIA MOL I, V7, P478, DOI 10.1002/cmmi.1470; Kok MB, 2011, CONTRAST MEDIA MOL I, V6, P19, DOI 10.1002/cmmi.398; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Lee HS, 2008, SCANNING, V30, P419, DOI 10.1002/sca.20118; LIBOVE JM, 1980, J PHYS E SCI INSTRUM, V13, P38, DOI 10.1088/0022-3735/13/1/013; Lilburn DML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073468; Mizukami S, 2008, J AM CHEM SOC, V130, P794, DOI 10.1021/ja077058z; Mizukami S, 2009, ANGEW CHEM INT EDIT, V48, P3641, DOI 10.1002/anie.200806328; Nordmeyer-Massner JA, 2011, J MAGN RESON, V210, P7, DOI 10.1016/j.jmr.2011.01.025; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Qiao HY, 2006, MAGN RESON IMAGING, V24, P1281, DOI 10.1016/j.mri.2006.08.002; Ruiz-Cabello J, 2011, NMR BIOMED, V24, P114, DOI 10.1002/nbm.1570; Srinivas M, 2012, BIOMATERIALS, V33, P8830, DOI 10.1016/j.biomaterials.2012.08.048; Srinivas M, 2010, TRENDS BIOTECHNOL, V28, P363, DOI 10.1016/j.tibtech.2010.04.002; Stupic KF, 2006, SOLID STATE NUCL MAG, V29, P79, DOI 10.1016/j.ssnmr.2005.08.008; Weibel S, 2013, J NUCL MED, V54, P3; Weise G, 2011, EXP NEUROL, V229, P494, DOI 10.1016/j.expneurol.2011.03.020; Ye YX, 2013, CIRCULATION, V128, P1878, DOI 10.1161/CIRCULATIONAHA.113.000731; Youssef K, 2015, IEEE T MED IMAGING, V34, P1822, DOI 10.1109/TMI.2015.2409265; Yu JX, 2013, PROG NUCL MAG RES SP, V70, P25, DOI 10.1016/j.pnmrs.2012.10.001; Zhao DW, 2009, MAGN RESON MED, V62, P357, DOI 10.1002/mrm.22020	38	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163704	10.1371/journal.pone.0163704	http://dx.doi.org/10.1371/journal.pone.0163704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727294	Green Submitted, gold, Green Published			2022-12-27	WOS:000385504400009
J	Vancura, P; Wolloscheck, T; Baba, K; Tosini, G; Luvone, PM; Spessert, R				Vancura, Patrick; Wolloscheck, Tanja; Baba, Kenkichi; Tosini, Gianluca; Luvone, P. Michael; Spessert, Rainer			Circadian and Dopaminergic Regulation of Fatty Acid Oxidation Pathway Genes in Retina and Photoreceptor Cells	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; MAMMALIAN RETINA; ENERGY-METABOLISM; MOUSE RETINA; COACTIVATOR PGC-1; ADENYLYL-CYCLASE; BETA-OXIDATION; RABBIT RETINA; CLOCK GENES; EXPRESSION	The energy metabolism of the retina might comply with daily changes in energy demand and is impaired in diabetic retinopathy-one of the most common causes of blindness in Europe and the USA. The aim of this study was to investigate putative adaptation of energy metabolism in healthy and diabetic retina. Hence expression analysis of metabolic pathway genes was performed using quantitative polymerase chain reaction, semi-quantitative western blot and immunohistochemistry. Transcriptional profiling of key enzymes of energy metabolism identified transcripts of mitochondrial fatty acid beta-oxidation enzymes, i.e. carnitine palmitoyltransferase-1 alpha (Cpt-1 alpha) and medium chain acyl-CoA dehydrogenase (Acadm) to display daily rhythms with peak values during daytime in preparations of the whole retina and microdissected photoreceptors. The cycling of both enzymes persisted in constant darkness, was dampened in mice deficient for dopamine D4 (D-4) receptors and was altered in db/db mice-a model of diabetic retinopathy. The data of the present study are consistent with circadian clock-dependent and dopaminergic regulation of fatty acid oxidation in retina and its putative disturbance in diabetic retina.	[Vancura, Patrick; Wolloscheck, Tanja; Spessert, Rainer] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Mainz, Germany; [Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Inst Neurosci, Atlanta, GA USA; [Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Dept Pharmacol & Toxicol, Atlanta, GA USA; [Luvone, P. Michael] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	Johannes Gutenberg University of Mainz; Morehouse School of Medicine; Morehouse School of Medicine; Emory University	Spessert, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Mainz, Germany.	Spessert@uni-mainz.de		tosini, gianluca/0000-0003-3645-4533	National Institutes of Health [R01EY004864, R01EY0222, P30EY006360]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022216, R01EY004864, P30EY006360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS083932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded in part by grants from the National Institutes of Health: R01EY004864 to PMI, R01EY0222 to GT, P30EY006360 to PMI, and anunrestricted departmental grant from Research to Prevent Blindness to PMI.	AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Atsuzawa K, 2010, HISTOCHEM CELL BIOL, V134, P565, DOI 10.1007/s00418-010-0752-4; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; Cook GA, 2001, J MOL CELL CARDIOL, V33, P317, DOI 10.1006/jmcc.2000.1304; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Dorenbos R, 2007, VISUAL NEUROSCI, V24, P573, DOI 10.1017/S0952523807070538; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Fletcher AL, 2012, MOL GENET METAB, V106, P18, DOI 10.1016/j.ymgme.2012.02.015; Foster Russell G, 2007, Methods Mol Biol, V362, P3; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Goldmann T, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-2; Gooley JJ, 2014, J GENET GENOMICS, V41, P231, DOI 10.1016/j.jgg.2014.04.001; Hiragaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106819; Holter P, 2012, INVEST OPHTH VIS SCI, V53, P6947, DOI 10.1167/iovs.12-10234; Hwang CK, 2013, J NEUROSCI, V33, P14989, DOI 10.1523/JNEUROSCI.2039-13.2013; Ishizawa M, 2012, BIOCHEM BIOPH RES CO, V418, P780, DOI 10.1016/j.bbrc.2012.01.102; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; IUVONE PM, 1978, SCIENCE, V202, P901, DOI 10.1126/science.30997; Jackson CR, 2011, EUR J NEUROSCI, V34, P57, DOI 10.1111/j.1460-9568.2011.07734.x; Jackson CR, 2009, J NEUROCHEM, V109, P148, DOI 10.1111/j.1471-4159.2009.05920.x; Joyal JS, 2016, NAT MED, V22, P439, DOI 10.1038/nm.4059; Kamphuis W, 2005, BIOCHEM BIOPH RES CO, V330, P18, DOI 10.1016/j.bbrc.2005.02.118; Keung W, 2013, DIABETES, V62, P711, DOI 10.2337/db12-0259; Kim T, 2014, J DIABETES METAB, V5, DOI [10.4172/2155-6156.1000401, 10.4172/2155-6156.1000361]; Kunst S, 2015, INVEST OPHTH VIS SCI, V56, P6084, DOI 10.1167/iovs.15-17503; Kunst S, 2013, J NEUROCHEM, V124, P757, DOI 10.1111/jnc.12089; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Louet JF, 2002, J BIOL CHEM, V277, P37991, DOI 10.1074/jbc.M205087200; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; OSBORNE NN, 1984, HISTOCHEMISTRY, V80, P389, DOI 10.1007/BF00495423; Osorio-Paz I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030822; Owino S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148214; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PARK EA, 1995, BIOCHEM J, V310, P853, DOI 10.1042/bj3100853; Pozdeyev N, 2008, EUR J NEUROSCI, V27, P2691, DOI 10.1111/j.1460-9568.2008.06224.x; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roomets E, 2008, INVEST OPHTH VIS SCI, V49, P1660, DOI 10.1167/iovs.07-1094; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sadana P, 2007, MOL CELL ENDOCRINOL, V267, P6, DOI 10.1016/j.mce.2006.11.012; Sancar G, 2014, CELL MOL LIFE SCI, V71, P2667, DOI 10.1007/s00018-014-1574-7; Schneider K, 2010, J NEUROCHEM, V115, P585, DOI 10.1111/j.1471-4159.2010.06953.x; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tikhonenko M, 2010, DIABETES, V59, P219, DOI 10.2337/db09-0728; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Tosini G, 2014, BIOESSAYS, V36, P778, DOI 10.1002/bies.201400017; Trojan P, 2008, PROG RETIN EYE RES, V27, P237, DOI 10.1016/j.preteyeres.2008.01.003; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; Tyni T, 2002, PEDIATR RES, V52, P595, DOI 10.1203/01.PDR.0000030874.20888.2D; Ushikubo S, 1996, AM J HUM GENET, V58, P979; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094829; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Xu LL, 2016, MOL VIS, V22, P275; Yang Q, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/757412	65	17	17	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164665	10.1371/journal.pone.0164665	http://dx.doi.org/10.1371/journal.pone.0164665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727308	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504400049
J	Ehlers, DK; Fanning, J; Awick, EA; Kramer, AF; McAuley, E				Ehlers, Diane K.; Fanning, Jason; Awick, Elizabeth A.; Kramer, Arthur F.; McAuley, Edward			Contamination by an Active Control Condition in a Randomized Exercise Trial	PLOS ONE			English	Article							OLDER-ADULTS; COGNITIVE FUNCTION; PHYSICAL-ACTIVITY; CANCER SURVIVORS; AEROBIC EXERCISE; ADHERENCE; EFFICACY; FITNESS; MODEL	Contamination is commonly overlooked in randomized trials. The present study examined contamination (minutes of aerobic activity outside of exercise sessions) within an active control condition in a 6-month randomized exercise trial for older adults. We hypothesized that outside aerobic activity would be greater in the control condition compared to the intervention conditions. Participants (mean age = 65.06 years, 66.2% female) were randomly assigned to: Dance (n = 50), Walking, (n = 108), or Strength/Stretching/Stability (SSS; n = 48). Dance and Walking represented the experimental conditions and SSS the control condition. Participants attended exercise sessions three times weekly for 24 weeks. Participants recorded their physical activity outside of class on a weekly home log. Group assignment and covariates (age, gender, body mass index, exercise session intensity and enjoyment, and program adherence) were examined as predictors of weekly aerobic activity outside of exercise sessions. Participants who returned zero home logs were removed from the dataset (final N = 195). Out-of-class aerobic activity was lowest in the Walking group. Significant effects of gender, group, enjoyment, and intensity on out-of-class weekly aerobic activity were observed, all p<0.003. Higher perceived enjoyment of exercise sessions was associated with more out-of-class aerobic activity, while higher perceived intensity was associated with less out-of-class aerobic activity. A group x intensity interaction, p = 0.002, indicated that group differences in out-of-class aerobic activity were evident only among those with lower intensity perceptions. Walkers may have perceived exercise sessions as sufficient weekly exercise, while the Dance and SSS groups may have perceived the sessions as necessary, but insufficient. The lower aerobic intensity Dancers attributed to exercise sessions and non-aerobic nature of SSS may partially explain contamination observed in this study. Further examination of contamination in randomized controlled exercise trials is critically needed.	[Ehlers, Diane K.; Fanning, Jason; Awick, Elizabeth A.; McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Kramer, Arthur F.] Northeastern Univ, Off Provost, Boston, MA 02115 USA	University of Illinois System; University of Illinois Urbana-Champaign; Northeastern University	Ehlers, DK (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	dkehlers@illinois.edu	Ehlers, Diane/I-4052-2018; Ehlers, Diane/AAK-4945-2021; Kramer, Arthur/AAB-2937-2019; Salerno, Elizabeth/N-1317-2019	Ehlers, Diane/0000-0002-9545-9556; Salerno, Elizabeth/0000-0001-5152-3168; Kramer, Arthur/0000-0001-5870-2724	National Institute on Aging [R37 AG025667]; Center for Nutrition Learning and Memory at the University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE ON AGING [R01AG025667] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Center for Nutrition Learning and Memory at the University of Illinois at Urbana-Champaign; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging (https://www.nia.nih.gov/; R37 AG025667; Arthur F. Kramer) and the Center for Nutrition Learning and Memory at the University of Illinois at Urbana-Champaign (http://cnlm.illinois. edu/; Arthur F. Kramer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; BEGG CB, 1980, BIOMETRICS, V36, P81, DOI 10.2307/2530497; Bisschop CNS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120996; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Carter MC, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2283; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Courneya KS, 2004, PSYCHO-ONCOL, V13, P857, DOI 10.1002/pon.802; Courneya KS, 2002, ANN BEHAV MED, V24, P257, DOI 10.1207/S15324796ABM2404_02; Czajkowski SM, 2015, HEALTH PSYCHOL, V34, P971, DOI 10.1037/hea0000161; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Freedland KE, 2011, PSYCHOSOM MED, V73, P323, DOI 10.1097/PSY.0b013e318218e1fb; Hawley-Hague H, 2016, J AGING PHYS ACTIV, V24, P119, DOI 10.1123/japa.2014-0108; Hawley-Hague H, 2014, GERONTOLOGIST, V54, P599, DOI 10.1093/geront/gnt075; Hertogh EM, 2010, J CLIN EPIDEMIOL, V63, P900, DOI 10.1016/j.jclinepi.2009.10.007; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; McAuley E, 2011, AM J PREV MED, V41, P284, DOI 10.1016/j.amepre.2011.04.014; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Segal RJ, 2009, J CLIN ONCOL, V27, P344, DOI 10.1200/JCO.2007.15.4963; Sternfeld B, 2014, MENOPAUSE, V21, P330, DOI 10.1097/GME.0b013e31829e4089; Stothart CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109557; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119	24	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164246	10.1371/journal.pone.0164246	http://dx.doi.org/10.1371/journal.pone.0164246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723781	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504100032
J	Girard, SL; Bourassa, CV; Perreault, LPL; Legault, MA; Barhdadi, A; Ambalavanan, A; Brendgen, M; Vitaro, F; Noreau, A; Dionne, G; Tremblay, RE; Dion, PA; Boivin, M; Dube, MP; Rouleau, GA				Girard, Simon L.; Bourassa, Cynthia V.; Perreault, Louis-Philippe Lemieux; Legault, Marc-Andre; Barhdadi, Amina; Ambalavanan, Amirthagowri; Brendgen, Mara; Vitaro, Frank; Noreau, Anne; Dionne, Ginette; Tremblay, Richard E.; Dion, Patrick A.; Boivin, Michel; Dube, Marie-Pierre; Rouleau, Guy A.			Paternal Age Explains a Major Portion of De Novo Germline Mutation Rate Variability in Healthy Individuals	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; COPY NUMBER VARIATION; SCHIZOPHRENIA; GENOME; RISK; SIGNATURES; ALIGNMENT; PATTERNS	De novo mutations (DNM) are an important source of rare variants and are increasingly being linked to the development of many diseases. Recently, the paternal age effect has been the focus of a number of studies that attempt to explain the observation that increasing paternal age increases the risk for a number of diseases. Using disease-free familial quartets we show that there is a strong positive correlation between paternal age and germline DNM in healthy subjects. We also observed that germline CNVs do not follow the same trend, suggesting a different mechanism. Finally, we observed that DNM were not evenly distributed across the genome, which adds support to the existence of DNM hotspots.	[Girard, Simon L.] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ, Canada; [Girard, Simon L.; Bourassa, Cynthia V.; Ambalavanan, Amirthagowri; Noreau, Anne; Dion, Patrick A.; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Perreault, Louis-Philippe Lemieux; Legault, Marc-Andre; Barhdadi, Amina; Dube, Marie-Pierre] Inst Cardiol Montreal, Ctr Pharmacogen Beaulieu Saucier, Montreal, PQ, Canada; [Perreault, Louis-Philippe Lemieux; Legault, Marc-Andre; Barhdadi, Amina; Dube, Marie-Pierre] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Brendgen, Mara] Univ Quebec, Dept Psychol, Montreal, PQ, Canada; [Vitaro, Frank] Univ Montreal, Dept Psychol Educ, Montreal, PQ, Canada; [Dionne, Ginette; Boivin, Michel] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth, Dublin, Ireland; [Tremblay, Richard E.] Univ Montreal, Pediat & Psychol, Montreal, PQ, Canada	University of Quebec; University of Quebec Chicoutimi; McGill University; Universite de Montreal; Institut de Cardiologie de Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal; Universite de Montreal; Laval University; University College Dublin; Universite de Montreal	Girard, SL (corresponding author), Univ Quebec Chicoutimi, Dept Sci Fondamentales, Saguenay, PQ, Canada.; Girard, SL (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	simon2_girard@uqac.ca	Legault, Marc-André/GNH-5935-2022; Legault, Marc-André/HHD-1804-2022; Tremblay, Richard E./O-1360-2014; Dubé, Marie-Pierre/B-9364-2008	Dubé, Marie-Pierre/0000-0001-8442-4393; Girard, Simon/0000-0002-4089-2280; Boivin, Michel/0000-0001-8621-9844	Canada Research Chair in Genetics of the Nervous System; Jeanne-et-J.-Louis-Levesque Chair for the Genetics of Brain Diseases; Fonds de Recherche Quebec-Sante; Canada Research Chair; Jeanne-et-J.-Louis-Levesque Chair; Fonds de Recherche Quebec Sante; Calcul Quebec / Calcul Canada	Canada Research Chair in Genetics of the Nervous System; Jeanne-et-J.-Louis-Levesque Chair for the Genetics of Brain Diseases; Fonds de Recherche Quebec-Sante; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Jeanne-et-J.-Louis-Levesque Chair; Fonds de Recherche Quebec Sante; Calcul Quebec / Calcul Canada	Guy A. Rouleau is grateful for the support received through his positions as Canada Research Chair in Genetics of the Nervous System and Jeanne-et-J.-Louis-Levesque Chair for the Genetics of Brain Diseases. Simon L. Girard is grateful for the financial support received from Fonds de Recherche Quebec Sante. This work was also supported by Calcul Quebec / Calcul Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the families involved in our study. Guy A. Rouleau is grateful for the support received through his positions as Canada Research Chair in Genetics of the Nervous System and Jeanne-et-J.-Louis-Levesque Chair for the Genetics of Brain Diseases. Simon L. Girard is grateful for the financial support received from Fonds de Recherche Quebec-Sante. We are grateful to Calcul Quebec / Calcul Canada for the time and resources.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ANTIPENKO YN, 1993, MUTAT RES, V289, P145, DOI 10.1016/0027-5107(93)90064-M; Boivin M, 2013, TWIN RES HUM GENET, V16, P64, DOI 10.1017/thg.2012.129; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Goldmann JM, 2016, NAT GENET, V48, P935, DOI 10.1038/ng.3597; Ikehata M, 1999, MUTAT RES-FUND MOL M, V427, P147, DOI 10.1016/S0027-5107(99)00087-1; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malaspina D, 2001, SCHIZOPHRENIA BULL, V27, P379, DOI 10.1093/oxfordjournals.schbul.a006882; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McRae J.R., 2016, BIORXIV, P049056, DOI [10.1101/049056, DOI 10.1101/049056]; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Wong WSW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10486; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	26	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164212	10.1371/journal.pone.0164212	http://dx.doi.org/10.1371/journal.pone.0164212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723766	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000385504100029
J	Vafaee, F; Krycer, JR; Ma, XQ; Burykin, T; James, DE; Kuncic, Z				Vafaee, Fatemeh; Krycer, James R.; Ma, Xiuquan; Burykin, Timur; James, David E.; Kuncic, Zdenka			ORTI: An Open-Access Repository of Transcriptional Interactions for Interrogating Mammalian Gene Expression Data	PLOS ONE			English	Article							REGULATORY ELEMENT DATABASE; PROSTATE-CANCER CELLS; TARGET GENES; ANDROGEN RECEPTOR; NEUROENDOCRINE DIFFERENTIATION; NETWORK MOTIFS; MICROARRAY; IDENTIFICATION; ADIPOGENESIS; HOMEOSTASIS	Transcription factors (TFs) play a fundamental role in coordinating biological processes in response to stimuli. Consequently, we often seek to determine the key TFs and their regulated target genes (TGs) amidst gene expression data. This requires a knowledge-base of TF-TG interactions, which would enable us to determine the topology of the transcriptional network and predict novel regulatory interactions. To address this, we generated an Open-access Repository of Transcriptional Interactions, ORTI, by integrating available TF-TG interaction databases. These databases rely on different types of experimental evidence, including low-throughput assays, high-throughput screens, and bioinformatics predictions. We have subsequently categorised TF-TG interactions in ORTI according to the quality of this evidence. To demonstrate its capabilities, we applied ORTI to gene expression data and identified modulated TFs using an enrichment analysis. Combining this with pairwise TF-TG interactions enabled us to visualise temporal regulation of a transcriptional network. Additionally, ORTI enables the prediction of novel TF-TG interactions, based on how well candidate genes co-express with known TGs of the target TF. By filtering out known TF-TG interactions that are unlikely to occur within the experimental context, this analysis predicts context-specific TF-TG interactions. We show that this can be applied to experimental designs of varying complexities. In conclusion, ORTI is a rich and publicly available database of experimentally validated mammalian transcriptional interactions which is accompanied with tools that can identify and predict transcriptional interactions, serving as a useful resource for unravelling the topology of transcriptional networks.	[Vafaee, Fatemeh; Krycer, James R.; Burykin, Timur; James, David E.; Kuncic, Zdenka] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Vafaee, Fatemeh] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Krycer, James R.; Ma, Xiuquan; James, David E.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Ma, Xiuquan] Garvan Inst Med Res, Diabet & Metab Div, Sydney, NSW, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Kuncic, Zdenka] Univ Sydney, Sch Phys, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; Garvan Institute of Medical Research; University of Sydney; University of Sydney	Vafaee, F; Kuncic, Z (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.; Vafaee, F (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia.; Kuncic, Z (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW, Australia.	fatemeh.vafaee@sydney.edu.au; zdenka.kuncic@sydney.edu.au	Ma, Hugh/S-4266-2019	Ma, Hugh/0000-0001-7227-1289; Krycer, James/0000-0003-1536-7270; James, David/0000-0001-5946-5257; Vafaee, Fatemeh/0000-0002-7521-2417; Kuncic, Zdenka/0000-0001-6765-3215	National Health and Medical Research Council (NHMRC) [GNT1061122]; DEJ is an NHMRC Senior Research Fellow [APP1019680]; NHMRC Early Career Fellowship [APP1072440]; Judith and David Coffey Gift	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); DEJ is an NHMRC Senior Research Fellow(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Judith and David Coffey Gift	This work was supported by a grant from the National Health and Medical Research Council (NHMRC; GNT1061122) and DEJ is an NHMRC Senior Research Fellow (APP1019680). JRK is supported by an NHMRC Early Career Fellowship (APP1072440). TB is supported by the Judith and David Coffey Gift. The contents of the published material are solely the responsibility of the University of Sydney or individual authors, and do not reflect the views of NHMRC. The funders had no role in study design, data collectionan danalysis, decision to publish, or preparation of the manuscript.	Aerts S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001115; Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen C, 2012, AM J PHYSIOL-GASTR L, V302, pG407, DOI 10.1152/ajpgi.00314.2011; Cui Song, 2014, PLoS One, V9, pe94519, DOI 10.1371/journal.pone.0094519; Dai XB, 2007, NUCLEIC ACIDS RES, V35, P4433, DOI 10.1093/nar/gkm454; Ensslen-Craig SE, 2004, DEV BIOL, V275, P12, DOI 10.1016/j.ydbio.2004.08.009; Essaghir A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039666; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Fertig EJ, 2013, IEEE T NANOBIOSCI, V12, P142, DOI 10.1109/TNB.2013.2263390; Fujiwara K, 2011, CANCER RES, V71, P1924, DOI 10.1158/0008-5472.CAN-10-2386; Gronostajski Richard M, 2011, J Clin Bioinforma, V1, P4, DOI 10.1186/2043-9113-1-4; Hemers H, 2004, J BIOL CHEM, V279, P30880, DOI 10.1074/jbc.M401615200; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Klingelhofer J, 2000, J CELL SCI, V113, P2829; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kolchanov NA, 2002, NUCLEIC ACIDS RES, V30, P312, DOI 10.1093/nar/30.1.312; Koutalellis G, 2012, BJU INT, V110, pE267, DOI 10.1111/j.1464-410X.2012.11152.x; Krycer JR, 2011, J BIOL CHEM, V286, P20637, DOI 10.1074/jbc.M111.227082; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Ma XQ, 2014, MOL CELL BIOL, V34, P3607, DOI 10.1128/MCB.00583-14; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Ocone A, 2011, BIOINFORMATICS, V27, P2873, DOI 10.1093/bioinformatics/btr487; Portales-Casamar E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r207; Portales-Casamar E, 2009, NUCLEIC ACIDS RES, V37, pD54, DOI 10.1093/nar/gkn783; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Schmitt I, 2009, CEREBELLUM, V8, P71, DOI 10.1007/s12311-009-0118-4; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wright ME, 2003, MOL ENDOCRINOL, V17, P1726, DOI 10.1210/me.2003-0031; Wu CY, 2006, PROSTATE, V66, P1125, DOI 10.1002/pros.20412; Xu Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-451; Zhang XQ, 2003, ONCOGENE, V22, P6704, DOI 10.1038/sj.onc.1206764; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004	45	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164535	10.1371/journal.pone.0164535	http://dx.doi.org/10.1371/journal.pone.0164535			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723773	Green Submitted, gold, Green Published			2022-12-27	WOS:000385504100072
J	Amanzougaghene, N; Mumcuoglu, KY; Fenollar, F; Alfi, S; Yesilyurt, G; Raoult, D; Mediannikov, O				Amanzougaghene, Nadia; Mumcuoglu, Kosta Y.; Fenollar, Florence; Alfi, Shir; Yesilyurt, Gonca; Raoult, Didier; Mediannikov, Oleg			High Ancient Genetic Diversity of Human Lice, Pediculus humanus, from Israel Reveals New Insights into the Origin of Clade B Lice	PLOS ONE			English	Article							HEAD LICE; BARTONELLA-QUINTANA; ACINETOBACTER-BAUMANNII; AFRICAN BODY; LOUSE; CAPITIS; IDENTIFICATION; VECTOR	The human head louse, Pediculus humanus capitis, is subdivided into several significantly divergent mitochondrial haplogroups, each with particular geographical distributions. Historically, they are among the oldest human parasites, representing an excellent marker for tracking older events in human evolutionary history. In this study, ancient DNA analysis using real-time polymerase chain reaction (qPCR), combined with conventional PCR, was applied to the remains of twenty-four ancient head lice and their eggs from the Roman period which were recovered from Israel. The lice and eggs were found in three combs, one of which was recovered from archaeological excavations in the Hatzeva area of the Judean desert, and two of which found in Moa, in the Arava region, close to the Dead Sea. Results show that the head lice remains dating approximately to 2,000 years old have a cytb haplogroup A, which is worldwide in distribution, and haplogroup B, which has thus far only been found in contemporary lice from America, Europe, Australia and, most recently, Africa. More specifically, this haplogroup B has a B36 haplotype, the most common among B haplogroups, and has been present in America for at least 4,000 years. The present findings confirm that clade B lice existed, at least in the Middle East, prior to contacts between Native Americans and Europeans. These results support a Middle Eastern origin for clade B followed by its introduction into the New World with the early peoples. Lastly, the presence of Acinetobacter baumannii DNA was demonstrated by qPCR and sequencing in four head lice remains belonging to clade A.	[Amanzougaghene, Nadia; Fenollar, Florence; Raoult, Didier; Mediannikov, Oleg] Aix Marseille Univ, INSERM 1095, URMITE, CNRS 7278,UM63,IRD 198, Marseille 05, France; [Mumcuoglu, Kosta Y.; Alfi, Shir; Yesilyurt, Gonca] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet,Parasitol Unit, Jerusalem, Israel; [Raoult, Didier; Mediannikov, Oleg] Campus Int UCAD IRD, Dakar, Senegal	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Hebrew University of Jerusalem	Mediannikov, O (corresponding author), Aix Marseille Univ, INSERM 1095, URMITE, CNRS 7278,UM63,IRD 198, Marseille 05, France.; Mediannikov, O (corresponding author), Campus Int UCAD IRD, Dakar, Senegal.	olegusss1@gmail.com	RAOULT, Didier/A-8434-2008; Mediannikov, Oleg/H-4018-2015; Mumcuoglu, Kosta/AAY-2122-2020	RAOULT, Didier/0000-0002-0633-5974; Mediannikov, Oleg/0000-0001-6039-2008; Mumcuoglu, Kosta/0000-0001-8125-6099	IHU Mediterranee Infection	IHU Mediterranee Infection	We would like to thank Dr. Orit Shamir and Dr. Naama Sukenik from the Israel Antiquities Authority, as well as Professor Simcha Lev-Yadun from Haifa University, for their help in identifying and allowing us to examine the ancient louse combs for louse remains. We also thank IHU Mediterranee Infection for financially supporting the study.	Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Araujo A, 2000, PARASITOL TODAY, V16, P269, DOI 10.1016/S0169-4758(00)01694-X; Arriaza B, 2012, J PARASITOL, V98, P433, DOI 10.1645/GE-2903.1; Ascunce MS, 2013, AM J PHYS ANTHROPOL, V152, P118, DOI 10.1002/ajpa.22336; Ascunce MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057619; Ashfaq M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14188; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boutellis A, 2015, MED VET ENTOMOL, V29, P94, DOI 10.1111/mve.12058; Boutellis A, 2014, INFECT GENET EVOL, V23, P209, DOI 10.1016/j.meegid.2014.01.017; Boutellis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076818; Boutellis A, 2013, EMERG INFECT DIS, V19, P796, DOI 10.3201/eid1905.121480; Bouvresse S, 2011, COMP IMMUNOL MICROB, V34, P475, DOI 10.1016/j.cimid.2011.08.007; Drali R, 2016, INFECT GENET EVOL, V39, P225, DOI 10.1016/j.meegid.2016.02.008; Drali R, 2015, AM J TROP MED HYG, V93, P990, DOI 10.4269/ajtmh.14-0686; Drali R, 2015, AM J TROP MED HYG, V93, P623, DOI 10.4269/ajtmh.14-0552; Drancourt M, 2005, J INFECT DIS, V191, P607, DOI 10.1086/427041; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Goldberger J, 1896, PUB HLTH REP, V27, P297, DOI [10.2307/4567527, DOI 10.2307/4567527]; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Houhamdi L, 2006, J INFECT DIS, V194, P1589, DOI 10.1086/508995; Kempf M, 2012, INT J INFECT DIS, V16, pE680, DOI 10.1016/j.ijid.2012.05.1024; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; La Scola B, 2004, EMERG INFECT DIS, V10, P1671, DOI 10.3201/eid1009.040242; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Light JE, 2008, J PARASITOL, V94, P1275, DOI 10.1645/GE-1618.1; Maurin M, 1996, CLIN MICROBIOL REV, V9, P273, DOI 10.1128/CMR.9.3.273; MURRAY ES, 1975, ANN NY ACAD SCI, V266, P25, DOI 10.1111/j.1749-6632.1975.tb35086.x; Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405; Parola P, 2011, EMERG INFECT DIS, V17, P883, DOI 10.3201/eid1705.100573; Pediculus Mumcuoglu K., 2008, PALEOMICROBIOLOGY HU, P215; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Raoult D, 2006, J INFECT DIS, V193, P112, DOI 10.1086/498534; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; Raoult D, 2008, J INFECT DIS, V197, P535, DOI 10.1086/526520; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Rivera MA, 2008, CHUNGARA, V40, P31, DOI 10.4067/S0717-73562008000100004; Sangare AK, 2014, AM J TROP MED HYG, V91, P294, DOI 10.4269/ajtmh.13-0707; Sunantaraporn S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0742-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461; Veracx A, 2012, TRENDS PARASITOL, V28, P563, DOI 10.1016/j.pt.2012.09.003	41	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164659	10.1371/journal.pone.0164659	http://dx.doi.org/10.1371/journal.pone.0164659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741281	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000052
J	Tan, DWN; Lim, SG; Wong, TT; Venkatraman, SS				Tan, Dulcia W. N.; Lim, Soo Ghim; Wong, Tina T.; Venkatraman, Subbu S.			Sustained Antibiotic-Eluting Intra-Ocular Lenses: A New Approach	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEM; CATARACT-SURGERY; IN-VITRO; FLUOROQUINOLONES; DEXAMETHASONE; LEVOFLOXACIN; MOXIFLOXACIN; MECHANISMS; SCAFFOLDS; RELEASE	Currently, infections following cataract surgery are not as effectively managed with antibiotic eye drops, which suffer from poor bioavailability of drug and low patient compliance. The ideal solution, which can help to overcome the issue of drug wastage and poor bioavailabilty, as well as the need for frequent applications (patient inconvenience), is a drug-eluting intraocular lens (IOL). We describe a novel approach to such a drug-eluting lens by using a peripheral IOL attachment as a drug depot to deliver antibiotics, Levofloxacin (LFX) or Moxifloxacin (MFX). In this work, drug was entrapped within a fully-degradable polymer, poly(L-lactide-co-epsilon-caprolactone) (PLC). The effects of drug loading and solvent type on drug release and film morphology were investigated using cast films. The study clearly demonstrated that a slower-evaporating solvent tetrahydrofuran (THF) resulted in a better surface morphology, as well as lower initial burst compared to dichloromethane (DCM), and hence, was better suited to developing a drug-eluting attachment with sustained release of drug. When attachments were fabricated with drugs at high loading percentages (20% and 25% in polymer), significant burst was observed compared to films: this is attributed to the higher surface-to-volume ratio of the attachments. When the levofloxacin (LFX) loading percentage was decreased to 3% and 5%, the attachments presented lower burst and sustained release with therapeutic efficacy. This work has demonstrated the potential of using an IOL attachment as a more efficacious anti-infective option compared to daily eye drops.	[Tan, Dulcia W. N.; Lim, Soo Ghim; Wong, Tina T.; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore; [Wong, Tina T.] Singapore Natl Eye Ctr, Singapore, Singapore; [Wong, Tina T.] Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tina T.; Venkatraman, Subbu S.] Nanyang Technol Univ, Ocular Therapeut Engn Ctr, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Venkatraman, SS (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.; Venkatraman, SS (corresponding author), Nanyang Technol Univ, Ocular Therapeut Engn Ctr, Singapore, Singapore.	ASSubbu@ntu.edu.sg	Venkatraman, Subramanian/A-2228-2011	Venkatraman, Subramanian/0000-0002-8693-1070	National Medical Research Council (NMRC) of Singapore, under its Translational and Clinical Research Programme [TCR/008-SERI/2013]; Nanyang Technological University	National Medical Research Council (NMRC) of Singapore, under its Translational and Clinical Research Programme(National Medical Research Council, Singapore); Nanyang Technological University(Nanyang Technological University)	This study was supported in part by the National Medical Research Council (NMRC) of Singapore, under its Translational and Clinical Research Programme (TCR/008-SERI/2013 EyeSITe grant), administered by the Ministry of Health (http://www.nmrc.gov.sg) and Nanyang Technological University (www.ntu.edu.sg). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by the National Medical Research Council (NMRC) of Singapore, under its Translational and Clinical Research Programme (TCR/008-SERI/2013 EyeSITe) grant, administered by the Ministry of Health. The author would also like to acknowledge the financial support provided by Nanyang Technological University.	Anderson EM, 2009, BIOMATERIALS, V30, P5675, DOI 10.1016/j.biomaterials.2009.06.047; Colin J, 2003, ACTA OPHTHALMOL SCAN, V81, P611, DOI 10.1111/j.1395-3907.2003.00173.x; DeCroos FC, 2008, CURR OPIN OPHTHALMOL, V19, P22, DOI 10.1097/ICU.0b013e3282f30577; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Eperon S, 2008, INT J PHARMACEUT, V352, P240, DOI 10.1016/j.ijpharm.2007.10.054; Fintelmann RE, 2010, DRUGS, V70, P1395, DOI 10.2165/11537950-000000000-00000; Garty S, 2011, INVEST OPHTH VIS SCI, V52, P6109, DOI 10.1167/iovs.10-6071; Gaudana R, 2009, PHARM RES-DORDR, V26, P1197, DOI 10.1007/s11095-008-9694-0; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; Huang JJ, 2012, OCULAR INFLAMMATORY, DOI [10.1089/iop.2008.0007, DOI 10.1089/JOP.2008.0007]; Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6; Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906; Jeong SI, 2004, BIOMACROMOLECULES, V5, P1303, DOI 10.1021/bm049921i; Jones ME, 2000, ANTIMICROB AGENTS CH, V44, P2645, DOI 10.1128/AAC.44.10.2645-2652.2000; Kim SH, 2006, J BIOMAT SCI-POLYM E, V17, P1359, DOI 10.1163/156856206778937244; Kleinmann G, 2006, J CATARACT REFR SURG, V32, P1717, DOI 10.1016/j.jcrs.2006.04.033; Kompella UB, 2010, THER DELIV, V1, P435, DOI 10.4155/TDE.10.40; Kugelberg M, 2010, ACTA OPHTHALMOL, V88, P241, DOI 10.1111/j.1755-3768.2008.01419.x; MAURICE DM, 1984, HDB EXPT PHARM, V69, P19; Miller D, 2008, CLIN OPHTHALMOL, V2, P77; Peng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022507; Pestova E, 2000, J ANTIMICROB CHEMOTH, V45, P583, DOI 10.1093/jac/45.5.583; Raizman MB, 2002, CLIN THER, V24, P1439, DOI 10.1016/S0149-2918(02)80047-9; Shaw J, 2010, J OCUL PHARMACOL TH, V26, P587, DOI 10.1089/jop.2010.0021; Siqueira RC, 2006, OPHTHALMOLOGICA, V220, P338, DOI 10.1159/000094626; Smith EF, 2008, J OCUL PHARMACOL TH, V24, P495, DOI 10.1089/jop.2008.0007; Taban M, 2005, ARCH OPHTHALMOL-CHIC, V123, P613, DOI 10.1001/archopht.123.5.613; Tsuchiya Y, 2008, CURR EYE RES, V33, P868, DOI 10.1080/02713680802382971; World Health Organization, BLINDN VIS 2020 CONT; Yagci R, 2007, EYE, V21, P990, DOI 10.1038/sj.eye.6702414	30	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163857	10.1371/journal.pone.0163857	http://dx.doi.org/10.1371/journal.pone.0163857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741256	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000007
J	Tang, HL; Wu, ZY; Mao, YR; Cepeda, J; Morano, J				Tang, Houlin; Wu, Zunyou; Mao, Yurong; Cepeda, Javier; Morano, Jamie			Risk Factor Associated with Negative Spouse HIV Seroconversion among Sero-Different Couples: A Nested Case-Control Retrospective Survey Study in 30 Counties in Rural China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; VIRAL LOAD; SERODISCORDANT COUPLES; TRANSMISSION; PREVENTION; INFECTION; CHALLENGES	Background Antiretroviral therapy (ART) and condom use have been proven to reduce the risk of sexual transmission of human immunodeficiency virus (HIV) among HIV sero-different couples, but its full implementation remains a challenge. This study aims to assess HIV seroconversion rate of HIV-negative spouse and its associated risk factors among HIV sero-different couples in rural China. Methods An open cohort of HIV sero-different couples enrolled in 30 counties in China between October 1, 2010, and September 30, 2012, and followed-up to December 31, 2012, was constructed retrospectively. A nested case-control study of risk factors of HIV seroconversion among sero-different couples was conducted in April and May of 2013, based on the open cohort. Sero-different couples with the HIV-negative spouse seroconverting at least 3 months after the previous negative diagnosis during cohort observation period were labeled as "case couples". The "control couples" were selected randomly from the same cohort that did not have the HIV-negative spouse seroconversion during the same period. The "case couples" and "control couples" were matched on gender, age, and region of residence. Sexual behaviors among HIV sero-different couples before and after the index spouses notifying their HIV infection status to their HIV-negative spouses were collected via face-to-face interview. Univariate and multivariate logistic regression models were used to assess factors associated with HIV seroconversion among HIV sero-different couples. Results Of 4481 HIV sero-different couples, a total of 53 seroconversions were observed within 5218 person-years of follow-up. The incidence rate was 1.02 (95% CI: 0.76-1.33) per 100 person-years. Forty "case couples" confirmed HIV-negative spouse seroconversions infected via marital sexual transmission, were matched to 80 "control couples". Of the 120 couples, 81(67.5%) were receiving ART, and 70 (58.3%) reported consistently used condoms during intercourse after the index spouse was diagnosed HIV infection. Multivariate conditional logistic regression analysis showed that the desire to conceive a child (OR = 5.18, 95% CI: 1.19-22.58) significantly increased the odds of HIV seroconversion. Protective factors of spousal HIV seroconversion were currently receiving ART (OR = 0.09, 95% CI: 0.01-0.67) and consistent condom use (OR = 0.05, 95% CI: 0.01-0.28). Conclusions Intention to conceive a child is the most important risk factor for HIV seroconversion among sero-different couples. Specific efforts on scientific use of ART to assist sero-different couples to achieve their wish to conceive a healthy child are needed to minimize the risk of HIV transmission.	[Tang, Houlin; Mao, Yurong] Chinese Ctr Dis Control & Prevent, Div Integrat & Evaluat, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Cepeda, Javier] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Morano, Jamie] Univ S Florida, Div Infect Dis & Int Med, Morsani Coll Med, Tampa, FL USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; State University System of Florida; University of South Florida	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzy@263.net	tang, houlin/HGA-1502-2022		National Health and Family Planning Commission of the People's Republic of China [2012ZX10001-007]	National Health and Family Planning Commission of the People's Republic of China	National Health and Family Planning Commission of the People's Republic of China supported the project (2012ZX10001-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A, 2013, JAMA-J AM MED ASSOC, V310, P1619, DOI [10.1001/jama.2013.278328, 10.1002/14651858.CD009153.pub3]; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barreiro P, 2007, HUM REPROD, V22, P2353, DOI 10.1093/humrep/dem226; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; Bavinton BR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-917; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Chu X, 2009, CHINESE J DIS CONTRO, V13, P256; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Curran K, 2012, CURR HIV-AIDS REP, V9, P160, DOI 10.1007/s11904-012-0114-z; Del Romero J, 2010, BMJ-BRIT MED J, P340; Demeter LM, 2001, ANN INTERN MED, V135, P954, DOI 10.7326/0003-4819-135-11-200112040-00007; Duan Song, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P997; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; He N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077981; Heard I, 2007, AIDS, V21, pS77, DOI 10.1097/01.aids.0000255089.44297.6f; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Kumarasamy N, 2010, HIV MED, V11, P178, DOI 10.1111/j.1468-1293.2009.00760.x; LI H, 2008, CHINESE J AIDS STD, V14, P39; Liu HX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0111175, 10.1371/journal.pone.0110887]; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Mehendale SM, 2006, JAIDS-J ACQ IMM DEF, V41, P371, DOI 10.1097/01.qai.0000209905.35620.48; Mmeje O, 2012, INFECT DIS OBSTET GY, P2012; Pan X, 2010, CHINESE J PREVENTIVE, V45, P1023; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Supervie V, 2014, CLIN INFECT DIS, V59, P115, DOI 10.1093/cid/ciu223; Tang CSK, 2001, AIDS EDUC PREV, V13, P329, DOI 10.1521/aeap.13.4.329.21426; Tang H, 2012, CHINESE J PREVENTIVE, V46, P4; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Zhuang K, 2002, FOREIGN MED INT J EP, V29, P321	40	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164761	10.1371/journal.pone.0164761	http://dx.doi.org/10.1371/journal.pone.0164761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741292	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000066
J	Beyene, GT; Balasingham, SV; Frye, SA; Namouchi, A; Homberset, H; Kalayou, S; Riaz, T; Tonjum, T				Beyene, Getachew Tesfaye; Balasingham, Seetha V.; Frye, Stephan A.; Namouchi, Amine; Homberset, Havard; Kalayou, Shewit; Riaz, Tahira; Tonjum, Tone			Characterization of the Neisseria meningitidis Helicase RecG	PLOS ONE			English	Article							STALLED REPLICATION FORKS; ESCHERICHIA-COLI; DNA-REPAIR; RECOMBINATIONAL REPAIR; ATPASE ACTIVITY; PROTEIN; SEQUENCE; DAMAGE; MODEL; IDENTIFICATION	Neisseria meningitidis (Nm) is a Gram-negative oral commensal that opportunistically can cause septicaemia and/or meningitis. Here, we overexpressed, purified and characterized the Nm DNA repair/recombination helicase RecG (RecG(Nm)) and examined its role during genotoxic stress. RecG(Nm) possessed ATP-dependent DNA binding and unwinding activities in vitro on a variety of DNA model substrates including a Holliday junction (HJ). Database searching of the Nm genomes identified 49 single nucleotide polymorphisms (SNPs) in the recG(Nm) including 37 non-synonymous SNPs (nsSNPs), and 7 of the nsSNPs were located in the codons for conserved active site residues of RecG(Nm). A transient reduction in transformation of DNA was observed in the Nm Delta recG strain as compared to the wildtype. The gene encoding recG(Nm) also contained an unusually high number of the DNA uptake sequence (DUS) that facilitate transformation in neisserial species. The differentially abundant protein profiles of the Nm wildtype and Delta recG strains suggest that expression of RecG(Nm) might be linked to expression of other proteins involved in DNA repair, recombination and replication, pilus biogenesis, glycan biosynthesis and ribosomal activity. This might explain the growth defect that was observed in the Nm Delta recG null mutant.	[Beyene, Getachew Tesfaye; Homberset, Havard; Kalayou, Shewit; Riaz, Tahira; Tonjum, Tone] Univ Oslo, Dept Microbiol, Oslo, Norway; [Balasingham, Seetha V.; Frye, Stephan A.; Namouchi, Amine; Tonjum, Tone] Oslo Univ Hosp, Dept Microbiol, Rikshosp, Oslo, Norway; [Beyene, Getachew Tesfaye] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia	University of Oslo; University of Oslo; National Hospital Norway; Mekelle University	Tonjum, T (corresponding author), Univ Oslo, Dept Microbiol, Oslo, Norway.	tone.tonjum@medisin.uio.no	Tønjum, Tone/J-4581-2014	Frye, Stephan/0000-0002-0786-8481; Tonjum, Tone/0000-0002-1709-6921; Kalayou, Shewit/0000-0001-5498-9836; Riaz, Tahira/0000-0002-9759-5316	Research Council of Norway (RCN) [1173185591033, 204747]; RCN Centre of Excellence funding to Centre for Molecular Biology and Neuroscience (SFF) [145977]; RCN GLOBVAC projects [204747, 220901]; Norwegian Agency for Development Cooperation (NORAD); University of Oslo Quota program / Norwegian State Educational Loan Fund	Research Council of Norway (RCN)(Research Council of Norway); RCN Centre of Excellence funding to Centre for Molecular Biology and Neuroscience (SFF); RCN GLOBVAC projects; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); University of Oslo Quota program / Norwegian State Educational Loan Fund	This work was supported by: The Research Council of Norway (RCN) [http://www.forskningsradet.no/no/Forsiden/1173185591033] (#204747), RCN Centre of Excellence funding to Centre for Molecular Biology and Neuroscience (SFF #145977) and RCN GLOBVAC projects #220901 and 204747 [Helse Sorost http://www.halse-sorost.no/] project 2014050; The Norwegian Agency for Development Cooperation (NORAD) research funding [https://www.norad.no/en/front/]; The University of Oslo Quota program / Norwegian State Educational Loan Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Wahab S, 2013, J BIOL CHEM, V288, P26397, DOI 10.1074/jbc.M113.500223; Ambur OH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039742; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; AZEROGLU B, 2016, PLOS GENET, V12, DOI DOI 10.1371/JOURNALPGEN.1005799; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; Battistoni A, 2003, BIOCHEM SOC T, V31, P1326; Benam AV, 2011, MICROBIOL-SGM, V157, P1329, DOI 10.1099/mic.0.046896-0; BILL NJ, 1977, ANTIMICROB AGENTS CH, V11, P470, DOI 10.1128/AAC.11.3.470; Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7; BLAKE MS, 1989, J EXP MED, V170, P1727, DOI 10.1084/jem.170.5.1727; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Brosh RM, 2006, METHOD ENZYMOL, V409, P52, DOI 10.1016/S0076-6879(05)09004-X; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; CAMPBELL LA, 1979, J BACTERIOL, V140, P1109, DOI 10.1128/JB.140.3.1109-1111.1979; Campsall PA, 2013, CRIT CARE CLIN, V29, P393, DOI 10.1016/j.ccc.2013.03.001; Carell T, 2001, CURR OPIN CHEM BIOL, V5, P491, DOI 10.1016/S1367-5931(00)00239-8; Collins RF, 2005, J BIOL CHEM, V280, P18923, DOI 10.1074/jbc.M411603200; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; Davidsen T, 2004, NUCLEIC ACIDS RES, V32, P1050, DOI 10.1093/nar/gkh255; DAVIDSEN T, 2005, J BACTERIOL, V187, DOI DOI 10.1128/JB187.8.2801; Davidsen T, 2007, J BACTERIOL, V189, P5728, DOI 10.1128/JB.00161-07; DENNIS PP, 1974, J MOL BIOL, V84, P407, DOI 10.1016/0022-2836(74)90449-5; Diez A, 2000, MOL MICROBIOL, V36, P1494, DOI 10.1046/j.1365-2958.2000.01979.x; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Findlay WA, 2009, GENOME BIOL EVOL, V1, P45, DOI 10.1093/gbe/evp005; FRASCH CE, 1972, INFECT IMMUN, V5, P98, DOI 10.1128/IAI.5.1.98-102.1972; Frye SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003458; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; Goosen N, 2001, RES MICROBIOL, V152, P401, DOI 10.1016/S0923-2508(01)01211-6; Grossman L, 2007, MUTAT RES, V1, P213; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LLOYD RG, 1993, EMBO J, V12, P17, DOI 10.1002/j.1460-2075.1993.tb05627.x; Lloyd RG, 2016, CURR GENET, V62, P827, DOI 10.1007/s00294-016-0589-z; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; Marians KJ, 2016, RESCUING STALLED DAM, P1; Masai H, 2010, BIOESSAYS, V32, P687, DOI 10.1002/bies.200900196; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; Meddows TR, 2004, MOL MICROBIOL, V52, P119, DOI 10.1111/j.1365-2958.2003.03970.x; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; Moore TDE, 1996, J BACTERIOL, V178, P4301, DOI 10.1128/jb.178.14.4301-4305.1996; Nagorska K, 2012, MOL MICROBIOL, V83, P1064, DOI 10.1111/j.1365-2958.2012.07989.x; Nassif X, 2000, SCIENCE, V287, P1767, DOI 10.1126/science.287.5459.1767; Nowosielska A, 2006, NUCLEIC ACIDS RES, V34, P2258, DOI 10.1093/nar/gkl222; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Pagliarulo C, 2004, MOL MICROBIOL, V51, P1757, DOI 10.1111/j.1365-2958.2003.03947.x; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Rudolph CJ, 2010, GENETICS, V186, P473, DOI 10.1534/genetics.110.120691; Rudolph CJ, 2009, MOL MICROBIOL, V74, P940, DOI 10.1111/j.1365-2958.2009.06909.x; Rudolph CJ, 2009, MOL MICROBIOL, V73, P352, DOI 10.1111/j.1365-2958.2009.06773.x; Sechman EV, 2006, MOL MICROBIOL, V61, P185, DOI 10.1111/j.1365-2958.2006.05213.x; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Seib KL, 2004, J INFECT DIS, V190, P136, DOI 10.1086/421299; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; Slocum SL, 2007, J MOL BIOL, V367, P647, DOI 10.1016/j.jmb.2007.01.007; Stohl EA, 2006, J BACTERIOL, V188, P7645, DOI 10.1128/JB.00801-06; Stokke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030981; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sun YH, 2005, J BACTERIOL, V187, P3273, DOI 10.1128/JB.187.9.3273-3276.2005; SWANSON J, 1990, J EXP MED, V171, P2131, DOI 10.1084/jem.171.6.2131; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thakur RS, 2013, FEBS J, V280, P1841, DOI 10.1111/febs.12208; Tobiason DM, 2006, PLOS BIOL, V4, P1069, DOI 10.1371/journal.pbio.0040185; Tonjum T, 1998, MOL MICROBIOL, V29, P111, DOI 10.1046/j.1365-2958.1998.00910.x; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Torheim NK, 2000, MOL MICROBIOL, V37, P629, DOI 10.1046/j.1365-2958.2000.02031.x; Treangen TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r60; Wallet C, 2015, PLANT CELL, V27, P2907, DOI 10.1105/tpc.15.00680; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Wu YY, 2009, CAN J MICROBIOL, V55, P841, DOI [10.1139/W09-028, 10.1139/w09-028]; Yu C, 2016, GENES CELLS, V21, P163, DOI 10.1111/gtc.12334; Zegeye ED, 2014, MICROBIOL-SGM, V160, P217, DOI 10.1099/mic.0.072140-0; Zegeye ED, 2012, MICROBIOL-SGM, V158, P1982, DOI 10.1099/mic.0.058693-0	89	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164588	10.1371/journal.pone.0164588	http://dx.doi.org/10.1371/journal.pone.0164588			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736945	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800090
J	Freedman, ZB; Upchurch, RA; Zak, DR				Freedman, Zachary B.; Upchurch, Rima A.; Zak, Donald R.			Microbial Potential for Ecosystem N Loss Is Increased by Experimental N Deposition	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN DEPOSITION; NORTHERN HARDWOOD FORESTS; NITRATE ASSIMILATION; SOIL RESPIRATION; ORGANIC-MATTER; NITRIC-OXIDE; FINE ROOTS; COMMUNITIES; BACTERIAL; RESPONSES	Fossil fuel combustion and fertilizer use has increased the amount of biologically available N entering terrestrial ecosystems. Nonetheless, our understanding of how anthropogenic N may alter the physiological mechanisms by which soil microorganisms cycle N in soil is still developing. Here, we applied shotgun metagenomics to a replicated long-term field experiment to determine how two decades of experimental N deposition, at a rate expected by mid-century, has affected the genetic potential of the soil microbial community to cycle N in soils. Experimental N deposition lead to a significant and persistent increase in functional assemblages mediating N cycle transformations associated with ecosystem N loss (i. e., denitrification and nitrification), whereas functional assemblages associated with N input and retention (i. e., N fixation and microbial N assimilation) were less positively affected. Furthermore, the abundance and composition of microbial taxa, as well as functional assemblages involved in housekeeping functions (i. e., DNA replication) were unaffected by experimental N deposition. Taken together, our results suggest that functional genes and gene pathways associated with ecosystem N loss have been favored by experimental N deposition, which may represent a genetic mechanism fostering increased N loss as anthropogenic N deposition increases in the future.	[Freedman, Zachary B.; Upchurch, Rima A.; Zak, Donald R.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Zak, Donald R.] Univ Michigan, Dept Ecol & Evolut, Ann Arbor, MI 48109 USA; [Freedman, Zachary B.] West Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; West Virginia University	Freedman, ZB (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.; Freedman, ZB (corresponding author), West Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA.	zachary.freedman@mail.wvu.edu	Freedman, Zachary/AAB-5538-2022	Zak, Donald/0000-0002-9730-7337; Freedman, Zachary/0000-0001-9160-7470	United States Department of Energy's Biological and Environmental Research program; National Science Foundation's Long Term Research in Environmental Biology program; Direct For Biological Sciences [1251529] Funding Source: National Science Foundation	United States Department of Energy's Biological and Environmental Research program(United States Department of Energy (DOE)); National Science Foundation's Long Term Research in Environmental Biology program(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Grants from the United States Department of Energy's Biological and Environmental Research program and the National Science Foundation's Long Term Research in Environmental Biology program provided support for our work.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Allison SD, 2007, SOIL BIOL BIOCHEM, V39, P1878, DOI 10.1016/j.soilbio.2007.02.001; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barnard RL, 2013, ISME J, V7, P2229, DOI 10.1038/ismej.2013.104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthrong ST, 2014, APPL ENVIRON MICROB, V80, P3103, DOI 10.1128/AEM.04034-13; Bottomley PJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00373; Braun E.L, 1950, SOIL SCI, V71, P155, DOI [10.1097/00010694-195102000-00012, DOI 10.1097/00010694-195102000-00012]; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Buhlmann T, 2015, ATMOS ENVIRON, V103, P94, DOI 10.1016/j.atmosenv.2014.12.037; Burger M, 2003, SOIL BIOL BIOCHEM, V35, P29, DOI 10.1016/S0038-0717(02)00233-X; Burton AJ, 2004, GLOBAL CHANGE BIOL, V10, P1080, DOI 10.1111/j.1365-2486.2004.00737.x; BURTON AJ, 1991, CAN J FOREST RES, V21, P1573, DOI 10.1139/x91-219; BURTON AJ, 1993, SOIL SCI SOC AM J, V57, P1619, DOI 10.2136/sssaj1993.03615995005700060036x; Cardenas E, 2015, ISME J, V9, P2465, DOI 10.1038/ismej.2015.57; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cline LC, 2015, ECOLOGY, V96, P3374, DOI 10.1890/15-0184.1; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Edwards IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020421; Eisenlord SD, 2010, SOIL SCI SOC AM J, V74, P1157, DOI 10.2136/sssaj2009.0240; Entwistle EM, 2013, SOIL SCI SOC AM J, V77, P1648, DOI 10.2136/sssaj2013.05.0179; Erisman JW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0116; Fields S., 2004, Environmental Health Perspectives, V112, pA557, DOI 10.1289/ehp.112-a556; Fierer N, 2011, ISME J; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; Freedman Z, 2014, APPL ENVIRON MICROB, V80, P4460, DOI 10.1128/AEM.01224-14; Freedman Z, 2013, SOIL BIOL BIOCHEM, V66, P130, DOI 10.1016/j.soilbio.2013.07.010; Freedman ZB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00259; Freedman ZB, 2015, SOIL BIOL BIOCHEM, V90, P275, DOI 10.1016/j.soilbio.2015.08.014; Freedman ZB, 2015, MOL ECOL, V24, P3170, DOI 10.1111/mec.13224; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Graham EB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00214; HENDRICK RL, 1992, ECOLOGY, V73, P1094, DOI 10.2307/1940183; Huang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07406; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Jefts S, 2004, FOREST ECOL MANAG, V189, P189, DOI 10.1016/j.foreco.2003.08.011; JOHNSTON H, 1971, SCIENCE, V173, P517, DOI 10.1126/science.173.3996.517; Lamontagne S, 2000, FOREST ECOL MANAG, V137, P13, DOI 10.1016/S0378-1127(99)00309-6; Lu M, 2011, NEW PHYTOL, V189, P1040, DOI 10.1111/j.1469-8137.2010.03563.x; LUQUE I, 1992, MOL GEN GENET, V232, P7, DOI 10.1007/BF00299130; MACDONALD NW, 1991, SOIL SCI SOC AM J, V55, P1709, DOI 10.2136/sssaj1991.03615995005500060034x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; MERRILL AG, 1992, CAN J FOREST RES, V22, P1597, DOI 10.1139/x92-212; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Niu SL, 2016, ECOL LETT, V19, P697, DOI 10.1111/ele.12591; Ochoa-Hueso R, 2013, ENVIRON POLLUT, V179, P185, DOI 10.1016/j.envpol.2013.03.060; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Penton CR, 2013, APPL ENVIRON MICROB, V79, P7063, DOI 10.1128/AEM.01702-13; Pinder RW, 2012, P NATL ACAD SCI USA, V109, P7671, DOI 10.1073/pnas.1114243109; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Pregitzer KS, 2004, BIOGEOCHEMISTRY, V68, P179, DOI 10.1023/B:BIOG.0000025737.29546.fd; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Program N. A. D, 2005, NAT ATM DEP PROGR 20; R Code Team, 2013, R LANG ENV STAT COMP; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; Rocca JD, 2015, ISME J, V9, P1693, DOI 10.1038/ismej.2014.252; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Sobota DJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/025006; Torseth K, 2012, ATMOS CHEM PHYS, V12, P5447, DOI 10.5194/acp-12-5447-2012; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Vitousek PM, 2002, AMBIO, V31, P97, DOI 10.1639/0044-7447(2002)031[0097:NAN]2.0.CO;2; Wallenstein MD, 2006, FOREST ECOL MANAG, V222, P459, DOI 10.1016/j.foreco.2005.11.002; Xia MX, 2015, NEW PHYTOL, V208, P715, DOI 10.1111/nph.13494; Zak DR, 2008, ECOL APPL, V18, P2016, DOI 10.1890/07-1743.1; Zak DR, 2006, ECOSYSTEMS, V9, P242, DOI 10.1007/s10021-005-0085-7; ZAK DR, 1990, FOREST SCI, V36, P367; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zifcakova L, 2016, ENVIRON MICROBIOL, V18, P288, DOI 10.1111/1462-2920.13026; Zogg GP, 2000, ECOLOGY, V81, P1858, DOI 10.1890/0012-9658(2000)081[1858:MIATRO]2.0.CO;2	77	9	9	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164531	10.1371/journal.pone.0164531	http://dx.doi.org/10.1371/journal.pone.0164531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737013	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800080
J	Puliga, M; Flori, A; Pappalardo, G; Chessa, A; Pammolli, F				Puliga, Michelangelo; Flori, Andrea; Pappalardo, Giuseppe; Chessa, Alessandro; Pammolli, Fabio			The Accounting Network: How Financial Institutions React to Systemic Crisis	PLOS ONE			English	Article							VALUATION; RISK	The role of Network Theory in the study of the financial crisis has been widely spotted in the latest years. It has been shown how the network topology and the dynamics running on top of it can trigger the outbreak of large systemic crisis. Following this methodological perspective we introduce here the Accounting Network, i.e. the network we can extract through vector similarities techniques from companies' financial statements. We build the Accounting Network on a large database of worldwide banks in the period 2001-2013, covering the onset of the global financial crisis of mid-2007. After a careful data cleaning, we apply a quality check in the construction of the network, introducing a parameter (the Quality Ratio) capable of trading off the size of the sample (coverage) and the representativeness of the financial statements (accuracy). We compute several basic network statistics and check, with the Louvain community detection algorithm, for emerging communities of banks. Remarkably enough sensible regional aggregations show up with the Japanese and the US clusters dominating the community structure, although the presence of a geographically mixed community points to a gradual convergence of banks into similar supranational practices. Finally, a Principal Component Analysis procedure reveals the main economic components that influence communities' heterogeneity. Even using the most basic vector similarity hypotheses on the composition of the financial statements, the signature of the financial crisis clearly arises across the years around 2008. We finally discuss how the Accounting Networks can be improved to reflect the best practices in the financial statement analysis.	[Puliga, Michelangelo; Flori, Andrea; Pappalardo, Giuseppe; Chessa, Alessandro; Pammolli, Fabio] IMT, Sch Adv Studies, Lucca, Italy; [Puliga, Michelangelo; Chessa, Alessandro] Linkalab, Complex Syst Computat Lab, I-09129 Cagliari, Italy	IMT School for Advanced Studies Lucca	Puliga, M (corresponding author), IMT, Sch Adv Studies, Lucca, Italy.; Puliga, M (corresponding author), Linkalab, Complex Syst Computat Lab, I-09129 Cagliari, Italy.	michelangelo.puliga@imtlucca.it	puliga, michelangelo/AAS-9954-2020; Flori, Andrea/E-9220-2018	Flori, Andrea/0000-0002-9861-3598; Pammolli, Fabio/0000-0001-7056-1303	Progetto di Interesse CNR CRISISLAB; Italian project CRISISLAB; Linkalab	Progetto di Interesse CNR CRISISLAB; Italian project CRISISLAB; Linkalab	The authors acknowledge support from the "Progetto di Interesse CNR CRISISLAB". Michelangelo Puliga and Alessandro Chessa are employed by Linkalab. Linkalab provided support in the form of salaries for authors MP and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; In this paper we thank the financial support of the Italian project CRISISLAB and the support of the Linkalab Laboratory for its open discussions and precious suggestions.	Allen F, 2012, J BANK FINANC, V36, P2960, DOI 10.1016/j.jbankfin.2012.06.002; Altunbas Y., 2011, 1394 ECB; [Anonymous], 2013, ECB BANKING STRUCTUR; [Anonymous], 2014, 84 BIS; Aronson BE, 2011, IMES DISCUSSION PAPE; Batten J, 2003, INT J EC BUSINESS, V10, P83, DOI [10.1080/1357151032000043348, DOI 10.1080/1357151032000043348]; Beck T, 2011, ROLE FINANCE EC DEV; Beck T, 2009, PALGRAVE HANDBOOK OF ECONOMETRICS, VOLUME 2: APPLIED ECONOMETRICS, P1180; Beltratti A, 2012, J FINANC ECON, V105, P1, DOI 10.1016/j.jfineco.2011.12.005; Berger AN, 2013, J FINANC ECON, V109, P146, DOI 10.1016/j.jfineco.2013.02.008; BIS, 2011, BAS 3 GLOB REG FRAM; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blundell-Wignall A., 2012, OECD J FINANCIAL MAR, V2, P7, DOI [10.1787/fmt-2012-5k4bxlxbd646, DOI 10.1787/FMT-2012-5K4BXLXBD646]; Brunnermeier MK, 2009, J ECON PERSPECT, V23, P77, DOI 10.1257/jep.23.1.77; Calomiris CW, 2014, J FINANC INTERMED, V23, P400, DOI 10.1016/j.jfi.2014.05.002; Dell'Ariccia G, 2008, J FINANC INTERMED, V17, P89, DOI 10.1016/j.jfi.2007.06.001; Demirguc-Kunt A, 2010, J FINANC ECON, V98, P626, DOI 10.1016/j.jfineco.2010.06.004; Diamond DW, 2009, AM ECON REV, V99, P606, DOI 10.1257/aer.99.2.606; FASB Comparability in international accounting standards: A brief history, 2016, FASB COMP INT ACC ST, V8; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Hoshi T, 1999, NBER WORKING PAPER S; Huizinga H, 2012, J FINANC ECON, V106, P614, DOI 10.1016/j.jfineco.2012.06.008; Levine R, 2005, HDB EC GROWTH, DOI DOI 10.1016/S1574-0684(05)01012-9; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pozsar Z, 2012, FEDERAL RESERVE BANK; Reinhart CM, 2009, THIS TIME IS DIFFERENT: EIGHT CENTURIES OF FINANCIAL FOLLY, P1; Shin H. S., 2008, 328 FED RES BANK NEW; Shin HS, 2012, IMF ECON REV, V60, P155, DOI 10.1057/imfer.2012.6; Traag VA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02930; van Dongen S, 2012, ABS12083145 CORR	30	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0162855	10.1371/journal.pone.0162855	http://dx.doi.org/10.1371/journal.pone.0162855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736865	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800008
J	Wang, XJ; Zhang, X; Zhao, CL; Yi, DY				Wang, Xiaojie; Zhang, Xue; Zhao, Chengli; Yi, Dongyun			Maximizing the Spread of Influence via Generalized Degree Discount	PLOS ONE			English	Article							NETWORKS; RANKING; NODES	It is a crucial and fundamental issue to identify a small subset of influential spreaders that can control the spreading process in networks. In previous studies, a degree-based heuristic called DegreeDiscount has been shown to effectively identify multiple influential spreaders and has severed as a benchmark method. However, the basic assumption of DegreeDiscount is not adequate, because it treats all the nodes equally without any differences. To consider a general situation in real world networks, a novel heuristic method named GeneralizedDegreeDiscount is proposed in this paper as an effective extension of original method. In our method, the status of a node is defined as a probability of not being influenced by any of its neighbors, and an index generalized discounted degree of one node is presented to measure the expected number of nodes it can influence. Then the spreaders are selected sequentially upon its generalized discounted degree in current network. Empirical experiments are conducted on four real networks, and the results show that the spreaders identified by our approach are more influential than several benchmark methods. Finally, we analyze the relationship between our method and three common degree-based methods.	[Wang, Xiaojie; Zhang, Xue; Zhao, Chengli; Yi, Dongyun] Natl Univ Def Technol, Coll Sci, Changsha, Hunan, Peoples R China; [Yi, Dongyun] Natl Univ Def Technol, State Key Lab High Performance Comp, Changsha, Hunan, Peoples R China	National University of Defense Technology - China; National University of Defense Technology - China	Yi, DY (corresponding author), Natl Univ Def Technol, Coll Sci, Changsha, Hunan, Peoples R China.; Yi, DY (corresponding author), Natl Univ Def Technol, State Key Lab High Performance Comp, Changsha, Hunan, Peoples R China.	dongyun.yi@gmail.com			HPCL open fund of NUDT [201403-01]; Postgraduate Innovation Fund of Hunan province [CX2015B010]; Postgraduate Innovation Fund of NUDT [B150203]; major pre-research project of National University of Defense Technology; HPCL open fund of National University of Defense Technology [201403-01]	HPCL open fund of NUDT; Postgraduate Innovation Fund of Hunan province; Postgraduate Innovation Fund of NUDT; major pre-research project of National University of Defense Technology; HPCL open fund of National University of Defense Technology	This work is partially supported by HPCL open fund of NUDT (201403-01), Postgraduate Innovation Fund of Hunan province (CX2015B010), and Postgraduate Innovation Fund of NUDT (B150203).; The authors would like to thank Yanyuan Su and Yirun Ruan for useful comments. This work is partially supported by the major pre-research project of National University of Defense Technology, HPCL open fund of National University of Defense Technology(201403-01), Postgraduate Innovation Fund of Hunan province(CX2015B010), and Postgraduate Innovation Fund of NUDT(B150203).	Bavelas A., 1950, J ACOUST SOC AM, V22, P725, DOI [10.1121/1.1906679, DOI 10.1121/1.1906679]; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chen DB, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/68006; Chen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077455; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Chen W, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P199, DOI 10.1145/1557019.1557047; Dangalchev C, 2006, PHYSICA A, V365, P556, DOI 10.1016/j.physa.2005.12.020; Domingos P., 2001, P 7 ACM SIGKDD INT C, P57, DOI DOI 10.1145/502512.502525; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; He JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145283; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Holme P, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60657-4; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hu Y, 2015, ARXIV150903484; Ji S, 2015, ARXIV150804294; Kempe D., 2003, P 9 ACM SIGKDD INT C, V11, P105, DOI DOI 10.1145/956750.956769; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Li Q, 2014, PHYSICA A, V404, P47, DOI 10.1016/j.physa.2014.02.041; Liu JG, 2013, PHYSICA A, V392, P4154, DOI 10.1016/j.physa.2013.04.037; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13172; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09602; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Morone F, 2015, NATURE, V524, P65, DOI 10.1038/nature14604; Narayanam R, 2011, IEEE T AUTOM SCI ENG, V8, P130, DOI 10.1109/TASE.2010.2052042; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Ren GM, 2014, CHAOS, V24, DOI 10.1063/1.4876436; Richardson M, 2003, LECT NOTES COMPUT SC, V2870, P351; Richardson M., 2002, P 8 ACM SIGKDD INT C, P61, DOI DOI 10.1145/775047.775057; Sheikhahmadi A, 2015, PHYSICA A, V436, P833, DOI 10.1016/j.physa.2015.04.035; Starnini M, 2013, J THEOR BIOL, V337, P89, DOI 10.1016/j.jtbi.2013.07.004; Yang JM, 2010, PHYSICA A, V389, P859, DOI 10.1016/j.physa.2009.10.034; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021; Zeng A, 2013, PHYS LETT A, V377, P1031, DOI 10.1016/j.physleta.2013.02.039; Zhang JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep27823; Zhao XY, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/68005	42	10	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164393	10.1371/journal.pone.0164393	http://dx.doi.org/10.1371/journal.pone.0164393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732681	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505300049
J	Kawasaki, A; Donn, S; Ryan, PR; Mathesius, U; Devilla, R; Jones, A; Watt, M				Kawasaki, Akitomo; Donn, Suzanne; Ryan, Peter R.; Mathesius, Ulrike; Devilla, Rosangela; Jones, Amanda; Watt, Michelle			Microbiome and Exudates of the Root and Rhizosphere of Brachypodium distachyon, a Model for Wheat	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; AGROBACTERIUM-MEDIATED TRANSFORMATION; FRAGMENT-LENGTH-POLYMORPHISMS; RICE ORYZA-SATIVA; BACTERIAL COMMUNITIES; SPATIAL-DISTRIBUTION; CHAETOMIUM-GLOBOSUM; MAIZE RHIZOSPHERE; PLANT-GROWTH; SOIL	The rhizosphere microbiome is regulated by plant genotype, root exudates and environment. There is substantial interest in breeding and managing crops that host root microbial communities that increase productivity. The eudicot model species Arabidopsis has been used to investigate these processes, however a model for monocotyledons is also required. We characterized the rhizosphere microbiome and root exudates of Brachypodium distachyon, to develop it as a rhizosphere model for cereal species like wheat. The Brachypodium rhizosphere microbial community was dominated by Burkholderiales. However, these communities were also dependent on how tightly they were bound to roots, the root type they were associated with (nodal or seminal roots), and their location along the roots. Moreover, the functional gene categories detected in microorganisms isolated from around root tips differed from those isolated from bases of roots. The Brachypodium rhizosphere microbiota and root exudate profiles were similar to those reported for wheat rhizospheres, and different to Arabidopsis. The differences in root system development and cell wall chemistry between monocotyledons and eudicots may also influence the microorganism composition of these major plant types. Brachypodium is a promising model for investigating the microbiome of wheat.	[Kawasaki, Akitomo; Ryan, Peter R.; Devilla, Rosangela; Jones, Amanda; Watt, Michelle] CSIRO Agr & Food, Canberra, ACT, Australia; [Donn, Suzanne] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW, Australia; [Mathesius, Ulrike] Australian Natl Univ, Res Sch Biol, Div Plant Sci, Canberra, ACT 0200, Australia; [Watt, Michelle] Forschungszentrum Julich, Plant Sci, Inst Bio & Geosci IBG 2, Julich, Germany	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Sydney University; Australian National University; Helmholtz Association; Research Center Julich	Watt, M (corresponding author), CSIRO Agr & Food, Canberra, ACT, Australia.; Watt, M (corresponding author), Forschungszentrum Julich, Plant Sci, Inst Bio & Geosci IBG 2, Julich, Germany.	m.watt@fz-juelich.de	Devilla, Rosangela A/D-4004-2011; Ryan, Peter R/I-4651-2012; Donn, Suzanne/B-2272-2012; Watt, Michelle/I-6226-2016; Kawasaki, Akitomo/F-2013-2013; Mathesius, Ulrike/C-9767-2009	Devilla, Rosangela A/0000-0003-2356-5891; Ryan, Peter R/0000-0002-1376-9543; Donn, Suzanne/0000-0002-3998-126X; Watt, Michelle/0000-0001-7843-0957; Kawasaki, Akitomo/0000-0001-5319-3844; Mathesius, Ulrike/0000-0002-3557-0105	CSIRO OCE Postdoctoral Fellowship	CSIRO OCE Postdoctoral Fellowship	AK had a CSIRO OCE Postdoctoral Fellowship to carry out this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Ai C, 2015, SOIL BIOL BIOCHEM, V80, P70, DOI 10.1016/j.soilbio.2014.09.028; Amin BAZ, 2014, BIOGEOCHEMISTRY, V117, P169, DOI 10.1007/s10533-013-9856-y; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDREWS JH, 1992, ANNU REV PHYTOPATHOL, V30, P603, DOI 10.1146/annurev.py.30.090192.003131; AZAIZEH HA, 1995, MYCORRHIZA, V5, P321, DOI 10.1007/BF00207404; Bacilio-Jimenez M, 2003, PLANT SOIL, V249, P271, DOI 10.1023/A:1022888900465; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Baldani J.I., 2014, PROKARYOTES, P919, DOI [10.1007/978-3-642-30197-1_291, DOI 10.1007/978-3-642-30197-1_291]; Balint M, 2014, ECOL EVOL, V4, P2642, DOI 10.1002/ece3.1107; Baudoin E, 2002, APPL SOIL ECOL, V19, P135, DOI 10.1016/S0929-1393(01)00185-8; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bissett A, 2010, MOL ECOL, V19, P4315, DOI 10.1111/j.1365-294X.2010.04804.x; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Buchan A, 2010, ENVIRON MICROBIOL, V12, P3171, DOI 10.1111/j.1462-2920.2010.02290.x; Budak H, 2014, GENOMICS PLANT GENET, P585, DOI DOI 10.1007/978-94-007-7572-5_24; Budak H, 2011, OMICS, V15, P791, DOI 10.1089/omi.2011.0073; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Calvo-Bado LA, 2011, ISME J, V5, P1426, DOI 10.1038/ismej.2011.25; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chochois V, 2015, PLANT PHYSIOL, V168, P953, DOI 10.1104/pp.15.00095; Chochois V, 2012, J EXP BOT, V63, P3467, DOI 10.1093/jxb/ers044; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Corgie SC, 2004, APPL ENVIRON MICROB, V70, P3552, DOI 10.1128/AEM.70.6.3552-3557.2004; Dias DA, 2015, J CHROMATOGR B, V1000, P1, DOI 10.1016/j.jchromb.2015.07.002; DIPIETRO A, 1992, PHYTOPATHOLOGY, V82, P131, DOI 10.1094/Phyto-82-131; do Amaral FP, 2016, PLANT MOL BIOL, V90, P689, DOI 10.1007/s11103-016-0449-8; Donn S, 2015, ENVIRON MICROBIOL, V17, P610, DOI 10.1111/1462-2920.12452; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Gagne-Bourque F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130456; Garcia R., 2014, PROKARYOTES DELTAPRO, P247, DOI DOI 10.1007/978-3-642-39044-9_308; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; HOAGLAND DR, 1950, 347 U CAL BERK COLL; Holland SM, 2016, ANAL RAREFACTION 1 3; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; James TY, 2006, MYCOLOGIA, V98, P860, DOI 10.3852/mycologia.98.6.860; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawasaki A, 2016, PLANT SOIL, V401, P365, DOI 10.1007/s11104-015-2756-2; Kawasaki A, 2012, PLANT SOIL, V358, P162, DOI 10.1007/s11104-011-1089-z; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Kopecky J, 2011, FEMS MICROBIOL ECOL, V78, P386, DOI 10.1111/j.1574-6941.2011.01173.x; Lakshmanan V, 2012, PLANT PHYSIOL, V160, P1642, DOI 10.1104/pp.112.200386; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Letcher PM, 2008, MYCOL RES, V112, P1031, DOI 10.1016/j.mycres.2008.03.007; LILJEROTH E, 1991, BIOL FERT SOILS, V10, P276, DOI 10.1007/BF00337378; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Loades KW, 2013, PLANT SOIL, V370, P407, DOI 10.1007/s11104-013-1643-y; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; OConnell KP, 1996, TRENDS BIOTECHNOL, V14, P83, DOI 10.1016/0167-7799(96)80928-0; Parker D, 2008, NAT PROTOC, V3, P435, DOI 10.1038/nprot.2007.499; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Phillips DA, 2004, PLANT PHYSIOL, V136, P2887, DOI 10.1104/pp.104.044222; Picard C, 2000, APPL ENVIRON MICROB, V66, P948, DOI 10.1128/AEM.66.3.948-955.2000; Pradella S, 2002, ARCH MICROBIOL, V178, P484, DOI 10.1007/s00203-002-0479-2; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Routledge APM, 2004, MOL PLANT PATHOL, V5, P253, DOI 10.1111/j.1364-3703.2004.00224.x; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Ryan PR, 2009, PLANT SOIL, V321, P363, DOI 10.1007/s11104-009-0001-6; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Sauer D, 2006, J PLANT NUTR SOIL SC, V169, P360, DOI 10.1002/jpln.200621974; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schneebeli K, 2015, PLANT PATHOL, V64, P91, DOI 10.1111/ppa.12227; Singer AC, 2003, TRENDS BIOTECHNOL, V21, P123, DOI 10.1016/S0167-7799(02)00041-0; SIVASITHAMPARAM K, 1979, SOIL BIOL BIOCHEM, V11, P155, DOI 10.1016/0038-0717(79)90094-4; Sleeman JR, 1979, 41 ACT CSIRO DIV SOI; Steer J, 2000, SOIL BIOL BIOCHEM, V32, P869, DOI 10.1016/S0038-0717(99)00219-9; Tan SY, 2013, APPL SOIL ECOL, V64, P15, DOI 10.1016/j.apsoil.2012.10.011; Tarafdar JC, 2006, APPL SOIL ECOL, V32, P273, DOI 10.1016/j.apsoil.2005.08.005; Tkacz A, 2015, ISME J, V9, P2349, DOI 10.1038/ismej.2015.41; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; VANCURA V., 1964, Plant and Soil, V21, P231, DOI 10.1007/BF01373607; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Vujanovic V, 2012, CROP PROT, V37, P26, DOI 10.1016/j.cropro.2012.02.006; Wang P, 2006, J AGR FOOD CHEM, V54, P10040, DOI 10.1021/jf061249o; Warren CR, 2015, PLANT SOIL, V397, P147, DOI 10.1007/s11104-015-2612-4; Watt M, 2006, AUST J SOIL RES, V44, P299, DOI 10.1071/SR05142; Watt M, 2006, ENVIRON MICROBIOL, V8, P871, DOI 10.1111/j.1462-2920.2005.00973.x; Watt M, 2008, NEW PHYTOL, V178, P135, DOI 10.1111/j.1469-8137.2007.02358.x; Watt M, 2009, FUNCT PLANT BIOL, V36, P960, DOI 10.1071/FP09214; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yang CH, 2000, APPL ENVIRON MICROB, V66, P345, DOI 10.1128/AEM.66.1.345-351.2000; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zhang YX, 2015, CURR OPIN BIOTECH, V32, P136, DOI 10.1016/j.copbio.2014.12.006	103	82	83	4	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164533	10.1371/journal.pone.0164533	http://dx.doi.org/10.1371/journal.pone.0164533			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727301	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400037
J	Li, Y; Ozment, T; Wright, GL; Peterson, JM				Li, Ying; Ozment, Tammy; Wright, Gary L.; Peterson, Jonathan M.			Identification of Putative Receptors for the Novel Adipokine CTRP3 Using Ligand-Receptor Capture Technology	PLOS ONE			English	Article							C1Q/TNF-RELATED PROTEIN-3 CTRP3; ADIPOSE-TISSUE; HEPATOMA-CELLS; LIVING CELLS; MEMBRANE; GLUCOSE; FAMILY; GENE; ACRP30/ADIPONECTIN; MOUSE	C1q TNF Related Protein 3 (CTRP3) is a member of a family of secreted proteins that exert a multitude of biological effects. Our initial work identified CTRP3' s promise as an effective treatment for Nonalcoholic fatty liver disease (NAFLD). Specifically, we demonstrated that mice fed a high fat diet failed to develop NAFLD when treated with CTRP3. The purpose of this current project is to identify putative receptors which mediate the hepatic actions of CTRP3. Methods We used Ligand-receptor glycocapture technology with TriCEPS T-based ligand-receptor capture (LRC-TriCEPS; Dualsystems Biotech AG). The LRC-TriCEPS experiment with CTRP3-FLAG protein as ligand and insulin as a control ligand was performed on the H4IIE rat hepatoma cell line. Results Initial analysis demonstrated efficient coupling of TriCEPS to CTRP3. Further, flow cytometry analysis (FACS) demonstrated successful oxidation and crosslinking of CTRP3-TriCEPS and Insulin-TriCEPS complexes to cell surface glycans. Demonstrating the utility of TriCEPS under these conditions, the insulin receptor was identified in the control dataset. In the CTRP3 treated cells a total enrichment of 261 peptides was observed. From these experiments 5 putative receptors for CTRP3 were identified with two reaching statistically significance: Lysosomal-associated membrane protein 1 (LAMP-1) and Lysosome membrane protein 2 (LIMP II). Follow-up Co-immunoprecipitation analysis confirmed the association between LAMP1 and CTRP3 and further testing using a polyclonal antibody to block potential binding sites of LAMP1 prevented CTRP3 binding to the cells. Conclusion The LRC-TriCEPS methodology was successful in identifying potential novel receptors for CTRP3. Relevance The identification of the receptors for CTRP3 are important prerequisites for the development of small molecule drug candidates, of which none currently exist, for the treatment NAFLD.	[Li, Ying; Wright, Gary L.; Peterson, Jonathan M.] East Tennessee State Univ, Dept Biomed Sci, Quillen Coll Med, Johnson City, TN 37614 USA; [Ozment, Tammy] East Tennessee State Univ, Dept Internal Med, Quillen Coll Med, Johnson City, TN 37614 USA; [Peterson, Jonathan M.] East Tennessee State Univ, Dept Hlth Sci, Coll Publ Hlth, Johnson City, TN 37614 USA	East Tennessee State University; East Tennessee State University; East Tennessee State University	Peterson, JM (corresponding author), East Tennessee State Univ, Dept Biomed Sci, Quillen Coll Med, Johnson City, TN 37614 USA.; Peterson, JM (corresponding author), East Tennessee State Univ, Dept Hlth Sci, Coll Publ Hlth, Johnson City, TN 37614 USA.	petersonjm1@etsu.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880	National Institute On Alcohol Abuse And Alcoholism of the National Institutes of Health [R03AA023612]; National Institutes of Health [C06RR0306551]; East Tennessee State University Research Development Committee [E82262]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R03AA023612] Funding Source: NIH RePORTER	National Institute On Alcohol Abuse And Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); East Tennessee State University Research Development Committee; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported in part by National Institute On Alcohol Abuse And Alcoholism of the National Institutes of Health under award number R03AA023612, by the National Institutes of Health award number C06RR0306551, and East Tennessee State University Research Development Committee (E82262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Llamas G, 2007, MOL CELL PROTEOMICS, V6, P589, DOI 10.1074/mcp.M600265-MCP200; Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Byerly MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062862; Compton SA, 2010, ENDOCRINOLOGY, V151, P5095, DOI 10.1210/en.2010-0916; Conde J, 2011, BIOFACTORS, V37, P413, DOI 10.1002/biof.185; Corpeleijn E, 2006, DIABETIC MED, V23, P907, DOI 10.1111/j.1464-5491.2006.01888.x; Crombie R, 1998, J BIOL CHEM, V273, P4855, DOI 10.1074/jbc.273.9.4855; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Frei AP, 2013, NAT PROTOC, V8, P1321, DOI 10.1038/nprot.2013.072; Frei AP, 2012, NAT BIOTECHNOL, V30, P997, DOI 10.1038/nbt.2354; Glazier AN, 2002, MAMM GENOME, V13, P108, DOI 10.1007/s00335-001-2132-9; Gonzalez A, 2014, MOL GENET METAB, V111, P84, DOI 10.1016/j.ymgme.2013.12.005; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; Hectors TLM, 2012, TOXICOL LETT, V212, P180, DOI 10.1016/j.toxlet.2012.05.016; Hou Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134006; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Kima PE, 2000, CELL MICROBIOL, V2, P477, DOI 10.1046/j.1462-5822.2000.00071.x; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Lehr S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010504; Leverve Xavier, 2007, Novartis Found Symp, V280, P108; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; Li YX, 2016, J CARDIOVASC PHARM, V67, P394, DOI 10.1097/FJC.0000000000000364; Lin SH, 2014, INT J CLIN EXP PATHO, V7, P2199; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; Lodish HF, 2013, MOL CELL BIOL, Vxxxiii, P701, DOI [10.1074/jbc.274.18.12692, DOI 10.1074/JBC.274.18.12692]; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Otani M, 2012, CYTOKINE, V58, P238, DOI 10.1016/j.cyto.2012.01.018; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pardo M, 2012, ENDOCRINE, V41, P374, DOI 10.1007/s12020-012-9617-z; Petersen PS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12735; Peterson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088535; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; WOLFLA CE, 1988, ARCH BIOCHEM BIOPHYS, V263, P69, DOI 10.1016/0003-9861(88)90614-5; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yokohama-Tamaki T, 2011, J ANAT, V218, P517, DOI 10.1111/j.1469-7580.2011.01354.x; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	60	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164593	10.1371/journal.pone.0164593	http://dx.doi.org/10.1371/journal.pone.0164593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727322	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400041
J	Vandenbussche, F; Mathijs, E; Lefebvre, D; De Clercq, K; Van Borm, S				Vandenbussche, Frank; Mathijs, Elisabeth; Lefebvre, David; De Clercq, Kris; Van Borm, Steven			A Tale of Tails: Dissecting the Enhancing Effect of Tailed Primers in Real-Time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MOUTH-DISEASE VIRUS; 5' FLAPS IMPROVE; ENZYMATIC AMPLIFICATION; GENOMIC SEQUENCES; REACTION ASSAY; DNA FRAGMENTS; IN-VITRO; RT-PCR; SOFTWARE	Non-specific tail sequences are often added to the 5'-terminus of primers to improve the robustness and overall performance of diagnostic assays. Despite the widespread use of tailed primers, the underlying working mechanism is not well understood. To address this problem, we conducted a detailed in vitro and in silico analysis of the enhancing effect of primer tailing on 2 well-established foot-and-mouth disease virus (FMDV) RT-qPCR assays using an FMDV reference panel. Tailing of the panFMDV-5UTR primers mainly affected the shape of the amplification curves. Modelling of the raw fluorescence data suggested a reduction of the amplification efficiency due to the accumulation of inhibitors. In depth analysis of PCR products indeed revealed the rapid accumulation of forward-primer derived artefacts. More importantly, tailing of the forward primer delayed artefacts formation and concomitantly restored the sigmoidal shape of the amplification curves. Our analysis also showed that primer tailing can alter utilisation patterns of degenerate primers and increase the number of primer variants that are able to participate in the reaction. The impact of tailed primers was less pronounced in the panFMDV-3D assay with only 5 out of 50 isolates showing a clear shift in Cq values. Sequence analysis of the target region of these 5 isolates revealed several mutations in the inter-primer region that extend an existing hairpin structure immediately downstream of the forward primer binding site. Stabilisation of the forward primer with either a tail sequence or cationic spermine units restored the sensitivity of the assay, which suggests that the enhancing effect in the panFMDV-3D assay is due to a more efficient extension of the forward primer. ur results show that primer tailing can alter amplification through various mechanisms that are determined by both the assay and target region. These findings expand our understanding of primer tailing and should enable a more targeted and efficient use of tailed primers.	[Vandenbussche, Frank; Mathijs, Elisabeth; Van Borm, Steven] CODA CERVA, Operat Directorate Viral Dis, Mol Platform, Brussels, Belgium; [Lefebvre, David; De Clercq, Kris] CODA CERVA, Vesicular & Exot Dis, Operat Directorate Viral Dis, Brussels, Belgium		Vandenbussche, F (corresponding author), CODA CERVA, Operat Directorate Viral Dis, Mol Platform, Brussels, Belgium.	frank.vandenbussche@coda-cerva.be	Mathijs, Elisabeth/GQA-8836-2022		Federal Public Service of Public Health, Safety of the Food Chain and Environment [RT13/03]	Federal Public Service of Public Health, Safety of the Food Chain and Environment	This study was supported by the Federal Public Service of Public Health, Safety of the Food Chain and Environment (convention RT13/03 EPIDIACAP, Contractual Research).	Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; Arif M, 2014, APPL ENVIRON MICROB, V80, P320, DOI 10.1128/AEM.02340-13; Armani A, 2016, FOOD ANAL METHOD, V9, P1199, DOI 10.1007/s12161-015-0301-9; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Bessaud M, 2008, J VIROL METHODS, V149, P277, DOI 10.1016/j.jviromet.2008.01.027; Bilodeau GJ, 2014, PHYTOPATHOLOGY, V104, P733, DOI 10.1094/PHYTO-09-13-0263-R; Binladen J, 2007, BIOTECHNIQUES, V42, P172, DOI 10.2144/000112316; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Clarke AC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-68; Dai ZM, 2007, J BIOTECHNOL, V128, P435, DOI 10.1016/j.jbiotec.2006.10.018; Daigle Derek, 2011, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0705s96; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Haegeman A, 2013, J VIROL METHODS, V193, P446, DOI 10.1016/j.jviromet.2013.07.010; Hayden N., RSAMTOOLS BINARY ALI; Hymas WC, 2010, J VIROL METHODS, V167, P113, DOI 10.1016/j.jviromet.2010.03.020; Kainz P, 2000, BBA-GENE STRUCT EXPR, V1494, P23, DOI 10.1016/S0167-4781(00)00200-1; Kainz P, 2000, BIOTECHNIQUES, V28, P278, DOI 10.2144/00282st04; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KAUFMAN DL, 1990, BIOTECHNIQUES, V9, P304; Koukhareva I, 2009, ANAL CHEM, V81, P4955, DOI 10.1021/ac8026977; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Lefever S, 2013, CLIN CHEM, V59, P1470, DOI 10.1373/clinchem.2013.203653; Leifer I, 2011, J VIROL METHODS, V171, P314, DOI 10.1016/j.jviromet.2010.11.014; Liu Q, 1997, BIOTECHNIQUES, V22, P292, DOI 10.2144/97222st01; LUKYANOV KA, 1995, ANAL BIOCHEM, V229, P198, DOI 10.1006/abio.1995.1402; Pages H, BIOSTRINGS STRING OB; Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468; Price EP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037723; R Core Team, 2013, R LANG ENV STAT COMP; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Reid SM, 2002, J VIROL METHODS, V105, P67, DOI 10.1016/S0166-0934(02)00081-2; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia John Jr., 2007, V402, P3; Sarkar D, 2008, USE R, P1; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; Shagin DA, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e23; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Timmons C, 2013, J FOOD PROTECT, V76, P668, DOI 10.4315/0362-028X.JFP-12-428; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Waitumbi JN, 2011, TROP MED INT HEALTH, V16, P786, DOI 10.1111/j.1365-3156.2011.02773.x; Wei T, 2008, J VIROL METHODS, V153, P16, DOI 10.1016/j.jviromet.2008.06.020; Wensman JJ, 2012, J FELINE MED SURG, V14, P573, DOI 10.1177/1098612X12446638; Wickham H, 2015, STRINGR SIMPLE CONSI; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; Zeng M, 2012, J MED VIROL, V84, P145, DOI 10.1002/jmv.22248	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164463	10.1371/journal.pone.0164463	http://dx.doi.org/10.1371/journal.pone.0164463			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723800	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504100063
J	Costarelli, S; Cozzi-Lepri, A; Lapadula, G; Bonora, S; Madeddu, G; Maggiolo, F; Antinori, A; Galli, M; Di Perri, G; Viale, P; Monforte, AD; Gori, A				Costarelli, Silvia; Cozzi-Lepri, Alessandro; Lapadula, Giuseppe; Bonora, Stefano; Madeddu, Giordano; Maggiolo, Franco; Antinori, Andrea; Galli, Massimo; Di Perri, Giovanni; Viale, Pierluigi; Monforte, Antonella d'Arminio; Gori, Andrea		ICONA Fdn Study Grp	Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; HIV-POSITIVE PATIENTS; RENAL-FUNCTION; DISOPROXIL FUMARATE; DAILY LOPINAVIR/RITONAVIR; KIDNEY-DISEASE; EFAVIRENZ; NAIVE; ATAZANAVIR; EXPOSURE	Background In clinical trials, toxicity leading to tenofovir disoproxil fumarate (TDF) discontinuation is rare (3% by 2 years); however in clinical practice it seems to be higher, particularly when TDF is co-administered with ritonavir-boosted protease inhibitors (PI/r). Aims of this study were to assess the rate of TDF discontinuations in clinical practice and to identify factors associated with the risk of stopping TDF. Methods All antiretroviral treatment (ART)-naive patients initiating a TDF-based regimen were selected from the ICONA Foundation Study cohort. The primary outcome was TDF discontinuation regardless of the reason; secondary outcome measures were TDF discontinuation due to toxicity and selective TDF discontinuation (that is, TDF discontinuation or substitution, maintaining unchanged the remaining antiretroviral treatment). Results 3,618 ART-naive patients were included: 54% started a PI/r-based and 46% a NNRTI-based based regimen. Two-hundred-seventy-seven patients discontinued TDF and reintroduced ART within 30 days without TDF. The probability of TDF discontinuation regardless of the reason was of 7.4% (95% CI: 6.4-8.5) by 2 years and 14.1% (95% CI: 12.2-16.1) by 5 years. The 5-year KM estimates in the PI/r vs. NNRTI group were 20.4% vs. 7.6%, respectively (log-rank p = 0.0001), for the outcome of stopping regardless of the reason, and 10.7% vs. 4.7% (p = 0.0001) for discontinuation due to toxicity. PI/r use and lower eGFR were associated with an increased risk of discontinuing TDF. Conclusion In our cohort, the frequency of TDF discontinuations was higher than that observed in clinical trials. Co-administration of TDF with PI/r was associated with an increased rate of TDF discontinuations. Further studies are needed to clarify the mechanisms that might have led to this outcome.	[Costarelli, Silvia; Lapadula, Giuseppe; Gori, Andrea] Univ Milano Bicocca, Dept Infect Dis, San Gerardo Hosp, Monza, Italy; [Cozzi-Lepri, Alessandro] Royal Free & Univ Coll Med Sch, Dept Virol, London, England; [Bonora, Stefano; Di Perri, Giovanni] Univ Torino, Dept Med Sci, Turin, Italy; [Madeddu, Giordano] Univ Sassari, Dept Clin & Expt Med, Infect Dis Unit, Sassari, Italy; [Maggiolo, Franco] Papa Giovanni XXIII Hosp, Dept Infect Dis, Bergamo, Italy; [Antinori, Andrea] Natl Inst Infect Dis IRCCS, Rome, Italy; [Galli, Massimo] Univ Milan, Dept Clin & Biomed Sci Luigi Sacco, Infect Dis Sect, Milan, Italy; [Viale, Pierluigi] Univ Bologna, S Orsola Malpighi Hosp, Clin Infect Dis, Bologna, Italy; [Monforte, Antonella d'Arminio] Univ Milan, Infect Dis Unit, Dept Hlth Sci, Milan, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of London; University College London; University of Turin; University of Sassari; ASST Papa Giovanni XXIII; University of Milan; Luigi Sacco Hospital; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Milan	Lapadula, G (corresponding author), Univ Milano Bicocca, Dept Infect Dis, San Gerardo Hosp, Monza, Italy.	g.lapadula@hsgerardo.org	Antinori, Andrea/K-7125-2016; Ursini, Tamara/AAB-3891-2019; Di Biagio, Antonio/J-4901-2019; Di Perri, Giovanni/AAC-1882-2019; Lapadula, Giuseppe/J-5163-2012; bonora, stefano/AAC-2993-2019; Gori, Andrea/AAC-6078-2022; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; Castagna, Antonella/K-3280-2018; MADEDDU, Giordano/AAP-4342-2020; MASTROIANNI, Claudio Maria/O-9741-2019; Rusconi, Stefano/H-9263-2012; QUIROS ROLDAN, Maria Eugenia/K-7586-2015; De Luca, Andrea/G-8810-2011; nicastri, emanuele/K-7780-2016; TINCATI, CAMILLA/K-4501-2018; Balotta, Claudia/L-7295-2017; LAZZARIN, Adriano/K-3607-2018; MARCHETTI, GIULIA CARLA/K-4384-2018; GALLI, MASSIMO/L-7282-2017	Antinori, Andrea/0000-0003-2121-4684; Ursini, Tamara/0000-0002-6012-0667; Di Biagio, Antonio/0000-0003-1436-5089; bonora, stefano/0000-0002-7537-3341; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; Castagna, Antonella/0000-0002-8338-9714; MADEDDU, Giordano/0000-0001-6099-2273; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Rusconi, Stefano/0000-0002-0375-9990; Ammassari, Adriana/0000-0002-0284-0340; Girardi, Enrico/0000-0001-8182-5896; QUIROS ROLDAN, Maria Eugenia/0000-0003-1452-9100; De Luca, Andrea/0000-0002-9561-9193; Segala, Daniela/0000-0001-6133-0386; PUZZOLANTE, CINZIA/0000-0002-1179-1341; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; nicastri, emanuele/0000-0002-5606-8712; TINCATI, CAMILLA/0000-0002-3083-2962; Cinque, Paola/0000-0003-2448-5957; LAPADULA, Giuseppe/0000-0002-9976-8102; Bonfanti, Paolo/0000-0001-7289-8823; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Cattelan, Anna Maria/0000-0003-2869-2945; Castelli, Francesco/0000-0001-9161-7804; Puoti, Massimo/0000-0003-3278-7138; Balotta, Claudia/0000-0002-1107-9119; Ippolito, Giuseppe/0000-0002-1076-2979; Gianotti, Nicola/0000-0002-7182-5080; LAZZARIN, Adriano/0000-0003-2551-7754; Vanino, Elisa/0000-0003-3510-1429; MONNO, Laura/0000-0002-2713-4258; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; GALLI, MASSIMO/0000-0001-8887-6215				Abgrall S, 2013, AIDS, V27, P803, DOI 10.1097/QAD.0b013e32835cb997; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Brown T, 2014, C RETR OPP INF 2014; Cicconi P, 2010, HIV MED, V11, P104, DOI 10.1111/j.1468-1293.2009.00750.x; Cuzin L, 2012, J AIDS CLIN RES S, VS1, P019; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; Foca E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-38; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Johnson MA, 2006, JAIDS-J ACQ IMM DEF, V43, P153, DOI 10.1097/01.qai.0000242449.67155.1a; Kearney BP, 2006, JAIDS-J ACQ IMM DEF, V43, P278, DOI 10.1097/01.qai.0000243103.03265.2b; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Monforte AD, 2009, CLIN INFECT DIS, V49, P612, DOI 10.1086/603557; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Reekie J, 2011, HIV MED, V12, P259, DOI 10.1111/j.1468-1293.2010.00877.x; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Walmsley S, 2009, JAIDS-J ACQ IMM DEF, V50, P367, DOI 10.1097/QAI.0b013e318198a815; Weiner NJ, 2003, KIDNEY INT, V63, P1618, DOI 10.1046/j.1523-1755.2003.00901.x; Young J, 2012, AIDS, V26, P567, DOI 10.1097/QAD.0b013e32834f337c	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0160761	10.1371/journal.pone.0160761	http://dx.doi.org/10.1371/journal.pone.0160761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716843	Green Submitted, Green Published, gold			2022-12-27	WOS:000385698100002
J	Han, L; Berry, JW; Zheng, Y				Han, Li; Berry, John W.; Zheng, Yong			The Relationship of Acculturation Strategies to Resilience: The Moderating Impact of Social Support among Qiang Ethnicity following the 2008 Chinese Earthquake	PLOS ONE			English	Article							MENTAL-HEALTH; ALZHEIMERS-DISEASE; LIFE EVENTS; PERSONALITY; STRESS; ADJUSTMENT; DEPRESSION; TRAUMA; INJURY; PSYCHOPATHOLOGY	International research has mostly confirmed the positive association between acculturation strategies and resilience in ethnic groups, but the mediating and moderating mechanisms underlying the relationships are still under-investigated. The present study aimed to investigate the associations between acculturation strategies (based on two cultural identities) and resilience of 898 Qiang ethnicity volunteers (mean age = 29.5), especially exploring the mediating and moderating effects of personality, spiritual belief and social support on the relationship between acculturation strategy (using two cultural identities as latent variables in model analysis) and resilience following the occurrence of 2008 Wenchuan earthquake in Sichuan, taking such mechanisms into account. Results were as follows: (1) All variable presented significant positive correlations; (2) Consistent with the mediating hypotheses, personality and spiritual beliefs played a partial mediating role in the relationship between two cultural identities and resilience; (3) High or low level of perceived social support had a moderating effect on cultural identities and resilience; (4) The integration strategy was the most optimal style to promote the development of resilience, but marginalization was the least effective style.	[Han, Li] Mianyang Normal Univ, Mianyang, Peoples R China; [Berry, John W.] Queens Univ, Kingston, ON, Canada; [Berry, John W.] Natl Res Univ, Higher Sch Econ, Moscow, Russia; [Zheng, Yong] Southwest Univ, Ctr Studies Educ & Psychol Ethn Minor Southwest C, Chongqing, Peoples R China	Mianyang Teachers' College; Queens University - Canada; HSE University (National Research University Higher School of Economics); Southwest University - China	Zheng, Y (corresponding author), Southwest Univ, Ctr Studies Educ & Psychol Ethn Minor Southwest C, Chongqing, Peoples R China.	zhengy@swu.edu.cn			MOE Project of Key Research Institute of Humanities and Social Sciences at Universities [15JJDZONGHE022]; Sichuan Provincial Research Center of Qiang People Project [QXY1410]; MianYang Normal University Project [QD2015B005]; Basic Research Program at the National Research University Higher School of Economics (HSE) by the Government of the Russian Federation	MOE Project of Key Research Institute of Humanities and Social Sciences at Universities; Sichuan Provincial Research Center of Qiang People Project; MianYang Normal University Project; Basic Research Program at the National Research University Higher School of Economics (HSE) by the Government of the Russian Federation	This work was funded by the MOE Project of Key Research Institute of Humanities and Social Sciences at Universities - 15JJDZONGHE022; Sichuan Provincial Research Center of Qiang People Project - QXY1410; MianYang Normal University Project - QD2015B005; the Basic Research Program at the National Research University Higher School of Economics (HSE) by the Government of the Russian Federation.	Adams RE, 2005, J COMMUNITY PSYCHOL, V33, P175, DOI 10.1002/jcop.20030; Adams Richard E, 2013, Int J Emerg Ment Health, V15, P85; Alim TN, 2008, AM J PSYCHIAT, V165, P1566, DOI 10.1176/appi.ajp.2008.07121939; [Anonymous], 2004, THESIS; Armstrong MaryI., 2005, J CHILD FAM STUD, V14, P269, DOI [DOI 10.1007/S10826-005-5054-4, 10.1007/s10826-005-5054-4]; Bensimon M, 2012, PERS INDIV DIFFER, V52, P782, DOI 10.1016/j.paid.2012.01.011; Berry J. W., 1980, ACCULTURATION THEORY, P9, DOI DOI 10.1525/AE.1981.8.4.02A00200; Berry J. W., 2006, CAMBRIDGE HDB ACCULT, P43, DOI DOI 10.1017/CBO9780511489891.007; Berry J.W., 2003, ACCULTURATION ADV TH, P17, DOI [10.1037/10472-000, DOI 10.1037/10472-004]; Berry J. W., 2014, OXFORD HDB MULTICULT, P97, DOI DOI 10.1093/OXFORDHB/9780199796694.001.0001/OXFORDHB-9780199796694; Berry JW, 2013, EUR PSYCHOL, V18, P151, DOI 10.1027/1016-9040/a000167; Berry JW, 2005, INT J INTERCULT REL, V29, P697, DOI 10.1016/j.ijintrel.2005.07.013; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Bhui K, 2005, J EPIDEMIOL COMMUN H, V59, P296, DOI 10.1136/jech.2003.014456; BLUMENTHAL JA, 1987, PSYCHOSOM MED, V49, P331, DOI 10.1097/00006842-198707000-00002; Brannon L., 2013, HLTH PSYCHOL INTRO B; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Catalano D, 2011, REHABIL PSYCHOL, V56, P200, DOI 10.1037/a0024571; Cheng SF, 2012, KAOHSIUNG J MED SCI, V28, P105, DOI 10.1016/j.kjms.2011.10.015; Clauss-Ehlers C. S., 2006, J INFANT CHILD ADOLE, V5, P124; Cloninger CR, 2011, J AFFECT DISORDERS, V128, P24, DOI 10.1016/j.jad.2010.06.012; Collishaw S, 2007, CHILD ABUSE NEGLECT, V31, P211, DOI 10.1016/j.chiabu.2007.02.004; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Costa PT, 2007, REVISED NEO PERSONAL; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Drogendijk AN, 2012, J AFFECT DISORDERS, V138, P485, DOI 10.1016/j.jad.2012.01.037; Eley DS, 2013, PEERJ, V1, DOI 10.7717/peerj.216; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Garity J, 2006, J GERONTOL NURS, V32, P39, DOI 10.3928/00989134-20060601-07; GARMEZY N, 1991, PEDIATR ANN, V20, P459, DOI 10.3928/0090-4481-19910901-05; Goldman M, 2012, THESIS MIT; Gorman BK, 2010, J HEALTH SOC BEHAV, V51, P440, DOI 10.1177/0022146510386792; Gungor D, 2013, J CROSS CULT PSYCHOL, V44, P701, DOI 10.1177/0022022112470749; Han L., 2014, THESIS; Harman HH, 1976, MODERNFACTOR ANAL; Hollister-Wagner GH, 2001, J APPL SOC PSYCHOL, V31, P445, DOI 10.1111/j.1559-1816.2001.tb02050.x; Ikizer G, 2014, THESIS; Knipscheer JW, 2006, J CLIN PSYCHOL, V62, P339, DOI 10.1002/jclp.20233; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Koenig HG, 1998, AM J PSYCHIAT, V155, P536, DOI 10.1176/ajp.155.4.536; Koenig HG, 2012, HDB RELIG HLTH; Kukihara H, 2014, PSYCHIAT CLIN NEUROS, V68, P524, DOI 10.1111/pcn.12159; LEPORE SJ, 1992, J PERS SOC PSYCHOL, V63, P857, DOI 10.1037/0022-3514.63.5.857; Lopez-Class M, 2011, SOC SCI MED, V72, P1555, DOI 10.1016/j.socscimed.2011.03.011; Lueck K, 2011, INT J INTERCULT REL, V35, P186, DOI 10.1016/j.ijintrel.2010.11.016; Maliski SL, 2012, J RELIG HEALTH, V51, P752, DOI 10.1007/s10943-010-9369-0; Manning LK, 2013, QUAL HEALTH RES, V23, P568, DOI 10.1177/1049732312471730; Masten AS, 2011, DEV PSYCHOPATHOL, V23, P493, DOI 10.1017/S0954579411000198; Migerode F, 2012, J DEV PHYS DISABIL, V24, P487, DOI 10.1007/s10882-012-9285-1; Nakash O, 2015, CULT DIVERS ETHN MIN, V21, P468, DOI 10.1037/a0037534; Napoles AM, 2011, ONCOL NURS FORUM, V38, P523, DOI 10.1188/11.ONF.523-531; Nguyen AMD, 2013, J CROSS CULT PSYCHOL, V44, P122, DOI 10.1177/0022022111435097; Nie Y, 2011, PSYCHOL DEV ED, V2, P151; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730; Pan JY, 2011, INT J INTERCULT REL, V35, P592, DOI 10.1016/j.ijintrel.2011.02.009; Papaneophytou NL, 2013, THESIS; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Pinquart M, 2009, J APPL DEV PSYCHOL, V30, P53, DOI 10.1016/j.appdev.2008.10.005; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Rayle AD, 2006, J COUNS DEV, V84, P483, DOI 10.1002/j.1556-6678.2006.tb00432.x; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Ryder AG, 2000, J PERS SOC PSYCHOL, V79, P49, DOI 10.1037//0022-3514.79.1.49; Sirikantraporn S, 2013, ASIAN AM J PSYCHOL, V4, P109, DOI 10.1037/a0030433; Smith C, 1997, SOC SERV REV, V71, P231, DOI 10.1086/604249; Song X-C, 2005, CHINESE J CLIN REHAB, V16, P46; Suinn RM, 2010, ASIAN AM J PSYCHOL, V1, P5, DOI 10.1037/a0018798; Ungar M., 2005, CHILD YOUTH CARE FOR, V34, P445, DOI [DOI 10.1007/S10566-005-7756-6, 10.1007/s10566-005-7756-6]; Vahia IV, 2011, AGING MENT HEALTH, V15, P97, DOI 10.1080/13607863.2010.501069; VALENTINE L, 1993, AM J FAM THER, V21, P216, DOI 10.1080/01926189308250920; Veronica O, 2007, THESIS; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041665; Ward C, 2001, J CROSS CULT PSYCHOL, V32, P636, DOI 10.1177/0022022101032005007; Wilks SE, 2008, AGING MENT HEALTH, V12, P357, DOI 10.1080/13607860801933323; Xinhua News Agency, JUN 9 THER WER 69 14; Ying LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089401; Yoon E, 2013, J COUNS PSYCHOL, V60, P15, DOI 10.1037/a0030652; Yu XN, 2011, COMPR PSYCHIAT, V52, P218, DOI 10.1016/j.comppsych.2010.05.010; Yu XN, 2007, SOC BEHAV PERSONAL, V35, P19, DOI 10.2224/sbp.2007.35.1.19; Zhang L. F., 2010, LEARN INDIVID DIFFER, V21, P109; Zheng Y., 2015, INT J EMERGENCY HLTH, V17, P573; Zheng YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029404; [周浩 Zhou Hao], 2004, [心理科学进展, ADVANCES IN PSYCHOLOGICAL SCIENCE], V12, P942; Zolkoski SM, 2012, CHILD YOUTH SERV REV, V34, P2295, DOI 10.1016/j.childyouth.2012.08.009	86	18	18	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164484	10.1371/journal.pone.0164484	http://dx.doi.org/10.1371/journal.pone.0164484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741274	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000038
J	Shishehgar, F; Tehrani, FR; Mirmiran, P; Hajian, S; Baghestani, AR				Shishehgar, Farnaz; Tehrani, Fahimeh Ramezani; Mirmiran, Parvin; Hajian, Sepideh; Baghestani, Ahmad Reza			Comparison of the Association of Excess Weight on Health Related Quality of Life of Women with Polycystic Ovary Syndrome: An Age- and BMI-Matched Case Control Study	PLOS ONE			English	Article							BODY-MASS INDEX; SEXUAL FUNCTION; POPULATION; OBESITY; DETERMINANTS; CRITERIA; ADULTS; IMPACT; SF-36; RISK	Background It is assumed that obesity adversely affects the health related quality of life (HRQOL) of women with polycystic ovary syndrome (PCOS), not only due to the excess weight, but also due to several other obesity induced metabolic and reproductive consequences. We aimed to compare the effects of excess body weight on the HRQOL between women with PCOS and controls. Methods This is a case control study of 142 women with PCOS and 140 age-and BMI-matched controls. The Iranian version of short form health survey 36 (SF 36) was used to assess HRQOL. Domains of SF 36 were compared in women with PCOS and controls using multivariate analysis of covariance. The Pearson correlation was used to assess the correlation between body mass index (BMI) and domain scores of SF 36, and the differences between two correlations in cases and controls, using Fisher's Z test. Results Women with PCOS had significantly lower scores for both, the physical and the mental component summary scales, compared to controls. In the cases, a significant negative correlations were observed for BMI with physical function (r = -0.301, P<0.001), bodily pain (r = -0.23, P = 0.006), and physical summary score (r = -0.3, P = 0.007). In controls, significant correlation was seen for BMI with bodily pain (r = -0.3, P< 0.001) and physical summary score (r = -0.27, P = 0.001). The differences between correlations of physical function with BMI in PCOS and controls were statistically significant ( Z = -2.41, P = 0.008). Conclusion Although the physical aspects of HRQOL are adversely affected by overweight in both PCOS and controls, these impaired effects are greater in women with PCOS.	[Shishehgar, Farnaz; Hajian, Sepideh] Shahid Beheshti Univ Med Sci, Fac Nursing & Midwifery, Dept Midwifery & Reprod Hlth, Tehran, Iran; [Tehrani, Fahimeh Ramezani] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran; [Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Nutr & Endocrine Res Ctr, Tehran, Iran; [Baghestani, Ahmad Reza] Shahid Beheshti Univ Med Sci, Sch Paramed Sci, Dept Biostat, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Tehrani, FR (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran.	ramezani@endocrine.ac.ir	Tehrani, Fahimeh Ramezani/H-6133-2017; Mirmiran, Parvin/V-1433-2019; Hajian, Sepideh/V-3455-2018; Shishehgar, Farnaz/ABH-7682-2020	Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; Baghestani, Ahmadreza/0000-0003-2813-6762; Mirmiran, Parvin/0000-0003-2391-4924; Hajian, sepideh/0000-0002-3368-0036				Aghamolaei T, 2011, IRAN J PUBLIC HEALTH, V40, P128; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Benetti-Pinto CL, 2015, ARCH GYNECOL OBSTET, V291, P451, DOI 10.1007/s00404-014-3423-1; Berger U, 2005, AGEING SOC, V25, P181, DOI 10.1017/S0144686X04002739; Brady C, 2009, DRUG HEALTHC PATIENT, V1, P9; Butland B, 2007, FORESIGHT TACKLING O; Coffey S, 2006, GYNECOL ENDOCRINOL, V22, P80, DOI 10.1080/09513590600604541; Grivetti L, 2001, NUTR REV, V59, pS5, DOI 10.1111/j.1753-4887.2001.tb01897.x; Hahn S, 2005, EUR J ENDOCRINOL, V153, P853, DOI 10.1530/eje.1.02024; Hashemi S, 2014, J SEX MED, V11, P2508, DOI 10.1111/jsm.12627; Hashimoto D M, 2003, Anthropol Anz, V61, P297; Hassan MK, 2003, INT J OBESITY, V27, P1227, DOI 10.1038/sj.ijo.0802396; Hatch R, 1981, OBSTET GYNECOL, V140, P815; Hollander EH, 2013, AM J EPIDEMIOLOGY AD, V2013, DOI [10.1093/aje/kwt053, DOI 10.1093/AJE/KWT053]; Hudecova M, 2009, HUM REPROD, V24, P1176, DOI 10.1093/humrep/den482; Khomami MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123608; Kim Ji-yeong, 2007, J Prev Med Public Health, V40, P191; Kozak AT, 2011, INT J OBESITY, V35, P134, DOI 10.1038/ijo.2010.120; Kumarapeli VL, 2011, BJOG-INT J OBSTET GY, V118, P319, DOI 10.1111/j.1471-0528.2010.02799.x; Li ZB, 2004, INT J GERIATR PSYCH, V19, P68, DOI 10.1002/gps.1040; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Montazeri A, 2005, QUAL LIFE RES, V14, P875, DOI 10.1007/s11136-004-1014-5; Carvalho MAN, 2012, ARQ BRAS CARDIOL, V98, P442, DOI 10.1590/S0066-782X2012005000032; Pappa E, 2005, QUAL LIFE RES, V14, P1433, DOI 10.1007/s11136-004-6014-y; Pasquali R, 2006, BJOG-INT J OBSTET GY, V113, P1148, DOI 10.1111/j.1471-0528.2006.00990.x; Ramezani tehrani F, 2011, REPROD BIOL ENDOCRIN, V9, P1; Seica A, 2009, NEPHROL DIAL TRANSPL, V24, P626, DOI 10.1093/ndt/gfn506; Sterne JAC, 2009, METAANALYSIS STATA T, P151; Tajvar M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-323; Talbott EO, 2001, OBSTET GYN CLIN N AM, V28, P111, DOI 10.1016/S0889-8545(05)70189-3; Thomson RL, 2012, CLIN ENDOCRINOL, V77, P343, DOI 10.1111/j.1365-2265.2012.04434.x; Trent M, 2005, AMBUL PEDIATR, V5, P107, DOI 10.1367/A04-130R.1; Ul-Haq Z, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-143; Wang R, 2012, EUR J PUBLIC HEALTH, V22, P497, DOI 10.1093/eurpub/ckr080	34	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0162911	10.1371/journal.pone.0162911	http://dx.doi.org/10.1371/journal.pone.0162911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736861	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800009
J	Ning, PS; Schwebel, DC; Huang, HL; Li, L; Li, J; Hu, GQ				Ning, Peishan; Schwebel, David C.; Huang, Helai; Li, Li; Li, Jun; Hu, Guoqing			Global Progress in Road Injury Mortality since 2010	PLOS ONE			English	Article								We aimed to examine progress in global road injury mortality since the initiation of Global Plan for the Decade of Action for Road Safety 2011-2020. We examined annual percent changes in age-adjusted road traffic mortality using data from the Global Burden of Disease Study 2013. Association between changes in road traffic mortality and legislative efforts in individual nations was explored using data from Global Status Reports on Road Safety 2013 and 2015. We found that global age-adjusted mortality, both overall and for user-specific road traffic injuries, decreased significantly between 2010 and 2013 (annual percent change in rates range from -1.43% to -0.99%). Developed countries witnessed a larger decrease than developing countries in both overall and user-specific road mortality (about 2.0-4.6 times). However, there were substantial disparities within developed countries and within developing countries, with some countries seeing large reductions in mortality rates and others seeing none. The annual percent change in road traffic mortality during 2010-2013 was significantly correlated with total national law enforcement score (Spearman r(s) = -0.38). We concluded that results highlight the need for continued effort to reduce the burden of road injury mortality, especially in LMIC countries.	[Ning, Peishan; Li, Li; Hu, Guoqing] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Huang, Helai] Cent South Univ, Sch Traff & Transportat Engn, Urban Transport Res Ctr, Changsha, Hunan, Peoples R China; [Li, Jun] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China	Central South University; University of Alabama System; University of Alabama Birmingham; Central South University; Beijing Normal University	Hu, GQ (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	huguoqing009@gmail.com	Schwebel, David/GXH-9944-2022	Hu, Guoqing/0000-0002-5002-8015	Natural Science Foundation of China [81573260, 71561167001, 71371192]; Natural Science Foundation of China [81573260, 71561167001, 71371192]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (grant numbers: 81573260, 71561167001, and 71371192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Institute for Health Metrics and Evaluation University of Washington, GBD COMP VIZ HUB; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mannering F, 2016, ANAL METHODS ACCID R, V11, P1, DOI 10.1016/j.amar.2016.04.001; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; The Global Goals campaign, THE GLOBAL GOALS FOR; United Nations Road Safety Collaboration, 2011, GLOB PLAN DEC ACT RO; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2009, GLOB STAT REP ROAD S	11	20	22	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164560	10.1371/journal.pone.0164560	http://dx.doi.org/10.1371/journal.pone.0164560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727318	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504400038
J	Seeker, LA; Holland, R; Underwood, S; Fairlie, J; Psifidi, A; Ilska, JJ; Bagnall, A; Whitelaw, B; Coffey, M; Banos, G; Nussey, DH				Seeker, Luise A.; Holland, Rebecca; Underwood, Sarah; Fairlie, Jennifer; Psifidi, Androniki; Ilska, Joanna J.; Bagnall, Ainsley; Whitelaw, Bruce; Coffey, Mike; Banos, Georgios; Nussey, Daniel H.			Method Specific Calibration Corrects for DNA Extraction Method Effects on Relative Telomere Length Measurements by Quantitative PCR	PLOS ONE			English	Article							EPIDEMIOLOGIC RESEARCH; DAIRY-COWS; DYNAMICS; EFFICIENCY; BIOLOGY; STRESS; VARIES; MODEL	Telomere length (TL) is increasingly being used as a biomarker in epidemiological, biomedical and ecological studies. A wide range of DNA extraction techniques have been used in telomere experiments and recent quantitative PCR (qPCR) based studies suggest that the choice of DNA extraction method may influence average relative TL (RTL) measurements. Such extraction method effects may limit the use of historically collected DNA samples extracted with different methods. However, if extraction method effects are systematic an extraction method specific (MS) calibrator might be able to correct for them, because systematic effects would influence the calibrator sample in the same way as all other samples. In the present study we tested whether leukocyte RTL in blood samples from Holstein Friesian cattle and Soay sheep measured by qPCR was influenced by DNA extraction method and whether MS calibration could account for any observed differences. We compared two silica membrane-based DNA extraction kits and a salting out method. All extraction methods were optimized to yield enough high quality DNA for TL measurement. In both species we found that silica membrane-based DNA extraction methods produced shorter RTL measurements than the non-membrane-based method when calibrated against an identical calibrator. However, these differences were not statistically detectable when a MS calibrator was used to calculate RTL. This approach produced RTL measurements that were highly correlated across extraction methods (r > 0.76) and had coefficients of variation lower than 10% across plates of identical samples extracted by different methods. Our results are consistent with previous findings that popular membrane-based DNA extraction methods may lead to shorter RTL measurements than non-membrane-based methods. However, we also demonstrate that these differences can be accounted for by using an extraction method-specific calibrator, offering researchers a simple means of accounting for differences in RTL measurements from samples extracted by different DNA extraction methods within a study.	[Seeker, Luise A.; Ilska, Joanna J.; Coffey, Mike; Banos, Georgios] SRUC, Anim & Vet Sci, Roslin Inst Bldg, Easter Bush EH25 9RG, Midlothian, Scotland; [Seeker, Luise A.; Psifidi, Androniki; Whitelaw, Bruce; Banos, Georgios] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Seeker, Luise A.; Psifidi, Androniki; Whitelaw, Bruce; Banos, Georgios] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Holland, Rebecca; Underwood, Sarah; Fairlie, Jennifer; Nussey, Daniel H.] Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Bagnall, Ainsley] SRUC Crichton Royal Farm, Glencaple Rd, Dumfries, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Seeker, LA (corresponding author), SRUC, Anim & Vet Sci, Roslin Inst Bldg, Easter Bush EH25 9RG, Midlothian, Scotland.; Seeker, LA (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.; Seeker, LA (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland.	Luise.seeker@sruc.ac.uk	Underwood, Sarah/GWD-1097-2022; Nussey, Daniel H/F-4155-2010; Seeker, Luise/Z-1448-2019	Ilska, Joanna Jadwiga/0000-0002-1563-0174; Seeker, Luise/0000-0001-6375-6372; Whitelaw, Bruce/0000-0002-2918-1605; Banos, Georgios/0000-0002-7674-858X	Biotechnology and Biological Sciences Research Council [BB/L007312/1]; Scotland's Rural College; Biotechnology and Biological Sciences Research Council; National Trust for Scotland; National Environment Research Council; BBSRC [BB/H021868/1, BB/L008238/1, BB/L020769/1, BB/L007312/1] Funding Source: UKRI; NERC [NE/M003035/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L020769/1, BB/L008238/1, BB/H021868/1] Funding Source: researchfish; Natural Environment Research Council [NE/M003035/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scotland's Rural College; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Trust for Scotland; National Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Our work was funded by the Biotechnology and Biological Sciences Research Council (BB/L007312/1; http://www.bbsrc.ac.uk/) awarded to GB.LS received a studentship from Scotland's Rural College (http://www.sruc.ac.uk/) and DN is a recipient of a David Phillips fellowship by the Biotechnology and Biological Sciences Research Council. The Soay sheep project is supported by the National Trust for Scotland (http://www.nts.org.uk/Home/) and the National Environment Research Council (http://www.nerc. ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Benetos A, 2011, AGING CELL, V10, P991, DOI 10.1111/j.1474-9726.2011.00744.x; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Brown DE, 2012, J DAIRY SCI, V95, P6384, DOI 10.3168/jds.2012-5593; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Clutton-Brock T, 2004, SOAY SHEEP DYNAMICS, P90, DOI [10.1007/300216-003-3150-9, DOI 10.1016/J.VETIMM.2008.02.017]; Cunningham JM, 2013, CANCER EPIDEM BIOMAR, V22, P2047, DOI 10.1158/1055-9965.EPI-13-0409; Demeke T, 2010, ANAL BIOANAL CHEM, V396, P1977, DOI 10.1007/s00216-009-3150-9; Denham J, 2014, LEUKOCYTE TELOMERE L, P1, DOI [10.1186/1756-0500-7-877, DOI 10.1186/1756-0500-7-877]; ELLIS SA, 1993, IMMUNOGENETICS, V38, P310, DOI 10.1007/BF00188812; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fairlie J, 2016, AGING CELL, V15, P140, DOI 10.1111/acel.12417; Hofmann JN, 2014, CANCER EPIDEM BIOMAR, V23, P1129, DOI 10.1158/1055-9965.EPI-14-0145; Laubenthal L, 2016, J DAIRY SCI, V99, P4881, DOI 10.3168/jds.2015-10095; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1673, DOI 10.1093/ije/dyu191; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2014, J EXP BIOL, V217, P57, DOI 10.1242/jeb.090043; Nussey DH, 2014, METHODS ECOL EVOL, V5, P299, DOI 10.1111/2041-210X.12161; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Psifidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115960; Raschenberger J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25398; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Tackney J, 2014, AM J HUM BIOL, V26, P452, DOI 10.1002/ajhb.22538; Tolios A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143889; VEERKAMP RF, 1994, LIVEST PROD SCI, V39, P229, DOI 10.1016/0301-6226(94)90202-X; Wu CX, 2008, VET IMMUNOL IMMUNOP, V123, P360, DOI 10.1016/j.vetimm.2008.02.017; Zanet DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057787	30	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164046	10.1371/journal.pone.0164046	http://dx.doi.org/10.1371/journal.pone.0164046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723841	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000385504100018
J	Krumholz, HM; Hsieh, A; Dreyer, RP; Welsh, J; Desai, NR; Dharmarajan, K				Krumholz, Harlan M.; Hsieh, Angela; Dreyer, Rachel P.; Welsh, John; Desai, Nihar R.; Dharmarajan, Kumar			Trajectories of Risk for Specific Readmission Diagnoses after Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia	PLOS ONE			English	Article							RETROSPECTIVE COHORT; PERFORMANCE; RATES; ICD-9-CM; SUPPORT; MODEL	Background The risk of rehospitalization is elevated in the immediate post-discharge period and declines over time. It is not known if the extent and timing of risk vary across readmission diagnoses, suggesting that recovery and vulnerability after discharge differ by physiologic system. Objective We compared risk trajectories for major readmission diagnoses in the year after discharge among all Medicare fee-for-service beneficiaries hospitalized with heart failure (HF), acute myocardial infarction (AMI), or pneumonia from 2008-2010. Methods We estimated the daily risk of rehospitalization for 12 major readmission diagnostic categories after accounting for the competing risk of death after discharge. For each diagnostic category, we identified (1) the time required for readmission risk to peak and then decline 50% from maximum values after discharge; (2) the time required for readmission risk to approach plateau periods of minimal day-to-day change; and (3) the extent to which hospitalization risks are higher among patients recently discharged from the hospital compared with the general elderly population. Results Among > 3,000,000 hospitalizations, the yearly rate of rehospitalization was 67.0%, 49.5%, and 55.3% after hospitalization for HF, AMI, and pneumonia, respectively. The extent and timing of risk varied by readmission diagnosis and initial admitting condition. Risk of readmission for gastrointestinal bleeding/anemia peaked particularly late after hospital discharge, occurring 10, 6, and 7 days after hospitalization for HF, AMI, and pneumonia, respectively. Risk of readmission for trauma/injury declined particularly slowly, requiring 38, 20, and 38 days to decline by 50% after hospitalization for HF, AMI, and pneumonia, respectively. Conclusions Patterns of vulnerability to different conditions that cause rehospitalization vary by time after hospital discharge. This finding suggests that recovery of various physiologic systems occurs at different rates and that post-discharge interventions to minimize vulnerability to specific conditions should be tailored to their underlying risks.	[Krumholz, Harlan M.; Desai, Nihar R.; Dharmarajan, Kumar] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Hsieh, Angela; Dreyer, Rachel P.; Welsh, John; Desai, Nihar R.; Dharmarajan, Kumar] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, Dept Internal Med, New Haven, CT 06510 USA; [Hsieh, Angela] Genentech Inc, San Francisco, CA USA	Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Roche Holding; Genentech	Krumholz, HM (corresponding author), Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.; Krumholz, HM (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, Dept Internal Med, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Dreyer, Rachel/0000-0003-2861-1383				Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Dharmarajan K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6571; Dharmarajan K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h411; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Pope GC, HHSM500200500029 RTI; Pope GC., 2000, DIAGNOSTIC COST GROU; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Ranasinghe I, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001737; Wijeysundera HC, 2013, CIRC-HEART FAIL, V6, P68, DOI 10.1161/CIRCHEARTFAILURE.112.971051	21	37	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0160492	10.1371/journal.pone.0160492	http://dx.doi.org/10.1371/journal.pone.0160492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716841	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100001
J	Eskikand, PZ; Kameneva, T; Ibbotson, MR; Burkitt, AN; Grayden, DB				Eskikand, Parvin Zarei; Kameneva, Tatiana; Ibbotson, Michael R.; Burkitt, Anthony N.; Grayden, David B.			A Possible Role for End-Stopped V1 Neurons in the Perception of Motion: A Computational Model	PLOS ONE			English	Article							VISUAL AREA MT; SURROUND SUPPRESSION; RESPONSE VARIABILITY; RECEPTIVE-FIELDS; CORTICAL-NEURONS; APERTURE PROBLEM; NEURAL DYNAMICS; INTEGRATION; SEGMENTATION; SIGNALS	We present a model of the early stages of processing in the visual cortex, in particular V1 and MT, to investigate the potential role of end-stopped V1 neurons in solving the aperture problem. A hierarchical network is used in which the incoming motion signals provided by complex V1 neurons and end-stopped V1 neurons proceed to MT neurons at the next stage. MT neurons are categorized into two types based on their function: integration and segmentation. The role of integration neurons is to propagate unambiguous motion signals arriving from those V1 neurons that emphasize object terminators (e. g. corners). Segmentation neurons detect the discontinuities in the input stimulus to control the activity of integration neurons. Although the activity of the complex V1 neurons at the terminators of the object accurately represents the direction of the motion, their level of activity is less than the activity of the neurons along the edges. Therefore, a model incorporating end-stopped neurons is essential to suppress ambiguous motion signals along the edges of the stimulus. It is shown that the unambiguous motion signals at terminators propagate over the rest of the object to achieve an accurate representation of motion.	[Eskikand, Parvin Zarei; Kameneva, Tatiana; Burkitt, Anthony N.; Grayden, David B.] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Parkville, Vic 3010, Australia; [Eskikand, Parvin Zarei] NICTA Victorian Res Lab, Parkville, Vic 3010, Australia; [Ibbotson, Michael R.] Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic 3053, Australia; [Grayden, David B.] Univ Melbourne, Ctr Neural Engn, Parkville, Vic 3030, Australia	University of Melbourne; University of Melbourne	Eskikand, PZ (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Parkville, Vic 3010, Australia.; Eskikand, PZ (corresponding author), NICTA Victorian Res Lab, Parkville, Vic 3010, Australia.	parvinz@student.unimelb.edu.au	Grayden, David B/L-5782-2018; ibbotson, michael/F-9030-2011	Grayden, David B/0000-0002-5497-7234; Zarei Eskikand, Parvin/0000-0002-1424-6445; ibbotson, michael/0000-0002-3803-6653	Australian Research Council (ARC) [DP140104533]; Centre of Excellence for Integrative Brain Function (ARC) [CE140100007]; Discovery Early Career Researcher Award (ARC) [DE120102210]; National ICT Australia	Australian Research Council (ARC)(Australian Research Council); Centre of Excellence for Integrative Brain Function (ARC); Discovery Early Career Researcher Award (ARC)(Australian Research Council); National ICT Australia	This work was supported by the Discovery Project grant from Australian Research Council (ARC), DP140104533, (http://www.arc.gov.au/) to ANB and TK, Centre of Excellence for Integrative Brain Function (ARC), CE140100007, (http://www.cibf.edu.au/) to MIR, Discovery Early Career Researcher Award (ARC), DE120102210, (http://www.arc.gov.au/) to TK and the National ICT Australia to PZE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Back T, 1993, EVOL COMPUT, V1, P1, DOI 10.1162/evco.1993.1.1.1; Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Beck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021254; Berzhanskaya J, 2007, SPATIAL VISION, V20, P337, DOI 10.1163/156856807780919000; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Born RT, 2002, PROG BRAIN RES, V140, P225; Bradley DC, 2008, NAT REV NEUROSCI, V9, P686, DOI 10.1038/nrn2472; Chey J, 1997, J OPT SOC AM A, V14, P2570, DOI 10.1364/JOSAA.14.002570; Goldberg D.E., 1989, GENETIC ALGORITHMS S; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; Grossberg S, 2015, FRONT PSYCHOL, P6; Gur M, 1997, J NEUROSCI, V17, P2914; Hildreth EC, 1982, MEASUREMENT VISUAL M; HORN BKP, 1981, P SOC PHOTO-OPT INST, V281, P319; Huang X, 2007, NEURON, V53, P761, DOI 10.1016/j.neuron.2007.01.032; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Koechlin E, 1999, BIOL CYBERN, V80, P25, DOI 10.1007/s004220050502; Liden L, 1999, VISION RES, V39, P3301, DOI 10.1016/S0042-6989(99)00055-3; Majaj NJ, 2007, J NEUROSCI, V27, P366, DOI 10.1523/JNEUROSCI.3183-06.2007; Mingolla E, 2003, NEURAL NETWORKS, V16, P939, DOI 10.1016/S0893-6080(03)00099-6; Movshon JA, 1996, J NEUROSCI, V16, P7733; Movshon JA, 1985, STUDY GROUP PATTERN, P117, DOI [DOI 10.1007/978-3-662-09224-8_7., DOI 10.1007/978-3-662-09224-8_]; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Tsui JMG, 2010, J NEUROPHYSIOL, V103, P3123, DOI 10.1152/jn.00654.2009; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164813	10.1371/journal.pone.0164813	http://dx.doi.org/10.1371/journal.pone.0164813			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741307	Green Published, gold			2022-12-27	WOS:000385507000071
J	Fischer, K; Guensch, DP; Shie, N; Lebel, J; Friedrich, MG				Fischer, Kady; Guensch, Dominik P.; Shie, Nancy; Lebel, Julie; Friedrich, Matthias G.			Breathing Maneuvers as a Vasoactive Stimulus for Detecting Inducible Myocardial Ischemia - An Experimental Cardiovascular Magnetic Resonance Study	PLOS ONE			English	Article							CORONARY-ARTERY; BLOOD; OXYGENATION	Background Breathing maneuvers can elicit a similar vascular response as vasodilatory agents like adenosine; yet, their potential diagnostic utility in the presence of coronary artery stenosis is unknown. The objective of the study is to investigate if breathing maneuvers can non-invasively detect inducible ischemia in an experimental animal model when the myocardium is imaged with oxygenation-sensitive cardiovascular magnetic resonance (OS-CMR). Methods and Findings In 11 anesthetised swine with experimentally induced significant stenosis (fractional flow reserve < 0.75) of the left anterior descending coronary artery (LAD) and 9 control animals, OS-CMR at 3T was performed during two different breathing maneuvers, a long breath-hold; and a combined maneuver of 60s of hyperventilation followed by a long breath-hold. The resulting change of myocardial oxygenation was compared to the invasive measurements of coronary blood flow, blood gases, and oxygen extraction. In control animals, all breathing maneuvers could significantly alter coronary blood flow as hyperventilation decreased coronary blood flow by 34 +/- 23%. A long breath-hold alone led to an increase of 97 +/- 88%, while the increase was 346 +/- 327% (p< 0.001), when the long breath-hold was performed after hyperventilation. In stenosis animals, the coronary blood flow response was attenuated after both hyperventilation and the following breath-hold. This was matched by the observed oxygenation response as breath-holds following hyperventilation consistently yielded a significant difference in the signal of the MRI images between the perfusion territory of the stenosis LAD and remote myocardium. There was no difference between the coronary territories during the other breathing maneuvers or in the control group at any point. Conclusion In an experimental animal model, the response to a combined breathing maneuver of hyperventilation with subsequent breath-holding is blunted in myocardium subject to significant coronary artery stenosis. This maneuver may allow for detecting severe coronary artery stenosis and have a significant clinical potential as a non-pharmacological method for diagnostic testing in patients with suspected coronary artery disease.	[Fischer, Kady; Guensch, Dominik P.; Shie, Nancy; Lebel, Julie; Friedrich, Matthias G.] Univ Montreal, Montreal Heart Inst, Philippa & Marvin Carsley CMR Ctr, Montreal, PQ, Canada; [Fischer, Kady; Guensch, Dominik P.] Univ Bern, Inselspital, Univ Hosp Bern, Dept Anaesthesiol & Pain Therapy, Bern, Switzerland; [Fischer, Kady; Guensch, Dominik P.] Univ Bern, Inselspital, Univ Hosp Bern, Inst Diagnost Intervent & Paediat Radiol, Bern, Switzerland; [Lebel, Julie] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Friedrich, Matthias G.] Univ Montreal, Dept Radiol, Montreal, PQ, Canada; [Friedrich, Matthias G.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Friedrich, Matthias G.] McGill Univ, Dept Diagnost Radiol, Montreal, PQ, Canada; [Friedrich, Matthias G.] Univ Heidelberg Hosp, Dept Cardiol, Heidelberg, Germany; [Friedrich, Matthias G.] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada; [Friedrich, Matthias G.] Univ Calgary, Dept Radiol, Calgary, AB, Canada	Universite de Montreal; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; McGill University; Universite de Montreal; McGill University; McGill University; Ruprecht Karls University Heidelberg; University of Calgary; University of Calgary	Friedrich, MG (corresponding author), Univ Montreal, Montreal Heart Inst, Philippa & Marvin Carsley CMR Ctr, Montreal, PQ, Canada.; Friedrich, MG (corresponding author), Univ Montreal, Dept Radiol, Montreal, PQ, Canada.; Friedrich, MG (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Friedrich, MG (corresponding author), McGill Univ, Dept Diagnost Radiol, Montreal, PQ, Canada.; Friedrich, MG (corresponding author), Univ Heidelberg Hosp, Dept Cardiol, Heidelberg, Germany.; Friedrich, MG (corresponding author), Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada.; Friedrich, MG (corresponding author), Univ Calgary, Dept Radiol, Calgary, AB, Canada.	mgwfriedrich@gmail.com	Friedrich, Matthias/H-8474-2015	Friedrich, Matthias/0000-0003-1204-5647; Gunsch, Dominik/0000-0003-4127-4086; Fischer, Kady/0000-0002-7765-4550	Montreal Heart Institute Foundation; Canadian Foundation for Innovation; Fonds de Recherche du Quebec	Montreal Heart Institute Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche du Quebec	Funding was provided by the Montreal Heart Institute Foundation, the Canadian Foundation for Innovation (https://www.innovation.ca.) and the Fonds de Recherche du Quebec (http://www.frq.gouv.qc.ca/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony R, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-57; Arnold JR, 2012, J AM COLL CARDIOL, V59, P1954, DOI 10.1016/j.jacc.2012.01.055; Breskovic T, 2012, RESP PHYSIOL NEUROBI, V181, P228, DOI 10.1016/j.resp.2012.03.007; BROTEN TP, 1991, CIRC RES, V68, P531, DOI 10.1161/01.RES.68.2.531; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Chareonthaitawee P, 2001, CARDIOVASC RES, V50, P151, DOI 10.1016/S0008-6363(01)00202-4; Donato P, 2012, SURG RADIOL ANAT, V34, P805, DOI 10.1007/s00276-012-0976-1; Fischer K, 2015, EUR HEART J-CARD IMG, V16, P395, DOI 10.1093/ehjci/jeu202; Friedrich MG, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-43; Friedrich MG, 2003, CIRCULATION, V108, P2219, DOI 10.1161/01.CIR.0000095271.08248.EA; Guensch DP, 2014, CURR CARDIOVASC IMAG, V7, DOI 10.1007/s12410-014-9261-5; Guensch DP, 2014, EUR HEART J-CARD IMG, V15, P409, DOI 10.1093/ehjci/jet171; Guensch DP, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.98; Guensch DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053282; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Kahn CM, 2010, MERCK VET MANUAL, V9; Kastrup A, 1998, STROKE, V29, P2641, DOI 10.1161/01.STR.29.12.2641; KLOCKE FJ, 1959, J APPL PHYSIOL, V14, P689, DOI 10.1152/jappl.1959.14.5.689; NEILL WA, 1975, CIRCULATION, V52, P854, DOI 10.1161/01.CIR.52.5.854; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Parkes MJ, 2006, EXP PHYSIOL, V91, P1, DOI 10.1113/expphysiol.2005.031625; Roubille F, 2016, J CARDIOL; Sasse SA, 1996, CHEST, V110, P958, DOI 10.1378/chest.110.4.958; Seiler C, 1997, CIRCULATION, V96, P4261; Stalder AF, 2015, MAGN RESON MED, V73, P577, DOI 10.1002/mrm.25164; Tanguay JF, 2003, J ENDOVASC THER, V10, P968, DOI 10.1583/1545-1550(2003)010<0968:CPANAA>2.0.CO;2; Teixeira T, 2016, J MAGN RESON IMAGING; Wacker CM, 2003, J AM COLL CARDIOL, V41, P834, DOI 10.1016/S0735-1097(02)02931-5; WILSON RF, 1990, CIRCULATION, V82, P1595, DOI 10.1161/01.CIR.82.5.1595; Yang HJ, 2014, RADIOLOGY, V272, P397, DOI 10.1148/radiol.14132549	30	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164524	10.1371/journal.pone.0164524	http://dx.doi.org/10.1371/journal.pone.0164524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741282	Green Published, gold			2022-12-27	WOS:000385507000040
J	Aljohi, HA; Liu, WF; Lin, Q; Zhao, YH; Zeng, JY; Alamer, A; Alanazi, IO; Alawad, AO; Al-Sadi, AM; Hu, SN; Yu, J				Aljohi, Hasan Awad; Liu, Wanfei; Lin, Qiang; Zhao, Yuhui; Zeng, Jingyao; Alamer, Ali; Alanazi, Ibrahim O.; Alawad, Abdullah O.; Al-Sadi, Abdullah M.; Hu, Songnian; Yu, Jun			Complete Sequence and Analysis of Coconut Palm (Cocos nucifera) Mitochondrial Genome	PLOS ONE			English	Article							TRANSFER-RNA GENES; PLANT MITOCHONDRIAL; SEQ DATA; DNA; CHLOROPLAST; EVOLUTION; ALIGNMENT; ARCHITECTURE; GENERATION; EXPRESSION	Coconut (Cocos nucifera L.), a member of the palm family (Arecaceae), is one of the most economically important crops in tropics, serving as an important source of food, drink, fuel, medicine, and construction material. Here we report an assembly of the coconut (C. nucifera, Oman local Tall cultivar) mitochondrial (mt) genome based on next-generation sequencing data. This genome, 678,653bp in length and 45.5% in GC content, encodes 72 proteins, 9 pseudogenes, 23 tRNAs, and 3 ribosomal RNAs. Within the assembly, we find that the chloroplast (cp) derived regions account for 5.07% of the total assembly length, including 13 proteins, 2 pseudogenes, and 11 tRNAs. The mt genome has a relatively large fraction of repeat content (17.26%), including both forward (tandem) and inverted (palin-dromic) repeats. Sequence variation analysis shows that the Ti/Tv ratio of the mt genome is lower as compared to that of the nuclear genome and neutral expectation. By combining public RNA-Seq data for coconut, we identify 734 RNA editing sites supported by at least two datasets. In summary, our data provides the second complete mt genome sequence in the family Arecaceae, essential for further investigations on mitochondrial biology of seed plants.	[Aljohi, Hasan Awad; Liu, Wanfei; Lin, Qiang; Alamer, Ali; Alanazi, Ibrahim O.; Hu, Songnian; Yu, Jun] King Abdulaziz City Sci & Technol, Joint Ctr Genom Res JCGR, Riyadh, Saudi Arabia; [Aljohi, Hasan Awad; Liu, Wanfei; Lin, Qiang; Alamer, Ali; Alanazi, Ibrahim O.; Hu, Songnian; Yu, Jun] Chinese Acad Sci, Riyadh, Saudi Arabia; [Liu, Wanfei; Lin, Qiang; Zhao, Yuhui; Zeng, Jingyao; Hu, Songnian; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Aljohi, Hasan Awad; Alamer, Ali; Alanazi, Ibrahim O.; Alawad, Abdullah O.] King Abdulaziz City Sci & Technol, Natl Ctr Genom Res, Riyadh, Saudi Arabia; [Al-Sadi, Abdullah M.] Sultan Qaboos Univ, Dept Crop Sci, Al Khoud, Oman	King Abdulaziz City for Science & Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; King Abdulaziz City for Science & Technology; Sultan Qaboos University	Hu, SN; Yu, J (corresponding author), King Abdulaziz City Sci & Technol, Joint Ctr Genom Res JCGR, Riyadh, Saudi Arabia.; Hu, SN; Yu, J (corresponding author), Chinese Acad Sci, Riyadh, Saudi Arabia.; Hu, SN; Yu, J (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China.	husn@big.ac.cn; junyu@big.ac.cn	Al-Amer, Ali/E-1597-2016; Al-Sadi, Abdullah M./D-6766-2012	Al-Amer, Ali/0000-0002-2589-1749; Al-Sadi, Abdullah M./0000-0002-3419-8268; Liu, Wanfei/0000-0002-6637-6807; Alanazi, Ibrahim O./0000-0002-8479-7875	KACST grant Joint Center for Genomics Research (JCGR), King Abdulaziz City for Science and Technology (KACST), Kingdom of Saudi Arabia [1035-35]; National Natural Science Foundation of China [31200957, 31501042]	KACST grant Joint Center for Genomics Research (JCGR), King Abdulaziz City for Science and Technology (KACST), Kingdom of Saudi Arabia; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by KACST grant 1035-35 to Hasan from the Joint Center for Genomics Research (JCGR), King Abdulaziz City for Science and Technology (KACST), Kingdom of Saudi Arabia and the grants from the National Natural Science Foundation of China (31200957 to Qiang and 31501042 to Wanfei).	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Alsaihati B, 2014, PLANT AN GEN 22 C PL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Binder S, 1996, PLANT MOL BIOL, V32, P303, DOI 10.1007/BF00039387; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Covello PS, 1989, RNA EDITING PLANT MI, DOI [10.1038/341662a0, DOI 10.1038/341662A0]; Cuenca A, 2013, COMPLETE SEQUENCE MI, DOI [10.1371/journal.pone.0061552, DOI 10.1371/JOURNAL.PONE.0061552]; Cummings MP, 2003, CURR GENET, V43, P131, DOI 10.1007/s00294-003-0378-3; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Freudenberg-Hua Y, 2003, GENOME RES, V13, P2271, DOI 10.1101/gr.1299703; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Gawel N.J., 1991, PLANT MOL BIOL REP, V9, P262, DOI [10.1007/BF02672076, DOI 10.1007/BF02672076]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gualberto JM, 1989, RNA EDITING WHEAT MI, DOI [10.1038/341660a0, DOI 10.1038/341660A0]; Gunn BF, 2015, AM J BOT, V102, P1625, DOI 10.3732/ajb.1500164; HIESEL R, 1989, SCIENCE, V246, P1632, DOI 10.1126/science.2480644; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P629, DOI 10.1073/pnas.91.2.629; Huang YY, 2014, G3-GENES GENOM GENET, V4, P2147, DOI 10.1534/g3.114.013409; Iorizzo M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-61; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Malek O, 1996, EMBO J, V15, P1403, DOI 10.1002/j.1460-2075.1996.tb00482.x; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nejat N, 2015, MOL GENET GENOMICS, V290, P1899, DOI 10.1007/s00438-015-1046-2; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schnell RJ, 2012, GENOMICS TREE CROPS, DOI [10.1007/978-1-4614-0920-5, DOI 10.1007/978-1-4614-0920-5]; Sloan DB, 2014, GENOME BIOL EVOL, V6, P3210, DOI 10.1093/gbe/evu253; Smith DR, 2013, BRIEF FUNCT GENOMICS, V12, P454, DOI 10.1093/bfgp/els066; STERN DB, 1982, NATURE, V299, P698, DOI 10.1038/299698a0; STERN DB, 1984, P NATL ACAD SCI-BIOL, V81, P1946, DOI 10.1073/pnas.81.7.1946; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tian XJ, 2007, J MOL EVOL, V64, P299, DOI 10.1007/s00239-005-0200-6; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Wang D, 2007, MOL BIOL EVOL, V24, P2040, DOI 10.1093/molbev/msm133; WINKLER M, 1991, CURR GENET, V20, P495, DOI 10.1007/BF00334778; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu ZQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2155-3; Wu ZQ, 2015, P NATL ACAD SCI USA, V112, P10185, DOI 10.1073/pnas.1421397112; Xin CQ, 2015, GENOMICS, V105, P242, DOI 10.1016/j.ygeno.2015.01.004; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	70	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163990	10.1371/journal.pone.0163990	http://dx.doi.org/10.1371/journal.pone.0163990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736909	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800032
J	Baughman, BM; Wang, HC; An, Y; Kireev, D; Stashko, MA; Jessen, HJ; Pearce, KH; Frye, SV; Shears, SB				Baughman, Brandi M.; Wang, Huanchen; An, Yi; Kireev, Dmitri; Stashko, Michael A.; Jessen, Henning J.; Pearce, Kenneth H.; Frye, Stephen V.; Shears, Stephen B.			A High-Throughput Screening-Compatible Strategy for the Identification of Inositol Pyrophosphate Kinase Inhibitors	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; BINDING; HEXAKISPHOSPHATE; DISCOVERY; DESIGN; TARGET	Pharmacological tools-'chemical probes'-that intervene in cell signaling cascades are important for complementing genetically-based experimental approaches. Probe development frequently begins with a high-throughput screen (HTS) of a chemical library. Herein, we describe the design, validation, and implementation of the first HTS-compatible strategy against any inositol phosphate kinase. Our target enzyme, PPIP5K, synthesizes 'highenergy' inositol pyrophosphates (PP-InsPs), which regulate cell function at the interface between cellular energy metabolism and signal transduction. We optimized a time-resolved, fluorescence resonance energy transfer ADP-assay to record PPIP5K-catalyzed, ATP-driven phosphorylation of 5-InsP7 to 1,5-InsP8 in 384-well format (Z' = 0.82 +/- 0.06). We screened a library of 4745 compounds, all anticipated to be membrane-permeant, which are known-or conjectured based on their structures-to target the nucleotide binding site of protein kinases. At a screening concentration of 13 mu M, fifteen compounds inhibited PPIP5K > 50%. The potency of nine of these hits was confirmed by dose-response analyses. Three of these molecules were selected from different structural clusters for analysis of binding to PPIP5K, using isothermal calorimetry. Acceptable thermograms were obtained for two compounds, UNC10112646 (Kd = 7.30 +/- 0.03 mu M) and UNC10225498 (Kd = 1.37 +/- 0.03 mu M). These Kd values lie within the 1 +/- 10 mu M range generally recognized as suitable for further probe development. In silico docking data rationalizes the difference in affinities. HPLC analysis confirmed that UNC10225498 and UNC10112646 directly inhibit PPIP5K-catalyzed phosphorylation of 5-InsP7 to 1,5-InsP8; kinetic experiments showed inhibition to be competitive with ATP. No other biological activity has previously been ascribed to either UNC10225498 or UNC10112646; moreover, at 10 mu M, neither compound inhibits IP6K2, a structurally-unrelated PP-InsP kinase. Our screening strategy may be generally applicable to inhibitor discovery campaigns for other inositol phosphate kinases.	[Baughman, Brandi M.; Wang, Huanchen; Shears, Stephen B.] NIEHS, Signal Transduct Lab, Res Triangle Pk, NC 27709 USA; [Baughman, Brandi M.; An, Yi; Kireev, Dmitri; Stashko, Michael A.; Pearce, Kenneth H.; Frye, Stephen V.] Univ Nortth Carolina, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA; [Jessen, Henning J.] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Freiburg	Shears, SB (corresponding author), NIEHS, Signal Transduct Lab, POB 12233, Res Triangle Pk, NC 27709 USA.	brandi.baughman@nih.gov	Jessen, Henning/O-1157-2019; Jessen, Henning/F-5108-2014	Jessen, Henning/0000-0002-1025-9484; Jessen, Henning/0000-0002-1025-9484	Intramural Research Program of the NIH/National Institute of Environmental Health Sciences; Swiss National Science Foundation [PP00P2_157607]; National Institutes of Health [R01DK101645]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101645] Funding Source: NIH RePORTER	Intramural Research Program of the NIH/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NIH/National Institute of Environmental Health Sciences. HJJ acknowledges support from the Swiss National Science Foundation (grant number PP00P2_157607). KHP and SVF acknowledge the support of the National Institutes of Health under Award Number R01DK101645. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acker M, 2014, PERSPECT SCI, V1, P56, DOI 10.1016/j.pisc.2013.12.001; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P887, DOI 10.1038/nchembio1115-887c; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; Barker A, 2013, DRUG DISCOV TODAY, V18, P298, DOI 10.1016/j.drudis.2012.10.008; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Brooks H. B., 2004, ASSAY GUIDANCE MANUA; Chang YT, 2002, CHEMBIOCHEM, V3, P897, DOI 10.1002/1439-7633(20020902)3:9<897::AID-CBIC897>3.0.CO;2-B; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Drewry DH, 2014, CURR TOP MED CHEM, V14, P340, DOI 10.2174/1568026613666131127160819; Drewry DH, 2010, CURR OPIN CHEM BIOL, V14, P289, DOI 10.1016/j.cbpa.2010.03.024; Endo-Streeter S, 2012, J BIOL CHEM, V287, P35360, DOI 10.1074/jbc.M112.365031; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Harris CJ, 2011, COMB CHEM HIGH T SCR, V14, P521; Hatch AJ, 2010, CELL, V143, P1030, DOI 10.1016/j.cell.2010.11.045; Hayward MM, 2010, LEAD SEEKING APPROAC, Vxiii; Hong L, 2009, ANAL BIOCHEM, V391, P31, DOI 10.1016/j.ab.2009.04.033; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Hutti JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041494; Iversen PW, 2004, ASSAY GUIDANCE MANUA; Janzen WP, 2014, CHEM BIOL, V21, P1162, DOI 10.1016/j.chembiol.2014.07.015; Moon SH, 2015, J PHARMACOL SCI, V129, P135, DOI 10.1016/j.jphs.2015.06.008; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Pavlovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10622; Peterson EJR, 2013, J BIOMOL SCREEN, V18, P247, DOI 10.1177/1087057112461153; Peterson EJR, 2012, ASSAY DRUG DEV TECHN, V10, P260, DOI 10.1089/adt.2011.0409; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Shears SB, 2016, BIOCHEM SOC T, V44, P191, DOI 10.1042/BST20150184; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; Sidik SM, 2016, J BIOL CHEM, V291, P9566, DOI 10.1074/jbc.M115.703546; Sui YW, 2007, J BIOMOL SCREEN, P1; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Tellinghuisen J, 2016, BBA-GEN SUBJECTS, V1860, P861, DOI 10.1016/j.bbagen.2015.10.011; Verdugo DE, 2001, J MED CHEM, V44, P2683, DOI 10.1021/jm010171u; Wang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5178; Wang HC, 2014, CHEM BIOL, V21, P689, DOI 10.1016/j.chembiol.2014.03.009; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; Weaver JD, 2013, FASEB J, V27; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Worley J, 2013, CELL REP, V3, P1476, DOI 10.1016/j.celrep.2013.03.043; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	48	1	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164378	10.1371/journal.pone.0164378	http://dx.doi.org/10.1371/journal.pone.0164378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736936	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800061
J	da Costa, TA; Di Gangi, R; Thome, R; Felisbino, MB; Bonfanti, AP; Ishikawa, LLW; Sartori, A; Burger, E; Verinaud, L				da Costa, Thiago Alves; Di Gangi, Rosaria; Thome, Rodolfo; Felisbino, Marina Barreto; Bonfanti, Amanda Pires; Watanabe Ishikawa, Larissa Lumi; Sartori, Alexandrina; Burger, Eva; Verinaud, Liana			Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis	PLOS ONE			English	Article							T-CELLS; EXPERIMENTAL CRYPTOCOCCOSIS; PLASMODIUM-BERGHEI; IMMUNE-RESPONSES; INFECTION; MICE; BRASILIENSIS; THYMOCYTES; ATROPHY; IMMUNOSUPPRESSION	T cell maturation takes place within the thymus, a primary lymphoid organ that is commonly targeted during infections. Previous studies showed that acute infection with Paracoccidioides brasiliensis (Pb), the causative agent of paracoccidioidomycosis (PCM), promotes thymic atrophy that is associated with the presence of yeast cells in the organ. However, as human PCM is a chronic infection, it is imperative to investigate the consequences of Pb infection over the thymic structure and function in chronic infection. In this sense, we developed a new experimental model where Pb yeast cells are injected through the intraperitoneal route and mice are evaluated over 120 days of infection. Thymuses were analyzed in chronically infected mice and we found that the thymus underwent extensive morphological alterations and severe infiltration of P. brasiliensis yeast cells. Further analyses showed an altered phenotype and function of thymocytes that are commonly found in peripheral mature T lymphocytes. We also observed activation of the NLRP3 inflammasome in the thymus. Our data provide new information on the severe changes observed in the thymic microenvironment in a model of PCM that more closely mimics the human infection.	[da Costa, Thiago Alves; Di Gangi, Rosaria; Thome, Rodolfo; Felisbino, Marina Barreto; Bonfanti, Amanda Pires; Verinaud, Liana] Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Watanabe Ishikawa, Larissa Lumi; Sartori, Alexandrina] Univ Estadual Paulista UNESP, Inst Biosci Botucatu, Dept Microbiol & Immunol, Botucatu, SP, Brazil; [Burger, Eva] Fed Univ Alfenas UNIFAL MG, Inst Biomed Sci, Dept Microbiol & Immunol, Alfenas, MG, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade Federal de Alfenas	Verinaud, L (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil.	verinaud@unicamp.br	Felisbino, Marina/N-9311-2019; Burger, Eva/F-2665-2012; Sartori, Alexandrina/AAA-6191-2020; Thome, Rodolfo/C-1564-2012; da Costa, Thiago Alves/F-8187-2016; Sartori, Alexandrina/B-2951-2013; Bonfanti, Amanda/AAS-4286-2021; Ishikawa, Larissa LW/I-5104-2014	Sartori, Alexandrina/0000-0003-4557-3331; Thome, Rodolfo/0000-0001-7627-4137; Sartori, Alexandrina/0000-0003-4557-3331; Ishikawa, Larissa LW/0000-0003-3481-2181; Alves da Costa, Thiago/0000-0001-9591-331X; Bonfanti, Amanda/0000-0003-0896-0105	Sao Paulo Research Foundation (FAPESP) [2014/19492-3, 2013/08194-9]; FAPESP [2012/22131-7, 2013/01401-9, 2014/02631-0, 2012/03238-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo Research Foundation (FAPESP, #2014/19492-3 and 2013/08194-9). TAC, RdG, RT and MBF were supported by FAPESP scholarships (#2012/22131-7, #2013/01401-9, #2014/02631-0 and #2012/03238-5, respectively). LV and EB are fellows of the National Council of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection, analysis and decision to publish.	Bocca AL, 2013, FUTURE MICROBIOL, V8, P1177, DOI 10.2217/fmb.13.68; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Brito VN, 2003, MED MYCOL, V41, P83, DOI 10.1080/714043902; Buitrago MJ, 2011, J TRAVEL MED, V18, P26, DOI 10.1111/j.1708-8305.2010.00477.x; Campanelli AP, 2003, J INFECT DIS, V187, P1496, DOI 10.1086/374646; CASTANEDA E, 1988, INFECT IMMUN, V56, P1771, DOI 10.1128/IAI.56.7.1771-1777.1988; Chen WX, 2005, MICROB PATHOGENESIS, V39, P189, DOI 10.1016/j.micpath.2005.08.005; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; da Costa TA, 2015, IMMUNOLOGY, V146, P486, DOI 10.1111/imm.12526; de Meis Juliana, 2012, J Parasitol Res, V2012, P574020, DOI 10.1155/2012/574020; Deobagkar-Lele M, 2013, IMMUNOLOGY, V138, P307, DOI 10.1111/imm.12047; Di Gangi R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1561-8; Lima ACD, 2012, CELL IMMUNOL, V279, P53, DOI 10.1016/j.cellimm.2012.09.006; FA VA NETTO Celeste., 1961, Revista do Instituto Adolfo Lutz, V21, P99; Fang RHT, 2008, AIDS, V22, P171, DOI 10.1097/QAD.0b013e3282f2589b; Francelin C, 2011, IMMUNOBIOLOGY, V216, P1148, DOI 10.1016/j.imbio.2011.03.009; Gameiro J, 2010, CELL ADHES MIGR, V4, P382, DOI 10.4161/cam.4.3.11789; Gopinathan R, 2001, TRANSPLANTATION, V72, P1533, DOI 10.1097/00007890-200111150-00011; GROCOTT RG, 1955, AM J CLIN PATHOL, V25, P975, DOI 10.1093/ajcp/25.8_ts.0975; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Hale JS, 2009, IMMUNOL CELL BIOL, V87, P58, DOI 10.1038/icb.2008.87; Jenkinson WE, 2008, J IMMUNOL, V181, P6101, DOI 10.4049/jimmunol.181.9.6101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Liu B, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.323; Luna L.G., 1992, HISTOPATHOLOGICAL ME; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Nagib PRA, 2010, IMMUNOBIOLOGY, V215, P971, DOI 10.1016/j.imbio.2010.02.001; NAPARSTEK Y, 1982, NATURE, V300, P262, DOI 10.1038/300262a0; Nobrega C, 2007, MICROBES INFECT, V9, P1521, DOI 10.1016/j.micinf.2007.08.006; Nobrega C, 2013, J IMMUNOL, V190, P1646, DOI 10.4049/jimmunol.1202412; Patterson Jr MK, 1973, TISSUE CULTURE METHO, P406; Pozzesi N, 2014, CELL DEATH DIFFER, V21, P226, DOI 10.1038/cdd.2013.166; Ramos e Silva M, 1981, AN BRAS DERMATOL, V56, P227; RAVIOLA E, 1972, J EXP MED, V136, P466, DOI 10.1084/jem.136.3.466; RESTREPO A, 1985, SABOURAUDIA, V23, P323; Ribatti D, 2015, IMMUNOL LETT, V168, P325, DOI 10.1016/j.imlet.2015.10.014; ROBLEDO MA, 1982, AM REV RESPIR DIS, V125, P563, DOI 10.1164/arrd.1982.125.5.563; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; SINGERVERMES LM, 1993, CLIN EXP IMMUNOL, V94, P75, DOI 10.1111/j.1365-2249.1993.tb05980.x; SOTOMAYOR CE, 1989, MYCOPATHOLOGIA, V108, P5, DOI 10.1007/BF00436777; SOTOMAYOR CE, 1995, CLIN IMMUNOL IMMUNOP, V77, P19, DOI 10.1016/0090-1229(95)90132-9; Tavares AH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002595; Thome R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110739; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG SD, 1994, J IMMUNOL, V152, P5014; Youm YH, 2012, CELL REP, V1, P56, DOI 10.1016/j.celrep.2011.11.005	50	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164745	10.1371/journal.pone.0164745	http://dx.doi.org/10.1371/journal.pone.0164745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736987	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800125
J	Direk, N; Dekker, MJHJ; Luik, AI; Kirschbaum, C; de Rijke, YB; Hofman, A; Hoogendijk, WJG; Tiemeier, H				Direk, Nese; Dekker, Marieke J. H. J.; Luik, Annemarie I.; Kirschbaum, Clemens; de Rijke, Yolanda B.; Hofman, Albert; Hoogendijk, Witte J. G.; Tiemeier, Henning			The Very Low-Dose Dexamethasone Suppression Test in the General Population: A Cross-Sectional Study	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; HPA AXIS; PSYCHOTIC EXPERIENCES; CORTISOL RESPONSE; SALIVARY CORTISOL; SEX-DIFFERENCES; RISK-FACTORS; LATE-LIFE; STRESS; DEPRESSION	Determinants of the hypothalamic-pituitary-adrenal (HPA) axis functioning are increasingly explored in population-based studies. However, functional tests measuring the negative feedback of the HPA axis cannot easily be implemented into large observational studies. Furthermore, high doses of dexamethasone often completely suppress the HPA axis in healthy persons. This study aimed to detect the effects of the health, lifestyle and sociodemographic factors, psychiatric problems and cognitive functions on the negative feedback of the HPA axis using a very low-dose (0.25 mg) dexamethasone suppression test (DST).We evaluated the associations of several determinants with the saliva cortisol concentrations after dexamethasone intake in a confounder-adjusted model also corrected for baseline saliva cortisol concentrations in the Rotterdam Study, a large population-based study (N = 1822). We found that female sex, low income, lack of exercise, instrumental disability and smoking were all independently associated with stronger suppression of the HPA axis. Even though there were no linear associations between psychiatric measures and cortisol suppression, we found that depressive symptoms and anxiety disorders were more common in persons with non-suppression of cortisol. Conversely, psychotropic medication use was related to enhanced suppression of cortisol after DST. In this large study, we found that female gender, low socioeconomic status and poor health were all related to suppression of the HPA axis. Non-linear associations were detected between the suppression of the HPA axis and common psychiatric disorders in community-dwelling persons.	[Direk, Nese; Hofman, Albert; Tiemeier, Henning] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Direk, Nese] Dokuz Eylul Univ, Dept Psychiat, Izmir, Turkey; [Dekker, Marieke J. H. J.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Luik, Annemarie I.] Univ Oxford, Nuffield Dept Clin Neurosci, Sleep & Circadian Neurosci Inst, Oxford, England; [Kirschbaum, Clemens] Tech Univ Dresden, Dept Biol Psychol, Dresden, Germany; [de Rijke, Yolanda B.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Hoogendijk, Witte J. G.; Tiemeier, Henning] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Dokuz Eylul University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Oxford; Technische Universitat Dresden; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Tiemeier, H (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.; Tiemeier, H (corresponding author), Erasmus MC, Dept Psychiat, Rotterdam, Netherlands.; Tiemeier, H (corresponding author), Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands.	h.tiemeier@erasmusmc.nl	Tiemeier, Henning/H-6534-2019; Tecirli, Nese Direk -/G-1746-2019; de Rijke, Yolanda/AAQ-5497-2020; Kirschbaum, Clemens/AAB-1752-2020; Luik, Annemarie I/E-1292-2015	Tiemeier, Henning/0000-0002-4395-1397; Tecirli, Nese Direk -/0000-0002-3631-5990; Luik, Annemarie I/0000-0001-7517-197X	Erasmus Medical Centre and Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative; Ministry of Education, Culture and Science; Ministry of Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Consortium for Healthy Ageing; VIDI grant of ZonMw [2009-017.106.370]	Erasmus Medical Centre and Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Consortium for Healthy Ageing; VIDI grant of ZonMw	The Rotterdam Study is supported by Erasmus Medical Centre and Erasmus University Rotterdam, the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Netherlands Genomics Initiative, the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. ND was supported by the Netherlands Consortium for Healthy Ageing. HT was supported by the VIDI grant of ZonMw (2009-017.106.370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2009, PSYCHONEUROENDOCRINO, V34, P1423, DOI 10.1016/j.psyneuen.2009.06.011; Alexandraki KI, 2010, NEUROENDOCRINOLOGY, V92, P35, DOI 10.1159/000314295; Allison P. D, 1990, SOCIOL METHODOL, P93; Badrick E, 2007, J CLIN ENDOCR METAB, V92, P819, DOI 10.1210/jc.2006-2155; Beck CK, 1997, ALZ DIS ASSOC DIS, V11, P73; Bijl RV, 2000, PSYCHOL MED, V30, P657, DOI 10.1017/S0033291799001841; BLAZER D, 1991, J GERONTOL, V46, pM210, DOI 10.1093/geronj/46.6.M210; Bremmer MA, 2007, BIOL PSYCHIAT, V62, P479, DOI 10.1016/j.biopsych.2006.11.033; BRIDGES M, 1986, BIOL PSYCHIAT, V21, P853, DOI 10.1016/0006-3223(86)90254-4; Bruce KR, 2012, PROG NEURO-PSYCHOPH, V38, P241, DOI 10.1016/j.pnpbp.2012.04.006; Cohen S, 2006, PSYCHOSOM MED, V68, P41, DOI 10.1097/01.psy.0000195967.51768.ea; Collip D, 2011, PSYCHOL MED, V41, P2305, DOI 10.1017/S0033291711000602; Diaz-Marsa Marina, 2007, CNS Spectr, V12, P675; Direk N, 2011, INT J PSYCHOPHYSIOL, V80, P157, DOI 10.1016/j.ijpsycho.2011.02.007; Duval Fabrice, 2005, Dialogues Clin Neurosci, V7, P273; Fernand SC, 2012, PSYCHONEUROENDOCRINO, V37, P1659, DOI 10.1016/j.psyneuen.2012.02.012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fountoulakis Konstantinos N, 2008, Ann Gen Psychiatry, V7, P22, DOI 10.1186/1744-859X-7-22; FRIES JF, 1982, J RHEUMATOL, V9, P789; Garcia MC, 2008, ANN NY ACAD SCI, V1148, P504, DOI 10.1196/annals.1410.065; GLASSMAN AH, 1987, AM J PSYCHIAT, V144, P1253; Golden SH, 2011, EUR J EPIDEMIOL, V26, P511, DOI 10.1007/s10654-011-9585-2; GOLDSTEIN S, 1987, AM J PSYCHIAT, V144, P1320; Griffin MG, 2005, AM J PSYCHIAT, V162, P1192, DOI 10.1176/appi.ajp.162.6.1192; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Handwerger K, 2009, HARVARD REV PSYCHIAT, V17, P184, DOI 10.1080/10673220902996775; Hek K, 2013, PSYCHONEUROENDOCRINO, V38, P300, DOI 10.1016/j.psyneuen.2012.06.006; Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x; Holtzman CW, 2013, NEUROSCIENCE, V249, P172, DOI 10.1016/j.neuroscience.2012.12.017; Hoogendam YY, 2014, EUR J EPIDEMIOL, V29, P133, DOI 10.1007/s10654-014-9885-4; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P47, DOI 10.1210/jc.83.1.47; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Kraft AJ, 2009, PSYCHONEUROENDOCRINO, V34, P1363, DOI 10.1016/j.psyneuen.2009.04.008; Kristenson M, 2001, SCAND J PUBLIC HEALT, V29, P140, DOI 10.1177/14034948010290020101; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LAWTON MP, 1982, J GERONTOL, V37, P91, DOI 10.1093/geronj/37.1.91; Maric NP, 2013, PSYCHIAT DANUB, V25, P299; Millan-Calenti JC, 2010, ARCH GERONTOL GERIAT, V50, P306, DOI 10.1016/j.archger.2009.04.017; Nelson JC, 1997, AM J PSYCHIAT, V154, P1497, DOI 10.1176/ajp.154.11.1497; Noordam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031166; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Pearlin LI, 2005, J HEALTH SOC BEHAV, V46, P205, DOI 10.1177/002214650504600206; Penninx BWJH, 2007, AM J GERIAT PSYCHIAT, V15, P522, DOI 10.1097/JGP.0b013e318033ed80; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REMILLARD AJ, 1993, BIOL PSYCHIAT, V33, P755, DOI 10.1016/0006-3223(93)90129-2; Reppermund S, 2013, PSYCHOL MED, V43, P2437, DOI 10.1017/S003329171200308X; Rhebergen D, 2015, PSYCHONEUROENDOCRINO, V51, P341, DOI 10.1016/j.psyneuen.2014.10.005; Rohleder N, 2006, INT J PSYCHOPHYSIOL, V59, P236, DOI 10.1016/j.ijpsycho.2005.10.012; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Spijker AT, 2012, NEUROENDOCRINOLOGY, V95, P179, DOI 10.1159/000329846; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Tajima-Pozo K, 2013, ENDOCRINOL NUTR, V60, P396, DOI 10.1016/j.endonu.2012.09.003; Tas U, 2007, PREV MED, V44, P272, DOI 10.1016/j.ypmed.2006.11.007; Tziomalos K, 2004, CLIN ENDOCRINOL, V61, P664, DOI 10.1111/j.1365-2265.2004.02161.x; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; Vreeburg SA, 2010, PSYCHOSOM MED, V72, P340, DOI 10.1097/PSY.0b013e3181d2f0c8; Vreeburg SA, 2009, PSYCHONEUROENDOCRINO, V34, P1109, DOI 10.1016/j.psyneuen.2009.04.024; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; WESTBERG P, 1991, BIOL PSYCHIAT, V30, P247, DOI 10.1016/0006-3223(91)90109-Y; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Yehuda R, 2004, PSYCHONEUROENDOCRINO, V29, P389, DOI 10.1016/S0306-4530(03)00052-0; Yehuda R, 2002, BIOL PSYCHIAT, V52, P393, DOI 10.1016/S0006-3223(02)01357-4; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83	66	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164348	10.1371/journal.pone.0164348	http://dx.doi.org/10.1371/journal.pone.0164348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736954	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800054
J	Muposhi, VK; Gandiwa, E; Bartels, P; Makuza, SM; Madiri, TH				Muposhi, Victor K.; Gandiwa, Edson; Bartels, Paul; Makuza, Stanley M.; Madiri, Tinaapi H.			Trophy Hunting and Sustainability: Temporal Dynamics in Trophy Quality and Harvesting Patterns of Wild Herbivores in a Tropical Semi-Arid Savanna Ecosystem	PLOS ONE			English	Article							GONAREZHOU NATIONAL-PARK; PROTECTED AREAS; POPULATION DECLINES; HORN SIZE; EVOLUTIONARY CONSEQUENCES; AFRICAN ELEPHANT; LAW-ENFORCEMENT; LION POPULATION; SOUTHERN AFRICA; CONSERVATION	The selective nature of trophy hunting may cause changes in desirable phenotypic traits in harvested species. A decline in trophy size of preferred species may reduce hunting destination competitiveness thus compromising the sustainability of trophy hunting as a conservation tool. We explored the trophy quality and trends in harvesting patterns (i.e., 2004-2015) of Cape buffalo (Syncerus caffer), African elephant (Loxodonta africana), greater kudu (Tragelaphus strepsiceros) and sable (Hippotragus niger) in Matetsi Safari Area, northwest Zimbabwe. We used long-term data on horn and tusk size, age, quota size allocation and offtake levels of selected species. To analyse the effect of year, area and age on the trophy size, quota size and offtake levels, we used linear mixed models. One sample t-test was used to compare observed trophy size with Safari Club International (SCI) minimum score. Trophy sizes for Cape buffalo and African elephant were below the SCI minimum score. Greater kudu trophy sizes were within the minimum score threshold whereas sable trophy sizes were above the SCI minimum score between 2004 and 2015. Age at harvest for Cape buffalo, kudu and sable increased whilst that of elephant remained constant between 2004 and 2015. Quota size allocated for buffalo and the corresponding offtake levels declined over time. Offtake levels of African elephant and Greater kudu declined whilst the quota size did not change between 2004 and 2015. The quota size for sable increased whilst the offtake levels fluctuated without changing for the period 2004-2015. The trophy size and harvesting patterns in these species pose a conservation and management dilemma on the sustainability of trophy hunting in this area. We recommend: (1) temporal and spatial rotational resting of hunting areas to create refuge to improve trophy quality and maintenance of genetic diversity, and (2) introduction of variable trophy fee pricing system based on trophy size.	[Muposhi, Victor K.; Gandiwa, Edson] Chinhoyi Univ Technol, Sch Wildlife Ecol & Conservat, Private Bag 7724, Chinhoyi, Zimbabwe; [Bartels, Paul] Tshwane Univ Technol, Nat Conservat Dept, Private Bag X680, ZA-0001 Pretoria, South Africa; [Makuza, Stanley M.] Chinhoyi Univ Technol, Sch Agr Sci & Technol, Private Bag 7724, Chinhoyi, Zimbabwe; [Madiri, Tinaapi H.] Zimbabwe Pk & Wildlife Management Author, POB CY140, Harare, Zimbabwe	Tshwane University of Technology	Muposhi, VK (corresponding author), Chinhoyi Univ Technol, Sch Wildlife Ecol & Conservat, Private Bag 7724, Chinhoyi, Zimbabwe.	vkmuposhi@gmail.com	Gandiwa, Edson/I-2925-2019; Muposhi, Victor K./AFJ-8216-2022	Gandiwa, Edson/0000-0003-0708-350X; Muposhi, Victor K./0000-0003-1258-8916	Chinhoyi University of Technology [PG4122]; Chinhoyi Univseristy of Technology [PG4122]	Chinhoyi University of Technology; Chinhoyi Univseristy of Technology	This study was funded by Chinhoyi University of Technology, Grant Number PG4122. We acknowledge the Director-General of the Zimbabwe Parks and Wildlife Management Authority for allowing us to conduct this research and for the permission to publish this work. We thank the management staff and rangers of Matetsi Safari Area for their support during the course of our study. We are indebted to Mellinda Rushinga, Admire Chanyandura, Kudzai Mpakari, Thelma Chademana and Vongai Masunga who helped in the capturing and compilation of trophy size and harvesting regime data. Our special thanks to ChidoMeda and Merillette M. Chihota for helping with the proofs. We acknowledge the comments from reviewers that improved the earlier versions of this paper particularly Staurt Primm and the Academic Editor, Suzannah Rutherford.; Funded by Chinhoyi Univseristy of Technology Postgraduate grant: PG4122 (www.cut.ac.zw). Authors who received funding: VKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WILDLIFE BIOL, V16, P419; Balme Guy A., 2010, P341; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Barnett R, 2005, SPORT HUNTING SO AFR; Buckley R, 2015, ANIM CONSERV, V18, P133, DOI 10.1111/acv.12204; Burkhardt-Holm P, 2005, ENVIRON SCI TECHNOL, V39, p441A, DOI 10.1021/es053375z; Chamaille-Jammes S, 2007, J ARID ENVIRON, V71, P323, DOI 10.1016/j.jaridenv.2007.05.005; Chamaille-Jammes S, 2006, INT J REMOTE SENS, V27, P5185, DOI 10.1080/01431160600702392; Chenje M., 1998, STATE ZIMBABWE; Child B, 2013, PARKS TRANSITION BIO; Chiyo PI, 2015, ECOL EVOL, V5, P5216, DOI 10.1002/ece3.1769; Chomba Chansa, 2014, Open Journal of Ecology, V4, P182; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Costanza R, 2012, ECOL ENG, V45, P24, DOI 10.1016/j.ecoleng.2012.03.023; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Crosmary WG, 2015, ANIM CONSERV, V18, P136, DOI 10.1111/acv.12205; Crosmary WG, 2015, ANIM CONSERV, V18, P117, DOI 10.1111/acv.12144; Crosmary WG, 2013, ANIM CONSERV, V16, P648, DOI 10.1111/acv.12043; Crosmary WG, 2015, AFR J ECOL, V53, P194, DOI 10.1111/aje.12207; Cumming D. H. M., 2011, CONSTRAINTS CONSERVA; Damm G.R, 2008, BEST PRACTICES SUSTA, P5; de Garine-Wichatitsky M, 2013, COMP IMMUNOL MICROB, V36, P321, DOI 10.1016/j.cimid.2012.10.007; Di Minin E, 2016, TRENDS ECOL EVOL, V31, P99, DOI 10.1016/j.tree.2015.12.006; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Dudley JP, 2001, AFR J ECOL, V39, P187, DOI 10.1046/j.0141-6707.2000.00297.x; Dunham KM, 2002, AERIAL CENSUS ELEPHA, P77; Fenberg PB, 2008, MOL ECOL, V17, P209, DOI 10.1111/j.1365-294X.2007.03522.x; Festa-Bianchet M, 2004, BEHAV ECOL, V15, P305, DOI 10.1093/beheco/arh014; Fryxell JM, 2010, SCIENCE, V328, P903, DOI 10.1126/science.1185802; Gandiwa E, 2014, J NAT CONSERV, V22, P413, DOI 10.1016/j.jnc.2014.03.009; Gandiwa E, 2014, TROP ECOL, V55, P119; Gandiwa E, 2013, TROP CONSERV SCI, V6, P493, DOI 10.1177/194008291300600404; Gandiwa E, 2013, J NAT CONSERV, V21, P133, DOI 10.1016/j.jnc.2012.11.009; Gandiwa E, 2011, TROP CONSERV SCI, V4, P445, DOI 10.1177/194008291100400407; Gandy S. E., 2004, Koedoe, V47, P119; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Grims dell J. J. R., 1973, AFR J ECOL, V11, P31, DOI DOI 10.1111/J.1365-2028.1973.TB00072.X; Hedrick PW, 2011, J HERED; Hengeveld PE, 2011, J WILDLIFE MANAGE, V75, P189, DOI 10.1002/jwmg.14; Johnson PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012866; Knapp A, 2007, REV EUROPEAN UNIONS, P81; Landete-Castillejos T, 2007, BONE, V40, P1095, DOI 10.1016/j.bone.2006.11.022; Laws R.W, 1966, E AFR WILDL J, V4, P1, DOI [10.1111/j.1365-2028.1966.tb00878.x, DOI 10.1111/J.1365-2028.1966.TB00878.X]; Leader-Williams N, 2005, DOES EXTRACTIVE USE; Lindsey P, 2012, S AFR J WILDL RES, V42, P11, DOI 10.3957/056.042.0103; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey PA, 2011, ORYX, V45, P96, DOI 10.1017/S0030605310000153; Lindsey PA, 2016, CONSERVATION LETT; Lindsey PA, 2007, CONSERV BIOL, V21, P880, DOI 10.1111/j.1523-1739.2006.00594.x; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Locke H, 2005, ENVIRON CONSERV, V32, P1, DOI 10.1017/S0376892905001852; Loehr J, 2010, J EVOLUTION BIOL, V23, P783, DOI 10.1111/j.1420-9101.2010.01948.x; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge Andrew J., 2006, P222; Malo JE, 2011, BIODIVERS CONSERV, V20, P3477, DOI 10.1007/s10531-011-0136-7; Martin A, 2013, AFR J ECOL, V51, P172, DOI 10.1111/aje.12000; MARTIN PS, 1966, NATURE, V212, P339, DOI 10.1038/212339a0; Milner JM, 2006, J APPL ECOL, V43, P721, DOI 10.1111/j.1365-2664.2006.01183.x; Milner-Gulland E.J., 2009, RECREATIONAL HUNTING, P75, DOI 10.1002/9781444303179; Morrill W. I., 1993, TOURIST SAFARI HUNTE; Muboko N, 2014, PACHYDERM, P92; Muboko N, 2016, TOURISM MANAGE, V52, P170, DOI 10.1016/j.tourman.2015.06.023; Muposhi VK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163084; Muposhi VK, AUSTR ECOLO IN PRESS; Mysterud A, 2011, J APPL ECOL, V48, P827, DOI 10.1111/j.1365-2664.2011.02006.x; Naidoo R, 2016, CONSERVATIO IN PRESS, DOI [10.1111/cobi.12643, DOI 10.1111/COBI.12643]; Naidoo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036527; Ndaimani H, 2013, GEOCARTO INT, V28, P130, DOI 10.1080/10106049.2012.677481; Nelson MP, 2016, CONSERV LETT, V9, P302, DOI 10.1111/conl.12232; Nyahongo JW, 2008, AFR J ECOL, V46, P227, DOI 10.1111/j.1365-2028.2007.00818.x; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Padilla E, 2002, ECOL ECON, V41, P69, DOI 10.1016/S0921-8009(02)00026-5; Perez JM, 2011, WILDLIFE BIOL, V17, P102, DOI 10.2981/09-102; Prins HH., 2012, WILDLIFE CONSERVATIO; Ramanzin M, 2014, EUR J WILDLIFE RES, V60, P1, DOI 10.1007/s10344-013-0744-5; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Rist J, 2010, CONSERV BIOL, V24, P489, DOI 10.1111/j.1523-1739.2010.01470.x; Rivrud IM, 2013, J APPL ECOL, V50, P168, DOI 10.1111/1365-2664.12004; Robinson JG, 2011, BIOL CONSERV, V144, P958, DOI 10.1016/j.biocon.2010.04.017; Sarvala J, 2006, INT VER THEOR ANGEW, V29, P1182; Schmidt JI, 2007, WILDLIFE BIOL, V13, P53, DOI 10.2981/0909-6396(2007)13[53:ASOAMA]2.0.CO;2; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Selier SAJ, 2014, J WILDLIFE MANAGE, V78, P122, DOI 10.1002/jwmg.641; Sharma A., 2014, REV RES J, V3, pROR; Short JL, 2008, J LAW ECON ORGAN, V24, P45, DOI 10.1093/jleo/ewm039; Songorwa AN, 1999, WORLD DEV, V27, P2061, DOI 10.1016/S0305-750X(99)00103-5; Spinage C, 1973, AFRICAN J ECOL, V11, P165; Sutherland WJ, 2001, WILDLIFE BIOL, V7, P131, DOI 10.2981/wlb.2001.017; Taylor W, 2007, AFRICAN INDABA, V5; UNEP-WCMC, 2013, ASS POT IMP TRAD T 2, P34; Vanpe C, 2009, J ANIM ECOL, V78, P42, DOI 10.1111/j.1365-2656.2008.01467.x; von Brandis RG, 2007, S AFR J WILDL RES, V37, P153, DOI 10.3957/0379-4369-37.2.153; von Brandis RG, 2008, S AFR J WILDL RES, V38, P17, DOI 10.3957/0379-4369-38.1.17; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Wilfred P., 2012, TANZANIAN J SCI, V38, P111; Wilkie DS, 1999, ORYX, V33, P339, DOI 10.1017/S003060530003074X; WILSON EO, 1989, SCI AM, V261, P108, DOI 10.1038/scientificamerican0989-108; Wroe S, 2004, ALCHERINGA, V28, P291, DOI 10.1080/03115510408619286	101	4	4	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164429	10.1371/journal.pone.0164429	http://dx.doi.org/10.1371/journal.pone.0164429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736930	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800066
J	Azarian, T; Maraqa, NF; Cook, RL; Johnson, JA; Bailey, C; Wheeler, S; Nolan, D; Rathore, MH; Morris, JG; Salemi, M				Azarian, Taj; Maraqa, Nizar F.; Cook, Robert L.; Johnson, Judith A.; Bailey, Christine; Wheeler, Sarah; Nolan, David; Rathore, Mobeen H.; Morris, J. Glenn, Jr.; Salemi, Marco			Genomic Epidemiology of Methicillin-Resistant Staphylococcus aureus in a Neonatal Intensive Care Unit	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; EVOLUTIONARY DYNAMICS; POPULATION-DYNAMICS; TRANSMISSION TREES; RISK-FACTORS; EMERGENCE; INFECTION; INFERENCE; COLONIZATION	Despite infection prevention efforts, neonatal intensive care unit (NICU) patients remain at risk of Methicillin-resistant Staphylococcus aureus (MRSA) infection. Modes of transmission for healthcare-associated (HA) and community-associated (CA) MRSA remain poorly understood and may vary by genotype, hindering the development of effective prevention and control strategies. From 2008-2010, all patients admitted to a level III NICU were screened for MRSA colonization, and all available isolates were spa-typed. Spa-type t008, the most prevalent CA- genotype in the United States, spa-type t045, a HA- related genotype, and a convenience sample of strains isolated from 2003-2011, underwent whole-genome sequencing and phylodynamic analysis. Patient risk factors were compared between colonized and noncolonized infants, and virulence and resistance genes compared between spa-type t008 and non-t008 strains. Epidemiological and genomic data were used to estimate MRSA importations and acquisitions through transmission reconstruction. MRSA colonization was identified in 9.1% (177/1940) of hospitalized infants and associated with low gestational age and birth weight. Among colonized infants, low gestational age was more common among those colonized with t008 strains. Our data suggest that approximately 70% of colonizations were the result of transmission events within the NICU, with the remainder likely to reflect importations of "outside" strains. While risk of transmission within the NICU was not affected by spa-type, patterns of acquisition and importation differed between t008 and t045 strains. Phylodynamic analysis showed the effective population size of spa-type t008 has been exponentially increasing in both community and hospital, with spa-type t008 strains possessed virulence genes not found among t045 strains; t045 strains, in contrast, appeared to be of more recent origin, with a possible hospital source. Our data highlight the importance of both intra-NICU transmission and recurrent introductions in maintenance of MRSA colonization within the NICU environment, as well as spa-type-specific differences in epidemiology.	[Azarian, Taj; Cook, Robert L.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Azarian, Taj; Cook, Robert L.] Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL 32611 USA; [Azarian, Taj; Cook, Robert L.; Johnson, Judith A.; Nolan, David; Morris, J. Glenn, Jr.; Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Maraqa, Nizar F.; Bailey, Christine; Wheeler, Sarah; Rathore, Mobeen H.] Wolfson Childrens Hosp, Infect Dis & Immunol, Jacksonville, FL USA; [Maraqa, Nizar F.; Rathore, Mobeen H.] Univ Florida, Coll Med, Ctr HIV AIDS Res Educ & Serv, Jacksonville, FL USA; [Johnson, Judith A.; Nolan, David; Salemi, Marco] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Div Infect Dis, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Azarian, T (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.; Azarian, T (corresponding author), Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL 32611 USA.; Azarian, T (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	taj.azaran@epi.ufl.edu	Azarian, Taj/H-5772-2019; Cook, Robert Lewis/ABI-4866-2020	Azarian, Taj/0000-0002-8611-5241; 	NIH/NCATS Clinical and Translational Science Award to the University of Florida [UL1 TR000064]; University of Florida Emerging Pathogens Institute and Wolfson Childrens Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427, UL1TR000064] Funding Source: NIH RePORTER	NIH/NCATS Clinical and Translational Science Award to the University of Florida; University of Florida Emerging Pathogens Institute and Wolfson Childrens Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded in part by the NIH/NCATS Clinical and Translational Science Award to the University of Florida UL1 TR000064 as well as seed funding from the University of Florida Emerging Pathogens Institute and Wolfson Childrens Hospital.	Alam MT, 2015, MBIO, V6, DOI 10.1128/mBio.00054-15; Azarian T, 2015, INFECT CONT HOSP EP, V36, P777, DOI 10.1017/ice.2015.73; Azarian T, 2014, MBIO, V5, DOI 10.1128/mBio.01824-14; Baele G, 2013, BIOINFORMATICS, V29, P1970, DOI 10.1093/bioinformatics/btt340; Baele G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-85; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Bush K, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0076-1; Carpaij N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016419; Choi SM, 2003, J KOREAN MED SCI, V18, P631, DOI 10.3346/jkms.2003.18.5.631; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; David MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092760; David MZ, 2013, J CLIN MICROBIOL, V51, P814, DOI 10.1128/JCM.02429-12; Deeny SR, 2013, J HOSP INFECT, V85, P33, DOI 10.1016/j.jhin.2013.03.011; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Geva A, 2011, PEDIATRICS, V128, pE1173, DOI 10.1542/peds.2010-2562; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Gray RR, 2011, MOL BIOL EVOL, V28, P1593, DOI 10.1093/molbev/msq319; Gregory ML, 2009, PEDIATRICS, V123, pE790, DOI 10.1542/peds.2008-1526; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Healy CM, 2004, CLIN INFECT DIS, V39, P1460, DOI 10.1086/425321; Hocevar SN, 2014, INFECT CONT HOSP EP, V35, P1126, DOI 10.1086/677636; Hsu LY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0643-z; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Lina G, 1999, ANTIMICROB AGENTS CH, V43, P1062, DOI 10.1128/AAC.43.5.1062; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Long SW, 2014, MBIO, V5, DOI 10.1128/mBio.01692-14; Maraqa NF, 2011, AM J INFECT CONTROL, V39, P35, DOI 10.1016/j.ajic.2010.07.013; MAYFORD M, 1989, EMBO J, V8, P4307, DOI 10.1002/j.1460-2075.1989.tb08617.x; Milstone AM, 2010, EMERG INFECT DIS, V16, P647, DOI 10.3201/eid1604.090107; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nubel U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054898; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Perovic O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145429; Popoola VO, 2014, INFECT CONT HOSP EP, V35, P412, DOI 10.1086/675594; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Prosperi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01902; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seybold U, 2008, PEDIATRICS, V122, P1039, DOI 10.1542/peds.2007-3161; Siegel JD, 2006, INFECT CONTROL; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uhlemann AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/pnas.1401006111; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Werner G, 2001, ANTIMICROB AGENTS CH, V45, P3267, DOI 10.1128/AAC.45.11.3267-3269.2001; Worby CJ, 2014, RECONSTRUCTING TRANS; Worby CJ, 2016, ANN APPL STAT, V10, P395, DOI 10.1214/15-AOAS898; Ypma RJF, 2012, P ROY SOC B-BIOL SCI, V279, P444, DOI 10.1098/rspb.2011.0913; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zervou FN, 2014, PEDIATRICS, V133, pE1015, DOI 10.1542/peds.2013-3413	62	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164397	10.1371/journal.pone.0164397	http://dx.doi.org/10.1371/journal.pone.0164397			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732618	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300051
J	Collins, K; Shiffman, D; Rock, J				Collins, Kimberley; Shiffman, David; Rock, Jenny			How Are Scientists Using Social Media in the Workplace?	PLOS ONE			English	Article							FACEBOOK; ONLINE	Social media has created networked communication channels that facilitate interactions and allow information to proliferate within professional academic communities as well as in informal social circumstances. A significant contemporary discussion in the field of science communication is how scientists are using (or might use) social media to communicate their research. This includes the role of social media in facilitating the exchange of knowledge internally within and among scientific communities, as well as externally for outreach to engage the public. This study investigates how a surveyed sample of 587 scientists from a variety of academic disciplines, but predominantly the academic life sciences, use social media to communicate internally and externally. Our results demonstrate that while social media usage has yet to be widely adopted, scientists in a variety of disciplines use these platforms to exchange scientific knowledge, generally via either Twitter, Facebook, Linkedln, or blogs. Despite the low frequency of use, our work evidences that scientists perceive numerous potential advantages to using social media in the workplace. Our data provides a baseline from which to assess future trends in social media use within the science academy.	[Collins, Kimberley; Rock, Jenny] Univ Otago, Ctr Sci Commun, Dunedin, New Zealand; [Shiffman, David] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Miami, FL USA	University of Otago; University of Miami	Rock, J (corresponding author), Univ Otago, Ctr Sci Commun, Dunedin, New Zealand.	Jennifer.rock@otago.ac.nz		Rock, Jenny/0000-0001-7250-6463				Ahlqvist T., 2008, SOCIAL MEDIA ROADMAP; Allgaier J, 2013, BIOSCIENCE, V63, P284, DOI 10.1525/bio.2013.63.4.8; Andrews E., 2005, J GEOSCIENCE ED, V53, P281, DOI [DOI 10.5408/1089-9995-53.3.281, 10.5408/1089-9995-53.3.281]; Barteau M, 2014, ACAD ENGAGEMENT PUBL; Bik HM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001535; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Costello K. L., 2010, PROC AM SOC INFORM S, V47, P1, DOI DOI 10.1002/MEET.14504701201; Darling ES, 2013, IDEAS ECOL EVOL, V6, DOI 10.4033/iee.2013.6.6.f; Duggan M, 2013, DEMOGRAPHICS SOCIAL; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Fauville G, 2015, COMPUT EDUC, V82, P60, DOI 10.1016/j.compedu.2014.11.003; Haythornthwaite C., 2005, Information Communication & Society, V8, P125, DOI 10.1080/13691180500146185; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Lampe C., 2006, P 2006 20 ANN C COMP, P167, DOI [DOI 10.1145/1180875.1180901, 10.1145/1180875.1180901]; Parsons ECM, 2014, CONSERV BIOL, V28, P299, DOI 10.1111/cobi.12226; Priem J., 2012, PREVALENCE USE TWITT; Rowlands I, 2011, SOCIAL MEDIA USE RES, DOI [10.3233/ISU-2011-0623, DOI 10.3233/ISU-2011-0623]; Shiffman D. S., 2012, J ENVIRON STUD SCI, V2, P257, DOI DOI 10.1007/S13412-012-0080-1; Subrahmanyam K, 2008, J APPL DEV PSYCHOL, V29, P420, DOI 10.1016/j.appdev.2008.07.003; Thaler A.D., 2012, ENV LEADERSHIP REFER, VVol. 39, P364, DOI DOI 10.4135/9781452218601.N39; Vie S., 2015, J FACULTY DEV, V29, P33; Vorhaus M, 2013, SLIDESHARE; Weller K., 2011, CEUR WORKSHOP P, P1; Wilkinson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084339	24	113	116	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0162680	10.1371/journal.pone.0162680	http://dx.doi.org/10.1371/journal.pone.0162680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732598	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505300002
J	Luna, MG; Desneux, N; Schneider, MI				Luna, Maria G.; Desneux, Nicolas; Schneider, Marcela I.			Encapsulation and Self-Superparasitism of Pseudapanteles dignus (Muesebeck) (Hymenoptera: Braconidae), a Parasitoid of Tuta absoluta (Meyrick) (Lepidoptera: Gelechiidae)	PLOS ONE			English	Article							HOSTS	Endoparasitoids can be killed by host encapsulation, a cellular-mediated host immunological response against parasitism that involves hemocytes aggregation. As a counteracting strategy, many parasitoids can evade this host response through self-superparasitism. The objectives of this study were: 1) to describe the parasitoid Pseudapanteles dignus (Hymenoptera: Braconidae) early immature stages (egg and larva) encapsulation by the host Tuta absoluta (Lepidoptera: Gelechiidae), and 2) to determine the occurrence of self-superparasitism and the rate of escaping to encapsulation of this parasitoid. Knowledge of host-parasitoid immunological interaction is crucial when evaluating the potential of an endoparasitoid as a biological control candidate. Parasitoid-exposed T. absoluta larvae were dissected in vivo under light stereoscope microscope at 24-h intervals, for five days after exposition to detect encapsulation. The preimaginal stages of P. dignus and numbers of healthy and encapsulated immature parasitoids per host were recorded. Samples of parasitoid eggs and larvae were processed for SEM visualization of encapsulation. Necropsies evidenced that only the early first larval instar of P. dignus (up to 96 h-old) was partially or completely encapsulated. A non-melanized capsule, formed by layers of granulocyte-type hemocytes enveloping around the parasitoid body, was recorded. Approximately 50% of the parasitized T. absoluta larvae had significantly only one P. dignus egg, meanwhile supernumerary parasitization yielded up to seven immature parasitoids per host. The proportion of single-early first larval instar of P. dignus reached approximate to 0.5 and decreased significantly as the number of parasitoid individuals per host increased. P. dignus encapsulation and its ability to overcome with the host immune defense through self-superparasitism indicate that T. absoluta is a semi-permissive host for this parasitoid.	[Luna, Maria G.; Schneider, Marcela I.] CEPAVE CONICET UNLP, La Plata, Buenos Aires, Argentina; [Desneux, Nicolas] Univ Nice Sophia Antipolis, INRA, French Natl Inst Agr Res, CNRS,UMR 1355 7254,Inst Sophia Agrobiotech, F-06903 Sophia Antipolis, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Luna, MG (corresponding author), CEPAVE CONICET UNLP, La Plata, Buenos Aires, Argentina.	lunam@cepave.edu.ar	Desneux, Nicolas/J-6262-2013; Schneider, Marcela Inés/ABE-8086-2021	Schneider, Marcela Inés/0000-0001-5666-7742	ANPCYT (AR) [IM-40-2000, PICT 2012-1624]; CONICET [PIP 0112, PIP 0205]; Universidad Nacional de La Plata [SA N 706]; Marie Curie Actions-International Research Staff Exchange Scheme, IRSES (IPRABIO)	ANPCYT (AR); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de La Plata(National University of La Plata); Marie Curie Actions-International Research Staff Exchange Scheme, IRSES (IPRABIO)	Funded by ANPCYT (AR) (IM-40-2000)-Dra. Maria G. Luna; CONICET (PIP 0112)-2012-2015; Universidad Nacional de La Plata (http://dx.doi.org/10.13039/501100003947 SA N 706 2013-2016) - Dra. Maria G. Luna; Marie Curie Actions-International Research Staff Exchange Scheme, IRSES (IPRABIO, 2011-2014); ANPCYT (AR) (PICT 2012-1624), CONICET (PIP 0205) 2015-2018 - Dra. Marcela I. Schneider.	Alleyne M, 2001, ENTOMOL EXP APPL, V100, P279, DOI 10.1023/A:1019216825648; [Anonymous], 2007, STAT 8 0 US GUID; BENNETT FD, 1995, FLA ENTOMOL, V78, P546, DOI 10.2307/3495543; CARDONA C, 1971, ANN ENTOMOL SOC AM, V64, P996, DOI 10.1093/aesa/64.5.996; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Chau NNB, 2009, ENTOMOL EXP APPL, V132, P250, DOI 10.1111/j.1570-7458.2009.00894.x; Cui LW, 2000, J INSECT PHYSIOL, V46, P1397, DOI 10.1016/S0022-1910(00)00059-7; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Eslin P, 2000, J INSECT PHYSIOL, V46, P1161, DOI 10.1016/S0022-1910(99)00227-9; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gotelli NJ, 2013, ECOSIMR 1 00; Havard S, 2014, INSECT SCI, V21, P93, DOI 10.1111/1744-7917.12009; Hayat MA, 1978, PRINCIPLES TECHNIQUE; Kadash K, 2003, J INSECT PHYSIOL, V49, P473, DOI 10.1016/S0022-1910(03)00064-7; Luna MG, 2007, ENVIRON ENTOMOL, V36, P887, DOI 10.1603/0046-225X(2007)36[887:POTALG]2.0.CO;2; Mochiah MB, 2002, ENTOMOL EXP APPL, V105, P111, DOI 10.1023/A:1022146029214; Nieves EL, 2015, J ECON ENTOMOL, V108, P1553, DOI 10.1093/jee/tov115; OATMAN E R, 1989, Proceedings of the Hawaiian Entomological Society, V29, P23; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Plantegenest M, 2004, J ANIM ECOL, V73, P802, DOI 10.1111/j.0021-8790.2004.00844.x; Quicke D. L. J., 1997, PARASITIC WASPS; Sanchez NE, 2009, ENVIRON ENTOMOL, V38, P365, DOI 10.1603/022.038.0208; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Zhang JH, 2010, ENVIRON ENTOMOL, V39, P1249, DOI 10.1603/EN09174; Zhang QQ, 2012, INSECT SCI, V19, P485, DOI 10.1111/j.1744-7917.2011.01454.x; [No title captured]	29	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163196	10.1371/journal.pone.0163196	http://dx.doi.org/10.1371/journal.pone.0163196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732609	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300011
J	Olivera, R; Moro, LN; Jordan, R; Luzzani, C; Miriuka, S; Radrizzani, M; Donadeu, FX; Vichera, G				Olivera, Ramiro; Natalia Moro, Lucia; Jordan, Roberto; Luzzani, Carlos; Miriuka, Santiago; Radrizzani, Martin; Donadeu, F. Xavier; Vichera, Gabriel			In Vitro and In Vivo Development of Horse Cloned Embryos Generated with iPSCs, Mesenchymal Stromal Cells and Fetal or Adult Fibroblasts as Nuclear Donors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; UMBILICAL-CORD BLOOD; OSTEOGENIC CAPACITY; IMMATURE FOLLICLES; TIME-INTERVAL; SPERM EXTRACT; ACTIVATION; BOVINE; DIFFERENTIATION; OOCYTES	The demand for equine cloning as a tool to preserve high genetic value is growing worldwide; however, nuclear transfer efficiency is still very low. To address this issue, we first evaluated the effects of time from cell fusion to activation (<1h, n = 1261; 1-2h, n = 1773; 2-3h, n = 1647) on in vitro and in vivo development of equine embryos generated by cloning. Then, we evaluated the effects of using different nuclear donor cell types in two successive experiments: I) induced pluripotent stem cells (iPSCs) vs. adult fibroblasts (AF) fused to ooplasts injected with the pluripotency-inducing genes OCT4, SOX2, MYC and KLF4, vs. AF alone as controls; II) umbilical cord-derived mesenchymal stromal cells (UC-MSCs) vs. fetal fibroblasts derived from an unborn cloned foetus (FF) vs. AF from the original individual. In the first experiment, both blastocyst production and pregnancy rates were higher in the 2-3h group (11.5% and 9.5%, respectively), respect to <1h (5.2% and 2%, respectively) and 1-2h (5.6% and 4.7%, respectively) groups (P<0.05). However, percentages of born foals/pregnancies were similar when intervals of 2-3h (35.2%) or 1-2h (35.7%) were used. In contrast to AF, the iPSCs did not generate any blastocyst-stage embryos. Moreover, injection of oocytes with the pluripotency-inducing genes did not improve blastocyst production nor pregnancy rates respect to AF controls. Finally, higher blastocyst production was obtained using UC-MSC (15.6%) than using FF (8.9%) or AF (9.3%), (P<0.05). Despite pregnancy rates were similar for these 3 groups (17.6%, 18.2% and 22%, respectively), viable foals (two) were obtained only by using FF. In summary, optimum blastocyst production rates can be obtained using a 2-3h interval between cell fusion and activation as well as using UC-MSCs as nuclear donors. Moreover, FF line can improve the efficiency of an inefficient AF line. Overall, 24 healthy foals were obtained from a total of 29 born foals.	[Olivera, Ramiro; Jordan, Roberto; Vichera, Gabriel] KHEIRON SA Lab, Buenos Aires, DF, Argentina; [Natalia Moro, Lucia; Luzzani, Carlos; Miriuka, Santiago] FLENI, Lab Biol Cell Dev, LIAN Unit, CONICET, Buenos Aires, DF, Argentina; [Radrizzani, Martin] Natl Univ San Martin, CONICET, Lab Neruogenet & Mol Cytogent, Sch Sci, Buenos Aires, DF, Argentina; [Donadeu, F. Xavier] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Donadeu, F. Xavier] Univ Edinburgh, Royal Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Donadeu, F. Xavier] Univ Edinburgh, Euan MacDonald Ctr MND Res, Edinburgh, Midlothian, Scotland	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Olivera, R; Vichera, G (corresponding author), KHEIRON SA Lab, Buenos Aires, DF, Argentina.	olivera@kheiron-biotech.com; vichera@kheiron-biotech.com	Miriuka, Santiago/AAM-4051-2020; Miriuka, Santiago/ABE-9614-2020	Miriuka, Santiago/0000-0003-2402-3920; 	Kheiron Company funds; PIP CONICET [2013-0161]; BBSRC [BBS/E/D/20221658] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20221658] Funding Source: researchfish	Kheiron Company funds; PIP CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Kheiron Company funds and PIP 2013-0161 CONICET.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Arnhold SJ, 2007, AM J VET RES, V68, P1095, DOI 10.2460/ajvr.68.10.1095; Aston KI, 2006, REPRODUCTION, V131, P45, DOI 10.1530/rep.1.00714; BAVISTER BD, 1977, BIOL REPROD, V16, P228, DOI 10.1095/biolreprod16.2.228; Breton A, 2013, STEM CELLS DEV, V22, P611, DOI 10.1089/scd.2012.0052; Choi JY, 2004, MOL REPROD DEV, V69, P289, DOI 10.1002/mrd.20131; Choi YH, 2004, BIOL REPROD, V70, P46, DOI 10.1095/biolreprod.103.018200; Choi YH, 2015, CELL REPROGRAM, V17, P124, DOI 10.1089/cell.2014.0093; Choi YH, 2014, THERIOGENOLOGY, V82, P411, DOI 10.1016/j.theriogenology.2014.04.021; Choi YH, 2013, THERIOGENOLOGY, V79, P791, DOI 10.1016/j.theriogenology.2012.12.005; Choi YH, 2009, CLONING STEM CELLS, V11, P301, DOI 10.1089/clo.2008.0077; Colleoni S, 2005, CLONING STEM CELLS, V7, P154, DOI 10.1089/clo.2005.7.154; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Galli C, 2007, ANIM REPROD SCI, V98, P39, DOI 10.1016/j.anireprosci.2006.10.011; Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Gambini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110998; Gambini A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.098855; German SD, 2015, CELL REPROGRAM, V17, P19, DOI 10.1089/cell.2014.0071; Hall V, 2013, VET J, V197, P128, DOI 10.1016/j.tvjl.2013.05.026; Hanna J, 2008, COLD SH Q B, V73, P147, DOI 10.1101/sqb.2008.73.025; Hinrichs K, 2007, REPRODUCTION, V134, P319, DOI 10.1530/REP-07-0069; Hinrichs K, 2006, REPRODUCTION, V131, P1063, DOI 10.1530/rep.1.01095; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; Johnson AK, 2010, JAVMA-J AM VET MED A, V236, P983, DOI 10.2460/javma.236.9.983; Kato Y, 2004, BIOL REPROD, V70, P415, DOI 10.1095/biolreprod.103.020271; Khodadadi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/429160; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Koerner J, 2006, STEM CELLS, V24, P1613, DOI 10.1634/stemcells.2005-0264; Koh S, 2014, THERIOGENOLOGY, V81, P103, DOI 10.1016/j.theriogenology.2013.09.009; Kwong PJ, 2014, REPROD DOMEST ANIM, V49, P249, DOI 10.1111/rda.12262; Lagutina I, 2005, REPRODUCTION, V130, P559, DOI 10.1530/rep.1.00772; Lee JH, 2014, CELL REPROGRAM, V16, P428, DOI 10.1089/cell.2014.0036; Lee W, 2015, J VET SCI, V16, P509, DOI 10.4142/jvs.2015.16.4.509; Li ZC, 2013, CELL REPROGRAM, V15, P459, DOI 10.1089/cell.2013.0010; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu J, 2013, CELL REPROGRAM, V15, P134, DOI 10.1089/cell.2012.0052; Liu L, 2001, Cloning, V3, P51, DOI 10.1089/15204550152475554; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ma LB, 2011, IN VITRO CELL DEV-AN, V47, P95, DOI 10.1007/s11626-010-9363-6; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; Reed SA, 2008, J CELL PHYSIOL, V215, P329, DOI 10.1002/jcp.21312; Ren Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093583; Samiec M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/814686; Sartori C, 2012, CELL REPROGRAM, V14, P8, DOI 10.1089/cell.2011.0050; Sharma R, 2014, STEM CELLS DEV, V23, P1524, DOI 10.1089/scd.2013.0565; Song Z, 2015, REPROD DOMEST ANIM, V50, P840, DOI 10.1111/rda.12577; Su XH, 2015, CELL REPROGRAM, V17, P288, DOI 10.1089/cell.2014.0109; Sumer H, 2011, J ANIM SCI, V89, P2708, DOI 10.2527/jas.2010-3666; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vanderwall DK, 2004, REPROD FERT DEVELOP, V16, P675, DOI 10.1071/RD04025; Vichera G, 2011, REPROD DOMEST ANIM, V46, P214, DOI 10.1111/j.1439-0531.2010.01642.x; Vidal MA, 2007, VET SURG, V36, P613, DOI 10.1111/j.1532-950X.2007.00313.x; Vidal MA, 2006, VET SURG, V35, P601, DOI 10.1111/j.1532-950X.2006.00197.x; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wells DN, 1999, THERIOGENOLOGY, V51, P217, DOI 10.1016/S0093-691X(99)91776-4; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Woods GL, 2003, SCIENCE, V301, P1063, DOI 10.1126/science.1086743; You J, 2010, REPROD FERT DEVELOP, V22, P977, DOI 10.1071/RD09309; Zhou SY, 2010, CELL RES, V20, P850, DOI 10.1038/cr.2010.78	61	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164049	10.1371/journal.pone.0164049	http://dx.doi.org/10.1371/journal.pone.0164049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732616	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300037
J	Servetto, N; Sahade, R				Servetto, Natalia; Sahade, Ricardo			Reproductive Seasonality of the Antarctic Sea Pen Malacobelemnon daytoni (Octocorallia, Pennatulacea, Kophobelemnidae)	PLOS ONE			English	Article							ECHINOID STERECHINUS-NEUMAYERI; STAR ODONTASTER-VALIDUS; SEXUAL REPRODUCTION; GAMETOGENIC ECOLOGY; LARVAL DEVELOPMENT; ATLANTIC-OCEAN; WEDDELL SEA; POTTER COVE; WEST-COAST; ANTHOZOA	The pennatulid Malacobelemnon daytoni is one of the dominant species in Potter Cove, Antarctica. Its abundance and range of distribution have increased in recent years probably related to climate change mediated alterations of environmental factors. This work is the second part of a study dealing on the reproductive ecology of Malacobelemnon daytoni, and aims to assess its reproductive seasonality over a two-year period. Sampling was carried out every month during 2009-2010 and samples were examined by histological analysis. Gametogenesis exhibited a seasonal pattern evidenced by the maturity stage index (MSI) and the number of mature oocytes and cysts throughout the year. Immature oocytes and spermatocytes were present year-round, but maturation was seasonal and it seems that more than one spawning per year was possible. These spawnings could be more linked with suspended particulate matter (SPM) (probably available via resuspension events) than with primary production pulses. This idea reinforces the hypothesis that winter time is not so stressful, in energy terms, in Potter Cove, which seems to depend on energy sources other than local phytoplankton production. There was not a strong inter-annual variability between the reproductive characteristics analyzed in 2009 and 2010; the only variable different was the size of oocytes (higher in 2009), suggesting different energy availability in each year, related with a higher concentration of SPM in 2009 (although it was not significant). Malacobelemnon daytoni could be the first reported Antarctic suspension feeder species that presents a reproductive cycle with more than a spawning event per year. This strategy would help to explain the success of this species in the Potter Cove ecosystem and in high ice-impacted areas.	[Servetto, Natalia; Sahade, Ricardo] Univ Nacl Cordoba, CONICET, Fac Ciencias Exactas Fis & Nat, Inst Diversidad & Ecol Anim,Marine Ecol Lab, Ave Velez Sarsfield 299, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Servetto, N (corresponding author), Univ Nacl Cordoba, CONICET, Fac Ciencias Exactas Fis & Nat, Inst Diversidad & Ecol Anim,Marine Ecol Lab, Ave Velez Sarsfield 299, RA-5000 Cordoba, Argentina.	biol.nataliaservetto@gmail.com		Sahade, Ricardo/0000-0001-5650-8135	Marie Curie Actions - IMCONet IRSES; ANPCyT-DNA [PICTO 2010-00119]; PICTO Antartida (ANPCyT-DNA) [36326]	Marie Curie Actions - IMCONet IRSES; ANPCyT-DNA; PICTO Antartida (ANPCyT-DNA)	This work was funded by Marie Curie Actions - IMCONet IRSES (2013-2016), for finances exchange of European and Latin American scientists in I & D centers (RS) (http://www.imconet.eu/); PICTO 2010-00119 (ANPCyT-DNA) (2012-2015) (The process of climate change in Antarctica: its impact on a coastal ecosystem) (RS) (http://www.agencia.mincyt.gob.ar); and PICTO Antartida Ref 36326 (ANPCyT-DNA) (2008-2010) (Antarctic benthic communities: an interdisciplinary approach to analyze the possible impact of global warming) (RS) (http://www.agencia.mincyt.gob.ar/).	Baillon S, 2015, MAR ECOL-EVOL PERSP, V36, P1364, DOI 10.1111/maec.12236; Baillon S, 2014, MAR BIOL, V161, P29, DOI 10.1007/s00227-013-2311-8; BIRKELAND C, 1974, ECOL MONOGR, V44, P211, DOI 10.2307/1942312; Brockington S, 2007, MAR ECOL PROG SER, V330, P139, DOI 10.3354/meps330139; CHIA FS, 1973, MAR BIOL, V23, P73, DOI 10.1007/BF00394113; Chiantore M, 2002, POLAR BIOL, V25, P251, DOI 10.1007/s00300-001-0331-1; CLARKE A, 1988, COMP BIOCHEM PHYS B, V90, P461, DOI 10.1016/0305-0491(88)90285-4; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Doyle GM, 2012, MAR BIOL, V159, P455, DOI 10.1007/s00227-011-1823-3; Eckelbarger KJ, 1998, GONADAL MORPHOLOGY, P677; Edwards DCB, 2008, MAR BIOL, V155, P303, DOI 10.1007/s00227-008-1028-6; Edwards DCB, 2009, ESTUAR COAST SHELF S, V82, P161, DOI 10.1016/j.ecss.2009.01.006; Elias-Piera F, 2013, MAR ECOL PROG SER, V477, P93, DOI 10.3354/meps10152; Gili JM, 2001, POLAR BIOL, V24, P473, DOI 10.1007/s003000100257; Goffredo S, 2002, MAR ECOL PROG SER, V229, P83, DOI 10.3354/meps229083; Gori A, 2007, MAR BIOL, V151, P1571, DOI 10.1007/s00227-006-0595-7; Grange LJ, 2007, MAR BIOL, V153, P15, DOI 10.1007/s00227-007-0776-z; Grange LJ, 2011, J EXP MAR BIOL ECOL, V404, P98, DOI 10.1016/j.jembe.2011.04.011; Grange LJ, 2004, MAR ECOL PROG SER, V278, P141, DOI 10.3354/meps278141; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Kahng SE, 2011, MAR ECOL PROG SER, V443, P265, DOI 10.3354/meps09414; Kruger A, 1998, I GAMETOGENESIS AND, P423; Lopes VM, 2012, MAR BIOL RES, V8, P893, DOI 10.1080/17451000.2012.693616; Lopez-Gonzalez PJ, 2009, POLAR BIOL, V32, P907, DOI 10.1007/s00300-009-0591-8; Mercier A, 2011, CORAL REEFS, V30, P337, DOI 10.1007/s00338-011-0724-8; MILEIKOVSKY SA, 1971, MAR BIOL, V10, P193, DOI 10.1007/BF00352809; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; Orejas C, 2002, MAR ECOL PROG SER, V231, P101, DOI 10.3354/meps231101; Orejas C, 2007, MAR BIOL, V150, P551, DOI 10.1007/s00227-006-0370-9; OREJAS C, 2000, CONTRIB SCI, V1, P299; Pearse J. S., 1965, Antarctic Research Series, V5, P39; Pearse J.S., 1994, REPROD LARVAL BIOL R, P26; PEARSE JS, 1966, BIOL BULL, V130, P387, DOI 10.2307/1539745; PEARSE JS, 1991, AM ZOOL, V31, P65; Peck LS, 2006, ENVIRONMENTAL CONSTR, P75, DOI [10.1017/, DOI 10.1017/S1464793105006871]; Pires DO, 2009, MAR ECOL PROG SER, V397, P103, DOI 10.3354/meps08322; Ribes M, 2007, INVERTEBR BIOL, V126, P307, DOI 10.1111/j.1744-7410.2007.00101.x; Rice AL, 1992, PENNATULID KOPHOBELE, P417; Sahade R, 2004, MAR ECOL PROG SER, V272, P131, DOI 10.3354/meps272131; Sahade R, 1998, POLAR BIOL, V19, P85, DOI 10.1007/s003000050218; Sahade R, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500050; Schloss IR, 2012, J MARINE SYST, V92, P53, DOI 10.1016/j.jmarsys.2011.10.006; Servetto N, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.20040; Slattery M, 1997, MAR ECOL PROG SER, V149, P299, DOI 10.3354/meps149299; Soong K, 2005, MAR BIOL, V146, P1103, DOI 10.1007/s00227-004-1509-1; Stanwell-Smith D, 1998, MAR BIOL, V131, P479, DOI 10.1007/s002270050339; Starmans A, 1999, MAR BIOL, V135, P269, DOI 10.1007/s002270050624; Tremblay MT, 2004, GEN COMP ENDOCR, V137, P9, DOI 10.1016/j.ygcen.2004.02.009; TYLER PA, 1995, INT REV GES HYDROBIO, V80, P187, DOI 10.1002/iroh.19950800207; Waller RG, 2005, CORAL REEFS, V24, P594, DOI 10.1007/s00338-005-0031-3; Waller RG, 2008, DEEP-SEA RES PT II, V55, P2527, DOI 10.1016/j.dsr2.2008.07.001; WALTON WH, 1948, NATURE, V162, P329, DOI 10.1038/162329b0; Williams GC, 2011, GLOBAL DIVERSITY SEA, P6, DOI [10.1371/journal.pone.0022747, DOI 10.1371/JOURNAL.PONE.0022747]	54	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163152	10.1371/journal.pone.0163152	http://dx.doi.org/10.1371/journal.pone.0163152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732608	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505300010
J	Valeri, L; Patterson-Lomba, O; Gurmu, Y; Ablorh, A; Bobb, J; Townes, FW; Harling, G				Valeri, Linda; Patterson-Lomba, Oscar; Gurmu, Yared; Ablorh, Akweley; Bobb, Jennifer; Townes, F. William; Harling, Guy			Predicting Subnational Ebola Virus Disease Epidemic Dynamics from Sociodemographic Indicators	PLOS ONE			English	Article							OUTBREAK; TRANSMISSION	Background The recent Ebola virus disease (EVD) outbreak in West Africa has spread wider than any previous human EVD epidemic. While individual-level risk factors that contribute to the spread of EVD have been studied, the population-level attributes of subnational regions associated with outbreak severity have not yet been considered. Methods To investigate the area-level predictors of EVD dynamics, we integrated time series data on cumulative reported cases of EVD from the World Health Organization and covariate data from the Demographic and Health Surveys. We first estimated the early growth rates of epidemics in each second-level administrative district (ADM2) in Guinea, Sierra Leone and Liberia using exponential, logistic and polynomial growth models. We then evaluated how these growth rates, as well as epidemic size within ADM2s, were ecologically associated with several demographic and socio-economic characteristics of the ADM2, using bivariate correlations and multivariable regression models. Results The polynomial growth model appeared to best fit the ADM2 epidemic curves, displaying the lowest residual standard error. Each outcome was associated with various regional characteristics in bivariate models, however in stepwise multivariable models only mean education levels were consistently associated with a worse local epidemic. Discussion By combining two common methods-estimation of epidemic parameters using mathematical models, and estimation of associations using ecological regression models-we identified some factors predicting rapid and severe EVD epidemics in West African subnational regions. While care should be taken interpreting such results as anything more than correlational, we suggest that our approach of using data sources that were publicly available in advance of the epidemic or in real-time provides an analytic framework that may assist countries in understanding the dynamics of future outbreaks as they occur.	[Valeri, Linda] McLean Hosp, Psychiat Biostat Lab, 115 Mill St, Belmont, MA 02178 USA; [Valeri, Linda] Harvard Med Sch, Boston, MA USA; [Patterson-Lomba, Oscar; Gurmu, Yared; Ablorh, Akweley; Bobb, Jennifer; Townes, F. William] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Ablorh, Akweley] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Bobb, Jennifer] Grp Hlth Res Inst, Seattle, WA USA; [Harling, Guy] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Harling, G (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	gharling@hsph.harvard.edu		Harling, Guy/0000-0001-6604-491X	Harvard Open-Access Publishing Equity (HOPE) fund; NATIONAL CANCER INSTITUTE [T32CA009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007142] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T32LM012411] Funding Source: NIH RePORTER	Harvard Open-Access Publishing Equity (HOPE) fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Publication of this manuscript was supported by the Harvard Open-Access Publishing Equity (HOPE) fund.	Agua-Agum J, 2015, NEW ENGL J MED, V372, P1274, DOI 10.1056/NEJMc1415318; Althaus CL, 2014, ARXIV14083505; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Castillo-Chavez C., 2011, MATH MODELS POPULATI; CDC, 2014, MMWR-MORBID MORTAL W, V63, P1199; Cenciarelli Orlando, 2015, Int J Microbiol, V2015, P769121, DOI 10.1155/2015/769121; Chowell G, 2015, PLOS CURRENTS OUTBRE; Chowell G, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002057, 10.1371/currents.outbreaks.8b55f4bad99ac5c5db3663e916803261]; Dixon MG, 2014, MMWR-MORBID MORTAL W, V63, P548; Elliot P, 2000, SPATIAL EPIDEMIOLOGY; Fairhead J., 2014, SIGNIFICANCE DEATH F; Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920; Fast SM, 2014, PLOS CURRENTS, V7; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Fisman D., 2014, PLOS CURR-TREE LIFE, P6, DOI DOI 10.1371/CURRENTS.OUTBREAKS.06-00D0546AD426FED83FF24A1D4C4CC; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Global Data Lab, INT WEALTH IND; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Institut National de la Statistique, TROIS REC POP HAB; James G., 2014, INTRO STAT LEARNING; Kentikelenis A, 2015, LANCET GLOB HEALTH, V3, pE69, DOI 10.1016/S2214-109X(14)70377-8; Liddell AM, 2015, ANN INTERN MED, V163, P81, DOI 10.7326/M15-0530; LISGIS, 2009, 2008 POP HOUS CENS F; Lisgis, 2013, LIB DEM HLTH SURV 20; Liu HN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106839, 10.1371/currents.outbreaks.b4690859d91684da963dc40e00f3da81]; Menendez C, 2014, NEW ENGL J MED, V371, P1481; Mirkovic K, 2014, MMWR-MORBID MORTAL W, V63, P873; Nielsen CF, 2015, MMWR-MORBID MORTAL W, V64, P20; O'Hare B, 2015, LANCET GLOB HEALTH, V3, pE71, DOI 10.1016/S2214-109X(14)70369-9; Olson SH, 2015, EMERG INFECT DIS, V21, P1285, DOI 10.3201/eid2108.141156; Organization WH, 2015, GLOB HLTH OBS; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Plaat A., 2015, ABS150402878 CORR; R Core Team, 2013, R LANG ENV STAT COMP; R Core Team, 2012, R LANG ENV STAT COMP; Richards P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003567; Smits J, 2015, SOC INDIC RES, V122, P65, DOI 10.1007/s11205-014-0683-x; Stadler T, 2014, PLOS CURR, P6, DOI DOI 10.1371/CURRENTS.OUTBREAKS; Stanturf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137208; Statistics Sierra Leone - SSL ICF International., 2014, SIERR LEON DEM HLTH; Towers Sherry, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.9e4c4294ec8ce1adad283172b16bc908; United Nations Department of Economic and Social Affairs, 2015, WORLD POPULATION PRO; Viboud C, 2016, EPIDEMICS-NETH, V15, P27, DOI 10.1016/j.epidem.2016.01.002; Wesolowski Amy, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e; WHO, 2015, EB DAT STAT SIT SUMM; Wong JY, 2016, EPIDEMIOL INFECT, V144, P1473, DOI 10.1017/S0950268815003003; Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a	51	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163544	10.1371/journal.pone.0163544	http://dx.doi.org/10.1371/journal.pone.0163544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732614	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000385505300019
J	Yuan, XY; Wang, RH; Zhao, XD; Luo, YB; Fu, DQ				Yuan, Xin-Yu; Wang, Rui-Heng; Zhao, Xiao-Dan; Luo, Yun-Bo; Fu, Da-Qi			Role of the Tomato Non-Ripening Mutation in Regulating Fruit Quality Elucidated Using iTRAQ Protein Profile Analysis	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASES; HEAT-SHOCK-PROTEIN; SIGNAL-TRANSDUCTION; PECTIN DEPOLYMERIZATION; LYCOPERSICON-ESCULENTUM; CAROTENOID ACCUMULATION; ETHYLENE BIOSYNTHESIS; ANTIMICROBIAL PEPTIDE; SOLANUM-LYCOPERSICON; GENE	Natural mutants of the Non-ripening (Nor) gene repress the normal ripening of tomato fruit. The molecular mechanism of fruit ripening regulation by the Nor gene is unclear. To elucidate how the Nor gene can affect ripening and fruit quality at the protein level, we used the fruits of Nor mutants and wild-type Ailsa Craig (AC) to perform iTRAQ (isobaric tags for relative and absolute quantitation) analysis. The Nor mutation altered tomato fruit ripening and affected quality in various respects, including ethylene biosynthesis by down-regulating the abundance of 1-aminocyclopropane-1-carboxylic acid oxidase (ACO), pigment biosynthesis by repressing phytoene synthase 1 (PSY1),zeta-carotene isomerase (Z-ISO), chalcone synthase 1 (CHS1) and other proteins, enhancing fruit firmness by increasing the abundance of cellulose synthase protein, while reducing those of polygalacturonase 2 (PG2) and pectate lyase (PL), altering biosynthesis of nutrients such as carbohydrates, amino acids, and anthocyanins. Conversely, Nor mutation also enhanced the fruit's resistance to some pathogens by up-regulating the expression of several genes associated with stress and defense. Therefore, the Nor gene is involved in the regulation of fruit ripening and quality. It is useful in the future as a means to improve fruit quality in tomato.	[Yuan, Xin-Yu; Wang, Rui-Heng; Luo, Yun-Bo; Fu, Da-Qi] China Agr Univ, Coll Food Sci & Nutr Engn, 17 Tsinghua East Rd, Beijing 100083, Peoples R China; [Zhao, Xiao-Dan] Beijing Technol & Business Univ, Beijing Engn & Technol Res Ctr Food Addit, 11 Fucheng Rd, Beijing 100048, Peoples R China	China Agricultural University; Beijing Technology & Business University	Fu, DQ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, 17 Tsinghua East Rd, Beijing 100083, Peoples R China.	daqifu@126.com			National Nature Science Foundation of China [31571898, 31601518]; Education Foundation of Da Bei Nong Group [1061-2413001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Foundation of Da Bei Nong Group	This work was supported by grants (No. 31571898 and No. 31601518) from the National Nature Science Foundation of China (http://www.nsfc.gov.cn) and the Education Foundation of Da Bei Nong Group (No. 1061-2413001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Balaji V, 2012, TRANSGENIC RES, V21, P23, DOI 10.1007/s11248-011-9506-x; Bargel H, 2004, J PLANT GROWTH REGUL, V23, P61, DOI 10.1007/s00344-004-0036-0; Barry CS, 2006, P NATL ACAD SCI USA, V103, P7923, DOI 10.1073/pnas.0602319103; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Berrocal-Lobo M, 2002, PLANT PHYSIOL, V128, P951, DOI 10.1104/pp.010685; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Buyuk I, 2016, PLANT PROTECT SCI, V52, P99, DOI 10.17221/125/2015-PPS; Cantu D, 2009, PLANT PHYSIOL, V150, P1434, DOI 10.1104/pp.109.138701; Cudic P, 2016, BIOCHEM BIOPH RES CO, V469, P863, DOI 10.1016/j.bbrc.2015.12.077; Dai C, 2012, PROTEIN J, V31, P285, DOI 10.1007/s10930-012-9403-z; Fantini E, 2013, PLANT PHYSIOL, V163, P986, DOI 10.1104/pp.113.224733; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Fujisawa M, 2014, PLANT CELL, V26, P89, DOI 10.1105/tpc.113.119453; Gao L, 2016, THEOR APPL GENET, V129, P717, DOI 10.1007/s00122-015-2660-4; Gimenez E, 2015, PLANT PHYSIOL, V168, P1036, DOI 10.1104/pp.15.00469; Herbel V, 2016, PEERJ, V4, DOI 10.7717/peerj.1987; Herbel V, 2015, MOLECULES, V20, P14889, DOI 10.3390/molecules200814889; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Karlova R, 2014, J EXP BOT, V65, P4527, DOI 10.1093/jxb/eru316; Khatoon A, 2012, AMINO ACIDS, V43, P2513, DOI 10.1007/s00726-012-1333-8; KING GJ, 1988, PLANT MOL BIOL, V10, P401, DOI 10.1007/BF00014946; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Klee HJ, 2004, PLANT PHYSIOL, V135, P660, DOI 10.1104/pp.104.040998; Lee JM, 2012, PLANT J, V70, P191, DOI 10.1111/j.1365-313X.2011.04863.x; Liu JA, 1999, PLANT CELL PHYSIOL, V40, P1297, DOI 10.1093/oxfordjournals.pcp.a029518; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Nguyen CV, 2014, PLANT CELL, V26, P585, DOI 10.1105/tpc.113.118794; Osorio S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00198; Paniagua C, 2014, ANN BOT-LONDON, V114, P1375, DOI 10.1093/aob/mcu149; Payasi Anurag, 2009, Physiology and Molecular Biology of Plants, V15, P103, DOI 10.1007/s12298-009-0012-z; Pressey R, 1997, PHYTOCHEMISTRY, V44, P1241, DOI 10.1016/S0031-9422(96)00667-X; Qin GZ, 2012, PLANT J, V70, P243, DOI 10.1111/j.1365-313X.2011.04861.x; Ramakrishna W, 2003, PLANT PHYSIOL, V131, P725, DOI 10.1104/pp.012401; RODRIGO I, 1991, PLANT MOL BIOL, V16, P931, DOI 10.1007/BF00015088; Santiago-Domenech N, 2008, J EXP BOT, V59, P2769, DOI 10.1093/jxb/ern142; SATO T, 1989, P NATL ACAD SCI USA, V86, P6621, DOI 10.1073/pnas.86.17.6621; Schijlen EGWM, 2007, PLANT PHYSIOL, V144, P1520, DOI 10.1104/pp.107.100305; Seymour GB, 2013, PLANT BIOTECHNOL J, V11, P269, DOI 10.1111/j.1467-7652.2012.00738.x; Shah DM, 1997, CURR OPIN BIOTECH, V8, P208, DOI 10.1016/S0958-1669(97)80104-8; Tam JP, 2015, PHARMACEUTICALS-BASE, V8, P711, DOI 10.3390/ph8040711; Tavares EQP, 2015, J EXP BOT, V66, P4133, DOI 10.1093/jxb/erv171; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang SF, 2014, J EXP BOT, V65, P3005, DOI 10.1093/jxb/eru137; Wehmeyer N, 2000, PLANT PHYSIOL, V122, P1099, DOI 10.1104/pp.122.4.1099; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807	54	19	21	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164335	10.1371/journal.pone.0164335	http://dx.doi.org/10.1371/journal.pone.0164335			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732677	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300047
J	Friciu, M; Zaraa, S; Roullin, VG; Leclair, G				Friciu, Mihaela; Zaraa, Sarra; Roullin, V. Gaelle; Leclair, Gregoire			Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions	PLOS ONE			English	Article							HYPERINSULINEMIC HYPOGLYCEMIA; HYDROCHLORIDE; MANAGEMENT; CHILDHOOD; INFANCY	The objective of this study was to evaluate the stability of diazoxide in extemporaneously compounded oral suspensions. Oral suspensions of diazoxide 10 mg/mL were prepared from either bulk drug or capsules dispersed in either Oral Mix or Oral Mix Sugar Free. These suspensions were stored at 5 degrees C and 25 degrees C/60%RH in bottles and oral syringes for a total of 90 days. At predetermined time intervals, suspensions were inspected for homogeneity, color or odor change; the pH was measured and the concentration of diazoxide was evaluated by ultraviolet detection using a stability-indicating high pressure liquid chromatography method. All preparations were demonstrated to be chemically stable for at least 90 days.	[Friciu, Mihaela; Zaraa, Sarra; Roullin, V. Gaelle; Leclair, Gregoire] Univ Montreal, Fac Pharm, Montreal, PQ, Canada	Universite de Montreal	Leclair, G (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ, Canada.	gregoire.leclair@umontreal.ca	Leclair, Grégoire/E-3095-2013; Roullin, V Gaelle/AAD-9187-2021	Leclair, Grégoire/0000-0003-3087-2646; Roullin, V Gaelle/0000-0002-0790-5246	Medisca Pharmaceutique Inc.	Medisca Pharmaceutique Inc.	This study was supported by an unrestricted grant from Medisca Pharmaceutique Inc. In compliance with Pr. Leclair's standard protocol, this study was conducted to evaluate the stability of extemporaneously compounded diazoxide suspensions prepared from bulk drug and commercial capsules in Oral Mix and Oral Mix SF vehicles and stored in plastic bottles and oral syringes. Oral Mix and Oral Mix SF are proprietary vehicles of Medisca Pharmaceutique Inc. Funding for this project was only conditional to the execution of the study and no commitments were taken regarding the outcome results of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. If accepted for publication in PLOS One, the publication costs will be covered by Medisca Pharmaceutique Inc.	[Anonymous], 2016, US PHARM 39 NAT FORM, V34, P3448; [Anonymous], 2016, US PHARM 39 NAT FORM, V34, P3447; [Anonymous], 2015, PROGL PROD MON; [Anonymous], 2016, US PHARM 39 NAT FORM, V34, P617; [Anonymous], 2015, PROGL PROD INF; BOULOS BM, 1971, J CLIN PHARMACOL N D, V11, P206; Boulos BM, 1970, JAMA-J AM MED ASSOC, V212, P720; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; EHRLICH RM, 1969, AM J DIS CHILD, V117, P411, DOI 10.1001/archpedi.1969.02100030413004; Ensom Mary H H, 2016, Can J Hosp Pharm, V69, P49; Ferreira AO, 2016, J PHARMACEUT BIOMED, V118, P105, DOI 10.1016/j.jpba.2015.10.032; GOODMAN HG, 1968, ANN NY ACAD SCI, V150, P367, DOI 10.1111/j.1749-6632.1968.tb19061.x; Huang Q, 2007, ENDOCRINOLOGY, V148, P81, DOI 10.1210/en.2006-0738; Li Q, 2016, AM J HEALTH-SYST PH, V73, P1331, DOI 10.2146/ajhp150581; Nahata Milap C, 2016, Int J Pharm Compd, V20, P164; Polonini HC, 2016, PHARMAZIE, V71, P185, DOI 10.1691/ph.2016.5177; Prohotsky Daniel L, 2014, J Pain Palliat Care Pharmacother, V28, P367, DOI 10.3109/15360288.2014.969874; RENNERT OM, 1968, ARCH DIS CHILD, V43, P358, DOI 10.1136/adc.43.229.358; Rozenkova K, 2015, J CLIN RES PEDIATR E, V7, P86, DOI 10.4274/jcrpe.1891; Stanisz BJ, 2014, ACTA POL PHARM, V71, P661; Touati G, 1998, EUR J PEDIATR, V157, P628, DOI 10.1007/s004310050900; vanHamersvelt HW, 1996, J HYPERTENS, V14, P1041; Vrignaud S, 2015, INT J PHARMACEUT, V487, P270, DOI 10.1016/j.ijpharm.2015.04.016	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164577	10.1371/journal.pone.0164577	http://dx.doi.org/10.1371/journal.pone.0164577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727306	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504400040
J	Huang, CJ; Lie, HH; Wan, JB; He, CW; Hu, YJ				Huang, Chuoji; Lie, Hui Heng; Wan, Jian-bo; He, Chengwei; Hu, Yuanjia			Research and Development of Hepatitis B Drugs: An Analysis Based on Technology Flows Measured by Patent Citations	PLOS ONE			English	Article							DIFFUSION; EVOLUTION; NETWORKS; THERAPY	Despite the existence of available therapies, the Hepatitis B virus infection continues to be one of the most serious threats to human health, especially in developing countries such as China and India. To shed light on the improvement of current therapies and development of novel anti-HBV drugs, we thoroughly investigated 212 US patents of anti-HBV drugs and analyzed the technology flow in research and development of anti-HBV drugs based on data from IMS LifeCycle databases. Moreover, utilizing the patent citation method, which is an effective indicator of technology flow, we constructed patent citation network models and performed network analysis in order to reveal the features of different technology clusters. As a result, we identified the stagnant status of anti-HBV drug development and pointed the way for development of domestic pharmaceuticals in developing countries. We also discussed about therapeutic vaccines as the potential next generation therapy for HBV infection. Lastly, we depicted the cooperation between entities and found that novel forms of cooperation added diversity to the conventional form of cooperation within the pharmaceutical industry. In summary, our study provides inspiring insights for investors, policy makers, researchers, and other readers interested in anti-HBV drug development.	[Huang, Chuoji; Lie, Hui Heng; Wan, Jian-bo; He, Chengwei; Hu, Yuanjia] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Ave Univ, Taipa 999078, Macau Sar, Peoples R China	University of Macau	Hu, YJ (corresponding author), Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Ave Univ, Taipa 999078, Macau Sar, Peoples R China.	yuanjiahu@umac.mo	Lin, Hui-Heng/AAM-9684-2021; Hu, Yuanjia/AAW-7721-2021; HUANG, Chuoji/AAZ-9689-2020; Wan, Jian-Bo/D-8368-2014	Lin, Hui-Heng/0000-0003-4060-7336; HUANG, Chuoji/0000-0002-3370-5002; Wan, Jian-Bo/0000-0002-6750-2617; He, Chengwei/0000-0003-4701-2984; yuanjia, Hu/0000-0001-5244-8577	University of Macau [MYRG2015-00145-ICMS-QRCM]; Science and Technology Development Fund [FDCT013/2015/A1]	University of Macau; Science and Technology Development Fund(Science and Technology Development Fund (STDF))	The research was financially supported by the project MYRG2015-00145-ICMS-QRCM from the University of Macau and the project FDCT013/2015/A1 from the Science and Technology Development Fund of Macao SAR. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Barnes E, 2015, MED MICROBIOL IMMUN, V204, P79, DOI 10.1007/s00430-014-0376-8; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Buchmann P, 2013, VACCINE, V31, P1197, DOI 10.1016/j.vaccine.2012.12.074; Chang SB, 2009, TECHNOL FORECAST SOC, V76, P107, DOI 10.1016/j.techfore.2008.03.014; Cho TS, 2011, SCIENTOMETRICS, V89, P795, DOI 10.1007/s11192-011-0457-z; Choe H, 2013, RENEW SUST ENERG REV, V26, P492, DOI 10.1016/j.rser.2013.05.037; Cox N, 2011, EXPERT OPIN EMERG DR, V16, P713, DOI 10.1517/14728214.2011.646260; Drozdoff V, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021014; Geng XM, 2015, HUM VACC IMMUNOTHER, V11, P2769, DOI 10.1080/21645515.2015.1074362; Gress B., 2010, WORLD PATENT INF, V32, P3, DOI DOI 10.1016/J.WPI.2009.05.005; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jaffe A.B., 1999, EC INNOVATION NEW TE, V8, P105, DOI [DOI 10.1080/10438599900000006, 10.1080/10438599900000006]; Karki M.S., 1997, WORLD PAT INF, V19, P269, DOI [10.1016/S0172-2190(97)00033-1, DOI 10.1016/S0172-2190(97)00033-1]; Kong XJ, 2015, HUM VACC IMMUNOTHER, V11, P682, DOI 10.1080/21645515.2015.1008857; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Li X, 2007, J NANOPART RES, V9, P337, DOI 10.1007/s11051-006-9194-2; Li X, 2009, J MANAGE INFORM SYST, V26, P129, DOI 10.2753/MIS0742-1222260106; Liaw YF, 2013, HEPATOLOGY, V58, P1856, DOI 10.1002/hep.26358; Locarnini S, 2015, J HEPATOL, V62, pS76, DOI 10.1016/j.jhep.2015.01.018; Loise V, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001481; Lok ASF, 2013, NAT REV GASTRO HEPAT, V10, P199, DOI 10.1038/nrgastro.2013.13; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Michel ML, 2011, J HEPATOL, V54, P1286, DOI 10.1016/j.jhep.2010.12.031; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; Park H, 2014, SCIENTOMETRICS, V98, P853, DOI 10.1007/s11192-013-1109-2; Smith H. L., 2006, IND INNOV, V13, P371, DOI DOI 10.1080/13662710601032697; Sorenson O, 2006, RES POLICY, V35, P994, DOI 10.1016/j.respol.2006.05.002; Stolpe M, 2002, RES POLICY, V31, P1181, DOI 10.1016/S0048-7333(01)00192-5; Stuart TE, 1996, STRATEGIC MANAGE J, V17, P21; Sun J, 2010, J VIRAL HEPATITIS, V17, P10, DOI 10.1111/j.1365-2893.2010.01274.x; Verspagen B, 2007, ADV COMPLEX SYST, V10, P93, DOI 10.1142/S0219525907000945; WHO, 2015, WHO GUID PREV CAR TR; Xu JC, 2014, EXPERT OPIN THER PAT, V24, P791, DOI 10.1517/13543776.2014.915943; Yoon J, 2011, SCIENTOMETRICS, V88, P213, DOI 10.1007/s11192-011-0383-0; Yoon SK, 2015, LIVER INT, V35, P805, DOI 10.1111/liv.12530; Yuen MF, 2015, HEPATOL INT, V9, P373, DOI 10.1007/s12072-014-9569-x; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x	37	4	4	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164328	10.1371/journal.pone.0164328	http://dx.doi.org/10.1371/journal.pone.0164328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CI	27727319	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504400027
J	Stevens, H; Williams, AB; Michael, WM				Stevens, Holly; Williams, Ashley B.; Michael, W. Matthew			Cell-Type Specific Responses to DNA Replication Stress in Early C. elegans Embryos	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; DAMAGE RESPONSE; FORK PROTECTION; CHECKPOINT; DIVISION; ACTIVATION; TIMELESS; TIPIN; ATR	To better understand how the cellular response to DNA replication stress is regulated during embryonic development, we and others have established the early C. elegans embryo as a model system to study this important problem. As is the case in most eukaryotic cell types, the replication stress response is controlled by the ATR kinase in early worm embryos. In this report we use RNAi to systematically characterize ATR pathway components for roles in promoting cell cycle delay during a replication stress response, and we find that these genetic requirements vary, depending on the source of stress. We also examine how individual cell types within the embryo respond to replication stress, and we find that the strength of the response, as defined by duration of cell cycle delay, varies dramatically within blastomeres of the early embryo. Our studies shed light on how the replication stress response is managed in the context of embryonic development and show that this pathway is subject to developmental regulation.	[Stevens, Holly; Williams, Ashley B.; Michael, W. Matthew] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Williams, Ashley B.] Univ Cologne, Fac Med, Inst Genome Stabil Ageing & Dis, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Williams, Ashley B.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany	University of Southern California; University of Cologne; University of Cologne	Michael, WM (corresponding author), Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.	mattm@usc.edu	McDermott, Michael Francis/GZM-5330-2022	Williams, Ashley/0000-0002-7558-9599	National Institutes of Health, National Institute for General Medical Sciences [R01GM099825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099825] Funding Source: NIH RePORTER	National Institutes of Health, National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, National Institute for General Medical Sciences, Award R01GM099825.	Benkemoun L, 2014, J CELL BIOL, V205, P447, DOI 10.1083/jcb.201312029; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; BRENNER S, 1974, GENETICS, V77, P71; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; Encalada SE, 2000, DEV BIOL, V228, P225, DOI 10.1006/dbio.2000.9965; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Gaggioli V, 2014, J CELL BIOL, V204, P507, DOI 10.1083/jcb.201310083; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Holway AH, 2006, J CELL BIOL, V172, P999, DOI 10.1083/jcb.200512136; Holway AH, 2005, GENETICS, V169, P1451, DOI 10.1534/genetics.104.036137; Hyun M, 2012, BIOCHEMISTRY-US, V51, P1336, DOI 10.1021/bi200791p; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Lee SJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000801; Lee SJ, 2004, DEVELOPMENT, V131, P2565, DOI 10.1242/dev.01136; Leman AR, 2012, CELL CYCLE, V11, P3945, DOI 10.4161/cc.21989; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Smith-Roe SL, 2011, CELL CYCLE, V10, P1618, DOI 10.4161/cc.10.10.15613; Sonneville R, 2015, CELL REP, V12, P405, DOI 10.1016/j.celrep.2015.06.046; Sonneville R, 2012, J CELL BIOL, V196, P233, DOI 10.1083/jcb.201110080; Tanaka K, 2010, BIOSCI BIOTECH BIOCH, V74, P2367, DOI 10.1271/bbb.100583; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wardlaw CP, 2014, DNA REPAIR, V22, P165, DOI 10.1016/j.dnarep.2014.06.004; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	27	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164601	10.1371/journal.pone.0164601	http://dx.doi.org/10.1371/journal.pone.0164601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727303	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400043
J	Troya, J; Ryan, P; Ribera, E; Podzamczer, D; Hontanon, V; Terron, JA; Boix, V; Moreno, S; Barrufee, P; Castano, M; Carrero, A; Galindo, MJ; Suarez-Lozano, I; Knobel, H; Raffo, M; Solis, J; Yllescas, M; Esteban, H; Gonzalez-Garcia, J; Berenguer, J; Imaz, A				Troya, Jesus; Ryan, Pablo; Ribera, Esteban; Podzamczer, Daniel; Hontanon, Victor; Alberto Terron, Jose; Boix, Vicente; Moreno, Santiago; Barrufee, Pilar; Castano, Manuel; Carrero, Ana; Jose Galindo, Maria; Suarez-Lozano, Ignacio; Knobel, Hernando; Raffo, Miguel; Solis, Javier; Yllescas, Maria; Esteban, Herminia; Gonzalez-Garcia, Juan; Berenguer, Juan; Imaz, Arkaitz		Gesida 8314 Study Grp	Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study	PLOS ONE			English	Article							NON-INFERIORITY TRIAL; TREATMENT-NAIVE; ANTIRETROVIRAL THERAPY; INFECTED ADULTS; OPEN-LABEL; EFAVIRENZ; EMTRICITABINE; TENOFOVIR; PHASE-3; THRIVE	Objectives Based on data from clinical practice, we evaluated the effectiveness and safety of switching to abacavir/lamivudine plus rilpivirine (ABC/3TC+RPV) treatment in virologically suppressed HIV-1-infected patients. Methods We performed a multicenter, non-controlled, retrospective study of HIV-1-infected patients who switched treatment to ABC/3TC+RPV. Patients had an HIV-RNA <50 copies/mL for at least 24 weeks prior to changing treatments. The primary objective was HIV-1 RNA <50 copies/mL at week 48. Effectiveness was analyzed by intention-to-treat (ITT), missing = failure and on-treatment (OT) analyses. The secondary objectives analyzed were adverse effects changes in renal, hepatic or lipid profiles, changes in CD4+ cell count and treatment discontinuations. Results Of the 205 patients included, 75.6% were men and the median age was 49. At baseline, before switching to ABC/3TC+RPV, median time since HIV diagnosis was 13.1 years, median time with undetectable HIV-1 RNA was 6.2 years and median time of previous antiretroviral regimen was 3.1 years (48.3% patients were taking efavirenz and ABC/3TC was the most frequent backbone coformulation in 69.7% of patients). The main reasons for switching were drug toxicity/poor tolerability (60.5%) and simplification (20%). At week 48, the primary objective was achieved by 187 out of 205 (91.2%) patients by ITT analysis, and 187 out of 192 (97.4%) patients by OT analysis. The CD4+ lymphocyte count and CD4+ percentage increased significantly from baseline to week 48 by a median of 48 cells/mu L (-50 to 189) and 1.2% (-1.3% to 4.1%), respectively, P<0.001. Thirty-eight adverse events (AE) were detected in 32 patients. Of these, 25 had no clear association with treatment. Three patients interrupted therapy due to AE. We observed a decrease in all lipid parameters, P<0.001, and a slight improvement in the glomerular filtration rate, P<0.01. Therapy was considered to have failed in 18 patients owing to virological failure (5 [2.4%]), toxicity/poor tolerability (4 [2%]), clinical decision (3 [1.5%]), loss to follow-up (3 [1.5%]), death (1 [0.5%]), and no clinical data (2 [1%]). Conclusions The results of this study confirms that ABC/3TC+RPV is an effective, safe, and cost-effective option for the treatment of patients with virologically stable HIV-1 infection.	[Troya, Jesus; Ryan, Pablo; Solis, Javier] Hosp Univ Infanta Leonor, Madrid, Spain; [Ribera, Esteban] Hosp Univ Vall dHebron, Barcelona, Spain; [Podzamczer, Daniel; Imaz, Arkaitz] Hosp Univ Bellvitge, Barcelona, Spain; [Hontanon, Victor; Gonzalez-Garcia, Juan] Hosp Univ La Paz IdiPAZ, Madrid, Spain; [Alberto Terron, Jose] Hosp Jerez De La Frontera, Jerez de la Frontera, Spain; [Boix, Vicente] Hosp Gen Univ Alicante, Alicante, Spain; [Moreno, Santiago] Hosp Univ Ramon y Cajal, Madrid, Spain; [Barrufee, Pilar] Hosp Matero, Mataro, Spain; [Castano, Manuel; Berenguer, Juan] Hosp Reg Univ Malaga, Malaga, Spain; [Carrero, Ana] Hosp Univ Gregorio Maranon, Madrid, Spain; [Jose Galindo, Maria] Hosp Clin Valencia, Valencia, Spain; [Suarez-Lozano, Ignacio; Raffo, Miguel] Hosp Univ Infanta Elena, Huelva, Spain; [Knobel, Hernando] Hosp del Mar, Barcelona, Spain; [Yllescas, Maria; Esteban, Herminia] Fdn SEIMC GESIDA, Madrid, Spain	Hospital Universitario Infanta Leonor; Hospital Universitari Vall d'Hebron; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Universitario La Paz; Hospital de Jerez; General University Hospital of Alicante; Hospital Universitario Ramon y Cajal; General University Gregorio Maranon Hospital; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Troya, J (corresponding author), Hosp Univ Infanta Leonor, Madrid, Spain.	jestrogar@hotmail.com	Boix, Vicente/AAH-1607-2020; Troya-García, Jesus/Y-9721-2019; Knobel, Hernando/AAD-3582-2020; Ryan, Pablo/AAM-1924-2021; RYAN, PABLO/GRF-3462-2022; Knobel, Hernando/B-5223-2016; Berenguer, Juan/A-1347-2009	Boix, Vicente/0000-0002-7015-3948; Troya-García, Jesus/0000-0001-7323-114X; Knobel, Hernando/0000-0003-3186-6416; Ryan, Pablo/0000-0002-4212-7419; RYAN, PABLO/0000-0002-4212-7419; Knobel, Hernando/0000-0003-3186-6416; Berenguer, Juan/0000-0001-8541-8200; Hontanon Antonana, Victor/0000-0003-3070-2647; Gonzalez-Garcia, Juan/0000-0002-3652-002X	ViiV Healthcare; SEIMC-GESIDA Foundation [Gesida-8314]; ViiV Healthcare Medical Scientific Liaison	ViiV Healthcare; SEIMC-GESIDA Foundation; ViiV Healthcare Medical Scientific Liaison	The study was supported by ViiV Healthcare and SEIMC-GESIDA Foundation (grant number Gesida-8314). ViiV Healthcare provided SEIMC-GESIDA funds for the coordination and operational aspects of this study (administrative costs, payment for including different hospitals, collecting patient data and data analysis) but did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SEIMC-GESIDA Foundation was the sponsor of the study and managed all the operational aspects, including design, data collection and data analysis. All authors are responsible for the veracity and completeness of the data reported. The corresponding author had full access to all the study data and had final responsibility for the decision to submit for publication.; We thank the SIMRIKI study patients and all investigators and Institutions of GESIDA-8314 study group**. We also thank Cristina Jimenez and Xolimar Pereiro (ViiV Healthcare Medical Scientific Liaison) for their continued support. Data presented at the 15th European AIDS Conference, Barcelona (21-24 October 2015).	[Anonymous], ED DAT SHEET; [Anonymous], 2016, PAN ANT GUID AD AD G; Casado Jose L, 2013, Enferm Infecc Microbiol Clin, V31 Suppl 2, P30, DOI 10.1016/S0213-005X(13)70140-X; Cazanave C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv018; Cevik M, 2012, J INT AIDS SOC, V15, P171, DOI 10.7448/IAS.15.6.18291; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; European AIDS Clinical Society (EACS), 2015, EUR GUID TREATM HIV; Ford N, 2013, CURR OPIN HIV AIDS, V8, P591, DOI 10.1097/COH.0000000000000010; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; Mills AM, 2013, HIV CLIN TRIALS, V14, P216, DOI 10.1310/hct1405-216; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Moyle GJ, 2013, ANTIVIR THER, V18, P905, DOI 10.3851/IMP2667; Murphy R L, 2002, HIV Med, V3, P146, DOI 10.1046/j.1468-1293.2002.00102.x; Nachega JB, 2011, PATIENT PREFER ADHER, V5, P357, DOI 10.2147/PPA.S22771; Nelson MR, 2013, HIV CLIN TRIALS, V14, P81, DOI 10.1310/hct1403-81; Nishijima T, 2014, AIDS, V28, P1903, DOI 10.1097/QAD.0000000000000347; Pozniak A, 2016, JAIDS-J ACQ IMM DEF, V71, P530, DOI 10.1097/QAI.0000000000000908; Pozniak A, 2014, LANCET INFECT DIS, V14, P590, DOI 10.1016/S1473-3099(14)70796-0; Putcharoen O, 2013, HIV AIDS S5, V16, pS231, DOI 10.2147/HIV.S25712; Rasmussen TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032445; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Tebas P, 2014, CLIN INFECT DIS, V59, P425, DOI 10.1093/cid/ciu234; Ward D, 2012, J INT AIDS SOC, V15, P163, DOI 10.7448/IAS.15.6.18351; Ward DJ, 2006, AIDS PATIENT CARE ST, V20, P542, DOI 10.1089/apc.2006.20.542; Waters L, 2007, INT J CLIN PRACT, V61, P999, DOI 10.1111/j.1742-1241.2007.01385.x	26	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164455	10.1371/journal.pone.0164455	http://dx.doi.org/10.1371/journal.pone.0164455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727331	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400033
J	Ehlken, H; Wroblewski, R; Corpechot, C; Arrive, L; Rieger, T; Hartl, J; Lezius, S; Hubener, P; Schulze, K; Zenouzi, R; Sebode, M; Peiseler, M; Denzer, UW; Quaas, A; Weiler-Normann, C; Lohse, AW; Chazouilleres, O; Schramm, C				Ehlken, Hanno; Wroblewski, Raluca; Corpechot, Christophe; Arrive, Lionel; Rieger, Tim; Hartl, Johannes; Lezius, Susanne; Huebener, Peter; Schulze, Kornelius; Zenouzi, Roman; Sebode, Marcial; Peiseler, Moritz; Denzer, Ulrike W.; Quaas, Alexander; Weiler-Normann, Christina; Lohse, Ansgar W.; Chazouilleres, Olivier; Schramm, Christoph			Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; FATTY LIVER-DISEASE; HEPATIC-FIBROSIS; PERFORMANCE; DIAGNOSIS; CANCER; RISK	Background Patients with primary sclerosing cholangitis (PSC) develop progressive liver fibrosis and end-stage liver disease. Non-invasive and widely available parameters are urgently needed to assess disease stage and the risk of clinical progression. Transient elastography (TE) has been reported to predict fibrosis stage and disease progression. However, these results have not been confirmed in an independent cohort and comparison of TE measurement to other non-invasive means is missing. Methods In a retrospective study we collected data from consecutive PSC patients receiving TE measurements from 2006 to 2014 (n = 139). Data from 62 patients who also underwent a liver biopsy were used to assess the performance of TE and spleen length (SL) measurement for the staging of liver fibrosis. Follow-up data from this cohort (n = 130, Hamburg) and another independent cohort (n = 80, Paris) was used to compare TE and SL as predictors of clinical outcome applying Harrel's C calculations. Results TE measurement had a very good performance for the diagnosis and exclusion of higher fibrosis stages (>= F3: AUROC 0.95) and an excellent performance for the diagnosis and exclusion of cirrhosis (F4 vs. < F4: AUROC 0.98). Single-point TE measurement had very similar predictive power for patient outcome as previously published. In a combined cohort of PSC patients (n = 210), SL measurements had a similar performance as TE for the prediction of patient outcome (5 x cross-validated Harrel's C 0.76 and 0.72 for SL and TE, respectively). Conclusions Baseline TE measurement has an excellent performance to diagnose higher fibrosis stages in PSC. Baseline measurements of SL and TE have similar usefulness as predictive markers for disease progression in patients with PSC.	[Ehlken, Hanno; Wroblewski, Raluca; Rieger, Tim; Hartl, Johannes; Huebener, Peter; Schulze, Kornelius; Zenouzi, Roman; Sebode, Marcial; Peiseler, Moritz; Weiler-Normann, Christina; Lohse, Ansgar W.; Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Martinistr 52, D-20246 Hamburg, Germany; [Corpechot, Christophe; Chazouilleres, Olivier] Hop St Antoine, AP HP, Serv Heapatol,Fac Med, Ctr Reference Malad Inflammatoires Voies Biliaire, Paris, France; [Corpechot, Christophe; Arrive, Lionel; Chazouilleres, Olivier] Univ Paris 06, Site St Antoine, Paris, France; [Arrive, Lionel] Hop St Antoine, AP HP, Fac Med, Serv Radiol, Paris, France; [Lezius, Susanne] Dept Med Biometry & Epidemiol, Martinistr 52, D-20246 Hamburg, Germany; [Ehlken, Hanno; Denzer, Ulrike W.] Univ Med Ctr Hamburg Eppendorf, Dept Interdisciplinary Endoscopy, Martinistr 52, D-20246 Hamburg, Germany; [Quaas, Alexander] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Martinistr 52, D-20246 Hamburg, Germany; [Quaas, Alexander] Inst Pathol, Kerpener Str 63, D-50936 Cologne, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne	Ehlken, H; Schramm, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Martinistr 52, D-20246 Hamburg, Germany.; Ehlken, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Interdisciplinary Endoscopy, Martinistr 52, D-20246 Hamburg, Germany.	h.ehlken@uke.de; cschramm@uke.de		Peiseler, Moritz/0000-0001-6195-3866; Denzer (Prof. Dr. med), Ulrike Walburga/0000-0001-8926-160X; Huebener, Peter/0000-0001-7558-7625; Lezius, Susanne/0000-0002-4832-4333	DFG [SFB841, KFO306]; YAEL-Foundation; Helmut and Hannelore Greve Foundation, Hamburg, Germany	DFG(German Research Foundation (DFG)); YAEL-Foundation; Helmut and Hannelore Greve Foundation, Hamburg, Germany	The study was supported by the DFG (SFB841 and KFO306), the YAEL-Foundation, and the Helmut and Hannelore Greve Foundation, Hamburg, Germany.	Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Claessen MMH, 2009, J HEPATOL, V50, P158, DOI 10.1016/j.jhep.2008.08.013; Corpechot C, 2006, HEPATOLOGY, V43, P1118, DOI 10.1002/hep.21151; Corpechot C, 2014, GASTROENTEROLOGY, V146, P970, DOI 10.1053/j.gastro.2013.12.030; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Eaton JE, 2016, J GASTROEN HEPATOL, V31, P1184, DOI 10.1111/jgh.13263; Ehlken H, 2016, GUT, V65, P1230, DOI 10.1136/gutjnl-2016-311452; Ehlken H, 2014, GASTROENTEROLOGY, V147, P542, DOI 10.1053/j.gastro.2014.04.058; Fevery J, 2012, LIVER INT, V32, P214, DOI 10.1111/j.1478-3231.2011.02575.x; Floreani A, 2011, DIGEST LIVER DIS, V43, P887, DOI 10.1016/j.dld.2011.06.011; Fraquelli M, 2011, DIGEST LIVER DIS, V43, pS25, DOI 10.1016/S1590-8658(10)60689-5; Frenzel C, 2012, LIVER INT, V32, P970, DOI 10.1111/j.1478-3231.2012.02767.x; Fung J, 2011, AM J GASTROENTEROL, V106, P492, DOI 10.1038/ajg.2010.463; Gaia S, 2011, J HEPATOL, V54, P64, DOI 10.1016/j.jhep.2010.06.022; Gomez-Dominguez E, 2008, ALIMENT PHARM THER, V27, P441, DOI 10.1111/j.1365-2036.2007.03585.x; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Merchante N, 2012, HEPATOLOGY, V56, P228, DOI 10.1002/hep.25616; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Ponsioen CY, 2016, HEPATOLOGY, V63, P1357, DOI 10.1002/hep.28256; Razumilava N, 2011, HEPATOLOGY, V54, P1842, DOI 10.1002/hep.24570; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Vesterhus M, 2015, HEPATOLOGY, V62, P188, DOI 10.1002/hep.27825; Wang JH, 2010, J GASTROEN HEPATOL, V25, P964, DOI 10.1111/j.1440-1746.2009.06194.x; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312	27	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164224	10.1371/journal.pone.0164224	http://dx.doi.org/10.1371/journal.pone.0164224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723798	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100031
J	Lai, HY; Lee, CH; Lee, CY				Lai, Hung-Yi; Lee, Ching-Hsin; Lee, Ching-Yi			The Intracranial Volume Pressure Response in Increased Intracranial Pressure Patients: Clinical Significance of the Volume Pressure Indicator	PLOS ONE			English	Article							CEREBROSPINAL-FLUID SYSTEM; SEVERE HEAD-INJURY; INDEX; DYNAMICS	Background For patients suffering from primary brain injury, monitoring intracranial pressure alone is not enough to reflect the dynamic intracranial condition. In our previous study, a segment of the pressure-volume curve can be expressed by the parabolic regression model with single indicator "a". The aim of this study is to evaluate if the indicator "a" can reflect intracranial conditions. Methods Patients with traumatic brain injury, spontaneous intracranial hemorrhage, and/or hydrocephalus who had external ventricular drainage from January 2009 to February 2010 were included. The successive volume pressure response values were obtained by successive drainage of cerebral spinal fluid from intracranial pressure 20-25 mm Hg to 10 mm Hg. The relationship between withdrawn cerebral spinal fluid volume and intracranial pressure was analyzed by the parabolic regression model with single parameter "a". Results The overall mean for indicator "a" was 0.422 +/- 0.046. The mean of "a" in hydrocephalus was 0.173 +/- 0.024 and in severe intracranial mass with slender ventricle, it was 0.663 +/- 0.062. The two extreme intracranial conditions had a statistical significant difference (p<0.001). Conclusion The indicator "a" of a pressure-volume curve can reflect the dynamic intracranial condition and is comparable in different situations. A significantly larger indicator "a" with increased intracranial pressure is always observed in severe intracranial mass lesions with cerebral edema. A significantly smaller indicator "a" with increased intracranial pressure is observed in hydrocephalus. Brain computed tomography should be performed early if a rapid elevation of indicator "a" is detected, as it can reveal some ongoing intracranial pathology prior to clinical deterioration. Increased intracranial pressure was frequently observed in patients with intracranial pathology. The progression can be differentiated using the pattern of the volume pressure indicator.	[Lai, Hung-Yi; Lee, Ching-Hsin; Lee, Ching-Yi] Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lee, CY (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, Coll Med, Taoyuan, Taiwan.	8702021@adm.cgmh.org.tw			Chang Gung Medical Research Council [CMRPG 371581]	Chang Gung Medical Research Council	The study was supported by the Chang Gung Medical Research Council (grant no. CMRPG 371581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the Chang Gung Medical Research Council (grant no. CMRPG 371581).	Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Kiening KL, 2003, BRIT J NEUROSURG, V17, P311, DOI 10.1080/02688690310001601199; Lai HY, 2012, ACTA NEUROCHIR, V154, P2271, DOI 10.1007/s00701-010-0765-8; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Marmarou A, 2011, YOUMANS NEUROLOGICAL, P169, DOI DOI 10.1016/B978-1-4160-5316-3.00011-3; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Miller J D, 1975, Clin Neurosurg, V22, P76; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; RYDER HW, 1953, J LAB CLIN MED, V41, P428; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SHAPIRO K, 1980, ANN NEUROL, V7, P508, DOI 10.1002/ana.410070603; SKLAR FH, 1980, J NEUROSURG, V53, P166, DOI 10.3171/jns.1980.53.2.0166; TANS JTJ, 1982, J NEUROSURG, V56, P524, DOI 10.3171/jns.1982.56.4.0524; TANS JTJ, 1983, J NEUROSURG, V59, P810, DOI 10.3171/jns.1983.59.5.0810	15	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164263	10.1371/journal.pone.0164263	http://dx.doi.org/10.1371/journal.pone.0164263			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723794	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100036
J	Collaco, JM; Dadlani, GH; Nies, MK; Leshko, J; Everett, AD; McGrath-Morrow, SA				Collaco, Joseph M.; Dadlani, Gul H.; Nies, Melanie K.; Leshko, Jenny; Everett, Allen D.; McGrath-Morrow, Sharon A.			Risk Factors and Clinical Outcomes in Preterm Infants with Pulmonary Hypertension	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; ENDOTHELIAL GROWTH-FACTOR; BIRTH-WEIGHT INFANTS; BRONCHOPULMONARY DYSPLASIA; PREMATURE-INFANTS; ARTERY HYPERTENSION; MORBIDITIES	Background Pulmonary hypertension (PH) is a significant cause of morbidity in preterm infants, but no screening guidelines exist. We sought to identify risk factors and clinical outcomes associated with PH in preterm infants to develop a PH risk score. Methods Retrospective analysis of two separate populations of preterm infants (NICU cohort n = 230; Clinic registry n = 580). Results 8.3% of the NICU cohort had PH after 4 weeks of age, while 14.8% of the clinic registry had PH after 2 months of age. Lower birth weights and longer initial hospitalizations were associated with PH in both populations (p< 0.001 for all tests). Using adjusted logistic regression, patent ductus arteriosus (PDA) requiring ligation was associated with PH in both the NICU cohort (OR: 3.19; p = 0.024) and the clinic registry (OR: 2.67; p< 0.001). Risk factors (birth weight-780 grams, home supplemental oxygen use, and PDA ligation) identified in the clinic registry (training dataset) were validated in the NICU cohort with 0-1 factors present were associated with <= 1.5% probability of having PH, any 2 factors with a 25% probability, and all 3 factors with a 40% probability. Conclusions Lower birth weight, PDA ligation, and respiratory support were associated with PH in both populations. A PH risk score based on clinical indicators from the training dataset predicted PH in the validation set. This risk score could help focus resources to preterm infants at higher risk for PH. Further work is needed to determine whether earlier or more aggressive management of ductal lesions could alter PH outcomes.	[Collaco, Joseph M.; McGrath-Morrow, Sharon A.] Johns Hopkins Med Inst, Eudowood Div Pediat Resp Sci, Baltimore, MD 21205 USA; [Dadlani, Gul H.] Nemours Childrens Hosp, Div Pediat Cardiol, Orlando, FL USA; [Nies, Melanie K.; Everett, Allen D.] Johns Hopkins Med Inst, Helen B Taussig Congenital Heart Ctr, Baltimore, MD USA; [Leshko, Jenny; Everett, Allen D.] All Childrens Hosp, Johns Hopkins Med, Div Pediat Cardiol, St Petersburg, FL USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Collaco, JM (corresponding author), Johns Hopkins Med Inst, Eudowood Div Pediat Resp Sci, Baltimore, MD 21205 USA.	mcollac1@jhmi.edu			Children's Hospital Foundation Institutional Research Grant; Johns Hopkins All Children's Hospital, via an intramural Johns Hopkins Department of Pediatrics grant	Children's Hospital Foundation Institutional Research Grant; Johns Hopkins All Children's Hospital, via an intramural Johns Hopkins Department of Pediatrics grant	All Children's Hospital Foundation Institutional Research Grant. The sponsor had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the families who participated in this study. JM Collaco had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. This work was supported by Johns Hopkins All Children's Hospital, via an intramural Johns Hopkins Department of Pediatrics grant award to Dr. Collaco; the institution was not involved in the design and conduct of the study, the collection, management, analysis, and interpretation of the data, the preparation, review, or approval of the manuscript, or the decision to submit the manuscript for publication.	An Hyo Soon, 2010, Korean Circ J, V40, P131, DOI 10.4070/kcj.2010.40.3.131; Aswani R, 2016, CARDIOL YOUNG, V26, P521, DOI 10.1017/S1047951115000608; Bancalari E, 2005, BIOL NEONATE, V88, P192, DOI 10.1159/000087582; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bhandari V, 2006, PEDIATRICS, V117, P1901, DOI 10.1542/peds.2005-1414; Bhat R, 2012, PEDIATRICS, V129, pE682, DOI 10.1542/peds.2011-1827; Bruno CJ, 2015, AM J PERINAT, V32, P1031, DOI 10.1055/s-0035-1547324; Check J, 2013, J PERINATOL, V33, P553, DOI 10.1038/jp.2012.164; Dereddy NR, 2015, AJP REP, V5, pE97, DOI 10.1055/s-0035-1548543; Jensen EA, 2014, BIRTH DEFECTS RES A, V100, P145, DOI 10.1002/bdra.23235; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Khemani E, 2007, PEDIATRICS, V120, P1260, DOI 10.1542/peds.2007-0971; Kim DH, 2012, NEONATOLOGY, V101, P40, DOI 10.1159/000327891; Kumar VH, 2007, J PERINATOL, V27, P214, DOI 10.1038/sj.jp.7211673; Lassus P, 2001, AM J RESP CRIT CARE, V164, P1981, DOI 10.1164/ajrccm.164.10.2012036; Li F, 2012, J AM SOC NEPHROL, V23, P652, DOI 10.1681/ASN.2011040369; Maniscalco WM, 2002, AM J PHYSIOL-LUNG C, V282, pL811, DOI 10.1152/ajplung.00325.2001; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Mestan KK, 2014, PLACENTA, V35, P570, DOI 10.1016/j.placenta.2014.05.003; Mirza H, 2014, J PEDIATR-US, V165, P909, DOI 10.1016/j.jpeds.2014.07.040; Mourani PM, 2008, PEDIATRICS, V121, P317, DOI 10.1542/peds.2007-1583; Mourani PM, 2015, CLIN PERINATOL, V42, P839, DOI 10.1016/j.clp.2015.08.010; Mourani PM, 2014, AM J RESP CRIT CARE; Ohlsson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003481.pub3; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Skinner JR, 1999, ARCH DIS CHILD-FETAL, V80, pF81, DOI 10.1136/fn.80.2.F81; Slaughter JL, 2011, J PERINATOL, V31, P635, DOI 10.1038/jp.2010.213; Stuart BD, 2013, J PERINATOL, V33, P543, DOI 10.1038/jp.2012.170; Tang JR, 2012, AM J PHYSIOL-LUNG C, V302, pL36, DOI 10.1152/ajplung.00294.2011; Trittmann JK, 2014, ACTA PAEDIATR, V103, pE439, DOI 10.1111/apa.12717; Yallapragada S, 2015, PEDIAT DEV PATHOL	31	15	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163904	10.1371/journal.pone.0163904	http://dx.doi.org/10.1371/journal.pone.0163904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716811	gold, Green Published, Green Submitted			2022-12-27	WOS:000385698100012
J	Keane, PA; Grossi, CM; Foster, PJ; Yang, Q; Reisman, CA; Chan, KP; Peto, T; Thomas, D; Patel, PJ				Keane, Pearse A.; Grossi, Carlota M.; Foster, Paul J.; Yang, Qi; Reisman, Charles A.; Chan, Kinpui; Peto, Tunde; Thomas, Dhanes; Patel, Praveen J.		UK Biobank Eye Vision Consortium	Optical Coherence Tomography in the UK Biobank Study - Rapid Automated Analysis of Retinal Thickness for Large Population-Based Studies	PLOS ONE			English	Article							SUBFOVEAL CHOROIDAL THICKNESS; MACULAR DEGENERATION; QUANTITATIVE SUBANALYSIS; DIABETIC-RETINOPATHY; AGE; EYES; OCT; ANGIOGRAPHY; PREVALENCE; PERFUSION	Purpose To describe an approach to the use of optical coherence tomography (OCT) imaging in large, population-based studies, including methods for OCT image acquisition, storage, and the remote, rapid, automated analysis of retinal thickness. Methods In UK Biobank, OCT images were acquired between 2009 and 2010 using a commercially available "spectral domain" OCT device (3D OCT-1000, Topcon). Images were obtained using a raster scan protocol, 6 mm x 6 mm in area, and consisting of 128 B-scans. OCT image sets were stored on UK Biobank servers in a central repository, adjacent to high performance computers. Rapid, automated analysis of retinal thickness was performed using custom image segmentation software developed by the Topcon Advanced Biomedical Imaging Laboratory (TABIL). This software employs dual-scale gradient information to allow for automated segmentation of nine intraretinal boundaries in a rapid fashion. Results 67,321 participants (134,642 eyes) in UK Biobank underwent OCT imaging of both eyes as part of the ocular module. 134,611 images were successfully processed with 31 images failing segmentation analysis due to corrupted OCT files or withdrawal of subject consent for UKBB study participation. Average time taken to call up an image from the database and complete segmentation analysis was approximately 120 seconds per data set per login, and analysis of the entire dataset was completed in approximately 28 days. Conclusions We report an approach to the rapid, automated measurement of retinal thickness from nearly 140,000 OCT image sets from the UK Biobank. In the near future, these measurements will be publically available for utilization by researchers around the world, and thus for correlation with the wealth of other data collected in UK Biobank. The automated analysis approaches we describe may be of utility for future large population-based epidemiological studies, clinical trials, and screening programs that employ OCT imaging.	[Keane, Pearse A.; Peto, Tunde; Thomas, Dhanes; Patel, Praveen J.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Keane, Pearse A.; Foster, Paul J.; Peto, Tunde; Thomas, Dhanes; Patel, Praveen J.] UCL Inst Ophthalmol, London, England; [Grossi, Carlota M.; Foster, Paul J.] UCL Inst Ophthalmol, Div Genet & Epidemiol, London, England; [Yang, Qi; Reisman, Charles A.; Chan, Kinpui] Topcon Adv Biomed Imaging Lab, Oakland, NJ USA	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London	Patel, PJ (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.; Patel, PJ (corresponding author), UCL Inst Ophthalmol, London, England.	praveen.patel@moorfields.nhs.uk	Foster, Paul/V-7288-2019; Peto, Tunde/G-8812-2018; Keane, Pearse/AAE-5709-2019	Foster, Paul/0000-0002-4755-177X; Peto, Tunde/0000-0001-6265-0381; Keane, Pearse/0000-0002-9239-745X; Grossi, carlota/0000-0003-3722-5425	Welsh Assembly Government; Richard Desmond Charitable Trust via Fight for Sight; Special Trustees of Moorfields Eye Hospital [ST 12 09]; Department for Health through the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust [BRC2_009]; National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Topcon Medical Systems, Inc.; British Heart Foundation; Diabetes UK; Medical Research Council [MC_qA137853] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10101, CS-2014-14-023, CL-2010-18-004] Funding Source: researchfish	Welsh Assembly Government; Richard Desmond Charitable Trust via Fight for Sight; Special Trustees of Moorfields Eye Hospital; Department for Health through the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Topcon Medical Systems, Inc.; British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and the Northwest Regional Development Agency. It has also had funding from the Welsh Assembly Government, British Heart Foundation and Diabetes UK. P.J.F. is supported by the Richard Desmond Charitable Trust via Fight for Sight (1956), the Special Trustees of Moorfields Eye Hospital (ST 12 09) and the Department for Health through the award made by the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust (BRC2_009). The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Topcon Medical Systems, Inc. provided support in the form of salaries to C.A.R. and Q.Y. The funding organizations had no role in the design or conduct of this research.	Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; Allen NE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008601; Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; Chan A, 2006, RETINA-J RET VIT DIS, V26, P655, DOI 10.1097/00006982-200607000-00011; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Drexler W, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.071412; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Galetta KM, 2011, NEUROTHERAPEUTICS, V8, P117, DOI 10.1007/s13311-010-0005-1; Garcia-Martin ES, 2014, OPHTHALMOLOGY, V121, P1149, DOI 10.1016/j.ophtha.2013.12.023; HEE MR, 1995, ARCH OPHTHALMOL-CHIC, V113, P1019, DOI 10.1001/archopht.1995.01100080071031; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Jung JW, 2014, BRIT J OPHTHALMOL, V98, P207, DOI 10.1136/bjophthalmol-2013-303645; Karampelas M, 2013, GRAEF ARCH CLIN EXP, V251, P2029, DOI 10.1007/s00417-013-2330-7; Keane PA, 2010, EYE, V24, P422, DOI 10.1038/eye.2009.309; Keane PA, 2008, INVEST OPHTH VIS SCI, V49, P3115, DOI 10.1167/iovs.08-1689; Keane Pearse A, 2011, Ophthalmic Surg Lasers Imaging, V42 Suppl, pS67, DOI 10.3928/15428877-20110627-06; Kim DY, 2013, ACTA OPHTHALMOL, V91, P183, DOI 10.1111/j.1755-3768.2011.02305.x; Nguyen L, 2014, INT J MED INFORM, V83, P779, DOI 10.1016/j.ijmedinf.2014.06.011; Liew G, 2011, REV ESP CARDIOL, V64, P515, DOI [10.1016/j.rec.2011.02.017, 10.1016/j.recesp.2011.02.014]; Lu CD, 2014, BIOMED OPT EXPRESS, V5, P293, DOI 10.1364/BOE.5.000293; Mackenzie S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014811; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Mitry D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071154; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Muraoka Y, 2013, AM J OPHTHALMOL, V156, P706, DOI 10.1016/j.ajo.2013.05.021; Myers CE, 2015, AM J OPHTHALMOL, V159, P445, DOI 10.1016/j.ajo.2014.11.025; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Owen CG, 2012, BRIT J OPHTHALMOL, V96, P752, DOI 10.1136/bjophthalmol-2011-301109; Patel PJ, 2016, OPHTHALMOLOGY, V123, P829, DOI 10.1016/j.ophtha.2015.11.009; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; Sadda SR, 2007, INVEST OPHTH VIS SCI, V48, P839, DOI 10.1167/iovs.06-0554; Sadda SR, 2010, INVEST OPHTH VIS SCI, V51, P1071, DOI 10.1167/iovs.09-4325; Saidha S, 2013, JAMA NEUROL, V70, P34, DOI 10.1001/jamaneurol.2013.573; Schwartz DM, 2014, OPHTHALMOLOGY, V121, P180, DOI 10.1016/j.ophtha.2013.09.002; Srinivasan PP, 2014, BIOMED OPT EXPRESS, V5, P3568, DOI 10.1364/BOE.5.003568; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Tufail A, 2014, OPHTHALMOLOGY, V121, P1092, DOI 10.1016/j.ophtha.2013.11.031; van Dijk HW, 2012, INVEST OPHTH VIS SCI, V53, P2715, DOI 10.1167/iovs.11-8997; Verma A, 2009, EYE, V23, P1824, DOI 10.1038/eye.2009.184; Walsh Alexander C, 2011, Ophthalmic Surg Lasers Imaging, V42 Suppl, pS95, DOI 10.3928/15428877-20110627-09; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Zarranz-Ventura J, 2014, OPHTHALMOLOGY, V121, P1966, DOI 10.1016/j.ophtha.2014.04.026; Zengin MO, 2014, BRIT J OPHTHALMOL, V98, P233, DOI 10.1136/bjophthalmol-2013-304044	53	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164095	10.1371/journal.pone.0164095	http://dx.doi.org/10.1371/journal.pone.0164095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716837	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000385698100021
J	Arias, VB; Nunez, DE; Martinez-Molina, A; Ponce, FP; Arias, B				Arias, Victor B.; Nunez, Daniel E.; Martinez-Molina, Agustin; Ponce, Fernando P.; Arias, Benito			Hierarchy and Psychometric Properties of ADHD Symptoms in Spanish Children: An Application of the Graded Response Model	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; PAPER-AND-PENCIL; DSM-IV; RATING-SCALE; MEASUREMENT INVARIANCE; PERSONALITY TESTS; TEACHER RATINGS; PARENT; AGE; PREVALENCE	The Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnostic criteria assume that the 18 symptoms carry the same weight in an Attention Deficit with Hyperactivity Disorder (ADHD) diagnosis and bear the same discriminatory capacity. However, it is reasonable to think that symptoms may differ in terms of severity and even in the reliability with they represent the disorder. To test this hypothesis, the aim of this study was to calibrate in a sample of Spanish children (age 4-7; n = 784) a scale for assessing the symptoms of ADHD proposed by Diagnostic and Statistical Manual of Mental Disorders, IV-TR within the framework of Item Response Theory. Samejima's Graded Response Model was used as a method for estimating the item difficulty and discrimination parameters. The results showed that ADHD subscales (Attention Deficit and Hyperactivity / Impulsivity) had good psychometric properties and had also a good fit to the model. However, relevant differences between symptoms were observed at the level of severity, informativeness and reliability for the assessment of ADHD. This finding suggests that it would be useful to identify the symptoms that are more important than the others with regard to diagnosing ADHD.	[Arias, Victor B.; Nunez, Daniel E.; Martinez-Molina, Agustin; Ponce, Fernando P.] Univ Talca, Fac Psicol, Talca, Chile; [Ponce, Fernando P.] Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, Chile; [Arias, Benito] Univ Valladolid, Fac Educ & Trabajo Social, Dept Psicol, E-47002 Valladolid, Spain	Universidad de Talca; Pontificia Universidad Catolica de Chile; Universidad de Valladolid	Arias, VB (corresponding author), Univ Talca, Fac Psicol, Talca, Chile.	viarias@utalca.cl	Arias, Victor B/R-6964-2018; Martínez, Agustín/AAF-4990-2019; ARIAS, BENITO/D-7925-2013; Ponce, Fernando P./M-4481-2019	Arias, Victor B/0000-0002-1260-7948; Martínez, Agustín/0000-0001-5251-6066; ARIAS, BENITO/0000-0002-6490-2076; Ponce, Fernando P./0000-0002-6283-4583; Nunez, Daniel/0000-0001-7091-2249	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) de Iniciacion [11140524]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) de Iniciacion	Support was provided by Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) de Iniciacion Nro.11140524 [http://www.conicyt.cl/fondecyt/].	Amador J. A., 2005, ANUARIO PSICOLOGIA, V36, P211; Amador-Campos JA, 2005, PSYCHOL REP, V97, P847, DOI 10.2466/PR0.97.7.847-860; Amador-Campos JA, 2006, J PSYCHOPATHOL BEHAV, V28, P23, DOI 10.1007/s10862-006-4538-x; Andrich D., 1988, SAGE PUBLICATIONS; Arias VB, 2016, J ABNORM PSYCHOL, V125, P125, DOI 10.1037/abn0000115; Baker F., 2001, BASICS ITEM RESPONSE; Barkley R.A, 1997, ADHD NATURE SELF CON; BAUERMEISTER JJ, 1990, J CLIN CHILD PSYCHOL, V19, P9, DOI 10.1207/s15374424jccp1901_2; Bauermeister JJ, 2010, J CLIN CHILD ADOLESC, V39, P362, DOI 10.1080/15374411003691743; Cai L, 2011, IRTPRO FLEXIBLE MULT; Cai L., 2011, IRTPRO USERS GUIDE; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; Chen WH, 1997, J EDUC BEHAV STAT, V22, P265, DOI 10.2307/1165285; Cooper J, 2001, BRIT J PSYCHIAT, V179, P85; Crocker L, 1986, INTRO CLASSICAL MODE; De Ayala R.J., 2009, THEORY PRACTICE ITEM; Embretson S., 2000, PSYCHOMETRIC METHODS; EMBRETSON SE, 1999, NEW RULES MEASUREMEN; Ferrando PJ, 2001, APPL PSYCH MEAS, V25, P3, DOI 10.1177/01466216010251001; Fouladi RT, 2002, ASSESSMENT, V9, P204, DOI 10.1177/10791102009002011; Fox C, 2001, APPL RASCH MODEL; Gadow K.D., 1994, CHILD SYMPTOM INVENT; Gomez R, 1999, J CHILD PSYCHOL PSYC, V40, P265, DOI 10.1111/1469-7610.00440; Gomez R, 2008, J ABNORM CHILD PSYCH, V36, P865, DOI 10.1007/s10802-008-9218-8; Gomez R, 2008, PERS INDIV DIFFER, V45, P181, DOI 10.1016/j.paid.2008.04.001; Gomez R, 2007, PERS INDIV DIFFER, V42, P733, DOI 10.1016/j.paid.2006.08.011; Gomez R, 2012, PERS INDIV DIFFER, V53, P963, DOI 10.1016/j.paid.2012.07.012; Gomez R, 2011, ASSESSMENT, V18, P476, DOI 10.1177/1073191110386341; Gomez R, 2011, J ATTEN DISORD, V15, P269, DOI 10.1177/1087054709356404; Hambleton R. K., 1991, FUNDAMENTAL ITEM RES; Herrero J, 2006, COMPUT HUM BEHAV, V22, P830, DOI 10.1016/j.chb.2004.03.007; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Li JP, 2015, J NANOMATER, V2015, DOI 10.1155/2015/431426; Linden WJVD, 1997, HDB MODERN ITEM RESP; Makransky G, 2014, ASSESSMENT, V21, P694, DOI 10.1177/1073191114535242; Meade AW, 2007, ORGAN RES METHODS, V10, P322, DOI 10.1177/1094428106289393; Peyre H, 2014, J CLIN PSYCHIAT, V75, P386, DOI 10.4088/JCP.13m08638; Polanczyk G, 2010, INT J METH PSYCH RES, V19, P177, DOI 10.1002/mpr.319; Purpura DJ, 2010, PSYCHOL ASSESSMENT, V22, P546, DOI 10.1037/a0019581; Reckases MD., 1979, J EDUC STATIST, V4, P207, DOI DOI 10.3102/10769986004003207; Reise SP, 2009, ANNU REV CLIN PSYCHO, V5, P27, DOI 10.1146/annurev.clinpsy.032408.153553; Rosales AG, 2015, EUR CHILD ADOLES PSY, V24, P1325, DOI 10.1007/s00787-015-0683-7; ROST J, 1988, APPL PSYCH MEAS, V12, P397, DOI 10.1177/014662168801200408; Rubio VJ, 2007, EUR J PSYCHOL ASSESS, V23, P39, DOI 10.1027/1015-5759.23.1.39; Samejima F., 1997, HDB MODERN ITEM RESP, P85, DOI [10.1007/978-1-4757-2691-6_5, DOI 10.1007/978-1-4757-2691-6_5]; Samejima F, 2010, HANDBOOK OF POLYTOMOUS ITEM RESPONSE THEORY MODELS, P77; THISSEN D, 1986, PSYCHOMETRIKA, V51, P567, DOI 10.1007/BF02295596; Thissen D, 2006, IRTPRO USERS GUIDE; Vecchione M, 2012, ASSESSMENT, V19, P243, DOI 10.1177/1073191111419091; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Wright B., 1999, MEASUREMENT ESSENTIA, V2nd; Wu A, 2006, PRACT ASSESSMENT RES, V12, P1; Young DJ, 2009, CHILD PSYCHIAT HUM D, V40, P543, DOI 10.1007/s10578-009-0143-z	55	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164474	10.1371/journal.pone.0164474	http://dx.doi.org/10.1371/journal.pone.0164474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736911	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800070
J	Custer, SK; Gilson, TD; Li, HX; Todd, AG; Astroski, JW; Lin, H; Liu, YL; Androphy, EJ				Custer, Sara K.; Gilson, Timra D.; Li, Hongxia; Todd, A. Gary; Astroski, Jacob W.; Lin, Hai; Liu, Yunlong; Androphy, Elliot J.			Altered mRNA Splicing in SMN-Depleted Motor Neuron-Like Cells	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOUSE MODEL; NEURITE OUTGROWTH; SINGLE NUCLEOTIDE; RIT CONTRIBUTES; GENE-PRODUCT; P38 MAPK; IN-VIVO; EXON 2B; PROTEIN	Spinal muscular atrophy (SMA) is an intractable neurodegenerative disease afflicting 1 in 6-10,000 live births. One of the key functions of the SMN protein is regulation of spliceosome assembly. Reduced levels of the SMN protein that are observed in SMA have been shown to result in aberrant mRNA splicing. SMN-dependent mis-spliced transcripts in motor neurons may cause stresses that are particularly harmful and may serve as potential targets for the treatment of motor neuron disease or as biomarkers in the SMA patient population. We performed deep RNA sequencing using motor neuron-like NSC-34 cells to screen for SMN-dependent mRNA processing changes that occur following acute depletion of SMN. We identified SMN-dependent splicing changes, including an intron retention event that results in the production of a truncated Rit1 transcript. This intron-retained transcript is stable and is mis-spliced in spinal cord from symptomatic SMA mice. Constitutively active Rit1 ameliorated the neurite outgrowth defect in SMN depleted NSC-34 cells, while expression of the truncated protein product of the mis-spliced Rit1 transcript inhibited neurite extension. These results reveal new insights into the biological consequence of SMN-dependent splicing in motor neuron-like cells.	[Custer, Sara K.; Gilson, Timra D.; Li, Hongxia; Todd, A. Gary; Astroski, Jacob W.; Androphy, Elliot J.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Lin, Hai; Liu, Yunlong] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Androphy, EJ (corresponding author), Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA.	eandro@iu.edu		Gilson, Timra/0000-0001-5514-2135; Androphy, Elliot/0000-0002-8104-0703	NIH/NINDS [R01 NS082284]; CureSMA Audrey Lewis Young Investigator award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082284] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CureSMA Audrey Lewis Young Investigator award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH/NINDS (http://www.ninds.nih.gov/) R01 NS082284 to EJA and the CureSMA (curesma.org) Audrey Lewis Young Investigator award to SKC.	Ahmad S, 2016, J EXP NEUROSCI, V10, P39, DOI 10.4137/JEN.S33122; Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Bevan AK, 2010, HUM MOL GENET, V19, P3895, DOI 10.1093/hmg/ddq300; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Cai WK, 2012, NEUROSCI LETT, V531, P125, DOI 10.1016/j.neulet.2012.10.036; Cai WK, 2012, J NEUROSCI, V32, P9887, DOI 10.1523/JNEUROSCI.0375-12.2012; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Colak D, 2013, CELL, V153, P1252, DOI 10.1016/j.cell.2013.04.056; Custer SK, 2013, HUM MOL GENET, V22, P4043, DOI 10.1093/hmg/ddt254; Doktor TK, 2017, NUCLEIC ACIDS RES, V45, P395, DOI 10.1093/nar/gkw731; Dombert B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110846; Donlin-Asp PG, 2016, CURR OPIN NEUROBIOL, V39, P53, DOI 10.1016/j.conb.2016.04.004; Fallini C, 2016, J NEUROSCI, V36, P3811, DOI 10.1523/JNEUROSCI.2396-15.2016; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Farooq F, 2013, HUM MOL GENET, V22, P3415, DOI 10.1093/hmg/ddt191; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; Garcia EL, 2013, RNA, V19, P1510, DOI 10.1261/rna.038919.113; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Gogliotti RG, 2010, BIOCHEM BIOPH RES CO, V391, P517, DOI 10.1016/j.bbrc.2009.11.090; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Huo Q, 2014, RNA BIOL, V11, P1430, DOI 10.1080/15476286.2014.996494; Hynds DL, 2003, J CELL SCI, V116, P1925, DOI 10.1242/jcs.00401; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kariya S, 2014, J CLIN INVEST, V124, P785, DOI 10.1172/JCI72017; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Khaladkar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076194; Kim SH, 2008, NEUROREPORT, V19, P521, DOI 10.1097/WNR.0b013e3282f9e473; Lee JA, 2016, NEURON, V89, P113, DOI 10.1016/j.neuron.2015.11.025; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li DK, 2014, SEMIN CELL DEV BIOL, V32, P22, DOI 10.1016/j.semcdb.2014.04.026; Li HX, 2015, HUM MOL GENET, V24, P7295, DOI 10.1093/hmg/ddv428; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Paduch M, 2001, ACTA BIOCHIM POL, V48, P829; Rathod R, 2012, HISTOCHEM CELL BIOL, V138, P737, DOI 10.1007/s00418-012-0989-1; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Rudolph JL, 2007, BBA-MOL CELL RES, V1773, P1793, DOI 10.1016/j.bbamcr.2007.09.008; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Shao HP, 1999, ARCH BIOCHEM BIOPHYS, V371, P207, DOI 10.1006/abbi.1999.1448; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; So BR, 2016, NAT STRUCT MOL BIOL, V23, P225, DOI 10.1038/nsmb.3167; Staropoli JF, 2015, GENOMICS, V105, P220, DOI 10.1016/j.ygeno.2015.01.007; TIAN M, 2012, THE JOURNAL OF NEURO, V32, P5937, DOI DOI 10.1523/JNEUROSCI.5332-11.2012; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wong JJL, 2016, BIOESSAYS, V38, P41, DOI 10.1002/bies.201500117; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Zhang ML, 2001, GENE THER, V8, P1532, DOI 10.1038/sj.gt.3301550; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhang ZX, 2013, P NATL ACAD SCI USA, V110, P19348, DOI 10.1073/pnas.1319280110; Zhou XX, 2014, NUCLEIC ACIDS RES, V42, P4019, DOI 10.1093/nar/gkt1387; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	67	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163954	10.1371/journal.pone.0163954	http://dx.doi.org/10.1371/journal.pone.0163954			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736905	Green Published, gold			2022-12-27	WOS:000385505800031
J	Dong, Z; Hu, JP; Du, BL; He, YZ				Dong, Zhi; Hu, Junpeng; Du, Bolun; He, Yunze			Improvement of Source Number Estimation Method for Single Channel Signal	PLOS ONE			English	Article							PHYSICAL IMPAIRMENTS; JACKKNIFE ESTIMATION; SOURCE SEPARATION; MDL METHOD	Source number estimation methods for single channel signal have been investigated and the improvements for each method are suggested in this work. Firstly, the single channel data is converted to multi-channel form by delay process. Then, algorithms used in the array signal processing, such as Gerschgorin's disk estimation (GDE) and minimum description length (MDL), are introduced to estimate the source number of the received signal. The previous results have shown that the MDL based on information theoretic criteria (ITC) obtains a superior performance than GDE at low SNR. However it has no ability to handle the signals containing colored noise. On the contrary, the GDE method can eliminate the influence of colored noise. Nevertheless, its performance at low SNR is not satisfactory. In order to solve these problems and contradictions, the work makes remarkable improvements on these two methods on account of the above consideration. A diagonal loading technique is employed to ameliorate the MDL method and a jackknife technique is referenced to optimize the data covariance matrix in order to improve the performance of the GDE method. The results of simulation have illustrated that the performance of original methods have been promoted largely.	[Dong, Zhi; Hu, Junpeng] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha 410073, Hunan, Peoples R China; [Du, Bolun; He, Yunze] Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China	National University of Defense Technology - China; Hunan University	Dong, Z (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha 410073, Hunan, Peoples R China.	409377168@qq.com						[Anonymous], 2002, IEEE T SIGNAL PROCES, V50, P20; Barbedo JGA, 2009, IEEE T AUDIO SPEECH, V17, P1435, DOI 10.1109/TASL.2009.2021542; CARLSON BD, 1988, IEEE T AERO ELEC SYS, V24, P397, DOI 10.1109/7.7181; Chambers MJ, 2013, STAT PROBABIL LETT, V83, P1677, DOI 10.1016/j.spl.2013.03.016; Chambers MJ, 2013, J ECONOMETRICS, V172, P142, DOI 10.1016/j.jeconom.2012.09.003; Cheng W, 2014, SENSORS-BASEL, V14, P7625, DOI 10.3390/s140507625; Cheng W, 2012, J SOUND VIB, V331, P5153, DOI 10.1016/j.jsv.2012.06.021; Cordeschi N, 2015, VEH COMMUN, V2, P1, DOI 10.1016/j.vehcom.2014.08.004; Davies ME, 2007, SIGNAL PROCESS, V87, P1819, DOI 10.1016/j.sigpro.2007.01.011; Gao B, 2016, IEEE T IND ELECTRON, V63, P6305, DOI 10.1109/TIE.2016.2574987; Gao B, 2013, IEEE T CIRCUITS-I, V60, P662, DOI 10.1109/TCSI.2012.2215735; Gu JF, 2007, IET SIGNAL PROCESS, V1, P2, DOI 10.1049/iet-spr:20060019; Han KY, 2013, IEEE T SIGNAL PROCES, V61, P6118, DOI 10.1109/TSP.2013.2283462; He YZ, 2012, IEEE SENS J, V12, P2113, DOI 10.1109/JSEN.2012.2184280; Huang L, 2009, IEEE T SIGNAL PROCES, V57, P4135, DOI 10.1109/TSP.2009.2024043; Huang L, 2009, IEEE SIGNAL PROC LET, V16, P798, DOI 10.1109/LSP.2009.2024785; James CJ, 2001, EMBS 2001; Jiang JM, 2002, ANN STAT, V30, P1782, DOI 10.1214/aos/1043351257; Jiling X, 2008, SYSTEMS ENG ELECT, V30, P46; King BJ, 2011, IEEE T AUDIO SPEECH, V19, P2591, DOI 10.1109/TASL.2011.2156786; Ma N, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL V, PROCEEDINGS, P341; QUENOUILLE MH, 1949, ANN MATH STAT, V20, P355, DOI 10.1214/aoms/1177729989; Reddy AM, 2007, IEEE T AUDIO SPEECH, V15, P1766, DOI 10.1109/TASL.2007.901310; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Roman-Montoya Y, 2008, COMPUTATION STAT, V23, P573, DOI 10.1007/s00180-007-0099-z; ROY R, 1989, IEEE T ACOUST SPEECH, V37, P984, DOI 10.1109/29.32276; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Shojafar M, 2015, WIRELESS PERS COMMUN, V82, P61, DOI 10.1007/s11277-014-2194-0; Song H., 2011, P IEEE INT C COMM IC; Song H, 2011, P IEEE GLOB COMM C G; Song H, 2013, P IEEE GLOB COMM C G; Song HB, 2013, J LIGHTWAVE TECHNOL, V31, P846, DOI 10.1109/JLT.2012.2235409; Song HB, 2012, J LIGHTWAVE TECHNOL, V30, P713, DOI 10.1109/JLT.2011.2180360; Szu H, 2002, NEUROCOMPUTING, V48, P1015, DOI 10.1016/S0925-2312(02)00595-7; Warner ES, 2003, IEE P-RADAR SON NAV, V150, P396, DOI 10.1049/ip-rsn:20031007; WAX M, 1985, IEEE T ACOUST SPEECH, V33, P387, DOI 10.1109/TASSP.1985.1164557; WU HT, 1994, INT CONF ACOUST SPEE, P261; Xiao M, 2012, J COMMUNICATIONS NET, V14; Xiao ML, 2012, J COMMUN NETW-S KOR, V14, P481, DOI 10.1109/JCN.2012.00004; Yang RZ, 2015, MEASUREMENT, V66, P54, DOI 10.1016/j.measurement.2015.01.024; 1974, IEEE T AUTOMATIC CON, V19, P716	42	4	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164654	10.1371/journal.pone.0164654	http://dx.doi.org/10.1371/journal.pone.0164654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736959	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800106
J	Gritsenko, V; Hardesty, RL; Boots, MT; Yakovenko, S				Gritsenko, Valeriya; Hardesty, Russell L.; Boots, Mathew T.; Yakovenko, Sergiy			Biomechanical Constraints Underlying Motor Primitives Derived from the Musculoskeletal Anatomy of the Human Arm	PLOS ONE			English	Article							MUSCLE SYNERGIES; LOCOMOTOR CONTROL; DYNAMIC SIMULATIONS; CORTICAL CONTROL; SPINAL-CORD; MOVEMENTS; PERSPECTIVE; CORTEX; LIMB; MICROSTIMULATION	Neural control of movement can only be realized though the interaction between the mechanical properties of the limb and the environment. Thus, a fundamental question is whether anatomy has evolved to simplify neural control by shaping these interactions in a beneficial way. This inductive data-driven study analyzed the patterns of muscle actions across multiple joints using the musculoskeletal model of the human upper limb. This model was used to calculate muscle lengths across the full range of motion of the arm and examined the correlations between these values between all pairs of muscles. Musculoskeletal coupling was quantified using hierarchical clustering analysis. Muscle lengths between multiple pairs of muscles across multiple postures were highly correlated. These correlations broadly formed two proximal and distal groups, where proximal muscles of the arm were correlated with each other and distal muscles of the arm and hand were correlated with each other, but not between groups. Using hierarchical clustering, between 11 and 14 reliable muscle groups were identified. This shows that musculoskeletal anatomy does indeed shape the mechanical interactions by grouping muscles into functional clusters that generally match the functional repertoire of the human arm. Together, these results support the idea that the structure of the musculoskeletal system is tuned to solve movement complexity problem by reducing the dimensionality of available solutions.	[Gritsenko, Valeriya; Hardesty, Russell L.; Yakovenko, Sergiy] West Virginia Univ, Sch Med, Dept Human Performance, Morgantown, WV 26506 USA; [Gritsenko, Valeriya; Boots, Mathew T.; Yakovenko, Sergiy] West Virginia Univ, Benjamin M Statler Coll Engn & Mineral Resources, Dept Mech & Aerosp Engn, Morgantown, WV 26506 USA; [Gritsenko, Valeriya; Hardesty, Russell L.; Boots, Mathew T.; Yakovenko, Sergiy] West Virginia Univ, Sch Med, Ctr Neurosci, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Yakovenko, S (corresponding author), West Virginia Univ, Sch Med, Dept Human Performance, Morgantown, WV 26506 USA.; Yakovenko, S (corresponding author), West Virginia Univ, Benjamin M Statler Coll Engn & Mineral Resources, Dept Mech & Aerosp Engn, Morgantown, WV 26506 USA.; Yakovenko, S (corresponding author), West Virginia Univ, Sch Med, Ctr Neurosci, Morgantown, WV 26506 USA.	seyakovenko@hsc.wvu.edu	Hardesty, Russell/ABF-2911-2020	Hardesty, Russell/0000-0001-5065-0157; Yakovenko, Sergiy/0000-0002-5946-6409; Gritsenko, Valeriya/0000-0002-6408-9433	U.S. Army Research Office; Defense Advanced Research Projects Agency (DARPA) [W911NF-15-2-0016]; National Institute of Health, National Institute of General Medical Sciences (NIH/NIGMS) [U54GM104942]; Ruby Distinguished Doctoral Fellowship; NIH/NIGMS Centers of Biomedical Research Excellence (CoBRE) award [P20GM109098]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109098] Funding Source: NIH RePORTER	U.S. Army Research Office; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institute of Health, National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruby Distinguished Doctoral Fellowship; NIH/NIGMS Centers of Biomedical Research Excellence (CoBRE) award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was sponsored by the U.S. Army Research Office and the Defense Advanced Research Projects Agency (DARPA) under Cooperative Agreement Number W911NF-15-2-0016 (http://www.darpa.mil). The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Office, Army Research Laboratory, or the U.S. Government. The U.S.Government is authorized to reproduce and distribute reprints for Government purposes not with standing any copyright notation here on. This study was also supported by National Institute of Health, National Institute of General Medical Sciences (NIH/NIGMS) U54GM104942 to RLH (https://www.nigms.nih.gov). MTB was supported by the Ruby Distinguished Doctoral Fellowship (http://graduate.wvu.edu/funding-and-costs/fellowships-and-scholarships/ruby-distinguished doctoral-fellowships). SY and VG were also supported with salary support by the NIH/NIGMS Centers of Biomedical Research Excellence (CoBRE) award P20GM109098 (https://www.nigms.nih.gov/research/crcb/IDeA/pages/COBRE.aspx). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asatryan DG., 1965, BIOPHYSICS-USSR, V10, P925; Bernstein NA, 1967, COORDINATION REGULAT, DOI [10.1234/12345678, DOI 10.1234/12345678]; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Brown IE, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P148; Cheung VCK, 2009, P NATL ACAD SCI USA, V106, P19563, DOI 10.1073/pnas.0910114106; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Cos I, 2014, J NEUROPHYSIOL, V112, P1256, DOI 10.1152/jn.00147.2014; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Drew T, 2015, CURR OPIN NEUROBIOL, V33, P25, DOI 10.1016/j.conb.2015.01.011; Full RJ, 1999, J EXP BIOL, V202, P3325; Gillard DM, 2000, J BIOMECH, V33, P1341, DOI 10.1016/S0021-9290(00)00127-5; GISZTER SF, 1993, J NEUROSCI, V13, P467; Gray H., 2000, ANATOMY HUMAN BODY; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Howard IS, 2009, J NEUROPHYSIOL, V102, P1902, DOI 10.1152/jn.00013.2009; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Jeannerod M, 1998, NOVART FDN SYMP, V218, P5; JOYCE GC, 1969, J PHYSIOL-LONDON, V204, P475, DOI 10.1113/jphysiol.1969.sp008925; Kawato M, 2007, CURR OPIN NEUROBIOL, V17, P205, DOI 10.1016/j.conb.2007.03.004; Krouchev N, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00083; Kuo A.D., 2001, CLASSICS MOVEMENT SC, P289; Kutch JJ, 2008, J NEUROPHYSIOL, V100, P2455, DOI 10.1152/jn.90274.2008; Kutch JJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002434; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Lombard WP., 1903, AME PHY EDU REV, V8, P141; Overduin SA, 2015, J NEUROSCI, V35, P12615, DOI 10.1523/JNEUROSCI.4302-14.2015; PATLA AE, 1985, J MOTOR BEHAV, V17, P443; Prochazka A, 2007, PROG BRAIN RES, V165, P255, DOI 10.1016/S0079-6123(06)65016-4; RACK PMH, 1974, J PHYSIOL-LONDON, V240, P331, DOI 10.1113/jphysiol.1974.sp010613; Rana M, 2015, J NEUROSCI, V35, P14708, DOI 10.1523/JNEUROSCI.1971-15.2015; Sartori M, 2012, J BIOMECH, V45, P595, DOI 10.1016/j.jbiomech.2011.10.040; Saul KR, 2015, COMPUT METHOD BIOMEC, V18, P1445, DOI 10.1080/10255842.2014.916698; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Sherrington CS, 1909, P R SOC LOND B-CONTA, V81, P249, DOI 10.1098/rspb.1909.0022; Stepniewska I, 2009, J COMP NEUROL, V517, P765, DOI 10.1002/cne.22181; TAGA G, 1991, BIOL CYBERN, V65, P147, DOI 10.1007/BF00198086; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; Valero-Cuevas FJ, 2015, J BIOMECH, V48, P2887, DOI 10.1016/j.jbiomech.2015.04.026; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001; Yakovenko S, 2004, BIOL CYBERN, V90, P146, DOI 10.1007/s00422-003-0449-z; Yakovenko S, 2015, J NEUROSCI, V35, P14476, DOI 10.1523/JNEUROSCI.1908-15.2015; Yakovenko S, 2011, PROG BRAIN RES, V188, P151, DOI 10.1016/B978-0-444-53825-3.00015-2; Yakovenko S, 2011, J NEUROPHYSIOL, V105, P388, DOI 10.1152/jn.00469.2010; Zehr EP, 2007, J PHYSIOL-LONDON, V582, P209, DOI 10.1113/jphysiol.2007.133843	51	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164050	10.1371/journal.pone.0164050	http://dx.doi.org/10.1371/journal.pone.0164050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736890	Green Published, gold			2022-12-27	WOS:000385505800037
J	Konno, A; Romero, T; Inoue-Murayama, M; Saito, A; Hasegawa, T				Konno, Akitsugu; Romero, Teresa; Inoue-Murayama, Miho; Saito, Atsuko; Hasegawa, Toshikazu			Dog Breed Differences in Visual Communication with Humans	PLOS ONE			English	Article							COMPARATIVE SOCIAL COGNITION; HUMAN POINTING GESTURES; WOLVES CANIS-LUPUS; DOMESTICATION; FAMILIARIS; PERFORMANCE; EVOLUTION; SELECTION; BEHAVIOR; COMPREHENSION	Domestic dogs (Canis familiaris) have developed a close relationship with humans through the process of domestication. In human-dog interactions, eye contact is a key element of relationship initiation and maintenance. Previous studies have suggested that canine ability to produce human-directed communicative signals is influenced by domestication history, from wolves to dogs, as well as by recent breed selection for particular working purposes. To test the genetic basis for such abilities in purebred dogs, we examined gazing behavior towards humans using two types of behavioral experiments: the 'visual contact task' and the 'unsolvable task'. A total of 125 dogs participated in the study. Based on the genetic relatedness among breeds subjects were classified into five breed groups: Ancient, Herding, Hunting, Retriever-Mastiff and Working). We found that it took longer time for Ancient breeds to make an eye-contact with humans, and that they gazed at humans for shorter periods of time than any other breed group in the unsolvable situation. Our findings suggest that spontaneous gaze behavior towards humans is associated with genetic similarity to wolves rather than with recent selective pressure to create particular working breeds.	[Konno, Akitsugu; Romero, Teresa] Japan Soc Promot Sci, Chiyoda Ku, Kojimachi 5-3-1, Tokyo, Japan; [Konno, Akitsugu; Romero, Teresa; Saito, Atsuko; Hasegawa, Toshikazu] Univ Tokyo, Dept Cognit & Behav Sci, Meguro Ku, Komaba 3-8-1, Tokyo, Japan; [Konno, Akitsugu; Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Tanaka Sekiden Cho 2-24, Kyoto, Japan	Japan Society for the Promotion of Science; University of Tokyo; Kyoto University	Konno, A (corresponding author), Japan Soc Promot Sci, Chiyoda Ku, Kojimachi 5-3-1, Tokyo, Japan.; Konno, A (corresponding author), Univ Tokyo, Dept Cognit & Behav Sci, Meguro Ku, Komaba 3-8-1, Tokyo, Japan.; Konno, A (corresponding author), Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Tanaka Sekiden Cho 2-24, Kyoto, Japan.	akitsugukonno@gmail.com	Saito, Atsuko/AAM-7028-2021	Konno, Akitsugu/0000-0003-2517-7761	MEXT [23650132, 25118005, 25118003]; JSPS [P10311, 213762, 243684]; Grants-in-Aid for Scientific Research [25118003] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the MEXT with a Grant-in-aid for Challenging Exploratory Research (No. 23650132, to T.H.), and for Scientific Research on Innovative Areas 'The Evolutionary Origin and Neural Basis of the Empathetic Systems' (No. 25118005 to M.M., No. 25118003 to T.H.) and by the JSPS Research Fellowships for Foreign Researchers to T.R. (No. P10311) and for Young Scientists to A.K. (No. 213762 and 243684).	[Anonymous], 1992, COMPL DOG BOOK; Barrera G, 2011, ANIM COGN, V14, P727, DOI 10.1007/s10071-011-0407-4; Bentosela M, 2008, BEHAV PROCESS, V78, P464, DOI 10.1016/j.beproc.2008.03.004; Bentosela M, 2009, J COMP PSYCHOL, V123, P125, DOI 10.1037/a0013340; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Clutton-Brock Juliet, 1995, P7; Federation Cynologique Internationale, 1993, COMPL DESCR ALL FCI; FRANK H, 1985, J COMP PSYCHOL, V99, P266, DOI 10.1037/0735-7036.99.3.266; FRANK H, 1982, ANIM BEHAV, V30, P95, DOI 10.1016/S0003-3472(82)80241-8; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Jakovcevic A, 2010, BEHAV PROCESS, V84, P602, DOI 10.1016/j.beproc.2010.04.003; Kubinyi E, 2007, COMP COGN BEHAV REV, V2, P26; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Marshall-Pescini S, 2008, BEHAV PROCESS, V78, P449, DOI 10.1016/j.beproc.2008.02.022; Marshall-Pescini S, 2009, BEHAV PROCESS, V81, P416, DOI 10.1016/j.beproc.2009.03.015; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; Nagasawa M, 2009, HORM BEHAV, V55, P434, DOI 10.1016/j.yhbeh.2008.12.002; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Passalacqua C, 2011, ANIM BEHAV, V82, P1043, DOI 10.1016/j.anbehav.2011.07.039; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Smith BP, 2010, ANIM COGN, V13, P367, DOI 10.1007/s10071-009-0287-z; Svartberg K, 2006, APPL ANIM BEHAV SCI, V96, P293, DOI 10.1016/j.applanim.2005.06.014; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wayne RK, 2012, MAMM GENOME, V23, P3, DOI 10.1007/s00335-011-9386-7; Wobber V, 2009, INTERACT STUD, V10, P206, DOI 10.1075/is.10.2.06wob; Wynne CDL, 2008, ANIM BEHAV, V76, pE1, DOI 10.1016/j.anbehav.2008.03.010	43	24	24	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164760	10.1371/journal.pone.0164760	http://dx.doi.org/10.1371/journal.pone.0164760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736990	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000385505800127
J	Lowe, CW; Satterfield, BA; Nelson, DB; Thiriot, JD; Heder, MJ; March, JK; Drake, DS; Lew, CS; Bunnell, AJ; Moore, ES; O'Neill, KL; Robison, RA				Lowe, Chinn-Woan; Satterfield, Benjamin A.; Nelson, Daniel B.; Thiriot, Joseph D.; Heder, Michael J.; March, Jordon K.; Drake, David S.; Lew, Cynthia S.; Bunnell, Annette J.; Moore, Emily S.; O'Neill, Kim L.; Robison, Richard A.			A Quadruplex Real-Time PCR Assay for the Rapid Detection and Differentiation of the Most Relevant Members of the B. pseudomallei Complex: B. mallei, B. pseudomallei, and B-thailandensis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; III SECRETION SYSTEM; BURKHOLDERIA-PSEUDOMALLEI; IMMUNOFLUORESCENCE MICROSCOPY; PSEUDOMONAS-PSEUDOMALLEI; CLINICAL-EVALUATION; IMMUNOGLOBULIN-M; API 20NE; MELIOIDOSIS; IDENTIFICATION	The Burkholderia pseudomallei complex classically consisted of B. mallei, B. pseudomallei, and B. thailandensis, but has now expanded to include B. oklahomensis, B. humptydooensis, and three unassigned Burkholderia clades. Methods for detecting and differentiating the B. pseudomallei complex has been the topic of recent research due to phenotypic and genotypic similarities of these species. B. mallei and B. pseudomallei are recognized as CDC Tier 1 select agents, and are the causative agents of glanders and melioidosis, respectively. Although B. thailandensis and B. oklahomensis are generally avirulent, both display similar phenotypic characteristics to that of B. pseudomallei. B. humptydooensis and the Burkholderia clades are genetically similar to the B. pseudomallei complex, and are not associated with disease. Optimal identification of these species remains problematic, and PCR-based methods can resolve issues with B. pseudomallei complex detection and differentiation. Currently, no PCR assay is available that detects the major species of the B. pseudomallei complex. A real-time PCR assay in a multiplex single-tube format was developed to simultaneously detect and differentiate B. mallei, B. pseudomallei, and B. thailandensis, and a common sequence found in B. pseudomallei, B. mallei, B. thailandensis, and B. oklahomensis. A total of 309 Burkholderia isolates and 5 other bacterial species were evaluated. The assay was 100% sensitive and specific, demonstrated sensitivity beyond culture and GC methods for the isolates tested, and is completed in about an hour with a detection limit between 2.6pg and 48.9pg of gDNA. Bioinformatic analyses also showed the assay is likely 100% specific and sensitive for all 84 fully sequenced B. pseudomallei, B. mallei, B. thailandensis, and B. oklahomensis strains currently available in GenBank. For these reasons, this assay could be a rapid and sensitive tool in the detection and differentiation for those species of the B. pseudomallei complex with recognized clinical and practical significance.	[Lowe, Chinn-Woan; Satterfield, Benjamin A.; Nelson, Daniel B.; Thiriot, Joseph D.; Heder, Michael J.; March, Jordon K.; Drake, David S.; Lew, Cynthia S.; Bunnell, Annette J.; Moore, Emily S.; O'Neill, Kim L.; Robison, Richard A.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University	Robison, RA (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	richard_robison@byu.edu		Nelson, Daniel/0000-0001-9249-4439; Robison, Richard/0000-0002-4324-5169; Satterfield, Benjamin/0000-0002-7798-0938	Office of Research & Creative Activities - Mentoring Environment Grants [547]	Office of Research & Creative Activities - Mentoring Environment Grants	This study was supported by the Office of Research & Creative Activities - Mentoring Environment Grants 547, https://orca.byu.edu/meg/.	Alibek K, 1999, BIOHAZARD CHILLING T; Amornchai P, 2007, J CLIN MICROBIOL, V45, P3774, DOI 10.1128/JCM.00935-07; Anuntagool N, 2000, J MED MICROBIOL, V49, P1075, DOI 10.1099/0022-1317-49-12-1075; Bowers Jolene R, 2010, PLoS One, V5, pe15413, DOI 10.1371/journal.pone.0015413; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Brilhante RSN, 2012, J CLIN MICROBIOL, V50, P3349, DOI 10.1128/JCM.01577-12; Carr-Gregory B, 2007, MED ASPECTS BIOL WAR, P121; Chantratita N, 2008, J CLIN MICROBIOL, V46, P568, DOI 10.1128/JCM.01817-07; Chantratita N, 2007, AM J TROP MED HYG, V77, P814, DOI 10.4269/ajtmh.2007.77.814; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Chen YS, 2010, J CLIN MICROBIOL, V48, P1432, DOI 10.1128/JCM.01720-09; Cheng AC, 2006, AM J TROP MED HYG, V74, P330, DOI 10.4269/ajtmh.2006.74.330; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2010, CURR OPIN INFECT DIS, V23, P554, DOI 10.1097/QCO.0b013e32833fb88c; Chenthamarakshan V, 2001, DIAGN MICR INFEC DIS, V39, P1, DOI 10.1016/S0732-8893(00)00212-1; Christopher GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/jama.278.5.412; Currie B.J., 2010, MANDELL DOUGLAS BENN, V7th ed., P2869; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Dance D.A, 1996, WELLCOME TRUST ILLUS, P72; Depoorter E, 2016, APPL MICROBIOL BIOT, V100, P5215, DOI 10.1007/s00253-016-7520-x; DeShazer D, 2007, FEMS MICROBIOL LETT, V277, P64, DOI 10.1111/j.1574-6968.2007.00946.x; Dharakul T, 1999, J CLIN MICROBIOL, V37, P1906, DOI 10.1128/JCM.37.6.1906-1912.1999; Fredricks DN, 1999, CLIN INFECT DIS, V29, P475, DOI 10.1086/598618; Frickmann H, 2012, EUR J MICROBIOL IMMU, V2, P148, DOI 10.1556/EuJMI.2.2012.2.8; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gee JE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-54; Gee JE, 2003, J CLIN MICROBIOL, V41, P4647, DOI 10.1128/JCM.41.10.4647-4654.2003; Gilad Jacob, 2007, Recent Pat Antiinfect Drug Discov, V2, P233, DOI 10.2174/157489107782497335; Ginther JL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003892; Glass MB, 2005, J CLIN MICROBIOL, V43, P479, DOI 10.1128/JCM.43.1.479-483.2005; Glass MB, 2006, INT J SYST EVOL MICR, V56, P2171, DOI 10.1099/ijs.0.63991-0; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Hagen RM, 2011, INT J MED MICROBIOL, V301, P585, DOI 10.1016/j.ijmm.2011.04.017; Hagen RM, 2002, J CLIN PATHOL-MOL PA, V55, P398, DOI 10.1136/mp.55.6.398; Ho CC, 2011, J CLIN MICROBIOL, V49, P814, DOI 10.1128/JCM.01702-10; Inglis TJJ, 2012, AM J TROP MED HYG, V86, P1039, DOI 10.4269/ajtmh.2012.11-0454; Inglis TJJ, 2005, J CLIN MICROBIOL, V43, P2201, DOI 10.1128/JCM.43.5.2201-2206.2005; Inglis TJJ, 2003, J CLIN MICROBIOL, V41, P4812, DOI 10.1128/JCM.41.10.4812-4814.2003; Inglis TJJ, 1998, PATHOLOGY, V30, P62, DOI 10.1080/00313029800169685; Innis MA, 1990, 1 OPTIMIZATION PCRS, P3; John TJ, 1996, INDIAN J MED RES, V103, P62; Kaestli M, 2007, APPL ENVIRON MICROB, V73, P6891, DOI 10.1128/AEM.01038-07; Kaestli M, 2012, J CLIN MICROBIOL, V50, P2059, DOI 10.1128/JCM.06737-11; Ke XY, 2001, BIOINFORMATICS, V17, P838, DOI 10.1093/bioinformatics/17.9.838; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Koh SF, 2012, J MICROBIOL METH, V90, P305, DOI 10.1016/j.mimet.2012.06.002; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; KWOK S, 1994, PCR METH APPL, V3, pS39; Lee MA, 2005, FEMS IMMUNOL MED MIC, V43, P413, DOI 10.1016/j.femsim.2004.10.008; Lehavi O, 2002, HAREFUAH, V141, P88; Lertpatanasuwan N, 1999, CLIN INFECT DIS, V28, P927, DOI 10.1086/517253; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Lowe P, 2002, J CLIN MICROBIOL, V40, P4625, DOI 10.1128/JCM.40.12.4625-4627.2002; Lowe W, 2014, CURR ISSUES MOL BIOL, V16, P23, DOI 10.21775/cimb.016.023; MCCORMICK JB, 1977, J INFECT DIS, V135, P103, DOI 10.1093/infdis/135.1.103; Meumann EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/cid/cir808; Neubauer H, 2007, ZOONOSES PUBLIC HLTH, V54, P44, DOI 10.1111/j.1863-2378.2007.01008.x; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; NUSSBAUM JJ, 1980, ARCH OPHTHALMOL-CHIC, V98, P1224; Pal V, 2012, CLIN VACCINE IMMUNOL, V19, P1193, DOI 10.1128/CVI.00137-12; Price EP, 2016, J MED MICROBIOL, V65, P992, DOI 10.1099/jmm.0.000312; Price EP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037723; Purcell MK, 2011, J AQUAT ANIM HEALTH, V23, P148, DOI 10.1080/08997659.2011.620217; Puthucheary SD, 2012, J MOL MICROB BIOTECH, V22, P198, DOI 10.1159/000338985; Rainbow L, 2002, J MED MICROBIOL, V51, P374, DOI 10.1099/0022-1317-51-5-374; RUBIN HL, 1963, MIL MED, V128, P538, DOI 10.1093/milmed/128.6.538; Samosornsuk N, 1999, AM J TROP MED HYG, V61, P735, DOI 10.4269/ajtmh.1999.61.735; Satterfield BA, 2010, J MED MICROBIOL, V59, P55, DOI 10.1099/jmm.0.012567-0; Scholz HC, 2006, DIAGN MICR INFEC DIS, V54, P241, DOI 10.1016/j.diagmicrobio.2005.09.018; Spickler A.R, 2008, HDB ZOONOTIC DIS COM, P133; Sprague LD, 2002, FEMS IMMUNOL MED MIC, V34, P231, DOI 10.1111/j.1574-695X.2002.tb00629.x; Steinmetz I, 1999, J CLIN MICROBIOL, V37, P225, DOI 10.1128/JCM.37.1.225-228.1999; Supaprom C, 2007, J CLIN MICROBIOL, V45, P2894, DOI 10.1128/JCM.00291-07; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanpiboonsak S, 2004, MOL CELL PROBE, V18, P97, DOI 10.1016/j.mcp.2003.09.010; Thibault FM, 2004, J CLIN MICROBIOL, V42, P5871, DOI 10.1128/JCM.42.12.5871-5874.2004; Tomaso H, 2006, CLIN CHEM, V52, P307, DOI 10.1373/clinchem.2005.059196; Trung TT, 2011, APPL ENVIRON MICROB, V77, P6486, DOI 10.1128/AEM.00735-11; U'Ren JM, 2005, J CLIN MICROBIOL, V43, P5771, DOI 10.1128/JCM.43.11.5771-5774.2005; Ulrich RL, 2006, DIAGN MICR INFEC DIS, V55, P37, DOI 10.1016/j.diagmicrobio.2005.11.007; Walsh AL, 1995, CLIN INFECT DIS, V21, P1498, DOI 10.1093/clinids/21.6.1498; WALSH AL, 1994, J CLIN PATHOL, V47, P377, DOI 10.1136/jcp.47.4.377; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; Winstanley C, 2000, J CLIN MICROBIOL, V38, P883, DOI 10.1128/JCM.38.2.883-885.2000; Woo PCY, 2002, DIAGN MICR INFEC DIS, V44, P143, DOI 10.1016/S0732-8893(02)00439-X; Wuthiekanun V, 2005, CLIN DIAGN LAB IMMUN, V12, P555, DOI 10.1128/CDLI.12.4.555-556.2005; Wuthiekanun V, 2004, J CLIN MICROBIOL, V42, P3435, DOI 10.1128/JCM.42.8.3435-3437.2004; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8	93	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164006	10.1371/journal.pone.0164006	http://dx.doi.org/10.1371/journal.pone.0164006			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736903	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800034
J	Wang, ZX; Hu, YD; Wang, YY; Han, W; Wang, L; Xue, F; Sui, X; Song, W; Shi, RH; Jiang, JM				Wang, Zixing; Hu, Yaoda; Wang, Yuyan; Han, Wei; Wang, Lei; Xue, Fang; Sui, Xin; Song, Wei; Shi, Ruihong; Jiang, Jingmei			Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DOSE COMPUTED-TOMOGRAPHY; HISTOLOGY SHIFT; SPIRAL CT; BASE-LINE; OVERDIAGNOSIS; TRIAL; SMOKERS; COHORT; ADENOCARCINOMA; ASSOCIATION	Objectives To portray the stage characteristics of lung cancers detected in CT screenings, and explore whether there's universal stage superiority over other methods for various pathological types using available data worldwide in a meta-analysis approach. Materials and Methods EMBASE and MEDLINE were searched for studies on lung cancer CT screening in natural populations through July 2015 without language or other filters. Twenty-four studies (8 trials and 16 cohorts) involving 1875 CT-detected lung cancer patients were enrolled and assessed by QUADAS-2. Pathology-confirmed stage information was carefully extracted by two reviewers. Stage I or limited stage proportions were pooled by random effect model with Freeman-Tukey double arcsine transformation. Results Pooled stage I cancer proportion in CT screenings was 73.2% (95% confidence interval: 68.6%, 77.5%), with a significant rising trend (P-trend <0.05) from baseline (64.7%) to >= 5 repeat rounds (87.1%). Relative to chest radiograph and usual care, the increased stage I proportions in CT were 12.2% (P>0.05), and 46.5% (P<0.05), respectively. Pathology-specifically, adenocarcinomas (66%) and squamous cell lung cancers (17%) composed the majority of CT-detected lung cancers, and had significantly higher stage I proportions relative to chest radiograph (bronchioloalveolar adenocarcinomas, 80.9% vs 51.4%; other adenocarcinomas, 58.8% vs 38.3%; squamous cell lung cancers, 52.3% vs 38.3%; all P<0.05). However, the percentage of small cell lung cancer was lower using CT than other detection routes, and no significant difference in limited stage proportion was observed (6.8% vs 10.8%, P>0.05). Conclusion CT screening can detect more early stage non-small cell lung cancers, but not all of them could be beneficial as there are a considerable number of indolent ones such as bronchioloalveolar adenocarcinomas. Still, current evidence is lacking regarding small cell lung cancers.	[Wang, Zixing; Hu, Yaoda; Wang, Yuyan; Han, Wei; Wang, Lei; Xue, Fang; Jiang, Jingmei] Chinese Acad Med Sci, Inst Basic Med Sci, Sci Basic Med, Peking Union Med Coll, Beijing, Peoples R China; [Sui, Xin; Song, Wei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Shi, Ruihong] State Food & Drug Adm, Natl Inst Food & Drug Control, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; National Institute of Food & Drug Control - China	Jiang, JM (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Sci Basic Med, Peking Union Med Coll, Beijing, Peoples R China.	jingmeijiang238@hotmail.com	Wang, Yuyan/GQZ-8255-2022	Wang, Yuyan/0000-0003-3747-0762				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ali MU, 2016, PREV MED, V89, P301, DOI 10.1016/j.ypmed.2016.04.015; Bach PB, 2008, LANCET ONCOL, V9, P693, DOI 10.1016/S1470-2045(08)70176-1; Bastarrika G, 2005, AM J RESP CRIT CARE, V171, P1378, DOI 10.1164/rccm.200411-1479OC; Becker N, 2015, J THORAC ONCOL, V10, P890, DOI 10.1097/JTO.0000000000000530; Braillon A, 2014, J CLIN ONCOL, V32, P3575, DOI 10.1200/JCO.2014.55.9732; Chong SM, 2005, J KOREAN MED SCI, V20, P402, DOI 10.3346/jkms.2005.20.3.402; Diederich S, 2004, EUR RADIOL, V14, P691, DOI 10.1007/s00330-003-2200-5; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Henschke CI, 2002, CANCER J, V8, pS47; Hillerdal G, 2008, J THORAC ONCOL, V3, P208, DOI 10.1097/JTO.0b013e3181653ce3; Horeweg N, 2014, LANCET ONCOL, V15, P1342, DOI 10.1016/S1470-2045(14)70387-0; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Jones GS, 2015, MINERVA MED, V106, P339; Li F, 2003, ACAD RADIOL, V10, P1013, DOI 10.1016/S1076-6332(03)00150-8; Liu XG, 2011, LUNG CANCER, V73, P230, DOI 10.1016/j.lungcan.2010.11.012; Manser R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001991.pub3; Mckee BJ, 2015, J AM COLL RADIOL, V12, P192, DOI 10.1016/j.jacr.2014.08.002; Menezes RJ, 2010, LUNG CANCER, V67, P177, DOI 10.1016/j.lungcan.2009.03.030; Mulshine JL, 2014, CA-CANCER J CLIN, V64, P352, DOI 10.3322/caac.21239; Nawa T, 2002, CHEST, V122, P15, DOI 10.1378/chest.122.1.15; Nawa T, 2015, J THORAC IMAG, V30, P108, DOI 10.1097/RTI.0000000000000138; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Pastorino U, 2012, EUR J CANCER PREV, V21, P308, DOI 10.1097/CEJ.0b013e328351e1b6; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Pegna AL, 2013, J THORAC ONCOL, V8, P866, DOI 10.1097/JTO.0b013e31828f68d6; Pelosi G, 2008, LUNG CANCER, V62, P202, DOI 10.1016/j.lungcan.2008.03.012; Rzyman W, 2015, POL ARCH MED WEWN, V125, P232, DOI 10.20452/pamw.2778; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Seki N, 2010, LUNG CANCER, V67, P318, DOI 10.1016/j.lungcan.2009.04.016; Shaham D, 2006, CLIN LUNG CANCER, V7, P262, DOI 10.3816/CLC.2006.n.004; Silva M, 2016, J THORAC ONCOL, V11, P187, DOI 10.1016/j.jtho.2015.10.014; Silvestri GA, 2011, ANN INTERN MED, V155, P537, DOI 10.7326/0003-4819-155-8-201110180-00364; Spiro SG, 2016, THORAX, V71, P91, DOI 10.1136/thoraxjnl-2015-207433; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Tang Wei, 2014, Zhonghua Zhong Liu Za Zhi, V36, P549; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Vazquez M, 2009, LUNG CANCER, V64, P148, DOI 10.1016/j.lungcan.2008.08.009; Veronesi G, 2013, LUNG CANCER, V82, P426, DOI 10.1016/j.lungcan.2013.08.026; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Wilson DO, 2012, AM J RESP CRIT CARE, V185, P85, DOI 10.1164/rccm.201107-1223OC; Young RP, 2015, AM J RESP CRIT CARE, V192, P1060, DOI 10.1164/rccm.201505-0894OC; Young RP, 2015, AM J RESP CRIT CARE, V192, P398, DOI 10.1164/rccm.201504-0801LE; Young RP, 2013, AM J RESP CRIT CARE, V188, P1034, DOI 10.1164/rccm.201305-0832LE; Yousem SA, 2007, ARCH PATHOL LAB MED, V131, P1027; Zhao SJ, 2015, THORAC CANCER, V6, P385, DOI 10.1111/1759-7714.12253	50	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164416	10.1371/journal.pone.0164416	http://dx.doi.org/10.1371/journal.pone.0164416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736916	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800065
J	Wilczynski, M; Danielska, J; Dzieniecka, M; Szymanska, B; Wojciechowski, M; Malinowski, A				Wilczynski, Milosz; Danielska, Justyna; Dzieniecka, Monika; Szymanska, Bozena; Wojciechowski, Michal; Malinowski, Andrzej			Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MICRORNAS; MIR-205; EXPRESSION; IDENTIFICATION; CARCINOMA; PROLIFERATION; DEREGULATION; INVASION; TISSUES	Endometrial cancer is one of the most common malignancies of the reproductive female tract, with endometrioid endometrial cancer being the most frequent type. Despite the relatively favourable prognosis in cases of endometrial cancer, there is a necessity to evaluate clinical and prognostic utility of new molecular markers. MiRNAs are small, non-coding RNA molecules that take part in RNA silencing and post-transcriptional regulation of gene expression. Altered expression of miRNAs may be associated with cancer initiation, progression and metastatic capabilities. MiRNA-205 seems to be one of the key regulators of gene expression in endometrial cancer. In this study, we investigated clinical and prognostic role of miRNA-205 in endometrioid endometrial cancer. After total RNA extraction from 100 archival formalin-fixed paraffin-embedded tissues, real-time quantitative RT-PCR was used to define miRNA-205 expression levels. The aim of the study was to evaluate miRNA-205 expression levels in regard to patients' clinical and histopathological features, such as: survival rate, recurrence rate, staging, myometrial invasion, grading and lymph nodes involvement. Higher levels of miRNA-205 expression were observed in tumours with less than half of myometrial invasion and non-advanced cancers. Kaplan-Maier analysis revealed that higher levels of miRNA-205 were associated with better overall survival (p = 0,034). These results indicate potential clinical utility of miRNA-205 as a prognostic marker.	[Wilczynski, Milosz; Wojciechowski, Michal] Polish Mothers Mem Hosp, Res Inst, Dept Operat Gynecol Endoscopy & Gynecol Oncol, Lodz, Poland; [Danielska, Justyna] Med Univ Lodz, Dept Radiotherapy, Lodz, Poland; [Dzieniecka, Monika] Polish Mothers Mem Hosp, Res Inst, Dept Pathol, Lodz, Poland; [Szymanska, Bozena] Med Univ Lodz, Cent Lab, Lodz, Poland; [Malinowski, Andrzej] Med Univ Lodz, Dept Surg & Endoscop Gynecol, Lodz, Poland	Polish Mother's Memorial Hospital - Research Institute; Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; Medical University Lodz; Medical University Lodz	Wilczynski, M (corresponding author), Polish Mothers Mem Hosp, Res Inst, Dept Operat Gynecol Endoscopy & Gynecol Oncol, Lodz, Poland.	jrwil@wp.pl		Malinowski, Andrzej/0000-0002-3129-1504; Wojciechowski, Michal/0000-0002-1597-9405; Szymanska, Bozena/0000-0002-0775-7570	Polish Mother's Memorial Hospital Research Institute [2014/VII/26-SZB]	Polish Mother's Memorial Hospital Research Institute	Polish Mother's Memorial Hospital Research Institute financial support: statutory research task No 2014/VII/26-SZB.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Banno K, 2013, INT J CLIN ONCOL, V18, P186, DOI 10.1007/s10147-013-0526-9; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Cai J., 2013, J BIOCATAL BIOTRANSF, V2, P1; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Cohn DE, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.051; Ferlay J, 2014, GLOBOCAN 2012 V1 1; Gammell P, 2007, CYTOTECHNOLOGY, V53, P55, DOI 10.1007/s10616-007-9049-4; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karaayvaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035158; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081421; Matias-Guiu X, 2013, HISTOPATHOLOGY, V62, P111, DOI 10.1111/his.12053; Maxwell GL, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.028; Murali R, 2014, LANCET ONCOL, V15, pE268, DOI 10.1016/S1470-2045(13)70591-6; Orang AV, 2014, ASIAN PAC J CANCER P, V15, P577, DOI 10.7314/APJCP.2014.15.2.577; Prat J, 2007, PATHOLOGY, V39, P72, DOI 10.1080/00313020601136153; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Ratner ES, 2010, GYNECOL ONCOL, V118, P251, DOI 10.1016/j.ygyno.2010.05.010; Sauer E, 2014, FORENSIC SCI INT-GEN, V13, P217, DOI 10.1016/j.fsigen.2014.08.005; Sorosky JI, 2012, OBSTET GYNECOL, V120, P383, DOI 10.1097/AOG.0b013e3182605bf1; Su N, 2013, ONCOL REP, V29, P2297, DOI 10.3892/or.2013.2400; Torres A, 2013, GYNECOL ONCOL, V130, P588, DOI 10.1016/j.ygyno.2013.06.026; Torres A, 2013, INT J CANCER, V132, P1633, DOI 10.1002/ijc.27840; Torres A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-369; Tsukamoto O, 2014, GYNECOL ONCOL, V132, P715, DOI 10.1016/j.ygyno.2014.01.029; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Zhai HY, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-12; Zhang JY, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006244; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	38	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164687	10.1371/journal.pone.0164687	http://dx.doi.org/10.1371/journal.pone.0164687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737015	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800113
J	Fletcher, R; Jones, JD; Shah, NS				Fletcher, Reid; Jones, Joshua D.; Shah, Neha S.			Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments	PLOS ONE			English	Article							NEW-YORK-CITY; PULMONARY TUBERCULOSIS; CARE; ERA	Objective Evaluate differences in TB outcomes among different provider types in Chicago, IL. Methods We retrospectively reviewed all TB cases reported to the Chicago Department of Public Health (CDPH) from 2008 through 2011. Provider type was stratified into three groups: public, public-private, and private providers. Multivariate regression was used to evaluate treatment duration and time to sputum culture conversion. A Cox proportional hazard model was used to assess treatment completion. Results Of 703 cases, 203 (28.9%), 314 (44.7%), and 186 (26.5%) were treated by public, publicprivate and private providers, respectively. Adjusted regression showed private provider patients had a 48-day (95% CI 22.0-74.3) increase in treatment duration and a 30-day (95% C.I. 9.5-51.1) increase in time to sputum culture conversion. Cox model showed increased risk of remaining on treatment was associated with extra-pulmonary TB (aHR 0.78, 95% C.I. 0.62-0.98), being foreign-born (aHR 0.74, 95% C.I. 0.58-0.95), and any drug resistance (aHR 0.59, 95% C.I. 0.46-0.76). There were no differences in outcomes between public and public-private providers. Conclusion Patients treated solely in the private sector had prolonged time to sputum culture conversion and treatment duration which lead to increased cost for treatment, prolonged infectiousness, potential for transmission, and the possibility for increased medication side effects.	[Fletcher, Reid] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Jones, Joshua D.; Shah, Neha S.] Chicago Dept Publ Hlth, Chicago, IL USA; [Shah, Neha S.] Ctr Dis Control & Prevent, Atlanta, GA USA	Northwestern University; Feinberg School of Medicine; Chicago Department of Public Health; Centers for Disease Control & Prevention - USA	Fletcher, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	reidnf@gmail.com						[Anonymous], 2013, THE AFFORDABLE CARE; Balaban V, 2015, PUBLIC HEALTH REP, V130, P349, DOI 10.1177/003335491513000413; BRUDNEY K, 1991, AM REV RESPIR DIS, V144, P745, DOI 10.1164/ajrccm/144.4.745; Centers for Disease Control and Prevention, 2009, REPORT OF VERIFIED C; Centers for Disease Control and Prevention, 2013, REPORTED TUBERCULOSI; City of Chicago Office of the Inspector General, 2011, 2011 BUDGET OPTION; Ehman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110645; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Hughes S., 2010, Morbidity and Mortality Weekly Report, V59, P295; Jones DS, 2012, NEW ENGL J MED, V366, P2333, DOI 10.1056/NEJMp1113569; Klein PW, 2014, J COMMUN HEALTH, V39, P494, DOI 10.1007/s10900-013-9783-9; Kong DG, 2013, J PUBLIC HEALTH MAN, V19, P169, DOI 10.1097/PHH.0b013e3182550a83; Liu ZY, 1998, CHEST, V113, P1446, DOI 10.1378/chest.113.6.1446; Liu ZY, 1999, ARCH INTERN MED, V159, P1110, DOI 10.1001/archinte.159.10.1110; Majerol M, 2014, HE UNINSURED A PRIME; Muniyandi M, 2006, J Commun Dis, V38, P204; Nahid P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-1; Pascopella L, 2014, OPEN FORUM INFECT DI, V1, P1, DOI DOI 10.1093/0FID/0FU090; Pusch T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-115; Rao SN, 2000, CHEST, V117, P734, DOI 10.1378/chest.117.3.734; Reina M, 2009, ANNUAL TUBERCULOSIS; Richardson N L, 2000, J Contin Educ Health Prof, V20, P146, DOI 10.1002/chp.1340200303; SBARBARO JA, 1970, AM REV RESPIR DIS, V101, P463; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1	24	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164162	10.1371/journal.pone.0164162	http://dx.doi.org/10.1371/journal.pone.0164162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732650	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300039
J	Fuermaier, ABM; Tucha, O; Koerts, J; Grabski, M; Lange, KW; Weisbrod, M; Aschenbrenner, S; Tucha, L				Fuermaier, Anselm B. M.; Tucha, Oliver; Koerts, Janneke; Grabski, Meryem; Lange, Klaus W.; Weisbrod, Matthias; Aschenbrenner, Steffen; Tucha, Lara			The Development of an Embedded Figures Test for the Detection of Feigned Attention Deficit Hyperactivity Disorder in Adulthood	PLOS ONE			English	Article							SYMPTOM VALIDITY TESTS; DEFICIT/HYPERACTIVITY DISORDER; COLLEGE-STUDENTS; INDIVIDUAL-DIFFERENCES; ADHD; PERFORMANCE; SAMPLE; INTELLIGENCE; EXAGGERATION; TASK	Objectives It has been shown that an increasing number of adults deliberately feign attention deficit hyperactivity disorder (ADHD), which demonstrates the need for new tests designed to detect feigned ADHD. Methods An Embedded Figures Test ( EFT) was developed for the detection of feigned ADHD in adulthood. EFT performance of 51 adults with ADHD was compared to the performance of 52 matched healthy individuals, as well as to 268 undergraduate students who were randomly allocated in a simulation design to one of four experimental conditions, i.e. a control group, a naive simulation group, a symptom-coached simulation group or a test-coached simulation group. Furthermore, an independent sample of 11 adults with ADHD as well as a sample of 17 clinicians experienced in the work with adults with ADHD were assessed for further validation of the EFT. Results The EFT was relatively easy to perform for both patients with ADHD and healthy comparisons as shown by low error rates and non-significant group differences. However, simulation groups differed from patients with ADHD by significant and large effects. An EFT index for the prediction of feigned ADHD was derived based on logistic regression coefficients. Receiver Operating Characteristics (ROC) demonstrated good classification accuracy of feigned ADHD relative to ADHD (AUC = 94.8%), i.e. high sensitivity (88%) and specificity (90%). Conclusions This study supports the utility of the EFT for the detection of feigned adult ADHD.	[Fuermaier, Anselm B. M.; Tucha, Oliver; Koerts, Janneke; Grabski, Meryem; Tucha, Lara] Univ Groningen, Dept Clin & Dev Neuropsychol, NL-9712 TS Groningen, Netherlands; [Lange, Klaus W.] Univ Regensburg, Dept Expt Psychol, D-93040 Regensburg, Germany; [Weisbrod, Matthias] SRH Clin Karlsbad Langensteinbach, Dept Psychiat & Psychotherapy, D-76307 Karlsbad, Germany; [Weisbrod, Matthias] Heidelberg Univ, Sect Expt Psychopathol & Neurophysiol, Ctr Psychosocial Med, D-69115 Heidelberg, Germany; [Aschenbrenner, Steffen] SRH Clin Karlsbad Langensteinbach, Dept Clin Psychol & Neuropsychol, D-76307 Karlsbad, Germany	University of Groningen; University of Regensburg; Ruprecht Karls University Heidelberg	Fuermaier, ABM (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, NL-9712 TS Groningen, Netherlands.	a.b.m.fuermaier@rug.nl	Tucha, Oliver/AAD-1403-2019	Grabski, Meryem/0000-0001-6364-5269; Fuermaier, Anselm/0000-0002-2331-0840				Allen LM, 1997, 97 MANUAL FOR THE CO; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Barkley RA, 2006, ATTENTION DEFICIT HY; BIEDERMAN J, 1993, AM J PSYCHIAT, V150, P1792; Binkau S, 2014, GEROPSYCH, V27, P33, DOI 10.1024/1662-9647/a000098; Booksh RL, 2010, J ATTEN DISORD, V13, P325, DOI 10.1177/1087054708329927; Boone K, 2002, THE DOT COUNTING TES; Boone K.B., 2002, THE B TEST; Boone KB., 2021, ASSESSMENT FEIGNED C, DOI [10.1080/23279095.2022.2064753, DOI 10.1080/23279095.2022.2064753]; Booth R, 2010, J EXP CHILD PSYCHOL, V107, P377, DOI 10.1016/j.jecp.2010.06.003; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Fuermaier ABM, 2016, J PSYCHOEDUC ASSESS, V34, P739, DOI 10.1177/0734282915626005; Glicksohn J, 2009, J INDIVID DIFFER, V30, P152, DOI 10.1027/1614-0001.30.3.152; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2005, US MAN LAMOTTE AIR S; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Harrison AG, 2007, ARCH CLIN NEUROPSYCH, V22, P577, DOI 10.1016/j.acn.2007.03.008; Harrison AG, 2010, ASSESSMENT, V17, P283, DOI 10.1177/1073191109348590; Hirsch O, 2018, J ATTEN DISORD, V22, P269, DOI 10.1177/1087054715596577; Jachimowicz G., 2004, COGNITIVE SCI ONLINE, V2, P6; Jasinski LJ, 2011, CLIN NEUROPSYCHOL, V25, P1415, DOI 10.1080/13854046.2011.630024; Kooij JJS, 2008, J ATTEN DISORD, V11, P445, DOI 10.1177/1087054707299367; Lange KW, 2014, ADHD-ATTEND DEFICIT, V6, P241, DOI 10.1007/s12402-014-0132-3; Leark RA, 2002, ARCH CLIN NEUROPSYCH, V17, P335, DOI 10.1016/S0887-6177(01)00118-4; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; Lensing MB, 2013, ADHD-ATTEND DEFICIT, V5, P369, DOI 10.1007/s12402-013-0116-8; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Ludwig I, 2004, PSYCHOL RES-PSYCH FO, V68, P277, DOI 10.1007/s00426-003-0141-x; Marchetta NDJ, 2008, J ATTEN DISORD, V11, P664, DOI 10.1177/1087054707305108; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; Mostert JC, 2015, EUR NEUROPSYCHOPHARM, V25, P2062, DOI 10.1016/j.euroneuro.2015.08.010; Musso MW, 2014, J ATTEN DISORD, V18, P186, DOI 10.1177/1087054712441970; Pella RD, 2012, ARCH CLIN NEUROPSYCH, V27, P45, DOI 10.1093/arclin/acr090; Quinn CA, 2003, ARCH CLIN NEUROPSYCH, V18, P379, DOI 10.1016/S0887-6177(02)00150-6; Rabiner DL, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0375-2; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R, 2008, CLINICAL ASSESSMENT; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Rosler M., 2008, UNTERSUCHUNGSVERFAHR; Schuhfried G., 2013, VIENNA TEST SYSTEM V; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Sturm W., 2006, TESTHANDBUCH WAHRNEH; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Suhr JA, 2011, ARCH CLIN NEUROPSYCH, V26, P1, DOI 10.1093/arclin/acq094; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Suslow T, 2009, NORD J PSYCHIAT, V63, P120, DOI 10.1080/08039480802316010; Thome J, 2012, WORLD J BIOL PSYCHIA, V13, P379, DOI 10.3109/15622975.2012.690535; Tombaugh TN, 1997, TEST OF MEMORY MALIN; Tucha L, 2013, TEST MANUAL NEUROPSY; Tucha L, 2017, J NEURAL TRANSM, V124, pS39, DOI 10.1007/s00702-015-1426-0; Tucha L, 2015, J NEURAL TRANSM, V122, P123, DOI 10.1007/s00702-014-1274-3; Tucha L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046080; Tucha L, 2009, ADHD-ATTEND DEFICIT, V1, P47, DOI 10.1007/s12402-009-0007-1; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Weinborn M, 2012, CLIN NEUROPSYCHOL, V26, P832, DOI 10.1080/13854046.2012.686630; White SJ, 2011, J AUTISM DEV DISORD, V41, P1565, DOI 10.1007/s10803-011-1182-4; Williamson KD, 2014, CLIN NEUROPSYCHOL, V28, P1182, DOI 10.1080/13854046.2014.956674; Witkin H A, 1981, Psychol Issues, P1; WITKIN HA, 1950, J PERS, V19, P1, DOI 10.1111/j.1467-6494.1950.tb01084.x; WITKIN HA, 1954, PERSONALITY THROUGH	68	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164297	10.1371/journal.pone.0164297	http://dx.doi.org/10.1371/journal.pone.0164297			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732620	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505300045
J	Kadivar, H; Kenzik, KM; Dewalt, DA; Huang, IC				Kadivar, Hajar; Kenzik, Kelly M.; Dewalt, Darren A.; Huang, I-Chan			The Association of English Functional Health Literacy and the Receipt of Mammography among Hispanic Women Compared to Non-Hispanic US-Born White Women	PLOS ONE			English	Article							MEXICAN-AMERICAN WOMEN; LANGUAGE PREFERENCE; BREAST-CANCER; INTERPRETER SERVICES; UNITED-STATES; ACCULTURATION; CARE; LATINO; QUALITY; RISK	Background Breast cancer is a leading cause of cancer death among Hispanic women in the U.S., and mammography is the recommended screening for early diagnosing and preventing breast cancer. Several barriers exist to influence mammography utilization including poor health literacy. However, it is unclear whether the effect of health literacy on mammography utilization is consistent between Hispanic women and non-Hispanic White women. The main objective of this study was to examine association between functional health literacy and the receipt of mammography among Hispanic women compared to non-Hispanic White women in the U.S. Methods A cross-sectional design using participants engaged in the National Assessment of Adult Literacy. Study sample comprised of 4,249 Hispanic and non-Hispanic U.S.-born White women >= 40 years of age who completed the functional health literacy assessment. Regression analyses were performed to test the association between health literacy and receipt of mammography. Among Hispanic women, analyses considered the influence of language-preference acculturation. Results Equal percentages of Hispanic (59.3%) and non-Hispanic White (60.6%) women received mammography. After adjusting for covariates, health literacy was positively associated with receiving mammography among U.S.-born White women (beta = 0.14, p<0.001), but negatively associated with mammography among Hispanic women (beta = -0.13, p<0.001). Analyses stratified by acculturation status revealed that higher health literacy was associated with lower mammography among language-preference acculturated Hispanic women (beta = -0.48, p<0.001), yet an opposite result among less acculturated Hispanic women ( beta = 0.08, p<0.001). Conclusion Functional health literacy has different associations with mammography depending upon ethnicity. Language-preference acculturation may explain the differing association.	[Kadivar, Hajar] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA; [Kadivar, Hajar] Univ Florida, Dept Hlth Outcomes & Policy, Gainesville, FL USA; [Kenzik, Kelly M.] Univ Alabama Birmingham, Sch Med, Div Prevent Med, Birmingham, AL USA; [Dewalt, Darren A.] Univ North Carolina Chapel Hill, Div Gen Internal Med, Chapel Hill, NC USA; [Huang, I-Chan] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 332 N Lauderdale St, Memphis, TN 38105 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; St Jude Children's Research Hospital	Huang, IC (corresponding author), St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 332 N Lauderdale St, Memphis, TN 38105 USA.	i-chan.huang@stjude.org			NICHD NIH HHS [K23 HD057146] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD057146] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams EK, 2007, CANCER-AM CANCER SOC, V109, P348, DOI 10.1002/cncr.22353; American Cancer Society, 2015, CANC FACTS FIG 2015; American College of Obstetricians and Gynecologists, 2003, OBSTET GYNECOL, V101, P821; Baker DW, 2006, J GEN INTERN MED, V21, P878, DOI 10.1111/j.1525-1497.2006.00540.x; Borrayo E A, 2000, Health Care Women Int, V21, P599; Chakraborty BM, 2010, COLLEGIUM ANTROPOL, V34, P1179; Cheng EM, 2007, J GEN INTERN MED, V22, P283, DOI 10.1007/s11606-007-0346-6; Davis JL, 2012, J HEALTH CARE POOR U, V23, P67, DOI 10.1353/hpu.2012.0148; de los Monteros KE, 2011, INT J BEHAV MED, V18, P310, DOI 10.1007/s12529-010-9119-4; Edwards LM, 2008, HISPANIC J BEHAV SCI, V30, P447, DOI 10.1177/0739986308322912; Fayanju OM, 2014, AM J SURG, V208, P425, DOI 10.1016/j.amjsurg.2014.03.005; Fuertes JN, 2007, PATIENT EDUC COUNS, V66, P29, DOI 10.1016/j.pec.2006.09.013; Gorin SS, 2005, PREV MED, V40, P515, DOI 10.1016/j.ypmed.2004.09.031; Grimm KA, 2011, PREV CHRONIC DIS, V8; Guerra CE, 2005, J HEALTH CARE POOR U, V16, P152, DOI 10.1353/hpu.2005.0012; Hauser RM, 2005, MEASURING LITERACY P; Ku L, 2005, HEALTH AFFAIR, V24, P435, DOI 10.1377/hlthaff.24.2.435; Kutner M, 2006, THE HEALTH LITERACY; Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615; Marfani F, 2013, J APPL COMMUN RES, V41, P126, DOI 10.1080/00909882.2012.754485; O'Malley AS, 1999, AM J PUBLIC HEALTH, V89, P219, DOI 10.2105/AJPH.89.2.219; Pagan JA, 2012, J CANCER EDUC, V27, P132, DOI 10.1007/s13187-011-0239-6; Pearson WS, 2008, ETHNIC DIS, V18, P93; Pearson WS, 2009, PREV CHRONIC DIS, V6; Rodriguez MA, 2005, ANN FAM MED, V3, P235, DOI 10.1370/afm.291; Roncancio AM, 2011, J HEALTH CARE POOR U, V22, P482, DOI 10.1353/hpu.2011.0038; Salazar MK, 1996, CANCER NURS, V19, P437, DOI 10.1097/00002820-199612000-00004; Schueler KM, 2008, J WOMENS HEALTH, V17, P1477, DOI 10.1089/jwh.2007.0603; Scott TL, 2002, MED CARE, V40, P395, DOI 10.1097/00005650-200205000-00005; Shippee ND, 2012, J HEALTH CARE POOR U, V23, P1073, DOI 10.1353/hpu.2012.0107; Skinner JH, 2001, MULTICULTURAL MEASUR; Smith RA, 2003, CA-CANCER J CLIN, V53, P27, DOI 10.3322/canjclin.53.1.27; STEIN JA, 1990, JNCI-J NATL CANCER I, V82, P1715, DOI 10.1093/jnci/82.21.1715; SUAREZ L, 1994, AM J PUBLIC HEALTH, V84, P742, DOI 10.2105/AJPH.84.5.742; Vyas A, 2012, J COMMUN HEALTH, V37, P632, DOI 10.1007/s10900-011-9494-z; Watson-Johnson LC, 2011, J WOMENS HEALTH, V20, P1887, DOI 10.1089/jwh.2010.2724; White S, 2005, KEY CONCEPTS AND FEA; White S., 2008, ASSESSING THE NATION; White S, 2008, AM J HEALTH BEHAV, V32, P227; Wu ZH, 2001, PREV MED, V33, P268, DOI 10.1006/pmed.2001.0880; Wyn R, 2004, RACIAL AND ETHNIC DI	41	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164307	10.1371/journal.pone.0164307	http://dx.doi.org/10.1371/journal.pone.0164307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732660	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300046
J	Pinne, M; Ponce, E; Raucy, JL				Pinne, Marija; Ponce, Elsa; Raucy, Judy L.			Transactivation Assays to Assess Canine and Rodent Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR) Activation	PLOS ONE			English	Article							DISTAL ENHANCER MODULE; CYP2B6 GENE-EXPRESSION; NUCLEAR RECEPTOR; PROTEIN-KINASE; SIGNALING PATHWAY; DRUG-INTERACTIONS; DISTINCT CLASSES; SPLICE VARIANTS; LIGAND-BINDING; MOUSE-LIVER	The pregnane X receptor (PXR/SXR, NR1I2) and constitutive androstane receptor (CAR, NR1I3) are nuclear receptors (NRs) involved in the regulation of many genes including cytochrome P450 enzymes (CYPs) and transporters important in metabolism and uptake of both endogenous substrates and xenobiotics. Activation of these receptors can lead to adverse drug effects as well as drug-drug interactions. Depending on which nuclear receptor is activated will determine which adverse effect could occur, making identification important. Screening for NR activation by New Molecular Entities (NMEs) using cell-based transactivation assays is the singular high throughput method currently available for identifying the activation of a particular NR. Moreover, screening for species-specific NR activation can minimize the use of animals in drug development and toxicology studies. With this in mind, we have developed in vitro transactivation assays to identify compounds that activate canine and rat PXR and CAR3. We found differences in specificity for canine and rat PXR, with the best activator for canine PXR being 10 mu M SR12813 (60.1 +/- 3.1-fold) and for rat PXR, 10 mu M dexamethasone (60.9 +/- 8.4 fold). Of the 19 test agents examined, 10 and 9 significantly activated rat and canine PXR at varying degrees, respectively. In contrast, 5 compounds exhibited statistically significant activation of rat CAR3 and 4 activated the canine receptor. For canine CAR3, 50 mu M artemisinin proved to be the best activator (7.3 +/- 1.8 and 10.5 +/- 2.2 fold) while clotrimazole (10 mu M) was the primary activator of the rat variant (13.7 +/- 0.8 and 26.9 +/- 1.3 fold). Results from these studies demonstrated that cell-based transactivation assays can detect species-specific activators and revealed that PXR was activated by at least twice as many compounds as was CAR3, suggesting that there are many more agonists for PXR than CAR.	[Pinne, Marija; Ponce, Elsa; Raucy, Judy L.] Puracyp Inc, Carlsbad, CA 92010 USA		Pinne, M (corresponding author), Puracyp Inc, Carlsbad, CA 92010 USA.	mpinne@puracyp.com			Puracyp, Inc.	Puracyp, Inc.	The study was funded solely by Puracyp, Inc., and all authors are employees of Puracyp, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach SS, 2007, DRUG METAB DISPOS, V35, P428, DOI 10.1124/dmd.106.012641; Auerbach SS, 2003, NUCLEIC ACIDS RES, V31, P3194, DOI 10.1093/nar/gkg419; Auerbach SS, 2005, MOL PHARMACOL, V68, P1239, DOI 10.1124/mol.105.013417; BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019; Chai XJ, 2013, EXPERT OPIN DRUG MET, V9, P253, DOI 10.1517/17425255.2013.754010; Chen T, 2010, J PHARMACOL EXP THER, V332, P106, DOI 10.1124/jpet.109.159210; Dussault I, 2002, MOL CELL BIOL, V22, P5270, DOI 10.1128/MCB.22.15.5270-5280.2002; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Eveillard A, 2009, BIOCHEM PHARMACOL, V77, P1735, DOI 10.1016/j.bcp.2009.02.023; Fahmi OA, 2012, DRUG METAB DISPOS, V40, P2204, DOI 10.1124/dmd.112.047456; Faucette SR, 2007, J PHARMACOL EXP THER, V320, P72, DOI 10.1124/jpet.106.112136; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Gao J, 2012, TRENDS PHARMACOL SCI, V33, P552, DOI 10.1016/j.tips.2012.07.003; Goodwin B, 2001, MOL PHARMACOL, V60, P427; Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Graham RA, 2002, DRUG METAB DISPOS, V30, P1206, DOI 10.1124/dmd.30.11.1206; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Ito Y, 2012, PPAR RES, V2012, DOI 10.1155/2012/201284; Jinno H, 2004, MOL PHARMACOL, V65, P496, DOI 10.1124/mol.65.3.496; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kanno Y, 2010, J TOXICOL SCI, V35, P571, DOI 10.2131/jts.35.571; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lamba JK, 2004, J PHARMACOL EXP THER, V311, P811, DOI 10.1124/jpet.104.069310; Li HS, 2009, DRUG METAB DISPOS, V37, P1098, DOI 10.1124/dmd.108.026005; Lynch C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10405; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Martignoni M, 2004, CHEM-BIOL INTERACT, V151, P1, DOI 10.1016/j.cbi.2004.10.002; Martin P, 2010, ACTA PHARMACOL SIN, V31, P51, DOI 10.1038/aps.2009.187; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Omiecinski CJ, 2011, TOXICOL SCI, V123, P550, DOI 10.1093/toxsci/kfr191; PAINE AJ, 1990, CHEM-BIOL INTERACT, V74, P1, DOI 10.1016/0009-2797(90)90055-R; Pinne M, 2014, EXPERT OPIN DRUG DIS, V9, P669, DOI 10.1517/17460441.2014.913019; Raucy J, 2002, J PHARMACOL EXP THER, V303, P412, DOI 10.1124/jpet.102.038653; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Reschly EJ, 2006, CURR DRUG METAB, V7, P349, DOI 10.2174/138920006776873526; Rysa J, 2013, CLIN PHARMACOL THER, V93, P556, DOI 10.1038/clpt.2013.48; Saito K, 2013, DRUG METAB DISPOS, V41, P1170, DOI 10.1124/dmd.113.051623; Savkur RS, 2003, MOL GENET METAB, V80, P216, DOI 10.1016/j.ymgme.2003.08.013; Shan L, 2004, MOL CELL, V16, P907, DOI 10.1016/S1097-2765(04)00728-2; Shukla SJ, 2011, DRUG METAB DISPOS, V39, P151, DOI 10.1124/dmd.110.035105; Sinz Michael W, 2007, Drug Metab Lett, V1, P147, DOI 10.2174/187231207780363561; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Tien ES, 2006, XENOBIOTICA, V36, P1152, DOI 10.1080/00498250600861827; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Wang HB, 2004, J BIOL CHEM, V279, P29295, DOI 10.1074/jbc.M400580200; Wang HB, 2003, J BIOL CHEM, V278, P14146, DOI 10.1074/jbc.M212482200; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042; Yang H, 2014, MOL PHARMACOL, V85, P249, DOI 10.1124/mol.113.089763; Yueh MF, 2005, DRUG METAB DISPOS, V33, P38, DOI 10.1124/dmd.104.001594; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001; Zhai YG, 2007, MOL ENDOCRINOL, V21, P138, DOI 10.1210/me.2006-0291; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067959	60	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164642	10.1371/journal.pone.0164642	http://dx.doi.org/10.1371/journal.pone.0164642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732639	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300072
J	Xu, ZW; Henderson, RD; David, M; McCombe, PA				Xu, Zhouwei; Henderson, Robert David; David, Michael; McCombe, Pamela Ann			Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SUBUNIT PNF-H; CEREBROSPINAL-FLUID; HEAVY-CHAIN; PROGNOSTIC BIOMARKER; LIGHT LEVELS; NF-H; CSF; DIAGNOSIS; PROTEIN; BLOOD	Background To allow early diagnosis and monitoring of disease progression, there is a need for biomarkers in amyotrophic lateral sclerosis (ALS). Neurofilaments (NF) are emerging protein biomarkers in other neurological diseases, and are of possible use in ALS. Objective The aim of this study is to evaluate the utility of NF levels as blood or cerebrospinal fluid (CSF) biomarker in patients with ALS. Methods A systematic search of Pubmed, Embase and Scopus was performed. Methodological quality assessment was applied to refine the final search results. Meta-analysis of the data was performed. Results Level of NF heavy chain and light chains were significantly elevated in the CSF of ALS patients compared to healthy controls/controls without parenchymal central nervous system (CNS) involvement and ALS mimic disease patients. NF light chain level in CSF was higher in ALS patients than in neurological patients with CNS involvement (SMD = 1.352, P = 0.01). NF light chain concentration in blood was higher in ALS patients than healthy controls/controls without CNS involvement (SMD = 1.448, P<0.0001). NF heavy chain levels in CSF were negatively correlated disease duration and ALSFRS-R ((r = -0.447, P<0.0001; r = -0.486, P<0.0001). NF light chain levels in CSF were negatively correlated with disease duration (r = -0.273, P = 0.011). Conclusion NF heavy and light chain levels have potential use as a marker of neural degeneration in ALS, but are not specific for the disease, and are more likely to be used as measures of disease progression.	[Xu, Zhouwei; McCombe, Pamela Ann] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Henderson, Robert David] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia; [David, Michael] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland	Xu, ZW (corresponding author), Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.	xzwsp@sina.com	Henderson, Robert/S-3558-2019; McCombe, Pamela/C-9692-2010	Henderson, Robert/0000-0002-2820-8183; McCombe, Pamela/0000-0003-2704-8517	Chinese scholarship council	Chinese scholarship council(China Scholarship Council)	The first author Zhouwei Xu's PhD scholarship was funded by the Chinese scholarship council.	Blasco H, 2012, AMYOTROPH LATERAL SC, V13, P585, DOI 10.3109/17482968.2012.706303; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Boylan KB, 2013, J NEUROL NEUROSUR PS, V84, P467, DOI 10.1136/jnnp-2012-303768; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cai JY, 2013, CLIN CHIM ACTA, V424, P182, DOI 10.1016/j.cca.2013.06.019; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; DONG DLY, 1993, J BIOL CHEM, V268, P16679; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Ganesalingam J, 2011, J NEUROCHEM, V117, P528, DOI 10.1111/j.1471-4159.2011.07224.x; Gnanapavan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070019; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; Goncalves M, 2015, CLIN CHIM ACTA, V438, P342, DOI 10.1016/j.cca.2014.09.011; Gresle MM, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/315406; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Katz Russell, 2004, NeuroRx, V1, P189, DOI 10.1602/neurorx.1.2.189; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kuhle J, 2010, J NEUROIMMUNOL, V220, P114, DOI 10.1016/j.jneuroim.2010.01.004; Lehnert S, 2014, AMYOTROPH LAT SCL FR, V15, P344, DOI 10.3109/21678421.2014.884592; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Lu CH, 2011, J NEUROSCI METH, V195, P143, DOI 10.1016/j.jneumeth.2010.11.026; McCombe PA, 2015, J NEUROL SCI, V353, P122, DOI 10.1016/j.jns.2015.04.032; Mendonca DMF, 2011, AMYOTROPH LATERAL SC, V12, P144, DOI 10.3109/17482968.2010.542002; Mendonca DMF, 2005, BRAZ J MED BIOL RES, V38, P925, DOI 10.1590/S0100-879X2005000600015; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Petzold A, 2015, J NEUROL NEUROSUR PS, V86, P1388, DOI 10.1136/jnnp-2014-309827; Pijnenburg Yolande A L, 2015, Alzheimers Dement (Amst), V1, P505, DOI 10.1016/j.dadm.2015.11.001; Reijn TS, 2009, J NEUROL, V256, P615, DOI 10.1007/s00415-009-0131-z; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Rysz-Gorzynska M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30060; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Steinacker P, 2016, J NEUROL NEUROSUR PS, V87, P12, DOI 10.1136/jnnp-2015-311387; Steinacker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023600; Su ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30780; Talbot K, 2014, J ANAT, V224, P45, DOI 10.1111/joa.12107; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Tortelli R, 2015, EUR J NEUROL, V22, P215, DOI 10.1111/ene.12421; Tortelli R, 2012, EUR J NEUROL, V19, P1561, DOI 10.1111/j.1468-1331.2012.03777.x; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Weydt P, 2016, ANN NEUROL, V79, P152, DOI 10.1002/ana.24552; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x	52	66	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164625	10.1371/journal.pone.0164625	http://dx.doi.org/10.1371/journal.pone.0164625			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732645	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300070
J	Branscheidt, M; Schneider, J; Michel, P; Eskioglou, E; Kaegi, G; Stark, R; Fischer, U; Jung, S; Arnold, M; Wertli, M; Held, U; Wegener, S; Luft, A; Sarikaya, H				Branscheidt, Meret; Schneider, Juliane; Michel, Patrik; Eskioglou, Elissavet; Kaegi, Georg; Stark, Robert; Fischer, Urs; Jung, Simon; Arnold, Marcel; Wertli, Maria; Held, Ulrike; Wegener, Susanne; Luft, Andreas; Sarikaya, Hakan			No Impact of Body Mass Index on Outcome in Stroke Patients Treated with IV Thrombolysis BMI and IV Thrombolysis Outcome	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; OBESITY PARADOX; MORTALITY	Background and Purpose The impact of excess body weight on prognosis after stroke is controversial. Many studies report higher survival rates in obese patients ("obesity paradox"). Recently, obesity has been linked to worse outcomes after intravenous (IV) thrombolysis, but the number and sample size of these studies were small. Here, we aimed to assess the relationship between body weight and stroke outcome after IV thrombolysis in a large cohort study. Methods In a prospective observational multicenter study, we analyzed baseline and outcome data of 896 ischemic stroke patients who underwent IV thrombolysis. Patients were categorized according to body mass index (BMI) as underweight (<18.5 kg/m(2)), normal weight (18.5-24.9 kg/m(2)), overweight (25-29.9 kg/m(2)), obese (30-34.9 kg/m(2)) or severely obese (>35 kg/m(2)). Using uni- and multivariate modeling, we assessed the relationship of BMI with favorable outcome (defined as modified Rankin Scale 0 or 1) and mortality 3 months after stroke as well as the occurrence of symptomatic intracerebral hemorrhages (sICH). We also measured the incidence of patients that had an early neurological improvement of >40% on the National Institutes of Health Stroke Scale (NIHSS) after 24 hours. Results Among 896 patients, 321 were normal weight (35.8%), 22 underweight (2.5%), 378 overweight (42.2%), 123 obese (13.7%) and 52 severely obese (5.8%). Three-month mortality was comparable in obese vs. non-obese patients (8.1% vs. 8.3%) and did not differ significantly among different BMI groups. This was also true for favorable clinical outcome, risk of sICH and early neurological improvement on NIHSS at 24 hours. These results remained unchanged after adjusting for potential confounding factors in the multivariate analyses. Conclusion BMI was not related to clinical outcomes in stroke patients treated with IVT. Our data suggest that the current weight-adapted dosage scheme of IV alteplase is appropriate for different body weight groups, and challenge the existence of the obesity paradox after stroke.	[Branscheidt, Meret; Schneider, Juliane; Wegener, Susanne; Luft, Andreas; Sarikaya, Hakan] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Branscheidt, Meret] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA; [Eskioglou, Elissavet; Kaegi, Georg] CHU Vaudois, Dept Neurol, Lausanne, Switzerland; [Michel, Patrik; Eskioglou, Elissavet] Univ Lausanne, CH-1015 Lausanne, Switzerland; [Kaegi, Georg; Stark, Robert] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland; [Fischer, Urs; Jung, Simon; Arnold, Marcel; Sarikaya, Hakan] Univ Hosp Bern, Dept Neurol, Bern, Switzerland; [Wertli, Maria; Held, Ulrike] Univ Zurich, Horten Ctr, CH-8006 Zurich, Switzerland; [Wertli, Maria] Univ Hosp Bern, Dept Internal Med, Bern, Switzerland	University of Zurich; University Zurich Hospital; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Kantonsspital St. Gallen; University of Bern; University Hospital of Bern; University of Zurich; University of Bern; University Hospital of Bern	Sarikaya, H (corresponding author), Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland.; Sarikaya, H (corresponding author), Univ Hosp Bern, Dept Neurol, Bern, Switzerland.	hakan.sarikaya@insel.ch	Held, Ulrike/O-8328-2019; Michel, Patrik/Q-2275-2016; Wertli, Maria/Q-3349-2017	Michel, Patrik/0000-0003-4954-7579; Branscheidt, Meret/0000-0002-4008-6916; Wegener, Susanne/0000-0003-4369-7023; Fischer, Urs/0000-0003-0521-4051; Wertli, Maria/0000-0001-6347-0198	Swiss National Science Foundation; Swiss Heart Foundation; Bangerter Foundation; Hermann Klaus Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; Bangerter Foundation; Hermann Klaus Foundation	HS was supported by research grants from the Swiss National Science Foundation, the Swiss Heart Foundation (https://www.swissheart.ch), Bangerter Foundation (http://www.bangerter-stiftung.ch) and the Hermann Klaus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Andersen KK, 2015, INT J STROKE, V10, P99, DOI 10.1111/ijs.12016; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Dehlendorff C, 2014, JAMA NEUROL, V71, P978, DOI 10.1001/jamaneurol.2014.1017; Gariballa SE, 1998, AM J CLIN NUTR, V68, P275, DOI 10.1093/ajcn/68.2.275; Gensicke H, 2013, NEUROLOGY, V81, P1780, DOI 10.1212/01.wnl.0000435550.83200.9e; Graves A, 2013, J NEUROSCI NURS, V45, P180, DOI 10.1097/JNN.0b013e318298641b; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hassan AE, 2013, J STROKE CEREBROVASC, V22, P545, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.022; Kharitonova T, 2011, STROKE, V42, P1638, DOI 10.1161/STROKEAHA.110.606194; Kim BJ, 2012, NEUROLOGY, V79, P856, DOI 10.1212/WNL.0b013e318266fad1; Kim Y, 2015, J NEUROL NEUROSUR PS, V86, P743, DOI 10.1136/jnnp-2014-308664; Nardi K, 2012, NEUROLOGY, V79, P1101, DOI 10.1212/WNL.0b013e3182608c82; R Core Team, 2021, R LANGUAGE ENV STAT; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Ryu WS, 2011, CEREBROVASC DIS, V32, P170, DOI 10.1159/000328250; Sarikaya H, 2011, STROKE, V42, P2330, DOI 10.1161/STROKEAHA.110.599613; Sarikaya H, 2011, STROKE, V42, P1967, DOI 10.1161/STROKEAHA.110.601252; Seet RCS, 2014, J STROKE CEREBROVASC, V23, P1, DOI 10.1016/j.jstrokecerebrovasdis.2012.04.001; Seo JH, 2013, J NEUROCRITICAL CARE, V6, P92; Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019; Towfighi A, 2009, STROKE, V40, P2704, DOI 10.1161/STROKEAHA.109.550228; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vemmos K, 2011, STROKE, V42, P30, DOI 10.1161/STROKEAHA.110.593434; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; World Health Organization, GLOB DAT BOD MASS IN; World Health Organization, OB OV; Yamada S, 2012, J NEUROL, V259, P2707, DOI 10.1007/s00415-012-6574-7; Yoo SH, 2008, ARCH NEUROL-CHICAGO, V65, P39, DOI 10.1001/archneurol.2007.12	30	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164413	10.1371/journal.pone.0164413	http://dx.doi.org/10.1371/journal.pone.0164413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727305	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000385504400031
J	Casanova, R; Saldana, S; Simpson, SL; Lacy, ME; Subauste, AR; Blackshear, C; Wagenknecht, L; Bertoni, AG				Casanova, Ramon; Saldana, Santiago; Simpson, Sean L.; Lacy, Mary E.; Subauste, Angela R.; Blackshear, Chad; Wagenknecht, Lynne; Bertoni, Alain G.			Prediction of Incident Diabetes in the Jackson Heart Study Using High-Dimensional Machine Learning	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LIFE-STYLE INTERVENTION; INSULIN-RESISTANCE; RISK; SENSITIVITY; TRIGLYCERIDE; ASSOCIATION; MODELS	Statistical models to predict incident diabetes are often based on limited variables. Here we pursued two main goals: 1) investigate the relative performance of a machine learning method such as Random Forests (RF) for detecting incident diabetes in a high-dimensional setting defined by a large set of observational data, and 2) uncover potential predictors of diabetes. The Jackson Heart Study collected data at baseline and in two follow-up visits from 5,301 African Americans. We excluded those with baseline diabetes and no follow-up, leaving 3,633 individuals for analyses. Over a mean 8-year follow-up, 584 participants developed diabetes. The full RF model evaluated 93 variables including demographic, anthropometric, blood biomarker, medical history, and echocardiogram data. We also used RF metrics of variable importance to rank variables according to their contribution to diabetes prediction. We implemented other models based on logistic regression and RF where features were preselected. The RF full model performance was similar (AUC = 0.82) to those more parsimonious models. The top-ranked variables according to RF included hemoglobin A1C, fasting plasma glucose, waist circumference, adiponectin, c-reactive protein, triglycerides, leptin, left ventricular mass, high-density lipoprotein cholesterol, and aldosterone. This work shows the potential of RF for incident diabetes prediction while dealing with high-dimensional data.	[Casanova, Ramon; Saldana, Santiago; Simpson, Sean L.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27101 USA; [Lacy, Mary E.] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Subauste, Angela R.; Blackshear, Chad] Univ Mississippi, Med Ctr, Div Endocrinol, Jackson, MS 39216 USA; [Subauste, Angela R.; Blackshear, Chad] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Wagenknecht, Lynne; Bertoni, Alain G.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA	Wake Forest University; Brown University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Wake Forest University	Simpson, SL (corresponding author), Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27101 USA.	slsimpso@wakehealth.edu		Bertoni, Alain/0000-0002-7503-6273	National Heart, Lung, and Blood Institute [HHSN268201300046C, HHSN26820130047C, HHSN26820130048C, HHSN26820130049C, HHSN26820130050C, R01 HL117285]; National Institute on Minority Health and Health Disparities; National Institute of Biomedical Imaging and Bioengineering [K25 EB012236-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB012236] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The Jackson Heart Study is supported by contracts HHSN268201300046C, HHSN26820130047C, HHSN26820130048C, HHSN26820130049C, HHSN26820130050C, and grant R01 HL117285 form the National Heart, Lung, and Blood Institute and the National Institute on Minority Health and Health Disparities. This work was also supported by the National Institute of Biomedical Imaging and Bioengineering (grant K25 EB012236-01A1).	Anderson A, 2015, ELECT HLTH RECORD PH; Annis Ann M, 2005, Prev Chronic Dis, V2, pA19; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Carpenter MA, 2004, AM J MED SCI, V328, P131, DOI 10.1097/00000441-200409000-00001; Casanova R, 2012, Open Neuroimag J, V6, P1, DOI 10.2174/1874440001206010001; Casanova R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098587; Casanova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077949; Casanova R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044877; Casanova R, 2011, MAGN RESON IMAGING, V29, P546, DOI 10.1016/j.mri.2010.12.001; Catena C, 2006, J CLIN ENDOCR METAB, V91, P3457, DOI 10.1210/jc.2006-0736; Choi SB, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/618976; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Cuspidi C, 2014, J HYPERTENS, V32, P16, DOI 10.1097/HJH.0b013e328364fb58; Effoe VS, 2015, DIABETES CARE, V38, P1694, DOI 10.2337/dc15-0221; Espeland MA, 2014, DIABETES CARE, V37, P2548, DOI 10.2337/dc14-0093; Farran B, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002457; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Friedman J, 2009, R PACKAGE VERSION, P1, DOI DOI 10.18637/JSS.V033.I01; Fuqua SR, 2005, ETHNIC DIS, V15, pS18; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Knowler WC., 2009, LANCET, V374, P1677, DOI [10.1016/S0140-6736(09)61457-4, DOI 10.1016/S0140-6736(09)61457-4, 10.1016/B978-0-323-29738-7]; Kumagai E, 2011, HYPERTENSION, V58, P1043, DOI 10.1161/HYPERTENSIONAHA.111.180521; Lebedev AV, 2014, NEUROIMAGE-CLIN, V6, P115, DOI 10.1016/j.nicl.2014.08.023; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Mani Subramani, 2012, AMIA Annu Symp Proc, V2012, P606; Noble Douglas, 2011, BMJ, V343, pd7163, DOI 10.1136/bmj.d7163; Pfutzner A, 2006, DIABETES TECHNOL THE, V8, P28, DOI 10.1089/dia.2006.8.28; Pfutzner A, 2006, CLIN CHEM LAB MED, V44, P556, DOI 10.1515/CCLM.2006.108; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Siroky DS, 2008, NAVIGATING RANDOM FO; Sumner AE, 2005, ARCH INTERN MED, V165, P1395, DOI 10.1001/archinte.165.12.1395; Sumner AE, 2008, ATHEROSCLEROSIS, V196, P696, DOI 10.1016/j.atherosclerosis.2006.12.018; Sumner Anne E, 2009, Ethn Dis, V19, P480; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16	40	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163942	10.1371/journal.pone.0163942	http://dx.doi.org/10.1371/journal.pone.0163942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727289	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400014
J	Jones, AL; Kramer, RSS				Jones, Alex L.; Kramer, Robin S. S.			Facial Cosmetics and Attractiveness: Comparing the Effect Sizes of Professionally-Applied Cosmetics and Identity	PLOS ONE			English	Article							PERCEPTION; BEAUTY; SEX; FACES; SKIN; JUDGMENTS; LUMINANCE; CONTRAST; MAKEUP; HEALTH	Forms of body decoration exist in all human cultures. However, in Western societies, women are more likely to engage in appearance modification, especially through the use of facial cosmetics. How effective are cosmetics at altering attractiveness? Previous research has hinted that the effect is not large, especially when compared to the variation in attractiveness observed between individuals due to differences in identity. In order to build a fuller understanding of how cosmetics and identity affect attractiveness, here we examine how professionally-applied cosmetics alter attractiveness and compare this effect with the variation in attractiveness observed between individuals. In Study 1, 33 YouTube models were rated for attractiveness before and after the application of professionally-applied cosmetics. Cosmetics explained a larger proportion of the variation in attractiveness compared with previous studies, but this effect remained smaller than variation caused by differences in attractiveness between individuals. Study 2 replicated the results of the first study with a sample of 45 supermodels, with the aim of examining the effect of cosmetics in a sample of faces with low variation in attractiveness between individuals. While the effect size of cosmetics was generally large, between-person variability due to identity remained larger. Both studies also found interactions between cosmetics and identity-more attractive models received smaller increases when cosmetics were worn. Overall, we show that professionally-applied cosmetics produce a larger effect than self-applied cosmetics, an important theoretical consideration for the field. However, the effect of individual differences in facial appearance is ultimately more important in perceptions of attractiveness.	[Jones, Alex L.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Kramer, Robin S. S.] Univ York, Dept Psychol, York, N Yorkshire, England	Swansea University; University of York - UK	Jones, AL (corresponding author), Swansea Univ, Dept Psychol, Swansea, W Glam, Wales.	alextonesphd@gmail.com	Jones, Alex L./J-2779-2019	Jones, Alex L./0000-0003-3600-3644; Kramer, Robin/0000-0001-8339-8832				Brain R., 1979, THE DECORATED BODY; CASH TF, 1989, J SOC PSYCHOL, V129, P349, DOI 10.1080/00224545.1989.9712051; Coetzee V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099629; COX CL, 1986, SEX ROLES, V14, P51, DOI 10.1007/BF00287847; CROSS JF, 1971, DEV PSYCHOL, V5, P433, DOI 10.1037/h0031591; Etcoff N., 1999, SURVIVAL PRETTIEST S; Etcoff NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025656; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gueguen N, 2008, N AM J PSYCHOL, V10, P221; Gueguen N, 2012, INT J HOSP MANAG, V31, P1333, DOI 10.1016/j.ijhm.2012.03.012; Gueguen N, 2011, J COSMET SCI, V62, P283; Holme SA, 2002, BRIT J DERMATOL, V147, P946, DOI 10.1046/j.1365-2133.2002.04900.x; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Huguet P, 2004, J APPL SOC PSYCHOL, V34, P1752, DOI 10.1111/j.1559-1816.2004.tb02796.x; Jablonski N. G., 2006, SKIN NATURAL HIST; Jacob C, 2010, INT J HOSP MANAG, V29, P188, DOI 10.1016/j.ijhm.2009.04.003; Jenkins R, 2011, COGNITION, V121, P313, DOI 10.1016/j.cognition.2011.08.001; Jones AL, 2016, BODY IMAGE, V17, P57, DOI 10.1016/j.bodyim.2016.02.001; Jones AL, 2015, EVOL PSYCHOL-US, V13, P210, DOI 10.1177/147470491501300113; Jones AL, 2014, Q J EXP PSYCHOL, V67, P2060, DOI 10.1080/17470218.2014.908932; Jonesu AL, 2015, PERCEPTION, V44, P79, DOI 10.1068/p7904; Korichi R, 2008, J COSMET SCI, V59, P127; Koscinski K, 2012, BEHAV ECOL, V23, P334, DOI 10.1093/beheco/arr190; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Mileva VR, 2016, PERCEPTION, V45, P1166, DOI 10.1177/0301006616652053; MILLER LC, 1982, PERS SOC PSYCHOL B, V8, P748, DOI 10.1177/0146167282084023; Morrison ER, 2013, J NONVERBAL BEHAV, V37, P59, DOI 10.1007/s10919-013-0145-1; Mulhern R., 2003, International Journal of Cosmetic Science, V25, P199, DOI 10.1046/j.1467-2494.2003.00188.x; Nash R, 2006, J APPL SOC PSYCHOL, V36, P493, DOI 10.1111/j.0021-9029.2006.00016.x; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Penton-Voak I., 2011, J EVOLUTIONARY PSYCH, V9, P173, DOI DOI 10.1556/JEP.9.2011.2.5; Porcheron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057985; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Robertson J., 2008, INDIVIDUAL DIFFERENC, V6, P38; Rossi E, 2007, STUDY EUROPEAN COSME; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Russell R., 2010, SCI SOCIAL VISION, P186, DOI DOI 10.1093/ACPROF:OSO/9780195333176.003.0011; Russell R, 2009, PERCEPTION, V38, P1211, DOI 10.1068/p6331; Said CP, 2011, PSYCHOL SCI, V22, P1183, DOI 10.1177/0956797611419169; Samson N., 2010, International Journal of Cosmetic Science, V32, P167, DOI 10.1111/j.1468-2494.2009.00535.x; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Tagai K, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00226; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Wickham LHV, 2003, AM J PSYCHOL, V116, P455, DOI 10.2307/1423503	45	31	31	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164218	10.1371/journal.pone.0164218	http://dx.doi.org/10.1371/journal.pone.0164218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CI	27727311	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000385504400023
J	Holleman, B; Kamoen, N; Krouwel, A; van de Pol, J; de Vreese, C				Holleman, Bregje; Kamoen, Naomi; Krouwel, Andre; van de Pol, Jasper; de Vreese, Claes			Positive vs. Negative: The Impact of Question Polarity in Voting Advice Applications	PLOS ONE			English	Article							SUSCEPTIBILITY; STRATEGIES; KNOWLEDGE	Online Voting Advice Applications (VAAs) are survey-like instruments that help citizens to shape their political preferences and compare them with those of political parties. Especially in multi-party democracies, their increasing popularity indicates that VAAs play an important role in opinion formation for citizens, as well as in the public debate prior to elections. Hence, the objectivity and transparency of VAAs are crucial. In the design of VAAs, many choices have to be made. Extant research in survey methodology shows that the seemingly arbitrary choice to word questions positively (e.g., 'The city council should allow cars into the city centre') or negatively ('The city council should ban cars from the city centre') systematically affects the answers. This asymmetry in answers is in line with work on negativity bias in other areas of linguistics and psychology. Building on these findings, this study investigated whether question polarity also affects the answers to VAA statements. In a field experiment (N = 31,112) during the Dutch municipal elections we analysed the effects of polarity for 16 out of 30 VAA statements with a large variety of linguistic contrasts. Analyses show a significant effect of question wording for questions containing a wide range of implicit negations (such as 'forbid' vs. 'allow'), as well as for questions with explicit negations (e.g., 'not'). These effects of question polarity are found especially for VAA users with lower levels of political sophistication. As these citizens are an important target group for Voting Advice Applications, this stresses the need for VAA builders to be sensitive to wording choices when designing VAAs. This study is the first to show such consistent wording effects not only for political attitude questions with implicit negations in VAAs, but also for political questions containing explicit negations.	[Holleman, Bregje; Kamoen, Naomi] Univ Utrecht, Uil OTS, Utrecht, Netherlands; [Kamoen, Naomi] Tilburg Univ, TiCC, Tilburg, Netherlands; [Krouwel, Andre] Free Univ Amsterdam, Social Cultural Sci, Amsterdam, Netherlands; [Krouwel, Andre] Kieskompas Bv, Amsterdam, Netherlands; [van de Pol, Jasper; de Vreese, Claes] Univ Amsterdam, ASCoR, Amsterdam, Netherlands	Utrecht University; Tilburg University; Vrije Universiteit Amsterdam; University of Amsterdam	Holleman, B (corresponding author), Univ Utrecht, Uil OTS, Utrecht, Netherlands.	b.holleman@uu.nl	Krouwel, André/D-3959-2016	Krouwel, André/0000-0003-0952-6028	Netherlands Organization for Scientific Research (NWO) [321-89-003]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Our research is supported by the Netherlands Organization for Scientific Research (NWO), nwo.nl. Grant 321-89-003 to Bregje Holleman (BH). The funder provided support in the form of salaries for authors NK and JvdP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis Ioannis., 2014, MATCHING VOTERS PART, P115; [Anonymous], 1941, PUBLIC OPIN QUART, V5, P91; Bassili JN, 2000, POLIT PSYCHOL, V21, P107, DOI 10.1111/0162-895X.00179; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BISHOP GF, 1988, WILEY S PRO, P321; de Pol JV, 2014, J INF TECHNOL POLITI, V11, P397, DOI 10.1080/19331681.2014.958794; Dillman D.A., 2014, TAILORED DESIGN METH; Elo K, 2010, J ELECT PUBLIC OPIN, V20, P133, DOI 10.1080/17457280903450799; FISKE ST, 1983, J EXP SOC PSYCHOL, V19, P381, DOI 10.1016/0022-1031(83)90029-X; Fossen T, 2014, ELECT STUD, V36, P244, DOI 10.1016/j.electstud.2014.04.001; Garzia D., 2012, INT J ELECT GOVERNAN, V5, P203, DOI [DOI 10.1504/IJEG.2012.051309, 10.1504/IJEG.2012.051309]; Gemenis K, 2010, COMP EUR POLIT, V8, P179, DOI 10.1057/cep.2008.28; HIPPLER HJ, 1986, PUBLIC OPIN QUART, V50, P87, DOI 10.1086/268961; Holleman B, 2013, TIJDSCHRIFT TAALBEHE, V35, P25; Holleman B., 1999, J QUANT LINGUIST, V6, P29, DOI [10.1076/jqul.6.1.29.4145, DOI 10.1076/JQUL.6.1.29.4145]; Holleman B, 2000, FORBIRD ALLOW ASYMME; Holleman BC, 2006, QUAL QUANT, V40, P1, DOI 10.1007/s11135-005-4479-6; Kamoen N, 2012, POSTIVE VERSUS NEGAT; Kamoen N, 2013, SURV RES METHODS-GER, V7, P181; Kamoen N, 2011, DISCOURSE PROCESS, V48, P355, DOI 10.1080/0163853X.2011.578910; KROSNICK JA, 1988, J PERS SOC PSYCHOL, V54, P940, DOI 10.1037/0022-3514.54.6.940; KROSNICK JA, 1991, APPL COGNITIVE PSYCH, V5, P213, DOI 10.1002/acp.2350050305; Krouwel Andre, 2012, International Journal of Electronic Governance, V5, P223; Lachat R, 2008, ELECT STUD, V27, P687, DOI 10.1016/j.electstud.2008.06.002; Lefevere J, 2014, ELECT STUD, V36, P252, DOI 10.1016/j.electstud.2014.04.002; Louwerse T, 2014, ACTA POLIT, V49, P286, DOI 10.1057/ap.2013.30; MACDONALD SE, 1995, BRIT J POLIT SCI, V25, P453, DOI 10.1017/S0007123400007316; Mayer Christine., 2010, VOTING ADVICE APPL E, P173; Narayan S, 1996, PUBLIC OPIN QUART, V60, P58, DOI 10.1086/297739; Petty R. E., 2014, ATTITUDE STRENGTH AN; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI 10.1016/j.specom 2004.02.004; Quene H, 2008, J MEM LANG, V59, P413, DOI 10.1016/j.jml.2008.02.002; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Ruusuvirta O, 2009, ECPR GEN C SPET; Savigny Heather., 2002, POLITICS, V22, P1, DOI [10.1111/1467-9256.00152, DOI 10.1111/1467-9256.00152]; Schuman H., 1981, QUESTIONS ANSWERS AT; Searle S.R., 2006, LINEAR MODELS UNBALA; Stroh P., 1990, POLITICAL BEHAV, V12, P41, DOI DOI 10.1007/BF00992331; Van Berkum JJA, 2009, PSYCHOL SCI, V20, P1092, DOI 10.1111/j.1467-9280.2009.02411.x; Van Camp K., 2014, MATCHING VOTERS PART, P11; Van de Ven D, 2014, THESIS; Walgrave S, 2009, WEST EUR POLIT, V32, P1161, DOI 10.1080/01402380903230637; Wall M, 2014, PARTY POLIT, V20, P416, DOI 10.1177/1354068811436054; Waterplas L, 2014, MENS MAATSCHAPPIJ, V63, P399	45	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164184	10.1371/journal.pone.0164184	http://dx.doi.org/10.1371/journal.pone.0164184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723776	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100025
J	Romero, D; Camara, O; Sachse, F; Sebastian, R				Romero, Daniel; Camara, Oscar; Sachse, Frank; Sebastian, Rafael			Analysis of Microstructure of the Cardiac Conduction System Based on Three-Dimensional Confocal Microscopy	PLOS ONE			English	Article							PURKINJE-FIBERS; VENTRICULAR MUSCLE; REGIONAL DIFFERENCES; CONNEXIN EXPRESSION; GAP-JUNCTIONS; MYOCYTE SIZE; RABBIT; HEART; MORPHOLOGY; NETWORK	The specialised conducting tissues present in the ventricles are responsible for the fast distribution of the electrical impulse from the atrio-ventricular node to regions in the subendocardial myocardium. Characterisation of anatomical features of the specialised conducting tissues in the ventricles is highly challenging, in particular its most distal section, which is connected to the working myocardium via Purkinje-myocardial junctions. The goal of this work is to characterise the architecture of the distal section of the Purkinje network by differentiating Purkinje cells from surrounding tissue, performing a segmentation of Purkinje fibres at cellular scale, and mathematically describing its morphology and interconnections. Purkinje cells from rabbit hearts were visualised by confocal microscopy using wheat germ agglutinin labelling. A total of 16 3D stacks including labeled Purkinje cells were collected, and semi-automatically segmented. State-of-the-art graph metrics were applied to estimate regional and global features of the Purkinje network complexity. Two types of cell types, tubular and star-like, were characterised from 3D segmentations. The analysis of 3D imaging data confirms the previously suggested presence of two types of Purkinje-myocardium connections, a 2D interconnection sheet and a funnel one, in which the narrow side of a Purkinje fibre connect progressively to muscle fibres. The complex network analysis of interconnected Purkinje cells showed no small-world connectivity or assortativity properties. These results might help building more realistic computational PK systems at high resolution levels including different cell configurations and shapes. Better knowledge on the organisation of the network might help in understanding the effects that several treatments such as radio-frequency ablation might have when the PK system is disrupted locally.	[Romero, Daniel] Inst Tecnol Metropolitano, Grp Invest & Innovac Biomed, Medellin, Colombia; [Romero, Daniel; Camara, Oscar] Univ Pompeu Fabra, Dept Informat & Commun Technol, Physense, Barcelona, Spain; [Sachse, Frank] Univ Utah, Cardiovasc Res & Training Inst, Salt Lake City, UT USA; [Sachse, Frank] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Sebastian, Rafael] Univ Valencia, Dept Comp Sci, CoMMLab, Valencia, Spain	Pompeu Fabra University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Valencia	Sebastian, R (corresponding author), Univ Valencia, Dept Comp Sci, CoMMLab, Valencia, Spain.	rafael.sebastian@uv.es	Sebastian, Rafael/E-9386-2011; Camara, Oscar/I-4710-2015	Sebastian, Rafael/0000-0001-6746-5740; Camara, Oscar/0000-0002-5125-6132; Sachse, Frank/0000-0003-4987-705X	Ministerio de Economia y Competitividad [TIN2011-28067]; Ministerio de Economia y Competitividad; European Commission (European Regional Development Funds - ERDF - FEDER) [TIN2014-59932-JIN]; Nora Eccles Treadwell Foundation [484]; University of Sheffield, UK	Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government); European Commission (European Regional Development Funds - ERDF - FEDER); Nora Eccles Treadwell Foundation; University of Sheffield, UK	This work was supported by Ministerio de Economia y Competitividad, grant number TIN2011-28067 (www.mineco.gov.es): OC; and Ministerio de Economia y Competitividad, the European Commission (European Regional Development Funds - ERDF - FEDER) grant number TIN2014-59932-JIN: RS. Furthermore, we acknowledge awards from the Nora Eccles Treadwell 484 Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge Prof. A.F. Frangi, University of Sheffield, UK for his financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anderson RH, 2013, J CARDIOVASC TRANSL, V6, P187, DOI 10.1007/s12265-012-9433-0; Ansari A, 1999, ANAT REC, V254, P92, DOI 10.1002/(SICI)1097-0185(19990101)254:1<92::AID-AR12>3.0.CO;2-3; Atkinson A, 2011, J MOL CELL CARDIOL, V51, P689, DOI 10.1016/j.yjmcc.2011.05.020; AYETTEY AS, 1978, J ANAT, V127, P125; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Behradfar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088000; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BHAVANANDAN VP, 1979, J BIOL CHEM, V254, P4000; BISHOP SP, 1979, HYPERTENSION, V1, P378, DOI 10.1161/01.HYP.1.4.378; Boccaletti S, 2006, COMPLEX NETWORKS STR; Bordas R, 2011, PROG BIOPHYS MOL BIO, V107, P90, DOI 10.1016/j.pbiomolbio.2011.05.002; Bordas R, 2010, IEEE ENG MED BIO, P6793, DOI 10.1109/IEMBS.2010.5625979; Boyett MR, 2006, ADV CARDIOL, V42, P175, DOI 10.1159/000092569; CAMPBELL SE, 1987, P SOC EXP BIOL MED, V186, P211; CANALE E, 1983, CELL TISSUE RES, V232, P97; Cardenes R, 2015, MED IMAGE ANAL, V24, P52, DOI 10.1016/j.media.2015.05.007; Cates AW, 2001, AM J PHYSIOL-HEART C, V281, pH490, DOI 10.1152/ajpheart.2001.281.2.H490; Cherry EM, 2012, AM J PHYSIOL-HEART C, V302, pH2451, DOI 10.1152/ajpheart.00770.2011; Cordeiro JM, 1998, J PHYSIOL-LONDON, V508, P811, DOI 10.1111/j.1469-7793.1998.811bp.x; Davies F, 1942, BRIT HEART J, V4, P66; De Almeida MC, 2015, ANAT SCI INT, V90, P240, DOI 10.1007/s12565-014-0255-9; Dobrzynski H, 2013, STRUCTURE FUNCTION C; DOLBER PC, 1992, J MOL CELL CARDIOL, V24, P1443, DOI 10.1016/0022-2828(92)91085-J; Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35; GERDES AM, 1986, ANAT RECORD, V215, P420, DOI 10.1002/ar.1092150414; GOURDIE RG, 1993, J CELL SCI, V105, P985; Guyton AC, 2006, TXB MED PHYSL, V51; Hyde ER, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1164, DOI 10.1161/CIRCEP.115.002677; Ijiri T, 2008, J PHYSIOL SCI, V58, P481, DOI 10.2170/physiolsci.RP003208; Krishnamoorthy Jaishankar, 2015, Asian Cardiovasc Thorac Ann, V23, P855, DOI 10.1177/0218492314526395; Lackey DP, 2011, ANN BIOMED ENG, V39, P2683, DOI 10.1007/s10439-011-0369-3; Lasher RA, 2009, IEEE T MED IMAGING, V28, P1156, DOI 10.1109/TMI.2009.2017376; Miquerol L, 2004, CARDIOVASC RES, V63, P77, DOI 10.1016/j.cardiores.2004.03.007; MYERBURG RJ, 1972, CIRC RES, V30, P217, DOI 10.1161/01.RES.30.2.217; Ono N, 2009, ARCH HISTOL CYTOL, V72, P139, DOI 10.1679/aohc.72.139; OOSTHOEK PW, 1993, CIRC RES, V73, P482, DOI 10.1161/01.RES.73.3.482; Pawley J., 2006, HANDBOOK OF BIOLOGIC; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Ramirez E, 2014, EUROPACE, V16, P444, DOI 10.1093/europace/eut386; RAWLING DA, 1987, CIRC RES, V60, P580, DOI 10.1161/01.RES.60.4.580; Romero D, 2011, LECT NOTES COMPUT SC, V6666, P28, DOI 10.1007/978-3-642-21028-0_4; Romero D, 2010, IEEE ENG MED BIO, P779, DOI 10.1109/IEMBS.2010.5626476; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ryu S, 2009, ANAT REC, V292, P12, DOI 10.1002/ar.20827; Satoh H, 1996, BIOPHYS J, V70, P1494, DOI 10.1016/S0006-3495(96)79711-4; Sebastian R, 2013, IEEE T MED IMAGING, V32, P45, DOI 10.1109/TMI.2012.2221474; Seidel T, 2016, ANN BIOMED ENG, V44, P1436, DOI 10.1007/s10439-015-1465-6; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; SHEETS MF, 1983, CIRC RES, V53, P544, DOI 10.1161/01.RES.53.4.544; SHIMADA T, 1986, ARCH HISTOL CYTOL, V49, P283, DOI 10.1679/aohc.49.283; Sinha AM, 2009, PACE, V32, P286, DOI 10.1111/j.1540-8159.2008.02233.x; Stankovicova T, 2003, GEN PHYSIOL BIOPHYS, V22, P329; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; Tabereaux PB, 2007, CIRCULATION, V116, P1113, DOI 10.1161/CIRCULATIONAHA.107.699264; Tawara S., 1906, REIZLEITUNGSSYSTEM S; Ten Tusscher KHWJ, 2008, PROG BIOPHYS MOL BIO, V96, P152, DOI 10.1016/j.pbiomolbio.2007.07.026; TRANUMJENSEN J, 1991, CIRC RES, V69, P429, DOI 10.1161/01.RES.69.2.429; Vadakkumpadan Fijoy, 2009, J Electrocardiol, V42, DOI 10.1016/j.jelectrocard.2008.12.003; Vaidyanathan R, 2013, HEART RHYTHM, V10, P80, DOI 10.1016/j.hrthm.2012.10.002; Vozzi C, 1999, J MOL CELL CARDIOL, V31, P991, DOI 10.1006/jmcc.1999.0937; Wiedmann RT, 1996, AM J PHYSIOL-HEART C, V271, pH1507, DOI 10.1152/ajpheart.1996.271.4.H1507; Xi P, 2007, AM J PHYS, V75, P203, DOI 10.1119/1.2388973	63	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164093	10.1371/journal.pone.0164093	http://dx.doi.org/10.1371/journal.pone.0164093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716829	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100020
J	Zhao, LX; Du, JR; Zhou, HJ; Liu, DL; Gu, MX; Long, FY				Zhao, Li-Xue; Du, Jun-Rong; Zhou, Hong-Jing; Liu, Dong-Ling; Gu, Man-Xia; Long, Fang-Yi			Differences in Proinflammatory Property of Six Subtypes of Peroxiredoxins and Anti-Inflammatory Effect of Ligustilide in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; ISCHEMIC-STROKE; BRAIN-DAMAGE; CELL-TYPES; INFLAMMATION; INJURY; TOLL-LIKE-RECEPTOR-4; NEUROINFLAMMATION; TRANSLATION; MECHANISMS	Background Peroxiredoxins (Prxs) are proposed to function as damage-associated molecular patterns (DAMPs) and contribute to post-ischemic neuroinflammation and brain injury by activating Toll-like receptor (TLR) 4 at the acute and subacute phases after ischemic stroke. However, there are few studies concerning the inflammatory profiles of six distinct subtypes of Prxs (Prx1-Prx6). Our previous study demonstrated that the protective effect of ligustilide (LIG) against cerebral ischemia was associated with inhibition of neuroinflammatory response and Prx/TLR4 signaling in rats. Herein, the present study explored the inflammatory members of Prxs and the effect of LIG on their inflammatory responses in macrophages. Methodology/Principal Findings The murine RAW264.7 macrophages were treated with each of exogenous recombinant Prxs at a range of 1 to 50 nM for 24 h. The WST-1 test showed that Prx3 exhibited a significant cytotoxicity, whereas the rest five Prxs did not affect cellular viability. The quantitative measurements with spectrometry or ELISA indicated that three subtypes, Prx1, Prx2 and Prx4, increased production of proinflammatory mediators, including nitric oxide (NO) metabolites, tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) in a concentration-dependent manner. Immunostaining demonstrated that 20 nM Prx1, Prx2 or Prx4 significantly increased expression of TLR4 and iNOS and nuclear translocation of NF-kappa B p65. However, Prx5 and Prx6 showed no poinflammatory effect in macrophages. Remarkably, LIG treatment effectively inhibited the inflammatory response induced by Prx1, Prx2 and Prx4. Conclusion Three members of Prxs, Prx1, Prx2 and Prx4, are inflammatory DAMPs that induce TLR4 activation and inflammatory response in macrophages, which is effectively inhibited by LIG. These results suggest that inflammatory Prxs-activated macrophages may provide a novel cellular model for screening the potential inhibitors of DAMPs-associated inflammatory diseases such as stroke. Moreover, selective blocking strategies targeting the inflammatory subtypes of Prxs probably provide promising therapeutic approaches with a prolonged time window for stroke.	[Zhao, Li-Xue; Du, Jun-Rong; Zhou, Hong-Jing; Liu, Dong-Ling; Gu, Man-Xia; Long, Fang-Yi] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Dept Pharmacol, Chengdu, Peoples R China	Sichuan University	Du, JR (corresponding author), Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Dept Pharmacol, Chengdu, Peoples R China.	dujr_1@163.com	Long, Fangyi/GMW-7467-2022		National Natural Science Foundation of China [81072636, 81473219]; Basic Research Projects in Sichuan Province [2014JY0151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Projects in Sichuan Province	This study was funded by the National Natural Science Foundation of China (81072636, 81473219), and Basic Research Projects in Sichuan Province (2014JY0151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, ACTA PHARM SINIGA, DOI DOI 10.16438/J.0513-4870.1979.09.004; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Gan Y, 2012, ANTIOXID REDOX SIGN, V17, P719, DOI 10.1089/ars.2011.4298; Garcia-Bonilla L, 2012, NAT MED, V18, P858, DOI 10.1038/nm.2797; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Kim SU, 2013, J NEUROIMMUNOL, V259, P26, DOI 10.1016/j.jneuroim.2013.03.006; Kuang X, 2008, PHARMACOL BIOCHEM BE, V88, P213, DOI 10.1016/j.pbb.2007.08.006; Kuang X, 2014, FREE RADICAL BIO MED, V71, P165, DOI 10.1016/j.freeradbiomed.2014.03.028; Kuang X, 2014, NEUROBIOL AGING, V35, P169, DOI 10.1016/j.neurobiolaging.2013.07.019; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lin YC, 2005, ATHEROSCLEROSIS, V180, P305, DOI 10.1016/j.atherosclerosis.2004.12.022; Miyamoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155220; Noh YH, 2009, J BIOL CHEM, V284, P8470, DOI 10.1074/jbc.M808981200; Plaisant F, 2003, FREE RADICAL BIO MED, V34, P862, DOI 10.1016/S0891-5849(02)01440-5; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Sarafian TA, 1999, J NEUROSCI RES, V56, P206, DOI 10.1002/(SICI)1097-4547(19990415)56:2<206::AID-JNR1>3.0.CO;2-X; Shah IM, 2009, CURR MOL MED, V9, P336, DOI 10.2174/156652409787847236; Shao M, 2011, PLANTA MED, V77, P809, DOI 10.1055/s-0030-1250573; Shichita T, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00319; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Su YW, 2011, INT IMMUNOPHARMACOL, V11, P1166, DOI 10.1016/j.intimp.2011.03.014; Wang J, 2010, ACTA PHARMACOL SIN, V31, P791, DOI 10.1038/aps.2010.71; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	31	20	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164586	10.1371/journal.pone.0164586	http://dx.doi.org/10.1371/journal.pone.0164586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716839	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100062
J	de Salas, F; Pardo, I; Salavagione, HJ; Aza, P; Amougi, E; Vind, J; Martinez, AT; Camarero, S				de Salas, Felipe; Pardo, Isabel; Salavagione, Horacio J.; Aza, Pablo; Amougi, Eleni; Vind, Jesper; Martinez, Angel T.; Camarero, Susana			Advanced Synthesis of Conductive Polyaniline Using Laccase as Biocatalyst	PLOS ONE			English	Article							CRITICAL MICELLE CONCENTRATION; CATALYZED SYNTHESIS; ANILINE; POLYMERIZATION; NANOCOMPOSITES; ELECTROPOLYMERIZATION; COMPOSITES; NANOFIBERS; MORPHOLOGY; EVOLUTION	Polyaniline is a conductive polymer with distinctive optical and electrical properties. Its enzymatic synthesis is an environmentally friendly alternative to the use of harsh oxidants and extremely acidic conditions. 7D5L, a high-redox potential laccase developed in our lab, is the biocatalyst of choice for the synthesis of green polyaniline (emeraldine salt) due to its superior ability to oxidize aniline and kinetic stability at the required polymerization conditions (pH 3 and presence of anionic surfactants) as compared with other fungal laccases. Doses as low as 7.6 nM of 7D5L catalyze the polymerization of 15 mM aniline (in 24 h, room temperature, 7% yield) in the presence of different anionic surfactants used as doping templates to provide linear and water-soluble polymers. Aniline polymerization was monitored by the increase of the polaron absorption band at 800 nm (typical for emeraldine salt). Best polymerization results were obtained with 5 mM sodium dodecylbenzenesulfonate (SDBS) as template. At fixed conditions (15 mM aniline and 5mM SDBS), polymerization rates obtained with 7D5L were 2.5-fold the rates obtained with commercial Trametes villosa laccase. Moreover, polyaniline yield was notably boosted to 75% by rising 7D5L amount to 0.15 mu M, obtaining 1g of green polyaniline in 1L-reaction volume. The green polymer obtained with the selected system (7D5L/SDBS) holds excellent electrochemical and electro-conductive properties displayed in water-dispersible nanofibers, which is advantageous for the nanomaterial to be readily cast into uniform films for different applications.	[de Salas, Felipe; Pardo, Isabel; Aza, Pablo; Martinez, Angel T.; Camarero, Susana] CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain; [Salavagione, Horacio J.] CSIC, Inst Ciencia & Tecnol Polimeros, Juan de la Cierva 3, E-28006 Madrid, Spain; [Amougi, Eleni; Vind, Jesper] Novozymes AS, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia & Tecnologia de Polimeros (ICTP); Novozymes	Camarero, S (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	susanacam@cib.csic.es	SALAVAGIONE, HORACIO J/J-7194-2016; de Salas, Felipe/GON-5080-2022; Martínez, Angel T/G-7284-2017; Pardo, Isabel/GLT-6378-2022; Camarero, Susana/K-3172-2014	SALAVAGIONE, HORACIO J/0000-0001-9588-7879; de Salas, Felipe/0000-0002-0057-0180; Martínez, Angel T/0000-0002-1584-2863; Pardo, Isabel/0000-0002-8568-1559; Camarero, Susana/0000-0002-2812-895X	INDOX European project [KBBE-2013-7-613549]; NOESIS Spanish national project [BIO2014-56388-R]; company Novozymes NS (Denmark)	INDOX European project; NOESIS Spanish national project; company Novozymes NS (Denmark)	This work was funded by INDOX (KBBE-2013-7-613549) European project and NOESIS (BIO2014-56388-R) Spanish national project. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company Novozymes NS (Denmark) provided support in the form of salaries for EA and JV and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.r This work was funded by the INDOX European project (KBBE-2013-7-613549) and NOESIS Spanish national project (BIO2014-56388-R). The authors thank David Gomez from ICTP, CSIC for SEM analyses.	Alcalde M, DIR ENZYM EVOL, P193, DOI [10.1385/1-59259-396-8:193, DOI 10.1385/1-59259-396-8:193]; BAYNTON KJ, 1994, BBA-PROTEIN STRUCT M, V1206, P272, DOI 10.1016/0167-4838(94)90218-6; Blinova NV, 2007, EUR POLYM J, V43, P2331, DOI 10.1016/j.eurpolymj.2007.03.045; Camarero S, 2012, APPL ENVIRON MICROB, V78, P1370, DOI 10.1128/AEM.07530-11; Chauhan S, 2014, J CHEM THERMODYN, V71, P205, DOI 10.1016/j.jct.2013.12.019; Cruz-Silva R, 2005, EUR POLYM J, V41, P1129, DOI 10.1016/j.eurpolymj.2004.11.012; Guo CG, 2013, POLYM POLYM COMPOS, V21, P449, DOI 10.1177/096739111302100706; Hino T, 2006, SYNTHETIC MET, V156, P1327, DOI 10.1016/j.synthmet.2006.10.001; Huang JX, 2003, J AM CHEM SOC, V125, P314, DOI 10.1021/ja028371y; Huang JX, 2006, CHEM COMMUN, P367, DOI 10.1039/b510956f; Junker K, 2014, ENZYME MICROB TECH, V55, P72, DOI 10.1016/j.enzmictec.2013.12.008; Karamyshev AV, 2003, ENZYME MICROB TECH, V33, P556, DOI 10.1016/S0141-0229(03)00163-7; Lin CE, 2004, J CHROMATOGR A, V1037, P467, DOI 10.1016/j.chroma.2003.11.059; Liu W, 1999, J AM CHEM SOC, V121, P71, DOI 10.1021/ja982270b; Martinez MV, 2015, POLYMER, V78, P94, DOI 10.1016/j.polymer.2015.09.054; Mate DM, 2013, BIOCATAL BIOTRANSFOR, V31, P8, DOI 10.3109/10242422.2012.749463; Matsui T, 2016, WO, Patent No. [2016026938 A1 Patent 2016, 2016026938]; Pardo I, 2012, BIOTECHNOL BIOENG, V109, P2978, DOI 10.1002/bit.24588; Sapurina I, 2008, POLYM INT, V57, P1295, DOI 10.1002/pi.2476; Shumakovich GP, 2010, J APPL POLYM SCI, V117, P1544, DOI 10.1002/app.32008; Shumakovich G, 2011, J MOL CATAL B-ENZYM, V69, P83, DOI 10.1016/j.molcatb.2011.01.016; Stejskal J, 2002, PURE APPL CHEM, P74; Stejskal J, 2008, MACROMOLECULES, V41, P3530, DOI 10.1021/ma702601q; Streltsov AV, 2008, APPL BIOCHEM MICRO+, V44, P264, DOI 10.1134/S000368380803006X; Tran HD, 2011, J MATER CHEM, V21, P3534, DOI 10.1039/c0jm02699a; Trchova M, 2011, PURE APPL CHEM, V83, P1803, DOI 10.1351/PAC-REP-10-02-01; Vasil'eva IS, 2007, SYNTHETIC MET, V157, P684, DOI 10.1016/j.synthmet.2007.07.018; Vasil'eva I S, 2009, Prikl Biokhim Mikrobiol, V45, P33; Wang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03568; Wang YM, 2014, SYNTHETIC MET, V198, P293, DOI 10.1016/j.synthmet.2014.10.038; Wen T, 2012, J NANOSCI NANOTECHNO, V12, P91, DOI 10.1166/jnn.2012.5143; Wu Q, 2010, ACS NANO, V4, P1963, DOI 10.1021/nn1000035; WUDL F, 1987, J AM CHEM SOC, V109, P3677, DOI 10.1021/ja00246a026; YANG HJ, 1992, J ELECTROANAL CHEM, V339, P423, DOI 10.1016/0022-0728(92)80466-H; Yang LYO, 2007, J AM CHEM SOC, V129, P8076, DOI 10.1021/ja072201+; Zhang HM, 2011, POLYMER, V52, P3059, DOI 10.1016/j.polymer.2011.02.031; Zhang J, 2014, COLLOID POLYM SCI, V292, P2549, DOI 10.1007/s00396-014-3301-1; Zhang K, 2010, CHEM MATER, V22, P1392, DOI 10.1021/cm902876u; Zhang WC, 2009, LANGMUIR, V25, P2363, DOI 10.1021/la803240x; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; Zhang Y, 2014, APPL BIOCHEM BIOTECH, V174, P820, DOI 10.1007/s12010-014-1094-9	41	26	27	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164958	10.1371/journal.pone.0164958	http://dx.doi.org/10.1371/journal.pone.0164958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741301	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000085
J	Kolola, T; Gezahegn, T; Addisie, M				Kolola, Tufa; Gezahegn, Takele; Addisie, Mesfin			Health Care Seeking Behavior for Common Childhood Illnesses in Jeldu District, Oromia Regional State, Ethiopia	PLOS ONE			English	Article							PNEUMONIA; DIARRHEA; CHILDREN	Background Even though health care seeking interventions potentially reduce child mortality from easily treatable diseases, significant numbers of children die without ever reaching a health facility or due to delays in seeking care in Ethiopia. This study aimed to assess health care seeking behavior for common childhood illnesses and associated factors. Methods A community-based cross-sectional study was conducted in Jeldu District from January to February 2011. A systematic sampling method was used for sample selection. Data were collected from 422 caregivers with under-five children who experienced diseases within six weeks before the survey. Interviewer administered structured and pre-tested questionnaire which were used to collect data. Data entry and cleaning were carried out using Epi Info version 3.5.1 and analyzed using SPSS version 16. Descriptive analysis was done to determine the magnitude of health care seeking behavior. Multivariate logistic regression analyses were performed to identify associated factors. Results A total of 422 caregivers of under-five children were participated in the study giving an overall response rate of 97.5%. Three hundred fifteen (74.6%) children sought care from health facilities for all conditions. However, only 55.4% of them were taken to health facilities as first source treatment during their illness and prompt care was also very low (13.7%). Marital status of the caregivers (AOR = 2.84; 95% CI: 1.62-4.98), number of symptoms experienced by the child (AOR = 2.04; 95% CI: 1.24-3.36) and perceived severity of the illness (AOR = 3.20; 95% CI: 1.96-5.22) were predictors of health care seeking behavior. Conclusion Health care seeking behavior for childhood illnesses was delayed and decision to seek care from health facilities was influenced by worsening of the illnesses. Thus, community level promotion of prompt health care seeking is essential to enhance the health care seeking behavior for child hood illnesses in the locality.	[Kolola, Tufa; Gezahegn, Takele] Debre Berhan Univ, Inst Med & Hlth Sci, Debre Berhan, Ethiopia; [Addisie, Mesfin] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Kolola, T (corresponding author), Debre Berhan Univ, Inst Med & Hlth Sci, Debre Berhan, Ethiopia.	tufabest@gmail.com	Demie, Takele/H-9397-2019	Demie, Takele/0000-0002-6296-7706	Addis Ababa University	Addis Ababa University	This study was funded by Addis Ababa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Addis Ababa University for funding and Jeldu District Health Office for permission to undertake this study. We are also grateful to study subjects for their time and valuable information.	Abdulraheem IS, 2009, EARLY CHILD DEV CARE, V179, P671, DOI 10.1080/03004430701500885; Adegboyega A A, 2005, Niger J Med, V14, P65; Assefa T., 2008, ETHIOPIAN J HLTH SCI, V18, P87; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Bustreo F, 2015, WHO PERSPECTIVES CON; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV 20; D'Souza RM, 2003, J BIOSOC SCI, V35, P131, DOI 10.1017/S0021932003001317; de Silva MWA, 2001, SOC SCI MED, V53, P1363, DOI 10.1016/S0277-9536(00)00425-1; Deressa W, 2007, ACTA TROP, V102, P1, DOI [10.1016/j.actatropica.2007, DOI 10.1016/J.ACTATROPICA.2007.]; Diaz T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-157; Federal Ministry of Health, 2010, HLTH SECT DEV PROGR; Geldsetzer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093427; Hildenwall H, 2009, ANN TROP PAEDIATR, V29, P281, DOI 10.1179/027249309X12547917869005; Kante AM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2264-6; Lulseged S, 2006, EPIDEMIOLOGY ECOLOGY, P25; Mash D, 2003, East Afr Med J, V80, P463; Mbagaya Grace M, 2005, Afr Health Sci, V5, P322; Oluwole D, 2000, BRIT MED J, V320, P594, DOI 10.1136/bmj.320.7235.594; Page AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-389; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Tessema F, 2002, ETHIOP J HEALTH DEV, V16, P51; UN, 2015, MILLENNIUM DEV GOALS; United Nations Children's Fund (UNICEF), 2010, PROGR CHILDR ACH MDG; United Nations Children's Fund WHO World Bank and United Nations, 2015, LEV TRENDS CHILD MOR; Vaahtera M, 2000, PAEDIATR PERINAT EP, V14, P363, DOI 10.1046/j.1365-3016.2000.00308.x; Wagstaff A, 2004, AM J PUBLIC HEALTH, V94, P726, DOI 10.2105/AJPH.94.5.726; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; Wiens MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118055; World Health Organization, 2016, WORLD HLTH STAT MON	31	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							0164534	10.1371/journal.pone.0164534	http://dx.doi.org/10.1371/journal.pone.0164534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741273	Green Submitted, gold, Green Published			2022-12-27	WOS:000385507000041
J	Shinoda, Y; Tagashira, H; Bhuiyan, MS; Hasegawa, H; Kanai, H; Zhang, C; Han, F; Fukunaga, K				Shinoda, Yasuharu; Tagashira, Hideaki; Bhuiyan, Md. Shenuarin; Hasegawa, Hideyuki; Kanai, Hiroshi; Zhang, Chen; Han, Feng; Fukunaga, Kohji			Corticosteroids Mediate Heart Failure-Induced Depression through Reduced sigma 1-Receptor Expression	PLOS ONE			English	Article							OVERLOAD-INDUCED HYPERTROPHY; SIGMA-1 RECEPTOR; CARDIOVASCULAR-DISEASE; SIGMA(1)-RECEPTOR STIMULATION; MAJOR DEPRESSION; ATP PRODUCTION; MOUSE-BRAIN; RAT-BRAIN; MICE; PROTEIN	Cardiovascular diseases are risk factors for depression in humans. We recently proposed that sigma(1) receptor (sigma R-1) stimulation rescued cardiac hypertrophy and heart failure induced by transverse aortic constriction (TAC) in mice. Importantly, sigma R-1 stimulation reportedly ameliorates depression-like behaviors in rodents. Thus, we hypothesized that impaired sigma R-1 activity in brain triggers depression-like behaviors in animals with cardiovascular disease. Indeed, here we found that cardiac hypertrophy and heart failure induced by TAC were associated with depression-like behaviors concomitant with downregulation of sigma R-1 expression in brain 6 weeks after surgery. sigma R-1 levels significantly decreased in astrocytes in both the hippocampal CA1 region and dentate gyrus. Oral administration of the specific sigma R-1 agonist SA4503 (0.3-1.0mg/kg) significantly improved TAC-induced depression-like behaviors concomitant with rescued astrocytic sigma R-1 expression in CA1 and the dentate gyrus. Plasma corticosterone levels significantly increased 6 weeks after TAC, and chronic treatment of mice with corticosterone for 3 weeks elicited depression-like behaviors concomitant with reduced astrocytic sigma R-1 expression in hippocampus. Furthermore, the glucocorticoid receptor antagonist mifepristone antagonized depressive-like behaviors and ameliorated decreased hippocampal sigma R-1 expression in TAC mice. We conclude that elevated corticosterone levels trigger hippocampal sigma R-1 downregulation and that sigma R-1 stimulation with SA4503 is an attractive therapy to improve not only cardiac dysfunction but depression-like behaviors associated with heart failure.	[Shinoda, Yasuharu; Tagashira, Hideaki; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi, Japan; [Bhuiyan, Md. Shenuarin] Cincinnati Childrens Hosp Med Ctr, Div Mol Cardiovasc Biol, Dept Pediat, Cincinnati, OH 45229 USA; [Hasegawa, Hideyuki; Kanai, Hiroshi] Tohoku Univ, Grad Sch Biomed Engn, Dept Elect Engn, Aoba Ku, 6-6 Aramaki Aoba, Sendai, Miyagi, Japan; [Zhang, Chen; Han, Feng] Zhejiang Univ, Dept Pharm, Coll Pharmaceut Sci, Hangzhou 31005, Zhejiang, Peoples R China	Tohoku University; Cincinnati Children's Hospital Medical Center; Tohoku University; Zhejiang University	Fukunaga, K (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi, Japan.	kfukunaga@roctohoku.ac.jp	Shinoda, Yasuharu/AAE-6135-2019; Fukunaga, Kohji/AAI-8811-2021; Kanai, Hiroshi/T-4996-2019; Bhuiyan, Shenuarin/O-5814-2019	Shinoda, Yasuharu/0000-0001-9910-048X; Kanai, Hiroshi/0000-0002-6567-1687; Fukunaga, Kohji/0000-0001-8526-2824	Ministry of Education, Science, Sports and Culture of Japan (KAKENHI) [25293124, 26102704]; Smoking Research Foundation; Japan Society for the Promotion of Science [265570, 244360]	Ministry of Education, Science, Sports and Culture of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Smoking Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (KAKENHI 25293124 and 26102704 to K. F.), the Smoking Research Foundation (K.F.), and from a Research Fellowship from the Japan Society for the Promotion of Science (265570 o Y. S.).; This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (KAKENHI 25293124 and 26102704 to K.F.), the Smoking Research Foundation (K.F.), and from a Research Fellowship from the Japan Society for the Promotion of Science (265570 and 244360 to Y.S. and H.T., respectively).	Ago Y, 2008, NEUROPHARMACOLOGY, V55, P1355, DOI 10.1016/j.neuropharm.2008.08.026; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Bhuiyan MS, 2013, J PHARMACOL SCI, V121, P177, DOI 10.1254/jphs.12R13CP; Bhuiyan MS, 2010, EXPERT OPIN THER TAR, V14, P1009, DOI 10.1517/14728222.2010.509348; Cao X, 2013, NAT MED, V19, P773, DOI 10.1038/nm.3162; Cattel C, 1997, J NEUROL NEUROSURG P, V63, P509; CHAOULOFF F, 1993, BRAIN RES REV, V18, P1, DOI 10.1016/0165-0173(93)90005-K; Chen FH, 2013, SYNAPSE, V67, P127, DOI 10.1002/syn.21622; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Fujimura K, 1997, BIOORGAN MED CHEM, V5, P1675, DOI 10.1016/S0968-0896(97)00093-X; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Gregus A, 2005, BEHAV BRAIN RES, V156, P105, DOI 10.1016/j.bbr.2004.05.013; Guder G, 2007, CIRCULATION, V115, P1754, DOI 10.1161/CIRCULATIONAHA.106.653964; Haddad JJ, 2002, J NEUROIMMUNOL, V133, P1, DOI 10.1016/S0165-5728(02)00357-0; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Ito K, 2012, CARDIOVASC RES, V93, P33, DOI 10.1093/cvr/cvr255; KATZ SD, 1994, CIRCULATION, V90, P12, DOI 10.1161/01.CIR.90.1.12; Liu WN, 2012, PSYCHONEUROENDOCRINO, V37, P1057, DOI 10.1016/j.psyneuen.2011.12.003; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Narita N, 1996, EUR J PHARMACOL, V307, P117, DOI 10.1016/0014-2999(96)00254-3; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Rumsfeld JS, 2005, CIRCULATION, V111, P250, DOI 10.1161/01.CIR.0000154573.62822.89; Rumsfeld JS, 2003, J AM COLL CARDIOL, V42, P1811, DOI 10.1016/j.jacc.2003.07.013; Shioda N, 2012, J BIOL CHEM, V287, P23318, DOI 10.1074/jbc.M112.349142; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; Silverman MN, 2013, MOL PSYCHIATR, V18, P1006, DOI 10.1038/mp.2012.131; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tagashira H, 2014, LIFE SCI, V95, P89, DOI 10.1016/j.lfs.2013.12.019; Tagashira H, 2013, CIRC J, V77, P2831, DOI 10.1253/circj.CJ-13-0256; Tagashira H, 2013, AM J PHYSIOL-HEART C, V305, pH1201, DOI 10.1152/ajpheart.00300.2013; Tagashira H, 2013, BBA-GEN SUBJECTS, V1830, P3082, DOI 10.1016/j.bbagen.2012.12.029; Tagashira H, 2011, MENOPAUSE, V18, P1317, DOI 10.1097/gme.0b013e31821f915b; Tagashira H, 2010, AM J PHYSIOL-HEART C, V299, pH1535, DOI 10.1152/ajpheart.00198.2010; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Wang DY, 2007, J PHARMACOL EXP THER, V322, P1305, DOI 10.1124/jpet.107.124685; Wei L, 2004, ANN INTERN MED, V141, P764, DOI 10.7326/0003-4819-141-10-200411160-00007; Yamaji M, 2009, CIRC-HEART FAIL, V2, P608, DOI 10.1161/CIRCHEARTFAILURE.109.868513; Zunszain PA, 2011, PROG NEURO-PSYCHOPH, V35, P722, DOI 10.1016/j.pnpbp.2010.04.011	47	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163992	10.1371/journal.pone.0163992	http://dx.doi.org/10.1371/journal.pone.0163992			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741227	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000013
J	Kammoun, M; Pouletaut, P; Canon, F; Subramaniam, M; Hawse, JR; Vayssade, M; Bensamoun, SF				Kammoun, Malek; Pouletaut, Philippe; Canon, Francis; Subramaniam, Malayannan; Hawse, John R.; Vayssade, Muriel; Bensamoun, Sabine F.			Impact of TIEG1 Deletion on the Passive Mechanical Properties of Fast and Slow Twitch Skeletal Muscles in Female Mice	PLOS ONE			English	Article							FINGER TRANSCRIPTION FACTOR; GENE-1 KNOCKOUT MICE; HEAVY-CHAIN ISOFORMS; INDUCIBLE EARLY GENE; HUMAN OSTEOBLASTS; DISPLAY DEFECTS; BETA; FIBERS; CELLS; RAT	As transforming growth factor (TGF)-beta inducible early gene-1 is highly expressed in skeletal muscle, the effect of TIEG1 gene deletion on the passive mechanical properties of slow and fast twitch muscle fibers was analyzed. Twenty five muscle fibers were harvested from soleus (Sol) and extensor digitorum longus (EDL) muscles from TIEG1(-/-)(N = 5) and control (N = 5) mice. Mechanical tests were performed on fibers and the dynamic and static stresses were measured. A viscoelastic Hill model of 3rd order was used to fit the experimental relaxation test data. In parallel, immunohistochemical analyses were performed on three serial transverse sections to detect the myosin isoforms within the slow and fast muscles. The percentage and the mean cross sectional area of each fiber type were calculated. These tests revealed a significant increase in the mechanical stress properties for the TIEG1(-/-)Sol fibers while a significant decrease appeared for the TIEG1(-/-)EDL fibers. Hill model tracked the shape of the experimental relaxation curve for both genotypes and both fiber types. Immunohistochemical results showed hypertrophy of all fiber types for TIEG1(-/-)muscles with an increase in the percentage of glycolytic fibers (IIX, and IIB) and a decrease of oxidative fibers (I, and IIA). This study has provided new insights into the role of TIEG1, known as KLF10, in the functional (Sol(typeI): more resistant, EDLtypeIIB: less resistant) and morphological (glycolytic hypertrophy) properties of fast and slow twitch skeletal muscles. Further investigation at the cellular level will better reveal the role of the TIEG1 gene in skeletal muscle tissue.	[Kammoun, Malek; Pouletaut, Philippe; Canon, Francis; Vayssade, Muriel; Bensamoun, Sabine F.] Univ Technol Compiegne, Sorbonne Univ, UMR CNRS 7338, Biomech & Bioengn Lab, Compiegne, France; [Subramaniam, Malayannan; Hawse, John R.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Picardie Universites; Universite de Technologie de Compiegne; UDICE-French Research Universities; Sorbonne Universite; Mayo Clinic	Bensamoun, SF (corresponding author), Univ Technol Compiegne, Sorbonne Univ, UMR CNRS 7338, Biomech & Bioengn Lab, Compiegne, France.	sabine.bensamoun@utc.fr			NIH [DE14036]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014036] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by NIH DE14036 Grant (JRH and MS).	Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Bensamoun S, 2006, J BIOMECH, V39, P568, DOI 10.1016/j.jbiomech.2004.04.036; Bensamoun SF, 2006, BONE, V39, P1244, DOI 10.1016/j.bone.2006.05.021; Bensamoun SF, 2006, J APPL PHYSIOL, V101, P1419, DOI 10.1152/japplphysiol.00800.2005; BLOK LJ, 1995, MOL ENDOCRINOL, V9, P1610, DOI 10.1210/me.9.11.1610; Chalaux E, 1999, FEBS LETT, V457, P478, DOI 10.1016/S0014-5793(99)01051-0; Curtin NA, 2015, J EXP BIOL, V218, P2856, DOI 10.1242/jeb.121897; Fung Y.C., 1981, BIOMECHANICS, DOI [10.1007/978-1-4757-1752-5, DOI 10.1007/978-1-4757-1752-5]; Gajdosik RL, 2001, CLIN BIOMECH, V16, P87, DOI 10.1016/S0268-0033(00)00061-9; Haddad Oualid, 2009, Journal of Musculoskeletal Research, V12, P127, DOI 10.1142/S0218957709002304; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Hefferan TE, 2000, J BIOL CHEM, V275, P20255, DOI 10.1074/jbc.C000135200; Hsu TH, 2011, LAB CHIP, V11, P1808, DOI 10.1039/c1lc20090a; Johnsen SA, 2002, J CELL BIOCHEM, V87, P233, DOI 10.1002/jcb.10299; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Kammoun M, 2017, MUSCLE NERVE, V55, P410, DOI 10.1002/mus.25252; Kruger M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00076; Meunier B, 2010, HISTOCHEM CELL BIOL, V134, P307, DOI 10.1007/s00418-010-0733-7; Meyer GA, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004993; Miyake M, 2010, BIOCHEM BIOPH RES CO, V393, P762, DOI 10.1016/j.bbrc.2010.02.077; PARRY DJ, 1981, EXP NEUROL, V73, P674, DOI 10.1016/0014-4886(81)90204-1; Rajamannan NM, 2007, J CELL BIOCHEM, V100, P315, DOI 10.1002/jcb.21049; Rehorn MR, 2014, J BIOMECH, V47, P687, DOI 10.1016/j.jbiomech.2013.11.044; Ribeiro A, 1999, HEPATOLOGY, V30, P1490, DOI 10.1002/hep.510300620; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2010, BIOCHEM BIOPH RES CO, V392, P72, DOI 10.1016/j.bbrc.2009.12.171; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Tau KR, 1998, ENDOCRINOLOGY, V139, P1346, DOI 10.1210/en.139.3.1346; Wang M, 2012, BIOCHEM BIOPH RES CO, V426, P83, DOI 10.1016/j.bbrc.2012.08.040; Wang Q, 2012, J PHYSIOL-LONDON, V590, P2151, DOI 10.1113/jphysiol.2011.226001; Weiwad WKK, 2000, J MOL CELL CARDIOL, V32, P247, DOI 10.1006/jmcc.1999.1069; West TG, 2013, J EXP BIOL, V216, P2974, DOI 10.1242/jeb.083667; Wheatley BB, 2016, J MECH BEHAV BIOMED, V53, P445, DOI 10.1016/j.jmbbm.2015.08.041; Wu MJ, 2015, INT J BIOCHEM CELL B, V60, P53, DOI 10.1016/j.biocel.2014.12.021	35	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164566	10.1371/journal.pone.0164566	http://dx.doi.org/10.1371/journal.pone.0164566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736981	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800086
J	Nilsson, ALK; Nilsson, JA; Mettke-Hofmann, C				Nilsson, Anna L. K.; Nilsson, Jan-Ake; Mettke-Hofmann, Claudia			Energy Reserves, Information Need and a Pinch of Personality Determine Decision-Making on Route in Partially Migratory Blue Tits	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; BIRD MIGRATION; HEAD COLOR; BEHAVIOR; EXPLORATION; NEOPHOBIA; WARBLERS; STOPOVER; DISPERSAL; RESPONSES	In facultative partial migrants some individuals in a population are migratory and others are resident and individuals decide each year anew which strategy to choose. While the proportion of birds migrating is in part determined by environmental conditions and competitive abilities, the timing of individual departure and behaviours on route are little understood. Individuals encounter different environmental conditions when migrating earlier or later. Based on cost/benefit considerations we tested whether behaviours on route were affected by time constraints, personality and/or age in a partially migrating population of Blue tits (Cyanistes caeruleus). We captured female Blue tits on migration at the Southern tip of Sweden during early, peak and late migration and measured latency to feed in an unfamiliar environment, exploration of a novel object and hesitation to feed beside a novel object (neophobia). Lean birds and birds with long wings started feeding earlier when released into the cage indicating that foraging decisions were mainly determined by energetic needs (lean and large birds). However, juveniles commenced feeding later with progression of the migratory season in concordance with predictions about personality effects. Furthermore, lean birds started to explore earlier than birds with larger fat reserves again indicating an effect of maintaining threshold energy reserves. Moreover, late migrating juveniles, started to explore earlier than early migrating juveniles possibly due to time constraints to find high-quality foraging patches or a suitable winter home. Finally, neophobia did not change over the migratory season indicating that this behaviour is not compromised by time constraints. The results overall indicate that decisions on route are mainly governed by energetic requirements and current needs to learn about the environment and only to a small extent by differences in personality.	[Nilsson, Anna L. K.] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Nilsson, Jan-Ake] Lund Univ, Dept Biol, Unit Evolutionary Ecol, Lund, Sweden; [Mettke-Hofmann, Claudia] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England	University of Oslo; Lund University; Liverpool John Moores University	Nilsson, ALK (corresponding author), Univ Oslo, Dept Biosci, CEES, Oslo, Norway.	anna.nilsson@ibv.uio.no		Nilsson, Anna/0000-0002-5609-4988	Royal Physiographic Society in Lund, Sweden (Nils Olof Berggrens fond)	Royal Physiographic Society in Lund, Sweden (Nils Olof Berggrens fond)	The Royal Physiographic Society in Lund, Sweden (Nils Olof Berggrens fond, 2007-11-14, to ALKN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborn DA, 1997, BEHAVIOUR, V134, P1077, DOI 10.1163/156853997X00412; ADRIAENSEN F, 1990, J ANIM ECOL, V59, P1077, DOI 10.2307/5033; ARCESE P, 1985, J ANIM ECOL, V54, P817, DOI 10.2307/4380; Bai ML, 2012, BEHAV ECOL, V23, P153, DOI 10.1093/beheco/arr168; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Bergman TJ, 2009, ANIM COGN, V12, P63, DOI 10.1007/s10071-008-0171-2; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Brodersen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090294; Brodersen J, 2012, BIOL LETTERS, V8, P21, DOI 10.1098/rsbl.2011.0634; Broggi J, 2007, FUNCT ECOL, V21, P528, DOI 10.1111/j.1365-2435.2007.01255.x; Brown GE, 2014, BEHAV ECOL SOCIOBIOL, V68, P127, DOI 10.1007/s00265-013-1629-z; Budaev SV, 1998, J COMP PSYCHOL, V112, P92, DOI 10.1037/0735-7036.112.1.92; Cagnacci F, 2011, OIKOS, V120, P1790, DOI 10.1111/j.1600-0706.2011.19441.x; Chan K, 2001, EMU, V101, P281, DOI 10.1071/MU00034; Chapman BB, 2012, J FISH BIOL, V81, P456, DOI 10.1111/j.1095-8649.2012.03342.x; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; Dall SRX, 2002, PHILOS T R SOC B, V357, P1519, DOI 10.1098/RSTB.2002.1061; Echeverria AI, 2008, ETHOLOGY, V114, P616, DOI 10.1111/j.1439-0310.2008.01512.x; Elliot AJ, 2002, J PERS SOC PSYCHOL, V82, P804, DOI 10.1037/0022-3514.82.5.804; Ferrari MCO, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2197; Fudickar AM, 2013, J ANIM ECOL, V82, P863, DOI 10.1111/1365-2656.12052; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Greenberg Russell, 2003, P175; Harrison PM, 2015, BEHAV ECOL, V26, P483, DOI 10.1093/beheco/aru216; Heinrich B, 1995, AUK, V112, P499, DOI 10.2307/4088740; Helbjerg H, 1997, ORNIS SVECICA, V7, P149; Hope DD, 2011, J AVIAN BIOL, V42, P522, DOI 10.1111/j.1600-048X.2011.05347.x; INGLIS IR, 1986, ANIM BEHAV, V34, P614, DOI 10.1016/S0003-3472(86)80136-1; Inglis IR, 2001, ANIM BEHAV, V62, P543, DOI 10.1006/anbe.2001.1780; Jokela M, 2008, PSYCHOL SCI, V19, P831, DOI 10.1111/j.1467-9280.2008.02164.x; Jokela M, 2009, J RES PERS, V43, P79, DOI 10.1016/j.jrp.2008.09.005; Karlsson Lennart, 2005, Ornis Svecica, V15, P183; Kasugai K, 2013, FISHERIES SCI, V79, P569, DOI 10.1007/s12562-013-0615-8; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Ktitorov P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1135, DOI 10.1007/s00265-010-0929-9; Langham GM, 2006, BEHAV ECOL, V17, P285, DOI 10.1093/beheco/arj027; LUNDBERG P, 1987, J THEOR BIOL, V125, P351, DOI 10.1016/S0022-5193(87)80067-X; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; Marchetti C, 2009, BEHAV PROCESS, V82, P293, DOI 10.1016/j.beproc.2009.07.008; Biondi LM, 2013, ETHOLOGY, V119, P221, DOI 10.1111/eth.12056; Meller K, 2013, J AVIAN BIOL, V44, P272, DOI 10.1111/j.1600-048X.2012.00016.x; Mettke-Hofmann C, 2006, J ZOOL, V268, P405, DOI 10.1111/j.1469-7998.2005.00037.x; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; Mettke-Hofmann C, 2004, ANIM BEHAV, V68, P1079, DOI 10.1016/j.anbehav.2004.02.012; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; Mettke-Hofmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057565; Mettke-Hofmann C, 2012, ETHOLOGY, V118, P906, DOI 10.1111/j.1439-0310.2012.02079.x; Mettke-Hofmann C, 2009, ETHOLOGY, V115, P482, DOI 10.1111/j.1439-0310.2009.01632.x; MILINSKI M, 1978, NATURE, V275, P642, DOI 10.1038/275642a0; Millot S, 2009, J FISH BIOL, V75, P1733, DOI 10.1111/j.1095-8649.2009.02425.x; Nilsson ALK, 2008, J ORNITHOL, V149, P365, DOI 10.1007/s10336-008-0280-3; Nilsson ALK, 2006, GLOBAL CHANGE BIOL, V12, P2014, DOI 10.1111/j.1365-2486.2006.01237.x; Nilsson ALK, 2010, NATURWISSENSCHAFTEN, V97, P981, DOI 10.1007/s00114-010-0714-7; Nilsson AK, 2006, AUK, V123, P537, DOI 10.1642/0004-8038(2006)123[537:DPARMD]2.0.CO;2; Nilsson JA, 2014, ANIMAL MOVEMENT ACROSS SCALES, P90; Paulauskaite Elma, 2010, INT J PSYCHOL BIOPSY, V7, P41; Paxton KL, 2008, CONDOR, V110, P672, DOI 10.1525/cond.2008.8602; Pinheiro J, R PACKAGE VERSION; Pulido F, 2011, OIKOS, V120, P1776, DOI 10.1111/j.1600-0706.2011.19844.x; Quinn JL, 2011, J ANIM ECOL, V80, P918, DOI 10.1111/j.1365-2656.2011.01835.x; R-Core-Team, 2015, LANG ENV STAT COMP; Rasmussen JE, 2012, CURR ZOOL, V58, P260, DOI 10.1093/czoolo/58.2.260; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Silventoinen K, 2008, EUR J PUBLIC HEALTH, V18, P150, DOI 10.1093/eurpub/ckm052; SMITH HG, 1987, AUK, V104, P109, DOI 10.2307/4087239; Svensson L., 1992, IDENTIFICATION GUIDE; Vardanis Y, 2016, ANIM BEHAV, V113, P177, DOI 10.1016/j.anbehav.2015.12.014; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Voelkl B, 2006, ANIM BEHAV, V72, P365, DOI 10.1016/j.anbehav.2005.10.013; Williams LJ, 2012, ANIM BEHAV, V84, P159, DOI 10.1016/j.anbehav.2012.04.025; WOODGUSH DGM, 1991, ANIM BEHAV, V42, P599, DOI 10.1016/S0003-3472(05)80243-X; WOODGUSH DGM, 1993, ANIM BEHAV, V45, P185, DOI 10.1006/anbe.1993.1017; Zuur Alain F., 2009, P1	76	16	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163213	10.1371/journal.pone.0163213	http://dx.doi.org/10.1371/journal.pone.0163213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732602	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000385505300013
J	Reblova, M; Hubka, V; Thureborn, O; Lundberg, J; Sallstedt, T; Wedin, M; Ivarsson, M				Reblova, Martina; Hubka, Vit; Thureborn, Olle; Lundberg, Johannes; Sallstedt, Therese; Wedin, Mats; Ivarsson, Magnus			From the Tunnels into the Treetops: New Lineages of Black Yeasts from Biofilm in the Stockholm Metro System and Their Relatives among Ant-Associated Fungi in the Chaetothyriales	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; ROCK-INHABITING FUNGI; RIBOSOMAL-RNA STRUCTURES; SECONDARY STRUCTURE; MICROCOLONIAL FUNGI; PCR PRIMERS; GEN. NOV; DNA; BIODETERIORATION; TRICHOMERIACEAE	Rock-inhabiting fungi harbour species-rich, poorly differentiated, extremophilic taxa of polyphyletic origin. Their closest relatives are often well-known species from various biotopes with significant pathogenic potential. Speleothems represent a unique rock-dwelling habitat, whose mycobiota are largely unexplored. Isolation of fungi from speleothem biofilm covering bare granite walls in the Kungstradgarden metro station in Stockholm yielded axenic cultures of two distinct black yeast morphotypes. Phylogenetic analyses of DNA sequences from six nuclear loci, ITS, nuc18S and nuc28S rDNA, rpb1, rpb2 and beta-tubulin, support their placement in the Chaetothyriales (Ascomycota). They are described as a new genus Bacillicladium with the type species B. lobatum, and a new species Bradymyces graniticola. Bacillicladium is distantly related to the known five chaetothyrialean families and is unique in the Chaetothyriales by variable morphology showing hyphal, meristematic and yeast-like growth in vitro. The nearest relatives of Bacillicladium are recruited among fungi isolated from cardboard-like construction material produced by arboricolous non-attine ants. Their sister relationship is weakly supported by the Maximum likelihood analysis, but strongly supported by Bayesian inference. The genus Bradymyces is placed amidst members of the Trichomeriaceae and is ecologically undefined; it includes an opportunistic animal pathogen while two other species inhabit rock surfaces. ITS rDNA sequences of three species accepted in Bradymyces and other undescribed species and environmental samples were subjected to phylogenetic analysis and in-depth comparative analysis of ITS1 and ITS2 secondary structures in order to study their intraspecific variability. Compensatory base change criterion in the ITS2 secondary structure supported delimitation of species in Bradymyces, which manifest a limited number of phenotypic features useful for species recognition. The role of fungi in the speleothem biofilm and relationships of Bacillicladium and Bradymyces with other members of the Chaetothyriales are discussed.	[Reblova, Martina] Czech Acad Sci, Inst Bot, Dept Taxon, Pruhonice 25243, Czech Republic; [Hubka, Vit] Charles Univ Prague, Dept Bot, Fac Sci, Prague 12801 2, Czech Republic; [Hubka, Vit] Czech Acad Sci, Lab Fungal Genet & Metab, Inst Microbiol, Prague 14220 4, Czech Republic; [Thureborn, Olle] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Lundberg, Johannes; Wedin, Mats] Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden; [Sallstedt, Therese] Univ Southern Denmark, Dept Biol, DK-5230 Odense, Denmark; [Sallstedt, Therese; Ivarsson, Magnus] Swedish Museum Nat Hist, Dept Palaeobiol, S-10405 Stockholm, Sweden	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Stockholm University; Swedish Museum of Natural History; University of Southern Denmark; Swedish Museum of Natural History	Reblova, M (corresponding author), Czech Acad Sci, Inst Bot, Dept Taxon, Pruhonice 25243, Czech Republic.	martina.reblova@ibot.cas.cz	Hubka, Vit/L-4124-2014; Réblová, Martina/H-1620-2014; Lundberg, Johannes/E-5844-2011	Hubka, Vit/0000-0003-4583-6496; Wedin, Mats/0000-0002-8295-5198; Lundberg, Johannes/0000-0003-4316-9183	Swedish Research Council [2012-4364, VR 621-2012-3990]; Swedish National Space Board [83/10]; Danish National Research Foundation [DNRF53]; Czech Science Foundation (GA CR project) [506/12/0038]; Ministry of Education, Youth and Sports of the Czech Republic; project "BIOCEV-Biotechnology and Biomedicine Centre of the Czech Academy of Sciences and Charles University" from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; Institute of Botany of the Czech Academy of Sciences [RVO 67985939]; Institute of Microbiology of the Czech Academy of Sciences [RVO 61388971]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Space Board; Danish National Research Foundation(Danmarks Grundforskningsfond); Czech Science Foundation (GA CR project); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); project "BIOCEV-Biotechnology and Biomedicine Centre of the Czech Academy of Sciences and Charles University" from the European Regional Development Fund; Institute of Botany of the Czech Academy of Sciences(Czech Academy of Sciences); Institute of Microbiology of the Czech Academy of Sciences(Czech Academy of Sciences)	The research was funded by grants from the Swedish Research Council (Contract No. 2012-4364 and grant VR 621-2012-3990; www.vr.se), the Swedish National Space Board (Contract No. 83/10; www.snsb.se), Danish National Research Foundation (DNRF53; dg.dk), Czech Science Foundation (GA CR project 506/12/0038; www.gacr.cz), by the Ministry of Education, Youth and Sports of the Czech Republic (SVV project; www.msmt.cz), and by the project "BIOCEV-Biotechnology and Biomedicine Centre of the Czech Academy of Sciences and Charles University" (CZ.1.05/1.1.00/02.0109; www.biocev.eu) from the European Regional Development Fund. Additional support was provided by a long-term research development project of the Institute of Botany of the Czech Academy of Sciences (No. RVO 67985939) to MR, and a long-term research development project of the Institute of Microbiology of the Czech Academy of Sciences (No. RVO 61388971) to VH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageitos JM, 2011, APPL MICROBIOL BIOT, V90, P1219, DOI 10.1007/s00253-011-3200-z; Ajello L, 1978, BLACK WHITE YEASTS, V356, P9; [Anonymous], 2010, HDB MICROBIOLOGICAL, DOI DOI 10.1201/EBK1439804063; ATTYGALLE AB, 1984, CHEM SOC REV, V13, P245, DOI 10.1039/cs9841300245; BARR ME, 1987, MYCOTAXON, V29, P501; Barton HA, 2001, GEOMICROBIOL J, V18, P359, DOI 10.1080/01490450152467840; Baskar S, 2009, ENVIRON GEOL, V57, P1169, DOI 10.1007/s00254-008-1413-y; BATISTA A. CHAVES, 1962, SYDOWIA ANN MYCOLOGICI SUPPL, V3, P1; Blasi B, 2016, GEOMICROBIOL J, V33, P308, DOI 10.1080/01490451.2015.1052118; Blatrix R, 2012, P ROY SOC B-BIOL SCI, V279, P3940, DOI 10.1098/rspb.2012.1403; Blazquez F, 1997, EUR J MINERAL, V9, P889; Bonants P, 1997, EUR J PLANT PATHOL, V103, P345, DOI 10.1023/A:1008640227432; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Chomnunti P, 2012, FUNGAL DIVERS, V56, P63, DOI 10.1007/s13225-012-0197-2; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2002, J MOL EVOL, V54, P246, DOI 10.1007/s00239-001-0006-0; Coleman AW, 2000, PROTIST, V151, P1, DOI 10.1078/1434-4610-00002; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; Coleman AW, 2001, J PHYCOL, V37, P345, DOI 10.1046/j.1529-8817.2001.037002345.x; Crous PW, 2007, STUD MYCOL, P185, DOI 10.3114/sim.2007.58.07; Crous PW, 2015, PERSOONIA, V35, P264, DOI 10.3767/003158515X690269; Crous PW, 2015, PERSOONIA, V34, P167, DOI 10.3767/003158515X688433; Crous PW, 2014, PERSOONIA, V32, P184, DOI 10.3767/003158514X682395; Crous PW, 2009, PERSOONIA, V22, P139, DOI 10.3767/003158509X461701; Crous PW, 2006, MYCOL RES, V110, P264, DOI 10.1016/j.mycres.2005.10.003; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; Defossez E, 2009, NEW PHYTOL, V182, P942, DOI 10.1111/j.1469-8137.2009.02793.x; DEHOOG GS, 1977, STUD MYCOL, V15, P1; Di Martino P, 2015, THE OPEN CONFERENCE, V6, P52; Doyle J. J., 1987, PHYTOCHEM B, P11; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Egenlauf B, 2015, PNEUMONOLOGIE, V69; Fassatiova O, 1986, MOULDS FILAMENTOUS F; GAMS W, 1975, T BRIT MYCOL SOC, V64, P389, DOI 10.1016/S0007-1536(75)80138-0; GARGAS A, 1992, MYCOLOGIA, V84, P589, DOI 10.2307/3760327; Geiser DM, 2006, MYCOLOGIA, V98, P1053, DOI 10.3852/mycologia.98.6.1053; GORBUSHINA AA, 1993, GEOMICROBIOL J, V11, P205, DOI 10.1080/01490459309377952; Gueidan C, 2008, STUD MYCOL, P111, DOI 10.3114/sim.2008.61.11; Gueidan C, 2007, MYCOL RES, V111, P1145, DOI 10.1016/j.mycres.2007.08.010; Gueidan C, 2014, MYCOL PROG, V13, P1027, DOI 10.1007/s11557-014-0990-2; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3051, DOI 10.1093/nar/21.13.3051; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamada N, 2010, BIOCONTROL SCI, V15, P111, DOI 10.4265/bio.15.111; Hansford CG, 1946, MYCOL PAP, V15, P1; Hofstetter V, 2007, MOL PHYLOGENET EVOL, V44, P412, DOI 10.1016/j.ympev.2006.10.016; Hubka V, 2015, MYCOLOGIA, V107, P169, DOI 10.3852/14-059; Hubka V, 2014, ANTON LEEUW INT J G, V106, P979, DOI 10.1007/s10482-014-0267-4; Hubka V, 2014, MED MYCOL, V52, P565, DOI 10.1093/mmy/myu022; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hutchison LJ, 1995, MYCOLOGIA, V87, P902, DOI 10.2307/3760868; Isola D, 2016, FUNGAL DIVERS, V76, P75, DOI 10.1007/s13225-015-0342-9; IVARSSON C, 1995, GFF, V117, P67, DOI 10.1080/11035899509546200; Ivarsson LN, 2013, INT J SPELEOL, V42, P289, DOI 10.5038/1827-806X.42.3.12; Ivarsson M, 2013, P 16 INT C SPEL; Jones B, 2001, GEOMICROBIOL J, V18, P345, DOI 10.1080/01490450152467831; Jones B, 2009, SEDIMENT GEOL, V219, P302, DOI 10.1016/j.sedgeo.2009.05.020; Joseph N, 1999, NUCLEIC ACIDS RES, V27, P4533, DOI 10.1093/nar/27.23.4533; Kaszycki P, 2006, ACTA BIOCHIM POL, V53, P463; Kelly KL., 1964, INTERSOCIETY COLOR C; Koprivica M., 2009, Pesticidi i Fitomedicina, V24, P177, DOI 10.2298/PIF0903177K; Kronestedt T., 1992, Fauna och Flora (Stockholm), V87, P49; KRUMBEIN WE, 1991, GEOMICROBIOL J, V9, P139, DOI 10.1080/01490459109385995; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P137, DOI 10.3354/meps117137; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Li DM, 2008, STUD MYCOL, P131, DOI 10.3114/sim.2008.61.13; Lian X, 2010, MED MYCOL, V48, P622, DOI 10.3109/13693780903405774; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; Marine M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004982; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Mayer VE, 2009, P ROY SOC B-BIOL SCI, V276, P3265, DOI 10.1098/rspb.2009.0768; Mayr E., 1982, GROWTH BIOL THOUGHT; Moreno-Rico O, 2014, IMA FUNGUS, V5, P7, DOI 10.5598/imafungus.2014.05.01.02; Morgan E. David, 2008, Myrmecological News, V11, P79; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; MUNK ANDERS, 1953, DANSK BOT ARK, V15, P1; Nascimento MMF, 2016, FUNGAL BIOL-UK, V120, P207, DOI 10.1016/j.funbio.2015.08.018; Nepel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112756; Nylander J, 2008, MRMODELTEST2 V 2 3; Onofri S, 2014, PLANT BIOSYST, V148, P384, DOI 10.1080/11263504.2013.877533; Pacton M, 2013, BIOGEOSCIENCES, V10, P6115, DOI 10.5194/bg-10-6115-2013; Palmer R J Jr, 1988, Polarforschung, V58, P189; PAPENDORF MC, 1969, T BRIT MYCOL SOC, V52, P483, DOI 10.1016/S0007-1536(69)80132-4; Prenafeta-Boldu FX, 2006, FEMS MICROBIOL REV, V30, P109, DOI 10.1111/j.1574-6976.2005.00007.x; Prenafeta-Boldu FX, 2004, BIODEGRADATION, V15, P59, DOI 10.1023/B:BIOD.0000009973.53531.96; Rambaut A, 2013, MCMC TRACE ANAL TOOL; Reblova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063547; Reblova M, 2013, MYCOL PROG, V12, P305, DOI 10.1007/s11557-012-0836-8; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Ruibal C, 2009, STUD MYCOL, P123, DOI 10.3114/sim.2009.64.06; Ruibal C, 2008, PERSOONIA, V21, P93, DOI 10.3767/003158508X371379; Sallstedt T, 2014, INT J SPELEOL, V43, P305, DOI 10.5038/1827-806X.43.3.7; Schlick-Steiner BC, 2008, P NATL ACAD SCI USA, V105, P940, DOI 10.1073/pnas.0708320105; Schluns H, 2009, MYRMECOL NEWS, V12, P237; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Selbmann L, 2005, STUD MYCOL, P1; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; STALEY JT, 1982, SCIENCE, V215, P1093, DOI 10.1126/science.215.4536.1093; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sterflinger K, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P501, DOI 10.1007/3-540-30985-3_20; Sterflinger K, 1997, ANTON LEEUW INT J G, V72, P349, DOI 10.1023/A:1000570429688; Sterflinger K, 1995, BOT ACTA, V108, P490, DOI 10.1111/j.1438-8677.1995.tb00526.x; Sterflinger K, 2000, GEOMICROBIOL J, V17, P97, DOI 10.1080/01490450050023791; Sterflinger K, 1997, GEOMICROBIOL J, V14, P219, DOI 10.1080/01490459709378045; Sterflinger K, 1999, STUD MYCOL, P5; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; Sterflinger Katja, 1997, Courier Forschungsinstitut Senckenberg, V201, P433; Sugita T, 2005, APPL ENVIRON MICROB, V71, P7626, DOI 10.1128/AEM.71.11.7626-7629.2005; Sugita T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P2015, DOI 10.1016/B978-0-444-52149-1.00161-0; Sukosd Z, 2012, BIOINFORMATICS, V28, P2691, DOI 10.1093/bioinformatics/bts488; Swart L, 1998, S AFR J BOT, V64, P137, DOI 10.1016/S0254-6299(15)30848-6; Tsuneda A, 2011, BOTANY, V89, P523, DOI [10.1139/B11-041, 10.1139/b11-041]; Ulson CM, 1959, CONTRIBUTION STUDY S; Untereiner WA, 1999, MYCOLOGIA, V91, P67, DOI 10.2307/3761194; Untereiner WA, 2011, FUNGAL DIVERS, V49, P225, DOI 10.1007/s13225-011-0097-x; Vazquez-Nion D, 2016, BIOFOULING, V32, P657, DOI 10.1080/08927014.2016.1183121; Vicente VA, 2008, STUD MYCOL, P137, DOI 10.3114/sim.2008.61.14; Vidal-Romani J.R., 2010, COMUN GEOL, V97, P71; Vidal-Romani J.R., 2013, INT C SPEL P, P479; Vidal-Romani JR, 2015, ENVIRON EARTH SCI, V73, P2997, DOI 10.1007/s12665-014-3743-2; VILGALYS R, 1990, Journal of Bacteriology, V172, P4238; Voglmayr H, 2011, FUNGAL BIOL-UK, V115, P1077, DOI 10.1016/j.funbio.2010.11.006; Wainwright M, 1993, STRESS TOLERANCE FUN, V10, P127; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WOLLENZIEN U, 1995, SCI TOTAL ENVIRON, V167, P287, DOI 10.1016/0048-9697(95)04589-S; Wollenzien U, 1997, ANTON LEEUW INT J G, V71, P281, DOI 10.1023/A:1000157803954; Xiong L, 2015, APPL BIOCHEM BIOTECH, V176, P563, DOI 10.1007/s12010-015-1595-1; Yang H, 2014, CHIANG MAI J SCI, V41, P873; Zhao JJ, 2010, MICROB ECOL, V60, P149, DOI 10.1007/s00248-010-9651-4; Zucconi L, 2012, INT BIODETER BIODEGR, V70, P40, DOI 10.1016/j.ibiod.2011.11.018; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	138	30	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163396	10.1371/journal.pone.0163396	http://dx.doi.org/10.1371/journal.pone.0163396			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732675	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300015
J	Wang, C; Lu, JJ; Zhou, L; Li, J; Xu, JM; Li, WJ; Zhang, LL; Zhong, X; Wang, T				Wang, Chao; Lu, Jianjun; Zhou, Le; Li, Jun; Xu, Jiaman; Li, Weijian; Zhang, Lili; Zhong, Xiang; Wang, Tian			Effects of Long-Term Exposure to Zinc Oxide Nanoparticles on Development, Zinc Metabolism and Biodistribution of Minerals (Zn, Fe, Cu, Mn) in Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; ACUTE TOXICITY; ORGAN WEIGHT; METALLOTHIONEIN; ANTIBACTERIAL; ABSORPTION; TRANSPORTER-1; EXPRESSION; SAFETY; TISSUE	Zinc oxide nanoparticles (nano-ZnOs) are widely used and possess great potentials in agriculture and biomedicine. It is inevitable for human exposure to these nanoparticles. However, no study had been conducted to investigate the long term effects of nano-ZnOs. This study aimed at investigating effects of nano-ZnOs on development, zinc metabolism and biodistribution of minerals (Zn, Fe, Cu, and Mn) in mice from week 3 to 35. After the characteristics of nano-ZnOs were determined, they were added into the basal diet at 0, 50, 500 and 5000 mg/kg. Results indicated that added 50 and 500 mg/kg nano-ZnOs showed minimal toxicity. However, 5000 mg/kg nano-ZnOs significantly decreased body weight (from week 4 to 16) and increased the relative weights of the pancreas, brain and lung. Added 5000 mg/kg nano-ZnOs significantly increased the serum glutamic-pyruvic transaminase activity and zinc content, and significantly enhanced mRNA expression of zinc metabolism-related genes, including metallothionein 1(32.66 folds), metallothionein 2 (31.42 folds), ZIP8 (2.21folds), ZIP14 (2.45 folds), ZnT1 (4.76 folds), ZnT2 (6.19 folds) and ZnT4 (1.82 folds). The biodistribution determination showed that there was a significant accumulation of zinc in the liver, pancreas, kidney, and bones (tibia and fibula) after receiving 5000 mg/kg nano-ZnO diet, while no significant effects on Cu, Fe, and Mn levels, except for liver Fe content and pancreas Mn level. Our results demonstrated that long term exposure to 50 and 500 mg/kg nano-ZnO diets showed minimal toxicity. However, high dose of nano-ZnOs (5000 mg/kg) caused toxicity on development, and altered the zinc metabolism and biodistribution in mice.	[Wang, Chao; Zhou, Le; Li, Jun; Xu, Jiaman; Li, Weijian; Zhang, Lili; Zhong, Xiang; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Lu, Jianjun] Zhejiang Univ, Coll Anim Sci, Inst Feed Sci, Key Lab Mol Anim Nutr,Minist Educ, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Zhejiang University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com			Hangzhou King Techina Technology CO., Ltd; Open Fund Project in Jiangsu Provincial Key Laboratory of Gastrointestinal Nutrition and Animal Health [2015js02]	Hangzhou King Techina Technology CO., Ltd; Open Fund Project in Jiangsu Provincial Key Laboratory of Gastrointestinal Nutrition and Animal Health	This work was financially supported by Hangzhou King Techina Technology CO., Ltd and by Open Fund Project in Jiangsu Provincial Key Laboratory of Gastrointestinal Nutrition and Animal Health (Grant No. 2015js02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by Hangzhou King Techina Technology CO., Ltd and by Open Fund Project in Jiangsu Provincial Key Laboratory of Gastrointestinal Nutrition and Animal Health (Grant No. 2015js02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen H, 1999, TOXICOLOGY, V136, P67, DOI 10.1016/S0300-483X(99)00056-6; Aneesh PM, 2007, PROC SPIE, V6639, DOI 10.1117/12.730364; Baek M, 2012, INT J NANOMED, V7, P3081, DOI 10.2147/IJN.S32593; Bailey SA, 2004, TOXICOL PATHOL, V32, P448, DOI 10.1080/01926230490465874; Bauer LA, 2004, J MATER CHEM, V14, P517, DOI 10.1039/b312655b; Boverhof DR, 2015, REGUL TOXICOL PHARM, V73, P137, DOI 10.1016/j.yrtph.2015.06.001; Chung CS, 2008, AM J CLIN NUTR, V87, P1224, DOI 10.1093/ajcn/87.5.1224; Davis SR, 1998, J NUTR, V128, P825, DOI 10.1093/jn/128.5.825; Demirbas A, 1999, FOOD CHEM, V67, P27, DOI 10.1016/S0308-8146(99)00103-X; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Esmaeillou M, 2013, ENVIRON TOXICOL PHAR, V35, P67, DOI 10.1016/j.etap.2012.11.003; Fong LY, 2016, AGING-US, V8, P1161, DOI 10.18632/aging.100978; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Hadley JA, 2003, FORENSIC SCI INT, V133, P190, DOI 10.1016/S0379-0738(03)00069-0; HAMILTON RP, 1979, J FOOD SCI, V44, P738, DOI 10.1111/j.1365-2621.1979.tb08488.x; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; HOADLEY JE, 1988, J NUTR, V118, P497, DOI 10.1093/jn/118.4.497; Hong JS, 2014, INT J NANOMED, V9, P145, DOI 10.2147/IJN.S57931; Hong JS, 2014, INT J NANOMED, V9, P159, DOI 10.2147/IJN.S57932; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; King JC, 2016, J NUTR, V146, p858S, DOI 10.3945/jn.115.220079; King JC, 2011, AM J CLIN NUTR, V94, p679S, DOI 10.3945/ajcn.110.005744; King JC, 2000, J NUTR, V130, p1360S, DOI 10.1093/jn/130.5.1360S; Krebs NF, 2000, J NUTR, V130, p1374S, DOI 10.1093/jn/130.5.1374S; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2003, J NUTR, V133, P342, DOI 10.1093/jn/133.2.342; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes S, 2014, ENVIRON TOXICOL CHEM, V33, P190, DOI 10.1002/etc.2413; Lu XF, 2013, SMALL, V9, P1654, DOI 10.1002/smll.201201517; Ma HB, 2013, ENVIRON POLLUT, V172, P76, DOI 10.1016/j.envpol.2012.08.011; Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a; Miller LV, 2012, BRITISH JOURNAL OF N, V109, P1; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Setyawati M. I., 2015, SMALL, V11, P3390, DOI [DOI 10.1002/SMLL.201570163, 10.1002/smll.201570163]; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Sharma V, 2012, MUTAT RES-GEN TOX EN, V745, P84, DOI 10.1016/j.mrgentox.2011.12.009; Singh S, 2007, J NANOSCI NANOTECHNO, V7, P3048, DOI 10.1166/jnn.2007.922; Sirelkhatim A, 2015, NANO-MICRO LETT, V7, P219, DOI 10.1007/s40820-015-0040-x; Surekha P, 2012, CUTAN OCUL TOXICOL, V31, P26, DOI 10.3109/15569527.2011.595750; Talebian N, 2013, J PHOTOCH PHOTOBIO B, V120, P66, DOI 10.1016/j.jphotobiol.2013.01.004; Wahab R, 2016, RSC ADV, V6, P32328, DOI 10.1039/c6ra05297e; Wahab R, 2016, RSC ADV, V6, P26111, DOI 10.1039/c5ra25668b; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P441, DOI 10.1166/jbn.2013.1593; Wang B, 2008, J NANOPART RES, V10, P263, DOI 10.1007/s11051-007-9245-3; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wang LJ, 2010, J NANOSCI NANOTECHNO, V10, P8617, DOI 10.1166/jnn.2010.2483; Wang XX, 2010, IUBMB LIFE, V62, P176, DOI 10.1002/iub.291; Wang Y, 2010, BIOL TRACE ELEM RES, V133, P325, DOI 10.1007/s12011-009-8437-3; Willis MS, 2005, AM J CLIN PATHOL, V123, P125, DOI 10.1309/V6GVYW2QTYD5C5PJ; Yah CS, 2012, PAK J PHARM SCI, V25, P477; Yan GY, 2012, J ENVIRON SCI HEAL A, V47, P577, DOI 10.1080/10934529.2012.650576; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006; Zhao CY, 2014, BIOL TRACE ELEM RES, V160, P361, DOI 10.1007/s12011-014-0052-2	55	59	61	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164434	10.1371/journal.pone.0164434	http://dx.doi.org/10.1371/journal.pone.0164434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732669	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300056
J	Asensio, I; Vicente-Rubiano, M; Munoz, MJ; Fernandez-Carrion, E; Sanchez-Vizcaino, JM; Carballo, M				Asensio, Irene; Vicente-Rubiano, Marina; Jesus Munoz, Maria; Fernandez-Carrion, Eduardo; Manuel Sanchez-Vizcaino, Jose; Carballo, Matilde			Importance of Ecological Factors and Colony Handling for Optimizing Health Status of Apiaries in Mediterranean Ecosystems	PLOS ONE			English	Article							DEFORMED-WING VIRUS; ACUTE PARALYSIS VIRUS; BEE APIS-MELLIFERA; HONEY-BEES; CHALKBROOD DEVELOPMENT; SPECIES RICHNESS; NOSEMA-CERANAE; POLLINATION; HYMENOPTERA; TEMPERATURE	We analyzed six apiaries in several natural environments with a Mediterranean ecosystem in Madrid, central Spain, in order to understand how landscape and management characteristics may influence apiary health and bee production in the long term. We focused on five criteria (habitat quality, landscape heterogeneity, climate, management and health), as well as 30 subcriteria, and we used the analytic hierarchy process (AHP) to rank them according to relevance. Habitat quality proved to have the highest relevance, followed by beehive management. Within habitat quality, the following subcriteria proved to be most relevant: orographic diversity, elevation range and important plant species located 1.5 km from the apiary. The most important subcriteria under beehive management were honey production, movement of the apiary to a location with a higher altitude and wax renewal. Temperature was the most important subcriterion under climate, while pathogen and Varroa loads were the most significant under health. Two of the six apiaries showed the best values in the AHP analysis and showed annual honey production of 70 and 28 kg/colony. This high productivity was due primarily to high elevation range and high orographic diversity, which favored high habitat quality. In addition, one of these apiaries showed the best value for beehive management, while the other showed the best value for health, reflected in the low pathogen load and low average number of viruses. These results highlight the importance of environmental factors and good sanitary practices to maximize apiary health and honey productivity.	[Asensio, Irene; Jesus Munoz, Maria; Carballo, Matilde] Anim Hlth Res Ctr CISA INIA, Epidemiol & Environm Hlth Dept, Madrid, Spain; [Vicente-Rubiano, Marina; Fernandez-Carrion, Eduardo; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Fac Vet Sci, VISAVET, Madrid, Spain; [Vicente-Rubiano, Marina; Fernandez-Carrion, Eduardo; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Fac Vet Sci, Dept Anim Hlth, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Asensio, I (corresponding author), Anim Hlth Res Ctr CISA INIA, Epidemiol & Environm Hlth Dept, Madrid, Spain.	irreasensio@gmail.com			Institute Nacional de Investigacion Agraria, INIA [RTA 2013-00042-C10-09]	Institute Nacional de Investigacion Agraria, INIA	This work was funded by RTA 2013-00042-C10-09 (JMSV, MJM) (Institute Nacional de Investigacion Agraria, INIA).	Abou-Shaara HF, 2014, VET MED-CZECH, V59, P1, DOI 10.17221/7240-VETMED; Abou-Shaara HF., 2012, ENVIRON EXP BIOL, V10, P133; Adjare S, 1990, BEEKEEPING IN AFRICA, V68; Al Naggar Y, 2015, ECOTOX ENVIRON SAFE, V114, P1, DOI 10.1016/j.ecoenv.2014.12.039; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; Bekesi L, 1999, ACTA VET HUNG, V47, P319, DOI 10.1556/AVet.47.1999.3.5; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Berry AJ, 2013, PLOS ONE, DOI [10.1371/journal.pone.0076536, DOI 10.1371/JOURNAL.PONE.0076536]; Bezabih G., 2010, THESIS; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Brittain C, 2013, GLOBAL CHANGE BIOL, V19, P540, DOI 10.1111/gcb.12043; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Budge GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133228; Chauzat M.P., 2014, EPILOBEE PAN EUROPEA; Codling G, 2016, CHEMOSPHERE, V144, P2321, DOI 10.1016/j.chemosphere.2015.10.135; Convertino M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065056; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; de Miranda JR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.22; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.16; Eischen FA., 2008, AM BEE J, V148, P555; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Flores JM, 1996, APIDOLOGIE, V27, P185, DOI 10.1051/apido:19960401; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Gallant AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099268; Genersch E, 2008, VIROLOGY HONEY BEE, P255; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Greene R, 2011, GEOGR COMPASS, V5, P412, DOI 10.1111/j.1749-8198.2011.00431.x; Hedtke K, 2011, J INVERTEBR PATHOL, V108, P167, DOI 10.1016/j.jip.2011.08.006; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Hladik ML, 2016, SCI TOTAL ENVIRON, V542, P469, DOI 10.1016/j.scitotenv.2015.10.077; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Kaukinen D., 2012, PATCH ANAL PATCH GRI; Kukielka D, 2008, J VIROL METHODS, V147, P275, DOI 10.1016/j.jviromet.2007.09.008; Kukielka D, 2009, J VIROL METHODS, V161, P240, DOI 10.1016/j.jviromet.2009.06.014; Linkov I, 2007, J NANOPART RES, V9, P543, DOI 10.1007/s11051-007-9211-0; Loucif-Ayad W, 2010, APIDOLOGIE, V41, P135, DOI 10.1051/apido/2009063; Fernandez JM, 2012, J INVERTEBR PATHOL, V111, P106, DOI 10.1016/j.jip.2012.06.008; MARÍN VALENCIA ALBA LUCIA, 2008, Bol. cienc. tierra, P43; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Martin-Hernandez R, 2009, APPL ENVIRON MICROB, V75, P2554, DOI 10.1128/AEM.02908-08; Mattila HR, 2006, J ECON ENTOMOL, V99, P604, DOI 10.1603/0022-0493-99.3.604; Medina-Cuellar SE, 2014, REV CHAPINGO SER CIE, V20, P159, DOI 10.5154/r.rchscfa.2013.09.031; Monzon V, 1998, THESIS; Morales R., 2003, BOT COMPLUT, V27, P31, DOI DOI 10.1146/ANNUREV.ECOLSYS.31.1.367; Moreno-Rueda G, 2009, ECOL RES, V24, P335, DOI 10.1007/s11284-008-0509-x; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Mwangi P., 2010, THESIS; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Polatto LP, 2014, J INSECT BEHAV, V27, P593, DOI 10.1007/s10905-014-9452-6; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PUERTA F, 1994, APIDOLOGIE, V25, P540, DOI 10.1051/apido:19940604; Puskadija Z., 2007, AGR SCI PROFESSIONAL, V13, P230; Rader R, 2013, GLOBAL CHANGE BIOL, V19, P3103, DOI 10.1111/gcb.12264; Roberts SP, 1999, J EXP BIOL, V202, P1523; Rodriguez MA, 2005, ACTA OECOL, V28, P65, DOI 10.1016/j.actao.2005.02.006; Saaty TL., 2005, ANAL HIERARCHY PROCE, DOI [10.1002/0470011815.b2a4a002, DOI 10.1002/0470011815.B2A4A002]; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Schroeder DC, 2012, VIRULENCE, V3, P589, DOI 10.4161/viru.22219; Senapathi D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0294; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Simioni LC, 2015, AN ACAD BRAS CIENC, V87, P137, DOI 10.1590/0001-3765201520130365; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Stoltz D, 1995, J APICULT RES, V34, P153, DOI 10.1080/00218839.1995.11100900; Todd JH, 2007, APIDOLOGIE, V38, P354, DOI 10.1051/apido:2007021; Tuell JK, 2010, J ECON ENTOMOL, V103, P557, DOI 10.1603/EC09387; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vicens N, 2000, ENVIRON ENTOMOL, V29, P413, DOI 10.1603/0046-225X-29.3.413; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Winston M., 1987, The biology of the honey bee.; Wojcik Victoria A., 2012, Journal of Pollination Ecology, V7, P16; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	87	9	9	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164205	10.1371/journal.pone.0164205	http://dx.doi.org/10.1371/journal.pone.0164205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727312	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400021
J	Duflos, CM; Solecki, K; Papinaud, L; Georgescu, V; Roubille, F; Mercier, G				Duflos, Claire M.; Solecki, Kamila; Papinaud, Laurence; Georgescu, Vera; Roubille, Francois; Mercier, Gregoire			The Intensity of Primary Care for Heart Failure Patients: A Determinant of Readmissions? The CarPaths Study: A French Region-Wide Analysis	PLOS ONE			English	Article							AVOIDABLE HOSPITALIZATIONS	Background We aimed to classify patients with heart failure (HF) by the style of primary care they receive. Methods and Results We used the claim data (SNIIRAM: Systeme National d'Information Inter-Regime de I'Assurance Maladie) of patients living in a French region. We evaluated three concepts. First, baseline clinical status with age and Charlson index. Second, primary care practice style with mean delay between consultations, quantity of nursing care, and variability of diuretic dose. Third, clinical outcomes with death during follow-up, readmission for HF, and rate of unforeseen consultations. The baseline clinical status and the clinical outcomes were included to give an insight in the reasons for, and performance of, primary care practice style. Patients were classified using a hierarchical ascending classification based on principal components. A total of 2,751 patients were included in this study and were followed for a median of 22 months. The mean age was 78 y (SD: 12); 484 (18%) died, and 818 (30%) were readmitted for HF. We found three different significant groups characterized by their need for care and the intensity of practice style: group 1 (N = 734) was "low need-low intensity"; group 2 (N = 1,060) was "high need-low intensity"; and group 3 (N = 957) was "high need-high intensity". Their readmission rates were 17%, 41% and 28%, respectively. Conclusions This study evaluated the link between primary care, clinical status and main clinical outcomes in HF patients. In higher need patients, a low-intensity practice style was associated with poorer clinical outcomes.	[Duflos, Claire M.; Mercier, Gregoire] Montpellier Teaching Hosp, Econ Evaluat Unit, Montpellier, France; [Duflos, Claire M.; Roubille, Francois] Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR 9214, F-34295 Montpellier 5, France; [Solecki, Kamila; Roubille, Francois] Montpellier Teaching Hosp, Dept Cardiol, Montpellier, France; [Papinaud, Laurence] Reg Med Off Assurance Malad, Informat Syst Unit, Montpellier, France; [Mercier, Gregoire] MACVIA LR Fighting Chron Dis Act & Hlth Ageing, Reference Site European Innovat Partnership Act &, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Duflos, CM (corresponding author), Montpellier Teaching Hosp, Econ Evaluat Unit, Montpellier, France.; Duflos, CM (corresponding author), Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR 9214, F-34295 Montpellier 5, France.	Claire.m.duflos@gmail.com		Duflos, Claire/0000-0002-7239-530X				BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; Bohm M, 2013, AM HEART J, V166, P306, DOI 10.1016/j.ahj.2013.04.016; Byrd L, 2009, GERIATR NURS, V30, P365, DOI 10.1016/j.gerinurse.2009.08.007; Capomolla S, 2002, J AM COLL CARDIOL, V40, P1259, DOI 10.1016/S0735-1097(02)02140-X; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Jong JD., 2008, EXPLAINING MED PRACT; Dinwiddie GY, 2013, SOC SCI MED, V80, P67, DOI 10.1016/j.socscimed.2012.11.024; Feltner C, 2014, ANN INTERN MED, V160, P774, DOI 10.7326/M14-0083; GIDROL J-C, 2009, REPERES CHIFFRES, P5; Hussey PS, 2014, JAMA INTERN MED, V174, P742, DOI 10.1001/jamainternmed.2014.245; Jay N, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-130; Kangovi S, 2011, JAMA-J AM MED ASSOC, V306, P1796, DOI 10.1001/jama.2011.1562; Khan H, 2015, EUR J HEART FAIL, V17, P1022, DOI 10.1002/ejhf.282; Lindquist LA, 2011, J HOSP MED, V6, P51, DOI 10.1002/jhm.901; McGrail K, 2015, MED CARE, V53, P276, DOI 10.1097/MLR.0000000000000310; Mercier G, 2015, HEALTH AFFAIR, V34, P836, DOI 10.1377/hlthaff.2014.1065; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Mousques J, 2010, SOC SCI MED, V70, P1176, DOI 10.1016/j.socscimed.2009.12.016; OECD, 2013, HLTH GLANC 2013 OECD; Padhukasahasram B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129553; Perel C, 2012, B EPIDEMIOLOGIQUE HE, V41, P466, DOI [10.1016/0021-9681(87)90171-8, DOI 10.1016/0021-9681(87)90171-8]; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Tuppin P, 2014, ARCH CARDIOVASC DIS, V107, P158, DOI 10.1016/j.acvd.2014.01.012; WEISSMAN JS, 1992, JAMA-J AM MED ASSOC, V268, P2388, DOI 10.1001/jama.268.17.2388	25	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163268	10.1371/journal.pone.0163268	http://dx.doi.org/10.1371/journal.pone.0163268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CI	27727296	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400005
J	Alvarez, CA; Gomez, FA; Mercado, L; Ramirez, R; Marshall, SH				Alvarez, Claudio A.; Gomez, Fernando A.; Mercado, Luis; Ramirez, Ramon; Marshall, Sergio H.			Piscirickettsia salmonis Imbalances the Innate Immune Response to Succeed in a Productive Infection in a Salmonid Cell Line Model	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; INTERLEUKIN-10; FISH; MODULATION; PATHOGEN; PHAGOCYTES; EXPRESSION; HEPCIDIN; CULTURE; GAMMA	Piscirickettsia salmonis is a facultative intracellular bacterium that causes the disease called ''salmon rickettsial syndrome''. Attempts to control this disease have been unsuccessful, because existing vaccines have not achieved the expected effectiveness and the antibiotics used fail to completely eradicate the pathogen. This is in part the product of lack of scientific information that still lacks on the mechanisms used by this bacterium to overcome infected-cell responses and survive to induce a productive infection in macrophages. For that, this work was focused in determining if P. salmonis is able to modify the expression and the imbalance of IL-12 and IL-10 using an in vitro model. Additionally, we also evaluated the role the antimicrobial peptide hepcidin had in the control of this pathogen in infected cells. Therefore, the expression of IL-10 and IL-12 was evaluated at earlier stages of infection in the RTS11 cell line derived from Oncorhynchus mykiss macrophages. Simultaneously, the hepcidin expression and location was analyzed in the macrophages infected with the pathogen. Our results suggest that IL-10 is clearly induced at early stages of infection with values peaking at 36 hours post infection. Furthermore, infective P. salmonis downregulates the expression of antimicrobial peptide hepcidin and vesicles containing this peptide were unable to merge with the infective bacteria. Our results suggest that P. salmonis is able to manipulate the behavior of host cytokines and likely might constitute a virulence mechanism that promotes intracellular bacterial replication in leukocytes cells lines of trout and salmon. This mechanism involves the generation of an optimum environment for the microorganism and the downregulation of antimicrobial effectors like hepcidin.	[Alvarez, Claudio A.; Gomez, Fernando A.; Mercado, Luis; Ramirez, Ramon; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Lab Genet & Inmunol Mol, Inst Biol, Valparaiso, Chile; [Mercado, Luis; Ramirez, Ramon; Marshall, Sergio H.] Fraunhofer Chile Res Fdn, Ctr Syst Biotechnol, Santiago, Chile	Pontificia Universidad Catolica de Valparaiso	Marshall, SH (corresponding author), Pontificia Univ Catolica Valparaiso, Lab Genet & Inmunol Mol, Inst Biol, Valparaiso, Chile.; Marshall, SH (corresponding author), Fraunhofer Chile Res Fdn, Ctr Syst Biotechnol, Santiago, Chile.	sergio.marshall@pucv.cl	Alvarez, Claudio Andres/GNM-7745-2022	Mercado, Luis/0000-0003-3883-5188; Alvarez, Claudio/0000-0003-3132-2187; marshall, sergio/0000-0003-0438-8252; Gomez, Fernando/0000-0002-8191-2153	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11130407, 1140797]; Beca CONICYT para doctorados Nacionales	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Beca CONICYT para doctorados Nacionales	Support was provided by: 1) Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Grantt 11130407 to FAG (www. conicyt.cl); 2) Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Grantt 1140797 to LM (www.conicyt.cl); 3) Beca CONICYT para doctorados Nacionales to CAA.	Alvarez CA, 2014, FISH SHELLFISH IMMUN, V41, P93, DOI 10.1016/j.fsi.2014.04.013; Alvarez CA, 2013, DEV COMP IMMUNOL, V41, P77, DOI 10.1016/j.dci.2013.04.002; ARAI T, 1995, BIOCHEM BIOPH RES CO, V213, P600, DOI 10.1006/bbrc.1995.2174; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barry AO, 2011, J LEUKOCYTE BIOL, V89, P373, DOI 10.1189/jlb.0510270; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Capsoni F, 1997, SCAND J IMMUNOL, V45, P269, DOI 10.1046/j.1365-3083.1997.d01-393.x; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Chiou PP, 2007, DEV COMP IMMUNOL, V31, P1297, DOI 10.1016/j.dci.2007.03.009; CVITANICH JD, 1991, J FISH DIS, V14, P121, DOI 10.1111/j.1365-2761.1991.tb00584.x; Dalmo RA, 1997, J FISH DIS, V20, P241, DOI 10.1046/j.1365-2761.1997.00302.x; Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137; Dupont CD, 2012, IMMUNITY, V37, P191, DOI 10.1016/j.immuni.2012.08.005; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153; Ghigo E, 2001, INFECT IMMUN, V69, P2345, DOI 10.1128/IAI.69.4.2345-2352.2001; Gomez F, 2009, ARCH MED VET, V41, P261, DOI 10.4067/S0301-732X2009000300011; Gomez FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054934; Grayfer L, 2014, DEV COMP IMMUNOL, V43, P223, DOI 10.1016/j.dci.2013.08.003; Guo Pengfei, 2010, Small GTPases, V1, P170, DOI 10.4161/sgtp.1.3.14511; Hackstadt T, 2000, TRAFFIC, V1, P93, DOI 10.1034/j.1600-0854.2000.010201.x; Harun NO, 2011, FISH SHELLFISH IMMUN, V31, P107, DOI 10.1016/j.fsi.2011.04.010; Henriquez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071830; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Hunt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037330; Ireland R, 2013, J IMMUNOL, V191, P1276, DOI 10.4049/jimmunol.1300867; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Labra A, 2016, MICROB PATHOGENESIS, V92, P11, DOI 10.1016/j.micpath.2015.12.002; Layoun A, 2012, INFLAMMATION, V35, P1500, DOI 10.1007/s10753-012-9463-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALEFYT RD, 1991, J EXP MED, V174, P1209; Marshall SH, 2007, VACCINE, V25, P2095, DOI 10.1016/j.vaccine.2006.11.035; Matsunaga K, 2001, LEGIONELLA PNEUMOPHI, V69, DOI [10.1128/IAI.69.3.1929, DOI 10.1128/IAI.69.3.1929]; Mauel MJ, 2008, J VET DIAGN INVEST, V20, P213, DOI 10.1177/104063870802000211; Mikalsen J, 2008, FEMS MICROBIOL LETT, V278, P43, DOI 10.1111/j.1574-6968.2007.00977.x; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; Nam Bo-Hye, 2014, Journal of Animal and Veterinary Advances, V13, P774; Nandan D, 2011, J IMMUNOL AM ASS IMM, V188, P367, DOI 10.4049/jimmunol.1100076; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Ostler N, 2014, MOL CELL BIOL, V34, P196, DOI 10.1128/MCB.00664-13; Park DR, 1996, J IMMUNOL, V157, P2528; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Rajas V, 2009, J CELL BIOCHEM, V108, P631, DOI 10.1002/jcb.22295; Ramirez R, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu012; Rosenzweig JA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00070; Salem M, 2008, J FISH BIOL, V72, P2187, DOI 10.1111/j.1095-8649.2008.01860.x; Santana PA, 2013, FISH SHELLFISH IMMUN, V35, P748, DOI 10.1016/j.fsi.2013.06.005; Sepulveda D, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-183; Stead CM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-222; Rojas MV, 2008, MICROB PATHOGENESIS, V44, P370, DOI 10.1016/j.micpath.2007.10.012; Wang TH, 2014, DEV COMP IMMUNOL, V46, P194, DOI 10.1016/j.dci.2014.04.008; Wang TH, 2014, EUR J IMMUNOL, V44, P1541, DOI 10.1002/eji.201344273; Wilkins MR, 1999, METH MOL B, V112, P531; Yanez AJ, 2012, DIS AQUAT ORGAN, V97, P197, DOI 10.3354/dao02403; Yoshizawa S, 2005, INFECT IMMUN, V73, P2709, DOI 10.1128/IAI.73.5.2709-2717.2005	59	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163943	10.1371/journal.pone.0163943	http://dx.doi.org/10.1371/journal.pone.0163943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723816	Green Submitted, gold, Green Published			2022-12-27	WOS:000385504100015
J	Berchtold, E; Csaba, G; Zimmer, R				Berchtold, Evi; Csaba, Gergely; Zimmer, Ralf			Evaluating Transcription Factor Activity Changes by Scoring Unexplained Target Genes in Expression Data	PLOS ONE			English	Article							NETWORKS	Several methods predict activity changes of transcription factors (TFs) from a given regulatory network and measured expression data. But available gene regulatory networks are incomplete and contain many condition-dependent regulations that are not relevant for the specific expression measurement. It is not known which combination of active TFs is needed to cause a change in the expression of a target gene. A method to systematically evaluate the inferred activity changes is missing. We present such an evaluation strategy that indicates for how many target genes the observed expression changes can be explained by a given set of active TFs. To overcome the problem that the exact combination of active TFs needed to activate a gene is typically not known, we assume a gene to be explained if there exists any combination for which the predicted active TFs can possibly explain the observed change of the gene. We introduce the i-score (inconsistency score), which quantifies how many genes could not be explained by the set of activity changes of TFs. We observe that, even for these minimal requirements, published methods yield many unexplained target genes, i.e. large i-scores. This holds for all methods and all expression datasets we evaluated. We provide new optimization methods to calculate the best possible (minimal) i-score given the network and measured expression data. The evaluation of this optimized i-score on a large data compendium yields many unexplained target genes for almost every case. This indicates that currently available regulatory networks are still far from being complete. Both the presented Act-SAT and Act-A* methods produce optimal sets of TF activity changes, which can be used to investigate the difficult interplay of expression and network data. A web server and a command line tool to calculate our i-score and to find the active TFs associated with the minimal i-score is available from https://services.bio.ifi.lmu.de/i-score.	[Berchtold, Evi; Csaba, Gergely; Zimmer, Ralf] Univ Munich, Inst Informat, Amalienstr 17, D-80333 Munich, Germany	University of Munich	Berchtold, E; Csaba, G; Zimmer, R (corresponding author), Univ Munich, Inst Informat, Amalienstr 17, D-80333 Munich, Germany.	berchtold@bio.ifi.lmu.de; csaba@bio.ifi.lmu.de; zimmer@bio.ifi.lmu.de	Zimmer, Ralf/L-9295-2019; Berchtold, Evi/J-6434-2019	Berchtold, Evi/0000-0002-0393-8120				Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Boulesteix AL, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-23; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cai SW, 2014, AAAI CONF ARTIF INTE, P2623; Chen W, 2010, IEEE ENG MED BIO, P1061, DOI 10.1109/IEMBS.2010.5627641; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Karp R. M., 1972, P COMPL COMP COMP, P85; Kuffner R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012807; Kugel A., 2010, POS SAT, V8, P15; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Pesch R, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0304-1; Rintala E, 2011, OMICS, V15, P461, DOI 10.1089/omi.2010.0082; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schacht T, 2014, BIOINFORMATICS, V30, pI401, DOI 10.1093/bioinformatics/btu446; Schulz MH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-104; Teixeira MC, 2013, NUCLEIC ACIDS RES, VD94, pD446, DOI [10.1093/nar/gkh012, DOI 10.1093/NAR/GKH012]	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164513	10.1371/journal.pone.0164513	http://dx.doi.org/10.1371/journal.pone.0164513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723775	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100070
J	Kong, IG; Kim, SY; Kim, MS; Park, B; Kim, JH; Choi, HG				Kong, Il Gyu; Kim, So Young; Kim, Min-Su; Park, Bumjung; Kim, Jin-Hwan; Choi, Hyo Geun			Olfactory Dysfunction Is Associated with the Intake of Macronutrients in Korean Adults	PLOS ONE			English	Article							QUALITY-OF-LIFE; OLDER-ADULTS; NUTRITIONAL-STATUS; DISORDERS; SMELL; TASTE; IDENTIFICATION; CONSUMPTION; IMPAIRMENT; DISEASE	Background Olfactory function can impact food selection. However, few large population-based studies have investigated this effect across different age groups. The objective of this study was to assess the association between subjective olfactory dysfunction (anosmia or hyposmia) and macronutrient intake. Methods A total of 24,990 participants aged 20 to 98 years were evaluated based on data collected through the Korea National Health and Nutrition Examination Survey from 2008 through 2012. Olfactory dysfunction was surveyed using a self-reported questionnaire, and the nutritional status was assessed through a validated 24-hour recall method. Simple and multiple linear regression analyses with complex sampling were performed to evaluate the relationships between olfactory dysfunction and protein intake (daily protein intake/ recommended protein intake [%]), carbohydrate intake (daily carbohydrate intake/total calories [%]), and fat intake (daily fat intake/total calories [%]) after adjusting for age, sex, body mass index, income, smoking history, alcohol consumption, and stress level. Results Olfactory dysfunction was reported by 5.4% of Korean adults and was found to be associated with decreased fat consumption (estimated value [EV] of fat intake [%] = -0.57, 95% confidence interval [CI] = -1.13 to -0.13, P = 0.045). A subgroup analysis according to age and sex revealed that among young females, olfactory dysfunction was associated with reduced fat consumption (EV = -2.30, 95% CI = -4.16 to -0.43, P = 0.016) and increased carbohydrate intake (EV = 2.80, 95% CI = 0.55 to 5.05, P = 0.015), and that among middleaged females, olfactory dysfunction was also associated with reduced fat intake (EV = -1.26, 95% CI = -2.37 to -0.16, P = 0.025). In contrast, among young males, olfactory dysfunction was associated with reduced protein intake (EV = -26.41 95% CI = -45.14 to -7.69, P = 0.006). Conclusion Olfactory dysfunction was associated with reduced fat intake. Moreover, olfactory dysfunction exerted differential effects on eating behavior depending on age and sex.	[Kong, Il Gyu; Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea; [Kim, Min-Su] Korea Univ Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Gyeonggi Do, South Korea; [Kim, Jin-Hwan] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Hallym University; Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38).; This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea and a research grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38). The manuscript was edited for proper English language, including grammar, punctuation, spelling, and overall style, by the highly qualified native English-speaking editors at American Journal Experts (6EB1-45FE-A67B-7FC4-76C0).	Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; Bourre JM, 2006, J NUTR HEALTH AGING, V10, P386; CHAUHAN J, 1989, J AM DIET ASSOC, V89, P834; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Drewnowski A, 1996, J AM DIET ASSOC, V96, P471, DOI 10.1016/S0002-8223(96)00131-9; DUFFY VB, 1995, J AM DIET ASSOC, V95, P879, DOI 10.1016/S0002-8223(95)00244-8; FERRIS AM, 1989, ANN NY ACAD SCI, V561, P113, DOI 10.1111/j.1749-6632.1989.tb20975.x; FERRIS AM, 1985, NUTR RES, V5, P149, DOI 10.1016/S0271-5317(85)80030-0; Gopinath B, 2016, EUR J NUTR, V55, P1081, DOI 10.1007/s00394-015-0921-2; Gopinath B, 2015, BRIT J NUTR, V114, P240, DOI 10.1017/S0007114515001257; Gopinath B, 2011, AM J CLIN NUTR, V93, P1073, DOI 10.3945/ajcn.110.009977; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Hutton JL, 2007, J PAIN SYMPTOM MANAG, V33, P156, DOI 10.1016/j.jpainsymman.2006.07.017; Institute RRD, 2006, FOOD COMP TABL; International Obesity Taskforce, 2000, AS PAC PERSP RED OB; Kim DW, 2015, PUBLIC HEALTH NUTR, V18, P1369, DOI 10.1017/S1368980014001712; Kim SY, 2015, BRIT J NUTR, V114, P1711, DOI 10.1017/S0007114515003463; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; Lee WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062725; Liu JJ, 2015, BRAIN RES, V1597, P220, DOI 10.1016/j.brainres.2014.11.059; MATTES RD, 1990, AM J CLIN NUTR, V51, P233, DOI 10.1093/ajcn/51.2.233; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Philpott CM, 2014, CHEM SENSES, V39, P711, DOI 10.1093/chemse/bju043; Poothullil JM, 1999, J WOMENS HEALTH, V8, P109, DOI 10.1089/jwh.1999.8.109; Rolls BJ, 1999, PHYSIOL BEHAV, V66, P193, DOI 10.1016/S0031-9384(98)00264-9; SHIP JA, 1993, J GERONTOL, V48, pM26, DOI 10.1093/geronj/48.1.M26; The Korean Nutrition Society, 2010, DIET REF INT KOR KDR; The Korean Nutrition Society, 2010, DIET REF INT KOR 201; Zou YM, 2016, NEUROPSYCH DIS TREAT, V12, P869, DOI 10.2147/NDT.S104886	29	20	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164495	10.1371/journal.pone.0164495	http://dx.doi.org/10.1371/journal.pone.0164495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723843	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504100066
J	Le Page, S; Niro, M; Fauconnier, J; Cellier, L; Tamareille, S; Gharib, A; Chevrollier, A; Loufrani, L; Grenier, C; Kamel, R; Sarzi, E; Lacampagne, A; Ovize, M; Henrion, D; Reynier, P; Lenaers, G; Mirebeau-Prunier, D; Prunier, F				Le Page, Sophie; Niro, Marjorie; Fauconnier, Jeremy; Cellier, Laura; Tamareille, Sophie; Gharib, Abdallah; Chevrollier, Arnaud; Loufrani, Laurent; Grenier, Celine; Kamel, Rima; Sarzi, Emmanuelle; Lacampagne, Alain; Ovize, Michel; Henrion, Daniel; Reynier, Pascal; Lenaers, Guy; Mirebeau-Prunier, Delphine; Prunier, Fabrice			Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1(+/-) Mouse Model	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; HEART-FAILURE; SARCOPLASMIC-RETICULUM; MITOCHONDRIAL FISSION; VENTRICULAR MYOCYTES; CA2+ TRANSIENTS; OPA1; CARDIOMYOCYTES; INHIBITION; AFTERDEPOLARIZATIONS	Background Recent data suggests the involvement of mitochondrial dynamics in cardiac ischemia/reperfusion (I/R) injuries. Whilst excessive mitochondrial fission has been described as detrimental, the role of fusion proteins in this context remains uncertain. Objectives To investigate whether Opa1 (protein involved in mitochondrial inner-membrane fusion) deficiency affects I/R injuries. Methods and Results We examined mice exhibiting Opa1(delTTAG) mutations (Opa1(+/-)), showing 70% Opa1 protein expression in the myocardium as compared to their wild-type (WT) littermates. Cardiac left-ventricular systolic function assessed by means of echocardiography was observed to be similar in 3-month-old WT and Opa1(+/-) mice. After subjection to I/R, infarct size was significantly greater in Opa1(+/-) than in WTs both in vivo (43.2 +/- 4.1% vs. 28.4 +/- 3.5%, respectively; p<0.01) and ex vivo (71.1 +/- 3.2% vs. 59.6 +/- 8.5%, respectively; p<0.05). No difference was observed in the expression of other main fission/fusion protein, oxidative phosphorylation, apoptotic markers, or mitochondrial permeability transition pore (mPTP) function. Analysis of calcium transients in isolated ventricular cardiomyocytes demonstrated a lower sarcoplasmic reticulum Ca2+ uptake, whereas cytosolic Ca2+ removal from the Na+/Ca2+ exchanger (NCX) was increased, whilst SER-CA2a, phospholamban, and NCX protein expression levels were unaffected in Opa1(+/-) compared to WT mice. Simultaneous whole-cell patch-clamp recordings of mitochondrial Ca2+ movements and ventricular action potential (AP) showed impairment of dynamic mitochondrial Ca2+ uptake and a marked increase in the AP late repolarization phase in conjunction with greater occurrence of arrhythmia in Opa1(+/)- mice. Conclusion Opa1 deficiency was associated with increased sensitivity to I/R, imbalance in dynamic mitochondrial Ca2+ uptake, and subsequent increase in NCX activity.	[Le Page, Sophie; Niro, Marjorie; Cellier, Laura; Tamareille, Sophie; Chevrollier, Arnaud; Loufrani, Laurent; Grenier, Celine; Kamel, Rima; Henrion, Daniel; Reynier, Pascal; Lenaers, Guy; Mirebeau-Prunier, Delphine; Prunier, Fabrice] Univ Angers, Inst MITOVASC, CHU Angers, Angers, France; [Le Page, Sophie; Niro, Marjorie; Cellier, Laura; Tamareille, Sophie; Kamel, Rima; Prunier, Fabrice] Lab Cardioprotect Remodelage & Thrombose, Angers, France; [Le Page, Sophie; Niro, Marjorie; Prunier, Fabrice] CHU Angers, Serv Cardiol, Angers, France; [Fauconnier, Jeremy; Lacampagne, Alain] Univ Montpellier I, INSERM U1046, Montpellier, France; [Fauconnier, Jeremy; Sarzi, Emmanuelle; Lacampagne, Alain] Univ Montpellier 2, Montpellier, France; [Gharib, Abdallah; Ovize, Michel] INSERM, UMR 1060, CarMeN, Lyon, France; [Chevrollier, Arnaud; Loufrani, Laurent; Grenier, Celine; Henrion, Daniel; Reynier, Pascal; Lenaers, Guy; Mirebeau-Prunier, Delphine] CNRS, UMR C6214, INSERM UMR S1083, BNMI, Angers, France; [Sarzi, Emmanuelle] Univ Montpellier I, Inst Neurosci Montpellier, INSERM U1051, Montpellier, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Prunier, F (corresponding author), Univ Angers, Inst MITOVASC, CHU Angers, Angers, France.; Prunier, F (corresponding author), Lab Cardioprotect Remodelage & Thrombose, Angers, France.; Prunier, F (corresponding author), CHU Angers, Serv Cardiol, Angers, France.	FaPrunier@chu-angers.fr	Henrion, Daniel/AAK-1995-2021; CHEVROLLIER, Arnaud/K-2853-2015; Henrion, Daniel/J-8141-2015; CHEVROLLIER, Arnaud/GSD-3887-2022; Henrion, Daniel/N-7023-2015; Tamareille, Sophie/K-1770-2015; Lenaers, guy/X-4727-2019; CHEVROLLIER, Arnaud/P-6630-2019; Lacampagne, Alain/S-3719-2016; Ovize, michel/AAL-9247-2020; Jeremy, Jeremy/N-6233-2018; lenaers, guy/K-2421-2015	Henrion, Daniel/0000-0003-1094-0285; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Henrion, Daniel/0000-0003-1094-0285; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Henrion, Daniel/0000-0003-1094-0285; Tamareille, Sophie/0000-0001-8563-6558; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Lacampagne, Alain/0000-0003-0264-1787; Grenier, Celine/0000-0003-4521-9404; Sarzi, Emmanuelle/0000-0002-7623-6699; Jeremy, Jeremy/0000-0003-2748-0983; lenaers, guy/0000-0003-2736-3349; Reynier, Pascal/0000-0003-0802-4608	French Ministry of Education and Research; Federation Francaise de Cardiologie; Fondation de France and Fondation pour la Recherche Medicale; University of Angers; University Hospital of Angers; French region Pays de la Loire and Angers Loire Metropole	French Ministry of Education and Research; Federation Francaise de Cardiologie; Fondation de France and Fondation pour la Recherche Medicale; University of Angers; University Hospital of Angers; French region Pays de la Loire and Angers Loire Metropole(Region Pays de la Loire)	SLP received funding from the French Ministry of Education and Research and MN from the Federation Francaise de Cardiologie. JF and AL were supported by the Fondation de France and Fondation pour la Recherche Medicale. This work was carried out in the context of the PREMMI (Pole de Recherche et d'Enseignementen Medecine Mitochondriale) project, supported by the University of Angers, the University Hospital of Angers, the French region Pays de la Loire and Angers Loire Metropole.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bogeholz N, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1210, DOI 10.1161/CIRCEP.115.002927; Brady NR, 2006, BBA-BIOENERGETICS, V1757, P667, DOI 10.1016/j.bbabio.2006.04.011; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Chen L, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-230; Dague E, 2014, J MOL CELL CARDIOL, V74, P162, DOI 10.1016/j.yjmcc.2014.05.006; de la Barca JMC, 2016, NEUROBIOL DIS, V90, P20, DOI 10.1016/j.nbd.2015.08.015; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Fauconnier J, 2005, DIABETES, V54, P2375, DOI 10.2337/diabetes.54.8.2375; Fauconnier J, 2003, CARDIOVASC RES, V57, P670, DOI 10.1016/S0008-6363(02)00731-9; Fauconnier J, 2013, PHARMACOL THERAPEUT, V138, P323, DOI 10.1016/j.pharmthera.2013.01.015; Ferre M, 2015, HUM MUTAT, V36, P20, DOI 10.1002/humu.22703; Gharib A, 2012, J MOL CELL CARDIOL, V52, P1091, DOI 10.1016/j.yjmcc.2012.02.005; Gomez L, 2009, CARDIOVASC RES, V83, P226, DOI 10.1093/cvr/cvp063; Hall AR, 2014, BRIT J PHARMACOL, V171, P1890, DOI 10.1111/bph.12516; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Heusch G, 2010, BASIC RES CARDIOL, V105, P151, DOI 10.1007/s00395-009-0080-9; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Kalakech H, 2013, J MOL CELL CARDIOL, V65, P98, DOI 10.1016/j.yjmcc.2013.10.001; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Paillard M, 2013, CIRCULATION, V128, P1555, DOI 10.1161/CIRCULATIONAHA.113.001225; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; Pott C, 2011, CURR DRUG TARGETS, V12, P737, DOI 10.2174/138945011795378559; Prunier F, 2002, AM J PHYSIOL-HEART C, V283, pH346, DOI 10.1152/ajpheart.01050.2001; Prunier F, 2008, CIRCULATION, V118, P614, DOI 10.1161/CIRCULATIONAHA.108.770883; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361; Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z; Teixeira G, 2015, ANESTHESIOLOGY, V123, P1374, DOI 10.1097/ALN.0000000000000876; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Wilding JR, 2006, J PHYSIOL-LONDON, V575, P191, DOI 10.1113/jphysiol.2006.114116; Yao AS, 1998, CIRC RES, V82, P657, DOI 10.1161/01.RES.82.6.657; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zepeda R, 2014, J CARDIOVASC PHARM, V63, P477, DOI 10.1097/FJC.0000000000000071	39	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164066	10.1371/journal.pone.0164066	http://dx.doi.org/10.1371/journal.pone.0164066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723783	Green Published, gold			2022-12-27	WOS:000385504100019
J	Nijhof, AD; Brass, M; Bardi, L; Wiersema, JR				Nijhof, Annabel D.; Brass, Marcel; Bardi, Lara; Wiersema, Jan R.			Measuring Mentalizing Ability: A Within-Subject Comparison between an Explicit and Implicit Version of a Ball Detection Task	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; EXECUTIVE FUNCTION; SOCIAL COGNITION; FUNCTIONING AUTISM; MIND DEVELOPMENT; OTHERS BELIEFS; FALSE BELIEFS; DUAL-TASK; INFANTS; METAANALYSIS	The concept of mentalizing has been widely studied, but almost exclusively through tasks with explicit instructions. Recent studies suggest that people also mentalize on a more implicit level. However, to our knowledge, no study to date has directly contrasted the effects of implicit and explicit mentalizing processes on an implicit dependent measure within-subjects. We implemented this by using two versions of an object detection task, differing only on secondary catch questions. We hypothesized that if explicit mentalizing relies on complementary processes beyond those underlying implicit mentalizing, this would be reflected in enhanced belief effects in the explicit version. Twenty-eight healthy adults watched movies in which, during the first phase, both they themselves and another agent formed a belief about the location of a ball, and although irrelevant, these beliefs could influence their ball detection reaction times in the second phase. After this response phase, there were occasional catch questions that were different for the explicit and implicit task version. Finally, self-report measures of autism spectrum disorder (ASD) symptomatology were included, as the literature suggests that ASD is related to a specific deficit in implicit mentalizing. Both in the explicit and implicit version, belief conditions had a significant effect on reaction times, with responses being slower when neither the participant nor the other agent expected the ball to be present compared to all other conditions. Importantly, after the implicit version, participants reported no explicit mentalizing awareness. In our neurotypical sample, ASD symptoms were not found to correlate with either explicit or implicit mentalizing. In conclusion, the reaction time patterns in the explicit and implicit version of the task show strikingly similar effects of mentalizing, indicating that participants processed beliefs to the same extent regardless of whether they mentalized explicitly or implicitly, with no additional effects for explicit processing.	[Nijhof, Annabel D.; Brass, Marcel; Bardi, Lara; Wiersema, Jan R.] Univ Ghent, Ghent, Belgium	Ghent University	Nijhof, AD (corresponding author), Univ Ghent, Ghent, Belgium.	annabel.nijhof@ugent.be	Brass, Marcel/J-7082-2012; Nijhof, Annabel/AFO-5612-2022	Brass, Marcel/0000-0002-3364-4019; Nijhof, Annabel/0000-0002-4153-1284; Bardi, Lara/0000-0002-1678-647X	Special Research Fund of Ghent University [BOF13/24J/083]; Research Foundation - Flanders (FWO) pagasus Fellowship [331323]	Special Research Fund of Ghent University(Ghent University); Research Foundation - Flanders (FWO) pagasus Fellowship(FWO)	This work was supported by the Special Research Fund of Ghent University (project number) BOF13/24J/083). LB was supported by a Research Foundation - Flanders (FWO) pagasus Fellowship and grant 331323 - "Mirroring and ToM", Marie Curie Fellowship (Marie Currie Intra-European fellowship for career development). The funders had no role in study design, data collection and analysis, preparing the manuscript or the decision to submit this work for publication.	Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Apperly IA, 2009, DEV PSYCHOL, V45, P190, DOI 10.1037/a0014098; Armstrong K, 2013, J AUTISM DEV DISORD, V43, P2228, DOI 10.1007/s10803-013-1769-z; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Bull R, 2008, COGNITION, V107, P663, DOI 10.1016/j.cognition.2007.07.015; Callenmark B, 2014, AUTISM, V18, P684, DOI 10.1177/1362361313492393; Carpendale JIM, 2004, BEHAV BRAIN SCI, V27, P79; Carruthers P, 2017, SYNTHESE, V194, P673, DOI 10.1007/s11229-015-0792-3; Constantino JN., 2002, SOCIAL RESPONSIVENES; Deschrijver E, 2016, COGN NEUROSCI-UK, V7, P192, DOI 10.1080/17588928.2015.1085375; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Frith U, 2012, Q J EXP PSYCHOL, V65, P2073, DOI 10.1080/17470218.2012.697178; HERMAN LM, 1970, PSYCHOL BULL, V73, P74, DOI 10.1037/h0028357; Hobson P. R., 2013, UNDERSTANDING OTHER; Kalbfleisch ML, 2012, J AUTISM DEV DISORD, V42, P390, DOI 10.1007/s10803-011-1257-2; Kovacs AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106558; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Low J, 2013, PSYCHOL SCI, V24, P305, DOI 10.1177/0956797612451469; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Ozonoff S, 2010, J AM ACAD CHILD PSY, V49, P256, DOI 10.1016/j.jaac.2009.11.009; Pellicano E, 2010, DEV PSYCHOL, V46, P530, DOI 10.1037/a0018287; Phillips J, 2015, PSYCHOL SCI, V26, P1353, DOI 10.1177/0956797614558717; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rosenblau G, 2015, J AUTISM DEV DISORD, V45, P953, DOI 10.1007/s10803-014-2249-9; Schneider D, 2014, COGNITION, V133, P43, DOI 10.1016/j.cognition.2014.05.016; Schneider D, 2013, COGNITION, V129, P410, DOI 10.1016/j.cognition.2013.08.004; Schneider D, 2012, J EXP PSYCHOL GEN, V141, P433, DOI 10.1037/a0025458; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Schuwerk T, 2015, AUTISM, V19, P459, DOI 10.1177/1362361314526004; Senju A, 2013, BRAIN DEV-JPN, V35, P96, DOI 10.1016/j.braindev.2012.08.002; Senju A, 2011, PSYCHOL SCI, V22, P878, DOI 10.1177/0956797611411584; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Spek AA, 2010, J AUTISM DEV DISORD, V40, P280, DOI 10.1007/s10803-009-0860-y; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; van der Wel RPRD, 2014, COGNITION, V130, P128, DOI 10.1016/j.cognition.2013.10.004; Van Overwalle F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00560; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	45	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164373	10.1371/journal.pone.0164373	http://dx.doi.org/10.1371/journal.pone.0164373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723814	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100048
J	Tai, MLS; Sharma, VK				Tai, Mei-Ling Sharon; Sharma, Vijay K.			Role of Transcranial Doppler in the Evaluation of Vasculopathy in Tuberculous Meningitis	PLOS ONE			English	Article							NERVOUS-SYSTEM INFECTIONS; CEREBRAL-BLOOD-FLOW; BACTERIAL-MENINGITIS; SONOGRAPHY; ADULTS; FREQUENCY; STENOSES; CHILDREN; SHOCK	Background Vascular complications are important causes of cerebral infarction in tuberculous meningitis (TBM). Transcranial Doppler ultrasonography (TCD) is a non-invasive tool that can provide real-time information about cerebral hemodynamics. However, the literature on the role of TCD in the diagnosis or monitoring of vasculopathy associated with TBM is scarce. We explored the role of TCD in the diagnosis and monitoring of TBM-related vasculopathy of the major intracranial arteries. Methods Consecutive patients with TBM admitted to our tertiary center between 2011 and 2015 were included. All patients underwent TCD evaluation within 2 weeks of hospitalisation and it was repeated 2 weeks later. Mean flow velocity (Vmean) and pulsatility index (PI) were recorded. Flow velocities obtained from the submandibular internal carotid artery were also measured to calculate the Lindegaard ratio. A correlation was made between the patients who demonstrated vasculopathy on TCD, and patients with confirmed focal narrowing on computed tomography angiography (CTA) or magnetic resonance angiography (MRA). The modified Rankin scale (mRS) was used to assess the clinical outcome at three and six months. Results A total of 36 patients were recruited. Focally elevated flow velocities in the middle cerebral artery (MCA) were observed in 11 (30.6%) patients, bilaterally in 6 of them. The Lindegaard ratio was elevated (>3) in 10 (90.9%) of them, which occurred as early as the fourth day of hospitalization and persisted as long as four months. Eighty percent of patients with TBM vasculopathy by TCD criteria, also had narrowing on CTA or MRA. Ten patients (27.8%) achieved good outcome (mRS 0-2) at 3 months, which increased to 13 (36.1%) at 6 months. Conclusion A considerable proportion of patients with TBM develops intracranial vasculopathy, which can be reliably diagnosed and monitored using TCD.	[Tai, Mei-Ling Sharon] Univ Malaya, Div Neurol, Dept Med, Fac Med, Kuala Lumpur, Malaysia; [Sharma, Vijay K.] Natl Univ Hlth Syst, Div Neurol, Singapore, Singapore	Universiti Malaya; National University of Singapore	Tai, MLS (corresponding author), Univ Malaya, Div Neurol, Dept Med, Fac Med, Kuala Lumpur, Malaysia.	sharont1990@gmail.com	sharma, Vijay/T-5286-2019; Sharon, Tai Mei Ling/C-4458-2011; sharma, Vijay K/A-6733-2009	sharma, Vijay/0000-0002-8976-5696; Sharon, Tai Mei Ling/0000-0001-9900-0446; sharma, Vijay K/0000-0002-8976-5696	High Impact Research grant of University of Malaya [UM.C/625/HIR/MOE/MED/08/07, UM.0000081/HIR.C1]	High Impact Research grant of University of Malaya	High Impact Research grant of University of Malaya UM.C/625/HIR/MOE/MED/08/07 UM.0000081/HIR.C1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLDS BJ, 1986, ULTRASOUND MED BIOL, V12, P115, DOI 10.1016/0301-5629(86)90016-5; ASHWAL S, 1992, NEUROLOGY, V42, P739, DOI 10.1212/WNL.42.4.739; Baumgartner RW, 1999, STROKE, V30, P87, DOI 10.1161/01.STR.30.1.87; HARING HP, 1993, ARCH NEUROL-CHICAGO, V50, P98, DOI 10.1001/archneur.1993.00540010092024; Kilic T, 1996, ACTA NEUROCHIR, V138, P1070, DOI 10.1007/BF01412310; Killic T, 2002, CHILD NERV SYST, V18, P142, DOI 10.1007/s00381-002-0571-6; Lu CH, 2006, QJM-INT J MED, V99, P863, DOI 10.1093/qjmed/hcl119; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; MILESKI WJ, 1990, SURGERY, V108, P206; Misra UK, 2011, J NEUROL SCI, V303, P22, DOI 10.1016/j.jns.2010.12.015; Morris J, 1984, PATHOLOGIC BASIS DIS; Muller M, 1996, ULTRASOUND MED BIOL, V22, P173, DOI 10.1016/0301-5629(95)02029-2; MULLER M, 1995, STROKE, V26, P1399, DOI 10.1161/01.STR.26.8.1399; Sharma VK, 2007, STROKE, V38, P3175, DOI 10.1161/STROKEAHA.107.490755; Smith SM, 1998, J CRIT CARE, V13, P104, DOI 10.1016/S0883-9441(98)90013-2; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; van Toorn R, 2014, CHILD NERV SYST, V30, P1711, DOI 10.1007/s00381-014-2435-2; Wakerley BR, 2015, J NEUROIMAGING, V25, P111, DOI 10.1111/jon.12100; Wasay M, 2014, J NEUROL NEUROSUR PS, V85, P1260, DOI 10.1136/jnnp-2013-307178; WHO, 2015, GLOB TUB CONTR	21	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164266	10.1371/journal.pone.0164266	http://dx.doi.org/10.1371/journal.pone.0164266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723828	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504100037
J	Tenland, E; Hakansson, G; Alaridah, N; Lutay, N; Ronnholm, A; Hallgren, O; Westergren-Thorsson, G; Godaly, G				Tenland, Erik; Hakansson, Gisela; Alaridah, Nader; Lutay, Nataliya; Ronnholm, Anna; Hallgren, Oskar; Westergren-Thorsson, Gunilla; Godaly, Gabriela			Innate Immune Responses after Airway Epithelial Stimulation with Mycobacterium bovis Bacille-Calmette Guerin	PLOS ONE			English	Article							CUTTING EDGE; TUBERCULOSIS; NEUTROPHILS; CD4(+); VACCINATION; INFECTION; CELLS; BCG; INFLAMMATION; RECRUITMENT	Mycobacterium bovis bacilli Calmette-Guerin (BCG) is used as a benchmark to compare the immunogenicity of new vaccines against tuberculosis. This live vaccine is administered intradermal, but several new studies show that changing the route to mucosal immunisation represents an improved strategy. We analysed the immunomodulatory functions of BCG on human neutrophils and primary airway epithelial cells (AECs), as the early events of mucosal immune activation are unclear. Neutrophils and the primary epithelial cells were found to express the IL-17A receptor subunit IL-17RA, while the expression of IL-17RE was only observed on epithelial cells. BCG stimulation specifically reduced neutrophil IL-17RA and epithelial IL-17RE expression. BCG induced neutrophil extracellular traps (NETs), but did not have an effect on apoptosis as measured by transcription factor forkhead box O3 (FOXO3). BCG stimulation of AECs induced CXCL8 secretion and neutrophil endothelial passage towards infected epithelia. Infected epithelial cells and neutrophils were not found to be a source of IL-17 cytokines or the interstitial collagenase MMP-1. However, the addition of IFNY or IL-17A to BCG stimulated primary epithelial cells increased epithelial IL-6 secretion, while the presence of IFNY reduced neutrophil recruitment. Using our model of mucosal infection we revealed that BCG induces selective mucosal innate immune responses that could lead to induction of vaccine-mediated protection of the lung.	[Tenland, Erik; Hakansson, Gisela; Lutay, Nataliya; Ronnholm, Anna] Lund Univ, Dept Lab Med, Div Microbiol Immunol & Glycobiol, Lund, Sweden; [Alaridah, Nader] Lund Univ, Div Clin Microbiol, Dept Translat Med, Lund, Sweden; [Hallgren, Oskar] Lund Univ, Div Resp Med & Allergol, Dept Clin Sci, Lund, Sweden; [Westergren-Thorsson, Gunilla] Lund Univ, Div Lung Biol, Dept Expt Med Sci, Lund, Sweden; [Godaly, Gabriela] Lund Univ, Div Med Microbiol, Dept Translat Med, Lund, Sweden	Lund University; Lund University; Lund University; Lund University; Lund University	Godaly, G (corresponding author), Lund Univ, Div Med Microbiol, Dept Translat Med, Lund, Sweden.	gabriela.godaly@med.lu.se	Godaly, Gabriela/AAD-7545-2019; Lutay, Nataliya/K-1733-2014	Godaly, Gabriela/0000-0002-3467-1350; Lutay, Nataliya/0000-0003-1852-1288; Alaridah, Nader/0000-0003-3659-8203	Swedish Medical Research Council [2005-7364, 7364, 11550]; Crafoord Foundation; Evy and Gunnar Sandberg Foundation; Swedish Heart-Lung Foundation [20140293, 20150741, 20130462]; Alfred Osterlund Foundation; Royal Physiographical Society in Lund; Swedish Foundation for Strategic Research; ALF (Government Public Health Grant) [ALFSKANE-441381]; Medical Faculty of Lund University	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoord Foundation; Evy and Gunnar Sandberg Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Alfred Osterlund Foundation; Royal Physiographical Society in Lund(Royal Society of London); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); ALF (Government Public Health Grant); Medical Faculty of Lund University	This work was supported by the Swedish Medical Research Council (http://www.vr.se/): 2005-7364, 7364, 11550 (GWT); the Crafoord Foundation; the Evy and Gunnar Sandberg Foundation (GWT), the Swedish Heart-Lung Foundation (https://www.hjart-lungfonden.se): 20140293 (GWT), 20150741 (OH), 20130462 (GG), the Alfred Osterlund Foundation (http://www.alfredosterlundsstiftelse.se/) (GWT), the Royal Physiographical Society in Lund (http://www.fysiografen.se/) (GWT and OH), the Swedish Foundation for Strategic Research (http://stratresearch.se/en/) (GWT), ALF (Government Public Health Grant, http://www.fou.nu/is/alfskane): ALFSKANE-441381 (GWT) and the Medical Faculty of Lund University (www.med.lu.se) (GWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2012, P NATL ACAD SCI USA, V109, P17317, DOI 10.1073/pnas.1215761109; Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Andersson M, 2012, INNATE IMMUN-LONDON, V18, P531, DOI 10.1177/1753425911426591; Barrios-Payan Jorge, 2006, Gac Med Mex, V142, P273; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Blok BA, 2015, J LEUKOCYTE BIOL, V98, P347, DOI 10.1189/jlb.5RI0315-096R; Bozzano F, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.027; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dominitzki S, 2007, J IMMUNOL, V179, P2041, DOI 10.4049/jimmunol.179.4.2041; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Elkington PTG, 2005, AM J RESP CRIT CARE, V172, P1596, DOI 10.1164/rccm.200505-753OC; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; Farinacci M, 2012, VACCINE, V30, P7608, DOI 10.1016/j.vaccine.2012.10.031; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Godaly G, 1997, INFECT IMMUN, V65, P3451, DOI 10.1128/IAI.65.8.3451-3456.1997; Gopal R, 2013, MUCOSAL IMMUNOL, V6, P972, DOI 10.1038/mi.2012.135; Hakansson G, 2013, IMMUNOBIOLOGY, V218, P984, DOI 10.1016/j.imbio.2012.11.001; Haoues M, 2014, CELL MICROBIOL, V16, P1378, DOI 10.1111/cmi.12298; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kaushal D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9533; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Kubler A, 2015, J PATHOL, V235, P431, DOI 10.1002/path.4432; Lerm M, 2016, J INTERN MED, V279, P337, DOI 10.1111/joim.12449; Li Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/791392; Lyadova IV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/854507; Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Mitchell C, 2011, J IMMUNOL, V187, P3815, DOI 10.4049/jimmunol.1100436; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Ramos-Kichik V, 2009, TUBERCULOSIS, V89, P29, DOI 10.1016/j.tube.2008.09.009; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Yang CW, 2013, J EXP MED, V210, P375, DOI 10.1084/jem.20122183; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Zawrotniak M, 2013, ACTA BIOCHIM POL, V60, P277; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	55	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164431	10.1371/journal.pone.0164431	http://dx.doi.org/10.1371/journal.pone.0164431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723804	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100059
J	Gil, M; Kim, YK; Hong, SB; Lee, KJ				Gil, Minchan; Kim, Yun Kyu; Hong, Sang Bum; Lee, Kyung Jin			Naringin Decreases TNF-alpha and HMGB1 Release from LPS-Stimulated Macrophages and Improves Survival in a CLP-Induced Sepsis Mice	PLOS ONE			English	Article							HEME OXYGENASE-1 GENE; RAW 264.7 CELLS; BOX 1 RELEASE; PROINFLAMMATORY CYTOKINE; ENDOTOXIN-SHOCK; CECAL LIGATION; EXPRESSION; INJURY; ACTIVATION; NRF2	Naringin, a flavanone glycoside extracted from various plants, has a wide range of pharmacological effects. In the present study, we investigated naringin's mechanism of action and its inhibitory effect on lipopolysaccharide-induced tumor necrosis factor-alpha and high-mobility group box 1 expression in macrophages, and on death in a cecal ligation and puncture induced mouse model of sepsis. Naringin increased heme oxygenase 1 expression in peritoneal macrophage cells through the activation of adenosine monophosphate-activated protein kinase, p38, and NF-E2-related factor 2. Inhibition of heme oxygenase 1 abrogated the naringin's inhibitory effect on high-mobility group box 1 expression and NF-kB activation in lipopolysaccharide-stimulated macrophages. Moreover, mice pretreated with naringin (200 mg/kg) exhibited decreased sepsis-induced mortality and lung injury, and alleviated lung pathological changes. However, the naringin's protective effects on sepsis-induced lung injury were eliminated by zinc protoporphyrin, a heme oxygenase 1 competitive inhibitor. These results revealed the mechanism underlying naringin's protective effect in inflammation and may be beneficial for the treatment of sepsis.	[Gil, Minchan] Sookmyung Womens Univ, Nanobio Resources Ctr, Dept Cosmet Sci, Seoul, South Korea; [Kim, Yun Kyu; Lee, Kyung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci,Dept Convergence Med, Seoul 05505, South Korea; [Hong, Sang Bum] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Pulm & Crit Care Med, Seoul 05505, South Korea	Sookmyung Women's University; University of Ulsan; University of Ulsan	Lee, KJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci,Dept Convergence Med, Seoul 05505, South Korea.; Hong, SB (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Pulm & Crit Care Med, Seoul 05505, South Korea.	sbhong@amc.seoul.kr; kjlee@amc.seoul.kr	Gil, Minchan/R-1280-2019		Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2015R1D1A1A02061508]; Cancer control, Ministry of Health and Welfare [1631040]; Asan Institute for Life Sciences, Seoul, Korea [2015-505]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Cancer control, Ministry of Health and Welfare; Asan Institute for Life Sciences, Seoul, Korea	This work was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Education, Science and Technology, Grant No 2015R1D1A1A02061508 (http://www.nrf.re.kr/) and Cancer control, Ministry of Health and Welfare Grant No 1631040. It was also supported by a grant (2015-505) from the Asan Institute for Life Sciences, Seoul, Korea.	Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Barnay-Verdier S, 2011, INTENS CARE MED, V37, P957, DOI 10.1007/s00134-011-2192-6; Bentzer P, 2015, CLIN CHEST MED, V36, P521, DOI 10.1016/j.ccm.2015.05.009; Bharti S, 2014, PLANTA MED, V80, P437, DOI 10.1055/s-0034-1368351; Chang BX, 2015, HEPATOLOGY, V62, P1070, DOI 10.1002/hep.27921; Chang KC, 2015, THROMB RES, V136, P456, DOI 10.1016/j.thromres.2015.06.017; Chen RC, 2015, FOOD FUNCT, V6, P1331, DOI [10.1039/C4FO01164C, 10.1039/c4fo01164c]; Ha YM, 2012, APOPTOSIS, V17, P463, DOI 10.1007/s10495-011-0688-8; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Jang HJ, 2012, ANTIOXID REDOX SIGN, V17, P878, DOI 10.1089/ars.2011.3994; Kanno S, 2006, LIFE SCI, V78, P673, DOI 10.1016/j.lfs.2005.04.051; Kawaguchi K, 2004, PLANTA MED, V70, P17, DOI 10.1055/s-2004-815449; Kim JM, 2015, INT IMMUNOPHARMACOL, V28, P540, DOI 10.1016/j.intimp.2015.07.010; Lee D, 2013, BIOCHEM BIOPH RES CO, V431, P506, DOI 10.1016/j.bbrc.2012.12.143; Lin HY, 2005, J CELL PHYSIOL, V202, P579, DOI 10.1002/jcp.20160; Liu C, 2015, INFLAMM RES, V64, P395, DOI 10.1007/s00011-015-0817-x; Liu XM, 2011, BIOCHEM PHARMACOL, V82, P371, DOI 10.1016/j.bcp.2011.05.016; Liu XM, 2011, AM J PHYSIOL-HEART C, V300, pH84, DOI 10.1152/ajpheart.00749.2010; Liu Y, 2012, MOL MED REP, V6, P1343, DOI 10.3892/mmr.2012.1072; Liu Y, 2011, INT IMMUNOPHARMACOL, V11, P1606, DOI 10.1016/j.intimp.2011.05.022; Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Seo ES, 2013, MOL CELLS, V35, P348, DOI 10.1007/s10059-013-0021-1; Srisook K, 2005, ANTIOXID REDOX SIGN, V7, P1674, DOI 10.1089/ars.2005.7.1674; Surh YJ, 2009, ARCH PHARM RES, V32, P1163, DOI 10.1007/s12272-009-1807-8; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Toscano MG, 2011, JOVE-J VIS EXP, V7, DOI [10.3791/286021587163, DOI 10.3791/286021587163]; Tsoyi K, 2009, MOL PHARMACOL, V76, P173, DOI 10.1124/mol.109.055137; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Wang HQ, 2012, NEUROTOX RES, V21, P368, DOI 10.1007/s12640-011-9292-5; Wang JS, 2011, N-S ARCH PHARMACOL, V383, P159, DOI 10.1007/s00210-010-0586-6; Weber GF, 2014, LANGENBECK ARCH SURG, V399, P1, DOI 10.1007/s00423-013-1129-7; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Wu ML, 2011, AM J CARDIOVASC DIS, V1, P150; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100	37	43	48	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164186	10.1371/journal.pone.0164186	http://dx.doi.org/10.1371/journal.pone.0164186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716835	Green Submitted, Green Published, gold			2022-12-27	WOS:000385698100030
J	Mitropoulos, AC; Favvas, EP; Stefanopoulos, KL; Vansant, EF				Mitropoulos, Athanasios Ch.; Favvas, Evangelos P.; Stefanopoulos, Konstantinos L.; Vansant, Etienne F.			Scanning of Adsorption Hysteresis In Situ with Small Angle X-Ray Scattering	PLOS ONE			English	Article							CAPILLARY CONDENSATION; MATHEMATICAL-MODELS; GENERAL-APPROACH; PREISACH MODEL; POROUS-GLASS; DOMAIN MODEL; NITROGEN; MEMORY; POINT; PERCOLATION	Everett's theorem-6 of the domain theory was examined by conducting adsorption in situ with small angle x-ray scattering (SAXS) supplemented by the contrast matching technique. The study focuses on the spectrum differences of a point to which the system arrives from different scanning paths. It is noted that according to this theorem at a common point the system has similar macroscopic properties. Furthermore it was examined the memory string of the system. We concluded that opposite to theorem-6: a) at a common point the system can reach in a finite (not an infinite) number of ways, b) a correction for the thickness of the adsorbed film prior to capillary condensation is necessary, and c) the scattering curves although at high-Q values coincide, at low-Q values are different indicating different microscopic states. That is, at a common point the system holds different metastable states sustained by hysteresis effects. These metastable states are the ones which highlight the way of a system back to a return point memory (RPM). Entering the hysteresis loop from different RPMs different histories are implanted to the paths toward the common point. Although in general the memory points refer to relaxation phenomena, they also constitute a characteristic feature of capillary condensation. Analogies of the no-passing rule and the adiabaticity assumption in the frame of adsorption hysteresis are discussed.	[Mitropoulos, Athanasios Ch.; Vansant, Etienne F.] Eastern Macedonia & Thrace Inst Technol, Dept Petr & Mech Engn, Hephaestus Lab, Cavala 65404, St Lucas, Greece; [Favvas, Evangelos P.; Stefanopoulos, Konstantinos L.] Natl Ctr Sci Res Demokritos, Inst Nanosci & Nanotechnol, Membranes & Mat Environm Separat Lab, Athens 15341, Greece; [Vansant, Etienne F.] Univ Antwerp, Lab Adsorpt & Catalysis, Dept Chem, Univ Pl 1, B-2610 Antwerp, Belgium	National Centre of Scientific Research "Demokritos"; University of Antwerp	Mitropoulos, AC (corresponding author), Eastern Macedonia & Thrace Inst Technol, Dept Petr & Mech Engn, Hephaestus Lab, Cavala 65404, St Lucas, Greece.; Favvas, EP (corresponding author), Natl Ctr Sci Res Demokritos, Inst Nanosci & Nanotechnol, Membranes & Mat Environm Separat Lab, Athens 15341, Greece.	amitrop@teiemt.gr; e.favvas@inn.demokritos.gr	MITROPOULOS, ATHANASIOS/AAN-9348-2021	Stefanopoulos, Konstantinos/0000-0003-0079-0877; Favvas, Evangelos/0000-0003-3369-8364; Mitropoulos, Athanasios/0000-0002-7962-8153	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES-EMaTTech-Nanocapillary [MIS 375233]	European Union (European Social Fund - ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES-EMaTTech-Nanocapillary	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES-EMaTTech-Nanocapillary, grant number MIS 375233.	Bruschi L, 2010, LANGMUIR, V26, P11894, DOI 10.1021/la1011082; Cimino R, 2013, COLLOID SURFACE A, V437, P76, DOI 10.1016/j.colsurfa.2013.03.025; Coasne B, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024304; Coey JMD, 2003, J APPL PHYS, V93, P8224, DOI 10.1063/1.1557815; DUNLOP DJ, 1990, PHYS EARTH PLANET IN, V65, P62, DOI 10.1016/0031-9201(90)90076-A; ENDERBY JA, 1956, T FARADAY SOC, V52, P106, DOI 10.1039/tf9565200106; ENDERBY JA, 1955, T FARADAY SOC, V51, P835, DOI 10.1039/tf9555100835; Eschricht N, 2007, LANGMUIR, V23, P2145, DOI 10.1021/la062587m; Everett D.H., 1967, SOLID GAS INTERFACE, P1055; EVERETT DH, 1954, T FARADAY SOC, V50, P1077, DOI 10.1039/tf9545001077; EVERETT DH, 1954, T FARADAY SOC, V50, P187, DOI 10.1039/tf9545000187; EVERETT DH, 1952, T FARADAY SOC, V48, P749, DOI 10.1039/tf9524800749; EVERETT DH, 1960, PROC R SOC LON SER-A, V259, P341, DOI 10.1098/rspa.1960.0229; EVERETT DH, 1955, T FARADAY SOC, V51, P1551, DOI 10.1039/tf9555101551; EVERETT DH, 1972, J COLLOID INTERF SCI, V38, P125, DOI 10.1016/0021-9797(72)90228-7; Everett DH, 1958, PROPERTIES POROUS MA, V10, P95; Ewing JA, 1892, MAGNETIC INDUCTION I; GOICOECHEA J, 1994, PHYS REV LETT, V72, P2203, DOI 10.1103/PhysRevLett.72.2203; Gregg S.J., 1982, ADSORPTION SURFACE A, VSecond; Grosman A, 2005, LANGMUIR, V21, P10515, DOI 10.1021/la051030o; Guyer RA, 1996, PHYS REV B, V54, P18, DOI 10.1103/PhysRevB.54.18; HAYNES JM, 1977, J COLLOID INTERF SCI, V59, P24, DOI 10.1016/0021-9797(77)90334-4; HEJDA P, 1990, CZECH J PHYS, V40, P57, DOI 10.1007/BF01598355; Hitchcock I, 2011, CHEM ENG SCI, V66, P582, DOI 10.1016/j.ces.2010.10.027; Hughes D, 1997, SMART MATER STRUCT, V6, P287, DOI 10.1088/0964-1726/6/3/007; HURD AJ, 1987, PHYS REV A, V35, P2361, DOI 10.1103/PhysRevA.35.2361; JOANNY JF, 1984, J CHEM PHYS, V81, P552, DOI 10.1063/1.447337; Kirman A.P., 2007, LONG MEMORY EC; Landers J, 2013, COLLOID SURFACE A, V437, P3, DOI 10.1016/j.colsurfa.2013.01.007; LI JC, 1994, PHYS REV B, V49, P5911, DOI 10.1103/PhysRevB.49.5911; Lilly MP, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.174503; LILLY MP, 1993, PHYS REV LETT, V71, P4186, DOI 10.1103/PhysRevLett.71.4186; MAYERGOYZ ID, 1986, IEEE T MAGN, V22, P603, DOI 10.1109/TMAG.1986.1064347; MAYERGOYZ ID, 1986, PHYS REV LETT, V56, P1518, DOI 10.1103/PhysRevLett.56.1518; MAYERGOYZ ID, 1988, J APPL PHYS, V63, P2995, DOI 10.1063/1.340926; MIDDLETON AA, 1992, PHYS REV LETT, V68, P670, DOI 10.1103/PhysRevLett.68.670; Mitropoulos AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep10943; Mitropoulos AC, 2008, J COLLOID INTERF SCI, V317, P643, DOI 10.1016/j.jcis.2007.10.001; Mitropoulos AC, 2009, J COLLOID INTERF SCI, V336, P679, DOI 10.1016/j.jcis.2009.04.054; Monson PA, 2012, MICROPOR MESOPOR MAT, V160, P47, DOI 10.1016/j.micromeso.2012.04.043; Morishige K, 2009, LANGMUIR, V25, P6221, DOI 10.1021/la900022s; MUALEM Y, 1973, WATER RESOUR RES, V9, P1324, DOI 10.1029/WR009i005p01324; MUALEM Y, 1974, WATER RESOUR RES, V10, P514, DOI 10.1029/WR010i003p00514; NEEL L, 1955, ADV PHYS, V4, P191, DOI 10.1080/00018735500101204; Nguyen PTM, 2013, J PHYS CHEM C, V117, P5475, DOI 10.1021/jp4002912; POULOVASSILIS A, 1977, WATER RESOUR RES, V13, P549, DOI 10.1029/WR013i003p00549; Preisach F, 1935, Z PHYS, V94, P277, DOI 10.1007/BF01349418; Rao KS, 1941, J PHYS CHEM-US, V45, P513, DOI 10.1021/j150408a018; Rao KS, 1941, J PHYS CHEM-US, V45, P517, DOI 10.1021/j150408a019; Rao KS, 1941, J PHYS CHEM-US, V45, P500, DOI 10.1021/j150408a016; Rao KS, 1941, J PHYS CHEM-US, V45, P506, DOI 10.1021/j150408a017; Rojas F, 2001, J MOL CATAL A-CHEM, V167, P141, DOI 10.1016/S1381-1169(00)00501-X; Rosinberg ML, 2003, EUROPHYS LETT, V62, P377, DOI 10.1209/epl/i2003-00407-y; SETHNA JP, 1993, PHYS REV LETT, V70, P3347, DOI 10.1103/PhysRevLett.70.3347; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; SINHA SK, 1989, PHYSICA D, V38, P310, DOI 10.1016/0167-2789(89)90212-1; TALSMA T, 1970, WATER RESOUR RES, V6, P964, DOI 10.1029/WR006i003p00964; Thommes M, 2006, LANGMUIR, V22, P756, DOI 10.1021/la051686h; Thommes M, 2014, ADSORPTION, V20, P233, DOI 10.1007/s10450-014-9606-z; Thommes M, 2010, CHEM-ING-TECH, V82, P1059, DOI 10.1002/cite.201000064; Tompsett GA, 2005, LANGMUIR, V21, P8214, DOI 10.1021/la050068y; VISINTIN A, 1984, NONLINEAR ANAL-THEOR, V8, P977, DOI 10.1016/0362-546X(84)90094-4	62	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164636	10.1371/journal.pone.0164636	http://dx.doi.org/10.1371/journal.pone.0164636			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741263	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000050
J	Nirmal, RC; Furtado, A; Wrigley, C; Henry, RJ				Nirmal, Ravi C.; Furtado, Agnelo; Wrigley, Colin; Henry, Robert J.			Influence of Gene Expression on Hardness in Wheat	PLOS ONE			English	Article							GRAIN HARDNESS; PUROINDOLINE-B; KERNEL HARDNESS; BAKING QUALITY; STARCH; FRIABILIN; TRITICUM; SEQUENCE; LOCUS; SOFT	Puroindoline (Pina and Pinb) genes control grain texture or hardness in wheat. Wild-type/soft alleles lead to softer grain while a mutation in one or both of these genes results in a hard grain. Variation in hardness in genotypes with identical Pin alleles (wild-type or mutant) is known but the molecular basis of this is not known. We now report the identification of wheat genotypes with hard grain texture and wild-type/soft Pin alleles indicating that hardness in wheat may be controlled by factors other than mutations in the coding region of the Pin genes. RNA-Seq analysis was used to determine the variation in the transcriptome of developing grains of thirty three diverse wheat genotypes including hard (mutant Pin) and soft (wild type) and those that were hard without having Pin mutations. This defined the role of pin gene expression and identified other candidate genes associated with hardness. Pina was not expressed in hard wheat with a mutation in the Pina gene. The ratio of Pina to Pinb expression was generally lower in the hard non mutant genotypes. Hardness may be associated with differences in Pin expression and other factors and is not simply associated with mutations in the PIN protein coding sequences.	[Nirmal, Ravi C.; Furtado, Agnelo; Wrigley, Colin; Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	University of Queensland	Henry, RJ (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.	robert.henry@uq.edu.au	Wrigley, Colin/Q-7771-2019; Henry, Robert J/B-5824-2008	Henry, Robert J/0000-0002-4060-0292; Furtado, Agnelo/0000-0001-6130-9026	Australian Research Council; Green Gold Seeds Ltd., Maharashtra, India	Australian Research Council(Australian Research Council); Green Gold Seeds Ltd., Maharashtra, India	Australian Research Council and Green Gold Seeds Ltd., Maharashtra, India provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Australian Research Council and Green Gold Seeds Ltd., Maharashtra, India for financial support.	Alfred RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075488; Amoroso MG, 2004, BIOTECHNOL LETT, V26, P1731, DOI 10.1007/s10529-004-3745-3; Beecher B, 2002, THEOR APPL GENET, V105, P870, DOI 10.1007/s00122-002-1034-x; Bhave M, 2008, PLANT MOL BIOL, V66, P205, DOI 10.1007/s11103-007-9263-7; Breseghello F, 2005, CROP SCI, V45, P1685, DOI 10.2135/cropsci2004.0310; Campbell KG, 1999, CROP SCI, V39, P1184, DOI 10.2135/cropsci1999.0011183X003900040039x; Capparelli R, 2003, THEOR APPL GENET, V107, P1463, DOI 10.1007/s00122-003-1392-z; Carter AH, 2012, THEOR APPL GENET, V124, P1079, DOI 10.1007/s00122-011-1770-x; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Chen F, 2010, THEOR APPL GENET, V120, P745, DOI 10.1007/s00122-009-1195-y; Clarke B, 2005, THEOR APPL GENET, V110, P1259, DOI 10.1007/s00122-005-1962-3; Clifton LA, 2007, BIOCHEMISTRY-US, V46, P13929, DOI 10.1021/bi701680w; Clifton LA, 2011, PHYS CHEM CHEM PHYS, V13, P8881, DOI 10.1039/c0cp02247k; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Day L, 2006, FEBS J, V273, P5358, DOI 10.1111/j.1742-4658.2006.05528.x; DOEKES GJ, 1976, EUPHYTICA, V25, P565, DOI 10.1007/BF00041594; Drea S, 2005, PLANT CELL, V17, P2172, DOI 10.1105/tpc.105.034058; Furtado A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10446; Furtado A, 2014, METHODS MOL BIOL, V1099, P1, DOI 10.1007/978-1-62703-715-0_1; Gaines CS, 1996, CEREAL CHEM, V73, P278; Gasparis S, 2011, J EXP BOT, V62, P4025, DOI 10.1093/jxb/err103; GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197; Gazza L, 2008, J CEREAL SCI, V47, P52, DOI 10.1016/j.jcs.2007.01.004; Giroux MJ, 2013, CROP SCI, V53, P833, DOI 10.2135/cropsci2012.06.0359; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; GREENWELL P, 1986, CEREAL CHEM, V63, P379; Hogg AC, 2004, THEOR APPL GENET, V108, P1089, DOI 10.1007/s00122-003-1518-3; Igrejas G, 2001, J CEREAL SCI, V34, P37, DOI 10.1006/jcrs.2000.0381; Krishnamurthy K, 2001, NAT BIOTECHNOL, V19, P162, DOI 10.1038/84435; Li GY, 2008, J CEREAL SCI, V47, P510, DOI 10.1016/j.jcs.2007.06.003; Lillemo M, 2006, J CEREAL SCI, V44, P86, DOI 10.1016/j.jcs.2006.03.004; Maghirang EB, 2003, CEREAL CHEM, V80, P316, DOI 10.1094/CCHEM.2003.80.3.316; McIntosh S, 2007, PLANT BIOTECHNOL J, V5, P69, DOI 10.1111/j.1467-7652.2006.00218.x; Morris CF, 1999, CEREAL CHEM, V76, P249, DOI 10.1094/CCHEM.1999.76.2.249; Oda S, 1997, J CEREAL SCI, V26, P29, DOI 10.1006/jcrs.1996.0113; Osborne BG, 2001, AUST J AGR RES, V52, P1275, DOI 10.1071/AR01056; Ramalingam A, 2012, J CEREAL SCI, V56, P171, DOI 10.1016/j.jcs.2012.02.006; Swan CG, 2006, CROP SCI, V46, P1656, DOI 10.2135/cropsci2005.06-0135; SYMES KJ, 1965, AUST J AGR RES, V16, P113, DOI 10.1071/AR9650113; Tranquilli G, 2002, CROP SCI, V42, P1812, DOI 10.2135/cropsci2002.1812; Turnbull KM, 2003, GENOME, V46, P330, DOI 10.1139/G02-124; Turnbull KM, 2003, PLANTA, V216, P699, DOI 10.1007/s00425-002-0911-5; Turnbull KM, 2000, AUST J PLANT PHYSIOL, V27, P153; Wanjugi HW, 2007, CROP SCI, V47, P67, DOI 10.2135/cropsci2006.05.0310; Wilkinson M, 2008, J CEREAL SCI, V48, P722, DOI 10.1016/j.jcs.2008.03.007; Zhang JR, 2009, PLANT BIOTECHNOL J, V7, P733, DOI 10.1111/j.1467-7652.2009.00438.x	47	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164746	10.1371/journal.pone.0164746	http://dx.doi.org/10.1371/journal.pone.0164746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741295	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000064
J	Scriven, JJ; Whitehorn, PR; Goulson, D; Tinsley, MC				Scriven, Jessica J.; Whitehorn, Penelope R.; Goulson, Dave; Tinsley, Matthew C.			Bergmann's Body Size Rule Operates in Facultatively Endothermic Insects: Evidence from a Complex of Cryptic Bumblebee Species	PLOS ONE			English	Article							LATITUDINAL CLINES; THERMOREGULATION; CONVERSE; LIZARDS; FOLLOW; LIMITS; DNA; BEE	According to Bergmann's rule we expect species with larger body size to inhabit locations with a cooler climate, where they may be well adapted to conserve heat and resist starvation. This rule is generally applied to endotherms. In contrast, body size in ectothermic invertebrates has been suggested to follow the reverse ecogeographic trend: these converse Bergmann's patterns may be driven by the ecological constraints of shorter season length and lower food availability in cooler high latitude locations. Such patterns are particularly common in large insects due to their longer development times. As large and facultatively endothermic insects, bumblebees could thus be expected to follow either trend. In this investigation, we studied body size of three bumblebee species over a large spatial area and investigated whether interspecific trends in body size correspond to differences in their distribution consistent with either Bergmann's or a converse Bergmann's rule. We examined the body size of queens, males and workers of the Bombus lucorum complex of cryptic bumblebee species from across the whole of Great Britain. We found interspecific differences in body size corresponding to Bergmann's rule: queens and males of the more northerly distributed, cool-adapted, species were largest. In contrast, the mean body size of the worker caste did not vary between the three species. These differences in body size may have evolved under selection pressures for thermoregulation or starvation resistance. We suggest that this case study in facultatively endothermic insects may help clarify the selection pressures governing Bergmann rule trends more generally.	[Scriven, Jessica J.; Whitehorn, Penelope R.; Tinsley, Matthew C.] Univ Stirling, Biol & Environm Sci, Stirling, Scotland; [Goulson, Dave] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Stirling; University of Sussex	Scriven, JJ (corresponding author), Univ Stirling, Biol & Environm Sci, Stirling, Scotland.	jjs2@stir.ac.uk	Goulson, David/A-2462-2010; Tinsley, Matthew/S-9707-2018	Goulson, David/0000-0003-4421-2876; Scriven, Jessica/0000-0002-4217-3490; Whitehorn, Penelope/0000-0001-9852-1012; Tinsley, Matthew/0000-0002-7715-1259	University of Stirling	University of Stirling	This research was funded by the University of Stirling (www.stir.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford D V., 1975, BUMBLEBEES; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Aragon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104026; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beekman M, 1998, ENTOMOL EXP APPL, V89, P207, DOI 10.1023/A:1003595306816; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; Bossert S, 2016, ZOOL STUD, V55, DOI 10.6620/ZS.2016.55-13; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; CLARK MG, 1973, BIOCHEM J, V134, P589, DOI 10.1042/bj1340589; Cruz FB, 2005, J EVOLUTION BIOL, V18, P1559, DOI 10.1111/j.1420-9101.2005.00936.x; Funk WC, 2008, HERPETOLOGICA, V64, P290, DOI 10.1655/08-019.1; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Gabaldon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057087; Garcia-Davilla C, 2013, GENETICA, V141, P347, DOI 10.1007/s10709-013-9734-5; Goulson D, 2002, ANIM BEHAV, V64, P123, DOI 10.1006/anbe.2002.3041; Goulson Dave, 2010, P415; HEINRICH B, 1975, J COMP PHYSIOL, V96, P155, DOI 10.1007/BF00706595; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; Heinrich B., 1979, BUMBLEBEE EC; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Lye G.C., 2010, DIVERSITY, V4, P46, DOI DOI 10.1111/J.1752-4598.2010; Makarieva AM, 2005, OIKOS, V111, P425, DOI 10.1111/j.1600-0706.2005.14095.x; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; Mayr E., 1963, ANIMAL SPECIES EVOLU; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; NEWSHOLME EA, 1972, BIOCHEM J, V128, P89, DOI 10.1042/bj1280089; Olalla-Tarraga MA, 2006, J BIOGEOGR, V33, P781, DOI 10.1111/j.1365-2699.2006.01435.x; Olalla-Tarraga MA, 2007, GLOBAL ECOL BIOGEOGR, V16, P606, DOI 10.1111/j.1466-8238.2007.00309.x; PARK O, 1949, PHYSIOL ZOOL, V22, P359, DOI 10.1086/physzool.22.4.30152061; Peat J, 2005, FUNCT ECOL, V19, P145, DOI 10.1111/j.0269-8463.2005.00946.x; Perry M, 2006, CLIMATE MEMORANDUM; R Core Team, 2021, R LANGUAGE ENV STAT; Ridley M., 1996, EVOLUTION; Scriven JJ, 2015, BIOL CONSERV, V182, P126, DOI 10.1016/j.biocon.2014.11.027; Scriven JJ, 2016, ECOL EVOL, DOI [10.1002/ece3.1965.10.1002/ece3.1965, DOI 10.1002/ECE3.1965.10.1002/ECE3]; Shelomi M, 2012, AM NAT, V180, P511, DOI 10.1086/667595; Tesche MR, 2015, OECOLOGIA, V179, P139, DOI 10.1007/s00442-015-3340-4; UK Meteorological Office, 2014, MET OFF INT DAT ARCH; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; WILLIAMS P.H., 2000, BWARS NEWSLETTER, V2000, P15; Williams PH, 2012, SYST BIODIVERS, V10, P21, DOI 10.1080/14772000.2012.664574	46	16	16	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163307	10.1371/journal.pone.0163307	http://dx.doi.org/10.1371/journal.pone.0163307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741245	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000385507000003
J	Dalziel, AE; Delean, S; Heinrich, S; Cassey, P				Dalziel, Antonia E.; Delean, Steven; Heinrich, Sarah; Cassey, Phillip			Persistence of Low Pathogenic Influenza A Virus in Water: A Systematic Review and Quantitative Meta-Analysis	PLOS ONE			English	Review							AVIAN INFLUENZA; ENVIRONMENTAL TRANSMISSION; SURFACE WATERS; INACTIVATION; DISEASE; ECOLOGY; SURVEILLANCE; ACCUMULATION; TEMPERATURE; INFECTIONS	Avian influenza viruses are able to persist in the environment, in-between the transmission of the virus among its natural hosts. Quantifying the environmental factors that affect the persistence of avian influenza virus is important for influencing our ability to predict future outbreaks and target surveillance and control methods. We conducted a systematic review and quantitative meta-analysis of the environmental factors that affect the decay of low pathogenic avian influenza virus (LPAIV) in water. Abiotic factors affecting the persistence of LPAIV have been investigated for nearly 40 years, yet published data was produced by only 26 quantitative studies. These studies have been conducted by a small number of principal authors (n = 17) and have investigated a narrow range of environmental conditions, all of which were based in laboratories with limited reflection of natural conditions. The use of quantitative meta-analytic techniques provided the opportunity to assess persistence across a greater range of conditions than each individual study can achieve, through the estimation of mean effect-sizes and relationships among multiple variables. Temperature was the most influential variable, for both the strength and magnitude of the effect-size. Moderator variables explained a large proportion of the heterogeneity among effect-sizes. Salinity and pH were important factors, although future work is required to broaden the range of abiotic factors examined, as well as including further diurnal variation and greater environmental realism generally. We were unable to extract a quantitative effect-size estimate for approximately half (50.4%) of the reported experimental outcomes and we strongly recommend a minimum set of quantitative reporting to be included in all studies, which will allow robust assimilation and analysis of future findings. In addition we suggest possible means of increasing the applicability of future studies to the natural environment, and evaluating the biological content of natural waterbodies.	[Dalziel, Antonia E.; Delean, Steven; Heinrich, Sarah; Cassey, Phillip] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Cassey, Phillip] Univ Adelaide, Ctr Conservat Sci & Technol, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Dalziel, AE (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.	antonia.dalziel@adelaide.edu.au	; Dalziel, Antonia/M-6793-2018	Cassey, Phillip/0000-0002-2626-0172; Heinrich, Sarah/0000-0001-7211-1947; Dalziel, Antonia/0000-0002-3976-3510	University of Adelaide postgraduate scholarship; ARC Discovery Grant [DP140102319]	University of Adelaide postgraduate scholarship; ARC Discovery Grant(Australian Research Council)	AD was funded by a University of Adelaide postgraduate scholarship. This study was supported by an ARC Discovery Grant (DP140102319) to PC.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Anderson T, 2010, INFLUENZA OTHER RESP, V4, P1, DOI 10.1111/j.1750-2659.2009.00114.x; Arnal A, 2015, CRIT REV MICROBIOL, V41, P508, DOI 10.3109/1040841X.2013.870967; ARNQVIST G, 1995, TRENDS ECOL EVOL, V10, P236, DOI 10.1016/S0169-5347(00)89073-4; Barlow J, 2012, BIOL CONSERV, V154, P1, DOI 10.1016/j.biocon.2012.03.034; Bibby K, 2015, ENVIRON SCI TECH LET, V2, P2, DOI 10.1021/ez5003715; Boleman M., 2011, PLOT DIGITIZER; Borenstein M, 2009, INTRO METAANALYSIS, P187; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Burham K. P., 2002, MODEL SELECTION MULT; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Committee WAS, 2002, PHYS CHEM PAR WAT AU; Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442; Ducatez MF, 2015, EMERG INFECT DIS, V21, P368, DOI 10.3201/eid2102.141449; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferenczi M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0308-2; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Franklin AB, 2011, PANDEMIC INFLUENZA V; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Handel A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3051; Harrison SC, 2015, FIELDS VIROLOGY, V1, P52; HEGGENESS MH, 1982, VIROLOGY, V118, P466, DOI 10.1016/0042-6822(82)90367-1; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Huyvaert KP, 2012, VECTOR-BORNE ZOONOT, V12, P904, DOI 10.1089/vbz.2012.0993; Irwin CK, 2011, APPL ENVIRON MICROB, V77, P1049, DOI 10.1128/AEM.02733-09; Jacobs AFG, 2008, INT J BIOMETEOROL, V52, P271, DOI 10.1007/s00484-007-0121-8; Keeler SP, 2014, APPL ENVIRON MICROB, V80, P2910, DOI 10.1128/AEM.03790-13; Keeler SP, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-13; Keeler SP, 2012, J WILDLIFE DIS, V48, P999, DOI 10.7589/2011-11-314; Klaassen M, 2011, EMU, V111, P103, DOI 10.1071/MU10042; Klenk HD, 2002, VIRUS RES, V82, P73; Lebarbenchon C, 2012, P ROY SOC B-BIOL SCI, V279, P3967, DOI 10.1098/rspb.2012.1271; Lebarbenchon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026566; Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111; Lucas W., 2001, ENCY LIFE SCI, V10; Meixell BW, 2013, APPL ENVIRON MICROB, V79, P7249, DOI 10.1128/AEM.02439-13; Mena JA, 2003, BIOTECHNIQUES, V34, P260, DOI 10.2144/03342bm05; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nakagawa S, 2007, BEHAV ECOL, V18, P831, DOI 10.1093/beheco/arm050; Nazir J, 2011, APPL ENVIRON MICROB, V77, P4981, DOI 10.1128/AEM.00415-11; Nazir J, 2010, AVIAN DIS, V54, P720, DOI 10.1637/8754-033109-ResNote.1; Nielsen AA, 2013, VET MICROBIOL, V166, P419, DOI 10.1016/j.vetmic.2013.06.024; OIE, 2016, AVIAN INFLUENZA; Oppel S, 2009, J ORNITHOL, V150, P109, DOI 10.1007/s10336-008-0325-7; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Pfeiffer D., 2013, DESIGNING EPIDMIOLOG, P33; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; R Core Team, 2021, R LANGUAGE ENV STAT; Regional Lead Centre in China Asian-Pacific Regional Research and Training Centre for Integrated Fish Farming Wuxi C. Pond fertilization and fish feed, 1985, POND FERT FISH FEED; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Shaw ML, 2015, FIELDS VIROLOGY, V1, P1152; Sobsey M.D., 2003, VIRUS SURVIVAL ENV S; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; Stallknecht DE, 2012, J WILDLIFE DIS, V48, P382, DOI 10.7589/0090-3558-48.2.382; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Stanberry L.A., 2014, VIRAL INFECT HUMANS, Vfifth, P455; Stumpf P, 2010, AVIAN DIS, V54, P1183, DOI 10.1637/9162-111709-Reg.1; Suarez D. L., 2008, AVIAN INFLUENZA, P3; Swayne DE, 2006, DEV BIOLOGICALS, V124, P61; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thorlund K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039471; Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WARD RL, 1986, APPL ENVIRON MICROB, V52, P450, DOI 10.1128/AEM.52.3.450-459.1986; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Zarkov IS, 2006, REV MED VET-TOULOUSE, V157, P471; Zhang HB, 2014, J GEN VIROL, V95, P1430, DOI 10.1099/vir.0.063438-0; Zou SM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-289	83	22	22	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0161929	10.1371/journal.pone.0161929	http://dx.doi.org/10.1371/journal.pone.0161929			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736884	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800003
J	Hurtado-Roca, Y; Ledesma, M; Gonzalez-Lazaro, M; Moreno-Loshuertos, R; Fernandez-Silva, P; Enriquez, JA; Laclaustra, M				Hurtado-Roca, Yamilee; Ledesma, Marta; Gonzalez-Lazaro, Monica; Moreno-Loshuertos, Raquel; Fernandez-Silva, Patricio; Antonio Enriquez, Jose; Laclaustra, Martin			Adjusting MtDNA Quantification in Whole Blood for Peripheral Blood Platelet and Leukocyte Counts	PLOS ONE			English	Article							MITOCHONDRIAL-DNA CONTENT; HIV-INFECTED PATIENTS; COPY NUMBER; MONONUCLEAR-CELLS; LYMPHOMA; DISEASE; RISK; MUTATIONS; DEPLETION; DYNAMICS	Alterations of mitochondrial DNA copy number (mtDNAcn) in the blood (mitochondrial to nuclear DNA ratio) appear associated with several systemic diseases, including primary mitochondrial disorders, carcinogenesis, and hematologic diseases. Measuring mtDNAcn in DNA extracted from whole blood (WB) instead of from peripheral blood mononuclear cells or buffy coat may yield different results due to mitochondrial DNA present in platelets. The aim of this work is to quantify the contribution of platelets to mtDNAcn in whole blood [mtDNAcn(WB)] and to propose a correction formula to estimate leukocytes' mtDNAcn [mtDNAcn(L)] from mtDNAcn(WB). Blood samples from 10 healthy adults were combined with platelet-enriched plasma and saline solution to produce artificial blood preparations. Aliquots of each sample were combined with five different platelet concentrations. In 46 of these blood preparations, mtDNAcn was measured by qPCR. MtDNAcn(WB) increased 1.07 (95% CI 0.86, 1.29; p<0.001) per 1000 platelets present in the preparation. We proved that leukocyte count should also be taken into account as mtDNAcn(WB) was inversely associated with leukocyte count; it increased 1.10 (95% CI 0.95, 1.25, p<0.001) per unit increase of the ratio between platelet and leukocyte counts. If hematological measurements are available, subtracting 1.10 the platelets/leukocyte ratio from mtDNAcn(WB) may serve as an estimation for mtDNAcn(L). Both platelet and leukocyte counts in the sample are important sources of variation if comparing mtDNAcn among groups of patients when mtDNAcn is measured in DNA extracted from whole blood. Not taking the platelet/leukocyte ratio into account in whole blood measurements, may lead to overestimation and misclassification if interpreted as leukocytes' mtDNAcn.	[Hurtado-Roca, Yamilee; Laclaustra, Martin] Univ Autonoma Madrid, Sch Med, Dept Prevent Med & Publ Hlth, CIBERESP, Madrid, Spain; [Hurtado-Roca, Yamilee; Gonzalez-Lazaro, Monica; Antonio Enriquez, Jose; Laclaustra, Martin] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Hurtado-Roca, Yamilee] Boca Raton Clin Res Global Peru, Lima, Peru; [Ledesma, Marta] Inst Aragones Ciencias Salud, Zaragoza, Spain; [Moreno-Loshuertos, Raquel; Fernandez-Silva, Patricio] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain; [Laclaustra, Martin] St Louis Univ, Dept Epidemiol, St Louis, MO 63103 USA	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Zaragoza; Saint Louis University	Laclaustra, M (corresponding author), Univ Autonoma Madrid, Sch Med, Dept Prevent Med & Publ Hlth, CIBERESP, Madrid, Spain.; Laclaustra, M (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain.; Laclaustra, M (corresponding author), St Louis Univ, Dept Epidemiol, St Louis, MO 63103 USA.	martin.laclaustra@uam.es	Moreno-Loshuertos, Raquel/H-4545-2015; Enríquez, J.A./M-8468-2016; Silva, Patricio Fernandez/U-2256-2017; Gonzalez-Lazaro, Monica/K-7032-2017; Laclaustra, Martín/C-6709-2015	Enríquez, J.A./0000-0002-3671-2961; Silva, Patricio Fernandez/0000-0001-8971-7355; Gonzalez-Lazaro, Monica/0000-0003-3878-5782; Laclaustra, Martín/0000-0003-3963-0846; HURTADO-ROCA, YAMILEE/0000-0003-1993-6223; Moreno Loshuertos, Raquel/0000-0002-6600-1618	Institute de Salud Carlos III [PI10/00021, PI14/00009]; FINCyT Scienceand Technology Program [088-FINCyT-BDE-2014, 1663/0C-PE]; Republic of Peru [088-FINCyT-BDE-2014, 1663/0C-PE]; Inter American Development Bank [088-FINCyT-BDE-2014, 1663/0C-PE]	Institute de Salud Carlos III(Instituto de Salud Carlos III); FINCyT Scienceand Technology Program; Republic of Peru; Inter American Development Bank	This work was supported by Grants PI10/00021 and PI14/00009 (which include FEDER funding) from Institute de Salud Carlos III supported for research material; FINCyT Scienceand Technology Program (Scholarships No088-FINCyT-BDE-2014 from agreement 1663/0C-PE, between the Republic of Peru and the Inter American Development Bank) provided support in the form of salaries for author [YHR]. None of the funding institutions had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, Yamilee Hurtado-Roca has a commercial affiliation with Boca Raton clinical Research Global Peru, which did not play a role in the study design, data collection and analysis, decision to publish, preparation of the manuscript nor provided financial support in the form of author' salaries and/or research materials.; The work of Dr. Laclaustra was supported in part by grants PI10/00021 and PI14/00009 from Instituto de Salud Carlos III, which include FEDER funding, providing funds for research material. Yamilee Hurtado-Roca was supported, in the form of salary, by FINCyT Science and Technology Program Scholarships N 088-FINCyT-BDE-2014 from agreement 1663/0C -PE, between the Republic of Peru and the Inter -American Development Bank. None of the funding institutions had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029; Banas B, 2004, EUR J MED RES, V9, P371; Beraud N, 2009, J BIOENERG BIOMEMBR, V41, P195, DOI 10.1007/s10863-009-9214-x; Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006; Casasnovas JA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-45; Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; Cossarizza A, 2003, ANTIVIR THER, V8, P315; Cossarizza A, 2003, CURR OPIN INFECT DIS, V16, P5, DOI 10.1097/00001432-200302000-00002; Edeas M., 2015, MITOCHONDRIAL MED; Gahan ME, 2001, J CLIN VIROL, V22, P241, DOI 10.1016/S1386-6532(01)00195-0; Hosnijeh FS, 2014, BLOOD, V124, P530, DOI 10.1182/blood-2013-10-532085; Jensen JMB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011723; Kim C, 2015, CANCER EPIDEM BIOMAR, V24, P148, DOI 10.1158/1055-9965.EPI-14-0753; Knez J, 2016, AM J EPIDEMIOL, V183, P138, DOI 10.1093/aje/kwv175; Kurz FT, 2010, P NATL ACAD SCI USA, V107, P14315, DOI 10.1073/pnas.1007562107; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7; Lee JY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/586017; Lee JE, 2009, EXP MOL MED, V41, P253, DOI 10.3858/emm.2009.41.4.028; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Marin-Garcia J, 2013, HEART FAIL REV, V18, P439, DOI 10.1007/s10741-012-9330-2; Meissner C, 2000, FORENSIC SCI INT, V113, P109, DOI 10.1016/S0379-0738(00)00249-8; Petersen MH, 2014, MITOCHONDRION, V17, P14, DOI 10.1016/j.mito.2014.05.001; Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887; Pouvreau S., 2010, PLOS ONE, P5, DOI DOI 10.1371/JOURNAL.PONE.0013035; Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865; Steinberg K, 2002, EPIDEMIOLOGY, V13, P246, DOI 10.1097/00001648-200205000-00003; Steinberg KK, 1997, EPIDEMIOL REV, V19, P156, DOI 10.1093/oxfordjournals.epirev.a017938; Timmermans EC, 2006, CLIN CHEM, V52, P979, DOI 10.1373/clinchem.2005.062901; Urata M, 2008, ANN CLIN BIOCHEM, V45, P513, DOI 10.1258/acb.2008.008008; Wakeman L, 2007, INT J LAB HEMATOL, V29, P279, DOI 10.1111/j.1365-2257.2006.00883.x; Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002; Wians Jr Frank H., THESIS; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133	38	50	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163770	10.1371/journal.pone.0163770	http://dx.doi.org/10.1371/journal.pone.0163770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736919	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800023
J	Kadiyala, S; Morgan, EH; Cyriac, S; Margolies, A; Roopnaraine, T				Kadiyala, Suneetha; Morgan, Emily H.; Cyriac, Shruthi; Margolies, Amy; Roopnaraine, Terry			Adapting Agriculture Platforms for Nutrition: A Case Study of a Participatory, Video-Based Agricultural Extension Platform in India	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; CHILD UNDERNUTRITION; LOW-INCOME; PROGRAMS; HELP; INTERVENTIONS; COUNTRIES; LITERACY; IMPACTS; MIDDLE	Successful integration of nutrition interventions into large-scale development programmes from nutrition-relevant sectors, such as agriculture, can address critical underlying determinants of undernutrition and enhance the coverage and effectiveness of on-going nutrition-specific activities. However, evidence on how this can be done is limited. This study examines the feasibility of delivering maternal, infant, and young child nutrition behaviour change communication through an innovative agricultural extension programme serving nutritionally vulnerable groups in rural India. The existing agriculture programme involves participatory production of low-cost videos promoting best practices and broad dissemination through village-level women's self-help groups. For the nutrition intervention, 10 videos promoting specific maternal, infant, and young child nutrition practices were produced and disseminated in 30 villages. A range of methods was used to collect data, including in-depth interviews with project staff, frontline health workers, and self-help group members and their families; structured observations of mediated video dissemination sessions; nutrition knowledge tests with project staff and self-help group members; and a social network questionnaire to assess diffusion of promoted nutrition messages. We found the nutrition intervention to be well-received by rural communities and viewed as complementary to existing frontline health services. However, compared to agriculture, nutrition content required more time, creativity, and technical support to develop and deliver. Experimentation with promoted nutrition behaviours was high, but sharing of information from the videos with non-viewers was limited. Key lessons learned include the benefits of and need for collaboration with existing health services; continued technical support for implementing partners; engagement with local cultural norms and beliefs; empowerment of women's group members to champion nutrition; and enhancement of message diffusion mechanisms to reach pregnant women and mothers of young children at scale. Understanding the experience of developing and delivering this intervention will benefit the design of new nutrition interventions which seek to leverage agriculture platforms.	[Kadiyala, Suneetha] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London, England; [Kadiyala, Suneetha; Morgan, Emily H.] Leverhulme Ctr Integrat Res Agr & Hlth, London, England; [Morgan, Emily H.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Cyriac, Shruthi] St Johns Res Inst, Bengaluru, Karnataka, India; [Margolies, Amy] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of London; London School of Hygiene & Tropical Medicine; Cornell University; St. John's National Academy of Health Sciences; St. John's Research Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kadiyala, S (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London, England.; Kadiyala, S (corresponding author), Leverhulme Ctr Integrat Res Agr & Hlth, London, England.	suneetha.kadiyala@lshtm.ac.uk			U.S. Agency for International Development [AID-OAA-A-11-00031]; Leveraging Agriculture for Nutrition in South Asia (LANSA); strengthening Partnerships, Results, and innovations in Nutrition Globally (SPRING) project; UK Government (Department for International Development); Leverhulme Centre for Integrative Research on Agriculture and Health (LCIRAH)	U.S. Agency for International Development(United States Agency for International Development (USAID)); Leveraging Agriculture for Nutrition in South Asia (LANSA); strengthening Partnerships, Results, and innovations in Nutrition Globally (SPRING) project; UK Government (Department for International Development); Leverhulme Centre for Integrative Research on Agriculture and Health (LCIRAH)	This research was funded by the U.S. Agency for International Development under Cooperative Agreement No. AID-OAA-A-11-00031, the strengthening Partnerships, Results, and innovations in Nutrition Globally (SPRING) project managed by JSI Research & Training Institute, Inc. The research was also supported by Leveraging Agriculture for Nutrition in South Asia (LANSA), an international research consortium funded by UK aid from the UK Government (Department for International Development; r4d.dfid.gov.uk/Project/61223/), and by the Leverhulme Centre for Integrative Research on Agriculture and Health (LCIRAH;www.lcirah.ac.uk/). JSI Research & Training Institute, Inc. for the SPRING project gave feedback on there search design and on the technical project report which informed components of this manuscript. Otherwise, the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker JC, 2011, AGR ECON-BLACKWELL, V42, P631, DOI 10.1111/j.1574-0862.2011.00545.x; Anderson J. R., 2007, HDB AGR EC, V3, P2343, DOI [10.1016/S1574-0072(06)03044-1, DOI 10.1016/S1574-0072(06)03044-1]; Anderson JR, 2006, WORLD BANK POLICY RE, DOI [DOI 10.1596/1813-9450-3928, 10.1596/1813-9450-3928]; Asaki B, 2011, GENDER DEV, V19, P241, DOI [10.1080/13552074.2011.592634, DOI 10.1080/13552074.2011.592634]; Babu BV, 2001, J HLTH MANAGEMENT, V3, P1, DOI DOI 10.1177/097206340100300101; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Birner R., 2009, CHANGING CONTOURS AS, P139; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Cox RH, 2003, J AM DIET ASSOC, V103, P1488, DOI 10.1016/j.jada.2003.08.024; Dangour AD, 2013, FOOD NUTR BULL, V34, P194, DOI 10.1177/156482651303400208; Davis K. E., 2008, Journal of International Agricultural and Extension Education, V15, P15; Davis TC, 2002, CA-CANCER J CLIN, V52, P134, DOI 10.3322/canjclin.52.3.134; DFID, 2013, NUTR GROWTH COMM; GAGLIANO ME, 1988, J MED EDUC, V63, P785; Gandhi R, 2009, INF TECHNOL INT DEV, V5, P1; Gillespie S., 2012, Reshaping agriculture for nutrition and health: an IFPRI 2020 book, P173; Glendenning C, 2011, 01067 INT FOOD POL R; Gupta A, 2014, DIGITAL LIB POOR FAC, V1; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Headey D, 2012, FOOD SECUR, V4, P87, DOI 10.1007/s12571-011-0161-0; Horton S, 2013, HOW MUCH HAVE GLOBAL PROBLEMS COST THE WORLD?: A SCORECARD FROM 1900 TO 2050, P247; IFPRI, 2014, GLOB NUTR REP 2014 A; IIPS and Macro International, 2007, IND NAT FAM HLTH SUR; Kalichman SC, 1999, J CONSULT CLIN PSYCH, V67, P959, DOI 10.1037/0022-006X.67.6.959; Kalra RK, 2013, AGROECOL SUST FOOD, V37, P509, DOI 10.1080/10440046.2012.719853; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; Leroy JL, 2009, J DEV EFFECT, V1, P103, DOI 10.1080/19439340902924043; Liu A, 2011, MT SINAI J MED, V78, P419, DOI 10.1002/msj.20260; Menon P, 2009, IDS BULL-I DEV STUD, V40, P60, DOI 10.1111/j.1759-5436.2009.00060.x; Olney DK, 2012, J NUTR, V142, p178S, DOI 10.3945/jn.110.137182; Pegurri E, 2005, VACCINE, V23, P1624, DOI 10.1016/j.vaccine.2004.02.029; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Quisumbing AR, 2011, J DEV EFFECT, V3, P220, DOI 10.1080/19439342.2011.570450; Ramachandran D, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1889; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Smith LC, 2015, WORLD DEV, V68, P180, DOI 10.1016/j.worlddev.2014.11.014; Sobel RM, 2009, J COMMUN HEALTH, V34, P321, DOI 10.1007/s10900-009-9153-9; SUN, 2011, SCAL NUTR FRAM ACT; Swanson B. E., 2008, GLOBAL REV GOOD AGR; Thompson FE, 2013, NUTR PREVENTION TREA, P5, DOI DOI 10.1016/B978-0-12-391884-0.00001-9; Tuong W, 2014, J BEHAV MED, V37, P218, DOI 10.1007/s10865-012-9480-7; Van de Poel E, 2009, ETHNIC HEALTH, V14, P271, DOI 10.1080/13557850802609931; von Grebmer K., 2014, SYNOPSIS 2014 GLOBAL; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Webb P, 2014, FOOD NUTR BULL, V35, P126, DOI 10.1177/156482651403500113	47	16	16	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164002	10.1371/journal.pone.0164002	http://dx.doi.org/10.1371/journal.pone.0164002			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736897	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000385505800033
J	Kanhayuwa, L; Coutts, RHA				Kanhayuwa, Lakkhana; Coutts, Robert H. A.			Short Interspersed Nuclear Element (SINE) Sequences in the Genome of the Human Pathogenic Fungus Aspergillus fumigatus Af293	PLOS ONE			English	Article							RICE BLAST FUNGUS; REPETITIVE ELEMENT; PLANT RETROTRANSPOSONS; TRANSPOSABLE ELEMENTS; MAGNAPORTHE-GRISEA; EUKARYOTIC GENOMES; ERYSIPHE-GRAMINIS; RNA; STRESS; FAMILY	Novel families of short interspersed nuclear element (SINE) sequences in the human pathogenic fungus Aspergillus fumigatus, clinical isolate Af293, were identified and categorised into tRNA-related and 5S rRNA-related SINEs. Eight predicted tRNA-related SINE families originating from different tRNAs, and nominated as AfuSINE2 sequences, contained target site duplications of short direct repeat sequences (4-14 bp) flanking the elements, an extended tRNA-unrelated region and typical features of RNA polymerase III promoter sequences. The elements ranged in size from 140-493 bp and were present in low copy number in the genome and five out of eight were actively transcribed. One putative tRNA(Arg)-derived sequence, AfuSINE2-1a possessed a unique feature of repeated trinucleotide ACT residues at its 3'-terminus. This element was similar in sequence to the I-4_AO element found in A. oryzae and an I-1_AF long nuclear interspersed element-like sequence identified in A. fumigatus Af293. Families of 5S rRNA-related SINE sequences, nominated as AfuSINE3, were also identified and their 5'-5S rRNA-related regions show 50-65% and 60-75% similarity to respectively A. fumigatus 5S rRNAs and SINE3-1_AO found in A. oryzae. A. fumigatus Af293 contains five copies of AfuSINE3 sequences ranging in size from 259-343 bp and two out of five AfuSINE3 sequences were actively transcribed. Investigations on AfuSINE distribution in the fungal genome revealed that the elements are enriched in pericentromeric and subtelomeric regions and inserted within gene-rich regions. We also demonstrated that some, but not all, AfuSINE sequences are targeted by host RNA silencing mechanisms. Finally, we demonstrated that infection of the fungus with mycoviruses had no apparent effects on SINE activity.	[Kanhayuwa, Lakkhana; Coutts, Robert H. A.] Imperial Coll London, Div Biol, Fac Nat Sci, Sir Alexander Fleming Bldg,Imperial Coll Rd, London, England; [Coutts, Robert H. A.] Univ Hertfordshire, Sch Life & Med Sci, Dept Biol & Environm Sci, Hatfield, Herts, England	Imperial College London; University of Hertfordshire	Kanhayuwa, L (corresponding author), Imperial Coll London, Div Biol, Fac Nat Sci, Sir Alexander Fleming Bldg,Imperial Coll Rd, London, England.	lakkhana_k@hotmail.com	Wingfield, Lakkhana Kanhayuwa/AAA-2081-2020	Wingfield, Lakkhana Kanhayuwa/0000-0003-1586-2511	Royal Thai Government; Leverhulme Trust	Royal Thai Government; Leverhulme Trust(Leverhulme Trust)	We would like to thank Dr Elaine Bignell for supplying us with the Aspergillus fumigatus Af293 isolate. We also thank Dr Stephen C. Whisson at the James Hutton Institute and Dr Michael Tristem at the Department of Life Sciences, Imperial College London for their valuable advice, comments and helpful discussions. LK thanks the Royal Thai Government for supporting her PhD program and RHAC thanks The Leverhulme Trust for an Emeritus Fellowship.	Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; BaoWand Jurka J., 2011, REPBASE REPORTS, V11, P2582; Borodulina OR, 1999, FEBS LETT, V457, P409, DOI 10.1016/S0014-5793(99)01059-5; BRADSHAW VA, 1989, MOL GEN GENET, V218, P465, DOI 10.1007/BF00332411; Brookfield JFY, 1997, GENETICA, V100, P281, DOI 10.1023/A:1018310418744; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; DANIELS GR, 1983, NUCLEIC ACIDS RES, V11, P7595, DOI 10.1093/nar/11.21.7595; Fantaccione S, 2004, GENE, V339, P189, DOI 10.1016/j.gene.2004.06.051; Fantaccione S, 2008, GENOMICS, V91, P178, DOI 10.1016/j.ygeno.2007.10.008; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gilsenan JM, 2012, NUCLEIC ACIDS RES, V40, pD660, DOI 10.1093/nar/gkr971; Grandbastien MA, 1998, TRENDS PLANT SCI, V3, P181, DOI 10.1016/S1360-1385(98)01232-1; Hammond TM, 2008, EUKARYOT CELL, V7, P350, DOI 10.1128/EC.00356-07; Huber F, 2014, FUNGAL GENET BIOL, V64, P36, DOI 10.1016/j.fgb.2014.01.002; Hubley R., 2013, REPEATMASKER OPEN 40; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; KACHROO P, 1995, P NATL ACAD SCI USA, V92, P11125, DOI 10.1073/pnas.92.24.11125; Kanhayuwa L, 2015, P NATL ACAD SCI USA, V112, P9100, DOI 10.1073/pnas.1419225112; Kapitonov VV, 2003, MOL BIOL EVOL, V20, P694, DOI 10.1093/molbev/msg075; Kapitonov VV, 2006, REPBASE REPORTS, V6, P45; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KIM HG, 1995, MOL PLANT MICROBE IN, V8, P524, DOI 10.1094/MPMI-8-0524; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Koval AP, 2011, GENE, V487, P113, DOI 10.1016/j.gene.2011.08.001; Kramerov DA, 2011, HEREDITY, V107, P487, DOI 10.1038/hdy.2011.43; Kramerov DA, 2011, WIRES RNA, V2, P772, DOI 10.1002/wrna.91; Kreuze JF, 2005, J VIROL, V79, P7227, DOI 10.1128/JVI.79.11.7227-7238.2005; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mes JJ, 2000, MOL GEN GENET, V263, P271, DOI 10.1007/PL00008681; Neuveglise C, 1996, NUCLEIC ACIDS RES, V24, P1428, DOI 10.1093/nar/24.8.1428; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Ogiwara I, 1999, MOL BIOL EVOL, V16, P1238, DOI 10.1093/oxfordjournals.molbev.a026214; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Paquin CE, 1988, EUKARYOTIC TRANSPOSA; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; RASMUSSEN M, 1993, MOL GEN GENET, V239, P298, DOI 10.1007/BF00281631; SMIT AFA, 1995, NUCLEIC ACIDS RES, V23, P98, DOI 10.1093/nar/23.1.98; SONE T, 1993, BIOSCI BIOTECH BIOCH, V57, P1228, DOI 10.1271/bbb.57.1228; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Wei YD, 1996, MOL GEN GENET, V250, P477; Wessler SR, 1996, CURR BIOL, V6, P959, DOI 10.1016/S0960-9822(02)00638-3; Whisson SC, 2005, FUNGAL GENET BIOL, V42, P351, DOI 10.1016/j.fgb.2005.01.004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163215	10.1371/journal.pone.0163215	http://dx.doi.org/10.1371/journal.pone.0163215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736869	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800014
J	Allet, L; Giet, O; Barral, J; Junod, N; Durrer, D; Amati, F; Sykiotis, GP; Marques-Vidal, P; Puder, JJ				Allet, Lara; Giet, Olivier; Barral, Jerome; Junod, Nicolas; Durrer, Dominique; Amati, Francesca; Sykiotis, Gerasimos P.; Marques-Vidal, Pedro; Puder, Jardena J.			Educational Level Is Related to Physical Fitness in Patients with Type 2 Diabetes - A Cross-Sectional Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LENGTH-OF-STAY; CARDIORESPIRATORY FITNESS; EXERCISE PARTICIPATION; SOCIOECONOMIC-STATUS; PREDICTS MORTALITY; GENERAL-POPULATION; OLDER-PEOPLE; MEN; ASSOCIATION	Introduction Low educational level (EL) and low physical fitness are both predictors of increased morbidity and mortality in patients with type 2 diabetes. It is unknown if EL is related to physical fitness. This would have important implication for the treatment approach of patients of low EL. Materials and Methods In 2011/12, we invited participants of a new nationwide Swiss physical activity program for patients with type 2 diabetes to participate in this study. EL was defined by self-report and categorized as low (mandatory education), middle (professional education) or high (high school/university). Physical fitness was determined using 5 validated measures that assessed aerobic fitness, functional lower limb muscle strength, walking speed, balance and flexibility. Potential confounder variables such as other socio-cultural factors, physical activity level, body composition, diabetes-related parameters and complications/co-morbidities as well as well-being were assessed. Results All invited 185 participants (mean age 59.6 +/- 9.8 yrs, 76 women) agreed to be included. Of all patients, 23.1% had a low, 32.7% a middle and 44.2% a high EL; 41.8% were professionally active. The study population had a mean BMI of 32.4 +/- 5.2 kg/m(2) and an HbA1c of 7.3 +/- 1.3%. The mean diabetes duration was 8.8 +/- 7.4 years. In the baseline assessment, higher EL was associated with increased aerobic fitness, increased functional lower limb muscle strength, and increased walking speed using linear regression analysis (values for low, middle and high EL, respectively: 91.8 +/- 27.9, 116.4 +/- 49.7 and 134.9 +/- 60.4 watts for aerobic fitness (p = 0.002), 15 +/- 4.7, 13.9 +/- 2.7, 12.6 +/- 2.9 seconds for strength (p = 0.001) and 8.8 +/- 1.6, 8.3 +/- 1.4, 7.8 +/- 1.4 seconds for walking speed (p = 0.004)). These associations were independent of potential confounders. Overall, aerobic fitness was 46%, functional limb muscle strength 16%, and walking speed 11% higher in patients of high compared to those of low EL. EL was not related to balance or flexibility. Discussion A main strength of the present study is that it addresses a population of importance and a factor (EL) whose understanding can influence future interventions. A second strength is its relatively large sample size of a high-risk population. Third, unlike studies that have shown an association between self-reported fitness and educational level we assessed physical fitness measures by a quantitative and validated test battery using assessors blinded to other data. Another novelty is the extensive evaluation of the role of many relevant confounder variables. Conclusions In conclusion, we show that in patients with type 2 diabetes EL correlates favorably and independently with important health-related physical fitness measures such as aerobic fitness, walking speed, and lower limb strength. Our findings underline that diabetic patients with low EL should be specifically encouraged to participate in physical activity intervention programs to further reduce social disparities in healthcare. Such programs should be structured and integrate the norms, needs and capacities (financial, time, physical capacities and self-efficacy) of this population, and their effectiveness should be tested in future studies.	[Allet, Lara] Univ Appl Sci Western Switzerland, Sch Hlth, Dept Physiotherapy, Geneva, Switzerland; [Allet, Lara] Univ Hosp, Dept Community Med, Geneva, Switzerland; [Allet, Lara] Univ Geneva, Geneva, Switzerland; [Giet, Olivier] Hop Fribourg, Serv Physiotherapie, Fribourg, Switzerland; [Barral, Jerome] Univ Lausanne, GRISSUL, Lausanne, Switzerland; [Junod, Nicolas; Sykiotis, Gerasimos P.; Puder, Jardena J.] Univ Lausanne, Serv Endocrinol Diabet & Metab, CHU Vaudois, Lausanne, Switzerland; [Durrer, Dominique] Eurobesitas Ctr, Vevey, Switzerland; [Amati, Francesca] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Marques-Vidal, Pedro] Univ Lausanne, Dept Internal Med, Internal Med, CHU Vaudois, Lausanne, Switzerland; [Puder, Jardena J.] Univ Lausanne, Div Pediat Endocrinol Diabet & Obes, CHU Vaudois, Lausanne, Switzerland	University of Applied Sciences & Arts Western Switzerland; University of Geneva; University of Geneva; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Allet, L (corresponding author), Univ Appl Sci Western Switzerland, Sch Hlth, Dept Physiotherapy, Geneva, Switzerland.; Allet, L (corresponding author), Univ Hosp, Dept Community Med, Geneva, Switzerland.; Allet, L (corresponding author), Univ Geneva, Geneva, Switzerland.	lara.allet@hcuge.ch	Sykiotis, Gerasimos P/E-7407-2017; Amati, Francesca/A-6326-2011; Marques-Vidal, Pedro M/C-9449-2009; Allet, Lara/C-2994-2009	Amati, Francesca/0000-0002-1731-0262; Marques-Vidal, Pedro M/0000-0002-4548-8500; Allet, Lara/0000-0003-3260-7176; Puder, Jardena/0000-0002-0460-7614; Barral, Jerome/0000-0002-6798-9891; Sykiotis, Gerasimos/0000-0002-9565-4941	Program Cantonal Diabete of the canton de Vaud; DIAfit Suisse	Program Cantonal Diabete of the canton de Vaud; DIAfit Suisse	This study was supported by an unrestricted grant of DIAfit Suisse (www.diafit.ch) and the Program Cantonal Diabete of the canton de Vaud (www.vd.ch/themes/sante/prevention/diabete/).	Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; ADA, 2014, DIABETES CARE, V37; Allet L, 2010, GAIT POSTURE, V32, P185, DOI 10.1016/j.gaitpost.2010.04.013; Allet L, 2010, DIABETOLOGIA, V53, P458, DOI 10.1007/s00125-009-1592-4; Allet L, 2009, GAIT POSTURE, V29, P488, DOI 10.1016/j.gaitpost.2008.11.012; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], GUIDELINES FOR EXERC; Bacchi E, 2012, DIABETES CARE, V35, P676, DOI 10.2337/dc11-1655; Bean JF, 2002, J AM GERIATR SOC, V50, P461; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Burgi F, 2012, PREV MED, V54, P335, DOI 10.1016/j.ypmed.2012.02.007; Burgi F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-733; Coe DP, 2012, J SPORT MED PHYS FIT, V52, P654; Crouter SE, 2005, MED SCI SPORT EXER, V37, P1673, DOI 10.1249/01.mss.0000181677.36658.a8; Droomers M, 2001, J EPIDEMIOL COMMUN H, V55, P562, DOI 10.1136/jech.55.8.562; Elbaz A, 2013, AGE, V35, P943, DOI 10.1007/s11357-012-9387-9; Freitas D, 2007, ANN HUM BIOL, V34, P107, DOI 10.1080/03014460601080983; Heun R, 1999, ACTA PSYCHIAT SCAND, V99, P171, DOI 10.1111/j.1600-0447.1999.tb00973.x; Katzmarzyk PT, 2007, DIABETOLOGIA, V50, P538, DOI 10.1007/s00125-006-0554-3; Lahana E, 2010, INT J PUBLIC HEALTH, V55, P391, DOI 10.1007/s00038-010-0171-2; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Lee JJ, 2012, PHYS THER, V92, P1546, DOI 10.2522/ptj.20110403; Lee YJ, 2011, AGING MENT HEALTH, V15, P873, DOI 10.1080/13607863.2011.569486; Mabry RM, 2010, OBES REV, V11, P457, DOI 10.1111/j.1467-789X.2009.00655.x; Miettinen ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100235; Mohamed H, 2013, PRIM CARE DIABETES, V7, P199, DOI 10.1016/j.pcd.2013.05.002; Nilsson PM, 1998, DIABETIC MED, V15, P213, DOI 10.1002/(SICI)1096-9136(199803)15:3<213::AID-DIA569>3.3.CO;2-R; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; Peters DM, 2013, J GERIATR PHYS THER, V36, P24, DOI 10.1519/JPT.0b013e318248e20d; Pulkkinen KR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-163; Quddus M A, 2013, Mymensingh Med J, V22, P527; Rossier P, 2001, ARCH PHYS MED REHAB, V82, P9, DOI 10.1053/apmr.2001.9396; Saydah S, 2010, PUBLIC HEALTH REP, V125, P377, DOI 10.1177/003335491012500306; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Smith L, 2014, DIABETIC MED, V31, P1572, DOI 10.1111/dme.12544; Snowden CP, 2013, ANN SURG, V257, P999, DOI 10.1097/SLA.0b013e31828dbac2; Soric M, 2014, ANN HUM BIOL, V41, P238, DOI 10.3109/03014460.2013.851739; Speybroeck N, 2010, INT J PUBLIC HEALTH, V55, P347, DOI 10.1007/s00038-009-0105-z; Stubbe JH, 2007, PREV MED, V44, P148, DOI 10.1016/j.ypmed.2006.09.002; Tol Azar, 2014, J Educ Health Promot, V3, P4, DOI 10.4103/2277-9531.127548; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Tulloch H, 2013, CAN J DIABETES, V37, P367, DOI 10.1016/j.jcjd.2013.09.002; Turcot K, 2009, CLIN BIOMECH, V24, P716, DOI 10.1016/j.clinbiomech.2009.07.003; Umpierre D, 2013, DIABETOLOGIA, V56, P242, DOI 10.1007/s00125-012-2774-z; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002	45	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164176	10.1371/journal.pone.0164176	http://dx.doi.org/10.1371/journal.pone.0164176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732627	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300040
J	Takenaka, Y; Takemoto, N; Yasui, T; Yamamoto, Y; Uno, A; Miyabe, H; Ashida, N; Shimizu, K; Nakahara, S; Hanamoto, A; Fukusumi, T; Michiba, T; Cho, H; Yamamoto, M; Inohara, H				Takenaka, Yukinori; Takemoto, Norihiko; Yasui, Toshimichi; Yamamoto, Yoshifumi; Uno, Atsuhiko; Miyabe, Haruka; Ashida, Naoki; Shimizu, Kotaro; Nakahara, Susumu; Hanamoto, Atshushi; Fukusumi, Takahito; Michiba, Takahiro; Cho, Hironori; Yamamoto, Masashi; Inohara, Hidenori			Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROGNOSTIC SCORE; METABOLISM; METAANALYSIS; BIOMARKERS; MARKERS; SITE	Various serum biomarkers have been developed for predicting head and neck squamous cell carcinoma (HNSCC) prognosis. However, none of them have been proven to be clinically significant. A recent study reported that the ratio of aspartate aminotransaminase (AST) to alanine aminotransaminase (ALT) had a prognostic effect on non-metastatic cancers. This study aimed to examine the effect of the AST/ALT ratio on the survival of patients with HNSCC. Clinical data of 356 patients with locoregionally advanced HNSCC were collected. The effect of the AST/ALT ratio on overall survival was analyzed using a Cox proportional hazard model. Moreover, recursive partitioning analysis (RPA) was used to divide the patients into groups on the basis of the clinical stage and AST/ALT ratio. The prognostic ability of this grouping was validated using an independent data set (N = 167). The AST/ALT ratio ranged from 0.42 to 4.30 (median, 1.42) and was a prognostic factor for overall survival that was independent of age, primary sites, and tumor stage (hazard ratio: 1.36, confidence interval: 1.08-1.68, P = 0.010). RPA divided patients with stage IVA into the following two subgroups: high AST/ALT (>= 2.3) and low AST/ALT (<2.3) subgroups. The 5-year survival rate for patients with stage III, stage IVA with a low AST/ALT ratio, stage IVA with a high AST/ALT ratio, and stage IVB were 64.8%, 49.2%, 28.6%, and 33.3%, respectively (p < 0.001). Compared with the low AST/ALT group, the adjusted hazard ratio for death was 2.17 for high AST/ALT group (confidence interval: 1.02-.22 P = 0.045). The AST/ALT ratio was demonstrated to be a prognostic factor of HNSCC. The ratio subdivided patients with stage IVA into low-and high-risk groups. Moreover, intensified treatment for the high-risk group may be considered.	[Takenaka, Yukinori; Yasui, Toshimichi; Yamamoto, Yoshifumi; Uno, Atsuhiko; Miyabe, Haruka; Ashida, Naoki; Shimizu, Kotaro] Osaka Gen Med Ctr, Dept Otorhinolaryngol Htaead & Neck Surg, Sumiyoshi Ku, Osaka, Japan; [Takemoto, Norihiko; Nakahara, Susumu; Hanamoto, Atshushi; Fukusumi, Takahito; Michiba, Takahiro; Cho, Hironori; Yamamoto, Masashi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan	Osaka University	Takemoto, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan.	ntakemoto@ent.med.osaka-u.ac.jp	Takenaka, Yukinori/I-3516-2019	Takenaka, Yukinori/0000-0002-3135-5635				Bezan A, 2015, J UROLOGY, V194, P30, DOI 10.1016/j.juro.2015.01.083; Botros Mona, 2013, Clin Biochem Rev, V34, P117; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chougule A, 2008, J CANCER RES THER, V4, P21, DOI 10.4103/0973-1482.39601; Conde VR, 2015, EXP CELL RES, V335, P91, DOI 10.1016/j.yexcr.2015.04.007; DERITIS F, 1957, CLIN CHIM ACTA, V2, P70, DOI 10.1016/0009-8981(57)90027-X; Hanamoto A, 2014, CANCER MED-US, V3, P1368, DOI 10.1002/cam4.295; Huang SH, 2015, CANCER-AM CANCER SOC, V121, P545, DOI 10.1002/cncr.29100; Imai R, 2015, ACTA OTO-LARYNGOL, V135, P295, DOI 10.3109/00016489.2014.951454; Inohara H, 2010, MOL IMAGING BIOL, V12, P89, DOI 10.1007/s11307-009-0229-9; Kim KY, 2014, HEAD NECK-J SCI SPEC, V36, P1069, DOI 10.1002/hed.23444; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kotani K, 1994, Nihon Shokakibyo Gakkai Zasshi, V91, P154; Lieberman BP, 2011, J NUCL MED, V52, P1947, DOI 10.2967/jnumed.111.093815; McMillan DC, 2002, NUTR CANCER, V42, P191, DOI 10.1207/S15327914NC422_7; Meyer F, 2010, CLIN CANCER RES, V16, P1008, DOI 10.1158/1078-0432.CCR-09-2014; Nakayama M, 2015, HEAD NECK-J SCI SPEC, V37, P1745, DOI 10.1002/hed.23823; OREILLY SM, 1990, EUR J CANCER, V26, P574, DOI 10.1016/0277-5379(90)90080-D; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Proctor MJ, 2010, BRIT J CANCER, V103, P870, DOI 10.1038/sj.bjc.6605855; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Rassouli A, 2015, HEAD NECK-J SCI SPEC, V37, P103, DOI 10.1002/hed.23567; Roman BR, 2016, HEAD NECK-J SCI SPEC, V38, P168, DOI 10.1002/hed.24100; Guerra ENS, 2016, CRIT REV ONCOL HEMAT, V101, P93, DOI 10.1016/j.critrevonc.2016.03.002; Guerra ENS, 2015, ORAL ONCOL, V51, P805, DOI 10.1016/j.oraloncology.2015.06.010; Stocken DD, 2008, BRIT J CANCER, V99, P883, DOI 10.1038/sj.bjc.6604568; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	28	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164057	10.1371/journal.pone.0164057	http://dx.doi.org/10.1371/journal.pone.0164057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732629	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300038
J	Odnoletkova, I; Ramaekers, D; Nobels, F; Goderis, G; Aertgeerts, B; Annemans, L				Odnoletkova, Irina; Ramaekers, Dirk; Nobels, Frank; Goderis, Geert; Aertgeerts, Bert; Annemans, Lieven			Delivering Diabetes Education through NurseLed Telecoaching. Cost-Effectiveness Analysis	PLOS ONE			English	Article							MULTICRITERIA DECISION-ANALYSIS; RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; UKPDS OUTCOMES MODEL; OF-THE-LITERATURE; GLYCEMIC CONTROL; SELF-MANAGEMENT; RISK EQUATIONS; CARDIOVASCULAR-DISEASE; ECONOMIC-EVALUATION	Background People with diabetes have a high risk of developing micro-and macrovascular complications associated with diminished life expectancy and elevated treatment costs. Patient education programs can improve diabetes control in the short term, but their cost-effectiveness is uncertain. Our study aimed to analyze the lifelong cost-effectiveness of a nurse-led tele-coaching program compared to usual care in people with type 2 diabetes from the perspective of the Belgian healthcare system. Methods The UKPDS Outcomes Model was populated with patient-level data from an 18-month randomized clinical trial in the Belgian primary care sector involving 574 participants; trial data were extrapolated to 40 years; Quality Adjusted Life Years (QALYs), treatment costs and Incremental Cost-Effectiveness Ratio (ICER) were calculated for the entire cohort and the subgroup with poor glycemic control at baseline ("elevated HbA1c subgroup") and the associated uncertainty was explored. Results The cumulative mean QALY (95% CI) gain was 0.21 (0.13; 0.28) overall and 0.56 (0.43; 0.68) in elevated HbA1c subgroup; the respective incremental costs were (sic)1,147 (188; 2,107) and (sic)2,565 (654; 4,474) and the respective ICERs (sic)5,569 ((sic)677; (sic)15,679) and (sic)4,615 (1,207; 9,969) per QALY. In the scenario analysis, repeating the intervention for lifetime had the greatest impact on the cost-effectiveness and resulted in the mean ICERs of (sic) 13,034 in the entire cohort and (sic)7,858 in the elevated HbA1c subgroup. Conclusion Taking into account reimbursement thresholds applied in West-European countries, nurseled telecoaching of people with type 2 diabetes may be considered highly cost-effective within the Belgian healthcare system.	[Odnoletkova, Irina; Ramaekers, Dirk] Katholieke Univ Leuven, Leuven Inst Healthcare Policy, Leuven, Belgium; [Nobels, Frank] OLV Hosp Aalst, Dept Endocrinol, Aalst, Belgium; [Goderis, Geert; Aertgeerts, Bert] Katholieke Univ Leuven, Acad Ctr Gen Practice, Leuven, Belgium; [Annemans, Lieven] Univ Ghent, Dept Publ Hlth, Ghent, Belgium	KU Leuven; KU Leuven; Ghent University	Odnoletkova, I (corresponding author), Katholieke Univ Leuven, Leuven Inst Healthcare Policy, Leuven, Belgium.	irina.v.odnoletkova@gmail.com	Albertin, Paloma C/X-1093-2018; Odnoletkova, Irina/A-3269-2015	Goderis, Geert/0000-0001-5303-2290; Aertgeerts, Bert/0000-0003-1142-5402; Odnoletkova, Irina/0000-0001-5224-1250	Independent Health Insurance Fund of Belgium	Independent Health Insurance Fund of Belgium	The authors received no specific funding for this work. During the study, IO was a salaried employee of the Independent Health Insurance Fund of Belgium. The funding source played no role in any part of the study.	American Diabetes Association, 2015, STAND MED CAR DIAB; Anderson DR, 2010, J GEN INTERN MED, V25, P1116, DOI 10.1007/s11606-010-1419-5; Belgian statistics, ED LEV BELG POP; Blackberry ID, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5272; Boren SA, 2009, DIABETES EDUCATOR, V35, P72, DOI 10.1177/0145721708326774; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Cleemput I, 2008, KCE REPORTS C; Cleemput I, 2012, 183C HTA KCE; Dakin H, 2015, HEALTH ECON, V24, P1256, DOI 10.1002/hec.3086; Davis WA, 2009, MED J AUSTRALIA, V190, P180, DOI 10.5694/j.1326-5377.2009.tb02343.x; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Devos S, 2015, SCI TOTAL ENVIRON, V527, P413, DOI 10.1016/j.scitotenv.2015.04.104; Diabetes Prevention Program Research Group, 2012, DIABETES CARE, V35, P723, DOI DOI 10.2337/DC11-1468; Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2; Duncan I, 2011, DIABETES EDUCATOR, V37, P638, DOI 10.1177/0145721711416256; Eakin EG, 2014, DIABETES CARE, V37, P2177, DOI 10.2337/dc13-2427; Gillett M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4093; Goderis G, 2009, EXP CLIN ENDOCR DIAB, V117, P367, DOI 10.1055/s-0028-1103286; Graves N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007135; Gruson D, 2014, CLIN BIOCHEM, V47, P1006, DOI 10.1016/j.clinbiochem.2014.06.001; Handley MA, 2008, ANN FAM MED, V6, P512, DOI 10.1370/afm.889; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Implications of the United Kingdom Prospective Diabetes Study. American Diabetes Association, 2002, DIABETES CARE, V25, ps28, DOI [10.2337/diacare.25.7.1159, DOI 10.2337/DIACARE.25.7.1159]; Irvine L, 2011, INT J TECHNOL ASSESS, V27, P275, DOI 10.1017/S0266462311000365; Kengne AP, 2010, DIABETOLOGIA, V53, P821, DOI 10.1007/s00125-010-1681-4; Kiadaliri AA, 2014, INT J ENV RES PUB HE, V11, P4939, DOI 10.3390/ijerph110504939; Kiberd BA, 1995, BRIT MED J, V311, P1595, DOI 10.1136/bmj.311.7020.1595; Kleintjens J, 2013, PHARMACOECONOMICS, V31, P909, DOI 10.1007/s40273-013-0087-9; Loveman E, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7220; Marsh K, 2014, PHARMACOECONOMICS, V32, P345, DOI 10.1007/s40273-014-0135-0; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Odnoletkova I, 2016, DIABETIC MED, V33, P777, DOI 10.1111/dme.13092; Odnoletkova I, 2014, J DIABETES METAB, V5, DOI 10.4172/2155-6156.1000438; Palmer AJ, 2013, VALUE HEALTH, V16, P670, DOI 10.1016/j.jval.2013.01.002; Robbins JM, 2008, DIABETES CARE, V31, P655, DOI 10.2337/dc07-1871; Schwander B, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0027-1; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Simmons RK, 2009, DIABETES CARE, V32, P708, DOI 10.2337/dc08-1918; Ski CF, 2015, MED J AUSTRALIA, V202, P148, DOI 10.5694/mja14.00575; Tao L, 2015, DIABETIC MED, V32, P907, DOI 10.1111/dme.12711; Tao LB, 2013, VALUE HEALTH, V16, P1074, DOI 10.1016/j.jval.2013.06.001; Thokala P, 2012, VALUE HEALTH, V15, P1172, DOI 10.1016/j.jval.2012.06.015; Vale MJ, 2003, ARCH INTERN MED, V163, P2775, DOI 10.1001/archinte.163.22.2775; Van Acker K, 2000, DIABETES RES CLIN PR, V50, P87, DOI 10.1016/S0168-8227(00)00157-1; van Asselt ADI, 2009, PHARMACOECONOMICS, V27, P519, DOI 10.2165/00019053-200927060-00007; Van Biesen Wim, 2007, Int J Health Care Finance Econ, V7, P133, DOI 10.1007/s10754-007-9013-z; Van Brabandt H, 2005, KCE REPORTS A, V14A; van der Heijden AAWA, 2009, DIABETES CARE, V32, P2094, DOI 10.2337/dc09-0745; van Dieren S, 2012, HEART, V98, P360, DOI 10.1136/heartjnl-2011-300734; Van Herck P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078662; Vijgen SMC, 2006, PHARMACOECONOMICS, V24, P425, DOI 10.2165/00019053-200624050-00002; Wagner M, 2015, VALUE HEALTH, V18, pA477, DOI 10.1016/j.jval.2015.09.1287; Youngkong S, 2012, VALUE HEALTH, V15, P961, DOI 10.1016/j.jval.2012.06.006; Zhang P, 2012, DIABETES CARE, V35, P2250, DOI 10.2337/dc11-2478	55	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e163997	10.1371/journal.pone.0163997	http://dx.doi.org/10.1371/journal.pone.0163997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727281	Green Submitted, gold, Green Published			2022-12-27	WOS:000385504400017
J	Chiba, T; Suzuki, S; Sato, Y; Itoh, T; Umegaki, K				Chiba, Tsuyoshi; Suzuki, Sachina; Sato, Yoko; Itoh, Tatsuki; Umegaki, Keizo			Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice	PLOS ONE			English	Article							LIVER-DISEASE; METABOLIC SYNDROME; MODEL; FIBROSIS; MOUSE; INFLAMMATION; PROGRESSION; RESISTANCE; IMPACT; RATS	Aim Non-alcoholic steatohepatitis (NASH) is a globally recognized liver disease. A methionine-and choline-deficient diet is used to induce NASH in mice; however, this diet also causes severe body weight loss. To resolve this issue, we examined the effects of methionine content in a high-fat and choline-deficient (HFCD) diet on body weight and the development of NASH in mice. Methods C57BL/6J mice (male, 10 weeks of age) were fed an L-amino acid rodent (control) diet, high-fat (HF) diet, or HFCD diet containing various amounts of methionine (0.1-0.6% (w/w)) for 12 weeks. Plasma lipid levels, hepatic lipid content and inflammatory marker gene expression were measured, and a pathological analysis was conducted to evaluate NASH. Results The 0.1% methionine in HFCD diet suppressed body weight gain, which was lower than that with control diet. On the other hand, the 0.2% methionine in HFCD diet yielded similar body weight gains as the control diet, while more than 0.4% methionine showed the same body weight gains as the HF diet. Liver weights and hepatic lipid contents were the greatest with 0.1% methionine and decreased in a methionine dose-dependent manner. Pathological analysis, NAFLD activity scores and gene expression levels in the liver revealed that 0.1% and 0.2% methionine for 12 weeks induced NASH, whereas 0.4% and 0.6% methionine attenuated the induction of NASH by HFCD diet. However, the 0.2% methionine in HFCD diet did not induce insulin resistance, despite the body weight gain. Conclusions The 0.2% methionine in HFCD diet for 12 weeks was able to induce NASH without weight loss.	[Chiba, Tsuyoshi; Suzuki, Sachina; Sato, Yoko; Umegaki, Keizo] Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Informat Ctr, Shinjuku Ku, Tokyo, Japan; [Itoh, Tatsuki] Kinki Univ, Fac Agr, Dept Food Sci & Nutr, Naka, Nara, Japan	National Institute of Health & Nutrition - Japan; Kindai University (Kinki University)	Chiba, T (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Informat Ctr, Shinjuku Ku, Tokyo, Japan.	tyschiba@nih.go.jp						Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Avila M. A., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P267, DOI 10.2174/1568016054368197; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Chitturi S, 2011, J GASTROEN HEPATOL, V26, P163, DOI 10.1111/j.1440-1746.2010.06548.x; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019; Hashimoto E, 2013, J GASTROEN HEPATOL, V28, P64, DOI 10.1111/jgh.12271; Ibrahim SH, 2016, DIGEST DIS SCI, V61, P1325, DOI 10.1007/s10620-015-3977-1; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Jeong W, 2005, J VET MED SCI, V67, P235, DOI 10.1292/jvms.67.235; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Luo XY, 2013, AM J PHYSIOL-GASTR L, V305, pG891, DOI 10.1152/ajpgi.00193.2013; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Machado RM, 2010, J NUTR, V140, P1127, DOI 10.3945/jn.109.117937; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Sahebkar A, 2014, EXPERT OPIN PHARMACO, V15, P493, DOI 10.1517/14656566.2014.876992; Salamone F, 2012, DIGEST LIVER DIS, V44, P334, DOI 10.1016/j.dld.2011.11.010; Sanches SCL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/574832; Schuppan D, 2013, J GASTROEN HEPATOL, V28, P68, DOI 10.1111/jgh.12212; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461	36	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164191	10.1371/journal.pone.0164191	http://dx.doi.org/10.1371/journal.pone.0164191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723801	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504100027
J	Pellarin, I; Arnoldo, L; Costantini, S; Pegoraro, S; Ros, G; Penzo, C; Triolo, G; Demarchi, F; Sgarra, R; Vindigni, A; Manfioletti, G				Pellarin, Ilenia; Arnoldo, Laura; Costantini, Silvia; Pegoraro, Silvia; Ros, Gloria; Penzo, Carlotta; Triolo, Gianluca; Demarchi, Francesca; Sgarra, Riccardo; Vindigni, Alessandro; Manfioletti, Guidalberto			The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; CANCER STEM-CELLS; TRANSCRIPTION FACTOR HMGA2; DEPENDENT PROTEIN-KINASE; BREAST-CANCER; HISTONE H1; PATHWAY CHOICE; EXPRESSION; GENE; LIGATION	The HMGA1 architectural transcription factor is an oncogene overexpressed in the vast majority of human cancers. HMGA1 is a highly connected node in the nuclear molecular network and the key aspect of HMGA1 involvement in cancer development is that HMGA1 simultaneously confers cells multiple oncogenic hits, ranging from global chromatin structural and gene expression modifications up to the direct functional alterations of key cellular proteins. Interestingly, HMGA1 also modulates DNA damage repair pathways. In this work, we provide evidences linking HMGA1 with Non-Homologous End Joining DNA repair. We show that HMGA1 is in complex with and is a substrate for DNA-PK. HMGA1 enhances Ligase IV activity and it counteracts the repressive histone H1 activity towards DNA ends ligation. Moreover, breast cancer cells overexpressing HMGA1 show a faster recovery upon induction of DNA double-strand breaks, which is associated with a higher survival. These data suggest that resistance to DNA-damaging agents in cancer cells could be partially attributed to HMGA1 overexpression thus highlighting the relevance of considering HMGA1 expression levels in the selection of valuable and effective pharmacological regimens.	[Pellarin, Ilenia; Arnoldo, Laura; Pegoraro, Silvia; Ros, Gloria; Penzo, Carlotta; Sgarra, Riccardo; Manfioletti, Guidalberto] Univ Trieste, Dept Life Sci, Trieste, Italy; [Costantini, Silvia; Triolo, Gianluca] ICGEB, Trieste, Italy; [Demarchi, Francesca] LNCIB, AREA Sci Pk, Trieste, Italy; [Vindigni, Alessandro] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63103 USA; [Pellarin, Ilenia] CRO, Aviano, Italy; [Arnoldo, Laura] United Word Coll Adriat, Duino Aurisina, Italy; [Costantini, Silvia] Azienda Osped Univ S Maria Misericordia, Udine, Italy	University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB); Saint Louis University; IRCCS Aviano (CRO); Hospital Santa Maria della Misericordia	Manfioletti, G (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	manfiole@units.it	Pellarin, Ilenia/AAY-2238-2020; Triolo, Gianluca/AAH-9610-2020; Pegoraro, Silvia/G-9217-2018	Pellarin, Ilenia/0000-0002-1041-1722; Pegoraro, Silvia/0000-0002-1819-7417; Demarchi, Francesca/0000-0003-1565-3162; MANFIOLETTI, GUIDALBERTO/0000-0001-7913-2601; Penzo, Carlotta/0000-0002-0558-0759	Associazione Italiana per la Ricerca sul Cancro (AIRC)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC), http://www.airc.it, to GM	Adair JE, 2005, J BIOL CHEM, V280, P32184, DOI 10.1074/jbc.M505600200; Adair JE, 2007, CANCER RES, V67, P6044, DOI 10.1158/0008-5472.CAN-06-1689; Arnoldo L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08552; Baldassarre G, 2005, ONCOGENE, V24, P6809, DOI 10.1038/sj.onc.1208831; Baldassarre G, 2003, MOL CELL BIOL, V23, P2225, DOI 10.1128/MCB.23.7.2225-2238.2003; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Boo LN, 2005, CANCER RES, V65, P6622, DOI 10.1158/0008-5472.CAN-05-0086; Borrmann L, 2003, NUCLEIC ACIDS RES, V31, P6841, DOI 10.1093/nar/gkg884; Bullerdiek J, 2010, CANCER RES, V70, P1742, DOI 10.1158/0008-5472.CAN-09-3081; Chiappetta G, 1996, ONCOGENE, V13, P2439; Cobleigh MA, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.04.005; Cojoc M, 2015, SEMIN CANCER BIOL, V31, P16, DOI 10.1016/j.semcancer.2014.06.004; D'Angelo D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-851; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; Edberg DD, 2005, J BIOL CHEM, V280, P8961, DOI 10.1074/jbc.M407348200; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Frasca F, 2006, CANCER RES, V66, P2980, DOI 10.1158/0008-5472.CAN-05-2637; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Kysela B, 2005, P NATL ACAD SCI USA, V102, P1877, DOI 10.1073/pnas.0401179102; Kysela B, 2003, J BIOL CHEM, V278, P22466, DOI 10.1074/jbc.M303273200; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Li AYJ, 2009, CANCER RES, V69, P5699, DOI 10.1158/0008-5472.CAN-08-4833; Maloney SC, 2007, DNA REPAIR, V6, P1371, DOI 10.1016/j.dnarep.2007.04.003; Marchetti C, 2006, DNA REPAIR, V5, P788, DOI 10.1016/j.dnarep.2006.03.011; Maugeri-Sacca M, 2012, MOL CANCER THER, V11, P1627, DOI 10.1158/1535-7163.MCT-11-1040; Maurizio E, 2011, J PROTEOME RES, V10, P3283, DOI 10.1021/pr200116w; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Nagaki S, 1998, BIOCHEM BIOPH RES CO, V246, P137, DOI 10.1006/bbrc.1998.8589; Natarajan S, 2013, NEOPLASIA, V15, P263, DOI 10.1593/neo.121988; Noro B, 2003, BIOCHEMISTRY-US, V42, P4569, DOI 10.1021/bi026605k; Palmieri D, 2011, ONCOGENE, V30, P3024, DOI 10.1038/onc.2011.21; Pegoraro S, 2015, ONCOTARGET, V6, P19087, DOI 10.18632/oncotarget.4236; Pegoraro S, 2013, ONCOTARGET, V4, P1293, DOI 10.18632/oncotarget.1136; Pentimalli F, 2008, EUR J CANCER, V44, P2668, DOI 10.1016/j.ejca.2008.07.033; Prados J, 2012, ANTI-CANCER AGENT ME, V12, P1058, DOI 10.2174/187152012803529646; Puca F, 2014, ONCOTARGET, V5, P3234, DOI 10.18632/oncotarget.1914; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Rosidi B, 2008, NUCLEIC ACIDS RES, V36, P1610, DOI 10.1093/nar/gkn013; Schipler A, 2013, NUCLEIC ACIDS RES, V41, P7589, DOI 10.1093/nar/gkt556; Sgarra R, 2005, PROTEOMICS, V5, P1494, DOI 10.1002/pmic.200401028; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Sgarra R, 2010, BBA-GENE REGUL MECH, V1799, P37, DOI 10.1016/j.bbagrm.2009.08.009; Sgarra R, 2009, J PROTEOME RES, V8, P2978, DOI 10.1021/pr900087r; Sgarra R, 2008, PROTEOMICS, V8, P4721, DOI 10.1002/pmic.200800193; Shah SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063419; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stros M, 2000, EUR J BIOCHEM, V267, P4088, DOI 10.1046/j.1432-1327.2000.01450.x; Summer H, 2009, NUCLEIC ACIDS RES, V37, P4371, DOI 10.1093/nar/gkp375; Takaha N, 2002, CANCER RES, V62, P647; Tessari MA, 2003, MOL CELL BIOL, V23, P9104, DOI 10.1128/MCB.23.24.9104-9116.2003; Watanabe M, 2012, CANCER LETT, V315, P18, DOI 10.1016/j.canlet.2011.10.005; Xiao DM, 2000, J NEUROCHEM, V74, P392, DOI 10.1046/j.1471-4159.2000.0740392.x; Yamanaka S, 2002, BIOCHEM BIOPH RES CO, V292, P268, DOI 10.1006/bbrc.2002.6647; Yanagisawa BL, 2014, EXPERT REV ANTICANC, V14, P23, DOI 10.1586/14737140.2013.859988; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164258	10.1371/journal.pone.0164258	http://dx.doi.org/10.1371/journal.pone.0164258			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723831	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504100035
J	Gong, WY; Liu, Y; Wu, ZH; Wang, SH; Qiu, GX; Lin, SQ				Gong, Weiyan; Liu, Yong; Wu, Zhihong; Wang, Shaohai; Qiu, Guixing; Lin, Shouqing			Meteorin-Like Shows Unique Expression Pattern in Bone and Its Overexpression Inhibits Osteoblast Differentiation	PLOS ONE			English	Article							POSTNATAL-GROWTH PLATE; CELLS IN-VITRO; EXTENSION; PROTEIN; SYSTEM; GENES	The present study was performed to identify and characterize genes involved in osteoblasts function. Firstly, we constructed and sequenced a human osteoblast full-length cDNA library to screen for genes whose functions have not been reported and further identify these candidate genes through detecting the relationship with the activator protein-1 (AP-1) transcription factor complex using a dual luciferase reporter system. Only one gene, namely METRNL (Meteorin, glial cell differentiation regulator-like) has been screened out. We performed immunohistochemistry to analyze expression patterns in bone and established a stable transfection MG63 cell line of METRNL-EGFP fusion protein overexpression to analyze the function of METRNL in mineralized nodule formation. Immunohistochemistry showed METRNL expression in hypertrophic chondrocytes and osteoblasts lining trabecular bone surfaces. Overexpression of METRNL inhibited mineralized nodule formation by the MG63 osteosarcoma cell line. Thus, the identified gene, METRNL, which is associated with AP-1 transcription factor complex activity, has a unique expression pattern in bone. In addition, the anomalous expression of METRNL may inhibit bone cell differentiation.	[Gong, Weiyan] Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan, Peoples R China; [Liu, Yong; Wu, Zhihong; Qiu, Guixing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed, Beijing, Peoples R China; [Liu, Yong; Wu, Zhihong; Wang, Shaohai; Qiu, Guixing; Lin, Shouqing] Peking Union Med Coll, Beijing, Peoples R China; [Wang, Shaohai; Lin, Shouqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Lin, SQ (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Lin, SQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China.	linsq6877@sina.com	wu, zhi/GXH-3041-2022		National High-tech R&D Program of China [2002BA711A01-07]	National High-tech R&D Program of China	This work is supported by a grant from the National High-tech R&D Program of China (No. 2002BA711A01-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JRJ, 2006, MATRIX BIOL, V25, P40, DOI 10.1016/j.matbio.2005.08.007; Chau M, 2011, J MOL ENDOCRINOL, V47, P99, DOI 10.1530/JME-10-0177; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; McCauley LK, 2001, ENDOCRINOLOGY, V142, P1975, DOI 10.1210/en.142.5.1975; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Stephens AS, 2011, J BIOL CHEM, V286, P30071, DOI 10.1074/jbc.M111.253518; Takeshita Akira, 2002, J Oral Sci, V44, P27; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Wang SH, 2007, LIB CONSTRUCTION LAR, P319; Watanabe K, 2012, J CELL SCI, V125, P2198, DOI 10.1242/jcs.097709; Zhao ZL, 2013, J CELL BIOCHEM, V114, P314, DOI 10.1002/jcb.24375	21	12	13	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164446	10.1371/journal.pone.0164446	http://dx.doi.org/10.1371/journal.pone.0164446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716826	Green Submitted, Green Published, gold			2022-12-27	WOS:000385698100054
J	Rebman, JK; Kirchoff, KE; Walsh, GS				Rebman, Jane K.; Kirchoff, Kathryn E.; Walsh, Gregory S.			Cadherin-2 Is Required Cell Autonomously for Collective Migration of Facial Branchiomotor Neurons	PLOS ONE			English	Article							N-CADHERIN; TANGENTIAL MIGRATION; REGULATE MIGRATION; MOTOR-NEURONS; ZEBRAFISH; GENE; DIRECTIONALITY; MORPHOGENESIS; POLARITY; PATHWAY	Collective migration depends on cell-cell interactions between neighbors that contribute to their overall directionality, yet the mechanisms that control the coordinated migration of neurons remains to be elucidated. During hindbrain development, facial branchiomotor neurons (FBMNs) undergo a stereotypic tangential caudal migration from their place of birth in rhombomere (r)4 to their final location in r6/7. FBMNs engage in collective cell migration that depends on neuron-to-neuron interactions to facilitate caudal directionality. Here, we demonstrate that Cadherin-2-mediated neuron-to-neuron adhesion is necessary for directional and collective migration of FBMNs. We generated stable transgenic zebrafish expressing dominant-negative Cadherin-2 (Cdh2 Delta EC) driven by the islet1 promoter. Cell-autonomous inactivation of Cadherin-2 function led to non-directional migration of FBMNs and a defect in caudal tangential migration. Additionally, mosaic analysis revealed that Cdh2 Delta EC-expressing FBMNs are not influenced to migrate caudally by neighboring wild-type FBMNs due to a defect in collective cell migration. Taken together, our data suggest that Cadherin-2 plays an essential cell-autonomous role in mediating the collective migration of FBMNs.	[Rebman, Jane K.; Kirchoff, Kathryn E.; Walsh, Gregory S.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA	Virginia Commonwealth University	Walsh, GS (corresponding author), Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA.	gwalsh@vcu.edu			Virginia Commonwealth University	Virginia Commonwealth University	The authors received no specific funding for this work except for start-up funds provided by Virginia Commonwealth University.	Arboleda-Estudillo Y, 2010, CURR BIOL, V20, P161, DOI 10.1016/j.cub.2009.11.036; Bingham S, 2002, DEV BIOL, V242, P149, DOI 10.1006/dbio.2001.0532; Bruses JL, 2011, J COMP NEUROL, V519, P1797, DOI 10.1002/cne.22602; Chandrasekhar A, 2004, DEV DYNAM, V229, P143, DOI 10.1002/dvdy.10444; Davey CF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005934; Dumortier JG, 2012, P NATL ACAD SCI USA, V109, P16945, DOI 10.1073/pnas.1205870109; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jontes JD, 2004, J NEUROSCI, V24, P9027, DOI 10.1523/JNEUROSCI.5399-04.2004; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lele Z, 2002, DEVELOPMENT, V129, P3281; Luccardini C, 2013, J NEUROSCI, V33, P18149, DOI 10.1523/JNEUROSCI.0593-13.2013; Mapp OM, 2011, DEVELOPMENT, V138, P2121, DOI 10.1242/dev.060442; Mapp OM, 2010, DEV DYNAM, V239, P1596, DOI 10.1002/dvdy.22283; Marin O, 2010, GUIDING NEURONAL CEL, V2, DOI [10.1101/cshperspect.a001834, DOI 10.1101/CSHPERSPECT.A001834]; Mayor R, 2016, NAT REV MOL CELL BIO, V17, P97, DOI 10.1038/nrm.2015.14; Nieman MT, 1999, MECH EXTRACELLULAR D, V1632, P1621, DOI [10.1186/gb-2007-8-s1-s7, DOI 10.1186/GB-2007-8-S1-S7]; Pan XF, 2014, MECH DEVELOP, V131, P1, DOI 10.1016/j.mod.2013.12.001; Qu YB, 2010, J NEUROSCI, V30, P9392, DOI 10.1523/JNEUROSCI.0124-10.2010; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Richardson J, 2016, CELL REP, V15, P2076, DOI 10.1016/j.celrep.2016.04.067; RIEGER S, 2009, PLOS BIOL, V7, P33828, DOI DOI 10.1371/J0URNAL.PBI0.1000240; Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012; Rorth P, 2011, DEV CELL, V20, P9, DOI 10.1016/j.devcel.2010.12.014; Sapede D, 2005, P NATL ACAD SCI USA, V102, P1714, DOI 10.1073/pnas.0406382102; Scarpa E, 2016, J CELL BIOL, V212, P143, DOI 10.1083/jcb.201508047; Shikanai Mima, 2011, Commun Integr Biol, V4, P326, DOI 10.4161/cib.4.3.14886; Stockinger P, 2011, DEVELOPMENT, V138, P4673, DOI 10.1242/dev.071233; Suzuki SC, 2008, DEV GROWTH DIFFER, V50, pS119, DOI 10.1111/j.1440-169X.2008.01002.x; Taniguchi H, 2006, DEVELOPMENT, V133, P1923, DOI 10.1242/dev.02354; Theveneau E, 2012, CURR OPIN CELL BIOL, V24, P677, DOI 10.1016/j.ceb.2012.08.002; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; Vivancos V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-7; Wada H, 2005, DEVELOPMENT, V132, P2273, DOI 10.1242/dev.01810; Wada H, 2006, DEVELOPMENT, V133, P4749, DOI 10.1242/dev.02665; Walsh GS, 2011, DEVELOPMENT, V138, P3033, DOI 10.1242/dev.063842; Wanner SJ, 2013, CURR OPIN NEUROBIOL, V23, P943, DOI 10.1016/j.conb.2013.09.001; Wanner SJ, 2013, DEVELOPMENT, V140, P906, DOI 10.1242/dev.087148; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, DOI [10.1523/JNEUROSCI.2596-11.2012, DOI 10.1523/JNEUROSCI.2596-11.2012]; Wong GKW, 2012, J NEUROSCI, V32, P223, DOI 10.1523/JNEUROSCI.2596-11.2012	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164433	10.1371/journal.pone.0164433	http://dx.doi.org/10.1371/journal.pone.0164433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716840	gold, Green Submitted, Green Published			2022-12-27	WOS:000385698100053
J	Abaigar, M; Robledo, C; Benito, R; Ramos, F; Diez-Campelo, M; Hermosin, L; Sanchez-del-Real, J; Alonso, JM; Cuello, R; Megido, M; Rodriguez, JN; Martin-Nunez, G; Aguilar, C; Vargas, M; Martin, AA; Garcia, JL; Kohlmann, A; del Canizo, MC; Hernandez-Rivas, JM				Abaigar, Maria; Robledo, Cristina; Benito, Rocio; Ramos, Fernando; Diez-Campelo, Maria; Hermosin, Lourdes; Sanchez-del-Real, Javier; Alonso, Jose M.; Cuello, Rebeca; Megido, Marta; Rodriguez, Juan N.; Martin-Nunez, Guillermo; Aguilar, Carlos; Vargas, Manuel; Martin, Ana A.; Garcia, Juan L.; Kohlmann, Alexander; Consuelo del Canizo, M.; Hernandez-Rivas, Jesus M.			Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CRYPTIC CHROMOSOMAL LESIONS; PROGNOSTIC SCORING SYSTEM; COPY NUMBER ALTERATIONS; ACUTE MYELOID-LEUKEMIA; SNP-ARRAY; MUTATIONS; HYBRIDIZATION; KARYOTYPE; REVEALS	To explore novel genetic abnormalities occurring in myelodysplastic syndromes (MDS) through an integrative study combining array-based comparative genomic hybridization (aCGH) and next-generation sequencing (NGS) in a series of MDS and MDS/ myeloproliferative neoplasms (MPN) patients. 301 patients diagnosed with MDS (n = 240) or MDS/ MPN (n = 61) were studied at the time of diagnosis. A genome-wide analysis of DNA copy number abnormalities was performed. In addition, a mutational analysis of DNMT3A, TET2, RUNX1, TP53 and BCOR genes was performed by NGS in selected cases. 285 abnormalities were identified in 71 patients (23.6%). Three high-risk MDS cases (1.2%) displayed chromothripsis involving exclusively chromosome 13 and affecting some cancer genes: FLT3, BRCA2 and RB1. All three cases carried TP53 mutations as revealed by NGS. Moreover, in the whole series, the integrative analysis of aCGH and NGS enabled the identification of cryptic recurrent deletions in 2p23.3 (DNMT3A; n = 2.8%), 4q24 (TET2; n = 10%) 17p13 (TP53; n = 8.5%), 21q22 (RUNX1; n = 7%), and Xp11.4 (BCOR; n = 2.8%), while mutations in the non-deleted allele where found only in DNMT3A (n = 1), TET2 (n = 3), and TP53 (n = 4). These cryptic abnormalities were detected mainly in patients with normal (45%) or non-informative (15%) karyotype by conventional cytogenetics, except for those with TP53 deletion and mutation (15%), which had a complex karyotype. In addition to well-known copy number defects, the presence of chromothripsis involving chromosome 13 was a novel recurrent change in high-risk MDS patients. Array CGH analysis revealed the presence of cryptic abnormalities in genomic regions where MDS-related genes, such as TET2, DNMT3A, RUNX1 and BCOR, are located.	[Abaigar, Maria; Robledo, Cristina; Benito, Rocio; Garcia, Juan L.; Hernandez-Rivas, Jesus M.] Ctr Invest Canc IBMCC USAL CSIC, Unidad Diagnost Mol & Celular Canc, Salamanca, Spain; [Ramos, Fernando] Univ Leon, Inst Biomed, IBIOMED, Leon, Spain; [Diez-Campelo, Maria; Sanchez-del-Real, Javier] Hosp Univ Leon, Serv Hematol, Leon, Spain; [Diez-Campelo, Maria; Martin, Ana A.; Consuelo del Canizo, M.; Hernandez-Rivas, Jesus M.] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain; [Hermosin, Lourdes] Hosp Jerez de la Frontera, Serv Hematol, Cadiz, Spain; [Alonso, Jose M.] Hosp Rio Carrion, Serv Hematol, Palencia, Spain; [Cuello, Rebeca] Hosp Clin Univ Valladolid, Serv Hematol, Valladolid, Spain; [Megido, Marta] Hosp Bierzo, Serv Hematol, Ponferrada, Spain; [Rodriguez, Juan N.] Hosp Juan Ramon Jimenez, Serv Hematol, Huelva, Spain; [Martin-Nunez, Guillermo] Hosp Virgen del Puerto, Serv Hematol, Plasencia, Spain; [Aguilar, Carlos] Hosp Gen Soria, Serv Hematol, Soria, Spain; [Vargas, Manuel] Hosp Comarcal Jarrio, Serv Hematol, Jarrio Coana, Spain; [Kohlmann, Alexander] AstraZeneca, Personalized Healthcare & Biomarkers, Innovat Med & Early Dev, Cambridge, England; [Consuelo del Canizo, M.; Hernandez-Rivas, Jesus M.] Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Universidad de Leon; Universidad de Leon; Hospital de Leon; University of Salamanca; Universidad de Valladolid; Hospital Juan Ramon Jimenez; AstraZeneca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Hernandez-Rivas, JM (corresponding author), Ctr Invest Canc IBMCC USAL CSIC, Unidad Diagnost Mol & Celular Canc, Salamanca, Spain.; Hernandez-Rivas, JM (corresponding author), Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain.; Hernandez-Rivas, JM (corresponding author), Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain.	jmhr@usal.es	BENITO, ROCIO/B-4271-2017; Ramos, Fernando/ACM-9938-2022; Alvarado, María Abáigar/V-9309-2017; Hernández, Jesus M/B-5459-2017; Robledo Montero, Cristina/B-4495-2017; garcia, Juan/B-4617-2017	BENITO, ROCIO/0000-0001-9781-4198; Alvarado, María Abáigar/0000-0002-5716-6242; Hernández, Jesus M/0000-0002-9661-9371; Robledo Montero, Cristina/0000-0003-0445-3210; garcia, Juan/0000-0002-2146-5726; Diez Campelo, Maria/0000-0003-0386-4835; Diez Campelo, Maria/0000-0002-1467-6779	Spanish Fondo de Investigaciones Sanitarias FIS [PI12/00281]; Proyectos de Investigacion del SACYL [BIO/SA47/13, BIO/SA52/14, GRS/874/A13, GRS 994/A/14]; COST Action "EuGESMA" [BM0801]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus) [CEI-2010-1-0010, RD12/0036/0069, RD12/0036/0029, RD12/0036/0044]; European Union Seventh Framework Programme [FP7] [306242-NGS-PTL]; Institute de Salud Carlos III (ISCIII); "Junta para Ampliacion de Estudios" fellowship of the Spanish National Research Council (Consejo Superior de Investigaciones Cientfficas, CSIC) [09-02402]; European Social Fund; Fundacion Espanola de Hematologia y Hemoterapia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER	Spanish Fondo de Investigaciones Sanitarias FIS(Instituto de Salud Carlos III); Proyectos de Investigacion del SACYL; COST Action "EuGESMA"(European Cooperation in Science and Technology (COST)); Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus); European Union Seventh Framework Programme [FP7]; Institute de Salud Carlos III (ISCIII); "Junta para Ampliacion de Estudios" fellowship of the Spanish National Research Council (Consejo Superior de Investigaciones Cientfficas, CSIC); European Social Fund(European Social Fund (ESF)); Fundacion Espanola de Hematologia y Hemoterapia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was partially supported by Grants from the Spanish Fondo de Investigaciones Sanitarias FIS (PI12/00281); Proyectos de Investigacion del SACYL (BIO/SA47/13; BIO/SA52/14; GRS/874/A13; GRS 994/A/14); COST Action "EuGESMA" (BM0801); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Institute de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus, CEI-2010-1-0010) (RD12/0036/0069; RD12/0036/0029; RD12/0036/0044); and the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no 306242-NGS-PTL. Mutation analyses were performed using oligonucleotide primer plates designed as part of the IRON-II collaborative network of hematological laboratories applying 454 amplicon next generation deep sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MA was supported by a "Junta para Ampliacion de Estudios" fellowship [09-02402] of the Spanish National Research Council (Consejo Superior de Investigaciones Cientfficas, CSIC), co-funded by the European Social Fund, and by a "Grant from Fundacion Espanola de Hematologia y Hemoterapia". AK is employed by AstraZeneca. The funders provided support in the form of salaries for these authors [MA, AK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors [MA, AK] are articulated in the 'author contributions' section.	Arenillas L, 2013, GENE CHROMOSOME CANC, V52, P1167, DOI 10.1002/gcc.22112; Bains A, 2011, AM J CLIN PATHOL, V135, P62, DOI 10.1309/AJCPEI9XU8PYBCIO; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Boeva V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072182; Cazzola M, 2013, BLOOD, V122, P4021, DOI 10.1182/blood-2013-09-381665; Coleman JF, 2011, AM J CLIN PATHOL, V135, P915, DOI 10.1309/AJCPW10YBRMWSWYE; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Edelmann J, 2012, BLOOD, V120, P4783, DOI 10.1182/blood-2012-04-423517; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Haferlach C, 2007, GENE CHROMOSOME CANC, V46, P494, DOI 10.1002/gcc.20433; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Heinrichs S, 2009, LEUKEMIA, V23, P1605, DOI 10.1038/leu.2009.82; Hirsch D, 2013, CANCER RES, V73, P1454, DOI 10.1158/0008-5472.CAN-12-0928; Jones MJK, 2012, DEV CELL, V23, P908, DOI 10.1016/j.devcel.2012.10.010; Klein HU, 2011, BIOINFORMATICS, V27, P1162, DOI 10.1093/bioinformatics/btr102; Kloosterman WP, 2014, CURR OPIN ONCOL, V26, P64, DOI 10.1097/CCO.0000000000000038; Kloosterman WP, 2013, CURR OPIN CELL BIOL, V25, P341, DOI 10.1016/j.ceb.2013.02.008; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kohlmann A, 2011, LEUKEMIA, V25, P1840, DOI 10.1038/leu.2011.155; Kolquist KA, 2011, CANCER GENET-NY, V204, P603, DOI 10.1016/j.cancergen.2011.10.004; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Lee H, 2014, EXP CELL RES, V329, P78, DOI 10.1016/j.yexcr.2014.10.008; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li YL, 2014, NATURE, V508, P98, DOI 10.1038/nature13115; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; MacKinnon RN, 2013, CANCER GENET-NY, V206, P238, DOI 10.1016/j.cancergen.2013.05.021; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Maher CA, 2012, CELL, V148, P29, DOI 10.1016/j.cell.2012.01.006; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Mallo M, 2011, LEUKEMIA, V25, P110, DOI 10.1038/leu.2010.231; Mardin BR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156505; Martinez-Ramirez A, 2005, GENE CHROMOSOME CANC, V42, P287, DOI 10.1002/gcc.20154; Merkerova MD, 2012, GENE CHROMOSOME CANC, V51, P419, DOI 10.1002/gcc.21927; Meyerson M, 2011, CELL, V144, P9, DOI 10.1016/j.cell.2010.12.025; Nagel S, 2013, GENE CHROMOSOME CANC, V52, P741, DOI 10.1002/gcc.22069; O'Keefe CL, 2007, EXP HEMATOL, V35, P240, DOI 10.1016/j.exphem.2006.09.016; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Robledo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024939; SHAFFER LG, 2013, ISCN 2013 INT SYSTEM, P140; Slovak ML, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-23; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Such E, 2013, BLOOD, V121, P3005, DOI 10.1182/blood-2012-08-452938; Such E, 2011, HAEMATOL-HEMATOL J, V96, P375, DOI 10.3324/haematol.2010.030957; Suela J, 2007, CYTOGENET GENOME RES, V118, P304, DOI 10.1159/000108314; Thiel A, 2011, LEUKEMIA, V25, P387, DOI 10.1038/leu.2010.293; Tiu RV, 2011, BLOOD, V117, P4552, DOI 10.1182/blood-2010-07-295857; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Zemanova Z, 2014, LEUKEMIA RES, V38, P537, DOI 10.1016/j.leukres.2014.01.012; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	53	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164370	10.1371/journal.pone.0164370	http://dx.doi.org/10.1371/journal.pone.0164370			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741277	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000028
J	Park, YH; Kim, JY; Yi, S; Lim, JS; Jang, JW; Im, CH; Kim, S				Park, Young Ho; Kim, Jeong-Youn; Yi, SangHak; Lim, Jae-Sung; Jang, Jae-Won; Im, Chang-Hwan; Kim, SangYun			Transient Global Amnesia Deteriorates the Network Efficiency of the Theta Band	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; WORKING-MEMORY; BRAIN NETWORKS; SMALL-WORLD; SYNCHRONIZATION; EEG; BONFERRONI; CORTEX; RHYTHM	Acute perturbation of the hippocampus, one of the connector hubs in the brain, is a key step in the pathophysiological cascade of transient global amnesia (TGA). We tested the hypothesis that network efficiency, meaning the efficiency of information exchange over a network, is impaired during the acute stage of TGA. Graph theoretical analysis was applied to resting-state EEG data collected from 21 patients with TGA. The EEG data were obtained twice, once during the acute stage (< 24 hours after symptom onset) and once during the resolved stage (> 2 months after symptom onset) of TGA. Characteristic path lengths and clustering coefficients of functional networks constructed using phase-locking values were computed and normalized as a function of the degree in the delta, theta, alpha, beta 1, beta 2 and gamma frequency bands of the EEG. We investigated whether the normalized characteristic path length (nCPL) and normalized clustering coefficients (nCC) differed significantly between the acute and resolved stages of TGA at each frequency band using the Wilcoxon signed-rank test. For networks where the nCPL or nCC differed significantly between the two stages, we also evaluated changes in the connections of the brain networks. During the acute stage of TGA, the nCPL of the theta band networks with mean degrees of 8, 8.5, 9 and 9.5 significantly increased (P < 0.05). During the acute stage, the lost edges for these networks were mostly found between the anterior (frontal and anterior temporal) and posterior (parieto-occipital and posterior temporal) brain regions, whereas newly developed edges were primarily found between the left and right frontotemporal regions. The nCC of the theta band with a mean degree of 5.5 significantly decreased during the acute stage (P < 0.05). Our results indicate that TGA deteriorates the network efficiency of the theta frequency band. This effect might be related to the desynchronization between the anterior and posterior brain areas.	[Park, Young Ho; Yi, SangHak; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seoul, South Korea; [Park, Young Ho; Yi, SangHak; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Seoul, South Korea; [Kim, Jeong-Youn; Im, Chang-Hwan] Hanyang Univ, Dept Biomed Engn, Seoul, South Korea; [Lim, Jae-Sung] Seoul Natl Univ, Boramae Hosp, Dept Neurol, Seoul, South Korea; [Jang, Jae-Won] Kangwon Natl Univ Hosp, Dept Neurol, Chunchon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Kangwon National University; Kangwon National University Hospital	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seoul, South Korea.; Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Seoul, South Korea.; Im, CH (corresponding author), Hanyang Univ, Dept Biomed Engn, Seoul, South Korea.	ich@hanyang.ac.kr; neuroksy@snu.ac.kr	Lim, Jae-Sung/D-5555-2012; Im, Chang-Hwan/ABB-4391-2021	Lim, Jae-Sung/0000-0001-6157-2908; Yi, SangHak/0000-0002-2701-9807; Im, Chang-Hwan/0000-0003-3795-3318				Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Babiloni C, 2016, INT J PSYCHOPHYSIOL, V103, P88, DOI 10.1016/j.ijpsycho.2015.02.008; Bartsch T, 2006, BRAIN, V129, P2874, DOI 10.1093/brain/awl248; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Christensen K. J., 1991, PSYCHOL ASSESSMENT J, V3, P168, DOI [10.1037/1040-3590.3.2.168, DOI 10.1037/1040-3590.3.2.168]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Fell J, 2003, EUR J NEUROSCI, V17, P1082, DOI 10.1046/j.1460-9568.2003.02522.x; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Joudaki Amir, 2012, PLoS One, V7, pe35673, DOI 10.1371/journal.pone.0035673; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Nishida K, 2013, CLIN NEUROPHYSIOL, V124, P1106, DOI 10.1016/j.clinph.2013.01.005; Park YH, 2016, CLIN EEG NEUROSCI, V47, P69, DOI 10.1177/1550059414543684; Park YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067447; Peer M, 2014, ANN NEUROL, V75, P634, DOI 10.1002/ana.24137; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pikovsky A, 2003, SYNCHRONIZATION, DOI [10.4249/scholarpedia.1459, DOI 10.4249/SCHOLARPEDIA.1459]; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Ryoo I, 2012, NEURORADIOLOGY, V54, P329, DOI 10.1007/s00234-011-0889-4; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Storti SF, 2016, CLIN EEG NEUROSCI, V47, P276, DOI 10.1177/1550059415598905; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zimmerman DW, 1997, J EDUC BEHAV STAT, V22, P349, DOI 10.3102/10769986022003349	38	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164884	10.1371/journal.pone.0164884	http://dx.doi.org/10.1371/journal.pone.0164884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741293	Green Submitted, Green Published, gold			2022-12-27	WOS:000385507000079
J	Sackey-Aboagye, B; Olsen, AL; Mukherjee, SM; Ventriglia, A; Yokosaki, Y; Greenbaum, LE; Lee, GY; Naga, H; Wells, RG				Sackey-Aboagye, Bridget; Olsen, Abby L.; Mukherjee, Sarmistha M.; Ventriglia, Alexander; Yokosaki, Yasuyuki; Greenbaum, Linda E.; Lee, Gi Yun; Naga, Hani; Wells, Rebecca G.			Fibronectin Extra Domain A Promotes Liver Sinusoid Repair following Hepatectomy	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; STELLATE CELLS; EIIIA SEGMENT; REGENERATION; EXPRESSION; RAT; INTEGRIN; ANGIOGENESIS; FIBROSIS	Liver sinusoidal endothelial cells (LSECs) are the main endothelial cells in the liver and are important for maintaining liver homeostasis as well as responding to injury. LSECs express cellular fibronectin containing the alternatively spliced extra domain A (EIIIA-cFN) and increase expression of this isoform after liver injury, although its function is not well understood. Here, we examined the role of EIIIA-cFN in liver regeneration following partial hepatectomy. We carried out two-thirds partial hepatectomies in mice lacking EIIIA-cFN and in their wild type littermates, studied liver endothelial cell adhesion on decellularized, EIIIA-cFN- containing matrices and investigated the role of cellular fibronectins in liver endothelial cell tubulogenesis. We found that liver weight recovery following hepatectomy was significantly delayed and that sinusoidal repair was impaired in EIIIA-cFN null mice, especially females, as was the lipid accumulation typical of the post-hepatectomy liver. In vitro, we found that liver endothelial cells were more adhesive to cell-deposited matrices containing the EIIIA domain and that cellular fibronectin enhanced tubulogenesis and vascular cord formation. The integrin alpha(9)beta(1), which specifically binds EIIIA-cFN, promoted tubulogenesis and adhesion of liver endothelial cells to EIIIA-cFN. Our findings identify a role for EIIIA-cFN in liver regeneration and tubulogenesis. We suggest that sinusoidal repair is enhanced by increased LSEC adhesion, which is mediated by EIIIA-cFN.	[Sackey-Aboagye, Bridget; Wells, Rebecca G.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Sackey-Aboagye, Bridget; Olsen, Abby L.; Wells, Rebecca G.] Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Mukherjee, Sarmistha M.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Ventriglia, Alexander; Lee, Gi Yun] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Yokosaki, Yasuyuki] Hiroshima Univ, Hiroshima, Japan; [Greenbaum, Linda E.] Janssen R&D LLC, Spring House, PA USA; [Naga, Hani] Univ Penn, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Hiroshima University; Johnson & Johnson; Janssen Pharmaceuticals; University of Pennsylvania	Wells, RG (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.; Wells, RG (corresponding author), Univ Penn, Perelman Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA.	rgwells@mail.med.upenn.edu	Olsen, Abby/AAJ-7345-2021	Olsen, Abby L./0000-0002-7680-1758	National Institutes of Health [R01 DK085123, F30 DK081265]; National Institute of Diabetes and Digestive and Kidney Diseases [DK066028]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058123, P30DK050306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R01 DK085123 to RGW and F30 DK081265 to ALO, and National Institute of Diabetes and Digestive and Kidney Diseases DK066028 (supported GYL, HN, and AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte U, 2009, HEPATOLOGY, V50, P844, DOI 10.1002/hep.23059; Astrof S, 2004, MOL CELL BIOL, V24, P8662, DOI 10.1128/MCB.24.19.8662-8670.2004; Augustus AS, 2003, AM J PHYSIOL-ENDOC M, V284, pE331, DOI 10.1152/ajpendo.00298.2002; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Beacham DA, 2007, CURR PROTOC CELL BIO, DOI [10.1002/1007/978-1-59745-413-1_19, DOI 10.1002/1007/978-1-59745-413-1_19]; Booth AJ, 2012, J PATHOL, V226, P609, DOI 10.1002/path.3010; Braet F, 2007, MICROSC RES TECHNIQ, V70, P230, DOI 10.1002/jemt.20408; CAPUTI M, 1995, NUCLEIC ACIDS RES, V23, P238, DOI 10.1093/nar/23.2.238; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; CLARK RAF, 1990, J INVEST DERMATOL, V94, pS128, DOI 10.1111/1523-1747.ep12876104; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Damianova R, 2008, CELL BIOL INT, V32, P229, DOI 10.1016/j.cellbi.2007.08.029; DAVIS GE, 1995, EXP CELL RES, V216, P113, DOI 10.1006/excr.1995.1015; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Farrell GC, 2004, HEPATOLOGY, V40, P1252, DOI 10.1002/hep.20522; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; FFRENCHCONSTANT C, 1989, DEVELOPMENT, V106, P375; Hammond JS, 2011, J HEPATOL, V54, P279, DOI 10.1016/j.jhep.2010.06.040; Hellerbrand C, 2013, PFLUG ARCH EUR J PHY, V465, P775, DOI 10.1007/s00424-012-1209-5; Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; Kim TH, 1997, HEPATOLOGY, V26, P896, DOI 10.1002/hep.510260415; Kosmehl H, 1999, BRIT J CANCER, V81, P1071, DOI 10.1038/sj.bjc.6690809; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Nieto N, 2006, HEPATOLOGY, V44, P1487, DOI 10.1002/hep.21427; Nishimichi N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13756; ODENTHAL M, 1993, BIOCHIM BIOPHYS ACTA, V1181, P266, DOI 10.1016/0925-4439(93)90031-U; Ohtani O, 2008, ANAT REC, V291, P643, DOI 10.1002/ar.20681; Olafsen T, 2010, J BIOL CHEM, V285, P39239, DOI 10.1074/jbc.M110.171041; Olsen AL, 2012, GASTROENTEROLOGY, V142, P928, DOI 10.1053/j.gastro.2011.12.038; Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; Tan MH, 2004, BLOOD, V104, P11, DOI 10.1182/blood-2003-09-3363; TSUKAMOTO I, 1990, BIOCHIM BIOPHYS ACTA, V1033, P287, DOI 10.1016/0304-4165(90)90135-J; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; XIA P, 1995, EXP CELL RES, V217, P517, DOI 10.1006/excr.1995.1117	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							0163737	10.1371/journal.pone.0163737	http://dx.doi.org/10.1371/journal.pone.0163737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741254	gold, Green Submitted, Green Published			2022-12-27	WOS:000385507000005
J	Zhang, ZC; Xu, QN; Lin, SL; Li, XY				Zhang, Ze-Chun; Xu, Qi-Ni; Lin, Sui-Ling; Li, Xu-Yuan			Capecitabine in Combination with Standard (Neo)Adjuvant Regimens in Early Breast Cancer: Survival Outcome from a Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; PACLITAXEL; EFFICACY; THERAPY; PHASE-3	Capecitabine has been investigated in early breast cancer in several studies, but it was undefined that whether it could improve survival. To investigate whether the addition of capecitabine affected survival in patients with early breast cancer, a meta-analysis was conducted and overall survival (OS), disease-free survival (DFS), and toxicity were assessed. The PubMed, Embase databases and the Cochrane Central Register of Controlled Trials were searched for studies between January 2006 and April 2016. Hazard ratios (HRs) with their 95% confidence intervals (CIs), or data for calculating HRs with 95% CI were derived. Seven trials with 9097 patients, consisted of 4 adjuvant and 3 neoadjuvant studies, were included in this meta-analysis. Adding capecitabine showed no improvement in DFS (HR = 0.93; 95% CI, 0.85-1.02; P = 0.12), whereas a significant improvement in OS was observed (HR = 0.85; 95% CI, 0.75-0.96; P = 0.008). A sub-analysis of DFS showed that benefit of capecitabine derived from patients with triple negative subtype and with extensive axillary involvement. Safety profiles were consistent with the known side-effects of capecitabine, but more patients discontinued scheduled treatment in the capecitabine group. Combining capecitabine with standard (neo)adjuvant regimens in early breast cancer demonstrated a significantly superior OS, and indicated DFS improvement in some subtypes with high risk of recurrence. Selection of subtypes was a key to identify patients who might gain survival benefit from capecitabine.	[Zhang, Ze-Chun] Sun Yat Sen Univ, Dept Diag, Shantou, Guangdong, Peoples R China; [Zhang, Ze-Chun] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Treatment Ctr Breast Dis, Shantou, Guangdong, Peoples R China; [Xu, Qi-Ni] Shantou Univ, Canc Hosp, Coll Med, Dept Resp Med Oncol, Shantou, Guangdong, Peoples R China; [Lin, Sui-Ling] Shantou Univ, Canc Hosp, Coll Med, Dept Prevent & Hlth Care, Shantou, Guangdong, Peoples R China; [Li, Xu-Yuan] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Dept Med Oncol, Shantou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Shantou University; Shantou University; Sun Yat Sen University	Li, XY (corresponding author), Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Dept Med Oncol, Shantou, Guangdong, Peoples R China.	lxuyuan@qq.com						Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Alagizy H A, 2015, Hematol Oncol Stem Cell Ther, V8, P22, DOI 10.1016/j.hemonc.2014.11.003; Bear HD, 2015, LANCET ONCOL, V16, P1037, DOI 10.1016/S1470-2045(15)00041-8; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Jiang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032474; Joensuu H, 2014, ACTA ONCOL, V53, P186, DOI 10.3109/0284186X.2013.820840; Joensuu H, 2012, J CLIN ONCOL, V30, P11, DOI 10.1200/JCO.2011.35.4639; Joensuu H, 2009, LANCET ONCOL, V10, P1145, DOI 10.1016/S1470-2045(09)70307-9; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; Martin M, 2008, JNCI-J NATL CANCER I, V100, P805, DOI 10.1093/jnci/djn151; Martin M, 2015, J CLIN ONCOL, V33, P3788, DOI 10.1200/JCO.2015.61.9510; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Muss HB, 2009, NEW ENGL J MED, V360, P2055, DOI 10.1056/NEJMoa0810266; O'Shaughnessy J, 2002, J CLIN ONCOL, V20, P2812, DOI 10.1200/JCO.2002.09.002; O'Shaughnessy J, 2015, CLIN CANCER RES, V21, P4305, DOI 10.1158/1078-0432.CCR-15-0636; Ohno S, 2013, BREAST CANCER RES TR, V142, P69, DOI 10.1007/s10549-013-2691-y; Smith JW, 2016, CLIN BREAST CANCER, V16, P31, DOI 10.1016/j.clbc.2015.07.007; Steger GG, 2014, ANN ONCOL, V25, P366, DOI 10.1093/annonc/mdt508; Toi M, 2015, SAN ANT BREAST CANC, pS1; von Minckwitz G, 2014, ANN ONCOL, V25, P81, DOI 10.1093/annonc/mdt410; von Minckwitz G, 2008, JNCI-J NATL CANCER I, V100, P542, DOI 10.1093/jnci/djn085; von Minckwitz G, 2015, CANCER-AM CANCER SOC, V121, P3639, DOI 10.1002/cncr.29506; Wang YQ, 2012, CURR MED RES OPIN, V28, P1911, DOI 10.1185/03007995.2012.748655; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Yoo C, 2015, CANCER RES TREAT, V47, P406, DOI 10.4143/crt.2014.073; Zhang XH, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0686-8; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164663	10.1371/journal.pone.0164663	http://dx.doi.org/10.1371/journal.pone.0164663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741288	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000053
J	Flower, A				Flower, Aquila			Three Centuries of Synchronous Forest Defoliator Outbreaks in Western North America	PLOS ONE			English	Article							SPRUCE BUDWORM OUTBREAKS; CHORISTONEURA-OCCIDENTALIS LEPIDOPTERA; SPATIAL SYNCHRONY; POPULATION-DYNAMICS; DOUGLAS-FIR; WATER-STRESS; MULTICENTURY; TORTRICIDAE; DISPERSAL; RECONSTRUCTION	Insect outbreaks often occur synchronously across large spatial scales, but the long-term temporal stability of the phenomenon and the mechanisms behind it are not well understood. In this study, I use a widespread lepidopteran defoliator native to western North America-the western spruce budworm-as a case study to explore patterns of and potential causes for synchronous population fluctuations. Analyses of synchrony are typically severely limited by the short historical records available for many species. To overcome this limitation, I compiled multi-century dendrochronological reconstructions of western spruce budworm outbreaks from across much of the species' range. This allowed me to analyze synchrony at a sub-continental spatial scale over the last three centuries. I found statistically significant synchrony among regional outbreak records up to 2,000 km apart and identified numerous outbreak periods that occurred synchronously across much of the species' range. I quantified spatial and temporal associations between climate and synchronous outbreak periods using paleoclimate reconstructions. The spatial patterns of outbreak histories and climate records were remarkably similar, with higher similarity in outbreak histories apparent between regions with more similar climate conditions. Synchronous outbreaks typically occurred during periods of average or above average moisture availability preceded by periods of low moisture availability. My results suggest that climatic variability has played a key role in synchronizing western spruce budworm population fluctuations in disjunct forests across western North America for at least the last three centuries. Widespread synchrony appears to be a natural part of this species' population dynamics, though synchronous outbreaks have occurred more frequently during the 20th century than during prior centuries. This study uses a novel combination of statistical methods and dendrochronological data to provide analyses of this species' population dynamics with an unprecedented combination of spatial extent and temporal depth.	[Flower, Aquila] Western Washington Univ, Huxley Coll Environm, Dept Environm Studies, Bellingham, WA 98225 USA	Western Washington University	Flower, A (corresponding author), Western Washington Univ, Huxley Coll Environm, Dept Environm Studies, Bellingham, WA 98225 USA.	Aquila.Flower@wwu.edu			United States Department of Agriculture Joint Fire Science Program [09-1-06-5]; Rocky Mountain Research Station, Forest Service, U.S. Department of Agriculture [09-JV-11221637]; University of Oregon; Western Washington University	United States Department of Agriculture Joint Fire Science Program; Rocky Mountain Research Station, Forest Service, U.S. Department of Agriculture(United States Department of Agriculture (USDA)United States Forest Service); University of Oregon; Western Washington University	My research was supported in part by funds provided by the United States Department of Agriculture Joint Fire Science Program as Project 09-1-06-5, the Rocky Mountain Research Station, Forest Service, U.S. Department of Agriculture under Research Joint Venture Agreement 09-JV-11221637; by the University of Oregon; and by Western Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KC, 2007, OIKOS, V116, P903, DOI 10.1111/j.0030-1299.2007.15856.x; ALFARO RI, 1982, CAN J FOREST RES, V12, P780, DOI 10.1139/x82-117; Axelson JN, 2015, FOREST ECOL MANAG, V335, P235, DOI 10.1016/j.foreco.2014.10.002; Bjornstad ON, 2013, NCF SPATIAL NONPARAM, V1, P1; Brown DP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018726; Buonaccorsi JP, 2001, ECOLOGY, V82, P1668, DOI 10.2307/2679809; Campbell R, 2006, CAN J FOREST RES, V36, P1758, DOI 10.1139/X06-069; CAMPBELL RW, 1993, US FOR SERV R P PNW, pU1; Cattaneo F, 2003, OIKOS, V100, P43, DOI 10.1034/j.1600-0706.2003.11912.x; CLANCY KM, 1991, FOREST ECOL MANAG, V39, P223, DOI 10.1016/0378-1127(91)90178-X; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Cooke Barry J., 2007, P487; Eberhart-Phillips LJ, 2016, BIRD CONSERV INT, V26, P119, DOI 10.1017/S0959270914000379; Ellis T., 2016, THESIS; Fellin DG, 1982, W SPRUCE BUDWORM, P9; Flower A, 2014, FOREST ECOL MANAG, V324, P16, DOI 10.1016/j.foreco.2014.03.042; Flower A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114282; Gavin D.G., 2010, K1D MULTIVARIATE RIP; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; GOWER ST, 1992, ECOL MONOGR, V62, P43, DOI 10.2307/2937170; GREENBANK DO, 1980, MEM ENTOMOL SOC CAN, P1, DOI 10.4039/entm112110fv; Grissino-Mayer H.D., 2001, TREE RES, V57, P115; Hard JS, 1980, W SPRUCE BUDWORM DEF, P26; Haynes KJ, 2009, ECOLOGY, V90, P2974, DOI 10.1890/08-1709.1; Hofacker TH, 1986, FOREST INSECT DIS CO; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Hudson PJ, 1999, TRENDS ECOL EVOL, V14, P1, DOI 10.1016/S0169-5347(98)01498-0; IMS RA, 1990, OIKOS, V57, P381, DOI 10.2307/3565968; Keane Robert E., 2002, CASCADING EFFECTS FI; Kendall BE, 2000, AM NAT, V155, P628, DOI 10.1086/303350; Koenig WD, 2002, ECOGRAPHY, V25, P283, DOI 10.1034/j.1600-0587.2002.250304.x; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Liebhold AM, 2006, POPUL ECOL, V48, P131, DOI 10.1007/s10144-005-0248-6; Little Jr E. L., 1971, ATLAS US TREES, V1; Lynch AM, 2012, WHAT TREE RING RECON, P126; Martinat PJ, 1987, ROLE CLIMATIC VARIAT, P241; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Mody K, 2009, ECOL ENTOMOL, V34, P133, DOI 10.1111/j.1365-2311.2008.01053.x; Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI DOI 10.4135/9781412983532; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; Paradis E, 2000, ECOLOGY, V81, P2112, DOI 10.1890/0012-9658(2000)081[2112:SSIPOB]2.0.CO;2; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; Post E, 2003, ECOLOGY, V84, P277, DOI 10.1890/0012-9658(2003)084[0277:LSCSTT]2.0.CO;2; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Ranta E, 1998, OIKOS, V83, P376, DOI 10.2307/3546852; ROYAMA T, 1984, ECOL MONOGR, V54, P429, DOI 10.2307/1942595; Ryerson DE, 2003, CAN J FOREST RES, V33, P1010, DOI 10.1139/X03-026; SANDERS CJ, 1978, CAN ENTOMOL, V110, P627, DOI 10.4039/Ent110627-6; SPERLING FAH, 1994, MOL BIOL EVOL, V11, P656; St George S., 2010, HOLOCENE, V20, P983, DOI [10.1177/0959683610365937, DOI 10.1177/0959683610365937]; Sutherland, 1985, AGR HDB, V639; Swanson BJ, 1999, OIKOS, V86, P265, DOI 10.2307/3546444; Swetnam T.W., 1995, HIST PATTERNS W SPRU; SWETNAM TW, 1993, ECOL MONOGR, V63, P399, DOI 10.2307/2937153; THOMSON AJ, 1984, CAN ENTOMOL, V116, P375, DOI 10.4039/Ent116375-3; Vasseur DA, 2009, NATURE, V460, P1007, DOI 10.1038/nature08208; WILLHITE EA, 1983, CAN ENTOMOL, V115, P41, DOI 10.4039/Ent11541-1; Wise EK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042193; Wulf W.N., 1987, W SPRUCE BUDWORM, P89	60	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164737	10.1371/journal.pone.0164737	http://dx.doi.org/10.1371/journal.pone.0164737			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737003	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505800124
J	Poot, AJ; Caljouw, MAA; de Waard, CS; Wind, AW; Gussekloo, J				Poot, Antonius J.; Caljouw, Monique A. A.; de Waard, Claudia S.; Wind, Annet W.; Gussekloo, Jacobijn			Satisfaction in Older Persons and General Practitioners during the Implementation of Integrated Care	PLOS ONE			English	Article							IMPROVING PRIMARY-CARE; HEALTH-CARE; SERVICES; ILLNESS; MODEL	Background Integrated care for older persons with complex care needs is widely advocated. Particularly professionals and policy makers have positive expectations. Care outcome results are ambiguous. Receiver and provider satisfaction is relevant but still poorly understood. Methods During implementation of integrated care in residential homes (The MOVIT project), we compared general satisfaction and satisfaction with specific aspects of General Practitioner (GP) care in older persons and GPs before (cohort I) and after at least 12 months of implementation (cohort II). Results The general satisfaction score for GP care given by older persons does not change (Cohort I (n = 762) mean score 8.0 (IQR: 7.0-9.0) vs. Cohort II (n = 505) mean score 8.0 (IQR: 7.0-8.0); P = 0.01). Expressions of general satisfaction in GPs do not show consistent change (Cohort I (n = 87) vs Cohort II (n = 66), percentage satisfied about; role as GP, 56% vs 67%; P = 0.194, ability to provide personal care, 60% vs 67%; P = 0.038, quality of care, 54% vs 62%; P = 0.316). Satisfaction in older persons about some specific aspects of care do show change; GP-patient relationship, points 61.6 vs 63.3; P = 0.001, willingness to talk about mistakes, score 3.47 vs 3.73; P = 0.001, information received about drugs, score 2.79 vs 2.46; P = 0.002. GPs also report changes in specific aspects: percentage satisfied about multidisciplinary meetings; occurrence, 21% vs 53%; P = <0.001, GP presence, 12% vs 41%; P = <0.001, and participation, 29% vs. 51%; P = 0.046. Conclusion General satisfaction about care received and provided shows no consistent change in older persons and GPs during the implementation of integrated care. Specific changes in satisfaction are found. These show an emphasis on inter-personal aspects in older persons and organizational aspects in GPs.	[Poot, Antonius J.; Caljouw, Monique A. A.; de Waard, Claudia S.; Wind, Annet W.; Gussekloo, Jacobijn] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Poot, AJ (corresponding author), Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands.	a.j.poot@lumc.nl	Gussekloo, Jacobijn/ABE-3879-2021	Gussekloo, Jacobijn/0000-0001-7186-8278; Caljouw, Monique A.A./0000-0002-2550-530X	ZonMw; Dutch Organization for Health Research, the Netherlands [311060401]	ZonMw(Netherlands Organization for Health Research and Development); Dutch Organization for Health Research, the Netherlands	This work was supported by a grant received from ZonMw, the Dutch Organization for Health Research, the Netherlands (Project: 311060401), http://www.zonmw.nl (AJP, MAAC, CSdeW, AWW, JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NATL CARE ELDERLY PR; Bastiaens H, 2007, PATIENT EDUC COUNS, V68, P33, DOI 10.1016/j.pec.2007.03.025; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Boorsma M, 2011, CAN MED ASSOC J, V183, pE724, DOI 10.1503/cmaj.101498; Caljouw MAA, 2008, BRIT J ANAESTH, V100, P637, DOI 10.1093/bja/aen034; Callahan CM, 2015, J AM GERIATR SOC, V63, P1938, DOI 10.1111/jgs.13599; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Davy C, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0319-5; Dijkstra A, 2005, J ADV NURS, V50, P410, DOI 10.1111/j.1365-2648.2005.03406.x; Dijkstra A, 2000, J ADV NURS, V31, P944, DOI 10.1046/j.1365-2648.2000.01354.x; Haggerty JL, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5915; Jager E, 2014, HUISARTS WETENSCHAP; Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335; Kadam U, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6202; Kane RL, 2015, J AM GERIATR SOC, V63, P1940, DOI 10.1111/jgs.1_13599; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; MacNeil Vroomen Janet L, 2012, PLoS One, V7, pe37444, DOI 10.1371/journal.pone.0037444; Makai P, 2015, EUR J HEALTH ECON, V16, P437, DOI 10.1007/s10198-014-0583-7; Metzelthin SF, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5264; Minkman M M N, 2005, Int J Integr Care, V5, pe14; Minkman M, 2009, INT J QUAL HEALTH C, V21, P66, DOI 10.1093/intqhc/mzn048; NIVEL Centrum Klantervaring Zorg, 2010, CQ IND HUIS OV VERS; Oliver D., 2014, MAKING OUR HLTH CARE; Poot AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094326; Salisbury C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5004; Wagner E H, 2001, Jt Comm J Qual Improv, V27, P63; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1994	28	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164536	10.1371/journal.pone.0164536	http://dx.doi.org/10.1371/journal.pone.0164536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27737012	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800081
J	Lycan, TW; Pardee, TS; Petty, WJ; Bonomi, M; Alistar, A; Lamar, ZS; Isom, S; Chan, MD; Miller, AA; Ruiz, J				Lycan, Thomas W.; Pardee, Timothy S.; Petty, William J.; Bonomi, Marcelo; Alistar, Angela; Lamar, Zanetta S.; Isom, Scott; Chan, Michael D.; Miller, Antonius A.; Ruiz, Jimmy			A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma	PLOS ONE			English	Article							CANCER; METABOLISM; TOPOTECAN	Background Small cell lung cancer (SCLC) is a common lung cancer which presents with extensive stage disease at time of diagnosis in two-thirds of patients. For treatment of advanced disease, traditional platinum doublet chemotherapy induces response rates up to 80% but with few durable responses. CPI-613 is a novel anti-cancer agent that selectively inhibits the altered form of mitochondrial energy metabolism in tumor cells. Methods We evaluated CPI-613 with a single-arm, open-label phase II study in patients with relapsed or refractory SCLC. CPI-613 was given at a dose of 3,000 mg/m2 on days 1 and 4 of weeks 1-3 of 4 week cycle. The primary outcome was response rate as assessed by CT imaging using RECIST v1.1 criteria. Secondary outcomes were progression-free survival (PFS), overall survival (OS), and toxicity. Twelve patients were accrued (median age 57yo) who had previously received between 1 and 4 lines of chemotherapy (median 1) for SCLC with a treatment-free interval of less than 60 days in 9 of the 12 patients. Results No complete or partial responses were seen. Ten patients (83%) progressed as best response and 2 (17%) were not evaluable for response. Median time to progression was 1.7 months (range 0.7 to 1.8 months). Eleven patients (92%) died with median overall survival of 4.3 months (range 1.2 to 18.2 months). The study was closed early due to lack of efficacy. Of note, three out of three patients who progressed after CPI-613 and were subsequently treated with standard topotecan then demonstrated treatment response with survival for 18.2, 7.4, and 5.1 months. We conducted laboratory studies which found synergy in-vitro for CPI-613 with topotecan. Conclusions Single agent CPI-613 had no efficacy in this study. Further study of CPI 613 in combination with a topoisomerase inhibitor is warranted.	[Lycan, Thomas W.; Pardee, Timothy S.; Petty, William J.; Bonomi, Marcelo; Alistar, Angela; Lamar, Zanetta S.; Miller, Antonius A.; Ruiz, Jimmy] Wake Forest Sch Med, Dept Med, Sect Hematol & Oncol, Winston Salem, NC 27101 USA; [Isom, Scott] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Chan, Michael D.] Wake Forest Sch Med, Dept Radiat Oncol, Winston Salem, NC USA; [Ruiz, Jimmy] WG Bill Hefner Veteran Adm Med Ctr, Ctr Canc, Salisbury, NC USA	Wake Forest University; Wake Forest University; Wake Forest University	Lycan, TW (corresponding author), Wake Forest Sch Med, Dept Med, Sect Hematol & Oncol, Winston Salem, NC 27101 USA.	TLycan@wakehealth.edu	Lycan, Thomas/S-3889-2016	Lycan, Thomas/0000-0001-9475-1558; Pardee, Timothy/0000-0002-1186-6948	Wake Forest Baptist Comprehensive Cancer Center's NCI Cancer Center [P30CA012197]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA197991] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001421] Funding Source: NIH RePORTER	Wake Forest Baptist Comprehensive Cancer Center's NCI Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The research was supported by the Wake Forest Baptist Comprehensive Cancer Center's NCI Cancer Center Support Grant P30CA012197. JR received the funding.	Alistar A, 2016, SESS B CANC PANC SMA; Bedell C., 2012, CASE STUDY CASE REP, V2, P38; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Lee K, 2011, CASE STUD CASE REP, V1, P137; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; Pardee T, 2015, AM SOC HEM 57 ANN M; Pardee TS, 2014, CLIN CANCER RES, V20, P5255, DOI 10.1158/1078-0432.CCR-14-1019; Retter A., 2012, GEN POST SESS DEV TH; SMITH IE, 1987, J CLIN ONCOL, V5, P185, DOI 10.1200/JCO.1987.5.2.185; von Pawel J, 1999, J CLIN ONCOL, V17, P658, DOI 10.1200/JCO.1999.17.2.658; Zachar Z, 2011, J MOL MED, V89, P1137, DOI 10.1007/s00109-011-0785-8	13	35	37	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164244	10.1371/journal.pone.0164244	http://dx.doi.org/10.1371/journal.pone.0164244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732654	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300043
J	Nimbalkar, SM; Patel, DV; Phatak, AG				Nimbalkar, Somashekhar Marutirao; Patel, Dipen Vasudev; Phatak, Ajay Gajanan			Are Parents of Preschool Children Inclined to Give Consent for Participation in Nutritional Clinical Trials?	PLOS ONE			English	Article							DECISION	Objective Micronutrient deficiencies can lead to anemia, growth restriction, and poor motor and cognitive development. A clinical trial was planned to assess the impact of nutritional supplementation on cognitive measures in preschool children. Conducting clinical trials in children is difficult due to underlying laws, hesitation of the research community, and difficult enrollment. We carried out a questionnaire-based feasibility survey to assess the interest of parents towards participation in such a nutrition-based study. Methods After approval from the Institutional Human Research Ethics Committee, the principals of four kindergarten schools at Vallabh Vidyanagar, Anand, Gujarat, India consented to participate. Children at the participating schools were distributed a consent form and pre-tested questionnaire, to be taken home for parents to sign, fill and return. Results Out of a total of 1049 consent forms and questionnaires distributed, 602 (57.39%) signed and filled forms were returned. Despite fair awareness regarding the need of research, parents' willingness to involve their children in a 6 month duration research study, not requiring invasive measures like blood pricks, was 180 (29.9%). Nearly half (250, 41.5%) did not respond and more than a quarter (172, 28.6%) declined participation on behalf of their children. Conclusion The interest level of a pre-school child's parents for participation of the child in a nutrition intervention study evaluating cognitive measures like memory is low. Understanding the study population's motivating and inhibiting factors leading to decreased participation in clinical trials is necessary to facilitate the creation of a pertinent evidence base.	[Nimbalkar, Somashekhar Marutirao; Patel, Dipen Vasudev] Shree Krishna Hosp, Dept Pediat, Pramukhswami Med Coll, Anand, Gujarat, India; [Phatak, Ajay Gajanan] Charutar Arogya Mandel, Cent Res Serv, Anand, Gujarat, India		Nimbalkar, SM (corresponding author), Shree Krishna Hosp, Dept Pediat, Pramukhswami Med Coll, Anand, Gujarat, India.	somu_somu@yahoo.com	Nimbalkar, Somashekhar/ABB-6334-2021; Patel, Dipen/AAU-9140-2021; Nimbalkar, Somashekhar/G-9853-2012; Phatak, Ajay/ABH-5135-2020	Nimbalkar, Somashekhar/0000-0003-2825-2819; Nimbalkar, Somashekhar/0000-0003-2825-2819; Phatak, Ajay/0000-0002-8876-8684; Patel, Dipen Vasudev/0000-0003-0671-8462	GlaxoSmithKline Consumer Healthcare India Ltd	GlaxoSmithKline Consumer Healthcare India Ltd	The study received funding from GlaxoSmithKline Consumer Healthcare India Ltd for its conduct. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068666; Burza S, 2015, AM J CLIN NUTR, V101, P847, DOI 10.3945/ajcn.114.093294; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Caldwell PHY, 2003, J PEDIATR-US, V142, P554, DOI 10.1067/mpd.2003.192; Choonara I, 2000, BRIT MED J, V321, P1093, DOI 10.1136/bmj.321.7269.1093; Field Marilyn J, 2004, ETHICAL CONDUCT CLIN; Hoberman A, 2013, JAMA PEDIATR, V167, P561, DOI 10.1001/jamapediatrics.2013.1050; Joseph PD, 2015, BRIT J CLIN PHARMACO, V79, P357, DOI 10.1111/bcp.12305; Joseph PD, 2016, PEDIATRICS; Lindell-Osuagwu L, 2009, J CLIN PHARM THER, V34, P277, DOI 10.1111/j.1365-2710.2008.01005.x; Martinez-Castaldi C, 2008, PEDIATRICS, V122, P52, DOI 10.1542/peds.2007-2849; Patterson CA, 2015, J PEDIAT HEMATOL ONC, V37, P415, DOI 10.1097/MPH.0000000000000216; Phatak AG., 2014, INT PUBLIC HLTH J, V6, P57; Salam RA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S22; Sammons Helen M, 2007, BMC Pediatr, V7, P12, DOI 10.1186/1471-2431-7-12; Shilling V, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-1; Tait AR, 2003, ANESTHESIOLOGY, V99, P819, DOI 10.1097/00000542-200310000-00012; Vanhelst J, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-7	18	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163502	10.1371/journal.pone.0163502	http://dx.doi.org/10.1371/journal.pone.0163502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732680	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300017
J	Cuppone, AV; Squeri, V; Semprini, M; Masia, L; Konczak, J				Cuppone, Anna Vera; Squeri, Valentina; Semprini, Marianna; Masia, Lorenzo; Konczak, Jurgen			Robot-Assisted Proprioceptive Training with Added Vibro-Tactile Feedback Enhances Somatosensory and Motor Performance	PLOS ONE			English	Article							GRIP FORCE CONTROL; PARKINSONS-DISEASE; REACHING MOVEMENTS; IMPAIRMENTS; VIBRATION; CORTEX	This study examined the trainability of the proprioceptive sense and explored the relationship between proprioception and motor learning. With vision blocked, human learners had to perform goal-directed wrist movements relying solely on proprioceptive/haptic cues to reach several haptically specified targets. One group received additional somatosensory movement error feedback in form of vibro-tactile cues applied to the skin of the forearm. We used a haptic robotic device for the wrist and implemented a 3-day training regimen that required learners to make spatially precise goal-directed wrist reaching movements without vision. We assessed whether training improved the acuity of the wrist joint position sense. In addition, we checked if sensory learning generalized to the motor domain and improved spatial precision of wrist tracking movements that were not trained. The main findings of the study are: First, proprioceptive acuity of the wrist joint position sense improved after training for the group that received the combined proprioceptive/haptic and vibro-tactile feedback (VTF). Second, training had no impact on the spatial accuracy of the untrained tracking task. However, learners who had received VTF significantly reduced their reliance on haptic guidance feedback when performing the untrained motor task. That is, concurrent VTF was highly salient movement feedback and obviated the need for haptic feedback. Third, VTF can be also provided by the limb not involved in the task. Learners who received VTF to the contralateral limb equally benefitted. In conclusion, somatosensory training can significantly enhance proprioceptive acuity within days when learning is coupled with vibro-tactile sensory cues that provide feedback about movement errors. The observable sensory improvements in proprioception facilitates motor learning and such learning may generalize to the sensorimotor control of the untrained motor tasks. The implications of these findings for neurorehabilitation are discussed.	[Cuppone, Anna Vera; Squeri, Valentina] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Motor Learning & Robot Rehabil Lab, Genoa, Italy; [Semprini, Marianna] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst, Neural Computat Lab, Rovereto, Italy; [Masia, Lorenzo] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore; [Konczak, Jurgen] Univ Minnesota, Human Sensorimotor Control Lab, Sch Kinesiol, Minneapolis, MN USA; [Konczak, Jurgen] Univ Minnesota, Ctr Clin Movement Sci, Minneapolis, MN USA; [Squeri, Valentina] Ist Italiano Tecnol IIT, Dept Rehab Technol RTECH, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; University of Genoa; Istituto Italiano di Tecnologia - IIT; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Istituto Italiano di Tecnologia - IIT	Cuppone, AV (corresponding author), Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Motor Learning & Robot Rehabil Lab, Genoa, Italy.	anna.cuppone@iit.it	Semprini, Marianna/AAC-3059-2019; Konczak, Jürgen/J-4001-2019	Semprini, Marianna/0000-0001-5504-0251; Konczak, Jürgen/0000-0002-4422-5610				Aman JE, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01075; BARBARESI P, 1989, J COMP NEUROL, V283, P355, DOI 10.1002/cne.902830305; Bernardi NF, 2013, J NEUROPHYSIOL, V110, P1804, DOI 10.1152/jn.01061.2012; Blanchard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062475; Blanchard C, 2011, BRAIN RES, V1382, P219, DOI 10.1016/j.brainres.2011.01.066; CAREY LM, 1993, ARCH PHYS MED REHAB, V74, P602, DOI 10.1016/0003-9993(93)90158-7; Cho S, 2014, COMPUT METH PROG BIO, V113, P258, DOI 10.1016/j.cmpb.2013.09.006; Conrad MO, 2011, NEUROREHAB NEURAL RE, V25, P61, DOI 10.1177/1545968310378507; Cuppone A, 2015, IEEE ENG MED BIO, P258, DOI 10.1109/EMBC.2015.7318349; De Santis D, 2015, FRONT HUM NEUROSCI, V8, P1, DOI [10.1152/jn.00122.2012, DOI 10.1152/JN.00122.2012]; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Elangovan N, 2014, PHYS THER, V94, P553, DOI 10.2522/ptj.20130103; EVARTS E V, 1971, Neurosciences Research Program Bulletin, V9, P86; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; Goble DJ, 2010, J NEUROPHYSIOL, V104, P1213, DOI 10.1152/jn.00543.2010; Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; Hermsdorfer J, 2008, NEUROREHAB NEURAL RE, V22, P374, DOI 10.1177/1545968307311103; Heuer H, 2015, NEUROSCI BIOBEHAV R, V56, P222, DOI 10.1016/j.neubiorev.2015.07.005; Heuer H, 2014, EXP BRAIN RES, V232, P675, DOI 10.1007/s00221-013-3775-y; Huang H, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-11; Iandolo R, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00072; KAAS JH, 1993, ANN ANAT, V175, P509, DOI 10.1016/S0940-9602(11)80212-8; Konczak J, 2012, BRAIN, V135, P3371, DOI 10.1093/brain/aws265; Masia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007004; Mattar AAG, 2013, J NEUROPHYSIOL, V109, P782, DOI 10.1152/jn.00734.2011; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Nowak DA, 2004, BRAIN, V127, P182, DOI 10.1093/brain/awh016; Putzki N, 2006, MOVEMENT DISORD, V21, P754, DOI 10.1002/mds.20799; RICHER F, 1993, EXP BRAIN RES, V93, P173; Rickards C, 1997, BRAIN, V120, P977, DOI 10.1093/brain/120.6.977; SAINBURG RL, 1993, J NEUROPHYSIOL, V70, P2136, DOI 10.1152/jn.1993.70.5.2136; Sciutti A, 2010, EXP BRAIN RES, V200, P259, DOI 10.1007/s00221-009-1996-x; Sienko KH, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-53; Sigrist R, 2013, PSYCHON B REV, V20, P21, DOI 10.3758/s13423-012-0333-8; Vahdat S, 2014, J NEUROSCI, V34, P2451, DOI 10.1523/JNEUROSCI.4291-13.2014; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wall C, 2001, IEEE T BIO-MED ENG, V48, P1153, DOI 10.1109/10.951518; Wang Wei, 2010, Phys Med Rehabil Clin N Am, V21, P157, DOI 10.1016/j.pmr.2009.07.003; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wong JD, 2012, J NEUROPHYSIOL, V108, P3313, DOI 10.1152/jn.00122.2012; Wong JD, 2011, J NEUROPHYSIOL, V105, P2512, DOI 10.1152/jn.00949.2010	43	36	37	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164511	10.1371/journal.pone.0164511	http://dx.doi.org/10.1371/journal.pone.0164511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727321	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400034
J	Yin, MH; Augustin, B; Shu, C; Qin, TT; Yin, P				Yin, Minghui; Augustin, Balekouzou; Shu, Chang; Qin, Tingting; Yin, Ping			Probit Models to Investigate Prevalence of Total Diagnosed and Undiagnosed Diabetes among Aged 45 Years or Older Adults in China	PLOS ONE			English	Article							BLOOD-PRESSURE; HYPERTENSION; HEALTH; GLUCOSE; RISK; AMERICANS; VALUES	The aims of this study are to identify the most important predictors of total diagnosed and undiagnosed diabetes and estimate the mean change in the predicted probability among aged 45+ adults in China. We used baseline data collected from 2011 wave of the China Health and Retirement Longitudinal Study (CHARLS) (n = 9,513). First, we estimated the prevalence of diagnosed, measured, total diagnosed, and undiagnosed diabetes. Second, we used probit models to determine whether individual attributes, socioeconomic characteristics and behavioral health factors, including smoking, alcohol consumption, obesity, central obesity, are associated with total diagnosed and undiagnosed diabetes. We also consider other factors, including contact with medical system, hypertension and urban/ rural settings. Third, we estimated average marginal effects of variables in probit models. Among Chinese people aged 45+, the prevalence of diagnosed, measured, total diagnosed and undiagnosed diabetes were 5.8% (95% CI, 5.3%-6.3%), 14.7% (95% CI, 14.0%-15.4%), 17.0% (95% CI, 16.3%-17.7%), 11.3% (95% CI, 10.6%-12.0%), respectively. The probability of total diagnosed diabetes is 3.3% (95% CI, 1.2%-5.3%) and 10.2% (95% CI, 7.0%-13.5%) higher for overweight and obesity than normal BMI, 5.0% (95% CI, 3.0%-7.1%) higher for central obesity than normal waist circumference, 5.4% (95% CI, 3.7%-7.0%) higher for hypertensive than normotensive and 1.8% (95% CI, 0.8%-2.7%) higher in urban areas than in rural areas, respectively. The probability of undiagnosed diabetes is 2.7% (95% CI, 1.2%-4.2%) and 7.2% (95% CI, 4.7%-9.6%) higher for overweight and obesity than normal BMI, 2.6% (95% CI, 0.9%-4.4%) higher for central obesity than normal waist circumference and 2.6% (95% CI, 1.2%-4.0%) higher for hypertensive than normotensive, respectively, and -1.5% (95% CI, -2.5% to -0.5%) lower for individuals who were in contact with the medical system. Greater focus on prevention of diabetes is necessary for obesity, central obesity, hypertensive and in urban areas for middle-aged and older in China.	[Yin, Minghui; Augustin, Balekouzou; Shu, Chang; Qin, Tingting; Yin, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Yin, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China.	pingyintj@163.com						Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Anderson S, 2003, ECON LETT, V81, P321, DOI 10.1016/S0165-1765(03)00212-X; Avendano M, 2008, STROKE, V39, P1533, DOI 10.1161/STROKEAHA.107.490383; Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; BUHMANN B, 1988, REV INCOME WEALTH, P115; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Christofides LN, 1997, ECON LETT, V54, P203, DOI 10.1016/S0165-1765(97)00025-6; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b; Emdin CA, 2015, J AM COLL CARDIOL, V66, P1552, DOI 10.1016/j.jacc.2015.07.059; Feng XL, 2014, B WORLD HEALTH ORGAN, V92, P29, DOI 10.2471/BLT.13.124495; Fox J, 2009, J STAT SOFTW, V32, P1; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hasebe T, 2013, ECON LETT, V121, P298, DOI 10.1016/j.econlet.2013.08.028; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; Hou XH, 2008, ASIA-PAC J PUBLIC HE, V20, P159, DOI 10.1177/1010539507312306; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Li SX, 2014, J DIABETES COMPLICAT, V28, P470, DOI 10.1016/j.jdiacomp.2014.03.015; Liotta L, 2013, ANAL BIOANAL CHEM, V405, P429, DOI 10.1007/s00216-012-6480-y; Little RR, 2007, DIABETES TECHNOL THE, V9, P36, DOI 10.1089/dia.2006.0055; Mosca I, 2014, INT J PUBLIC HEALTH, V59, P759, DOI 10.1007/s00038-014-0573-7; Murphy A, 2007, ECON LETT, V95, P374, DOI 10.1016/j.econlet.2006.11.010; National Diabetes Research Group, 1981, CHINESE MED J-PEKING, V20, P678; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; R Core Team, 2013, R LANG ENV STAT COMP; Shen H, 2008, EFFECTIVENESS PEER L; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steffes M, 2005, CLIN CHEM, V51, P753, DOI 10.1373/clinchem.2004.042143; Taylor J, 2013, DIABETIC MED, V30, P16, DOI 10.1111/dme.12027; Trivedi RB, 2008, J BEHAV MED, V31, P489, DOI 10.1007/s10865-008-9173-4; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203; Zhao YJSG., 2013, CHINA HLTH RETIREMEN; Zhou MG, 2015, DIABETES CARE, V38, P72, DOI 10.2337/dc14-1100	41	6	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164481	10.1371/journal.pone.0164481	http://dx.doi.org/10.1371/journal.pone.0164481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723833	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100065
J	Tabak, BM; Moreira, TBS; Fazio, DM; Cavalcanti, ALC; Cunha, GHD				Tabak, Benjamin Miranda; Silva Moreira, Tito Belchior; Fazio, Dimas Mateus; Cordeiro Cavalcanti, Andre Luiz; de Moura Cunha, George Henrrique			Monetary Expansion and the Banking Lending Channel	PLOS ONE			English	Article							PANEL-DATA; MODELS; TRANSMISSION; POLICY	This paper examines the bank lending channel, which considers how monetary authority actions affect the variation of loans. We focus on the BRICS (Brazil, Russia, India, China and South Africa) totalizing 1254 banks from five countries in the period 2000-2012 (totalizing 13 years). The empirical results show that the effect of money supply growth on the growth of loans is non-linear and inverted U-shaped. In this context, our results show empirical evidence expansionary monetary policies do not increase the propensity of economic agents to systematically take greater risks on the market. After a certain level of money stock, increases in the money supply do not lead to increased negotiated credit.	[Tabak, Benjamin Miranda] Univ Catolica Brasilia, Dept Law & Econ, Brasilia, DF, Brazil; [Silva Moreira, Tito Belchior; de Moura Cunha, George Henrrique] Univ Catolica Brasilia, Dept Econ, Brasilia, DF, Brazil; [Fazio, Dimas Mateus] London Business Sch, London, England; [Cordeiro Cavalcanti, Andre Luiz] Univ Catolica Brasilia, Dept Business, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; Universidade Catolica de Brasilia; University of London; London Business School; Universidade Catolica de Brasilia	Tabak, BM (corresponding author), Univ Catolica Brasilia, Dept Law & Econ, Brasilia, DF, Brazil.	benjaminm.tabak@gmail.com	Tabak, Benjamin M/F-9952-2018; Fazio, Dimas/AAP-7277-2020; de Moura Cunha, George Henrique/AAS-9753-2020	Tabak, Benjamin M/0000-0002-7935-3188; Cunha, George Henrique de Moura/0000-0003-1163-0975	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Foundation [305427/2014-8]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Foundation	This work was supported through a grant (305427/2014-8) from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported through a grant (305427/2014-8) from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Barroso Joao Barata R. B., 2015, J INT MONEY IN PRESS, DOI [10.1016/j.jimonfin.2015.06.013, DOI 10.1016/J.JIMONFIN.2015.06.013]; BERNANKE BS, 1988, AM ECON REV, V78, P435; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Borio C, 2012, J FINANC STABIL, V8, P236, DOI 10.1016/j.jfs.2011.12.003; Bruno V, 2015, J MONETARY ECON, V71, P119, DOI 10.1016/j.jmoneco.2014.11.011; Disyatat P, 2011, J MONEY CREDIT BANK, V43, P711, DOI 10.1111/j.1538-4616.2011.00394.x; Fawley BW, 2013, FED RESERVE BANK ST, V95, P51; Joseph Gagnon, 2011, INT J CENT BANK, V7, P3; Kashyap AK, 2000, AM ECON REV, V90, P407, DOI 10.1257/aer.90.3.407; Kohn Donald, 2009, COMMUNICATION; Lim Jamus J., 2016, J INT MONEY IN PRESS, DOI [10.1016/j.jimonfin.2016.02.009, DOI 10.1016/J.JIMONFIN.2016.02.009]; Meyer Laurence H., 2010, MACROECONOMIC A 0617; Neely Christopher J., 2010, 2010018D FED RES BAN; NICKELL S, 1981, ECONOMETRICA, V49, P1417, DOI 10.2307/1911408; Periklis Gogas, 2013, OPEN ECON REV, V24, P51, DOI [10.1007/s11079-012-9253-5, DOI 10.1007/S11079-012-9253-5]; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Roodman D, 2009, OXFORD B ECON STAT, V71, P135, DOI 10.1111/j.1468-0084.2008.00542.x; Sack B., 2011, EC POLICY REV, V17, P41, DOI DOI 10.2139/SSRN.1576596; Stroebel J.C., 2009, 15626 NBER; Williamson Stephen D., 2015, J EC THEORY IN PRESS, DOI [10.2139/ssrn.2417388, DOI 10.2139/SSRN.2417388]; Wu J. C., 2011, 16956 NBER	23	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164338	10.1371/journal.pone.0164338	http://dx.doi.org/10.1371/journal.pone.0164338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UW	27716816	gold, Green Published			2022-12-27	WOS:000385698100046
J	Yan, XD; Zhang, XR; Zhang, YT; Li, XM; Yang, Z				Yan, Xuedong; Zhang, Xinran; Zhang, Yuting; Li, Xiaomeng; Yang, Zhuo			Changes in Drivers' Visual Performance during the Collision Avoidance Process as a Function of Different Field of Views at Intersections	PLOS ONE			English	Article							SIGHT-DISTANCE; EYE-MOVEMENTS; OF-VIEW; ATTENTION; RISK; AGE; ROAD; INFORMATION; EXPERIENCE; CRASHES	The intersection field of view (IFOV) indicates an extent that the visual information can be observed by drivers. It has been found that further enhancing IFOV can significantly improve emergent collision avoidance performance at intersections, such as faster brake reaction time, smaller deceleration rate, and lower traffic crash involvement risk. However, it is not known how IFOV affects drivers' eye movements, visual attention and the relationship between visual searching and traffic safety. In this study, a driving simulation experiment was conducted to uncover the changes in drivers' visual performance during the collision avoidance process as a function of different field of views at an intersection by using an eye tracking system. The experimental results showed that drivers' ability in identifying the potential hazard in terms of visual searching was significantly affected by different IFOV conditions. As the IFOVs increased, drivers had longer gaze duration (GD) and more number of gazes (NG) in the intersection surrounding areas and paid more visual attention to capture critical visual information on the emerging conflict vehicle, thus leading to a better collision avoidance performance and a lower crash risk. It was also found that female drivers had a better visual performance and a lower crash rate than male drivers. From the perspective of drivers' visual performance, the results strengthened the evidence that further increasing intersection sight distance standards should be encouraged for enhancing traffic safety.	[Yan, Xuedong; Zhang, Xinran; Zhang, Yuting; Li, Xiaomeng] Beijing Jiaotong Univ, Sch Traff & Transportat, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing 100044, Peoples R China; [Yang, Zhuo] George Mason Univ, Dept Civil Environm & Infrastruct Engn, Fairfax, VA 22030 USA	Beijing Jiaotong University; George Mason University	Yan, XD (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing 100044, Peoples R China.	xdyan@bjtu.edu.cn	Yan, Xuedong/L-6957-2019; Yan, Xuedong/A-5126-2009; Yan, Xuedong/S-3681-2019	Yan, Xuedong/0000-0003-0120-9183; Yan, Xuedong/0000-0003-0120-9183; Li, Xiaomeng/0000-0003-2129-1671	National Natural Science Foundation of China [71210001]; BJTU Basic Scientific Research [2016YJS084, 2015YJS092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BJTU Basic Scientific Research	The work described in this paper was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (71210001) and the BJTU Basic Scientific Research (2016YJS084, 2015YJS092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASHTO, 2011, POLICY GEOMETRIC DES; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Bener A., 2013, EUR PSYCHIAT, V28, P1, DOI DOI 10.1016/S0924-9338(13)75901-7; BERLYNE DE, 1966, SCIENCE, V153, P25, DOI 10.1126/science.153.3731.25; Braitman KA, 2008, J SAFETY RES, V39, P47, DOI 10.1016/j.jsr.2007.12.002; Broughton KLM, 2007, ACCIDENT ANAL PREV, V39, P106, DOI 10.1016/j.aap.2006.06.009; Caird JK, 2005, HUM FACTORS, V47, P235, DOI 10.1518/0018720054679542; Coeckelbergh TRM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1509, DOI 10.1001/archopht.120.11.1509; Crundall D, 2011, HANDBOOK OF TRAFFIC PSYCHOLOGY, P137, DOI 10.1016/B978-0-12-381984-0.10011-6; Crundall DE, 1998, ERGONOMICS, V41, P448, DOI 10.1080/001401398186937; DEJOY DM, 1992, ACCIDENT ANAL PREV, V24, P237, DOI 10.1016/0001-4575(92)90003-2; Easa SM, 1998, J TRANSP ENG-ASCE, V124, P156, DOI 10.1061/(ASCE)0733-947X(1998)124:2(156); ELANDER J, 1993, PSYCHOL BULL, V113, P279, DOI 10.1037/0033-2909.113.2.279; Fell JC, 2000, P 44 ANN C ASS ADV A; Green P., 2002, HUMAN FACTORS TRAFFI, P77; Guerrier JH, 1999, APPL ERGON, V30, P109, DOI 10.1016/S0003-6870(98)00017-9; Habibovic A, 2012, ACCIDENT ANAL PREV, V49, P493, DOI 10.1016/j.aap.2012.03.022; Harwood DW, 2000, TRANSPORT RES REC, P32; HILLS BL, 1980, PERCEPTION, V9, P183, DOI 10.1068/p090183; Holland C, 2010, PERS INDIV DIFFER, V48, P821, DOI 10.1016/j.paid.2010.02.003; Konstantopoulos P, 2010, ACCIDENT ANAL PREV, V42, P827, DOI 10.1016/j.aap.2009.09.022; LandTransport, 2005, ROAD SAFETY ISSUES T; Lee HC, 2003, ACCIDENT ANAL PREV, V35, P797, DOI 10.1016/S0001-4575(02)00083-0; Li GH, 1998, EPIDEMIOLOGY, V9, P379, DOI 10.1097/00001648-199807000-00006; Mazer BL, 2001, AM J OCCUP THER, V55, P552, DOI 10.5014/ajot.55.5.552; McGwin G, 1999, ACCIDENT ANAL PREV, V31, P181; McKnight AJ, 2003, ACCIDENT ANAL PREV, V35, P921, DOI 10.1016/S0001-4575(02)00100-8; Miura T., 1992, IATSS RES, V16, P42; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Ni R, 2010, ACCIDENT ANAL PREV, V42, P818, DOI 10.1016/j.aap.2009.04.023; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Obst P, 2011, TRANSPORT RES F-TRAF, V14, P539, DOI 10.1016/j.trf.2011.06.005; Olmsted-Hawala E, 2009, SURV METHODOL, P15; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Ozkan T, 2006, TRANSPORT RES F-TRAF, V9, P269, DOI 10.1016/j.trf.2006.01.005; Peruch P, 1997, PERCEPTION, V26, P301, DOI 10.1068/p260301; Pradhan AK, 2009, ERGONOMICS, V52, P657, DOI 10.1080/00140130802550232; Pradhan AK, 2005, HUM FACTORS, V47, P840, DOI 10.1518/001872005775570961; Prasetijo J., 2007, THESIS; Ramsey D. J, 2006, IMPACT DRIVER INATTE; Recarte MA, 2000, J EXP PSYCHOL-APPL, V6, P31, DOI 10.1037/1076-898X.6.1.31; ROBINSON GH, 1972, HUM FACTORS, V14, P315, DOI 10.1177/001872087201400404; Rogers SD, 2005, ECOL PSYCHOL, V17, P19, DOI 10.1207/s15326969eco1701_2; RUMAR K, 1990, ERGONOMICS, V33, P1281, DOI 10.1080/00140139008925332; SCIALFA CT, 1994, OPTOMETRY VISION SCI, V71, P736, DOI 10.1097/00006324-199412000-00003; SHINAR D, 1991, HUM FACTORS, V33, P507, DOI 10.1177/001872089103300503; SHINAR D, 1978, HUM FACTORS, V20, P553, DOI 10.1177/001872087802000505; Sivak M, 1996, PERCEPTION, V25, P1081, DOI 10.1068/p251081; Staplin L, 1997, INTERSECTION GEOMETR, P1; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Treat JR, 1979, 805099 DOT HS; Turner Cathy, 2003, Inj Control Saf Promot, V10, P123, DOI 10.1076/icsp.10.3.123.14560; Underwood G, 2007, ERGONOMICS, V50, P1235, DOI 10.1080/00140130701318707; Van Houten R, 2001, J APPL BEHAV ANAL, V34, P185, DOI 10.1901/jaba.2001.34-185; Velichkovsky B.M., 2003, OPERATOR FUNCTIONAL, P313; Yan XD, 2007, ACCIDENT ANAL PREV, V39, P843, DOI 10.1016/j.aap.2006.12.006; Yan XD, 2016, J ADV TRANSPORT, V50, P683, DOI 10.1002/atr.1369	57	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164101	10.1371/journal.pone.0164101	http://dx.doi.org/10.1371/journal.pone.0164101			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UW	27716824	Green Published, gold			2022-12-27	WOS:000385698100022
J	Allyn, J; Ferdynus, C; Bohrer, M; Dalban, C; Valance, D; Allou, N				Allyn, Jerome; Ferdynus, Cyril; Bohrer, Michel; Dalban, Cecile; Valance, Dorothee; Allou, Nicolas			Simplified Acute Physiology Score II as Predictor of Mortality in Intensive Care Units: A Decision Curve Analysis	PLOS ONE			English	Article							LIFE-SUSTAINING TREATMENT; HEALTH EVALUATION II; DIAGNOSTIC-TESTS; SAPS-II; WITHDRAWAL; MODELS; VARIABILITY	Background End-of-life decision-making in Intensive care Units (ICUs) is difficult. The main problems encountered are the lack of a reliable prediction score for death and the fact that the opinion of patients is rarely taken into consideration. The Decision Curve Analysis (DCA) is a recent method developed to evaluate the prediction models and which takes into account the wishes of patients (or surrogates) to expose themselves to the risk of obtaining a false result. Our objective was to evaluate the clinical usefulness, with DCA, of the Simplified Acute Physiology Score II (SAPS II) to predict ICU mortality. Methods We conducted a retrospective cohort study from January 2011 to September 2015, in a medical-surgical 23-bed ICU at University Hospital. Performances of the SAPS II, a modified SAPS II (without AGE), and age to predict ICU mortality, were measured by a Receiver Operating Characteristic (ROC) analysis and DCA. Results Among the 4.370 patients admitted, 23.3% died in the ICU. Mean (standard deviation) age was 56.8 (16.7) years, and median (first-third quartile) SAPS II was 48 (34-65). Areas under ROC curves were 0.828 (0.813-0.843) for SAPS II, 0.814 (0.798-0.829) for modified SAPS II and of 0.627 (0.608-0.646) for age. DCA showed a net benefit whatever the probability threshold, especially under 0.5.	[Allyn, Jerome; Valance, Dorothee; Allou, Nicolas] St Denis Univ Hosp, Intens Care Unit, St Denis, Reunion Isl, France; [Ferdynus, Cyril; Dalban, Cecile] St Denis Univ Hosp, Unite Soutien Methodol, St Denis, Reunion Isl, France; [Ferdynus, Cyril] INSERM, CIC 1410, St Denis, Reunion Isl, France; [Bohrer, Michel] St Denis Univ Hosp, Dept Med Informat, St Denis, Reunion Isl, France	CHU Reunion; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Reunion	Allyn, J (corresponding author), St Denis Univ Hosp, Intens Care Unit, St Denis, Reunion Isl, France.	allyn.jer@gmail.com	ferdynus, cyril/AFV-1963-2022	ferdynus, cyril/0000-0003-1502-0672; Allyn, Jerome/0000-0001-8057-0393; VALANCE, Dorothee/0000-0001-8338-2777				Alizadeh AM, 2014, BASIC CLIN PHARMACOL, V115, P297, DOI 10.1111/bcpt.12210; Barnato AE, 2004, CRIT CARE CLIN, V20, P345, DOI 10.1016/j.ccc.2004.03.002; Cabre L, 2005, INTENS CARE MED, V31, P927, DOI 10.1007/s00134-005-2640-2; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; Cook D, 2014, NEW ENGL J MED, V370, P2506, DOI 10.1056/NEJMra1208795; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fitzgerald M, 2015, JAMA-J AM MED ASSOC, V313, P409, DOI 10.1001/jama.2015.37; Girou E, 1996, J HOSP INFECT, V34, P131, DOI 10.1016/S0195-6701(96)90138-3; Hernandez JM, 2014, ANN SURG, V259, P1208, DOI 10.1097/SLA.0000000000000310; Hoel H, 2014, ACTA ANAESTH SCAND, V58, P329, DOI 10.1111/aas.12246; Kim KI, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0135-x; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lesieur O, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0056-x; Luce JM, 2010, AM J RESP CRIT CARE, V182, P6, DOI 10.1164/rccm.201001-0071CI; Mark NM, 2015, INTENS CARE MED, V41, P1572, DOI 10.1007/s00134-015-3810-5; Park SK, 2009, J KOREAN MED SCI, V24, P420, DOI 10.3346/jkms.2009.24.3.420; Phua J, 2015, JAMA INTERN MED, V175, P363, DOI 10.1001/jamainternmed.2014.7386; Popovic B, 2014, SHOCK, V42, P22, DOI 10.1097/SHK.0000000000000170; Schuiling WJ, 2005, NEUROSURGERY, V57, P230, DOI 10.1227/01.NEU.0000166536.42876.9C; Schuster HP, 1997, INTENS CARE MED, V23, P1056, DOI 10.1007/s001340050456; Shariat SF, 2011, CANCER-AM CANCER SOC, V117, P2892, DOI 10.1002/cncr.25903; Shigeta K, 2014, WORLD J SURG, V38, P3248, DOI 10.1007/s00268-014-2738-1; Strand K, 2010, INTENS CARE MED, V36, P850, DOI 10.1007/s00134-010-1772-1; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Vickers AJ, 2008, AM STAT, V62, P314, DOI 10.1198/000313008X370302; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wilkinson DJC, 2013, INTENS CARE MED, V39, P1128, DOI 10.1007/s00134-013-2871-6; Yamamoto S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007049; Zastrow S, 2015, WORLD J UROL, V33, P381, DOI 10.1007/s00345-014-1321-6	31	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164828	10.1371/journal.pone.0164828	http://dx.doi.org/10.1371/journal.pone.0164828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741304	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000072
J	Kalron, A; Givon, U; Frid, L; Dolev, M; Achiron, A				Kalron, Alon; Givon, Uri; Frid, Lior; Dolev, Mark; Achiron, Anat			Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis	PLOS ONE			English	Article							POSTURAL CONTROL; RISK-FACTORS; IMPAIRMENTS; BALANCE; SCALE; EDSS	Balance impairment is common in people with multiple sclerosis (PwMS) and frequently impacts quality of life by decreasing mobility and increasing the risk of falling. However, there are only scarce data examining the contribution of specific neurological functional systems on balance measures in MS. Therefore, the primary aim of our study was to examine the differences in posturography parameters and fall incidence according to the pyramidal, cerebellar and sensory systems functional systems in PwMS. The study included 342 PwMS, 211 women and mean disease duration of 8.2 (S.D = 8.3) years. The study sample was divided into six groups according to the pyramidal, cerebellar and sensory functional system scores, derived from the Expanded Disability Status Scale (EDSS) data. Static postural control parameters were obtained from the Zebris FDM-T Treadmill (zebris((R)) Medical GmbH, Germany). Participants were defined as "fallers" and "non-fallers" based on their fall history. Our findings revealed a trend that PwMS affected solely in the pyramidal system, have reduced stability compared to patients with cerebellar and sensory dysfunctions. Moreover, the addition of sensory impairments to pyramidal dysfunction does not exacerbate postural control. The patients in the pure sensory group demonstrated increased stability compared to each of the three combined groups; pyramidal-cerebellar, pyramidal-sensory and pyramidal-cerebellar-sensory groups. As for fall status, the percentage of fallers in the pure pyramidal, cerebellar and sensory groups were 44.3%, 33.3% and 19.5%, respectively. As for the combined functional system groups, the percentage of fallers in the pyramidal-cerebellar, pyramidal-sensory and pyramidal-cerebellar-sensory groups were 59.7%, 40.7% and 65%, respectively. This study confirms that disorders in neurological functional systems generate different effects on postural control and incidence of falls in the MS population. From a clinical standpoint, the present information can benefit all those engaged in physical rehabilitation of PwMS.	[Kalron, Alon] Tel Aviv Univ, Dept Phys Therapy, Sch Hlth Profess, Sackler Fac Med, Tel Aviv, Israel; [Givon, Uri; Frid, Lior; Dolev, Mark; Achiron, Anat] Sheba Med Ctr, Multiple Sclerosis Ctr, Ramat Gan, Israel; [Givon, Uri] Sheba Med Ctr, Mot Anal Lab, Ramat Gan, Israel; [Givon, Uri; Achiron, Anat] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Kalron, A (corresponding author), Tel Aviv Univ, Dept Phys Therapy, Sch Hlth Profess, Sackler Fac Med, Tel Aviv, Israel.	alkalron@gmail.com	Kalron, Alon/AAT-2960-2021; Kalron, Alon/AAB-3396-2019	Kalron, Alon/0000-0001-7999-0868; 				Behrens JR, 2016, MULT SCLER; Cameron MH, 2008, SOMATOSENS MOT RES, V25, P113, DOI 10.1080/08990220802131127; Cattaneo D, 2009, MULT SCLER, V15, P59, DOI 10.1177/1352458508096874; Cattaneo D, 2007, DISABIL REHABIL, V29, P1920, DOI 10.1080/09638280701191859; DALEY ML, 1981, IEEE T BIO-MED ENG, V28, P668, DOI 10.1109/TBME.1981.324761; Finlayson ML, 2006, ARCH PHYS MED REHAB, V87, P1274, DOI 10.1016/j.apmr.2006.06.002; Gunn H, 2015, ARCH PHYS MED REHAB, V96, P1898, DOI 10.1016/j.apmr.2015.05.018; Gunn HJ, 2013, PHYS THER, V93, P504, DOI 10.2522/ptj.20120231; Kalron A, 2011, EUR J PHYS REHAB MED, V47, P579; Kalron A, 2016, J NEUROL; Kalron A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0603-6; Kalron A, 2015, PM&R, V7, P17, DOI 10.1016/j.pmrj.2014.08.942; Kalron A, 2013, J NEUROL SCI, V335, P186, DOI 10.1016/j.jns.2013.09.029; Kelleher KJ, 2010, GAIT POSTURE, V32, P67, DOI 10.1016/j.gaitpost.2010.03.008; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Matsuda PN, 2012, PHYS THER, V92, P407, DOI 10.2522/ptj.20100380; McLaughlin J, 2015, INT J MS CARE, V17, P146, DOI [10.7224/1537-2073.2014-003, DOI 10.7224/1537-2073.2014-003]; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Prosperini L, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/756564; Prosperini L, 2013, NEUROREHAB NEURAL RE, V27, P45, DOI 10.1177/1545968312445638; Sosnoff JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028021; Tjernstrom F, 2015, GAIT POSTURE, V42, P27, DOI 10.1016/j.gaitpost.2014.12.007; Uszynski M, 2015, GAIT POSTURE, V41, P228, DOI 10.1016/j.gaitpost.2014.10.010; WEINSHENKER BG, 1995, NEUROL CLIN, V13, P119, DOI 10.1016/S0733-8619(18)30064-1	24	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164467	10.1371/journal.pone.0164467	http://dx.doi.org/10.1371/journal.pone.0164467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741268	gold, Green Published, Green Submitted			2022-12-27	WOS:000385507000035
J	Kurlander, JE; Sondhi, AR; Waljee, AK; Menees, SB; Connell, CM; Schoenfeld, PS; Saini, SD				Kurlander, Jacob E.; Sondhi, Arjun R.; Waljee, Akbar K.; Menees, Stacy B.; Connell, Cathleen M.; Schoenfeld, Philip S.; Saini, Sameer D.			How Efficacious Are Patient Education Interventions to Improve Bowel Preparation for Colonoscopy? A Systematic Review	PLOS ONE			English	Review							ADENOMA MISS RATES; QUALITY; IMPACT; VALIDATION; COLON; METAANALYSIS; ENDOSCOPY; FAILURE; BOOKLET; COST	Background Bowel preparation is inadequate in a large proportion of colonoscopies, leading to multiple clinical and economic harms. While most patients receive some form of education before colonoscopy, there is no consensus on the best approach. Aims This systematic review aimed to evaluate the efficacy of patient education interventions to improve bowel preparation. Methods We searched the Cochrane Database, CINAHL, EMBASE, Ovid, and Web of Science. Inclusion criteria were: (1) a patient education intervention; (2) a primary aim of improving bowel preparation; (3) a validated bowel preparation scale; (4) a prospective design; (5) a concurrent control group; and, (6) adult participants. Study validity was assessed using a modified Downs and Black scale. Results 1,080 abstracts were screened. Seven full text studies met inclusion criteria, including 2,660 patients. These studies evaluated multiple delivery platforms, including paper-based interventions (three studies), videos (two studies), re-education telephone calls the day before colonoscopy (one study), and in-person education by physicians (one study). Bowel preparation significantly improved with the intervention in all but one study. All but one study were done in a single center. Validity scores ranged from 13 to 24 (maximum 27). Four of five abstracts and research letters that met inclusion criteria also showed improvements in bowel preparation. Statistical and clinical heterogeneity precluded meta-analysis. Conclusion Compared to usual care, patient education interventions appear efficacious in improving the quality of bowel preparation. However, because of the small scale of the studies and individualized nature of the interventions, results of these studies may not be generalizable to other settings. Healthcare practices should consider systematically evaluating their current bowel preparation education methods before undertaking new interventions.	[Kurlander, Jacob E.; Sondhi, Arjun R.; Waljee, Akbar K.; Menees, Stacy B.; Schoenfeld, Philip S.; Saini, Sameer D.] Univ Michigan, Sch Med, Dept Internal Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Kurlander, Jacob E.; Menees, Stacy B.] Vet Affairs Ann Arbor Hlth Care Syst, 2215 Fuller Rd, Ann Arbor, MI 48105 USA; [Waljee, Akbar K.; Schoenfeld, Philip S.; Saini, Sameer D.] Vet Affairs Ctr Clin Management Res, 2215 Fuller Rd, Ann Arbor, MI USA; [Connell, Cathleen M.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, 3790 SPH 1,1415 Washington Hts, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Kurlander, JE (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.; Kurlander, JE (corresponding author), Vet Affairs Ann Arbor Hlth Care Syst, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	jkurland@umich.edu	Waljee, Akbar K/G-2067-2010	Waljee, Akbar K/0000-0003-1964-8790	VA HSR&D CDA-2 Career Development Award [1IK2HX000775]	VA HSR&D CDA-2 Career Development Award	Dr. Waljee's research is funded by a VA HSR&D CDA-2 Career Development Award 1IK2HX000775.	Abuksis G, 2001, AM J GASTROENTEROL, V96, P1786, DOI 10.1016/S0002-9270(01)02435-2; Aronchick CA, 1999, AM J GASTROENTEROL, V94, P2667; Bollegala N, 2016, CLIN GASTROENTEROL H, V14, P1230, DOI 10.1016/j.cgh.2016.04.042; Bowman E.A., 2014, GASTROINTEST ENDOSC, V79, pAB180; Brega AG., 2015, PREPARED COLORADO HL, V15-0023EF; Brill JV, 2014, GASTROENTEROLOGY, V146, P849, DOI 10.1053/j.gastro.2014.01.043; Calderwood AH, 2011, GASTROINTEST ENDOSC, V73, P307, DOI 10.1016/j.gie.2010.10.013; Chang CW, 2015, ENDOSC INT OPEN, V3, pE646, DOI 10.1055/s-0034-1392365; Clark BT, 2014, AM J GASTROENTEROL, V109, P1714, DOI 10.1038/ajg.2014.232; Daniels G, 2012, GASTROENTEROL NURS, V35, P182, DOI 10.1097/SGA.0b013e318255b94a; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Ergen W.F., 2014, GASTROINTEST ENDOSC, V79, pAB180; Felley C, 2008, BMC GASTROENTEROL, P8; Griffin JM, 2011, AM J MANAG CARE, V17, P199; Guo X, GASTROINTEST ENDOSC; Hassan C, 2012, CLIN GASTROENTEROL H, V10, P501, DOI 10.1016/j.cgh.2011.12.037; Hendry PO, 2007, COLORECTAL DIS, V9, P745, DOI 10.1111/j.1463-1318.2007.01220.x; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hsueh Feng-Chi, 2014, Appl Nurs Res, V27, pe1, DOI 10.1016/j.apnr.2013.12.004; Johnson DA, 2014, GASTROINTEST ENDOSC, V80, P543, DOI 10.1016/j.gie.2014.08.002; Kakkar A, 2013, JAMA INTERN MED, V173, P1374, DOI 10.1001/jamainternmed.2013.6477; Kamel MA, 2010, GASTROENTEROLOGY, V138, pS636; Kavathia N.H., 2014, GASTROINTEST ENDOSC, V79, pAB216; Kilgore TW, 2011, GASTROINTEST ENDOSC, V73, P1240, DOI 10.1016/j.gie.2011.02.007; Kurlander J, 2014, PROSPERO; Lai EJ, 2009, GASTROINTEST ENDOSC, V69, P620, DOI 10.1016/j.gie.2008.05.057; Lebwohl B, 2011, GASTROINTEST ENDOSC, V73, P1207, DOI 10.1016/j.gie.2011.01.051; Lee A, 2013, GASTROENTEROLOGY, V144, pS191; Lee JK, 2015, GASTROINTEST ENDOSC, V81, P575, DOI 10.1016/j.gie.2014.07.031; Lee JK, 2013, CLIN GASTROENTEROL H, V11, P204, DOI 10.1016/j.cgh.2012.12.014; Liu X., 2013, GUT; M'Imunya JM, 1996, COCHRANE DATABASE SY; Makoul G, 2009, PATIENT EDUC COUNS, V76, P220, DOI 10.1016/j.pec.2009.01.006; Menees SB, 2014, GASTROINTEST ENDOSC, V79, P811, DOI 10.1016/j.gie.2014.01.024; Menees SB, 2013, GASTROINTEST ENDOSC, V78, P510, DOI 10.1016/j.gie.2013.03.1334; Modi Chintan, 2009, Qual Prim Care, V17, P397; Parmar R, 2016, AM J GASTROENTEROL, V111, P197, DOI 10.1038/ajg.2015.417; Pillai A, 2013, GASTROINTEST ENDOSC, V77, pAB510; Prakash SR, 2013, CAN J GASTROENTEROL, V27, P696, DOI 10.1155/2013/292636; Rex DK, 2002, AM J GASTROENTEROL, V97, P1696; Rex DK, 2015, AM J GASTROENTEROL, V110, P72, DOI 10.1038/ajg.2014.385; Riemsma RP, 1996, COCHRANE DATABASE SY; Rosenfeld G, 2010, CAN J GASTROENTEROL, V24, P543, DOI 10.1155/2010/718628; Rostom A, 2004, GASTROINTEST ENDOSC, V59, P482, DOI 10.1016/S0016-5107(03)02875-X; Saltzman JR, 2015, GASTROINTEST ENDOSC, V81, P781, DOI 10.1016/j.gie.2014.09.048; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Shaikh AA, 2010, EUR J GASTROEN HEPAT, V22, P444, DOI 10.1097/MEG.0b013e328333fca6; Shieh TY, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/570180; Smith SG, 2012, DIS COLON RECTUM, V55, P1074, DOI 10.1097/DCR.0b013e31826359ac; Spiegel BMR, 2011, AM J GASTROENTEROL, V106, P875, DOI 10.1038/ajg.2011.75; Tae JW, 2012, GASTROINTEST ENDOSC, V76, P804, DOI 10.1016/j.gie.2012.05.026; Ton L, 2014, DIGEST DIS SCI, V59, P1726, DOI 10.1007/s10620-014-3262-8; Unger RZ, 2010, DIGEST DIS SCI, V55, P2030, DOI 10.1007/s10620-009-1092-x; van Zuuren FJ, 2006, PATIENT EDUC COUNS, V64, P173, DOI 10.1016/j.pec.2005.12.014; Yun H.-W., 2014, GASTROINTEST ENDOSC, V79, pAB480	55	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164442	10.1371/journal.pone.0164442	http://dx.doi.org/10.1371/journal.pone.0164442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741260	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000033
J	Wan, TW; Khokhlova, OE; Iwao, Y; Higuchi, W; Hung, WC; Reva, IV; Singur, OA; Gostev, VV; Sidorenko, SV; Peryanova, OV; Salmina, AB; Reva, GV; Teng, LJ; Yamamoto, T				Wan, Tsai-Wen; Khokhlova, Olga E.; Iwao, Yasuhisa; Higuchi, Wataru; Hung, Wei-Chun; Reva, Ivan V.; Singur, Olga A.; Gostev, Vladimir V.; Sidorenko, Sergey V.; Peryanova, Olga V.; Salmina, Alla B.; Reva, Galina V.; Teng, Lee-Jene; Yamamoto, Tatsuo			Complete Circular Genome Sequence of Successful ST8/SCCmecIV Community-Associated Methicillin-Resistant Staphylococcus aureus (OC8) in Russia: One-Megabase Genomic Inversion, IS256's Spread, and Evolution of Russia ST8-IV	PLOS ONE			English	Article							GIANT PROTEIN EBH; VIRULENCE DETERMINANTS; INSERTION-SEQUENCE; STRAIN; MRSA; CLONE; INFECTIONS; USA300; LINEAGE; RECOMBINATION	ST8/SCCmecIV community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has been a common threat, with large USA300 epidemics in the United States. The global geographical structure of ST8/SCCmecIV has not yet been fully elucidated. We herein determined the complete circular genome sequence of ST8/SCCmecIVc strain OC8 from Siberian Russia. We found that 36.0% of the genome was inverted relative to USA300. Two IS256, oppositely oriented, at IS256-enriched hot spots were implicated with the one-mega-base genomic inversion (MbIN) and vSa beta split. The behavior of IS256 was flexible: its insertion site (att) sequences on the genome and junction sequences of extrachromosomal circular DNA were all divergent, albeit with fixed sizes. A similar multi-IS256 system was detected, even in prevalent ST239 healthcare-associated MRSA in Russia, suggesting IS256's strong transmission potential and advantage in evolution. Regarding epidemiology, all ST8/SCCmecIVc strains from European, Siberian, and Far Eastern Russia, examined had MbIN, and geographical expansion accompanied divergent spa types and resistance to fluoroquinolones, chloramphenicol, and often rifampicin. Russia ST8/SCCmecIVc has been associated with life-threatening infections such as pneumonia and sepsis in both community and hospital settings. Regarding virulence, the OC8 genome carried a series of toxin and immune evasion genes, a truncated giant surface protein gene, and IS256 insertion adjacent to a pan-regulatory gene. These results suggest that unique single ST8/spa1(t008)/SCCmecIVc CA-MRSA (clade, Russia ST8-IVc) emerged in Russia, and this was followed by large geographical expansion, with MbIN as an epidemiological marker, and fluoroquinolone resistance, multiple virulence factors, and possibly a multi-IS256 system as selective advantages.	[Wan, Tsai-Wen; Khokhlova, Olga E.; Iwao, Yasuhisa; Reva, Ivan V.; Yamamoto, Tatsuo] Int Med Educ & Res Ctr, Dept Epidemiol Genom & Evolut, Niigata, Japan; [Wan, Tsai-Wen; Teng, Lee-Jene] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan; [Khokhlova, Olga E.; Iwao, Yasuhisa; Peryanova, Olga V.; Yamamoto, Tatsuo] Krasnoyarsk State Med Univ, Russia Japan Ctr Microbiol Metagen & Infect Dis, Krasnoyarsk, Russia; [Khokhlova, Olga E.; Peryanova, Olga V.] Krasnoyarsk State Med Univ, Dept Microbiol, Krasnoyarsk, Russia; [Higuchi, Wataru] Niigata Univ, Div Bacteriol, Dept Infect Dis Control & Int Med, Grad Sch Med & Dent Sci, Niigata, Japan; [Hung, Wei-Chun] Kaohsiung Med Univ, Dept Microbiol & Immunol, Kaohsiung, Taiwan; [Reva, Ivan V.; Reva, Galina V.; Yamamoto, Tatsuo] Far Eastern Fed Univ, Dept Clin & Fundamental Med, Sch Biomed, Vladivostok, Russia; [Singur, Olga A.] Pacific State Med Univ, Dept Venereal & Skin Dis & Cosmetol, Vladivostok, Russia; [Gostev, Vladimir V.; Sidorenko, Sergey V.] Sci Res Inst Childrens Infect, Dept Med Microbiol & Mol Epidemiol, St Petersburg, Russia; [Salmina, Alla B.] Krasnoyarsk State Med Univ, Res Inst Mol Med & Pathobiochem, Krasnoyarsk, Russia	National Taiwan University; Krasnoyarsk State Medical University; Krasnoyarsk State Medical University; Niigata University; Kaohsiung Medical University; Far Eastern Federal University; Krasnoyarsk State Medical University	Yamamoto, T (corresponding author), Int Med Educ & Res Ctr, Dept Epidemiol Genom & Evolut, Niigata, Japan.; Yamamoto, T (corresponding author), Krasnoyarsk State Med Univ, Russia Japan Ctr Microbiol Metagen & Infect Dis, Krasnoyarsk, Russia.; Yamamoto, T (corresponding author), Far Eastern Fed Univ, Dept Clin & Fundamental Med, Sch Biomed, Vladivostok, Russia.	tatsuoy@imerc.jp	Gostev, Vladimir/AAC-8438-2020; Sidorenko, Sergey/E-5870-2011; Salmina, Alla B./L-7977-2013; Gostev, Vladimir V/P-1949-2016; Khokhlova, Olga/J-3119-2017; Olga, Peryanova/N-7432-2015	Gostev, Vladimir/0000-0002-3480-8089; Sidorenko, Sergey/0000-0003-3550-7875; Gostev, Vladimir V/0000-0002-3480-8089; Khokhlova, Olga/0000-0002-2829-5117; Olga, Peryanova/0000-0001-7150-9670; Reva, Ivan/0000-0002-3727-393X; TENG, LEE-JENE/0000-0003-0104-741X; Reva, Galina/0000-0001-6502-4271	Japan-Russia joint research on infections from Far Eastern Federal University School of Biomedicine and Krasnoyarsk State Medical University	Japan-Russia joint research on infections from Far Eastern Federal University School of Biomedicine and Krasnoyarsk State Medical University	This study was supported by each institutional sources, including those to the 10th anniversary of the Japan-Russia joint research on infections from Far Eastern Federal University School of Biomedicine and Krasnoyarsk State Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranovich T, 2007, EUROSURVEILLANCE, V12; Benson MA, 2014, MOL MICROBIOL, V93, P664, DOI 10.1111/mmi.12682; BI X, 1994, J MOL BIOL, V235, P414, DOI 10.1006/jmbi.1994.1002; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Brandenberger M, 2000, BBA-GEN SUBJECTS, V1523, P135, DOI 10.1016/S0304-4165(00)00133-1; CDC, 1999, MMWR-MORBID MORTAL W, V48, P707; Cheng AG, 2014, J BACTERIOL, V196, P971, DOI 10.1128/JB.01366-13; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Clinical and Laboratory Standards Institute, 2015, M100S25 CLIN LAB STA; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Fluit AC, 2015, J ANTIMICROB CHEMOTH, V70, P664, DOI 10.1093/jac/dku459; Glaser P, 2016, MBIO, V7, DOI 10.1128/mBio.02183-15; Gostev V, 2015, INT J ANTIMICROB AG, V45, pS97; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Harro JM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00037-12; Hennig S, 2008, J BACTERIOL, V190, P1488, DOI 10.1128/JB.01290-07; Hennig S, 2010, J BACTERIOL, V192, P4153, DOI 10.1128/JB.00226-10; HIGUCHI W, 2010, J INFECT CHEMOTHER, V16, P144, DOI DOI 10.1007/s10156-010-0029-9; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; HILL CW, 1981, P NATL ACAD SCI-BIOL, V78, P7069, DOI 10.1073/pnas.78.11.7069; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Huang TW, 2012, J BACTERIOL, V194, P1256, DOI 10.1128/JB.06666-11; Hung WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046987; Iguchi A, 2006, GENE, V372, P199, DOI 10.1016/j.gene.2006.01.005; Isobe H, 2012, BIOMED RES-TOKYO, V33, P97, DOI 10.2220/biomedres.33.97; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Iwao Y, 2012, J INFECT CHEMOTHER, V18, P228, DOI 10.1007/s10156-012-0379-6; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Khokhlova O, 2015, J MICROBIOL IMMUNOL, V48, P335, DOI 10.1016/j.jmii.2012.09.004; Khokhlova OE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128017; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kresse AU, 2003, MOL MICROBIOL, V47, P145, DOI 10.1046/j.1365-2958.2003.03261.x; Kuroda M, 2008, BIOCHEM BIOPH RES CO, V374, P237, DOI 10.1016/j.bbrc.2008.07.037; Li TM, 2016, INFECT IMMUN, V84, P723, DOI 10.1128/IAI.01088-15; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Loessner I, 2002, J BACTERIOL, V184, P4709, DOI 10.1128/JB.184.17.4709-4714.2002; LYON BR, 1987, J GEN MICROBIOL, V133, P3031; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maki H, 2004, ANTIMICROB AGENTS CH, V48, P1953, DOI 10.1128/AAC.48.6.1953-1959.2004; Murphy E., 1990, MOL BIOL STAPHYLOCOC, P123; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42, DOI 10.1159/000100857; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; RILEY M, 1978, ANNU REV MICROBIOL, V32, P519, DOI 10.1146/annurev.mi.32.100178.002511; Sawanobori E, 2015, J MICROBIOL IMMUNOL, V48, P565, DOI 10.1016/j.jmii.2014.04.015; Sekiguchi Jun-ichiro, 2006, Journal of Infection and Chemotherapy, V12, P47, DOI 10.1007/s10156-005-0417-8; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Snustad DP, 2015, PRINCIPLES GENETICS, DOI [10.1128/JB.00325-09, DOI 10.1128/JB.00325-09]; Stegger M, 2012, J BACTERIOL, V194, P1625, DOI 10.1128/JB.06653-11; Strommenger B, 2014, J ANTIMICROB CHEMOTH, V69, P616, DOI 10.1093/jac/dkt413; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Takano T, 2013, ANTIMICROB AGENTS CH, V57, P1589, DOI 10.1128/AAC.01147-12; Takano T, 2009, J INFECT CHEMOTHER, V15, P54, DOI 10.1007/s10156-008-0665-5; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Thompson MK, 2014, BIOCHEMISTRY-US, V53, P755, DOI 10.1021/bi4015852; Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Xia GQ, 2014, INFECT GENET EVOL, V21, P593, DOI 10.1016/j.meegid.2013.04.022; Yamamoto T, 2013, BIOMEDICINE-TAIWAN, V3, P2, DOI 10.1016/j.biomed.2012.12.001; Yamamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029187; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x	72	8	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164168	10.1371/journal.pone.0164168	http://dx.doi.org/10.1371/journal.pone.0164168			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741255	Green Submitted, Green Published, gold			2022-12-27	WOS:000385507000019
J	Caram, LMD; Ferrari, R; Bertani, AL; Garcia, T; Mesquita, CB; Knaut, C; Tanni, SE; Godoy, I				de Oliveira Caram, Laura Miranda; Ferrari, Renata; Bertani, Andre Luis; Garcia, Thais; Mesquita, Carolina Bonfanti; Knaut, Caroline; Tanni, Suzana Erico; Godoy, Irma			Smoking and Early COPD as Independent Predictors of Body Composition, Exercise Capacity, and Health Status	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; 6-MINUTE WALK TEST; AIR-FLOW OBSTRUCTION; TO-MODERATE COPD; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; FAT DISTRIBUTION; MUSCLE STRENGTH; MILD COPD	The effects of tobacco smoke, mild/moderate COPD disease and their combined effect on health status (HS), body composition (BC), and exercise capacity (EC) impairment are still unclear. We hypothesized that smoking and early COPD have a joint negative influence on these outcomes. We evaluated 32 smokers (smoking history > 10 pack/years), 32 mild/moderate COPD (current smokers or former smokers), and 32 never smokers. All individuals underwent medical and smoking status evaluations, pre and post-bronchodilator spirometry, BC [fat-free mass (FFM) and FFM index (FFMI)], EC [six-minute walk distance (6MWD)] and HS [Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)]. FFM (p = 0.02) and FFMI (p = 0.008) were lower in COPD than never smokers. 6MWT, as a percentage of reference values for the Brazilian population, was lower in COPD and smokers than never smokers (p = 0.01). Smokers showed worse SF-36 score for functional capacity than never smokers (p<0.001). SF-36 score for physical functioning (p<0.001) and role-emotional (p<0.001) were impaired in COPD patients than smokers. SF-36 scores for physical functioning (p<0.001), role-physical (p = 0.01), bodily pain (p = 0.01), vitality (p = 0.04) and role-emotional (p<0.001) were lower in COPD than never smokers. Multiple linear regression analysis showed that both COPD diagnosis and smoking were inversely associated with FFMI, 6MWD and HS. Smoking and early COPD have a joint negative influence on body composition, exercise capacity and health status.	[de Oliveira Caram, Laura Miranda; Ferrari, Renata; Bertani, Andre Luis; Garcia, Thais; Mesquita, Carolina Bonfanti; Knaut, Caroline; Tanni, Suzana Erico; Godoy, Irma] Univ Estadual Paulista, UNESP, Botucatu Med Sch, Dept Internal Med,Pneumol Area, Botucatu, SP, Brazil	Universidade Estadual Paulista	Caram, LMD (corresponding author), Univ Estadual Paulista, UNESP, Botucatu Med Sch, Dept Internal Med,Pneumol Area, Botucatu, SP, Brazil.	laucaram@hotmail.com	Minamoto, Suzana E T/C-2264-2012; tanni, suzana erico/AAE-9728-2020; Caram, Laura/F-5019-2015; GODOY, IRMA/J-8519-2014	Minamoto, Suzana E T/0000-0002-2587-2759; tanni, suzana erico/0000-0002-2587-2759; Knaut, Caroline/0000-0002-9005-818X; Caram, Laura/0000-0002-5863-2006; Ferrari, Renata/0000-0002-6740-5278; GODOY, IRMA/0000-0002-6588-5626	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/22321-0]; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support: This study received financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Foundation for the Support of Research in Sao Paulo State, grant no: 2012/22321-0). Laura Miranda de Oliveira Caram was a recipient of a scholarship grant from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro MPF, 2007, INT J IMMUNOPATH PH, V20, P753, DOI 10.1177/039463200702000411; Bjorngaard JH, 2013, PSYCHOL MED, V43, P711, DOI 10.1017/S0033291712001274; Borg, ESCALA BORG DOR ESFO; Boyer L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121539; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Clark CJ, 2000, EUR RESPIR J, V15, P92, DOI 10.1034/j.1399-3003.2000.15a17.x; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Cooper CB, 2009, RESP MED, V103, P325, DOI 10.1016/j.rmed.2008.10.026; Coronell C, 2004, EUR RESPIR J, V24, P129, DOI 10.1183/09031936.04.00079603; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Cukier A., 2001, J PNEUMOL, V27, P231, DOI DOI 10.1590/S0102-35862001000500001; de Oca MM, 2008, CHEST, V133, P13, DOI 10.1378/chest.07-1592; Degens H, 2015, AM J RESP CRIT CARE, V191, P620, DOI 10.1164/rccm.201410-1830PP; Diaz AA, 2013, RESP MED, V107, P570, DOI 10.1016/j.rmed.2012.12.011; Eliason G, 2009, SCAND J MED SCI SPOR, V19, P865, DOI 10.1111/j.1600-0838.2008.00858.x; Furlanetto KC, 2014, RESPIROLOGY, V19, P369, DOI 10.1111/resp.12236; Genc A, 2014, TURK J MED SCI, V44, P972, DOI 10.3906/sag-1308-65; GOLD, GLOB STRAT DIAGN MAN; Gosker HR, 2002, EUR RESPIR J, V19, P617, DOI 10.1183/09031936.02.00762001; Hoonhorst SJM, 2014, METABOLISM, V63, P1149, DOI 10.1016/j.metabol.2014.06.006; Iwama AM, 2009, BRAZ J MED BIOL RES, V42, P1080, DOI 10.1590/S0100-879X2009005000032; Janson C, 2013, EUR RESPIR J, V42, P1472, DOI 10.1183/09031936.00153712; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Langen RCJ, 2013, INT J BIOCHEM CELL B, V45, P2245, DOI 10.1016/j.biocel.2013.06.015; Maltais F, 2013, COPD, V10, P79, DOI 10.3109/15412555.2012.719048; Martinez JAB, 2004, CHEST, V125, P425, DOI 10.1378/chest.125.2.425; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; McDonough P, 1999, SPORTS MED, V27, P275, DOI 10.2165/00007256-199927050-00001; Meerwaldt R, 2008, AM J EPIDEMIOL, V167, P756, DOI 10.1093/aje/kwn018; Mesquita R, 2015, PHYSIOTHERAPY, V101, P55, DOI 10.1016/j.physio.2014.04.008; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Negi H, 2014, J POSTGRAD MED, V60, P7, DOI 10.4103/0022-3859.128797; Nollet F, 1999, ARCH PHYS MED REHAB, V80, P1316, DOI 10.1016/S0003-9993(99)90036-9; Northrop-Clewes CA, 2007, CLIN CHIM ACTA, V377, P14, DOI 10.1016/j.cca.2006.08.028; O'Donnell DE, 2014, INT J CHRONIC OBSTR, V9, P577, DOI 10.2147/COPD.S62766; O'Shea SD, 2007, ARCH PHYS MED REHAB, V88, P32, DOI 10.1016/j.apmr.2006.10.002; Pereira CAC, 1992, J PNEUMOL, V18, P10; Possani H, 2009, COMP REDUCTION MUSCL, P33; Puig-Vilanova E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102296; Reichert Jonatas, 2008, J. bras. pneumol., V34, P845, DOI 10.1590/S1806-37132008001000014; Roca J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-S2-S3; Rutten EPA, 2013, ANN NUTR METAB, V63, P239, DOI 10.1159/000353211; Saravanan C, 2014, ASIAN PAC J CANCER P, V15, P7629, DOI 10.7314/APJCP.2014.15.18.7629; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Statement of the American Thoracic Society, 1987, AM REV RESPIR DIS, V136, P1285, DOI [10.1164/ajrccm/136.5.1285, DOI 10.1164/AJRCCM/136.5.1285]; Steiner MC, 2005, THORAX, V60, P932, DOI 10.1136/thx.2004.038802; Sales MPU, 2009, J BRAS PNEUMOL, V35, P436, DOI 10.1590/S1806-37132009000500008; van den Borst B, 2011, THORAX, V66, P961, DOI 10.1136/thoraxjnl-2011-200010; Vernooy JH, 2002, AM J RESP CRIT CARE, V166, P1218, DOI 10.1164/rccm.2202023; Wacker ME, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-134; Wannamethee SG, 2005, AM J CLIN NUTR, V82, P996, DOI 10.1093/ajcn/82.5.996; who, CHRONIC RESP DIS; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001; Wust RCI, 2008, EUR J APPL PHYSIOL, V104, P103, DOI 10.1007/s00421-008-0792-9; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	57	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164290	10.1371/journal.pone.0164290	http://dx.doi.org/10.1371/journal.pone.0164290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737010	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800048
J	Hoiles, W; Gupta, R; Cornell, B; Cranfield, C; Krishnamurthy, V				Hoiles, William; Gupta, Rini; Cornell, Bruce; Cranfield, Charles; Krishnamurthy, Vikram			The Effect of Tethers on Artificial Cell Membranes: A Coarse-Grained Molecular Dynamics Study	PLOS ONE			English	Article							LIPID-BILAYER MEMBRANES; REVERSIBLE ELECTRICAL BREAKDOWN; FREE-ENERGY; SURFACE-TENSION; PORE-FORMATION; FORCE-FIELD; SIMULATIONS; MODEL; ELECTROPORATION; SIZE	Tethered bilayer lipid membranes (tBLMs) provide a stable platform for modeling the dynamics and order of biological membranes where the tethers mimic the cytoskeletal supports present in biological cell membranes. In this paper coarse-grained molecular dynamics (CGMD) is applied to study the effects of tethers on lipid membrane properties. Using results from the CGMD model and the overdamped Fokker-Planck equation, we show that the diffusion tensor and particle density of water in the tBLM is spatially dependent. Further, it is shown that the membrane thickness, lipid diffusion, defect density, free energy of lipid flip-flop, and membrane dielectric permittivity are all dependent on the tether density. The numerically computed results from the CGMD model are in agreement with the experimentally measured results from tBLMs containing different tether densities and lipids derived from Archaebacteria. Additionally, using experimental measurements from Escherichia coli bacteria and Saccharomyces Cerevisiae yeast tethered membranes, we illustrate how previous molecular dynamics results can be combined with the proposed model to estimate the dielectric permittivity and defect density of these membranes as a function of tether density.	[Hoiles, William; Gupta, Rini] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC, Canada; [Cornell, Bruce] Surgical Diagnost Pty Ltd, Sci & Technol, Unit 6 30-32 Barcoo St, Roseville, NSW 2069, Australia; [Cranfield, Charles] Univ Technol Sydney, Sch Life Sci, Broadway, NSW, Australia; [Krishnamurthy, Vikram] Cornell Univ, Elect & Comp Engn, New York, NY 10021 USA	University of British Columbia; University of Technology Sydney; Cornell University	Krishnamurthy, V (corresponding author), Cornell Univ, Elect & Comp Engn, New York, NY 10021 USA.	vikramk@cornell.edu		Cranfield, Charles/0000-0003-3608-5440; cornell, bruce/0000-0003-4166-3241	Surgical Diagnostics Pty Ltd.	Surgical Diagnostics Pty Ltd.	Surgical Diagnostics Pty Ltd. provided research materials and support in the form of salaries for author BC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section.	Asgari M, 2015, INT J NONLIN MECH, V76, P135, DOI 10.1016/j.ijnonlinmec.2015.06.001; Awasthi N, 2016, J CHEM THEORY COMPUT, V12, P3261, DOI 10.1021/acs.jctc.6b00369; BARNETT A, 1991, BIOELECTROCH BIOENER, V25, P163, DOI 10.1016/0302-4598(91)87001-W; Beerlink A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3263946; Bennett WFD, 2014, BIOPHYS J, V106, P210, DOI 10.1016/j.bpj.2013.11.4486; Bennett WFD, 2011, J CHEM THEORY COMPUT, V7, P2981, DOI 10.1021/ct200291v; Bennett WFD, 2009, J AM CHEM SOC, V131, P1972, DOI 10.1021/ja808541r; Bressloff PC, 2013, REV MOD PHYS, V85, P135, DOI 10.1103/RevModPhys.85.135; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Camley BA, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4932980; Camley BA, 2013, SOFT MATTER, V9, P4767, DOI 10.1039/c3sm00073g; Castellana ET, 2006, SURF SCI REP, V61, P429, DOI 10.1016/j.surfrep.2006.06.001; Castro-Roman F, 2006, J PHYS CHEM B, V110, P24157, DOI 10.1021/jp064746g; Cicero G, 2011, J PHYS CHEM LETT, V2, P2582, DOI 10.1021/jz200989n; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; de Joannis J, 2006, LANGMUIR, V22, P998, DOI 10.1021/la051278d; de los Santos F, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.010602; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Falck E, 2008, J AM CHEM SOC, V130, P44, DOI 10.1021/ja7103558; FELLER SE, 1995, J CHEM PHYS, V103, P10267, DOI 10.1063/1.469928; Flenner E, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011907; FREEMAN SA, 1994, BIOPHYS J, V67, P42, DOI 10.1016/S0006-3495(94)80453-9; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Goetz R, 1998, J CHEM PHYS, V108, P7397, DOI 10.1063/1.476160; Heinrich F, 2009, LANGMUIR, V25, P4219, DOI 10.1021/la8033275; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinczewski M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3442716; Hoiles W, 2014, BIOPHYS J, V107, P1339, DOI 10.1016/j.bpj.2014.07.056; Hu Y, 2015, LANGMUIR, V31, P6615, DOI 10.1021/la504049q; Jahnig F, 1996, BIOPHYS J, V71, P1348, DOI 10.1016/S0006-3495(96)79336-0; Jiang FY, 2004, BIOPHYS J, V87, P182, DOI 10.1529/biophysj.103.031054; Jiang Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2430714; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Klauda JB, 2008, CURR TOP MEMBR, V60, P1, DOI 10.1016/S1063-5823(08)00001-X; Klauda JB, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2354486; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee H, 2009, J PHYS CHEM B, V113, P13186, DOI 10.1021/jp9058966; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Lin WC, 2006, BIOPHYS J, V90, P228, DOI 10.1529/biophysj.105.067066; Liu C, 2012, LANGMUIR, V28, P15907, DOI 10.1021/la303511p; Liu P, 2004, J PHYS CHEM B, V108, P6595, DOI 10.1021/jp0375057; Lyubartsev AP, 2016, BBA-BIOMEMBRANES, V1858, P2483, DOI 10.1016/j.bbamem.2015.12.033; Malmstadt N, 2008, ADV MATER, V20, P84, DOI 10.1002/adma.200700810; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Marrink SJ, 2001, J PHYS CHEM B, V105, P6122, DOI 10.1021/jp0103474; McGillivray DJ, 2007, BIOINTERPHASES, V2, P21, DOI 10.1116/1.2709308; Naumann CA, 2002, BIOMACROMOLECULES, V3, P27, DOI 10.1021/bm0100211; Neu JC, 1999, PHYS REV E, V59, P3471, DOI 10.1103/PhysRevE.59.3471; Parisio G, 2016, INT J ADV ENG SCI AP, V8, P134, DOI 10.1007/s12572-015-0155-9; Pastushenko V. F., 1979, J ELECTROANAL CHEM I, V104, P53, DOI [10.1016/S0022-0728(79)81007-4, DOI 10.1016/S0022-0728(79)81007-4, 10.1016/S0022-0728(79), DOI 10.1016/S0022-0728(79]; Piggot TJ, 2011, J PHYS CHEM B, V115, P13381, DOI 10.1021/jp207013v; Poger D, 2016, BBA-BIOMEMBRANES, V1858, P1556, DOI 10.1016/j.bbamem.2016.01.029; Polak A, 2013, J MEMBRANE BIOL, V246, P843, DOI 10.1007/s00232-013-9570-7; Raguse B, 1998, LANGMUIR, V14, P648, DOI 10.1021/la9711239; Raicu V., 2008, INTEGRATED MOL CELLU, DOI [10.1007/978-1-4020-8268-9, DOI 10.1007/978-1-4020-8268-9]; Roark M, 2009, J PHYS CHEM B, V113, P13229, DOI 10.1021/jp902186f; Rog T, 2002, CHEM PHYS LETT, V352, P323, DOI 10.1016/S0009-2614(02)00002-7; Sedlmeier F, 2011, J STAT PHYS, V145, P240, DOI 10.1007/s10955-011-0338-0; Shinoda W, 2004, CHEM PHYS LETT, V390, P35, DOI 10.1016/j.cplett.2004.03.145; Shinoda W, 2003, J PHYS CHEM B, V107, P14030, DOI 10.1021/jp035493j; Simunovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8219; Singh MB, 2014, J PHYS CHEM C, V118, P5122, DOI 10.1021/jp410999b; Smith KC, 2004, BIOPHYS J, V86, P2813, DOI 10.1016/S0006-3495(04)74334-9; Tieleman DP, 2006, J AM CHEM SOC, V128, P12462, DOI 10.1021/ja0624321; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; von Hansen Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.118103; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Wang SH, 2013, SOFT MATTER, V9, P480, DOI 10.1039/c2sm26850g; Wohlert J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2171965; Xing CY, 2008, J PHYS CHEM B, V112, P7086, DOI 10.1021/jp077305l; Xing CY, 2009, SOFT MATTER, V5, P4526, DOI 10.1039/b912719d; Xing CY, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3262315; Yamamoto E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04720; ZHELEV DV, 1993, BIOCHIM BIOPHYS ACTA, V1147, P89, DOI 10.1016/0005-2736(93)90319-U	78	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0162790	10.1371/journal.pone.0162790	http://dx.doi.org/10.1371/journal.pone.0162790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736860	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800006
J	Dal Molin, M; Brant, A; Blackford, AL; Griffin, JF; Shindo, K; Barkley, T; Rezaee, N; Hruban, RH; Wolfgang, CL; Goggins, M				Dal Molin, Marco; Brant, Aaron; Blackford, Amanda L.; Griffin, James F.; Shindo, Koji; Barkley, Thomas; Rezaee, Neda; Hruban, Ralph H.; Wolfgang, Christopher L.; Goggins, Michael			Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							CANCER INCIDENCE; INTERMITTENT HYPOXIA; PREVALENCE; MORTALITY; COHORT; CELLS; ASSOCIATION; LINKS	Background Prospective studies have identified obstructive sleep apnea (OSA) as a risk factor for increased overall cancer incidence and mortality. The potential role of OSA in the risk or progression of specific cancers is not well known. We hypothesized that pathological differences in pancreatic cancers from OSA cases compared to non-OSA cases would implicate OSA in pancreatic cancer progression. Methods We reviewed the medical records of 1031 patients who underwent surgical resection without neoadjuvant therapy for pancreatic ductal adenocarcinoma (PDAC) at Johns Hopkins Hospital between 2003 and 2014 and compared the TNM classification of their cancer and their overall survival by patient OSA status. Results OSA cases were significantly more likely than non-OSA cases to have lymph node-negative tumors (37.7% vs. 21.8%, p = 0.004). Differences in the prevalence of nodal involvement of OSA vs. non-OSA cases were not associated with differences in other pathological characteristics such as tumor size, tumor location, resection margin status, vascular or perineural invasion, or other comorbidities more common to OSA cases (BMI, smoking, diabetes). A logistic regression model found that a diagnosis of OSA was an independent predictor of lymph node status (hazard ratio, 0.051, p = 0.038). Patients with OSA had similar overall survival compared to those without OSA (HR, 0.89, (0.65-1.24), p = 0.41). Conclusion The observed pathological differences between OSA-associated and non-OSA-associated pancreatic cancers supports the hypothesis that OSA can influence the pathologic features of pancreatic ductal adenocarcinoma.	[Dal Molin, Marco; Brant, Aaron; Shindo, Koji; Barkley, Thomas; Hruban, Ralph H.; Wolfgang, Christopher L.; Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Blackford, Amanda L.; Hruban, Ralph H.; Wolfgang, Christopher L.; Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Griffin, James F.; Rezaee, Neda; Wolfgang, Christopher L.] Johns Hopkins Univ, Sch Med, Dept Surg, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Goggins, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA.; Goggins, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA.; Goggins, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA.	mgoggins@jhmi.edu	Wolfgang, Christopher/HGD-0863-2022		NCI [CA62924, CA176828]; Pancreatic Cancer Action Network; Susan Wojcicki; Dennis Troper; Rolfe Pancreatic Cancer Foundation	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pancreatic Cancer Action Network; Susan Wojcicki; Dennis Troper; Rolfe Pancreatic Cancer Foundation	This work was supported by NCI (CA62924, CA176828), Pancreatic Cancer Action Network, Susan Wojcicki, Dennis Troper, and the Rolfe Pancreatic Cancer Foundation. The funders did not have any role in the design of the study.	Almendros I, 2014, AM J RESP CRIT CARE, V189, P593, DOI 10.1164/rccm.201310-1830OC; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500; Dhani NC, 2015, BRIT J CANCER, V113, P864, DOI 10.1038/bjc.2015.284; Gaoatswe G, 2015, SLEEP, V38, P1629, DOI 10.5665/sleep.5062; Gozal D, 2015, CHEST, V148, P1140, DOI 10.1378/chest.15-0634; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hiestand DM, 2006, CHEST, V130, P780, DOI 10.1378/chest.130.3.780; Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Jeong HS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv155; Kendzerska T, 2014, CAN MED ASSOC J, V186, P985, DOI 10.1503/cmaj.140238; Klein AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072311; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Luoto Kaisa R, 2013, Genome Integr, V4, P5, DOI 10.1186/2041-9414-4-5; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; Martinez-Garcia MA, 2014, SLEEP MED, V15, P742, DOI 10.1016/j.sleep.2014.01.020; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1661, DOI 10.1183/09031936.00115413; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; Myers KA, 2013, JAMA-J AM MED ASSOC, V310, P731, DOI 10.1001/jama.2013.276185; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; Palazon A, 2012, CLIN CANCER RES, V18, P1207, DOI 10.1158/1078-0432.CCR-11-1591; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Pawlik TM, 2007, SURGERY, V141, P610, DOI 10.1016/j.surg.2006.12.013; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Sharma S, 2015, J CLIN SLEEP MED JCS, V3, P00378; Sipos B, 2005, J PATHOL, V207, P301, DOI 10.1002/path.1840; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Stromnes IM, 2015, CANCER CELL, V28, P638, DOI 10.1016/j.ccell.2015.09.022; Verduzco D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120958; Vgontzas AN, 2016, J PHYSIOL-LONDON, V594, P4687, DOI 10.1113/JP272114; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Yu J, 2015, GUT, V64, P1783, DOI 10.1136/gutjnl-2014-308653	37	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164195	10.1371/journal.pone.0164195	http://dx.doi.org/10.1371/journal.pone.0164195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732623	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505300042
J	Ceccarelli, FS; Opell, BD; Haddad, CR; Raven, RJ; Soto, EM; Ramirez, MJ				Sara Ceccarelli, F.; Opell, Brent D.; Haddad, Charles R.; Raven, Robert J.; Soto, Eduardo M.; Ramirez, Martin J.			Around theWorld in Eight Million Years: Historical Biogeography and Evolution of the Spray Zone Spider Amaurobioides (Araneae: Anyphaenidae)	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; WEST WIND DRIFT; NEW-ZEALAND; VICARIANCE ANALYSIS; DIVERGENCE TIMES; SPECIES TREES; GENE TREES; DIVERSIFICATION; ARACHNIDA; ISLANDS	Closely related organisms with transoceanic distributions have long been the focus of historical biogeography, prompting the question of whether long-distance dispersal, or tectonic-driven vicariance shaped their current distribution. Regarding the Southern Hemisphere continents, this question deals with the break-up of the Gondwanan landmass, which has also affected global wind and oceanic current patterns since the Miocene. With the advent of phylogenetic node age estimation and parametric bioinformatic advances, researchers have been able to disentangle historical evolutionary processes of taxa with greater accuracy. In this study, we used the coastal spider genus Amaurobioides to investigate the historical biogeographical and evolutionary processes that shaped the modernday distribution of species of this exceptional genus of spiders. As the only genus of the subfamily Amaurobioidinae found on three Southern Hemisphere continents, its distribution is well-suited to study in the context of Gondwanic vicariance versus long-distance, transoceanic dispersal. Ancestral species of the genus Amaurobioides appear to have undergone several long-distance dispersal events followed by successful establishments and speciation, starting from the mid-Miocene through to the Pleistocene. The most recent common ancestor of all present-day Amaurobioides species is estimated to have originated in Africa after arriving from South America during the Miocene. From Africa the subsequent dispersals are likely to have taken place predominantly in an eastward direction. The longdistance dispersal events by Amaurobioides mostly involved transoceanic crossings, which we propose occurred by rafting, aided by the Antarctic Circumpolar Current and the West Wind Drift.	[Sara Ceccarelli, F.; Ramirez, Martin J.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Aracnol, Av Angel Gallardo 470,C1405DJR, Buenos Aires, DF, Argentina; [Opell, Brent D.] Virginia Tech, Dept Biol Sci, 1405 Perry St, Blacksburg, VA 24061 USA; [Haddad, Charles R.] Univ Free State, Dept Zool & Entomol, POB 339, ZA-9300 Bloemfontein, South Africa; [Raven, Robert J.] Queensland Museum, Terr Biodivers Grp, Arachnid Collect, Grey St,POB 3300, South Brisbane, Qld 4101, Australia; [Soto, Eduardo M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IEGEBA CONICET UBA, Dept Ecol Genet & Evoluc, Ciudad Univ,Pabellon 2,C1428 EHA, Buenos Aires, DF, Argentina	Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Virginia Polytechnic Institute & State University; University of the Free State; Queensland Museum; University of Buenos Aires	Ceccarelli, FS (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Aracnol, Av Angel Gallardo 470,C1405DJR, Buenos Aires, DF, Argentina.	saracecca@hotmail.com	Raven, Robert/GZK-2774-2022; Ceccarelli, F. Sara/L-3208-2019	Soto, Eduardo M./0000-0001-6500-5978; Ceccarelli, Fadia Sara/0000-0003-4117-7366; Haddad, Charles/0000-0002-2317-7760	National Geographic Society [7557-03]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011-1007]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [BecaPosdoc13]	National Geographic Society(National Geographic Society); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas	This work was supported by the National Geographic Society (http://www.nationalgeographic.com) research grant 7557-03 to BDO. Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/) research grant PICT 2011-1007 to MJR. Consejo Nacional de Investigaciones Cientificas y Tecnologicas (http://www.conicet.gov.ar/) BecaPosdoc13 to FSC.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; [Anonymous], 2016, WORLD SPIDER CATALOG; Arnedo MA, 2001, CLADISTICS, V17, P313, DOI 10.1111/j.1096-0031.2001.tb00129.x; Arnedo MA, 2007, ZOOL SCR, V36, P337, DOI 10.1111/j.1463-6409.2007.00280.x; Barker P.F., 1982, ANTARCTIC GEOSCIENCE, P377; Bergh NG, 2009, MOL PHYLOGENET EVOL, V51, P5, DOI 10.1016/j.ympev.2008.09.001; Blandenier G, 1998, P 17 EUR C AR 1998 E, V1997, P178; Bonte D, 2003, P ROY SOC B-BIOL SCI, V270, P1601, DOI 10.1098/rspb.2003.2432; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cook LG, 2005, J BIOGEOGR, V32, P741, DOI 10.1111/j.1365-2699.2005.01261.x; Cumming RA, 2014, J BIOGEOGR, V41, P2357, DOI 10.1111/jbi.12376; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; DEAN DA, 1985, J ARACHNOL, V13, P111; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Foelix R. F, 2011, BIOL SPIDERS; Forster R. R., 1955, RECORDS DOMINION MUS, V2, P167; Forster RR., 1999, SPIDERS NZ THEIR WOR; Forster RR, 1970, OTAGO MUS B, V3, P1; Garb JE, 2006, J BIOGEOGR, V33, P201, DOI 10.1111/j.1365-2699.2005.01398.x; Gillespie RG, 2002, J BIOGEOGR, V29, P655, DOI 10.1046/j.1365-2699.2002.00714.x; Gillespie RG, 2008, PHILOS T R SOC B, V363, P3335, DOI 10.1098/rstb.2008.0124; Gillespie RG, 2016, EVOL APPL, V9, P53, DOI 10.1111/eva.12302; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Giribet G, 2012, BIOL J LINN SOC, V105, P92, DOI 10.1111/j.1095-8312.2011.01774.x; Goloboff P, 2008, CLADISTICS, V24, P91; Hayashi M, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0402-5; HEATWOLE H, 1972, ECOLOGY, V53, P112, DOI 10.2307/1935715; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HELMUTH B, 1994, MAR BIOL, V120, P421, DOI 10.1007/BF00680216; Hewitt J, 1917, ANN NAT MUS, V3, P687; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kayaalp P, 2013, MOL PHYLOGENET EVOL, V66, P668, DOI 10.1016/j.ympev.2012.10.018; Kodandaramaiah U, 2007, J EVOLUTION BIOL, V20, P2181, DOI 10.1111/j.1420-9101.2007.01425.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Labarque FM, 2015, ZOOL SCR, V44, P550, DOI 10.1111/zsc.12119; Lamoral B. H., 1968, Annals of the Natal Museum, V20, P139; Landis MJ, 2013, SYST BIOL, V62, P789, DOI 10.1093/sysbio/syt040; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lanier HC, 2012, SYST BIOL, V61, P691, DOI 10.1093/sysbio/syr128; Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maddison WP., 2021, MESQUITE MODULAR SYS; Matzke N.J., 2012, FRONTIERS BIOGEOGRAP, V4, P210; Matzke N.J., 2013, PACKAGE BIOGEOBEARS; Matzke NJ, 2014, SYST BIOL, V63, P951, DOI 10.1093/sysbio/syu056; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; MCQUEEN DJ, 1983, NEW ZEAL J ZOOL, V10, P383, DOI 10.1080/03014223.1983.10423933; Miller M.A., 2010, P GAT COMP ENV WORKS; NIKULA R, 2012, BIOL LETT, V0009; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Opatova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115078; Opell BD, 2007, ZOOTAXA, P1; Opell BD, 2016, BIOL J LINN SOC, V118, P959, DOI 10.1111/bij.12788; Opell BD, 2010, BIOL J LINN SOC, V101, P78, DOI 10.1111/j.1095-8312.2010.01480.x; Penney D, 2000, J ARACHNOL, V28, P223, DOI 10.1636/0161-8202(2000)028[0223:AIMDRA]2.0.CO;2; Petrunkevitch Alexander, 1946, AMER MUS NOVITATES, V1328, P1; Piganeau G, 2004, MOL BIOL EVOL, V21, P2319, DOI 10.1093/molbev/msh244; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Pugh PJA, 2004, J NAT HIST, V38, P1461, DOI 10.1080/0022293031000155403; R Core Team, 2013, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 5; Ramirez MJ, 2003, B AM MUS NAT HIST, P1; RAVEN RJ, 1980, J ARACHNOL, V8, P251; Ree RH, 2005, EVOLUTION, V59, P2299; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sanmartin I, 2007, J BIOGEOGR, V34, P398, DOI 10.1111/j.1365-2699.2006.01655.x; Schiesari L, 2003, J TROP ECOL, V19, P333, DOI 10.1017/S0266467403003365; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Smith SDA, 2002, GLOBAL ECOL BIOGEOGR, V11, P67, DOI 10.1046/j.1466-822X.2001.00259.x; Soto EM, 2012, ZOOTAXA, P1; Thiel M, 2006, OCEANOGR MAR BIOL, V44, P323, DOI 10.1201/9781420006391.ch7; Waters JM, 2008, J BIOGEOGR, V35, P417, DOI 10.1111/j.1365-2699.2007.01724.x; Winkworth RC, 2002, TRENDS ECOL EVOL, V17, P514, DOI 10.1016/S0169-5347(02)02590-9; Wood HM, 2013, SYST BIOL, V62, P264, DOI 10.1093/sysbio/sys092; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Zabka M, 2002, ANN ZOOL, V52, P459; Zhang JX, 2013, MOL PHYLOGENET EVOL, V68, P81, DOI 10.1016/j.ympev.2013.03.017	85	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163740	10.1371/journal.pone.0163740	http://dx.doi.org/10.1371/journal.pone.0163740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732621	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300027
J	Harrison, OJ; Moorjani, N; Torrens, C; Ohri, SK; Cagampang, FR				Harrison, Oliver J.; Moorjani, Narain; Torrens, Christopher; Ohri, Sunil K.; Cagampang, Felino R.			Endogenous Reference Genes for Gene Expression Studies on Bicuspid Aortic Valve Associated Aortopathy in Humans	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; ANEURYSMS; DISEASE; RNA	Bicuspid aortic valve (BAV) disease is the most common congenital cardiac abnormality and predisposes patients to life-threatening aortic complications including aortic aneurysm. Quantitative real-time reverse transcription PCR (qRT-PCR) is one of the most commonly used methods to investigate underlying molecular mechanisms involved in aortopathy. The accuracy of the gene expression data is dependent on normalization by appropriate housekeeping (HK) genes, whose expression should remain constant regardless of aortic valve morphology, aortic diameter and other factors associated with aortopathy. Here, we identified an appropriate set of HK genes to be used as endogenous reference for quantifying gene expression in ascending aortic tissue using a spin column-based RNA extraction method. Ascending aortic biopsies were collected intra-operatively from patients undergoing aortic valve and/or ascending aortic surgery. These patients had BAV or tricuspid aortic valve (TAV), and the aortas were either dilated (>= 4.5cm) or undilated. The cohort had an even distribution of gender, valve disease and hypertension. The expression stability of 12 reference genes were investigated (ATP5B, ACTB, B2M, CYC1, EIF4A2, GAPDH, SDHA, RPL13A, TOP1, UBC, YWHAZ, and 18S) using geNorm software. The most stable HK genes were found to be GAPDH, UBC and ACTB. Both GAPDH and UBC demonstrated relative stability regardless of valve morphology, aortic diameter, gender and age. The expression of B2M and SDHA were found to be the least stable HK genes. We propose the use of GAPDH, UBC and ACTB as reference genes for gene expression studies of BAV aortopathy using ascending aortic tissue.	[Harrison, Oliver J.; Torrens, Christopher; Cagampang, Felino R.] Univ Southampton, Fac Med, Inst Dev Sci, Southampton, Hants, England; [Moorjani, Narain] Papworth Hosp NHS Fdn Trust, Dept Cardiac Surg, Cambridge, England; [Ohri, Sunil K.] Southampton Univ Hosp, Dept Cardiac Surg, Southampton, Hants, England	University of Southampton; Papworth Hospital; University of Southampton	Harrison, OJ (corresponding author), Univ Southampton, Fac Med, Inst Dev Sci, Southampton, Hants, England.	O.J.Harrison@soton.ac.uk	Cagampang, Felino/AAG-5141-2019; Torrens, Christopher/A-8117-2013	Cagampang, Felino/0000-0003-4404-9853; Torrens, Christopher/0000-0003-4377-0112	PrimerDesign UK	PrimerDesign UK	This work was supported by PrimerDesign UK (htts://www.primerdesign.co. LK). PrimerDesign UK provided funding in form of Gold Sponsorship of OH and provided geNorm kit free of charge.	Abdulkareem N, 2013, INTERACT CARDIOV TH, V17, P554, DOI 10.1093/icvts/ivt196; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Cleal JK, 2009, PLACENTA, V30, P1002, DOI 10.1016/j.placenta.2009.09.002; Cleal JK, 2014, BRAIN RES, V1575, P72, DOI 10.1016/j.brainres.2014.05.031; Della Corte A, 2007, EUR J CARDIO-THORAC, V31, P397, DOI 10.1016/j.ejcts.2006.12.006; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Henn D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054132; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Isselbacher EM, 2005, CIRCULATION, V111, P816, DOI 10.1161/01.CIR.0000154569.08857.7A; Majumdar R, 2007, CARDIOVASC PATHOL, V16, P144, DOI 10.1016/j.carpath.2006.12.001; Pfister Christina, 2011, BMC Res Notes, V4, P275, DOI 10.1186/1756-0500-4-275; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Pisano C, 2012, INTERACT CARDIOV TH, V14, P300, DOI 10.1093/icvts/ivr114; Rueda-Martinez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097449; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Tzemos N, 2008, JAMA-J AM MED ASSOC, V300, P1317, DOI 10.1001/jama.300.11.1317; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	19	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164329	10.1371/journal.pone.0164329	http://dx.doi.org/10.1371/journal.pone.0164329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727313	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000385504400028
J	Panpisut, P; Liaqat, S; Zacharaki, E; Xia, W; Petridis, H; Young, AM				Panpisut, Piyaphong; Liaqat, Saad; Zacharaki, Eleni; Xia, Wendy; Petridis, Haralampos; Young, Anne Margaret			Dental Composites with Calcium / Strontium Phosphates and Polylysine	PLOS ONE			English	Article							RESIN-COMPOSITES; IN-VITRO; CONVERSION; POLYMERIZATION; CHLORHEXIDINE; MECHANISMS; RESTORATIONS; CONTRACTION; KINETICS; ADHESION	Purpose This study developed light cured dental composites with added monocalcium phosphate monohydrate (MCPM), tristrontium phosphate (TSrP) and antimicrobial polylysine (PLS). The aim was to produce composites that have enhanced water sorption induced expansion, can promote apatite precipitation and release polylysine. Materials and Methods Experimental composite formulations consisted of light activated dimethacrylate monomers combined with 80 wt% powder. The powder phase contained a dental glass with and without PLS (2.5 wt%) and/or reactive phosphate fillers (15 wt% TSrP and 10 wt% MCPM). The commercial composite, Z250, was used as a control. Monomer conversion and calculated polymerization shrinkage were assessed using FTIR. Subsequent mass or volume changes in water versus simulated body fluid (SBF) were quantified using gravimetric studies. These were used, along with Raman and SEM, to assess apatite precipitation on the composite surface. PLS release was determined using UV spectroscopy. Furthermore, biaxial flexural strengths after 24 hours of SBF immersion were obtained. Results Monomer conversion of the composites decreased upon the addition of phosphate fillers (from 76 to 64%) but was always higher than that of Z250 (54%). Phosphate addition increased water sorption induced expansion from 2 to 4% helping to balance the calculated polymerization shrinkage of similar to 3.4%. Phosphate addition promoted apatite precipitation from SBF. Polylysine increased the apatite layer thickness from similar to 10 to 20 mu m after 4 weeks. The novel composites showed a burst release of PLS (3.7%) followed by diffusion-controlled release irrespective of phosphate addition. PLS and phosphates decreased strength from 154 MPa on average by 17% and 18%, respectively. All formulations, however, had greater strength than the ISO 4049 requirement of > 80 MPa. Conclusion The addition of MCPM with TSrP promoted hygroscopic expansion, and apatite formation. These properties are expected to help compensate polymerization shrinkage and help remineralize demineralized dentin. Polylysine can be released from the composites at early time. This may kill residual bacteria.	[Panpisut, Piyaphong; Liaqat, Saad; Xia, Wendy; Young, Anne Margaret] UCL Eastman Dent Inst, Dept Biomat & Tissue Engn, London, England; [Liaqat, Saad] COMBATS, IRCBM, Lahore, Pakistan; [Zacharaki, Eleni; Petridis, Haralampos] UCL Eastman Dent Inst, Unit Prosthodont, Dept Restorat Dent, London, England	University of London; University College London; University of London; University College London	Young, AM (corresponding author), UCL Eastman Dent Inst, Dept Biomat & Tissue Engn, London, England.	Anne.Young@ucl.ac.uk	Panpisut, Piyaphong/AAJ-5419-2021; Panpisut, Piyaphong/AAW-1712-2020; Liaqat, Saad/J-1740-2014; panpisut, piyaphong/L-7363-2019	Panpisut, Piyaphong/0000-0002-8649-857X; Liaqat, Saad/0000-0002-8164-1875; Young, Anne/0000-0001-8485-2056	Royal Thai Government (Ministry of Sciences and Technology); National Institute for Health Research (Invention for Innovation); UK EPSRC (Engineering and Physical Sciences Research Council) [EPI/I02234/1]; Welcome trust (Wtissf 3: Institutional Strategic Support Fund (Issf) Third Tranche;  [II-LB-0214-2002]; EPSRC [EP/I022341/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I022341/1] Funding Source: researchfish; National Institute for Health Research [II-LB-0214-20002] Funding Source: researchfish	Royal Thai Government (Ministry of Sciences and Technology); National Institute for Health Research (Invention for Innovation); UK EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Welcome trust (Wtissf 3: Institutional Strategic Support Fund (Issf) Third Tranche; ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Royal Thai Government (Ministry of Sciences and Technology) (PP), National Institute for Health Research (Invention for Innovation (i4i, http://www.nihr.ac.uk/funding/invention-for-innovation.htm)); Optimisation and commercial manufacture of tooth-coloured composite dental fillings with added poly-antimicrobial (PAM) and remineralising calcium phosphate (CaP), II-LB-0214-2002) (WX), UK EPSRC (Engineering and Physical Sciences Research Council, https://www.epsrc.ac.uk) (EPI/I02234/1) (WX); and Welcome trust (Wtissf 3: Institutional Strategic Support Fund (Issf) Third Tranche, www.wellcome.ac.uk/Funding/WTP057769.htm) (WX) have provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilias DS, 2002, J MACROMOL SCI PURE, VA39, P1435, DOI 10.1081/MA-120016045; Aljabo A, 2015, DENT MATER, V31, P1279, DOI 10.1016/j.dental.2015.08.149; Aljabo A, 2016, MAT SCI ENG C-MATER, V60, P285, DOI 10.1016/j.msec.2015.11.047; Alshali RZ, 2013, DENT MATER, V29, pE213, DOI 10.1016/j.dental.2013.05.011; ANTONUCCI JM, 1991, DENT MATER, V7, P124, DOI 10.1016/0109-5641(91)90058-7; Asaoka K, 2003, BIOMATERIALS, V24, P975, DOI 10.1016/S0142-9612(02)00435-0; Austin R, 2016, DENT UPDATE, V43, P6; Austin R, 2016, DENT UPDATE, V43, P2; Austin Rupert, 2016, Dent Update, V43, P8; Banerjee A, 2013, BRIT DENT J, V214, P107, DOI 10.1038/sj.bdj.2013.106; Benetti AR, 2015, OPER DENT, V40, P190, DOI 10.2341/13-324-L; Brauer DS, 2015, ANGEW CHEM INT EDIT, V54, P4160, DOI 10.1002/anie.201405310; British Standard, 2009, 40492009 BS EN ISO; British Standard, 2012, 233172012 ISO BRIT S; Calogiuri G.F., 2013, J ALLERGY THER, V4, P141, DOI [10.4172/2155-6121.1000141, DOI 10.4172/2155-6121.1000141]; Dewaele M, 2006, DENT MATER, V22, P359, DOI 10.1016/j.dental.2005.03.014; Drouet C, 2008, MAT SCI ENG C-BIO S, V28, P1544, DOI 10.1016/j.msec.2008.04.011; Durner J, 2012, DENT MATER, V28, P46, DOI 10.1016/j.dental.2012.08.006; Farrugia C, 2015, DENT MATER, V31, pE89, DOI 10.1016/j.dental.2014.12.005; Ferracane JL, 2013, DENT MATER, V29, P51, DOI 10.1016/j.dental.2012.06.013; Ferracane JL, 2006, DENT MATER, V22, P211, DOI 10.1016/j.dental.2005.05.005; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002; Fu Y, 2010, EXPERT OPIN DRUG DEL, V7, P429, DOI 10.1517/17425241003602259; Fujita K, 2005, DENT MATER J, V24, P403, DOI 10.4012/dmj.24.403; Gandolfi MG, 2011, DENT MATER, V27, P1055, DOI 10.1016/j.dental.2011.07.007; Goldberg M, 2008, CLIN ORAL INVEST, V12, P1, DOI 10.1007/s00784-007-0162-8; Grotzky A, 2010, ANAL METHODS-UK, V2, P1448, DOI 10.1039/c0ay00116c; Hidalgo E, 2001, TOXICOL IN VITRO, V15, P271, DOI 10.1016/S0887-2333(01)00020-0; Higgs WAJ, 2001, J BIOMED MATER RES, V58, P188, DOI 10.1002/1097-4636(2001)58:2<188::AID-JBM1006>3.3.CO;2-M; Howard B, 2010, ACTA BIOMATER, V6, P2053, DOI 10.1016/j.actbio.2009.11.006; Kopperud SE, 2012, EUR J ORAL SCI, V120, P539, DOI 10.1111/eos.12004; Kulik EM, 2015, CLIN ORAL INVEST, V19, P1547, DOI 10.1007/s00784-014-1379-y; Leung D, 2005, BIOMATERIALS, V26, P7145, DOI 10.1016/j.biomaterials.2005.05.014; Lippert F, 2013, CARIES RES, V47, P34, DOI 10.1159/000343008; Lubbert A, 2005, LANGMUIR, V21, P6582, DOI 10.1021/la0502600; Marovic D, 2014, DENT MATER, V30, P1052, DOI 10.1016/j.dental.2014.06.001; Mehdawi I, 2009, ACTA BIOMATER, V5, P2525, DOI 10.1016/j.actbio.2009.03.030; Mehdawi IM, 2013, DENT MATER, V29, P473, DOI 10.1016/j.dental.2013.01.010; Nagem H, 2007, J APPL ORAL SCI, V15, P448, DOI 10.1590/S1678-77572007000500014; Nedeljkovic I, 2015, DENT MATER, V31, pE247, DOI 10.1016/j.dental.2015.09.001; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Overton JD, 2012, J DENT EDUC, V76, P338; Park JW, 2014, J DENT RES, V93, P195, DOI 10.1177/0022034513513905; Pemberton MN, 2012, BRIT DENT J, V213, P547, DOI 10.1038/sj.bdj.2012.1086; Pick B, 2010, DENT MATER, V26, P83, DOI 10.1016/j.dental.2009.09.002; Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178; Roumanas Eleni D, 2010, J Evid Based Dent Pract, V10, P23, DOI 10.1016/j.jebdp.2009.11.009; Schneider Luis Felipe J, 2010, J Dent Biomech, V2010, DOI 10.4061/2010/131630; Shahid S, 2014, DENT MATER, V30, P308, DOI 10.1016/j.dental.2013.12.003; Shukla SC, 2012, BIOCHEM ENG J, V65, P70, DOI 10.1016/j.bej.2012.04.001; Sideridou I, 2002, BIOMATERIALS, V23, P1819, DOI 10.1016/S0142-9612(01)00308-8; Smiline Girija A S, 2012, Indian J Dent Res, V23, P26, DOI 10.4103/0970-9290.99033; Walters NJ, 2016, DENT MATER, V32, P264, DOI 10.1016/j.dental.2015.11.017; Wu JL, 2015, J DENT, V43, P317, DOI 10.1016/j.jdent.2015.01.009; Yan SF, 2011, COLLOID SURFACE B, V86, P218, DOI 10.1016/j.colsurfb.2011.04.004; Yang Y, 2006, PHYS MED BIOL, V51, P1649, DOI 10.1088/0031-9155/51/7/001; Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9; Young AM, 2004, BIOMATERIALS, V25, P823, DOI 10.1016/S0142-9612(03)00599-4; Young AM, 2008, ACTA BIOMATER, V4, P1081, DOI 10.1016/j.actbio.2007.12.009; Zorzin J, 2015, DENT MATER, V31, P293, DOI 10.1016/j.dental.2014.12.010	61	22	25	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164653	10.1371/journal.pone.0164653	http://dx.doi.org/10.1371/journal.pone.0164653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727330	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504400047
J	Su, C; Liang, ZH; Li, XL; Li, D; Li, YW; Ursino, M				Su, Cui; Liang, Zhenhu; Li, Xiaoli; Li, Duan; Li, Yongwang; Ursino, Mauro			A Comparison of Multiscale Permutation Entropy Measures in On-Line Depth of Anesthesia Monitoring	PLOS ONE			English	Article							CLOSED-LOOP CONTROL; QUANTITATIVE EEG-ANALYSIS; BISPECTRAL INDEX; APPROXIMATE ENTROPY; TIME-SERIES; ELECTROENCEPHALOGRAPHIC MEASURE; PROPOFOL ANESTHESIA; BIOLOGICAL SIGNALS; FEEDBACK-CONTROL; SIMULATION	Objective Multiscale permutation entropy (MSPE) is becoming an interesting tool to explore neurophysiological mechanisms in recent years. In this study, six MSPE measures were proposed for on-line depth of anesthesia (DoA) monitoring to quantify the anesthetic effect on the real-time EEG recordings. The performance of these measures in describing the transient characters of simulated neural populations and clinical anesthesia EEG were evaluated and compared. Methods Six MSPE algorithms-derived from Shannon permutation entropy (SPE), Renyi permutation entropy (RPE) and Tsallis permutation entropy (TPE) combined with the decomposition procedures of coarse-graining (CG) method and moving average (MA) analysis-were studied. A thalamo-cortical neural mass model (TCNMM) was used to generate noise-free EEG under anesthesia to quantitatively assess the robustness of each MSPE measure against noise. Then, the clinical anesthesia EEG recordings from 20 patients were analyzed with these measures. To validate their effectiveness, the ability of six measures were compared in terms of tracking the dynamical changes in EEG data and the performance in state discrimination. The Pearson correlation coefficient (R)was used to assess the relationship among MSPE measures. Results CG-based MSPEs failed in on-line DoA monitoring at multiscale analysis. In on-line EEG analysis, the MA-based MSPE measures at 5 decomposed scales could track the transient changes of EEG recordings and statistically distinguish the awake state, unconsciousness and recovery of consciousness (RoC) state significantly. Compared to single-scale SPE and RPE, MSPEs had better anti-noise ability and MA-RPE at scale 5 performed best in this aspect. MA-TPE outperformed other measures with faster tracking speed of the loss of unconsciousness. Conclusions MA-based multiscale permutation entropies have the potential for on-line anesthesia EEG analysis with its simple computation and sensitivity to drug effect changes. CG-based multiscale permutation entropies may fail to describe the characteristics of EEG at high decomposition scales.	[Su, Cui; Liang, Zhenhu; Li, Xiaoli] Yanshan Univ, Dept Elect Engn, Qinhuangdao 066004, Peoples R China; [Li, Duan] Yanshan Univ, Dept Informat Sci & Engn, Qinhuangdao 066004, Peoples R China; [Li, Yongwang] Second Artillery Gen Hosp, Dept Anesthesiol, Beijing 100088, Peoples R China; [Ursino, Mauro] Univ Bologna, Dept Elect Elect & Informat Engn, Viale Risorgimento 2, I-40136 Bologna, Italy	Yanshan University; Yanshan University; University of Bologna	Liang, ZH (corresponding author), Yanshan Univ, Dept Elect Engn, Qinhuangdao 066004, Peoples R China.	zhl@ysu.edu.cn	Ursino, Mauro/AAE-7389-2020; Li, Xiaoli/GYQ-7384-2022; Li, Xiaoli/B-6565-2016	Ursino, Mauro/0000-0002-0911-0308; Li, Xiaoli/0000-0003-1359-5130	National Natural Science Foundation of China [61304247, 61273063, 81230023]; China Postdoctoral Science Foundation [2015T80231, 2014M551051]; Natural Science Foundation of HebeiProvince of China [F2014203127]; Education Department of Hebeiprovince [GCC2014019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of HebeiProvince of China(Natural Science Foundation of Hebei Province); Education Department of Hebeiprovince	This research was supported by National Natural Science Foundation of China (61304247, 61273063, 81230023). China Postdoctoral Science Foundation (2015T80231, 2014M551051), Natural Science Foundation of HebeiProvince of China (F2014203127) and the Education Department of Hebeiprovince (GCC2014019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalom AR, 2003, BRIT J ANAESTH, V90, P737, DOI 10.1093/bja/aeg137; Aziz W., 2005, 9 INT MULT C IEEE IN; Bandt C, 2005, ECOL MODEL, V182, P229, DOI 10.1016/j.ecolmodel.2004.04.003; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Bibian S, 2011, J CLIN MONIT COMPUT, V25, P81, DOI 10.1007/s10877-010-9266-9; Boveroux P, 2008, INT ANESTHESIOL CLIN, V46, P131, DOI 10.1097/AIA.0b013e318181a8b3; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Bruhn J, 2000, ANESTHESIOLOGY, V92, P715, DOI 10.1097/00000542-200003000-00016; Bruzzo AA, 2008, NEUROL SCI, V29, P3, DOI 10.1007/s10072-008-0851-3; Cao YH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046217; Chen WT, 2007, IEEE T NEUR SYS REH, V15, P266, DOI 10.1109/TNSRE.2007.897025; Chen Y, 2012, CHAOS SOLITON FRACT, V45, P978, DOI 10.1016/j.chaos.2012.03.013; Cona F, 2014, J COMPUT NEUROSCI, V37, P125, DOI 10.1007/s10827-013-0493-1; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Fang MQ, 2014, J CLIN MONIT COMPUT, V28, P13, DOI 10.1007/s10877-013-9483-0; Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019; Ferenets R, 2006, C P ANN INT C IEEE E; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gao JB, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00064; Gentilini A, 2001, IEEE T BIO-MED ENG, V48, P874, DOI 10.1109/10.936364; Hahn J-O, 2012, BIOMEDICAL SIGNAL PR, V7; Hashemi M, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00232; Heier T, 1996, ACTA ANAESTH SCAND, V40, P1087, DOI 10.1111/j.1399-6576.1996.tb05570.x; Hsu WY, 2007, J NEUROSCI METH, V163, P145, DOI 10.1016/j.jneumeth.2007.02.004; Ionescu CM, 2011, IFMBE PROC, V36, P234, DOI 10.1007/978-3-642-22586-4_50; Ionescu CM, 2008, IEEE T BIO-MED ENG, V55, P2161, DOI 10.1109/TBME.2008.923142; John ER, 2001, CONSCIOUS COGN, V10, P165, DOI 10.1006/ccog.2001.0507; Jospin M, 2007, IEEE T BIO-MED ENG, V54, P840, DOI 10.1109/TBME.2007.893453; Keifer JC, 1996, ANESTHESIOLOGY, V84, P945, DOI 10.1097/00000542-199604000-00023; Kim PJ, 2015, J PHARMACOKINET PHAR, V42, P123, DOI 10.1007/s10928-015-9405-5; Klockars JGM, 2012, ANESTHESIOLOGY, V116, P340, DOI 10.1097/ALN.0b013e3182410b5e; Li D, 2013, J CLIN MONIT COMPUT, V27, P113, DOI 10.1007/s10877-012-9419-0; Li D, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046010; Li XL, 2008, ANESTHESIOLOGY, V109, P448, DOI 10.1097/ALN.0b013e318182a91b; Li XL, 2007, EPILEPSY RES, V77, P70, DOI 10.1016/j.eplepsyres.2007.08.002; Li XL, 2008, CLIN NEUROPHYSIOL, V119, P2465, DOI 10.1016/j.clinph.2008.08.006; Liang ZH, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00016; Liu N, 2012, ANESTHESIOLOGY, V116, P286, DOI 10.1097/ALN.0b013e318242ad4f; Lydic R, 2005, ANESTHESIOLOGY, V103, P1268; McKay IDH, 2006, ANESTH ANALG, V102, P91, DOI 10.1213/01.ane.0000184825.65124.24; Morabito FC, 2012, ENTROPY-SWITZ, V14, P1186, DOI 10.3390/e14071186; Morley A, 2000, ANAESTHESIA, V55, P953, DOI 10.1046/j.1365-2044.2000.01527.x; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Ouyang G, 2006, ENG MED BIOL SOC 200; Ouyang GX, 2010, CLIN NEUROPHYSIOL, V121, P694, DOI 10.1016/j.clinph.2009.12.030; Pal D, 2011, FRONTIERS NEUROSCIEN, V26, P704; Pilge S, 2006, ANESTHESIOLOGY, V104, P488, DOI 10.1097/00000542-200603000-00016; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Renyi A., 1970, PROBABILITY THEORY; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Sarkela MOK, 2007, ANESTHESIOLOGY, V107, P928; SCHWILDEN H, 1993, BRIT J ANAESTH, V70, P389, DOI 10.1093/bja/70.4.389; SCHWILDEN H, 1987, ANESTHESIOLOGY, V67, P341, DOI 10.1097/00000542-198709000-00011; SCHWILDEN H, 1989, BRIT J ANAESTH, V62, P290, DOI 10.1093/bja/62.3.290; Shah G, 2010, 2010 18 MED C JUN; Shalbaf R, 2013, J NEUROSCI METH, V218, P17, DOI 10.1016/j.jneumeth.2013.03.008; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Stamoulis C, 2011, ENG MED BIOL SOC EMB; Struys MMRF, 2004, ANESTHESIOLOGY, V100, P640, DOI 10.1097/00000542-200403000-00026; Struys MMRF, 2001, ANESTHESIOLOGY, V95, P6, DOI 10.1097/00000542-200107000-00007; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Thuraisingham RA, 2006, PHYSICA A, V366, P323, DOI 10.1016/j.physa.2005.10.008; Tsallis C, 1998, PHYSICA A, V261, P534, DOI 10.1016/S0378-4371(98)00437-3; Tung A, 2004, SLEEP MED REV, V8, P213, DOI 10.1016/j.smrv.2004.01.003; Unser M, 1996, P IEEE, V84, P626, DOI 10.1109/5.488704; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Wu SD, 2013, PHYSICA A, V392, P5865, DOI 10.1016/j.physa.2013.07.075; Zhang Z, 2013, NEURAL REGEN RES, V8, P1844, DOI 10.3969/j.issn.1673-5374.2013.20.003; Zunino L, 2008, PHYSICA A, V387, P6057, DOI 10.1016/j.physa.2008.07.004	70	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164104	10.1371/journal.pone.0164104	http://dx.doi.org/10.1371/journal.pone.0164104			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723803	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100020
J	Weber, D; Long, J; Leonard, MB; Zemel, B; Baker, JF				Weber, David; Long, Jin; Leonard, Mary B.; Zemel, Babette; Baker, Joshua F.			Development of Novel Methods to Define Deficits in Appendicular Lean Mass Relative to Fat Mass	PLOS ONE			English	Article							MUSCLE MASS; RHEUMATOID-ARTHRITIS; ALTERNATIVE DEFINITIONS; FUNCTIONAL IMPAIRMENT; PHYSICAL PERFORMANCE; SARCOPENIC OBESITY; REFERENCE VALUES; HEALTH; DISABILITY; STRENGTH	Background Recent studies suggest that adjustment of measures of lean mass for adiposity improves associations with physical function. Our objective was to develop and test a method to adjust appendicular lean mass for adiposity. Methods Whole-body DXA data in 14,850 adults in the National Health and Nutrition Examination Survey were used to generate sex-, and race-specific standard deviation scores (Z-Scores relative to age and T-scores relative to 25 year-olds) for appendicular lean mass index (ALMI, kg/m(2)) and fat mass index (FMI, kg/m(2)). Correlations between ALMI and FMI Z- and T-Scores were assessed within demographic categories. Fat-adjusted ALMI (ALMI(FMI)) scores were determined using residual methods. Sarcopenia was defined as a T-Score <-2.0 and low lean for age as a Z- Score <-1.0. Correlations with physical function were assessed in an at-risk population. Results Positive associations between ALMI and FMI Z- and T-Scores were significant (R >0.50; p<0.001) within all demographic categories. The impact of a unit greater FMI Z- score on ALMI Z- score was less in the elderly, men, white subjects, and among individuals with lower FMI (all tests for interaction p<0.001). There was fair agreement between ALMI and ALMIFMI estimates of sarcopenia and low lean for age [ Kappa: 0.46, 0.52, respectively (p<0.0001)]. Elderly subjects were likely to be re-classified as sarcopenic while young subjects were likely to be re-classified as normal using ALMIFMI. ALMIFMI T-scores resulted in approximately twice the number of subjects defined as sarcopenic, compared with ALMI T-Scores. (1299 v. 534). Among rheumatoid arthritis patients, ALMIFMI Z- scores correlated with physical function (Health Assessment Questionnaire: rho = -0.22, p = 0.04; Short Physical Performance Battery: rho = 0.27, p = 0.01); however, the ALMI Z-Score did not. Conclusions Adjustment of ALMI for the confounding association with FMI impacts the definition of lean mass deficits. These methods provide a practical tool for investigators and clinicians based on population-based reference data.	[Weber, David] Univ Rochester, Golisano Childrens Hosp, Div Endocrinol & Diabet, Rochester, NY 14627 USA; [Long, Jin; Zemel, Babette] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Long, Jin; Leonard, Mary B.] Stanford Univ, Dept Pediat & Med, Stanford, CA 94305 USA; [Baker, Joshua F.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Baker, Joshua F.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Baker, Joshua F.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Rochester; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Stanford University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Baker, JF (corresponding author), Philadelphia Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.; Baker, JF (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.; Baker, JF (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	bakerjo@uphs.upenn.edu	Weber, David R/R-5290-2017; Weber, David R/AAU-9831-2020; Zemel, Babette S./D-1117-2009	Weber, David R/0000-0001-6895-2372; Weber, David R/0000-0001-6895-2372; Zemel, Babette S./0000-0002-6164-7348	Veterans Affairs Clinical Science Research and Development Career Development Award [IK2 CX000955]; NIH [K24 DK076808, K12 HD068373]; University of Pennsylvania Clinical and Translational Research Center [UL1 RR024134]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068373] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000955] Funding Source: NIH RePORTER	Veterans Affairs Clinical Science Research and Development Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Clinical and Translational Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Veterans Affairs(US Department of Veterans Affairs)	Dr. Baker is supported by a Veterans Affairs Clinical Science Research and Development Career Development Award (IK2 CX000955). This work was also supported by NIH grants K24 DK076808 (MBL), K12 HD068373 (DRW) and the University of Pennsylvania Clinical and Translational Research Center (UL1 RR024134).	Baker JF, 2015, ARTHRIT CARE RES, V67, P112, DOI 10.1002/acr.22396; Baker JF, 2014, ARTHRIT CARE RES, V66, P1612, DOI 10.1002/acr.22328; Batsis JA, 2013, J AM GERIATR SOC, V61, P974, DOI 10.1111/jgs.12260; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Coin A, 2013, J AM MED DIR ASSOC, V14, P507, DOI 10.1016/j.jamda.2013.02.010; Cooper R, 2014, J GERONTOL A-BIOL, V69, P1253, DOI 10.1093/gerona/glu039; Corsonello A, 2012, REJUV RES, V15, P41, DOI 10.1089/rej.2011.1215; De Stefano F, 2015, J NUTR HEALTH AGING, V19, P785, DOI 10.1007/s12603-015-0482-3; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Dufour AB, 2013, J GERONTOL A-BIOL, V68, P168, DOI 10.1093/gerona/gls109; Flegal K. M., 2013, NATL HLTH STAT REPOR, V63, P1; Hairi NN, 2010, J AM GERIATR SOC, V58, P2055, DOI 10.1111/j.1532-5415.2010.03145.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Katz PP, 2013, ARTHRIT CARE RES, V65, P62, DOI 10.1002/acr.21810; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; McLean RR, 2015, J BONE MINER RES, V30, P588, DOI 10.1002/jbmr.2492; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Mihalko SL, 2006, MED SCI SPORT EXER, V38, P112, DOI 10.1249/01.mss.0000183230.08341.6b; National Center for Health Statistics, 2006, NAT HLTH NUTR EX SUR; National Health and Nutrition, 2008, NAT HLTH NUTR EX SUR; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Ostir GV, 2002, J CLIN EPIDEMIOL, V55, P916, DOI 10.1016/S0895-4356(02)00436-5; Schautz B, 2012, EUR J CLIN NUTR, V66, P1356, DOI 10.1038/ejcn.2012.138; Schoeller DA, 2005, AM J CLIN NUTR, V81, P1018; Weber DR, 2013, AM J CLIN NUTR, V98, P49, DOI 10.3945/ajcn.112.053611; WOLFE F, 1988, J RHEUMATOL, V15, P1480	26	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164385	10.1371/journal.pone.0164385	http://dx.doi.org/10.1371/journal.pone.0164385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723820	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504100053
J	Almeida, R; Lyons, D				Almeida, Rafael; Lyons, David			Oligodendrocyte Development in the Absence of Their Target Axons In Vivo	PLOS ONE			English	Article							INTRINSIC MATURATION PROGRAM; MOTOR-NEURON IDENTITY; RAT OPTIC-NERVE; PRECURSOR CELLS; GROWTH-FACTOR; WALLERIAN DEGENERATION; MYELIN MEMBRANE; PROGENITOR-CELL; THYROID-HORMONE; POSTNATAL RAT	Oligodendrocytes form myelin around axons of the central nervous system, enabling saltatory conduction. Recent work has established that axons can regulate certain aspects of oligodendrocyte development and myelination, yet remarkably oligodendrocytes in culture retain the ability to differentiate in the absence of axons and elaborate myelin sheaths around synthetic axon-like substrates. It remains unclear the extent to which the life-course of oligodendrocytes requires the presence of, or signals derived from axons in vivo. In particular, it is unclear whether the specific axons fated for myelination regulate the oligodendrocyte population in a living organism, and if so, which precise steps of oligodendrocyte-cell lineage progression are regulated by target axons. Here, we use live-imaging of zebrafish larvae carrying transgenic reporters that label oligodendrocyte-lineage cells to investigate which aspects of oligodendrocyte development, from specification to differentiation, are affected when we manipulate the target axonal environment. To drastically reduce the number of axons targeted for myelination, we use a previously identified kinesin-binding protein (kbp) mutant, in which the first myelinated axons in the spinal cord, reticulospinal axons, do not fully grow in length, creating a region in the posterior spinal cord where most initial targets for myelination are absent. We find that a 73% reduction of reticulospinal axon surface in the posterior spinal cord of kbp mutants results in a 27% reduction in the number of oligodendrocytes. By time-lapse analysis of transgenic OPC reporters, we find that the reduction in oligodendrocyte number is explained by a reduction in OPC proliferation and survival. Interestingly, OPC specification and migration are unaltered in the near absence of normal axonal targets. Finally, we find that timely differentiation of OPCs into oligodendrocytes does not depend at all on the presence of target axons. Together, our data illustrate the power of zebrafish for studying the entire life-course of the oligodendrocyte lineage in vivo in an altered axonal environment.	[Almeida, Rafael; Lyons, David] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Almeida, Rafael; Lyons, David] Univ Edinburgh, MS Soc Ctr Translat Res, Edinburgh, Midlothian, Scotland; [Almeida, Rafael; Lyons, David] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Almeida, R; Lyons, D (corresponding author), Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland.; Almeida, R; Lyons, D (corresponding author), Univ Edinburgh, MS Soc Ctr Translat Res, Edinburgh, Midlothian, Scotland.; Almeida, R; Lyons, D (corresponding author), Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland.	rgalmeid@staffmail.ed.ac.uk; david.lyons@ed.ac.uk		Lyons, David/0000-0003-1166-4454; Almeida, Rafael/0000-0003-3563-5463	FCT; Wellcome Trust; BBSRC; Lister Research Prize; Biotechnology and Biological Sciences Research Council [BB/F023243/1] Funding Source: researchfish; Wellcome Trust [102836/Z/13/Z] Funding Source: researchfish; BBSRC [BB/F023243/1] Funding Source: UKRI	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lister Research Prize; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an FCT doctoral studentship to R.A. and Wellcome Trust Senior Research Fellowship, a BBSRC David Phillips Fellowship and a Lister Research Prize to D.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNEY ER, 1981, DEV BIOL, V83, P301, DOI 10.1016/0012-1606(81)90476-0; Akitake CM, 2011, DEV BIOL, V352, P191, DOI 10.1016/j.ydbio.2011.01.002; Almeida RG, 2011, DEVELOPMENT, V138, P4443, DOI 10.1242/dev.071001; Almeida RG, 2015, ZEBRAFISH, V12, P377, DOI 10.1089/zeb.2015.1086; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Bechler ME, 2015, CURR BIOL, V25, P2411, DOI 10.1016/j.cub.2015.07.056; BRADEL EJ, 1983, J NEUROSCI RES, V9, P381, DOI 10.1002/jnr.490090404; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Czopka T, 2011, METHOD CELL BIOL, V105, P25, DOI 10.1016/B978-0-12-381320-6.00002-3; DUBOISDALCQ M, 1986, J CELL BIOL, V102, P384, DOI 10.1083/jcb.102.2.384; Durand B, 2000, BIOESSAYS, V22, P64; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Ford MC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9073; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; FULCRAND J, 1977, J COMP NEUROL, V176, P189, DOI 10.1002/cne.901760204; Gao FB, 1997, J CELL BIOL, V138, P1367, DOI 10.1083/jcb.138.6.1367; Gao FB, 1998, DEV BIOL, V197, P54, DOI 10.1006/dbio.1998.8877; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; HILDEBRAND C, 1978, J NEUROL SCI, V38, P421, DOI 10.1016/0022-510X(78)90147-8; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Howe CL, 2006, CELLS TISSUES ORGANS, V183, P180, DOI 10.1159/000096509; KACHAR B, 1986, CELL TISSUE RES, V244, P27; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; KNAPP PE, 1987, DEV BIOL, V120, P356, DOI 10.1016/0012-1606(87)90238-7; Koudelka S, 2016, CURR BIOL, V26, P1447, DOI 10.1016/j.cub.2016.03.070; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Li YC, 2014, BIOMACROMOLECULES, V15, P319, DOI 10.1021/bm401558c; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Lyons DA, 2008, DEVELOPMENT, V135, P599, DOI 10.1242/dev.012377; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Nusslein-Volhard C, 2002, ZEBRAFISH; Nusslein-Volhard C., 2002, ZEBRAFISH A PRACTICA; Pang SC, 2015, MAR BIOTECHNOL, V17, P593, DOI 10.1007/s10126-015-9641-0; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; RAFF MC, 1985, CELL, V42, P61, DOI 10.1016/S0092-8674(85)80101-X; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Reimer MM, 2013, DEV CELL, V25, P478, DOI 10.1016/j.devcel.2013.04.012; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; ROME LH, 1986, J NEUROSCI RES, V15, P49, DOI 10.1002/jnr.490150106; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Seidl AH, 2014, J NEUROSCI, V34, P4914, DOI 10.1523/JNEUROSCI.5460-13.2014; Seidl AH, 2010, J NEUROSCI, V30, P70, DOI 10.1523/JNEUROSCI.3464-09.2010; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Simmons T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032317; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; Snyder JL, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-15; SZUCHET S, 1986, DEV NEUROSCI-BASEL, V8, P208, DOI 10.1159/000112254; Takada N, 2011, MOL CELL NEUROSCI, V48, P225, DOI 10.1016/j.mcn.2011.08.003; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tsai HH, 2016, SCIENCE, V351, P379, DOI 10.1126/science.aad3839; Ueda H, 1999, J CELL BIOL, V146, P1365, DOI 10.1083/jcb.146.6.1365; VALAT J, 1978, ACTA NEUROPATHOL, V42, P205, DOI 10.1007/BF00690358; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Waxman SG, 1997, CURR BIOL, V7, pR406, DOI 10.1016/S0960-9822(06)00203-X; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yang Y, 2011, DEV BIOL, V350, P127, DOI 10.1016/j.ydbio.2010.11.028; Yuen TJ, 2014, CELL, V158, P383, DOI 10.1016/j.cell.2014.04.052; ZELLER NK, 1985, J NEUROSCI, V5, P2955; Zuchero JB, 2013, CURR OPIN NEUROBIOL, V23, P914, DOI 10.1016/j.conb.2013.06.005	79	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164432	10.1371/journal.pone.0164432	http://dx.doi.org/10.1371/journal.pone.0164432			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716830	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100052
J	Inoue, Y; Stickley, A; Yazawa, A; Shirai, K; Amemiya, A; Kondo, N; Kondo, K; Ojima, T; Hanazato, M; Suzuki, N; Fujiwara, T				Inoue, Yosuke; Stickley, Andrew; Yazawa, Aki; Shirai, Kokoro; Amemiya, Airi; Kondo, Naoki; Kondo, Katsunori; Ojima, Toshiyuki; Hanazato, Masamichi; Suzuki, Norimichi; Fujiwara, Takeo			Neighborhood Characteristics and Cardiovascular Risk among Older People in Japan: Findings from the JAGES Project	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TYPE-2 DIABETES-MELLITUS; PHYSICAL-ACTIVITY; MENTAL-HEALTH; GREEN SPACE; LIFE-STYLE; ENVIRONMENT ATTRIBUTES; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS; DIETARY PATTERNS	Previous studies have found an association between neighborhood characteristics (i.e., aspects of the physical and social environment) and the incidence of cardiovascular disease (CVD) and elevated CVD risk. This study investigated the relationship between neighborhood characteristics and CVD risk among older people in Japan where research on this association is scarce. Data came from the Japan Gerontological Evaluation Study project; questionnaire data collected from 3,810 people aged 65 years or older living in 20 primary school districts in Aichi prefecture, Japan, was linked to a computed composite CVD risk score based on biomarker data (i.e., hemoglobin A1c, systolic blood pressure, diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and estimated glomerular filtration rate). A sex-stratified multilevel linear regression analysis revealed that for male participants, living in neighborhoods with a higher perceived occurrence of traffic accidents and reduced personal safety was associated with an elevated CVD risk (coefficient = 1.08 per interquartile range increase, 95% confidence interval [CI] = 0.30 to 1.86) whereas males living in neighborhoods with a higher perceived proximity of exercise facilities had a lower risk (coefficient = -1.00, 95% CI = -1.78 to -0.21). For females, there was no statistically significant association between neighborhood characteristics and CVD risk. This study suggests that aspects of the neighborhood environment might be important for CVD morbidity and mortality in Japan, particularly among men.	[Inoue, Yosuke; Stickley, Andrew; Yazawa, Aki] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, Tokyo, Japan; [Stickley, Andrew] Sodertorn Univ, Stockholm Ctr Hlth & Social Change Scohost, Huddinge, Sweden; [Shirai, Kokoro] Univ Ryukyus, Sch Law & Letters, Dept Human Sci, Okinawa, Japan; [Amemiya, Airi] Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo, Japan; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, Tokyo, Japan; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Dept Hlth Educ & Hlth Sociol, Bunkyo Ku, Tokyo, Japan; [Kondo, Katsunori; Hanazato, Masamichi; Suzuki, Norimichi] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Kondo, Katsunori] Nihon Fukushi Univ, Ctr Well Being & Soc, Nagoya, Aichi, Japan; [Kondo, Katsunori] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Gerontol Evaluat, Obu City, Aichi, Japan; [Ojima, Toshiyuki] Hamamatsu Univ Sch Med, Sch Med, Hamamatsu, Shizuoka, Japan; [Fujiwara, Takeo] Tokyo Med & Dent Univ, Dept Global Hlth Promot, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Sodertorn University; University of the Ryukyus; National Center for Child Health & Development - Japan; University of Tokyo; University of Tokyo; Chiba University; National Center for Geriatrics & Gerontology; Hamamatsu University School of Medicine; Tokyo Medical & Dental University (TMDU)	Inoue, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, Tokyo, Japan.	yosuke.yoshi.yosky@gmail.com	hanazato, masamichi/L-6267-2019; Norimichi, Suzuki/Y-4487-2019; Kondo, Naoki/ABC-5865-2020; Kondo, Katsunori/AAI-6373-2020; Kondo, Naoki/K-3898-2012; Yazawa, Aki/R-9176-2019	hanazato, masamichi/0000-0002-0317-7616; Kondo, Naoki/0000-0002-6425-6844; Kondo, Naoki/0000-0002-6425-6844; 	Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); Japanese Ministry of Health, Labour and Welfare [H22-Choju-Shitei-008, H24-Junkankitou-Ippan-007, H24-Chikyukibo-Ippan-009, H24-Choju-Wakate-009, H25-Kenki-Wakate-015, H25-Irryo-Shitei-003, H26-Choju-Ippan-006, H28-Chouju-Ippan-02]; JSPS KAKENHI [JP22330172, JP22390400, JP23243070, JP23590786, JP23790710, JP24390469, JP24530698, JP24653150, JP24683018, JP25253052, JP25870573, JP25870881, 22390400, JP15K18174, JP15KT0007, JP15H01972]; Japan Society for the Promotion of Science; National Center for Geriatrics and Gerontology [24-17, 24-23]; Research and Development Grants for Longevity Science from AMED (Japan Agency for Medical Research and Development); Grants-in-Aid for Scientific Research [26460831] Funding Source: KAKEN	Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Center for Geriatrics and Gerontology; Research and Development Grants for Longevity Science from AMED (Japan Agency for Medical Research and Development)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant of the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT), 2009-2013, for the Center for Well-being and Society, Nihon Fukushi University, and also Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health (H22-Choju-Shitei-008, H24-Junkankitou-Ippan-007, H24-Chikyukibo-Ippan-009, H24-Choju-Wakate-009, H25-Kenki-Wakate-015, H25-Irryo-Shitei-003 (Fukkou), H26-Choju-Ippan-006, H28-Chouju-Ippan-02) from the Japanese Ministry of Health, Labour and Welfare, JSPS KAKENHI (JP22330172, JP22390400, JP23243070, JP23590786, JP23790710, JP24390469, JP24530698, JP24653150, JP24683018, JP25253052, JP25870573, JP25870881, 22390400, JP15K18174, JP15KT0007, JP15H01972) from the Japan Society for the Promotion of Science, grant from National Center for Geriatrics and Gerontology (24-17, 24-23), and also the Research and Development Grants for Longevity Science from AMED (Japan Agency for Medical Research and Development).	Auchincloss AH, 2009, ARCH INTERN MED, V169, P1698, DOI 10.1001/archinternmed.2009.302; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; Cho Y, 2005, SOC SCI MED, V60, P1285, DOI 10.1016/j.socscimed.2004.06.054; Christine PJ, 2015, JAMA INTERN MED, V175, P1311, DOI 10.1001/jamainternmed.2015.2691; Coombes E, 2010, SOC SCI MED, V70, P816, DOI 10.1016/j.socscimed.2009.11.020; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Eichinger M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126010; Fish JS, 2010, AM J PUBLIC HEALTH, V100, P2296, DOI 10.2105/AJPH.2009.183293; Fujiwara T, 2008, AM J PREV MED, V35, P139, DOI 10.1016/j.amepre.2008.04.015; Fukuda Y, 2005, ANN EPIDEMIOL, V15, P365, DOI 10.1016/j.annepidem.2004.09.003; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gomez LF, 2010, AM J PREV MED, V38, P592, DOI 10.1016/j.amepre.2010.02.005; Grafova IB, 2008, AM J PUBLIC HEALTH, V98, P2065, DOI 10.2105/AJPH.2007.127712; Gupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044098; Hamano T, 2011, AM J HYPERTENS, V24, P643, DOI 10.1038/ajh.2011.37; Hilisdon M, 2006, PUBLIC HEALTH, V120, P1127, DOI 10.1016/j.puhe.2006.10.007; Inoue Y, 2016, AM J HUM BIOL, V28, P186, DOI 10.1002/ajhb.22771; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Iso H, 2011, J ATHEROSCLER THROMB, V18, P83, DOI 10.5551/jat.6866; Jeemon P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000068; Kaczynski AT, 2008, AM J PUBLIC HEALTH, V98, P1451, DOI 10.2105/AJPH.2007.129064; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Lynch JP, 2011, CRIME INT PERSPECTIV; Maas J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-206; Mathis AL, 2017, J APPL GERONTOL, V36, P692, DOI 10.1177/0733464815584670; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; Ministry of Land Infrastructure, TRANSPORT AND TOURIS; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Mytton OT, 2012, HEALTH PLACE, V18, P1034, DOI 10.1016/j.healthplace.2012.06.003; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Nishi A, 2011, J EPIDEMIOL, V21, P151, DOI 10.2188/jea.JE20100135; Nishimura K, 2014, J ATHEROSCLER THROMB, V21, P784, DOI 10.5551/jat.19356; OECD, 2011, DIV WE STAND WHY IN; Parra DC, 2010, SOC SCI MED, V70, P1070, DOI 10.1016/j.socscimed.2009.12.024; Phongsavan P, 2006, SOC SCI MED, V63, P2546, DOI 10.1016/j.socscimed.2006.06.021; Pollack CE, 2012, PUBLIC HEALTH, V126, P827, DOI 10.1016/j.puhe.2012.05.028; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; Rodriguez-Monforte M, 2015, BRIT J NUTR, V114, P1341, DOI 10.1017/S0007114515003177; Scheffler RM, 2008, SOC SCI MED, V66, P1603, DOI 10.1016/j.socscimed.2007.12.007; Stafford M, 2007, AM J PUBLIC HEALTH, V97, P2076, DOI 10.2105/AJPH.2006.097154; Steptoe A, 1996, J PSYCHOSOM RES, V41, P171, DOI 10.1016/0022-3999(96)00095-5; Sundquist K, 2006, SOC SCI MED, V62, P2061, DOI 10.1016/j.socscimed.2005.08.051; Tryon MS, 2013, PHYSIOL BEHAV, V114, P32, DOI 10.1016/j.physbeh.2013.02.018; Tryon MS, 2013, PHYSIOL BEHAV, V120, P233, DOI 10.1016/j.physbeh.2013.08.010; Unger E, 2014, CIRC-CARDIOVASC QUAL, V7, P524, DOI 10.1161/CIRCOUTCOMES.113.000698; Vaananen A, 2009, OCCUP ENVIRON MED, V66, P432, DOI 10.1136/oem.2008.042044; Vallee J, 2011, SOC SCI MED, V73, P1133, DOI 10.1016/j.socscimed.2011.08.009; Villanueva K, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-59; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Winkleby M, 2007, AM J PREV MED, V32, P97, DOI 10.1016/j.amepre.2006.10.002; World Health Organization, PHYS ACTIVITY; Yasunaga A, 2008, J AGING PHYS ACTIV, V16, P3, DOI 10.1123/japa.16.1.3; Yazawa A, HYPERTENS R IN PRESS, DOI [10.1038/hr.2016.78, DOI 10.1038/HR.2016.78]	54	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164525	10.1371/journal.pone.0164525	http://dx.doi.org/10.1371/journal.pone.0164525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UW	27716825	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100061
J	Campos, JA; Garcia-Baquero, G; Cano, L; Biurrun, I; Garcia-Mijangos, I; Loidi, J; Herrera, M				Campos, Juan Antonio; Garcia-Baquero, Gonzalo; Cano, Lidia; Biurrun, Idoia; Garcia-Mijangos, Itziar; Loidi, Javier; Herrera, Mercedes			Climate and Human Pressure Constraints Co-Explain Regional Plant Invasion at Different Spatial Scales	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; PROPAGULE PRESSURE; LAND-COVER; ECOLOGICAL DATA; BASQUE COUNTRY; ALIEN; RICHNESS; VEGETATION; ENERGY; HETEROGENEITY	Alien species invasion represents a global threat to biodiversity and ecosystems. Explaining invasion patterns in terms of environmental constraints will help us to assess invasion risks and plan control strategies. We aim to identify plant invasion patterns in the Basque Country (Spain), and to determine the effects of climate and human pressure on that pattern. We modeled the regional distribution of 89 invasive plant species using two approaches. First, distance-based Moran's eigenvector maps were used to partition variation in the invasive species richness, S, into spatial components at broad and fine scales; redundancy analysis was then used to explain those components on the basis of climate and human pressure descriptors. Second, we used generalized additive mixed modeling to fit species-specific responses to the same descriptors. Climate and human pressure descriptors have different effects on S at different spatial scales. Broad-scale spatially structured temperature and precipitation, and fine-scale spatially structured human population density and percentage of natural and semi-natural areas, explained altogether 38.7% of the total variance. The distribution of 84% of the individually tested species was related to either temperature, precipitation or both, and 68% was related to either population density or natural and semi-natural areas, displaying similar responses. The spatial pattern of the invasive species richness is strongly environmentally forced, mainly by climate factors. Since individual species responses were proved to be both similarly constrained in shape and explained variance by the same environmental factors, we conclude that the pattern of invasive species richness results from individual species' environmental preferences.	[Campos, Juan Antonio; Garcia-Baquero, Gonzalo; Cano, Lidia; Biurrun, Idoia; Garcia-Mijangos, Itziar; Loidi, Javier; Herrera, Mercedes] Univ Basque Country UPV EHU, Dept Plant Biol & Ecol, Bilbao, Spain; [Cano, Lidia] Basque Fundat Sci, Ikerbasque, Bilbao, Spain	University of Basque Country	Campos, JA (corresponding author), Univ Basque Country UPV EHU, Dept Plant Biol & Ecol, Bilbao, Spain.	juanan.campos@ehu.es	, Lidia/E-4977-2012; Lodi, Javier/L-7601-2014; Campos, Juan Antonio/L-7472-2014; García-Mijangos, Itziar/AAV-3160-2021; Biurrun, Idoia/L-7590-2014; Cano, Lidia/E-4977-2012; Herrera, Mercedes/L-7504-2014	, Lidia/0000-0003-4515-1198; Lodi, Javier/0000-0003-3163-2409; Campos, Juan Antonio/0000-0001-5992-2753; García-Mijangos, Itziar/0000-0002-6642-7782; Biurrun, Idoia/0000-0002-1454-0433; Cano, Lidia/0000-0002-3456-861X; Herrera, Mercedes/0000-0003-2812-8666; GARCIA-BAQUERO MONEO, GONZALO/0000-0001-6550-1584	project of Etortek program of the Basque Government [ETORTEK10/34]; Spanish Ministry of Science and Innovation [CGL2009-13317-C03-02]; Catedra Unesco of the University of the Basque Country UPV/EHU [17/91];  [IT299-10]	project of Etortek program of the Basque Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catedra Unesco of the University of the Basque Country UPV/EHU; 	This study was supported by the projects IT299-10 for research groups and ETORTEK10/34 of Etortek program of the Basque Government, CGL2009-13317-C03-02 of the Spanish Ministry of Science and Innovation and 17/91 of Catedra Unesco of the University of the Basque Country UPV/EHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the projects IT299-10 for research groups and ETORTEK10/34 of Etortek program of the Basque Government, CGL2009-13317-C03-02 of the Spanish Ministry of Science and Innovation and 17/91 of Catedra Unesco of the University of the Basque Country UPV/EHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Miguel de Caceres (Forest Science Center of Catalonia) and the editor and two anonymous referees for the revision of previous versions of the manuscript and the suggestion of many useful improvements.	Aikio S, 2012, GLOBAL ECOL BIOGEOGR, V21, P778, DOI 10.1111/j.1466-8238.2011.00711.x; [Anonymous], 2005, METODOLOGIA APLICACI; [Anonymous], CROP PROTECTION COMP; Antonio Campos Juan, 2009, Lazaroa, V30, P7; Basque Government Dpto. Medio Ambiente Planificacion Territorial Agricultura y Pesca, 2009, MED AMB PLAN TERR AG; Biurrun Idoia, 2012, Biodiversity Ecol, V4, P328, DOI 10.7809/b-e.00121; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P1511, DOI 10.1111/j.1365-2486.2008.01824.x; Campos JA, 2013, PLANT BIOSYST, V147, P1148, DOI 10.1080/11263504.2013.861538; Campos JA, 2004, BIODIVERS CONSERV, V13, P2275, DOI 10.1023/B:BIOC.0000047902.27442.92; Campos JA, 2010, THESIS; Carboni M, 2010, DIVERS DISTRIB, V16, P537, DOI 10.1111/j.1472-4642.2010.00677.x; Catford JA, 2011, DIVERS DISTRIB, V17, P1099, DOI 10.1111/j.1472-4642.2011.00794.x; Cressie N.A.C., 2015, STAT SPATIAL DATA; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DAISIE, 2015, EUR INV AL SPEC GAT; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Gasso N, 2012, APPL VEG SCI, V15, P4, DOI 10.1111/j.1654-109X.2011.01159.x; Gazol A, 2010, PLANT ECOL, V207, P1, DOI 10.1007/s11258-009-9649-5; Giannini TC, 2013, ECOGRAPHY, V36, P649, DOI 10.1111/j.1600-0587.2012.07191.x; Griffith D.A., 1992, LESPACE GE OGRAPHIQU, V21, P265, DOI DOI 10.3406/SPGE0.1992.3091; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; HOLM S, 1979, SCAND J STAT, V6, P65; Huntley B, 1995, J BIOGEOGR, V22, P967, DOI 10.2307/2845830; Ibanez I, 2009, J APPL ECOL, V46, P1219, DOI 10.1111/j.1365-2664.2009.01736.x; Jodoin Y, 2008, J APPL ECOL, V45, P459, DOI 10.1111/j.1365-2664.2007.01362.x; Lewis RJ, 2014, J VEG SCI, V25, P184, DOI 10.1111/jvs.12071; Hernandez-Stefanoni JL, 2011, LANDSCAPE ECOL, V26, P355, DOI 10.1007/s10980-010-9561-3; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Marini L, 2008, J BIOGEOGR, V35, P1826, DOI 10.1111/j.1365-2699.2008.01924.x; Marini L, 2012, GLOBAL ECOL BIOGEOGR, V21, P534, DOI 10.1111/j.1466-8238.2011.00702.x; Marini L, 2009, GLOBAL ECOL BIOGEOGR, V18, P652, DOI 10.1111/j.1466-8238.2009.00484.x; McKinney ML, 2002, DIVERS DISTRIB, V8, P311, DOI 10.1046/j.1472-4642.2002.00153.x; MiraMon Pons X., 2002, SISTEMA INFORM GEOGR; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nobis MP, 2009, DIVERS DISTRIB, V15, P928, DOI 10.1111/j.1472-4642.2009.00610.x; Parker-Allie F, 2009, CLIMATIC CHANGE, V94, P87, DOI 10.1007/s10584-009-9549-7; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pengelly S.D., 2005, TROPICAL FORAGES; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pino J, 2005, BIOL CONSERV, V122, P339, DOI 10.1016/j.biocon.2004.08.006; Polce C, 2011, GLOBAL ECOL BIOGEOGR, V20, P367, DOI 10.1111/j.1466-8238.2010.00619.x; Pottier J, 2009, J APPL ECOL, V46, P1248, DOI 10.1111/j.1365-2664.2009.01714.x; Pysek P, 2005, INVASIVE PLANTS: ECOLOGICAL AND AGRICULTURAL ASPECTS, P77, DOI 10.1007/3-7643-7380-6_5; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; R. Development Core Team, 2015, R LANG ENV STAT COMP; Richardson DM, 2012, NEW PHYTOL, V196, P383, DOI 10.1111/j.1469-8137.2012.04292.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; USDA NRCS, 2015, PLANTS DAT NAT PLANT; von der Lippe M, 2012, PERSPECT PLANT ECOL, V14, P123, DOI 10.1016/j.ppees.2011.09.006; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur AF, 2010, MIXED EFFECTS MODELS	67	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164629	10.1371/journal.pone.0164629	http://dx.doi.org/10.1371/journal.pone.0164629			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741276	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000048
J	Gupta, A; Juneja, S; Vitoria, M; Habiyambere, V; Nguimfack, BD; Doherty, M; Low-Beer, D				Gupta, Aastha; Juneja, Sandeep; Vitoria, Marco; Habiyambere, Vincent; Nguimfack, Boniface Dongmo; Doherty, Meg; Low-Beer, Daniel			Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025	PLOS ONE			English	Article							HIV-1 INFECTION; TREATMENT-NAIVE; LOPINAVIR/RITONAVIR; TENOFOVIR; EFFICACY; ZIDOVUDINE/LAMIVUDINE; EMTRICITABINE; SAFETY; TRIAL	With anti-retroviral treatment (ART) scale-up set to continue over the next few years it is of key importance that manufacturers and planners in low- and middle-income countries (LMICs) hardest hit by the HIV/AIDS pandemic are able to anticipate and respond to future changes to treatment regimens, generics pipeline and demand, in order to secure continued access to all ARV medicines required. We did a forecast analysis, using secondary WHO and UNAIDS data sources, to estimate the number of people living with HIV (PLHIV) and the market share and demand for a range of new and existing ARV drugs in LMICs up to 2025. UNAIDS estimates 24.7 million person-years of ART in 2020 and 28.5 million person-years of ART in 2025 (24.3 million on first-line treatment, 3.5 million on second-line treatment, and 0.6 million on third-line treatment). Our analysis showed that TAF and DTG will be major players in the ART regimen by 2025, with 8 million and 15 million patients using these ARVs respectively. However, as safety and efficacy of dolutegravir (DTG) and tenofovir alafenamide (TAF) during pregnancy and among TB/HIV co-infected patients using rifampicin is still under debate, and ART scale-up is predicted to increase considerably, there also remains a clear need for continuous supplies of existing ARVs including TDF and EFV, which 16 million and 10 million patients-respectively-are predicted to be using in 2025. It will be important to ensure that the existing capacities of generics manufacturers, which are geared towards ARVs of higher doses (such as TDF 300mg and EFV 600mg), will not be adversely impacted due to the introduction of lower dose ARVs such as TAF 25mg and DTG 50mg. With increased access to viral load testing, more patients would be using protease inhibitors containing regimens in second-line, with 1 million patients on LPV/r and 2.3 million on ATV/r by 2025. However, it will remain important to continue monitoring the evolution of ARV market in LMICs to guarantee the availability of these medicines.	[Gupta, Aastha; Juneja, Sandeep] Med Patent Pool, Geneva, Switzerland; [Vitoria, Marco; Habiyambere, Vincent; Nguimfack, Boniface Dongmo; Doherty, Meg; Low-Beer, Daniel] WHO, Dept HIV AIDS, Geneva, Switzerland	World Health Organization	Gupta, A (corresponding author), Med Patent Pool, Geneva, Switzerland.	agupta@medicinespatentpool.org	juneja, sandeep/AAP-3404-2020	Gupta, Aastha/0000-0002-3278-4351	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Boender TS, 2016, J INFECT DIS, V214, P873, DOI 10.1093/infdis/jiw219; Bygrave H, 2011, JAIDS-J ACQ IMM DEF, V56, pE75, DOI 10.1097/QAI.0b013e3182097505; Fisher M, 2009, JAIDS-J ACQ IMM DEF, V51, P562, DOI 10.1097/QAI.0b013e3181ae2eb9; Greig SL, 2015, DRUGS, V75, P503, DOI 10.1007/s40265-015-0361-6; Habiyambere V, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002088; HIV-iBase/TAG, 2016, ANT TREATM OPT; Lecher S, 2015, MMWR-MORBID MORTAL W, V64, P1287, DOI 10.15585/mmwr.mm6446a3; Lennox JL, 2014, ANN INTERN MED, V161, P461, DOI 10.7326/M14-1084; Medicines Patent Pool, SUB LICENSEES WORKIN; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077268; Orkin C, 2013, HIV MED, V14, P49, DOI 10.1111/j.1468-1293.2012.01060.x; Patel DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105653; Pinheiro ED, 2008, ANTIVIR RES, V79, P143, DOI 10.1016/j.antiviral.2008.05.001; Ribera E, 2013, HIV MED, V14, P327, DOI 10.1111/hiv.12011; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Stover J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154893; The World Bank, DATA LOW MIDDLE INCO; UNAIDS, 2015, UNDERSTANDING FAST T; UNAIDS, 2016, GLOBAL STATISTICS 20; UNAIDS, 2014, FAST TRACK ENDING TH; UNAIDS, DATABASE AIDSINFO ON; UNAIDS, 2015, HOW AIDS CHANGED EVE; US NIH, DAT CLIN TRIALS GOV; Walmsley S, 2014, TOPICS ANTIVIRAL MED, V22, P261; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; WHO, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2009, ANNUAL 2010 SURVEY O; World Health Organization, 2006, ANTIRETROVIRAL THERA; World Health Organization, 2016, CONSOLIDATED GUIDELI; World Health Organization, DATABASE GLOBAL PRIC; World Health Organization, 2012, WHO SURVEY ON ARV AN; World Health Organization, 2014, WHO GLOBAL ARVS AND; World Health Organization, 2013, WHO GLOBAL SURVEY ON; World Health Organization, 2010, WHO SURVEY ON ARV US; World Health Organization, 2011, WHO SURVEY ON ARV AN	38	30	29	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164619	10.1371/journal.pone.0164619	http://dx.doi.org/10.1371/journal.pone.0164619			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736953	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800098
J	Kim, JY; Lee, EY; Park, JK; Song, YW; Kim, JR; Cho, KH				Kim, Jae-Yong; Lee, Eun-Young; Park, Jin Kyun; Song, Yeong Wook; Kim, Jae-Ryong; Cho, Kyung-Hyun			Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; ESTER TRANSFER PROTEIN; SERUM URIC-ACID; CHOLESTERYL ESTER; ANTIATHEROSCLEROTIC ACTIVITY; CARDIOVASCULAR-DISEASE; APOA-I; HDL; GLYCATION; RISK	Objective In order to identify putative biomarkers in lipoprotein, we compared lipid and lipoprotein properties between rheumatoid arthritis (RA) patients and control with similar age. Methods We analyzed four classes of lipoproteins (VLDL, LDL, HDL2, HDL3) from both male (n = 8, 69 +/- 4 year-old) and female (n = 25, 53 +/- 7 year-old) rheumatoid arthritis (RA) patients as well as controls with similar age (n = 13). Results Although RA group showed normal levels of total cholesterol (TC), low-density lipoprotein (LDL)-cholesterol, and glucose, however, the RA group showed significantly reduced high-density lipoprotein (HDL)-C level and ratio of HDL-C/TC. The RA group showed significantly elevated levels of blood triglyceride (TG), uric acid, and cholesteryl ester transfer protein (CETP) activity. The RA group also showed elevated levels of advanced glycated end (AGE) products in all lipoproteins and severe aggregation of apoA-I in HDL. As CETP activity and TG contents were 2-fold increased in HDL from RA group, paraoxonase activity was reduced upto 20%. Electron microscopy revealed that RA group showed much less HDL2 particle number than control. LDL from the RA group was severely oxidized and glycated with greater fragmentation of apo-B, especially in female group, it was more atherogenic via phagocytosis. Conclusion Lipoproteins from the RA patients showed severely altered structure with impaired functionality, which is very similar to that observed in coronary heart patients. These dysfunctional properties in lipoproteins from the RA patients might be associated with high incidence of cardiovascular events in RA patients.	[Kim, Jae-Yong; Lee, Eun-Young; Cho, Kyung-Hyun] Yeungnam Univ, Dept Med Biotechnol, Gyongsan 712749, South Korea; [Kim, Jae-Yong; Lee, Eun-Young; Cho, Kyung-Hyun] Yeungnam Univ, Res Inst Prot Sensor, Gyongsan 712749, South Korea; [Kim, Jae-Yong; Lee, Eun-Young; Cho, Kyung-Hyun] Yeungnam Univ, Program BK21plus, Serum Biomed Res & Educ Team, Gyongsan 712749, South Korea; [Park, Jin Kyun; Song, Yeong Wook] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Program BK21plus, Seoul, South Korea; [Park, Jin Kyun; Song, Yeong Wook] Seoul Natl Univ, Coll Med, Med Res Ctr, Seoul, South Korea; [Park, Jin Kyun; Song, Yeong Wook] Seoul Natl Univ Hosp, Div Rheumatol, Dept Internal Med, Seoul, South Korea; [Kim, Jae-Ryong] Yeungnam Univ, Dept Biochem & Mol Biol, Coll Med, Daegu 705717, South Korea	Yeungnam University; Yeungnam University; Yeungnam University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Yeungnam University	Cho, KH (corresponding author), Yeungnam Univ, Dept Med Biotechnol, Gyongsan 712749, South Korea.	chok@yu.ac.kr		Park, Jin Kyun/0000-0003-2167-9393	Medical Research Center Program through the National Research Foundation (NRF) [2014-11049455, 2015R1A5A2009124]; Ministry of Science, ICT and Future Planning of Korea; Ministry of Science, ICT and Future Planning [NRF-2015M3A9B6052011]	Medical Research Center Program through the National Research Foundation (NRF)(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by a grant from the Mid-carrier Researcher Program (2014-11049455) and Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation (NRF), funded by the Ministry of Science, ICT and Future Planning of Korea. This work also funded by the Ministry of Science, ICT and Future Planning of Korea and a grant from the Ministry of Science, ICT and Future Planning (NRF-2015M3A9B6052011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali KM, 2012, BRIT J PHARMACOL, V167, P1177, DOI 10.1111/j.1476-5381.2012.02081.x; Anderson J, 2012, ARTHRIT CARE RES, V64, P640, DOI 10.1002/acr.21649; Arnett FC, 1987, ARTHR RHEUM, V1988, P315, DOI DOI 10.1002/ART.1780310302; Arts E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3842; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Barter PJ, 2015, CLIN THER, V37, P2716, DOI 10.1016/j.clinthera.2015.07.021; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Botta E, 2016, ATHEROSCLEROSIS, V251, P438, DOI 10.1016/j.atherosclerosis.2016.06.009; CARAWAY WT, 1955, AM J CLIN PATHOL, V25, P840, DOI 10.1093/ajcp/25.7_ts.0840; Charles-Schoeman C, 2017, ARTHRITIS RHEUMATOL, V69, P46, DOI 10.1002/art.39833; Cho KH, 2008, CLIN BIOCHEM, V41, P56, DOI 10.1016/j.clinbiochem.2007.10.007; Cho KH, 2009, MOL CELLS, V27, P291, DOI 10.1007/s10059-009-0037-8; Desai RJ, 2015, ARTHRIT CARE RES, V67, P457, DOI 10.1002/acr.22483; Dhawan SS, 2008, CURR ATHEROSCLER REP, V10, P128, DOI 10.1007/s11883-008-0019-x; Dullaart RPF, 2015, EUR J CLIN INVEST, V45, P36, DOI 10.1111/eci.12377; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hedrick CC, 2000, DIABETOLOGIA, V43, P312, DOI 10.1007/s001250050049; Herova M, 2014, ATHEROSCLEROSIS, V235, P256, DOI 10.1016/j.atherosclerosis.2014.05.912; Lee H, 2009, BMB REP, V42, P605, DOI 10.5483/BMBRep.2009.42.9.605; Libby P, 2007, CIRC RES, V100, P299, DOI 10.1161/01.RES.0000259393.89870.58; Liou TH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05110; Lopez LR, 2005, ANN NY ACAD SCI, V1051, P97, DOI 10.1196/annals.1361.050; Magnus JH, 2010, CURR MED RES OPIN, V26, P2157, DOI 10.1185/03007995.2010.502007; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATZ CE, 1982, J BIOL CHEM, V257, P4535; McMahon M, 2006, ARTHRITIS RHEUM, V54, P2541, DOI 10.1002/art.21976; MCPHERSON JD, 1988, BIOCHEMISTRY-US, V27, P1901, DOI 10.1021/bi00406a016; Moro E, 1999, DIABETIC MED, V16, P663, DOI 10.1046/j.1464-5491.1999.00136.x; Morris SJ, 2011, ARTHRIT CARE RES, V63, P530, DOI 10.1002/acr.20393; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Newkirk MM, 2003, ARTHRITIS RES THER, V5, pR82, DOI 10.1186/ar622; NOBLE RP, 1968, J LIPID RES, V9, P693; Panoulas VF, 2007, RHEUMATOLOGY, V46, P1466, DOI 10.1093/rheumatology/kem159; Park KH, 2011, J GERONTOL A-BIOL, V66, P511, DOI 10.1093/gerona/glr016; Park KH, 2010, J GERONTOL A-BIOL, V65, P600, DOI 10.1093/gerona/glq034; Park KH, 2010, INT J MOL MED, V25, P129, DOI 10.3892/ijmm_00000322; Park KH, 2010, BIOCHEM BIOPH RES CO, V392, P295, DOI 10.1016/j.bbrc.2009.12.179; Park KH, 2010, J MED FOOD, V13, P91, DOI 10.1089/jmf.2009.1077; Park YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068975; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Pinheiro FAG, 2015, J RHEUMATOL, V42, P2221, DOI 10.3899/jrheum.150166; Ronda N, 2015, ARTHRITIS RHEUMATOL, V67, P1155, DOI 10.1002/art.39039; Schroeder LL, 2015, RHEUMATOL INT, V35, P1059, DOI 10.1007/s00296-014-3194-9; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Shen Y, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0221-4; SPARKS DL, 1989, J LIPID RES, V30, P1491; Vaziri ND, 2014, NAT REV NEPHROL, V10, P621, DOI 10.1038/nrneph.2014.169; Vivekanandan-Giri A, 2013, ANN RHEUM DIS, V72, P1725, DOI 10.1136/annrheumdis-2012-202033; Zhang C, 2015, Z RHEUMATOL, V74, P258, DOI 10.1007/s00393-014-1537-2	52	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164564	10.1371/journal.pone.0164564	http://dx.doi.org/10.1371/journal.pone.0164564			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736980	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800085
J	Parker, M; Kingori, P				Parker, Michael; Kingori, Patricia			Good and Bad Research Collaborations: Researchers' Views on Science and Ethics in Global Health Research	PLOS ONE			English	Article							GOVERNANCE	There has been a dramatic rise in the scale and scope of collaborative global health research. A number of structural and scientific factors explain this growth and there has been much discussion of these in the literature. Little, if any, attention has been paid, however, to the factors identified by scientists and other research actors as important to successful research collaboration. This is surprising given that their decisions are likely to play a key role in the sustainability and effectiveness of global health research initiatives. In this paper, we report on qualitative research with leading scientists involved in major international research collaborations about their views on good and bad collaborations and the factors that inform their decision-making about joining and participating actively in research networks. We identify and discuss eight factors that researchers see as essential in judging the merits of active participation in global health research collaborations: opportunities for active involvement in cutting-edge, interesting science; effective leadership; competence of potential partners in and commitment to good scientific practice; capacity building; respect for the needs, interests and agendas of partners; opportunities for discussion and disagreement; trust and confidence; and, justice and fairness in collaboration. Our findings suggest that the sustainability and effectiveness of global health research collaborations has an important ethical or moral dimension for the research actors involved.	[Parker, Michael; Kingori, Patricia] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Old Rd Campus, Oxford, England	University of Oxford	Parker, M (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Old Rd Campus, Oxford, England.	michael.parker@ethox.ox.ac.uk			Wellcome Trust [96527, 096527]; Wellcome Trust Society; Ethics Research Fellowship [095889]; MRC [MR/L016265/1] Funding Source: UKRI; Medical Research Council [MR/L016265/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Society; Ethics Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by Wellcome Trust (wellcome.ac.uk) grant number (96527). Patricia Kingori is supported by a Wellcome Trust Society and Ethics Research Fellowship (095889). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.; The Ethox Centre's research in global health bioethics, and that of the Global Health Bioethics Network, is supported by a Strategic Award from the Wellcome Trust (096527). The Network is a research and capacity building collaboration between the Ethox Centre in Oxford and the Wellcome Trust Major Overseas Programmes in Africa and South East Asia. Patricia Kingori is supported by a Wellcome Trust Society and Ethics Research Fellowship (095889). Ethics approval for this research was obtained from the Oxford University Tropical Research Ethics Committee (020-06). Michael Parker is a member of MalariaGEN Consortium and leads ethics team that both provides ethics advice and support to MalariaGEN partners and carries out research into ethical issues relating to the work of the MalariaGEN network.	Agar Jon, 2012, SCI 20 CENTURY; Anderson W, 2002, SOC STUD SCI, V32, P643, DOI 10.1177/030631270203200502; [Anonymous], INV HLTH RES DEV; Benjamin Ruha, 2009, POLICY SOC, V28, P341, DOI DOI 10.1016/J.POLSOC.2009.09.007; Boshoff N, 2009, SCIENTOMETRICS, V81, P413, DOI 10.1007/s11192-008-2211-8; Bull S, 2015, J EMPIR RES HUM RES, V10, P302, DOI 10.1177/1556264615594606; Carpenter-Song E, 2013, CULT MED PSYCHIAT, V37, P288, DOI 10.1007/s11013-013-9311-5; Council on Health Research for Development (COHRED), 2001, INT C HLTH RES DEV; Council on Health Research for Development (COHRED), 2013, THER IS NO LAW GUID; Council on Health Research for Development (COHRED), 2015, COHRED FAIRN IND INT; Crane J.T., 2013, SCRAMBLING AFRICA AI; Crane J, 2011, LANCET, V377, P1388, DOI 10.1016/S0140-6736(10)61920-4; Dunbar K., 1995, NATURE INSIGHT, P365, DOI DOI 10.1016/S0193-3973(99)00050-7; Gerrets Rene, 2010, GLOBALIZING INT HLTH; Glanzel W., 2005, HDB QUANTITATIVE SCI, P257, DOI [DOI 10.1007/1-4020-2755-9_12, DOI 10.1007/1-4020-2755-9]; Henderson GE, 2007, J EMPIR RES HUM RES, V2, P41, DOI 10.1525/jer.2007.2.2.41; InterAcademy Council and InterAcademy Panel, 2012, RESP COND GLOB RES E; Kingori P, 2013, SOC SCI MED, V98, P361, DOI 10.1016/j.socscimed.2013.10.013; Krubiner CB, 2014, HEALTH SYST, V3, P124, DOI 10.1057/hs.2014.1; Macdonald H, 2013, ANTHROPOL SOUTH AFR, V36, P146, DOI 10.1080/02580144.2013.10887040; Mwangoka G, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-86; Parker M., 2012, CAMB BIOETH LAW, DOI 10.1017/CBO9781139107792; Parker M, 2015, J MED ETHICS, V41, P134, DOI 10.1136/medethics-2014-102303; Schmoch U, 2008, SCIENTOMETRICS, V74, P361, DOI 10.1007/s11192-007-1818-5; Schwartz-Marin E, 2013, SOCIOLOGY, V47, P993, DOI 10.1177/0038038513494506; Simon C, 2007, SOC SCI MED, V64, P1960, DOI 10.1016/j.socscimed.2007.01.009; Sonnenwald DH, 2007, ANNU REV INFORM SCI, V41, P643, DOI 10.1002/aris.2007.1440410121; Thompson C, 2013, INSIDE TECHNOL, P1; Wahlberg A, 2013, SOC SCI MED, V98, P293, DOI 10.1016/j.socscimed.2013.03.041; World Conferences on Research Integrity, 2013, WORLD C RES INT	30	70	70	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163579	10.1371/journal.pone.0163579	http://dx.doi.org/10.1371/journal.pone.0163579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27737006	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800017
J	Isitman, G; Tremblay-McLean, A; Lisovsky, I; Bruneau, J; Lebouche, B; Routy, JP; Bernard, NF				Isitman, Gamze; Tremblay-McLean, Alexandra; Lisovsky, Irene; Bruneau, Julie; Lebouche, Bertrand; Routy, Jean-Pierre; Bernard, Nicole F.			NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+than Their iKIR Negative Counterparts	PLOS ONE			English	Article							CLASS-I MOLECULES; MHC CLASS-I; HLA-C; EFFECTOR FUNCTIONS; CD57 DEFINES; T-CELLS; EDUCATION; HIV-1; ANTIBODIES; ALLELES	Natural Killer (NK) cell education, which requires the engagement of inhibitory NK cell receptors (iNKRs) by their ligands, is important for generating self-tolerant functional NK cells. While the potency of NK cell education is directly related to their functional potential upon stimulation with HLA null cells, the influence of NK cell education on the potency of the antibody dependent cellular cytotoxicity (ADCC) function of NK cells is unclear. ADCC occurs when the Fc portion of an immunoglobulin G antibody bridges the CD16 Fc receptor on NK cells and antigen on target cells, resulting in NK cell activation, cytotoxic granule release, and target cell lysis. We previously reported that education via the KIR3DL1/HLA-Bw4 iNKR/HLA ligand combination supported higher KIR3DL1(+) than KIR3DL1(-) NK cell activation levels but had no impact on ADCC potency measured as the frequency of granzyme B positive (%GrB(+)) targets generated in an ADCC GranToxiLux assay. A lower frequency of KIR3DL1(+) compared to KIR3DL1(-) NK cells were CD16(+), which may in part explain the discrepancy between NK cell activation and target cell effects. Here, we investigated the frequency of CD16(+) cells among NK cells expressing other iNKRs. We found that CD16(+) cells were significantly more frequent among NK cells negative for the inhibitory KIR (iKIR) KIR2DL1, KIR2DL3, and KIR3DL1 than those positive for any one of these iKIR to the exclusion of the others, making iKIR(+) NK cells poorer ADCC effectors than iKIR- NK cells. The education status of these iKIR(+) populations had no effect on the frequency of CD16(+) cells.	[Isitman, Gamze; Tremblay-McLean, Alexandra; Lisovsky, Irene; Lebouche, Bertrand; Routy, Jean-Pierre; Bernard, Nicole F.] McGill Univ, Hlth Ctr RI MUHC, Res Inst, Montreal, PQ, Canada; [Isitman, Gamze; Tremblay-McLean, Alexandra; Lisovsky, Irene; Routy, Jean-Pierre; Bernard, Nicole F.] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Bruneau, Julie] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Bruneau, Julie] Univ Montreal, Dept Family Med, Montreal, PQ, Canada; [Lebouche, Bertrand; Routy, Jean-Pierre; Bernard, Nicole F.] MUHC, Chron Viral Illness Serv, Montreal, PQ, Canada; [Lebouche, Bertrand] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [Routy, Jean-Pierre] MUHC, Div Hematol, Montreal, PQ, Canada; [Bernard, Nicole F.] MUHC, Div Clin Immunol, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; McGill University	Bernard, NF (corresponding author), McGill Univ, Hlth Ctr RI MUHC, Res Inst, Montreal, PQ, Canada.; Bernard, NF (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ, Canada.; Bernard, NF (corresponding author), MUHC, Chron Viral Illness Serv, Montreal, PQ, Canada.; Bernard, NF (corresponding author), MUHC, Div Clin Immunol, Montreal, PQ, Canada.	nicole.bernard@mcgill.ca	LEBOUCHE, Bertrand/AAC-6047-2022; LEBOUCHE, Bertrand/GZL-8127-2022	LEBOUCHE, Bertrand/0000-0002-1273-9393; 	Canadian Institutes for Health Research [HOP-123800, MOP-142494]; Fonds de Recherchedu Quebec-Sante AIDS and Infectious Diseases Network; Canadian HIV Trials Network; CIHR; FRQ-S; Junior I scholarship from FRQ-S; Alberta Innovates [201201140] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherchedu Quebec-Sante AIDS and Infectious Diseases Network; Canadian HIV Trials Network; CIHR(Canadian Institutes of Health Research (CIHR)); FRQ-S; Junior I scholarship from FRQ-S; Alberta Innovates	This study received support from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca) HOP-123800 and MOP-142494 and the Fonds de Recherchedu Quebec-Sante (http://www.frqs.gouv.qc.ca) AIDS and Infectious Diseases Network (http://www.reseausidami.quebec/fr) to NFB. GI was supported by a post-doctoral scholarship from Canadian HIV Trials Network (http://www.hivnet.ubc.ca/) and CIHR (http://www.cihr-irsc.gc.ca). IL was supported by a Ph.D. scholarship from FRQ-S (http://www.frqs.gouv.qc.ca) and CIHR (http://www.cihr-irsc.gc.ca). BL is supported by a Junior I scholarship from FRQ-S (http://www.frqs.gouv.qc. ca). NFB is a member of the RI-MUHC, an institution funded in part by the FRQ-S (http://www.frqs.gouv.qc.ca).	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Boulassel MR, 2003, J CLIN APHERESIS, V18, P55, DOI 10.1002/jca.10051; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Davis ZB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005421; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Gooneratne SL, 2015, J VIROL, V89, P97, DOI 10.1128/JVI.02461-14; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Isitman G, 2015, AIDS, V29, P1433, DOI 10.1097/QAD.0000000000000729; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Kulkarni S, 2010, METHODS MOL BIOL, V612, P365, DOI 10.1007/978-1-60761-362-6_25; LANIER LL, 1986, J IMMUNOL, V136, P4480; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Parsons MS, 2014, AIDS, V28, P2781, DOI 10.1097/QAD.0000000000000489; Parsons MS, 2010, J LEUKOCYTE BIOL, V88, P905, DOI 10.1189/jlb.1009687; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sivori S, 2003, EUR J IMMUNOL, V33, P3439, DOI 10.1002/eji.200324533; Smalls-Mantey A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074858; Tomasec P, 2000, SCIENCE, V287, P1031, DOI 10.1126/science.287.5455.1031; Ulbrecht M, 2000, J IMMUNOL, V164, P5019, DOI 10.4049/jimmunol.164.10.5019; WAN AM, 1986, J IMMUNOL, V137, P3671; Winter CC, 1998, J IMMUNOL, V161, P571; Yawata M, 2008, BLOOD, V112, P2369, DOI 10.1182/blood-2008-03-143727; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491; Yu J, 2007, J IMMUNOL, V179, P5977, DOI 10.4049/jimmunol.179.9.5977	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164517	10.1371/journal.pone.0164517	http://dx.doi.org/10.1371/journal.pone.0164517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732638	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300062
J	Kodaman, N; Aldrich, MC; Sobota, R; Asselbergs, FW; Poku, KA; Brown, NJ; Moore, JH; Williams, SM				Kodaman, Nuri; Aldrich, Melinda C.; Sobota, Rafal; Asselbergs, Folkert W.; Poku, Kwabena A.; Brown, Nancy J.; Moore, Jason H.; Williams, Scott M.			Cardiovascular Disease Risk Factors in Ghana during the Rural-to-Urban Transition: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SUB-SAHARAN AFRICA; BLOOD-PRESSURE; DENSITY-LIPOPROTEIN; PRIMARY PREVENTION; METABOLIC SYNDROME; DIABETES-MELLITUS; WEST-AFRICA; HYPERTENSION; PREVALENCE	Populations in sub-Saharan Africa are shifting from rural to increasingly urban. Although the burden of cardiovascular disease is expected to increase with this changing landscape, few large studies have assessed a wide range of risk factors in urban and rural populations, particularly in West Africa. We conducted a cross-sectional, population-based survey of 3317 participants from Ghana (>= 18 years old), of whom 2265 (57% female) were from a mid-sized city (Sunyani, population similar to 250,000) and 1052 (55% female) were from surrounding villages (populations <5000). We measured canonical cardiovascular disease risk factors (BMI, blood pressure, fasting glucose, lipids) and fibrinolytic markers (PAI-1 and t-PA), and assessed how their distributions and related clinical outcomes (including obesity, hypertension and diabetes) varied with urban residence and sex. Urban residence was strongly associated with obesity (OR: 7.8, 95% CI: 5.3-11.3), diabetes (OR 3.6, 95% CI: 2.3-5.7), and hypertension (OR 3.2, 95% CI: 2.6-4.0). Among the quantitative measures, most affected were total cholesterol (+0.81 standard deviations, 95% CI 0.73-0.88), LDL cholesterol (+0.89, 95% CI: 0.79-0.99), and t-PA (+0.56, 95% CI: 0.48-0.63). Triglycerides and HDL cholesterol profiles were similarly poor in both urban and rural environments, but significantly worse among rural participants after BMI-adjustment. For most of the risk factors, the strength of the association with urban residence did not vary with sex. Obesity was a major exception, with urban women at particularly high risk (26% age-standardized prevalence) compared to urban men (7%). Overall, urban residents had substantially worse cardiovascular risk profiles, with some risk factors at levels typically seen in the developed world.	[Kodaman, Nuri; Sobota, Rafal; Williams, Scott M.] Dartmouth Coll, Geisel Sch Med, Dept Genet, Hanover, NH 03755 USA; [Kodaman, Nuri; Sobota, Rafal] Vanderbilt Univ, Sch Med, Vanderbilt Genet Inst, Nashville, TN 37235 USA; [Aldrich, Melinda C.] Vanderbilt Univ, Sch Med, Dept Thorac Surg, Nashville, TN 37235 USA; [Aldrich, Melinda C.] Vanderbilt Univ, Sch Med, Div Epidemiol, Nashville, TN 37235 USA; [Asselbergs, Folkert W.] UMC Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Asselbergs, Folkert W.] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England; [Poku, Kwabena A.] Univ Ghana, Legon, Ghana; [Brown, Nancy J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37235 USA; [Moore, Jason H.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Williams, Scott M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Dartmouth College; Vanderbilt University; Vanderbilt University; Vanderbilt University; Utrecht University; Utrecht University Medical Center; University of London; University College London; University of Ghana; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Case Western Reserve University	Williams, SM (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Genet, Hanover, NH 03755 USA.; Williams, SM (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	smw154@case.edu	Williams, Scott/Q-4812-2019; Moore, Jason H./AAV-9645-2021; Asselbergs, Folkert W./ABD-6752-2021	Williams, Scott/0000-0002-4835-9544; Moore, Jason H./0000-0002-5015-1099; Asselbergs, Folkert W./0000-0002-1692-8669; Sobota, Rafal/0000-0002-5945-5830	National Institutes of Health [HL65234, LM010098]; SMW National Institutes of Health [K07 CA172294]; Dekker scholarship - Netherlands Heart Foundation [2014T001]; UCL Hospitals NIHR Biomedical Research Centre; NATIONAL CANCER INSTITUTE [K07CA172294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SMW National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dekker scholarship - Netherlands Heart Foundation; UCL Hospitals NIHR Biomedical Research Centre; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding was provided by National Institutes of Health, http://www.nih.gov/, HL65234 and LM010098 FWA, JHL, and SMW National Institutes of Health, http://www.nih.gov/, K07 CA172294 MDA, and a Dekker scholarship - Netherlands Heart Foundation, http://www.cavaris. nl, 2014T001 FWA and UCL Hospitals NIHR Biomedical Research Centre, http://www.uclhospitals.brc.nihr.ac.uk/ FWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Addo J, 2006, ETHNIC DIS, V16, P894; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Ahmad O.B., 2001, TECHNICAL REPORT; Amoah AGB, 2002, DIABETES RES CLIN PR, V56, P197, DOI 10.1016/S0168-8227(01)00374-6; [Anonymous], 2008, WORLD URBANIZATION P; [Anonymous], 2006, DEFINITION AND DIAGN; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Awuah RB, 2014, J HYPERTENS, V32, P1203, DOI 10.1097/HJH.0000000000000165; Bartlett J, 2016, CIRC-CARDIOVASC QUAL, V9, P206, DOI 10.1161/CIRCOUTCOMES.115.002436; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Bernabe-Ortiz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035127; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Bosu WK, 2015, P NUTR SOC, V74, P466, DOI 10.1017/S0029665114001669; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Commodore-Mensah Y, 2014, J HYPERTENS, V32, P464, DOI 10.1097/HJH.0000000000000061; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 2015, J HYPERTENS, V33, P473, DOI 10.1097/HJH.0000000000000429; Council TWAE, 2015, BASIC EDUCATION CERT; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Dichtl W, 2000, THROMB HAEMOSTASIS, V84, P706; DODU S R, 1958, West Afr Med J, V7, P129; Dodu SRAdH N, 1964, GHANA MED J, p75 ~ 80, DOI [10.1136/heartjnl-2012-303316, DOI 10.1136/HEARTJNL-2012-303316]; Duda RB, 2007, INT J CARDIOL, V117, P115, DOI 10.1016/j.ijcard.2006.05.004; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gavin JR, 1999, DIABETES CARE, V22, pS5; Genuth S, 2003, DIABETES CARE, V26, P3160; Glew RH, 2004, J HEALTH POPUL NUTR, V22, P357; Gorog DA, 2010, J AM COLL CARDIOL, V55, P2701, DOI 10.1016/j.jacc.2009.11.095; Greenhalgh S, 2007, POPUL DEV REV, V33, P639; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Hitimana L, 2011, REPORT NO; Holmes MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000244; Isezuo SA, 2011, J HUM HYPERTENS, V25, P224, DOI 10.1038/jhh.2010.56; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Kaufman JS, 1996, AM J EPIDEMIOL, V143, P1203, DOI 10.1093/oxfordjournals.aje.a008708; Kaufman JS, 1999, HUM BIOL, V71, P641; Kavey REW, 2003, J PEDIATR-US, V142, P368, DOI 10.1067/mpd.2003.205; Kengne AP, 2013, HEART, V99, P1072, DOI 10.1136/heartjnl-2013-303773; Kengne AP, 2013, HEART, V99, P979, DOI 10.1136/heartjnl-2012-303316; Kumar V, 2014, ROBBINS COTRAN PATHO; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mathers C, 2008, THE GLOBAL BURDEN OF; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; MILLER GJ, 1975, LANCET, V1, P16; Monda KL, 2009, J LIPID RES, V50, P1685, DOI 10.1194/jlr.P900029-JLR200; Moran A, 2013, PROG CARDIOVASC DIS, V56, P234, DOI 10.1016/j.pcad.2013.09.019; Morange PE, 2013, THROMB HAEMOSTASIS, V110, P669, DOI 10.1160/TH13-01-0075; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Nicholls SJ, 2007, J AM COLL CARDIOL, V49, P1546, DOI 10.1016/j.jacc.2006.12.039; Nicholls SJ, 2006, J AM COLL CARDIOL, V47, P1967, DOI 10.1016/j.jacc.2005.12.058; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; POBEE JOM, 1977, T ROY SOC TROP MED H, V71, P66, DOI 10.1016/0035-9203(77)90211-5; POULTER N, 1984, HYPERTENSION, V6, P810, DOI 10.1161/01.HYP.6.6.810; Reddy KS, 1998, CIRCULATION, V97, P596; Regitz-Zagrosek V, 2007, PROG CARDIOVASC DIS, V49, P241, DOI 10.1016/j.pcad.2006.08.011; Renzaho AMN, 2004, HEALTH PLACE, V10, P105, DOI 10.1016/S1353-8292(03)00051-0; SCADDING H, 1989, COMPARE, V19, P43, DOI 10.1080/0305792890190105; Scheer FAJL, 2014, BLOOD, V123, P590, DOI 10.1182/blood-2013-07-517060; Schoenhard JA, 2008, HUM GENET, V124, P479, DOI 10.1007/s00439-008-0573-x; Schunemann HJ, 2008, COCHRANE HANDBOOK FO; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sheridan S, 2003, J GEN INTERN MED, V18, P1039, DOI 10.1111/j.1525-1497.2003.30107.x; Smith R, 2013, JAMA-J AM MED ASSOC, V309, P1595, DOI 10.1001/jama.2013.3180; Torun B, 2002, INT J EPIDEMIOL, V31, P218, DOI 10.1093/ije/31.1.218; Vaccarino V, 2011, CARDIOVASC RES, V90, P9, DOI 10.1093/cvr/cvq394; van der Sande MAB, 2001, AM J PUBLIC HEALTH, V91, P1641, DOI 10.2105/AJPH.91.10.1641; van der Sande MAB, 2000, J HUM HYPERTENS, V14, P489, DOI 10.1038/sj.jhh.1001050; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Vorster HH, 2002, PUBLIC HEALTH NUTR, V5, P239, DOI 10.1079/PHN2001299; Williams SM, 2007, ETHNIC DIS, V17, P492; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; World Health Organization,Report of a WHO Expert Committee, 1995, PHYSICAL STATUS THE; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yajnik CS, 2013, INT J CARDIOL, V165, P255, DOI 10.1016/j.ijcard.2011.08.053; Yamamoto-Kimura L, 2006, J ADOLESCENT HEALTH, V38, P591, DOI 10.1016/j.jadohealth.2005.04.004; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zeba AN, 2012, PUBLIC HEALTH NUTR, V15, P2210, DOI 10.1017/S1368980012000729	88	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0162753	10.1371/journal.pone.0162753	http://dx.doi.org/10.1371/journal.pone.0162753			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732601	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300004
J	Braunisch, V; Patthey, P; Arlettaz, R				Braunisch, Veronika; Patthey, Patrick; Arlettaz, Raphael			Where to Combat Shrub Encroachment in Alpine Timberline Ecosystems: Combining Remotely-Sensed Vegetation Information with Species Habitat Modelling	PLOS ONE			English	Article							MOUNTAIN GRASSLANDS; BREEDING SUCCESS; ALPS; MANAGEMENT; CLIMATE; DISTRIBUTIONS; CONSEQUENCES; LANDSCAPE; DIVERSITY; SELECTION	In many cultural landscapes, the abandonment of traditional grazing leads to encroachment of pastures by woody plants, which reduces habitat heterogeneity and impacts biodiversity typical of semi-open habitats. We developed a framework of mutually interacting spatial models to locate areas where shrub encroachment in Alpine treeline ecosystems deteriorates vulnerable species' habitat, using black grouse Tetrao tetrix (L.) in the Swiss Alps as a study model. Combining field observations and remote-sensing information we 1) identified and located the six predominant treeline vegetation types; 2) modelled current black grouse breeding habitat as a function thereof so as to derive optimal habitat profiles; 3) simulated from these profiles the theoretical spatial extension of breeding habitat when assuming optimal vegetation conditions throughout; and used the discrepancy between (2) and (3) to 4) locate major aggregations of homogeneous shrub vegetation in otherwise suitable breeding habitat as priority sites for habitat restoration. All six vegetation types (alpine pasture, coniferous forest, Alnus viridis (Chaix), Rhododendron-dominated, Juniperus-dominated and mixed heathland) were predicted with high accuracy (AUC > 0.9). Breeding black grouse preferred a heterogeneous mosaic of vegetation types, with none exceeding 50% cover. While 15% of the timberline belt currently offered suitable breeding habitat, twice that fraction (29%) would potentially be suitable when assuming optimal shrub and ground vegetation conditions throughout the study area. Yet, only 10% of this difference was attributed to habitat deterioration by shrub-encroachment of dense heathland (all types 5.2%) and Alnus viridis (4.8%). The presented method provides both a general, large-scale assessment of areas covered by dense shrub vegetation as well as specific target values and priority areas for habitat restoration related to a selected target organism. This facilitates optimizing the spatial allocation of management resources in geographic regions where shrub encroachment represents a major biodiversity conservation issue.	[Braunisch, Veronika; Arlettaz, Raphael] Univ Bern, Inst Ecol & Evolut, Conservat Biol, Baltzerstr 6, CH-3012 Bern, Switzerland; [Braunisch, Veronika] Forest Res Inst Baden Wuerttemberg FVA, Wonnhaldestr 4, D-79100 Freiburg, Germany; [Patthey, Patrick] Direct Gen Environm, Conservat Faune, Ch Marquisat 1, CH-1025 St Sulpice, Switzerland; [Arlettaz, Raphael] Swiss Ornithol Inst, Valais Field Stn, Rue Rhone 11, CH-1950 Sion, Switzerland	University of Bern; Swiss Ornithological Institute	Braunisch, V (corresponding author), Univ Bern, Inst Ecol & Evolut, Conservat Biol, Baltzerstr 6, CH-3012 Bern, Switzerland.; Braunisch, V (corresponding author), Forest Res Inst Baden Wuerttemberg FVA, Wonnhaldestr 4, D-79100 Freiburg, Germany.	Veronika.Braunisch@iee.unibe.ch	Braunisch, Veronika/AAH-8260-2020; Arlettaz, Raphael/O-2182-2016	Braunisch, Veronika/0000-0001-7035-4662; Arlettaz, Raphael/0000-0001-6360-5339	Forestry Administration of the Canton of Valais, Switzerland	Forestry Administration of the Canton of Valais, Switzerland	The study was partly funded by the Forestry Administration of the Canton of Valais, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthelme F, 2001, FOREST ECOL MANAG, V145, P57, DOI 10.1016/S0378-1127(00)00574-0; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Arlettaz R, 2015, ECOL APPL, V25, P1197, DOI 10.1890/14-1141.1; Baines D., 1992, GAME CONSERVANCY REV, V23, P98; Balthazar V, 2012, INT J APPL EARTH OBS, V18, P436, DOI 10.1016/j.jag.2012.03.010; Berk A, 1998, REMOTE SENS ENVIRON, V65, P367, DOI 10.1016/S0034-4257(98)00045-5; Berk A., 2003, MODTRAN4 VERSION 3 R; Boschetti M, 2007, AGR ECOSYST ENVIRON, V118, P267, DOI 10.1016/j.agee.2006.05.024; Brandt JS, 2013, BIOL CONSERV, V158, P116, DOI 10.1016/j.biocon.2012.07.026; Braunisch V, 2011, ECOL APPL, V21, P955, DOI 10.1890/09-2167.1; Braunisch V, 2010, ECOGRAPHY, V33, P826, DOI 10.1111/j.1600-0587.2009.05891.x; Burnham KP., 1998, MODEL SELECTION INFE, P75, DOI [10.1007/978-1-4757-2917-7_3, DOI 10.1007/978-1-4757-2917-7_3, DOI 10.1007/978-1-4757-2917-7]; Busetto L, 2010, GLOBAL CHANGE BIOL, V16, P2504, DOI 10.1111/j.1365-2486.2010.02189.x; Camarero JJ, 2002, PLANT ECOL, V162, P247, DOI 10.1023/A:1020367918521; Carlson BZ, 2014, ECOL APPL, V24, P1213, DOI 10.1890/13-0910.1; Dirnbock T, 2003, APPL VEG SCI, V6, P85, DOI 10.1658/1402-2001(2003)006[0085:MAVBOI]2.0.CO;2; Dullinger S, 2003, ARCT ANTARCT ALP RES, V35, P434, DOI 10.1657/1523-0430(2003)035[0434:POSIIH]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fatehi P, 2015, IEEE J-STARS, V8, P3123, DOI 10.1109/JSTARS.2015.2432075; Fontana F, 2008, SENSORS-BASEL, V8, P2833, DOI 10.3390/s8042833; Franklin SE, 1994, CANADIAN J REMOTE SE, V20, P49; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Gartzia M, 2014, PROG PHYS GEOG, V38, P201, DOI 10.1177/0309133314524429; Gartzia M, 2013, MT RES DEV, V33, P63, DOI 10.1659/MRD-JOURNAL-D-12-00011.1; Geary M, 2013, IBIS, V155, P792, DOI 10.1111/ibi.12090; Gehrig-Fasel J, 2007, J VEG SCI, V18, P571, DOI 10.1111/j.1654-1103.2007.tb02571.x; Gonseth Y, 2001, 137 BUWALOFEFP, V137; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holtmeier FK, 2005, GLOBAL ECOL BIOGEOGR, V14, P395, DOI 10.1111/j.1466-822x.2005.00168.x; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Korner Christian, 2000, Gayana Botanica, V57, P1; Kurki S, 2000, ECOLOGY, V81, P1985, DOI 10.1890/0012-9658(2000)081[1985:LFAFCE]2.0.CO;2; Laiolo P, 2004, J APPL ECOL, V41, P294, DOI 10.1111/j.0021-8901.2004.00893.x; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Ludwig GX, 2008, J APPL ECOL, V45, P325, DOI 10.1111/j.1365-2664.2007.01396.x; Maurer K, 2006, BIOL CONSERV, V130, P438, DOI 10.1016/j.biocon.2006.01.005; Panigrahy S, 2010, TROP ECOL, V51, P87; Parolo G, 2008, J APPL ECOL, V45, P1410, DOI 10.1111/j.1365-2664.2008.01516.x; Patthey P, 2008, J APPL ECOL, V45, P1704, DOI 10.1111/j.1365-2664.2008.01547.x; Patthey P, 2012, EUR J WILDLIFE RES, V58, P59, DOI 10.1007/s10344-011-0540-z; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2004, 21 INT C MACH LEARN, DOI [10.1111/j.2006.0906-7590.04596.x, DOI 10.1111/J.2006.0906-7590.04596.X]; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Richter R., 2007, 5650107 DLRIB; Rodriguez-Galiano V, 2012, APPL GEOGR, V35, P208, DOI 10.1016/j.apgeog.2012.06.014; Sankey TT, 2008, RANGELAND ECOL MANAG, V61, P412, DOI 10.2111/07-141.1; Schirmel J, 2011, J INSECT CONSERV, V15, P633, DOI 10.1007/s10841-010-9362-7; Signorell N, 2010, WILDLIFE BIOL, V16, P249, DOI 10.2981/09-028; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sitko I, 2008, MT RES DEV, V28, P263, DOI 10.1659/mrd.0963; STORCH I, 1991, ORNIS SCAND, V22, P271, DOI 10.2307/3676602; Storch I, 2007, WILDLIFE BIOL, V13, P5, DOI 10.2981/0909-6396(2007)13[5:CSOGWA]2.0.CO;2; Tonolli S, 2011, REMOTE SENS ENVIRON, V115, P2486, DOI 10.1016/j.rse.2011.05.009; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Wei YX, 2014, J MT SCI-ENGL, V11, P967, DOI 10.1007/s11629-012-2615-z; Zimmermann N.E., 2001, MLP CLIMATE BIOPHYSI; ZWEIG MH, 1993, CLIN CHEM, V39, P561	63	21	23	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164318	10.1371/journal.pone.0164318	http://dx.doi.org/10.1371/journal.pone.0164318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727325	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400026
J	Case, AJ; Roessner, CT; Tian, J; Zimmerman, MC				Case, Adam J.; Roessner, Colton T.; Tian, Jun; Zimmerman, Matthew C.			Mitochondrial Superoxide Signaling Contributes to Norepinephrine-Mediated T-Lymphocyte Cytokine Profiles	PLOS ONE			English	Article							IMMUNE-SYSTEM; NADPH OXIDASE; ENDOGENOUS CATECHOLAMINES; RESONANCE SPECTROSCOPY; CELL-DIFFERENTIATION; RESPIRATORY CAPACITY; RECEPTOR STIMULATION; OXIDATIVE STRESS; NERVOUS-SYSTEM; ANGIOTENSIN-II	Norepinephrine (NE) produces multifaceted regulatory patterns in T-lymphocytes. Recently, we have shown that NE utilizes redox signaling as evidenced by increased superoxide (O-2(center dot-)) causally linked to the observed changes in these cells; however, the source of this reactive oxygen species (ROS) remains elusive. Herein, we hypothesized that the source of increased O-2(center dot-) in NE-stimulated T-lymphocytes is due to disruption of mitochondrial bioenergetics. To address this hypothesis, we utilized purified mouse splenic CD4+ and CD8+ T-lymphocytes stimulated with NE and assessed O-2(center dot-) levels, mitochondrial metabolism, cellular proliferation, and cytokine profiles. We demonstrate that the increase in O-2(center dot-) levels in response to NE is time-dependent and occurs at later points of T-lymphocyte activation. Moreover, the source of O-2(center dot-) was indeed the mitochondria as evidenced by enhanced MitoSOX Red oxidation as well as abrogation of this signal by the addition of the mitochondrial-targeted O-2(center dot-)-scavenging antioxidant MitoTempol. NE-stimulated T-lymphocytes also demonstrated decreased mitochondrial respiratory capacity, which suggests disruption of mitochondrial metabolism and the potential source of increased mitochondrial O-2(center dot-). The effects of NE in regards to redox signaling appear to be adrenergic receptor-dependent as specific receptor antagonists could reverse the increase in O-2(center dot-) ; however, differential receptors regulating these processes were observed in CD4+ versus CD8+ T-lymphocytes. Finally, mitochondrial O-2(center dot-) was shown to be mechanistic to the NE-mediated T-lymphocyte phenotype as supplementation of MitoTempol could reverse specific changes in cytokine expression observed with NE treatment. Overall, these studies indicate that mitochondrial metabolism and O-2(center dot-)-mediated redox signaling play a regulatory role in the T-lymphocyte response to NE.	[Case, Adam J.; Roessner, Colton T.; Tian, Jun; Zimmerman, Matthew C.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Case, AJ (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA.	adam.case@unmc.edu		Zimmerman, Matthew/0000-0001-5658-9051; Case, Adam/0000-0003-3404-1428	National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI) [K99HL123471, R00HL123471, R01HL103942]; Nebraska Research Initiative; Fred and Pamela Buffett Cancer Center's National Cancer Institute Cancer Support Grant; National Institute of General Medical Sciences of the National Institutes of Health [P30GM103335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL123471, R00HL123471, R01HL103942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Nebraska Research Initiative; Fred and Pamela Buffett Cancer Center's National Cancer Institute Cancer Support Grant; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health (NIH; https://www.nih.gov/), National Heart, Lung, and Blood Institute (NHLBI; http://www.nhlbi.nih.gov/) K99HL123471 (to AJC), R00HL123471 (to AJC), and R01HL103942 (to MCZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the University of Nebraska Medical Center Flow Cytometry Research Facility for their assistance in all flow cytometric analyses. The UNMC Flow Cytometry Research Facility is administrated through the Office of the Vice Chancellor for Research and supported by state funds from the Nebraska Research Initiative and The Fred and Pamela Buffett Cancer Center's National Cancer Institute Cancer Support Grant. Major instrumentation has been provided by the Office of the Vice Chancellor for Research, The University of Nebraska Foundation, the Nebraska Banker's Fund, and by the NIH-NCRR Shared Instrument Program. EPR Spectroscopy data was collected in the University of Nebraska's EPR Spectroscopy Core, which is supported, in part, by a grant from the National Institute of General Medical Sciences of the National Institutes of Health (P30GM103335) awarded to the University of Nebraska's Redox Biology Center.	Alaniz RC, 1999, P NATL ACAD SCI USA, V96, P2274, DOI 10.1073/pnas.96.5.2274; Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; Baerwald CGO, 1999, IMMUNOBIOLOGY, V200, P77, DOI 10.1016/S0171-2985(99)80034-5; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bi Y, 2012, SCAND J IMMUNOL, V75, P543, DOI 10.1111/j.1365-3083.2012.02686.x; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Carter JR, 2015, COMPR PHYSIOL, V5, P119, DOI 10.1002/cphy.c140030; Case AJ, 2016, J PHYSIOL-LONDON, V594, P527, DOI 10.1113/JP271516; Case AJ, 2015, HYPERTENSION, V65, P916, DOI 10.1161/HYPERTENSIONAHA.114.05075; Case AJ, 2013, AM J PHYSIOL-HEART C, V305, pH19, DOI 10.1152/ajpheart.00974.2012; Case AJ, 2013, FREE RADICAL BIO MED, V56, P17, DOI 10.1016/j.freeradbiomed.2012.11.018; Case AJ, 2011, FREE RADICAL BIO MED, V50, P448, DOI 10.1016/j.freeradbiomed.2010.11.025; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; CHOUAIB S, 1985, J IMMUNOL, V134, P940; Deo SH, 2013, AM J PHYSIOL-REG I, V305, pR1124, DOI 10.1152/ajpregu.00347.2013; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; FARAJ BA, 1994, INT J IMMUNOPHARMACO, V16, P561, DOI 10.1016/0192-0561(94)90107-4; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Gordon J, 2003, TRENDS IMMUNOL, V24, P438, DOI 10.1016/S1471-4906(03)00176-5; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Huang H., 2014, J NANOMATER, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0091570; Iyngkaran P, 2013, DIABETES METAB, V39, P290, DOI 10.1016/j.diabet.2013.05.002; Jackson EK, 2011, AM J PHYSIOL-RENAL, V301, pF1160, DOI 10.1152/ajprenal.00450.2011; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; KALYANARAMAN B, 1984, J BIOL CHEM, V259, P7584; Kenney MJ, 2014, COMPR PHYSIOL, V4, P1177, DOI 10.1002/cphy.c130051; Kin NW, 2006, J LEUKOCYTE BIOL, V79, P1093, DOI 10.1189/jlb.1105625; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kohm AP, 2001, PHARMACOL REV, V53, P487; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; LANDI MS, 1982, AM J VET RES, V43, P1654; Lee YC, 2016, ARTHRIT CARE RES, V68, P292, DOI 10.1002/acr.22683; LIVNAT S, 1987, PROG NEURO-PSYCHOPH, V11, P145, DOI 10.1016/0278-5846(87)90052-2; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; MADDEN KS, 1994, J NEUROIMMUNOL, V49, P77, DOI 10.1016/0165-5728(94)90183-X; Maestroni GJM, 2005, CURR NEUROVASC RES, V2, P169, DOI 10.2174/1567202053586776; MASON HS, 1961, BIOCHEM BIOPH RES CO, V4, P236, DOI 10.1016/0006-291X(61)90278-9; Mata S, 2005, J NEUROIMMUNOL, V170, P134, DOI 10.1016/j.jneuroim.2005.08.007; Mikuls TR, 2013, ARTHRIT CARE RES, V65, P227, DOI 10.1002/acr.21778; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; NOVAK TJ, 1990, P NATL ACAD SCI USA, V87, P9353, DOI 10.1073/pnas.87.23.9353; O'Donovan A, 2015, BIOL PSYCHIAT, V77, P365, DOI 10.1016/j.biopsych.2014.06.015; O'Sullivan D, 2015, SCIENCE, V348, P976, DOI 10.1126/science.aac4997; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Olfe Jakob, 2010, BMC Physiology, V10, P2, DOI 10.1186/1472-6793-10-2; Padro CJ, 2014, SEMIN IMMUNOL, V26, P357, DOI 10.1016/j.smim.2014.01.003; PALM S, 1992, EUR J CLIN INVEST, V22, P26; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Qiu YH, 2005, J NEUROIMMUNOL, V167, P45, DOI 10.1016/j.jneuroim.2005.06.007; Qiu YH, 2004, NEUROIMMUNOMODULAT, V11, P75, DOI 10.1159/000075316; Ramer-Quinn DS, 2000, BRAIN BEHAV IMMUN, V14, P239, DOI 10.1006/brbi.2000.0603; Sanders VM, 2012, BRAIN BEHAV IMMUN, V26, P195, DOI 10.1016/j.bbi.2011.08.001; Sanders VM, 1995, ADV NEUROIMMUNOL, V5, P283, DOI 10.1016/0960-5428(95)00019-X; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Slota C, 2015, BRAIN BEHAV IMMUN, V46, P168, DOI 10.1016/j.bbi.2015.01.015; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Strell C, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-62; Swanson MA, 2001, J IMMUNOL, V166, P232, DOI 10.4049/jimmunol.166.1.232; Takayanagi Y, 2012, J NEUROIMMUNOL, V245, P66, DOI 10.1016/j.jneuroim.2012.02.007; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wahle M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2028; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; YAMAZAKI I, 1960, J BIOL CHEM, V235, P2444; Zimmerman MC, 2004, CIRC RES, V95, P532, DOI 10.1161/01.RES.0000139957.22530.b9; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013; Zucker IH, 2006, HYPERTENSION, V48, P1005, DOI 10.1161/01.HYP.0000246614.47231.25	76	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164609	10.1371/journal.pone.0164609	http://dx.doi.org/10.1371/journal.pone.0164609			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727316	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400045
J	Forgaard, CJ; Franks, IM; Maslovat, D; Chua, R				Forgaard, Christopher J.; Franks, Ian M.; Maslovat, Dana; Chua, Romeo			Perturbation Predictability Can Influence the Long-Latency Stretch Response	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; SIMPLE REACTION-TIME; DEPENDENT MODULATION; FEEDBACK-CONTROL; HAND MUSCLES; EMG ACTIVITY; HUMAN WRIST; REFLEX; DISPLACEMENTS	Perturbations applied to the upper limbs elicit short (M1: 25-50 ms) and long-latency (M2: 50-100 ms) responses in the stretched muscle. M1 is produced by a spinal reflex loop, and M2 receives contribution from multiple spinal and supra-spinal pathways. While M1 is relatively immutable to voluntary intention, the remarkable feature of M2 is that its size can change based on intention or goal of the participant (e.g., increasing when resisting the perturbation and decreasing when asked to let-go or relax following the perturbation). While many studies have examined modulation of M2 between passive and various active conditions, through the use of constant foreperiods (interval between warning signal and a perturbation), it has also been shown that the magnitude of the M2 response in a passive condition can change based on factors such as habituation and anticipation of perturbation delivery. To prevent anticipation of a perturbation, most studies have used variable foreperiods; however, the range of possible foreperiod duration differs between experiments. The present study examined the influence of different variable foreperiods on modulation of the M2 response. Fifteen participants performed active and passive responses to a perturbation that stretched wrist flexors. Each block of trials had either a short (2.5-3.5 seconds; high predictability) or long (2.5-10.5 seconds; low predictability) variable foreperiod. As expected, no differences were found between any conditions for M1, while M2 was larger in the active rather than passive conditions. Interestingly, within the two passive conditions, the long variable foreperiods resulted in greater activity at the end of the M2 response than the trials with short foreperiods. These results suggest that perturbation predictability, even when using a variable foreperiod, can influence circuitry contributing to the long-latency stretch response.	[Forgaard, Christopher J.; Franks, Ian M.; Maslovat, Dana; Chua, Romeo] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada	University of British Columbia	Chua, R (corresponding author), Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada.	Romeo.Chua@ubc.ca		Franks, Ian/0000-0001-8687-5892; Forgaard, Christopher/0000-0001-8081-1572	NSERC Discovery Grants [6051]; Ian Franks [434]; NSERC Doctoral Fellowship	NSERC Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ian Franks; NSERC Doctoral Fellowship	This work was supported by NSERC Discovery Grants awarded to Romeo Chua (6051) and Ian Franks (434), and an NSERC Doctoral Fellowship awarded to CJF.	CALANCIE B, 1985, J NEUROPHYSIOL, V53, P1179, DOI 10.1152/jn.1985.53.5.1179; CHENEY PD, 1984, J PHYSIOL-LONDON, V349, P249, DOI 10.1113/jphysiol.1984.sp015155; CRAGO PE, 1976, J NEUROPHYSIOL, V39, P925, DOI 10.1152/jn.1976.39.5.925; Davranche K, 2007, EUR J NEUROSCI, V25, P3766, DOI 10.1111/j.1460-9568.2007.05588.x; DRAZIN DH, 1961, J EXP PSYCHOL, V62, P43, DOI 10.1037/h0046860; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; Forgaard CJ, 2015, J NEUROPHYSIOL, V114, P3386, DOI 10.1152/jn.00648.2015; GOODIN DS, 1992, BRAIN RES, V589, P39, DOI 10.1016/0006-8993(92)91159-C; GOODIN DS, 1990, BRAIN, V113, P1075, DOI 10.1093/brain/113.4.1075; HAGBARTH KE, 1981, J PHYSIOL-LONDON, V312, P81, DOI 10.1113/jphysiol.1981.sp013617; HAMMOND PH, 1956, J PHYSIOL-LONDON, V132, pP17; Ivry R, 2000, HUM BRAIN MAPP, V9, P115, DOI 10.1002/(SICI)1097-0193(200003)9:3<115::AID-HBM1>3.3.CO;2-X; Kimura T, 2006, J NEUROSCI, V26, P9272, DOI 10.1523/JNEUROSCI.3886-05.2006; KLEMMER ET, 1957, J EXP PSYCHOL, V54, P195, DOI 10.1037/h0046227; Kourtis D, 2008, J NEUROPHYSIOL, V99, P545, DOI 10.1152/jn.01112.2006; Kurtzer I, 2013, J NEUROPHYSIOL, V109, P2228, DOI 10.1152/jn.00145.2012; Lee R G, 1975, Can J Neurol Sci, V2, P285; Lewis GN, 2004, EXP BRAIN RES, V156, P72, DOI 10.1007/s00221-003-1767-z; Liddell EGT, 1924, P R SOC LOND B-CONTA, V96, P212, DOI 10.1098/rspb.1924.0023; Lourenco G, 2006, J PHYSIOL-LONDON, V572, P585, DOI 10.1113/jphysiol.2005.102806; MacKinnon CD, 2000, EXP BRAIN RES, V131, P477, DOI 10.1007/s002219900317; Manning CD, 2012, EXP BRAIN RES, V221, P155, DOI 10.1007/s00221-012-3157-x; MATTHEWS PBC, 1990, J PHYSIOL-LONDON, V428, P561, DOI 10.1113/jphysiol.1990.sp018228; MATTHEWS PBC, 1984, J PHYSIOL-LONDON, V348, P383, DOI 10.1113/jphysiol.1984.sp015116; Nikaido Y, 2016, HUM MOVEMENT SCI, V47, P38, DOI 10.1016/j.humov.2016.01.016; Omrani M, 2014, J NEUROPHYSIOL, V112, P2985, DOI 10.1152/jn.00270.2014; Pruszynski JA, 2008, J NEUROPHYSIOL, V100, P224, DOI 10.1152/jn.90262.2008; Pruszynski JA, 2014, J NEUROSCI, V34, P4608, DOI 10.1523/JNEUROSCI.4520-13.2014; Pruszynski JA, 2012, EXP BRAIN RES, V218, P341, DOI 10.1007/s00221-012-3041-8; Pruszynski JA, 2011, NATURE, V478, P387, DOI 10.1038/nature10436; Ravichandran VJ, 2013, EXP BRAIN RES, V230, P59, DOI 10.1007/s00221-013-3630-1; ROTHWELL JC, 1986, EXP BRAIN RES, V63, P197; ROTHWELL JC, 1980, NATURE, V286, P496, DOI 10.1038/286496a0; Shemmell J, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00002; STRICK PL, 1983, J NEUROSCI, V3, P2007; Tesche CD, 2000, HUM BRAIN MAPP, V9, P119, DOI 10.1002/(SICI)1097-0193(200003)9:3<119::AID-HBM2>3.0.CO;2-R	36	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e 0 1 6 3 8 5 4	10.1371/journal.pone.0163854	http://dx.doi.org/10.1371/journal.pone.0163854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727293	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504400011
J	Milosavljevic, V; Haddad, Y; Rodrigo, MAM; Moulick, A; Polanska, H; Hynek, D; Heger, Z; Kopel, P; Adam, V				Milosavljevic, Vedran; Haddad, Yazan; Rodrigo, Miguel Angel Merlos; Moulick, Amitava; Polanska, Hana; Hynek, David; Heger, Zbynek; Kopel, Pavel; Adam, Vojtech			The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer Therapy	PLOS ONE			English	Article							STEADY-STATE; EXPRESSION; MICROARRAY; APOPTOSIS; SP1; P53; METALLOTHIONEINS; OVEREXPRESSION; PROLIFERATION; TRANSPORTERS	Prostate cancer cells control energy metabolism by chelating intracellular zinc. Thus, zinc delivery has been a popular therapeutic approach for prostate cancer. Here, we propose the use of the membrane-penetrating peptide Novicidin connected to zinc-Schiff base as a carrier vehicle for the delivery of zinc to prostate cells. Mass spectrometry, electrochemistry and spectrophotometry confirmed the formation/stability of this complex and provided insight regarding the availability of zinc for complex interactions. This delivery system showed minor toxicity in normal PNT1A cells and high potency towards PC3 tumor cells. The complex preferentially penetrated PC3 tumor cells in contrast to confinement to the membranes of PNT1A. Furthermore, zinc uptake was confirmed in both cell lines. Molecular analysis was used to confirm the activation of zinc stress (e.g., ZnT-1) and apoptosis (e.g., CASP-1). Our results strongly suggest that the zinc-Schiff base-Novicidin complex has great potential as a novel anticancer drug.	[Milosavljevic, Vedran; Haddad, Yazan; Rodrigo, Miguel Angel Merlos; Hynek, David; Heger, Zbynek; Kopel, Pavel; Adam, Vojtech] Mendel Univ Brno, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic; [Rodrigo, Miguel Angel Merlos; Moulick, Amitava; Hynek, David; Heger, Zbynek; Kopel, Pavel; Adam, Vojtech] Brno Univ Technol, Cent European Inst Technol, Purkynova 123, CZ-61200 Brno, Czech Republic; [Polanska, Hana] Masaryk Univ, Fac Med, Dept Physiol, Kamenice 5, CZ-62500 Brno, Czech Republic	Mendel University in Brno; Brno University of Technology; Masaryk University Brno	Adam, V (corresponding author), Mendel Univ Brno, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic.; Adam, V (corresponding author), Brno Univ Technol, Cent European Inst Technol, Purkynova 123, CZ-61200 Brno, Czech Republic.	vojtech.adam@mendelu.cz	Holcova Polanska, Hana/N-2075-2014; Rodrigo, Miguel Angel Merlos/AAA-2451-2020; Kopel, Pavel/E-5711-2012; Merlos, Miguel/H-7196-2012; Hynek, David/E-5702-2012; Heger, Zbyněk/D-1973-2013; Milosavljević, Vedran/L-9078-2019; Haddad, Yazan/J-2985-2015; Moulick, Amitava/I-9677-2016; Adam, Vojtech/D-7686-2012	Holcova Polanska, Hana/0000-0003-2970-7408; Rodrigo, Miguel Angel Merlos/0000-0002-1920-0948; Kopel, Pavel/0000-0003-4216-9544; Merlos, Miguel/0000-0002-1920-0948; Hynek, David/0000-0002-7318-6470; Heger, Zbyněk/0000-0002-3915-7270; Milosavljević, Vedran/0000-0003-4122-0694; Haddad, Yazan/0000-0002-7844-4336; Moulick, Amitava/0000-0001-5769-6748; Adam, Vojtech/0000-0002-8527-286X	project CEITEC [LQ1601]; Ministry of Education,Youth and Sports of the Czech Republic under the National Sustainability Programme II [GACR 16-18917S]	project CEITEC; Ministry of Education,Youth and Sports of the Czech Republic under the National Sustainability Programme II	This research was carriedout under the project CEITEC 2020 (LQ1601) with financial support from the Ministry of Education,Youth and Sports of the Czech Republic under the National Sustainability Programme II and GACR 16-18917S.	Allam A, 2014, BIOCONJUGATE CHEM, V25, P1811, DOI 10.1021/bc500317u; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Biancardi MF, 2010, ANAT REC, V293, P2163, DOI 10.1002/ar.21250; BORELLINI F, 1993, J BIOL CHEM, V268, P7923; Brooks CL, 2010, CELL RES, V20, P614, DOI 10.1038/cr.2010.53; Cermakova S, 2010, INORG CHEM COMMUN, V13, P778, DOI 10.1016/j.inoche.2010.03.045; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Coffey RNT, 2001, J UROLOGY, V165, P5, DOI 10.1097/00005392-200101000-00003; Costello LC, 2004, PROSTATE CANCER P D, V7, P111, DOI 10.1038/sj.pcan.4500712; Costello LC, 1998, PROSTATE, V35, P285, DOI 10.1002/(SICI)1097-0045(19980601)35:4<285::AID-PROS8>3.0.CO;2-F; Costello LC, 2011, CANCER BIOL THER, V12, P1078, DOI 10.4161/cbt.12.12.18367; Cousins RJ, 2000, J NUTR, V130, p1384S, DOI 10.1093/jn/130.5.1384S; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; Dorosz J, 2010, J PHYS CHEM B, V114, P11053, DOI 10.1021/jp1052248; Eroglu C, 2015, TUMOR BIOL, V36, P9437, DOI 10.1007/s13277-015-3689-3; Evans BC, 2013, JOVE-J VIS EXP, DOI 10.3791/50166; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Franklin RB, 2003, J INORG BIOCHEM, V96, P435, DOI 10.1016/S0162-0134(03)00249-6; Franklin RB, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-32; Franklin RB, 2009, J CELL BIOCHEM, V106, P750, DOI 10.1002/jcb.22049; Franz MC, 2013, MOL ASPECTS MED, V34, P735, DOI 10.1016/j.mam.2012.11.007; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Gong PF, 2000, IND HEALTH, V38, P224, DOI 10.2486/indhealth.38.224; Guzow K, 2004, J PHYS CHEM B, V108, P3879, DOI 10.1021/jp036721c; Hasumi M, 2003, CANCER LETT, V200, P187, DOI 10.1016/S0304-3835(03)00441-5; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Hodgson MC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0061-y; Jackson P, 2002, UROL ONCOL, V7, P99, DOI 10.1016/S1078-1439(01)00175-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson LN, 2008, MOL THER, V16, P107, DOI 10.1038/sj.mt.6300324; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kopel P, 1998, TRANSIT METAL CHEM, V23, P139, DOI 10.1023/A:1006990925318; Kopel P, 2015, MOLECULES, V20, P10360, DOI 10.3390/molecules200610360; Kostova I, 2013, CURR MED CHEM, V20, P4609, DOI 10.2174/09298673113209990149; Krizkova S, 2016, J PHARMACEUT BIOMED, V117, P464, DOI 10.1016/j.jpba.2015.09.031; Krizkova S, 2012, DRUG METAB REV, V44, P287, DOI 10.3109/03602532.2012.725414; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Lin P, 2012, MOL CELL BIOCHEM, V359, P235, DOI 10.1007/s11010-011-1018-8; Lodemann U, 2013, TOXICOL IN VITRO, V27, P834, DOI 10.1016/j.tiv.2012.12.019; Lose F, 2013, UROL ONCOL-SEMIN ORI, V31, P635, DOI 10.1016/j.urolonc.2011.05.011; Maxim C, 2008, INORG CHIM ACTA, V361, P3903, DOI 10.1016/j.ica.2008.03.013; Meplan C, 2000, ONCOGENE, V19, P5227, DOI 10.1038/sj.onc.1203907; Ogra Y, 2001, J BIOL CHEM, V276, P16534, DOI 10.1074/jbc.M100570200; Osowole AA, 2008, J COORD CHEM, V61, P1046, DOI 10.1080/00958970701482446; Pan TJ, 2015, BIOCHEM BIOPH RES CO, V456, P452, DOI 10.1016/j.bbrc.2014.11.105; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Regberg J, 2012, PHARMACEUTICALS, V5, P991, DOI 10.3390/ph5090991; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Rodrigo MAM, 2014, INT J ELECTROCHEM SC, V9, P3431; Roth KM, 2006, ELECTROANAL, V18, P1982, DOI 10.1002/elan.200603603; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Shan ZJ, 2014, ONCOL REP, V32, P1939, DOI 10.3892/or.2014.3407; Shit S, 2009, Z NATURFORSCH B, V64, P403, DOI 10.1515/znb-2009-0408; Sigel A, 2009, METALLOTHIONEINS REL; Sirma H, 2013, ONCOL LETT, V6, P1245, DOI 10.3892/ol.2013.1563; Stark JL, 2014, BIOCHEMISTRY-US, V53, P1360, DOI 10.1021/bi401329a; SUNDERMAN FW, 1995, ANN CLIN LAB SCI, V25, P134; Truong-Tran AQ, 2001, BIOMETALS, V14, P315, DOI 10.1023/A:1012993017026; Voicescu M, 2009, J FLUORESC, V19, P257, DOI 10.1007/s10895-008-0411-5; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Zhu JH, 2013, ASIAN PAC J CANCER P, V14, P1017, DOI 10.7314/APJCP.2013.14.2.1017	66	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0163983	10.1371/journal.pone.0163983	http://dx.doi.org/10.1371/journal.pone.0163983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727290	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504400015
J	Ashbaugh, AR; Houle-Johnson, S; Herbert, C; El-Hage, W; Brunet, A				Ashbaugh, Andrea R.; Houle-Johnson, Stephanie; Herbert, Christophe; El-Hage, Wissam; Brunet, Alain			Psychometric Validation of the English and French Versions of the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSES; PTSD CHECKLIST; NONCLINICAL SAMPLE; TRAUMATIC EVENTS; SYMPTOMS; PREVALENCE; SCALE	The purpose of this study is to assess the psychometric properties of a French version of the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5), a self-report measure of posttraumatic stress disorder (PTSD) symptoms, and to further validate the existing English version of the measure. Undergraduate students (n = 838 English, n = 262 French) completed the PCL-5 as well as other self-report symptom measures of PTSD and depression online. Both the English and French versions PCL-5 total scores demonstrated excellent internal consistency (English: alpha = .95; French: alpha = .94), and strong convergent and divergent validity. Strong internal consistency was also observed for each of the four subscales for each version (alpha's > .79). Test-retest reliability for the French version of the measure was also very good (r = .89). Confirmatory factor analysis indicated that the four-factor DSM-5 model was not a good fit of the data. The seven-factor hybrid model best fit the data in each sample, but was only marginally superior to the six-factor anhedonia model. The French version of the PCL-5 demonstrated the same psychometric qualities as both the English version of the same measure and previous versions of the PCL. Thus clinicians serving French-speaking clients now have access to this highly used screening instrument. With regards to the structural validity of the PCL-5 and of the new PTSD diagnostic structure of the DSM-5, additional research is warranted. Replication of our results in clinical samples is much needed.	[Ashbaugh, Andrea R.; Houle-Johnson, Stephanie] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Herbert, Christophe] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [El-Hage, Wissam] Univ Tours, Inserm U930, Dept Psychiat, CHRU Tours, F-37041 Tours, France; [Brunet, Alain] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Brunet, Alain] McGill Univ, Dept Neurol, Montreal, PQ, Canada	University of Ottawa; McGill University; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; McGill University; McGill University	Brunet, A (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Brunet, A (corresponding author), McGill Univ, Dept Neurol, Montreal, PQ, Canada.	alain.brunet@mcgill.ca	EL-HAGE, WISSAM/S-5014-2019	EL-HAGE, WISSAM/0000-0003-3877-0855; Houle, Stephanie A./0000-0002-8501-2822				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Arbuckle J. L., 2014, AMOS VERSION 23 0 CO; Armour C, 2015, J PSYCHIATR RES, V61, P106, DOI 10.1016/j.jpsychires.2014.10.012; Ashbaugh A.R., 2010, INTERNET USE AFTERMA, P99, DOI DOI 10.3233/978-I-60750-626-3-99; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bernat JA, 1998, J TRAUMA STRESS, V11, P645, DOI 10.1023/A:1024485130934; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Brunet A, 2003, CAN J PSYCHIAT, V48, P56, DOI 10.1177/070674370304800111; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Elhai JD, 2012, J ANXIETY DISORD, V26, P58, DOI 10.1016/j.janxdis.2011.08.013; Elhai JD, 2011, J ANXIETY DISORD, V25, P849, DOI 10.1016/j.janxdis.2011.04.007; Frazier P, 2009, J COUNS PSYCHOL, V56, P450, DOI 10.1037/a0016412; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Fuhrer R, 1989, EUROPEAN PSYCHIAT, V4, P163, DOI DOI 10.1037/T10444-000; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; IBM, 2012, IBM SPSS STAT; Keane, ASSESSING PSYCHOL TR, P168, DOI DOI 10.1007/978-0-387-70990-1_10; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Kline R.B., 2011, PRINCIPLES PRACTICE; Liu P, 2014, J ANXIETY DISORD, V28, P345, DOI 10.1016/j.janxdis.2014.03.008; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Ministry of Foreign Affairs of Japan, 2016, OTH INT ORG; Nezu A. M., 2000, PRACTITIONERS GUIDE; Palmieri PA, 2007, J ABNORM PSYCHOL, V116, P329, DOI 10.1037/0021-843X.116.2.329; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ryan C., 2013, AM COMMUNITY LANGUAG; Shelby RA, 2005, J TRAUMA STRESS, V18, P347, DOI 10.1002/jts.20033; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Statistics Canada, 2015, LING CHAR CAN; Statistics Canada, 2015, FRENCH FRANC CAN; Tabachnick B. G., 2001, USING MULTIVARIATE S; Ventureyra VAG, 2002, PSYCHOTHER PSYCHOSOM, V71, P47, DOI 10.1159/000049343; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Weathers F.W., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Weathers F.W., 2013, CLIN ADMINISTERED PT; Yao SN, 2003, ENCEPHALE, V29, P232; Zelazny K, 2015, J ANXIETY DISORD, V34, P15, DOI 10.1016/j.janxdis.2015.05.009; Zou GY, 2012, STAT MED, V31, P3972, DOI 10.1002/sim.5466	44	239	240	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0161645	10.1371/journal.pone.0161645	http://dx.doi.org/10.1371/journal.pone.0161645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723815	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504100001
J	Field, A; Xiang, J; Anderson, WR; Graham, P; Pick, L				Field, Amanda; Xiang, Jie; Anderson, W. Ray; Graham, Patricia; Pick, Leslie			Activation of Ftz-F1-Responsive Genes through Ftz/Ftz-F1 Dependent Enhancers	PLOS ONE			English	Article							POLYCOMB RESPONSE ELEMENT; HOMEODOMAIN PROTEIN FTZ; DROSOPHILA-FUSHI-TARAZU; NUCLEAR RECEPTOR FTZ-F1; ZINC-FINGER PROTEIN; DNA-BINDING; TRANSCRIPTION FACTOR; SEGMENTATION GENE; TARGET GENES; GAGA FACTOR	The orphan nuclear receptor Ftz-F1 is expressed in all somatic nuclei in Drosophila embryos, but mutations result in a pair-rule phenotype. This was explained by the interaction of Ftz-F1 with the homeodomain protein Ftz that is expressed in stripes in the primordia of segments missing in either ftz-f1 or ftz mutants. Ftz-F1 and Ftz were shown to physically interact and coordinately activate the expression of ftz itself and engrailed by synergistic binding to composite Ftz-F1/Ftz binding sites. However, attempts to identify additional target genes on the basis of Ftz-F1/Ftz binding alone has met with only limited success. To discern rules for Ftz-F1 target site selection in vivo and to identify additional target genes, a microarray analysis was performed comparing wildtype and ftz-f1 mutant embryos. Ftz-F1-responsive genes most highly regulated included engrailed and nine additional genes expressed in patterns dependent on both ftz and ftz-f1. Candidate enhancers for these genes were identified by combining BDTNP Ftz ChIP-chip data with a computational search for Ftz-F1 binding sites. Of eight enhancer reporter genes tested in transgenic embryos, six generated expression patterns similar to the corresponding endogenous gene and expression was lost in ftz mutants. These studies identified a new set of Ftz-F1 targets, all of which are co-regulated by Ftz. Comparative analysis of enhancers containing Ftz/Ftz-F1 binding sites that were or were not bona fide targets in vivo suggested that GAF negatively regulates enhancers that contain Ftz/Ftz-F1 binding sites but are not actually utilized. These targets include other regulatory factors as well as genes involved directly in morphogenesis, providing insight into how pair-rule genes establish the body pattern.	[Pick, Leslie] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Univ Maryland, Program Mol & Cell Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Pick, L (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	lpick@umd.edu			National Science Foundation [IOS-0950765, IOS-1457145]; Training Program in Cell & Molecular Biology [T32 GM080201]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080201] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1457145] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Training Program in Cell & Molecular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation grants to LP (IOS-0950765 and IOS-1457145). AF received support from T32 GM080201, Training Program in Cell & Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbouzova NI, 2006, CURR BIOL, V16, P80, DOI 10.1016/j.cub.2005.11.033; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bowler T, 2006, DEV BIOL, V299, P78, DOI 10.1016/j.ydbio.2006.07.007; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Buescher M, 2006, DEV BIOL, V292, P418, DOI 10.1016/j.ydbio.2006.01.016; Busturia A, 2001, DEVELOPMENT, V128, P2163; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; CHANG Z, 1993, DEV BIOL, V160, P315, DOI 10.1006/dbio.1993.1310; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; CHOU TB, 1992, GENETICS, V131, P643; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Colas JF, 1999, MECH DEVELOP, V87, P77, DOI 10.1016/S0925-4773(99)00141-0; Colas JF, 1999, MECH DEVELOP, V87, P67, DOI 10.1016/S0925-4773(99)00140-9; Core N, 1997, MECH DEVELOP, V68, P157, DOI 10.1016/S0925-4773(97)00144-5; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Dabney A, 2011, QVALUE Q VALUE ESTIM; Dejardin J, 2004, EMBO J, V23, P857, DOI 10.1038/sj.emboj.7600108; Florence B, 1997, DEVELOPMENT, V124, P839; Fujioka M, 2008, DEVELOPMENT, V135, P4131, DOI 10.1242/dev.024554; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guichet A, 1997, NATURE, V385, P548, DOI 10.1038/385548a0; GUTJAHR T, 1994, MECH DEVELOP, V48, P119, DOI 10.1016/0925-4773(94)90021-3; Hagstrom K, 1997, GENETICS, V146, P1365; Han W, 1998, MOL CELL BIOL, V18, P3384, DOI 10.1128/MCB.18.6.3384; Heffer A, 2013, EVOL DEV, V15, P406, DOI 10.1111/ede.12050; Heffer A, 2011, BIOESSAYS, V33, P910, DOI 10.1002/bies.201100112; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Hou HY, 2009, DEV BIOL, V335, P442, DOI 10.1016/j.ydbio.2009.08.004; Hur MW, 2002, DEVELOPMENT, V129, P1339; INGHAM PW, 1986, NATURE, V324, P592, DOI 10.1038/324592a0; Johnson K, 1999, DEV BIOL, V212, P440, DOI 10.1006/dbio.1999.9351; Kal AJ, 2000, GENE DEV, V14, P1058; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Krause C, 2006, DEV BIOL, V296, P253, DOI 10.1016/j.ydbio.2006.04.462; Kuhnlein RP, 1998, MECH DEVELOP, V79, P161, DOI 10.1016/S0925-4773(98)00183-X; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Liu QX, 2009, GENE DEV, V23, P1165, DOI 10.1101/gad.1774209; Lohr U, 2005, CURR BIOL, V15, P643, DOI 10.1016/j.cub.2005.02.048; Lohr U, 2001, CURR BIOL, V11, P1403, DOI 10.1016/S0960-9822(01)00443-2; Lukacsovich T, 2003, ARCH INSECT BIOCHEM, V54, P77, DOI 10.1002/arch.10105; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Mahmoudi T, 2003, NUCLEIC ACIDS RES, V31, P4147, DOI 10.1093/nar/gkg479; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Mao Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001827; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matyash A, 2004, J BIOL CHEM, V279, P30689, DOI 10.1074/jbc.M403345200; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Miskolczi-McCallum CM, 2005, DEV BIOL, V278, P459, DOI 10.1016/j.ydbio.2004.11.026; Mulholland NM, 2003, GENE DEV, V17, P2741, DOI 10.1101/gad.1143303; MULLER J, 1992, EMBO J, V11, P3653, DOI 10.1002/j.1460-2075.1992.tb05450.x; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; PHELAN ML, 1994, MOL CELL BIOL, V14, P5066, DOI 10.1128/MCB.14.8.5066; PICK L, 1990, GENE DEV, V4, P1224, DOI 10.1101/gad.4.7.1224; PICK L, 1990, METHOD ENZYMOL, V181, P480; Pick L, 2016, CHROMOSOMA, V125, P535, DOI 10.1007/s00412-015-0553-6; Pick L, 2006, AD DEV BIOL, V16, P255, DOI 10.1016/S1574-3349(06)16008-1; PIRROTTA V, 1995, GENETICS, V141, P1439; Prokopenko SN, 2000, GENETICS, V156, P1691; QIAN S, 1993, EMBO J, V12, P3865, DOI 10.1002/j.1460-2075.1993.tb06065.x; RILEY GR, 1991, DEVELOPMENT, P177; Russell SRH, 1996, DEVELOPMENT, V122, P3669; Salzberg A, 1997, GENETICS, V147, P1723; Schaerlinger B, 2007, DEV DYNAM, V236, P991, DOI 10.1002/dvdy.21110; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz CJE, 2001, EMBO J, V20, P510, DOI 10.1093/emboj/20.3.510; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Telford MJ, 2000, CURR BIOL, V10, P349, DOI 10.1016/S0960-9822(00)00387-0; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yu Y, 1997, NATURE, V385, P552, DOI 10.1038/385552a0; Yussa M, 2001, MECH DEVELOP, V107, P39, DOI 10.1016/S0925-4773(01)00448-8	88	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163128	10.1371/journal.pone.0163128	http://dx.doi.org/10.1371/journal.pone.0163128			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723822	Green Published, gold			2022-12-27	WOS:000385504100003
J	Ignacio, RMC; Kabir, SM; Lee, ES; Adunyah, SE; Son, DS				Ignacio, Rosa Mistica C.; Kabir, Syeda M.; Lee, Eun-Sook; Adunyah, Samuel E.; Son, Deok-Soo			NF-kappa B-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; NECROSIS-FACTOR-ALPHA; TUMOR-GROWTH; CHEMOKINE EXPRESSION; COLORECTAL-CANCER; EOTAXIN-2 CCL24; MURINE MELANOMA; CELL-LINE; CXCR2; MICROENVIRONMENT	Ovarian cancer is an inflammation-associated malignancy with a high mortality rate. CXCR2 expressing ovarian cancers are aggressive with poorer outcomes. We previously demonstrated that CXCR2-driven ovarian cancer progression potentiated NF-kappa B activation through EGFR-transactivated Akt. Here, we identified the chemokine signature involved in CXCR2-driven ovarian cancer progression using a mouse peritoneal xenograft model for ovarian cancer spreading with CXCR2-negative (SKA) and positive (SKCXCR2) cells generated previously from parental SKOV-3 cells. Compared to SKA bearing mice, SKCXCR2 bearing mice had the following characteristics: 1) shorter survival time, 2) greater tumor spreading in the peritoneal cavity and 3) higher tumor weight in the omentum and pelvic site. Particularly, SKCXCR2-derived tumor tissues induced higher activation of the NF-kappa B signaling pathway, while having no change in EGFR-activated signaling such as Raf, MEK, Akt, mTOR and Erk compared to SKA-derived tumors. Chemokine PCR array revealed that CCL20 mRNA levels were significantly increased in SKCXCR2-derived tumor tissues. The CCL20 promoter activity was regulated by NF-kappa B dependent pathways. Interestingly, all three kappa B-like sites in the CCL20 promoter were involved in regulating CCL20 and the proximal region between -92 and -83 was the most critical kappa B-like site. In addition, SKCXCR2-derived tumor tissues maintained high CCL20 mRNA expression and induced greater CCL24 and CXCR4 compared to SKCXCR2 cells, indicating the shift of chemokine network during the peritoneal spreading of tumor cells via interaction with other cell types in tumor microenvironment. Furthermore, we compared expression profiling array between human ovarian cancer cell lines and tumor tissues based on GEO datasets. The expression profiles in comparison with cell lines revealed that dominant chemokines expressed in ovarian tumor tissues are likely shifted from CXCL1-3 and 8 to CCL20. Taken together, the progression of ovarian cancer in the peritoneal cavity involves NF-kappa B-mediated CCL20 as a main chemokine network, which is potentiated by CXCR2 expression.	[Ignacio, Rosa Mistica C.; Kabir, Syeda M.; Adunyah, Samuel E.; Son, Deok-Soo] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Lee, Eun-Sook] Florida A&M Univ, Coll Pharm, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA	Meharry Medical College; State University System of Florida; Florida A&M University	Son, DS (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA.	dson@mmc.edu	Ignacio, Rosa Mistica/AHC-6413-2022	Ignacio, Rosa Mistica/0000-0002-5343-4190	National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS) [SC1 089630]; National Institute of Environmental Health Sciences (NIEHS) [R01ES024756]; National Cancer Institute (NCI) [U54CA163069-05, 5U54MD0007593-07, SC1CA200519]; National Institute of Allergy and Infectious Diseases (NIAID) [SC1AI089073]; NATIONAL CANCER INSTITUTE [SC1CA200519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI089073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024756] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007586, U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported, in whole or in part, by National Institutes of Health (NIH) as the following grants: National Institute of General Medical Sciences (NIGMS) SC1 089630 and National Institute of Environmental Health Sciences (NIEHS) R01ES024756 (EL), National Cancer Institute (NCI) U54CA163069-05 and 5U54MD0007593-07 (SEA), and National Institute of Allergy and Infectious Diseases (NIAID) SC1AI089073 and NCI SC1CA200519 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthoni M, 2008, BRIT J DERMATOL, V159, P546, DOI 10.1111/j.1365-2133.2008.08696.x; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Beider K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005125; Ben-Yehuda C, 2008, EXP LUNG RES, V34, P467, DOI 10.1080/01902140802220625; Bobbs AS, 2015, CANCER GROWTH METAST, P29, DOI 10.4137/CGM.S21221; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Cheadle EJ, 2007, CLIN CANCER RES, V13, P5719, DOI 10.1158/1078-0432.CCR-07-1145; Chen KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024671; Chobanian N, 2008, SURG CLIN N AM, V88, P285, DOI 10.1016/j.suc.2007.12.002; Dobrzycka B, 2009, EUR CYTOKINE NETW, V20, P131, DOI 10.1684/ecn.2009.0161; Dong YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083789; Frick VO, 2013, SCAND J IMMUNOL, V78, P298, DOI 10.1111/sji.12087; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Harant H, 2001, FEBS LETT, V509, P439, DOI 10.1016/S0014-5793(01)03138-6; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim KY, 2009, ONCOL REP, V22, P1497, DOI 10.3892/or_00000593; Kirshberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024856; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; Maccio A, 2012, CYTOKINE, V58, P133, DOI 10.1016/j.cyto.2012.01.015; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Murakami T, 2003, J EXP MED, V198, P1337, DOI 10.1084/jem.20030593; Murakami T, 2002, CANCER RES, V62, P7328; Oladipo O, 2011, BRIT J CANCER, V104, P480, DOI 10.1038/sj.bjc.6606055; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Roberti MP, 2012, CANCER BIOL THER, V13, P1123, DOI 10.4161/cbt.21187; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Rubie C, 2006, WORLD J GASTROENTERO, V12, P6627, DOI 10.3748/wjg.v12.i41.6627; Rubie C, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-45; Sale Sanja, 2006, Drug Discov Today Dis Models, V3, P149, DOI 10.1016/j.ddmod.2006.05.006; Schaefer D, 2006, INT ARCH ALLERGY IMM, V140, P205, DOI 10.1159/000093206; Shen H, 2006, PROSTATE, V66, P1721, DOI 10.1002/pros.20476; Singh Rajesh, 2011, Front Biosci (Schol Ed), V3, P1569; Siwak DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/568938; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Son DS, 2007, CANCER BIOL THER, V6, P1302; Son DS, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-25; Son DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051116; Szlosarek PW, 2006, MOL CANCER THER, V5, P382, DOI 10.1158/1535-7163.MCT-05-0303; Vicinus B, 2013, ONCOL REP, V30, P1285, DOI 10.3892/or.2013.2580; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Yang G, 2010, CLIN CANCER RES, V16, P3875, DOI 10.1158/1078-0432.CCR-10-0483; Yeung TL, 2013, CANCER RES, V73, P5016, DOI 10.1158/0008-5472.CAN-13-0023; Yoshida N, 2007, BIOL PHARM BULL, V30, P1826, DOI 10.1248/bpb.30.1826; YU DH, 1993, CANCER RES, V53, P891	53	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164189	10.1371/journal.pone.0164189	http://dx.doi.org/10.1371/journal.pone.0164189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723802	gold, Green Published, Green Submitted			2022-12-27	WOS:000385504100026
J	Stone, NE; Sidak-Loftis, LC; Sahl, JW; Vazquez, AJ; Wiggins, KB; Gillece, JD; Hicks, ND; Schupp, JM; Busch, JD; Keim, P; Wagner, DM				Stone, Nathan E.; Sidak-Loftis, Lindsay C.; Sahl, Jason W.; Vazquez, Adam J.; Wiggins, Kristin B.; Gillece, John D.; Hicks, Nathan D.; Schupp, James M.; Busch, Joseph D.; Keim, Paul; Wagner, David M.			More than 50% of Clostridium difficile Isolates from Pet Dogs in Flagstaff, USA, Carry Toxigenic Genotypes	PLOS ONE			English	Article							BLAST SCORE RATIO; BINARY TOXIN; INFECTION EPIDEMIOLOGY; GENOME ANALYSIS; PREVALENCE; RESISTANCE; PATHOGEN; OUTBREAK; HISTORY; SPREAD	Nosocomial acquisition of Clostridium difficile is well documented, yet recent studies have highlighted the importance of community acquired infections and identified community associated reservoirs for this pathogen. Multiple studies have implicated companion pets and farm animals as possible sources of community acquired C. difficile infections in humans. To explore the potential role of pet dogs in human C. difficile infections we systematically collected canine fecal samples (n = 197) in Flagstaff, AZ. Additionally, nineteen fecal samples were collected at a local veterinary clinic from diarrheic dogs. We used these combined samples to investigate important questions regarding C. difficile colonization in pet canines: 1) What is the prevalence and diversity of C. difficile in this companion pet population, and 2) Do C. difficile isolates collected from canines genetically overlap with isolates that cause disease in humans? We used a two-step sequence typing approach, including multilocus sequence typing to determine the overall genetic diversity of C. difficile present in Flagstaff canines, and whole-genome sequencing to assess the fine-scale diversity patterns within identical multilocus sequence types from isolates obtained within and among multiple canine hosts. We detected C. difficile in 17% of the canine fecal samples with 10% containing toxigenic strains that are known to cause human disease. Sequencing analyses revealed similar genotypes in dogs and humans. These findings suggest that companion pets are a potential source of community acquired C. difficile infections in humans.	[Stone, Nathan E.; Sidak-Loftis, Lindsay C.; Sahl, Jason W.; Vazquez, Adam J.; Busch, Joseph D.; Keim, Paul; Wagner, David M.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Wiggins, Kristin B.; Gillece, John D.; Hicks, Nathan D.; Schupp, James M.; Keim, Paul] Translat Genom Res Inst, Flagstaff, AZ 86001 USA	Northern Arizona University; Translational Genomics Research Institute	Wagner, DM (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	Dave.Wagner@nau.edu		Wagner, David/0000-0003-2684-6007; , Jason/0000-0002-2497-0138	Northern Arizona University Technology & Research Initiative Fund (TRIF); Flinn Foundation	Northern Arizona University Technology & Research Initiative Fund (TRIF); Flinn Foundation	This project was funded by the Northern Arizona University Technology & Research Initiative Fund (TRIF) and the Flinn Foundation, https://nau.edu/research/funding/technology-research-initiative-fund/, http://www.flinn.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the Northern Arizona University Technology & Research Initiative Fund (TRIF) and the Flinn Foundation.	Aldeyab MA, 2011, INFECT CONT HOSP EP, V32, P210, DOI 10.1086/658333; [Anonymous], 2012, US PET OWNERSHIP DEM; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Arroyo LG, 2005, J MED MICROBIOL, V54, P163, DOI 10.1099/jmm.0.45805-0; Barbut F, 2011, CURR OPIN INFECT DIS, V24, P370, DOI 10.1097/QCO.0b013e32834748e5; Barlow Miriam, 2009, V532, P397, DOI 10.1007/978-1-60327-853-9_23; BARTLETT JG, 1994, CLIN INFECT DIS, V18, pS265, DOI 10.1093/clinids/18.Supplement_4.S265; Bureau USC, 2013, POPULATION 2013 ESTI, DOI 10.1186/1471-2180-12-56; Center UGaS, 2004, CALC DET NUMB COP TE, DOI 10.1128/JCM.01796-09; Clooten J, 2008, VET MICROBIOL, V129, P209, DOI 10.1016/j.vetmic.2007.11.013; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Deng K, 2015, FOOD MICROBIOL, V46, P218, DOI 10.1016/j.fm.2014.07.022; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Dingle KE, 2014, GENOME BIOL EVOL, V6, P36, DOI 10.1093/gbe/evt204; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Edwards AN, 2013, JOVE-J VIS EXP, DOI 10.3791/50787; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Eyre DW, 2012, J CLIN MICROBIOL, V50, P142, DOI 10.1128/JCM.05177-11; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Gupta A, 2014, INFECT DRUG RESIST, V7, P63, DOI 10.2147/IDR.S46780; Hallewell J, 2014, APPL ENVIRON MICROB, V80, P3819, DOI 10.1128/AEM.00708-14; Hink T, 2013, ANAEROBE, V19, P39, DOI 10.1016/j.anaerobe.2012.12.001; Hussain I, 2015, ANAEROBE, V36, P9, DOI 10.1016/j.anaerobe.2015.09.006; Janezic S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-173; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Keel K, 2007, J CLIN MICROBIOL, V45, P1963, DOI 10.1128/JCM.00224-07; Keim P, 2015, EBIOMEDICINE, V2, P1613, DOI 10.1016/j.ebiom.2015.10.004; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Knetsch CW, 2014, EUROSURVEILLANCE, V19, P30, DOI 10.2807/1560-7917.ES2014.19.45.20954; Koene MGJ, 2012, CLIN MICROBIOL INFEC, V18, P778, DOI 10.1111/j.1469-0691.2011.03651.x; Kozarewa I, 2011, METHODS MOL BIOL, V733, P279, DOI 10.1007/978-1-61779-089-8_20; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Martin JSH, 2016, NAT REV GASTRO HEPAT, V13, P206, DOI 10.1038/nrgastro.2016.25; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P265, DOI 10.1086/427113; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; PetSecure, 2016, GLOB STAT PET OWN, DOI 10.1128/JCM.05177-11; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Reigadas E, 2016, EPIDEMIOL INFECT, V144, P2691, DOI 10.1017/S0950268816001096; Rupnik M, 2003, ANAEROBE, V9, P289, DOI 10.1016/j.anaerobe.2003.09.002; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sahl JW, 2014, PEERJ, V2, DOI 10.7717/peerj.332; Sahl JW, 2016, BIORXIV; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Spigaglia P, 2011, J ANTIMICROB CHEMOTH, V66, P2227, DOI 10.1093/jac/dkr292; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Usui M, 2016, ANAEROBE, V37, P58, DOI 10.1016/j.anaerobe.2015.10.002; Vedantam G, 2012, GUT MICROBES, V3, P121, DOI 10.4161/gmic.19399	53	47	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164504	10.1371/journal.pone.0164504	http://dx.doi.org/10.1371/journal.pone.0164504			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723795	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100068
J	Aho-Ozhan, HEA; Keller, J; Heimrath, J; Uttner, I; Kassubek, J; Birbaumer, N; Ludolph, AC; Lule, D				Aho-Oezhan, Helena E. A.; Keller, Juergen; Heimrath, Johanna; Uttner, Ingo; Kassubek, Jan; Birbaumer, Niels; Ludolph, Albert C.; Lule, Dorothee			Perception of Emotional Facial Expressions in Amyotrophic Lateral Sclerosis (ALS) at Behavioural and Brain Metabolic Level	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL HYPEREXCITABILITY; MEMORY; METAANALYSIS; ACTIVATION; DEPRESSION; FMRI; HIPPOCAMPUS; DYSFUNCTION; RESPONSES	Introduction Amyotrophic lateral sclerosis (ALS) primarily impairs motor abilities but also affects cognition and emotional processing. We hypothesise that subjective ratings of emotional stimuli depicting social interactions and facial expressions is changed in ALS. It was found that recognition of negative emotions and ability to mentalize other's intentions is reduced. Methods Processing of emotions in faces was investigated. A behavioural test of Ekman faces expressing six basic emotions was presented to 30 ALS patients and 29 age-, gender and education matched healthy controls. Additionally, a subgroup of 15 ALS patients that were able to lie supine in the scanner and 14 matched healthy controls viewed the Ekman faces during functional magnetic resonance imaging (fMRI). Affective state and a number of daily social contacts were measured. Results ALS patients recognized disgust and fear less accurately than healthy controls. In fMRI, reduced brain activity was seen in areas involved in processing of negative emotions replicating our previous results. During processing of sad faces, increased brain activity was seen in areas associated with social emotions in right inferior frontal gyrus and reduced activity in hippocampus bilaterally. No differences in brain activity were seen for any of the other emotional expressions. Inferior frontal gyrus activity for sad faces was associated with increased amount of social contacts of ALS patients. Conclusion ALS patients showed decreased brain and behavioural responses in processing of disgust and fear and an altered brain response pattern for sadness. The negative consequences of neurodegenerative processes in the course of ALS might be counteracted by positive emotional activity and positive social interactions.	[Aho-Oezhan, Helena E. A.; Keller, Juergen; Heimrath, Johanna; Uttner, Ingo; Kassubek, Jan; Ludolph, Albert C.; Lule, Dorothee] Univ Ulm, Dept Neurol, Ulm, Germany; [Birbaumer, Niels; Lule, Dorothee] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Birbaumer, Niels] Wyss Ctr Bio & Neuroengn, Geneva, Switzerland	Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ludolph, AC (corresponding author), Univ Ulm, Dept Neurol, Ulm, Germany.	albert.ludolph@rku.de	Kassubek, Jan/F-2774-2015; Kassubek, Jan/GPX-0910-2022; Kassubek, Jan/O-1740-2019	Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Birbaumer, Niels/0000-0002-6786-5127	EU Joint Programme - Neurodegenerative Disease Research (JPND) project [01ED1405]; Germany, Bundesministerium fur Bildung und Forschung (BMBF, FKZ); Swedan, Vetenskapradet Sverige; Poland, Narodowe, Narodowe Centrum Badan i Rozwoju (NCBR); Deutsche Forschungsgemeinschaft [DFG LU 336/13-2, BI 195/54-2]; Bundesministerium fur Bildung und Forschung (BMBF) [01GM1103A]; National Institutes of Health (NIH)	EU Joint Programme - Neurodegenerative Disease Research (JPND) project; Germany, Bundesministerium fur Bildung und Forschung (BMBF, FKZ); Swedan, Vetenskapradet Sverige; Poland, Narodowe, Narodowe Centrum Badan i Rozwoju (NCBR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This is an EU Joint Programme - Neurodegenerative Disease Research (JPND) project (01ED1405). The project is supported through the following organisations under the aegis of JPND - www.jpnd.edu e.g. Germany, Bundesministerium fur Bildung und Forschung (BMBF, FKZ), Sweden, Vetenskapradet Sverige, Poland, Narodowe Centrum Badan i Rozwoju (NCBR). This work was additionally supported by the Deutsche Forschungsgemeinschaft (DFG LU 336/13-2 and BI 195/54-2) and the Bundesministerium fur Bildung und Forschung (BMBF #01GM1103A), and the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2013, NEUROBIOL AGING, V34, P419, DOI 10.1016/j.neurobiolaging.2012.04.015; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Bede P, 2013, NEUROLOGY, V81, P2107, DOI 10.1212/01.wnl.0000437313.80913.2c; Bistricky SL, 2011, PSYCHOL BULL, V137, P998, DOI 10.1037/a0025348; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; Deichmann R, 2002, P INT SOC MAGN RESON, V10, P1414; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Fankhauser S, 2014, J GERIATR PSYCHIAT N; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Goldstein LH, 2013, LANCET NEUROL, V12, P368, DOI 10.1016/S1474-4422(13)70026-7; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Hautzinger M., 1995, BECK DEPRESSIONS INV; Hecht MJ, 2003, PALLIATIVE MED, V17, P327, DOI 10.1191/0269216303pm754oa; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Kawashima T, 2001, ACTA NEUROPATHOL, V102, P467; KEW JJM, 1993, BRAIN, V116, P1399, DOI 10.1093/brain/116.6.1399; Khedr EM, 2011, NEUROPHYSIOL CLIN, V41, P73, DOI 10.1016/j.neucli.2011.03.001; Lehrl, 1989, MEHRFACHWAHL WORTSCH; LEWANDOWSKI LJ, 1984, PERCEPT MOTOR SKILL, V59, P615, DOI 10.2466/pms.1984.59.2.615; Lillo P, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-156; Ludolph A, 2015, AMYOTROPH LAT SCL FR, V16, P291, DOI 10.3109/21678421.2015.1049183; Lule D, 2005, J NEUROL, V252, P1517, DOI 10.1007/s00415-005-0907-8; Lule D, 2007, J NEUROL, V254, P519, DOI 10.1007/s00415-006-0409-3; Lule D, 2014, J NEUROL, V261, P518, DOI 10.1007/s00415-013-7229-z; Lule D, 2013, J NEUROL, V260, P2836, DOI 10.1007/s00415-013-7068-y; Lule D, 2012, J NEUROL, V259, P334, DOI 10.1007/s00415-011-6191-x; Lule D, 2010, J NEUROL NEUROSUR PS, V81, P899, DOI 10.1136/jnnp.2009.192260; Machts J, 2015, NEUROLOGY, V85, P1301, DOI 10.1212/WNL.0000000000002017; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Menon P, 2015, CLIN NEUROPHYSIOL, V126, P803, DOI 10.1016/j.clinph.2014.04.023; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papps B, 2005, NEUROPSYCHOLOGIA, V43, P1107, DOI 10.1016/j.neuropsychologia.2004.11.027; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pisa FE, 2015, NEUROEPIDEMIOLOGY, V44, P91, DOI 10.1159/000374119; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Robinson P, 2006, NEUROIMAGE, V31, P585, DOI 10.1016/j.neuroimage.2005.12.026; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Thomas SA, 2015, HIPPOCAMPUS, V25, P415, DOI 10.1002/hipo.22394; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2006, BRAIN, V129, P2436, DOI 10.1093/brain/awl172; Young AW, 2002, FACIAL EXPRESSIONS E; Ziemann U, 1997, NEUROLOGY, V49, P1292, DOI 10.1212/WNL.49.5.1292	53	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164655	10.1371/journal.pone.0164655	http://dx.doi.org/10.1371/journal.pone.0164655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741285	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000051
J	Lalouni, M; Olen, O; Bonnert, M; Hedman, E; Serlachius, E; Ljotsson, B				Lalouni, Maria; Olen, Ola; Bonnert, Marianne; Hedman, Erik; Serlachius, Eva; Ljotsson, Brjann			Exposure-Based Cognitive Behavior Therapy for Children with Abdominal Pain: A Pilot Trial	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; ANXIETY; RELIABILITY; DEPRESSION; DISORDERS; CHILDHOOD; SYMPTOMS; VALIDITY	Background Children with pain-related functional gastrointestinal disorders (P-FGIDs) have an increased risk for school absenteeism, depression, anxiety and low quality of life. Exposure-based cognitive behavior therapy (CBT) has shown large treatment effects in adults with irritable bowel syndrome, but has not been tested for children 8-12 years with PFGIDs. Aim The aim of this trial was to test the feasibility, acceptability and potential efficacy of a newly developed exposure-based CBT for children with P-FGIDs. Method The children (n = 20) with a P-FGID, were referred by their treating physicians. The participants received 10 weekly sessions of exposure-based CBT and were assessed at pretreatment, post-treatment and 6-month follow-up. Results Children improved significantly on the primary outcome measure pain intensity at post (Cohen's d = 0.40, p = 0.049) and at 6-month follow-up (Cohen's d = 0.85, p = 0.004). Improvements were also seen in pain frequency, gastrointestinal symptoms, quality of life, depression, anxiety, school absenteeism and somatic symptoms. Improvements were maintained or further increased at 6-month follow-up. The children engaged in the exposures and were satisfied with the treatment. Conclusions Exposure-based CBT for children with P-FGIDs is feasible, acceptable and potentially efficacious.	[Lalouni, Maria; Olen, Ola] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Lalouni, Maria; Bonnert, Marianne; Serlachius, Eva] Stockholm Cty Council, Stockholm Hlth Care Serv, Stockholm, Sweden; [Olen, Ola] Sachs Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Stockholm, Sweden; [Bonnert, Marianne; Hedman, Erik; Ljotsson, Brjann] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Serlachius, Eva; Ljotsson, Brjann] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Karolinska Institutet; Karolinska Institutet	Lalouni, M (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden.	maria.lalouni@ki.se	Bonnert, Marianne/P-3021-2017; Bonnert, Marianne/M-8358-2019; Serlachius, Eva/E-8956-2013	Bonnert, Marianne/0000-0002-0140-773X; Serlachius, Eva/0000-0001-7115-6422; Lalouni, Maria/0000-0002-6818-8156; Olen, Ola/0000-0002-5478-7019; Hedman-Lagerlof, Erik/0000-0002-7939-9848	Jane and Dan Olsson foundation [4-1559/2013]; Kempe-Carlgrenska foundation; Ruth and Richard Julin foundation [2012Juli0048]; Ishizu Matsumurais Donation; Majblomman foundation; Bengt lhre research fellowship; Bengt lhre foundation [SLS-331861]; Samariten foundation; Swedish society of medicine [SLS-331681, SLS-410501]; Varkstadststiftelsen; Gadelius foundation; Swedish Research Council [521-2013-2846]; Stockholm County Council [20130129]; Karolinska Institutet [20130129]	Jane and Dan Olsson foundation; Kempe-Carlgrenska foundation; Ruth and Richard Julin foundation; Ishizu Matsumurais Donation; Majblomman foundation; Bengt lhre research fellowship; Bengt lhre foundation; Samariten foundation; Swedish society of medicine; Varkstadststiftelsen; Gadelius foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This research was supported by grants from: Jane and Dan Olsson foundation, 4-1559/2013 [http://www.jodfoundations.com] (to 00); Kempe-Carlgrenska foundation, [http://www.kc-fonden.se] (to 00); Ruth and Richard Julin foundation, 2012Juli0048, [https://fonder.ki.se] (to 00); Ishizu Matsumurais Donation, [https://fonder.ki.se] (to 00); Majblomman foundation,[http://www.majblomman.se] (to 00); Bengt lhre research fellowship, [http://ihrefellowship.se] (to 00); Bengt lhre foundation, SLS-331861, [http://www.sls.se] (to 00); The Samariten foundation, [http://www.stiftelsensamariten.se] (to 00); The Swedish society of medicine, SLS-331681, SLS-410501, [http://www.sls.se] (to 00); Varkstadststiftelsen, [http://www.varkstaden.se] (to 00); Gadelius foundation, [http://stiftelse madel.se/stiftelsen-professor-bror-gadelius-minnesfond/] (to MB); Swedish Research Council, 521-2013-2846, [www.vr.se] (to BL); Regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet, 20130129, [https://forskningsstod.sll.se] (to BL). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barrett PM, 1996, J CONSULT CLIN PSYCH, V64, P333, DOI 10.1037/0022-006X.64.2.333; Bonnert M., 2014, INTERNET INTERVENTIO, V1, P141, DOI [10.1016/j.invent.2014.07.002, DOI 10.1016/J.INVENT.2014.07.002]; Borenstein M., 2011, INTRO META ANAL, V17, P58; Campo JV, 2004, PEDIATRICS, V113, P817, DOI 10.1542/peds.113.4.817; Carlson MJ, 2014, J ACAD NUTR DIET, V114, P403, DOI 10.1016/j.jand.2013.10.013; Claar RL, 2006, PAIN, V121, P77, DOI 10.1016/j.pain.2005.12.002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Craske MG, 2014, BEHAV RES THER, V58, P10, DOI 10.1016/j.brat.2014.04.006; Craske MG, 2011, BEHAV RES THER, V49, P413, DOI 10.1016/j.brat.2011.04.001; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Horst S, 2014, CLIN GASTROENTEROL H, V12, P2026, DOI 10.1016/j.cgh.2014.03.034; Kearney CA, 2008, CLIN PSYCHOL REV, V28, P451, DOI 10.1016/j.cpr.2007.07.012; Korterink JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126982; Korterink JJ, 2015, J PEDIATR-US, V166, P424, DOI 10.1016/j.jpeds.2014.09.067; Labus JS, 2004, ALIMENT PHARM THER, V20, P89, DOI 10.1111/j.1365-2036.2004.02007.x; LARSSON B, 1992, ACTA PSYCHIAT SCAND, V85, P17, DOI 10.1111/j.1600-0447.1992.tb01436.x; Levy RL, 2010, AM J GASTROENTEROL, V105, P946, DOI 10.1038/ajg.2010.106; Ljotsson B, 2011, AM J GASTROENTEROL, V106, P1481, DOI 10.1038/ajg.2011.139; Ljotsson B, 2010, BEHAV RES THER, V48, P531, DOI 10.1016/j.brat.2010.03.003; Ljotsson B, 2010, J BEHAV THER EXP PSY, V41, P185, DOI 10.1016/j.jbtep.2010.01.001; Nguyen T D, 1983, Eval Program Plann, V6, P299, DOI 10.1016/0149-7189(83)90010-1; Noel M, 2016, J PEDIATR PSYCHOL, V41, P350, DOI 10.1093/jpepsy/jsv095; Noel M, 2015, J PAIN, V16, P31, DOI 10.1016/j.jpain.2014.10.005; Olofsdotter S, 2015, ASSESSING ADOLESCENT, DOI [10.1177/1073191115583858, DOI 10.1177/1073191115583858]; Palermo TM, 2009, PAIN, V146, P205, DOI 10.1016/j.pain.2009.07.034; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Reme SE, 2010, J PSYCHOSOM RES, V69, P319, DOI 10.1016/j.jpsychores.2010.01.025; Rutten JMTM, 2015, PEDIATRICS, V135, P522, DOI 10.1542/peds.2014-2123; SANDERS MR, 1994, J CONSULT CLIN PSYCH, V62, P306, DOI 10.1037/0022-006X.62.2.306; Saps M, 2009, J PEDIATR-US, V154, P322, DOI 10.1016/j.jpeds.2008.09.047; SMUCKER MR, 1986, J ABNORM CHILD PSYCH, V14, P25, DOI 10.1007/BF00917219; Spence SH, 2003, J ANXIETY DISORD, V17, P605, DOI 10.1016/S0887-6185(02)00236-0; van der Veek SMC, 2013, PEDIATRICS, V132, pE1163, DOI 10.1542/peds.2013-0242; Varni JW, 2006, J DEV BEHAV PEDIATR, V27, P451, DOI 10.1097/00004703-200612000-00001; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Walker LS, 2006, PAIN, V122, P43, DOI 10.1016/j.pain.2005.12.020; Walker LS, 2009, J PEDIATR PSYCHOL, V34, P430, DOI 10.1093/jpepsy/jsn093	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164647	10.1371/journal.pone.0164647	http://dx.doi.org/10.1371/journal.pone.0164647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736943	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800104
J	Myojin, S; Yoshimura, T; Yoshida, S; Takeda, A; Murakami, Y; Kawano, Y; Oshima, Y; Ishibashi, T; Sonoda, KH				Myojin, Sayaka; Yoshimura, Takeru; Yoshida, Shigeo; Takeda, Atsunobu; Murakami, Yusuke; Kawano, Yoichi; Oshima, Yuji; Ishibashi, Tatsuro; Sonoda, Koh-Hei			Gene Expression Analysis of the Irrigation Solution Samples Collected during Vitrectomy for Idiopathic Epiretinal Membrane	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN DIABETIC-RETINOPATHY; RETINAL-PIGMENT EPITHELIUM; MULLER GLIAL-CELLS; PROLIFERATIVE VITREORETINOPATHY; GROWTH-FACTOR; RECEPTORS; PATHOGENESIS; INVOLVEMENT; ACTIVATION	Purpose The analysis of gene expression in idiopathic epiretinal membranes (iERMs) may help elucidate ERM formation and its pathology. Here, we conducted a case-control study, in order to determine the expression levels of cytokines and other genes in eyes with macular hole (MH) or iERM. Methods Twenty eyes, obtained from seven male and 13 female patients, were included in the study. The average age of the study subjects was 69.1 +/- 7.67 years, and 15 eyes had iERM, while five eyes had MH. Irrigation solution samples were collected during vitrectomy, centrifuged, and the levels of cytokine and other mRNAs in the sediment were assessed using real-time PCR. The expression level of 11 cytokine genes, four transcription factor genes, two cytoskeletal genes, and genes encoding two extracellular matrix proteins in eyes with MH or iERM were determined and compared. Results The expression levels of interleukin 6 (IL6), tumor growth factor B2 (TGFB2), vascular endothelial growth factor A (VEGFA), chemokine C-X-C motif ligand 1 (CXCL1), v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA), glial fibrillary acidic protein (GFAP), and tenascin C (TNC) were significantly higher in eyes with iERM than in eyes with MH. The expression of these genes was not associated with the preoperative visual acuity of the investigated patients. Conclusions The obtained results indicate that real-time PCR analysis of irrigation solution samples collected during vitrectomy can help assess the expression levels of several genes, and that iERM is associated with the expression of pro-inflammatory genes and the genes expressed during angiogenesis and wound healing process ( IL6, TGFB2, VEGFA, CXCL1, RELA, GFAP, and TNC).	[Myojin, Sayaka; Yoshimura, Takeru; Yoshida, Shigeo; Takeda, Atsunobu; Murakami, Yusuke; Oshima, Yuji; Ishibashi, Tatsuro; Sonoda, Koh-Hei] Kyushu Univ, Dept Ophthalmol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Kawano, Yoichi] Fukuoka Dent Coll, Dept Med, Sect Ophthalmol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan	Kyushu University; Fukuoka Dental College (FDC)	Yoshimura, T (corresponding author), Kyushu Univ, Dept Ophthalmol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takeruy@med.kyushu-u.ac.jp		Yoshida, Shigeo/0000-0003-1049-8909; Yoshimura, Takeru/0000-0002-5983-7193	Japan Society for the Promotion of Science [24791859, 15K10896]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (24791859 to T.Y. and 15K10896 to A.T.; https://www.jsps.go.jp/english/e-grants/) and by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (to Y.K.; http://www.mext.go.jp/english/).	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BELLHORN MB, 1975, AM J OPHTHALMOL, V79, P366, DOI 10.1016/0002-9394(75)90608-X; Bringmann A, 2009, GRAEF ARCH CLIN EXP, V247, P865, DOI 10.1007/s00417-009-1082-x; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; CANFIELD AE, 1995, J CELL SCI, V108, P797; FOOS RY, 1977, INVEST OPHTH VIS SCI, V16, P416; GASS JDM, 1988, ARCH OPHTHALMOL-CHIC, V106, P629, DOI 10.1001/archopht.1988.01060130683026; Goczalik IM, 2005, J NEUROIMMUNOL, V161, P49, DOI 10.1016/j.jneuroim.2004.12.004; Harada C, 2006, PROG RETIN EYE RES, V25, P149, DOI 10.1016/j.preteyeres.2005.09.001; Harada C, 2004, MOL VIS, V10, P31; Harada T, 2002, DIABETES CARE, V25, P1060, DOI 10.2337/diacare.25.6.1060; HATA Y, 1995, VIRCHOWS ARCH, V426, P479; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P698, DOI 10.1136/bjo.68.10.698; Iannetti L, 2011, INVEST OPHTH VIS SCI, V52, P5786, DOI 10.1167/iovs.10-7116; KAMPIK A, 1981, ARCH OPHTHALMOL-CHIC, V99, P1445, DOI 10.1001/archopht.1981.03930020319025; KAUFFMANN DJH, 1994, INVEST OPHTH VIS SCI, V35, P900; Kohno RI, 2009, BRIT J OPHTHALMOL, V93, P1020, DOI 10.1136/bjo.2008.155069; Mandelcorn E, 2003, CAN J OPHTHALMOL, V38, P457, DOI 10.1016/S0008-4182(03)80023-6; MCLEOD D, 1987, EYE-T OPHTH SOC UK, V1, P263, DOI 10.1038/eye.1987.46; Minchiotti S, 2008, RETINA-J RET VIT DIS, V28, P628, DOI 10.1097/IAE.0b013e31815ec275; Mitamura Y, 2003, DIABETOLOGIA, V46, P699, DOI 10.1007/s00125-003-1084-x; SMIDDY WE, 1989, OPHTHALMOLOGY, V96, P811; Snead DRJ, 2008, EYE, V22, P1310, DOI 10.1038/eye.2008.36; VINORES SA, 1990, INVEST OPHTH VIS SCI, V31, P2529; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Wang XC, 1999, INVEST OPHTH VIS SCI, V40, P477; Zaja-Milatovic S, 2008, HISTOL HISTOPATHOL, V23, P1399, DOI 10.14670/HH-23.1399	27	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164355	10.1371/journal.pone.0164355	http://dx.doi.org/10.1371/journal.pone.0164355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736918	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800058
J	Nalbant, A; Kant, M				Nalbant, Ayten; Kant, Melis			Bacterial Heat Shock Protein GroEL (Hsp64) Exerts Immunoregulatory Effects on T Cells by Utilizing Apoptosis	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; HEAT-SHOCK-PROTEIN-60; DISEASE; LOCALIZATION; DEATH	Aggregatibacter actinomycetemcomitans (Aa) expresses a 64-kDa GroEL protein belonging to the heat shock family of proteins. This protein has been shown to influence human host cells, but the apoptotic capacity of the GroEL protein regarding T cells is not yet known. The purpose of this study was to investigate the ability of A. actinomycetemcomitans GroEL (AaGroEL) protein to induce human peripheral blood T-cell apoptosis. Endogenous, purified AaGroEL protein was used as an antigen. In AaGroEL-treated T cells, the data indicated that phosphatidylserine exposure, an early apoptotic event, was dose-and time-dependent. The AaGroEL-treated T cells were also positive for active caspase-3 in a dose-dependent manner. The rate of AaGroEL-induced apoptosis was suppressed by the addition of the general caspase inhibitor Z-VAD-FMK. Furthermore, cleaved caspase-8 bands (40/36 kDa and 23 kDa) were identified in cells responding to AaGroEL. DNA fragmentation was also detected in the AaGroEL-treated T cells. Overall, we demonstrated that the endogenous GroEL from A. actinomycetemcomitans has the capacity to induce T-cell apoptosis.	[Nalbant, Ayten; Kant, Melis] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey; [Kant, Melis] Dokuz Eylul Univ, Dept Med Biochem, Izmir, Turkey	Izmir Institute of Technology; Dokuz Eylul University	Nalbant, A (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey.	aytennalbant@iyte.edu.tr	kant, melis/AAM-4598-2021	kant, melis/0000-0002-1556-4920	Scientific and Technological Research Council of Turkey (TUBITAK) [106T417]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by a grant from the Scientific and Technological Research Council of Turkey (TUBITAK) (Grant # 106T417 to Dr. Ayten Nalbant). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; DIRIENZO JM, 1990, ORAL MICROBIOL IMMUN, V5, P49, DOI 10.1111/j.1399-302X.1990.tb00227.x; Equils O, 2006, J IMMUNOL, V177, P1257, DOI 10.4049/jimmunol.177.2.1257; Goulhen F, 2003, CRIT REV ORAL BIOL M, V14, P399, DOI 10.1177/154411130301400603; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; Hinode D, 1996, J MICROBIOL METH, V25, P349, DOI 10.1016/0167-7012(96)00008-5; Jha HC, 2011, J CARDIOL, V58, P216, DOI 10.1016/j.jjcc.2011.07.010; Kant M, 2015, TURK J BIOL, V39, P104, DOI 10.3906/biy-1404-64; KOGA T, 1993, J PERIODONTAL RES, V28, P475, DOI 10.1111/j.1600-0765.1993.tb02107.x; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; LOKENSGARD I, 1994, FEMS IMMUNOL MED MIC, V8, P321, DOI 10.1016/0928-8244(94)00007-7; NAKANO Y, 1995, ORAL MICROBIOL IMMUN, V10, P151, DOI 10.1111/j.1399-302X.1995.tb00136.x; Nalbant A, 2003, ORAL MICROBIOL IMMUN, V18, P339, DOI 10.1046/j.0902-0055.2003.00082.x; Paju S, 2000, FEMS MICROBIOL LETT, V182, P231, DOI 10.1016/S0378-1097(99)00595-9; Saygili T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049252; SLOTS J, 1982, J PERIODONTAL RES, V17, P447, DOI 10.1111/j.1600-0765.1982.tb02022.x; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Winkelhoff AJ, 1999, PERIODONTOL 2000, V20, P122; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Zhang LX, 2004, INFECT IMMUN, V72, P38, DOI 10.1128/IAI.72.1.38-45.2004; Zhang LX, 2004, EXP CELL RES, V292, P231, DOI 10.1016/j.yexcr.2003.08.012	22	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164380	10.1371/journal.pone.0164380	http://dx.doi.org/10.1371/journal.pone.0164380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736933	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505800062
J	Soderquist, F; Janson, ET; Rasmusson, AJ; Alit, A; Stridsberg, M; Cunningham, JL				Soderquist, Fanny; Janson, Eva Tiensuu; Rasmusson, Annica J.; Alit, Abir; Stridsberg, Mats; Cunningham, Janet L.			Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours	PLOS ONE			English	Article							CELL-PROLIFERATION; CARCINOID-TUMORS; APOPTOSIS; RECEPTORS; SYSTEM; GROWTH; GUIDELINES; DIAGNOSIS; AGONISTS; CANCER	Background/ Aims Small intestinal neuroendocrine tumours (SI-NETs) are derived from enterochromaffin cells. After demonstrating melatonin in enterochromaffin cells, we hypothesized that SI-NETs may express and secrete melatonin, which may have an impact on clinical factors and treatment response. Methods Tumour tissue from 26 patients with SI-NETs, representing paired sections of primary tumour and metastasis, were immunohistochemically stained for melatonin and its receptors, MT1 and MT2. Plasma melatonin and immunoreactivity (IR) for melatonin, MT1 and MT2 in tumour cells were compared to other tumour markers and clinical parameters. Melatonin was measured at two time points in fasting morning plasma from 43 patients with SI-NETs. Results Melatonin IR was found in all SI-NETS. Melatonin IR intensity in primary tumours correlated inversely to proliferation index (p = 0.022) and patients reported less diarrhoea when melatonin IR was high (p = 0.012). MT1 IR was low or absent in tumours. MT2 expression was medium to high in primary tumours and generally reduced in metastases (p = 0.007). Plasma-melatonin ranged from 4.5 to 220.0 pg/L. Higher levels were associated with nausea at both time points (p = 0.027 and p = 0.006) and flush at the second sampling. In cases with disease stabilization or remission (n = 34), circulating melatonin levels were reduced in the second sample (p = 0.038). Conclusion Immunoreactive melatonin is present in SI-NETs. Circulating levels of melatonin in patients with SI-NETs are reduced after treatment. Our results are congruent with recent understanding of melatonin's endocrine and paracrine functions and SI-NETs may provide a model for further studies of melatonin function.	[Soderquist, Fanny; Cunningham, Janet L.] Uppsala Univ, Dept Neurosci, Psychiat, Uppsala, Sweden; [Janson, Eva Tiensuu; Alit, Abir] Uppsala Univ, Dept Med Sci, Sect Endocrine Oncol, Uppsala, Sweden; [Rasmusson, Annica J.] Uppsala Univ, Dept Med Sci Clin Pharmacol & Osteoporosis, Uppsala, Sweden; [Stridsberg, Mats] Uppsala Univ, Dept Med Sci, Biochem Endocrinol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Cunningham, JL (corresponding author), Uppsala Univ, Dept Neurosci, Psychiat, Uppsala, Sweden.	janet.cunningham@neuro.uu.se	Cunningham, Janet/C-4719-2013	Cunningham, Janet/0000-0001-7876-7779; Rasmusson, Annica/0000-0002-7228-7755	Marta och Nicke Nasvells fond; Anna-Britta Gustafssons stiftelse; Stiftelsen Apotekare Hedbergs Fund; Erik, Karin and Gosta Selanders Stiftelse; Stiftelsen Soderstrom-Konigska sjukhem met; Swedish Medical Association; Swedish Cancer Society; ALF Funds from Uppsala University Hospital	Marta och Nicke Nasvells fond; Anna-Britta Gustafssons stiftelse; Stiftelsen Apotekare Hedbergs Fund; Erik, Karin and Gosta Selanders Stiftelse; Stiftelsen Soderstrom-Konigska sjukhem met; Swedish Medical Association; Swedish Cancer Society(Swedish Cancer Society); ALF Funds from Uppsala University Hospital	This work was funded by grants from the Marta och Nicke Nasvells fond, Anna-Britta Gustafssons stiftelse, Stiftelsen Apotekare Hedbergs Fund, Erik, Karin and Gosta Selanders Stiftelse, Stiftelsen Soderstrom-Konigska sjukhem met, Swedish Medical Association, Swedish Cancer Society and ALF Funds from Uppsala University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAMBILLA F, 1988, PSYCHIAT RES, V23, P267, DOI 10.1016/0165-1781(88)90017-0; Bubenik GA, 2008, J PHYSIOL PHARMACOL, V59, P33; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Canavese G, 2001, HUM PATHOL, V32, P1094, DOI 10.1053/hupa.2001.28234; Caplin ME, 2014, NEW ENGL J MED, V371, P1556, DOI 10.1056/NEJMc1409757; Carvalho LA, 2009, J PSYCHOPHARMACOL, V23, P315, DOI 10.1177/0269881108089871; Cunningham JL, 2007, ACTA ONCOL, V46, P747, DOI 10.1080/02841860701218659; Cunningham JL, 2011, GENE CHROMOSOME CANC, V50, P82, DOI 10.1002/gcc.20834; Das A, 2010, J PINEAL RES, V48, P157, DOI 10.1111/j.1600-079X.2009.00739.x; Delagrange P, 2003, J NEUROENDOCRINOL, V15, P442, DOI 10.1046/j.1365-2826.2003.01016.x; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Espino J, 2010, FERTIL STERIL, V94, P1915, DOI 10.1016/j.fertnstert.2009.12.082; Espino J, 2010, J MEMBRANE BIOL, V233, P105, DOI 10.1007/s00232-010-9230-0; Francis JM, 2013, NAT GENET, V45, P1483, DOI 10.1038/ng.2821; Janson ET, 1997, ANN ONCOL, V8, P685, DOI 10.1023/A:1008215730767; Janson ET, 2014, ACTA ONCOL, V53, P1284, DOI 10.3109/0284186X.2014.941999; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Laudon M, 2014, INT J MOL SCI, V15, P15924, DOI 10.3390/ijms150915924; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; Malhotra Samir, 2004, MedGenMed, V6, P46; Martin-Renedo J, 2008, J PINEAL RES, V45, P532, DOI 10.1111/j.1600-079X.2008.00641.x; Masana MI, 2002, J PHARMACOL EXP THER, V302, P1295, DOI 10.1124/jpet.302.3.1295; Nemeth C, 2011, J BIOL REG HOMEOS AG, V25, P531; Oberg K, 2010, ANN ONCOL, V21, pv223, DOI 10.1093/annonc/mdq192; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Sanchez-Hidalgo M, 2012, J PINEAL RES, V53, P366, DOI 10.1111/j.1600-079X.2012.01006.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shiu SY, 2012, J PINEAL RES, DOI [10.1111/j.1600-079X.2012, DOI 10.1111/J.1600-079X.2012]; Sjoblom M, 2003, J PINEAL RES, V34, P288; Slominski A, 2002, FASEB J, V16, P896, DOI 10.1096/fj.01-0952fje; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; Slominski RM, 2012, MOL CELL ENDOCRINOL, V351, P152, DOI 10.1016/j.mce.2012.01.004; Soderquist F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120195; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Thor PJ, 2007, J PHYSIOL PHARMACOL, V58, P97; Turner GB, 2006, GUT, V55, P1586, DOI 10.1136/gut.2006.092320; WALDHAUSER F, 1988, J CLIN ENDOCR METAB, V66, P648, DOI 10.1210/jcem-66-3-648; Wetterberg L, 1999, EUR ARCH PSY CLIN N, V249, P256, DOI 10.1007/s004060050095; Winczyk K, 2002, NEUROENDOCRINOL LETT, V23, P50; Xin ZL, 2015, J PINEAL RES, V58, P375, DOI 10.1111/jpi.12227	41	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164354	10.1371/journal.pone.0164354	http://dx.doi.org/10.1371/journal.pone.0164354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736994	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800057
J	Soultanova, A; Mikulski, Z; Pfeil, U; Grau, V; Kummer, W				Soultanova, Aichurek; Mikulski, Zbigniew; Pfeil, Uwe; Grau, Veronika; Kummer, Wolfgang			Calcitonin Peptide Family Members Are Differentially Regulated by LPS and Inhibit Functions of Rat Alveolar NR8383 Macrophages	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; CELL-LINE; PNEUMOCOCCAL PNEUMONIA; KLEBSIELLA PNEUMONIA; MESSENGER-RNA; L6 MYOCYTES; LUNG INJURY; ADRENOMEDULLIN; RECEPTOR; INTERMEDIN	Members of the calcitonin peptide family-calcitonin gene-related peptide (CGRP), adrenomedullin (AM), and adrenomedullin2/intermedin (IMD)-exert modulatory effects upon monocytes and macrophages of various extrapulmonary origins. Utilizing the rat alveolar macrophage (AM phi) cell line NR8383, we here set out to determine to which extent these three peptides and their receptors are differentially regulated in AMf and what specific effects they have on AMf key functions. LPS treatment differentially up-regulated expression of the peptides and receptors. Among the three peptides, IMD mRNA content was lowest both in primary rat AMf and NR8383 cells, whereas IMD peptide dominated in basal and LPS-stimulated secretion from NR8383 cells. Fc(Y) receptor-mediated phagocytosis and TNF-alpha production were inhibited by AM, IMD, and CGRP, whereas pro-IL-1 beta mRNA was slightly down-regulated exclusively by CGRP. Neither of these peptides affected IL-6 or IL-10 production. None increased intracellular calcium concentration, but AM significantly inhibited store-operated calcium entry. In conclusion, the rat AMf cell line NR8383 is both a source and a target of the calcitonin peptide family members AM, IMD, and CGRP. Despite sharing proteins of the receptor complexes, AM, IMD, and CGRP each showed a characteristic pattern of effects and regulation, suggesting that these closely related peptides are not just redundant members of one common signaling pathway but act in concert by addressing parallel signaling cascades. Since peptide and receptor expression are up-regulated by LPS, these signaling pathways might act as inhibitory feedback mechanisms in pulmonary bacterial infection.	[Soultanova, Aichurek; Mikulski, Zbigniew; Pfeil, Uwe; Kummer, Wolfgang] Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany; [Grau, Veronika] Univ Giessen, Dept Gen & Thorac Surg, Expt Surg Lab, Giessen, Germany; [Grau, Veronika; Kummer, Wolfgang] German Ctr Lung Res DZL, Excellence Cluster Cardiopulm Syst ECCPS, Giessen, Germany; [Mikulski, Zbigniew] La Jolla Inst, La Jolla, CA USA	Justus Liebig University Giessen; Justus Liebig University Giessen	Soultanova, A (corresponding author), Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany.	aichurek.soultanova@anatomie.med.uni.giessen.de	Mikulski, Zbigniew/AAB-4447-2020	Mikulski, Zbigniew/0000-0002-1918-9216; Kummer, Wolfgang/0000-0002-3946-0683	Deutsche Forschungsgemeinschaft [IRTG 1062]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to WK and VG (IRTG 1062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Aiyar N, 1999, MOL CELL BIOCHEM, V197, P179, DOI 10.1023/A:1006962221332; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Ashizuka S, 2013, CURR PROTEIN PEPT SC, V14, P246, DOI 10.2174/13892037113149990044; Ashizuka S, 2009, MICROBIOL IMMUNOL, V53, P573, DOI 10.1111/j.1348-0421.2009.00159.x; Aslam M, 2012, BRIT J PHARMACOL, V165, P208, DOI 10.1111/j.1476-5381.2011.01540.x; Bailie MB, 1996, J IMMUNOL, V157, P5221; BrougHolub E, 1997, INFECT IMMUN, V65, P1139, DOI 10.1128/IAI.65.4.1139-1146.1997; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Chang CL, 2004, PEPTIDES, V25, P1633, DOI 10.1016/j.peptides.2004.05.021; Consonni A, 2011, MOL CELL NEUROSCI, V48, P151, DOI 10.1016/j.mcn.2011.07.006; Dai XY, 2014, CARDIOVASC RES, V101, P297, DOI 10.1093/cvr/cvt254; DENNIS T, 1990, J PHARMACOL EXP THER, V254, P123; Di Paola R, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-41; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Elena T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/717851; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Garcia JEL, 1999, MEDIAT INFLAMM, V8, P43, DOI 10.1080/09629359990711; Gomes RN, 2005, SHOCK, V24, P590, DOI 10.1097/01.shk.0000183395.29014.7c; Gosset P, 1999, J ALLERGY CLIN IMMUN, V103, P289, DOI 10.1016/S0091-6749(99)70504-X; Granholm S, 2011, J CELL BIOCHEM, V112, P3300, DOI 10.1002/jcb.23256; Haslett C, 1999, AM J RESP CRIT CARE, V160, pS5, DOI 10.1164/ajrccm.160.supplement_1.4; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Hippenstiel S, 2002, CIRC RES, V91, P618, DOI 10.1161/01.RES.0000036603.61868.F9; Hiraiwa K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/619523; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Howitt SG, 1997, BRIT J PHARMACOL, V121, P1000, DOI 10.1038/sj.bjp.0701212; Itoh T, 2007, AM J PHYSIOL-LUNG C, V293, pL446, DOI 10.1152/ajplung.00412.2005; Jablonski H, 2015, NEUROIMMUNOMODULAT, V22, P152, DOI 10.1159/000360988; KAMOI H, 1995, BIOCHEM BIOPH RES CO, V211, P1031, DOI 10.1006/bbrc.1995.1914; Kindt F, 2007, J INVEST DERMATOL, V127, P605, DOI 10.1038/sj.jid.5700576; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; Kubo A, 1998, J BIOL CHEM, V273, P16730, DOI 10.1074/jbc.273.27.16730; LAVNIKOVA N, 1993, AM J RESP CELL MOL, V8, P384, DOI 10.1165/ajrcmb/8.4.384; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065278; LOHMANNMATTHES ML, 1994, EUR RESPIR J, V7, P1678; Ma WY, 2006, J NEUROCHEM, V98, P180, DOI 10.1111/j.1471-4159.2006.03856.x; Ma WY, 2010, IMMUNOLOGY, V130, P399, DOI 10.1111/j.1365-2567.2009.03239.x; MacManus CF, 2011, FASEB J, V25, P1856, DOI 10.1096/fj.10-170316; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Muller-Redetzky HC, 2014, CRIT CARE, V18, DOI 10.1186/cc13830; MURPHY JK, 1993, AM J RESP CELL MOL, V9, P505, DOI 10.1165/ajrcmb/9.5.505; NONG YH, 1989, J IMMUNOL, V143, P45; Pedreno M, 2014, BRAIN BEHAV IMMUN, V37, P152, DOI 10.1016/j.bbi.2013.11.021; Peres CM, 2007, J IMMUNOL, V179, P5454, DOI 10.4049/jimmunol.179.8.5454; Pfeil U, 2009, AM J PHYSIOL-LUNG C, V297, pL837, DOI 10.1152/ajplung.90608.2008; POYNER DR, 1992, BRIT J PHARMACOL, V105, P441, DOI 10.1111/j.1476-5381.1992.tb14272.x; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Russell REK, 2002, AM J PHYSIOL-LUNG C, V283, pL867, DOI 10.1152/ajplung.00020.2002; SHIMEKAKE Y, 1995, J BIOL CHEM, V270, P4412, DOI 10.1074/jbc.270.9.4412; Stokes L, 2007, J IMMUNOL, V179, P6016, DOI 10.4049/jimmunol.179.9.6016; Upton PD, 2001, AM J RESP CELL MOL, V24, P170, DOI 10.1165/ajrcmb.24.2.4210; Wong LYF, 2005, ENDOCRINOLOGY, V146, P1321, DOI 10.1210/en.2004-1080; Yanagawa B, 2007, CARDIOVASC RES, V76, P110, DOI 10.1016/j.cardiores.2007.05.027	55	2	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163483	10.1371/journal.pone.0163483	http://dx.doi.org/10.1371/journal.pone.0163483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737007	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800016
J	Wang, J; Dong, X; Wu, HY; Wu, N; Zhang, XJ; Wang, X; Shang, LX				Wang, Jing; Dong, Xing; Wu, Hong-yan; Wu, Nan; Zhang, Xue-jun; Wang, Xin; Shang, Li-xin			Relationship of Liver X Receptors alpha and Endoglin Levels in Serum and Placenta with Preeclampsia	PLOS ONE			English	Article							EXPRESSION; SECRETION; INVASION; MARKER	Background Liver X receptor alpha (LXR alpha) and endoglin have been postulated to play roles in trophoblast invasion and lipid metabolic disturbances. However, the relationship between LXR alpha and endoglin levels in serum and placenta of patients with preeclampsia remains poorly understood. The objective of this study was to identify correlations between LXR alpha, endoglin and preeclampsia and provide new feasible methods of clinical prediction and treatment for preeclampsia. Methods We enrolled 45 patients with preeclampsia (24 with moderate preeclampsia and 21 with severe preeclampsia) and 15 normal pregnant women (control group) who were admitted to the Department of Obstetrics of the General Hospital of Beijing Command between October 2012 and July 2013 in this study. Serum and placental LXR alpha and endoglin levels were analyzed by enzyme-linked immunosorbent assay, real-time quantitative PCR, tissue microarray and immunohistochemistry. Results Serum and placental LXR alpha and endoglin levels were significantly higher in patients with preeclampsia than those in control group (P<0.05, each). Moreover, patients with severe preeclampsia displayed significantly higher LXR alpha and endoglin levels than those with moderate preeclampsia (P<0.05, each). The LXR alpha sensitivity, specificity and positive and negative predictive values were 66.00%, 80.00%, 89.19% and 48.48%, respectively, while those of endoglin levels were 62.00%, 85.00%, 91.18% and 47.22%, respectively. LXR alpha and endoglin levels in serum and placenta from patients with preeclampsia were positively correlated (serum: r = 0.486, P<0.01; placenta: r = 0.569, P<0.01). Conclusions Elevated LXR alpha and endoglin levels may be associated with preeclampsia pathogenesis and development and could be used as potential predictors for this disorder.	[Wang, Jing; Wu, Hong-yan; Wu, Nan; Zhang, Xue-jun; Wang, Xin; Shang, Li-xin] Beijing Mil Command, Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Dong, Xing] Beijing Mil Command, Gen Hosp, Dept Gen Surg, Beijing, Peoples R China	Seventh Medical Center of Chinese PLA General Hospital; Seventh Medical Center of Chinese PLA General Hospital	Shang, LX (corresponding author), Beijing Mil Command, Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China.	13581598951@163.com			National Natural Science Foundation of China [81050001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China, numbers 81050001, http://www.nsfc.gov.cn/. WJ received the funding. The funder had role in study design.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Ahmed A, 2015, BRIT J PHARMACOL, V172, P1574, DOI 10.1111/bph.12977; Aye ILMH, 2011, PLACENTA, V32, P183, DOI 10.1016/j.placenta.2010.12.007; Bell MJ, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-82; Bell MJ, 2013, BIOL RES NURS, V15, P129, DOI 10.1177/1099800411420133; Burke KT, 2009, J LIPID RES, V50, P1146, DOI 10.1194/jlr.M800538-JLR200; Craici IM, 2014, KIDNEY INT, V86, P275, DOI 10.1038/ki.2014.17; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Elhawary TM, 2012, INT J WOMENS HEALTH, V4, P521, DOI 10.2147/IJWH.S35318; Henry-Berger J, 2008, BIOL REPROD, V78, P968, DOI 10.1095/biolreprod.107.066498; Jeyabalan A, 2008, PLACENTA, V29, P555, DOI 10.1016/j.placenta.2008.03.006; Landis MS, 2002, J BIOL CHEM, V277, P4713, DOI 10.1074/jbc.M108807200; Larkin JC, 2014, PLACENTA, V35, P919, DOI 10.1016/j.placenta.2014.09.002; Mano Y, 2011, ENDOCRINOLOGY, V152, P4386, DOI 10.1210/en.2011-1088; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Mouzat K, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-145; Pavan L, 2004, ENDOCRINOLOGY, V145, P4583, DOI 10.1210/en.2003-1747; Ramma W, 2011, BIOCHEM SOC T, V39, P1619, DOI 10.1042/BST20110672; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Stepan H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.052; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Viennois E, 2011, EXPERT OPIN THER TAR, V15, P219, DOI 10.1517/14728222.2011.547853; Weedon-Fekjaer MS, 2005, PLACENTA, V26, P721, DOI 10.1016/j.placenta.2004.10.005; Yan DW, 2010, BRIT J CANCER, V103, P961, DOI 10.1038/sj.bjc.6605870; Zhang Y, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0261-3	26	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163742	10.1371/journal.pone.0163742	http://dx.doi.org/10.1371/journal.pone.0163742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736929	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800022
J	Yang, ZF; Landry, JF; Hebert, PDN				Yang, Zhaofu; Landry, Jean-Francois; Hebert, Paul D. N.			A DNA Barcode Library for North American Pyraustinae (Lepidoptera: Pyraloidea: Crambidae)	PLOS ONE			English	Article							CLASSIFICATION; SPECIMEN; PROMISE; LARVAE	Although members of the crambid subfamily Pyraustinae are frequently important crop pests, their identification is often difficult because many species lack conspicuous diagnostic morphological characters. DNA barcoding employs sequence diversity in a short standardized gene region to facilitate specimen identifications and species discovery. This study provides a DNA barcode reference library for North American pyraustines based upon the analysis of 1589 sequences recovered from 137 nominal species, 87% of the fauna. Data from 125 species were barcode compliant (> 500bp, < 1% n), and 99 of these taxa formed a distinct cluster that was assigned to a single BIN. The other 26 species were assigned to 56 BINs, reflecting frequent cases of deep intraspecific sequence divergence and a few instances of barcode sharing, creating a total of 155 BINs. Two systems for OTU designation, ABGD and BIN, were examined to check the correspondence between current taxonomy and sequence clusters. The BIN system performed better than ABGD in delimiting closely related species, while OTU counts with ABGD were influenced by the value employed for relative gap width. Different species with low or no interspecific divergence may represent cases of unrecognized synonymy, whereas those with high intraspecific divergence require further taxonomic scrutiny as they may involve cryptic diversity. The barcode library developed in this study will also help to advance understanding of relationships among species of Pyraustinae.	[Yang, Zhaofu] Northwest A&F Univ, Key Iaboratory Plant Protect Resources & Pest Man, Minist Educ, Yangling, Shaanxi, Peoples R China; [Yang, Zhaofu] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Landry, Jean-Francois] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada; [Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON, Canada	Northwest A&F University - China; Northwest A&F University - China; Agriculture & Agri Food Canada; University of Guelph	Yang, ZF (corresponding author), Northwest A&F Univ, Key Iaboratory Plant Protect Resources & Pest Man, Minist Educ, Yangling, Shaanxi, Peoples R China.; Yang, ZF (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	yangzhaofu@nwsuaf.edu.cn			National Natural Science Foundation of China [31201733]; Natural Science Foundation of Shaanxi Province [2016JM3026]; Ministry of Science and Technology of the People's Republic of China [2011FY120200]; NSERC; Canada Research Chairs Program; Genome Canada through the Ontario Genomics Institute; Agriculture & Agri-Food Canada Research and Development Branch	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); Genome Canada through the Ontario Genomics Institute(Genome Canada); Agriculture & Agri-Food Canada Research and Development Branch	This study was supported by the National Natural Science Foundation of China (31201733), Natural Science Foundation of Shaanxi Province (2016JM3026), and by the Ministry of Science and Technology of the People's Republic of China (2011FY120200), as well as by grants from NSERC, the Canada Research Chairs Program, and Genome Canada through the Ontario Genomics Institute to PDNH, and Agriculture & Agri-Food Canada Research and Development Branch to JFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLYSON S, 1981, CAN ENTOMOL, V113, P463, DOI 10.4039/Ent113463-6; ALLYSON S, 1976, CAN ENTOMOL, V108, P89, DOI 10.4039/Ent10889-1; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Costa FO, 2010, THEOR BIOSCI, V129, P149, DOI 10.1007/s12064-010-0091-y; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Guillemin ML, 2016, MOL PHYLOGENET EVOL, V94, P814, DOI 10.1016/j.ympev.2015.09.027; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kristensen N. P., 2003, HDB ZOOL, V4; Landry JF, 2007, CAN ENTOMOL, V139, P319, DOI 10.4039/N06-098; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Liu XF, 2014, ECOL EVOL, V4, P2472, DOI 10.1002/ece3.1110; Luo AR, 2015, ECOL EVOL, V5, pS869, DOI 10.1002/ece3.1846; Maes K.V.N., 1987, Nota Lepidopterologica, V10, P175; Maes K. V. N., 1994, Bulletin and Annales de la Societe Royale Belge d'Entomologie, V130, P159; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Minet J., 1982, Bulletin de la Societe Entomologique de France, V86, P262; Munroe (E.), 1999, HDB ZOOLOGY, V4, P35; Munroe EG, 1976, MOTHS AM N MEXICO, V13, P1; NUSS M., 2003, GLOBAL INFORM SYSTEM; Nuss M, 2005, MICROLEPIDOPTERA EUR, V4, P7; Powell JA, 2009, MOTHS W N AM, P1, DOI [10.1525/california/9780520251977.001.0001, DOI 10.1525/CALIFORNIA/9780520251977.001.0001]; Prosser SWJ, 2016, MOL ECOL RESOUR, V16, P487, DOI 10.1111/1755-0998.12474; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Scholtens BG, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.535.6086; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Solis MA, 2007, REV COLOMB ENTOMOL, V33, P1; Solis M. Alma, 2002, Belgian Journal of Entomology, V4, P53; Solis MA, 2010, J LEPID SOC, V64, P33; Speidel W, 2015, ZOOTAXA, V3999, P401, DOI 10.11646/zootaxa.3999.3.5; Strutzenberger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049710; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Yang ZF, 2012, SYST ENTOMOL, V37, P686, DOI 10.1111/j.1365-3113.2012.00637.x; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014	57	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0161449	10.1371/journal.pone.0161449	http://dx.doi.org/10.1371/journal.pone.0161449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736878	Green Published, gold			2022-12-27	WOS:000385505800001
J	Alpers, DL; Walker, FM; Taylor, AC; Sunnucks, P; Bellman, S; Hansen, BD; Sherwin, WB				Alpers, Deryn L.; Walker, Faith M.; Taylor, Andrea C.; Sunnucks, Paul; Bellman, Steven; Hansen, Birgita D.; Sherwin, William B.			Evidence of Subdivisions on Evolutionary Timescales in a Large, Declining Marsupial Distributed across a Phylogeographic Barrier	PLOS ONE			English	Article							HAIRY-NOSED WOMBATS; MITOCHONDRIAL-DNA EVOLUTION; POPULATION HISTORY; GENETIC DISTANCES; CONSERVATION; MICROSATELLITES; DIVERGENCE; MUTATION; BIOGEOGRAPHY; PROBABILITY	Major prehistoric forces, such as the climatic shifts of the Pleistocene, can remain visible in a species' population genetics. Inference of refuges via genetic tools is useful for conservation management as it can identify populations whose preservation may help retain a species' adaptive potential. Such investigation is needed for Australia's southern hairy-nosed wombat (Lasiorhinus latifrons), whose conservation status has recently deteriorated, and whose phylogeographic history during the Pleistocene may be atypical compared to other species. Its contemporary range spans approximately 2000 km of diverse habitat on either side of the Spencer Gulf, which was a land bridge during periods of Pleistocene aridity that may have allowed for migration circumventing the arid Eyrean barrier. We sampled from animals in nearly all known sites within the species' current distribution, mainly using non-invasive methods, and employed nuclear and mitochondrial DNA analyses to assess alternative scenarios for Pleistocene impacts on population structure. We found evidence for mildly differentiated populations at the range extremes on either side of Spencer Gulf, with secondary contact between locations neighbouring each side of the barrier. These extreme western and eastern regions, and four other regions in between, were genetically distinct in genotypic clustering analyses. Estimates indicate modest, but complex gene flow patterns among some of these regions, in some cases possibly restricted for several thousand years. Prior to this study there was little information to aid risk assessment and prioritization of conservation interventions facilitating gene flow among populations of this species. The contributions of this study to that issue are outlined.	[Alpers, Deryn L.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia; [Walker, Faith M.; Taylor, Andrea C.; Sunnucks, Paul; Hansen, Birgita D.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Bellman, Steven] Univ South Australia, Adelaide, SA, Australia; [Walker, Faith M.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Alpers, Deryn L.; Sherwin, William B.] Univ New South Wales, Kensington, NSW, Australia; [Hansen, Birgita D.] Federat Univ Australia, Ctr ERes & Digital Innovat, Ballarat, Vic, Australia; [Sherwin, William B.] Murdoch Univ, Cetacean Res Unit, Murdoch, WA, Australia	Murdoch University; Monash University; University of South Australia; Northern Arizona University; University of New South Wales Sydney; Federation University Australia; Murdoch University	Alpers, DL (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia.; Alpers, DL (corresponding author), Univ New South Wales, Kensington, NSW, Australia.	D.Alpers@Murdoch.edu.au	Bellman, Steven/AAZ-3806-2021; Bellman, Steven/GQB-1716-2022; Sherwin, William B B/C-3432-2008	Bellman, Steven/0000-0002-0085-2014; Bellman, Steven/0000-0002-0085-2014; Sherwin, William B B/0000-0002-1578-8473; Walker, Faith/0000-0001-8435-4452; Hansen, Birgita/0000-0003-3608-7622; Sunnucks, Paul/0000-0002-8139-7059	Australian Research Council; South Australian Department of the Environment and Natural Resources; Monash University's Logan Fellowship; National Geographic Society; Sir Mark Mitchell Fund; Australian Geographic Society; RSPCA (Royal Society for the Prevention of Cruelty To Animals) Alan White Scholarship	Australian Research Council(Australian Research Council); South Australian Department of the Environment and Natural Resources; Monash University's Logan Fellowship; National Geographic Society(National Geographic Society); Sir Mark Mitchell Fund; Australian Geographic Society; RSPCA (Royal Society for the Prevention of Cruelty To Animals) Alan White Scholarship	Australian Research Council (www.arc.gov.au) and South Australian Department of the Environment and Natural Resources (environmentsa.gov.au) provided funding to WS. ACT was supported by Monash University's Logan Fellowship (monash.edu). The National Geographic Society (nationalgeographic.com), Sir Mark Mitchell Fund (https://www.adelaide.edu.au/rb/funding-opportunities/sciences/docs/sir-mark-mitchell-foundation-guidelines.pdf), Australian Geographic Society (australiangeographic.com.au), and an RSPCA (Royal Society for the Prevention of Cruelty To Animals) Alan White Scholarship (rspca.org.au/facts/students/scholarships) provided funding to FMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN P F, 1971, South Australian Naturalist, V45, P93; Alpers D, 1998, WOMBATS, P192; Alpers DL, 2003, CONSERV GENET, V4, P779, DOI 10.1023/B:COGE.0000006119.77842.4b; Alpers DL, 1998, THESIS; AMOS B, 1991, P99; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Beheregaray Luciano B., 2000, Conservation Genetics, V1, P89, DOI 10.1023/A:1010146107009; Burbidge A.A., 2014, P15; Burbidge AA, 2008, AUST J ZOOL, V56, P411, DOI 10.1071/ZO08027; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Coller M., 2007, EXPLORE SAHUL TIME; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; DALLAS JF, 1992, MAMM GENOME, V3, P452, DOI 10.1007/BF00356155; Department for Environment and Heritage, 2007, COD PRACT HUM DESTR; DeYoung RW, 2005, J WILDLIFE MANAGE, V69, P1362, DOI 10.2193/0022-541X(2005)69[1362:TMTGTI]2.0.CO;2; Dolman G, 2015, EMU, V115, P35, DOI 10.1071/MU14047; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Finlayson G. R., 2010, Australian Mammalogy, V32, P39, DOI 10.1071/AM09024; Fisher MC, 2000, MOL BIOL EVOL, V17, P1164, DOI 10.1093/oxfordjournals.molbev.a026399; FORD J, 1987, EMU, V87, P158, DOI 10.1071/MU9870158; FORD J, 1974, Emu, V74, P161; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Fu YX, 1997, GENETICS, V147, P915; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Harrisson KA, 2014, EVOL APPL, V7, P1008, DOI 10.1111/eva.12149; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Joseph L, 2006, EMU, V106, P49, DOI 10.1071/MU05035; Kearns AM, 2009, J AVIAN BIOL, V40, P7, DOI 10.1111/j.1600-048X.2008.04383.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kivela M, 2015, MOL ECOL RESOUR, V15, P117, DOI 10.1111/1755-0998.12290; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Macqueen P, 2012, AUSTRAL ECOL, V37, P479, DOI 10.1111/j.1442-9993.2011.02309.x; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; MCELROY D, 1992, J HERED, V83, P157, DOI 10.1093/oxfordjournals.jhered.a111180; McLean AJ, 2012, MOL PHYLOGENET EVOL, V63, P668, DOI 10.1016/j.ympev.2012.02.016; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Neaves LE, 2012, J BIOGEOGR, V39, P1545, DOI 10.1111/j.1365-2699.2012.02702.x; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Pavlova A, 2014, BIOL CONSERV, V174, P136, DOI 10.1016/j.biocon.2014.04.005; Pavlova A, 2010, CONSERV GENET, V11, P2393, DOI 10.1007/s10592-010-0125-5; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ridley M., 2003, EVOLUTION; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; Ruykys L, 2009, AUST J ZOOL, V57, P129, DOI 10.1071/ZO09010; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schneider S., 2000, ARLEQUIN VER 2 000 S; Schodde R., 1990, MALLEE LANDS CONSERV; Scoble J, 2010, DIVERS DISTRIB, V16, P343, DOI 10.1111/j.1472-4642.2010.00658.x; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; SHIELDS GF, 1987, J MOL EVOL, V24, P212, DOI 10.1007/BF02111234; Sloane MA, 2000, MOL ECOL, V9, P1233, DOI 10.1046/j.1365-294x.2000.00993.x; Sparrow E., 2010, THESIS; St John B. J., 1989, PLAN MANAGEMENT SO H; Sun JX, 2009, MOL BIOL EVOL, V26, P1017, DOI 10.1093/molbev/msp025; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; Taggart DA, 2008, MAMMALS AUSTR, P204; TAJIMA F, 1989, GENETICS, V123, P585; TAYLOR AC, 1994, MOL ECOL, V3, P277, DOI 10.1111/j.1365-294X.1994.tb00068.x; Taylor AC, 1995, THESIS; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Walker F. M., 2004, SOCIOBIOLOGY INFERRE; Walker FM, 2008, MOL ECOL, V17, P1674, DOI 10.1111/j.1365-294X.2008.03701.x; Walker FM, 2008, MOL ECOL, V17, P1361, DOI 10.1111/j.1365-294X.2008.03670.x; Walker FM, 2007, MOL ECOL, V16, P199, DOI 10.1111/j.1365-294X.2006.03131.x; Walker FM, 2006, J MAMMAL, V87, P690, DOI 10.1644/05-MAMM-A-287R2.1; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	82	3	3	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0162789	10.1371/journal.pone.0162789	http://dx.doi.org/10.1371/journal.pone.0162789			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732594	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000385505300005
J	Amano, T; Toichi, M				Amano, Tamaki; Toichi, Motomi			The Role of Alternating Bilateral Stimulation in Establishing Positive Cognition in EMDR Therapy: A Multi-Channel Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							RESOURCE DEVELOPMENT; EYE-MOVEMENTS; INSTALLATION; RESPONSES; MEMORIES; BOLD; EMOTION; CORTEX; FMRI	Eye movement desensitisation and reprocessing (EMDR) is a standard method for treating post-traumatic stress disorder. EMDR treatment consists of desensitisation and resource development and installation (RDI) stages. Both protocols provide a positive alternating bilateral stimulation (BLS). The effect of desensitisation with BLS has been elucidated. However, a role for BLS in RDI remains unknown. Therefore, it is important to measure feelings as subjective data and physiological indicators as objective data to clarify the role of BLS in RDI. RDI was administered to 15 healthy volunteer subjects who experienced pleasant memories. Their oxygenated haemoglobin concentration ([oxy-Hb]), a sensitive index of brain activity, was measured from the prefrontal cortex (PFC) to the temporal cortex using multi-channel near-infrared spectroscopy during recall of a pleasant memory with or without BLS. The BLS used was alternating bilateral tactile stimulation with a vibration machine. The psychological evaluation suggested that RDI was successful. The results showed that, compared with non-BLS conditions, accessibility was increased and subjects were more relaxed under BLS conditions. A significant increase in [oxy-Hb] was detected in the right superior temporal sulcus (STS), and a decrease in the wide bilateral areas of the PFC was observed in response to BLS. The significant BLS-induced activation observed in the right STS, which is closely related to memory representation, suggests that BLS may help the recall of more representative pleasant memories. Furthermore, the significant reduction in the PFC, which is related to emotion regulation, suggests that BLS induces relaxation and comfortable feelings. These results indicate an important neural mechanism of RDI that emotional processing occurred rather than higher cognitive processing during this stage. Considering the neuroscientific evidence to date, BLS in RDI may enhance comfortable feelings about pleasant memories. Based on the current findings, the use of BLS in RDI may be warranted in some clinical situations.	[Amano, Tamaki; Toichi, Motomi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Amano, Tamaki; Toichi, Motomi] Org Promoting Neurodevel Disorder Res, Kyoto, Japan	Kyoto University	Amano, T (corresponding author), Kyoto Univ, Grad Sch Med, Kyoto, Japan.; Amano, T (corresponding author), Org Promoting Neurodevel Disorder Res, Kyoto, Japan.	yiu60432@nifty.com						Amano T, 2011, JAPANESE J EMDR RES, V4, P18; Amano T., 2012, JAPANESE J EMDR RES, V4, P18; Amano T, 2014, J EMDR PRACT RES, V8, P50, DOI 10.1891/1933-3196.8.2.50; Amano T, 2013, J EMDR PRACT RES, V7, P144, DOI 10.1891/1933-3196.7.3.144; Bergmann U, 2012, NEUROBIOLOGICAL FDN, P171; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Fletcher PC, 1998, BRAIN, V121, P1249, DOI 10.1093/brain/121.7.1249; Goldberg RF, 2006, J NEUROSCI, V26, P4917, DOI 10.1523/JNEUROSCI.5389-05.2006; Grant M, 2002, J CLIN PSYCHOL, V58, P1505, DOI 10.1002/jclp.10101; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornsveld HK, 2012, J EMDR PRACT RES, V6, P174, DOI 10.1891/1933-3196.6.4.174; Hornsveld HK, 2011, J EMDR PRACT RES, V5, P146, DOI 10.1891/1933-3196.5.4.146; Hornsveld HK, 2010, J EMDR PRACT RES, V4, P106, DOI 10.1891/1933-3196.4.3.106; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Jenkins AC, 2011, SOC NEUROSCI-UK, V6, P211, DOI 10.1080/17470919.2010.507948; Keller B, 2014, J EMDR PRACT RES, V8, P113, DOI 10.1891/1933-3196.8.3.113; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Korn DL, 2002, J CLIN PSYCHOL, V58, P1465, DOI 10.1002/jclp.10099; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lee CW, 2013, J BEHAV THER EXP PSY, V44, P231, DOI 10.1016/j.jbtep.2012.11.001; Leeds A, 1998, EXTENDING EMDR CASE, P256; Leeds A. M., 2000, BRIEF THERAPY STRATE, P469; Leeds AM, 2001, EYE MOVEMENT DESENSI, P434; Leeds AM, 2012, J EMDR PRACT RES, V6, P170, DOI 10.1891/1933-3196.6.4.170; Leeds AM, 2009, J EMDR PRACT RES, V3, P152, DOI 10.1891/1933-3196.3.3.152; Maier Steven F, 2006, Dialogues Clin Neurosci, V8, P397; Markowitsch H. J., 2003, NEUROIMAGE, V20, P132, DOI 10.1016/j.neuroimage.2003.09.010; McNair D.M., 1971, MANUAL PROFILES MOOD; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; PENFIELD W, 1955, Can Med Assoc J, V73, P515; Rodenburg R, 2009, CLIN PSYCHOL REV, V29, P599, DOI 10.1016/j.cpr.2009.06.008; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Sato W, 2010, BMC NEUROSCI, V13-99, P2; Seiyama A, 2004, NEUROIMAGE, V21, P1204, DOI 10.1016/j.neuroimage.2003.12.002; SHAPIRO F, 1989, J BEHAV THER EXP PSY, V20, P211, DOI 10.1016/0005-7916(89)90025-6; Shapiro F., 2001, EYE MOVEMENT DESENSI; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Taber K. H., 2010, J NEUROPSYCHIATRY CL, V22, piv, DOI DOI 10.1176/JNP.2010.22.4.IV; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; van den Hout M, 2001, BRIT J CLIN PSYCHOL, V40, P121	42	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0162735	10.1371/journal.pone.0162735	http://dx.doi.org/10.1371/journal.pone.0162735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732592	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300003
J	Du, XN; Peterson, W; Fisher, J; Hunter, M; Peterson, J				Du, Xiuning; Peterson, William; Fisher, Jennifer; Hunter, Matt; Peterson, Jay			Initiation and Development of a Toxic and Persistent Pseudo-nitzschia Bloom off the Oregon Coast in Spring/Summer2015	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; DOMOIC ACID PRODUCTION; PSEUDONITZSCHIA-AUSTRALIS; ENVIRONMENTAL-CONDITIONS; INTERANNUAL VARIATIONS; MONTEREY BAY; RAZOR CLAMS; BACILLARIOPHYCEAE; CALIFORNIA; IMPACTS	In spring/summer 2015, a toxic bloom by the diatom Pseudo-nitzschia (PN) occurred along the west coast of the United States which led to closures of the harvest of razor clams and Dungeness crabs. Twice monthly observations of temperature, salinity, nutrients, chlorophyll and phytoplankton species composition allowed us to track oceanographic conditions preceding and during the development of the bloom. PN cells were first detected during late winter 2015. A PN bloom was initiated following the onset of coastal upwelling in mid-April; subsequent peaks in May and June were sustained by episodic upwelling events and reached magnitudes of 10(5) cells/L and 10(6) cells/L, 40% and 90% of the total diatom abundance, respectively. The bloom temporarily crashed in July due to a lack of upwelling, but PN cells increased again in August due to a resumption of upwelling, albeit with lower magnitude. Macronutrient conditions prior to this bloom likely played a critical role in triggering the bloom and its toxicity (particularly silicic acid limitation stress). Nutrient stress preceding the toxic bloom was related to two oceanographic events: an anomalously warm and thick water mass that occupied the northern North Pacific from September 2014 through 2015 leading to a highly-stratified water column, and the drawdown of nitrate and silicic acid during an unusually intense winter phytoplankton bloom in February and early March 2015.	[Du, Xiuning; Fisher, Jennifer; Peterson, Jay] Oregon State Univ, Hatfield Marine Sci Ctr, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA; [Peterson, William] Natl Ocean & Atmospher Adm Fisheries, Northwest Fisheries Sci Ctr, Newport, OR USA; [Hunter, Matt] Oregon Dept Fish & Wildlife, Shellfish Program, Astoria, OR USA; [Peterson, Jay] Natl Ocean & Atmospher Adm Fisheries, Off Sci & Technol, Silver Spring, MD USA	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Du, XN (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA.	xiuningdu@gmail.com			National Oceanic and Atmospheric Administration Monitoring and Event Response for Harmful Algal Blooms (MERHAB) Research Program as part of the Monitoring Oregon Coastal Harmful Algae program [NA07NOS4780195]	National Oceanic and Atmospheric Administration Monitoring and Event Response for Harmful Algal Blooms (MERHAB) Research Program as part of the Monitoring Oregon Coastal Harmful Algae program	XD was supported by a grant from the National Oceanic and Atmospheric Administration Monitoring and Event Response for Harmful Algal Blooms (MERHAB) Research Program (NA07NOS4780195) (http://coastaiscience.noaa. gov/research/habsi/merhab) as part of the Monitoring Oregon Coastal Harmful Algae program (http://bioweb.coas.oregonstate.edu/-mocha/) This is MERHAB publication #197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NG, 2000, J SHELLFISH RES, V19, P1007; Anderson CR, 2006, MAR ECOL PROG SER, V327, P119, DOI 10.3354/meps327119; Bates S.S., 1998, PHYSL ECOLOGY HARMFU, P267; Berdalet E, 2014, DEEP-SEA RES PT II, V101, P4, DOI 10.1016/j.dsr2.2013.09.042; Bograd SJ, 2015, DEEP-SEA RES PT II, V112, P42, DOI 10.1016/j.dsr2.2014.04.009; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; BREESE WP, 1981, AQUACULTURE, V22, P27, DOI 10.1016/0044-8486(81)90130-7; BUCK KR, 1992, MAR ECOL PROG SER, V84, P293, DOI 10.3354/meps084293; Chase Z, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002590; Du XN, 2015, MAR ECOL PROG SER, V519, P75, DOI 10.3354/meps11097; Du XN, 2014, ESTUAR COAST, V37, P299, DOI 10.1007/s12237-013-9679-z; Du XN, 2011, HARMFUL ALGAE, V10, P784, DOI 10.1016/j.hal.2011.06.011; Eberhart BTL, 2012, HARMFUL ALGAE, V19, P39, DOI 10.1016/j.hal.2012.05.005; Feinberg LR, 2010, DEEP-SEA RES PT II, V57, P572, DOI 10.1016/j.dsr2.2009.10.007; Giddings SN, 2014, J GEOPHYS RES-OCEANS, V119, P2439, DOI 10.1002/2013JC009622; Hickey BM, 2013, HARMFUL ALGAE, V25, P1, DOI 10.1016/j.hal.2013.01.006; Holtermann KE, 2010, J PHYCOL, V46, P41, DOI 10.1111/j.1529-8817.2009.00792.x; Horner RA, 1997, LIMNOL OCEANOGR, V42, P1076, DOI 10.4319/lo.1997.42.5_part_2.1076; Howard MDA, 2007, HARMFUL ALGAE, V6, P206, DOI 10.1016/j.hal.2006.06.003; Kudela RM, 2010, PROG OCEANOGR, V85, P122, DOI 10.1016/j.pocean.2010.02.008; Lelong A, 2012, PHYCOLOGIA, V51, P168, DOI 10.2216/11-37; McKibben SM, 2015, HARMFUL ALGAE, V50, P32, DOI 10.1016/j.hal.2015.10.004; Pan Youlian, 1998, Natural Toxins, V6, P127, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<127::AID-NT9>3.3.CO;2-U; Peterson W, 1998, J MARINE SYST, V15, P313, DOI 10.1016/S0924-7963(97)00082-1; PETERSON W, 2015, WARM BLOB CONTINUES, V23, P44; Peterson W., 2015, WARM BLOB CONTINUES, V23, P36; Peterson WT, 2015, PROG OCEANOGR, V138, P32, DOI 10.1016/j.pocean.2015.09.007; PETERSON WT, 1979, DEEP-SEA RES, V26, P467, DOI 10.1016/0198-0149(79)90091-8; Peterson WT, 2016, PICES PRESS, V24, P46; Ryan JP, 2005, MAR ECOL PROG SER, V287, P23, DOI 10.3354/meps287023; Schnetzer A, 2013, J PLANKTON RES, V35, P1080, DOI 10.1093/plankt/fbt051; Seegers BN, 2015, LIMNOL OCEANOGR, V60, P754, DOI 10.1002/lno.10082; Terseleer N, 2013, HARMFUL ALGAE, V24, P45, DOI 10.1016/j.hal.2013.01.004; Trainer Vera L., 2005, Oceanography, V18, P228; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Trainer VL, 2009, LIMNOL OCEANOGR, V54, P289, DOI 10.4319/lo.2009.54.1.0289; Trainer VL, 2002, LIMNOL OCEANOGR, V47, P1438, DOI 10.4319/lo.2002.47.5.1438; Trainer VL, 2000, LIMNOL OCEANOGR, V45, P1818, DOI 10.4319/lo.2000.45.8.1818; Tweddle JF, 2010, MAR ECOL PROG SER, V405, P131, DOI 10.3354/meps08497; VILLAC MC, 1993, J SHELLFISH RES, V12, P457; Wells ML, 2015, HARMFUL ALGAE, V49, P68, DOI 10.1016/j.hal.2015.07.009; Whitney FA, 2015, GEOPHYS RES LETT, V42, P428, DOI 10.1002/2014GL062634; Wood AM, 1992, ORESU W 94 001	43	33	35	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163977	10.1371/journal.pone.0163977	http://dx.doi.org/10.1371/journal.pone.0163977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732630	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505300034
J	Furtado, F; Goncalves, BDB; Abranches, ILL; Abrantes, AF; Forner-Cordero, A				Furtado, Fabianne; Goncalves, Bruno da Silva B.; Laguardia Abranches, Isabela Lopes; Abrantes, Ana Flavia; Forner-Cordero, Arturo			Chronic Low Quality Sleep Impairs Postural Control in Healthy Adults	PLOS ONE			English	Article							BODY-WEIGHT; DEPRIVATION; SWAY; ACTIGRAPHY; FATIGUE; BALANCE; CONSEQUENCES; PERFORMANCE; INDICATOR; ALERTNESS	The lack of sleep, both in quality and quantity, is an increasing problem in modern society, often related to workload and stress. A number of studies have addressed the effects of acute (total) sleep deprivation on postural control. However, up to date, the effects of chronic sleep deficits, either in quantity or quality, have not been analyzed. Thirty healthy adults participated in the study that consisted of registering activity with a wrist actigraph for more than a week before performing a series of postural control tests. Sleep and circadian rhythm variables were correlated and the sum of activity of the least active 5-h period, L5, a rhythm variable, obtained the greater coefficient value with sleep quality variables (wake after sleep onset WASO and efficiency sleep). Cluster analysis was performed to classify subjects into two groups based on L5 (low and high). The balance tests scores used to asses postural control were measured using Biodex Balance System and were compared between the two groups with different sleep quality. The postural tests were divided into dynamic (platform tilt with eyes open, closed and cursor) and static (clinical test of sensory integration). The results showed that during the tests with eyes closed, the group with worse sleep quality had also worse postural control performance. Lack of vision impairs postural balance more deeply in subjects with chronic sleep inefficiency. Chronic poor sleep quality impairs postural control similarly to total sleep deprivation.	[Furtado, Fabianne; Forner-Cordero, Arturo] Univ Sao Paulo, Dept Mechatron, Escola Politecn, Sao Paulo, Brazil; [Furtado, Fabianne; Laguardia Abranches, Isabela Lopes; Abrantes, Ana Flavia] Southeast Minas Gerais, Fed Inst Educ Sci & Technol, Barbacena, MG, Brazil; [Goncalves, Bruno da Silva B.] Univ Fed Sao Paulo Unifesp, Dept Psychiat, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Federal do Sudeste de Minas Gerais; Universidade Federal de Sao Paulo (UNIFESP)	Forner-Cordero, A (corresponding author), Univ Sao Paulo, Dept Mechatron, Escola Politecn, Sao Paulo, Brazil.	aforner@usp.br	Furtado, Fabianne/C-3460-2012; Forner-Cordero, Arturo/G-5054-2013	Furtado, Fabianne/0000-0002-6423-5373; Forner-Cordero, Arturo/0000-0002-0352-1640	Office of Naval Research Global (ONR-G) [N62909-13-1-N278]; Research Foundation of the State of Minas Gerais (FAPEMIG, Brazil)	Office of Naval Research Global (ONR-G); Research Foundation of the State of Minas Gerais (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The funding from the Office of Naval Research Global (ONR-G Grant N62909-13-1-N278) is acknowledged. The author ILLA thanks the Research Foundation of the State of Minas Gerais (FAPEMIG, Brazil) for the undergraduate research grant.	Aguiar SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122340; Aguiar SA, 2014, NEUROSCI LETT, V574, P47, DOI 10.1016/j.neulet.2014.05.028; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Albuquerque A, 2012, BIOL RHYTHM RES, V43, P663, DOI 10.1080/09291016.2011.631789; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Banks S, 2007, J CLIN SLEEP MED, V3, P519; BENEDITOSILVA AA, 1990, PROG CLIN BIOL RES, V341, P89; Bertolazi AN, 2008, THESIS; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Bougard C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/287436; Buysse D J, 1989, Psychiatry Res, V28, P193; Cai ZJ, 2015, PHYSIOL BEHAV, V144, P110, DOI 10.1016/j.physbeh.2015.03.013; Cuthbertson DW, 2015, LARYNGOSCOPE, V125, P337, DOI 10.1002/lary.24792; De Weerd A, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00155; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Ehsani F, 2016, MAN THER; Gauchard GC, 2003, OCCUP ENVIRON MED, V60, P330, DOI 10.1136/oem.60.5.330; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Gomez S, 2008, CLIN NEUROPHYSIOL, V119, P617, DOI 10.1016/j.clinph.2007.10.058; Goncalves BSB, 2015, SLEEP MED REV, V20, P84, DOI 10.1016/j.smrv.2014.06.002; Gribble PA, 2004, PERCEPT MOTOR SKILL, V99, P1035, DOI 10.2466/pms.99.3.1035-1045; Hinman MR, 2000, J SPORT REHABIL, V9, P240, DOI 10.1123/jsr.9.3.240; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kantermann T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040655; Karita K, 2006, J OCCUP HEALTH, V48, P65, DOI 10.1539/joh.48.65; Kiers H, 2013, SPORTS MED, V43, P1171, DOI 10.1007/s40279-013-0082-5; Ku PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041539; Kurz I, 2013, J ELECTROMYOGR KINES, V23, P814, DOI 10.1016/j.jelekin.2013.04.001; Laposky AD, 2016, SLEEP MED, V18, P3, DOI 10.1016/j.sleep.2015.01.007; Liu Y, 2001, OCCUP MED-OXFORD, V51, P490, DOI 10.1093/occmed/51.8.490; Ma J, 2009, J INT MED RES, V37, P1311, DOI 10.1177/147323000903700506; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Morad Y, 2007, AVIAT SPACE ENVIR MD, V78, P859; Nakano T, 2001, PSYCHIAT CLIN NEUROS, V55, P277, DOI 10.1046/j.1440-1819.2001.00858.x; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Pham Quang-Cuong, 2014, Rev. Bras. Eng. Bioméd., V30, P322, DOI 10.1590/1517-3151.0611; Robillard R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028731; Robillard R, 2011, CLIN NEUROPHYSIOL, V122, P1771, DOI 10.1016/j.clinph.2011.02.010; Sargent C, 2012, ACCIDENT ANAL PREV, V45, P74, DOI 10.1016/j.aap.2011.09.030; Smith SS, 2012, EXP BRAIN RES, V221, P329, DOI 10.1007/s00221-012-3175-8; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thomas M, THALAMUS RELATED SYS, V2, P199; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Zaback M, 2016, GAIT POSTURE, V45, P19, DOI 10.1016/j.gaitpost.2015.12.033	46	32	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163310	10.1371/journal.pone.0163310	http://dx.doi.org/10.1371/journal.pone.0163310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732604	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505300014
J	Gala, TD; Geisel, MH; Peters, A; Thorand, B; Baumert, J; Lehmann, N; Jockel, KH; Moebus, S; Erbel, R; Meisinger, C; Mahabadi, AA; Koenig, W				Gala, Tonia de las Heras; Geisel, Marie Henrike; Peters, Annette; Thorand, Barbara; Baumert, Jens; Lehmann, Nils; Joeckel, Karl-Heinz; Moebus, Susanne; Erbel, Raimund; Meisinger, Christine; Mahabadi, Amir Abbas; Koenig, Wolfgang		KORA Study Grp; Heinz Nixdorf Recall Study Grp	Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEART-DISEASE; PERFORMANCE; GUIDELINES; DISCRIMINATION; PREVENTION; PACKAGE; MEN	Background The 2013 ACC/AHA guidelines introduced an algorithm for risk assessment of atherosclerotic cardiovascular disease (ASCVD) within 10 years. In Germany, risk assessment with the ESC SCORE is limited to cardiovascular mortality. Applicability of the novel ACC/AHA risk score to the German population has not yet been assessed. We therefore sought to recalibrate and evaluate the ACC/AHA risk score in two German cohorts and to compare it to the ESC SCORE. Methods We studied 5,238 participants from the KORA surveys S3 (1994-1995) and S4 (1999-2001) and 4,208 subjects from the Heinz Nixdorf Recall (HNR) Study (2000-2003). There were 383 (7.3%) and 271 (6.4%) first non-fatal or fatal ASCVD events within 10 years in KORA and in HNR, respectively. Risk scores were evaluated in terms of calibration and discrimination performance. Results The original ACC/AHA risk score overestimated 10-year ASCVD rates by 37% in KORA and 66% in HNR. After recalibration, miscalibration diminished to 8% underestimation in KORA and 12% overestimation in HNR. Discrimination performance of the ACC/AHA risk score was not affected by the recalibration (KORA: C = 0.78, HNR: C = 0.74). The ESC SCORE overestimated by 5% in KORA and by 85% in HNR. The corresponding C-statistic was 0.82 in KORA and 0.76 in HNR. Conclusions The recalibrated ACC/AHA risk score showed strongly improved calibration compared to the original ACC/AHA risk score. Predicting only cardiovascular mortality, discrimination performance of the commonly used ESC SCORE remained somewhat superior to the ACC/AHA risk score. Nevertheless, the recalibrated ACC/AHA risk score may provide a meaningful tool for estimating 10-year risk of fatal and non-fatal cardiovascular disease in Germany.	[Gala, Tonia de las Heras; Peters, Annette; Thorand, Barbara; Baumert, Jens; Meisinger, Christine] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Gala, Tonia de las Heras; Peters, Annette; Koenig, Wolfgang] Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany; [Geisel, Marie Henrike; Lehmann, Nils; Joeckel, Karl-Heinz; Moebus, Susanne; Erbel, Raimund] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Erbel, Raimund; Mahabadi, Amir Abbas] Univ Duisburg Essen, Dept Cardiol, West German Heart & Vasc Ctr, Essen, Germany; [Meisinger, Christine] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Duisburg Essen; University of Duisburg Essen; Ulm University; German Heart Centre Munich; Technical University of Munich	Koenig, W (corresponding author), Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany.; Koenig, W (corresponding author), Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany.; Koenig, W (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany.	koenig@dhm.mhn.de	Peters, Annette/A-6117-2011; Mahabadi, Amir/ABE-6057-2020; Meisinger, Christine/B-5358-2014; Thorand, Barbara/B-5349-2014; Heinrich, Joachim/N-1720-2013	Peters, Annette/0000-0001-6645-0985; Thorand, Barbara/0000-0002-8416-6440; Heinrich, Joachim/0000-0002-9620-1629; Koenig, Wolfgang/0000-0002-2064-9603; Moebus, Susanne/0000-0002-0072-5410	BiomarCare; German Research Foundation; BMBF; AtheroRemo; AIRGENE; Heinz Nixdorf Foundation; TDLHG; University Hospital Ulm	BiomarCare; German Research Foundation(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); AtheroRemo; AIRGENE; Heinz Nixdorf Foundation; TDLHG; University Hospital Ulm	WK reports honoraria for lectures from AstraZeneca, Novartis, MSD, Amgen and Actavis as well as payments for consulting services from Novartis, Pfizer, The Medicine Company, Amgen, AstraZeneca, MSD, GSK and Sanderling Ventures. He is supported by grants from BiomarCare, the German Research Foundation, BMBF, AtheroRemo and AIRGENE. MHG, RE and AAM were supported by grants from the German Research Foundation. AAM and NL were supported by the Heinz Nixdorf Foundation and TDLHG by cooperation with the University Hospital Ulm. AP, CM, BT and JB did not declare any conflicts of interest. The funders stated in Competing Interests and Financial Disclosure Statement that no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Assmann G, 2007, EUR J CLIN INVEST, V37, P925, DOI 10.1111/j.1365-2362.2007.01888.x; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Committee on Preventing the Global Epidemic of Cardiovascular Disease, 2010, PROMOT ING CARDIOVAS; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Crowson CS, 2014, STAT METHODS MED RES; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; LOWEL H, 1991, J CLIN EPIDEMIOL, V44, P249, DOI 10.1016/0895-4356(91)90036-9; Menotti A, 2000, EUR HEART J, V21, P365, DOI 10.1053/euhj.1999.1864; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; Muller-Nordhorn J, 2004, J EPIDEMIOL COMMUN H, V58, P481, DOI 10.1136/jech.2003.013367; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schmermund Axel, 2007, Atherosclerosis, V195, pe207, DOI 10.1016/j.atherosclerosis.2007.04.009; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Stang A, 2014, DTSCH ARZTEBL INT, V111, P530, DOI 10.3238/arztebl.2014.0530; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Vaucher J, 2014, EUR HEART J, V35, P958, DOI 10.1093/eurheartj/ehu064	32	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164688	10.1371/journal.pone.0164688	http://dx.doi.org/10.1371/journal.pone.0164688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732641	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505300076
J	Pantelic, M; Dabic Zagorac, D; Natic, M; Gasic, U; Jovic, S; Vujovic, D; Djordjevic, JP				Pantelic, Milica; Dabic Zagorac, Dragana; Natic, Maja; Gasic, Uros; Jovic, Sonja; Vujovic, Dragan; Djordjevic, Jelena Popovic			Impact of Clonal Variability on Phenolics and Radical Scavenging Activity of Grapes and Wines: A Study on the Recently Developed Merlot and Cabernet Franc Clones (Vitis vinifera L.)	PLOS ONE			English	Article							RED WINES; PHYTOCHEMICAL PROFILES; ANTIOXIDANT ACTIVITIES; COLOR; ANTHOCYANINS; BERRIES; QUALITY	In this study, grapes and corresponding wines of Merlot /No 022, 025 and 029/ and Cabernet Franc /No 02, 010 and 012/ clones (recently developed) were evaluated regarding the total phenolic content, total anthocyanin content, and radical scavenging activity, aiming to better understand their quality and market potential. The nineteen individual polyphenols were quantified in studied grape samples using UHPLC coupled to a triple-quadrupole mass spectrometer. The mother grapes and wines were used as the relevant standards. In the grape, studied characteristics were monitored at three stages of berry development: green berry, veraison and mature berry. The mature grape of clones presented high values of total phenolics (3.81-10.89 g gallic acid equivalent kg(-1) frozen weight), anthocyanin content (359.00-1668.18 mg malvidin-3-O-glucoside kg(-1) frozen weight) and the radical scavenging activity (41.37-80.48 mmol trolox equivalent kg(-1) frozen weight) depending on the clone. Grapes and wines of Merlot No 025 and Cabernet Franc No 010 stood out with the highest values of all three parameters. Generally, the high correlation was observed between TPC and RSA values for green berries and mature grapes, as well as for wine samples. The most abundant phenolics in both Merlot and Cabernet Franc grapes were gallic acid, p-hydroxybenzoic acid, ferulic acid, catechin, epicatechin, gallocatechin gallate, catechin gallate, and rutin. Catechin, epicatechin, epigallocatechin, and catechin gallate, typical for the ripe grape of Merlot and Cabernet Franc clones, showed significant correlation with RSA values. Concentrations of individual polyphenols varied depending on the sample being studied and berry development stages. Merlot No 025 and Cabernet Franc No 010 grapes showed particularly interesting attributes for the production of high quality wines.	[Pantelic, Milica; Dabic Zagorac, Dragana] Univ Belgrade, Innovat Ctr, Fac Chem Ltd, Belgrade, Serbia; [Natic, Maja; Gasic, Uros] Univ Belgrade, Fac Chem, Belgrade, Serbia; [Jovic, Sonja] Univ Belgrade, ODPF Radmilovac, Fac Agr, Belgrade, Serbia; [Vujovic, Dragan] Univ Belgrade, Dept Hort, Fac Agr, Belgrade, Serbia; [Djordjevic, Jelena Popovic] Univ Belgrade, Dept Food Technol & Biochem, Fac Agr, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade	Djordjevic, JP (corresponding author), Univ Belgrade, Dept Food Technol & Biochem, Fac Agr, Belgrade, Serbia.	jelenadj@agrif.bg.ac.rs	Pantelić, Milica/R-1869-2016; Natić, Maja/Q-9299-2016; Popović-Đorđević, Jelena/AAH-3659-2020; Gašić, Uroš/P-2239-2016; Dabić Zagorac, Dragana/S-1899-2016	Pantelić, Milica/0000-0002-9039-3201; Natić, Maja/0000-0002-6610-297X; Popović-Đorđević, Jelena/0000-0003-4057-3826; Gašić, Uroš/0000-0001-5384-8396; Dabić Zagorac, Dragana/0000-0001-5454-5696	Ministry of Education, Science and Technological Development of the Republic of Serbia [172017, 46009]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia: Research grants Nos. 172017 - MP, DDZ, MN, and UG; and 46009 - JPD.	Adams DO, 2006, AM J ENOL VITICULT, V57, P249; [Anonymous], 2006, OIV COMP INT METH WI, V1; Auger C, 2005, J AGR FOOD CHEM, V53, P2015, DOI 10.1021/jf048177q; Avramov L, 1996, POLJOPRIVREDA, V383-385, P117; Barbeau G., 1999, Bulletin de l'OIV, V72, P731; Barros A, 2015, PHYTOCHEM REV, V14, P921, DOI 10.1007/s11101-015-9421-5; Boursiquot JM, 2009, AUST J GRAPE WINE R, V15, P144, DOI 10.1111/j.1755-0238.2008.00041.x; Brouillard R, 2003, PHYTOCHEMISTRY, V64, P1179, DOI 10.1016/S0031-9422(03)00518-1; Conde C, 2007, FOOD, V22, DOI DOI 10.1186/S12864-016-2660-Z; Dai ZW, 2011, AM J ENOL VITICULT, V62, P413, DOI 10.5344/ajev.2011.10116; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Du Bin, 2012, Journal of Medicinal Plants Research, V6, P3381, DOI 10.5897/JMPR12.238; Ferrandino A, 2010, EUR FOOD RES TECHNOL, V230, P417, DOI 10.1007/s00217-009-1180-3; Fillion L, 1999, PLANT PHYSIOL, V120, P1083, DOI 10.1104/pp.120.4.1083; Gasic UM, 2015, J FOOD COMPOS ANAL, V44, P128, DOI 10.1016/j.jfca.2015.08.008; Gris EF, 2013, J FOOD COMPOS ANAL, V31, P31, DOI 10.1016/j.jfca.2013.03.002; He F, 2012, MOLECULES, V17, P1571, DOI 10.3390/molecules17021571; Hogan S, 2009, LWT-FOOD SCI TECHNOL, V42, P1269, DOI 10.1016/j.lwt.2009.02.006; Martinez-Esteso MJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-167; Kennedy J. A., 2000, Australian Journal of Grape and Wine Research, V6, P244, DOI 10.1111/j.1755-0238.2000.tb00185.x; Lorrain B, 2011, FOOD CHEM, V126, P1991, DOI 10.1016/j.foodchem.2010.12.062; Mattivi F, 2009, AUST J GRAPE WINE R, V15, P27, DOI 10.1111/j.1755-0238.2008.00027.x; Mitic MN, 2012, FOOD SCI BIOTECHNOL, V21, P1619, DOI 10.1007/s10068-012-0215-x; Pajovic R, 2014, S AFR J ENOL VITIC, V35, P139; Pantelic M, 2014, SCI WORLD J, DOI 10.1155/2014/454797; Pavlovic AV, 2013, J AGR FOOD CHEM, V61, P4188, DOI 10.1021/jf400607f; Pereira V, 2013, MOLECULES, V18, P2997, DOI 10.3390/molecules18032997; Puertolas E, 2011, FOOD SCI TECHNOL INT, V17, P77, DOI 10.1177/1082013210368555; Robinson S. P., 2000, Australian Journal of Grape and Wine Research, V6, P175, DOI 10.1111/j.1755-0238.2000.tb00177.x; Sauvignon V. Cabernet, 1996, POLJOPRIVREDA, V383-385, P35; Van Leeuw R, 2014, J FOOD COMPOS ANAL, V36, P40, DOI 10.1016/j.jfca.2014.07.001; van Leeuwen C, 2013, J AGR FOOD CHEM, V61, P19, DOI 10.1021/jf304687c; Vrhovsek U, 1998, J AGR FOOD CHEM, V46, P4203, DOI 10.1021/jf980461s; Vujovic DS, 2015, J INT SCI VIGNE VIN, V49, P267; Yang J, 2009, FOOD CHEM, V116, P332, DOI 10.1016/j.foodchem.2009.02.021; Zamuz S, 2007, J FOOD COMPOS ANAL, V20, P591, DOI 10.1016/j.jfca.2007.04.003; Zhu L, 2012, MOLECULES, V17, P3304, DOI 10.3390/molecules17033304; Zunic D., 2010, AMPELOGRAFIJA	38	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163823	10.1371/journal.pone.0163823	http://dx.doi.org/10.1371/journal.pone.0163823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732619	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300031
J	Takeuchi, S; Iwama, S; Takagi, H; Kiyota, A; Nakashima, K; Izumida, H; Fujisawa, H; Iwata, N; Suga, H; Watanabe, T; Kaibuchi, K; Oiso, Y; Arima, H; Sugimura, Y				Takeuchi, Seiji; Iwama, Shintaro; Takagi, Hiroshi; Kiyota, Atsushi; Nakashima, Kohtaro; Izumida, Hisakazu; Fujisawa, Haruki; Iwata, Naoko; Suga, Hidetaka; Watanabe, Takashi; Kaibuchi, Kozo; Oiso, Yutaka; Arima, Hiroshi; Sugimura, Yoshihisa			Tomosyn Negatively Regulates Arginine Vasopressin Secretion in Embryonic Stem Cell-Derived Neurons	PLOS ONE			English	Article							DENSE-CORE VESICLES; NEUROTRANSMITTER RELEASE; NERVE-ENDINGS; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; RAT NEUROHYPOPHYSIS; EXOCYTOSIS PROTEINS; MEMBRANE-FUSION; SNARE PROTEINS; BETA-CELLS; SYNAPTOTAGMIN	Arginine vasopressin (AVP) is secreted via exocytosis; however, the precise molecular mechanism underlying the exocytosis of AVP remains to be elucidated. To better understand the mechanisms of AVP secretion, in our study we have identified proteins that bind with a 25 kDa synaptosomal-associated protein (SNAP25). SNAP25 plays a crucial role in exocytosis, in the posterior pituitary. Embryonic stem (ES) cell-derived AVP neurons were established to investigate the functions of the identified proteins. Using glutathione S-transferase (GST)-pulldown assays and proteomic analyses, we identified tomosyn-1 (syntaxin-binding protein 5) as a SNAP25-binding protein in the posterior pituitary. Coimmunoprecipitation assays indicated that tomosyn formed N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complexes with SNAP25 and syntaxin1. Immunohistochemistry showed that tomosyn localized to the posterior pituitary. Mouse ES cells self-differentiated into AVP neurons (mES-AVP) that expressed tomosyn and two transmembrane SNARE proteins, including SNAP25 and syntaxin1. KCl increased AVP secretion in mES-AVP, and overexpression of tomosyn-1 reduced KCl-stimulated AVP secretion. Downregulation of tomosyn-1 with siRNA increased KCl-stimulated AVP secretion. These results suggested that tomosyn-1 negatively regulated AVP secretion in mES-AVP and further suggest the possibility of using mES-AVP culture systems to evaluate the role of synaptic proteins from AVP neurons.	[Takeuchi, Seiji; Iwama, Shintaro; Takagi, Hiroshi; Kiyota, Atsushi; Nakashima, Kohtaro; Izumida, Hisakazu; Fujisawa, Haruki; Iwata, Naoko; Suga, Hidetaka; Oiso, Yutaka; Arima, Hiroshi; Sugimura, Yoshihisa] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan; [Watanabe, Takashi; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Sugimura, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan.	sugiyosi@med.nagoya-u.ac.jp	Sugimura, Yoshihisa/Q-8716-2019	Watanabe, Takashi/0000-0002-9015-5246; Suga, Hidetaka/0000-0003-1924-7639	Japanese Society for the Promotion of Science [24591360]; Ministry of Health, Labor and Welfare, Japan	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a grant-in-aid for scientific research from the Japanese Society for the Promotion of Science 24591360 (to Y.S.) and a grant-in-aid for scientific research (Research on Hypothalamo-hypophyseal Disorders) (to Y.S. and Y.O.) from the Ministry of Health, Labor and Welfare, Japan.	Bielopolski N, 2014, J BIOL CHEM, V289, P17087, DOI 10.1074/jbc.M113.515296; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; CAZALIS M, 1987, J PHYSIOL-LONDON, V390, P55, DOI 10.1113/jphysiol.1987.sp016686; Di Iorgi N, 2014, J CLIN ENDOCR METAB, V99, P1264, DOI 10.1210/jc.2013-3724; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gainer H, 1998, CELL MOL NEUROBIOL, V18, P211, DOI 10.1023/A:1022568904002; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Iwama S, 2015, J CLIN ENDOCR METAB, V100, pE946, DOI 10.1210/jc.2014-4209; Jacobsson G, 1996, ENDOCRINOLOGY, V137, P5344, DOI 10.1210/en.137.12.5344; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Jurgutis P, 1996, NEUROENDOCRINOLOGY, V64, P379, DOI 10.1159/000127141; Kapoor JR, 2000, J NEUROSCI, V20, P8868; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; Morris JF, 2000, EXP PHYSIOL, V85, p131S, DOI 10.1111/j.1469-445X.2000.tb00016.x; NORDMANN JJ, 1986, EXP BRAIN RES, V61, P560; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Pupier S, 1997, J NEUROSCI, V17, P2722; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; SARIDAKI E, 1989, J ENDOCRINOL, V121, P343, DOI 10.1677/joe.0.1210343; Schwab Y, 2001, MOL BRAIN RES, V96, P1, DOI 10.1016/S0169-328X(01)00244-3; SLADEK CD, 1977, ENDOCRINOLOGY, V101, P1834, DOI 10.1210/endo-101-6-1834; Somm E, 2012, J CLIN INVEST, V122, P3295, DOI 10.1172/JCI63232; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugimura Y, 2005, EXP NEUROL, V192, P178, DOI 10.1016/j.expneurol.2004.10.018; Sugimura Y, 2003, ENDOCRINOLOGY, V144, P2791, DOI 10.1210/en.2002-0017; Tobin V, 2012, J NEUROENDOCRINOL, V24, P629, DOI 10.1111/j.1365-2826.2011.02237.x; Tobin V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00261; WALCHSOLIMENA C, 1993, J NEUROSCI, V13, P3895; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yu HJ, 2014, J BIOL CHEM, V289, P25571, DOI 10.1074/jbc.M114.591487; Zhang LX, 2000, J NEUROCYTOL, V29, P19, DOI 10.1023/A:1007108012667; ZHANG SLJ, 1995, J PHYSIOL-LONDON, V483, P583, DOI 10.1113/jphysiol.1995.sp020608; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Zhang ZJ, 2009, NAT NEUROSCI, V12, P163, DOI 10.1038/nn.2252	43	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164544	10.1371/journal.pone.0164544	http://dx.doi.org/10.1371/journal.pone.0164544			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732637	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505300063
J	Muranyi, G; Szabo, M; Olasz, F; Kiss, J				Muranyi, Gabor; Szabo, Monika; Olasz, Ferenc; Kiss, Janos			Determination and Analysis of the Putative AcaCD-Responsive Promoters of Salmonella Genomic Island 1	PLOS ONE			English	Article							ENTERICA SEROVAR KENTUCKY; MULTIDRUG-RESISTANCE REGION; TYPHIMURIUM DT104; ANTIBIOTIC-RESISTANCE; INSERTION-SEQUENCE; SGI1; VARIANT; CHINA; AGONA	The integrative genomic island SGI1 and its variants confer multidrug resistance in numerous Salmonella enterica serovariants and several Proteus mirabilis and Acinetobacter strains. SGI1 is mobilized by the IncA/C family plasmids. The island exploits not only the conjugation apparatus of the plasmid, but also utilizes the plasmid-encoded master regulator AcaCD to induce the excision and formation of its transfer-competent form, which is a key step in the horizontal transfer of SGI1. Triggering of SGI1 excision occurs via the AcaCD-dependent activation of xis gene expression. AcaCD binds in P-xis to an unusually long recognition sequence. Beside the Pxis promoter, upstream regions of four additional SGI1 genes, S004, S005, S012 and S018, also contain putative AcaCD-binding sites. Furthermore, SGI1 also encodes an AcaCD-related activator, FlhDC(SGI1), which has no known function. Here, we have analysed the functionality of the putative AcaCD-dependent promoter regions and proved their activation by either AcaCD or FlhDC(SGI1). Moreover, we provide evidence that both activators act on the same binding site in P-xis and that FlhDC(SGI1) is able to complement the acaCD deletion of the IncA/C family plasmid R16a. We determined the transcription start sites for the AcaCD-responsive promoters and showed that orf S004 is expressed probably from a different start codon than predicted earlier. Additionally, expression of S003 from promoter P-S004 was ruled out. Pxis and the four SGI1 promoters examined here also lack obvious -35 promoter box and their promoter profile is consistent with the class II-type activation pathway. Although the role of the four additionally analysed AcaCD/FlhDC(SGI1)-controlled genes in transfer and/or maintenance of SGI1 is not yet clear, the conservation of the whole region suggests the existence of some selection for their functionality.	[Muranyi, Gabor; Szabo, Monika; Olasz, Ferenc; Kiss, Janos] Natl Agr Res & Innovat Ctr, Agr Biotechnol Inst, Godollo, Hungary		Kiss, J (corresponding author), Natl Agr Res & Innovat Ctr, Agr Biotechnol Inst, Godollo, Hungary.	kiss.janos@abc.naik.hu		Kiss, Janos/0000-0002-0506-5474; Muranyi, Gabor/0000-0001-7021-378X	Hungarian Scientific Research Fund OTKA [K 105635]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund OTKA (K 105635 to J. K.) (http://nkfih.gov.hu/palyazatok/otka-nemzetkozi/nemzetkozi).	Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P340, DOI 10.1128/AAC.00902-07; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Carraro N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004714; Douard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015302; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2008, ANTIMICROB AGENTS CH, V52, P3745, DOI 10.1128/AAC.00525-08; Doublet B, 2009, J ANTIMICROB CHEMOTH, V63, P282, DOI 10.1093/jac/dkn500; Golding GR, 2007, MICROBES INFECT, V9, P21, DOI 10.1016/j.micinf.2006.10.004; Hall RM, 2010, FUTURE MICROBIOL, V5, P1525, DOI 10.2217/FMB.10.122; Hamidian M, 2015, J ANTIMICROB CHEMOTH, V70, P2519, DOI 10.1093/jac/dkv137; Kiss J, 2015, NUCLEIC ACIDS RES, V43, P8735, DOI 10.1093/nar/gkv758; Kiss J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032497; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Le Hello S, 2012, ANTIMICROB AGENTS CH, V56, P5096, DOI 10.1128/AAC.00732-12; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Lei CW, 2014, ANTIMICROB AGENTS CH, V58, P7570, DOI 10.1128/AAC.03992-14; Levings RS, 2007, ANTIMICROB AGENTS CH, V51, P317, DOI 10.1128/AAC.01229-06; Levings RS, 2005, J BACTERIOL, V187, P4401, DOI 10.1128/JB.187.13.4401-4409.2005; Poulin-Laprade D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00837; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7	24	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164561	10.1371/journal.pone.0164561	http://dx.doi.org/10.1371/journal.pone.0164561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727307	Green Published, gold, Green Submitted			2022-12-27	WOS:000385504400039
J	Matsunami, K; Nishida, N; Kaneko, N; Ikeo, K; Toyo-Oka, L; Takeuchi, H; Matsuura, K; Tamori, A; Nomura, H; Yoshiji, H; Imamura, M; Masaki, N; Hayakawa, T; Ide, T; Shimada, N; Ikeda, F; Hino, K; Nishiguchi, S; Okuse, C; Nojiri, S; Sawamoto, K; Tokunaga, K; Joh, T; Tanaka, Y				Matsunami, Kayoko; Nishida, Nao; Kaneko, Naoko; Ikeo, Kazuho; Toyo-oka, Licht; Takeuchi, Hiroshi; Matsuura, Kentaro; Tamori, Akihiro; Nomura, Hideyuki; Yoshiji, Hitoshi; Imamura, Masatoshi; Masaki, Naohiko; Hayakawa, Tatsuro; Ide, Tatsuya; Shimada, Noritomo; Ikeda, Fusao; Hino, Keisuke; Nishiguchi, Shuhei; Okuse, Chiaki; Nojiri, Shunsuke; Sawamoto, Kazunobu; Tokunaga, Katsushi; Joh, Takashi; Tanaka, Yasuhito			Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR-BINDING; FINGER TRANSCRIPTION FACTOR; PLUS RIBAVIRIN; ZINC-FINGER; INVENTORY-II; ALPHA; GENE; EXPRESSION; POLYMORPHISMS; PROTEIN-3	The therapeutic use of interferon (IFN) is known to cause depression that frequently interrupts treatment. To identify genetic variants associated with IFN-induced depression, we conducted a genome-wide association study (GWAS) of 224 Japanese chronic hepatitis C patients receiving IFN-based therapy in a multicenter prospective study and stratified them into two groups according to the Beck Depression Inventory, Second Edition (BDI-II) score. In the GWAS stage, we selected 42 candidate single nucleotide polymorphisms (SNPs) to perform replication analysis in an independent set of 160 subjects. The SNP rs1863918 in strong linkage disequilibrium with SNPs located around the Zinc finger 354C (ZNF354C) gene on chromosome 5 showed a significant association when the results of GWAS and replication were combined (odds ratio = 2.55, P = 7.89x10(-8) in the allele frequency model), suggesting that the rs1863918 T allele was associated with IFN-induced depression. Furthermore, logistic regression analysis showed that rs1863918 T allele, a history of depression, and younger age were independent predictive factors for IFN-induced depression. Interestingly, western blotting and immunofluorescence showed that ZNF354C was highly expressed in the hippocampus in mice, a region implicated in the pathology of psychiatric symptoms. In conclusion, we identified rs1863918 as significantly associated with IFN-induced depression, and revealed that the candidate gene ZNF354C is highly expressed in the hippocampus of mice. Our data might be useful for elucidating the pathogenic mechanisms of depression induced by drugs including IFN.	[Matsunami, Kayoko; Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Matsunami, Kayoko; Matsuura, Kentaro; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Matsunami, Kayoko; Matsuura, Kentaro; Nojiri, Shunsuke; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Nishida, Nao] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Japan; [Nishida, Nao; Toyo-oka, Licht; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Kaneko, Naoko; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Nagoya, Aichi, Japan; [Ikeo, Kazuho] Natl Inst Genet, Lab DNA Data Anal, Ctr Informat Biol, Mishima, Shizuoka, Japan; [Ikeo, Kazuho] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka, Japan; [Takeuchi, Hiroshi] Japanese Red Cross Nagoya Daini Hosp, Dept Psychiat, Nagoya, Aichi, Japan; [Tamori, Akihiro] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan; [Nomura, Hideyuki] Shin Kokura Hosp, Ctr Liver Dis, Kitakyushu, Fukuoka, Japan; [Yoshiji, Hitoshi] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara, Japan; [Imamura, Masatoshi; Masaki, Naohiko; Hayakawa, Tatsuro] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Ichikawa, Japan; [Ide, Tatsuya] Kurume Univ, Div Gastroenterol, Dept Med, Kurume, Fukuoka, Japan; [Shimada, Noritomo] Ootakanomori Hosp, Div Gastroenterol & Hepatol, Kashiwa, Chiba, Japan; [Ikeda, Fusao] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Hino, Keisuke] Kawasaki Med Coll, Div Hepatol & Pancreatol, Kurashiki, Okayama, Japan; [Nishiguchi, Shuhei] Hyogo Coll Med, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Okuse, Chiaki] St Marianna Univ, Sch Med, Dept Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan	Nagoya City University; Nagoya City University; Nagoya City University; National Center for Global Health & Medicine - Japan; University of Tokyo; Nagoya City University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japanese Red Cross Nagoya Daini Hospital; Osaka Metropolitan University; Nara Medical University; National Center for Global Health & Medicine - Japan; Kurume University; Okayama University; Kawasaki Medical School; Hyogo College of Medicine; Saint Marianna University	Tanaka, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan.; Tanaka, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan.	ytanaka@med.nagoya-cu.ac.jp	Kaneko, Naoko/P-2054-2019	Yoshiji, Hitoshi/0000-0002-5243-8544; Tanaka, Yasuhito/0000-0002-2473-6966; Kaneko, Naoko/0000-0003-3121-7117; Sawamoto, Kazunobu/0000-0003-1984-5129	Japan Agency for Medical Research and Development, AMED [16fk0210101h0001]; Grants-in-Aid for Scientific Research [26293179] Funding Source: KAKEN	Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the "Research Program on Hepatitis" from the Japan Agency for Medical Research and Development, AMED (16fk0210101h0001) to YT. http://www.amed.go.jp/.	Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT S R, 1996, MANUAL BECK DEPRESSI; Bull SJ, 2009, MOL PSYCHIATR, V14, P1095, DOI 10.1038/mp.2008.48; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Colige A, 1997, P NATL ACAD SCI USA, V94, P2374, DOI 10.1073/pnas.94.6.2374; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; Dan AA, 2006, J HEPATOL, V44, P491, DOI 10.1016/j.jhep.2005.11.046; Dieperink E, 2000, AM J PSYCHIAT, V157, P867, DOI 10.1176/appi.ajp.157.6.867; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Jheon A, 2002, J HISTOCHEM CYTOCHEM, V50, P973, DOI 10.1177/002215540205000711; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Kesteloot F, 2007, HEPATOLOGY, V46, P1620, DOI 10.1002/hep.21868; Kojima M, 2002, PSYCHIAT RES, V110, P291, DOI 10.1016/S0165-1781(02)00106-3; Kraus MR, 2007, GASTROENTEROLOGY, V132, P1279, DOI 10.1053/j.gastro.2007.02.053; Lim JH, 2014, BMB REP, V47, P405, DOI 10.5483/BMBRep.2014.47.7.075; Lotrich FE, 2009, BIOL PSYCHIAT, V65, P344, DOI 10.1016/j.biopsych.2008.08.009; Michel TM, 2012, CURR PHARM DESIGN, V18, P5890; Nelligan JA, 2008, J CLIN PSYCHIAT, V69, P810, DOI 10.4088/JCP.v69n0514; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Nomura H, 2012, HEPATOL RES, V42, P241, DOI 10.1111/j.1872-034X.2011.00930.x; Oxenkrug G, 2011, J NEURAL TRANSM, V118, P271, DOI 10.1007/s00702-010-0525-1; Polman JAE, 2013, ENDOCRINOLOGY, V154, P1832, DOI 10.1210/en.2012-2187; Polman JAE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-118; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Rosse SA, 2014, CANCER INFORM, V13, P5, DOI 10.4137/CIN.S13789; Saw WY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17855; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Stokes PE, 1995, EUR NEUROPSYCHOPHARM, V5, P77, DOI 10.1016/0924-977X(95)00039-R; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tsai SJ, 2009, PROG NEURO-PSYCHOPH, V33, P637, DOI 10.1016/j.pnpbp.2009.02.020; Watson RP, 2000, BBA-GENE STRUCT EXPR, V1490, P153, DOI 10.1016/S0167-4781(99)00239-0; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yoshida H, 2004, GUT, V53, P425, DOI 10.1136/gut.2003.030353; Yoshida K, 2005, NEUROPSYCHOBIOLOGY, V52, P55, DOI 10.1159/000086605; Zheng LS, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.015	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164418	10.1371/journal.pone.0164418	http://dx.doi.org/10.1371/journal.pone.0164418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723809	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100058
J	Santillo, AF; Lundblad, K; Nilsson, M; Waldo, ML; van Westen, D; Latt, J; Nordstrom, EB; Vestberg, S; Lindberg, O; Nilsson, C				Santillo, Alexander Frizell; Lundblad, Karl; Nilsson, Markus; Waldo, Maria Landqvist; van Westen, Danielle; Latt, Jimmy; Nordstrom, Erik Blennow; Vestberg, Susanna; Lindberg, Olof; Nilsson, Christer			Grey and White Matter Clinico-Anatomical Correlates of Disinhibition in Neurodegenerative Disease	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; FRONTOTEMPORAL DEMENTIA; BEHAVIORAL VARIANT; ORBITOFRONTAL CORTEX; INHIBITORY DYSFUNCTION; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; STRIATAL ATROPHY; SOCIAL COGNITION; HUMAN BRAIN	Disinhibition is an important symptom in neurodegenerative diseases. However, the clinico-anatomical underpinnings remain controversial. We explored the anatomical correlates of disinhibition in neurodegenerative disease using the perspective of grey and white matter imaging. Disinhibition was assessed with a neuropsychological test and a caregiver information-based clinical rating scale in 21 patients with prefrontal syndromes due to behavioural variant frontotemporal dementia (n = 12) or progressive supranuclear palsy (n = 9), and healthy controls (n = 25). Cortical thickness was assessed using the Freesurfer software on 3T MRI data. The integrity of selected white matter tracts was determined by the fractional anisotropy (FA) from Diffusion Tensor Imaging. Disinhibition correlated with the cortical thickness of the right parahippocampal gyrus, right orbitofrontal cortex and right insula and the FA of the right uncinate fasciculus and right anterior cingulum. Notably, no relationship was seen with the thickness of ventromedial prefrontal cortex. Our results support an associative model of inhibitory control, distributed in a medial temporal lobe-insular-orbitofrontal network, connected by the intercommunicating white matter tracts. This reconciles some of the divergences among previous studies, but also questions the current conceptualisation of the "prefrontal" syndrome and the central role attributed to the ventromedial prefrontal cortex in inhibitory control.	[Santillo, Alexander Frizell; Lundblad, Karl; Nilsson, Christer] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden; [Nilsson, Markus] Lund Univ, Lund Univ Bioimaging Ctr LBIC, Lund, Sweden; [Waldo, Maria Landqvist; Vestberg, Susanna] Lund Univ, Dept Clin Sci, Geriatr Psychiat Unit, Lund, Sweden; [van Westen, Danielle; Latt, Jimmy] Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden; [Nordstrom, Erik Blennow] Skane Univ Hosp, Dept Neurol & Rehabil Med, Lund, Sweden; [Vestberg, Susanna] Lund Univ, Dept Psychol, Lund, Sweden; [Lindberg, Olof] Karolinska Inst, Div Clin Geriatr, Stockholm, Sweden	Lund University; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Karolinska Institutet	Santillo, AF (corresponding author), Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden.	alexander.santillo@med.lu.se	Nordström, Erik Blennow/ABH-1339-2020; Landqvist, Maria/B-6270-2019; Nilsson, Markus/C-6920-2012	Nordström, Erik Blennow/0000-0003-1117-4412; Landqvist, Maria/0000-0003-3262-8938; van Westen, Danielle/0000-0001-8649-9874; Nilsson, Markus/0000-0002-3140-8223; Santillo, Alexander/0000-0001-9717-0820	NHS Sweden; Basal Ganglia Disorders Linneaus Consortium (BAGADILICO); MultiPark; Fromma Foundation; Fromma Foundation, The Swedish Alzheimer Foundation; Thureus's Foundation; Konsul Thure Carlssons Minne Foundation; Trolle-Wachtmeister Foundation for Medical Research; Marta Lundqvist Foundation; Swedish Research Council [521-210-3034]	NHS Sweden; Basal Ganglia Disorders Linneaus Consortium (BAGADILICO); MultiPark; Fromma Foundation; Fromma Foundation, The Swedish Alzheimer Foundation; Thureus's Foundation; Konsul Thure Carlssons Minne Foundation; Trolle-Wachtmeister Foundation for Medical Research; Marta Lundqvist Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by government funding of clinical research within NHS Sweden (ALF), The Basal Ganglia Disorders Linneaus Consortium (BAGADILICO), MultiPark, The Fromma Foundation, The Swedish Alzheimer Foundation, The Thureus's Foundation, The Konsul Thure Carlssons Minne Foundation, The Trolle-Wachtmeister Foundation for Medical Research, The Marta Lundqvist Foundation, and the Swedish Research Council Grant No 521-210-3034. The financial sponsors did not have any role in the study design, in the collection, analysis and interpretation of data, in the writing of the report, nor in the decision to submit the article for publication.	Agosta F, 2012, CEREB CORTEX, V22, P2705, DOI 10.1093/cercor/bhr288; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Bak TH, 2010, J NEUROL NEUROSUR PS, V81, P1057, DOI 10.1136/jnnp.2008.157974; Bartolomeo P, 2011, CORTEX, V47, P1010, DOI 10.1016/j.cortex.2010.11.007; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Borroni B, 2012, BEHAV BRAIN RES, V235, P124, DOI 10.1016/j.bbr.2012.08.003; Burgess P.W., 1997, HAYLING BRIXTON TEST; Canu E, 2011, MOVEMENT DISORD, V26, P1752, DOI 10.1002/mds.23739; Catani M., 2012, ATLAS HUMAN BRAIN CO, DOI [10.1093/med/9780199541164.001.0001, DOI 10.1093/MED/9780199541164.001.0001]; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2012, CORTEX, V48, P1262, DOI 10.1016/j.cortex.2012.07.001; Chiu WZ, 2012, J NEUROL NEUROSUR PS, V83, P910, DOI 10.1136/jnnp-2011-302035; Clark C, 2000, J ABNORM CHILD PSYCH, V28, P403, DOI 10.1023/A:1005176320912; Cordato NJ, 2005, BRAIN, V128, P1259, DOI 10.1093/brain/awh508; de Frias CM, 2006, NEUROPSYCHOLOGY, V20, P206, DOI 10.1037/0894-4105.20.2.206; Eslinger PJ, 2007, J NEUROL NEUROSUR PS, V78, P457, DOI 10.1136/jnnp.2006.098228; Franceschi M, 2005, ANN NEUROL, V57, P216, DOI 10.1002/ana.20365; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Ghosh BCP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074486; Gupta R, 2011, NEUROPSYCHOLOGIA, V49, P760, DOI 10.1016/j.neuropsychologia.2010.09.029; Hornberger M, 2010, DEMENT GERIATR COGN, V30, P547, DOI 10.1159/000321670; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Huey ED, 2007, CORTEX, V43, P1097, DOI 10.1016/S0010-9452(08)70710-X; Hughes LE, 2015, BRAIN, V138, P1961, DOI 10.1093/brain/awv133; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Irish M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113081; Jantscher SWU, 2011, EUROPEAN PSYCHIAT, V26, P420, DOI 10.1016/S0924-9338(11)72128-9; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Josephs KA, 2008, ANN NEUROL, V64, P4, DOI 10.1002/ana.21426; Kaat LD, 2007, NEUROLOGY, V69, P723, DOI 10.1212/01.wnl.0000267643.24870.26; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kertesz A, 2004, DEMENT GERIATR COGN, V17, P282, DOI 10.1159/000077155; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Knopman DS, 2008, BRAIN, V131, P2957, DOI 10.1093/brain/awn234; Kobylecki C, 2015, J NEUROL, V262, P916, DOI 10.1007/s00415-015-7657-z; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kvickstrom P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-13; Lagarde J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080353; Litvan I, 1996, NEUROLOGY, V47, P1184, DOI 10.1212/WNL.47.5.1184; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Macfarlane MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129692; Mahoney CJ, 2014, HUM BRAIN MAPP, V35, P4163, DOI 10.1002/hbm.22468; MARCZEWSKI P, 2001, COGNITIVE NEUROPSYCH, V6, P175, DOI DOI 10.1080/13546800042000115; Massimo L, 2009, DEMENT GERIATR COGN, V27, P96, DOI 10.1159/000194658; Mathias JL, 2010, J CLIN EXP NEUROPSYC, V32, P682, DOI 10.1080/13803390903427414; Mesulam M. M., 2000, PRINCIPLES BEHAV COG; Mesulam M, 2012, NEUROIMAGE, V62, P2182, DOI 10.1016/j.neuroimage.2011.12.033; Miller B, 2009, BEHAV NEUROLOGY DEME, DOI [10.1017/CBO9780511581410, DOI 10.1017/CBO9780511581410]; Nilsson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141825; O'Callaghan C, 2013, CORTEX, V49, P1833, DOI 10.1016/j.cortex.2012.12.003; O'Callaghan C, 2013, ALZ DIS ASSOC DIS, V27, P102, DOI 10.1097/WAD.0b013e318265bbc9; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; Olson IR, 2013, SOC COGN AFFECT NEUR, V8, P123, DOI 10.1093/scan/nss119; Peters F, 2006, DEMENT GERIATR COGN, V21, P373, DOI 10.1159/000091898; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Santillo AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066932; Sarubbo S, 2013, BRAIN STRUCT FUNCT, V218, P21, DOI 10.1007/s00429-011-0372-3; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Schroeter ML, 2014, CORTEX, V57, P22, DOI 10.1016/j.cortex.2014.02.022; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Stamelou M, 2015, PARKINSONISM RELAT D, V21, P1264, DOI 10.1016/j.parkreldis.2015.08.006; Surova Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066022; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Williams DR, 2009, LANCET NEUROL, V8, P270, DOI 10.1016/S1474-4422(09)70042-0; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Woolley JD, 2007, NEUROLOGY, V69, P1424, DOI 10.1212/01.wnl.0000277461.06713.23; Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071	77	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164122	10.1371/journal.pone.0164122	http://dx.doi.org/10.1371/journal.pone.0164122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723823	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100022
J	Tan, BSN; Kwek, J; Wong, CKE; Saner, NJ; Yap, C; Felquer, F; Morris, MB; Gardner, DK; Rathjen, PD; Rathjen, J				Tan, Boon Siang Nicholas; Kwek, Joly; Wong, Chong Kum Edwin; Saner, Nicholas J.; Yap, Charlotte; Felquer, Fernando; Morris, Michael B.; Gardner, David K.; Rathjen, Peter D.; Rathjen, Joy			Src Family Kinases and p38 Mitogen-Activated Protein Kinases Regulate Pluripotent Cell Differentiation in Culture	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PRIMITIVE ECTODERM FORMATION; WIDE RNAI SCREEN; SELF-RENEWAL; ES CELLS; MOUSE EPIBLAST; GROUND-STATE; TYROSINE KINASE; PROLINE OXIDASE; AMINO-ACID	Multiple pluripotent cell populations, which together comprise the pluripotent cell lineage, have been identified. The mechanisms that control the progression between these populations are still poorly understood. The formation of early primitive ectoderm-like (EPL) cells from mouse embryonic stem (mES) cells provides a model to understand how one such transition is regulated. EPL cells form from mES cells in response to L-proline uptake through the transporter Slc38a2. Using inhibitors of cell signaling we have shown that Src family kinases, p38 MAPK, ERK1/2 and GSK3 beta are required for the transition between mES and EPL cells. ERK1/2, c-Src and GSK3 beta are likely to be enforcing a receptive, primed state in mES cells, while Src family kinases and p38 MAPK are involved in the establishment of EPL cells. Inhibition of these pathways prevented the acquisition of most, but not all, features of EPL cells, suggesting that other pathways are required. L-proline activation of differentiation is mediated through metabolism and changes to intracellular metabolite levels, specifically reactive oxygen species. The implication of multiple signaling pathways in the process suggests a model in which the context of Src family kinase activation determines the outcomes of pluripotent cell differentiation.	[Tan, Boon Siang Nicholas; Kwek, Joly; Wong, Chong Kum Edwin; Yap, Charlotte; Gardner, David K.; Rathjen, Peter D.; Rathjen, Joy] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Tan, Boon Siang Nicholas; Felquer, Fernando; Gardner, David K.; Rathjen, Joy] Univ Melbourne, Stem Cells Australia, Parkville, Vic, Australia; [Kwek, Joly; Wong, Chong Kum Edwin; Morris, Michael B.; Rathjen, Peter D.; Rathjen, Joy] Monash Univ, Australian Stem Cell Ctr, Clayton, Vic, Australia; [Saner, Nicholas J.; Rathjen, Peter D.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Felquer, Fernando; Morris, Michael B.; Rathjen, Peter D.; Rathjen, Joy] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Rathjen, Joy] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Tan, Boon Siang Nicholas] Univ Edinburgh, Scottish Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Kwek, Joly] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Wong, Chong Kum Edwin] Univ Melbourne, Agr & Food Syst, Parkville, Vic, Australia; [Morris, Michael B.] Univ Sydney, Bosch Inst & Physiol, Sch Med Sci, Sydney, NSW, Australia	University of Melbourne; University of Melbourne; Monash University; University of Tasmania; Menzies Institute for Medical Research; University of Adelaide; University of Tasmania; University of Edinburgh; Australian Regenerative Medicine Institute; Monash University; University of Melbourne; University of Sydney	Rathjen, J (corresponding author), Univ Melbourne, Sch Biosci, Parkville, Vic, Australia.; Rathjen, J (corresponding author), Univ Melbourne, Stem Cells Australia, Parkville, Vic, Australia.; Rathjen, J (corresponding author), Monash Univ, Australian Stem Cell Ctr, Clayton, Vic, Australia.; Rathjen, J (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.; Rathjen, J (corresponding author), Univ Tasmania, Sch Med, Hobart, Tas, Australia.	joy.rathjen@utas.edu.au	Morris, Michael/AAP-6590-2021	Saner, Nicholas/0000-0002-6011-7126; Morris, Michael/0000-0002-1286-4784	University of Melbourne; Australian Stem Cell Centre, Stem Cells Australia [P019, P084]; David Hay Postgraduate Writing Up award; University of Tasmania; Endeavour International Postgraduate Research Scholarship; Melbourne International Research Scholarship; Australian Postgraduate Awards; Australian Stem Cell Centre	University of Melbourne(University of Melbourne); Australian Stem Cell Centre, Stem Cells Australia; David Hay Postgraduate Writing Up award; University of Tasmania; Endeavour International Postgraduate Research Scholarship(Australian Government); Melbourne International Research Scholarship; Australian Postgraduate Awards(Australian Government); Australian Stem Cell Centre	This work was funded by the University of Melbourne, the Australian Stem Cell Centre (funding agreements P019 and P084), Stem Cells Australia, the David Hay Postgraduate Writing Up award and the University of Tasmania. BSNT was supported by an Endeavour International Postgraduate Research Scholarship and a Melbourne International Research Scholarship. CY was supported by an Australian Postgraduate Awards with additional support from the Australian Stem Cell Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Aouadi M, 2006, STEM CELLS, V24, P1399, DOI 10.1634/stemcells.2005-0398; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barruet E, 2011, STEM CELLS DEV, V20, P1233, DOI 10.1089/scd.2010.0213; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Casalino L, 2011, J MOL CELL BIOL, V3, P108, DOI 10.1093/jmcb/mjr001; Chakraborty S, 2009, DIFFERENTIATION, V78, P143, DOI 10.1016/j.diff.2009.05.006; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Choi TG, 2011, BBA-MOL CELL RES, V1813, P1412, DOI 10.1016/j.bbamcr.2011.04.001; Comes S, 2013, STEM CELL REP, V1, P307, DOI 10.1016/j.stemcr.2013.09.001; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Donald SP, 2001, CANCER RES, V61, P1810; ERNST M, 1994, EMBO J, V13, P1574, DOI 10.1002/j.1460-2075.1994.tb06420.x; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hamilton WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060907; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Harvey NT, 2010, J CELL SCI, V123, P1796, DOI 10.1242/jcs.047530; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Hughes JN, 2009, STEM CELLS, V27, P2941, DOI 10.1002/stem.218; Hughes JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005579; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Kong L, 2011, MOL CELL BIOCHEM, V348, P11, DOI 10.1007/s11010-010-0632-1; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lake JA, 2000, J CELL SCI, V113, P555; Lee SH, 2011, J CELL PHYSIOL, V226, P1850, DOI 10.1002/jcp.22510; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Liu W, 2012, BIOFACTORS, V38, P398, DOI 10.1002/biof.1036; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Meyn MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000311; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Pelton TA, 2002, J CELL SCI, V115, P329; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Rathjen J, 1999, J CELL SCI, V112, P601; Rathjen J, 2003, METHOD ENZYMOL, V365, P3; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Rathjen J., 2014, ISRN STEM CELLS, V2014, P19, DOI [10.1155/2014/208067, DOI 10.1155/2014/208067]; Rathjen Joy, 2002, TheScientificWorldJOURNAL, V2, P690; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rodda SJ, 2002, INT J DEV BIOL, V46, P449; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Shimizu T, 2012, STEM CELLS, V30, P1394, DOI 10.1002/stem.1119; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Tamm C, 2012, EXP CELL RES, V318, P336, DOI 10.1016/j.yexcr.2011.12.008; Tan BSN, 2011, AM J PHYSIOL-CELL PH, V300, pC1270, DOI 10.1152/ajpcell.00235.2010; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Vassilieva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038645; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Washington JM, 2010, AM J PHYSIOL-CELL PH, V298, pC982, DOI 10.1152/ajpcell.00498.2009; Westerman BA, 2011, J EXP MED, V208, P2675, DOI 10.1084/jem.20102037; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu JZ, 2010, STEM CELLS DEV, V19, P1723, DOI 10.1089/scd.2010.0066; Wu JX, 1996, DEVELOPMENT, V122, P3331; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037; Yap C, 2014, J CELL SCI, V127, P2204, DOI 10.1242/jcs.134502; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]	84	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163244	10.1371/journal.pone.0163244	http://dx.doi.org/10.1371/journal.pone.0163244			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723793	Green Published, Green Accepted, gold			2022-12-27	WOS:000385504100004
J	DeLaney, E; Luse, DS				DeLaney, Elizabeth; Luse, Donal S.			Gdown1 Associates Efficiently with RNA Polymerase II after Promoter Clearance and Displaces TFIIF during Transcript Elongation	PLOS ONE			English	Article							POL-II; PREINITIATION COMPLEX; HUMAN GENES; IN-VITRO; INITIATION; DNA; PHOSPHORYLATION; TERMINATION; INSIGHTS; MEDIATOR	Pausing during the earliest stage of transcript elongation by RNA polymerase II (Pol II) is a nearly universal control point in metazoan gene expression. The substoichiometric Pol II subunit Gdown1 facilitates promoter proximal pausing in vitro in extract-based transcription reactions, out-competes the initiation/elongation factor TFIIF for binding to free Pol II and co-localizes with paused Pol II in vivo. However, we have shown that Gdown1 cannot functionally associate with the Pol II preinitiation complex (PIC), which contains TFIIF. In the present study, we determined at what point after initiation Gdown1 can associate with Pol II and how rapidly this competition with TFIIF occurs. We show that, as with the PIC, Gdown1 cannot functionally load into open complexes or complexes engaged in abortive synthesis of very short RNAs. Gdown1 can load into early elongation complexes (EECs) with 5-9 nt RNAs, but efficient association with EECs does not take place until the point at which the upstream segment of the long initial transcription bubble reanneals. Tests of EECs assembled on a series of promoter variants confirm that this bubble collapse transition, and not transcript length, modulates Gdown1 functional affinity. Gdown1 displaces TFIIF effectively from all complexes downstream of the collapse transition, but this displacement is surprisingly slow: complete loss of TFIIF stimulation of elongation requires 5 min of incubation with Gdown1. The relatively slow functional loading of Gdown1 in the presence of TFIIF suggests that Gdown1 works in promoter-proximal pausing by locking in the paused state after elongation is already antagonized by other factors, including DSIF, NELF and possibly the first downstream nucleosome.	[DeLaney, Elizabeth; Luse, Donal S.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Luse, DS (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44106 USA.	lused@ccf.org			National Science Foundation (US) [1121210]; Div Of Molecular and Cellular Bioscience [1121210] Funding Source: National Science Foundation	National Science Foundation (US)(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grant 1121210 from the National Science Foundation (US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482; Buckley MS, 2014, GENE DEV, V28, P14, DOI 10.1101/gad.231886.113; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; Cabart P, 2012, J BIOL CHEM, V287, P961, DOI 10.1074/jbc.M111.297572; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Davis MAM, 2014, J BIOL CHEM, V289, P11143, DOI 10.1074/jbc.M113.544395; Dvir A, 1996, J BIOL CHEM, V271, P23352, DOI 10.1074/jbc.271.38.23352; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Elmendorf BJ, 2001, J BIOL CHEM, V276, P23109, DOI 10.1074/jbc.M101445200; Fazal FM, 2015, NATURE, V525, P274, DOI 10.1038/nature14882; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guo JN, 2014, J BIOL CHEM, V289, P12657, DOI 10.1074/jbc.M113.537662; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jiang Y, 2004, MOL CELL, V14, P375, DOI 10.1016/S1097-2765(04)00234-5; Jishage M, 2012, MOL CELL, V45, P51, DOI 10.1016/j.molcel.2011.12.014; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; KEPHART DD, 1994, J BIOL CHEM, V269, P13536; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lei L, 1998, MOL CELL BIOL, V18, P2130, DOI 10.1128/MCB.18.4.2130; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Luse DS, 2013, BBA-GENE REGUL MECH, V1829, P63, DOI 10.1016/j.bbagrm.2012.08.010; Luse DS, 2012, TRANSCR-AUSTIN, V3, P156, DOI 10.4161/trns.20725; LUSE DS, 1987, J BIOL CHEM, V262, P14990; LUSE DS, 1987, J BIOL CHEM, V262, P289; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Murakami K, 2015, P NATL ACAD SCI USA, V112, P13543, DOI 10.1073/pnas.1518255112; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Pal M, 2001, MOL CELL BIOL, V21, P5815, DOI 10.1128/MCB.21.17.5815-5825.2001; Pal M, 2002, MOL CELL BIOL, V22, P30, DOI 10.1128/MCB.22.1.30-40.2002; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Ujvari A, 2011, J BIOL CHEM, V286, P23160, DOI 10.1074/jbc.M110.205658; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; Wu YM, 2012, EMBO J, V31, P3575, DOI 10.1038/emboj.2012.205; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	52	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163649	10.1371/journal.pone.0163649	http://dx.doi.org/10.1371/journal.pone.0163649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716820	gold, Green Published, Green Submitted			2022-12-27	WOS:000385698100009
J	McBride, RS; Ferreri, R; Towle, EK; Boucher, JM; Basilone, G				McBride, Richard S.; Ferreri, Rosalie; Towle, Emilee K.; Boucher, Jason M.; Basilone, Gualtiero			Yolked Oocyte Dynamics Support Agreement between Determinate- and Indeterminate-Method Estimates of Annual Fecundity for a Northeastern United States Population of American Shad	PLOS ONE			English	Article							ALOSA-SAPIDISSIMA; PSEUDOPLEURONECTES-AMERICANUS; CONNECTICUT RIVER; BATCH FECUNDITY; WINTER FLOUNDER; MATURITY; ATRESIA; VALIDATION; FISHES; GROWTH	Reports of American shad fecundity identify two important themes regarding egg production in fishes. First, geographic variation occurs and is biologically meaningful. Shad annual fecundity decreases with increasing latitude, but predicted lifetime fecundity does not, because of a counter-gradient of survival probability, all of which can explain the adaptive significance of natal homing. Second, the appropriate method of measuring fecundity depends on the pattern of oocyte development. Historically, the relatively simple determinate- fecundity method was used; however, a recent study in a Virginia river indicates that this method may be biased, requiring the more complicated indeterminate method. We address both themes with collections from the 2015 shad spawning run in the Connecticut River, USA. Criteria for using a determinate method were satisfied for this northern population: 1) a size gap evident in the oocyte size frequency distribution, indicating group-synchronous development of yolked oocytes; 2) a decline, early in spawning, in the standing stock of yolked oocytes; and 3) low levels of atresia at the end of spawning. The determinate- method estimate of American shad annual (2015) fecundity (303,000+/-73,400; mean +/- sd) overlapped historic estimates for this and a neighboring river. The indeterminate-method estimate of annual (2015) fecundity (311,500+/-4,500 sd) was not significantly different from the determinate-method estimate (Student's t-test, P > 0.05). In contrast, indeterminate- method estimates of annual fecundity for a Virginia population were twice as high as that measured by the determinate method in the past. This can all be explained by fundamentally different patterns of oogenesis (i.e., group synchrony versus asynchrony with respect to yolk development) at different latitudes. American shad, which is distributed within its native range from the Canadian maritimes to Florida, USA (50+/-30 degrees N), may be particularly well suited to evaluate intra-specific variation in oocyte development, a relatively unexplored life history trait.	[McBride, Richard S.] NOAA Fisheries, Northeast Fisheries Sci Ctr, Woods Hole, MA USA; [Ferreri, Rosalie; Basilone, Gualtiero] Inst Coastal Marine Environm Natl Res Council IAM, Detached Units Capo Granitola, Campobello Di Mazara, TP, Italy; [Towle, Emilee K.; Boucher, Jason M.] NOAA Fisheries Affiliates, Contract Integrated Stat, Woods Hole, MA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Ferreri, R (corresponding author), Inst Coastal Marine Environm Natl Res Council IAM, Detached Units Capo Granitola, Campobello Di Mazara, TP, Italy.	rosalia.ferreri@iamc.cnr.it	Boucher, Jason/D-9395-2017; Basilone, Gualtiero/D-2896-2017; McBride, Richard S./C-2818-2012; Ferreri, Rosalia/AAQ-8033-2020	Boucher, Jason/0000-0002-4984-7275; Basilone, Gualtiero/0000-0002-5732-5055; McBride, Richard S./0000-0003-1120-0414; Ferreri, Rosalia/0000-0001-7339-4942	Habitat Conservation Program at NOAA Fisheries' Great Atlantic Regional Fisheries Office; RITMARE Project; Italian Ministry MIUR	Habitat Conservation Program at NOAA Fisheries' Great Atlantic Regional Fisheries Office; RITMARE Project; Italian Ministry MIUR(Ministry of Education, Universities and Research (MIUR))	This research was made possible by a grant from the Habitat Conservation Program at NOAA Fisheries' Great Atlantic Regional Fisheries Office. Cooperation between IAMC-CNR and NOAA Fisheries was supported by the RITMARE Project, funded by the Italian Ministry MIUR. Funders provided support in the form of salaries [EKT, JMB] or travel funds [RF, GB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, a proposal was submitted to NOAA prior to the research, making them aware of research methods and designs.	Blaylock J, 2013, TRANSLATION MARZA VD; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Castro-Santos T, 2010, CAN J FISH AQUAT SCI, V67, P806, DOI 10.1139/F10-026; Clark F. N., 1934, Fishery Bulletin Sacramento, V42, P1; Davis W. S., 1957, Research Report U S Fish Serv, VNo. 49, P1; Duffy WJ, 2012, T AM FISH SOC, V141, P1664, DOI 10.1080/00028487.2012.720631; Elzey SP, 2015, FISH B-NOAA, V113, P47, DOI 10.7755/FB.113.1.5; Ferreri R, 2009, MAR ECOL-EVOL PERSP, V30, P181, DOI 10.1111/j.1439-0485.2009.00312.x; Ganias K, 2015, T AM FISH SOC, V144, P1143, DOI 10.1080/00028487.2015.1073620; Ganias K, 2013, FISH RES, V138, P23, DOI 10.1016/j.fishres.2012.05.006; Gordo LS, 2008, FISH RES, V89, P181, DOI 10.1016/j.fishres.2007.09.024; HUNTER JR, 1992, FISH B-NOAA, V90, P101; Hyle AR, 2014, T AM FISH SOC, V143, P618, DOI 10.1080/00028487.2013.862178; Kurita Y, 2003, J SEA RES, V49, P203, DOI 10.1016/S1385-1101(03)00004-2; Kurita Y, 2009, J SEA RES, V61, P188, DOI 10.1016/j.seares.2008.10.010; Lambert Yvan, 2009, Journal of Northwest Atlantic Fishery Science, V41, P93; LEGGETT WC, 1978, J FISH RES BOARD CAN, V35, P1469, DOI 10.1139/f78-230; Leggett WC, 2004, AM FI SOC M, V9, P181; Leggett WCG, 1969, THESIS; LEHMAN BURTON A., 1953, U S FISH AND WILDLIFE SERV RES REPT, V33, P1; Limburg KE, 2003, AM FISH S S, V35, P125; McBride RS, 2015, FISH FISH, V16, P23, DOI 10.1111/faf.12043; McElroy WD, 2016, J SEA RES, V107, P76, DOI 10.1016/j.seares.2015.06.015; McElroy WD, 2013, J SEA RES, V75, P52, DOI 10.1016/j.seares.2012.05.018; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P23, DOI 10.2960/J.v33.a2; Olney JE, 2003, AM FISH S S, V35, P185; Olney JE, 2001, B FR PECHE PISCIC, P881, DOI 10.1051/kmae:2001025; Pina T, 2003, SCI MAR, V67, P313; Press YK, 2014, J FISH BIOL, V85, P421, DOI 10.1111/jfb.12431; Saber S, 2016, FISH RES, V176, P76, DOI 10.1016/j.fishres.2015.12.013; Schismenou E, 2012, MAR BIOL, V159, P757, DOI 10.1007/s00227-011-1852-y; Thorsen A, 2001, J SEA RES, V46, P295, DOI 10.1016/S1385-1101(01)00090-9; WITTHAMES PR, 1995, AQUAT LIVING RESOUR, V8, P91, DOI 10.1051/alr:1995007	34	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164203	10.1371/journal.pone.0164203	http://dx.doi.org/10.1371/journal.pone.0164203			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716845	gold, Green Published, Green Submitted			2022-12-27	WOS:000385698100033
J	Bell, K; Fleckenstein, J; Nuesken, F; Licht, N; Rube, C; Dzierma, Y				Bell, Katharina; Fleckenstein, Jochen; Nuesken, Frank; Licht, Norbert; Ruebe, Christian; Dzierma, Yvonne			mARC Treatment of Hypopharynx Carcinoma with Flat and Flattening-Filter-Free Beam Energies - A Planning Study	PLOS ONE			English	Article							MODULATED ARC THERAPY; LINEAR-ACCELERATOR; CELL-SURVIVAL; NECK-CANCER; DOSE-RATE; IMRT; PROSTATE; VMAT; RADIOTHERAPY; DELIVERY	Background The recently implemented mARC-rotation-technique is capable to deliver high dose rate bursts. For the case of hypopharynx cancer plans we evaluate whether the mARC can achieve an advantage in treatment time in comparison to IMRT. These plans consider two arcs with flat and flattening filter free (FFF) beam energies. Materials and Methods For 8 hypopharynx-cancer patients step-and-shoot-IMRT and mARC plans were created retrospectively using flat and FFF beam energy. The comparison of the plan scenarios considered measures of quality for PTV coverage and sparing of organs at risk. All plans were irradiated on an anthromorphic phantom equipped with thermoluminescent dosimeters to measure scattered dose and treatment times. Results A visual comparison of the dose distribution did not show a marked preference for either technique or energy. The statistical evaluation yielded significant differences in favor of the mARC technique and the FFF energy. Scattered dose could be decreased markedly by the use of the mARC technique. Treatment times could be reduced up to 3 minutes with the use of mARC in comparison to IMRT. The high dose rate energy results in another time advantage of about 1 minute. Conclusions All four plan scenarios yielded equally good quality plans. A combination of the mARC technique with FFF 7 MV high dose rate resulted in a decrease of treatment times from about 9 minutes to 5-6 minutes in comparison to 6 MV IMRT.	[Bell, Katharina; Fleckenstein, Jochen; Nuesken, Frank; Licht, Norbert; Ruebe, Christian; Dzierma, Yvonne] Univ Saarland, Med Ctr, Dept Radiotherapy & Radiat Oncol, Kirrberger Str Geb 6-5, D-66421 Homburg, Germany	Saarland University	Bell, K (corresponding author), Univ Saarland, Med Ctr, Dept Radiotherapy & Radiat Oncol, Kirrberger Str Geb 6-5, D-66421 Homburg, Germany.	katharina.bell@uks.eu						Alvarez-Moret J, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-110; Bell K, 2016, PHYS MEDICA, V32, P474, DOI 10.1016/j.ejmp.2016.02.011; Cashmore J, 2011, INT J RADIAT ONCOL, V80, P1220, DOI 10.1016/j.ijrobp.2010.10.002; Dogan N, 2003, INT J RADIAT ONCOL, V57, P1480, DOI 10.1016/S0360-3016(03)01569-4; Dzierma Y, 2016, Z MED PHYS IN PRESS, DOI [10.1016/j, DOI 10.1016/J]; Dzierma Y, 2015, STRAHLENTHER ONKOL, V191, P961, DOI 10.1007/s00066-015-0889-0; Dzierma Y, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0250-2; Dzierma Y, 2014, STRAHLENTHER ONKOL, V190, P1046, DOI 10.1007/s00066-014-0662-9; Dzierma Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094371; Dzierma Y, 2014, PRACT RADIAT ONCOL, V4, pE109, DOI 10.1016/j.prro.2013.04.004; Dzierma Y, 2012, MED PHYS, V39, P2595, DOI 10.1118/1.3703835; Guckenberger M, 2009, RADIOTHER ONCOL, V93, P259, DOI 10.1016/j.radonc.2009.08.015; Kainz K, 2011, MED PHYS, V38, P5104, DOI 10.1118/1.3622612; King RB, 2013, PHYS MED BIOL, V58, pN83, DOI 10.1088/0031-9155/58/5/N83; Kragl G, 2011, Z MED PHYS, V21, P91, DOI 10.1016/j.zemedi.2010.07.003; Kry SF, 2010, PHYS MED BIOL, V55, P2155, DOI 10.1088/0031-9155/55/8/003; Lechner W, 2013, RADIOTHER ONCOL, V109, P437, DOI 10.1016/j.radonc.2013.09.020; Lohse I, 2011, RADIOTHER ONCOL, V101, P226, DOI 10.1016/j.radonc.2011.05.072; Murray LJ, 2015, PHYS MED BIOL, V60, P1237, DOI 10.1088/0031-9155/60/3/1237; Mynampati DK, 2012, J APPL CLIN MED PHYS, V13, P108, DOI 10.1120/jacmp.v13i5.3382; Salter BJ, 2011, PHYS MED BIOL, V56, P1931, DOI 10.1088/0031-9155/56/7/002; Sarkar V, 2015, J APPL CLIN MED PHYS, V16, P458, DOI 10.1120/jacmp.v16i2.5351; Sorensen BS, 2011, RADIOTHER ONCOL, V101, P223, DOI 10.1016/j.radonc.2011.06.018; Spahn U, 2013, STRAHLENTHER ONKOL, V189, P62; Stromberger C, 2016, STRAHLENTHER ONKOL, V192, P17, DOI 10.1007/s00066-015-0913-4; Teoh M, 2011, BRIT J RADIOL, V84, P967, DOI 10.1259/bjr/22373346; Vanetti E, 2009, RADIOTHER ONCOL, V92, P111, DOI 10.1016/j.radonc.2008.12.008; vantRiet A, 1997, INT J RADIAT ONCOL, V37, P731, DOI 10.1016/S0360-3016(96)00601-3; Verbakel WFAR, 2013, ACTA ONCOL, V52, P652, DOI 10.3109/0284186X.2012.737021	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164616	10.1371/journal.pone.0164616	http://dx.doi.org/10.1371/journal.pone.0164616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741272	Green Published, gold, Green Submitted			2022-12-27	WOS:000385507000046
J	Citirak, G; Cejvanovic, S; Andersen, H; Vissing, J				Citirak, Gulsenay; Cejvanovic, Sanja; Andersen, Henning; Vissing, John			Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis	PLOS ONE			English	Article							HAND-HELD DYNAMOMETRY; MUSCULAR-DYSTROPHY; RELIABILITY; MANAGEMENT; CHILDREN	Introduction The aim of this observational, cross-sectional study was to quantify the potential presence of muscle weakness among patients with generalized myasthenia gravis (gMG). The influence of gender, treatment intensity and disease duration on muscle strength and disease progression was also assessed. Methods Muscle strength was tested in 8 muscle groups by manual muscle testing and by hand-held dynamometry in 107 patients with gMG and 89 healthy age-and gender-matched controls. Disease duration, severity and treatment history were reviewed and compared with muscle strength. Results Patients had reduced strength in all tested muscle group compared to control subjects (p<0.05). Women with gMG were stronger than men (decrease in strength 22.6% vs. 32.7% in men, P<0.05). Regional differences in muscle weakness were also evident, with proximal muscles being more affected. Interestingly, muscle strength did not correlate with disease duration and treatment intensity. Conclusions The results of this study show that in patients with gMG; 1) there is significant muscle weakness, 2) muscle weakness is more pronounced in men than women, 3) shoulder abductors, hip flexors, and neck muscles are the most affected muscle groups and 4) disease duration or treatment intensity alone are not predictors of loss of muscle strength in gMG.	[Citirak, Gulsenay; Cejvanovic, Sanja; Vissing, John] Univ Copenhagen, Dept Neurol, Neuromuscular Res Unit, Rigshosp, Copenhagen, Denmark; [Andersen, Henning] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark	Rigshospitalet; University of Copenhagen; Aarhus University	Vissing, J (corresponding author), Univ Copenhagen, Dept Neurol, Neuromuscular Res Unit, Rigshosp, Copenhagen, Denmark.	john.vissing@regionh.dk		Andersen, Henning/0000-0002-9082-2694	Augustinus Foundation; National University Hospital, Rigshospitalet; Genzyme Corporation	Augustinus Foundation; National University Hospital, Rigshospitalet; Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	Gulsenay Citirak performed the studies during a scholarship year, sponsored by the Augustinus Foundation, and the study was supported financially by the National University Hospital, Rigshospitalet. Dr. Vissing is a member of Genzyme's Global Advisory Board for Pompe disease, and Drs. Andersen and Vissing have received travel grants and honoraria from Genzyme Corporation. The authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarli JA, 1999, ARCH NEUROL-CHICAGO, V56, P25, DOI 10.1001/archneur.56.1.25; BESINGER UA, 1983, NEUROLOGY, V33, P1316, DOI 10.1212/WNL.33.10.1316; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; Cejvanovic S, 2014, ACTA NEUROL SCAND, V129, P367, DOI 10.1111/ane.12193; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; El ML, 2013, AM J PHYS MED REHABI, V92, P163, DOI [10.1097/PHM.0b013e31826ed94cPMID:23051758, DOI 10.1097/PHM.0B013E31826ED94C]; ENGEL AG, 1981, ANN NY ACAD SCI, V377, P158, DOI 10.1111/j.1749-6632.1981.tb33730.x; FLORENCE JM, 1992, PHYS THER, V72, P115, DOI 10.1093/ptj/72.2.115; Hughes BW, 2004, SEMIN NEUROL, V24, P21, DOI 10.1055/s-2004-829585; Jaretzki A, 2000, ANN THORAC SURG, V70, P327, DOI 10.1016/S0003-4975(00)01595-2; Juel VC, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-44; Juel Vern C, 2005, Curr Treat Options Neurol, V7, P3, DOI 10.1007/s11940-005-0001-7; Keesey JC, 2004, MUSCLE NERVE, V29, P484, DOI 10.1002/mus.20030; Kuks JBM, 2009, MYASTHENIA GRAVIS RE, P79, DOI DOI 10.1007/978-1-59745-156-7_5; Mao ZF, 2010, EUR J NEUROL, V17, P913, DOI 10.1111/j.1468-1331.2010.03017.x; Merlini L, 2002, MUSCLE NERVE, V26, P64, DOI 10.1002/mus.10166; Nicolle MW, 2002, NEUROLOGIST, V8, P2, DOI 10.1097/00127893-200201000-00002; Ponseti JM, 2008, ANN NY ACAD SCI, V1132, P254, DOI 10.1196/annals.1405.000; Rajabally YA, 2013, J NEUROL SCI, V325, P36, DOI 10.1016/j.jns.2012.11.010; Rose KJ, 2008, MUSCLE NERVE, V37, P626, DOI 10.1002/mus.20961; Saperstein DS, 2004, SEMIN NEUROL, V24, P41, DOI 10.1055/s-2004-829586; STUBERG WA, 1988, PHYS THER, V68, P977, DOI 10.1093/ptj/68.6.977; Suh Joome, 2013, Yale Journal of Biology and Medicine, V86, P255; Symonette CJ, 2010, MUSCLE NERVE, V41, P362, DOI 10.1002/mus.21493; Tiffreau V, 2007, NEUROMUSCULAR DISORD, V17, P524, DOI 10.1016/j.nmd.2007.03.014; VANDERPLOEG RJO, 1984, J NEUROL, V231, P200	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0164092	10.1371/journal.pone.0164092	http://dx.doi.org/10.1371/journal.pone.0164092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741232	Green Submitted, Green Published, gold			2022-12-27	WOS:000385507000017
J	Redfern, J; Santo, K; Coorey, G; Thakkar, J; Hackett, M; Thiagalingam, A; Chow, CK				Redfern, Julie; Santo, Karla; Coorey, Genevieve; Thakkar, Jay; Hackett, Maree; Thiagalingam, Aravinda; Chow, Clara K.			Factors Influencing Engagement, Perceived Usefulness and Behavioral Mechanisms Associated with a Text Message Support Program	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SECONDARY PREVENTION; SMOKING-CESSATION; RISK; INTERVENTIONS; REHABILITATION; ADHERENCE; METAANALYSIS; EXERCISE	Introduction Many studies have now demonstrated the efficacy of text messaging in positively changing behaviours. We aimed to identify features and factors that explain the effectiveness of a successful text messaging program in terms of user engagement, perceived usefulness, behavior change and program delivery preferences. Methods Mixed methods qualitative design combining four data sources; (i) analytic data extracted directly from the software system, (ii) participant survey, (iii) focus groups to identify barriers and enablers to implementation and mechanisms of effect and (iv) recruitment screening logs and text message responses to examine engagement. This evaluation was conducted within the TEXT ME trial-a parallel design, single-blind randomized controlled trial (RCT) of 710 patients with coronary heart disease (CHD). Qualitative data were interpreted using inductive thematic analysis. Results 307/352 (87% response rate) of recruited patients with CHD completed the program evaluation survey at six months and 25 participated in a focus group. Factors increasing engagement included (i) ability to save and share messages, (ii) having the support of providers and family, (iii) a feeling of support through participation in the program, (iv) the program being initiated close to the time of a cardiovascular event, (v) personalization of the messages, (vi) opportunity for initial face-to-face contact with a provider and (vii) that program and content was perceived to be from a credible source. Clear themes relating to program delivery were that diet and physical activity messages were most valued, four messages per week was ideal and most participants felt program duration should be provided for at least for six months or longer. Conclusions This study provides context and insight into the factors influencing consumer engagement with a text message program aimed at improving health-related behavior. The study suggests program components that may enhance potential success but will require integration at the development stage to optimize up-scaling.	[Redfern, Julie; Santo, Karla; Coorey, Genevieve; Hackett, Maree; Chow, Clara K.] George Inst Global Hlth, Sydney, NSW, Australia; [Redfern, Julie; Santo, Karla; Coorey, Genevieve; Thakkar, Jay; Hackett, Maree; Chow, Clara K.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Thakkar, Jay; Thiagalingam, Aravinda; Chow, Clara K.] Westmead Hosp, Sydney, NSW, Australia; [Hackett, Maree] Univ Cent Lancashire, Preston, Lancs, England; [Thiagalingam, Aravinda] Westmead Inst Med Res, Sydney, NSW, Australia	George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; University of Central Lancashire; University of Sydney; Westmead Institute for Medical Research	Redfern, J (corresponding author), George Inst Global Hlth, Sydney, NSW, Australia.; Redfern, J (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	jradfern@georgeinstitute.org.au	Hackett, Maree L/O-8752-2016; Redfern, Julie/AAM-8617-2020; Coorey/AAM-1503-2021; Santo, Karla/L-2889-2016; Thakkar, Jay/H-1723-2017	Hackett, Maree L/0000-0003-1211-9087; Redfern, Julie/0000-0001-8707-5563; Santo, Karla/0000-0001-9047-8865; Thiagalingam, Aravinda/0000-0002-7763-7806; Thakkar, Jay/0000-0002-5509-6009	National Heart Foundation of Australia [G10S5110]; BUPA Health Foundation Grant; National Health and Medical Research Council (NHMRC) Career Development Fellowship [1061793]; National Heart Foundation Future Leader Fellowship [G160523, 1000034]; University of Sydney International Postgraduate Research Scholarship; University of Sydney Australian Postgraduate Award scholarship; Career Development Fellowship - NHMRC; National Heart Foundation; Sydney Medical Foundation Chapman Fellowship; Westmead Hospital Cardiologists	National Heart Foundation of Australia(National Heart Foundation of Australia); BUPA Health Foundation Grant; National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation Future Leader Fellowship(National Heart Foundation of Australia); University of Sydney International Postgraduate Research Scholarship(University of Sydney); University of Sydney Australian Postgraduate Award scholarship; Career Development Fellowship - NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia); Sydney Medical Foundation Chapman Fellowship; Westmead Hospital Cardiologists	This work is supported by a National Heart Foundation of Australia Grant-in-Aid (G10S5110) and a BUPA Health Foundation Grant. JR is funded by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (1061793) co-funded with a National Heart Foundation Future Leader Fellowship (G160523). KS is funded by a University of Sydney International Postgraduate Research Scholarship. JT is funded by a University of Sydney Australian Postgraduate Award scholarship. MH is funded by a National Heart Foundation Future Leader Fellowship (1000034). CKC is funded by a Career Development Fellowship co-funded by the NHMRC and National Heart Foundation as well as a Sydney Medical Foundation Chapman Fellowship.; We thank the Westmead Hospital Cardiologists for supporting the recruitment and TEXT ME program development at Westmead hospital: Robert Abraham, FRACP, Mikhail Altman, PhD, William Chik, PhD, James Chong, PhD, Mark Cooper, PhD, Lloyd Davis, PhD, A. Robert Denniss, PhD, Eddy Kizana, PhD, Pramesh Kovoor, PhD, Mahidi Mardini, PhD, Andrew Ong, PhD, Paul Russell, FRACP, David Ross, FRACP, Norman Sadick, PhD, Gopal Sivagangabalan, PhD, Michael Skinner, PhD, David Tanous, PhD, Timothy Tan, PhD, and Stuart Thomas, PhD.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Allan Steckler, 2002, PROCESS EVALUATION P; Austin JT, 1996, PSYCHOL BULL, V120, P338, DOI 10.1037/0033-2909.120.3.338; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Barbour R., 2007, DOING FOCUS GROUPS; Bobrow K, 2016, CIRCULATION, V133, P592, DOI 10.1161/CIRCULATIONAHA.115.017530; Briffa TG, 2011, CIRC-CARDIOVASC QUAL, V4, P107, DOI 10.1161/CIRCOUTCOMES.110.957944; Buis LR, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2929; Chow CK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000606; Chow CK, 2015, JAMA-J AM MED ASSOC, V314, P1255, DOI 10.1001/jama.2015.10945; Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523; Clark AM, 2013, SOC SCI MED, V93, P185, DOI 10.1016/j.socscimed.2012.03.035; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Free C, 2011, LANCET, V378, P49, DOI 10.1016/S0140-6736(11)60701-0; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Hurling R, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e7; Leon N, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0289-7; Martin JJ, 2020, ROUT INT HANDB, P280; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; NICE, 2007, NICE PUBL HLTH GUID; O'Cathain A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002889; Patrick K, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1100; Pavlov I.P., 1955, SELECTED WORKS; Pawson R., 1997, REALISTIC EVALUATION; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Redfern J, 2014, EUR J PREV CARDIOL, V21, P492, DOI 10.1177/2047487312449416; Redfern J, 2014, HEART, V100, P1281, DOI 10.1136/heartjnl-2013-305296; Ritchie J, 1994, QUALITATIVE DATA ANA; Scott-Sheldon LAJ, 2016, JMIR MHEALTH UHEALTH, V4, P337, DOI 10.2196/mhealth.5436; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Smith SC, 2006, AM J CARDIOL, V97, p28A, DOI 10.1016/j.amjcard.2005.11.013; Spohr SA, 2015, J SUBST ABUSE TREAT, V56, P1, DOI 10.1016/j.jsat.2015.01.011; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Walker ER, 2014, EPILEPSY BEHAV, V31, P152, DOI 10.1016/j.yebeh.2013.11.023	40	46	46	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163929	10.1371/journal.pone.0163929	http://dx.doi.org/10.1371/journal.pone.0163929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741244	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000385507000010
J	Khadka, J; Huang, JH; Chen, HS; Chen, CW; Gao, RR; Bao, FJ; Zhang, SF; Wang, QM; Pesudovs, K				Khadka, Jyoti; Huang, Jinhai; Chen, Haisi; Chen, Chengwei; Gao, Rongrong; Bao, Fangjun; Zhang, Sifang; Wang, Qinmei; Pesudovs, Konrad			Assessment of Cataract Surgery Outcome Using the Modified Catquest Short-Form Instrument in China	PLOS ONE			English	Article							VISUAL IMPAIRMENT; QUESTIONNAIRE; QUALITY; VISION; ABILITY; IMPACT; SCALE; VF-14	Purpose To assess cataract surgery outcome using the Rasch scaled Chinese version of the Catquest short-form. Methods The Chinese translated and culturally adapted version of the Catquest-9SF was interviewer- administered to patients, pre and post cataract surgery. Rasch analysis was performed on the baseline data to revise the Catquest. For the surgical outcome assessment, we stacked pre-and post-surgical Catquest data to demonstrate improvement in visual function scores and responsiveness of the instrument to cataract surgery. Results A total of 247 cataract patients (median age, 70 yrs; male 51.0%) completed the Catquest 9SF at baseline. The Catquest-9SF possessed adequate measurement precision of 2.15. No disordering of response categories were observed and all the items perfectly fit to the Rasch model except item 7 (outfit > 1.5). A slight reduction in precision was observed after removing misfitting item 7 (Catquest-8SF-CN), but the precision value was well above the acceptable value of 2.00. Notably, the instrument was well targeted (mean person location 0.30), demonstrated no evidence of multidimensionality and DIF. At 12 months post-surgery, 74 (30%) patients came for follow-up and completed the Catquest. There was a significant improvement in the Catquest scores post cataract surgery with a considerably large effect size. Conclusion The Catquest-8SF-CN demonstrated promising Rasch based psychometric properties and was highly responsive to cataract surgery.	[Khadka, Jyoti; Huang, Jinhai; Chen, Haisi; Chen, Chengwei; Gao, Rongrong; Bao, Fangjun; Zhang, Sifang; Wang, Qinmei] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Khadka, Jyoti; Huang, Jinhai; Chen, Haisi; Chen, Chengwei; Gao, Rongrong; Bao, Fangjun; Zhang, Sifang; Wang, Qinmei] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Gao, Rongrong; Wang, Qinmei] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Khadka, Jyoti; Pesudovs, Konrad] Flinders Univ South Australia, Discipline Optometry & Vis Sci, Bedford Pk, SA, Australia	Wenzhou Medical University; Wenzhou Medical University; Flinders University South Australia	Gao, RR; Wang, QM (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.; Gao, RR; Wang, QM (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.; Gao, RR; Wang, QM (corresponding author), Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China.	beargrr@163.com; wqm6@mail.eye.ac.cn	Huang, Jinhai/ABH-4519-2020; Pesudovs, Konrad/T-9403-2019; Khadka, Jyoti/P-3935-2018	Pesudovs, Konrad/0000-0002-6322-9369; Khadka, Jyoti/0000-0003-1012-2119	National Natural Science Foundation of China [81300807]; Foundation of Wenzhou City Science & Technology Bureau [Y20140705, Y20140159]; Zhejiang Provincial & Ministry of Health Research Fund For Medical Sciences [WKJ-ZJ-1530]; Scientific Research Fund of Zhejiang Provincial Kangenbei [2015ZHA-KEB206]; Science and Technology Planning Project of Zhejiang Province [2016C33082]; National Science and Technology Major Project [2014ZX09303301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Wenzhou City Science & Technology Bureau; Zhejiang Provincial & Ministry of Health Research Fund For Medical Sciences; Scientific Research Fund of Zhejiang Provincial Kangenbei; Science and Technology Planning Project of Zhejiang Province; National Science and Technology Major Project	This work was supported in part by the National Natural Science Foundation of China (81300807); Foundation of Wenzhou City Science & Technology Bureau (Y20140705, Y20140159; vegargez@gov.cn); Zhejiang Provincial & Ministry of Health Research Fund For Medical Sciences (WKJ-ZJ-1530); Scientific Research Fund of Zhejiang Provincial Kangenbei (2015ZHA-KEB206); Science and Technology Planning Project of Zhejiang Province (2016C33082); National Science and Technology Major Project (2014ZX09303301). The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	[Anonymous], 2000, Community Eye Health, V13, P17; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis JC, 2012, BMC GERIATRICS, V12; Fenwick EK, 2013, QUAL LIFE RES, V22, P1851, DOI 10.1007/s11136-012-0307-3; Fenwick EK, 2012, QUAL LIFE RES, V21, P1771, DOI 10.1007/s11136-012-0110-1; Gothwal VK, 2009, BRIT J OPHTHALMOL, V93, P1652, DOI 10.1136/bjo.2009.159806; Gothwal VK, 2011, J CATARACT REFR SURG, V37, P1208, DOI 10.1016/j.jcrs.2011.01.028; Gothwal VK, 2010, J CATARACT REFR SURG, V36, P1181, DOI 10.1016/j.jcrs.2010.01.029; Gothwal VK, 2009, CLIN EXP OPHTHALMOL, V37, P785, DOI 10.1111/j.1442-9071.2009.02133.x; Harrer A, 2013, J CATARACT REFR SURG, V39, P680, DOI 10.1016/j.jcrs.2012.11.028; Kassebaum NJ, 2014, LANCET, V384, P2209, DOI 10.1016/S0140-6736(14)62425-9; Khadka J, 2016, OPTOM IN PRESS  0623; Khadka J, 2016, OPTOM IN PRESS  0610; Khadka J, 2013, J GLAUCOMA, V2, DOI [10.1097/IJG.1090b1013e318287ac318211, DOI 10.1097/IJG.1090B1013E318287AC318211]; Khadka J, 2014, INVEST OPHTH VIS SCI, V55, P4413, DOI 10.1167/iovs.14-14017; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Khadka J, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-80; Khadka J, 2012, INVEST OPHTH VIS SCI, V53, P4042, DOI 10.1167/iovs.12-9728; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; Khadka J, 2010, BRIT J OPHTHALMOL, V94, P730, DOI 10.1136/bjo.2009.171181; Lamoureux EL, 2006, INVEST OPHTH VIS SCI, V47, P4732, DOI 10.1167/iovs.06-0220; Limburg H, 1996, World Health Forum, V17, P15; Lin XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103860; Linacre J.M., 2002, RASCH MEAS T, V16, P878; Lundstrom M, 2006, J CATARACT REFR SURG, V32, P826, DOI 10.1016/j.jcrs.2006.01.075; Lundstrom M, 2011, ACTA OPHTHALMOL, V89, P718, DOI 10.1111/j.1755-3768.2009.01801.x; Lundstrom M, 2011, J CATARACT REFR SURG, V37, P945, DOI 10.1016/j.jcrs.2011.03.010; Lundstrom M, 2009, J CATARACT REFR SURG, V35, P504, DOI 10.1016/j.jcrs.2008.11.038; McAlinden C, 2011, OPHTHALMOLOGY, V118, P2374, DOI 10.1016/j.ophtha.2011.06.008; Mollazadegan K, 2014, J CATARACT REFR SURG, V40, P774, DOI 10.1016/j.jcrs.2013.10.040; Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732; Norman GR, 2007, QUAL LIFE RES, V16, P815, DOI 10.1007/s11136-007-9180-x; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pesudovs K, 2003, INVEST OPHTH VIS SCI, V44, P2892, DOI 10.1167/iovs.02-1075; Pesudovs K, 2010, BRIT J OPHTHALMOL, V94, P777, DOI 10.1136/bjo.2009.169490; Pesudovs K, 2010, OPTOMETRY VISION SCI, V87, P285, DOI 10.1097/OPX.0b013e3181d408d7; Ren Xue-tao, 2015, Chinese Medical Sciences Journal, V30, P1; Revicki DA, 2007, LANCET, V369, P540, DOI 10.1016/S0140-6736(07)60250-5; Skiadaresi E, 2012, ARCH OPHTHALMOL-CHIC, V130, P1377, DOI 10.1001/archophthalmol.2012.1603; Smith RM, 1995, USING ITEM MEAN SQUA; Soper DS, 2016, POSTHOC STAT POWER C; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P630, DOI 10.1001/archopht.1994.01090170074026; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Weigle S.C., 2002, ASSESS WRIT; World Health Organization, 2012, GLOB DAT VIS IMP; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124; Wright BD, 2003, RASCH MEAS T, P17905; Yin QX, 2009, INVEST OPHTH VIS SCI, V50, P1069, DOI 10.1167/iovs.08-2783; Zhao JL, 2010, OPHTHALMOLOGY, V117, P2120, DOI 10.1016/j.ophtha.2010.03.005; Zhu MM, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-3	50	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164182	10.1371/journal.pone.0164182	http://dx.doi.org/10.1371/journal.pone.0164182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736889	gold, Green Published, Green Submitted			2022-12-27	WOS:000385505800045
J	Storck, M; Krumm, R; Dugas, M				Storck, Michael; Krumm, Rainer; Dugas, Martin			ODMSummary: A Tool for Automatic Structured Comparison of Multiple Medical Forms Based on Semantic Annotation with the Unified Medical Language System	PLOS ONE			English	Article							CLINICAL-RESEARCH; SECONDARY USE; TERMINOLOGY; CHALLENGES; STANDARDS; CANCER; MODELS; ODM	Introduction Medical documentation is applied in various settings including patient care and clinical research. Since procedures of medical documentation are heterogeneous and developed further, secondary use of medical data is complicated. Development of medical forms, merging of data from different sources and meta-analyses of different data sets are currently a predominantly manual process and therefore difficult and cumbersome. Available applications to automate these processes are limited. In particular, tools to compare multiple documentation forms are missing. The objective of this work is to design, implement and evaluate the new system ODMSummary for comparison of multiple forms with a high number of semantically annotated data elements and a high level of usability. Methods System requirements are the capability to summarize and compare a set of forms, enable to estimate the documentation effort, track changes in different versions of forms and find comparable items in different forms. Forms are provided in Operational Data Model format with semantic annotations from the Unified Medical Language System. 12 medical experts were invited to participate in a 3-phase evaluation of the tool regarding usability. Results ODMSummary (available at https://odmtoolbox.uni-muenster.de/summary/summary.html) provides a structured overview of multiple forms and their documentation fields. This comparison enables medical experts to assess multiple forms or whole datasets for secondary use. System usability was optimized based on expert feedback. Discussion The evaluation demonstrates that feedback from domain experts is needed to identify usability issues. In conclusion, this work shows that automatic comparison of multiple forms is feasible and the results are usable for medical experts.	[Storck, Michael; Krumm, Rainer; Dugas, Martin] Univ Munster, Inst Med Informat, Munster, Germany	University of Munster	Storck, M (corresponding author), Univ Munster, Inst Med Informat, Munster, Germany.	michael.storck@uni-muenster.de	Storck, Michael/A-7752-2013	Storck, Michael/0000-0002-8160-0184	Ministry of Health, Equalities, Care and Ageing of the State of Northrhine-Westphalia (MGEPA) [005-GW02-024F]	Ministry of Health, Equalities, Care and Ageing of the State of Northrhine-Westphalia (MGEPA)	This work was supported by Ministry of Health, Equalities, Care and Ageing of the State of Northrhine-Westphalia (MGEPA http://www.mgepa.nrw.de/) Grant ID: 005-GW02-024F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 111793 ISOIEC; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Baorto D, 2009, J BIOMED INFORM, V42, P494, DOI 10.1016/j.jbi.2009.03.005; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Breil B, 2012, APPL CLIN INFORM, V3, P276, DOI 10.4338/ACI-2012-03-RA-0011; Brookes AJ, 2015, NAT REV GENET, V16, P702, DOI 10.1038/nrg3932; Clinical Data Interchange Standards Consortium, ODM VERS 1 3 1; Clinical Data Interchange Standards Consortium, ODM VERS 1 3 2; Clinical Data Interchange Standards Consortium (CDISC), 2013, ODM CERT ARCH INT ME; Dugas M, 2015, METHOD INFORM MED, V54, P376, DOI 10.3414/ME15-05-0007; Dugas M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0164-9; Dugas M, 2016, DATABASE-OXFORD, DOI 10.1093/database/bav121; Dugas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067883; Dugas M, 2009, J AM MED INFORM ASSN, V16, P400, DOI 10.1197/jamia.M2882; FDA, FDA TEST REP DS XML; Huser V, 2015, J BIOMED INFORM, V57, P88, DOI 10.1016/j.jbi.2015.06.023; Jiang G, 2015, METHOD INFORM MED, V54, P65, DOI 10.3414/ME13-02-0019; Krumm R, 2014, J BIOMED INFORM, V51, P86, DOI 10.1016/j.jbi.2014.04.008; Nadkarni PM, 2006, METHOD INFORM MED, V45, P594; Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273; Saitwal H, 2012, J BIOMED INFORM, V45, P613, DOI 10.1016/j.jbi.2012.06.005; University Princeton, WORDNET	22	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164569	10.1371/journal.pone.0164569	http://dx.doi.org/10.1371/journal.pone.0164569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736972	gold, Green Submitted, Green Published			2022-12-27	WOS:000385505800087
J	Waaijer, CJF; Sonneveld, H; Buitendijk, SE; van Bochove, CA; van der Weijden, ICM				Waaijer, Cathelijn J. F.; Sonneveld, Hans; Buitendijk, Simone E.; van Bochove, Cornelis A.; van der Weijden, Inge C. M.			The Role of Gender in the Employment, Career Perception and Research Performance of Recent PhD Graduates from Dutch Universities	PLOS ONE			English	Article							WOMENS UNDERREPRESENTATION; JOB-SATISFACTION; PRODUCTIVITY; MOBILITY; SCIENCE; TENURE; IMPACT	Recent decades have seen a sharp increase in the number of female PhD graduates in the Netherlands. Currently, the share of females among newly graduated PhDs is almost on par with that of males. A considerable body of scientific studies has investigated the role of gender in the academic workplace. However, the role of gender in the careers of all PhD graduates, including those outside academia, has been studied less. In this study, we investigate gender differences in type of job, occupation, career perception and research performance of recent PhDs. The study is based on a survey of persons who obtained a PhD from one of five Dutch universities between 2008 and early 2012. We show that gender differences in post-PhD careers are non-existent in some aspects studied, but there are small differences in other aspects, such as sector of employment, type of contract, involvement in teaching and management, and career perception. In contrast, male and female PhDs differ sharply on two factors. The first is field of PhD, females being heavily underrepresented in engineering and the natural sciences. The second is part-time employment, females being much more likely to work part-time than males, especially if they work in the Netherlands. In later career stages, the combination of the small and large differences can be presumed to affect the career progression of female PhDs through cumulative disadvantage.	[Waaijer, Cathelijn J. F.; van Bochove, Cornelis A.; van der Weijden, Inge C. M.] Leiden Univ, Fac Social & Behav Sci, Ctr Sci & Technol Studies, Leiden, Netherlands; [Sonneveld, Hans] Netherlands Ctr Grad & Res Sch, Amsterdam, Netherlands; [Sonneveld, Hans] Tilburg Univ, Tilburg Law Sch, Tilburg, Netherlands; [Buitendijk, Simone E.] Leiden Univ, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Tilburg University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Waaijer, CJF (corresponding author), Leiden Univ, Fac Social & Behav Sci, Ctr Sci & Technol Studies, Leiden, Netherlands.	cathelijnwaaijer@gmail.com		Waaijer, Cathelijn/0000-0002-1192-4909; van der Weijden, Inge/0000-0001-5255-3430				[Anonymous], 2015, CBS STAT HOG OND ING; [Anonymous], 2012, FEM MAL SHAR PART TI; Auriol L., 2013, CAREERS DOCTORATE HO; Austen S, 2004, AUSTR B LABOUR, V30, P113; Baker M, 2010, J SOCIOL, V46, P317, DOI 10.1177/1440783310371402; Bellas ML, 1999, REV HIGH EDUC, V22, P367; Bender KA, 2006, SCOT J POLIT ECON, V53, P253, DOI 10.1111/j.1467-9485.2006.00379.x; Blickenstaff JC, 2005, GENDER EDUC, V17, P369, DOI 10.1080/09540250500145072; Bloch C, 2015, RES EVALUAT, V24, P171, DOI 10.1093/reseval/rvv004; Bordons M, 2003, SCIENTOMETRICS, V57, P159, DOI 10.1023/A:1024181400646; Bosch N., 2009, FEMALE PART TIME WOR; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Cooray A, 2014, APPL ECON, V46, P2441, DOI 10.1080/00036846.2014.904496; de Goede M., 2014, PROMOVEREN NEDERLAND; Dever M., 2008, GENDER DIFFERENCES E; European Commission, 2015, SHE FIG 2015 GEND RE; European Research Council, 2014, GEN STAT; Fox MF, 2001, SOC STUD SCI, V31, P109, DOI 10.1177/030631201031001006; Ginther D., 2009, SCI ENG CAREERS US A, P163, DOI DOI 10.7208/CHICAGO/9780226261904.003.0006; Hango, 2013, GENDER DIFFERENCES S; Hessels L. K., 2013, TALENT CENTRAAL ONTW; Hoobler JM, 2011, ORGAN DYN, V40, P151, DOI 10.1016/j.orgdyn.2011.04.001; Hoyem Tom., 2007, BERLINGSKE TIDE 0109; International Labour Organization, 2008, INT STAND CLASS OCC; Jacobs JA, 1996, ANNU REV SOCIOL, V22, P153, DOI 10.1146/annurev.soc.22.1.153; Kaminski D, 2012, SCIENCE, V335, P864, DOI 10.1126/science.1214844; Landelijk Netwerk Vrouwelijke Hoogleraren, 2015, MON VROUW HOOGL 2015; Lariviere V, 2011, SCIENTOMETRICS, V87, P483, DOI 10.1007/s11192-011-0369-y; Maas B, 2014, CAREERS DOCTORATE HO; Maes Katrien, 2012, WOMEN RES U EXCELLEN; Mandel H, 2013, SOC FORCES, V91, P1183, DOI 10.1093/sf/sot018; Miller DI, 2015, J EDUC PSYCHOL, V107, P631, DOI 10.1037/edu0000005; Ministerie van Sociale Zaken en Werkgelegenheid, 2014, MON ARB; [National Science Foundation National Center for Science and Engineering Statistics], 2015, 15311 NSF NAT CTR SC; Netherlands Institute for Social Researh/Statistics Netherland, 2014, EM 2014; OECD, 2002, FRASC MAN PROP STAND; Portegijs Wil, 2006, HOE WERKT MET KINDER; Prpic K, 2002, SCIENTOMETRICS, V55, P27, DOI 10.1023/A:1016046819457; Schuster J. K., 2006, AM FACULTY RESTRUCTU; Shen H, 2013, NATURE, V495, P22, DOI [10.1038/495022a, 10.1038/495021a]; Sowell, 2010, 2010 NC STATE GRADUA; Statistics Netherlands, 2014, EMANCIPATIEMONITOR 2; Statistics Netherlands, 2014, AANT GEPR VROUW NEEM; Steinpreis RE, 1999, SEX ROLES, V41, P509, DOI 10.1023/A:1018839203698; Stephan P, 2014, A YOUNG SCH POLICY S; Van Arensbergen P, 2014, THESIS; van den Besselaar P, 2016, SCIENTOMETRICS, V106, P143, DOI 10.1007/s11192-015-1775-3; van den Brink M, 2012, ORGANIZATION, V19, P507, DOI 10.1177/1350508411414293; van den Brink M, 2012, GENDER WORK ORGAN, V19, P71, DOI 10.1111/j.1468-0432.2011.00566.x; Van der Brink M., 2006, EMPL RELAT, V28, P523, DOI DOI 10.1108/01425450610704470; van der Lee R, 2015, P NATL ACAD SCI USA, V112, P12349, DOI 10.1073/pnas.1510159112; Van der Steeg M, 2014, INDIVIDUAL RETURNS P; Visser J, 2002, J EUR SOC POLICY, V12, P23, DOI 10.1177/0952872002012001561; Volker B, 2015, P NATL ACAD SCI USA, V112, pE7036, DOI 10.1073/pnas.1519046112; Waaijer C. J., 2015, SURVEY LABOUR MARKET; Waaijer CJF, 2017, HIGH EDUC, V74, P321, DOI 10.1007/s10734-016-0050-8; Ward ME, 2001, SCOT J POLIT ECON, V48, P283, DOI 10.1111/1467-9485.00199	57	10	10	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164784	10.1371/journal.pone.0164784	http://dx.doi.org/10.1371/journal.pone.0164784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736968	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505800129
J	Chung, WJ; Goeckeler-Fried, JL; Havasi, V; Chiang, A; Rowe, SM; Plyler, ZE; Hong, JS; Mazur, M; Piazza, GA; Keeton, AB; White, EL; Rasmussen, L; Weissman, AM; Denny, RA; Brodsky, JL; Sorscher, EJ				Chung, W. Joon; Goeckeler-Fried, Jennifer L.; Havasi, Viktoria; Chiang, Annette; Rowe, Steven M.; Plyler, Zackery E.; Hong, Jeong S.; Mazur, Marina; Piazza, Gary A.; Keeton, Adam B.; White, E. Lucile; Rasmussen, Lynn; Weissman, Allan M.; Denny, R. Aldrin; Brodsky, Jeffrey L.; Sorscher, Eric J.			Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics	PLOS ONE			English	Article							DELTA-F508 CFTR; IN-VITRO; MUTANT PROTEIN; PHE508DEL CFTR; MESSENGER-RNA; DEGRADATION; MUTATION; PROTEASOME; IVACAFTOR; RESCUE	Small molecules that correct the folding defects and enhance surface localization of the F508del mutation in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) comprise an important therapeutic strategy for cystic fibrosis lung disease. However, compounds that rescue the F508del mutant protein to wild type (WT) levels have not been identified. In this report, we consider obstacles to obtaining robust and therapeutically relevant levels of F508del CFTR. For example, markedly diminished steady state amounts of F508del CFTR compared to WT CFTR are present in recombinant bronchial epithelial cell lines, even when much higher levels of mutant transcript are present. In human primary airway cells, the paucity of Band B F508del is even more pronounced, although F508del and WT mRNA concentrations are comparable. Therefore, to augment levels of "repairable" F508del CFTR and identify small molecules that then correct this pool, we developed compound library screening protocols based on automated protein detection. First, cell-based imaging measurements were used to semi-quantitatively estimate distribution of F508del CFTR by high content analysis of two-dimensional images. We evaluated similar to 2,000 known bioactive compounds from the NIH Roadmap Molecular Libraries Small Molecule Repository in a pilot screen and identified agents that increase the F508del protein pool. Second, we analyzed similar to 10,000 compounds representing diverse chemical scaffolds for effects on total CFTR expression using a multi-plate fluorescence protocol and describe compounds that promote F508del maturation. Together, our findings demonstrate proof of principle that agents identified in this fashion can augment the level of endoplasmic reticulum (ER) resident "Band B" F508del CFTR suitable for pharmacologic correction. As further evidence in support of this strategy, PYR-41 D a compound that inhibits the E1 ubiquitin activating enzyme D was shown to synergistically enhance F508del rescue by C18, a small molecule corrector. Our combined results indicate that increasing the levels of ER-localized CFTR available for repair provides a novel route to correct F508del CFTR.	[Chung, W. Joon; Havasi, Viktoria; Rowe, Steven M.; Plyler, Zackery E.; Hong, Jeong S.; Mazur, Marina] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL USA; [Chung, W. Joon] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Goeckeler-Fried, Jennifer L.; Chiang, Annette; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Rowe, Steven M.; Hong, Jeong S.] Univ Alabama Birmingham, Dept Cellular Dev & Integrat Biol, Birmingham, AL USA; [Piazza, Gary A.; Keeton, Adam B.] Univ S Alabama, USA Mitchell Canc Inst, Oncol Sci, Mobile, AL 36688 USA; [White, E. Lucile; Rasmussen, Lynn] Southern Res Inst, Drug Discovery Div, Birmingham, AL 35255 USA; [Weissman, Allan M.] NIH, Ctr Canc Res, Frederick, MD USA; [Denny, R. Aldrin] Pfizer, Worldwide Med Chem, Cambridge, MA USA; [Sorscher, Eric J.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pfizer; Emory University	Sorscher, EJ (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.	esorscher@emory.edu	Havasi, Viktoria/B-1309-2009	Goeckeler-Fried, Jennifer/0000-0001-5940-9917; Piazza, Gary/0000-0003-4418-887X; Sorscher, Eric J./0000-0001-9341-3354	Cystic Fibrosis Foundation [SORSCH05XXO, BRODSK13XX0]; National Institutes of Health [P30DK072482, DK79307]; Center for Cancer Research; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC009392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, P30DK079307] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Cystic Fibrosis Foundation grant to EJS, SORSCH05XXO, cff.org; National Institutes of Health grant to EJS, P30DK072482, nih.gov; Center for Cancer Research, National Cancer Institute, National Institutes of Health grant to AMW, ccr.cancer.gov; Cystic Fibrosis Foundation grant to JLB, BRODSK13XX0; and National Institutes of Health grant to JLB, DK79307, nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; [Anonymous], 2013, NAT CHEM BIOL, V9, P444, DOI 10.1038/; [Anonymous], 2012, CELL, V148, P164; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Boinot C, 2014, J PHARMACOL EXP THER, V350, P624, DOI 10.1124/jpet.114.214890; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Boyle MP, 2012, 26 ANN N AM CYST FIB; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Brown D, 2003, DRUG DISCOV TODAY, V8, P1067, DOI 10.1016/S1359-6446(03)02902-7; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chung WJ, 2012, PEDIATR PULM, V47, P204; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; Helfand C, 2016, FIERCEPHARMA, V8, P16; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mendoza Juan L, 2012, CELL, V148, P164, DOI [10.1016/j.cell.2011.11.023, DOI 10.1016/J.CELL.2011.11.023]; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Okiyoneda T, 2012, J CELL BIOL, V199, P199, DOI 10.1083/jcb.201208083; Pedemonte N, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00175; Prokofjeva MM, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-1; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stanke F, 2008, J MED GENET, V45, P47, DOI 10.1136/jmg.2007.053561; Tomati V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12138; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	50	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0163615-	10.1371/journal.pone.0163615	http://dx.doi.org/10.1371/journal.pone.0163615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732613	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505300023
J	Lorenz, JH				Lorenz, Jan-Hendrik			Completion Probabilities and Parallel Restart Strategies under an Imposed Deadline	PLOS ONE			English	Article								Let A be any fixed cut-off restart algorithm running in parallel on multiple processors. If the algorithm is only allowed to run for up to time D, then it is no longer guaranteed that a result can be found. In this case, the probability of finding a solution within the time D becomes a measure for the quality of the algorithm. In this paper we address this issue and provide upper and lower bounds for the probability of A finding a solution before a deadline passes under varying assumptions. We also show that the optimal restart times for a fixed cut-off algorithm running in parallel is identical for the optimal restart times for the algorithm running on a single processor. Finally, we conclude that the odds of finding a solution scale superlinearly in the number of processors.	[Lorenz, Jan-Hendrik] Univ Ulm, Inst Theoret Informat, D-89069 Ulm, Germany	Ulm University	Lorenz, JH (corresponding author), Univ Ulm, Inst Theoret Informat, D-89069 Ulm, Germany.	jan-hendrik.lorenz@uni-ulm.de						Battiti R., 2009, OPERATIONS RES COMPU, V45; Cire AA, 2014, AAAI CONF ARTIF INTE, P842; Hoos H.H., 2000, SATLIB ONLINE RESOUR, P283; LUBY M, 1993, INFORM PROCESS LETT, V47, P173, DOI 10.1016/0020-0190(93)90029-9; Luby M., 1994, LECT NOTES COMPUTER, V775, P461; Sheskin D. J, 2007, HDB PARAMETRIC NONPA, VFourth; Shylo OV, 2011, OPER RES LETT, V39, P49, DOI 10.1016/j.orl.2010.10.003; Shylo OV, 2011, PARALLEL COMPUT, V37, P60, DOI 10.1016/j.parco.2010.08.004; van Moorsel A P, 2004, P 12 GI ITG C MEAS M, P155; van Moorsel APA, 2004, INT CONF QUANT EVAL, P195; Wu H, 2006, THESIS	11	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164605	10.1371/journal.pone.0164605	http://dx.doi.org/10.1371/journal.pone.0164605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732631	Green Published, Green Submitted, gold			2022-12-27	WOS:000385505300067
J	Hatch, RJ; Leinenga, G; Gotz, J				Hatch, Robert John; Leinenga, Gerhard; Gotz, Jurgen			Scanning Ultrasound (SUS) Causes No Changes to Neuronal Excitability and Prevents Age-Related Reductions in Hippocampal CA1 Dendritic Structure in Wild-Type Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; FOCUSED ULTRASOUND; ALZHEIMERS-DISEASE; MOUSE MODEL; PULSED ULTRASOUND; MICROBUBBLES; NEUROGENESIS; DYSFUNCTION; DISRUPTION; RETRIEVAL	Scanning ultrasound (SUS) is a noninvasive approach that has recently been shown to ameliorate histopathological changes and restore memory functions in an Alzheimer's disease mouse model. Although no overt neuronal damage was reported, the short-and long-term effects of SUS on neuronal excitability and dendritic tree morphology had not been investigated. To address this, we performed patch-clamp recordings from hippocampal CA1 pyramidal neurons in wild-type mice 2 and 24 hours after a single SUS treatment, and one week and 3 months after six weekly SUS treatments, including sham treatments as controls. In both treatment regimes, no changes in CA1 neuronal excitability were observed in SUS-treated neurons when compared to sham-treated neurons at any time-point. For the multiple treatment groups, we also determined the dendritic morphology and spine densities of the neurons from which we had recorded. The apical trees of sham-treated neurons were reduced at the 3 month time-point when compared to one week; however, surprisingly, no longitudinal change was detected in the apical dendritic trees of SUS-treated neurons. In contrast, the length and complexity of the basal dendritic trees were not affected by SUS treatment at either time-point. The apical dendritic spine densities were reduced, independent of the treatment group, at 3 months compared to one week. Collectively, these data suggest that ultrasound can be employed to prevent an age-associated loss of dendritic structure without impairing neuronal excitability.	[Hatch, Robert John; Leinenga, Gerhard; Gotz, Jurgen] Univ Queensland, Clem Jones Ctr Ageing Dementia Res, Queensland Brain Inst, St Lucia Campus, Brisbane, Qld 4072, Australia	University of Queensland	Gotz, J (corresponding author), Univ Queensland, Clem Jones Ctr Ageing Dementia Res, Queensland Brain Inst, St Lucia Campus, Brisbane, Qld 4072, Australia.	j.goetz@uq.edu.au	Götz, Jürgen/C-2448-2014	Götz, Jürgen/0000-0001-8501-7896; Leinenga, Gerhard/0000-0002-3149-0909; Hatch, Robert/0000-0001-7119-5990	Australian Research Council [DP130101932]; National Health and Medical Research Council of Australia [GNT1037746, GNT1003150]; Australian Research Council Linkage Infrastructure, Equipment and Facilities scheme [LE100100074]	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Linkage Infrastructure, Equipment and Facilities scheme(Australian Research Council)	This work was supported by the Estate of Dr Clem Jones AO and by grants from the Australian Research Council [DP130101932], the National Health and Medical Research Council of Australia [GNT1037746, GNT1003150] and the Australian Research Council Linkage Infrastructure, Equipment and Facilities scheme [LE100100074]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes C. A., 2000, Neural Plasticity, V7, P167, DOI 10.1155/NP.2000.167; BARNES CA, 1992, HIPPOCAMPUS, V2, P457, DOI 10.1002/hipo.450020413; Baseri B, 2010, ULTRASOUND MED BIOL, V36, P1445, DOI 10.1016/j.ultrasmedbio.2010.06.005; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Burgess A, 2014, RADIOLOGY, V273, P736, DOI 10.1148/radiol.14140245; Burgess A, 2014, J CONTROL RELEASE, V192, P243, DOI 10.1016/j.jconrel.2014.07.051; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Chen ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5486; de Brabander JM, 1998, EUR J NEUROSCI, V10, P1261; Downs ME, 2015, SCI REP-UK, V5, DOI 10.1038/srep15076; Downs ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125911; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Hatch RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52877; Hong S, 2016, SCIENCE; Jordao JF, 2013, EXP NEUROL, V248, P16, DOI 10.1016/j.expneurol.2013.05.008; Kabaso D, 2009, CEREB CORTEX, V19, P2248, DOI 10.1093/cercor/bhn242; Kerrigan TL, 2014, NEUROPHARMACOLOGY, V79, P515, DOI 10.1016/j.neuropharm.2013.09.004; Konofagou EE, 2012, THERANOSTICS, V2, P1223, DOI 10.7150/thno.5576; Leinenga G, 2016, NAT REV NEUROL, V12, P161, DOI 10.1038/nrneurol.2016.13; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Lin WT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09671; Markham JA, 2005, HIPPOCAMPUS, V15, P97, DOI 10.1002/hipo.20034; Matamales M, 2016, NEURON, V90, P362, DOI 10.1016/j.neuron.2016.03.006; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; MERVIS R, 1978, EXP NEUROL, V62, P417, DOI 10.1016/0014-4886(78)90065-1; NAKAMURA S, 1985, ACTA NEUROPATHOL, V65, P281, DOI 10.1007/BF00687009; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pyapali GK, 1996, NEUROBIOL AGING, V17, P601; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Scarcelli T, 2014, BRAIN STIMUL, V7, P304, DOI 10.1016/j.brs.2013.12.012; SCHEIBEL ME, 1975, EXP NEUROL, V47, P392, DOI 10.1016/0014-4886(75)90072-2; Shimada A, 2006, NEUROPATH APPL NEURO, V32, P1, DOI 10.1111/j.1365-2990.2006.00632.x; Siskova Z, 2014, NEURON, V84, P1023, DOI 10.1016/j.neuron.2014.10.024; Stuart GJ, 2015, NAT NEUROSCI, V18, P1713, DOI 10.1038/nn.4157; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008	41	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0164278	10.1371/journal.pone.0164278	http://dx.doi.org/10.1371/journal.pone.0164278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727310	Green Published, gold			2022-12-27	WOS:000385504400025
J	Liu, ZJ; Chen, HX; Chen, XL; Gao, JM; Guo, ZJ				Liu, Zhongjuan; Chen, Huaxia; Chen, Xiaolan; Gao, Jinming; Guo, Zijian			Characteristics of Allergic Pulmonary Inflammation in CXCR3Knockout Mice Sensitized and Challenged with House Dust Mite Protein	PLOS ONE			English	Article							ASTHMA; CXCR3; RESPONSES; SEVERITY; LIGANDS; ADULTS; CXCL9	Chemokine C-X-C motif receptor 3 (CXCR3) is a chemokine receptor that is mainly expressed by activated T lymphocytes. T cells play important roles in allergic pulmonary inflammation, which is a hallmark of asthma and elicits the localized accumulation of activated T cells in the lung. In China, a marked increase in the incidence rate of chronic allergic pulmonary inflammation has made it a major public health threat. In the present study, we investigated the role of CXCR3 and its ligands in airway inflammation induced by house dust mite protein (HDMP) in a CXCR3 knockout (CXCR3KO) asthma mouse model. Pathological manifestations in the lung, cell counts and bronchoalveolar lavage fluid (BALF) classifications were studied using hematoxylin and eosin (H&E) staining. The levels of IL-4 and IFN-gamma in the BALF and splenocyte supernatants were measured using ELISA. CD4(+) and CD8(+) T cells in the lung and spleen were analyzed by flow cytometry. RT-PCR was applied to measure the mRNA transcript levels of monokines induced by IFN-gamma (CXCL9)and IFN-gamma inducible protein 10(CXCL10). The total cell counts, eosinophil counts, and IL-4 levels in the BALF and cultured splenocyte supernatants were significantly increased, while the levels of IFN-gamma were reduced in the HDMP groups(P< 0.01). Changes in the total cell counts, eosinophil counts, and lymphocyte counts, as well as the total protein levels in the BALF, the levels of IL-4 in splenocyte supernatants, and the pathological manifestations in the lung, were all greater in CXCR3KO mice than in C57BL/6 wild-type mice. Furthermore, the expression levels of CXCL9 and CXCL10 mRNA transcripts in the lungs of CXCR3KO mice were lower than those in C57BL/6 wild-type mice (P< 0.05). CXCR3 and its ligands (i.e., CXCL9 and CXCL10) may play anti-inflammatory roles in this animal model. Promoting the expression of CXCR3 and its ligands may represent a novel therapeutic approach for preventing and curing asthma.	[Liu, Zhongjuan; Guo, Zijian] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Lab Med, Beijing, Peoples R China; [Chen, Huaxia; Chen, Xiaolan; Gao, Jinming] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Dis, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Guo, ZJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Lab Med, Beijing, Peoples R China.; Gao, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Dis, Beijing, Peoples R China.	gaojm@pumch.cn; guozj@pumch.cn			National Natural Science Foundation of China [30470768, 30470767]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by The National Natural Science Foundation of China, Website:http://www.nsfc.gov.cn/, grant number: ZJG 30470768; JMG 30470767	Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bochner BS, 2003, J ALLERGY CLIN IMMUN, V112, P930, DOI 10.1016/j.jaci.2003.08.012; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; [陈华夏 CHEN Hua-xia], 2009, [基础医学与临床, Basic & Clinical Medicine], V29, P901; Dutow P, 2013, INFECT IMMUN, V81, P3366, DOI 10.1128/IAI.00334-13; Fulkerson PC, 2005, BLOOD, V106, P436, DOI 10.1182/blood-2005-02-0489; Gandhi VD, 2013, CURR ALLERGY ASTHM R, V13, P262, DOI 10.1007/s11882-013-0349-9; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022; Kurashima K, 2006, RESPIROLOGY, V11, P152, DOI 10.1111/j.1440-1843.2006.00822.x; Lama M, 2011, CYTOKINE, V55, P335, DOI 10.1016/j.cyto.2011.05.011; Lee Young-Cheol, 2008, Int J Biomed Sci, V4, P8; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Lin Yi, 2011, Respir Res, V12, P123, DOI 10.1186/1465-9921-12-123; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Meyer-Martin H, 2014, METHODS MOL BIOL, V1193, P127, DOI 10.1007/978-1-4939-1212-4_13; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; Rosenblum JM, 2010, J IMMUNOL, V184, P3450, DOI 10.4049/jimmunol.0903831; Schatz M, 2014, J ALLER CL IMM-PRACT, V2, P645, DOI 10.1016/j.jaip.2014.09.004; Shin YS, 2011, ANN ALLERG ASTHMA IM, V107, P145, DOI 10.1016/j.anai.2011.04.013; Takaku Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-138; Thomas MS, 2004, J IMMUNOL, V173, P615, DOI 10.4049/jimmunol.173.1.615; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Trian T, 2015, AM J RESP CRIT CARE, V191, P538, DOI 10.1164/rccm.201409-1582OC; Xanthou G, 2003, EUR J IMMUNOL, V33, P2241, DOI 10.1002/eji.200323787; Zhang Y, 2004, FASEB J, V18, pA232	31	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2016	11	10							e0162905	10.1371/journal.pone.0162905	http://dx.doi.org/10.1371/journal.pone.0162905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CI	27727269	gold, Green Submitted, Green Published			2022-12-27	WOS:000385504400002
J	Lin, J; Zhang, YY; Wang, HG; Chang, J; Wei, LX; Cao, L; Zhang, Z; Zhang, XM				Lin, Jia; Zhang, Yanyan; Wang, Hongge; Chang, Jiang; Wei, Lixuan; Cao, Lei; Zhang, Zhi; Zhang, Xuemei			Genetic Polymorphisms in the Apoptosis-Associated Gene CASP3 and the Risk of Lung Cancer in Chinese Population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN PROSTATE-CANCER; BREAST-CANCER; CASPASE-3; EXPRESSION; SUSCEPTIBILITY; MUTATIONS; VARIANT; CYCLE; HEAD	Caspase-3 (CASP3) plays a central role in executing cell apoptosis and thus in carcinogenesis. We previously investigated the relationship between functional polymorphisms in CAPS3 829 A>C and 20541 C>T and risk of esophageal squamous cell carcinoma. However little is known about the role of CASP3 variants in susceptibility to lung cancer. To figure out the contribution of CASP3 polymorphisms to lung cancer risk, genotypes of 1000 lung cancer patients and 1000 controls were conducted by RFLP-PCR (restriction fragment length polymorphism PCR). The transcriptional activity of CASP3 829 A>C was examined by dual luciferase reporter assay. Logistic regression was applied to calculate Odds ratios (OR) and 95% confidence intervals (95% CI). Compared with CASP3 829 AA genotype, AC and CC genotype had significantly increased risk of lung cancer with OR (95% CI) of 1.33 (1.09-1.63) and 1.55 (1.19-2.01), respectively. To further explore the possible impact of 829 A>C SNP on CASP3 transcriptional activity, we detected the dual luciferase activity of PGL3-promoter vectors containing 829A or 829C alleles in lung cancer cell lines and found that report gene expressions driven by 829A containing CASP3 promoter were 1.64-fold, 1.94-fold greater than those driven by CASP3 829C containing counterparts in A549 and NCI-H1975 cells (P<0.001). When stratified by sex, the significantly increased risk associated with CASP3 829 AC or CC genotype was obviousl in males with OR (95% CI) of 1.42 (1.11-1.81) and 1.51 (1.11-2.05), but not in females. When stratified by age, we found that CASP3 829 AC or CC genotype contributed to the risk of lung cancer in youngers with OR (95% CI) of 2.73 (1.71-4.34) and 4.02 (2.20-7.32), but not in elder group. We also found that 829AC or 829CC genotype increased adenocarcinoma risk compared with the AA genotype with OR (95% CI) of 1.33 (1.04-1.70) and 1.51(1.09-2.07). CASP3 polymorphism and smoking interaction was demonstrated related with higher risk of lung cancer. We achieved that the CASP3 829AC or 829CC genotypes was associated with increased risk of lung cancer in both non-smoker and smoker group, with OR (95% CI) of 1.48 (1.08-2.02) and OR (95% CI) of 1.64 (1.09-2.48) among non-smokers and OR (95% CI) of 2.68 (1.89- 3.81) and OR (95% CI) of 3.23 (2.21-4.92) among smokers, respectively. Among carriers with 20541CT genotype, the ORs (95% CI) of risk with lung cancer for smoking < 16, 16-28, or > 28 pack-years were 1.16(0.65-2.07), 1.66(0.98-2.82) and 5.01(3.31-7.58) compared with the 20541CC carriers. And among carriers with 20541CT genotype, the ORs (95% CI) were 0.86(0.33-2.20), 2.12(0.83-5.41) and 5.71(2.68-12.16). These results highlight apoptosis-related CASP3 as an important gene in human carcinogenesis and further support the CASP3 polymorphisms confer to the lung cancer susceptibility.	[Lin, Jia; Zhang, Yanyan; Wang, Hongge; Cao, Lei; Zhang, Xuemei] North China Univ Sci & Technol, Coll Life Sci, Dept Mol Genet, Tangshan, Peoples R China; [Zhang, Yanyan] North China Univ Sci & Technol, Sch Publ Hlth, Dept Epidemiol, Tangshan, Peoples R China; [Chang, Jiang] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Tongji Med Coll, Sch Publ Hlth, Wuhan, Peoples R China; [Chang, Jiang] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubat,Tongji Med Co, Minist Educ,Key Lab Environm & Hlth Wuhan,Sch Pub, Key Lab Environm & Hlth,Minist Environm Protect, Wuhan, Peoples R China; [Wei, Lixuan] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing, Peoples R China; [Wei, Lixuan] Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Zhi] Tangshan Gongren Hosp, Dept Chemotherapy & Radiotherapy, Tangshan, Peoples R China; [Zhang, Xuemei] North China Univ Sci & Technol, Coll Life Sci, Inst Mol Genet, Tangshan, Peoples R China	North China University of Science & Technology; North China University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; North China University of Science & Technology	Zhang, XM (corresponding author), North China Univ Sci & Technol, Coll Life Sci, Dept Mol Genet, Tangshan, Peoples R China.; Zhang, XM (corresponding author), North China Univ Sci & Technol, Coll Life Sci, Inst Mol Genet, Tangshan, Peoples R China.	jyxuemei@gmail.com		wei, lixuan/0000-0001-7465-7513	National Natural Science Foundation of China [81101483]; Program for New Century Excellent Talents in University [NCET-11-0933]; Leader talent cultivation plan of innovation team in Hebei province [LJRC001]; Leader talent cultivation plan of innovation team in Tangshan city [2060402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Leader talent cultivation plan of innovation team in Hebei province; Leader talent cultivation plan of innovation team in Tangshan city	This study was supported by the National Natural Science Foundation of China (81101483 to X. Zhang), Program for New Century Excellent Talents in University (NCET-11-0933 to X. Zhang), Leader talent cultivation plan of innovation team in Hebei province (LJRC001 to X. Zhang), and Leader talent cultivation plan of innovation team in Tangshan city (2060402 to X. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KX, 2008, CLIN CANCER RES, V14, P6343, DOI 10.1158/1078-0432.CCR-08-1198; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jang JS, 2008, MOL CARCINOGEN, V47, P383, DOI 10.1002/mc.20397; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kania J, 2003, DIGEST DIS SCI, V48, P266, DOI 10.1023/A:1021915124064; Kiyohara C, 2010, GENDER MED, V7, P381, DOI 10.1016/j.genm.2010.10.002; Kurokawa H, 1999, ONCOL REP, V6, P33; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mandruzzato S, 1997, J EXP MED, V186, P785, DOI 10.1084/jem.186.5.785; Mittal RD, 2012, DNA CELL BIOL, V31, P67, DOI 10.1089/dna.2011.1285; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Park JY, 2006, HUM MOL GENET, V15, P1963, DOI 10.1093/hmg/ddl119; Porter AG, 1997, BIOESSAYS, V19, P501, DOI 10.1002/bies.950190609; Royle JS, 2004, J UROLOGY, V172, P338, DOI 10.1097/01.ju.0000132367.02834.41; Rozen S, 2000, Methods Mol Biol, V132, P365; Schwartz AG, 2007, CARCINOGENESIS, V28, P507, DOI 10.1093/carcin/bgl253; Shields PG, 2000, J CLIN ONCOL, V18, P2309, DOI 10.1200/JCO.2000.18.11.2309; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Soung YH, 2004, HUM GENET, V115, P112, DOI 10.1007/s00439-004-1129-3; Takata T, 2001, INT J CANCER, V96, P54, DOI 10.1002/ijc.10347; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wickenden JA, 2003, AM J RESP CELL MOL, V29, P562, DOI 10.1165/rcmb.2002-0235OC; Winter RN, 2001, CANCER RES, V61, P1227; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Xie Yun, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P633; Xu HL, 2009, CANCER EPIDEM BIOMAR, V18, P2114, DOI 10.1158/1055-9965.EPI-09-0152; Yan S, 2013, GENET MOL RES, V12, P1561, DOI 10.4238/2013.May.13.10; Yoo SS, 2009, J CLIN ONCOL, V27, P5823, DOI 10.1200/JCO.2009.23.1738; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang Z, 2012, CANCER EPIDEMIOL, V36, pE111, DOI 10.1016/j.canep.2011.11.004; Zhang Z, 2012, CANCER SCI, V103, P555, DOI 10.1111/j.1349-7006.2011.02173.x; Zheng TS, 1998, P NATL ACAD SCI USA, V95, P13618, DOI 10.1073/pnas.95.23.13618	36	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164358	10.1371/journal.pone.0164358	http://dx.doi.org/10.1371/journal.pone.0164358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CF	27723786	Green Published, Green Submitted, gold			2022-12-27	WOS:000385504100046
J	Wouters, E; Booysen, FL; Masquillier, C				Wouters, Edwin; Booysen, Frederik le Roux; Masquillier, Caroline			Who Should We Target? The Impact of Individual and Family Characteristics on the Expressed Need for Community-Based Treatment Support in HIV Patients in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT OUTCOMES; SUB-SAHARAN AFRICA; RESOURCE-LIMITED COUNTRIES; QUALITY-OF-LIFE; ADHERENCE SUPPORT; HEALTH WORKERS; CLINICAL-EFFICACY; TREATMENT PROGRAM; HIV/AIDS; PEOPLE	Reviews of impact evaluations of community-based health workers and peer support groups highlight the considerable variability in the effectiveness of such support in improving antiretroviral treatment (ART) outcomes. Evidence indicates that community-based support interventions targeting patients known to be at risk will probably display better results than generic interventions aimed at the entire population of people living with HIV. It is however difficult to identify these at-risk populations, rendering knowledge on the characteristics of patients groups who are in need of community-based support a clear research priority. The current study aims to address the knowledge gap by exploring the predictors of the willingness to (1) receive the support from a community-based health worker or (2) to participate in a support group in public sector ART programme of the Free State Province of South Africa. Based on the Individual-Family-Community framework for HIV research, the study employs a comprehensive approach by not only testing classical individual-level but also family-level predictors of the willingness to receive community-based support. In addition to individual-level predictors-such as age, health status and coping styles-our analysis demonstrated the importance of family characteristics. The results indicated that discrepancies in the family's changeability level were an important predictor of the demand for community-based support services. Conversely, the findings indicated that patients living in a family more flexible than deemed ideal are more likely to require the support of a community health worker. The current study expands theory by indicating the need to acknowledge all social ecological levels in the study of chronic HIV care. The detection of both individual level and family level determinants of the expressed need for community-based support can inform health policy to devise strategies to target scarce resources to those vulnerable patients who report the greatest need for this support. In this way, the study results are a first step in an attempt to move away from generic, broad based community-based interventions towards community support that is tailored to the patient needs at both the individual and family level.	[Wouters, Edwin; Masquillier, Caroline] Univ Antwerp, Dept Sociol, Antwerp, Belgium; [Wouters, Edwin; Masquillier, Caroline] Univ Antwerp, Ctr Longitudinal & Life Course Studies, Antwerp, Belgium; [Wouters, Edwin] Univ Free State, Ctr Hlth Syst Res & Dev, Bloemfontein, South Africa; [Booysen, Frederik le Roux] Univ Free State, Dept Econ, Bloemfontein, South Africa	University of Antwerp; University of Antwerp; University of the Free State; University of the Free State	Wouters, E (corresponding author), Univ Antwerp, Dept Sociol, Antwerp, Belgium.; Wouters, E (corresponding author), Univ Antwerp, Ctr Longitudinal & Life Course Studies, Antwerp, Belgium.; Wouters, E (corresponding author), Univ Free State, Ctr Hlth Syst Res & Dev, Bloemfontein, South Africa.	edwin.wouters@uantwerpen.be	le R Booysen, Frederik/K-9152-2015; Booysen, Frederik/ABB-2868-2021; Wouters, Edwin/AAE-1649-2021	le R Booysen, Frederik/0000-0001-7449-3221; Wouters, Edwin/0000-0003-2268-3829; Masquillier, Caroline/0000-0003-1748-5967	World Bank Research Committee; Bank-Netherlands Partnership Program; WB-DfiD "Evaluation of the Community Response; Programme to Support Pro-Poor Policy Development (PSPPD); Republic of South Africa; European Union; Health Economics and Aids Research Division (HEARD) at the University of Kwazulu-Natal; University of the Free State (UFS); South Africa's National Research Foundation (NRF)	World Bank Research Committee; Bank-Netherlands Partnership Program; WB-DfiD "Evaluation of the Community Response; Programme to Support Pro-Poor Policy Development (PSPPD); Republic of South Africa; European Union(European Commission); Health Economics and Aids Research Division (HEARD) at the University of Kwazulu-Natal; University of the Free State (UFS); South Africa's National Research Foundation (NRF)(National Research Foundation - South Africa)	The authors would like to give special thanks to the following funding agencies: the World Bank Research Committee; the Bank-Netherlands Partnership Program; WB-DfiD "Evaluation of the Community Response to HIV and AIDS; the Programme to Support Pro-Poor Policy Development (PSPPD), a partnership between the Presidency, Republic of South Africa and the European Union; the Health Economics and Aids Research Division (HEARD) at the University of Kwazulu-Natal; the University of the Free State (UFS); and South Africa's National Research Foundation (NRF).	Apondi R, 2007, JAIDS-J ACQ IMM DEF, V44, P71, DOI 10.1097/01.qai.0000243113.29412.dd; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS91, DOI 10.1097/QAI.0b013e3182218441; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Brandt R, 2009, AJAR-AFR J AIDS RES, V8, P123, DOI 10.2989/AJAR.2009.8.2.1.853; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Celletti F, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000366082.68321.d6; Chandola T, 2003, J EPIDEMIOL COMMUN H, V57, P56, DOI 10.1136/jech.57.1.56; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Etienne M, 2010, TROP MED INT HEALTH, V15, P76, DOI 10.1111/j.1365-3156.2010.02513.x; Fatti G, 2012, JAIDS-J ACQ IMM DEF, V61, pE50, DOI 10.1097/QAI.0b013e31826a6aee; Finocchario-Kessler S, 2011, AIDS PATIENT CARE ST, V25, P103, DOI 10.1089/apc.2010.0319; FLEISHMAN JA, 1994, HEALTH PSYCHOL, V13, P156, DOI 10.1037/0278-6133.13.2.156; Funck-Brentano I, 2005, AIDS, V19, P1501, DOI 10.1097/01.aids.0000183124.86335.0a; Greeff AP, 2007, FAM COMMUNITY HEALTH, V30, P189, DOI 10.1097/01.FCH.0000277762.70031.44; Greeff AP, 2000, J FAM ISSUES, V21, P948, DOI 10.1177/019251300021008001; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; Heunis JC, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-27; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Hontelez JAC, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-39; Igumbor JO, 2011, AIDS CARE, V23, P231, DOI 10.1080/09540121.2010.498909; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Kabore I, 2010, AIDS PATIENT CARE ST, V24, P581, DOI 10.1089/apc.2009.0307; Liamputtong P, 2015, QUAL HEALTH RES, V25, P253, DOI 10.1177/1049732314550005; Mannheimer SB, 2006, AIDS CARE, V18, P853, DOI 10.1080/09540120500465160; Masquillier C, 2015, AIDS BEHAV, V19, P214, DOI 10.1007/s10461-014-0865-1; McCubbin H, 2000, MARRIAGE FAM REV, V30, P47; McCubbin H.I., 1996, FAMILY ASSESSMENT RE; McCubbin H.I., 1996, FAMILY ASSESSMENT RE, P725; Motsoaledi A., 2016, PRETORIA2016; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Nyirenda M, 2013, J AFFECT DISORDERS, V151, P31, DOI 10.1016/j.jad.2013.05.005; Olley BO, 2004, AIDS PATIENT CARE ST, V18, P481, DOI 10.1089/1087291041703700; Pappin M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-244; PORTER LW, 1961, J APPL PSYCHOL, V45, P1, DOI 10.1037/h0043121; Rains JC, 2005, HEADACHE, V45, P479, DOI 10.1111/j.1526-4610.2005.05099.x; Russell S, 2010, SOC SCI MED, V70, P375, DOI 10.1016/j.socscimed.2009.10.039; Siegel J, 2015, GLOB PUBLIC HEALTH, V10, P995, DOI 10.1080/17441692.2015.1021365; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Talukdar Arunansu, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P115, DOI 10.1177/1545109710393309; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; Wolitski RJ, 2009, AIDS BEHAV, V13, P1222, DOI 10.1007/s10461-008-9455-4; Wouters E, 2009, AIDS CARE, V21, P1401, DOI 10.1080/09540120902884034; Wouters E, 2008, AIDS, V22, P2545, DOI 10.1097/QAD.0b013e32831c5562; Wouters E, 2014, SOC SCI MED, V113, P145, DOI 10.1016/j.socscimed.2014.05.020; Wouters E, 2012, SOC THEOR HEALTH, V10, P368, DOI 10.1057/sth.2012.12; Wouters E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-194; Wouters E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034881; Wouters E, 2010, HEALTH POLICY PLANN, V25, P171, DOI 10.1093/heapol/czp057; Wouters E, 2009, LANCET, V374, P1501, DOI 10.1016/S0140-6736(09)61905-X; Wouters E, 2009, SOC SCI MED, V69, P1177, DOI 10.1016/j.socscimed.2009.07.034; Wouters E, 2009, AIDS PATIENT CARE ST, V23, P357, DOI 10.1089/apc.2008.0201; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010; Zachariah R, 2006, 16 INT AIDS C TOR CA	56	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e0163963	10.1371/journal.pone.0163963	http://dx.doi.org/10.1371/journal.pone.0163963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0DG	27741239	Green Published, Green Submitted, gold			2022-12-27	WOS:000385507000012
J	Yiannakas, MC; Grussu, F; Louka, P; Prados, F; Samson, RS; Battiston, M; Altmann, DR; Ourselin, S; Miller, DH; Wheeler-Kingshott, CAMG				Yiannakas, Marios C.; Grussu, Francesco; Louka, Polymnia; Prados, Ferran; Samson, Rebecca S.; Battiston, Marco; Altmann, Daniel R.; Ourselin, Sebastien; Miller, David H.; Wheeler-Kingshott, Claudia A. M. Gandini			Reduced Field-of-View Diffusion-Weighted Imaging of the Lumbosacral Enlargement: A Pilot In Vivo Study of the Healthy Spinal Cord at 3T	PLOS ONE			English	Article							BLADDER DYSFUNCTION; THE-ART; ECHO; MRI; DISABILITY; FIBERS; MATTER; INJURY; BRAIN; DTI	Diffusion tensor imaging (DTI) has recently started to be adopted into clinical investigations of spinal cord (SC) diseases. However, DTI applications to the lower SC are limited due to a number of technical challenges, related mainly to the even smaller size of the SC structure at this level, its position relative to the receiver coil elements and the effects of motion during data acquisition. Developing methods to overcome these problems would offer new means to gain further insights into microstructural changes of neurological conditions involving the lower SC, and in turn could help explain symptoms such as bladder and sexual dysfunction. In this work, the feasibility of obtaining grey and white matter (GM/WM) DTI indices such as axial/radial/mean diffusivity (AD/RD/MD) and fractional anisotropy (FA) within the lumbosacral enlargement (LSE) was investigated using a reduced field-of-view (rFOV) single-shot echo-planar imaging (ss-EPI) acquisition in 14 healthy participants using a clinical 3T MR system. The scan-rescan reproducibility of the measurements was assessed by calculating the percentage coefficient of variation (% COV). Mean FA was higher in WM compared to GM (0.58 and 0.4 in WM and GM respectively), AD and MD were higher in WM compared to GM (1.66 mu m(2) ms(-1) and 0.94 mu m(2) ms(-1) in WM and 1.2 mu m(2) ms(-1) and 0.82 mu m(2) ms(-1) in GM for AD and MD respectively) and RD was lower in WM compared to GM (0.58 mu m(2) ms(-1) and 0.63 mu m(2) ms(-1) respectively). The scan-rescan % COV was lower than 10% in all cases with the highest values observed for FA and the lowest for MD. This pilot study demonstrates that it is possible to obtain reliable tissue-specific estimation of DTI indices within the LSE using a rFOV ss-EPI acquisition. The DTI acquisition and analysis protocol presented here is clinically feasible and may be used in future investigations of neurological conditions implicating the lower SC.	[Yiannakas, Marios C.; Grussu, Francesco; Louka, Polymnia; Prados, Ferran; Samson, Rebecca S.; Battiston, Marco; Altmann, Daniel R.; Miller, David H.; Wheeler-Kingshott, Claudia A. M. Gandini] UCL, UCL Inst Neurol, Queen Sq MS Ctr, Dept Neuroinflammat,NMR Res Unit, London, England; [Prados, Ferran; Ourselin, Sebastien] UCL, Ctr Med Image Comp Med Phys & Biomed Engn, Translat Imaging Grp, London, England; [Altmann, Daniel R.] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Prados, Ferran; Ourselin, Sebastien; Miller, David H.] UCL, Univ Coll London Hosp, Biomed Res Ctr, NIHR, London, England; [Wheeler-Kingshott, Claudia A. M. Gandini] C Mondino Natl Neurol Inst, Brain MRI Mondino Res Ctr 3T, Pavia, Italy; [Wheeler-Kingshott, Claudia A. M. Gandini] Univ Pavia, Dept Brain & Behav Sci, Pavia, PV, Italy	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; King's College London; University College London; IRCCS Fondazione Casimiro Mondino; University of Pavia	Yiannakas, MC (corresponding author), UCL, UCL Inst Neurol, Queen Sq MS Ctr, Dept Neuroinflammat,NMR Res Unit, London, England.	m.yiannakas@ucl.ac.uk	Grussu, Francesco/AAE-8109-2019; Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019; Carrasco, Ferran Prados/AAR-4157-2021; Ourselin, Sebastien/K-6960-2015	Grussu, Francesco/0000-0002-0945-3909; Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Samson, Rebecca/0000-0002-0197-702X; Prados Carrasco, Ferran/0000-0002-7872-0142; Ourselin, Sebastien/0000-0002-5694-5340	U.K Multiple Sclerosis Society; National Institute for Health Research University College London Hospitals Biomedical Research Centre; NIHR BRC UCLH/UCL High Impact Initiative; EPSRC [EP/H046410/1, EP/J020990/1, EP/K005278]; MRC [MR/J01107X/1]; NIHR Biomedical Research Unit (Dementia) at UCL; NIHR BRC UCLH/UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL); NIHR BRC UCLH/UCL High Impact Initiative [BW.mn.BRC10269]; Engineering and Physical Sciences Research Council [EP/J020990/1, EP/H046410/1] Funding Source: researchfish; Medical Research Council [MR/J01107X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10058] Funding Source: researchfish	U.K Multiple Sclerosis Society; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); NIHR BRC UCLH/UCL High Impact Initiative; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Unit (Dementia) at UCL; NIHR BRC UCLH/UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL); NIHR BRC UCLH/UCL High Impact Initiative; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work and the NMR Research Unit are supported by the U.K Multiple Sclerosis Society (http://www.mssociety.org.uk/). This work was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. FP is funded by NIHR BRC UCLH/UCL High Impact Initiative. SO receives funding from the EPSRC (EP/H046410/1, EP/J020990/1, EP/K005278), the MRC (MR/J01107X/1), the NIHR Biomedical Research Unit (Dementia) at UCL and the NIHR BRC UCLH/UCL.; This work and the NMR Research Unit are funded by the U.K Multiple Sclerosis Society (http://www.mssociety.org.uk/). This work was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL). FP and SO are funded by NIHR BRC UCLH/UCL High Impact Initiative (BW.mn.BRC10269). SO also receives funding from the EPSRC (EP/H046410/1, EP/J020990/1, EP/K005278), the MRC (MR/J01107X/1) and the NIHR Biomedical Research Unit (Dementia) at UCL.	Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; Bammer R, 2003, AM J NEURORADIOL, V24, P5; Bammer R, 2002, J MAGN RESON IMAGING, V15, P364, DOI 10.1002/jmri.10075; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bosma RL, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/143705; Cercignani M, 2003, AM J NEURORADIOL, V24, P1254; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; DUBOULAY GH, 1966, BRIT J RADIOL, V39, P255, DOI 10.1259/0007-1285-39-460-255; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1279, DOI 10.3174/ajnr.A1064; Feirabend HKP, 2002, BRAIN, V125, P1137, DOI 10.1093/brain/awf111; Fernandez O, 2002, J NEUROL, V249, P1, DOI 10.1007/PL00007835; Gaggl W, 2014, MAGN RESON MED, V72, P1668, DOI 10.1002/mrm.25092; Goto N, 1997, NEUROPATHOLOGY, V17, P25, DOI 10.1111/j.1440-1789.1997.tb00007.x; Gregory S, 2015, J HUNTINGTONS DIS, V4, P333, DOI 10.3233/JHD-150173; Grussu F, 2015, NEUROIMAGE, V111, P590, DOI 10.1016/j.neuroimage.2015.01.045; Gudbjartsson H, 1996, MAGNET RESON MED, V36, P509, DOI 10.1002/mrm.1910360403; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jeong EK, 2005, MAGNET RESON MED, V54, P1575, DOI 10.1002/mrm.20711; Jones Derek K, 2010, Top Magn Reson Imaging, V21, P87, DOI 10.1097/RMR.0b013e31821e56ac; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kearney H, 2015, J NEUROL NEUROSUR PS, V86, P608, DOI 10.1136/jnnp-2014-308241; LANE B, 1974, RADIOLOGY, V110, P579, DOI 10.1148/110.3.579; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Roux PH, 2002, MAGN RESON MATER PHY, V14, P243, DOI 10.1016/S1352-8661(02)00069-8; Mahoney CJ, 2015, ANN NEUROL, V77, P33, DOI 10.1002/ana.24296; Mamata H, 2006, NEUROIMAGE, V31, P24, DOI 10.1016/j.neuroimage.2005.11.038; McCombe PA, 2009, EXPERT REV NEUROTHER, V9, P331, DOI 10.1586/14737175.9.3.331; Naismith RT, 2013, NEUROLOGY, V80, P2201, DOI 10.1212/WNL.0b013e318296e8f1; Papadakis NG, 2000, MAGN RESON IMAGING, V18, P671, DOI 10.1016/S0730-725X(00)00151-X; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Rieseberg S, 2002, MAGN RESON MED, V47, P1186, DOI 10.1002/mrm.10157; Sakakibara R, 2000, J NEUROL NEUROSUR PS, V68, P65, DOI 10.1136/jnnp.68.1.65; SAKAKIBARA R, 1993, JPN J PSYCHIAT NEUR, V47, P591; Samson RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155557; Saritas EU, 2008, MAGN RESON MED, V60, P468, DOI 10.1002/mrm.21640; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Tsuchiya K, 2005, AM J NEURORADIOL, V26, P398; TURNER R, 1990, J MAGN RESON, V86, P445, DOI 10.1016/0022-2364(90)90023-3; Watanabe T, 1998, J UROLOGY, V159, P965, DOI 10.1016/S0022-5347(01)63786-8; Wheeler-Kingshott CA, 2014, NEUROIMAGE, V84, P1082, DOI 10.1016/j.neuroimage.2013.07.014; Wheeler-Kingshott CAM, 2002, NEUROIMAGE, V16, P93, DOI 10.1006/nimg.2001.1022; Wilm BJ, 2007, MAGN RESON MED, V57, P625, DOI 10.1002/mrm.21167; Wilm BJ, 2009, NMR BIOMED, V22, P174, DOI 10.1002/nbm.1298; Xu JQ, 2013, NEUROIMAGE, V67, P64, DOI 10.1016/j.neuroimage.2012.11.014; Yiannakas MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105544	46	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2016	11	10							e164890	10.1371/journal.pone.0164890	http://dx.doi.org/10.1371/journal.pone.0164890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0DG	27741303	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000385507000080
J	Gurjav, U; Outhred, AC; Jelfs, P; McCallum, N; Wang, QN; Hill-Cawthorne, GA; Marals, B; Sintchenko, V				Gurjav, Ulziijargal; Outhred, Alexander C.; Jelfs, Peter; McCallum, Nadine; Wang, Qinning; Hill-Cawthorne, Grant A.; Marais, Ben J.; Sintchenko, Vitali			Whole Genome Sequencing Demonstrates Limited Transmission within Identified Mycobacterium tuberculosis Clusters in New South Wales, Australia	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; BEIJING GENOTYPE; MUTATION-RATE; POPULATION; DIVERSITY; EPIDEMIC; STRAINS; PROGRAM; LINEAGE; SPREAD	Australia has a low tuberculosis incidence rate with most cases occurring among recent immigrants. Given suboptimal cluster resolution achieved with 24-locus mycobacterium interspersed repetitive unit (MIRU-24) genotyping, the added value of whole genome sequencing was explored. MIRU-24 profiles of all Mycobacterium tuberculosis culture-confirmed tuberculosis cases diagnosed between 2009 and 2013 in New South Wales (NSW), Australia, were examined and clusters identified. The relatedness of cases within the largest MIRU-24 clusters was assessed using whole genome sequencing and phylogenetic analyses. Of 1841 culture-confirmed TB cases, 91.9% (1692/1841) had complete demographic and genotyping data. East-African Indian (474; 28.0%) and Beijing (470; 27.8%) lineage strains predominated. The overall rate of MIRU-24 clustering was 20.1% (340/1692) and was highest among Beijing lineage strains (35.7%; 168/470). One Beijing and three East-African Indian (EAI) clonal complexes were responsible for the majority of observed clusters. Whole genome sequencing of the 4 largest clusters (30 isolates) demonstrated diverse single nucleotide polymorphisms (SNPs) within identified clusters. All sequenced EAI strains and 70% of Beijing lineage strains clustered by MIRU-24 typing demonstrated distinct SNP profiles. The superior resolution provided by whole genome sequencing demonstrated limited M. tuberculosis transmission within NSW, even within identified MIRU-24 clusters. Routine whole genome sequencing could provide valuable public health guidance in low burden settings.	[Gurjav, Ulziijargal; Outhred, Alexander C.; McCallum, Nadine; Hill-Cawthorne, Grant A.; Marais, Ben J.; Sintchenko, Vitali] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Gurjav, Ulziijargal; Jelfs, Peter; McCallum, Nadine; Wang, Qinning; Sintchenko, Vitali] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Sydney, NSW, Australia; [Outhred, Alexander C.; Marais, Ben J.] Childrens Hosp Westmead, Sydney, NSW, Australia; [Jelfs, Peter] Inst Clin Pathol & Med Res Pathol West, Ctr Infect Dis, NSW Mycobacterium Reference Lab, Sydney, NSW, Australia; [Jelfs, Peter] Inst Clin Pathol & Med Res Pathol West, Microbiol Lab Serv, Sydney, NSW, Australia; [Hill-Cawthorne, Grant A.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Hill-Cawthorne, Grant A.] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research	Gurjav, U (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.; Gurjav, U (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Sydney, NSW, Australia.	ugur6096@uni.sydney.edu.au	Marais, Ben/AAX-2626-2021; Hill-Cawthorne, Grant/B-8039-2009	Holmes, Nadine/0000-0001-7470-3786; Hill-Cawthorne, Grant/0000-0002-3828-5473; Gurjav, Ulziijargal/0000-0002-7344-8274; Sintchenko, Vitali/0000-0002-9261-3650	Centre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Sydney, Australia; NSW Mycobacterium Reference Laboratory, Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research - Pathology West, Sydney, Australia; Mongolian Government Postgraduate scholarship; National Health and Medical Research Council Centre for Research Excellence in Tuberculosis Control (Canberra, ACT, Australia); Centre for Infectious Diseases and Microbiology-Public Health; NHMRC Centre for Research Excellence in Tuberculosis Control; Westmead Foundation for Medical Research	Centre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Sydney, Australia; NSW Mycobacterium Reference Laboratory, Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research - Pathology West, Sydney, Australia; Mongolian Government Postgraduate scholarship; National Health and Medical Research Council Centre for Research Excellence in Tuberculosis Control (Canberra, ACT, Australia); Centre for Infectious Diseases and Microbiology-Public Health; NHMRC Centre for Research Excellence in Tuberculosis Control(National Health and Medical Research Council (NHMRC) of Australia); Westmead Foundation for Medical Research	The research study was sponsored by the Centre for Infectious Diseases and Microbiology Public Health, Westmead Hospital, Sydney, Australia and the NSW Mycobacterium Reference Laboratory, Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research - Pathology West, Sydney, Australia. Mrs. Gurjav was funded by a Mongolian Government Postgraduate scholarship supplemented by Westmead Foundation for Medical Research (Sydney, NSW) and the National Health and Medical Research Council Centre for Research Excellence in Tuberculosis Control (Canberra, ACT, Australia).; The authors thank the staff of the Centre for Infectious Diseases and Microbiology and NSW Mycobacterium Reference Laboratory for technical assistance in MIRU-24 typing and sequencing. UG was funded by a Mongolian Government Postgraduate scholarship and the Centre for Infectious Diseases and Microbiology-Public Health supplemented by a grant from the NHMRC Centre for Research Excellence in Tuberculosis Control and The Westmead Foundation for Medical Research.	Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075; Barry C, 2012, COMMUN DIS INTELL, V36, P82; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Couvin D, 2015, TUBERCULOSIS, V95, pS177, DOI 10.1016/j.tube.2015.02.023; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gallego B, 2010, PATHOLOGY, V42, P267, DOI 10.3109/00313021003631346; Garrison E, 2012, ARXIV12073907QBIO; Gurjav U, 2016, INFECT GENET EVOL, V40, P346, DOI 10.1016/j.meegid.2015.07.014; Gurjav U, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-455; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Hill V, 2012, INFECT GENET EVOL, V12, P755, DOI [10.1016/j.meegid.2012.02.004, DOI 10.1016/J.MEEGID.2012.02.004]; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kwong JC, 2015, PATHOLOGY, V47, P199, DOI 10.1097/PAT.0000000000000235; Li H., 2013, QUANT BIOL; Lowbridge Chris, 2013, N S W Public Health Bull, V24, P3, DOI 10.1071/NB12115; Luo T, 2013, NAT GENET, V45, P1176, DOI [10.1038/ng.2744, DOI 10.1038/NG.2744]; Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005; Marais BJ, 2013, J CLIN MICROBIOL, V51, P1818, DOI 10.1128/JCM.00200-13; Massey PD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-62; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Millet J, 2007, J CLIN MICROBIOL, V45, P3606, DOI 10.1128/JCM.00348-07; NGUYEN VAT, 2012, PLOS ONE, V0007; Outhred AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150550; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Ragheb MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-145; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Sia IG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-571; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; World Health Organization, 2020, GLOBAL TUBERCULOSIS	38	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0163612	10.1371/journal.pone.0163612	http://dx.doi.org/10.1371/journal.pone.0163612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27737005	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800018
J	Harris, LF; Awoonor-Williams, JK; Gerdts, C; Urbano, LG; Velez, ACG; Halpern, J; Prata, N; Baffoe, P				Harris, Laura Florence; Awoonor-Williams, John Koku; Gerdts, Caitlin; Gil Urbano, Laura; Gonzalez Velez, Ana Cristina; Halpern, Jodi; Prata, Ndola; Baffoe, Peter			Development of a Conceptual Model and Survey Instrument to Measure Conscientious Objection to Abortion Provision	PLOS ONE			English	Article							WILLINGNESS; PHYSICIANS; RELIGION; GHANA	Background and Objective Conscientious objection to abortion, clinicians' refusal to perform legal abortions because of their religious or moral beliefs, has been the subject of increasing debate among bioethicists, policymakers, and public health advocates in recent years. Conscientious objection policies are intended to balance reproductive rights and clinicians' beliefs. However, in practice, clinician objection can act as a barrier to abortion access-impinging on reproductive rights, and increasing unsafe abortion and related morbidity and mortality. There is little information about conscientious objection from a medical or public health perspective. A quantitative instrument is needed to assess prevalence of conscientious objection and to provide insight on its practice. This paper describes the development of a survey instrument to measure conscientious objection to abortion provision. Methods A literature review, and in-depth formative interviews with stakeholders in Colombia were used to develop a conceptual model of conscientious objection. This model led to the development of a survey, which was piloted, and then administered, in Ghana. Results The model posits three domains of conscientious objection that form the basis for the survey instrument: 1) beliefs about abortion and conscientious objection; 2) actions related to conscientious objection and abortion; and 3) self-identification as a conscientious objector. Conclusions The instrument is intended to be used to assess prevalence among clinicians trained to provide abortions, and to gain insight on how conscientious objection is practiced in a varietyof settings. Its results can inform more effective and appropriate strategies to regulate conscientious objection.	[Harris, Laura Florence; Halpern, Jodi; Prata, Ndola] Univ Calif Berkeley, UCSF Joint Med Program, Sch Publ Hlth, Berkeley, CA 94720 USA; [Awoonor-Williams, John Koku; Baffoe, Peter] Global Doctors Choice Ghana, Bolgatanga, Upper East Regi, Ghana; [Gerdts, Caitlin] Ibis Reprod Hlth, Oakland, CA USA; [Gil Urbano, Laura; Gonzalez Velez, Ana Cristina] Global Doctors Choice Colombia, Bogota, Colombia; [Prata, Ndola] Univ Calif Berkeley, Sch Publ Hlth, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Harris, LF (corresponding author), Univ Calif Berkeley, UCSF Joint Med Program, Sch Publ Hlth, Berkeley, CA 94720 USA.	Laura.Harris@ucsf.edu		Gonzalez, Ana Cristina/0000-0002-0841-2224	UC Berkeley Bixby Center for Population Health and Sustainability Summer Internship; Safe Abortion Action Fund; Helen Marguerite Schoeneman Fund; UC Berkeley UCSF Joint Medical Program Thesis Grant	UC Berkeley Bixby Center for Population Health and Sustainability Summer Internship; Safe Abortion Action Fund; Helen Marguerite Schoeneman Fund; UC Berkeley UCSF Joint Medical Program Thesis Grant	This work was supported by UC Berkeley Bixby Center for Population Health and Sustainability Summer Internship (LFH) (http://bixby.berkeley.edu/whtat-we-do/opportunities/internships-introduction/); Safe Abortion Action Fund (LFH, JKAW, PB) (www.saafund.org); Helen Marguerite Schoeneman Fund (LFH)(http://sph.berkeley.edu/jmp/home); and UC Berkeley UCSF Joint Medical Program Thesis Grant (LFH) (http://sph.berkeley.edu/jmp/home). None of the funding sources assigned grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniteye P, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-23; Charo RA, 2005, NEW ENGL J MED, V352, P2471, DOI 10.1056/NEJMp058112; Chavkin W, 2013, INT J GYNECOL OBSTET, V123, P541; Cook Rebecca J, 2006, Virtual Mentor, V8, P337, DOI 10.1001/virtualmentor.2006.8.5.oped1-0605; Curlin FA, 2007, NEW ENGL J MED, V356, P593, DOI 10.1056/NEJMsa065316; da Silva M, 2009, EUR J CONTRACEP REPR, V14, P245, DOI 10.1080/13625180903053740; Davidson LA, 2010, SOC SCI MED, V71, P161, DOI 10.1016/j.socscimed.2010.03.027; De Zordo S., 2012, CIENC SAUDE COLETIVA; De Zordo S., 2015, SOCIOL SANTE, V38, P107; De Zordo S, 2011, WOMEN HEALTH ISS, V21, pS32, DOI 10.1016/j.whi.2011.01.006; Diniz D, 2014, REPROD HEALTH MATTER, V22, P141, DOI 10.1016/S0968-8080(14)43754-6; Faundes Anibal, 2013, Int J Gynaecol Obstet, V123 Suppl 3, pS57, DOI 10.1016/S0020-7292(13)60003-X; Fiala C, WOMAN PSYCHOSOM GYNA; Fiala C, 2016, EUR J CONTRACEP REPR, V21, P201, DOI 10.3109/13625187.2016.1138458; Fink L, CONSCIENTIOUS OBJECT; Ghana Health Service, 2012, PREV MAN UNS AB COMP; Gonza A lez Ve A lez AC, 2012, DENIAL SERVICES DUE; Harries J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-16; Harris L. F., 2016, GLOB PUBLIC HEALTH, V18, P1; Heino A, 2013, EUR J CONTRACEP REPR, V18, P231, DOI 10.3109/13625187.2013.819848; Kantymir L, 2014, BIOETHICS, V28, P16, DOI 10.1111/bioe.12055; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; La Mesa por la Vida y la Salud de las Mujeres, 2014, SEM REG APR; Lo SST, 2009, J OBSTET GYNAECOL RE, V35, P767, DOI 10.1111/j.1447-0756.2008.00995.x; Martin LA, 2014, WOMEN HEALTH, V54, P641, DOI 10.1080/03630242.2014.919981; McCafferty C., 2010, WOMENS ACCESS LAWFUL; Sepper E., 2012, 1888375 SOC SCI RES; Shellenberg KM, 2014, WOMEN HEALTH, V54, P599, DOI 10.1080/03630242.2014.919982; Suh S, 2015, SOC SCI MED, V135, P56, DOI 10.1016/j.socscimed.2015.04.030; Suh S, 2014, SOC SCI MED, V108, P20, DOI 10.1016/j.socscimed.2014.02.030; Sundaram A, 2014, HLTH POLICY PLAN; Voetagbe G, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-2; Wicclair M.R., 2011, CONSCIENTIOUS OBJECT	33	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164368	10.1371/journal.pone.0164368	http://dx.doi.org/10.1371/journal.pone.0164368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CV	27736992	Green Published, gold, Green Submitted			2022-12-27	WOS:000385505800060
J	Schwartz, M; Didierjean, C; Hecker, A; Girardet, JM; Morel-Rouhier, M; Gelhaye, E; Favier, F				Schwartz, Mathieu; Didierjean, Claude; Hecker, Arnaud; Girardet, Jean-Michel; Morel-Rouhier, Melanie; Gelhaye, Eric; Favier, Frederique			Crystal Structure of Saccharomyces cerevisiae ECM4, a Xi-Class Glutathione Transferase that Reacts with Glutathionyl-(hydro) quinones	PLOS ONE			English	Article							N-CAPPING BOX; S-GLUTATHIONYL-(CHLORO)HYDROQUINONE REDUCTASES; EXPRESSION; IDENTIFICATION; REDUCTION; MECHANISM; CELLS; MODEL	Glutathionyl-hydroquinone reductases (GHRs) belong to the recently characterized Xi-class of glutathione transferases (GSTXs) according to unique structural properties and are present in all but animal kingdoms. The GHR ScECM4 from the yeast Saccharomyces cerevisiae has been studied since 1997 when it was found to be potentially involved in cell-wall biosynthesis. Up to now and in spite of biological studies made on this enzyme, its physiological role remains challenging. The work here reports its crystallographic study. In addition to exhibiting the general GSTX structural features, ScECM4 shows extensions including a huge loop which contributes to the quaternary assembly. These structural extensions are probably specific to Saccharomycetaceae. Soaking of ScECM4 crystals with GS-menadione results in a structure where glutathione forms a mixed disulfide bond with the cysteine 46. Solution studies confirm that ScECM4 has reductase activity for GS-menadione in presence of glutathione. Moreover, the high resolution structures allowed us to propose new roles of conserved residues of the active site to assist the cysteine 46 during the catalytic act.	[Schwartz, Mathieu; Didierjean, Claude; Favier, Frederique] Univ Lorraine, CRM2, UMR 7036, F-54500 Vandoeuvre Les Nancy, France; [Schwartz, Mathieu; Didierjean, Claude; Favier, Frederique] CNRS, CRM2, UMR 7036, F-54500 Vandoeuvre Les Nancy, France; [Hecker, Arnaud; Girardet, Jean-Michel; Morel-Rouhier, Melanie; Gelhaye, Eric] Univ Lorraine, Interact Arbres Microorganismes, UMR1136, F-54500 Vandoeuvre Les Nancy, France; [Hecker, Arnaud; Girardet, Jean-Michel; Morel-Rouhier, Melanie; Gelhaye, Eric] INRA, Interact Arbres Microorganismes, UMR1136, F-54280 Champenoux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Universite de Lorraine; INRAE; Universite de Lorraine	Didierjean, C; Favier, F (corresponding author), Univ Lorraine, CRM2, UMR 7036, F-54500 Vandoeuvre Les Nancy, France.; Didierjean, C; Favier, F (corresponding author), CNRS, CRM2, UMR 7036, F-54500 Vandoeuvre Les Nancy, France.	claude.didierjean@univ-lorraine.fr; Frederique.favier@univ-lorraine.fr	DIDIERJEAN, Claude/L-1493-2013; Favier, Frederique/B-3090-2013; HECKER, Arnaud/AAA-4853-2019; Schwartz, Mathieu/ABG-1517-2021	DIDIERJEAN, Claude/0000-0002-3176-8974; Favier, Frederique/0000-0003-3249-997X; HECKER, Arnaud/0000-0003-4511-5410; Schwartz, Mathieu/0000-0002-2670-5274; Morel-Rouhier, Melanie/0000-0001-5149-0474	CNRS/University of Lorraine (PEPS Mirabelle); Laboratory of Excellence ARBRE [ANR-11-LABX-0002-01]	CNRS/University of Lorraine (PEPS Mirabelle); Laboratory of Excellence ARBRE	Access to the 'Plateforme de mesures de diffractionX' of the Universite de Lorraine is appreciated. We are grateful to the staff members of the BM30A beamline at ESRF (Grenoble, France). Financial support was received from CNRS/University of Lorraine (PEPS Mirabelle 2016) and the Laboratory of Excellence ARBRE (ANR-11-LABX-0002-01).; Financial support was received from CNRS/University of Lorraine (PEPS Mirabelle 2016) and the Laboratory of Excellence ARBRE (ANR-11-LABX-0002-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allocati N, 2012, BIOCHIMIE, V94, P588, DOI 10.1016/j.biochi.2011.09.008; Belchik SM, 2011, DRUG METAB REV, V43, P307, DOI 10.3109/03602532.2011.552909; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Caba E, 2005, MUTAT RES-FUND MOL M, V575, P34, DOI 10.1016/j.mrfmmm.2005.02.005; Cocco R, 2001, J BIOL CHEM, V276, P32177, DOI 10.1074/jbc.M104057200; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dragani B, 1997, J BIOL CHEM, V272, P25518, DOI 10.1074/jbc.272.41.25518; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Garcera A, 2010, FEMS YEAST RES, V10, P422, DOI 10.1111/j.1567-1364.2010.00613.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Green AR, 2012, J BIOL CHEM, V287, P35838, DOI 10.1074/jbc.M112.395541; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Huang Y, 2008, J BACTERIOL, V190, P7595, DOI 10.1128/JB.00489-08; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Lallement PA, 2015, FEBS LETT, V589, P37, DOI 10.1016/j.febslet.2014.11.021; Lam LKM, 2012, BIOCHEMISTRY-US, V51, P5014, DOI 10.1021/bi300477z; Lussier M, 1997, GENETICS, V147, P435; Mashiyama ST, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001843; Meux E, 2011, J BIOL CHEM, V286, P9162, DOI 10.1074/jbc.M110.194548; Pei JM, METHODS MOL BIOL, P263, DOI 10.1007/978-1-62703-646-7_17; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Tickle IJ, 2007, ACTA CRYSTALLOGR D, V63, P1274, DOI 10.1107/S0907444907050196; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xun LY, 2010, BIOCHEM J, V428, P419, DOI 10.1042/BJ20091863	31	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2016	11	10							e0164678	10.1371/journal.pone.0164678	http://dx.doi.org/10.1371/journal.pone.0164678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CV	27736955	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505800111
J	Cvoro, A; Bajic, A; Zhang, AJ; Simon, M; Golic, I; Sieglaff, DH; Maletic-Savatic, M; Korac, A; Webb, P				Cvoro, Aleksandra; Bajic, Aleksander; Zhang, Aijun; Simon, Marisa; Golic, Igor; Sieglaff, Douglas H.; Maletic-Savatic, Mirjana; Korac, Aleksandra; Webb, Paul			Ligand Independent and Subtype-Selective Actions of Thyroid Hormone Receptors in Human Adipose Derived Stem Cells	PLOS ONE			English	Article							PREDICTING GENE-FUNCTION; NETWORK INTEGRATION; ENRICHMENT ANALYSIS; XENOPUS-TROPICALIS; BREAST-CANCER; MUTANT MICE; DNA-BINDING; ALPHA; ISOFORMS; DIFFERENTIATION	Thyroid hormone (TH) receptors (TR alpha a and beta) are homologous ligand-dependent transcription factors (TFs). While the TRs display distinct actions in development, metabolic regulation and other processes, comparisons of TR alpha and TR beta dependent gene regulation mostly reveal similar mechanisms of action and few TR subtype specific genes. Here, we show that TRa predominates in multipotent human adipose derived stem cells (hADSC) whereas TR beta is expressed at lower levels and is upregulated during hADSC differentiation. The TRs display several unusual properties in parental hADSC. First, TRs display predominantly cytoplasmic intracellular distribution and major TRa variants TR alpha 1 and TR alpha 2 colocalize with mitochondria. Second, knockdown experiments reveal that endogenous TRs influence hADSC cell morphology and expression of hundreds of genes in the absence of hormone, but do not respond to exogenous TH. Third, TR alpha and TR beta affect hADSC in completely distinct ways; TR alpha regulates cell cycle associated processes while TR beta may repress aspects of differentiation. TR alpha splice variant specific knockdown reveals that TR alpha 1 and TR alpha 2 both contribute to TR alpha-dependent gene expression in a gene specific manner. We propose that TRs work in a non-canonical and hormone independent manner in hADSC and that prominent subtype-specific activities emerge in the context of these unusual actions.	[Cvoro, Aleksandra; Zhang, Aijun; Simon, Marisa; Sieglaff, Douglas H.; Webb, Paul] Houston Methodist Res Inst, Genom Med, Houston, TX 77030 USA; [Bajic, Aleksander; Maletic-Savatic, Mirjana] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Bajic, Aleksander; Maletic-Savatic, Mirjana] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Golic, Igor; Korac, Aleksandra] Univ Belgrade, Fac Biol, Belgrade 11000, Serbia	The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; University of Belgrade	Webb, P (corresponding author), Houston Methodist Res Inst, Genom Med, Houston, TX 77030 USA.	PWebb@houstonmethodist.org	Golic, Igor/B-4492-2009	Golic, Igor/0000-0001-5944-5053; Bajic, Aleksandar/0000-0002-1255-9835; Maletic-Savatic, Mirjana/0000-0002-6548-4662	NIH [U01 GM094614, P30 A1036211, P30 CM 25123, S10 RR024574]; IDDRC from Eunice Kennedy Shriver NICHD [1U54 HD083092]; Center for Electron Microscopy at Faculty of Biology, University of Belgrade; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDDRC from Eunice Kennedy Shriver NICHD; Center for Electron Microscopy at Faculty of Biology, University of Belgrade; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH U01 GM094614 subcontract to PW. Confocal microscopy was done in IDDRC Microscopy Core and supported by IDDRC grant 1U54 HD083092 from Eunice Kennedy Shriver NICHD and Center for Electron Microscopy at Faculty of Biology, University of Belgrade. Flow cytometry was done by the Cytometry and Cell Sorting Core at Baylor College of Medicine with NIH funding (P30 A1036211, P30 CM 25123, and S10 RR024574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH U01 GM094614 subcontract to PW. Confocal microscopy was done in IDDRC Microscopy Core and supported by IDDRC grant 1U54 HD083092 from Eunice Kennedy Shriver NICHD and Center for Electron Microscopy at Faculty of Biology, University of Belgrade. Flow cytometry was done by the Cytometry and Cell Sorting Core at Baylor College of Medicine with NIH funding (P30 AI036211, P30 CA125123, and S10 RR024574) and expert assistance of Joel M. Sederstrom.	ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; Aranda A, 2009, TRENDS ENDOCRIN MET, V20, P318, DOI 10.1016/j.tem.2009.03.011; Astapova I, 2013, BBA-GEN SUBJECTS, V1830, P3876, DOI 10.1016/j.bbagen.2012.07.001; Ayers S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081186; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal J, 2013, BBA-GEN SUBJECTS, V1830, P3893, DOI 10.1016/j.bbagen.2012.04.014; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cheng SY, 2005, STEROIDS, V70, P450, DOI 10.1016/j.steroids.2005.02.003; Cheng SY, 2003, MOL CELL ENDOCRINOL, V213, P23, DOI 10.1016/j.mce.2003.10.051; Chiamolera MI, 2012, MOL ENDOCRINOL, V26, P926, DOI 10.1210/me.2011-1290; Choi JY, 2015, ENDOCRINOLOGY, V156, P735, DOI 10.1210/en.2014-1554; Cvoro A, 2015, STEM CELLS, V33, P416, DOI 10.1002/stem.1875; DARLING DS, 1993, J BIOL CHEM, V268, P10221; Davis PJ, 2016, NAT REV ENDOCRINOL, V12, P111, DOI 10.1038/nrendo.2015.205; Dey P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128239; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; Farwell AP, 2005, CURR OPIN ENDOCRINOL, V12, P17, DOI [DOI 10.1097/01.MED.0000152036.70617.1E, 10.1097/01.med.0000152036.70617.1, DOI 10.1097/01.MED.0000152036.70617.1]; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Flamant F, 2002, MOL ENDOCRINOL, V16, P24, DOI 10.1210/me.16.1.24; Flamant F, 2013, BBA-GEN SUBJECTS, V1830, P3900, DOI 10.1016/j.bbagen.2012.06.003; Fugier C, 2006, J BIOL CHEM, V281, P11553, DOI 10.1074/jbc.M512554200; Gauthier K, 2014, ENDOCRINOLOGY, V155, P3206, DOI 10.1210/en.2014-1597; Hahm JB, 2014, MOL CELL ENDOCRINOL, V383, P80, DOI 10.1016/j.mce.2013.11.015; Harbers M, 1996, NUCLEIC ACIDS RES, V24, P2252, DOI 10.1093/nar/24.12.2252; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Huang B, 2014, P NATL ACAD SCI USA, V111, P1933, DOI 10.1073/pnas.1323719111; Iglesias P, 2001, THYROID, V11, P1043, DOI 10.1089/105072501753271734; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Kim WG, 2013, BBA-GEN SUBJECTS, V1830, P3928, DOI 10.1016/j.bbagen.2012.04.002; Leung YK, 2006, P NATL ACAD SCI USA, V103, P13162, DOI 10.1073/pnas.0605676103; Li DS, 2004, J BIOL CHEM, V279, P7427, DOI 10.1074/jbc.M311596200; Lin JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052407; Lindemann JAL, 2014, MOL CELL ENDOCRINOL, V388, P32, DOI 10.1016/j.mce.2014.02.003; Liu YY, 2015, J BIOL CHEM, V290, P7402, DOI 10.1074/jbc.M114.600312; Liu YY, 2012, J BIOL CHEM, V287, P36499, DOI 10.1074/jbc.M112.344317; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Mardin BR, 2012, J CELL BIOL, V197, P11, DOI 10.1083/jcb.201108006; Milanesi A, 2016, ENDOCRINOLOGY, V157, P4, DOI 10.1210/en.2015-1443; Mittag J, 2010, HEART FAIL REV, V15, P111, DOI 10.1007/s10741-008-9119-5; Moran C, 2015, BEST PRACT RES CL EN, V29, P647, DOI 10.1016/j.beem.2015.07.007; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Ng L, 2013, NAT REV ENDOCRINOL, V9, P296, DOI 10.1038/nrendo.2013.58; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Obregon MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00479; Ortiga-Carvalho TM, 2014, NAT REV ENDOCRINOL, V10, P582, DOI 10.1038/nrendo.2014.143; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; R Core Team, 2020, R LANG ENV STAT COMP; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wen L, 2016, DEV GROWTH DIFFER, V58, P106, DOI 10.1111/dgd.12231; Wen L, 2015, ENDOCRINOLOGY, V156, P721, DOI 10.1210/en.2014-1439; Williams GR, 2013, EUR THYROID J, V2, P3, DOI 10.1159/000345548; Xu B, 2005, MOL CELL ENDOCRINOL, V245, P147, DOI 10.1016/j.mce.2005.11.010; Xu Y, 2005, CURR OPIN MOL THER, V7, P300; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yourek G, 2007, ASAIO J, V53, P219, DOI 10.1097/MAT.0b013e31802deb2d; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325; Zhang AJ, 2015, J ENDOCRINOL, V224, P289, DOI 10.1530/JOE-14-0440; Zhang HM, 2015, NUCLEIC ACIDS RES, V43, pD76, DOI 10.1093/nar/gku887; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	78	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164407	10.1371/journal.pone.0164407	http://dx.doi.org/10.1371/journal.pone.0164407			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732649	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300053
J	Maulik, PK; Tewari, A; Devarapalli, S; Kallakuri, S; Patel, A				Maulik, Pallab K.; Tewari, Abha; Devarapalli, Siddhardha; Kallakuri, Sudha; Patel, Anushka			The Systematic Medical Appraisal, Referral and Treatment (SMART) Mental Health Project: Development and Testing of Electronic Decision Support System and Formative Research to Understand Perceptions about Mental Health in Rural India	PLOS ONE			English	Article							CARE; DISCRIMINATION; BELIEFS; STIGMA; ACCESS	Introduction Common mental disorders (CMD) such as depression, suicidal risk and emotional/medically unexplained complaints affect a large number of people in India, but few receive appropriate care. Key reasons for this include few trained mental health professionals and stigma associated with mental health. A potential approach to address poor access to care is by training village healthcare workers in providing basic mental health care, and harnessing India's vast mobile network to support such workers using mobile-based applications. We propose an intervention to implement such an approach that incorporates the use of mobile-based electronic decision support systems (EDSS) to provide mental health services for CMD, combined with a community-based anti-stigma campaign. This will be implemented and evaluated across 42 villages in Andhra Pradesh, a south Indian state. This paper discusses the development and testing of the EDSS, and the formative research that informed the anti-stigma campaign. Materials and Methods The development of the EDSS used an iterative process that was validated against clinical diagnosis. A mixed methods approach tested the user acceptability of the EDSS. Focus group discussions and in-depth interviews provided community-level perceptions about mental health. This study involved 3 villages and one primary health centre. Results The EDSS application was found to be acceptable, but some modifications were needed. The community lacked adequate knowledge about CMD and its treatment and there was stigma associated with mental illness. Faith and traditional healers were considered to be important mental health service providers. Discussion A number of barriers and facilitators were identified in implementing the intervention analysed in a framework using Andersen's behavioural model of health services use. Conclusion The findings assisted with refining the intervention prior to large-scale implementation and evaluation.	[Maulik, Pallab K.; Tewari, Abha; Devarapalli, Siddhardha; Kallakuri, Sudha] George Inst Global Hlth, New Delhi, India; [Maulik, Pallab K.] Univ Oxford, George Inst Global Hlth, Oxford, England; [Patel, Anushka] George Inst Global Hlth, Sydney, NSW, Australia; [Patel, Anushka] Univ Sydney, Dept Med, Sydney, NSW, Australia	University of Oxford; George Institute for Global Health; University of Sydney; University of Sydney	Maulik, PK (corresponding author), George Inst Global Hlth, New Delhi, India.; Maulik, PK (corresponding author), Univ Oxford, George Inst Global Hlth, Oxford, England.	pmaulik@georgeinstitute.org.in		kumar, satya/0000-0003-1411-8846; Patel, Anushka/0000-0003-3825-4092; Maulik, Pallab Kumar/0000-0001-6835-6175	Wellcome Trust/Department of Biotechnology India Alliance Intermediate Career Fellowship [IA/I/13/1/500879]; Grand Challenges Canada [0524-01-10]	Wellcome Trust/Department of Biotechnology India Alliance Intermediate Career Fellowship; Grand Challenges Canada(CGIAR)	The funding for this project is from the Wellcome Trust/Department of Biotechnology India Alliance Intermediate Career Fellowship that PKM has received (IA/I/13/1/500879) and a Grand Challenges Canada Grant (No: 0524-01-10) on which PKM is the Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Gururaj G, 2005, BURDEN OF DISEASE IN; Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396; Joshi R, 2015, TROP MED INT HEALTH, V20, P188, DOI 10.1111/tmi.12416; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Kermode M, 2009, SOC PSYCH PSYCH EPID, V44, P1087, DOI 10.1007/s00127-009-0031-7; Kochhar PH, 2007, J POSTGRAD MED, V53, P102, DOI 10.4103/0022-3859.32209; Koschorke M, 2014, SOC SCI MED, V123, P149, DOI 10.1016/j.socscimed.2014.10.035; Math Suresh Bada, 2010, Indian J Psychiatry, V52, pS95, DOI 10.4103/0019-5545.69220; Maulik PK, 2015, GLOB MENT HEALTH, V2, DOI 10.1017/gmh.2015.11; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Pfizer Inc, 2013, INSTR PAT HLTH QUEST; Pfizer Inc, 2013, GENERALIZED ANXIETY; Pfizer Inc, 2013, PATIENT HEALTH QUEST; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Richards L, 2002, README FIRST FOR A U; Sheikh S, 2000, SOC PSYCH PSYCH EPID, V35, P326, DOI 10.1007/s001270050246; STATA Corp, 2013, STATA VERSION 13; Thornicroft G, 2008, EPIDEMIOL PSICHIAT S, V17, P14, DOI 10.1017/S1121189X00002621; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; World Health Organization, 2001, THE WORLD HEALTH REP; World Health Organization, 2011, WHO MENTAL HEALTH GA	24	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164404	10.1371/journal.pone.0164404	http://dx.doi.org/10.1371/journal.pone.0164404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CQ	27732652	Green Submitted, Green Published, gold			2022-12-27	WOS:000385505300052
J	Serrao, M; Rinaldi, M; Ranavolo, A; Lacquaniti, F; Martino, G; Leonardi, L; Conte, C; Varrecchia, T; Draicchio, F; Coppola, G; Casalil, C; Pierelli, F				Serrao, Mariano; Rinaldi, Martina; Ranavolo, Alberto; Lacquaniti, Francesco; Martino, Giovanni; Leonardi, Luca; Conte, Carmela; Varrecchia, Tiwana; Draicchio, Francesco; Coppola, Gianluca; Casalil, Carlo; Pierelli, Francesco			Gait Patterns in Patients with Hereditary Spastic Paraparesis	PLOS ONE			English	Article							QUALITY-OF-LIFE; MUSCLE COACTIVATION; ANTAGONIST MUSCLES; CEREBELLAR-ATAXIA; DISEASE SEVERITY; PARAPLEGIA; STROKE; DETERMINANTS; PERFORMANCE; DISORDERS	Background Spastic gait is a key feature in patients with hereditary spastic paraparesis, but the gait characterization and the relationship between the gait impairment and clinical characteristics have not been investigated. Objectives To describe the gait patterns in hereditary spastic paraparesis and to identify subgroups of patients according to specific kinematic features of walking. Methods We evaluated fifty patients by computerized gait analysis and compared them to healthy participants. We computed time-distance parameters of walking and the range of angular motion at hip, knee, and ankle joints, and at the trunk and pelvis. Lower limb joint moments and muscle co-activation values were also evaluated. Results We identified three distinct subgroups of patients based on the range of motion values. Subgroup one was characterized by reduced hip, knee, and ankle joint range of motion. These patients were the most severely affected from a clinical standpoint, had the highest spasticity, and walked at the slowest speed. Subgroup three was characterized by an increased hip joint range of motion, but knee and ankle joint range of motion values close to control values. These patients were the most mildly affected and had the highest walking speed. Finally, subgroup two showed reduced knee and ankle joint range of motion, and hip range of motion values close to control values. Disease severity and gait speed in subgroup two were between those of subgroups one and three. Conclusions We identified three distinctive gait patterns in patients with hereditary spastic paraparesis that correlated robustly with clinical data. Distinguishing specific features in the gait patterns of these patients may help tailor pharmacological and rehabilitative treatments and may help evaluate therapeutic effects over time.	[Serrao, Mariano; Leonardi, Luca; Casalil, Carlo; Pierelli, Francesco] Univ Rome Sapienza, Dept Medicosurg Sci & Biotechnol, Latina, Italy; [Serrao, Mariano] Policlin Italia, Rehabil Ctr, Rome, Italy; [Rinaldi, Martina; Varrecchia, Tiwana] Roma TRE Univ, Dept Engn, Rome, Italy; [Ranavolo, Alberto; Draicchio, Francesco] INAIL, Dept Occupat & Environm Med, Epidemiol & Hyg, Rome, Italy; [Lacquaniti, Francesco; Martino, Giovanni] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy; [Lacquaniti, Francesco; Martino, Giovanni] Santa Lucia Fdn, Ist Ric & Cura Carattere Sci, Lab Neuromotor Physiol, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Conte, Carmela] Fdn Don C Gnocchi, Milan, Italy; [Pierelli, Francesco] IRCCS, Neuromed, Pozzilli, Isernia, Italy; [Coppola, Gianluca] IRCCS, GB Bietti Fdn, Dept Neurophysiol Vis & Neurophthalmol, Rome, Italy	Sapienza University Rome; Roma Tre University; University of Rome Tor Vergata; IRCCS Santa Lucia; University of Rome Tor Vergata; IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Neuromed; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Serrao, M (corresponding author), Univ Rome Sapienza, Dept Medicosurg Sci & Biotechnol, Latina, Italy.; Serrao, M (corresponding author), Policlin Italia, Rehabil Ctr, Rome, Italy.	mariano.serrao@uniroma1.it	VARRECCHIA, TIWANA/AAC-7561-2022; Francesco, Draicchio/AAC-7681-2022; Serrao, Mariano/K-6972-2016; Ranavolo, Alberto/AAC-7576-2022; Coppola, Gianluca/K-6987-2016; Conte, Carmela/AAA-6758-2019; Martino, Giovanni/L-1581-2018; Leonardi, Luca/AAA-3276-2021	VARRECCHIA, TIWANA/0000-0003-3910-2728; Francesco, Draicchio/0000-0003-0677-2573; Serrao, Mariano/0000-0003-3031-680X; Ranavolo, Alberto/0000-0002-0197-6166; Coppola, Gianluca/0000-0002-8510-6925; Conte, Carmela/0000-0001-8911-0748; Martino, Giovanni/0000-0003-2202-257X; Leonardi, Luca/0000-0002-1267-864X				Adams RD, 2015, PRINCIPLES NEUROLOGY; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Bertolucci F, 2015, NEUROREHABILITATION, V36, P93, DOI 10.3233/NRE-141196; Borghese NA, 1996, J PHYSIOL-LONDON, V494, P863, DOI 10.1113/jphysiol.1996.sp021539; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; DeQuervain IAK, 1996, J BONE JOINT SURG AM, V78A, P1506; DeVita P, 1998, AM J SPORT MED, V26, P778, DOI 10.1177/03635465980260060701; Don R, 2007, CLIN BIOMECH, V22, P905, DOI 10.1016/j.clinbiomech.2007.06.002; Faber I, 2014, ARQ NEURO-PSIQUIAT, V72, P219, DOI 10.1590/0004-282X20130248; Falconer K, 1985, Electromyogr Clin Neurophysiol, V25, P135; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; France CR, 2009, PAIN, V145, P211, DOI 10.1016/j.pain.2009.06.022; Goizet C, 2009, BRAIN, V132, P1589, DOI 10.1093/brain/awp073; Heetla HW, 2015, ARCH PHYS MED REHAB, V96, P1166, DOI 10.1016/j.apmr.2015.01.012; Henson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036505; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Klebe S, 2004, J NEUROL, V251, P571, DOI 10.1007/s00415-004-0366-7; Klimpe S, 2012, EUR J NEUROL, V19, P168, DOI 10.1111/j.1468-1331.2011.03443.x; Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011; Mao YR, 2015, TECHNOL HEALTH CARE, V23, pS355, DOI 10.3233/THC-150972; Mari S, 2014, CEREBELLUM, V13, P226, DOI 10.1007/s12311-013-0533-4; Marsden J, 2012, GAIT POSTURE, V35, P266, DOI 10.1016/j.gaitpost.2011.09.018; Martino G, 2014, J NEUROPHYSIOL, V112, P2810, DOI 10.1152/jn.00275.2014; Martinuzzi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153283; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; Meunier S, 2000, BRAIN, V123, P1017, DOI 10.1093/brain/123.5.1017; Meyer ACL, 2013, NEUROEPIDEMIOLOGY, V41, P208, DOI 10.1159/000354629; Orsucci D, 2014, CLIN NEUROL NEUROSUR, V120, P14, DOI 10.1016/j.clineuro.2014.02.002; Piccinini L, 2011, EUR J PAEDIATR NEURO, V15, P138, DOI 10.1016/j.ejpn.2010.07.009; Rainoldi A., 2012, ATLAS MUSCLE INNERVA, DOI DOI 10.1007/978-88-470-2463-2; Ranavolo A, 2015, ERGONOMICS, V58, P966, DOI 10.1080/00140139.2014.991764; Roche N, 2014, GAIT POSTURE, V39, P235, DOI 10.1016/j.gaitpost.2013.07.110; Rowland LP, 2011, NEUROLOGIA MERRITT; Schule R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90; Schule R, 2016, ANN NEUROL, V79, P646, DOI 10.1002/ana.24611; SIMMONS RW, 1988, BRAIN RES, V473, P134, DOI 10.1016/0006-8993(88)90324-1; Solowska JM, 2015, BRAIN, V138, P2471, DOI 10.1093/brain/awv178; van der Waal JM, 2005, QUAL LIFE RES, V14, P1141, DOI 10.1007/s11136-004-4599-9; Vasudevan EVL, 2011, J NEUROSCI, V31, P3055, DOI 10.1523/JNEUROSCI.5781-10.2011; Vaughan C.L., 1992, DYNAMICS HUMAN GAIT; Wasser K, 2011, J VASC SURG, V53, P61, DOI 10.1016/j.jvs.2010.07.061; Wedding IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086340; Weinstein G, 2013, STROKE, V44, P2787, DOI 10.1161/STROKEAHA.113.000947; Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125; Winter DA, 1979, BIOMECHANICS HUMAN M; Zhang YX, 2014, GAIT POSTURE, V39, P1074, DOI 10.1016/j.gaitpost.2014.01.010	46	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2016	11	10							e0164623	10.1371/journal.pone.0164623	http://dx.doi.org/10.1371/journal.pone.0164623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0CQ	27732632	Green Submitted, gold, Green Published			2022-12-27	WOS:000385505300069
J	Chen, WJ; Howe, PDL				Chen, Weijia; Howe, Piers D. L.			Comparing Breast Screening Protocols: Inserting Catch Trials Does Not Improve Sensitivity over Double Screening	PLOS ONE			English	Article							LOW TARGET PREVALENCE; VISUAL SEARCHES; RARE TARGETS; CORRECTABLE SEARCH	Breast screening is an important tool for the early detection of breast cancers. However, tumours are typically present in less than 1% of mammograms. This low prevalence could cause radiologists to detect fewer tumours than they otherwise would, an issue known as the prevalence effect. The aim of our study was to investigate a novel breast screening protocol, designed to decrease the number of tumours missed by radiologists, without increasing their workload. We ran two laboratory-based experiments to assess the degree to which the novel protocol, called the catch trial (CT) protocol, resulted in greater sensitivity (d') than the double screener protocol (DS), currently utilised in Australia. In our first experiment we found evidence that the CT protocol resulted in a criterion shift relative to the DS protocol but the evidence that sensitivity was greater in the CT protocol relative to the DS protocol was less clear. A second experiment, using more realistic stimuli that were more representative of actual tumours, also failed to find convincing evidence that sensitivity was greater in the CT protocol than in the DS protocol. This experiment instead found that both the hit rate and the false alarm rate increased in the CT protocol relative to the DS protocol. So while there was again evidence that the CT protocol induced a criterion shift, the sensitivity appeared to be approximately the same in both protocols. Our results suggest the CT protocol is unlikely to result in an improvement in sensitivity over the DS protocol, so we cannot recommend that it be trialled in a clinical setting.	[Chen, Weijia; Howe, Piers D. L.] Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia	University of Melbourne	Chen, WJ (corresponding author), Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia.	weijiac@student.unimelb.edu.au						Bech AG, 2012, BREAST CANC AUSTR OV; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chun MM, 1996, COGNITIVE PSYCHOL, V30, P39, DOI 10.1006/cogp.1996.0002; Efron B, 1998, INTRO BOOTSTRAP; Evans KK, 2011, ARCH PATHOL LAB MED, V135, P1557, DOI 10.5858/arpa.2010-0739-OA; Evans KK, 2013, YOU DONT FIND IT OFT, DOI [10.1371/journal.pone.0064366, DOI 10.1371/JOURNAL.PONE.0064366]; Fleck MS, 2007, PSYCHOL SCI, V18, P943, DOI 10.1111/j.1467-9280.2007.02006.x; Fleck MS, 2010, J EXP PSYCHOL-APPL, V16, P60, DOI 10.1037/a0018629; Godwin HJ, 2015, PSYCHON B REV, V22, P469, DOI 10.3758/s13423-014-0686-2; Godwin HJ, 2010, VIS COGN, V18, P1439, DOI 10.1080/13506285.2010.500605; Godwin HJ, 2010, ACTA PSYCHOL, V134, P79, DOI 10.1016/j.actpsy.2009.12.009; Green DM, 1966, SIGNAL DETECTION THE; Ishibashi K, 2014, I-PERCEPTION, V5, P170, DOI 10.1068/i0649rep; Kunar MA, 2010, VIS COGN, V18, P881, DOI 10.1080/13506280903361988; Macmillan N. A., 2004, DETECTION THEORY USE; Menneer T, 2010, J EXP PSYCHOL-APPL, V16, P133, DOI 10.1037/a0019569; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rich AN, 2006, ANN M VIS SCI SOC SA; Rich AN, 2008, J VISION, V8, DOI 10.1167/8.15.15; Van Wert MJ, 2009, ATTEN PERCEPT PSYCHO, V71, P541, DOI 10.3758/APP.71.3.541; Wolfe JM, 2007, J EXP PSYCHOL GEN, V136, P623, DOI 10.1037/0096-3445.136.4.623; Wolfe JM, 2013, J VISION, V13, DOI 10.1167/13.3.10; Wolfe JM, 2010, CURR BIOL, V20, P121, DOI 10.1016/j.cub.2009.11.066; Wolfe JM, 2005, NATURE, V435, P439, DOI 10.1038/435439a; Zhang J, 2005, PSYCHOMETRIKA, V70, P203, DOI 10.1007/s11336-003-1119-8	25	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0163928	10.1371/journal.pone.0163928	http://dx.doi.org/10.1371/journal.pone.0163928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723788	gold, Green Published			2022-12-27	WOS:000385504100013
J	Minas, AG; Ganga-Limando, M				Minas, Anteneh Girma; Ganga-Limando, Makombo			Social-Cognitive Predictors of Exclusive Breastfeeding among Primiparous Mothers in Addis Ababa, Ethiopia	PLOS ONE			English	Article							SELF-EFFICACY INTERVENTION; DURATION	Background Despite the presence of high impact interventions to improve infant and young child feeding, only about 52% of mothers in Ethiopia exclusively breastfeed their child for the first six months after delivery. Although the decision to breastfeed a child is ultimately that of the mother, this decision could be influenced by a variety of factors including social-cognitive ones. Objectives The objectives of the study were to describe the breastfeeding behaviour of primiparous mothers during their prenatal period in terms of intentions/goals, outcome expectancies, self-efficacy, and socio-structural factors and assess their exclusive breastfeeding (EBF) practices as well as identify the social-cognitive predictors of EBF practices among these mothers in Addis Ababa, Ethiopia. Methods A prospective follow up health facility-based study with quantitative methods was used with a sample of 233 primiparous women. Both structured and semi-structured questions were used for collection of data. The Statistical Package for Social Sciences (SPSS) version 21 was used for data analysis. Findings at the 95% confidence interval and P-value of 5% were reported as statistically significant. Results 39.1% (n = 59) of the respondents were found to have high breastfeeding self-efficacy, 51.4% (n = 71) have good breastfeeding outcome expectancies, and 6.5% (n = 9) respondents had supportive breastfeeding socio-structural factors. Bivariate correlation analysis showed positive and statistically significant correlation between each of breastfeeding self-efficacy, outcome expectancy, and socio-structural factors, with EBF practice. However, only breastfeeding self-efficacy and outcome expectancies were statistically significant predictors of EBF among the primiparous women when controlling for confounding variables. Conclusions and Recommendations Health programmes aimed at improving EBF among primiparous mothers should look beyond providing health information alone. Rather improving primiparous women's breastfeeding self-efficacy and outcome expectancy is strongly recommended. Further community based large scale research is also recommended among similar groups of women.	[Minas, Anteneh Girma] Univ South Africa, Addis Ababa, Ethiopia; [Ganga-Limando, Makombo] Univ South Africa, Coll Human Sci, Dept Hlth Studies, Pretoria, South Africa	University of South Africa	Minas, AG (corresponding author), Univ South Africa, Addis Ababa, Ethiopia.	agirma2005@gmail.com	Minas, Anteneh Girma/H-4223-2019; Ganga-Limando, Makombo/AAB-7743-2020	Ganga-Limando, Makombo/0000-0003-3392-8406	UNISA; University of South Africa (UNISA)	UNISA; University of South Africa (UNISA)	This work was financially supported by the University of South Africa (UNISA) to AGM. The funders has no role in study design, data collection and analysis, decision to publish, or perparation of the manuscript.; We want to extend our appreciation and deepest acknowledgments to all who directly and indirectly contributed for this study, including Prof Thandisizwe R. Mavundla, Rebecca Egan, the Ethics Review Committees at UNISA, and AACAHB; the study hospital, all the study participants, and the data collectors. Finally, we want to extend our appreciation for UNISA for financially supporting the study.	Adhikari M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0021-6; Agu U, 2011, TROPICAL J MED RES, V15; Al-Akour NA, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-6; Aluko-Arowolo SO, 2012, GENDER BEHAV, V10, P4657; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bandura A., 2000, HDB PRINCIPLES ORG B, P120, DOI DOI 10.1002/9781119206422.CH10; CSA [Ethiopia] and ICF, 2012, 2011 ETH DEM HLTH SU; Dreesmann F., 2014, BREASTFEEDING KNOWLE; Glassman ME, 2014, BREASTFEED MED, V9, P301, DOI 10.1089/bfm.2014.0015; Ishak S, 2014, BREASTFEED MED, V9, P308, DOI 10.1089/bfm.2013.0124; Lewallen LP, 2006, JOGNN-J OBST GYN NEO, V35, P166, DOI 10.1111/J.1552-6909.2006.00031.x; Lewallen LP, 2006, J PERINAT EDUC, V15, P26, DOI 10.1624/105812406X92967; McAlister AL, 2008, HLTH BEHAV HLTH ED T, P169; McLnnes R J, 2001, BMC Public Health, V1, P10, DOI 10.1186/1471-2458-1-10; McQueen KA, 2011, JOGNN-J OBST GYN NEO, V40, P35, DOI 10.1111/j.1552-6909.2010.01210.x; Minas AG, 2016, AFRICA J NU IN PRESS, V18; O'Brien M, 2008, J ADV NURS, V63, P397, DOI 10.1111/j.1365-2648.2008.04722.x; Riordan J., 2005, BREASTFEEDING HUMAN; Semenic S, 2008, RES NURS HEALTH, V31, P428, DOI 10.1002/nur.20275; Tokat MA, 2010, MIDWIFERY, V26, P101, DOI 10.1016/j.midw.2008.04.002; UNICEF, 2012, PROGR GUID INF YOUNG; Wambach KA, 1997, RES NURS HEALTH, V20, P51, DOI 10.1002/(SICI)1098-240X(199702)20:1<51::AID-NUR6>3.0.CO;2-T; WHO, 2013, PROM PROP FEED INF Y; Wu DS, 2014, J ADV NURS, V70, P1867, DOI 10.1111/jan.12349	24	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2016	11	10							e0164128	10.1371/journal.pone.0164128	http://dx.doi.org/10.1371/journal.pone.0164128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0CF	27723797	Green Submitted, Green Published, gold			2022-12-27	WOS:000385504100023
J	Chong, J; Caya, C; Levesque, S; Quach, C				Chong, Jasmine; Caya, Chelsea; Levesque, Simon; Quach, Caroline			Heteroresistant Vancomycin Intermediate Coagulase Negative Staphylococcus in the NICU: A Systematic Review	PLOS ONE			English	Review							INTENSIVE-CARE-UNIT; RESISTANT; EPIDERMIDIS; INFECTIONS; CAPITIS; SUSCEPTIBILITY; DISSEMINATION; STRAINS; SEPSIS; AUREUS	Context NICUs in the province of Que A bec have seen an increase in hVICoNS, detected in the clinical laboratory. Objective To investigate the clinical relevance of hVICoNS on the course of infection, and to determine the prevalence of hVICoNS sepsis in the NICU. Methods We searched MEDLINE, EMBASE, and PubMed from 1 January 1980 to 1 July 2016. Both observational and interventional studies were considered eligible if they provided data on hVICoNS in the NICU population. Two investigators independently reviewed studies for data extraction. Data extracted included: number of CoNS cultures, prevalence of hVICoNS, and clonality of strains. Results Of the 613 studies identified, 19 studies were reviewed, and 5 studies included in the final review. No studies addressed the clinical significance of hVICoNS in the NICU. The prevalence of hVICoNS in the NICU varied greatly, ranging from 2.3% to 100%. Limitations Publication bias could not be assessed, and risk of bias in some of the included studies due to small sample size and poor methods reporting. The quality of all included studies was low according to GRADE criteria, and the inclusion criteria restricted to either English or French studies. Conclusions Our review suggests that heteroresistance to vancomycin is much more common than previously believed. Our search however did not identify any studies that explicitly assessed any clinical implications of hVICoNS infections, thereby highlighting the need for research to assess the true impact of hVICoNS infection and to determine its significance on patient mortality and morbidity in the NICU.	[Chong, Jasmine; Caya, Chelsea; Quach, Caroline] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Levesque, Simon] Lab Sante Publ Quebec, Montreal, PQ, Canada; [Quach, Caroline] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pediat,Infect Dis Div, Montreal, PQ, Canada; [Quach, Caroline] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Med Microbiol, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Quach, C (corresponding author), McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.; Quach, C (corresponding author), McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pediat,Infect Dis Div, Montreal, PQ, Canada.; Quach, C (corresponding author), McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Med Microbiol, Montreal, PQ, Canada.	caroline.quach@mcgill.ca	Quach, Caroline/AAT-6987-2021; Chong, Jasmine/HCI-9390-2022	Quach, Caroline/0000-0002-1170-9475; Levesque, Simon/0000-0002-4356-9702				Brodie SB, 2000, PEDIATR INFECT DIS J, V19, P56, DOI 10.1097/00006454-200001000-00012; Butin M, 2016, CLIN MICROBIOL INFEC, V22, P46, DOI 10.1016/j.cmi.2015.09.008; Casapao AM, 2013, ANTIMICROB AGENTS CH, V57, P4252, DOI 10.1128/AAC.00380-13; Chong J, 2016, ANTIMICROB AGENTS CH, V60, P5673, DOI 10.1128/AAC.00726-16; D'mello D, 2008, J CLIN MICROBIOL, V46, P3124, DOI 10.1128/JCM.00592-08; Duah M, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-9; Garrett DO, 1999, INFECT CONT HOSP EP, V20, P167, DOI 10.1086/501605; Gaynes RP, 1996, PEDIATRICS, V98, P357; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Jean-Baptiste N, 2011, INFECT CONT HOSP EP, V32, P679, DOI 10.1086/660361; Jones RN, 2006, CLIN INFECT DIS, V42, pS13, DOI 10.1086/491710; Kredriet TG, 2001, J CLIN MICROBIOL, V39, P3376, DOI 10.1128/JCM.39.9.3376-3378.2001; Liljedahl M, 2004, ACTA PAEDIATR, V93, P211, DOI 10.1080/08035250310008168; Mittendorf R, 1999, LANCET, V354, P1875, DOI 10.1016/S0140-6736(99)01111-3; Rasigade JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031548; Schulman J, 2011, PEDIATRICS, V127, P436, DOI 10.1542/peds.2010-2873; Sieradzki K, 1998, ANTIMICROB AGENTS CH, V42, P100, DOI 10.1128/AAC.42.1.100; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Van Der Zwet WC, 2002, J CLIN MICROBIOL, V40, P2520, DOI 10.1128/JCM.40.7.2520-2525.2002; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; Venkatesh Mohan P, 2006, Semin Pediatr Infect Dis, V17, P120, DOI 10.1053/j.spid.2006.06.005; Villari P, 2000, J CLIN MICROBIOL, V38, P1740, DOI 10.1128/JCM.38.5.1740-1746.2000; Walsh TR, 2001, J CLIN MICROBIOL, V39, P2439, DOI 10.1128/JCM.39.7.2439-2444.2001; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399; Zubair M, 2011, PAK J MED HEALTH SCI, V5, P716	26	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164136	10.1371/journal.pone.0164136	http://dx.doi.org/10.1371/journal.pone.0164136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716838	Green Submitted, gold, Green Published			2022-12-27	WOS:000385698100025
